PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Das, SN; Wagenknecht, M; Nareddy, PK; Bhuvanachandra, B; Niddana, R; Balamurugan, R; Swamy, MJ; Moerschbacher, BM; Podile, AR				Das, Subha Narayan; Wagenknecht, Martin; Nareddy, Pavan Kumar; Bhuvanachandra, Bhoopal; Niddana, Ramana; Balamurugan, Rengarajan; Swamy, Musti J.; Moerschbacher, Bruno M.; Podile, Appa Rao			Amino Groups of Chitosan Are Crucial for Binding to a Family 32 Carbohydrate Binding Module of a Chitosanase from Paenibacillus elgii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; CELL-WALLS; POLYSACCHARIDE RECOGNITION; GALACTOSE RECOGNITION; CHITIN DEACETYLASE; CELLULOMONAS-FIMI; IN-VITRO; IDENTIFICATION; OLIGOSACCHARIDES; SPECIFICITY	We report here the role and mechanism of specificity of a family 32 carbohydrate binding module (CBM32) of a glycoside hydrolase family 8 chitosanase from Paenibacillus elgii (PeCsn). Both the activity and mode of action of PeCsn toward soluble chitosan polymers were not different with/without the CBM32 domain of P. elgii (PeCBM32). The decreased activity of PeCsn without PeCBM32 on chitosan powder suggested that PeCBM32 increases the relative concentration of enzyme on the substrate and thereby enhanced enzymatic activity. PeCBM32 specifically bound to polymeric and oligomeric chitosan and showed very weak binding to chitin and cellulose. In isothermal titration calorimetry, the binding stoichiometry of 2 and 1 for glucosamine monosaccharide (GIcN) and disaccharide (GIcN)2, respectively, was indicative of two binding sites in PeCBM32. A three-dimensional model guided site-directed mutagenesis and the use of defined disaccharides varying in the pattern of acetylation suggested that the amino groups of chitosan and the polar residues Glu-16 and Glu-38 of PeCBM32 play a crucial role for the observed binding. The specificity of CBM32 has been further elucidated by a generated fusion protein PeCBM32-eGFP that binds to the chitosan exposing endophytic infection structures of Puccinia graminis f. sp. tritici. Phylogenetic analysis showed that CBM32s appended to chitosanases are highly conserved across different chitosanase families suggesting their role in chitosan recognition and degradation. We have identified and characterized a chitosan-specific CBM32 useful for in situ staining of chitosans in the fungal cell wall during plant-fungus interaction.	[Das, Subha Narayan; Bhuvanachandra, Bhoopal; Podile, Appa Rao] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India; [Nareddy, Pavan Kumar] Univ Hyderabad, Dept Biochem, Hyderabad 500046, Andhra Pradesh, India; [Niddana, Ramana; Balamurugan, Rengarajan; Swamy, Musti J.] Univ Hyderabad, Sch Chem, Hyderabad 500046, Andhra Pradesh, India; [Wagenknecht, Martin; Moerschbacher, Bruno M.] Univ Munster, Inst Plant Biol & Biotechnol, D-48143 Munster, Germany	University of Hyderabad; University of Hyderabad; University of Hyderabad; University of Munster	Podile, AR (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India.	podilerao@gmail.com	Balamurugan, Rengarajan/X-9584-2018; Swamy, Musti/B-9418-2009; Moerschbacher, Bruno M/C-2012-2017; Podile, Appa Rao/W-5077-2018	Balamurugan, Rengarajan/0000-0002-8373-5736; Swamy, Musti/0000-0002-3108-3633; Bhuvanachandra, Bhoopal/0000-0002-2129-009X; Podile, Appa Rao/0000-0003-3208-765X	Department of Science and Technology, Government of India; University Grants Commission	Department of Science and Technology, Government of India(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India)	We thank the Department of Science and Technology, Government of India, for Funds for Infrastructure in Science and Technology and Level II support to the Department of Plant Sciences and School of Chemistry, University of Hyderabad. We also thank University Grants Commission-supported University with Potential for Excellence (Phase to the University of Hyderabad for the infrastructural support. We thank Dr. Nour Eddine El Gueddari and Stefan Cord-Landwehr for the suggestions during revision of the manuscript.	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; Adachi W, 2004, J MOL BIOL, V343, P785, DOI 10.1016/j.jmb.2004.08.028; Baker LG, 2007, EUKARYOT CELL, V6, P855, DOI 10.1128/EC.00399-06; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2003, J BIOL CHEM, V278, P6120, DOI 10.1074/jbc.M209554200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cuskin F, 2012, P NATL ACAD SCI USA, V109, P20889, DOI 10.1073/pnas.1212034109; Das SN, 2010, J PLANT GROWTH REGUL, V29, P409, DOI 10.1007/s00344-010-9152-1; Das SN, 2010, WORLD J MICROB BIOT, V26, P1875, DOI 10.1007/s11274-010-0369-8; DIN N, 1991, BIO-TECHNOL, V9, P1096, DOI 10.1038/nbt1191-1096; Ding R, 2011, J BACTERIOL, V193, P4537, DOI 10.1128/JB.00406-11; El Gueddari NE, 2002, NEW PHYTOL, V156, P103, DOI 10.1046/j.1469-8137.2002.00487.x; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Ficko-Blean E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033524; Ficko-Blean E, 2009, J MOL BIOL, V390, P208, DOI 10.1016/j.jmb.2009.04.066; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; GRENIER J, 1991, J GEN MICROBIOL, V137, P2007, DOI 10.1099/00221287-137-8-2007; Grondin JM, 2014, J MOL BIOL, V426, P869, DOI 10.1016/j.jmb.2013.11.029; Gupta V, 2010, APPL ENVIRON MICROB, V76, P2769, DOI 10.1128/AEM.02673-09; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Kormos J, 2000, BIOCHEMISTRY-US, V39, P8844, DOI 10.1021/bi000607s; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; McLean BW, 2000, PROTEIN ENG, V13, P801, DOI 10.1093/protein/13.11.801; Mizutani K, 2014, FEBS LETT, V588, P1726, DOI 10.1016/j.febslet.2014.03.022; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nampally M, 2012, APPL ENVIRON MICROB, V78, P3114, DOI 10.1128/AEM.07506-11; Narahari A, 2011, J PHYS CHEM B, V115, P4110, DOI 10.1021/jp110468n; Newstead SL, 2005, ACTA CRYSTALLOGR D, V61, P1483, DOI 10.1107/S0907444905026132; Notenboom V, 2001, J MOL BIOL, V314, P797, DOI 10.1006/jmbi.2001.5153; Peberdy J., 1990, BIOCH CELL WALLS MEM, P5, DOI [10.1007/978-3-642-74215-6_2, DOI 10.1007/978-3-642-74215-6_2]; Pell G, 2003, BIOCHEMISTRY-US, V42, P9316, DOI 10.1021/bi0347510; Privalov PL, 2011, NUCLEIC ACIDS RES, V39, P2483, DOI 10.1093/nar/gkq984; Purushotham P, 2012, J BACTERIOL, V194, P4260, DOI 10.1128/JB.06473-11; Reyes-Ortiz V, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-93; Rinaudo M, 2006, PROG POLYM SCI, V31, P603, DOI 10.1016/j.progpolymsci.2006.06.001; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200; Schatz C, 2003, BIOMACROMOLECULES, V4, P641, DOI 10.1021/bm025724c; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Schubert M, 2010, J MICROBIOL BIOTECHN, V20, P1179, DOI 10.4014/jmb.1001.02023; Shinya S, 2013, J BIOL CHEM, V288, P30042, DOI 10.1074/jbc.M113.503243; Sorlier P, 2003, J BIOMED MATER RES A, V67A, P766, DOI 10.1002/jbm.a.10132; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tokuyasu K, 1999, CARBOHYD RES, V322, P26, DOI 10.1016/S0008-6215(99)00213-X; Tokuyasu K, 1997, CARBOHYD RES, V303, P353, DOI 10.1016/S0008-6215(97)00166-3; Vachoud L, 1997, CARBOHYD RES, V302, P169, DOI 10.1016/S0008-6215(97)00126-2; Zheng CL, 2013, J BIOL CHEM, V288, P20499, DOI 10.1074/jbc.M113.461434	54	13	13	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18977	18990		10.1074/jbc.M116.721332	http://dx.doi.org/10.1074/jbc.M116.721332			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27405759	hybrid, Green Published			2022-12-26	WOS:000383242300033
J	Prasad, JM; Young, PA; Strickland, DK				Prasad, Joni M.; Young, Patricia A.; Strickland, Dudley K.			High Affinity Binding of the Receptor-associated Protein D1D2 Domains with the Low Density Lipoprotein Receptor-related Protein (LRP1) Involves Bivalent Complex Formation CRITICAL ROLES OF LYSINES 60 AND 191	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chaperone; low density lipoprotein (LDL); mutagenesis; receptor endocytosis; surface plasmon resonance (SPR); LRP1; RAP; ligand	CRITICAL LYSINE RESIDUES; TRANSFER-RNA SYNTHETASE; ALPHA-2-MACROGLOBULIN RECEPTOR; LIGAND-BINDING; MOLECULAR CHAPERONE; ENDOCYTIC RECEPTORS; TERMINAL DOMAIN; ER RETENTION; RAP COMPLEX; RECOGNITION	The LDL receptor-related protein 1 (LRP1) is a large endocytic receptor that binds and mediates the endocytosis of numerous structurally diverse ligands. Currently, the basis for ligand recognition by LRP1 is not well understood. LRP1 requires a molecular chaperone, termed the receptor-associated protein (RAP), to escort the newly synthesized receptor from the endoplasmic reticulum to the Golgi. RAP is a three-domain protein that contains the following two high affinity binding sites for LRP1: one is located within domains 1 and 2, and one is located in its third domain. Studies on the interaction of the RAP third domain with LRP1 reveal critical contributions by lysine 256 and lysine 270 for this interaction. From these studies, a model for ligand recognition by this class of receptors has been proposed. Here, we employed surface plasmon resonance to investigate the binding of RAP D1D2 to LRP1. Our results reveal that the high affinity of D1D2 for LRP1 results from avidity effects mediated by the simultaneous interactions of lysine 60 in D1 and lysine 191 in D2 with sites on LRP1 to form a bivalent D1D2-LRP1 complex. When lysine 60 and 191 are both mutated to alanine, the binding of D1D2 to LRP1 is ablated. Our data also reveal that D1D2 is able to bind to a second distinct site on LRP1 to form a monovalent complex. The studies confirm the canonical model for ligand recognition by this class of receptors, which is initiated by pairs of lysine residues that dock into acidic pockets on the receptor.	Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Strickland, DK (corresponding author), Ctr Vasc Inflammatory Dis, Biopark 1,R219,800 W Baltimore St, Baltimore, MD 21201 USA.	dstrickland@som.umaryland.edu		Prasad, Joni/0000-0001-5224-6502	National Institutes of Health [HL114379, HL120388, T32 HL007698]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL114379, R01HL120388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants HL114379 and HL120388 (to D. K. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant T32 HL007698.	Andersen OM, 2001, BIOCHEMISTRY-US, V40, P15408, DOI 10.1021/bi0110692; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; Bloem E, 2015, BIOCHEM J, V468, P65, DOI 10.1042/BJ20140977; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000448; Boucher P, 2011, BIOCHEM PHARMACOL, V81, P1, DOI 10.1016/j.bcp.2010.09.018; Bu GJ, 1997, J CELL SCI, V110, P65; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Dagil R, 2013, J BIOL CHEM, V288, P4424, DOI 10.1074/jbc.M112.434159; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Guttman M, 2010, J MOL BIOL, V398, P306, DOI 10.1016/j.jmb.2010.03.022; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; HERZ J, 1993, CELL, V73, P428, DOI 10.1016/0092-8674(93)90130-I; HERZ J, 1991, J BIOL CHEM, V266, P21232; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; KRAUSS G, 1976, EUR J BIOCHEM, V68, P81, DOI 10.1111/j.1432-1033.1976.tb10766.x; Lee CJ, 2010, STRUCTURE, V18, P366, DOI 10.1016/j.str.2009.12.013; Lee D, 2007, PROTEIN SCI, V16, P1628, DOI 10.1110/ps.072865407; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Mantuano E, 2016, P NATL ACAD SCI USA, V113, P1369, DOI 10.1073/pnas.1515480113; May P, 2005, CELL MOL LIFE SCI, V62, P2325, DOI 10.1007/s00018-005-5231-z; Medved LV, 1999, J BIOL CHEM, V274, P717, DOI 10.1074/jbc.274.2.717; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; Muratoglu SC, 2013, ARTERIOSCL THROM VAS, V33, P2137, DOI 10.1161/ATVBAHA.113.301893; Nakajima C, 2014, DEVELOPMENT, V141, P4513, DOI 10.1242/dev.109124; Nielsen KL, 1996, J BIOL CHEM, V271, P12909, DOI 10.1074/jbc.271.22.12909; Nielsen PR, 1997, P NATL ACAD SCI USA, V94, P7521, DOI 10.1073/pnas.94.14.7521; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; RIESNER D, 1976, EUR J BIOCHEM, V68, P71, DOI 10.1111/j.1432-1033.1976.tb10765.x; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; van den Biggelaar M, 2015, J BIOL CHEM, V290, P16463, DOI 10.1074/jbc.M115.650911; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; Xiao T, 2000, PROTEIN SCI, V9, P1889, DOI 10.1110/ps.9.10.1889; Yamamoto K, 2014, J BIOL CHEM, V289, P6462, DOI 10.1074/jbc.M113.545376; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Yasui N, 2007, P NATL ACAD SCI USA, V104, P9988, DOI 10.1073/pnas.0700438104	52	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18430	18439		10.1074/jbc.M116.744904	http://dx.doi.org/10.1074/jbc.M116.744904			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402839	Green Published, hybrid			2022-12-26	WOS:000383241800033
J	Lv, XY; Sun, W; Yin, JF; Ni, R; Su, R; Wang, QZ; Gao, W; Bao, JJ; Yu, JR; Wang, LH; Chen, L				Lv, Xiaoyang; Sun, Wei; Yin, Jinfeng; Ni, Rong; Su, Rui; Wang, Qingzeng; Gao, Wen; Bao, Jianjun; Yu, Jiarui; Wang, Lihong; Chen, Ling			An Integrated Analysis of MicroRNA and mRNA Expression Profiles to Identify RNA Expression Signatures in Lambskin Hair Follicles in Hu Sheep	PLOS ONE			English	Article							GROWTH; IDENTIFICATION; CELLS; MORPHOGENESIS; ACTIVATION; MECHANISM; PROTEIN; GENE; SKIN	Wave patterns in lambskin hair follicles are an important factor determining the quality of sheep's wool. Hair follicles in lambskin from Hu sheep, a breed unique to China, have 3 types of waves, designated as large, medium, and small. The quality of wool from small wave follicles is excellent, while the quality of large waves is considered poor. Because no molecular and biological studies on hair follicles of these sheep have been conducted to date, the molecular mechanisms underlying the formation of different wave patterns is currently unknown. The aim of this article was to screen the candidate microRNAs (miRNA) and genes for the development of hair follicles in Hu sheep. Two-day-old Hu lambs were selected from full-sib individuals that showed large, medium, and small waves. Integrated analysis of microRNA and mRNA expression profiles employed high-throughout sequencing technology. Approximately 13, 24, and 18 differentially expressed miRNAs were found between small and large waves, small and medium waves, and medium and large waves, respectively. A total of 54, 190, and 81 differentially expressed genes were found between small and large waves, small and medium waves, and medium and large waves, respectively, by RNA sequencing (RNA-seq) analysis. Differentially expressed genes were classified using gene ontology and pathway analyses. They were found to be mainly involved in cell differentiation, proliferation, apoptosis, growth, immune response, and ion transport, and were associated with MAPK and the Notch signaling pathway. Reverse transcriptionpolymerase chain reaction (RT-PCR) analyses of differentially-expressed miRNA and genes were consistent with sequencing results. Integrated analysis of miRNA and mRNA expression indicated that, compared to small waves, large waves included 4 downregulated miRNAs that had regulatory effects on 8 upregulated genes and 3 upregulated miRNAs, which in turn influenced 13 downregulated genes. Compared to small waves, medium waves included 13 downregulated miRNAs that had regulatory effects on 64 upregulated genes and 4 upregulated miRNAs, which in turn had regulatory effects on 22 downregulated genes. Compared to medium waves, large waves consisted of 13 upregulated miRNAs that had regulatory effects on 48 downregulated genes. These differentially expressed miRNAs and genes may play a significant role in forming different patterns, and provide evidence for the molecular mechanisms underlying the formation of hair follicles of varying patterns.	[Lv, Xiaoyang; Sun, Wei; Yin, Jinfeng; Ni, Rong; Su, Rui; Wang, Qingzeng; Gao, Wen; Bao, Jianjun; Yu, Jiarui; Wang, Lihong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China; [Chen, Ling] Anim Sci & Vet Med Bur Suzhou City, Suzhou, Peoples R China	Yangzhou University	Sun, W (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	dkxmsunwei@163.com			Ministry of Science and Technology of China, Jiangsu Agricultural Science and the Technology support program of China [BE2012331]; graduate education innovation project of Jiangsu province of China [KYLX15_1375]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Project of Jiangsu Province Engineering Research Center of China [BM2012308]; key project of Jiangsu Province of the national Spark Program of China [2012GA690003]; Subei Science and Technology program of Jiangsu Province of China [BN2014003, BN2015013, BN2015014]; Project of Jiangsu Province Agricultural Science and Technology Innovation Fund [CX(14)2073]; Project of Six Peak of Talents of Jiangsu Province of China	Ministry of Science and Technology of China, Jiangsu Agricultural Science and the Technology support program of China; graduate education innovation project of Jiangsu province of China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Project of Jiangsu Province Engineering Research Center of China; key project of Jiangsu Province of the national Spark Program of China; Subei Science and Technology program of Jiangsu Province of China; Project of Jiangsu Province Agricultural Science and Technology Innovation Fund; Project of Six Peak of Talents of Jiangsu Province of China	This work was supported by the projects of the domesticated animals platform of the Ministry of Science and Technology of China, Jiangsu Agricultural Science and the Technology support program of China (BE2012331), the graduate education innovation project of Jiangsu province of China (KYLX15_1375), the project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Project of Jiangsu Province Engineering Research Center of China (BM2012308), the key project of Jiangsu Province of the national Spark Program of China (2012GA690003), the Subei Science and Technology program of Jiangsu Province of China (BN2014003, BN2015013, BN2015014), the Project of Jiangsu Province Agricultural Science and Technology Innovation Fund (CX(14)2073), and the Project of Six Peak of Talents of Jiangsu Province of China.; This work was supported by the projects of the domesticated animals platform of the Ministry of Science and Technology of China, Jiangsu Agricultural Science and the Technology support program of China (BE2012331), the graduate education innovation project of Jiangsu province of China (KYLX15_1375), the project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions, the Project of Jiangsu Province Engineering Research Center of China (BM2012308), the key project of Jiangsu Province of the national Spark Program of China (2012GA690003), the Subei Science and Technology program of Jiangsu Province of China (BN2014003, BN2015013, BN2015014), the Project of Jiangsu Province Agricultural Science and Technology Innovation Fund (CX(14)2073), and the Project of Six Peak of Talents of Jiangsu Province of China.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Assa-Kunik E, 2007, DEVELOPMENT, V134, P1161, DOI 10.1242/dev.02800; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Boras K, 2002, J BIOL CHEM, V277, P1120, DOI 10.1074/jbc.M109912200; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cha HJ, 2010, INT J DEV BIOL, V54, P135, DOI 10.1387/ijdb.082735hc; Cheng R. H., 1980, J EC ANIMAL, P40; Cheung HH, 2011, ONCOGENE, V30, P3404, DOI 10.1038/onc.2011.60; DAVIDSON P, 1952, J ANAT, V86, P342; Foitzik K, 1999, DEV BIOL, V212, P278, DOI 10.1006/dbio.1999.9325; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Guo TF, 2013, CHINA HERBIVORE SCI, V33, P68; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Harris PJ, 2010, CANCER PREV RES, V3, P1217, DOI 10.1158/1940-6207.CAPR-10-0210; He XL, 2014, SMALL RUMINANT RES, V116, P111, DOI 10.1016/j.smallrumres.2013.10.020; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li W, 2012, EXP CELL RES, V318, P1633, DOI 10.1016/j.yexcr.2012.05.003; Li XP, 2013, MOL CELLS, V36, P316, DOI 10.1007/s10059-013-0093-y; Liu GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077801; Liu J, 2008, DEV CELL, V14, P751, DOI 10.1016/j.devcel.2008.02.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu B. G., 1979, CHINESE J ANIMAL SCI, P14; Lu Z, 2006, ONCOGENE, V25, P2920, DOI 10.1038/sj.onc.1209318; Lund AH, 2010, CELL DEATH DIFFER, V17, P209, DOI 10.1038/cdd.2009.58; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Miao Y, 2008, SHANDONG MED J, V48, P17; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; Nakamura M, 2013, J DERMATOL SCI, V69, P6, DOI 10.1016/j.jdermsci.2012.10.001; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Standley HJ, 2006, DEV BIOL, V289, P318, DOI 10.1016/j.ydbio.2005.10.012; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Su J, 2012, INT J ONCOL, V40, P1162, DOI 10.3892/ijo.2011.1322; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Trakooljul N, 2010, ANIM GENET, V41, P357, DOI 10.1111/j.1365-2052.2009.02015.x; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yuan C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-511; Zhao JA, 2011, J NUTR BIOCHEM, V22, P227, DOI 10.1016/j.jnutbio.2010.01.008	51	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0157463	10.1371/journal.pone.0157463	http://dx.doi.org/10.1371/journal.pone.0157463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404636	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508200003
J	Sloan, CD; Gebretsadik, T; Rosas-Salazar, C; Wu, PS; Carroll, KN; Mitchel, E; Anderson, LJ; Larkin, EK; Hartert, TV				Sloan, Chantel D.; Gebretsadik, Tebeb; Rosas-Salazar, Christian; Wu, Pingsheng; Carroll, Kecia N.; Mitchel, Edward; Anderson, Larry J.; Larkin, Emma K.; Hartert, Tina V.			Seasonal Timing of Infant Bronchiolitis, Apnea and Sudden Unexplained Infant Death	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; INFECTION	Rates of Sudden Unexplained Infant Death (SUID), bronchiolitis, and central apnea increase in winter in temperate climates. Though associations between these three conditions are suggested, more work is required to establish if there is a causal pathway linking bronchiolitis to SUID through inducing central apnea. Utilizing a large population-based cohort of infants studied over a 20-year period (n = 834,595, from birth years 1989-2009)), we analyzed ecological associations between timing of SUID cases, bronchiolitis, and apnea healthcare visits. Data were analyzed between 2013 and 2015. We used a Cox Proportional Hazards model to analyze possible interactions between maternal smoking and maternal asthma with infant bronchiolitis on time to SUID. SUID and bronchiolitis both occurred more frequently in winter. An increase in bronchiolitis clinical visits occurred within a few days prior to apnea visits. We found a temporal relationship between infant bronchiolitis and apnea. In contrast, no peak in SUID cases was seen during peaks of bronchiolitis. Among those without any bronchiolitis visits, maternal smoking was associated with an increased risk of SUID: Hazard Ratio (HR) of 2.38 (95% CI: 2.11, 2.67, p-value <0.001). Maternal asthma was associated with an increased risk of SUID among infants with at least one bronchiolitis visit: HR of 2.40 (95% CI: 1.04, 5.54, p-value = 0.04). Consistent trends between bronchiolitis, apnea, and SUID were not established due to small numbers of SUID cases. However, interaction analysis revealed potential differential associations of bronchiolitis and SUID by maternal smoking, maternal asthma status.	[Sloan, Chantel D.] Brigham Young Univ, Dept Hlth Sci, Provo, UT USA; [Gebretsadik, Tebeb; Rosas-Salazar, Christian; Wu, Pingsheng; Carroll, Kecia N.; Larkin, Emma K.; Hartert, Tina V.] Vanderbilt Univ, Sch Med, Ctr Asthma Res, Nashville, TN USA; [Gebretsadik, Tebeb; Wu, Pingsheng] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN USA; [Rosas-Salazar, Christian; Carroll, Kecia N.; Hartert, Tina V.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN USA; [Wu, Pingsheng; Larkin, Emma K.; Hartert, Tina V.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA; [Mitchel, Edward] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN USA; [Anderson, Larry J.] Emory Univ, Sch Med, Dept Pediat Pediat Infect Dis, Atlanta, GA USA	Brigham Young University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University	Hartert, TV (corresponding author), Vanderbilt Univ, Sch Med, Ctr Asthma Res, Nashville, TN USA.; Hartert, TV (corresponding author), Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN USA.; Hartert, TV (corresponding author), Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN USA.	tina.hartert@vanderbilt.edu	Rosas-Salazar, Christian/AAC-8571-2021; Sloan-Aagard, Chantel/GWC-7572-2022	Rosas-Salazar, Christian/0000-0001-6644-5780; 	National Institute of Environmental Health Sciences [ES00267]; National Institute of Allergy and Infectious Diseases [K24 77930]; National Institutes of Health [ES15855, R01 HS 018454]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI077930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, K12ES015855] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by a National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) ES00267 to TVH and CS, National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov) K24 77930 to TVH, National Institutes of Health (http://www.nih.gov/) ES15855 to TVH, and R01 HS 018454 to TVH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are indebted to the Tennessee Bureau of TennCare of the Department of Finance and Administration, and the Tennessee Department of Health, Office of Policy, Planning & Assessment, for providing the data. This work was supported by a National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/) ES00267 to TVH and CS, National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov) K24 77930 to TVH, National Institutes of Health (http://www.nih.gov/) ES15855 to TVH, and R01 HS 018454 to TVH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carroll KN, 2009, J ALLERGY CLIN IMMUN, V124, P1121, DOI 10.1016/j.jaci.2009.07.060; HEDNER J, 1984, J APPL PHYSIOL, V56, P849, DOI 10.1152/jappl.1984.56.4.849; Kelly D H, 1985, Pediatr Pulmonol, V1, P215, DOI 10.1002/ppul.1950010409; Limelette A, 2013, ANN BIOL CLIN-PARIS, V71, P299, DOI 10.1684/abc.2013.0825; Martin Richard J, 2004, Paediatr Respir Rev, V5 Suppl A, pS377, DOI 10.1016/S1526-0542(04)90067-X; Moon RY, 2007, LANCET, V370, P1578, DOI 10.1016/S0140-6736(07)61662-6; Ralston S, 2009, J PEDIATR-US, V155, P728, DOI 10.1016/j.jpeds.2009.04.063; Ricart S, 2014, PEDIATR INFECT DIS J, V33, P988, DOI 10.1097/INF.0000000000000365; Rothman KJ., 2012, EPIDEMIOLOGY INTRO; Sabogal C, 2005, PEDIATR RES, V57, P819, DOI 10.1203/01.PDR.0000157679.67227.11; Samuels Martin, 2003, Paediatr Respir Rev, V4, P178, DOI 10.1016/S1526-0542(03)00050-2; Schiller O, 2011, ACTA PAEDIATR, V100, P216, DOI 10.1111/j.1651-2227.2010.02004.x; Sekizawa SI, 2010, TOXICOL APPL PHARM, V242, P199, DOI 10.1016/j.taap.2009.10.009; Sloan Chantel D, 2013, Ann Am Thorac Soc, V10, P131, DOI 10.1513/AnnalsATS.201209-076BC; Thach B, 2008, EMBO REP, V9, P114, DOI 10.1038/sj.embor.7401163; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; Tripp RA, 2003, J VIROL, V77, P6580, DOI 10.1128/JVI.77.11.6580-6584.2003; Urrego F, 2009, PEDIATR PULM, V44, P1075, DOI 10.1002/ppul.21099; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC; Zhao J, 2011, EUR J PEDIATR, V170, P1097, DOI 10.1007/s00431-011-1409-6	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158521	10.1371/journal.pone.0158521	http://dx.doi.org/10.1371/journal.pone.0158521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404386	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508200011
J	von Websky, MW; Kitamura, K; Ludwig-Portugall, I; Kurts, C; von Laffert, M; LeMaoult, J; Carosella, ED; Abu-Elmagd, K; Kalff, JC; Schafer, N				von Websky, Martin W.; Kitamura, Koji; Ludwig-Portugall, Isis; Kurts, Christian; von Laffert, Maximilian; LeMaoult, Joel; Carosella, Edgardo D.; Abu-Elmagd, Kareem; Kalff, Joerg C.; Schaefer, Nico			Recombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel Transplantation	PLOS ONE			English	Article							T-CELL; INTESTINAL TRANSPLANTATION; G EXPRESSION; REJECTION; INFLAMMATION; DYSFUNCTION; ALLOGRAFTS; APOPTOSIS	The non-classical MHC I paralogue HLA-G is expressed by cytotrophoblast cells and implicated with fetomaternal tolerance by downregulating the maternal adaptive and innate immune response against the fetus. HLA-G expression correlates with favorable graft outcome in humans and recently promising immunosuppressive effects of therapeutic HLA-G in experimental transplantation (skin allograft acceptance) were shown. Consequently, we examined this novel therapeutic approach in solid organ transplantation. In this study, therapeutic recombinant HLA-G5 was evaluated for the first time in a solid organ model of acute rejection (ACR) after orthotopic intestinal transplantation (ITX). Allogenic ITX was performed in rats (Brown Norway to Lewis) with and without HLA-G treatment. It was found that HLA-G treatment significantly reduced histologically proven ACR at both an early and late postoperative timepoint (POD 4/7), concomitant to a functionally preserved graft contractility at POD 7. Interestingly, graft infiltration by myeloperoxidase+ cells was significantly reduced at POD7 by HLA-G treatment. Moreover, HLA-G treatment showed an effect on the allogenic T-cell immune response as assessed by flow cytometry: The influx of recipient-derived CD8(+) T-cells into the graft mesenteric lymphnodes at POD7 was significantly reduced while CD4(+) populations were not affected. As a potential mechanism of action, an induction of T-reg populations in the mesenteric lymphnodes was postulated, but flow cytometric analysis of classical CD4(+)/CD25(+)/FoxP3(+)T(reg)-cells showed no significant alteration by HLA-G treatment. The novel therapeutic approach using recombinant HLA-G5 reported herein demonstrates a significant immunosuppressive effect in this model of allogenic experimental intestinal transplantation. This effect may be mediated via inhibition of recipient-derived CD8(+) T-cell populations either directly or by induction of non-classical T-reg populations.	[von Websky, Martin W.; Kitamura, Koji; Kalff, Joerg C.; Schaefer, Nico] Univ Hosp Bonn, Dept Surg, Bonn, Germany; [Kitamura, Koji] Kyoto Univ Hosp, Dept Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan; [Ludwig-Portugall, Isis; Kurts, Christian] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [von Laffert, Maximilian] Charite, Inst Pathol, Berlin, Germany; [LeMaoult, Joel; Carosella, Edgardo D.] St Louis Hosp, CEA, iMETI, Res Div Hematol & Immunol, Paris, France; [Abu-Elmagd, Kareem] Cleveland Clin, Transplant Ctr, Cleveland, OH 44106 USA	University of Bonn; Kyoto University; University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Cleveland Clinic Foundation	Schafer, N (corresponding author), Univ Hosp Bonn, Dept Surg, Bonn, Germany.	nico.schaefer@ukb.uni-bonn.de	Kalff, Joerg C/U-8580-2017; LeMaoult, Joel/E-9583-2011	von Laffert, Maximilian/0000-0002-8799-0427; LeMaoult, Joel/0000-0002-4513-9482	Else-Kroner Fresenius Foundation	Else-Kroner Fresenius Foundation	Martin W von Websky received a scholarship from the Else-Kroner Fresenius Foundation [http://www.ekfs.de/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Elmagd K, 1998, J AM COLL SURGEONS, V186, P512, DOI 10.1016/S1072-7515(98)00083-0; Abu-Elmagd KM, 2009, ANN SURG, V250, P567, DOI 10.1097/SLA.0b013e3181b67725; Abu-Elmagd KM, 2009, TRANSPL INT, V22, P96, DOI 10.1111/j.1432-2277.2008.00785.x; Briscoe DDM, 2002, NAT MED, V8, P220, DOI 10.1038/nm0302-220; Brugiere O, 2009, AM J TRANSPLANT, V9, P1427, DOI 10.1111/j.1600-6143.2009.02650.x; Carosella ED, 2011, BLOOD, V118, P6499, DOI 10.1182/blood-2011-07-370742; Contini P, 2003, EUR J IMMUNOL, V33, P125, DOI 10.1002/immu.200390015; Creput C, 2003, AM J TRANSPLANT, V3, P348, DOI 10.1034/j.1600-6143.2003.00050.x; Favier B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021011; Fuzzi B, 2002, EUR J IMMUNOL, V32, P311, DOI 10.1002/1521-4141(200202)32:2<311::AID-IMMU311>3.3.CO;2-#; Grant D, INTESTINAL TRANSPLAN; Horne PH, 2007, J IMMUNOL, V179, P80, DOI 10.4049/jimmunol.179.1.80; Ito T, 2005, J INVEST DERMATOL, V125, P1139, DOI 10.1111/j.0022-202X.2005.23927.x; Kalff JC, 1999, SURGERY, V126, P498, DOI 10.1016/S0039-6060(99)70091-7; Kitamura K, 2012, JOVE-J VIS EXP, DOI 10.3791/4102; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; Krams SM, 1998, J IMMUNOL, V160, P3673; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Le Discorde M, 2003, HUM IMMUNOL, V64, P1039, DOI 10.1016/j.humimm.2003.08.346; Le Rond S, 2006, J IMMUNOL, V176, P3266, DOI 10.4049/jimmunol.176.5.3266; LeMaoult J, 2013, FASEB J, V27, P3643, DOI 10.1096/fj.13-228247; Liang SY, 2002, EUR J IMMUNOL, V32, P2418, DOI 10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L; Newell KA, 1997, TRANSPLANTATION, V64, P959, DOI 10.1097/00007890-199710150-00004; Pech T, 2012, AM J TRANSPLANT, V12, pS9, DOI 10.1111/j.1600-6143.2012.04262.x; Puppo Francesco, 2002, ScientificWorldJournal, V2, P421; Riteau B, 1999, J REPROD IMMUNOL, V43, P203, DOI 10.1016/S0165-0378(99)00034-0; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Schaefer N, 2007, AM J TRANSPLANT, V7, P1062, DOI 10.1111/j.1600-6143.2007.01747.x; Schaefer N, 2008, TRANSPLANTATION, V85, P1465, DOI 10.1097/TP.0b013e31816fc189; Shin CR, 2011, J PEDIATR SURG, V46, P1732, DOI 10.1016/j.jpedsurg.2011.04.016; Starkey HDV, 2012, J MOL NEUROSCI, V48, P111, DOI 10.1007/s12031-012-9783-8; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; Tsuruyama T, 2012, TRANSPL INT, V25, P537, DOI 10.1111/j.1432-2277.2012.01450.x; Tuler A, 2002, TRANSPLANT P, V34, P921, DOI 10.1016/S0041-1345(02)02670-2; Wu T, 2003, TRANSPLANTATION, V75, P1241, DOI 10.1097/01.TP.0000062840.49159.2F	35	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158907	10.1371/journal.pone.0158907	http://dx.doi.org/10.1371/journal.pone.0158907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404095	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508200020
J	Asemaninejad, A; Weerasuriya, N; Gloor, GB; Lindo, Z; Thorn, RG				Asemaninejad, Asma; Weerasuriya, Nimalka; Gloor, Gregory B.; Lindo, Zoe; Thorn, R. Greg			New Primers for Discovering Fungal Diversity Using Nuclear Large Ribosomal DNA	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; PHYLOGENETIC ANALYSIS; COMMUNITY ANALYSIS; SEQUENCE-DATA; RNA; IDENTIFICATION; BARCODE; REGION; PENICILLIUM; GENERATION	Metabarcoding has become an important tool in the discovery of biodiversity, including fungi, which are the second most speciose group of eukaryotes, with diverse and important ecological roles in terrestrial ecosystems. We have designed and tested new PCR primers that target the D1 variable region of nuclear large subunit (LSU) ribosomal DNA; one set that targets the phylum Ascomycota and another that recovers all other fungal phyla. The primers yield amplicons compatible with the Illumina MiSeq platform, which is cost-effective and has a lower error rate than other high throughput sequencing platforms. The new primer set LSU200A-F/LSU476A-R (Ascomycota) yielded 95-98% of reads of target taxa from environmental samples, and primers LSU200-F/LSU481-R (all other fungi) yielded 72-80% of target reads. Both primer sets have fairly low rates of data loss, and together they cover a wide variety of fungal taxa. We compared our results with these primers by amplifying and sequencing a subset of samples using the previously described ITS3_KYO2/ITS4_KYO3 primers, which amplify the internal transcribed spacer 2 (ITS2) of Ascomycota and Basidiomycota. With approximately equivalent read depth, our LSU primers recovered a greater number and phylogenetic diversity of sequences than the ITS2 primers. For instance, ITS3_KYO2/ITS4_KYO3 primers failed to pick up any members of Eurotiales, Mytilinidiales, Pezizales, Saccharomycetales, or Venturiales within Ascomycota, or members of Exobasidiomycetes, Microbotryomycetes, Pucciniomycetes, or Tremellomycetes within Basidiomycota, which were retrieved in good numbers from the same samples by our LSU primers. Among the OTUs recovered using the LSU primers were 127 genera and 28 species that were not obtained using the ITS2 primers, although the ITS2 primers recovered 10 unique genera and 16 species that were not obtained using either of the LSU primers These features identify the new primer sets developed in this study as useful complements to other universal primers for the study of fungal diversity and community composition.	[Asemaninejad, Asma; Weerasuriya, Nimalka; Lindo, Zoe; Thorn, R. Greg] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [Gloor, Gregory B.] Univ Western Ontario, Dept Biochem, London, ON N6A 5B7, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Thorn, RG (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	rgthorn@uwo.ca	Gloor, Greg B/D-1671-2013; Thorn, R Greg/I-3398-2012	Thorn, R Greg/0000-0002-7199-6226; Gloor, Gregory/0000-0001-5803-3380; Lindo, Zoe/0000-0001-9942-7204; Weerasuriya, Nimalka Manori/0000-0002-8909-3551	Natural Sciences and Engineering Research Council (Canada) [EGP 446568-13]; Entomogen, Inc. Parks Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) [418241-2012]; NSERC Engage grant [EGP 446568-13]	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Entomogen, Inc. Parks Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Engage grant	This work was supported in part by Natural Sciences and Engineering Research Council (Canada) Engage Partnership Grant Program EGP 446568-13 to RGT and partner Entomogen, Inc. Parks Canada provided financial and logistical support for fieldwork by M. Bidochka and F. Hunter (Entomogen) in Torngat Mountains National Park. Funding for ZL is from the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants Program (#418241-2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by NSERC Engage grant EGP 446568-13 to RGT and partner Entomogen, Inc. Parks Canada provided financial and logistical support for fieldwork by M. Bidochka and F. Hunter (Entomogen) in Torngat Mountains National Park, and Michael Burzysnki (formerly with Parks Canada, Rocky Harbour, Newfoundland) identified plants from photos of the sampling areas in Torngat. Peat samples are provided as part of a larger experiment supported by Dr. James McLaughlin (Ontario Ministry of Natural Resources-Ontario Forest Research Institute), Dr. Brian Branfireun (University of Western Ontario, Biotron), and Dr. Charmaine Dean, Dean of the Faculty of Science, University of Western Ontario. Funding for ZL is from the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grants Program (#418241-2012). The supportive comments, feedback and discussion provided by two anonymous reviewers were greatly appreciated and significantly improved the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Atkins Simon D., 2004, Journal of Applied Genetics, V45, P3; Balint M, 2014, ECOL EVOL, V4, P2642, DOI 10.1002/ece3.1107; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Brown SP, 2015, FUNGAL ECOL, V13, P221, DOI 10.1016/j.funeco.2014.08.006; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Clemmensen KE, 2013, SCIENCE, V339, P1615, DOI 10.1126/science.1231923; Dentinger BTM, 2010, MOL ECOL RESOUR, V10, P628, DOI 10.1111/j.1755-0998.2009.02825.x; Dieleman CM, 2015, GLOBAL CHANGE BIOL, V21, P388, DOI 10.1111/gcb.12643; Dumbrell AJ, 2011, NEW PHYTOL, V190, P794, DOI 10.1111/j.1469-8137.2010.03636.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; GEORGIEV OI, 1981, NUCLEIC ACIDS RES, V9, P6953, DOI 10.1093/nar/9.24.6953; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; HASSOUNA N, 1984, NUCLEIC ACIDS RES, V12, P3563, DOI 10.1093/nar/12.8.3563; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Hert DG, 2008, ELECTROPHORESIS, V29, P4618, DOI 10.1002/elps.200800456; Hibbett D, 2014, SYSTEMATICS EVOLUTIO, P373, DOI DOI 10.1007/978-3-642-55318-9_14; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jang J-h, 2014, KOREAN J PUBLIC HLTH, V2, P81; Kohout P, 2014, SOIL BIOL BIOCHEM, V68, P482, DOI 10.1016/j.soilbio.2013.08.027; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; Lawley B, 2004, APPL ENVIRON MICROB, V70, P5963, DOI 10.1128/AEM.70.10.5963-5972.2004; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Lindner DL, 2011, MYCOLOGIA, V103, P731, DOI 10.3852/10-331; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Moncalvo JM, 2002, MOL PHYLOGENET EVOL, V23, P357, DOI 10.1016/S1055-7903(02)00027-1; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Parenicova L, 2001, APPL ENVIRON MICROB, V67, P521, DOI 10.1128/AEM.67.2.521-527.2001; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rosling A, 2011, SCIENCE, V333, P876, DOI 10.1126/science.1206958; Sato Kouichi, 2005, Grassland Science, V51, P179, DOI 10.1111/j.1744-697X.2005.00023.x; Schmidt PA, 2013, SOIL BIOL BIOCHEM, V65, P128, DOI 10.1016/j.soilbio.2013.05.014; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Seifert KA, 2007, P NATL ACAD SCI USA, V104, P3901, DOI 10.1073/pnas.0611691104; Shenoy BD, 2007, FUNGAL DIVERS, V26, P1; SIMON L, 1992, APPL ENVIRON MICROB, V58, P291, DOI 10.1128/AEM.58.1.291-295.1992; Skouboe P, 1999, MYCOL RES, V103, P873, DOI 10.1017/S0953756298007904; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Sun Xiang, 2012, Mycology - An International Journal on Fungal Biology, V3, P65; Taylor DL, 2014, ECOL MONOGR, V84, P3, DOI 10.1890/12-1693.1; Tedersoo L, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5594; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Treseder KK, 2015, MICROBIOL MOL BIOL R, V79, P243, DOI 10.1128/MMBR.00001-15; Valverde JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058118; Varga J, 2000, FUNGAL GENET BIOL, V30, P71, DOI 10.1006/fgbi.2000.1204; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Wang H, 2011, J CLIN MICROBIOL, V49, P1890, DOI 10.1128/JCM.02415-10; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Watanabe M, 2011, J SCI FOOD AGR, V91, P2500, DOI 10.1002/jsfa.4507; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	61	28	29	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159043	10.1371/journal.pone.0159043	http://dx.doi.org/10.1371/journal.pone.0159043			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391306	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400198
J	Moneim, AEA				Moneim, Ahmed E. Abdel			Indigofera oblongifolia Prevents Lead Acetate-Induced Hepatotoxicity, Oxidative Stress, Fibrosis and Apoptosis in Rats	PLOS ONE			English	Article							FLAXSEED OIL; LIVER; EXPRESSION; REVERSAL; CADMIUM; KIDNEY; TESTES; ASSAY; NRF2	The current study was aimed to evaluate the preventive effects of Indigofera oblongifolia leaf extract (IOLE) on lead acetate (PbAc)-induced hepatotoxicity in adult male Wistar rats. PbAc was intraperitoneally injected at a dose of 20 mg/kg body weight for 5 days alone or in combination with the IOLE (100 mg/kg). Liver lead concentration and oxidative stress markers such as lipid peroxidation, hydrogen peroxide, nitric oxide, and glutathione content were investigated in addition to the enzymatic antioxidant activities. PbAc injection caused a significant elevation in the liver function parameters, lead level, lipid peroxidation, hydrogen peroxide, and nitric oxide, with a concomitant decline in the glutathione content compared with the control, accompanied by a significant inhibition of antioxidant enzyme activities. The induction of oxidative stress, lead accumulation, and histological alterations in the liver were successfully minimized by pre-administration of IOLE. In addition, the PbAc group showed increase in the levels of Bax, caspase-3, and matrix metalloproteinase-9 proteins, while the expression of Bcl-2 protein was decreased. Prior administration of IOLE significantly mitigated apoptosis and fibrosis in the liver. Finally, the major components in I. oblongifolia extract were identified as polyphenols, flavonoids, and organic acids using liquid chromatography coupled mass spectroscopy. Thus, the findings of the current study revealed that I. oblongifolia had protective, anti-fibrotic, antioxidant, and anti-apoptotic activities on PbAc-induced hepatotoxicity. The beneficial effects of I. oblongifolia were in part mediated by Nrf2/HO-1 pathway.	[Moneim, Ahmed E. Abdel] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Helwan University	Moneim, AEA (corresponding author), Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt.	aest1977@hotmail.com	Moneim, Ahmed E. Abdel/C-7461-2012	Moneim, Ahmed E. Abdel/0000-0002-2654-2591				Moneim AEA, 2012, BIOL TRACE ELEM RES, V148, P363, DOI 10.1007/s12011-012-9370-4; Abdel-Moneim AE, 2011, BIOL TRACE ELEM RES, V143, P457, DOI 10.1007/s12011-010-8882-z; Abdou HM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/435857; Aggarwal BB, 2011, CURR DRUG TARGETS, V12, P1595; Al-Olayan EM, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-164; Al-Olayan E, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/381413; Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Aykin-Burns N, 2003, ARCH ENVIRON CON TOX, V44, P417, DOI 10.1007/s00244-002-2023-4; BELFIELD A, 1971, ENZYME, V12, P561, DOI 10.1159/000459586; Berrahal AA, 2011, ENVIRON TOXICOL, V26, P68, DOI 10.1002/tox.20530; Dkhil MA, 2016, BIOL TRACE ELEM RES, V173, P354, DOI 10.1007/s12011-016-0689-0; Dkhil MA, 2016, DRUG DES DEV THER, V10, P1847, DOI 10.2147/DDDT.S105511; El-Nekeety AA, 2009, FOOD CHEM TOXICOL, V47, P2209, DOI 10.1016/j.fct.2009.06.019; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Flora SJS, 2008, INDIAN J MED RES, V128, P501; Flora SJS, 2007, J PHARMACOL EXP THER, V322, P108, DOI 10.1124/jpet.107.121996; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Jia QH, 2012, TOXICOL MECH METHOD, V22, P705, DOI 10.3109/15376516.2012.718811; Kumar S, 2013, SCI WORLD J, DOI 10.1155/2013/162750; Lahat N, 2002, J NEUROIMMUNOL, V132, P123, DOI 10.1016/S0165-5728(02)00323-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lubbad MY, 2015, PARASITOL RES, V114, P3431, DOI 10.1007/s00436-015-4568-y; Mohamed OI, 2016, PHARM BIOL, V54, P1164, DOI 10.3109/13880209.2015.1057651; Mudipalli A, 2007, INDIAN J MED RES, V126, P518; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oyagbemi A, 2014, FASEB J, V28; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Parola M, 2001, J HEPATOL, V35, P297, DOI 10.1016/S0168-8278(01)00142-8; Ponce-Canchihuaman JC, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-35; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Reyes JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/730789; Schmidt M, 1975, Fortschr Med, V93, P1461; Sethi G, 2006, J BIOL CHEM, V281, P23425, DOI 10.1074/jbc.M602627200; Shahjahan M, 2005, J MED FOOD, V8, P261, DOI 10.1089/jmf.2005.8.261; Sharif A, 2005, ARCH PHARM RES, V28, P761, DOI 10.1007/BF02977339; Sternberger LA., 1979, IMMUNOCYTOCHEMISTRY; Szkoda J, 2005, B VET I PULAWY, V49, P89; Tantawy EI- WH, 2015, J TRADIT COMPLEMENT; Wang Y, 2013, ENVIRON TOXICOL PHAR, V35, P109, DOI 10.1016/j.etap.2012.12.001; Wang Y, 2013, NEURAL REGEN RES, V8, P2021, DOI 10.3969/j.issn.1673-5374.2013.22.001; Ye F, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2075915; Yu CL, 2016, MOL NEUROBIOL, V53, P6489, DOI 10.1007/s12035-015-9555-x; Yuan GP, 2014, INT J CLIN EXP PATHO, V7, P2905	44	88	89	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158965	10.1371/journal.pone.0158965	http://dx.doi.org/10.1371/journal.pone.0158965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391413	Green Published, gold			2022-12-26	WOS:000380005400174
J	Nasi, S; Ea, HK; Liote, F; So, A; Busso, N				Nasi, Sonia; Ea, Hang-Korng; Liote, Frederic; So, Alexander; Busso, Nathalie			Sodium Thiosulfate Prevents Chondrocyte Mineralization and Reduces the Severity of Murine Osteoarthritis	PLOS ONE			English	Article							BASIC CALCIUM-PHOSPHATE; PROTEIN-KINASE-C; CHRONIC KIDNEY-DISEASE; ANNEXIN-V; TERMINAL DIFFERENTIATION; INFLAMMATORY CYTOKINES; CRYSTALS; CALCIFICATION; EXPRESSION; CARTILAGE	Objectives Calcium-containing crystals participate in the pathogenesis of OA. Sodium thiosulfate (STS) has been shown to be an effective treatment in calcification disorders such as calciphylaxis and vascular calcification. This study investigated the effects and mechanisms of action of STS in a murine model of OA and in chondrocyte calcification. Methods Hydroxyapatite (HA) crystals-stimulated murine chondrocytes and macrophages were treated with STS. Mineralization and cellular production of IL-6, MCP-1 and reactive oxygen species (ROS) were assayed. STS's effects on genes involved in calcification, inflammation and cartilage matrix degradation were studied by RT-PCR. STS was administered in the menisectomy model of murine OA, and the effect on periarticular calcific deposits and cartilage degeneration was investigated by micro-CT-scan and histology. Results In vitro, STS prevented in a dose-dependent manner calcium crystal deposition in chondrocytes and inhibited Annexin V gene expression. In addition, there was a reduction in crystal-induced IL-6 and MCP-1 production. STS also had an antioxidant effect, diminished HA-induced ROS generation and abrogated HA-induced catabolic responses in chondrocytes. In vivo, administration of STS reduced the histological severity of OA, by limiting the size of new periarticular calcific deposits and reducing the severity of cartilage damage. Conclusions STS reduces the severity of periarticular calcification and cartilage damage in an animal model of OA via its effects on chondrocyte mineralization and its attenuation of crystalinduced inflammation as well as catabolic enzymes and ROS generation. Our study suggests that STS may be a disease-modifying drug in crystal-associated OA.	[Nasi, Sonia; So, Alexander; Busso, Nathalie] CHU Vaudois, Dept Musculoskeletal Med, Serv Rheumatol, Lausanne, Switzerland; [Nasi, Sonia; So, Alexander; Busso, Nathalie] Univ Lausanne, Lausanne, Switzerland; [Ea, Hang-Korng; Liote, Frederic] Univ Sch Med, Serv Rheumatol, Hosp Lariboisiere, Paris VII, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP	Nasi, S (corresponding author), CHU Vaudois, Dept Musculoskeletal Med, Serv Rheumatol, Lausanne, Switzerland.; Nasi, S (corresponding author), Univ Lausanne, Lausanne, Switzerland.	Sonia.Nasi@chuv.ch	Liote, Frederic/AAD-6926-2020; Ea, HK/P-5527-2016	Nasi, Sonia/0000-0002-6625-8309; Liote, Frederic/0000-0003-4419-0726; Ea, HK/0000-0002-2393-7475	Fonds National Suisse de la recherche scientifique [310030-130085/1]; Institute of Arthritis Research; Fondation RMR; Fondation Jean and Linette Warnery	Fonds National Suisse de la recherche scientifique; Institute of Arthritis Research; Fondation RMR; Fondation Jean and Linette Warnery	This work was supported by the Fonds National Suisse de la recherche scientifique (grant 310030-130085/1) and the Institute of Arthritis Research, the Fondation RMR, the Fondation Jean and Linette Warnery.; We thank Nathaliane Bagnoud and Veronique Chobaz for their excellent technical support. We are grateful to Dr Laurent Galibert for his suggestions, critical reading and editing of the manuscript. Hydroxyapatite (HA) and calcium pyrophosphate dihydrate (CPPD) crystals were kindly provided by Prof. Christele Combes (CIRIMAT, INPT-UPS-CNRS, Toulouse France). This work was supported by the Fonds national suisse de la recherche scientifique (grant 310030-130085/1).	Abdoon ASS, 2011, THERIOGENOLOGY, V76, P1207, DOI 10.1016/j.theriogenology.2011.05.019; Agharazii M, 2015, AM J HYPERTENS, V28, P746, DOI 10.1093/ajh/hpu225; Brogley MA, 1999, J CELL PHYSIOL, V180, P215, DOI 10.1002/(SICI)1097-4652(199908)180:2<215::AID-JCP9>3.0.CO;2-J; Cheung HS, 2006, ARTHRITIS RHEUM-US, V54, P2452, DOI 10.1002/art.22017; Cunningham CC, 2012, CLIN IMMUNOL, V144, P228, DOI 10.1016/j.clim.2012.06.007; Ding M, 2008, CALCIFIED TISSUE INT, V82, P77, DOI 10.1007/s00223-007-9093-2; Ea HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057352; Ea HK, 2005, ARTHRITIS RES THER, V7, pR915, DOI 10.1186/ar1763; Fox B, 2012, J CELL MOL MED, V16, P896, DOI 10.1111/j.1582-4934.2011.01357.x; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; GOEL R, 1989, J NATL CANCER I, V81, P1552, DOI 10.1093/jnci/81.20.1552; Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Grskovic I, 2012, J BONE MINER RES, V27, P2399, DOI 10.1002/jbmr.1682; Hayden MR, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-4; Hayden MR, 2010, SEMIN DIALYSIS, V23, P258, DOI 10.1111/j.1525-139X.2010.00738.x; Horn DA, 2004, BIOTECH HISTOCHEM, V79, P151, DOI 10.1080/10520290400004708; Ives A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7555; Ju YJ, 2013, CAN J PHYSIOL PHARM, V91, P8, DOI 10.1139/cjpp-2012-0293; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Karageuzyan Konstantin G., 2005, Current Drug Targets - Inflammation and Allergy, V4, P85, DOI 10.2174/1568010053622939; Kim HJ, 2008, J BIOL CHEM, V283, P10310, DOI 10.1074/jbc.M708456200; Kirsch T, 2000, OSTEOARTHR CARTILAGE, V8, P294, DOI 10.1053/joca.1999.0304; Legendre F, 2005, J RHEUMATOL, V32, P1307; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; MARKMAN M, 1985, CANCER, V56, P2364, DOI 10.1002/1097-0142(19851115)56:10<2364::AID-CNCR2820561003>3.0.CO;2-4; Marutani E, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002125; Mathy-Hartert M, 2008, OSTEOARTHR CARTILAGE, V16, P756, DOI 10.1016/j.joca.2007.10.009; Matsui S, 2009, J ENDODONT, V35, P67, DOI 10.1016/j.joen.2008.08.034; McCarthy GM, 1998, J BIOL CHEM, V273, P35161, DOI 10.1074/jbc.273.52.35161; Mollenhauer J, 1999, J HISTOCHEM CYTOCHEM, V47, P209, DOI 10.1177/002215549904700209; Morita K, 2007, J EXP MED, V204, P1613, DOI 10.1084/jem.20062525; Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2; Nair D, 1997, J BIOL CHEM, V272, P18920, DOI 10.1074/jbc.272.30.18920; Nalbant S, 2003, OSTEOARTHR CARTILAGE, V11, P50, DOI 10.1053/joca.2002.0861; Nasi S, 2015, ANN RHEUMATIC DIS; Neuwelt EA, 1998, J PHARMACOL EXP THER, V286, P77; Pasch A, 2008, KIDNEY INT, V74, P1444, DOI 10.1038/ki.2008.455; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Prudhommeaux F, 1996, ARTHRITIS RHEUM, V39, P1319, DOI 10.1002/art.1780390809; Ramjan KA, 2009, NAT CLIN PRACT ENDOC, V5, P167, DOI 10.1038/ncpendmet1067; Reuben PM, 2004, J BIOL CHEM, V279, P35719, DOI 10.1074/jbc.M403406200; Ryu JH, 2011, ARTHRITIS RHEUM-US, V63, P2732, DOI 10.1002/art.30451; Sakaguchi M, 2014, ANESTHESIOLOGY, V121, P1248, DOI 10.1097/ALN.0000000000000456; Shirozu K, 2014, ANTIOXID REDOX SIGN, V20, P204, DOI 10.1089/ars.2013.5354; Sun YB, 2002, J BIOL CHEM, V277, P1544, DOI 10.1074/jbc.M100567200; Sun YB, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/326267; Tokuda K, 2012, ANTIOXID REDOX SIGN, V17, P11, DOI 10.1089/ars.2011.4363; vonderMark K, 1997, CELL MOL LIFE SCI, V53, P539, DOI 10.1007/s000180050069; Wang W, 2005, EXP CELL RES, V305, P156, DOI 10.1016/j.yexcr.2004.12.022	51	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158196	10.1371/journal.pone.0158196	http://dx.doi.org/10.1371/journal.pone.0158196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391970	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400036
J	Nusrat, S; Siddiqi, MK; Zaman, M; Zaidi, N; Ajmal, MR; Alam, P; Qadeer, A; Abdelhameed, AS; Khan, RH				Nusrat, Saima; Siddiqi, Mohammad Khursheed; Zaman, Masihuz; Zaidi, Nida; Ajmal, Mohammad Rehan; Alam, Parvez; Qadeer, Atiyatul; Abdelhameed, Ali Saber; Khan, Rizwan Hasan			A Comprehensive Spectroscopic and Computational Investigation to Probe the Interaction of Antineoplastic Drug Nordihydroguaiaretic Acid with Serum Albumins	PLOS ONE			English	Article							CIRCULAR-DICHROISM; BINDING-SITES; BOVINE; FLUORESCENCE; AGGREGATION; DERIVATIVES; NDGA; ABSORPTION; MECHANISMS; INHIBITORS	Exogenous drugs that are used as antidote against chemotheray, inflammation or viral infection, gets absorbed and interacts reversibly to the major serum transport protein i.e. albumins, upon entering the circulatory system. To have a structural guideline in the rational drug designing and in the synthesis of drugs with greater efficacy, the binding mechanism of an antineoplastic and anti-inflammatory drug Nordihydroguaiaretic acid (NDGA) with human and bovine serum albumins (HSA & BSA) were examined by spectroscopic and computational methods. NDGA binds to site II of HSA with binding constant (K-b) similar to 10(5) M-1 and free energy (Delta G) similar to -7.5 kcal.mol(-1). It also binds at site II of BSA but with lesser binding affinity (K-b) similar to 10(5) M-1 and Delta G similar to -6.5 kcal.mol(-1). The negative value of Delta G, Delta H and Delta S for both the albumins at three different temperatures confirmed that the complex formation process between albumins and NDGA is spontaneous and exothermic. Furthermore, hydrogen bonds and hydrophobic interactions are the main forces involved in complex formation of NDGA with both the albumins as evaluated from fluorescence and molecular docking results. Binding of NDGA to both the albumins alter the conformation and causes minor change in the secondary structure of proteins as indicated by the CD spectra.	[Nusrat, Saima; Siddiqi, Mohammad Khursheed; Zaman, Masihuz; Zaidi, Nida; Ajmal, Mohammad Rehan; Alam, Parvez; Qadeer, Atiyatul; Khan, Rizwan Hasan] Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India; [Abdelhameed, Ali Saber] King Saud Univ, Dept Pharmaceut Chem, Coll Pharm, POB 2457, Riyadh 11451, Saudi Arabia	Aligarh Muslim University; King Saud University	Khan, RH (corresponding author), Aligarh Muslim Univ, Interdisciplinary Biotechnol Unit, Aligarh 202002, Uttar Pradesh, India.	rizwanhkhan@hotmail.com	Abdelhameed, Ali/A-1333-2012; Khan, Rizwan/GXZ-5789-2022; Khan, Rizwan Hasan/F-8276-2014; Siddiqi, Mohammad Khursheed/V-9183-2018; Khan, Rehan/AAR-4803-2020; Alam, Dr Parvez/E-9136-2013	Abdelhameed, Ali/0000-0002-5910-2832; Khan, Rizwan Hasan/0000-0002-9965-8982; Siddiqi, Mohammad Khursheed/0000-0002-6522-1643; Khan, Rehan/0000-0001-8724-5788; Zaidi, Dr Nida/0000-0003-2579-2190; Alam, Dr Parvez/0000-0002-4484-8340; khan, mohammad rehan ajmal/0000-0002-2480-9379	Department of biotechnology, Government of India [BT/PR 13194/BRP/10/742/2009]; University Grant Commission, New Delhi, MANF-SRF; University Grant Commission, New Delhi, UGC-post doctoral fellowship; University Grant Commission, New Delhi, UGC-SRF (NET) fellowship; Department of Biotechnology (DBT) DBT-JRF (NET) fellowship; University Grant Commission, New Delhi; Department of Biotechnology (DBT); DBT [BT/PR 13194/10/742/2009]; DST [SR/SO/BB-0018/2011]; Deanship of Scientific Research at King Saud University [RG-1435-025];  [0014];  [RG-1435-02]	Department of biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grant Commission, New Delhi, MANF-SRF; University Grant Commission, New Delhi, UGC-post doctoral fellowship; University Grant Commission, New Delhi, UGC-SRF (NET) fellowship; Department of Biotechnology (DBT) DBT-JRF (NET) fellowship(Department of Biotechnology (DBT) India); University Grant Commission, New Delhi(University Grants Commission, India); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); DST(Department of Science & Technology (India)); Deanship of Scientific Research at King Saud University(King Saud University); ; 	Funding was provided by the Department of biotechnology, Government of India as project BT/PR 13194/BRP/10/742/2009 and DST SR/SO/BB-0018/2011 to RHK; the University Grant Commission, New Delhi, MANF-SRF to SN and MZ; the University Grant Commission, New Delhi, UGC-post doctoral fellowship to NZ; the University Grant Commission, New Delhi, UGC-SRF (NET) fellowship to MRA; the Department of Biotechnology (DBT) DBT-JRF (NET) fellowship to MKS; and the International Scientific Partnership Program ISPP at King Saud University for funding the research work through ISPP#0014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r Facilities provided by Interdisciplinary Biotechnology Unit, AMU, Aligarh are highly acknowledged. SN and MZ are highly thankful to University Grant Commission, New Delhi, for financial assistance in the form of MANF-SRF. MKS is highly thankful to Department of Biotechnology (DBT) for financial assistance in the form of DBT-JRF (NET) fellowship. NZ is highly thankful to University Grant Commission, New Delhi, for financial assistance in the form of UGC-post doctoral fellowship. MRA is highly thankful to University Grant Commission, New Delhi, for financial assistance in the form of UGC-SRF (NET) fellowship. We are thankful to Dr. AtiyatulQadeer for the careful revision of the manuscript to fix the grammatical errors and improve the overall readability of the text. RHK is thankful to DBT and DST for project numbers BT/PR 13194/10/742/2009 and SR/SO/BB-0018/2011, respectively. The authors would like to extend their sincere appreciation to the Deanship of ScientificResearch at King Saud University for its funding this Research Group No. RG-1435-025	Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmad E, 2011, CELL BIOCHEM BIOPHYS, V61, P313, DOI 10.1007/s12013-011-9214-4; Ajmal MR, 2016, J MOL STRUCT, V1117, P208, DOI 10.1016/j.molstruc.2016.03.081; Ajmal MR, 2016, SPECTROCHIM ACTA A, V159, P199, DOI 10.1016/j.saa.2016.01.049; Ajmal M, 2015, J HYDRO-ENVIRON RES, V9, P592, DOI 10.1016/j.jher.2014.11.003; Alam P, 2015, J LUMINESCENCE; Arteaga S, 2005, J ETHNOPHARMACOL, V98, P231, DOI 10.1016/j.jep.2005.02.002; CARTER DC, 1994, EUR J BIOCHEM, V226, P1049, DOI 10.1111/j.1432-1033.1994.01049.x; Chaturvedi SK, 2015, MOL BIOSYST, V11, P307, DOI 10.1039/c4mb00548a; Chi ZX, 2011, BIOMACROMOLECULES, V12, P203, DOI 10.1021/bm1011568; Feroz SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076067; Floriano-Sanchez E, 2006, FREE RADICAL RES, V40, P523, DOI 10.1080/10715760500419365; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Gentili PL, 2008, J PHYS CHEM B, V112, P16793, DOI 10.1021/jp805922g; Ghuman J, 2005, J MOL BIOL, V353, P38, DOI 10.1016/j.jmb.2005.07.075; Gong AQ, 2007, TALANTA, V73, P668, DOI 10.1016/j.talanta.2007.04.041; GOODMAN Y, 1994, BRAIN RES, V654, P171, DOI 10.1016/0006-8993(94)91586-5; He X.M, 1992, ATOMIC STRUCTURE CHE; Hu YJ, 2005, J MOL STRUCT, V750, P174, DOI 10.1016/j.molstruc.2005.04.032; Il'ichev YV, 2002, J PHYS CHEM B, V106, P452, DOI 10.1021/jp012314u; Jiang N, 2014, ORG BIOMOL CHEM, V12, P5250, DOI 10.1039/c4ob00405a; KASAI S, 1987, J PHARM SCI, V76, P387, DOI 10.1002/jps.2600760510; Khan AB, 2011, COLLOID SURFACE B, V87, P447, DOI 10.1016/j.colsurfb.2011.06.007; KRAGHHANSEN U, 1981, PHARMACOL REV, V33, P17; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, P63; Lakowicz JR, 1999, INTRO FLUORESCENCE P, P1; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; LIU L, 1995, INT J CANCER, V62, P345, DOI 10.1002/ijc.2910620319; Lu JM, 2010, MED SCI MONITOR, V16, pRA93; Matsuzaki K, 2007, BBA-BIOMEMBRANES, V1768, P122, DOI 10.1016/j.bbamem.2006.09.014; Olson RE, 1996, ANNU REP MED CHEM, V31, P327, DOI 10.1016/S0065-7743(08)60472-8; Ono K, 2002, J NEUROCHEM, V81, P434, DOI 10.1046/j.1471-4159.2002.00904.x; Paul BK, 2010, J PHYS CHEM B, V114, P6183, DOI 10.1021/jp100004t; Perry JL, 2003, J PHYS CHEM B, V107, P6644, DOI 10.1021/jp034284w; PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0; Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200; Qadeer A, 2014, BIOCHEMISTRY-MOSCOW+, V79, P785, DOI 10.1134/S0006297914080069; Qadeer A, 2013, ARCH BIOCHEM BIOPHYS, V540, P101, DOI 10.1016/j.abb.2013.10.015; ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017; Shu Y, 2011, J PHYS CHEM B, V115, P12306, DOI 10.1021/jp2071925; Singh SS, 2006, CURR DRUG METAB, V7, P165, DOI 10.2174/138920006775541552; SUDLOW G, 1976, MOL PHARMACOL, V12, P1052; Sulkowska A, 2002, J MOL STRUCT, V614, P227, DOI 10.1016/S0022-2860(02)00256-9; TAKIKAWA H, 1987, BIOCHIM BIOPHYS ACTA, V926, P145, DOI 10.1016/0304-4165(87)90231-5; VANDERKOOI JM, 1987, SCIENCE, V236, P568, DOI 10.1126/science.3576185; Varlan A, 2010, MOLECULES, V15, P3905, DOI 10.3390/molecules15063905; You KM, 1999, ARCH PHARM RES, V22, P18, DOI 10.1007/BF02976430; Youngren JF, 2005, BREAST CANCER RES TR, V94, P37, DOI 10.1007/s10549-005-6939-z; Yu MR, 2011, SPECTROCHIM ACTA A, V83, P453, DOI 10.1016/j.saa.2011.08.065; Zaidi N, 2014, J PHYS CHEM B, V118, P13025, DOI 10.1021/jp501515g; Zaidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071422; Zaidi N, 2013, J PHYS CHEM B, V117, P2595, DOI 10.1021/jp3069877; Zaman M, 2016, RSC ADV, V6, P37591, DOI 10.1039/c6ra01079b; Zaman M, 2014, INT J NANOMED, V9, P899, DOI 10.2147/IJN.S54171; Zavodovskaya M, 2008, J CELL BIOCHEM, V103, P624, DOI 10.1002/jcb.21435; Zhang HM, 2009, J MOL STRUCT, V938, P221, DOI 10.1016/j.molstruc.2009.09.032; Zsila F, 2003, BIOCHEM PHARMACOL, V65, P447, DOI 10.1016/S0006-2952(02)01521-6	57	57	57	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158833	10.1371/journal.pone.0158833	http://dx.doi.org/10.1371/journal.pone.0158833			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391941	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400139
J	Zhou, ZQ; Song, LY; Zhang, XX; Li, XH; Yan, N; Xia, RP; Zhu, H; Weng, JF; Hao, ZF; Zhang, DG; Yong, HJ; Li, MS; Zhang, SH				Zhou, Zhiqiang; Song, Liya; Zhang, Xiaoxing; Li, Xinhai; Yan, Na; Xia, Renpei; Zhu, Hui; Weng, Jianfeng; Hao, Zhuanfang; Zhang, Degui; Yong, Hongjun; Li, Mingshun; Zhang, Shihuang			Introgression of opaque2 into Waxy Maize Causes Extensive Biochemical and Proteomic Changes in Endosperm	PLOS ONE			English	Article							QUALITY PROTEIN MAIZE; ENDOPLASMIC-RETICULUM STRESS; GAMMA-ZEIN; TRANSCRIPTIONAL ACTIVATOR; BRANCHING ENZYME; AMINO-ACID; LYSINE; EXPRESSION; GENE; MUTANTS	Waxy maize is prevalently grown in China and other countries due to the excellent characters and economic value. However, its low content of lysine can't meet the nutritional requirements of humans and livestock. In the present study, we introgressed the opaque2 (o2) allele into waxy maize line Zhao OP-6/O2O2 by using marker-assisted selection (MAS) technique and successfully improved the lysine content and quality of waxy maize. Transcript abundance analysis indicated that the wx1 expression levels had no difference between Zhao OP-6/o2o2 and Zhao OP-6/O2O2. However, Zhao OP-6/o2o2 was characterized by a phenotype of hard and vitreous kernels and accumulation of protein bodies at smaller size (one third of that of parents) but in larger numbers. Biochemical analyses showed that Zhao OP-6/o2o2 had 16.7% less free amino acids than Zhao OP-6/O2O2, especially those derived from glycolytic intermediates, but its content of lysine was increased by 51.6%(0.47% vs. 0.31%). The content of amylopectin was 98.5% in Zhao OP-6/o2o2, significantly higher than that in Zhao OP-6/O2O2 (97.7%). Proteomic analyses indicated that o2 introgression not only decreased the accumulation of various zein proteins except for 27-kDa gamma-zein, but also affected other endosperm proteins related to amino acid biosynthesis, starch-protein balance, stress response and signal transduction. This study gives us an intriguing insight into the metabolism changes in endosperm of waxy maize introgressed with opaque2.	[Zhou, Zhiqiang; Zhang, Xiaoxing; Li, Xinhai; Yan, Na; Xia, Renpei; Zhu, Hui; Weng, Jianfeng; Hao, Zhuanfang; Zhang, Degui; Yong, Hongjun; Li, Mingshun; Zhang, Shihuang] Chinese Acad Agr Sci, Inst Crop Sci, Dept Crop Genet & Breeding, Beijing, Peoples R China; [Song, Liya] Beijing Technol & Business Univ, Beijing Key Lab Plant Resource Res & Dev, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Beijing Technology & Business University	Li, MS; Zhang, SH (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Dept Crop Genet & Breeding, Beijing, Peoples R China.	limingshun@caas.cn; zhangshihuang@caas.cn	yan, na/HDM-3747-2022		China Agriculture Research System [CARS-02-01]; Beijing Municipal Natural Science Foundation [31401390]	China Agriculture Research System; Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the China Agriculture Research System (CARS-02-01) and the funding was received by MSL. The Beijing Municipal Natural Science Foundation (31401390) and the funding was received by LYS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu BK, 2015, PLANT CELL REP, V34, P37, DOI 10.1007/s00299-014-1685-5; BOYER CD, 1978, CARBOHYD RES, V61, P321, DOI 10.1016/S0008-6215(00)84492-4; BRIGGS RW, 1965, NATURE, V207, P890, DOI 10.1038/207890a0; BROCHETTOBRAGA MR, 1992, PLANT PHYSIOL, V98, P1139, DOI 10.1104/pp.98.3.1139; Chen Y, 2014, PLOS ONE, V9, pe10; Damerval C, 1998, MOL GEN GENET, V257, P354, DOI 10.1007/s004380050657; Gallusci P, 1996, PLANT MOL BIOL, V31, P45, DOI 10.1007/BF00020605; GEETHA KB, 1991, PLANT CELL, V3, P1207, DOI 10.1105/tpc.3.11.1207; Gibbon BC, 2005, TRENDS GENET, V21, P227, DOI 10.1016/j.tig.2005.02.009; Gibbon BC, 2003, P NATL ACAD SCI USA, V100, P15329, DOI 10.1073/pnas.2136854100; Guan HP, 1997, ARCH BIOCHEM BIOPHYS, V342, P92, DOI 10.1006/abbi.1997.0115; HARTINGS H, 1989, EMBO J, V8, P2795, DOI 10.1002/j.1460-2075.1989.tb08425.x; Hartings H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-41; Holding DR, 2006, MAYDICA, V51, P243; HOSPITAL F, 1992, GENETICS, V132, P1199; Huizen VR, 2003, J BIOL CHEM, V278, P15558; Hunter BG, 2002, PLANT CELL, V14, P2591, DOI 10.1105/tpc.003905; Iwata Y, 2008, PLANT CELL, V20, P3107, DOI 10.1105/tpc.108.061002; Jia H, 2007, CROP SCI, V47, pS45, DOI 10.2135/cropsci2006-00025tpg; Jia M, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-60; Kemper EL, 1999, PLANT CELL, V11, P1981, DOI 10.1105/tpc.11.10.1981; Kirst ME, 2005, PLANT PHYSIOL, V138, P218, DOI 10.1104/pp.105.060087; Klosgen RB, 1986, MOL GEN GENET, V227, P91; Klucinec JD, 2002, CEREAL CHEM, V79, P19, DOI 10.1094/CCHEM.2002.79.1.19; KULESHOV N. N., 1954, Ann. Mo. Bot. Gdn., V41, P271, DOI 10.2307/2394586; Li X. Y., 1993, Acta Agronomica Sinica, V19, P460; LOHMER S, 1991, EMBO J, V10, P617, DOI 10.1002/j.1460-2075.1991.tb07989.x; LOPES MA, 1991, CROP SCI, V31, P1655, DOI 10.2135/cropsci1991.0011183X003100060055x; Lu DL, 2012, STARCH-STARKE, V64, P874, DOI 10.1002/star.201200038; Maddaloni M, 1996, MOL GEN GENET, V250, P647, DOI 10.1007/s004380050117; Mason-Gamer RJ, 1998, MOL BIOL EVOL, V15, P1658, DOI 10.1093/oxfordjournals.molbev.a025893; Meng ZD, 2001, J MAIZE SCI, V9, P14; MERTZ ET, 1964, SCIENCE, V145, P279, DOI 10.1126/science.145.3629.279; Moro GL, 1996, CROP SCI, V36, P1651, DOI 10.2135/cropsci1996.0011183X003600060039x; NELSON OE, 1962, BIOCHEM BIOPH RES CO, V9, P297, DOI 10.1016/0006-291X(62)90043-8; PAULIS JW, 1974, J AGR FOOD CHEM, V22, P318, DOI 10.1021/jf60192a001; PAULIS JW, 1992, THEOR APPL GENET, V85, P407, DOI 10.1007/BF00222321; Pereira CA, 2014, EXP PARASITOL, V142, P43, DOI 10.1016/j.exppara.2014.04.009; Prasanna BM, 2001, CURR SCI INDIA, V81, P1308; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; ROBINSON K, 1995, BIOCHEM J, V307, P267, DOI 10.1042/bj3070267; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; SCHMIDT RJ, 1990, P NATL ACAD SCI USA, V87, P46, DOI 10.1073/pnas.87.1.46; SCHMIDT RJ, 1992, PLANT CELL, V4, P689, DOI 10.1105/tpc.4.6.689; Smith AM, 1997, ANNU REV PLANT PHYS, V48, P65, DOI 10.1146/annurev.arplant.48.1.67; SODEK L, 1970, ARCH BIOCHEM BIOPHYS, V140, P29, DOI 10.1016/0003-9861(70)90006-8; SODEK L, 1971, J AGR FOOD CHEM, V19, P1144, DOI 10.1021/jf60178a011; Sprague G. F., 1943, JOUR AMER SOC AGRON, V35, P817; Tian QZ, 2004, J MAIZE SCI, V12; WALLACE JC, 1990, PLANT PHYSIOL, V92, P191, DOI 10.1104/pp.92.1.191; Wang Y, 2014, J BIOL CHEM, V289, P31361, DOI 10.1074/jbc.M114.597153; Wu YR, 2010, PLANT PHYSIOL, V153, P337, DOI 10.1104/pp.110.154690; Xia Tao, 1997, Acta Agronomica Sinica, V23, P753; Yang LQ, 2013, MOL BREEDING, V31, P767, DOI 10.1007/s11032-012-9830-8; Yang Yin-fu, 2009, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V29, P2213; Yao Y, 2004, PLANT PHYSIOL, V136, P3515, DOI 10.1104/pp.104.043315; Yuan LL, 2014, PLANT PHYSIOL, V164, P119, DOI 10.1104/pp.113.230961; Zeng MQ, 1987, CROP BREED RESOURCE, V3, P8; Zhang W., 2013, INT J COMPUT CONSUM, V2, P37; Zhao G, 2012, PLANTA, V235, P205, DOI 10.1007/s00425-011-1491-z; Zheng HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066606	61	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158971	10.1371/journal.pone.0158971	http://dx.doi.org/10.1371/journal.pone.0158971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391593	gold, Green Submitted, Green Published			2022-12-26	WOS:000380005400175
J	Joshi, RK; Megha, S; Basu, U; Rahman, MH; Kav, NNV				Joshi, Raj Kumar; Megha, Swati; Basu, Urmila; Rahman, Muhammad H.; Kav, Nat N. V.			Genome Wide Identification and Functional Prediction of Long Non-Coding RNAs Responsive to Sclerotinia sclerotiorum Infection in Brassica napus	PLOS ONE			English	Article							NATURAL ANTISENSE TRANSCRIPTS; DIFFERENTIAL GENE; MESSENGER-RNA; STEM ROT; SEQ; EXPRESSION; ARABIDOPSIS; L.; REVEALS; CANOLA	Sclerotinia stem rot caused by Sclerotinia sclerotiorum affects canola production worldwide. Emerging evidence suggests that long non-coding RNAs (lncRNAs) play important roles in the regulation of gene expression in plants, in response to both abiotic and biotic stress. So far, identification of lncRNAs has been limited to a few model plant species, and their roles in mediating responses to biotic stresses are yet to be characterized in Brassica napus. The present study reports the identification of novel lncRNAs responsive to S. sclerotiorum infection in B. napus at two time points after infection (24 hpi and 48 hpi) using a stranded RNA-Sequencing technique and a detection pipeline for lncRNAs. Of the total 3,181 lncRNA candidates, 2,821 lncRNAs were intergenic, 111 were natural antisense transcripts, 76 possessed exonic overlap with the reference coding transcripts while the remaining 173 represented novel lnc-isoforms. Forty one lncRNAs were identified as the precursors for microRNAs (miRNAs) including miR156, miR169 and miR394, with significant roles in mediating plant responses to fungal phytopathogens. A total of 931 differentially expressed lncRNAs were identified in response to S. sclerotiorum infection and the expression of 12 such lncRNAs was further validated using qRT-PCR. B. napus antisense lncRNA, TCONS_00000966, having 90% overlap with a plant defensin gene, showed significant induction at both infection stages, suggesting its involvement in the transcriptional regulation of defense responsive genes under S. sclerotiorum infection. Additionally, nine lncRNAs showed overlap with cis-regulatory regions of differentially expressed genes of B. napus. Quantitative RT-PCR verification of a set of S. sclerotiorum responsive sense/anti-sense transcript pairs revealed contrasting expression patterns, supporting the hypothesis that steric clashes of transcriptional machinery may lead to inactivation of sense promoter. Our findings highlight the potential contributions of lncRNAs in regulating expression of plant genes that respond to biotic stress.	[Joshi, Raj Kumar; Megha, Swati; Basu, Urmila; Rahman, Muhammad H.; Kav, Nat N. V.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada; [Joshi, Raj Kumar] Siksha O Anusandhan Univ, Ctr Biotechnol, Bhubaneswar 751003, Orissa, India	University of Alberta; Siksha 'O' Anusandhan University	Kav, NNV (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB T6G 2P5, Canada.	nat@ualberta.ca	Megha, Swati/AAV-6859-2021; JOSHI, RAJ KUMAR/S-8886-2019; JOSHI, RAJ K/N-3982-2016	JOSHI, RAJ KUMAR/0000-0003-0505-2881; JOSHI, RAJ K/0000-0003-0505-2881	Department of Biotechnology, Government of India [BT/IN/DBT-CREST Awards/32/RKJ/2012-13]; Natural Sciences and Engineering Research Council (NSERC) of Canada	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	RKJ is grateful to Department of Biotechnology, Government of India for providing DBT-CRESTaward (Sanction letter no. BT/IN/DBT-CREST Awards/32/RKJ/2012-13) to pursue research as a Visiting Scientist at the University of Alberta. Work in NNVK's laboratory was supported in part by a Discovery Grant from the Natural Sciences and Engineering Research Council (NSERC) of Canada awarded to NNVK.; RKJ is grateful to Department of Biotechnology, Government of India for providing DBT-CREST award (Sanction letter no. BT/IN/DBT-CREST Awards/32/RKJ/2012-13) to pursue research as a Visiting Scientist at the University of Alberta.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Arthanari Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091353; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Benjamini Y, 2001, ANN STAT, V29, P1165; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Campalans A, 2004, PLANT CELL, V16, P1047, DOI 10.1105/tpc.019406; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chen L, 2012, PLANTA, V235, P873, DOI 10.1007/s00425-011-1548-z; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Cho JK, 2005, EUPHYTICA, V146, P271, DOI 10.1007/s10681-005-9023-1; Darzacq X, 2002, EMBO J, V21, P2746, DOI 10.1093/emboj/21.11.2746; del Rio LE, 2007, PLANT DIS, V91, P191, DOI 10.1094/PDIS-91-2-0191; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gontan C, 2011, PROG MOL SUBCELL BIO, V51, P43, DOI 10.1007/978-3-642-16502-3_3; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Jin WB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0410-4; Joshi RK, 2016, GENE, V590, P57, DOI 10.1016/j.gene.2016.06.003; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim ED, 2012, TRENDS PLANT SCI, V17, P16, DOI 10.1016/j.tplants.2011.10.008; Koch S, 2007, PHYTOPATHOLOGY, V97, P1186, DOI 10.1094/PHYTO-97-9-1186; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Li L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r40; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liang Y, 2008, J AGR FOOD CHEM, V56, P1963, DOI 10.1021/jf073012d; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Lu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-721; Ma JX, 2008, J CELL BIOCHEM, V105, P136, DOI 10.1002/jcb.21807; Malvarez G, 2007, PHYTOPATHOLOGY, V97, P470, DOI 10.1094/PHYTO-97-4-0470; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Sanchez-Leon N, 2012, J EXP BOT, V63, P3829, DOI 10.1093/jxb/ers075; Seo JK, 2013, MOL PLANT MICROBE IN, V26, P617, DOI 10.1094/MPMI-10-12-0255-IA; Shuai P, 2014, J EXP BOT, V65, P4975, DOI 10.1093/jxb/eru256; Stotz HU, 2009, PLANT SIGNAL BEHAV, V4, P1010, DOI 10.4161/psb.4.11.9755; Sun K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S2-S7; Sun L, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-331; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang H, 2015, PLANT J, V84, P404, DOI 10.1111/tpj.13018; Wang H, 2014, GENOME RES, V24, P444, DOI 10.1101/gr.165555.113; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wu HJ, 2013, PLANT PHYSIOL, V161, P1875, DOI 10.1104/pp.113.215962; Wu YG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-107; Xie CY, 2014, NUCLEIC ACIDS RES, V42, pD98, DOI 10.1093/nar/gkt1222; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Yang B, 2007, PLANT SCI, V173, P156, DOI 10.1016/j.plantsci.2007.04.012; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098958; Zhang YC, 2013, BIOCHEM BIOPH RES CO, V436, P111, DOI 10.1016/j.bbrc.2013.05.086; Zhao JW, 2009, MOL PLANT PATHOL, V10, P635, DOI [10.1111/J.1364-3703.2009.00558.X, 10.1111/j.1364-3703.2009.00558.x]; Zhu Q-H, 2012, GENES, V3, P15; Zhu QH, 2014, NEW PHYTOL, V201, P574, DOI 10.1111/nph.12537; Zwieb C, 1997, NUCLEIC ACIDS RES, V25, P102, DOI 10.1093/nar/25.1.102	75	86	93	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158784	10.1371/journal.pone.0158784	http://dx.doi.org/10.1371/journal.pone.0158784			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388760	gold, Green Published, Green Submitted			2022-12-26	WOS:000379811500046
J	Blauenburg, B; Mielcarek, A; Altegoer, F; Fage, CD; Linne, U; Bange, G; Marahiel, MA				Blauenburg, Bastian; Mielcarek, Andreas; Altegoer, Florian; Fage, Christopher D.; Linne, Uwe; Bange, Gert; Marahiel, Mohamed A.			Crystal Structure of Bacillus subtilis Cysteine Desulfurase SufS and Its Dynamic Interaction with Frataxin and Scaffold Protein SufU	PLOS ONE			English	Article							FE-S CLUSTER; IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; YEAST FRATAXIN; BIOGENESIS; HOMOLOG; CYAY; GENE; BIOSYNTHESIS; SEQUENCE	The biosynthesis of iron sulfur (Fe-S) clusters in Bacillus subtilis is mediated by a SUF-type gene cluster, consisting of the cysteine desulfurase SufS, the scaffold protein SufU, and the putative chaperone complex SufB/SufC/SufD. Here, we present the high-resolution crystal structure of the SufS homodimer in its product-bound state (i.e., in complex with pyrodoxal-5'-phosphate, alanine, Cys361-persulfide). By performing hydrogen/deuterium exchange (H/DX) experiments, we characterized the interaction of SufS with SufU and demonstrate that SufU induces an opening of the active site pocket of SufS. Recent data indicate that frataxin could be involved in Fe-S cluster biosynthesis by facilitating iron incorporation. H/DX experiments show that frataxin indeed interacts with the SufS/SufU complex at the active site. Our findings deepen the current understanding of Fe-S cluster biosynthesis, a complex yet essential process, in the model organism B. subtilis.	[Blauenburg, Bastian; Mielcarek, Andreas; Fage, Christopher D.; Linne, Uwe; Bange, Gert; Marahiel, Mohamed A.] Philipps Univ Marburg, Dept Chem, Biochem, Hans Meerwein Str 4, D-35043 Marburg, Germany; [Altegoer, Florian; Bange, Gert] Philipps Univ Marburg, LOEWE Ctr Synthet Microbiol, D-35043 Marburg, Germany	Philipps University Marburg; Philipps University Marburg	Marahiel, MA (corresponding author), Philipps Univ Marburg, Dept Chem, Biochem, Hans Meerwein Str 4, D-35043 Marburg, Germany.	marahiel@staff.uni-marburg.de	Bange, Gert/AAB-3734-2021; Altegoer, Florian/AAM-1354-2020	Fage, Christopher Dane/0000-0001-5015-644X; Altegoer, Florian/0000-0002-6012-9047; Bange, Gert/0000-0002-7826-0932	Deutsche Forschungsgemeinschaft (DFG) by Sonderforschungsbereich 987 [SFB 987]; LOEWE excellence initiative of the state of Hesse, Germany; Deutsche Forschungsgemeinschaft (DFG) Scientific Instrumentation Grant [160/621-1 FUGG]; European Synchrotron Radiation Facility (ESRF), Grenoble, France	Deutsche Forschungsgemeinschaft (DFG) by Sonderforschungsbereich 987(German Research Foundation (DFG)); LOEWE excellence initiative of the state of Hesse, Germany; Deutsche Forschungsgemeinschaft (DFG) Scientific Instrumentation Grant(German Research Foundation (DFG)); European Synchrotron Radiation Facility (ESRF), Grenoble, France	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) by Sonderforschungsbereich 987 (SFB 987) Project B1 (http://www.sfb987.de) to MAM, LOEWE excellence initiative of the state of Hesse, Germany (http://www.synmikro.com/en/) to GB and MAM and the Deutsche Forschungsgemeinschaft (DFG) Scientific Instrumentation Grant 160/621-1 FUGG (http://www.dfg.de/en/research_funding/programmes/infrastructure/scientific_instrumentation/ equipment_programmes/index.html) to GB and UL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by SFB987 Project B1 (M.A.M.) and the LOEWE excellence initiative of the state of Hesse, Germany, (M.A.M. and G.B.) and the Scientific Instrumentation Grant 160/621-1 FUGG (G.B. and U.L.). We also acknowledge excellent support by the European Synchrotron Radiation Facility (ESRF), Grenoble, France.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adinolfi S, 2002, HUM MOL GENET, V11, P1865, DOI 10.1093/hmg/11.16.1865; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Agar JN, 2000, BIOCHEMISTRY; Albrecht AG, 2011, CHEMBIOCHEM, V12, P2052, DOI 10.1002/cbic.201100190; Albrecht AG, 2011, FEBS LETT, V585, P465, DOI 10.1016/j.febslet.2011.01.005; Albrecht AG, 2010, J BACTERIOL, V192, P1643, DOI 10.1128/JB.01536-09; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Beinert H, 2000, J BIOL INORG CHEM, V5, P2, DOI 10.1007/s007750050002; Beinert H, 1999, CURR OPIN CHEM BIOL, V3, P152, DOI 10.1016/S1367-5931(99)80027-1; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Black KA, 2015, J BACTERIOL, V197, P1952, DOI 10.1128/JB.02625-14; Bridwell-Rabb J, 2012, BIOCHEMISTRY-US, V51, P2506, DOI 10.1021/bi201628j; Cho SJ, 2000, P NATL ACAD SCI USA, V97, P8932, DOI 10.1073/pnas.160270897; Clausen T, 2000, P NATL ACAD SCI USA, V97, P3856, DOI 10.1073/pnas.97.8.3856; Cook JD, 2010, BIOCHEMISTRY-US, V49, P8756, DOI 10.1021/bi1008613; Correia AR, 2010, BIOCHEM J, V426, P197, DOI 10.1042/BJ20091612; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; Dhe-Paganon S, 2000, J BIOL CHEM, V275, P30753, DOI 10.1074/jbc.C000407200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flint DH, 1996, J BIOL CHEM, V271, P16068; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Hoff KG, 2000, P NATL ACAD SCI USA, V97, P7790, DOI 10.1073/pnas.130201997; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kim S, 2013, J BIOL CHEM, V288, P27172, DOI 10.1074/jbc.M113.480277; Leidgens S, 2010, HUM MOL GENET, V19, P276, DOI 10.1093/hmg/ddp495; Li DS, 1999, FEBS LETT, V456, P13, DOI 10.1016/S0014-5793(99)00896-0; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Marinoni EN, 2012, ANGEW CHEM INT EDIT, V51, P5439, DOI 10.1002/anie.201201708; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mielcarek A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122538; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Musco G, 2000, STRUCTURE, V8, P695, DOI 10.1016/S0969-2126(00)00158-1; Outten FW, 2003, J BIOL CHEM, V278, P45713, DOI 10.1074/jbc.M308004200; Pastore C, 2006, STRUCTURE, V14, P857, DOI 10.1016/j.str.2006.02.010; Pohl Thomas, 2007, BMC Biochemistry, V8, DOI 10.1186/1471-2091-8-13; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Qi WB, 2010, CHEM COMMUN, V46, P719, DOI 10.1039/b911975b; Roche B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005134; Selbach B, 2010, BIOCHEMISTRY-US, V49, P8794, DOI 10.1021/bi101358k; Selbach BP, 2014, BIOCHEMISTRY-US, V53, P152, DOI 10.1021/bi4011978; Shi R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000354; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; Silberg JJ, 2001, J BIOL CHEM, V276, P1696, DOI 10.1074/jbc.M009542200; Singh H, 2013, J BIOL CHEM, V288, P36189, DOI 10.1074/jbc.M113.525709; SUN DX, 1993, J BACTERIOL, V175, P1423, DOI 10.1128/JB.175.5.1423-1432.1993; Takahashi Y, 2002, J BIOL CHEM, V277, P28380, DOI 10.1074/jbc.C200365200; Tokumoto U, 2001, J BIOCHEM, V130, P63, DOI 10.1093/oxfordjournals.jbchem.a002963; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Wang T, 2008, J BIOL CHEM, V283, P12674, DOI 10.1074/jbc.M800399200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wollers S, 2010, J BIOL CHEM, V285, P23329, DOI 10.1074/jbc.M110.127449; Yoon H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005135; Yoon H, 2012, BIOCHEM J, V441, P473, DOI 10.1042/BJ20111637; Yoon T, 2003, J AM CHEM SOC, V125, P6078, DOI 10.1021/ja027967i; Zheng LM, 1998, J BIOL CHEM, V273, P13264, DOI 10.1074/jbc.273.21.13264	68	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158749	10.1371/journal.pone.0158749	http://dx.doi.org/10.1371/journal.pone.0158749			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27382962	Green Submitted, gold, Green Published			2022-12-26	WOS:000379809400082
J	Campoy, EM; Laurito, SR; Branham, MT; Urrutia, G; Mathison, A; Gago, F; Orozco, J; Urrutia, R; Mayorga, LS; Roque, M				Campoy, Emanuel M.; Laurito, Sergio R.; Branham, Maria T.; Urrutia, Guillermo; Mathison, Angela; Gago, Francisco; Orozco, Javier; Urrutia, Raul; Mayorga, Luis S.; Roque, Maria			Asymmetric Cancer Hallmarks in Breast Tumors on Different Sides of the Body	PLOS ONE			English	Article							PROMOTER HYPERMETHYLATION; METHYLATION PROFILE; LATERALITY; ASSOCIATION; SURVIVAL	During the last decades it has been established that breast cancer arises through the accumulation of genetic and epigenetic alterations in different cancer related genes. These alterations confer the tumor oncogenic abilities, which can be resumed as cancer hallmarks (CH). The purpose of this study was to establish the methylation profile of CpG sites located in cancer genes in breast tumors so as to infer their potential impact on 6 CH: i.e. sustained proliferative signaling, evasion of growth suppressors, resistance to cell death, induction of angiogenesis, genome instability and invasion and metastasis. For 51 breast carcinomas, MS-MLPA derived-methylation profiles of 81 CpG sites were converted into 6 CH profiles. CH profiles distribution was tested by different statistical methods and correlated with clinical-pathological data. Unsupervised Hierarchical Cluster Analysis revealed that CH profiles segregate in two main groups (bootstrapping 90-100%), which correlate with breast laterality (p = 0.05). For validating these observations, gene expression data was obtained by RealTime-PCR in a different cohort of 25 tumors and converted into CH profiles. This analyses confirmed the same clustering and a tendency of association with breast laterality (p = 0.15). In silico analyses on gene expression data from TCGA Breast dataset from left and right breast tumors showed that they differed significantly when data was previously converted into CH profiles (p = 0.033). We show here for the first time, that breast carcinomas arising on different sides of the body present differential cancer traits inferred from methylation and expression profiles. Our results indicate that by converting methylation or expression profiles in terms of Cancer Hallmarks, it would allow to uncover veiled associations with clinical features. These results contribute with a new finding to the better understanding of breast tumor behavior, and can moreover serve as proof of principle for other bilateral cancers like lung, testes or kidney.	[Campoy, Emanuel M.; Laurito, Sergio R.; Branham, Maria T.; Urrutia, Guillermo; Mayorga, Luis S.; Roque, Maria] IHEM CONICET, Mendoza, Argentina; [Campoy, Emanuel M.; Gago, Francisco; Orozco, Javier; Mayorga, Luis S.] Natl Univ Cuyo, Fac Med Sci, Mendoza, Argentina; [Laurito, Sergio R.; Roque, Maria] Natl Univ Cuyo, Fac Exact Sci, Mendoza, Argentina; [Mathison, Angela; Urrutia, Raul] Mayo Clin, Epigenet & Chromatin Dynam Lab, Div Gastroenterol & Hepatol, GI Res Unit,Epigen Translat Program,Ctr Individua, Rochester, MN USA; [Gago, Francisco; Orozco, Javier] Gineco Mamario Inst, Mendoza, Argentina; [Gago, Francisco; Orozco, Javier] Italian Hosp Mendoza, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza; University Nacional Cuyo Mendoza; Mayo Clinic	Roque, M (corresponding author), IHEM CONICET, Mendoza, Argentina.; Roque, M (corresponding author), Natl Univ Cuyo, Fac Exact Sci, Mendoza, Argentina.	mroque@mendoza-conicet.gob.ar		Mayorga, Luis S/0000-0002-5995-0671; Campoy, Emanuel/0000-0003-0521-6073; Mathison, Angela/0000-0002-6763-2710	Argentine National Institute of Cancer from Argentina; Scientific and Technical Secretary (SECTyP) of the National University of Cuyo, Argentina; Argentine National Institute of Cancer (INC); American Society of Biochemist and Molecular Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER	Argentine National Institute of Cancer from Argentina; Scientific and Technical Secretary (SECTyP) of the National University of Cuyo, Argentina; Argentine National Institute of Cancer (INC); American Society of Biochemist and Molecular Biology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been in part supported by a Grant from the Argentine National Institute of Cancer from Argentina and from the Scientific and Technical Secretary (SECTyP) of the National University of Cuyo, Argentina (MR received the funding).; This work has been in part supported by a Grant from the Argentine National Institute of Cancer (INC) and from the Scientific and Technical Secretary (SECTyP) of the National University of Cuyo, Argentina. EC obtained a fellowship from the American Society of Biochemist and Molecular Biology to perform the gene expression assays.	Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Bediaga NG, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2721; Borisenkov MF, 2001, SURVIVAL HUMAN BREAS, V27, P631; Branham MT, 2012, ONCOGENESIS, V1, DOI 10.1038/oncsis.2012.17; Brim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020216; Cappello F, 2001, J ANAT, V199, P617, DOI 10.1017/S002187820100841X; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Dammann R, 2001, CANCER RES, V61, P3105; Dane S, 2008, LYMPHOLOGY, V41, P75; de Blacam C, 2011, IRISH J MED SCI, V180, P727, DOI 10.1007/s11845-011-0713-5; Delahunt B, 1994, RENAL CELL CARCINOMA, P300; Dong SM, 2005, MODERN PATHOL, V18, P170, DOI 10.1038/modpathol.3800261; Fatima N, 2013, ASIAN PAC J CANCER P, V14, P43, DOI 10.7314/APJCP.2013.14.1.43; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Garfinkel L, 1969, APPRAISAL LEFT RIGHT, V1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARTVEIT F, 1984, ONCOLOGY, V41, P149, DOI 10.1159/000225812; HSIEH CC, 1991, EUR J CANCER, V27, P131, DOI 10.1016/0277-5379(91)90469-T; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Marzese DM, 2012, J MOL DIAGN, V14, P613, DOI 10.1016/j.jmoldx.2012.07.001; Marzese DM, 2010, MOL CELL PROBE, V24, P271, DOI 10.1016/j.mcp.2010.05.002; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Moelans CB, 2011, J PATHOL, V225, P222, DOI 10.1002/path.2930; Onibokun O, 2015, BREAST J, V21, P213, DOI 10.1111/tbj.12385; Perkins CI, 2004, CANCER CAUSE CONTROL, V15, P637, DOI 10.1023/B:CACO.0000036171.44162.5f; Robichaux JP, 2015, ONCOGENE, V34, P2003, DOI 10.1038/onc.2014.149; Roychoudhuri R, 2006, CANCER CAUSE CONTROL, V17, P655, DOI 10.1007/s10552-005-0615-9; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Sodir NM, 2011, ONCOTARGET, V2, P1307; STONE JM, 1991, BRIT J CANCER, V64, P132, DOI 10.1038/bjc.1991.256; Twelves D, 2013, BREAST CANCER RES TR, V139, P341, DOI 10.1007/s10549-013-2544-8; Veltmaat JM, 2013, J MAMMARY GLAND BIOL, V18, P179, DOI 10.1007/s10911-013-9287-3; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Waterland RA, 2009, EPIGENETICS-US, V4, P523, DOI 10.4161/epi.4.8.10155; Wilting J, 2011, CURR MED CHEM, V18, P5519, DOI 10.2174/092986711798347252	38	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157416	10.1371/journal.pone.0157416	http://dx.doi.org/10.1371/journal.pone.0157416			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383829	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400013
J	Groot, E; Kouyoumdjian, FG; Kiefer, L; Madadi, P; Gross, J; Prevost, B; Jhirad, R; Huyer, D; Snowdon, V; Persaud, N				Groot, Emily; Kouyoumdjian, Fiona G.; Kiefer, Lori; Madadi, Parvaz; Gross, Jeremy; Prevost, Brittany; Jhirad, Reuven; Huyer, Dirk; Snowdon, Victoria; Persaud, Navindra			Drug Toxicity Deaths after Release from Incarceration in Ontario, 2006-2013: Review of Coroner's Cases	PLOS ONE			English	Review							THERAPEUTIC-COMMUNITY TREATMENT; OPIOID SUBSTITUTION THERAPY; MORTALITY; PRISON; RISK; INMATES; OFFENDERS; OVERDOSE; SCOTLAND; IMPACT	Background There is an increased risk of death due to drug toxicity after release from incarceration. The purpose of this study was to describe the timing, rate and circumstances of drug toxicity deaths following release from incarceration. This information can be used to help design potential preventive interventions. Methods and Findings We reviewed coroner's files to identify deaths in adults in Ontario between 2006 and 2013 caused by drug toxicity (n = 6,978) and these records were matched with provincial correctional records to identify individuals who died within one year of being released from incarceration (n = 702). Twenty percent (n = 137) of the 702 deaths occurred within one week of release. The majority (77%, n = 538) of deaths after release involved one or more opioids. Of the deaths involving opioids, intervention by another person may have been possible in 318 cases. Conclusions Between 2006 and 2013 in Ontario, one in ten drug toxicity deaths in adults occurred within one year of release from provincial incarceration. These findings may help to inform the implemention and assessment of interventions aimed at reducing drug toxicity deaths following release from incarceration.	[Groot, Emily] Queens Univ, Dept Family Med, Kingston, ON, Canada; [Kouyoumdjian, Fiona G.; Persaud, Navindra] St Michaels Hosp, Toronto, ON, Canada; [Kiefer, Lori] Ontario Minist Community Safety & Correct Serv, Toronto, ON, Canada; [Kiefer, Lori] Unviers Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Madadi, Parvaz] Ctr Forens Sci, Toronto, ON, Canada; [Gross, Jeremy; Prevost, Brittany] Univ Toronto, Fac Med, Toronto, ON, Canada; [Jhirad, Reuven; Huyer, Dirk; Snowdon, Victoria; Persaud, Navindra] Off Chief Coroner Ontario, Toronto, ON, Canada; [Persaud, Navindra] Univ Toronto, Toronto, ON, Canada	Queens University - Canada; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto	Persaud, N (corresponding author), St Michaels Hosp, Toronto, ON, Canada.; Persaud, N (corresponding author), Off Chief Coroner Ontario, Toronto, ON, Canada.; Persaud, N (corresponding author), Univ Toronto, Toronto, ON, Canada.	nav.persaud@utoronto.ca	Cuscó, Xavier Garcia/S-7576-2019	Cuscó, Xavier Garcia/0000-0001-7199-6931				Andrews JY, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-270; [Anonymous], 2010, MICR EXC; [Anonymous], 2014, PREV OV DEATHS CRIM; Beswick T, 2002, J DRUG ISSUES, V32, P1103, DOI 10.1177/002204260203200406; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Binswanger IA, 2013, ANN INTERN MED, V159, P592, DOI 10.7326/0003-4819-159-9-201311050-00005; Binswanger IA, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-3; Bird SM, 2015, ADDICTION, V110, P1617, DOI 10.1111/add.12969; Bird SM, 2003, ADDICTION, V98, P185, DOI 10.1046/j.1360-0443.2003.00264.x; Christensen PB, 2006, INT J PRISON HEALTH, V2, P13, DOI 10.1080/17449200600743644; Degenhardt L, 2014, ADDICTION, V109, P1306, DOI 10.1111/add.12536; Farrell M, 2008, ADDICTION, V103, P251, DOI 10.1111/j.1360-0443.2007.02081.x; Forsberg LG, 2011, SUBST USE MISUSE, V46, P1477, DOI 10.3109/10826084.2011.591880; Freudenberg N, 2010, J ADOLESCENT HEALTH, V47, P448, DOI 10.1016/j.jadohealth.2010.01.008; Grommon E, 2013, J OFFENDER REHABIL, V52, P287, DOI 10.1080/10509674.2013.782775; HARDINGPINK D, 1988, BRIT MED J, V297, P596, DOI 10.1136/bmj.297.6648.596; Information Services Division of the NHS National Services Scotland [Internet], 2014, NAT NAL PROGR SCOTL; Joukamaa M, 1998, FORENSIC SCI INT, V96, P11, DOI 10.1016/S0379-0738(98)00098-X; Kariminia A, 2007, INT J EPIDEMIOL, V36, P310, DOI 10.1093/ije/dyl225; Kouyoumdjian Fiona G, 2016, CMAJ Open, V4, pE153, DOI 10.9778/cmajo.20150098; Kouyoumdjian FG, 2015, AM J PUBLIC HEALTH, V105, pE13, DOI 10.2105/AJPH.2014.302498; Kouyoumdjian FG, 2014, CAN J PUBLIC HEALTH, V105, pE198, DOI 10.17269/cjph.105.4193; Krinsky CS, 2009, AM J FOREN MED PATH, V30, P6, DOI 10.1097/PAF.0b013e3181873784; Lattimore PK, 1997, J RES CRIME DELINQ, V34, P187, DOI 10.1177/0022427897034002002; Luce J, 2011, CROSS CANADA SCAN ME; Lyons S, 2010, INT J PRISON HLTH, V35, P26; Madadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060600; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Needels K, 2005, J URBAN HEALTH, V82, P420, DOI 10.1093/jurban/jti092; Prendergast M, 2011, J EXP CRIMINOL, V7, P225, DOI 10.1007/s11292-011-9123-y; Putkonen H, 2001, FORENSIC SCI INT, V119, P221, DOI 10.1016/S0379-0738(00)00431-X; Sacks JY, 2012, J ADDICT DIS, V31, P258, DOI 10.1080/10550887.2012.694601; Statistics Canada, 2014, POP AG SEX POP EST A; Stewart LM, 2004, AUST NZ J PUBL HEAL, V28, P32, DOI 10.1111/j.1467-842X.2004.tb00629.x; Strang J, 2013, J URBAN HEALTH, V90, P983, DOI 10.1007/s11524-013-9803-1; Sullivan CJ, 2007, AM J DRUG ALCOHOL AB, V33, P823, DOI 10.1080/00952990701653800; Verger P, 2003, J FORENSIC SCI, V48, P614; WHO, 2014, COMM MAN OP OV; Zakaria D., 2010, SUMMARY EMERGING FIN; Zlotnick C, 2009, BEHAV THER, V40, P325, DOI 10.1016/j.beth.2008.09.004	40	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157512	10.1371/journal.pone.0157512	http://dx.doi.org/10.1371/journal.pone.0157512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27384044	gold, Green Published, Green Submitted			2022-12-26	WOS:000379809400014
J	Song, YF; Nikoloff, JM; Fu, G; Chen, JQ; Li, QG; Xie, NZ; Zheng, P; Sun, JB; Zhang, DW				Song, Yafeng; Nikoloff, Jonas M.; Fu, Gang; Chen, Jingqi; Li, Qinggang; Xie, Nengzhong; Zheng, Ping; Sun, Jibin; Zhang, Dawei			Promoter Screening from Bacillus subtilis in Various Conditions Hunting for Synthetic Biology and Industrial Applications	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAIN; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; RIBOFLAVIN PRODUCTION; RNA-POLYMERASE; SYSTEMS; DESIGN; BIOSYNTHESIS; ADAPTATION; STRESS	The use of Bacillus subtilis in synthetic biology and metabolic engineering is highly desirable to take advantage of the unique metabolic pathways present in this organism. To do this, an evaluation of B. subtilis' intrinsic biological parts is required to determine the best strategies to accurately regulate metabolic circuits and expression of target proteins. The strengths of promoter candidates were evaluated by measuring relative fluorescence units of a green fluorescent protein reporter, integrated into B. subtilis' chromosome. A total of 84 predicted promoter sequences located upstream of different classes of proteins including heat shock proteins, cell-envelope proteins, and proteins resistant against toxic metals (based on similarity) and other kinds of genes were tested. The expression levels measured ranged from 0.0023 to 4.53-fold of the activity of the well-characterized strong promoter P43. No significant shifts were observed when strains, carrying different promoter candidates, were cultured at high temperature or in media with ethanol, but some strains showed increased activity when cultured under high osmotic pressure. Randomly selected promoter candidates were tested and found to activate transcription of thermostable beta-galactosidase (bgaB) at a similar level, implying the ability of these sequences to function as promoter elements in multiple genetic contexts. In addition, selected promoters elevated the final production of both cytoplasmic bgaB and secreted protein alpha-amylase to about fourfold and twofold, respectively. The generated data allows a deeper understanding of B. subtilis' metabolism and will facilitate future work to develop this organism for synthetic biology.	[Song, Yafeng; Nikoloff, Jonas M.; Fu, Gang; Chen, Jingqi; Li, Qinggang; Zheng, Ping; Sun, Jibin; Zhang, Dawei] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China; [Song, Yafeng; Fu, Gang; Chen, Jingqi; Li, Qinggang; Zheng, Ping; Sun, Jibin; Zhang, Dawei] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China; [Xie, Nengzhong] Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass Energy & Enzyme Tec, Nanning 5300074, Peoples R China; [Xie, Nengzhong] Guangxi Acad Sci, Guangxi Biomass Ind Engn Inst, Nanning 530007, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Chinese Academy of Sciences	Zhang, DW (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin 300308, Peoples R China.; Zhang, DW (corresponding author), Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin 300308, Peoples R China.	zhang_dw@tib.cas.cn	Chen, Jingqi/AAE-6883-2022	Chen, Jingqi/0000-0003-0750-8539; Sun, Jibin/0000-0002-0208-504X	National Nature Science Foundation of China [31370089, 21506244, 31400079]; State Key Development 973 Program for Basic Research of China [2013CB733601]; Nature Science Foundation of Tianjin City (CN) [16JCYBJC23500, 15JCQNJC09500]; Guangxi Science and Technology Development Project [14125008-2-22]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Development 973 Program for Basic Research of China; Nature Science Foundation of Tianjin City (CN); Guangxi Science and Technology Development Project	This work was supported by National Nature Science Foundation of China (31370089 to DZ, 21506244 to GF, 31400079 to NX; http://www.nsfc.gov.cn/), State Key Development 973 Program for Basic Research of China (2013CB733601 to DZ, http://www.most.gov.cn/), Nature Science Foundation of Tianjin City (CN) (16JCYBJC23500 to DZ, 15JCQNJC09500 to DZ; http://www.tstc.gov.cn/) and the Guangxi Science and Technology Development Project (14125008-2-22 to NX; http://www.gxsti.net.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Asai K, 2007, MICROBIOL-SGM, V153, P92, DOI 10.1099/mic.0.29239-0; Bai C, 2015, P NATL ACAD SCI US; Bernhardt J, 2003, GENOME RES, V13, P224, DOI 10.1101/gr.905003; Bienick MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109105; Blazeck J, 2011, APPL ENVIRON MICROB, V77, P7905, DOI 10.1128/AEM.05763-11; Brewster RC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002811; Chen JQ, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0282-9; Chen JQ, 2015, BIOTECHNOL LETT, V37, P899, DOI 10.1007/s10529-014-1755-3; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curran KA, 2013, METAB ENG, V19, P88, DOI 10.1016/j.ymben.2013.07.001; Davis JH, 2011, NUCLEIC ACIDS RES, V39, P1131, DOI 10.1093/nar/gkq810; Dempwolff F, 2012, J BACTERIOL, V194, P4652, DOI 10.1128/JB.00910-12; Duan YX, 2010, APPL MICROBIOL BIOT, V85, P1907, DOI 10.1007/s00253-009-2247-6; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Ferreira LCS, 2005, AN ACAD BRAS CIENC, V77, P113, DOI 10.1590/S0001-37652005000100009; Gerosa L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.14; Guo XR, 2005, J BIOL CHEM, V280, P39601, DOI 10.1074/jbc.M508132200; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; HALDENWANG WG, 1995, MICROBIOL REV, V59, P1; Haynes KA, 2009, J CELL BIOL, V187, P589, DOI 10.1083/jcb.200908138; Higgins D, 2012, FEMS MICROBIOL REV, V36, P131, DOI 10.1111/j.1574-6976.2011.00310.x; Jervis AJ, 2007, J BACTERIOL, V189, P4534, DOI 10.1128/JB.00130-07; Jones KL, 2000, METAB ENG, V2, P328, DOI 10.1006/mben.2000.0161; Kang SY, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0268-7; Kang SY, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-153; Keren L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.59; Kingston AW, 2013, MOL MICROBIOL, V90, P502, DOI 10.1111/mmi.12380; Koga K, 2006, J GEN APPL MICROBIOL, V52, P119, DOI 10.2323/jgam.52.119; Kohlstedt M, 2014, ENVIRON MICROBIOL, V16, P1898, DOI 10.1111/1462-2920.12438; Liu L, 2013, APPL MICROBIOL BIOT, V97, P6113, DOI 10.1007/s00253-013-4960-4; Lou CB, 2012, NAT BIOTECHNOL, V30, P1137, DOI 10.1038/nbt.2401; Ng CY, 2015, CURR OPIN CHEM BIOL, V28, P105, DOI 10.1016/j.cbpa.2015.06.026; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Overkamp W, 2015, ENVIRON MICROBIOL, V17, P346, DOI 10.1111/1462-2920.12676; Qi H, 2015, BIOTECHNOL ADV; Quan JY, 2011, NAT BIOTECHNOL, V29, P449, DOI 10.1038/nbt.1847; Rollenhagen C, 2003, J BACTERIOL, V185, P35, DOI 10.1128/JB.185.1.35-40.2003; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schumann W, 2003, CELL STRESS CHAPERON, V8, P207, DOI 10.1379/1466-1268(2003)008<0207:TBSHSS>2.0.CO;2; Smolke CD, 2011, CELL, V144, P855, DOI 10.1016/j.cell.2011.02.020; Tamehiro N, 2002, ANTIMICROB AGENTS CH, V46, P315, DOI 10.1128/AAC.46.2.315-320.2002; Tojo S, 2008, J BACTERIOL, V190, P6134, DOI 10.1128/JB.00606-08; Trang TPP, 2012, J BIOTECHNOL, V157, P167, DOI 10.1016/j.jbiotec.2011.10.006; Wang GL, 2014, WORLD J MICROB BIOT, V30, P1893, DOI [10.1007/s11274-014-1611-6, 1]; Wang JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062960; WANG PZ, 1984, J BIOL CHEM, V259, P8619; Wang ZW, 2011, BIORESOURCE TECHNOL, V102, P3934, DOI 10.1016/j.biortech.2010.11.120; Westers L, 2004, BBA-MOL CELL RES, V1694, P299, DOI 10.1016/j.bbamcr.2004.02.011; Wong Ng J., 2010, PHYS REV E, V81; Yamanishi M, 2013, ACS SYNTH BIOL, V2, P337, DOI 10.1021/sb300116y; You C, 2012, APPL ENVIRON MICROB, V78, P1593, DOI 10.1128/AEM.07105-11; YUAN G, 1995, J BACTERIOL, V177, P5427, DOI 10.1128/jb.177.19.5427-5433.1995; Zhang FZ, 2012, NAT BIOTECHNOL, V30, P354, DOI 10.1038/nbt.2149; Zhang XZ, 2014, METHODS MOL BIOL, V1151, P95, DOI 10.1007/978-1-4939-0554-6_7	57	73	83	8	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158447	10.1371/journal.pone.0158447	http://dx.doi.org/10.1371/journal.pone.0158447			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380260	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700032
J	Best, CM; Pressman, EK; Cao, C; Cooper, E; Guillet, R; Yost, OL; Galati, J; Kent, TR; O'Brien, KO				Best, Cora M.; Pressman, Eva K.; Cao, Chang; Cooper, Elizabeth; Guillet, Ronnie; Yost, Olivia L.; Galati, Jonathan; Kent, Tera R.; O'Brien, Kimberly O.			Maternal iron status during pregnancy compared with neonatal iron status better predicts placental iron transporter expression in humans	FASEB JOURNAL			English	Article						anemia; heme; TfR1 hepcidin; adolescents	FETAL IRON; MOLECULAR-BASIS; HEME EXPORTER; IDENTIFICATION; HEPCIDIN; RECEPTOR; METABOLISM; ANEMIA; DEFICIENCY; PROTEINS	The placenta richly expresses nonheme and heme Fe transport proteins. To address the impact of maternal and neonatal Fe status and hepcidin on the regulation of these proteins, mRNA expression and protein abundance of nonheme and heme Fe transport proteins were evaluated in placental tissue from 154 adolescents. Regression analyses found maternal Fe status was significantly associated with multiple placental nonheme and heme transporters, whereas neonatal Fe status was related to only 3 heme transporters. Across statistical analyses, maternal Fe status was consistently associated with the placental nonheme Fe importer transferrin receptor 1 (TfR1). Protein abundance of TfR1 was related to midgestation maternal serum ferritin (SF) (beta = -0.32; P = 0.005) and serum TfR (beta = 0.25; P = 0.024). Protein abundance of the heme importer, proton-coupled folate transporter, was related to neonatal SF (beta = 0.30; P = 0.016) and serum TfR (beta = -0.46; P < 0.0001). Neonatal SF was also related to mRNA expression of the heme exporter feline leukemia virus subgroup C receptor 1 (beta = -0.30; P = 0.004). In summary, maternal Fe insufficiency during pregnancy predicts increased expression of the placental nonheme Fe transporter TfR1. Associations between placental heme Fe transporters and neonatal Fe status require further study.	[Best, Cora M.; Yost, Olivia L.; Galati, Jonathan; Kent, Tera R.; O'Brien, Kimberly O.] Cornell Univ, Div Nutr Sci, 230 Savage Hall, Ithaca, NY 14853 USA; [Pressman, Eva K.; Cooper, Elizabeth; Guillet, Ronnie] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Cao, Chang] Boston Childrens Hosp, Dept Pathol, Boston, MA USA	Cornell University; University of Rochester; Harvard University; Boston Children's Hospital	O'Brien, KO (corresponding author), Cornell Univ, Div Nutr Sci, 230 Savage Hall, Ithaca, NY 14853 USA.	koo4@cornell.edu	Cao, Chang/AAP-6072-2021; Pressman, Eva K/AAG-5564-2020	Cao, Chang/0000-0003-3625-8807; Pressman, Eva K/0000-0002-2556-9290; Best, Cora/0000-0001-8400-9288	U.S. Department of Agriculture [2005-35200, 2008-01857]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [T32-DK007158]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007158] Funding Source: NIH RePORTER	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. Department of Agriculture Grants 2005-35200 and 2008-01857, and by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant T32-DK007158. The authors thank Francoise Vermeylen and Dr. Erika Mudrak (Cornell University) for technical assistance with statistical analyses and Ann Lei for work to create Supplemental Fig. 1. The authors also thank Dr. Iqbal Hamza (University of Maryland, College Park, MD, USA) for the gift of HRG1 antibody, and Dr. Janis Abkowitz (University of Washington, Seattle, WA, USA) for the gift of the FLVCR1 antibody. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK or the NIH. The authors declare no conflicts of interest.	Balesaria S, 2012, HAEMATOL-HEMATOL J, V97, P661, DOI 10.3324/haematol.2011.055046; Bastin J, 2006, BRIT J HAEMATOL, V134, P532, DOI 10.1111/j.1365-2141.2006.06216.x; Bradley J, 2004, AM J PHYSIOL-REG I, V287, pR894, DOI 10.1152/ajpregu.00525.2003; Cao C, 2014, REPRODUCTION, V148, P295, DOI 10.1530/REP-14-0053; Cao C, 2013, NUTR REV, V71, P35, DOI 10.1111/j.1753-4887.2012.00550.x; CARPENTER CE, 1992, CRIT REV FOOD SCI, V31, P333, DOI 10.1080/10408399209527576; Carter AM, 2012, PHYSIOL REV, V92, P1543, DOI 10.1152/physrev.00040.2011; Center for Disease Control and Prevention, 1998, MMWR MORB MORTAL WKL, V47, P1; Chen HJ, 2010, J NUTR, V140, P1728, DOI 10.3945/jn.109.117531; Earl R., 1993, IRON DEFICIENCY ANEM; Evans P, 2011, MOL HUM REPROD, V17, P227, DOI 10.1093/molehr/gaq101; Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x; Gambling L, 2001, BIOCHEM J, V356, P883, DOI 10.1042/0264-6021:3560883; Gambling L, 2009, AM J PHYSIOL-REG I, V296, pR1063, DOI 10.1152/ajpregu.90793.2008; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Garcia-Valdes L, 2015, INT J OBESITY, V39, P571, DOI 10.1038/ijo.2015.3; Georgieff MK, 2007, AM J CLIN NUTR, V85, p614S; Georgieff MK, 2000, PLACENTA, V21, P799, DOI 10.1053/plac.2000.0566; Gleason PM, 2015, J ACAD NUTR DIET, V115, P1072, DOI 10.1016/j.jand.2015.03.011; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Institute of Medicine Panel on Micronutrients, 2001, DIET REF INT VIT A V; Jaacks LM, 2011, J NUTR, V141, P1267, DOI 10.3945/jn.110.135798; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Latunde-Dada GO, 2006, FEBS LETT, V580, P6865, DOI 10.1016/j.febslet.2006.11.048; Le Blanc S, 2012, AM J PHYSIOL-CELL PH, V302, pC1780, DOI 10.1152/ajpcell.00080.2012; Lee S. M., 2014, ICAN: Infant, Child & Adolescent Nutrition, V6, P152, DOI 10.1177/1941406414525993; Lee S, 2016, PEDIATR RES, V79, P42, DOI 10.1038/pr.2015.183; Lee S, 2014, J NUTR, V144, P1524, DOI 10.3945/jn.114.191445; Martin ME, 2004, FEBS LETT, V574, P187, DOI 10.1016/j.febslet.2004.08.010; Muehlenbachs A, 2007, J IMMUNOL, V179, P557, DOI 10.4049/jimmunol.179.1.557; Nathan DG, 2009, HEMATOLOGY INFANCY C, V7th; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; O'Brien KO, 2014, J CLIN ENDOCR METAB, V99, P1348, DOI 10.1210/jc.2013-1366; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rao R, 2007, SEMIN FETAL NEONAT M, V12, P54, DOI 10.1016/j.siny.2006.10.007; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; VITERI FE, 1994, ADV EXP MED BIOL, V352, P127; Whisner CM, 2014, J BONE MINER RES, V29, P2109, DOI 10.1002/jbmr.2233; Young BE, 2014, FASEB J, V28, P2029, DOI 10.1096/fj.13-246736; Young MF, 2010, PLACENTA, V31, P1010, DOI 10.1016/j.placenta.2010.08.009; Young ME, 2012, J NUTR, V142, P33, DOI 10.3945/jn.111.145961	45	25	25	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3541	3550		10.1096/fj.201600069R	http://dx.doi.org/10.1096/fj.201600069R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27402672	Green Published			2022-12-26	WOS:000384329800023
J	Wijayathilaka, N; Meegaskumbura, M				Wijayathilaka, Nayana; Meegaskumbura, Madhava			An Acoustic Analysis of the Genus Microhyla (Anura: Microhylidae) of Sri Lanka	PLOS ONE			English	Article							ADVERTISEMENT CALLS; VOCAL REPERTOIRE; WESTERN-GHATS; FROG; BEHAVIOR; TOADS	Vocalizing behavior of frogs and toads, once quantified, is useful for systematics, rapid species identification, behavioral experimentation and conservation monitoring. But yet, for many lineages vocalizations remain unknown or poorly quantified, especially in diversity rich tropical regions. Here we provide a quantitative acoustical analysis for all four Sri Lankan congeners of the genus Microhyla. Three of these species are endemic to the island, but Microhyla ornata is regionally widespread. Two of these endemics, M. karunaratnei (Critically Endangered) and M. zeylanica (Endangered), are highly threatened montane isolates; the other, M. mihintalei, is relatively common across the dry lowlands. We recorded and analyzed 100 advertisement calls from five calling males for each species, except for M. zeylanica, which only had 53 calls from three males suitable for analyses. All four species call in choruses and their vocal repertoires are simple compared to most frogs. Their calls contain multiple pulses and no frequency modulation. We quantified eight call characters. Call duration and number of pulses were higher for the two montane isolates (inhabiting cooler habitats at higher altitudes) compared to their lowland congeners. Microhyla zeylanica has the longest call duration (of 1.8 +/- 0.12 s) and the highest number of pulses (of 6192 pulses). The smallest of the species, Microhyla karunaratnei (16.2-18.3 mm), has the highest mean dominant frequency (3.3 +/- 0.14 kHz) and pulse rate (77 +/- 5.8 pulses per second). The calls separate well in the Principal Component space: PC1 axis is mostly explained by the number of pulses per call and call duration; PC2 is mostly explained by the pulse rate. A canonical means plot of a Discriminant Function analysis shows non-overlapping 95% confidence ellipses. This suggests that some call parameters can be used to distinguish these species effectively. We provide detailed descriptions for eight call properties and compare these with congeners for which data is available. This work provides a foundation for comparative bioacoustic analyses and species monitoring while facilitating the systematics of Microhyla across its range.	[Meegaskumbura, Madhava] Univ Peradeniya, Dept Mol Biol & Biotechnol, Fac Sci, Peradeniya 20400, Sri Lanka; Univ Peradeniya, Postgrad Inst Sci, Peradeniya 20400, Sri Lanka	University of Peradeniya; University of Peradeniya	Meegaskumbura, M (corresponding author), Univ Peradeniya, Dept Mol Biol & Biotechnol, Fac Sci, Peradeniya 20400, Sri Lanka.	madhavam@pdn.ac.lk	Meegaskumbura, Madhava/F-8782-2013; Wijayathilaka, Nayana/B-2652-2018	Meegaskumbura, Madhava/0000-0002-4599-6724; Wijayathilaka, Nayana/0000-0002-7376-7355	National Research Council of Sri Lanka [NRC 11-124]; University of Peradeniya Research Grant [RG/2012/45/S]	National Research Council of Sri Lanka; University of Peradeniya Research Grant	This research was supported by the National Research Council of Sri Lanka (NRC 11-124) to MM, and the University of Peradeniya Research Grant (RG/2012/45/S) to MM.	Aide TM, 2013, PEERJ, V1, DOI 10.7717/peerj.103; Angulo A, 2010, SYST BIODIVERS, V8, P357, DOI 10.1080/14772000.2010.507264; [Anonymous], 2015, IUCN RED LIST THREAT; ARAK A, 1983, ANIM BEHAV, V31, P292, DOI 10.1016/S0003-3472(83)80199-7; Bee MA, 2001, ETHOLOGY, V107, P65, DOI 10.1046/j.1439-0310.2001.00640.x; Bee MA, 2013, BIOACOUSTICS, V22, P67, DOI 10.1080/09524622.2012.712750; Bee MA, 2013, HERPETOLOGICA, V69, P22, DOI 10.1655/HERPETOLOGICA-D-11-00042; Bosch J, 2004, CAN J ZOOL, V82, P880, DOI 10.1139/Z04-060; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; Bridges AS, 2000, COPEIA, P587, DOI 10.1643/0045-8511(2000)000[0587:TVIACB]2.0.CO;2; COCROFT RB, 1995, ANIM BEHAV, V49, P283, DOI 10.1006/anbe.1995.0043; Dehling JM, 2010, SALAMANDRA, V46, P114; Dring JCM., 1979, B BR MUS, V34; Dutta SK, 1996, AMPHIBIAN FAUNA SRI; Fernando Prithiviraj, 1996, Journal of South Asian Natural History, V2, P135; Frost DR., 2015, AMPHIBIAN SPECIES OF; GAYOU DC, 1984, COPEIA, P733, DOI 10.2307/1445157; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Glaw F., 2010, ZOOTAXA, V2383, P82; Grosselet Olivier, 2004, Hamadryad, V29, P131; Heyer R, 2014, MEASURING AND MONITO; HEYER W R, 1971, Fieldiana Zoology, V58, P61; Howlader MSA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119825; KANAMADI RD, 1994, CURR SCI INDIA, V66, P683; Kelley DB, 2004, CURR OPIN NEUROBIOL, V14, P751, DOI 10.1016/j.conb.2004.10.015; KURAMOTO M, 1987, ZOOL SCI, V4, P563; Kuramoto Mitsuru, 2006, Current Herpetology, V25, P15, DOI 10.3105/1345-5834(2006)25[15:MAACOM]2.0.CO;2; Marquez R, 2006, J NAT HIST, V40, P571, DOI 10.1080/00222930600712129; Meegaskumbura M, 2002, SCIENCE, V298, P379, DOI 10.1126/science.298.5592.379; Meegaskumbura M, 2015, ZOOTAXA, V3911, P245, DOI 10.11646/zootaxa.3911.2.6; Narins PM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0401; Narins PM, 2006, SPRINGER HANDBOOK OF, DOI [10.1007/978-0-387-47796-1, DOI 10.1007/978-0-387-47796-1]; Padial JM, 2009, ZOOL J LINN SOC-LOND, V155, P97, DOI 10.1111/j.1096-3642.2008.00424.x; Parker H., 1948, J NAT HIST, V1, P759, DOI [10.1080/00222934808653944, DOI 10.1080/00222934808653944]; RAND AS, 1981, Z TIERPSYCHOL, V57, P209; Seshadri KS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149727; Toledo LF, 2015, SCIENCE, V347, P484, DOI 10.1126/science.347.6221.484-b; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; WELLS KD, 1977, ANIM BEHAV, V25, P666, DOI 10.1016/0003-3472(77)90118-X; Wells KD, 2010, THE ECOLOGY AND BEHA; Wells KD, 2007, SPR HDB AUD, V28, P44; Wijayathilaka N, 2016, ZOOTAXA, V4066, P331, DOI 10.11646/zootaxa.4066.3.9; Zoological Society of London, 2015, EDGE EX PROGR	43	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159003	10.1371/journal.pone.0159003	http://dx.doi.org/10.1371/journal.pone.0159003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403744	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508200028
J	Bishop, DVM; Snowling, MJ; Thompson, PA; Greenhalgh, T; Adams, C; Archibald, L; Baird, G; Bauer, A; Bellair, J; Boyle, C; Brownlie, E; Carter, G; Clark, B; Clegg, J; Cohen, N; Conti-Ramsden, G; Dockrell, J; Dunn, J; Ebbels, S; Gallagher, A; Gibbs, S; -Langton, EG; Grist, M; Hartshorne, M; Huneke, A; Joanisse, M; Kedge, S; Klee, T; Krishnan, S; Lascelles, L; Law, J; Leonard, L; Lynham, S; Arnold, EM; Mathura, N; McCartney, E; McKean, C; McNeill, B; Morgan, A; Murphy, CA; Norbury, C; O'Hare, A; Cardy, JO; O'Toole, C; Paul, R; Purdy, S; Redmond, S; Reilly, S; Restrepo, L; Rice, M; Slonims, V; Snow, P; Soppitt, R; Speake, J; Spencer, S; Stringer, H; Tager-Flusberg, H; Tannock, R; Taylor, C; Tomblin, B; Volden, J; Westerveld, M; Whitehouse, A				Bishop, D. V. M.; Snowling, Margaret J.; Thompson, Paul A.; Greenhalgh, Trisha; Adams, Catherine; Archibald, Lisa; Baird, Gillian; Bauer, Ann; Bellair, Jude; Boyle, Christopher; Brownlie, Elizabeth; Carter, Glenn; Clark, Becky; Clegg, Judy; Cohen, Nancy; Conti-Ramsden, Gina; Dockrell, Julie; Dunn, Janet; Ebbels, Susan; Gallagher, Aoife; Gibbs, Simon; -Langton, Emma Gore; Grist, Mandy; Hartshorne, Mary; Huneke, Alison; Joanisse, Marc; Kedge, Sally; Klee, Thomas; Krishnan, Saloni; Lascelles, Linda; Law, James; Leonard, Laurence; Lynham, Stephanie; Arnold, Elina Mainela; Mathura, Narad; McCartney, Elspeth; McKean, Cristina; McNeill, Brigid; Morgan, Angela; Murphy, Carol-Anne; Norbury, Courtenay; O'Hare, Anne; Cardy, Janis Oram; O'Toole, Ciara; Paul, Rhea; Purdy, Suzanne; Redmond, Sean; Reilly, Sheena; Restrepo, Laida; Rice, Mabel; Slonims, Vicky; Snow, Pamela; Soppitt, Richard; Speake, Jane; Spencer, Sarah; Stringer, Helen; Tager-Flusberg, Helen; Tannock, Rosemary; Taylor, Cate; Tomblin, Bruce; Volden, Joanne; Westerveld, Marleen; Whitehouse, Andrew		CATALISE Consortium	CATALISE: A Multinational and Multidisciplinary Delphi Consensus Study. Identifying Language Impairments in Children	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; DYNAMIC ASSESSMENT; YOUNG-CHILDREN; SPEECH; COMMUNICATION; DELAY; OUTCOMES; PREVALENCE; THERAPY; COMPREHENSION	Delayed or impaired language development is a common developmental concern, yet there is little agreement about the criteria used to identify and classify language impairments in children. Children's language difficulties are at the interface between education, medicine and the allied professions, who may all adopt different approaches to conceptualising them. Our goal in this study was to use an online Delphi technique to see whether it was possible to achieve consensus among professionals on appropriate criteria for identifying children who might benefit from specialist services. We recruited a panel of 59 experts representing ten disciplines (including education, psychology, speech-language therapy/pathology, paediatrics and child psychiatry) from English-speaking countries (Australia, Canada, Ireland, New Zealand, United Kingdom and USA). The starting point for round 1 was a set of 46 statements based on articles and commentaries in a special issue of a journal focusing on this topic. Panel members rated each statement for both relevance and validity on a seven-point scale, and added free text comments. These responses were synthesised by the first two authors, who then removed, combined or modified items with a view to improving consensus. The resulting set of statements was returned to the panel for a second evaluation (round 2). Consensus (percentage reporting 'agree' or 'strongly agree') was at least 80 percent for 24 of 27 round 2 statements, though many respondents qualified their response with written comments. These were again synthesised by the first two authors. The resulting consensus statement is reported here, with additional summary of relevant evidence, and a concluding commentary on residual disagreements and gaps in the evidence base.	[Bishop, D. V. M.; Snowling, Margaret J.; Thompson, Paul A.] Univ Oxford, Dept Expt Psychol, Oxford, Oxon, England; [Greenhalgh, Trisha] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxon, England; [Adams, Catherine; Conti-Ramsden, Gina] Univ Manchester, Manchester, Lancs, England; [Archibald, Lisa; Joanisse, Marc; Cardy, Janis Oram] Univ Western Ontario, London, ON, Canada; [Baird, Gillian; Bellair, Jude; Carter, Glenn; Lynham, Stephanie; Mathura, Narad; Slonims, Vicky; Soppitt, Richard; Speake, Jane] NHS, London, England; [Bauer, Ann] Vyne Community Sch, Language Resource Provis, Basingstoke, Hants, England; [Boyle, Christopher] Univ New England, Armidale, NSW, Australia; [Brownlie, Elizabeth; Cohen, Nancy; Arnold, Elina Mainela; Tannock, Rosemary] Univ Toronto, Toronto, ON, Canada; [Clark, Becky] ClarkSLT, RALLI, Surrey, England; [Clegg, Judy; Spencer, Sarah] Univ Sheffield, Sheffield, S Yorkshire, England; [Dockrell, Julie] UCL, Inst Educ, London, England; [Dunn, Janet] Meath Sch, Surrey, England; [Ebbels, Susan] Moor House Sch & Coll, Surrey, England; [Ebbels, Susan; -Langton, Emma Gore] UCL, London, England; [Gallagher, Aoife; Murphy, Carol-Anne] Univ Limerick, Dept Clin Therapies, Limerick, Ireland; [Gibbs, Simon; Law, James; McKean, Cristina; Stringer, Helen] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Grist, Mandy; Hartshorne, Mary] ICAN, London, England; [Huneke, Alison; Lascelles, Linda] Afasic, London, England; [Kedge, Sally; Purdy, Suzanne] Univ Auckland, Auckland, New Zealand; [Klee, Thomas; McNeill, Brigid] Univ Canterbury, Canterbury, New Zealand; [Krishnan, Saloni] Univ Oxford, Oxford, England; [Leonard, Laurence] Purdue Univ, W Lafayette, IN 47907 USA; [McCartney, Elspeth] Univ Strathclyde, Glasgow, Lanark, Scotland; [Morgan, Angela] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Norbury, Courtenay] Royal Holloway Univ London, London, England; [O'Hare, Anne] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [O'Toole, Ciara] Univ Coll Cork, Cork, Ireland; [Paul, Rhea] Sacred Heart Univ, Fairfield, CT USA; [Redmond, Sean] Univ Utah, Salt Lake City, UT 84112 USA; [Reilly, Sheena] Griffith Univ, Menzies Hlth Inst Queensland, Nathan, Qld, Australia; [Restrepo, Laida] Arizona State Univ, Tempe, AZ 85287 USA; [Rice, Mabel] Univ Kansas, Lawrence, KS 66045 USA; [Snow, Pamela] La Trobe Univ, Bundoora, Vic, Australia; [Tager-Flusberg, Helen] Boston Univ, Boston, MA 02215 USA; [Taylor, Cate] Univ Western Australia, Nedlands, WA, Australia; [Tomblin, Bruce] Univ Iowa, Iowa City, IA 52242 USA; [Volden, Joanne] Univ Alberta, Edmonton, AB, Canada; [Westerveld, Marleen] Griffith Univ, Nathan, Qld, Australia; [Whitehouse, Andrew] Univ Western Australia, Telethon Kids Inst, Nedlands, WA, Australia	University of Oxford; University of Oxford; University of Manchester; Western University (University of Western Ontario); University of New England; University of Toronto; University of Sheffield; University of London; University College London; UCL Institute of Education; University of London; University College London; University of Limerick; Newcastle University - UK; University of Auckland; University of Canterbury; University of Oxford; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Strathclyde; Murdoch Children's Research Institute; University of London; Royal Holloway University London; University of Edinburgh; University College Cork; Sacred Heart University; Utah System of Higher Education; University of Utah; Griffith University; Arizona State University; Arizona State University-Tempe; University of Kansas; La Trobe University; Boston University; University of Western Australia; University of Iowa; University of Alberta; Griffith University; Telethon Kids Institute; University of Western Australia	Bishop, DVM (corresponding author), Univ Oxford, Dept Expt Psychol, Oxford, Oxon, England.	dorothy.bishop@psy.ox.ac.uk	Gallagher, Aoife Lily/AAE-3283-2021; Krishnan, Saloni/I-2642-2019; Westerveld, Marleen/C-6638-2011; Dockrell, Julie/A-3613-2008; Ebbels, Susan/AAE-1709-2022; Cardy, Janis Oram/AAF-4147-2019; Westerveld, Marleen/ABB-3561-2021; Boyle, Chris/F-5138-2012; Whitehouse, Andrew J.O./AGJ-2519-2022; Greenhalgh, Trisha/B-1825-2015; Klee, Thomas/I-2270-2012	Gallagher, Aoife Lily/0000-0001-9291-9361; Krishnan, Saloni/0000-0002-6466-141X; Westerveld, Marleen/0000-0002-5194-2335; Dockrell, Julie/0000-0003-3595-6064; Cardy, Janis Oram/0000-0002-7170-6145; Westerveld, Marleen/0000-0002-5194-2335; Boyle, Chris/0000-0001-6196-7619; Whitehouse, Andrew J.O./0000-0001-8722-1575; Greenhalgh, Trisha/0000-0003-2369-8088; Klee, Thomas/0000-0002-1577-8689	Wellcome Trust [082498/Z/07/Z]; National Institute for Health Research [NF-SI-0512-10031] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by Wellcome Trust (http://www.wellcome.ac.uk/) grant 082498/Z/07/Z to DVMB.	Adams C, 2012, INT J LANG COMM DIS, V47, P233, DOI 10.1111/j.1460-6984.2011.00146.x; Akins RB, 2005, BMS RES METH, V5; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Archibald LMD, 2009, J SPEECH LANG HEAR R, V52, P899, DOI 10.1044/1092-4388(2009/08-0099); Armon-Lotem S., 2015, ASSESSING MULTILINGU; Baglieri S, 2004, J LEARN DISABIL-US, V37, P525, DOI 10.1177/00222194040370060701; BAIRD G., 2014, INT J LANG COMM DIS, V49, P381, DOI [10.1111/1460-6984.12101, DOI 10.1111/1460-6984.12101]; Beitchman J., 2014, LANGUAGE DISORDERS C; Bishop D, 2008, RUTTERS CHILD ADOLES, P32, DOI DOI 10.1002/9781444300895.CH3; Bishop DVM, 2014, INT J LANG COMM DIS, V49, P381, DOI 10.1111/1460-6984.12101; Bishop D.V.M., 2000, SPEECH LANGUAGE IMPA; Bishop DVM, 2012, CHILD LANG TEACH THE, V28, P259, DOI 10.1177/0265659012459467; Bishop DVM, 2011, ACTA PAEDIATR, V100, P903, DOI 10.1111/j.1651-2227.2011.02150.x; Bishop DVM, 2009, INT J LANG COMM DIS, V44, P600, DOI 10.1080/13682820802259662; Bishop DVM, 2006, INT J LANG COMM DIS, V41, P19, DOI 10.1080/13682820500144000; Bishop DVM, 2006, GENES BRAIN BEHAV, V5, P158, DOI 10.1111/j.1601-183X.2005.00148.x; Bishop DVM, 2004, CLASSIFICATION OF DEVELOPMENTAL LANGUAGE DISORDERS: THEORETICAL ISSUES AND CLINICAL IMPLICATIONS, P309; BISHOP DVM, 1987, J SPEECH HEAR DISORD, V52, P156, DOI 10.1044/jshd.5202.156; Bishop DVM, 1988, LANGUAGE DEV EXCEPTI, P203; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Bowyer-Crane C, 2011, LEARN DISAB, V9, P107; Boyle J, 2007, HEALTH TECHNOL ASSES, V11, P1; Briscoe J, 2001, J CHILD PSYCHOL PSYC, V42, P329, DOI 10.1111/1469-7610.00726; Camilleri B, 2014, INT J SPEECH-LANG PA, V16, P507, DOI 10.3109/17549507.2013.847497; Campbell T, 1997, J SPEECH LANG HEAR R, V40, P519, DOI 10.1044/jslhr.4003.519; Cattani A, 2014, INT J LANG COMM DIS, V49, P649, DOI 10.1111/1460-6984.12082; Christensen CA., 2018, PERSPECTIVES LEARNIN, P227, DOI [10.4324/9780429498381-10, DOI 10.4324/9780429498381-10]; COHEN NJ, 1989, J AM ACAD CHILD PSY, V28, P107, DOI 10.1097/00004583-198901000-00020; COLE KN, 1990, APPL PSYCHOLINGUIST, V11, P291, DOI 10.1017/S0142716400008900; COLE KN, 1995, APPL PSYCHOLINGUIST, V16, P103, DOI 10.1017/S0142716400006445; Conti-Ramsden G, 2001, J CHILD PSYCHOL PSYC, V42, P741, DOI 10.1111/1469-7610.00770; Dawes P, 2010, ARCH DIS CHILD, V95, P432, DOI 10.1136/adc.2009.170118; De Villiers MR, 2005, MED TEACH, V27, P639, DOI 10.1080/13611260500069947; Deevy P, 2010, LANG SPEECH HEAR SER, V41, P277, DOI 10.1044/0161-1461(2009/08-0096); Department for Education, 2014, EYFSP ATT PUP CHAR 2; Dockrell J, 2012, UNDERSTANDING SPEECH; Dockrell JE, 2006, INT J LANG COMM DIS, V41, P423, DOI 10.1080/13682820500442073; Dockrell JE, 2015, BRIT J SPEC EDUC, V42, P411, DOI 10.1111/1467-8578.12115; Dockrell JE, 2015, CHILD LANG TEACH THE, V31, P271, DOI 10.1177/0265659015572165; Dodd B, 2014, CURR DEV DISORD REP, V1; Dollaghan CA, 2011, J SPEECH LANG HEAR R, V54, P1361, DOI 10.1044/1092-4388(2011/10-0187); Dyck MJ, 2011, RES DEV DISABIL, V32, P2704, DOI 10.1016/j.ridd.2011.06.001; Eadie P, 2015, DEV MED CHILD NEUROL, V57, P578, DOI 10.1111/dmcn.12635; Ebbels S, 2014, INT J LANG COMM DIS, V49, P377, DOI 10.1111/1460-6984.12119; Fletcher JM, 2009, CHILD DEV PERSPECT, V3, P30, DOI 10.1111/j.1750-8606.2008.00072.x; Greenhalgh T, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-115; Greenspan S, 2014, CURR OPIN PSYCHIATR, V27, P110, DOI 10.1097/YCO.0000000000000037; Grigorenko EL, 2009, J LEARN DISABIL-US, V42, P111, DOI 10.1177/0022219408326207; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hasson N, 2013, CHILD LANG TEACH THE, V29, P57, DOI 10.1177/0265659012459526; Hawker K, 2008, EAR HEARING, V29, P467, DOI 10.1097/AUD.0b013e318167b857; Haynes C., 1991, CHILDREN SPECIFIC SP; Heilmann JJ, 2010, LANG SPEECH HEAR SER, V41, P84, DOI 10.1044/0161-1461(2009/08-0075); Hsu C.C, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [DOI 10.7275/PDZ9-TH90, 10.7275/pdz9-th90]; Jeltova I., 2007, INT J SPEECH LANGUAG, V9, P273, DOI DOI 10.1080/14417040701460390; Jones RB, 2001, J MED ETHICS, V27, P377, DOI 10.1136/jme.27.6.377; Kjelgaard MM, 2001, LANG COGNITIVE PROC, V16, P287, DOI 10.1080/01690960042000058; Kohnert K, 2010, J COMMUN DISORD, V43, P456, DOI 10.1016/j.jcomdis.2010.02.002; Landeta J, 2006, TECHNOL FORECAST SOC, V73, P467, DOI 10.1016/j.techfore.2005.09.002; Law J, 2000, DEV MED CHILD NEUROL, V42, P190, DOI 10.1017/S0012162200000335; Law J, 2013, INT J LANG COMM DIS, V48, P486, DOI 10.1111/1460-6984.12027; Laws G, 2004, INT J LANG COMM DIS, V39, P423, DOI 10.1080/13682820410001681207; Leonard L., 1991, LANG SPEECH HEAR SER, V22, P66, DOI DOI 10.1044/0161-1461.2202.66; Loucas T, 2008, J CHILD PSYCHOL PSYC, V49, P1184, DOI 10.1111/j.1469-7610.2008.01951.x; McCauley RJ, 2013, ASSESSMENT LANGUAGE; Morgan A, 2013, INT J SPEECH-LANG PA, V15, P245, DOI 10.3109/17549507.2013.777786; Morgan G, 2007, INT J LANG COMM DIS, V42, P97, DOI 10.1080/13682820600783178; Nation K, 2004, J SPEECH LANG HEAR R, V47, P199, DOI 10.1044/1092-4388(2004/017); Norbury CF, 2004, INT J LANG COMM DIS, V39, P345, DOI 10.1080/13682820410001654883; Norbury CF, 2016, J CHILD PSYCHOL PSYC, V57; Norbury CF, 2016, J CHILD PSY IN PRESS; Norbury CF, 2014, J CHILD PSYCHOL PSYC, V55, P204, DOI 10.1111/jcpp.12154; O'Neill DK, 2007, J SPEECH LANG HEAR R, V50, P214, DOI 10.1044/1092-4388(2007/017); Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Paquier PF, 1996, ACTA NEUROL SCAND, V93, P428; Paradis J., 2011, DUAL LANGUAGE DEV DI; Paradis J, 2015, J SPEECH LA IN PRESS; Paradis J, 2010, J COMMUN DISORD, V43, P474, DOI 10.1016/j.jcomdis.2010.01.002; Paul R., 2012, LANGUAGE DISORDERS I; Paul R, 2011, LANG SPEECH HEAR SER, V42, P331, DOI 10.1044/0161-1461(2010/09-0067); Pena E. D., 2007, ADV SPEECH LANGUAGE, V9, P332, DOI [DOI 10.1080/14417040701413738, 10.1080/14417040701413738]; Pena ED, 2014, J SPEECH LANG HEAR R, V57, P2208, DOI 10.1044/2014_JSLHR-L-13-0151; Pennington BF, 2009, ANNU REV PSYCHOL, V60, P283, DOI 10.1146/annurev.psych.60.110707.163548; R Core Team, 2021, R LANGUAGE ENV STAT; Redmond SM, 2011, J SPEECH LANG HEAR R, V54, P99, DOI 10.1044/1092-4388(2010/10-0010); Reilly S, 2014, INT J LANG COMM DIS, V49, P452, DOI 10.1111/1460-6984.12111; Reilly S, 2014, INT J LANG COMM DIS, V49, P416, DOI 10.1111/1460-6984.12102; Reilly S, 2010, PEDIATRICS, V126, pE1530, DOI 10.1542/peds.2010-0254; RICE M. L, 2014, INT J LANG COMM DIS, V49, P381, DOI [10.1111/1460-6984.12101, DOI 10.1111/1460-6984.12101]; Rice ML, 2016, J SPEECH LANG HEAR R, V59, P122, DOI 10.1044/2015_JSLHR-L-15-0255; Rice ML, 1996, J SPEECH HEAR RES, V39, P1239, DOI 10.1044/jshr.3906.1239; Rice ML, 1998, J SPEECH LANG HEAR R, V41, P419, DOI 10.1044/jslhr.4102.419; Roberts JE, 2004, PEDIATRICS, V113, pE238, DOI 10.1542/peds.113.3.e238; Roy P, 2013, CURR ISS DEV PSYCHOL, P125; Royal College of Speech and Language Therapists, 2014, SLI IJLCD SPEC ISS D; SANDGREN O., 2014, INT J LANG COMM DIS, V49, P381, DOI [10.1111/1460-6984.12101, DOI 10.1111/1460-6984.12101]; Shriberg LD, 1999, J SPEECH LANG HEAR R, V42, P1461, DOI 10.1044/jslhr.4206.1461; Siu AL, 2015, PEDIATRICS, V136, pE474, DOI 10.1542/peds.2015-1711; Snowling MJ, 2016, J CHILD PSYCHOL PSYC; Spaulding TJ, 2012, LANG SPEECH HEAR SER, V43, P176, DOI 10.1044/0161-1461(2011/10-0103); Spaulding TJ, 2006, LANG SPEECH HEAR SER, V37, P61, DOI 10.1044/0161-1461(2006/007); Spencer M, 2014, LEARN DISABILITY Q, V37, P161, DOI 10.1177/0731948714530967; Spencer S, 2012, INT J LANG COMM DIS, V47, P274, DOI 10.1111/j.1460-6984.2011.00104.x; Stevenson J, 1996, LANGUAGE LEARNING BE, P78; Strand S., 2015, ENGLISH ADDITIONAL L; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Thomas-Stonell N, 2013, DEV MED CHILD NEUROL, V55, P546, DOI 10.1111/dmcn.12123; Thomas-Stonell NL, 2010, DEV MED CHILD NEUROL, V52, P47, DOI 10.1111/j.1469-8749.2009.03410.x; Tomblin J.B., 2008, UNDERSTANDING DEV LA, P93; Tomblin JB, 2004, DEVELOPMENTAL LANGUAGE DISORDERS: FROM PHENOTYPES TO ETIOLOGIES, P53; Tomblin JB, 1999, DEV COGN NEUROSCI, P361; Tomblin JB, 1996, J SPEECH HEAR RES, V39, P1284, DOI 10.1044/jshr.3906.1284; Visser-Bochane MI, 2016, INT J LANG COMMUN DI; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Washington K.N., 2007, ADV SPEECH LANGUAGE, V9, P242, DOI [10.1080/14417040701261525, DOI 10.1080/14417040701261525]; WHO, 2001, WHO INT CLASS FUNCT; Williams D, 2013, J AUTISM DEV DISORD, V43, P404, DOI 10.1007/s10803-012-1579-8; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; WOODS BT, 1978, ANN NEUROL, V3, P273, DOI 10.1002/ana.410030315; World Health Organization, 1992, ICD 10 CLASSIFICATIO, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P; Zambrana IM, 2014, INT J LANG COMM DIS, V49, P304, DOI 10.1111/1460-6984.12073	121	160	161	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158753	10.1371/journal.pone.0158753	http://dx.doi.org/10.1371/journal.pone.0158753			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27392128	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000380005400115
J	Costa, NS; Pinto, TCA; Merquior, VLC; Castro, LFS; da Rocha, FSP; Morais, JM; Peralta, JM; Teixeira, LM				Costa, Natalia S.; Pinto, Tatiana C. A.; Merquior, Vania L. C.; Castro, Luciana F. S.; da Rocha, Filomena S. P.; Morais, Jaqueline M.; Peralta, Jose M.; Teixeira, Lucia M.			MLVA Typing of Streptococcus pneumoniae Isolates with Emphasis on Serotypes 14, 9N and 9V: Comparison of Previously Described Panels and Proposal of a Novel 7 VNTR Loci-Based Simplified Scheme	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; CLONAL COMPLEX; RESISTANCE; CHILDREN; STRAINS; PNEUMOCOCCUS; PROTEIN	Streptococcus pneumoniae remains as an important cause of community-acquired bacterial infections, and the nasopharynx of asymptomatic carriers is the major reservoir of this microorganism. Pneumococcal strains of serotype 14 and serogroup 9 are among the most frequently isolated from both asymptomatic carriers and patients with invasive disease living in Brazil. Internationally disseminated clones belonging to such serotypes have been associated with the emergence and spread of antimicrobial resistance in our setting, highlighting the need for epidemiological tracking of these isolates. In this scenario, Multiple Loci VNTR Analysis (MLVA) has emerged as an alternative tool for the molecular characterization of pneumococci, in addition to more traditional techniques such as Multi-Locus Sequence Typing (MLST) and Pulsed-Field Gel Electrophoresis (PFGE). In the present study, 18 VNTR loci, as well as other previously described reduced MLVA panels (7 VNTR loci), were evaluated as tools to characterize pneumococcal strains of serotypes 14, 9N and 9V belonging to international and regional clones isolated in Brazil. The 18 VNTR loci panel was highly congruent with MLST and PFGE, being also useful for indicating the genetic relationship with international clones and for discriminating among strains with indistinguishable STs and PFGE profiles. Analysis of the results also allowed deducing a novel shorter 7 VNTR loci panel, keeping a high discriminatory power for isolates of the serotypes investigated and a high congruence level with MLST and PFGE. The newly proposed simplified panel was then evaluated for typing pneumococcal strains of other commonly isolated serotypes. The results indicate that MLVA is a faster and easier to perform, reliable approach for the molecular characterization of S. pneumoniae isolates, with potential for cost-effective application, especially in resource-limited countries.	[Costa, Natalia S.; Pinto, Tatiana C. A.; Castro, Luciana F. S.; da Rocha, Filomena S. P.; Morais, Jaqueline M.; Peralta, Jose M.; Teixeira, Lucia M.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil; [Costa, Natalia S.; Merquior, Vania L. C.] Univ Estado Rio de Janeiro, Fac Ciencias Med, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade do Estado do Rio de Janeiro	Teixeira, LM (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil.	lmt2@micro.ufrj.br	Pinto, Tatiana CA/O-1265-2015; Teixeira, Lucia Martins/AAO-7988-2020; Merquior, Vânia Lúcia Carreira/AAL-9502-2021	Pinto, Tatiana CA/0000-0002-7878-9377; Teixeira, Lucia Martins/0000-0002-4017-7076; Merquior, Vânia Lúcia Carreira/0000-0001-6593-5489	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported in part by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ).; This work was supported in part by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ). We thank Drs. Bernard Beall and Lesley McGee (Streptococcus Laboratory, Centers for Diseases Control and Prevention, Atlanta, GA, USA) for kindly providing reference strains of the PMEN clones.	Andrade AL, 2012, VACCINE, V30, P1901, DOI 10.1016/j.vaccine.2011.12.012; Barroso DE, 2012, PEDIATR INFECT DIS J, V31, P30, DOI 10.1097/INF.0b013e31822f8a92; Blumental S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133885; Caierao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111129; Calix JJ, 2012, J BIOL CHEM, V287, P27885, DOI 10.1074/jbc.M112.380451; Camargos P, 2006, PAEDIATR RESPIR REV, V7, P209, DOI 10.1016/j.prrv.2006.04.004; Croucher NJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-120; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Dias CA, 2007, J MED MICROBIOL, V56, P1185, DOI 10.1099/jmm.0.47347-0; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020390; Elberse KEM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019668; Franco CM, 2010, PEDIATR INFECT DIS J, V29, P77, DOI 10.1097/INF.0b013e3181af7e90; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Imohl M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-299; KLUGMAN KP, 1990, CLIN MICROBIOL REV, V3, P171, DOI 10.1128/CMR.3.2.171-196.1990; Koeck JL, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-66; Lambertsen L, 2010, SCAND J INFECT DIS, V42, P333, DOI 10.3109/00365540903501616; Mantese OC, 2009, J PEDIAT-BRAZIL, V85, P495, DOI [10.2223/JPED.1950, 10.1590/S0021-75572009000600005]; MARTIN B, 1992, NUCLEIC ACIDS RES, V20, P3479, DOI 10.1093/nar/20.13.3479; Melin MM, 2008, CLIN VACCINE IMMUNOL, V15, P1555, DOI 10.1128/CVI.00177-08; Mendonca-Souza CRV, 2004, MICROB DRUG RESIST, V10, P313, DOI 10.1089/mdr.2004.10.313; Ministerio da Saude, 2010, PROP INTR VAC PNEUM; Pichon B, 2010, J CLIN MICROBIOL, V48, P1926, DOI 10.1128/JCM.02054-09; Pinto TCA, 2013, J CLIN MICROBIOL, V51, P3242, DOI 10.1128/JCM.01168-13; Pinto TCA, STREPTOCOCCUS  UNPUB; Qian J, 2012, EUR J CLIN MICROBIOL, V31, P217, DOI 10.1007/s10096-011-1296-9; Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016; Rayner RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121870; Sa-Leao R, 2011, J CLIN MICROBIOL, V49, P1369, DOI 10.1128/JCM.01763-10; Sadowy E, 2010, ANTIMICROB AGENTS CH, V54, P1720, DOI 10.1128/AAC.01340-09; Sanchez-Beato AR, 1998, FEMS MICROBIOL LETT, V164, P207, DOI 10.1016/S0378-1097(98)00206-7; Sanda AA, 2015, T ROY SOC TROP MED H, V109, P477, DOI 10.1093/trstmh/trv033; Severiano A, 2011, J CLIN MICROBIOL, V49, P3997, DOI 10.1128/JCM.00624-11; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Spellerberg B, 2011, MANUAL CLIN MICROBIO, V2, P340; Staples M, 2015, EPIDEMIOL INFECT, V143, P325, DOI 10.1017/S0950268814000648; van Cuyck H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-241; Weiser JN, 2010, J MOL MED, V88, P97, DOI 10.1007/s00109-009-0557-x	40	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158651	10.1371/journal.pone.0158651	http://dx.doi.org/10.1371/journal.pone.0158651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391462	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400096
J	Lumbreras, B; Vilar, J; Gonzalez-Alvarez, I; Gomez-Saez, N; Domingo, ML; Lorente, MF; Pastor-Valero, M; Hernandez-Aguado, I				Lumbreras, Blanca; Vilar, Jose; Gonzalez-Alvarez, Isabel; Gomez-Saez, Noemi; Domingo, Maria L.; Lorente, Maria F.; Pastor-Valero, Maria; Hernandez-Aguado, Ildefonso			The Fate of Patients with Solitary Pulmonary Nodules: Clinical Management and Radiation Exposure Associated	PLOS ONE			English	Article							DOSE CT; RISK; PROBABILITY; MULTICENTER; MALIGNANCY; CARE	Background The appropriate management of the large number of lung nodules detected during the course of routine medical care presents a challenge. We aimed to evaluate the usual clinical practice in solitary pulmonary nodule (SPN) management and associated radiation exposure. Methods We examined 893 radiology reports of consecutive patients undergoing chest computed tomography (CT) and radiography at two public hospitals in Spain. Information on diagnostic procedures from SPN detection and lung cancer diagnosis was collected prospectively for 18 months. Results More than 20% of patients with SPN detected on either chest radiograph (19.8%) or CT (26.1%) underwent no additional interventions and none developed lung cancer (100% negative predictive value). 346 (72.0%) patients with SPN detected on chest radiograph and 254 (61.5%) patients with SPN detected on CT had additional diagnostic tests and were not diagnosed with lung cancer. In patients undergoing follow-up imaging for SPNs detected on CT median number of additional imaging tests was 3.5 and the mean cumulative effective dose was 24.4 mSv; for those detected on chest radiograph the median number of additional imaging tests was 2.8 and the mean cumulative effective dose was 10.3 mSv. Conclusions Patients who did not have additional interventions were not diagnosed of lung cancer. There was an excessive amount of interventions in a high percentage of patients presenting SPN, which was associated with an excess of radiation exposure.	[Lumbreras, Blanca; Gomez-Saez, Noemi; Pastor-Valero, Maria; Hernandez-Aguado, Ildefonso] Miguel Hernandez Univ, Dept Publ Hlth, Alicante, Spain; [Lumbreras, Blanca; Pastor-Valero, Maria; Hernandez-Aguado, Ildefonso] CIBER Epidemiol Salud Publ, Madrid, Spain; [Vilar, Jose; Domingo, Maria L.] Peset Hosp, Radiodiagnost Dept, Valencia, Spain; [Gonzalez-Alvarez, Isabel; Lorente, Maria F.] San Juan Hosp, Radiodiagnost Dept, Alicante, Spain	Universidad Miguel Hernandez de Elche; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Lumbreras, B (corresponding author), Miguel Hernandez Univ, Dept Publ Hlth, Alicante, Spain.; Lumbreras, B (corresponding author), CIBER Epidemiol Salud Publ, Madrid, Spain.	blumbreras@umh.es	Gonzalez-Alvarez, Isabel/AAD-5896-2019; Hernandez-Aguado, Ildefonso/I-2634-2015	Gonzalez-Alvarez, Isabel/0000-0002-1685-142X; Lumbreras, Blanca/0000-0003-1665-0860; Pastor-Valero, Maria/0000-0001-9282-5787; Hernandez-Aguado, Ildefonso/0000-0003-1911-5759	Instituto de Salud Carlos III (Minister of Science, Spain) [PI09/0477]; Fondo Europeo de Desarrollo Regional (FEDER)	Instituto de Salud Carlos III (Minister of Science, Spain); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This study has received funding by Instituto de Salud Carlos III (Minister of Science, Spain) (Ref. PI09/0477) and and co-funded by the Fondo Europeo de Desarrollo Regional (FEDER).	Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Al-Ameri A, 2015, LUNG CANCER, V89, P27, DOI 10.1016/j.lungcan.2015.03.018; Alzahouri K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-93; Berlin L, 2003, AM J ROENTGENOL, V180, P317, DOI 10.2214/ajr.180.2.1800317; Bhargavan M, 2008, HEALTH PHYS, V95, P612, DOI 10.1097/01.HP.0000327659.42618.c1; Callister ME, 2015, THORAX, V70, P1188, DOI 10.1136/thoraxjnl-2015-207168corr1; Deyo RA, 2002, ANNU REV PUBL HEALTH, V23, P23, DOI 10.1146/annurev.publhealth.23.092101.134534; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; Fritz A, 2000, INT CLASSIFICATION D; Gomez-Saez N, 2014, EUR RADIOL, V24, P2174, DOI 10.1007/s00330-014-3249-z; Gomez-Saez N, 2015, EUR RADIOL, V25, P3518, DOI 10.1007/s00330-015-3775-3; Gould MK, 2007, CHEST, V132, p108S, DOI 10.1378/chest.07-1353; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Hein PA, 2010, J DIGIT IMAGING, V23, P8, DOI 10.1007/s10278-008-9157-5; Horeweg N, 2014, LANCET ONCOL, V15, P1332, DOI 10.1016/S1470-2045(14)70389-4; Lin EC, 2010, MAYO CLIN PROC, V85, P1142, DOI 10.4065/mcp.2010.0260; Lumbreras B, 2010, BRIT J RADIOL, V83, P276, DOI 10.1259/bjr/98067945; Lumbreras B, 2010, EUR J RADIOL, V74, P269, DOI 10.1016/j.ejrad.2009.01.029; MacMahon H, 2005, RADIOLOGY, V237, P395, DOI 10.1148/radiol.2372041887; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; MOLD JW, 1986, NEW ENGL J MED, V314, P512, DOI 10.1056/NEJM198602203140809; Swensen SJ, 1999, MAYO CLIN PROC, V74, P319, DOI 10.4065/74.4.319; Swensen SJ, 1997, ARCH INTERN MED, V157, P849, DOI 10.1001/archinte.157.8.849; Tanner NT, 2015, CHEST, V148, P1405, DOI 10.1378/chest.15-0630; VIGGIANO RW, 1992, CLIN CHEST MED, V13, P83; Wiener RS, 2014, JAMA INTERN MED, V174, P871, DOI 10.1001/jamainternmed.2014.561	28	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158458	10.1371/journal.pone.0158458	http://dx.doi.org/10.1371/journal.pone.0158458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392032	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400063
J	Singh, B; Kinne, HE; Milligan, RD; Washburn, LJ; Olsen, M; Lucci, A				Singh, Balraj; Kinne, Hannah E.; Milligan, Ryan D.; Washburn, Laura J.; Olsen, Mark; Lucci, Anthony			Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; CLONAL EVOLUTION; OBESITY GENE; METASTASIS; RISK; ENCODES; IMPACT; TUMOR	We have previously shown that only 0.01% cells survive a metabolic challenge involving lack of glutamine in culture medium of SUM149 triple-negative Inflammatory Breast Cancer cell line. These cells, designated as SUM149-MA for metabolic adaptability, are resistant to chemotherapeutic drugs, and they efficiently metastasize to multiple organs in nude mice. We hypothesized that obesity-related molecular networks, which normally help in cellular and organismal survival under metabolic challenges, may help in the survival of MA cells. The fat mass and obesity-associated protein FTO is overexpressed in MA cells. Obesity-associated cis-acting elements in non-coding region of FTO regulate the expression of IRX3 gene, thus activating obesity networks. Here we found that IRX3 protein is significantly overexpressed in MA cells (5 to 6-fold) as compared to the parental SUM149 cell line, supporting our hypothesis. We also obtained evidence that additional key regulators of energy balance such as ARID5B, IRX5, and CUX1 P200 repressor could potentially help progenitor-like TNBC cells survive in glutamine-free medium. MO-I-500, a pharmacological inhibitor of FTO, significantly (> 90%) inhibited survival and/or colony formation of SUM149-MA cells as compared to untreated cells or those treated with a control compound MO-I-100. Curiously, MO-I-500 treatment also led to decreased levels of FTO and IRX3 proteins in the SUM149 cells initially surviving in glutamine-free medium as compared to MO-I-100 treatment. Interestingly, MO-I-500 treatment had a relatively little effect on cell growth of either the SUM149 or SUM149-MA cell line when added to a complete medium containing glutamine that does not pose a metabolic challenge. Importantly, once selected and cultured in glutamine-free medium, SUM149-MA cells were no longer affected by MO-I-500 even in Gln-free medium. We conclude that panresistant MA cells contain interconnected molecular networks that govern developmental status and energy balance, and genetic and epigenetic alterations that are selected during cancer evolution.	[Singh, Balraj; Kinne, Hannah E.; Milligan, Ryan D.; Washburn, Laura J.; Lucci, Anthony] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA; [Singh, Balraj; Kinne, Hannah E.; Milligan, Ryan D.; Washburn, Laura J.; Lucci, Anthony] Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA; [Olsen, Mark] Midwestern Univ, Coll Pharm Glendale, Dept Pharmaceut Sci, Glendale, AZ USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Midwestern University; Midwestern University - College of Pharmacy - Glendale	Lucci, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA.; Lucci, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Morgan Welch Inflammatory Breast Canc Res Program, Houston, TX 77030 USA.	alucci@mdanderson.org		Lucci, Anthony/0000-0003-4039-174X	State of Texas Rare and Aggressive Breast Cancer Research Program Grant; Breast Cancer Metastasis Research Program at MD Anderson Cancer Center; National Institutes of Health [CA16672]	State of Texas Rare and Aggressive Breast Cancer Research Program Grant; Breast Cancer Metastasis Research Program at MD Anderson Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by a State of Texas Rare and Aggressive Breast Cancer Research Program Grant, Breast Cancer Metastasis Research Program at MD Anderson Cancer Center, and CA16672 (Core) from the National Institutes of Health. Sponsors or funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnabas N, 2013, INT J BREAST CANCER, V2013, DOI 10.1155/2013/872743; Bellefroid EJ, 1998, EMBO J, V17, P191, DOI 10.1093/emboj/17.1.191; Berulava T, 2013, EUR J HUM GENET, V21, P317, DOI 10.1038/ejhg.2012.168; Chao HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051719; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Hernandez-Caballero ME, 2015, MOL BIOL REP, V42, P699, DOI 10.1007/s11033-014-3817-y; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gulati P, 2013, P NATL ACAD SCI USA, V110, P2557, DOI 10.1073/pnas.1222796110; Jacobsson JA, 2012, OBES REV, V13, P1096, DOI 10.1111/j.1467-789X.2012.01025.x; Jain R, 2013, J MAMMARY GLAND BIOL, V18, P257, DOI 10.1007/s10911-013-9307-3; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Masuda H, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3579; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Peters U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003171; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Singh B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109487; Singh B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036510; Singh B, 2010, CLIN EXP METASTAS, V27, P233, DOI 10.1007/s10585-010-9321-4; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Stratigopoulos G, 2011, J BIOL CHEM, V286, P2155, DOI 10.1074/jbc.M110.188482; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tiwari A, 2012, DOMEST ANIM ENDOCRIN, V42, P1, DOI 10.1016/j.domaniend.2011.08.001; Van Laere SJ, 2013, CLIN CANCER RES, V19, P4685, DOI 10.1158/1078-0432.CCR-12-2549; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Yamakawa T, 2010, BIOCHEM BIOPH RES CO, V391, P277, DOI 10.1016/j.bbrc.2009.11.049; Zheng GQ, 2014, ACS CHEM NEUROSCI, V5, P658, DOI 10.1021/cn500042t	32	58	58	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159072	10.1371/journal.pone.0159072	http://dx.doi.org/10.1371/journal.pone.0159072			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390851	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400207
J	Johnson, GR; Knibbs, LD; Kidd, TJ; Wainwright, CE; Wood, ME; Ramsay, KA; Bell, SC; Morawska, L				Johnson, Graham R.; Knibbs, Luke D.; Kidd, Timothy J.; Wainwright, Claire E.; Wood, Michelle E.; Ramsay, Kay A.; Bell, Scott C.; Morawska, Lidia			A Novel Method and Its Application to Measuring Pathogen Decay in Bioaerosols from Patients with Respiratory Disease	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; HYGROSCOPIC BEHAVIOR; ROTATING DRUM; INFLUENZA-A; AEROSOLS; SIZE; TRANSMISSION; MECHANISMS; BACTERIA; OXYGEN	This work aimed to develop an in vivo approach for measuring the duration of human bioaerosol infectivity. To achieve this, techniques designed to target short-term and long-term bioaerosol aging, were combined in a tandem system and optimized for the collection of human respiratory bioaerosols, without contamination. To demonstrate the technique, cough aerosols were sampled from two persons with cystic fibrosis and chronic Pseudomonas aeruginosa infection. Measurements and cultures from aerosol ages of 10, 20, 40, 900 and 2700 seconds were used to determine the optimum droplet nucleus size for pathogen transport and the airborne bacterial biological decay. The droplet nuclei containing the greatest number of colony forming bacteria per unit volume of airborne sputum were between 1.5 and 2.6 mu m. Larger nuclei of 3.9 mu m, were more likely to produce a colony when impacted onto growth media, because the greater volume of sputum comprising the larger droplet nuclei, compensated for lower concentrations of bacteria within the sputum of larger nuclei. Although more likely to produce a colony, the larger droplet nuclei were small in number, and the greatest numbers of colonies were instead produced by nuclei from 1.5 to 5.7 mu m. Very few colonies were produced by smaller droplet nuclei, despite their very large numbers. The concentration of viable bacteria within the dried sputum comprising the droplet nuclei exhibited an orderly dual decay over time with two distinct half-lives. Nuclei exhibiting a rapid biological decay process with a 10 second half-life were quickly exhausted, leaving only a subset characterized by a half-life of greater than 10 minutes. This finding implied that a subset of bacteria present in the aerosol was resistant to rapid biological decay and remained viable in room air long enough to represent an airborne infection risk.	[Johnson, Graham R.; Morawska, Lidia] Queensland Univ Technol, ILAQH, Brisbane, Qld, Australia; [Knibbs, Luke D.] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia; [Kidd, Timothy J.] Univ Queensland, Child Hlth Res Ctr, Herston, Qld, Australia; [Kidd, Timothy J.] Queens Univ, Ctr Med Expt, Belfast, Antrim, North Ireland; [Wainwright, Claire E.; Ramsay, Kay A.; Bell, Scott C.] Univ Queensland, Sch Med, Herston, Qld, Australia; [Wainwright, Claire E.] Royal Lady Cilento Childrens Hosp, Dept Resp & Sleep Med, South Brisbane, Qld, Australia; [Wood, Michelle E.; Ramsay, Kay A.; Bell, Scott C.] QIMR Berghofer Med Res Inst, Lung Bacteria Res Grp, Herston, Qld, Australia; [Wood, Michelle E.; Bell, Scott C.] Prince Charles Hosp, Dept Thorac Med, Chermside, Qld, Australia	Queensland University of Technology (QUT); University of Queensland; University of Queensland; Queens University Belfast; University of Queensland; QIMR Berghofer Medical Research Institute; Prince Charles Hospital	Johnson, GR (corresponding author), Queensland Univ Technol, ILAQH, Brisbane, Qld, Australia.	g.johnson@qut.edu.au	Knibbs, Luke/C-7865-2012; Kidd, Timothy/F-2149-2010; Bell, Scott/AAJ-4298-2020; Wainwright, Claire E/G-4218-2013; Johnson, Graham/B-4128-2011; Bell, Scott C/A-7241-2011; Morawska, Lidia/B-4140-2011	Kidd, Timothy/0000-0002-6135-6364; Bell, Scott/0000-0001-8651-7139; Wainwright, Claire E/0000-0001-8389-3809; Johnson, Graham/0000-0001-6874-0230; Bell, Scott C/0000-0001-8651-7139; Morawska, Lidia/0000-0002-0594-9683; Knibbs, Luke/0000-0002-0399-2370	Prince Charles Hospital Foundation [MS2010-42]; Children's Health Foundation Queensland [50005]; Institute of Health and Biomedical Innovation-Queensland University of Technology (IHBI) (Collaborative Research Development Grants) [2010002239]; Institute of Health and Biomedical Innovation-Queensland University of Technology (IHBI) (Collaborative Research Development Grants) (IHBI Early Career Researcher's Grant) [2009001211]; Australian Research Council Discovery Grant [DP0558410]; Perpetual Philanthropy; Queensland Health Office of Health and Medical Research (Health Fellowships) [QCOS012808, QCOS013795]; National Health and Medical Research Council (NHMRC) Early Career (Australian Public Health) Fellowship [1036620]; ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship [4571-2013]	Prince Charles Hospital Foundation; Children's Health Foundation Queensland; Institute of Health and Biomedical Innovation-Queensland University of Technology (IHBI) (Collaborative Research Development Grants); Institute of Health and Biomedical Innovation-Queensland University of Technology (IHBI) (Collaborative Research Development Grants) (IHBI Early Career Researcher's Grant); Australian Research Council Discovery Grant(Australian Research Council); Perpetual Philanthropy; Queensland Health Office of Health and Medical Research (Health Fellowships); National Health and Medical Research Council (NHMRC) Early Career (Australian Public Health) Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship	The study was funded by grants from The Prince Charles Hospital Foundation (#MS2010-42), Children's Health Foundation Queensland (#50005), Institute of Health and Biomedical Innovation-Queensland University of Technology (IHBI) (Collaborative Research Development Grants to LM, LDK, and GRJ (#2010002239), IHBI Early Career Researcher's Grant to GRJ (#2009001211)), Australian Research Council Discovery Grant to LM (DP0558410), Perpetual Philanthropy, Queensland Health Office of Health and Medical Research (Health Fellowships CEW (QCOS012808) and SCB (QCOS013795)), National Health and Medical Research Council (NHMRC) Early Career (Australian Public Health) Fellowship to LDK (#1036620), and a ERS-EU RESPIRE2 Marie Sklodowska-Curie Postdoctoral Research Fellowship to TJK (#4571-2013).	Agranovski V, 2003, J AEROSOL SCI, V34, P1711, DOI 10.1016/S0021-8502(03)00191-5; [American Society of Heating R Air-Conditioning Engineers], 2015, ASHRAE POS DOC FILTR; ANDERSEN AA, 1958, J BACTERIOL, V76, P471, DOI 10.1128/JB.76.5.471-484.1958; ASGHARIAN B, 1992, AEROSOL SCI TECH, V17, P263, DOI 10.1080/02786829208959575; BENBOUGH JE, 1967, J GEN MICROBIOL, V47, P325, DOI 10.1099/00221287-47-3-325; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Chao CYH, 2009, J AEROSOL SCI, V40, P122, DOI 10.1016/j.jaerosci.2008.10.003; Clifton IJ, 2010, J CYST FIBROS, V9, P64, DOI 10.1016/j.jcf.2009.11.004; Cox C. S., 1995, BIOAEROSOLS HDB; Cox CS., 1987, AEROBIOLOGICAL PATHW; DAHL TA, 1989, J BACTERIOL, V171, P2188, DOI 10.1128/jb.171.4.2188-2194.1989; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Frostling H., 1973, J AEROSOL SCI, V4, P411, DOI [10.1016/0021-8502(73)90030-x, DOI 10.1016/0021-8502(73)90030-X]; GOLDBERG LJ, 1971, APPL MICROBIOL, V21, P244, DOI 10.1128/AEM.21.2.244-252.1971; GOLDBERG LJ, 1958, AM J HYG, V68, P85, DOI 10.1093/oxfordjournals.aje.a119954; GRUEL RL, 1987, J AEROSOL SCI, V18, P17, DOI 10.1016/0021-8502(87)90004-8; Hairston PP, 1997, J AEROSOL SCI, V28, P471, DOI 10.1016/S0021-8502(96)00448-X; HALLIWELL B, 1978, CELL BIOL INT REP, V2, P113, DOI 10.1016/0309-1651(78)90032-2; HESS GE, 1965, APPL MICROBIOL, V13, P781, DOI 10.1128/AEM.13.5.781-787.1965; Hinds W. C., 1999, AEROSOL TECHNOLOGY P; Holmgren H, 2010, J AEROSOL SCI, V41, P439, DOI 10.1016/j.jaerosci.2010.02.011; JANNING B, 1994, J APPL BACTERIOL, V77, P319, DOI 10.1111/j.1365-2672.1994.tb03080.x; Johnson G, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020126; Johnson GR, 2008, J AEROSOL SCI, V39, P850, DOI 10.1016/j.jaerosci.2008.05.005; Johnson GR, 2011, J AEROSOL SCI, V42, P839, DOI 10.1016/j.jaerosci.2011.07.009; Johnson GR, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005657; Johnson GR, 2004, J AEROSOL SCI, V35, P443, DOI 10.1016/j.jaerosci.2003.10.008; Johnson GR, 2009, J AEROSOL MED PULM D, V22, P229, DOI 10.1089/jamp.2008.0720; Kidd TJ, 2011, J CLIN MICROBIOL, V49, P263, DOI 10.1128/JCM.01421-10; Kidd TJ, 2009, J CLIN MICROBIOL, V47, P1503, DOI 10.1128/JCM.00014-09; Kim J, 2009, J ANTIMICROB CHEMOTH, V63, P129, DOI 10.1093/jac/dkn462; Knibbs LD, 2014, THORAX, V69, P740, DOI 10.1136/thoraxjnl-2014-205213; KOLTER R, 1993, ANNU REV MICROBIOL, V47, P855, DOI 10.1146/annurev.micro.47.1.855; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kreidenweis SM, 2005, ATMOS CHEM PHYS, V5, P1357, DOI 10.5194/acp-5-1357-2005; Lindsley WG, 2012, J OCCUP ENVIRON HYG, V9, P443, DOI 10.1080/15459624.2012.684582; MACHER JM, 1989, AM IND HYG ASSOC J, V50, P561, DOI 10.1080/15298668991375164; MCMURRY PH, 1989, ATMOS ENVIRON, V23, P497, DOI 10.1016/0004-6981(89)90593-3; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Morawska L, 2009, ENVIRON SCI TECHNOL, V43, P1015, DOI 10.1021/es802193n; Neidhardt FC, 1992, PHYSL BACTERIAL CELL, P124; Nicas M, 2005, J OCCUP ENVIRON HYG, V2, P143, DOI 10.1080/15459620590918466; REYNOLDS HY, 1984, DM-DIS MON, V30, P1, DOI 10.1016/0011-5029(84)90008-7; SATTAR SA, 1987, CRIT REV ENV CONTR, V17, P89, DOI 10.1080/10643388709388331; Sutton TA, 2005, ANAL AEROSOL AGING R; TANG IN, 1993, ATMOS ENVIRON A-GEN, V27, P467, DOI 10.1016/0960-1686(93)90204-C; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Todar K, 2015, TXB BACTERIOLOGY; Verreault D, 2011, APPL ENVIRON MICROB, V77, P491, DOI 10.1128/AEM.01391-10; Wainwright CE, 2009, THORAX, V64, P926, DOI 10.1136/thx.2008.112466; Wexler A. S., 2002, J GEOPHYS RES-ATMOS, V7, DOI [10.1029/ 2001jd000451, 2002., DOI 10.1029/2001JD000451]; Yang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021481; Yao M., 2008, REMOVAL VOLATILE ORG	53	12	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158763	10.1371/journal.pone.0158763	http://dx.doi.org/10.1371/journal.pone.0158763			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388489	gold, Green Published, Green Submitted			2022-12-26	WOS:000379811500044
J	Kuntzen, T; Kuhn, S; Kuntzen, D; Seifert, B; Mullhaupt, B; Geier, A				Kuntzen, Thomas; Kuhn, Sereina; Kuntzen, Daniela; Seifert, Burkhardt; Mullhaupt, Beat; Geier, Andreas			Influence of Ribavirin Serum Levels on Outcome of Antiviral Treatment and Anemia in Hepatitis C Virus Infection	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; GENOTYPE 2/3 INFECTION; PLASMA-CONCENTRATION; PEGINTERFERON-ALPHA; HCV INFECTION; SOFOSBUVIR; THERAPY; POLYMORPHISMS; LEDIPASVIR; PREDICTOR	Background Ribavirin blood levels vary considerably between patients with standard weight-based dosing. Their impact on sustained virological response (SVR) with pegylated interferon and ribavirin is controversial, but has mostly been studied before the IL28b gene polymorphism as a possible confounder was discovered. Methods The impact of serum ribavirin trough levels at week 4, at the end of treatment and of mean levels across the entire antiviral treatment with pegylated interferon and ribavirin on relapse, SVR rates and anemia was retrospectively studied by univariate and multivariable logistic regression analyses in 214 patients with HCV genotype 1-4 infection, including 88 patients with available IL28b genotyping. Results Mean ribavirin levels varied between 0.68-5.65 mg/l and significantly differed between patients with or without SVR. By multivariable regression including age, sex, HCV viral load, HCV genotype, liver fibrosis stage, prior treatments, immunosuppression and IL28b genotype, ribavirin levels consistently displayed significant influence on SVR and relapse without indication for a specific importance of higher concentrations early or late in the treatment course. Although hemoglobin decline was on average more pronounced in patients with higher ribavirin levels, hemoglobin remained relatively stable in a significant proportion of these, indicating that ribavirin levels alone are insufficient to predict anemia. Conclusion While data are scarce to draw conclusions applicable for modern DAA therapies, these results support ribavirin treatment based on serum levels instead of purely weight-based dosing in combination with pegylated interferon.	[Kuntzen, Thomas; Kuhn, Sereina; Mullhaupt, Beat; Geier, Andreas] Univ Zurich Hosp, Dept Gastroenterol & Hepatol, Zurich, Switzerland; [Kuntzen, Daniela] Kantonsspital Baden, Dept Internal Med, Baden, Switzerland; [Seifert, Burkhardt] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Geier, Andreas] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany	University of Zurich; University Zurich Hospital; University of Zurich; University of Wurzburg	Kuntzen, T (corresponding author), Univ Zurich Hosp, Dept Gastroenterol & Hepatol, Zurich, Switzerland.	thomas.kuntzen@usz.ch	Müllhaupt, Beat/O-3744-2016	Müllhaupt, Beat/0000-0002-9020-8192; Seifert, Burkhardt/0000-0002-5829-2478				Ackefors M, 2012, J VIRAL HEPATITIS, V19, P635, DOI 10.1111/j.1365-2893.2012.01587.x; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bodeau S, 2013, THER DRUG MONIT, V35, P791, DOI 10.1097/FTD.0b013e3182966dee; Bourliere M, 2015, LANCET INFECT DIS, V15, P397, DOI 10.1016/S1473-3099(15)70050-2; Brochot E, 2015, THER DRUG MONIT, V37, P550, DOI 10.1097/FTD.0000000000000161; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Chan AHW, 2009, ANN PHARMACOTHER, V43, P2044, DOI 10.1345/aph.1M225; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; D'Avolio A, 2012, THER DRUG MONIT, V34, P165, DOI 10.1097/FTD.0b013e31824bf778; de Kanter CT, 2016, ANTIVIR THER, V21, P153, DOI 10.3851/IMP2994; de Kanter CTMM, 2015, ANTIVIR THER, V20, P515, DOI 10.3851/IMP2935; Eslam M, 2014, J HEPATOL, V61, P235, DOI 10.1016/j.jhep.2014.03.039; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Jen JF, 2000, THER DRUG MONIT, V22, P555, DOI 10.1097/00007691-200010000-00010; Jin RY, 2012, AM J GASTROENTEROL, V107, P1675, DOI 10.1038/ajg.2012.306; Kovari H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133879; Labarga P, 2012, J INFECT DIS, V206, P961, DOI 10.1093/infdis/jis449; Lindahl K, 2005, HEPATOLOGY, V41, P275, DOI 10.1002/hep.20563; Lindahl K, 2004, J VIRAL HEPATITIS, V11, P84, DOI 10.1046/j.1365-2893.2003.00475.x; Lindahl K, 2015, THER DRUG MONIT; Mangia A, 2013, WORLD J GASTROENTERO, V19, P8924, DOI 10.3748/wjg.v19.i47.8924; Maynard M, 2008, ANTIVIR THER, V13, P607; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pedersen C, 2011, J VIRAL HEPATITIS, V18, P245, DOI 10.1111/j.1365-2893.2010.01303.x; Rau M, 2013, J HEPATOL, V58, P669, DOI 10.1016/j.jhep.2012.11.027; Reddy KR, 2015, HEPATOLOGY, V62, P79, DOI 10.1002/hep.27826; Rower JE, 2015, J ANTIMICROB CHEMOTH, V70, P2322, DOI 10.1093/jac/dkv122; Russmann S, 2006, CURR MED CHEM, V13, P3351, DOI 10.2174/092986706778773059; Sarrazin C, 2010, Z GASTROENTEROL, V48, P289, DOI 10.1055/s-0028-1110008; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P1181, DOI 10.1053/j.gastro.2010.06.016; Torres-Cornejo A, 2014, J VIRAL HEPATITIS, V21, P178, DOI 10.1111/jvh.12128; Wu LS, 2015, ANTIMICROB AGENTS CH, V59, P2179, DOI 10.1128/AAC.04618-14	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158512	10.1371/journal.pone.0158512	http://dx.doi.org/10.1371/journal.pone.0158512			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388623	Green Published, gold			2022-12-26	WOS:000379811500025
J	Lecomte, X; Fedriani, JM; Caldeira, MC; Clemente, AS; Olmi, A; Bugalho, MN				Lecomte, Xavier; Fedriani, Jose M.; Caldeira, Maria C.; Clemente, Adelaide S.; Olmi, Alessandro; Bugalho, Miguel N.			Too Many Is Too Bad: Long-Term Net Negative Effects of High Density Ungulate Populations on a Dominant Mediterranean Shrub	PLOS ONE			English	Article							DEER CERVUS-ELAPHUS; SEED BANK DYNAMICS; REPRODUCTIVE-BIOLOGY; LARGE HERBIVORES; PLANT; RED; GROWTH; PRODUCTIVITY; DISPERSAL; MANAGEMENT	Plant-animal interactions imply costs and benefits with net balance depending on interacting species and ecological context. Ungulates, in particular, confer costs (e.g., plant leaf consumption, flower bud predation) and benefits (e.g., plant overcompensation, seed dispersal) to plants. Magnitude of costs and benefits may be altered by habitat management or ecological conditions favoring high density ungulate populations. Little is known however on whether plant costs or benefits predominate over the years, or the long-term outcomes of plant-animal interactions in habitat types sustaining high density ungulate populations. We investigated how high density ungulate populations alter plant costs and benefits by quantifying ungulate long-term effects on the shrub Cistus ladanifer (Cistaceae) individual size, seed weight and number, seed bank, and population density, through a 12-year ungulate exclusion experiment in a Mediterranean scrubland. We monitored plant size and flower buds in plants exposed or protected from ungulates and number of developed capsules and seeds consumed (potential seed dispersal) by ungulates during three reproductive seasons. We found that ungulates negatively affected shrub size and led to a dramatically decline of shrub reproductive structures and seed production, affecting the plant reproductive cycle. Number of buds was 27 times higher and number of developed seed 5 times higher in ungulate-excluded as compared to ungulate-exposed plots. After 9 years of ungulate exclusion, the C. ladanifer seed bank was 2.6 times higher in ungulate-excluded plots. The population density of C. ladanifer was 4 times higher in ungulate-excluded plots. Our long-term experiment showed that high density ungulate populations can alter plant-animal interactions by reducing plant benefits and increasing plant costs.	[Lecomte, Xavier; Caldeira, Maria C.] Univ Lisbon, Sch Agr, Forest Res Ctr CEF, Lisbon, Portugal; [Fedriani, Jose M.; Olmi, Alessandro; Bugalho, Miguel N.] Univ Lisbon, Sch Agr, Ctr Appl Ecol CEABN InBio, Lisbon, Portugal; [Fedriani, Jose M.] CSIC, Estn Biol Donana, Seville, Spain; [Clemente, Adelaide S.] Univ Lisbon, Fac Sci, Ctr Ecol Evolut & Environm Changes cE3c, Lisbon, Portugal; [Olmi, Alessandro] Univ Florence, Fac Agron Sci, Florence, Italy	Universidade de Lisboa; Forest Research Centre; Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universidade de Lisboa; University of Florence	Lecomte, X (corresponding author), Univ Lisbon, Sch Agr, Forest Res Ctr CEF, Lisbon, Portugal.	xlecomte@isa.ulisboa.pt	Bugalho, Miguel N/J-2993-2013; Lecomte, Xavier/T-4036-2018; Fedriani, Jose/R-1328-2018; Caldeira, Maria/D-4107-2013	Bugalho, Miguel N/0000-0002-7081-657X; Lecomte, Xavier/0000-0003-3518-5490; Fedriani, Jose/0000-0002-1581-2621; Caldeira, Maria/0000-0002-3586-8526; Clemente, Adelaide/0000-0002-8961-4791; Bugalho, Miguel/0000-0001-9449-4424	Fundacao para a Ciencia e a Tecnologia [SFRH/BD/90753/2012, SFRH/BPD/87690/2012, IF/740/2014, BGCT/33418/2008, SFRH/BPD/90668/2012, IF/01171/2014, IF/00728/2013, UID/AGR/00239/2013]; Portuguese Foundation for Science and Technology (FCT)	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology)	This work was funded by the Fundacao para a Ciencia e a Tecnologia: SFRH/BD/90753/2012, SFRH/BPD/87690/2012 and IF/740/2014, BGCT/33418/2008, SFRH/BPD/90668/2012 and IF/01171/2014, IF/00728/2013, and UID/AGR/00239/2013.; We are grateful to M. Lopez Ramos for help during field work and to Fundacao da Casa de Braganca for granting access to Tapada Real de Vila Vicosa. The Portuguese Foundation for Science and Technology (FCT) funded research project and research grants.	Acevedo P, 2008, J ZOOL, V276, P37, DOI 10.1111/j.1469-7998.2008.00464.x; Albert A, 2015, ECOGRAPHY, V38, P440, DOI 10.1111/ecog.00709; ALLISON TD, 1990, OECOLOGIA, V83, P523, DOI 10.1007/BF00317204; ANDERSON JE, 1981, J RANGE MANAGE, V34, P25, DOI 10.2307/3898446; [Anonymous], 2006, SAS MIXED MODELS; Augustine DJ, 2004, J APPL ECOL, V41, P45, DOI 10.1111/j.1365-2664.2004.00864.x; Azorit C, 2012, ANIM PROD SCI, V52, P720, DOI 10.1071/AN12016; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Bastida F, 2002, ANN BOT-LONDON, V89, P427, DOI 10.1093/aob/mcf065; Beauchamp VB, 2013, APPL VEG SCI, V16, P571, DOI 10.1111/avsc.12036; Bugalho MN, 2013, FOREST ECOL MANAG, V308, P90, DOI 10.1016/j.foreco.2013.07.036; Bugalho MN, 2011, FOREST ECOL MANAG, V261, P2133, DOI 10.1016/j.foreco.2011.03.009; Bugalho MN, 2011, FRONT ECOL ENVIRON, V9, P278, DOI 10.1890/100084; Bugalho MN, 2003, FOREST ECOL MANAG, V181, P23, DOI 10.1016/S0378-1127(03)00125-7; Bugalho MN, 2001, J ZOOL, V255, P285, DOI 10.1017/S0952836901001376; Caldeira MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15110; Chaideftou E, 2009, PLANT ECOL, V201, P255, DOI 10.1007/s11258-008-9548-1; Chamberlain SA, 2014, ECOL LETT, V17, P881, DOI 10.1111/ele.12279; Clemente AS, 2007, PLANT ECOL, V190, P175, DOI 10.1007/s11258-006-9199-z; Clemente AS, 1996, INT J WILDLAND FIRE, V6, P5, DOI 10.1071/WF9960005; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Delgado JA, 2001, ENVIRON EXP BOT, V46, P11, DOI 10.1016/S0098-8472(01)00076-4; Diaz-Villa MD, 2003, J VEG SCI, V14, P701, DOI 10.1111/j.1654-1103.2003.tb02202.x; DiTommaso A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091155; Fedriani JM, 2013, J ECOL, V101, P1581, DOI 10.1111/1365-2745.12146; Fedriani JM, 2012, ECOLOGY, V93, P575, DOI 10.1890/11-0429.1; Fornara DA, 2007, ECOLOGY, V88, P200, DOI 10.1890/0012-9658(2007)88[200:BLROAN]2.0.CO;2; Frerker K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115843; Goheen JR, 2007, J ECOL, V95, P129, DOI 10.1111/j.1365-2745.2006.01196.x; Gomez JM, 2005, ECOL MONOGR, V75, P231, DOI 10.1890/04-0722; Gordon IJ, 2004, J APPL ECOL, V41, P1021, DOI 10.1111/j.0021-8901.2004.00985.x; Guzman B, 2009, J BIOGEOGR, V36, P954, DOI 10.1111/j.1365-2699.2008.02040.x; Haarmeyer DH, 2010, BIOL CONSERV, V143, P588, DOI 10.1016/j.biocon.2009.11.008; Harrison RD, 2013, ECOL LETT, V16, P687, DOI 10.1111/ele.12102; HOFMANN RR, 1989, OECOLOGIA, V78, P443, DOI 10.1007/BF00378733; Holland JN, 2009, ECOL LETT, V12, P1357, DOI 10.1111/j.1461-0248.2009.01390.x; Huffman DW, 2003, J RANGE MANAGE, V56, P358, DOI 10.2307/4004039; Iravani M, 2011, BASIC APPL ECOL, V12, P505, DOI 10.1016/j.baae.2011.07.004; JANZEN DH, 1984, AM NAT, V123, P338, DOI 10.1086/284208; Kay CE, 1995, BROWS NAT UNG EFF SH; Kiers ET, 2010, ECOL LETT, V13, P1459, DOI 10.1111/j.1461-0248.2010.01538.x; MALO JE, 1995, OECOLOGIA, V104, P246, DOI 10.1007/BF00328589; Maron JL, 2014, J ECOL, V102, P1485, DOI 10.1111/1365-2745.12305; Mathisen KM, 2010, J VEG SCI, V21, P705, DOI 10.1111/j.1654-1103.2010.01180.x; Miranda M, 2011, PLANT BIOLOGY, V13, P160, DOI 10.1111/j.1438-8677.2009.00316.x; Oba G, 2000, ECOL APPL, V10, P1133, DOI 10.1890/1051-0761(2000)010[1133:CGOTAD]2.0.CO;2; OCONNOR TG, 1992, J APPL ECOL, V29, P247, DOI 10.2307/2404367; Paige KN, 1999, OECOLOGIA, V118, P316, DOI 10.1007/s004420050732; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; Papanastasis VP, 2008, ANIM FEED SCI TECH, V140, P1, DOI 10.1016/j.anifeedsci.2007.03.012; Paton D, 1998, J ARID ENVIRON, V38, P221, DOI 10.1006/jare.1997.0328; Pringle RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0390; Roberts H. A., 1981, Advances in Applied Biology, V6, P1; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Sankaran M, 2013, J ECOL, V101, P1389, DOI 10.1111/1365-2745.12147; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Seligman N G, 1996, ECOLOGY MANAGEMENT G, P359; Sternberg M, 2003, J VEG SCI, V14, P375, DOI 10.1658/1100-9233(2003)014[0375:EOGOSS]2.0.CO;2; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; TALAVERA S, 1993, PLANT SYST EVOL, V186, P123, DOI 10.1007/BF00940792; Thompson J., 2013, RELENTLESS EVOLUTION, DOI DOI 10.7208/CHICAGO/9780226018898.001.0001; Thompson JD., 2005, PLANT EVOLUTION MEDI, DOI DOI 10.1093/ACPROF:OSO/9780198515340.001.0001; Traveset A, 2014, ANNU REV ECOL EVOL S, V45, P89, DOI 10.1146/annurev-ecolsys-120213-091857; VARGAS JD, 1995, AGROFOREST SYST, V29, P77, DOI 10.1007/BF00711283; Webster CR, 2008, OECOLOGIA, V157, P497, DOI 10.1007/s00442-008-1085-z; White MA, 2012, FOREST ECOL MANAG, V269, P222, DOI 10.1016/j.foreco.2011.12.043; Willan R. L., 1991, GUIDE FOREST SEED HA; Zar J. H., 1996, BIOSTATISTICAL ANAL	68	12	12	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158139	10.1371/journal.pone.0158139	http://dx.doi.org/10.1371/journal.pone.0158139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387134	Green Published, gold			2022-12-26	WOS:000379811500014
J	Saez-Lopez, E; Cossa, A; Benmessaoud, R; Madrid, L; Moraleda, C; Villanueva, S; Tligui, H; Moiane, B; Alami, H; Massora, S; Bezad, R; Mandomando, I; Bosch, J; Vila, J; Bassat, Q; Soto, SM				Saez-Lopez, Emma; Cossa, Anelsio; Benmessaoud, Rachid; Madrid, Lola; Moraleda, Cinta; Villanueva, Sonia; Tligui, Houssain; Moiane, Benilde; Alami, Hassan; Massora, Sergio; Bezad, Rachid; Mandomando, Inacio; Bosch, Jordi; Vila, Jordi; Bassat, Quique; Soto, Sara M.			Characterization of Vaginal Escherichia coli Isolated from Pregnant Women in Two Different African Sites	PLOS ONE			English	Article							STRAINS; COLONIZATION; PREVALENCE; COMMENSAL; RESISTANCE; SEROTYPES; DIARRHEA	The relevance of vaginal colonization of pregnant women by Escherichia coli is poorly understood, despite these strains sharing a similar virulence profile with other extraintestinal pathogenic E. coli producing severe obstetric and neonatal infections. We characterized the epidemiology, antimicrobial susceptibility and virulence profiles of 84 vaginal E. coli isolates from pregnant women from Rabat (Morocco) and Manhica (Mozambique), two very distinct epidemiological settings. Low levels of antimicrobial resistance were observed to all drugs tested, except for trimethoprim-sulfamethoxazole in Manhica, where this drug is extensively used as prophylaxis for opportunistic HIV infections. The most prevalent virulence factors were related to iron acquisition systems. Phylogroup A was the most common in Rabat, while phylogroups E and non-typeable were the most frequent in Manhica. Regardless of the apparently "low virulence" of these isolates, the frequency of infections is higher and the outcomes more devastating in constrained-resources conditions, especially among pregnant women and newborns.	[Saez-Lopez, Emma; Villanueva, Sonia; Bosch, Jordi; Vila, Jordi; Soto, Sara M.] Univ Barcelona, Hosp Clin, Dept Clin Microbiol, Barcelona, Spain; [Saez-Lopez, Emma; Benmessaoud, Rachid; Madrid, Lola; Moraleda, Cinta; Villanueva, Sonia; Bosch, Jordi; Vila, Jordi; Bassat, Quique; Soto, Sara M.] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Cossa, Anelsio; Madrid, Lola; Moiane, Benilde; Massora, Sergio; Mandomando, Inacio; Bassat, Quique] CISM, Maputo, Mozambique; [Tligui, Houssain] Univ Mohammed V Souissi, Fac Med & Pharm, Equipe Rech Sante & Nutr Couple Mere Enfant, Rabat, Morocco; [Alami, Hassan; Bezad, Rachid] Univ Mohammed V Souissi, Equipe Rech Perinatol, Rabat, Morocco	University of Barcelona; Hospital Clinic de Barcelona; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat	Soto, SM (corresponding author), Univ Barcelona, Hosp Clin, Dept Clin Microbiol, Barcelona, Spain.; Soto, SM (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	sara.soto@isglobal.org	Vila, Jordi/P-3613-2016; Mandomando, Inacio/ABD-8007-2020; Soto, Sara M/J-6297-2012; Bassat, Quique/P-2341-2016; Sáez-López, Emma/AAA-8170-2020	Vila, Jordi/0000-0002-8025-3926; Mandomando, Inacio/0000-0002-1078-2187; Soto, Sara M/0000-0002-9507-105X; Bassat, Quique/0000-0003-0875-7596; Moraleda, Cinta/0000-0002-8335-903X; Madrid, Lola/0000-0003-4034-6033; Bosch, Jordi/0000-0001-9263-3371; Saez-Lopez, Emma/0000-0001-8313-3017	Instituto de Salud Carlos III [CM13/00260, CP11/00269, PI10/01579, PI13/00127]; European Directorate-General for Research and Innovation [612216]; Spanish Agency of International Cooperation and Development (AECID) [07-CO1-021]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Directorate-General for Research and Innovation; Spanish Agency of International Cooperation and Development (AECID)	This study was supported by the Instituto de Salud Carlos III under the grants CM13/00260, CP11/00269, PI10/01579 and PI13/00127; the European Directorate-General for Research and Innovation Grant Agreement 612216; the Spanish Agency of International Cooperation and Development (AECID) 07-CO1-021. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barman N., 2014, CLIN MICROBIOL OPEN, P3; Bergstrom S, 2003, J NUTR, V133, p1656S, DOI 10.1093/jn/133.5.1656S; Birosova E, 2004, CLIN MICROBIOL INFEC, V10, P569, DOI 10.1111/j.1469-0691.2004.00922.x; Breman JG, 2016, MALARIA ENDEMIC AREA; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Chongsomchai C, ANTIBIOTIC REGIMENS; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S24 CLSI S; Cook S W, 2001, Infect Dis Obstet Gynecol, V9, P203, DOI 10.1155/S1064744901000333; Duriez P, 2001, MICROBIOL-SGM, V147, P1671, DOI 10.1099/00221287-147-6-1671; Villar HE, 2013, J CHEMOTHERAPY, V25, P324, DOI 10.1179/1973947813Y.0000000081; Edwards RK, 2005, OBSTET GYN CLIN N AM, V32, P287, DOI 10.1016/j.ogc.2004.12.002; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; Gonzalez R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132053; Gordon DM, 2008, ENVIRON MICROBIOL, V10, P2484, DOI 10.1111/j.1462-2920.2008.01669.x; Guiral E, 2015, J CLIN MICROBIOL, V53, P1745, DOI 10.1128/JCM.00487-15; Guiral E, 2011, FEMS MICROBIOL LETT, V314, P170, DOI 10.1111/j.1574-6968.2010.02160.x; Hemati Z, 2014, ADV CLIN EXP MED, V23, P523, DOI 10.17219/acem/37217; Iranpour D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/846219; Iregbu K. C., 2013, African Journal of Clinical and Experimental Microbiology, V14, P95; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; KORHONEN TK, 1985, INFECT IMMUN, V48, P486, DOI 10.1128/IAI.48.2.486-491.1985; Krohn MA, 1997, J INFECT DIS, V175, P606, DOI 10.1093/infdis/175.3.606; Lescat M, 2013, ENV MICROBIOL REP, V5, P49, DOI 10.1111/j.1758-2229.2012.00374.x; Mandomando I, 2010, AM J TROP MED HYG, V83, P152, DOI 10.4269/ajtmh.2010.09-0578; Mandomando IM, 2007, AM J TROP MED HYG, V76, P522, DOI 10.4269/ajtmh.2007.76.522; Mentr F, 2014, CLIN MICROBIOL INFEC, V20, P01035; Mobley HLT, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010001; Moreno E, 2006, J ANTIMICROB CHEMOTH, V57, P204, DOI 10.1093/jac/dki468; Motayo BO, 2012, J MICROBIOL RES, V2, P141, DOI [10.5923/j.microbiology.20120205.05, DOI 10.5923/J.MICROBIOLOGY.20120205.05]; Mshana SE, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-28; Obata-Yasuoka M, 2002, MICROBIOL-SGM, V148, P2745, DOI 10.1099/00221287-148-9-2745; PERCIVALSMITH R, 1983, CONTRACEPTION, V27, P497, DOI 10.1016/0010-7824(83)90046-X; Pitout JDD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00009; Pons MJ, 2015, J GLOB ANTIMICROB RE, V3, P19, DOI 10.1016/j.jgar.2015.01.004; Radouani Ma, 2014, J INFECT DIS THER, V02, P2, DOI [10.4172/2332-0877.1000167, DOI 10.4172/2332-0877.1000167]; Rani S, 2014, ASIAN J MED SCI, V5, P58, DOI [10.3126/ajms.v5i4.9889, DOI 10.3126/AJMS.V5I4.9889]; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Sabate M, 2006, CLIN MICROBIOL INFEC, V12, P880, DOI 10.1111/j.1469-0691.2006.01461.x; Saez-Lopez E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146531; Tameliene R, 2012, MEDICINA-LITHUANIA, V48, P71, DOI 10.3390/medicina48020013; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003; World Health Organization, 2013, POCK BOOK HOSP CAR C; Yusuf L, ANTIBIOTIC REGIMENS	44	17	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158695	10.1371/journal.pone.0158695	http://dx.doi.org/10.1371/journal.pone.0158695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387665	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000379811500038
J	Dang, YF; Xu, XY; Shen, YB; Hu, MY; Zhang, M; Li, LS; Lv, LQ; Li, JL				Dang, Yunfei; Xu, Xiaoyan; Shen, Yubang; Hu, Moyan; Zhang, Meng; Li, Lisen; Lv, Liqun; Li, Jiale			Transcriptome Analysis of the Innate Immunity-Related Complement System in Spleen Tissue of Ctenopharyngodon idella Infected with Aeromonas hydrophila	PLOS ONE			English	Article							RNA-SEQ ANALYSIS; GRASS CARP; FUNCTIONAL-CHARACTERIZATION; EXPRESSION ANALYSIS; SIGNALING PATHWAY; MOLECULAR-CLONING; TELEOST FISH; IDENTIFICATION; GENES; ANNOTATION	The grass carp (Ctenopharyngodon idella) is an important commercial farmed herbivorous fish species in China, but is susceptible to Aeromonas hydrophila infections. In the present study, we performed de novo RNA-Seq sequencing of spleen tissue from specimens of a disease-resistant family, which were given intra-peritoneal injections containing PBS with or without a dose of A. hydrophila. The fish were sampled from the control group at 0 h, and from the experimental group at 4, 8, 12, 24, 48 and 72 h. 122.18 million clean reads were obtained from the normalized cDNA libraries; these were assembled into 425,260 contigs and then 191,795 transcripts. Of those, 52,668 transcripts were annotated with the NCBI Nr database, and 41,347 of the annotated transcripts were assigned into 90 functional groups. 20,569 unigenes were classified into six main categories, including 38 secondary KEGG pathways. 2,992 unigenes were used in the analysis of differentially expressed genes (DEGs). 89 of the putative DEGs were related to the immune system and 41 of them were involved in the complement and coagulation cascades pathway. This study provides insights into the complement and complement-related pathways involved in innate immunity, through expression profile analysis of the genomic resources in C. idella. We conclude that complement and complement-related genes play important roles during defense against A. hydrophila infection. The immune response is activated at 4 h after the bacterial injections, indicating that the complement pathways are activated at the early stage of bacterial infection. The study has improved our understanding of the immune response mechanisms in C. idella to bacterial pathogens.	[Dang, Yunfei; Xu, Xiaoyan; Shen, Yubang; Hu, Moyan; Zhang, Meng; Li, Lisen; Li, Jiale] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China; [Lv, Liqun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Natl Pathogen Collect Ctr Aquat Anim, 999 Huchenghuan Rd, Shanghai 201306, Peoples R China	Shanghai Ocean University; Shanghai Ocean University	Li, JL (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai 201306, Peoples R China.	jlli2009@126.com	li, jia/GVT-7587-2022		China's Agricultural Research System [CARS-46-04]; National Key Technology R&D Program of China [2012BAD26B02]	China's Agricultural Research System; National Key Technology R&D Program of China(National Key Technology R&D Program)	The work was supported by the following: the China's Agricultural Research System (CARS-46-04), Jiale Li; and the National Key Technology R&D Program of China (2012BAD26B02), Jiale Li.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Boshra H, 2004, J IMMUNOL, V173, P349, DOI 10.4049/jimmunol.173.1.349; Chen J, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-108; Chen XH, 2013, DEV COMP IMMUNOL, V41, P82, DOI 10.1016/j.dci.2013.04.015; Chu Q, 2015, FISH SHELLFISH IMMUN, V47, P168, DOI 10.1016/j.fsi.2015.08.032; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Du FK, 2013, FISH SHELLFISH IMMUN, V34, P1476, DOI 10.1016/j.fsi.2013.03.352; Du JL, 2014, MOL BIOSYST, V10, P2441, DOI 10.1039/c4mb00287c; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Figueras MJ, 2005, REV MED MICROBIOL, V16, P145; Gao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088804; Gao ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042637; Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Thanh HN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109656; Hallstrom T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147709; He L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053915; Heng JF, 2011, FISH SHELLFISH IMMUN, V30, P45, DOI 10.1016/j.fsi.2010.09.004; Hewavisenti RV, 2016, PEERJ, V4, DOI 10.7717/peerj.1569; Hirano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142062; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Hu MY, 2016, DEV COMP IMMUNOL, V54, P20, DOI 10.1016/j.dci.2015.08.010; Huang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131146; Igbinosa IH, 2012, SCI WORLD J, DOI 10.1100/2012/625023; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Jiang HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105122; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li FG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142801; Lintner KE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00036; Liu L, 2015, FISH SHELLFISH IMMUN, V45, P175, DOI 10.1016/j.fsi.2015.03.043; Liu QL, 2013, FISH SHELLFISH IMMUN, V35, P618, DOI 10.1016/j.fsi.2013.05.015; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Lujan E, 2016, INFECT IMMUN, V84, P452, DOI 10.1128/IAI.01267-15; Mao WF, 2004, AQUACULTURE, V242, P93, DOI 10.1016/j.aquaculture.2004.07.020; Meng FX, 2012, FISH SHELLFISH IMMUN, V32, P1171, DOI 10.1016/j.fsi.2012.02.010; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Qi ZT, 2016, VET IMMUNOL IMMUNOP, V169, P85, DOI 10.1016/j.vetimm.2015.11.004; Rao YL, 2013, DEV COMP IMMUNOL, V41, P164, DOI 10.1016/j.dci.2013.06.002; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robledo D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1149; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Song XH, 2014, AQUACULTURE, V434, P171, DOI 10.1016/j.aquaculture.2014.08.015; Su JG, 2012, DEV COMP IMMUNOL, V36, P450, DOI 10.1016/j.dci.2011.08.015; Su JG, 2009, FISH SHELLFISH IMMUN, V27, P33, DOI 10.1016/j.fsi.2009.02.016; Su JG, 2009, FISH SHELLFISH IMMUN, V26, P828, DOI 10.1016/j.fsi.2008.12.007; Su JG, 2009, FISH SHELLFISH IMMUN, V26, P164, DOI 10.1016/j.fsi.2008.10.002; Tong C, 2015, FISH SHELLFISH IMMUN, V46, P366, DOI 10.1016/j.fsi.2015.06.025; Tsujikura M, 2015, J IMMUNOL, V194, P262, DOI 10.4049/jimmunol.1303179; Unamba CIN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01074; Wang YD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1102; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wixon J, 2000, YEAST, V17, P48, DOI 10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H; Wu Chao, 2004, Acta Zoologica Sinica, V50, P137; Xu XY, 2013, FISH SHELLFISH IMMUN, V35, P801, DOI 10.1016/j.fsi.2013.06.009; Xu XY, 2012, FISH SHELLFISH IMMUN, V33, P251, DOI 10.1016/j.fsi.2012.05.015; Xu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112722; Yan NN, 2015, DEV COMP IMMUNOL, V48, P102, DOI 10.1016/j.dci.2014.09.009; Yu HY, 2014, DEV COMP IMMUNOL, V47, P215, DOI 10.1016/j.dci.2014.07.019; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zheng WD, 2012, AFR J MICROBIOL RES, V6, P4512, DOI 10.5897/AJMR11.1405	67	55	60	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157413	10.1371/journal.pone.0157413	http://dx.doi.org/10.1371/journal.pone.0157413			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383749	gold, Green Published			2022-12-26	WOS:000379809400012
J	Renauld, E; Descoteaux, M; Bernier, M; Garyfallidis, E; Whittingstall, K				Renauld, Emmanuelle; Descoteaux, Maxime; Bernier, Michael; Garyfallidis, Eleftherios; Whittingstall, Kevin			Semi-Automatic Segmentation of Optic Radiations and LGN, and Their Relationship to EEG Alpha Waves	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; MILD COGNITIVE IMPAIRMENT; TENSOR FIBER TRACTOGRAPHY; MAGNETIC-RESONANCE IMAGES; VISUAL-FIELD DEFICITS; THALAMIC NUCLEI; ARTERIOVENOUS-MALFORMATIONS; PROBABILISTIC TRACTOGRAPHY; DIFFUSION TRACTOGRAPHY; AUTOMATIC SEGMENTATION	At rest, healthy human brain activity is characterized by large electroencephalography (EEG) fluctuations in the 8-13 Hz range, commonly referred to as the alpha band. Although it is well known that EEG alpha activity varies across individuals, few studies have investigated how this may be related to underlying morphological variations in brain structure. Specifically, it is generally believed that the lateral geniculate nucleus (LGN) and its efferent fibres (optic radiation, OR) play a key role in alpha activity, yet it is unclear whether their shape or size variations contribute to its inter-subject variability. Given the widespread use of EEG alpha in basic and clinical research, addressing this is important, though difficult given the problems associated with reliably segmenting the LGN and OR. For this, we employed a multi-modal approach and combined diffusion magnetic resonance imaging (dMRI), functional magnetic resonance imaging (fMRI) and EEG in 20 healthy subjects to measure structure and function, respectively. For the former, we developed a new, semi-automated approach for segmenting the OR and LGN, from which we extracted several structural metrics such as volume, position and diffusivity. Although these measures corresponded well with known morphology based on previous post-mortem studies, we nonetheless found that their inter-subject variability was not significantly correlated to alpha power or peak frequency (p > 0.05). Our results therefore suggest that alpha variability may be mediated by an alternative structural source and our proposed methodology may in general help in better understanding the influence of anatomy on function such as measured by EEG or fMRI.	[Renauld, Emmanuelle; Bernier, Michael; Whittingstall, Kevin] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Nucl Med & Radiobiol, Sherbrooke, PQ, Canada; [Whittingstall, Kevin] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Diagnost Radiol, Sherbrooke, PQ, Canada; [Descoteaux, Maxime; Garyfallidis, Eleftherios] Univ Sherbrooke, Fac Sci, Dept Comp Sci, SCIL, Sherbrooke, PQ, Canada; [Descoteaux, Maxime; Whittingstall, Kevin] CHUS, Sherbrooke, PQ, Canada; [Descoteaux, Maxime; Whittingstall, Kevin] CHUS, Ctr Rech, CIMS, Sherbrooke, PQ, Canada	University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke; University of Sherbrooke	Whittingstall, K (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Nucl Med & Radiobiol, Sherbrooke, PQ, Canada.; Whittingstall, K (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Diagnost Radiol, Sherbrooke, PQ, Canada.; Whittingstall, K (corresponding author), CHUS, Sherbrooke, PQ, Canada.; Whittingstall, K (corresponding author), CHUS, Ctr Rech, CIMS, Sherbrooke, PQ, Canada.	kevin.whittingstall@usherbrooke.ca		Renauld, Emmanuelle/0000-0003-1292-5097	Natural Sciences and Engineering Research Council of Canada (NSERC); Fonds Quebecois de Recherche en Nature et Technologie (FQRNT); Faculty of Medicine of the University of Sherbrooke	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds Quebecois de Recherche en Nature et Technologie (FQRNT)(FQRNT); Faculty of Medicine of the University of Sherbrooke	This work was supported by The Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/); The Fonds Quebecois de Recherche en Nature et Technologie (FQRNT) (http://www.frqnt.gouv.qc.ca/en/bourses-et-subventions); and The Faculty of Medicine of the University of Sherbrooke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Many thanks to Gabriel Girard and Maxime Chamberland for their precious listening and their valued suggestions. Thanks to the Fonds Quebecois de Recherche en Nature et Technologie (FQRNT), to the Faculty of Medecine of the University of Sherbrooke and to the The Natural Sciences and Engineering Research Council of Canada (NSERC) for their financial support.	Alvarez I, 2014, BRAIN STRUCTURE FUNC, P1; Amini L, 2004, IEEE T BIO-MED ENG, V51, P800, DOI 10.1109/TBME.2004.826654; Andrews TJ, 1997, J NEUROSCI, V17, P2859; Avants BB., 2009, INSIGHT J, V2, P1, DOI DOI 10.54294/UVNHIN; Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P1113, DOI 10.1016/j.clinph.2006.01.020; Barnes GR, 2010, INVEST OPHTH VIS SCI, V51, P1432, DOI 10.1167/iovs.09-3931; Bazanova O., 2013, NEUROSCIENCE BIOBEHA; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Benjamin CFA, 2014, HUM BRAIN MAPP, V35, P683, DOI 10.1002/hbm.22204; Bernier M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00715; Burgel U, 1999, NEUROIMAGE, V10, P489, DOI 10.1006/nimg.1999.0497; Calamante F, 2015, NEUROIMAGE, V117, P284, DOI 10.1016/j.neuroimage.2015.05.070; Calamante F, 2013, HUM BRAIN MAPP, V34, P2538, DOI 10.1002/hbm.22083; Chen X, 2009, NEUROIMAGE, V45, P286, DOI 10.1016/j.neuroimage.2008.11.038; Cote MA, 2013, MED IMAGE ANAL, V17, P844, DOI 10.1016/j.media.2013.03.009; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DASILVA FHL, 1980, ELECTROEN CLIN NEURO, V50, P449, DOI 10.1016/0013-4694(80)90011-5; de Gervai PD, 2014, EPILEPSY RES, V108, P872, DOI 10.1016/j.eplepsyres.2014.03.006; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Deoni SCL, 2007, NEUROIMAGE, V34, P117, DOI 10.1016/j.neuroimage.2006.09.016; Descoteaux M, 2008, LECT NOTES COMPUT SC, V5242, P122, DOI 10.1007/978-3-540-85990-1_15; Duan Y, 2007, INT J BIOMEDICAL IMA, V2007, P7; EBELING U, 1988, ACTA NEUROCHIR, V92, P29, DOI 10.1007/BF01401969; Elias WJ, 2012, NEUROIMAGE, V59, P2025, DOI 10.1016/j.neuroimage.2011.10.049; Fujita N, 2001, AM J NEURORADIOL, V22, P1719; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Haueisen J, 2002, NEUROIMAGE, V15, P159, DOI 10.1006/nimg.2001.0962; Hindriks R, 2015, NEUROIMAGE, V106, P328, DOI 10.1016/j.neuroimage.2014.10.057; Jbabdi S, 2007, NEUROIMAGE, V37, P116, DOI 10.1016/j.neuroimage.2007.04.039; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Jonasson L, 2007, SIGNAL PROCESS, V87, P309, DOI 10.1016/j.sigpro.2005.12.017; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kammen A, 2016, NEUROIMAGE, V125, P767, DOI 10.1016/j.neuroimage.2015.11.005; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Keller SS, 2012, NEUROINFORMATICS, V10, P341, DOI 10.1007/s12021-012-9147-0; Kikuta K, 2006, NEUROSURGERY, V58, P331, DOI 10.1227/01.NEU.0000195017.82776.90; Leh SE, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/789539; Lilja Y, 2014, EPILEPSY RES, V108, P481, DOI 10.1016/j.eplepsyres.2014.01.017; Liu ZM, 2012, NEUROIMAGE, V63, P1060, DOI 10.1016/j.neuroimage.2012.08.025; Magnotta VA, 2000, NEUROIMAGE, V11, P341, DOI 10.1006/nimg.2000.0552; Mang SC, 2012, MAGN RESON MED, V67, P118, DOI 10.1002/mrm.22996; Martinez-Heras E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137064; Mcketton L, 2014, J COMP NEUROL, V522, P2680, DOI 10.1002/cne.23565; Moretti DV, 2012, NEUROIMAGE, V60, P489, DOI 10.1016/j.neuroimage.2011.11.086; Musall S, 2014, CEREB CORTEX, V24, P1045, DOI 10.1093/cercor/bhs389; Nunez PL, 2011, NEUROIMAGE, V57, P1293, DOI 10.1016/j.neuroimage.2010.03.087; NUNEZ PL, 1978, ELECTROEN CLIN NEURO, V44, P344, DOI 10.1016/0013-4694(78)90309-7; Nunez PL, 2014, CLIN NEUROPHYSIOLOGY; Okada T, 2007, AM J NEURORADIOL, V28, P1107, DOI 10.3174/ajnr.A0493; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Posthuma D, 2001, BEHAV GENET, V31, P567, DOI 10.1023/A:1013345411774; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Rex DE, 2003, NEUROIMAGE, V19, P1033, DOI 10.1016/S1053-8119(03)00185-X; Rittner L, 2010, I S BIOMED IMAGING, P1173, DOI 10.1109/ISBI.2010.5490203; Schultz T, 2011, LECT NOTES COMPUT SC, V6892, P141, DOI 10.1007/978-3-642-23629-7_18; Sherbondy AJ, 2008, J VISION, V8, DOI 10.1167/8.10.12; Smit DJA, 2012, TWIN RES HUM GENET, V15, P384, DOI 10.1017/thg.2012.6; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sporns O, 2013, CURR OPIN NEUROBIOL, V23, P162, DOI 10.1016/j.conb.2012.11.015; Steele CJ, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00289; Stieglitz LH, 2011, NEUROSURGERY, V68, P1239, DOI 10.1227/NEU.0b013e31820b52e1; Tourdias T, 2014, NEUROIMAGE, V84, P534, DOI 10.1016/j.neuroimage.2013.08.069; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Traynor C, 2010, NEUROIMAGE, V52, P69, DOI 10.1016/j.neuroimage.2010.04.024; Traynor CR, 2011, NEUROIMAGE, V56, P939, DOI 10.1016/j.neuroimage.2011.01.083; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Unrath A, 2008, NEUROSCI LETT, V434, P322, DOI 10.1016/j.neulet.2008.02.013; Valdes-Hernandez PA, 2010, NEUROIMAGE, V49, P2328, DOI 10.1016/j.neuroimage.2009.10.030; Whitford TJ, 2007, HUM BRAIN MAPP, V28, P228, DOI 10.1002/hbm.20273; Whittingstall K, 2010, MAGN RESON IMAGING, V28, P1135, DOI 10.1016/j.mri.2010.03.042; Wiegell MR, 2003, NEUROIMAGE, V19, P391, DOI 10.1016/S1053-8119(03)00044-2; Willats L, 2014, NEUROIMAGE, V87, P18, DOI 10.1016/j.neuroimage.2013.11.016; Winston GP, 2011, EPILEPSY RES, V97, P124, DOI 10.1016/j.eplepsyres.2011.07.019; Wu W, 2013, NEUROSURGERY, V70, P1; Yamamoto A, 2007, AM J NEURORADIOL, V28, P92; Yogarajah M, 2009, BRAIN, V132, P1656, DOI 10.1093/brain/awp114; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Ziyan U, 2006, LECT NOTES COMPUT SC, V4191, P807; Ziyan U, 2008, LECT NOTES COMPUT SC, V5241, P279, DOI 10.1007/978-3-540-85988-8_34	85	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0156436	10.1371/journal.pone.0156436	http://dx.doi.org/10.1371/journal.pone.0156436			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383146	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400004
J	Du, MM; Jiao, S; Bien, SA; Gala, M; Abecasis, G; Bezieau, S; Brenner, H; Butterbach, K; Caan, BJ; Carlson, CS; Casey, G; Chang-Claude, J; Conti, DV; Curtis, KR; Duggan, D; Gallinger, S; Haile, RW; Harrison, TA; Hayes, RB; Hoffmeister, M; Hopper, JL; Hudson, TJ; Jenkins, MA; Kury, S; Le Marchand, L; Leal, SM; Newcomb, PA; Nickerson, DA; Potter, JD; Schoen, RE; Schumacher, FR; Seminara, D; Slattery, ML; Hsu, L; Chan, AT; White, E; Berndt, SI; Peters, U				Du, Mengmeng; Jiao, Shuo; Bien, Stephanie A.; Gala, Manish; Abecasis, Goncalo; Bezieau, Stephane; Brenner, Hermann; Butterbach, Katja; Caan, Bette J.; Carlson, Christopher S.; Casey, Graham; Chang-Claude, Jenny; Conti, David V.; Curtis, Keith R.; Duggan, David; Gallinger, Steven; Haile, Robert W.; Harrison, Tabitha A.; Hayes, Richard B.; Hoffmeister, Michael; Hopper, John L.; Hudson, Thomas J.; Jenkins, Mark A.; Kury, Sebastien; Le Marchand, Loic; Leal, Suzanne M.; Newcomb, Polly A.; Nickerson, Deborah A.; Potter, John D.; Schoen, Robert E.; Schumacher, Fredrick R.; Seminara, Daniela; Slattery, Martha L.; Hsu, Li; Chan, Andrew T.; White, Emily; Berndt, Sonja I.; Peters, Ulrike			Fine-Mapping of Common Genetic Variants Associated with Colorectal Tumor Risk Identified Potential Functional Variants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANCER SUSCEPTIBILITY LOCUS; GENOTYPE IMPUTATION; SNP RS6983267; 8Q24; SCAN; METAANALYSIS; REFINEMENT; TRANSCRIPTOME; EXPRESSION	Genome-wide association studies (GWAS) have identified many common single nucleotide polymorphisms (SNPs) associated with colorectal cancer risk. These SNPs may tag correlated variants with biological importance. Fine-mapping around GWAS loci can facilitate detection of functional candidates and additional independent risk variants. We analyzed 11,900 cases and 14,311 controls in the Genetics and Epidemiology of Colorectal Cancer Consortium and the Colon Cancer Family Registry. To fine-map genomic regions containing all known common risk variants, we imputed high-density genetic data from the 1000 Genomes Project. We tested single-variant associations with colorectal tumor risk for all variants spanning genomic regions 250-kb upstream or downstream of 31 GWAS-identified SNPs (index SNPs). We queried the University of California, Santa Cruz Genome Browser to examine evidence for biological function. Index SNPs did not show the strongest association signals with colorectal tumor risk in their respective genomic regions. Bioinformatics analysis of SNPs showing smaller P-values in each region revealed 21 functional candidates in 12 loci (5q31.1, 8q24, 11q13.4, 11q23, 12p13.32, 12q24.21, 14q22.2, 15q13, 18q21, 19q13.1, 20p12.3, and 20q13.33). We did not observe evidence of additional independent association signals in GWAS-identified regions. Our results support the utility of integrating data from comprehensive fine-mapping with expanding publicly available genomic databases to help clarify GWAS associations and identify functional candidates that warrant more onerous laboratory follow-up. Such efforts may aid the eventual discovery of disease-causing variant(s).	[Du, Mengmeng] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Du, Mengmeng; Jiao, Shuo; Bien, Stephanie A.; Carlson, Christopher S.; Curtis, Keith R.; Harrison, Tabitha A.; Newcomb, Polly A.; Hsu, Li; White, Emily; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Bien, Stephanie A.; Newcomb, Polly A.; Potter, John D.; White, Emily; Peters, Ulrike] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA; [Gala, Manish; Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Gala, Manish; Chan, Andrew T.] Harvard Med Sch, Boston, MA USA; [Abecasis, Goncalo] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Bezieau, Stephane; Kury, Sebastien] CHU Nantes, Serv Genet Med, Nantes, France; [Brenner, Hermann; Butterbach, Katja; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Consortium DKTK, Heidelberg, Germany; [Caan, Bette J.] Kaiser Permanente Med Care Program Northern Calif, Div Res, Oakland, CA USA; [Casey, Graham; Conti, David V.; Haile, Robert W.; Schumacher, Fredrick R.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany; [Duggan, David] Translat Genom Res Inst, Phoenix, AZ USA; [Gallinger, Steven] Mt Sinai Hosp, Dept Surg, Toronto, ON, Canada; [Hayes, Richard B.] NYU, Sch Med, Dept Populat Hlth, Div Epidemiol, New York, NY USA; [Hopper, John L.; Jenkins, Mark A.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Program Epidemiol, Honolulu, HI 96822 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Nickerson, Deborah A.] Univ Washington, Genome Sci, Seattle, WA 98195 USA; [Potter, John D.] Massey Univ, Ctr Publ Hlth Res, Wellington, New Zealand; [Schoen, Robert E.] Univ Pittsburgh, Med Ctr, Dept Med & Epidemiol, Pittsburgh, PA USA; [Seminara, Daniela] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA; [Slattery, Martha L.] Univ Utah, Hlth Sci Ctr, Dept Internal Med, Salt Lake City, UT USA; [Chan, Andrew T.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Berndt, Sonja I.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Memorial Sloan Kettering Cancer Center; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Nantes Universite; CHU de Nantes; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Kaiser Permanente; University of Southern California; Helmholtz Association; German Cancer Research Center (DKFZ); Translational Genomics Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; New York University; University of Melbourne; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; Cancer Research Center of Hawaii; University of Hawaii System; Baylor College of Medicine; University of Washington; University of Washington Seattle; Massey University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Du, MM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.; Du, MM; Peters, U (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Peters, U (corresponding author), Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA.	dumeng@mskcc.org; upeters@fhcrc.org	Hoffmeister, Michael/T-7187-2019; Hoffmeister, Michael/AAB-2321-2022; KÜRY, Sébastien/G-5971-2015; Jenkins, Mark/P-7803-2015; Brenner, Hermann/B-4627-2017	Hoffmeister, Michael/0000-0002-8307-3197; Hoffmeister, Michael/0000-0002-8307-3197; KÜRY, Sébastien/0000-0001-5497-0465; Hayes, Richard/0000-0002-0918-661X; Schumacher, Fredrick/0000-0002-3073-7463; Harrison, Tabitha/0000-0002-4173-7530; Caan, Bette/0000-0002-5803-310X; Bien, Stephanie/0000-0002-8713-4583; Jenkins, Mark/0000-0002-8964-6160; Brenner, Hermann/0000-0002-6129-1572	GECCO: National Cancer Institute; GECCO: National Institutes of Health; GECCO: U.S. Department of Health and Human Services [U01 CA137088, R01 CA059045, U01 CA164930]; National Cancer Institute [R25 CA94880, P30 CA008748]; Regional Council of Pays de la Loire; Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Cancer Institute, National Institutes of Health [U01 CA122839]; National Institutes of Health: Australasian Colorectal Cancer Family Registry [U01 CA097735]; National Institutes of Health: Ontario Registry for Studies of Familial Colorectal Cancer [U01 CA074783]; National Institutes of Health: Seattle Colorectal Cancer Family Registry [U01 CA074794]; DACHS: German Research Council (Deutsche Forschungsgemeinschaft) [BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH 117/1-1]; COLO2&3: National Institutes of Health [R01 CA60987]; CCFR: National Institutes of Health (RFA) [CA-95-011]; German Federal Ministry of Education and Research [01KH0404, 01ER0814]; DALS: National Institutes of Health [R01 CA48998]; NHS; PHS: HPFS by National Institutes of Health [P01 CA 055075, UM1 CA167552, R01 137178, P50 CA 127003]; NHS by the National Institutes of Health [P50 CA 127003, R01 CA137178, P01 CA 087969]; National Institutes of Health [CA42182]; Damon Runyon Clinical investigator Award; MEC: National Institutes of Health [R37 CA54281, P01 CA033619, R01 CA63464]; OFCCR: National Institutes of Health [U01 CA074783]; GL2 grant from Ontario Research Fund; Canadian Institutes of Health Research; Cancer Risk Evaluation (CaRE) Program grant from Canadian Cancer Society Research Institute; Senior Investigator Awards from Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation; PLCO: Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS; National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI) [Z01 CP 010200]; NIH [U01 HG004446]; NIH GEI [U01 HG 004438]; PMH-CCFR: National Institutes of Health [R01 CA076366]; VITAL: National Institutes of Health [K05 CA154337]; National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services [HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, HHSN271201100004C]; CORECT: National Cancer Institute, National Institutes of Health under RFA [CA-09-002 (U19 CA148107)];  [K24 DK098311]; NATIONAL CANCER INSTITUTE [R25CA094880, P30CA071789, U01CA164930, P30CA008748, UM1CA167551] Funding Source: NIH RePORTER	GECCO: National Cancer Institute; GECCO: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GECCO: U.S. Department of Health and Human Services; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Regional Council of Pays de la Loire(Region Pays de la Loire); Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC); Association Anne de Bretagne Genetique; Ligue Regionale Contre le Cancer (LRCC); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health: Australasian Colorectal Cancer Family Registry(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health: Ontario Registry for Studies of Familial Colorectal Cancer(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health: Seattle Colorectal Cancer Family Registry(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DACHS: German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); COLO2&3: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFR: National Institutes of Health (RFA); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); DALS: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHS; PHS: HPFS by National Institutes of Health; NHS by the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Clinical investigator Award; MEC: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USASpanish Government); OFCCR: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GL2 grant from Ontario Research Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Risk Evaluation (CaRE) Program grant from Canadian Cancer Society Research Institute; Senior Investigator Awards from Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); PLCO: Intramural Research Program of the Division of Cancer Epidemiology and Genetics; Division of Cancer Prevention, National Cancer Institute, NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH GEI; PMH-CCFR: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VITAL: National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CORECT: National Cancer Institute, National Institutes of Health under RFA; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the following: GECCO: National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services (U01 CA137088; R01 CA059045; U01 CA164930), M.D. is supported by grants R25 CA94880 and P30 CA008748 from the National Cancer Institute. ASTERISK: Hospital Clinical Research Program (PHRC) and supported by the Regional Council of Pays de la Loire, the Groupement des Entreprises Francaises dans la Lutte contre le Cancer (GEFLUC), the Association Anne de Bretagne Genetique and the Ligue Regionale Contre le Cancer (LRCC). COLO2&3: National Institutes of Health (R01 CA60987). CCFR: National Institutes of Health (RFA # CA-95-011) and through cooperative agreements with members of the Colon Cancer Family Registry and P.I.s. This genome wide scan was supported by the National Cancer Institute, National Institutes of Health by U01 CA122839. The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the CFRs, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the CFR. The following Colon CFR centers contributed data to this manuscript and were supported by National Institutes of Health: Australasian Colorectal Cancer Family Registry (U01 CA097735), Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783), and Seattle Colorectal Cancer Family Registry (U01 CA074794). DACHS: German Research Council (Deutsche Forschungsgemeinschaft, BR 1704/6-1, BR 1704/6-3, BR 1704/6-4 and CH 117/1-1), and the German Federal Ministry of Education and Research (01KH0404 and 01ER0814). DALS: National Institutes of Health (R01 CA48998 to M.L.S.); HPFS, NHS, and PHS: HPFS by the National Institutes of Health (P01 CA 055075, UM1 CA167552, R01 137178, and P50 CA 127003), NHS by the National Institutes of Health (R01 CA137178, P01 CA 087969 and P50 CA 127003,) and PHS by the National Institutes of Health (CA42182). A.T.C. is also supported by a Damon Runyon Clinical investigator Award and K24 DK098311. MEC: National Institutes of Health (R37 CA54281, P01 CA033619, and R01 CA63464). OFCCR: National Institutes of Health, through funding allocated to the Ontario Registry for Studies of Familial Colorectal Cancer (U01 CA074783); see CCFR section above. As subset of ARCTIC, OFCCR is supported by a GL2 grant from the Ontario Research Fund, the Canadian Institutes of Health Research, and the Cancer Risk Evaluation (CaRE) Program grant from the Canadian Cancer Society Research Institute. T.J.H. is a recipient of Senior Investigator Awards from the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation. PLCO: Intramural Research Program of the Division of Cancer Epidemiology and Genetics and supported by contracts from the Division of Cancer Prevention, National Cancer Institute, NIH, DHHS. Additionally, a subset of control samples were genotyped as part of the Cancer Genetic Markers of Susceptibility (CGEMS) Prostate Cancer GWAS (Yeager, M et al. Nat Genet 2007 May;39(5):645-9), Colon CGEMS pancreatic cancer scan (PanScan) (Amundadottir, L et al. Nat Genet. 2009 Sep;41(9):986-90 and Petersen, GM et al Nat Genet. 2010 Mar;42(3):2248), and the Lung Cancer and Smoking study. The prostate and PanScan study datasets were accessed with appropriate approval through the dbGaP online resource (http://cgems.cancer.gov/data/) accession numbers phs000207v.1p1 and phs000206.v3.; p2, respectively, and the lung datasets were accessed from the dbGaP website (http://www.ncbi.nlm.nih.gov/gap) through accession number phs000093v2.p2. Funding for the Lung Cancer and Smoking study was provided by National Institutes of Health (NIH), Genes, Environment and Health Initiative (GEI) Z01 CP 010200, NIH U01 HG004446, and NIH GEI U01 HG 004438. For the lung study, the GENEVA Coordinating Center provided assistance with genotype cleaning and general study coordination, and the Johns Hopkins University Center for Inherited Disease Research conducted genotyping. PMH-CCFR: National Institutes of Health (R01 CA076366 to P.A.N.). VITAL: National Institutes of Health (K05 CA154337). WHI: The WHI program is funded by the National Heart, Lung, and Blood Institute, National Institutes of Health, U.S. Department of Health and Human Services through contracts HHSN268201100046C, HHSN268201100001C, HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and HHSN271201100004C. CORECT: National Cancer Institute, National Institutes of Health under RFA #CA-09-002 (U19 CA148107). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in CORECT, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or CORECT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Biancolella M, 2014, HUM MOL GENET, V23, P2198, DOI 10.1093/hmg/ddt584; Birnbaum RY, 2012, GENOME RES, V22, P1059, DOI 10.1101/gr.133546.111; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Carvajal-Carmona LG, 2011, HUM MOL GENET, V20, P2879, DOI 10.1093/hmg/ddr190; Chung CC, 2011, HUM MOL GENET, V20, P2869, DOI 10.1093/hmg/ddr189; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dunlop MG, 2013, GUT, V62, P871, DOI 10.1136/gutjnl-2011-300537; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Durkin ME, 1997, FEBS LETT, V411, P296, DOI 10.1016/S0014-5793(97)00686-8; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Harley ITW, 2009, NAT REV GENET, V10, P285, DOI 10.1038/nrg2571; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Howie B, 2012, NAT GENET, V44, P955, DOI 10.1038/ng.2354; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huang L, 2009, AM J HUM GENET, V85, P692, DOI 10.1016/j.ajhg.2009.09.017; Hutter CM, 2012, CANCER RES, V72, P2036, DOI 10.1158/0008-5472.CAN-11-4067; Hutter CM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-670; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jaeger E, 2012, NAT GENET, V44, P699, DOI 10.1038/ng.2263; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Jiao S, 2011, GENET EPIDEMIOL, V35, P597, DOI 10.1002/gepi.20608; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kocarnik JD, 2010, CANCER EPIDEM BIOMAR, V19, P3131, DOI 10.1158/1055-9965.EPI-10-0878; Kote-Jarai Z, 2013, HUM MOL GENET, V22, P2520, DOI 10.1093/hmg/ddt086; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Montgomery SB, 2010, NATURE, V464, P773, DOI 10.1038/nature08903; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Pittman AM, 2008, HUM MOL GENET, V17, P3720, DOI 10.1093/hmg/ddn267; Pittman AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001126; Pittman AM, 2009, GENOME RES, V19, P987, DOI 10.1101/gr.092668.109; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Spain SL, 2012, HUM MOL GENET, V21, P934, DOI 10.1093/hmg/ddr523; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang HS, 2013, HUM MOL GENET, V22, P5048, DOI 10.1093/hmg/ddt337; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Whiffin N, 2014, HUM MOL GENET, V23, P4729, DOI 10.1093/hmg/ddu177; Whiffin N, 2013, HUM MOL GENET, V22, P5075, DOI 10.1093/hmg/ddt357; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zheng J, 2011, GENET EPIDEMIOL, V35, P102, DOI 10.1002/gepi.20552	75	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157521	10.1371/journal.pone.0157521	http://dx.doi.org/10.1371/journal.pone.0157521			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379672	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700007
J	Hilligan, KL; Connor, LM; Schmidt, AJ; Ronchese, F				Hilligan, Kerry L.; Connor, Lisa M.; Schmidt, Alfonso J.; Ronchese, Franca			Activation-Induced TIM-4 Expression Identifies Differential Responsiveness of Intestinal CD103+CD11b+Dendritic Cells to a Mucosal Adjuvant	PLOS ONE			English	Article							CD103(+) DENDRITIC CELLS; LAMINA-PROPRIA; APOPTOTIC CELLS; ORAL TOLERANCE; CHOLERA-TOXIN; T-CELLS; ANTIGEN; LYMPH; PHOSPHATIDYLSERINE; MACROPHAGES	Macrophage and dendritic cell (DC) populations residing in the intestinal lamina propria (LP) are highly heterogeneous and have disparate yet collaborative roles in the promotion of adaptive immune responses towards intestinal antigen. Under steady-state conditions, macrophages are efficient at acquiring antigen but are non-migratory. In comparison, intestinal DC are inefficient at antigen uptake but migrate to the mesenteric lymph nodes (mLN) where they present antigen to T cells. Whether such distinction in the roles of DC and macrophages in the uptake and transport of antigen is maintained under immunostimulatory conditions is less clear. Here we show that the scavenger and phosphatidylserine receptor T cell Immunoglobulin and Mucin (TIM)-4 is expressed by the majority of LP macrophages at steady-state, whereas DC are TIM-4 negative. Oral treatment with the mucosal adjuvant cholera toxin (CT) induces expression of TIM-4 on a proportion of CD103+ CD11b+ DC in the LP. TIM-4+ DC selectively express high levels of co-stimulatory molecules after CT treatment and are detected in the mLN a short time after appearing in the LP. Importantly, intestinal macrophages and DC expressing TIM-4 are more efficient than their TIM-4 negative counterparts at taking up apoptotic cells and soluble antigen ex vivo. Taken together, our results show that CT induces phenotypic changes to migratory intestinal DC that may impact their ability to take up local antigens and in turn promote the priming of mucosal immunity.	[Hilligan, Kerry L.; Connor, Lisa M.; Schmidt, Alfonso J.; Ronchese, Franca] Malaghan Inst Med Res, Wellington, New Zealand; [Hilligan, Kerry L.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand	Malaghan Institute; Victoria University Wellington; Victoria University Wellington	Connor, LM (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.	lconnor@malaghan.org.nz	Hilligan, Kerry/AAK-8480-2021; Connor, Lisa/N-7803-2017; Ronchese, Franca/M-9618-2019	Connor, Lisa/0000-0002-3882-8765; Ronchese, Franca/0000-0001-5835-8230; Hilligan, Kerry/0000-0003-1238-1552	Health Research Council of New Zealand [14034FRA]; Masters scholarship from the Victoria University of Wellington	Health Research Council of New Zealand(Health Research Council of New Zealand); Masters scholarship from the Victoria University of Wellington	This study was funded by a grant (14034FRA) awarded to FR from the Health Research Council of New Zealand (http://www.hrc.govt.nz/). KLH was supported by a Masters scholarship from the Victoria University of Wellington (http://www.victoria.ac.nz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albacker LA, 2013, MUCOSAL IMMUNOL, V6, P580, DOI 10.1038/mi.2012.100; Albacker LA, 2010, J IMMUNOL, V185, P6839, DOI 10.4049/jimmunol.1001360; Anjuere F, 2004, J IMMUNOL, V173, P5103, DOI 10.4049/jimmunol.173.8.5103; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; Blazquez AB, 2008, J IMMUNOL, V180, P4441, DOI 10.4049/jimmunol.180.7.4441; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Czuczman MA, 2014, NATURE, V509, P230, DOI 10.1038/nature13168; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Feng BS, 2008, J ALLERGY CLIN IMMUN, V122, P55, DOI 10.1016/j.jaci.2008.04.036; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Gustafsson T, 2013, EUR J IMMUNOL, V43, P1779, DOI 10.1002/eji.201242867; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang FP, 2000, J EXP MED, V191, P435, DOI 10.1084/jem.191.3.435; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jang MH, 2006, J IMMUNOL, V176, P803, DOI 10.4049/jimmunol.176.2.803; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Kawamura YI, 2003, EUR J IMMUNOL, V33, P3205, DOI 10.1002/eji.200324135; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Liu T, 2007, MOL IMMUNOL, V44, P3580, DOI 10.1016/j.molimm.2007.03.004; Mattsson J, 2015, MUCOSAL IMMUNOL, V8, P815, DOI 10.1038/mi.2014.111; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185; Nakano H, 2014, J IMMUNOL, V192; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Nishi C, 2014, MOL CELL BIOL, V34, P1512, DOI 10.1128/MCB.01394-13; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Rodriguez-Manzanet R, 2008, J IMMUNOL, V180, P4706, DOI 10.4049/jimmunol.180.7.4706; Saeki H, 1999, J IMMUNOL, V162, P2472; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Scott CL, 2015, MUCOSAL IMMUNOL, V8, P327, DOI 10.1038/mi.2014.70; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Torchinsky MB, 2009, NATURE, V458, P78, DOI 10.1038/nature07781; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Valente M, 2014, EUR J IMMUNOL, V44, P2274, DOI 10.1002/eji.201344191; Vermaelen KY, 2001, J EXP MED, V193, P51, DOI 10.1084/jem.193.1.51; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; Wong K, 2010, P NATL ACAD SCI USA, V107, P8712, DOI 10.1073/pnas.0910929107; Worbs T, 2006, J EXP MED, V203, P519, DOI 10.1084/jem.20052016; Yang PC, 2007, GASTROENTEROLOGY, V133, P1522, DOI 10.1053/j.gastro.2007.08.006	50	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158775	10.1371/journal.pone.0158775	http://dx.doi.org/10.1371/journal.pone.0158775			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379516	Green Submitted, gold, Green Published			2022-12-26	WOS:000379798700046
J	Tarutani, A; Suzuki, G; Shimozawa, A; Nonaka, T; Akiyama, H; Hisanaga, S; Hasegawa, M				Tarutani, Airi; Suzuki, Genjiro; Shimozawa, Aki; Nonaka, Takashi; Akiyama, Haruhiko; Hisanaga, Shin-ichi; Hasegawa, Masato			The Effect of Fragmented Pathogenic alpha-Synuclein Seeds on Prion-like Propagation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC PARKINSONS-DISEASE; MULTIPLE SYSTEM ATROPHY; LEWY BODIES; NEURODEGENERATIVE-DISEASES; IN-VIVO; FIBRILS; MICE; TAU; BODY; AGGREGATION	Aggregates of abnormal proteins are widely observed in neuronal and glial cells of patients with various neurodegenerative diseases, and it has been proposed that prion-like behavior of these proteins can account for not only the onset but also the progression of these diseases. However, it is not yet clear which abnormal protein structures function most efficiently as seeds for prion-like propagation. In this study, we aimed to identify the most pathogenic species of alpha-synuclein (alpha-syn), the main component of the Lewy bodies and Lewy neurites that are observed in alpha-synucleinopathies. We prepared various forms of alpha-syn protein and examined their seeding properties in vitro in cells and in mouse experimental models. We also characterized these alpha-syn species by means of electron microscopy and thioflavin fluorescence assays and found that fragmented beta sheet rich fibrous structures of alpha-syn with a length of 50 nm or less are the most efficient promoters of accumulation of phosphorylated alpha-syn, which is the hallmark of alpha-synucleinopathies. These results indicate that fragmented amyloid-like aggregates of short alpha-syn fibrils are the key pathogenic seeds that trigger prion-like conversion.	[Tarutani, Airi; Suzuki, Genjiro; Shimozawa, Aki; Nonaka, Takashi; Akiyama, Haruhiko; Hasegawa, Masato] Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Tokyo 1568506, Japan; [Tarutani, Airi; Shimozawa, Aki; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan University	Hasegawa, M (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Dementia & Higher Brain Funct, Setagaya Ku, Tokyo 1568506, Japan.	hasegawa-ms@igakuken.or.jp	Tarutani, Airi/AAU-7462-2021; Nonaka, Takashi/L-8572-2017	Nonaka, Takashi/0000-0002-0830-9403; Tarutani, Airi/0000-0003-3835-9070	Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI) [JP26117005, JP26111730]; Japan Society for the Promotion of Science (KAKENHI) [JP23228004]; Ministry of Health, Labor, and Welfare of Japan [JP12946221]; Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development (AMED)	Ministry of Education, Culture, Sports, Science, and Technology (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid for Scientific Research (KAKENHI) Grants JP26117005 (to M. H.) and JP26111730 (to T. N.), Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) Grant JP23228004 (to M. H.), Ministry of Health, Labor, and Welfare of Japan Grant JP12946221 (to M. H.), a grant-in-aid for research on rare and intractable diseases, the Research Committee on Establishment of Novel Treatments for Amyotrophic Lateral Sclerosis, and Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from the Japan Agency for Medical Research and Development (AMED) (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aulic S, 2014, BMC NEUROSCI, V15, DOI 10.1186/1471-2202-15-69; Baba M, 1998, AM J PATHOL, V152, P879; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brahic M, 2016, ACTA NEUROPATHOL, V131, P539, DOI 10.1007/s00401-016-1538-0; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; Falcon B, 2015, J BIOL CHEM, V290, P1049, DOI 10.1074/jbc.M114.589309; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Jackson SJ, 2016, J NEUROSCI, V36, P762, DOI 10.1523/JNEUROSCI.3542-15.2016; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Masuda M, 2009, FEBS LETT, V583, P787, DOI 10.1016/j.febslet.2009.01.037; Masuda-Suzukake M, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0088-8; Masuda-Suzukake M, 2013, BRAIN, V136, P1128, DOI 10.1093/brain/awt037; Monsellier E, 2016, SCI REP-UK, V6, DOI 10.1038/srep19180; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Recasens A, 2014, ANN NEUROL, V75, P351, DOI 10.1002/ana.24066; Sacino AN, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-17; Shimonaka S, 2016, J BIOL CHEM, V291, P8896, DOI 10.1074/jbc.M115.713552; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takahashi M, 2015, ACTA NEUROPATHOL, V129, P895, DOI 10.1007/s00401-015-1415-2; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Volpicelli-Daley LA, 2014, NAT PROTOC, V9, P2135, DOI 10.1038/nprot.2014.143; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wakabayashi K, 1998, NEUROSCI LETT, V249, P180, DOI 10.1016/S0304-3940(98)00407-8; Watts JC, 2013, P NATL ACAD SCI USA, V110, P19555, DOI 10.1073/pnas.1318268110; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wu JW, 2013, J BIOL CHEM, V288, P1856, DOI 10.1074/jbc.M112.394528; Xue WF, 2009, J BIOL CHEM, V284, P34272, DOI 10.1074/jbc.M109.049809; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200	49	61	61	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18675	18688		10.1074/jbc.M116.734707	http://dx.doi.org/10.1074/jbc.M116.734707			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27382062	Green Published, hybrid			2022-12-26	WOS:000383242300007
J	Zhu, YH; Liberton, M; Pakrasi, HB				Zhu, Yuehui; Liberton, Michelle; Pakrasi, Himadri B.			A Novel Redoxin in the Thylakoid Membrane Regulates the Titer of Photosystem I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCOCCUS SP PCC-7002; BLUE-GREEN-ALGAE; PROTEOMIC ANALYSIS; SCAFFOLD PROTEIN; ANALYSIS REVEALS; INACTIVATION; ACCUMULATION; ARABIDOPSIS; BIOGENESIS; COMPLEX	In photosynthetic organisms like cyanobacteria and plants, the main engines of oxygenic photosynthesis are the pigment protein complexes photosystem I (PSI) and photosystem II (PSII) located in the thylakoid membrane. In the cyanobacterium Synechocystis sp. PCC 6803, the str1796 gene encodes a single cysteine thioredoxin-like protein, orthologs of which are found in multiple cyanobacterial strains as well as chloroplasts of higher plants. Targeted inactivation of slr1796 in Synechocystis 6803 resulted in compromised photoautotrophic growth. The mutant displayed decreased chlorophyll a content. These changes correlated with a decrease in the PSI titer of the mutant cells, whereas the PSII content was unaffected. In the mutant, the transcript levels of genes for PSI structural and accessory proteins remained unaffected, whereas the levels of PSI structural proteins were severely diminished, indicating that Slr1796 acts at a posttranscriptional level. Biochemical analysis indicated that Slr1796 is an integral thylakoid membrane protein. We conclude that Slr1796 is a novel regulatory factor that modulates PSI titer.	[Zhu, Yuehui; Liberton, Michelle; Pakrasi, Himadri B.] Washington Univ, Dept Biol, One Brookings Dr, St Louis, MO 63130 USA	Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, One Brookings Dr, St Louis, MO 63130 USA.	pakrasi@wustl.edu	ZHU, YUEHUI/Q-1836-2015	ZHU, YUEHUI/0000-0003-0552-448X	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy [DE-FG02-99ER20350]	Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy under Grant DE-FG02-99ER20350 (to H. B. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Albus CA, 2010, PLANT CELL, V22, P2838, DOI 10.1105/tpc.110.073908; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Amunts A, 2009, STRUCTURE, V17, P637, DOI 10.1016/j.str.2009.03.006; ARNON DI, 1974, BIOCHIM BIOPHYS ACTA, V357, P231, DOI 10.1016/0005-2728(74)90063-2; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Bartsevich VV, 1997, J BIOL CHEM, V272, P6382, DOI 10.1074/jbc.272.10.6382; Boudreau E, 1997, EMBO J, V16, P6095, DOI 10.1093/emboj/16.20.6095; Buchanan BB, 2005, ANNU REV PLANT BIOL, V56, P187, DOI 10.1146/annurev.arplant.56.032604.144246; Cameron JC, 2011, PLANT SIGNAL BEHAV, V6, P89, DOI 10.4161/psb.6.1.14145; Chi W, 2012, PHILOS T R SOC B, V367, P3420, DOI 10.1098/rstb.2012.0065; CHITNIS PR, 1989, J BIOL CHEM, V264, P18374; During U, 2007, J BIOL CHEM, V282, P10915, DOI 10.1074/jbc.M609206200; Foyer CH, 2009, ANTIOXID REDOX SIGN, V11, P861, DOI 10.1089/ars.2008.2177; Fristedt R, 2014, J BIOL CHEM, V289, P30657, DOI 10.1074/jbc.M114.587758; Gohre V, 2006, PLANT CELL, V18, P1454, DOI 10.1105/tpc.105.038695; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Krech K, 2012, PLANT PHYSIOL, V159, P579, DOI 10.1104/pp.112.196642; Kubota H, 2010, BBA-BIOENERGETICS, V1797, P98, DOI 10.1016/j.bbabio.2009.09.001; Liberton M, 2006, PROTOPLASMA, V227, P129, DOI 10.1007/s00709-006-0145-7; Liberton M, 2016, MOL CELL PROTEOMICS, V15, P2021, DOI 10.1074/mcp.M115.057240; Liu HJ, 2014, P NATL ACAD SCI USA, V111, P4638, DOI 10.1073/pnas.1323063111; Liu J, 2012, PLANT CELL, V24, P4992, DOI 10.1105/tpc.112.106542; Lyska D, 2013, PLANTA, V237, P413, DOI 10.1007/s00425-012-1752-5; Ng AH, 2015, APPL ENVIRON MICROB, V81, P6857, DOI 10.1128/AEM.01349-15; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Ossenbuhl F, 2006, PLANT CELL, V18, P2236, DOI 10.1105/tpc.106.043646; Ozawa S, 2009, PLANT CELL, V21, P2424, DOI 10.1105/tpc.108.063313; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Quan JY, 2011, NAT PROTOC, V6, P242, DOI 10.1038/nprot.2010.181; Rochaix JD, 2011, PLANT PHYSIOL, V155, P1493, DOI 10.1104/pp.110.169839; Ruf S, 1997, J CELL BIOL, V139, P95, DOI 10.1083/jcb.139.1.95; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schottler MA, 2011, J PLANT PHYSIOL, V168, P1452, DOI 10.1016/j.jplph.2010.12.009; Schottkowski M, 2009, MOL PLANT, V2, P1289, DOI 10.1093/mp/ssp075; Schwenkert S, 2010, BIOCHEM J, V425, P207, DOI 10.1042/BJ20091290; SHEN GZ, 1993, PLANT CELL, V5, P1853, DOI 10.1105/tpc.5.12.1853; Shen GZ, 2002, J BIOL CHEM, V277, P20355, DOI 10.1074/jbc.M201104200; Shen GZ, 2002, J BIOL CHEM, V277, P20343, DOI 10.1074/jbc.M201103200; Srivastava R, 2005, PROTEOMICS, V5, P4905, DOI 10.1002/pmic.200500111; Stockel J, 2004, J BIOL CHEM, V279, P10243, DOI 10.1074/jbc.M309246200; Stockel J, 2006, PLANT PHYSIOL, V141, P870, DOI 10.1104/pp.106.078147; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; Vermaas WFJ, 2008, P NATL ACAD SCI USA, V105, P4050, DOI 10.1073/pnas.0708090105; Wilde A, 2001, BIOCHEM J, V357, P211, DOI 10.1042/0264-6021:3570211; WILDE A, 1995, PLANT CELL, V7, P649, DOI 10.1105/tpc.7.5.649; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Yang HX, 2015, BBA-BIOENERGETICS, V1847, P838, DOI 10.1016/j.bbabio.2014.12.011; Zak E, 2000, PLANT PHYSIOL, V123, P215, DOI 10.1104/pp.123.1.215; Zhang SY, 2014, J BIOL CHEM, V289, P15904, DOI 10.1074/jbc.M114.555631	52	9	9	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18689	18699		10.1074/jbc.M116.721175	http://dx.doi.org/10.1074/jbc.M116.721175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27382055	Green Published, hybrid			2022-12-26	WOS:000383242300008
J	Gupta, A; Leslie, NR				Gupta, Amit; Leslie, Nicholas R.			Controlling PTEN (Phosphatase and Tensin Homolog) Stability A DOMINANT ROLE FOR LYSINE 66	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer; phosphatase; phosphatase and tensin homolog (PTEN); phosphoinositide; protein stability; ubiquitylation (ubiquitination); phosphoinositide 3-kinase; tumor suppressor	TUMOR-SUPPRESSOR; UBIQUITINATION; MUTATIONS; TUMORIGENESIS; ACTIVATION; CANCER; GENE; REVEALS; AUTISM; LIGASE	Phosphatase and tensin homolog (PTEN) is a phosphoinositide lipid phosphatase and one of the most frequently disrupted tumor suppressors in many forms of cancer, with even small reductions in the expression levels of PTEN promoting cancer development. Although the post-translational ubiquitination of PTEN can control its stability, activity, and localization, a detailed understanding of how PTEN ubiquitination integrates with other cellular regulatory processes and may be dysregulated in cancer has been hampered by a poor understanding of the significance of ubiquitination at individual sites. Here we show that Lys(66) is not required for cellular activity, yet dominates over other PTEN ubiquitination sites in the regulation of protein stability. Notably, combined mutation of other sites (Lys(13), Lys(80), and Lys(289)) has relatively little effect on protein expression, protein stability, or PTEN polyubiquitination. The present work identifies a key role for Lys(66) in the regulation of PTEN expression and provides both an opportunity to improve the stability of PTEN as a protein therapy and a mechanistic basis for efforts to stabilize endogenous PTEN.	[Gupta, Amit; Leslie, Nicholas R.] Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, James Nasmyth Bldg,Riccarton Campus, Edinburgh EH14 4AS, Midlothian, Scotland; [Gupta, Amit] Inst Canc Res, Chester Beatty Labs, 237 Fulham Rd, London SW3 6JB, England	Heriot Watt University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Gupta, A; Leslie, NR (corresponding author), Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, James Nasmyth Bldg,Riccarton Campus, Edinburgh EH14 4AS, Midlothian, Scotland.; Gupta, A (corresponding author), Inst Canc Res, Chester Beatty Labs, 237 Fulham Rd, London SW3 6JB, England.	amit.gupta@icr.ac.uk; n.r.leslie@hw.ac.uk		/0000-0002-7163-687X; LESLIE, Nicholas/0000-0001-5131-0541	Medical Research Council [G0801865/2, SU2P]; Medical Research Council [G0801865, G9403619] Funding Source: researchfish; MRC [G0801865, G9403619] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council Grant G0801865/2 and SU2P. The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed SF, 2012, J BIOL CHEM, V287, P15996, DOI 10.1074/jbc.M111.321083; Chen MH, 2011, CANCER CELL, V20, P173, DOI 10.1016/j.ccr.2011.07.013; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Gupta A, 2016, METHODS MOL BIOL, P155, DOI 10.1007/978-1-4939-3299-3_11; Han SY, 2000, CANCER RES, V60, P3147; He X, 2013, CANCER RES, V73, P3029, DOI 10.1158/0008-5472.CAN-12-3811; Nguyen HN, 2014, P NATL ACAD SCI USA, V111, pE2684, DOI 10.1073/pnas.1409433111; Hopkins BD, 2013, SCIENCE, V341, P399, DOI 10.1126/science.1234907; Kwak YD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-49; Lee C, 2004, CANCER RES, V64, P6906, DOI 10.1158/0008-5472.CAN-04-1767; Lee JT, 2013, CELL RES, V23, P552, DOI 10.1038/cr.2013.27; Leslie NR, 2011, TRENDS PHARMACOL SCI, V32, P131, DOI 10.1016/j.tips.2010.12.005; Li GQ, 2014, CANCER CELL, V25, P455, DOI 10.1016/j.ccr.2014.02.007; Liang H, 2014, CELL METAB, V19, P836, DOI 10.1016/j.cmet.2014.03.023; Maccario H, 2010, J BIOL CHEM, V285, P12620, DOI 10.1074/jbc.M109.072280; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Rodriguez-Escudero I, 2011, HUM MOL GENET, V20, P4132, DOI 10.1093/hmg/ddr337; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Singh G, 2011, CURR CANCER DRUG TAR, V11, P536, DOI 10.2174/156800911795655930; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Spinelli L, 2015, J MED GENET, V52, P128, DOI 10.1136/jmedgenet-2014-102803; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114250; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Worby CA, 2014, ANNU REV BIOCHEM, V83, P641, DOI 10.1146/annurev-biochem-082411-113907; Yuan L, 2015, NAT CELL BIOL, V17, P1169, DOI 10.1038/ncb3218; Zhang JS, 2013, NAT CELL BIOL, V15, P1486, DOI 10.1038/ncb2874	33	14	15	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18465	18473		10.1074/jbc.M116.727750	http://dx.doi.org/10.1074/jbc.M116.727750			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27405757	Green Published, hybrid			2022-12-26	WOS:000383241800036
J	Forstneric, V; Ivicak-Kocjan, K; Ljubetic, A; Jerala, R; Bencina, M				Forstneric, Vida; Ivicak-Kocjan, Karolina; Ljubetic, Ajasja; Jerala, Roman; Bencina, Mojca			Ditsinctive Recognition of Flagellin by Human and Mouse Toll-Like Receptor 5	PLOS ONE			English	Article							BACTERIAL FLAGELLIN; MOLECULAR-DYNAMICS; PROTEIN STRUCTURES; STRUCTURAL BASIS; ACTIVATION; CELLS; TLR5; TOLL-LIKE-RECEPTOR-5; SEQUENCE; PROTOFILAMENT	Toll-like receptor 5 (TLR5) is a receptor of the innate immune system that recognizes flagellin from certain bacterial species and triggers an inflammatory response. The Salmonella dublin flagellin in complex with zebrafish TLR5 has been crystallized previously. In the present study, we extrapolate the structure of this complex using structure-guided mutagenesis to determine the recognition modes of human and mouse TLR5 receptors and demonstrate species-specific differences in flagellin recognition. In general, the recognition mode of the mouse receptor can be said to be more robust in comparison to that of the human receptor. All-atom molecular dynamics simulation showed differences between the two receptors within the primary binding region. Using a functional motility assay, we show that although the highly conserved area of the flagellin analyzed in this study encompasses key structural requirements for flagella formation, a direct correlation between immune recognition and structure on the level of amino acid residues is not observed.	[Forstneric, Vida; Ivicak-Kocjan, Karolina; Ljubetic, Ajasja; Jerala, Roman; Bencina, Mojca] Natl Inst Chem, Dept Synthet Biol & Immunol, Ljubljana, Slovenia; [Jerala, Roman; Bencina, Mojca] Ctr Excellence EN FIST, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Jerala, R; Bencina, M (corresponding author), Natl Inst Chem, Dept Synthet Biol & Immunol, Ljubljana, Slovenia.; Jerala, R; Bencina, M (corresponding author), Ctr Excellence EN FIST, Ljubljana, Slovenia.	roman.jerala@ki.si; mojca.bencina@ki.si		Ljubetic, Ajasja/0000-0002-2171-1579	state budget by the Slovenian Research Agency; EN-FIST Centre of Excellence	state budget by the Slovenian Research Agency(Slovenian Research Agency - Slovenia); EN-FIST Centre of Excellence	The authors acknowledge the financial support from the state budget by the Slovenian Research Agency (VF, KIK, AL, MB, RJ), EN-FIST Centre of Excellence (RJ, MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo R, 2004, AM J RESP CELL MOL, V30, P627, DOI 10.1165/rcmb.2003-0260OC; Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Andersen-Nissen E, 2007, J EXP MED, V204, P393, DOI 10.1084/jem.20061400; Beatson SA, 2006, TRENDS MICROBIOL, V14, P151, DOI 10.1016/j.tim.2006.02.008; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Eaves-Pyles T, 2001, J IMMUNOL, V166, P1248, DOI 10.4049/jimmunol.166.2.1248; Eaves-Pyles TD, 2001, J IMMUNOL, V167, P7009, DOI 10.4049/jimmunol.167.12.7009; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Grabiec A, 2004, J BIOL CHEM, V279, P48004, DOI 10.1074/jbc.M405311200; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Ivicak-Kocjan K, 2013, BIOCHEM BIOPH RES CO, V435, P40, DOI 10.1016/j.bbrc.2013.04.030; Keestra AM, 2008, MOL IMMUNOL, V45, P1298, DOI 10.1016/j.molimm.2007.09.013; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kulka M, 2004, J ALLERGY CLIN IMMUN, V114, P174, DOI 10.1016/j.jaci.2004.03.049; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Means TK, 2003, J IMMUNOL, V170, P5165, DOI 10.4049/jimmunol.170.10.5165; Murthy KGK, 2004, J BIOL CHEM, V279, P5667, DOI 10.1074/jbc.M307759200; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pohar J, 2015, J IMMUNOL, V195, P4396, DOI 10.4049/jimmunol.1500600; Pohar J, 2015, J IMMUNOL, V194, P3901, DOI 10.4049/jimmunol.1402755; Rhee SH, 2005, P NATL ACAD SCI USA, V102, P13610, DOI 10.1073/pnas.0502174102; Samatey FA, 2001, NATURE, V410, P331, DOI 10.1038/35066504; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Taylor DN, 2012, VACCINE, V30, P5761, DOI 10.1016/j.vaccine.2012.06.086; Treanor JJ, 2010, VACCINE, V28, P8268, DOI 10.1016/j.vaccine.2010.10.009; Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Vergara-Jaque A, 2013, J PHYS CHEM B, V117, P6801, DOI 10.1021/jp4000363; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	41	16	20	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158894	10.1371/journal.pone.0158894	http://dx.doi.org/10.1371/journal.pone.0158894			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391968	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400153
J	Guo, DD; Wu, JF; Hu, YY; Sun, W; Lv, TL; Jiang, WJ; Wu, H; Wang, XR; Jonas, JB; Bi, HS				Guo, Da-dong; Wu, Jian-feng; Hu, Yuan-yuan; Sun, Wei; Lv, Tai-liang; Jiang, Wen-jun; Wu, Hui; Wang, Xing-rong; Jonas, Jost B.; Bi, Hong-sheng			Stereoacuity and Related Factors: The Shandong Children Eye Study	PLOS ONE			English	Article							UNILATERAL VISUAL IMPAIRMENT; PRESCHOOL-CHILDREN; YOUNG-CHILDREN; AMBLYOPIA; STEREOPSIS; ANISOMETROPIA; VISION; ACUITY	Objective To assess stereoacuity in a population-based sample of children and to examine ocular and systemic parameters related to stereoacuity. Methods Using a random cluster sampling method, four-to 18-year-old children from kindergartens, elementary schools, junior high schools and senior high schools from a rural area and an urban area in the East Chinese province of Shandong were included in the school-based cross-sectional study. All participants underwent a comprehensive eye examination including assessment of cycloplegic refraction and measurement of stereoacuity using the Titmus Stereo test. Results Out of 6364 eligible children, 5780 (90.8%) children with a mean age of 10.1 +/- 3.2 years (range: 4 to 18 years) participated. Mean (+/- standard deviation) stereoacuity was 50.2 +/- 50.6 arc seconds. Stereoacuity improved significantly (P<0.01) from the age group of 4 years to the age group of 6 to 7 years, then showed a plateau, deteriorated (P = 0.001) for both sexes from the age group of 9 years to the age group of 12 years (P<0.001), after which it improved (P = 0.001) again in the age group of 16 years or older to the pre-puberty values. In multivariate analysis, larger angle of binocular disparity (i.e., lower stereoacuity) was significantly associated with lower best corrected visual acuity (logMAR; P<0.001), higher intereye difference in refractive error (spherical equivalent) (P<0.001), higher cylindrical refractive error (P<0.001), higher refractive error (spherical value; P<0.001), higher intereye difference in best corrected visual acuity (logMAR) (P = 0.001), higher intereye difference in axial length (P = 0.001), and rural region of habitation (P = 0.006). Conclusions Stereoacuity as tested with the Titmus Stereo test improved significantly from an age of 4 years to an age of 6 and 7 years, then remained constant, temporarily deteriorated for both sexes in pre-puberty and puberty, after which it improved again to pre-puberty or better values at the age of 16 years or older. Lower stereoacuity was associated with lower best corrected visual acuity and higher intereye difference in best corrected visual acuity, higher cylindrical and spherical refractive errors, higher inter-eye difference in refractive error, higher intereye difference in axial length, and rural region of habitation.	[Guo, Da-dong; Jiang, Wen-jun; Wu, Hui; Bi, Hong-sheng] Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China; [Wu, Jian-feng] Shandong Univ Tradit Chinese Med, Ophthalmol & Optometry Sch, Jinan, Shandong, Peoples R China; [Hu, Yuan-yuan; Sun, Wei; Lv, Tai-liang; Wang, Xing-rong] Shandong Univ Tradit Chinese Med, Affiliated Hosp 2, Jinan, Shandong, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, Bergheimer Str 58, D-69115 Heidelberg, Germany	Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine; Ruprecht Karls University Heidelberg	Bi, HS (corresponding author), Shandong Univ Tradit Chinese Med, Inst Eye, Jinan, Shandong, Peoples R China.	hongshengbi@126.com		Guo, Dadong/0000-0002-1712-0055; Jonas, Jost/0000-0003-2972-5227	Mundipharma Co. (Cambridge, UK); Alimera Co. (Alpharetta, GA, USA); Boehringer Ingelheim Co. (Ingelheim, Germany); Sanofi Co. (Paris, France); Allergan Co. (Dublin, Ireland); National Health and Family Planning Commission of China [201302015]; National Ministry of Science Technology [2015BAI04B04]; National Natural Science Foundation of China [81303081]; Science and Technology Development Plan of Shandong Province [2014GGH219004]; Medicine and Health Development Plan of Shandong Province [2015WS0141]	Mundipharma Co. (Cambridge, UK); Alimera Co. (Alpharetta, GA, USA); Boehringer Ingelheim Co. (Ingelheim, Germany)(Boehringer Ingelheim); Sanofi Co. (Paris, France); Allergan Co. (Dublin, Ireland); National Health and Family Planning Commission of China; National Ministry of Science Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Plan of Shandong Province; Medicine and Health Development Plan of Shandong Province	This work was funded by Jost P. Jonas, Consultant for Mundipharma Co. (Cambridge, UK), Alimera Co. (Alpharetta, GA, USA), Boehringer Ingelheim Co. (Ingelheim, Germany), Sanofi Co. (Paris, France), and Allergan Co. (Dublin, Ireland); Patent holder with Biocompatibles UK Ltd. (Franham, Surrey, UK) (Title: Treatment of eye diseases using encapsulated cells encoding and secreting neuroprotective factor and / or anti-angiogenic factor; Patent number: 20120263794), and patent application with University of Heidelberg (Heidelberg, Germany) (Title: Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia; Europaische Patentanmeldung 15 000 771.4). This study was also supported by National Health and Family Planning Commission of China (201302015), National Ministry of Science & Technology (2015BAI04B04), National Natural Science Foundation of China (81303081), Science and Technology Development Plan of Shandong Province (2014GGH219004) and Medicine and Health Development Plan of Shandong Province (2015WS0141).	Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Birch E, 2008, J AAPOS, V12, P23, DOI 10.1016/j.jaapos.2007.06.003; BURIAN H M, 1951, Doc Ophthalmol, V5-6, P169, DOI 10.1007/BF00143660; Ciner EB, 2014, OPTOMETRY VISION SCI, V91, P351, DOI 10.1097/OPX.0000000000000165; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; FOX R, 1986, INVEST OPHTH VIS SCI, V27, P598; Goddings AL, 2014, NEUROIMAGE, V88, P242, DOI 10.1016/j.neuroimage.2013.09.073; HERON G, 1985, AM J OPTOM PHYS OPT, V62, P505; Hong SW, 2008, BRIT J OPHTHALMOL, V92, P1186, DOI 10.1136/bjo.2008.138362; Hrisos S, 2006, BRIT J OPHTHALMOL, V90, P836, DOI 10.1136/bjo.2006.090910; Hu YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117482; Jiang WJ, 2014, INVEST OPHTH VIS SCI, V55, P4128, DOI 10.1167/iovs.14-14244; Li SS, 2014, J PEDIAT OPHTH STRAB, V51, P105, DOI 10.3928/01913913-20140220-04; McKean-Cowdin R, 2013, OPHTHALMOLOGY, V120, P2117, DOI 10.1016/j.ophtha.2013.03.001; Noorden GK., 2002, BINOCULAR VISION OCU, V25, P298; Oduntan Alabi O, 1998, Clin Exp Optom, V81, P193; Oguz H, 2000, J PEDIAT OPHTH STRAB, V37, P214; Richardson SR, 2005, INVEST OPHTH VIS SCI, V46, P150, DOI 10.1167/iovs.04-0672; ROGERS BJ, 1993, NATURE, V361, P253, DOI 10.1038/361253a0; ROMANO PE, 1975, AM J OPHTHALMOL, V79, P966, DOI 10.1016/0002-9394(75)90679-0; Rubin GS, 1997, INVEST OPHTH VIS SCI, V38, P557; SIMONS K, 1981, ARCH OPHTHALMOL-CHIC, V99, P439; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Tomac S, 2000, Binocul Vis Strabismus Q, V15, P221; Wallace DK, 2011, J AAPOS, V15, P455, DOI 10.1016/j.jaapos.2011.06.007; Watanabe H, 2014, GRAEF ARCH CLIN EXP, V252, P1207, DOI 10.1007/s00417-014-2566-x; Wu JB, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082763, 10.1371/journal.pone.0081986, 10.1371/journal.pone.0081982]; Yang JW, 2013, JPN J OPHTHALMOL, V57, P316, DOI 10.1007/s10384-013-0231-2; Ying GS, 2013, OPHTHALMOLOGY, V120, P495, DOI 10.1016/j.ophtha.2012.08.014	29	17	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157829	10.1371/journal.pone.0157829	http://dx.doi.org/10.1371/journal.pone.0157829			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391873	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400022
J	Kumar, N; Malik, YS; Kumar, S; Sharma, K; Sircar, S; Saurabh, S; Gulati, BR; Singh, N; Singh, AK; Joshi, VG; Banyai, K; Dhama, K				Kumar, Naveen; Malik, Yashpal Singh; Kumar, Satish; Sharma, Kuldeep; Sircar, Subhankar; Saurabh, Sharad; Gulati, Baldev R.; Singh, Neeraj; Singh, Arvind Kumar; Joshi, Vinay G.; Banyai, Krisztian; Dhama, Kuldeep			Peptide-Recombinant VP6 Protein Based Enzyme Immunoassay for the Detection of Group A Rotaviruses in Multiple Host Species	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; BURSAL DISEASE VIRUS; MAJOR CAPSID PROTEIN; DIAGNOSING ROTAVIRUS; LATEX AGGLUTINATION; CIRCULAR-DICHROISM; CHEMICAL-SYNTHESIS; ESCHERICHIA-COLI; ANTIBODIES; INFECTION	We developed a novel enzyme immunoassay for the detection of group A rotavirus (RVA) antigen in fecal samples of multiple host species. The assay is based on the detection of conserved VP6 protein using anti-recombinant VP6 antibodies as capture antibodies and anti-multiple antigenic peptide (identified and constructed from highly immunodominant epitopes within VP6 protein) antibodies as detector antibodies. The clinical utility of the assay was evaluated using a panel of 914 diarrhoeic fecal samples from four different host species (bovine, porcine, poultry and human) collected from diverse geographical locations in India. Using VP6-based reverse transcription-polymerase chain reaction (RT-PCR) as the gold standard, we found that the diagnostic sensitivity (DSn) and specificity (DSp) of the new assay was high [bovine (DSn = 94.2% & DSp = 100%); porcine (DSn = 94.6% & DSp = 93.3%); poultry (DSn = 74.2%& DSp = 97.7%) and human (DSn = 82.1%& DSp = 98.7%)]. The concordance with RT-PCR was also high [weighted kappa (k) = 0.831-0.956 at 95% CI = 0.711-1.0] as compared to RNA-polyacrylamide gel electrophoresis (RNA-PAGE). The performance characteristics of the new immunoassay were comparable to those of the two commercially available ELISA kits. Our results suggest that this peptide-recombinant protein based assay may serve as a preliminary assay for epidemiological surveillance of RVA antigen and for evaluation of vaccine effectiveness especially in low and middle income settings.	[Kumar, Naveen; Malik, Yashpal Singh; Sircar, Subhankar; Saurabh, Sharad; Singh, Neeraj] Indian Vet Res Inst, Biol Standardizat Div, Izatnagar, Uttar Pradesh, India; [Kumar, Satish; Singh, Arvind Kumar; Joshi, Vinay G.] Indian Vet Res Inst, Div Anim Biotechnol, Izatnagar, Uttar Pradesh, India; [Sharma, Kuldeep] Natl Inst Res Tribal Hlth, Jabalpur, Madhya Pradesh, India; [Gulati, Baldev R.] Natl Res Ctr Equines, Hisar, Haryana, India; [Banyai, Krisztian] Hungarian Acad Sci, Vet Med Res Inst, Agr Res Ctr, Hungariakrt 21, Budapest, Hungary; [Dhama, Kuldeep] Indian Vet Res Inst, Div Vet Immunol, Izatnagar, Uttar Pradesh, India; [Kumar, Naveen] Natl Inst High Secur Anim Dis, Bhopal, Madhya Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of High Security Animal Diseases	Malik, YS (corresponding author), Indian Vet Res Inst, Biol Standardizat Div, Izatnagar, Uttar Pradesh, India.	malikyps@ivri.res.in	Gulati, Baldev/AAF-7492-2020; sircar, Shubhankar/D-3691-2019; Dhama, Kuldeep/B-7852-2015; Kumar, Naveen/V-1009-2019; Kumar, Naveen/GZK-9881-2022; Malik, Yashpal Singh/AAI-2259-2019; Kumar, Naveen/L-1588-2019; Joshi, Vinay Ganeshrao/AAW-8156-2021	Gulati, Baldev/0000-0002-4338-7941; sircar, Shubhankar/0000-0002-1947-4463; Dhama, Kuldeep/0000-0001-7469-4752; Kumar, Naveen/0000-0003-2529-8344; Kumar, Naveen/0000-0002-3326-5465; Joshi, Vinay Ganeshrao/0000-0001-8872-1838; Banyai, Krisztian/0000-0002-6270-1772; Singh, Arvind Kumar/0000-0001-8711-9191	Education Division, Indian Council of Agricultural Research, Ministry of Agriculture & Farmer's Welfare, Govt. of India, New Delhi; Hungarian Scientific Research Fund (OTKA) [T100727]	Education Division, Indian Council of Agricultural Research, Ministry of Agriculture & Farmer's Welfare, Govt. of India, New Delhi; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The financial support from Education Division, Indian Council of Agricultural Research, Ministry of Agriculture & Farmer's Welfare, Govt. of India, New Delhi in the form of National Fellow project is acknowledged. Dr. Krisztian Banyai was supported by the Hungarian Scientific Research Fund (OTKA, T100727).	Bennett A, 2015, J CLIN MICROBIOL, V53, P1951, DOI 10.1128/JCM.00875-15; Choi AHC, 2004, PROTEIN EXPRES PURIF, V38, P205, DOI 10.1016/j.pep.2004.08.009; Choi AHC, 2003, VACCINE, V21, P761, DOI 10.1016/S0264-410X(02)00595-9; Choi AHC, 2000, J VIROL, V74, P11574, DOI 10.1128/JVI.74.24.11574-11580.2000; Cunliffe NA, 2010, J INFECT DIS, V202, pS168, DOI 10.1086/653577; Dechamma HJ, 2006, VET MICROBIOL, V118, P201, DOI 10.1016/j.vetmic.2006.07.023; DYSON HJ, 1988, ANNU REV BIOPHYS BIO, V17, P305; Erk I, 2003, J VIROL, V77, P3595, DOI 10.1128/JVI.77.6.3595-3601.2003; ERNST H, 1988, GENE, V68, P345, DOI 10.1016/0378-1119(88)90037-6; Espejo RT, 1977, J INFECT DIS, V139, P879; Gladstone BP, 2011, NEW ENGL J MED, V365, P337, DOI 10.1056/NEJMoa1006261; GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276, DOI 10.1128/JCM.28.2.276-282.1990; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084; Iturriza-Gomara M, 2009, EPIDEMIOL INFECT, V137, P922, DOI 10.1017/S0950268808001556; Jackwood M W, 1995, Adv Exp Med Biol, V380, P213; Kawada T, 2012, CLIN RADIOL, V67, P940, DOI 10.1016/j.crad.2012.04.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LANG E, 1994, J IMMUNOL METHODS, V170, P103, DOI 10.1016/0022-1759(94)90250-X; LANGEVELD JPM, 1994, J VIROL, V68, P4506, DOI 10.1128/JVI.68.7.4506-4513.1994; de Goes ACMA, 2008, J VIROL METHODS, V148, P211, DOI 10.1016/j.jviromet.2007.11.013; Malik YS, 2012, J VET SCI, V13, P271, DOI 10.4142/jvs.2012.13.3.271; Matthijnssens J, 2012, ARCH VIROL, V157, P1177, DOI 10.1007/s00705-012-1273-3; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; McNeal MM, 2007, VIROLOGY, V363, P410, DOI 10.1016/j.virol.2007.01.041; Merrifield B, 1996, PROTEIN SCI, V5, P1947, DOI 10.1002/pro.5560050925; Merrifield B., 1963, J AM CHEM SOC, V85, P2149; Mihalov-Kovacs E, 2015, EMERG INFECT DIS, V21, P660, DOI 10.3201/eid2104.141370; Mukhopadhya I, 2010, EPIDEMIOL INFECT, V138, P442, DOI 10.1017/S0950268809990732; Nilsson BL, 2005, ANNU REV BIOPH BIOM, V34, P91, DOI 10.1146/annurev.biophys.34.040204.144700; Papp H, 2013, VET MICROBIOL, V165, P190, DOI 10.1016/j.vetmic.2013.03.020; Phillips G, 2009, J CLIN VIROL, V44, P242, DOI 10.1016/j.jcv.2008.12.001; POSNETT DN, 1988, J BIOL CHEM, V263, P1719; Sambrook J., 2001, MOL CLONING LAB MANU; SANEKATA T, 1981, J IMMUNOL METHODS, V41, P377, DOI 10.1016/0022-1759(81)90199-X; Saravanan P, 2004, ACTA VIROL, V48, P39; Saravanan P, 2004, J IMMUNOL METHODS, V293, P61, DOI 10.1016/j.jim.2004.07.001; Seo JH, 2010, KOREAN J PEDIAT GAST, V13, P134; SIMMONDS P, 1993, J CLIN MICROBIOL, V31, P1493, DOI 10.1128/JCM.31.6.1493-1503.1993; SVENSSON L, 1986, J MED VIROL, V18, P101, DOI 10.1002/jmv.1890180202; TAM JP, 1988, P NATL ACAD SCI USA, V85, P5409, DOI 10.1073/pnas.85.15.5409; Tang BZ, 1997, VIROLOGY, V237, P89, DOI 10.1006/viro.1997.8762; TANIGUCHI K, 1992, EPIDEMIOL INFECT, V109, P303, DOI 10.1017/S0950268800050263; Tate JE, 2013, EMERG INFECT DIS, V19, P1245, DOI 10.3201/eid1908.130461; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zamorano PI, 1998, VACCINE, V16, P558, DOI 10.1016/S0264-410X(97)00244-2; Zhu JY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-91	51	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159027	10.1371/journal.pone.0159027	http://dx.doi.org/10.1371/journal.pone.0159027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391106	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400196
J	Thomas, MA; Nyanhete, T; Tuero, I; Venzon, D; Robert-Guroff, M				Thomas, Michael A.; Nyanhete, Tinashe; Tuero, Iskra; Venzon, David; Robert-Guroff, Marjorie			Beyond Oncolytics: E1B55K-Deleted Adenovirus as a Vaccine Delivery Vector	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL RESPONSES; RHESUS MACAQUES; PROTECTIVE EFFICACY; IMMUNE-RESPONSES; E1B PROTEINS; CHALLENGE; IMMUNIZATION; EXPRESSION; REPLICATION	Type 5 human adenoviruses (Ad5) deleted of genes encoding the early region 1B 55-kDa (E1B55K) protein including Onyx-015 (dl1520) and H101 are best known for their oncolytic potential. As a vaccine vector the E1B55K deletion may allow for the insertion of a transgene nearly 1,000 base pairs larger than now possible. This has the potential of extending the application for which the vectors are clinically known. However, the immune priming ability of E1B55K-deleted vectors is unknown, undermining our ability to gauge their usefulness in vaccine applications. For this reason, we created an E1B55K-deleted Ad5 vector expressing full-length single chain HIV(BaL)gp120 attached to a flexible linker and the first two domains of rhesus CD4 (rhFLSC) in exchange for the E3 region. In cell-based experiments the E1B55K-deleted vector promoted higher levels of innate immune signals including chemokines, cytokines, and the NKG2D ligands MIC A/B compared to an E1B55K wild-type vector expressing the same immunogen. Based on these results we evaluated the immune priming ability of the E1B55K-deleted vector in mice. The E1B55K-deleted vector promoted similar levels of Ad5-, HIVgp120, and rhFLSC-specific cellular and humoral immune responses as the E1B55K wild-type vector. In pre-clinical HIV-vaccine studies the wild-type vector has been employed as part of a very effective prime-boost strategy. This study demonstrates that E1B55K-deleted adenoviruses may serve as effective vaccine delivery vectors.	[Thomas, Michael A.; Nyanhete, Tinashe; Tuero, Iskra; Robert-Guroff, Marjorie] NCI, Sect Immune Biol Retroviral Infect, Vaccine Branch, NIH, Bethesda, MD USA; [Venzon, David] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD USA; [Thomas, Michael A.] Howard Univ, Dept Biol, Washington, DC USA; [Nyanhete, Tinashe] Duke Univ, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard University; Duke University	Thomas, MA; Robert-Guroff, M (corresponding author), NCI, Sect Immune Biol Retroviral Infect, Vaccine Branch, NIH, Bethesda, MD USA.; Thomas, MA (corresponding author), Howard Univ, Dept Biol, Washington, DC USA.	michael.thomas1@howard.edu; guroffm@mail.nih.gov		Tuero, Iskra/0000-0002-5788-1051	Pathway to Independence Award (K99) [1K99AI114379 - 01]; Intramural Research Program of the National Institutes of Health, National Cancer Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R00AI114379] Funding Source: NIH RePORTER	Pathway to Independence Award (K99); Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Pathway to Independence Award (K99) Grant Number 1K99AI114379 - 01 to MAT and by the Intramural Research Program of the National Institutes of Health, National Cancer Institute to MRG.	Alexander J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082380; Alexander J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031177; BABISS LE, 1985, MOL CELL BIOL, V5, P2552, DOI 10.1128/MCB.5.10.2552; BARKER DD, 1987, VIROLOGY, V156, P107, DOI 10.1016/0042-6822(87)90441-7; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; Bogers WMJM, 2008, VIROLOGY, V382, P217, DOI 10.1016/j.virol.2008.09.016; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64; Crompton AM, 2007, CURR CANCER DRUG TAR, V7, P133; Demberg T, 2007, J VIROL, V81, P3414, DOI 10.1128/JVI.02453-06; Dutt S, 2011, BLOOD, V117, P3230, DOI 10.1182/blood-2010-10-312751; Fouts TR, 2000, J VIROL, V74, P11427, DOI 10.1128/JVI.74.24.11427-11436.2000; Garber K, 2006, J NATL CANCER I, V98, P298, DOI 10.1093/jnci/djj111; Goodrum FD, 1999, J VIROL, V73, P7474, DOI 10.1128/JVI.73.9.7474-7488.1999; Gurwith M, 2013, LANCET INFECT DIS, V13, P238, DOI 10.1016/S1473-3099(12)70345-6; Lubeck MD, 1997, NAT MED, V3, P651, DOI 10.1038/nm0697-651; Malkevitch NV, 2006, VIROLOGY, V353, P83, DOI 10.1016/j.virol.2006.05.012; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Miller DL, 2009, J VIROL, V83, P3591, DOI 10.1128/JVI.02269-08; Patterson LJ, 2008, EXPERT OPIN BIOL TH, V8, P1347, DOI [10.1517/14712598.8.9.1347, 10.1517/14712598.8.9.1347 ]; Patterson LJ, 2004, J VIROL, V78, P2212, DOI 10.1128/JVI.78.5.2212-2221.2004; Qiu F, 2012, INT J MOL MED, V29, P12, DOI 10.3892/ijmm.2011.801; Robert-Guroff M, 1998, J VIROL, V72, P10275, DOI 10.1128/JVI.72.12.10275-10280.1998; Routes JM, 2005, J EXP MED, V202, P1477, DOI 10.1084/jem.20050240; Schaack J, 2004, P NATL ACAD SCI USA, V101, P3124, DOI 10.1073/pnas.0303709101; Tanghe A, 2001, INFECT IMMUN, V69, P3041, DOI 10.1128/IAI.69.5.3041-3047.2001; Thomas MA, 2014, VIROLOGY, V471, P81, DOI 10.1016/j.virol.2014.10.001; Thomas MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076344; Thomas MA, 2009, J VIROL, V83, P2406, DOI 10.1128/JVI.01972-08	29	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158505	10.1371/journal.pone.0158505	http://dx.doi.org/10.1371/journal.pone.0158505			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391605	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400072
J	Wang, XX; Long, WX; Schamp, BS; Yang, XB; Kang, Y; Xie, ZX; Xiong, MH				Wang, Xixi; Long, Wenxing; Schamp, Brandon S.; Yang, Xiaobo; Kang, Yong; Xie, Zhixu; Xiong, Menghui			Vascular Epiphyte Diversity Differs with Host Crown Zone and Diameter, but Not Orientation in a Tropical Cloud Forest	PLOS ONE			English	Article							SPATIAL-DISTRIBUTION; AIR-TEMPERATURE; RAIN-FOREST; TREE SIZE; ASSOCIATIONS; VEGETATION; PATTERNS; CANOPY	Vascular epiphytes are important components of biological diversity in tropical forests. We measured the species richness and abundance of vascular epiphytes along four vertical crown zones and five horizontal orientations on 376 trees, as well as the diameter at breast height (DBH) of host trees in tropical cloud forests in Bawangling, Hainan, China. The relationship between vascular epiphyte species richness and host tree DBH was assessed using a generalized linear model. There were 1,453 vascular individual epiphytes attributed to 9 families, 24 genera and 35 species, with orchids and pteridophytes dominating. Both the species richness and abundance of epiphytes significantly differed among the four crown zones for all collections and each host tree, suggesting that vertical microhabitats contribute to the distribution of epiphytes on host trees. Neither epiphyte abundance nor species richness differed among the eastern, southern, western, and northern orientations for all host trees; however, both richness and abundance were significantly higher for epiphytes that encircled host tree trunks. This suggests that morphological and physiological characteristics of the tree, but not microclimates probably contribute to the distribution of epiphytes on host trees. Epiphyte species richness was positively correlated with tree DBH across the six host tree species studied, with increases in DBH among smaller trees resulting in larger increases in richness, while increases in DBH among larger host trees resulting in more modest increases in ephiphyte richness. Our findings contribute support for a positive relationship between epiphyte species richness and host tree DBH and provide important guidance for future surveys of epiphyte community development.	[Wang, Xixi; Long, Wenxing; Yang, Xiaobo; Kang, Yong; Xie, Zhixu; Xiong, Menghui] Hainan Univ, Minist Educ, Coll Hort & Landscape Agr, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Haikou, Peoples R China; [Schamp, Brandon S.] Algoma Univ, Dept Biol, Sault Ste Marie, ON P6A 2G4, Canada	Hainan University; Algoma University	Long, WX (corresponding author), Hainan Univ, Minist Educ, Coll Hort & Landscape Agr, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Haikou, Peoples R China.	oklong@hainu.edu.cn			National Natural Science Foundation of China [31260109]; Innovative Research Team grant of the Natural Science Foundation of Hainan Province [2016CXTD003]; Natural Science Foundation of Hainan Province [312064]; Natural Science and Engineering Research Council of Canada	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Research Team grant of the Natural Science Foundation of Hainan Province; Natural Science Foundation of Hainan Province; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Financial support came from National Natural Science Foundation of China (Grant 31260109), the Innovative Research Team grant of the Natural Science Foundation of Hainan Province (2016CXTD003), Natural Science Foundation of Hainan Province (312064) (to W.X.), and a Natural Science and Engineering Research Council of Canada grant (to B. Schamp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Fordjour P, 2009, AFR J ECOL, V47, P767, DOI 10.1111/j.1365-2028.2009.01072.x; BALFOUR DA, 1993, J ECOL, V81, P93, DOI 10.2307/2261227; BENNETT BC, 1987, B TORREY BOT CLUB, V114, P265, DOI 10.2307/2996464; Benzing D., 1990, J TROP ECOL, V8, P55, DOI [10.1017/S0266467400006088, DOI 10.1017/S0266467400006088]; BENZING D H, 1978, Selbyana, V2, P133; Benzing D. H., 1981, SELBYANA, V5, P248; Boelter CR, 2014, J VEG SCI, V25, P1090, DOI 10.1111/jvs.12154; Bubb P., 2004, CLOUD FOREST AGENDA; Burns KC, 2010, ECOLOGY, V91, P377, DOI 10.1890/08-2004.1; Burns KC, 2005, AUSTRAL ECOL, V30, P891; Chazdon R.L., 2008, INTROPICAL FORESTCOM, P384; Kersten RD, 2009, REV BIOL TROP, V57, P749; Editorial Committee of Flora of China, FLORA REIPUBLICAE PO; Eisermann K, 2005, REV BIOL TROP, V53, P577; Flores-Palacios A, 2006, J BIOGEOGR, V33, P323, DOI 10.1111/j.1365-2699.2005.01382.x; Flores-Palacios A., 2001, Selbyana, V22, P181; GUSTAFSSON L, 1995, J APPL ECOL, V32, P412, DOI 10.2307/2405107; Ingram Stephen W., 1995, P587; JOHANSSON D, 1974, Acta Phytogeographica Suecica, V59, P1; KRESS W J, 1986, Selbyana, V9, P2; Laube S, 2006, ANN BOT-LONDON, V97, P1103, DOI 10.1093/aob/mcl067; Lie MH, 2009, BIODIVERS CONSERV, V18, P3579, DOI 10.1007/s10531-009-9661-z; Long WX, 2015, BIOTROPICA, V47, P416, DOI 10.1111/btp.12235; Long WX, 2015, J VEG SCI, V26, P513, DOI 10.1111/jvs.12256; Long WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060252; Long WenXing, 2011, Biodiversity Science, V19, P558, DOI 10.3724/SP.J.1003.2011.09309; Long WX, 2011, FLORA, V206, P896, DOI 10.1016/j.flora.2011.05.007; Long WX, 2011, OECOLOGIA, V167, P1103, DOI 10.1007/s00442-011-2050-9; Male TD, 2005, AUSTRAL ECOL, V30, P229, DOI 10.1111/j.1442-9993.2005.01442.x; Nieder J, 2001, PLANT ECOL, V153, P51, DOI 10.1023/A:1017517119305; Nieder Juergen, 1999, Selbyana, V20, P66; PERRY DR, 1978, BIOTROPICA, V10, P155, DOI 10.2307/2388019; Quaresma AC, 2014, ACTA BOT BRAS, V28, P68, DOI 10.1590/S0102-33062014000100007; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; SANFORD WW, 1968, J ECOL, V56, P697, DOI 10.2307/2258101; Song L, 2012, OECOLOGIA, V170, P847, DOI 10.1007/s00442-012-2341-9; SOUTHWOOD TRE, 1983, OIKOS, V41, P359, DOI 10.2307/3544094; Stadtmuller T, 1987, CLOUD FOREST HUMID T; Stanton DE, 2014, FUNCT ECOL, V28, P1274, DOI 10.1111/1365-2435.12249; Taylor A, 2015, J VEG SCI, V26, P902, DOI 10.1111/jvs.12289; Tremblay RL, 2009, TROP ECOL, V50, P211; Woods CL, 2015, J ECOL, V103, P421, DOI 10.1111/1365-2745.12357; Xu HaiQing, 2005, Biodiversity Science, V13, P137, DOI 10.1360/biodiv.040123; Zhao ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005125; Zotz G, 2003, J TROP ECOL, V19, P81, DOI 10.1017/S0266467403003092	45	12	13	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158548	10.1371/journal.pone.0158548	http://dx.doi.org/10.1371/journal.pone.0158548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391217	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400080
J	Labib, RM; Abdelrahim, MEA; Elnadi, E; Hesham, RM; Yassin, D				Labib, Rania M.; Abdelrahim, Mohamed E. A.; Elnadi, Enas; Hesham, Reem M.; Yassin, Dina			CYP2B6rs2279343 Is Associated with Improved Survival of Pediatric Rhabdomyosarcoma Treated with Cyclophosphamide	PLOS ONE			English	Article							BREAST-CANCER; GENETIC POLYMORPHISMS; HUMAN CYP2B6; HUMAN LIVER; IN-VIVO; PHARMACOKINETICS; PHARMACOGENETICS; CHEMOTHERAPY; TOXICITY; 4-HYDROXYCYCLOPHOSPHAMIDE	Background Rhabdomyosarcoma (RMS) is a small round blue cell malignant tumor, representing 7% of childhood malignancies, and over 50% of all soft tissue sarcomas. Cyclophosphamide (CPA) is a prodrug and is the mainstay of RMS treatment. CYP2B6 is a highly polymorphic drug metabolizing enzyme involved in CPA bioactivation. The influence of CYP2B6 single nucleotide polymorphisms (SNPs) on the survival of RMS is still unknown. Methods We genotyped CYP2B6SNPs rs2279343, rs3745274, and rs3211371 by restriction fragment polymorphism (RFLP) after PCR amplification in a cohort of 73 pediatric RMS patients treated with CPA-based first line treatment. We then analyzed the association between those genotypes and survival outcome of RMS. Results The frequencies of CYP2B6 rs2279343, rs3745274, and rs3211371 were 63%, 45.2%, and 5.5%, respectively. There was no association between rs3745274, rs3211371 genotypes and survival outcomes of RMS. However, the carriers of at least one mutant allele CYP2B6rs2279343 had significantly longer event-free survival (p-value = 0.03). Conclusion Our results demonstrated that CYP2B6 rs2279343 may predict EFS in RMS patients and warrants future studies to clarify the pharmacogenetics of CPA in pediatrics. If validated, integration of genetic factors with clinical and molecular characteristics could be used for a composite algorithm to better stratify risk prior to treatment.	[Labib, Rania M.] Childrens Canc Hosp Egypt 57357, Res Dept, Cairo, Egypt; [Labib, Rania M.; Abdelrahim, Mohamed E. A.] Beni Suef Univ, Fac Pharm, Clin Pharm, Dept, Bani Suwayf, Egypt; [Elnadi, Enas] Beni Suef Univ, Fac Med, Dept Pediat Oncol, Bani Suwayf, Egypt; [Elnadi, Enas] Childrens Canc Hosp Egypt 57357, Dept Pediat Oncol, Cairo, Egypt; [Hesham, Reem M.] Beni Suef Univ, Dept Biochem, Fac Pharm, Bani Suwayf, Egypt; [Yassin, Dina] Childrens Canc Hosp Egypt 57357, Dept Mol Biol, Cairo, Egypt	Children's Cancer Hospital 57357; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Beni Suef University; Children's Cancer Hospital 57357; Egyptian Knowledge Bank (EKB); Beni Suef University; Children's Cancer Hospital 57357	Labib, RM (corresponding author), Childrens Canc Hosp Egypt 57357, Res Dept, Cairo, Egypt.; Labib, RM (corresponding author), Beni Suef Univ, Fac Pharm, Clin Pharm, Dept, Bani Suwayf, Egypt.	raniamlabib@gmail.com	Emam, Mohamed/AAJ-7075-2020; Singab, Abdel Nasser Badawi/AAD-7134-2021; labib, Rania/AAM-8316-2021; Labib, Rania/AAO-6770-2020	Singab, Abdel Nasser Badawi/0000-0001-7445-963X; Labib, Rania/0000-0001-6774-9911; abdelrahim, mohamed/0000-0003-0227-8404				Bray J, 2010, BRIT J CANCER, V102, P1003, DOI 10.1038/sj.bjc.6605587; Breitfeld PP, 2005, ONCOLOGIST, V10, P518, DOI 10.1634/theoncologist.10-7-518; Crist WM, 2001, J CLIN ONCOL, V19, P3091, DOI 10.1200/JCO.2001.19.12.3091; Egas-Bejar D, 2014, ADOLESC HEALTH MED T, V5, P115, DOI 10.2147/AHMT.S44582; Ekhart C, 2008, PHARMACOGENET GENOM, V18, P515, DOI 10.1097/FPC.0b013e3282fc9766; Gor PP, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2570; Haroun F, 2015, CANCER CHEMOTH PHARM, V75, P207, DOI 10.1007/s00280-014-2632-4; Hayes-Jordan A, 2009, CURR OPIN PEDIATR, V21, P373, DOI 10.1097/MOP.0b013e32832b4171; Helsby NA, 2012, DRUG METAB DISPOS, V40, P635, DOI 10.1124/dmd.111.043646; Kim J, 2014, ASIA LIFE SCI, P115; Lang T, 2001, PHARMACOGENETICS, V11, P399, DOI 10.1097/00008571-200107000-00004; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Naik Adviti, 2013, Frontiers in Genetics, V4, P2, DOI 10.3389/fgene.2013.00002; Perez EA, 2011, J SURG RES, V170, pE243, DOI 10.1016/j.jss.2011.03.001; Petros WP, 2005, J CLIN ONCOL, V23, P6117, DOI 10.1200/JCO.2005.06.075; Preissner SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082562; Raccor BS, 2012, DRUG METAB DISPOS, V40, P54, DOI 10.1124/dmd.111.039347; Radzikowska J, 2015, WSPOLCZESNA ONKOL, V19, P98, DOI 10.5114/wo.2015.49158; Riccardi LN, 2015, GENET TEST MOL BIOMA, V19, P103, DOI 10.1089/gtmb.2014.0239; Roy P, 1999, DRUG METAB DISPOS, V27, P655; Takada K, 2004, ARTHRITIS RHEUM-US, V50, P2202, DOI 10.1002/art.20338; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Timm R, 2005, PHARMACOGENOMICS J, V5, P365, DOI 10.1038/sj.tpj.6500330; Turpeinen Miia, 2012, Drug Metabolism and Drug Interactions, V27, P185, DOI 10.1515/dmdi-2012-0027; Uppugunduri CRS, 2014, PHARMACOGENOMICS J, V14, P263, DOI 10.1038/tpj.2013.38; Watanabe T, 2010, PHARMACOGENET GENOM, V20, P459, DOI 10.1097/FPC.0b013e32833bba0e; Xie HJ, 2003, PHARMACOGENOMICS J, V3, P53, DOI 10.1038/sj.tpj.6500157; Xu C, 2013, DRUG METAB DISPOS, V41, P2004, DOI 10.1124/dmd.113.051755; Yao S, 2010, CLIN CANCER RES, V16, P6169, DOI 10.1158/1078-0432.CCR-10-0281; Zanger UM, 2007, PHARMACOGENOMICS, V8, P743, DOI 10.2217/14622416.8.7.743	30	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158890	10.1371/journal.pone.0158890	http://dx.doi.org/10.1371/journal.pone.0158890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388155	Green Submitted, Green Published, gold			2022-12-26	WOS:000379811500061
J	Anderson, JL; Mota, TM; Evans, VA; Kumar, N; Rezaei, SD; Cheong, K; Solomon, A; Wightman, F; Cameron, PU; Lewin, SR				Anderson, Jenny L.; Mota, Talia M.; Evans, Vanessa A.; Kumar, Nitasha; Rezaei, Simin D.; Cheong, Karey; Solomon, Ajantha; Wightman, Fiona; Cameron, Paul U.; Lewin, Sharon R.			Understanding Factors That Modulate the Establishment of HIV Latency in Resting CD4+T-Cells In Vitro	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; CHEMOKINE RECEPTOR; ACTIN CYTOSKELETON; INFECTION; TRANSCRIPTION; REPLICATION; RESTRICTION; IDENTIFICATION; LYMPHOCYTES	Developing robust in vitro models of HIV latency is needed to better understand how latency is established, maintained and reversed. In this study, we examined the effects of donor variability, HIV titre and co-receptor usage on establishing HIV latency in vitro using two models of HIV latency. Using the CCL19 model of HIV latency, we found that in up to 50% of donors, CCL19 enhanced latent infection of resting CD4+T-cells by CXCR4-tropic HIV in the presence of low dose IL-2. Increasing the infectious titre of CXCR4-tropic HIV increased both productive and latent infection of resting CD4+T-cells. In a different model where myeloid dendritic cells (mDC) were co-cultured with resting CD4+T-cells, we observed a higher frequency of latently infected cells in vitro than CCL19-treated or unstimulated CD4+T-cells in the presence of low dose IL-2. In the DC-T-cell model, latency was established with both CCR5- and CXCR4-tropic virus but higher titres of CCR5- tropic virus was required in most donors. The establishment of latency in vitro through direct infection of resting CD4+T-cells is significantly enhanced by CCL19 and mDC, but the efficiency is dependent on virus titre, co-receptor usage and there is significant donor variability.	[Anderson, Jenny L.; Mota, Talia M.; Evans, Vanessa A.; Kumar, Nitasha; Rezaei, Simin D.; Cheong, Karey; Solomon, Ajantha; Wightman, Fiona; Cameron, Paul U.; Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Cameron, Paul U.; Lewin, Sharon R.] Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia; [Cameron, Paul U.; Lewin, Sharon R.] Alfred Hosp, Melbourne, Vic, Australia	University of Melbourne; Monash University; Florey Institute of Neuroscience & Mental Health	Lewin, SR (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Lewin, SR (corresponding author), Monash Univ, Dept Infect Dis, Melbourne, Vic, Australia.; Lewin, SR (corresponding author), Alfred Hosp, Melbourne, Vic, Australia.	sharon.lewin@unimelb.edu.au	Lewin, Sharon/Z-3297-2019	Lewin, Sharon Ruth/0000-0002-0330-8241; Anderson, Jenny/0000-0003-4636-6633; Wightman, Fiona/0000-0003-1203-1325; Mota, Talia/0000-0002-8925-0158; Cameron, Paul Urquhart/0000-0002-1906-6945	National Health and Medical Research Council of Australia Program Grant [1052979]; Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE) [U19AI096109]	National Health and Medical Research Council of Australia Program Grant(National Health and Medical Research Council (NHMRC) of Australia); Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE)	This study was funded by a National Health and Medical Research Council of Australia Program Grant 1052979 (http://www.nhmrc.gov.au). SRL, PUC and JLA are supported by the Division of AIDS, National Institute of Allergy and Infectious Diseases, US National Institutes of Health (Delaney AIDS Research Enterprise, DARE; U19AI096109, http://www.niaid.nih.gov). SRL is also a National Health and Medical Research Council of Australia Practitioner Fellow (http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Agosto LM, 2007, VIROLOGY, V368, P60, DOI 10.1016/j.virol.2007.06.001; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Cameron PU, 2010, P NATL ACAD SCI USA, V107, P16934, DOI 10.1073/pnas.1002894107; Chavez L, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004955; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; ENGELMAN A, 1995, J VIROL, V69, P2729, DOI 10.1128/JVI.69.5.2729-2736.1995; Evans VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003799; Evans VA, 2012, CYTOKINE GROWTH F R, V23, P151, DOI 10.1016/j.cytogfr.2012.05.002; Evans VA, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-43; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; GOFF S, 1981, J VIROL, V38, P239, DOI 10.1128/JVI.38.1.239-248.1981; Guo J, 2011, J VIROL, V85, P9824, DOI 10.1128/JVI.05170-11; Hazuda DJ, 2004, SCIENCE, V305, P528, DOI 10.1126/science.1098632; HO WZ, 1993, J LEUKOCYTE BIOL, V53, P208, DOI 10.1002/jlb.53.2.208; Iyer SR, 2009, J VIROL, V83, P8662, DOI 10.1128/JVI.00874-09; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kumar NA, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0204-2; Kumari S, 2014, BBA-BIOMEMBRANES, V1838, P546, DOI 10.1016/j.bbamem.2013.05.004; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lassen KG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030176; Lewin SR, 2008, JAIDS-J ACQ IMM DEF, V47, P140, DOI 10.1097/QAI.0b013e31815dbf7f; Majetschak M, 2011, J LEUKOCYTE BIOL, V89, P205, DOI 10.1189/jlb.0510316; MCKEATING JA, 1991, J VIROL, V65, P852, DOI 10.1128/JVI.65.2.852-860.1991; Melar M, 2007, J VIROL, V81, P1773, DOI 10.1128/JVI.01316-06; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Pace MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002818; Pierson T, 2000, J VIROL, V74, P7824, DOI 10.1128/JVI.74.17.7824-7833.2000; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saini V, 2010, J BIOL CHEM, V285, P15566, DOI 10.1074/jbc.M110.103408; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Saleh S, 2007, BLOOD, V110, P4161, DOI 10.1182/blood-2007-06-097907; Saleh S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-80; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Shen AD, 2013, J VIROL, V87, P9768, DOI 10.1128/JVI.01478-13; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Soares H, 2013, IMMUNOL REV, V256, P118, DOI 10.1111/imr.12110; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Swiggard WJ, 2005, J VIROL, V79, P14179, DOI 10.1128/JVI.79.22.14179-14188.2005; Trinite B, 2013, J VIROL, V87, P12701, DOI 10.1128/JVI.01939-13; Weissman D, 1997, NATURE, V389, P981, DOI 10.1038/40173; Wightman F, 2013, AIDS, V27, P2853, DOI 10.1097/QAD.0000000000000067; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Yamamoto T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000279; Yoder A, 2008, CELL, V134, P782, DOI 10.1016/j.cell.2008.06.036; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zack JA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-37	56	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158778	10.1371/journal.pone.0158778	http://dx.doi.org/10.1371/journal.pone.0158778			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383184	gold, Green Published, Green Submitted			2022-12-26	WOS:000379809400084
J	Pickell, PD; Coops, NC; Gergel, SE; Andison, DW; Marshall, PL				Pickell, Paul D.; Coops, Nicholas C.; Gergel, Sarah E.; Andison, David W.; Marshall, Peter L.			Evolution of Canada's Boreal Forest Spatial Patterns as Seen from Space	PLOS ONE			English	Article							LANDSAT TIME-SERIES; NATURAL DISTURBANCES; MANAGEMENT; RECOVERY; WILDFIRE; MAP; INDEXES; ALBERTA; TRENDS	Understanding the development of landscape patterns over broad spatial and temporal scales is a major contribution to ecological sciences and is a critical area of research for forested land management. Boreal forests represent an excellent case study for such research because these forests have undergone significant changes over recent decades. We analyzed the temporal trends of four widely-used landscape pattern indices for boreal forests of Canada: forest cover, largest forest patch index, forest edge density, and core (interior) forest cover. The indices were computed over landscape extents ranging from 5,000 ha (n = 18,185) to 50,000 ha (n = 1,662) and across nine major ecozones of Canada. We used 26 years of Landsat satellite imagery to derive annualized trends of the landscape pattern indices. The largest declines in forest cover, largest forest patch index, and core forest cover were observed in the Boreal Shield, Boreal Plain, and Boreal Cordillera ecozones. Forest edge density increased at all landscape extents for all ecozones. Rapidly changing landscapes, defined as the 90th percentile of forest cover change, were among the most forested initially and were characterized by four times greater decrease in largest forest patch index, three times greater increase in forest edge density, and four times greater decrease in core forest cover compared with all 50,000 ha landscapes. Moreover, approximately 18% of all 50,000 ha landscapes did not change due to a lack of disturbance. The pattern database results provide important context for forest management agencies committed to implementing ecosystem-based management strategies.	[Pickell, Paul D.; Coops, Nicholas C.; Gergel, Sarah E.; Marshall, Peter L.] Univ British Columbia, Fac Forestry, Vancouver, BC, Canada; [Andison, David W.] Bandaloop Landscape Ecosyst Serv, N Vancouver, BC, Canada	University of British Columbia	Pickell, PD (corresponding author), Univ British Columbia, Fac Forestry, Vancouver, BC, Canada.	paul.pickell@forestry.ubc.ca	Coops, Nicholas/L-3652-2019; Coops, Nicholas C/J-1543-2012	Coops, Nicholas/0000-0002-0151-9037; Coops, Nicholas C/0000-0002-0151-9037				Andison DW, 2012, CAN J FOREST RES, V42, P1253, DOI [10.1139/X2012-074, 10.1139/x2012-074]; Banskota A, 2014, CAN J REMOTE SENS, V40, P362, DOI 10.1080/07038992.2014.987376; Bergeron Y, 2007, FOREST CHRON, V83, P326, DOI 10.5558/tfc83326-3; Bouchard M, 2011, FOREST ECOL MANAG, V261, P811, DOI 10.1016/j.foreco.2010.11.020; Brandt JP, 2009, ENVIRON REV, V17, P101, DOI 10.1139/A09-004; Canada Forest Inventory, 2013, CAN FOR INV 2013 DEC; Cardille J, 2005, BIOSCIENCE, V55, P983, DOI 10.1641/0006-3568(2005)055[0983:MCSPAS]2.0.CO;2; Cardille JA, 2012, ENVIRON MANAGE, V49, P163, DOI 10.1007/s00267-011-9785-2; Carslaw DC, 2012, ENVIRON MODELL SOFTW, V27-28, P52, DOI 10.1016/j.envsoft.2011.09.008; Chapin FS, 2010, CAN J FOREST RES, V40, P1360, DOI 10.1139/X10-074; CRIST EP, 1985, REMOTE SENS ENVIRON, V17, P301, DOI 10.1016/0034-4257(85)90102-6; Cumming SG, 2001, CAN J FOREST RES, V31, P1297, DOI 10.1139/cjfr-31-8-1297; DeLong SC, 1996, BIODIVERS CONSERV, V5, P1191, DOI 10.1007/BF00051571; Drever CR, 2006, CAN J FOREST RES, V36, P2285, DOI 10.1139/X06-132; EBERHART KE, 1987, CAN J FOREST RES, V17, P1207, DOI 10.1139/x87-186; Ecological Stratification Working Group, 1996, NATL ECOLOGICAL FRAM; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Flannigan MD, 1998, J VEG SCI, V9, P469, DOI 10.2307/3237261; Forest Stewardship Council Canada Working Group, 2004, NAT BOR STAND; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Gergel S. E., 2007, UNDERSTANDING FOREST; Gillis MD, 2005, FOREST CHRON, V81, P214, DOI 10.5558/tfc81214-2; Gustafson EJ, 1998, ECOSYSTEMS, V1, P143, DOI 10.1007/s100219900011; HainesYoung R, 1996, PROG PHYS GEOG, V20, P418, DOI 10.1177/030913339602000403; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Healey SP, 2005, REMOTE SENS ENVIRON, V97, P301, DOI 10.1016/j.rse.2005.05.009; Hermosilla T, 2015, REMOTE SENS ENVIRON, V158, P220, DOI 10.1016/j.rse.2014.11.005; Homer C, 2007, PHOTOGRAMM ENG REM S, V73, P337; Huang CQ, 2010, REMOTE SENS ENVIRON, V114, P183, DOI 10.1016/j.rse.2009.08.017; HUNTER ML, 1993, BIOL CONSERV, V65, P115, DOI 10.1016/0006-3207(93)90440-C; James ARC, 2000, J WILDLIFE MANAGE, V64, P154, DOI 10.2307/3802985; Jin SM, 2013, REMOTE SENS ENVIRON, V132, P159, DOI 10.1016/j.rse.2013.01.012; Klenk N, 2008, CAN J FOREST RES, V38, P2159, DOI 10.1139/X08-054; Kupfer JA, 2012, PROG PHYS GEOG, V36, P400, DOI 10.1177/0309133312439594; Landres PB, 1999, ECOL APPL, V9, P1179, DOI 10.2307/2641389; Langford WT, 2006, ECOSYSTEMS, V9, P474, DOI 10.1007/s10021-005-0119-1; Lee P, 2006, J ENVIRON MANAGE, V78, P240, DOI 10.1016/j.jenvman.2005.03.016; Lee P., 2003, CANADAS LARGE INTACT; McGarigal K., FRAGSTATS V4 SPATIAL; McLeod A.I., 2011, PACKAGE KENDALL KEND; Metzger MJ, 2013, GLOBAL ECOL BIOGEOGR, V22, P630, DOI 10.1111/geb.12022; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Morgan P., 1994, Journal of Sustainable Forestry, V2, P87, DOI 10.1300/J091v02n01_04; Ontario Ministry of Natural Resources (OMNR), FOR MAN GUID NAT DIS; Pasher J, 2013, CAN J REMOTE SENS, V39, P42, DOI 10.5589/m13-007; Pflugmacher D, 2014, REMOTE SENS ENVIRON, V151, P124, DOI 10.1016/j.rse.2013.05.033; Pickell PD, 2016, INT J REMOTE SENS, V37, P138, DOI 10.1080/2150704X.2015.1126375; Pickell PD, 2015, CAN J FOREST RES, V45, P732, DOI 10.1139/cjfr-2014-0546; Pickell PD, 2014, REMOTE SENS LETT, V5, P783, DOI 10.1080/2150704X.2014.967881; Pickell PD, 2013, FOREST ECOL MANAG, V304, P243, DOI 10.1016/j.foreco.2013.04.031; Pyrcz M., 2003, NEWSLETTER, V18, P3; Remmel T., 2003, J GEOGR SYST, V5, P331, DOI DOI 10.1007/S10109-003-0116-X; Scheffer M, 2012, P NATL ACAD SCI USA, V109, P21384, DOI 10.1073/pnas.1219844110; Schneider RR, 2003, CONSERV ECOL, V7; Schroeder TA, 2011, REMOTE SENS ENVIRON, V115, P1421, DOI 10.1016/j.rse.2011.01.022; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Shvidenko A., 2005, MILLENNIUM ECOSYSTEM, P585; Statistics Canada, 2011, CENS AGR; Thomas NE, 2011, REMOTE SENS ENVIRON, V115, P19, DOI 10.1016/j.rse.2010.07.009; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Venables WN., 2002, MODERN APPL STAT S 4; Vogelmann JE, 2001, PHOTOGRAMM ENG REM S, V67, P650; White JC, 2014, CAN J REMOTE SENS, V40, P192, DOI 10.1080/07038992.2014.945827; Wilcox RR, 1998, STAT PROBABIL LETT, V39, P43, DOI 10.1016/S0167-7152(98)00022-4; Woodcock CE, 2008, SCIENCE, V320, P1011, DOI 10.1126/science.320.5879.1011a; Wu JG, 2004, LANDSCAPE ECOL, V19, P125, DOI 10.1023/B:LAND.0000021711.40074.ae; Wu JG, 2002, LANDSCAPE ECOL, V17, P355, DOI 10.1023/A:1020561630963; Wulder MA, EOSD LAND COVER CLAS; Wulder MA, 2011, CAN GEOGR-GEOGR CAN, V55, P288, DOI 10.1111/j.1541-0064.2010.00335.x; Wulder MA, 2008, CAN J REMOTE SENS, V34, P563, DOI 10.5589/m08-081; Yue S, 2004, HYDROLOG SCI J, V49, P21, DOI 10.1623/hysj.49.1.21.53996; Zeng HQ, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045508; Zhang XY, 2004, GLOBAL CHANGE BIOL, V10, P1133, DOI 10.1111/j.1529-8817.2003.00784.x	74	16	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157736	10.1371/journal.pone.0157736	http://dx.doi.org/10.1371/journal.pone.0157736			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383055	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400023
J	Akamatsu, M; Makino, N; Ikeda, Y; Matsuda, A; Ito, M; Kakizaki, Y; Saito, Y; Ishizawa, T; Kobayashi, T; Furukawa, T; Ueno, Y				Akamatsu, Manabu; Makino, Naohiko; Ikeda, Yushi; Matsuda, Akiko; Ito, Miho; Kakizaki, Yasuharu; Saito, Yoshihiko; Ishizawa, Tetsuya; Kobayashi, Toshikazu; Furukawa, Toru; Ueno, Yoshiyuki			Specific MAPK-Associated MicroRNAs in Serum Differentiate Pancreatic Cancer from Autoimmune Pancreatitis	PLOS ONE			English	Article							NEEDLE-ASPIRATION BIOPSY; DIAGNOSTIC-CRITERIA; EXPRESSION; PATHWAY; GENES; ADENOCARCINOMA; BIOMARKERS; BLOOD; IGG4	Pancreatic ductal adenocarcinoma (PDAC) is difficult to distinguish from autoimmune pancreatitis (AIP) because of their clinical and radiological similarities, and therefore simple and minimally invasive surrogate markers for differential diagnosis would be useful. In our previous studies, we identified four microRNAs (miRNAs)-miR-7, miR-34a, miR-181d, and miR-193b -as MAPK-associated microRNAs whose expression was altered significantly with upregulation of the MAPK signaling pathway. Recently it has been reported that these miRNAs could be used as biomarkers in serum samples for accurate diagnosis of pancreatic lesions. The aim of the present study was to evaluate whether these MAPK-associated miRNAs in serum could be used as biomarkers for differentiating PDAC from AIP. We enrolled 69 patients with PDAC, 26 with intraductal papillary mucinous neoplasm (IPMN) and 15 with AIP. The expression of MAPK-associated miRNAs in serum was measured by quantitative real-time PCR. The 2(-Delta CT) method was used to quantify the expression of miRNAs, and the data were normalized using spiked-in synthetic cel-miR-39. Patients with PDAC or IPMN showed significantly higher amounts of serum MAPK-associated miRNAs than those with AIP (p<0.009 for miR-7, p<0.002 for miR-34a, p<0.001 for miR-181d, p<0.002 for miR-193b). ROC curve analysis demonstrated that these miRNAs had an area under the ROC curve (AUC) of 0.723-0.882 for differentiation between PDAC or IPMN from AIP. Furthermore, serum miR-181d was significantly associated with the presence of metastasis in patients with PDA (p = 0.014). Serum MAPK-associated miRNAs could be novel noninvasive biomarkers for differentiation between PDAC or IPMN and AIP.	[Akamatsu, Manabu; Makino, Naohiko; Ikeda, Yushi; Matsuda, Akiko; Ito, Miho; Kakizaki, Yasuharu; Saito, Yoshihiko; Ishizawa, Tetsuya; Kobayashi, Toshikazu; Ueno, Yoshiyuki] Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata, Japan; [Furukawa, Toru] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo, Japan	Yamagata University; Tokyo Women's Medical University	Makino, N (corresponding author), Yamagata Univ, Fac Med, Dept Gastroenterol, Yamagata, Japan.	namakino@med.id.yamagata-u.ac.jp	Furukawa, Toru/AAF-5596-2021; Ueno, Yoshiyuki/R-9242-2019	Furukawa, Toru/0000-0002-1083-2324; Ueno, Yoshiyuki/0000-0001-5623-4250				ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Deshpande V, 2005, AM J SURG PATHOL, V29, P1464, DOI 10.1097/01.pas.0000173656.49557.48; Furukawa T, 2003, AM J PATHOL, V162, P1807, DOI 10.1016/S0002-9440(10)64315-5; Furukawa T., 1993, ANN CANCER RES THER, V2, P121; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Holmes BJ, 2012, ACTA CYTOL, V56, P228, DOI 10.1159/000336135; Ikeda Y, 2012, MOL CANCER RES, V10, P259, DOI 10.1158/1541-7786.MCR-11-0035; Imai K, 2011, DIGEST LIVER DIS, V43, P869, DOI 10.1016/j.dld.2011.05.021; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamisawa T, 2006, WORLD J GASTROENTERO, V12, P6225, DOI 10.3748/wjg.v12.i38.6225; Kato H, 2008, CANC STAT JAPAN; Khalid A, 2011, PANCREATOLOGY, V11, P482, DOI 10.1159/000331505; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mizuno N, 2009, J GASTROENTEROL, V44, P742, DOI 10.1007/s00535-009-0062-6; Nalls D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024099; Ogura T, 2012, GASTROINTEST ENDOSC, V75, P769, DOI 10.1016/j.gie.2011.11.012; Schultz NA, 2014, JAMA-J AM MED ASSOC, V311, P392, DOI 10.1001/jama.2013.284664; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Thatcher JD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3119tr1; Toiyama Y, 2013, JNCI-J NATL CANCER I, V105, P849, DOI 10.1093/jnci/djt101; Wang XF, 2012, J CANCER RES CLIN, V138, P573, DOI 10.1007/s00432-011-1114-x	32	21	21	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158669	10.1371/journal.pone.0158669	http://dx.doi.org/10.1371/journal.pone.0158669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380024	Green Published, gold, Green Submitted			2022-12-26	WOS:000379798700040
J	Newton, CL; Wood, MD; Strange, PG				Newton, Claire L.; Wood, Martyn D.; Strange, Philip G.			Examining the Effects of Sodium Ions on the Binding of Antagonists to Dopamine D-2 and D-3 Receptors	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; ALLOSTERIC MODULATION; SITE CREVICE; AGONIST; D2; SENSITIVITY; DISORDERS; PLATELETS; MEMBRANE; AFFINITY	Many G protein-coupled receptors have been shown to be sensitive to the presence of sodium ions (Na+). Using radioligand competition binding assays, we have examined and compared the effects of sodium ions on the binding affinities of a number of structurally diverse ligands at human dopamine D-2 and dopamine D-3 receptor subtypes, which are important therapeutic targets for the treatment of psychotic disorders. At both receptors, the binding affinities of the antagonists/inverse agonists SB-277011-A, L, 741,626, GR 103691 and U 99194 were higher in the presence of sodium ions compared to those measured in the presence of the organic cation, N-methyl-D-glucamine, used to control for ionic strength. Conversely, the affinities of spiperone and (+)-butaclamol were unaffected by the presence of sodium ions. Interestingly, the binding of the antagonist/inverse agonist clozapine was affected by changes in ionic strength of the buffer used rather than the presence of specific cations. Similar sensitivities to sodium ions were seen at both receptors, suggesting parallel effects of sodium ion interactions on receptor conformation. However, no clear correlation between ligand characteristics, such as subtype selectivity, and sodium ion sensitivity were observed. Therefore, the properties which determine this sensitivity remain unclear. However these findings do highlight the importance of careful consideration of assay buffer composition for in vitro assays and when comparing data from different studies, and may indicate a further level of control for ligand binding in vivo.	[Newton, Claire L.; Strange, Philip G.] Univ Reading, Sch Pharm, Reading RG6 6AJ, Berks, England; [Wood, Martyn D.] GlaxoSmithKline, Psychiat CEDD, Harlow CM19 5AW, Essex, England; [Newton, Claire L.] Univ Pretoria, Fac Hlth Sci, Ctr Neuroendocrinol, POB 2034, ZA-0001 Pretoria, South Africa; [Newton, Claire L.] Univ Pretoria, Fac Hlth Sci, Dept Immunol, POB 2034, ZA-0001 Pretoria, South Africa; [Wood, Martyn D.] UCB Bioprod SA, CNS Res, Allee Rech 60, B-1070 Brussels, Belgium	University of Reading; GlaxoSmithKline; University of Pretoria; University of Pretoria; UCB Pharma SA	Newton, CL (corresponding author), Univ Reading, Sch Pharm, Reading RG6 6AJ, Berks, England.; Newton, CL (corresponding author), Univ Pretoria, Fac Hlth Sci, Ctr Neuroendocrinol, POB 2034, ZA-0001 Pretoria, South Africa.; Newton, CL (corresponding author), Univ Pretoria, Fac Hlth Sci, Dept Immunol, POB 2034, ZA-0001 Pretoria, South Africa.	claire.newton@up.ac.za	Newton, Claire L/B-7114-2011; Newton, Claire/AAC-4663-2019; Newton, Claire/R-1783-2019	Newton, Claire L/0000-0001-6050-556X; Newton, Claire/0000-0001-6050-556X	Biotechnology and Biological Sciences Research Council (BBSRC); GlaxoSmithKline (GSK); GSK	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); GlaxoSmithKline (GSK)(GlaxoSmithKline); GSK(GlaxoSmithKline)	Financial support for this work was provided through a CASE PhD studentship awarded jointly by the Biotechnology and Biological Sciences Research Council (BBSRC) and GlaxoSmithKline (GSK). This studentship provided support in the form of a PhD stipend for CLN (who was involved in study design, data collection/analysis and preparation of the manuscript) and project running expenses. The BBSRC did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. GSK also provided support in the form of salary for MDW (who was involved in the study design and decision to publish). GSK did not have any additional role in the study design, data collection and analysis or decision to publish, but did review the manuscript prior to submission. The specific role of all authors are articulated in the 'author contributions' section.	Akam E, 2004, BIOCHEM PHARMACOL, V67, P2039, DOI 10.1016/j.bcp.2004.02.017; BALLESTEROS JA, 1992, BIOPHYS J, V62, P107, DOI 10.1016/S0006-3495(92)81794-0; Boundy VA, 1996, J PHARMACOL EXP THER, V276, P784; CERESA BP, 1994, J BIOL CHEM, V269, P29557; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cordeaux Y, 2001, J BIOL CHEM, V276, P28667, DOI 10.1074/jbc.M008644200; Ericksen SS, 2009, J PHARMACOL EXP THER, V328, P40, DOI 10.1124/jpet.108.141531; GOODMAN RR, 1982, MOL PHARMACOL, V21, P329; Heidbreder C, 2013, N-S ARCH PHARMACOL, V386, P167, DOI 10.1007/s00210-012-0803-6; Heidbreder CA, 2010, ANN NY ACAD SCI, V1187, P4, DOI 10.1111/j.1749-6632.2009.05149.x; HORSTMAN DA, 1990, J BIOL CHEM, V265, P21590; Javitch JA, 1999, BIOCHEMISTRY-US, V38, P7961, DOI 10.1021/bi9905314; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; LIMBIRD LE, 1982, MOL PHARMACOL, V21, P609; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MALMBERG A, 1993, MOL PHARMACOL, V43, P749; MALMBERG A, 1995, J PHARMACOL EXP THER, V274, P790; Michino M, 2015, CHEM COMMUN, V51, P8618, DOI 10.1039/c5cc02204e; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MOTULSKY HJ, 1983, J BIOL CHEM, V258, P3913; NEVE KA, 1991, MOL PHARMACOL, V39, P733; NEVE KA, 1990, J PHARMACOL EXP THER, V252, P1108; NEVE KA, 1991, MOL PHARMACOL, V39, P570; Neve KA, 2001, MOL PHARMACOL, V60, P373, DOI 10.1124/mol.60.2.373; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; PERT CB, 1974, MOL PHARMACOL, V10, P868; Schetz JA, 2001, J PHARMACOL EXP THER, V296, P359; Schwartz JC, 2000, BRAIN RES REV, V31, P277, DOI 10.1016/S0165-0173(99)00043-0; Selent J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000884; SOKOLOFF P, 1992, EUR J PHARM-MOLEC PH, V225, P331, DOI 10.1016/0922-4106(92)90107-7; Strange PG, 2008, TRENDS PHARMACOL SCI, V29, P314, DOI 10.1016/j.tips.2008.03.009; TEETER MM, 1994, J MED CHEM, V37, P2874, DOI 10.1021/jm00044a008; TSAI BS, 1978, MOL PHARMACOL, V14, P540; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6	34	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158808	10.1371/journal.pone.0158808	http://dx.doi.org/10.1371/journal.pone.0158808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379794	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000379798700048
J	Sadhukhan, P; Saha, S; Sinha, K; Brahmachari, G; Sil, PC				Sadhukhan, Pritam; Saha, Sukanya; Sinha, Krishnendu; Brahmachari, Goutam; Sil, Parames C.			Selective Pro-Apoptotic Activity of Novel 3,3 '-(Aryl/Alkyl-Methylene) Bis(2-Hydroxynaphthalene-1,4-Dione) Derivatives on Human Cancer Cells via the Induction Reactive Oxygen Species	PLOS ONE			English	Article							OXIDATIVE STRESS; ARJUNOLIC ACID; IN-VITRO; INDUCED CYTOTOXICITY; MEDICINAL CHEMISTRY; REDUCED GLUTATHIONE; LAWSONIA-INERMIS; PROTECTIVE ROLE; FLOW-CYTOMETRY; PATHWAYS	Selective induction of apoptosis in cancer cells barring the normal cells is considered as an effective strategy to combat cancer. In the present study, a series of twenty-two (22) synthetic 3,3'-(aryl/alkyl-methylene)bis(2-hydroxynaphthalene-1,4-dione)bis-lawsone derivatives were assayed for their pro-apoptotic activity in six different cell lines (five cancerous and one normal) using MTT assay. Out of these 22 test compounds, 1j was found to be the most effective in inducing apoptosis in human glioma cells (CCF-4) among the different cell lines used in the study. The activity of this compound, 1j, was then compared to a popular anticancer drug, cisplatin, having limited usage because of its nephrotoxic nature. In this study, 1j derivative showed much less toxicity to the normal kidney cells compared to cisplatin, thus indicating the superiority of 1j as a possible anticancer agent. This compound was observed to induce apoptosis in the glioma cells by inducing the caspase dependent apoptotic pathways via ROS and downregulating the PI3K/AKT/mTOR pathway. Estimation of different oxidative stress markers also confirms the induction of oxidative stress in 1j exposed cancer cells. The toxicity of 1j compound toward cancer cells was confirmed further by different flow cytometrical analyses to estimate the mitochondrial membrane potential and cell cycle. The sensitivity of malignant cells to apoptosis, provoked by this synthetic derivative in vitro, deserves further studies in suitable in vivo models. These studies not only identified a novel anticancer drug candidate but also help to understand the metabolism of ROS and its application in cancer treatment.	[Sadhukhan, Pritam; Saha, Sukanya; Sinha, Krishnendu; Sil, Parames C.] Bose Inst, Div Mol Med, P-1-12,CIT Scheme 7 M, Kolkata 700054, India; [Brahmachari, Goutam] Visva Bharati, Lab Nat Prod & Organ Synth, Dept Chem, Santini Ketan 731235, W Bengal, India	Department of Science & Technology (India); Bose Institute; Visva Bharati University	Sil, PC (corresponding author), Bose Inst, Div Mol Med, P-1-12,CIT Scheme 7 M, Kolkata 700054, India.	parames@jcbose.ac.in	Saha, Sukanya/AHC-8389-2022; Sadhukhan, Pritam/AAB-2655-2021; Brahmachari, Goutam/H-9416-2017; saha, sukanya/AHD-1166-2022	Saha, Sukanya/0000-0001-7592-8936; Sadhukhan, Pritam/0000-0003-4948-1012; Brahmachari, Goutam/0000-0001-9925-6281; saha, sukanya/0000-0001-7592-8936; Sinha, Krishnendu/0000-0001-9590-3875	SERB-DST, New Delhi [EMR/2014/001220]	SERB-DST, New Delhi	This work was funded by SERB-DST, New Delhi (No. EMR/2014/001220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, BIOMARKERS J; Ayhan-Kilcigil G, 2012, CHEM BIOL DRUG DES, V79, P869, DOI 10.1111/j.1747-0285.2012.01347.x; Banerjee S, 2016, BIOCH ANAL BIOCH, V5, P255, DOI [10.4172/2161-1009.1000255, DOI 10.4172/2161-1009.1000255]; Benada J, 2015, BIOMOLECULES, V5, P1912, DOI 10.3390/biom5031912; Biradar S, 2013, INDIAN J EXP BIOL, V51, P256; Brahmachari G, 2015, ACS SUSTAIN CHEM ENG, V3, P2058, DOI 10.1021/acssuschemeng.5b00325; CANMAN CE, 1995, SEMIN CANCER BIOL, V6, P17, DOI 10.1006/scbi.1995.0003; Caron S, 2007, ORG PROCESS RES DEV, V11, P1015, DOI 10.1021/op7001886; Cerqueira BB, 2015, EUROPEAN J PHARM BIO; Chai EZ, 2015, PHARMACOL THERAPEUT, V162, P86; Chakraborty S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7184; Choi YJ, 2012, CANCER CELL, V22, P438, DOI 10.1016/j.ccr.2012.09.015; Corbett JW, 2000, J MED CHEM, V43, P2019, DOI 10.1021/jm990580e; Cossarizza A, 2009, NAT PROTOC, V4, P1790, DOI 10.1038/nprot.2009.189; Cui Q, 2007, ACTA PHARMACOL SIN, V28, P1057, DOI 10.1111/j.1745-7254.2007.00588.x; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Das J, 2015, TOXICOL REP, V2, P600, DOI 10.1016/j.toxrep.2015.03.013; Das Joydeep, 2008, Pathophysiology, V15, P181, DOI 10.1016/j.pathophys.2008.06.002; DesMarteau D., 2010, J AM CHEM SOC, V132, P3229, DOI [10.1021/ja100496w, DOI 10.1021/JA100496W]; Dho SH, 2015, ONCOTARGET, V6, P39235, DOI 10.18632/oncotarget.5743; DIDRY N, 1994, PHARMAZIE, V49, P681; Dixit S. N., 1980, Indian Phytopathol., V31, P131; EASTMAN A, 1990, CANCER CELL-MON REV, V2, P275; Fetoni AR, 2015, BRIT J CANCER, V113, P1434, DOI 10.1038/bjc.2015.359; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Ghosh J, 2008, TOXICOL IN VITRO, V22, P1918, DOI 10.1016/j.tiv.2008.09.010; Ghosh J, 2011, BIOMATERIALS, V32, P4857, DOI 10.1016/j.biomaterials.2011.03.048; Gonec T, 2013, BIOORGAN MED CHEM, V21, P6531, DOI 10.1016/j.bmc.2013.08.030; Hagmann WK, 2008, J MED CHEM, V51, P4359, DOI 10.1021/jm800219f; Hassan M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/150845; Hattangadi DK, 2004, BIOCHEM PHARMACOL, V68, P1699, DOI 10.1016/j.bcp.2004.06.033; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; Kamiya K, 2015, LANCET, V386, P469, DOI 10.1016/S0140-6736(15)61167-9; Kirk KL, 2006, J FLUORINE CHEM, V127, P1013, DOI 10.1016/j.jfluchem.2006.06.007; Kirsch P., 2013, MODERN FLUOROORGANIC, P179, DOI [DOI 10.1002/9783527651351, 10.1002/9783527651351]; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li J, 2015, BIOMATERIALS, V47, P51, DOI 10.1016/j.biomaterials.2015.01.005; Liang T, 2013, ANGEW CHEM INT EDIT, V52, P8214, DOI 10.1002/anie.201206566; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu RM, 2015, REDOX BIOL, V6, P565, DOI 10.1016/j.redox.2015.09.009; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Ma JA, 2004, CHEM REV, V104, P6119, DOI 10.1021/cr030143e; Manna P, 2009, CHEM-BIOL INTERACT, V181, P297, DOI 10.1016/j.cbi.2009.08.004; McConkey DJ, 2009, CANCER METAST REV, V28, P335, DOI 10.1007/s10555-009-9194-7; Mendez I, 2016, BIOCHIMIE, V124, P178, DOI 10.1016/j.biochi.2015.04.014; Monti D, 2000, MECH AGEING DEV, V121, P239; Ojima I, 2009, FLUORINE MED CHEM CH, DOI [10.1002/9781444312096, DOI 10.1002/9781444312096]; Pal S, 2011, TOXICOLOGY, V283, P129, DOI 10.1016/j.tox.2011.03.006; Philchenkov A, 2004, EXP ONCOL, V26, P82; Pratibha G., 1999, Journal of Medicinal and Aromatic Plant Sciences, V21, P658; RAO VR, 1993, INDIAN J CHEM B, V32, P903; Rapoport BL, 2015, LANCET ONCOL, V16, P1079, DOI 10.1016/S1470-2045(15)00035-2; Ravishankar D, 2013, INT J BIOCHEM CELL B, V45, P2821, DOI 10.1016/j.biocel.2013.10.004; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Roy A, 2009, FREE RADICAL RES, V43, P995, DOI 10.1080/10715760903164998; Saadeh HA, 2009, MOLECULES, V14, P2758, DOI 10.3390/molecules14082758; Saha Sukanya, 2016, Biochem Biophys Rep, V5, P313, DOI 10.1016/j.bbrep.2016.01.011; Saha S, 2014, MINI-REV MED CHEM, V14, P920, DOI 10.2174/1389557514666141029233442; Sarkar A, 2011, TOXICOLOGY, V290, P208, DOI 10.1016/j.tox.2011.09.086; Sarkar K, 2006, TOXICOL IN VITRO, V20, P634, DOI 10.1016/j.tiv.2005.11.003; Sauriasari R, 2007, TOXICOLOGY, V235, P103, DOI 10.1016/j.tox.2007.03.019; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Sengupta D, 2014, BBA-GEN SUBJECTS, V1840, P219, DOI 10.1016/j.bbagen.2013.08.020; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Shan J, 2009, MOL CELL, V36, P469, DOI 10.1016/j.molcel.2009.10.018; Sil, 2015, BIOCH ANAL BIOCH, V4; Sinha K, 2015, BBA-GEN SUBJECTS, V1850, P769, DOI 10.1016/j.bbagen.2015.01.008; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Sinha M, 2008, J MED FOOD, V11, P733, DOI 10.1089/jmf.2007.0130; Sinha M, 2007, TOXICOL IN VITRO, V21, P1419, DOI 10.1016/j.tiv.2007.05.010; Sinha M, 2007, J NAT MED-TOKYO, V61, P251, DOI 10.1007/s11418-007-0133-z; Sultana N, 2009, J ENZYM INHIB MED CH, V24, P257, DOI [10.1080/14756360802057500, 10.1080/14756360802057500 ]; Takasu A, 2016, CANCER GENE THER, V23, P107, DOI 10.1038/cgt.2016.8; Tetsu O, 2015, PHARMACOL RES, V102, P132, DOI 10.1016/j.phrs.2015.09.022; Tsukahara T, 2015, CELL MOL BIOL LETT, V20, P38, DOI 10.2478/s11658-014-0224-2; Vidak M, 2015, MOLECULES, V20, P19406, DOI 10.3390/molecules201019406; Wang HN, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/6264317; Warren GW, 2014, LANCET ONCOL, V15, pE568, DOI 10.1016/S1470-2045(14)70266-9; Yan H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095609; Yogisha S, 2002, FITOTERAPIA, V73, P690, DOI 10.1016/S0367-326X(02)00214-9; Zhang Wei, 2014, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V30, P1209	82	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158694	10.1371/journal.pone.0158694	http://dx.doi.org/10.1371/journal.pone.0158694			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380262	gold, Green Published, Green Submitted			2022-12-26	WOS:000379798700042
J	Franco, OE; Tyson, DR; Konvinse, KC; Udyavar, AR; Estrada, L; Quaranta, V; Crawford, SE; Hayward, SW				Franco, Omar E.; Tyson, Darren R.; Konvinse, Katherine C.; Udyavar, Akshata R.; Estrada, Lourdes; Quaranta, Vito; Crawford, Susan E.; Hayward, Simon W.			Altered TGF-alpha/beta signaling drives cooperation between breast cancer cell populations	FASEB JOURNAL			English	Article						epithelial paracrine interactions; intratumor cooperation; tumor heterogeneity	TUMOR PROGRESSION; INTRATUMOR HETEROGENEITY; STEM-CELLS; EVOLUTION; MICROENVIRONMENT; LINE; CARCINOGENESIS; COMPETITION; DISEASE; MODEL	The role of tumor heterogeneity in regulating disease progression is poorly understood. We hypothesized that interactions between subpopulations of cancer cells can affect the progression of tumors selecting for a more aggressive phenotype. We developed an in vivo assay based on the immortalized nontumorigenic breast cell line MCF10A and its Ras-transformed derivatives AT1 (mildly tumorigenic) and CA1d (highly tumorigenic). CA1d cells outcompeted MCF10A, forming invasive tumors. AT1 grafts were approximately 1% the size of CA1d tumors when initiated using identical cell numbers. In contrast, CA1d/AT1 mixed tumors were larger than tumors composed of AT1 alone (100-fold) or CA1d (3-fold), suggesting cooperation in tumor growth. One of the mechanisms whereby CA1d and AT1 were found to cooperate was by modulation of TGF-alpha and TGF-beta signaling. Both of these molecules were sufficient to induce changes in AT1 proliferative potential in vitro. Reisolation of AT1 tumor-derived (AT1(-TD)) cells from these mixed tumors revealed that AT1(-TD) cells grew in vivo, forming tumors as large as tumorigenic CA1d cells. Cooperation between subpopulations of cancer epithelium is an understudied mechanism of tumor growth and invasion that may have implications on tumor resistance to current therapies.	[Franco, Omar E.; Crawford, Susan E.; Hayward, Simon W.] NorthShore Univ HealthSyst, Dept Surg, 1001 Univ Pl, Evanston, IL 60201 USA; [Konvinse, Katherine C.; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN USA; [Tyson, Darren R.; Udyavar, Akshata R.; Estrada, Lourdes; Quaranta, Vito; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	NorthShore University Health System; Vanderbilt University; Vanderbilt University	Hayward, SW (corresponding author), NorthShore Univ HealthSyst, Dept Surg, 1001 Univ Pl, Evanston, IL 60201 USA.	shayward@northshore.org	Tyson, Darren/Z-2815-2019	Tyson, Darren/0000-0002-3272-4308; Estrada, Lourdes/0000-0002-3645-4456; Konvinse, Katherine/0000-0003-2451-9256; Hayward, Simon/0000-0002-6059-6550	U.S. National Institutes of Health/National Cancer Institute Integrative Cancer Biology Program [5U54 CA113007, 5U01 CA151924]; NATIONAL CANCER INSTITUTE [U54CA113007, U01CA151924] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Cancer Institute Integrative Cancer Biology Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank L. Chin (University of Texas System at Austin, Austin, TX, USA), A. Protopopov (University of Texas M. D. Anderson Cancer Center), and Y. Xiao (Lion Bioscience, Heidelberg, Germany) for help with the array-CGH experiments and analysis. The authors also thank J. R. Nevins and M. West (Duke University Durham, NC, USA) for performing the cDNA microarray experiments and for their guidance on the analysis. The authors are grateful to J. Jourquin (Susan G. Komen, Nashville, TN, USA) for his help in the analysis of microarray expression data and pathway enrichment analysis. This work was supported by the U.S. National Institutes of Health/National Cancer Institute Integrative Cancer Biology Program (5U54 CA113007 and 5U01 CA151924).	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson ARA, 2009, CANCER RES, V69, P8797, DOI 10.1158/0008-5472.CAN-09-0437; ARTEAGA CL, 1993, J CLIN INVEST, V92, P2569, DOI 10.1172/JCI116871; Axelrod R, 2012, J THEOR BIOL, V299, P21, DOI 10.1016/j.jtbi.2011.04.015; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Bessette DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125232; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Chapman A, 2014, CELL REP, V8, P688, DOI 10.1016/j.celrep.2014.06.045; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Ene CI, 2011, CANCER CELL, V20, P695, DOI 10.1016/j.ccr.2011.11.018; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hayward SW, 2001, CANCER RES, V61, P8135; HEPPNER GH, 1993, STEM CELLS, V11, P199, DOI 10.1002/stem.5530110306; Ivanovic V, 2003, EUR J CANCER, V39, P454, DOI 10.1016/S0959-8049(02)00502-6; Kaiser J, 2013, SCIENCE, V339, P1543, DOI 10.1126/science.339.6127.1543; Kajita M, 2015, J BIOCHEM, V158, P15, DOI 10.1093/jb/mvv050; Kiskowski MA, 2011, CANCER RES, V71, P3459, DOI 10.1158/0008-5472.CAN-10-2999; Li Jian, 2010, BMC Res Notes, V3, P321, DOI 10.1186/1756-0500-3-321; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mancino M, 2011, BBA-REV CANCER, V1816, P105, DOI 10.1016/j.bbcan.2011.04.005; MILLER BE, 1980, CANCER RES, V40, P3977; Miller FR, 2000, J MAMMARY GLAND BIOL, V5, P379, DOI 10.1023/A:1009577811584; Olumi AF, 1999, CANCER RES, V59, P5002; Phillips JL, 2001, CANCER RES, V61, P8143; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Protopopov Alexei, 2008, V439, P87, DOI 10.1007/978-1-59745-188-8_6; Rhee J, 2011, BREAST CANCER RES TR, V125, P107, DOI 10.1007/s10549-010-1200-9; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shibata D, 2012, SCIENCE, V336, P304, DOI 10.1126/science.1222361; SOULE HD, 1990, CANCER RES, V50, P6075; Strickland LB, 2000, BREAST CANCER RES TR, V64, P235, DOI 10.1023/A:1026562720218; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Tamori Y, 2011, J GENET GENOMICS, V38, P483, DOI 10.1016/j.jgg.2011.09.006	45	5	5	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3441	3452		10.1096/fj.201500187RR	http://dx.doi.org/10.1096/fj.201500187RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27383183	Green Published			2022-12-26	WOS:000384329800015
J	Li, Z; Hwang, S; Bar-Peled, M				Li, Zi; Hwang, Soyoun; Bar-Peled, Maor			Discovery of a Unique Extracellular Polysaccharide in Members of the Pathogenic Bacillus That Can Co-form with Spores	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREUS ATCC-14579; STAPHYLOCOCCUS-AUREUS; BIOFILM FORMATION; CHLORINE DIOXIDE; VIRULENCE GENES; STAINLESS-STEEL; TOXIN GENES; ANTHRACIS; SUBTILIS; SPORULATION	An exopolysaccharide, produced during the late stage of stationary growth phase, was discovered and purified from the culture medium of Bacillus cereus, Bacillus anthracis, and Bacillus thuringiensis when strains were grown in a defined nutrient medium that induces biofilm. Two-dimensional NMR structural characterization of the polysaccharide, named pzX, revealed that it is composed of an unusual three amino-sugar sequence repeat of [-3)XylNAc40Ac(alpha 1-3)(GlcNAcA4OAc(alpha 1-3)XylNAc(alpha 1-](n). The sugar residue XylNAc had never been described previously in any glycan structure. The XNAC operon that contains the genes for the assembly of pzX is also unique and so far has been identified only in members of the Bacillus cereus sensu lato group. Microscopic and biochemical analyses indicate that pzX co-forms during sporulation, so that upon the release of the spore to the extracellular milieu it becomes surrounded by pzX. The relative amounts of pzX produced can be manipulated by specific nutrients in the medium, but rich medium appears to suppress pzX formation. pzX has the following unique characteristics: a surfactant property that lowers surface tension, a cell/spore antiaggregant, and an adherence property that increases spores binding to surfaces. pzX in Bacillus could represent a trait shared by many spore-producing microorganisms. It suggests pzX is an active player in spore physiology and may provide new insights to the successful survival of the B. cereus species in natural environments or in the hosts.	[Li, Zi; Hwang, Soyoun; Bar-Peled, Maor] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Li, Zi; Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu			BioEnergy Science Center by Office of Biological and Environmental Research in the Department of Energy Office of Science [DE-PS02-06ER64304]	BioEnergy Science Center by Office of Biological and Environmental Research in the Department of Energy Office of Science	This work was supported by the BioEnergy Science Center Grant DE-PS02-06ER64304, which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science. The authors declare that they have no conflicts of interest with the contents of this article.	ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Avashia SB, 2007, CLIN INFECT DIS, V44, P414, DOI 10.1086/510429; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Cherkasskiy BL, 1999, J APPL MICROBIOL, V87, P192, DOI 10.1046/j.1365-2672.1999.00868.x; Clements MO, 1998, J BACTERIOL, V180, P6729, DOI 10.1128/JB.180.24.6729-6735.1998; Cliff JB, 2005, APPL ENVIRON MICROB, V71, P6524, DOI 10.1128/AEM.71.11.6524-6530.2005; Derzelle S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134699; ELLWOOD DC, 1972, J GEN MICROBIOL, V73, P395, DOI 10.1099/00221287-73-2-395; Epstein AK, 2011, P NATL ACAD SCI USA, V108, P995, DOI 10.1073/pnas.1011033108; Fedhila S, 2006, MOL MICROBIOL, V62, P339, DOI 10.1111/j.1365-2958.2006.05362.x; Fedtke I, 2004, INT J MED MICROBIOL, V294, P189, DOI 10.1016/j.ijmm.2004.06.016; Girault G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-288; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; Gu XG, 2010, J BIOL CHEM, V285, P24825, DOI 10.1074/jbc.M110.125872; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Hornstra LM, 2006, APPL ENVIRON MICROB, V72, P3746, DOI 10.1128/AEM.72.5.3746-3749.2006; Hsueh YH, 2007, APPL ENVIRON MICROB, V73, P7225, DOI 10.1128/AEM.00690-07; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Joseph P, 2001, FEMS MICROBIOL LETT, V205, P91; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Kolsto AB, 2009, ANNU REV MICROBIOL, V63, P451, DOI 10.1146/annurev.micro.091208.073255; Lemon KP, 2008, CURR TOP MICROBIOL, V322, P1; Miller JM, 1997, J CLIN MICROBIOL, V35, P504, DOI 10.1128/JCM.35.2.504-507.1997; NAKATA HM, 1964, J BACTERIOL, V88, P1522, DOI 10.1128/JB.88.5.1522-1524.1964; Nam H, 2014, INT J FOOD MICROBIOL, V188, P122, DOI 10.1016/j.ijfoodmicro.2014.07.009; Pereira PM, 2010, APPL ENVIRON MICROB, V76, P4346, DOI 10.1128/AEM.00359-10; Purohit M, 2010, J MICROBIOL METH, V82, P282, DOI 10.1016/j.mimet.2010.07.004; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Ryu JH, 2005, J FOOD PROTECT, V68, P2614, DOI 10.4315/0362-028X-68.12.2614; Severson KM, 2009, J BACTERIOL, V191, P7587, DOI 10.1128/JB.01110-09; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; STERNE MAX, 1939, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V13, P307; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Thapa NK, 2014, EMERG INFECT DIS, V20, P1524, DOI 10.3201/eid2009.140181; Turgeon N, 2006, J MICROBIOL METH, V67, P543, DOI 10.1016/j.mimet.2006.05.005; Van der Auwera GA, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00380-13; Van Houdt R, 2010, J APPL MICROBIOL, V109, P1117, DOI 10.1111/j.1365-2672.2010.04756.x; Vlamakis H, 2013, NAT REV MICROBIOL, V11, P157, DOI 10.1038/nrmicro2960; YORK WS, 1986, METHOD ENZYMOL, V118, P3	43	11	11	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19051	19067		10.1074/jbc.M116.724708	http://dx.doi.org/10.1074/jbc.M116.724708			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402849	Green Published, hybrid			2022-12-26	WOS:000383242300039
J	Matei, E; Basu, R; Furey, W; Shi, J; Calnan, C; Aiken, C; Gronenborn, AM				Matei, Elena; Basu, Rohan; Furey, William; Shi, Jiong; Calnan, Conor; Aiken, Christopher; Gronenborn, Angela M.			Structure and Glycan Binding of a New Cyanovirin-N Homolog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE GLYCOPROTEIN GP120; VIRUS-INACTIVATING PROTEIN; HIV ENTRY INHIBITORS; CRYSTAL-STRUCTURE; ANTIBODY 2G12; X-RAY; POTENT; BROAD; NEUTRALIZATION; OLIGOMANNOSIDES	The HIV-1 envelope glycoprotein gp120 is heavily glycosylated and bears numerous high mannose sugars. These sugars can serve as targets for HIV-inactivating compounds, such as antibodies and lectins, which bind to the glycans and interfere with viral entry into the target cell. We determined the 1.6 angstrom x-ray structure of Cyt-CVNH, a recently identified lectin from the cyanobacterium Cyanothece(7424), and elucidated its glycan specificity by NMR. The Cyt-CVNH structure and glycan recognition profile are similar to those of other CVNH proteins, with each domain specifically binding to Man alpha(1-2)Man alpha units on the D1 and D3 arms of high mannose glycans. However, in contrast to CV-N, no cross-linking and precipitation of the cross linked species in solution was observed upon Man-9 binding, allowing, for the first time, investigation of the interaction of Man-9 with a member of the CVNH family by NMR. HIV assays showed that Cyt-CVNH is able to inhibit HIV-1 with similar to 4-fold higher potency than CV-N-P51G, a stabilized version of wild type CV-N. Therefore, Cyt-CVNH may qualify as a valuable lectin for potential microbicidal use.	[Matei, Elena; Basu, Rohan; Calnan, Conor; Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 Fifth Ave,BST3 Rm 1050, Pittsburgh, PA 15260 USA; [Basu, Rohan] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA; [Shi, Jiong; Aiken, Christopher] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Calnan, Conor] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 Fifth Ave,BST3 Rm 1050, Pittsburgh, PA 15260 USA.	amg100@pitt.edu	Matei, Elena/AAP-8706-2020; Aiken, Christopher/Y-9252-2019; matei, elena/HHC-6815-2022	Matei, Elena/0000-0002-1625-2814	National Institutes of Health [RO1GM080642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant RO1GM080642 (to A. M. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bandyopadhyay A, 2011, MBIO, V2, DOI 10.1128/mBio.00214-11; Barrientos LG, 2006, PROTEIN ENG DES SEL, V19, P525, DOI 10.1093/protein/gzl040; Barrientos LG, 2002, STRUCTURE, V10, P673, DOI 10.1016/S0969-2126(02)00758-X; Barrientos LG, 2005, MINI-REV MED CHEM, V5, P21, DOI 10.2174/1389557053402783; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; BLOEMBERGEN N, 1948, PHYS REV, V73, P679, DOI 10.1103/PhysRev.73.679; Bolmstedt AJ, 2001, MOL PHARMACOL, V59, P949, DOI 10.1124/mol.59.5.949; Botos I, 2002, J BIOL CHEM, V277, P34336, DOI 10.1074/jbc.M205909200; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Briz V, 2006, J ANTIMICROB CHEMOTH, V57, P619, DOI 10.1093/jac/dkl027; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Castagna A, 2005, DRUGS, V65, P879, DOI 10.2165/00003495-200565070-00001; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; CLORE GM, 1987, PROTEIN ENG, V1, P275, DOI 10.1093/protein/1.4.275; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FESIK SW, 1990, Q REV BIOPHYS, V23, P97, DOI 10.1017/S0033583500005515; Fromme R, 2007, BIOCHEMISTRY-US, V46, P9199, DOI 10.1021/bi700666m; Gupta SK, 2013, HIV AIDS-RES PALLIAT, V5, P295, DOI 10.2147/HIV.S39164; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Koharudin LMI, 2008, STRUCTURE, V16, P570, DOI 10.1016/j.str.2008.01.015; Koharudin LMI, 2014, CURR OPIN VIROL, V7, P95, DOI 10.1016/j.coviro.2014.05.006; Kuritzkes DR, 2009, CURR OPIN HIV AIDS, V4, P82, DOI 10.1097/COH.0b013e328322402e; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Matei E, 2008, STRUCTURE, V16, P1183, DOI 10.1016/j.str.2008.05.011; Matei E, 2011, PROTEINS, V79, P1538, DOI 10.1002/prot.22981; Matei E, 2010, J BIOL CHEM, V285, P13057, DOI 10.1074/jbc.M109.094938; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; O'Keefe BR, 2003, ANTIMICROB AGENTS CH, V47, P2518, DOI 10.1128/AAC.47.8.2518-2525.2003; Olsen JS, 2011, FUTURE MED CHEM, V3, P2101, DOI [10.4155/FMC.11.153, 10.4155/fmc.11.153]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pritchard LK, 2015, CELL REP, V11, P1604, DOI 10.1016/j.celrep.2015.05.017; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sandstrom C, 2004, BIOCHEMISTRY-US, V43, P13926, DOI 10.1021/bi048676k; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Shenoy SR, 2002, CHEM BIOL, V9, P1109, DOI 10.1016/S1074-5521(02)00237-5; Shenoy SR, 2001, J PHARMACOL EXP THER, V297, P704; Shi J, 2015, J VIROL, V89, P208, DOI 10.1128/JVI.01411-14; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Ward AB, 2015, TRENDS BIOCHEM SCI, V40, P101, DOI 10.1016/j.tibs.2014.12.006; Yang F, 1999, J MOL BIOL, V288, P403, DOI 10.1006/jmbi.1999.2693; Yang RF, 2007, J VIROL, V81, P3749, DOI 10.1128/JVI.02634-06	60	10	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18967	18976		10.1074/jbc.M116.740415	http://dx.doi.org/10.1074/jbc.M116.740415			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402833	Green Published, hybrid			2022-12-26	WOS:000383242300032
J	Mathieu, C; de la Sierra-Gallay, IL; Duval, R; Xu, XM; Cocaign, A; Leger, T; Woffendin, G; Camadro, JM; Etchebest, C; Haouz, A; Dupret, JM; Rodrigues-Lima, F				Mathieu, Cecile; de la Sierra-Gallay, Ines Li; Duval, Romain; Xu, Ximing; Cocaign, Angelique; Leger, Thibaut; Woffendin, Gary; Camadro, Jean-Michel; Etchebest, Catherine; Haouz, Ahmed; Dupret, Jean-Marie; Rodrigues-Lima, Fernando			Insights into Brain Glycogen Metabolism THE STRUCTURE OF HUMAN BRAIN GLYCOGEN PHOSPHORYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; brain metabolism; crystal structure; energy metabolism; glycogen; Lafora disease (Lafora progressive myoclonic epilepsy; MELF); brain functions; glycogen metabolism	TERM-MEMORY FORMATION; HUMAN-LIVER; ACTIVATION; MECHANISM; EPILEPSY; DISEASE; HYPOGLYCEMIA; ACCUMULATION; IMPAIRMENT; ASTROCYTES	Brain glycogen metabolism plays a critical role in major brain functions such as learning or memory consolidation. However, alteration of glycogen metabolism and glycogen accumulation in the brain contributes to neurodegeneration as observed in Lafora disease. Glycogen phosphorylase (GP), a key enzyme in glycogen metabolism, catalyzes the rate-limiting step of glycogen mobilization. Moreover, the allosteric regulation of the three GP isozymes (muscle, liver, and brain) by metabolites and phosphorylation, in response to hormonal signaling, fine-tunes glycogenolysis to fulfill energetic and metabolic requirements. Whereas the structures of muscle and liver GPs have been known for decades, the structure of brain GP (bGP) has remained elusive despite its critical role in brain glycogen metabolism. Here, we report the crystal structure of human bGP in complex with PEG 400 (2.5 angstrom) and in complex with its allosteric activator AMP (3.4 angstrom). These structures demonstrate that bGP has a closer structural relationship with muscle GP, which is also activated by AMP, contrary to liver GP, which is not. Importantly, despite the structural similarities between human bGP and the two other mammalian isozymes, the bGP structures reveal molecular features unique to the brain isozyme that provide a deeper understanding of the differences in the activation properties of these allosteric enzymes by the allosteric effector AMP. Overall, our study further supports that the distinct structural and regulatory properties of GP isozymes contribute to the different functions of muscle, liver, and brain glycogen.	[Mathieu, Cecile; Duval, Romain; Xu, Ximing; Cocaign, Angelique; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, Sorbonne Paris Cite, CNRS UMR 8251, Unite BFA, F-75013 Paris, France; [de la Sierra-Gallay, Ines Li] Univ Paris 11, Inst Biol Integrat Cellule, Fonct & Architecture Assemblages Macromol, UMR 9198, F-91405 Orsay, France; [Leger, Thibaut; Camadro, Jean-Michel] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS UMR 7592, F-75013 Paris, France; [Woffendin, Gary] Thermo Fisher Sci, Hemel Hempstead HP2 7GE, England; [Etchebest, Catherine] Univ Paris Diderot, INSERM, UMR S1134, F-75015 Paris, France; [Etchebest, Catherine] Univ Paris Diderot, Sorbonne Paris Cite, F-75004 Paris, France; [Etchebest, Catherine] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Etchebest, Catherine] Lab Excellence GR Ex, F-75015 Paris, France; [Etchebest, Catherine; Dupret, Jean-Marie; Rodrigues-Lima, Fernando] Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France; [Haouz, Ahmed] Inst Pasteur, Plateforme Cristallog, CNRS UMR 3528, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Thermo Fisher Scientific; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, CNRS UMR 8251, Unite BFA, F-75013 Paris, France.; Rodrigues-Lima, F (corresponding author), Univ Paris Diderot, UFR Sci Vivant, F-75013 Paris, France.	fernando.rodrigues-lima@univ-paris-diderot.fr	Duval, Romain/D-7764-2015; Léger, Thibaut/GPP-5828-2022; etchebest, catherine/O-2485-2019	etchebest, catherine/0000-0002-5871-2372; Duval, Romain/0000-0002-5785-0685; Leger, Thibaut/0000-0002-6304-3433; Li de la Sierra-Gallay, Ines/0000-0003-2770-7439; HAOUZ, Ahmed/0000-0003-1196-1635; Camadro, Jean-Michel/0000-0002-8549-2707	University Paris Diderot; CNRS; Institut Pasteur; French Ministry of Research (Ecole Doctorale BioSPC); Region Ile de France (DIM); China Scholarship Council	University Paris Diderot; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); French Ministry of Research (Ecole Doctorale BioSPC); Region Ile de France (DIM)(Region Ile-de-France); China Scholarship Council(China Scholarship Council)	This work was supported by running grants from University Paris Diderot, CNRS, and Institut Pasteur. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Ph.D. fellowships from the French Ministry of Research (Ecole Doctorale BioSPC).; Supported by a Ph.D. fellowship from Region Ile de France (appel hors DIM 2013).; Supported by a fellowship from the China Scholarship Council. Present address: Institut Pasteur, Unite de Pathogenese des Infections Vasculaires, 75015 Paris, France.	Agius L, 2010, MINI-REV MED CHEM, V10, P1175, DOI 10.2174/1389557511009011175; BARFORD D, 1989, NATURE, V340, P609, DOI 10.1038/340609a0; BARFORD D, 1991, J MOL BIOL, V218, P233, DOI 10.1016/0022-2836(91)90887-C; BARFORD D, 1992, PROTEIN SCI, V1, P472; Berg J. M., 2002, BIOCHEMISTRY-US, P831; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brown AM, 2004, J NEUROCHEM, V89, P537, DOI 10.1111/j.1471-4159.2004.02421.x; Choi IY, 2003, J NEUROSCI RES, V72, P25, DOI 10.1002/jnr.10574; Cloix J. -F., 2011, ISRN PATHOL, V2011, P1; Cloix JF, 2009, CURR MED CHEM, V16, P841, DOI 10.2174/092986709787549316; CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748; Duran J, 2015, MOL ASPECTS MED, V46, P70, DOI 10.1016/j.mam.2015.08.007; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; Duran J, 2013, J CEREBR BLOOD F MET, V33, P550, DOI 10.1038/jcbfm.2012.200; Duran J, 2012, EMBO MOL MED, V4, P719, DOI 10.1002/emmm.201200241; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLETTERICK RJ, 1976, J BIOL CHEM, V251, P6142; Gaboriaud-Kolar N, 2013, EXPERT OPIN THER PAT, V23, P1017, DOI 10.1517/13543776.2013.794790; Gibbs ME, 2006, GLIA, V54, P214, DOI 10.1002/glia.20377; Gibbs ME, 2012, NEUROCHEM RES, V37, P2456, DOI 10.1007/s11064-012-0805-2; Hossain MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097570; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LEBO RV, 1984, SCIENCE, V225, P57, DOI 10.1126/science.6587566; Lopez-Ramos JC, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00431, 10.3389/fncel.2015.00431]; MADDAIAH VT, 1966, J BIOL CHEM, V241, P3873; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller MS, 2015, GLIA, V63, P154, DOI 10.1002/glia.22741; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEWGARD CB, 1988, J BIOL CHEM, V263, P3850; NEWGARD CB, 1987, AM J HUM GENET, V40, P351; NEWGARD CB, 1989, CRIT REV BIOCHEM MOL, V24, P69, DOI 10.3109/10409238909082552; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; Obel Linea F, 2012, Front Neuroenergetics, V4, P3, DOI 10.3389/fnene.2012.00003; Oz G, 2015, NEUROCHEM RES, V40, P2473, DOI 10.1007/s11064-015-1664-4; Pellerin L, 2012, J CEREBR BLOOD F MET, V32, P1152, DOI 10.1038/jcbfm.2011.149; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Rath VL, 2000, MOL CELL, V6, P139, DOI 10.1016/S1097-2765(00)00015-0; Rose RJ, 2012, NAT METHODS, V9, P1084, DOI [10.1038/nmeth.2208, 10.1038/NMETH.2208]; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; SPRANG SR, 1991, SCIENCE, V254, P1367, DOI 10.1126/science.1962195; Suh SW, 2007, J PHARMACOL EXP THER, V321, P45, DOI 10.1124/jpet.106.115550; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Swanson R A, 1989, Neurol Res, V11, P24; Vaidya HB, 2013, J PHARM PHARM SCI, V16, P530, DOI 10.18433/J3FS4F; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu L, 2010, MINI-REV MED CHEM, V10, P1188, DOI 10.2174/1389557511009011188	48	33	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18072	18083		10.1074/jbc.M116.738898	http://dx.doi.org/10.1074/jbc.M116.738898			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402852	Green Published, hybrid			2022-12-26	WOS:000383241800002
J	McAndrew, MJ; Gjidoda, A; Tagore, M; Miksanek, T; Floer, M				McAndrew, Michael J.; Gjidoda, Alison; Tagore, Mohita; Miksanek, Tyler; Floer, Monique			Chromatin Remodeler Recruitment during Macrophage Differentiation Facilitates Transcription Factor Binding to Enhancers in Mature Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin remodeling; gene expression; gene regulation; macrophage; nucleosome occupancy; chromatin remodeler	NUCLEOSOME OCCUPANCY; GENE-EXPRESSION; REVEALS; COMPLEX; ACTIVATION; PROMOTER; PU.1; BRG1	We show how enhancers of macrophage-specific genes are rendered accessible in differentiating macrophages to allow their induction in mature cells in response to an appropriate stimulus. Using a lentiviral knockdown approach in primary differentiating macrophages from mouse bone marrow, we demonstrate that enhancers of Il12b and Il1a are kept relatively lowly occupied by nucleosomes and accessible through recruitment of the nucleosome remodeler BAF/PBAF. Our results using an inducible cell line that expresses an estrogen receptor fusion of the macrophage-specific transcription factor PU.1 (PUER) show that BAF/PBAF recruitment to these enhancers is a consequence of translocation of PUER to the nucleus in the presence of tamoxifen, and we speculate that remodeler recruitment may be directly mediated by PU.1. In the absence of BAF/PBAF recruitment, nucleosome occupancy at the enhancer of Il12b (and to a lesser extent at Il1a) reaches high levels in bone marrow-derived macrophages (BMDMs), and the enhancers are not fully cleared of nucleosomes upon LPS induction, resulting in impaired gene expression. Analysis of Il12b expression in single cells suggests that recruitment of the remodeler is necessary for high levels of transcription from the same promoter, and we propose that remodelers function by increasing nucleosome turnover to facilitate transcription factor over nucleosome binding in a process we have termed remodeler-assisted competition.	[McAndrew, Michael J.; Gjidoda, Alison; Tagore, Mohita; Miksanek, Tyler; Floer, Monique] Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 410, E Lansing, MI 48824 USA; [McAndrew, Michael J.; Tagore, Mohita; Floer, Monique] Michigan State Univ, Genet Grad Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Floer, M (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, 603 Wilson Rd,Rm 410, E Lansing, MI 48824 USA.	floer@msu.edu		McAndrew, Michael/0000-0003-3479-0576; Tagore, Mohita/0000-0002-2586-1427	American Heart Association [13SDG17260004]	American Heart Association(American Heart Association)	This work was supported by a Scientist-Development-Grant from the American Heart Association (to M. F.) (13SDG17260004). The authors declare that they have no conflicts of interest with the contents of this article.	Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Choi J, 2012, J IMMUNOL, V188, P3791, DOI 10.4049/jimmunol.1103390; Doan DN, 2004, ONCOGENE, V23, P3462, DOI 10.1038/sj.onc.1207472; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gjidoda A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093971; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Klochendler-Yeivin A, 2000, EMBO REP, V1, P500, DOI 10.1093/embo-reports/kvd129; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Mouse EC, 2012, GENOME BIOL, V13, P418, DOI DOI 10.1186/GB-2012-13-8-418; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Roberts CWM, 2000, P NATL ACAD SCI USA, V97, P13796, DOI 10.1073/pnas.250492697; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Tagore M, 2015, MOL CELL BIOL, V35, P2610, DOI 10.1128/MCB.00027-15; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111	31	10	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18058	18071		10.1074/jbc.M116.734186	http://dx.doi.org/10.1074/jbc.M116.734186			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382057	Green Published, hybrid			2022-12-26	WOS:000383241800001
J	Lee, MN; Kim, JW; Oh, SH; Jeong, BC; Hwang, YC; Koh, JT				Lee, Mi Nam; Kim, Jung-Woo; Oh, Sin-Hye; Jeong, Byung-Chul; Hwang, Yun-Chan; Koh, Jeong-Tae			FGF2 Stimulates COUP-TFII Expression via the MEK1/2 Pathway to Inhibit Osteoblast Differentiation in C3H10T1/2 Cells	PLOS ONE			English	Article							FIBROBLAST GROWTH FACTOR-2; MESENCHYMAL STEM-CELLS; TRANSCRIPTION FACTOR-II; ACTIVATED PROTEIN-KINASE; OSTEOGENIC DIFFERENTIATION; CYCLIN D1; C-FOS; PROLIFERATION; MAINTENANCE; PROGRESSION	Chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) is an orphan nuclear receptor that regulates many key biological processes, including organ development and cell fate determination. Although the biological functions of COUP-TFII have been studied extensively, little is known about what regulates its gene expression, especially the role of inducible extracellular factors in triggering it. Here we report that COUP-TFII expression is regulated specifically by fibroblast growth factor 2 (FGF2), which mediates activation of the MEK1/2 pathway in mesenchymal lineage C3H10T1/2 cells. Although FGF2 treatment increased cell proliferation, the induction of COUP-TFII expression was dispensable. Instead, FGF2-primed cells in which COUP-TFII expression was induced showed a low potential for osteoblast differentiation, as evidenced by decreases in alkaline phosphatase activity and osteogenic marker gene expression. Reducing COUP-TFII by U0126 or siRNA against COUP-TFII prevented the anti-osteogenic effect of FGF2, indicating that COUP-TFII plays a key role in the FGF2-mediated determination of osteoblast differentiation capability. This report is the first to suggest that FGF2 is an extracellular inducer of COUP-TFII expression and may suppress the osteogenic potential of mesenchymal cells by inducing COUP-TFII expression prior to the onset of osteogenic differentiation.	[Lee, Mi Nam; Kim, Jung-Woo; Oh, Sin-Hye; Jeong, Byung-Chul; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Res Ctr Biomineralizat Disorders, Gwangju, South Korea; [Lee, Mi Nam; Kim, Jung-Woo; Oh, Sin-Hye; Jeong, Byung-Chul; Hwang, Yun-Chan; Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Gwangju, South Korea; [Hwang, Yun-Chan] Chonnam Natl Univ, Sch Dent, Dept Conservat Dent, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University	Koh, JT (corresponding author), Chonnam Natl Univ, Sch Dent, Res Ctr Biomineralizat Disorders, Gwangju, South Korea.; Koh, JT (corresponding author), Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Gwangju, South Korea.	jtkoh@chonnam.ac.kr			National Research Foundation of Korea (NRF) grants - Korean government [2011-0030121]; Chonnam National University Hospital Research Institute of Clinical Medicine [CRI 13905-21]	National Research Foundation of Korea (NRF) grants - Korean government; Chonnam National University Hospital Research Institute of Clinical Medicine	This study was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (2011-0030121) and Chonnam National University Hospital Research Institute of Clinical Medicine (CRI 13905-21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (2011-0030121) and Chonnam National University Hospital Research Institute of Clinical Medicine (CRI 13905-21).	Ahn HJ, 2009, FEBS LETT, V583, P2922, DOI 10.1016/j.febslet.2009.07.056; Byun MR, 2014, BONE, V58, P72, DOI 10.1016/j.bone.2013.09.024; Carreira AC, 2014, J DENT RES, V93, P335, DOI 10.1177/0022034513518561; Chen XP, 2012, MOL ENDOCRINOL, V26, P1268, DOI 10.1210/me.2011-1305; Choi SC, 2008, STEM CELLS DEV, V17, P725, DOI 10.1089/scd.2007.0230; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Debiais F, 1998, J BONE MINER RES, V13, P645, DOI 10.1359/jbmr.1998.13.4.645; Deschaseaux F, 2009, TRENDS MOL MED, V15, P417, DOI 10.1016/j.molmed.2009.07.002; Di Maggio N, 2012, STEM CELLS, V30, P1455, DOI 10.1002/stem.1106; El Agha E, 2016, SEMIN CELL DEV BIOL, V53, P76, DOI 10.1016/j.semcdb.2015.10.009; Eom YW, 2014, BIOCHEM BIOPH RES CO, V445, P16, DOI 10.1016/j.bbrc.2014.01.084; Frederick TJ, 2007, GLIA, V55, P1011, DOI 10.1002/glia.20520; Hu SJ, 2013, STEM CELLS, V31, P259, DOI 10.1002/stem.1278; Hur SW, 2015, J DENT RES, V94, P1135, DOI 10.1177/0022034515585125; Ito T, 2007, BIOCHEM BIOPH RES CO, V359, P108, DOI 10.1016/j.bbrc.2007.05.067; Jeong BC, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.485; Kakudo N, 2007, BIOCHEM BIOPH RES CO, V359, P239, DOI 10.1016/j.bbrc.2007.05.070; Kalajzic I, 2003, J CELL BIOCHEM, V88, P1168, DOI 10.1002/jcb.10459; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Kang IH, 2015, J CELL PHYSIOL, V230, P911, DOI 10.1002/jcp.24822; Kim S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120073; Lai WT, 2011, STEM CELLS, V29, P1102, DOI 10.1002/stem.661; Lee KN, 2012, J BIOL CHEM, V287, P18888, DOI 10.1074/jbc.M111.311878; Lim S, 2016, CELL TISSUE RES, V364, P137, DOI 10.1007/s00441-015-2311-8; Martin I, 1997, ENDOCRINOLOGY, V138, P4456, DOI 10.1210/en.138.10.4456; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Nakshatri H, 2000, BIOCHEM BIOPH RES CO, V270, P1144, DOI 10.1006/bbrc.2000.2562; Okamura M, 2009, P NATL ACAD SCI USA, V106, P5819, DOI 10.1073/pnas.0901676106; OKAZAKI R, 1992, J BONE MINER RES, V7, P1149; Pereira FA, 1999, GENE DEV, V13, P1037, DOI 10.1101/gad.13.8.1037; Qin J, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-58; Quarto N, 2008, BONE, V42, P1040, DOI 10.1016/j.bone.2008.01.026; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Solchaga LA, 2010, TISSUE ENG PT A, V16, P1009, DOI [10.1089/ten.tea.2009.0100, 10.1089/ten.TEA.2009.0100]; Song T, 2013, INT J BIOCHEM CELL B, V45, P1639, DOI 10.1016/j.biocel.2013.05.005; Standal T, 2007, BLOOD, V109, P3024, DOI 10.1182/blood-2006-07-034884; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Uhlik MT, 2004, BIOCHEM CELL BIOL, V82, P658, DOI 10.1139/O04-114; van Gastel N, 2014, STEM CELLS, V32, P2407, DOI 10.1002/stem.1783; Wen Q, 2012, J CELL MOL MED, V16, P1260, DOI 10.1111/j.1582-4934.2011.01407.x; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xie X, 2011, P NATL ACAD SCI USA, V108, P14843, DOI 10.1073/pnas.1110236108; Xu Z, 2008, P NATL ACAD SCI USA, V105, P2421, DOI 10.1073/pnas.0707082105	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159234	10.1371/journal.pone.0159234	http://dx.doi.org/10.1371/journal.pone.0159234			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404388	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508200044
J	Song, J; Liu, ZX; Hong, HL; Ma, YS; Tian, L; Li, XX; Li, YH; Guan, RX; Guo, Y; Qiu, LJ				Song, Jian; Liu, Zhangxiong; Hong, Huilong; Ma, Yansong; Tian, Long; Li, Xinxiu; Li, Ying-Hui; Guan, Rongxia; Guo, Yong; Qiu, Li-Juan			Identification and Validation of Loci Governing Seed Coat Color by Combining Association Mapping and Bulk Segregation Analysis in Soybean	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GENOME-WIDE ASSOCIATION; IRON-DEFICIENCY CHLOROSIS; GENETIC-LINKAGE MAP; NATURAL VARIATION; FLAVONOID 3'-HYDROXYLASE; MARKER DEVELOPMENT; TOLERANCE; PIGMENTATION; RESISTANCE	Soybean seed coat exists in a range of colors from yellow, green, brown, black, to bicolor. Classical genetic analysis suggested that soybean seed color was a moderately complex trait controlled by multi-loci. However, only a couple of loci could be detected using a single biparental segregating population. In this study, a combination of association mapping and bulk segregation analysis was employed to identify genes/loci governing this trait in soybean. A total of 14 loci, including nine novel and five previously reported ones, were identified using 176,065 coding SNPs selected from entire SNP dataset among 56 soybean accessions. Four of these loci were confirmed and further mapped using a biparental population developed from the cross between ZP95-5383 (yellow seed color) and NY279 (brown seed color), in which different seed coat colors were further dissected into simple trait pairs (green/yellow, green/black, green/brown, yellow/black, yellow/brown, and black/brown) by continuously developing residual heterozygous lines. By genotyping entire F-2 population using flanking markers located in fine-mapping regions, the genetic basis of seed coat color was fully dissected and these four loci could explain all variations of seed colors in this population. These findings will be useful for map-based cloning of genes as well as marker-assisted breeding in soybean. This work also provides an alternative strategy for systematically isolating genes controlling relative complex trait by association analysis followed by biparental mapping.	[Guo, Yong; Qiu, Li-Juan] Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China; Chinese Acad Agr Sci, MOA Key Lab Soybean Biol Beijing, Inst Crop Sci, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Guo, Y; Qiu, LJ (corresponding author), Chinese Acad Agr Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing, Peoples R China.	guoyong@caas.cn; qiulijuan@caas.cn	Song, Jian/HGD-2320-2022		Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences; State High-tech Research and Development Program [2013AA102602]; National Natural Science Foundation of China [31271753]; Accurate Identification and Display of Soybean Germplasm [NB2010-2130315-25-05]; National Crop Germplasm Platform [2012-004, 2014-004]	Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences; State High-tech Research and Development Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Accurate Identification and Display of Soybean Germplasm; National Crop Germplasm Platform	This work was supported by the Agricultural Science and Technology Innovation Program (ASTIP) of Chinese Academy of Agricultural Sciences, recipient: LJQ; the State High-tech Research and Development Program, grant no. 2013AA102602, recipient: YG; National Natural Science Foundation of China, grant no. 31271753; Accurate Identification and Display of Soybean Germplasm, grant no. NB2010-2130315-25-05; and National Crop Germplasm Platform, grant no. 2012-004; 2014-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appels R, 2013, FUNCT INTEGR GENOMIC, V13, P1, DOI 10.1007/s10142-013-0319-2; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Bastien M, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.10.0030; Benitez ER, 2004, CROP SCI, V44, P2038, DOI 10.2135/cropsci2004.2038; Brachi B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000940; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; BUZZELL RI, 1987, J HERED, V78, P53, DOI 10.1093/oxfordjournals.jhered.a110309; Carpenter J, 2002, COMP ENV IMPACTS BIO, P15; Cho YB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076954; Clough SJ, 2004, GENOME, V47, P819, DOI 10.1139/G04-049; Cregan PB, 1999, CROP SCI, V39, P1464, DOI 10.2135/cropsci1999.3951464x; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Dixon RA, 2003, PLANT PHYSIOL, V131, P878, DOI 10.1104/pp.102.017319; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Famoso AN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002221; Fang C, 2014, PLANT J, V77, P700, DOI 10.1111/tpj.12419; Gillman JD, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-155; Githiri SM, 2007, J HERED, V98, P360, DOI 10.1093/jhered/esm042; Gore MA, 2002, GENOME, V45, P592, DOI 10.1139/G02-009; Guan RX, 2014, PLANT J, V80, P937, DOI 10.1111/tpj.12695; Guiamet JJ, 1996, PHYSIOL PLANTARUM, V96, P655, DOI 10.1111/j.1399-3054.1996.tb00239.x; Guo Y, 2013, THEOR APPL GENET, V126, P1445, DOI 10.1007/s00122-013-2063-3; Hao DR, 2012, THEOR APPL GENET, V124, P447, DOI 10.1007/s00122-011-1719-0; Hartman GL, 2011, FOOD SECUR, V3, P5, DOI 10.1007/s12571-010-0108-x; Henry IM, 2014, PLANT CELL, V26, P181, DOI 10.1105/tpc.113.120626; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Huang XH, 2012, NAT GENET, V44, P32, DOI 10.1038/ng.1018; Hymowitz T., 1980, Advances in legume science (Summerfield, R.J.; Bunting, A.H. [Editors])., P251; Kadam S, 2016, PLANT SCI, V242, P342, DOI 10.1016/j.plantsci.2015.08.015; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Korir PC, 2013, THEOR APPL GENET, V126, P1659, DOI 10.1007/s00122-013-2082-0; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; LARK KG, 1993, THEOR APPL GENET, V86, P901, DOI 10.1007/BF00211039; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li YB, 2011, NAT GENET, V43, P1266, DOI 10.1038/ng.977; Li YH, 2014, NAT BIOTECHNOL, V32, P1045, DOI 10.1038/nbt.2979; Li YH, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0251-1; Li YH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-579; Li YH, 2011, CONSERV GENET, V12, P1145, DOI 10.1007/s10592-011-0216-y; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Lohnes DG, 1997, CROP SCI, V37, P254, DOI 10.2135/cropsci1997.0011183X003700010045x; Mamidi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107469; Mamidi S, 2011, PLANT GENOME-US, V4, P154, DOI 10.3835/plantgenome2011.04.0011; Mitchell-Olds T, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-113; Motte H, 2014, P NATL ACAD SCI USA, V111, P8305, DOI 10.1073/pnas.1404978111; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nakano M, 2014, PLANT CELL PHYSIOL, V55, P1763, DOI 10.1093/pcp/pcu107; Niu Y, 2013, MOL BREEDING, V31, P785, DOI 10.1007/s11032-012-9833-5; Ohnishi S, 2011, THEOR APPL GENET, V122, P633, DOI 10.1007/s00122-010-1475-6; Owen FV, 1928, GENETICS, V13, P0050; Oyoo ME, 2011, CROP SCI, V51, P464, DOI 10.2135/cropsci2010.02.0121; Palmer R, 2004, QUALITATIVE GENETICS, V3rd; REESE PF, 1989, J HERED, V80, P86, DOI 10.1093/oxfordjournals.jhered.a110803; Ren ZH, 2010, P NATL ACAD SCI USA, V107, P5669, DOI 10.1073/pnas.0910798107; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Senda M, 2004, PLANT CELL, V16, P807, DOI 10.1105/tpc.019885; Senda M, 2013, BREEDING SCI, V63, P384, DOI 10.1270/jsbbs.63.384; Senda M, 2011, BREEDING SCI, V61, P523, DOI 10.1270/jsbbs.61.523; Sonah H, 2015, PLANT BIOTECHNOL J, V13, P211, DOI 10.1111/pbi.12249; Song QJ, 2010, CROP SCI, V50, P1950, DOI 10.2135/cropsci2009.10.0607; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sterken R, 2012, P NATL ACAD SCI USA, V109, P4678, DOI 10.1073/pnas.1120811109; Takahashi R, 1996, CROP SCI, V36, P559, DOI 10.2135/cropsci1996.0011183X003600030004x; Takahashi R, 1997, CROP SCI, V37, P1755, DOI 10.2135/cropsci1997.0011183X003700060014x; Tardivel A, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2013.10.0034; Toda K, 2002, PLANT MOL BIOL, V50, P187, DOI 10.1023/A:1016087221334; TODD JJ, 1993, PLANT PHYSIOL, V102, P663, DOI 10.1104/pp.102.2.663; Todd JJ, 1996, PLANT CELL, V8, P687, DOI 10.1105/tpc.8.4.687; Turner S.D., 2018, BIORXIV, V3, P731, DOI [10.1101/005165, 10.21105/joss.00731, DOI 10.1101/005165.V1]; Tuteja JH, 2004, PLANT CELL, V16, P819, DOI 10.1105/tpc.021352; Tuteja JH, 2009, PLANT CELL, V21, P3063, DOI 10.1105/tpc.109.069856; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Vuong TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1811-y; Wang J, 2008, THEOR APPL GENET, V116, P777, DOI 10.1007/s00122-008-0710-x; Watanabe S, 2011, GENETICS, V188, P395, DOI 10.1534/genetics.110.125062; Watanabe S, 2009, GENETICS, V182, P1251, DOI 10.1534/genetics.108.098772; WEISS MG, 1970, CROP SCI, V10, P300, DOI 10.2135/cropsci1970.0011183X001000030027x; Woodworth CM, 1921, GENETICS, V6, P487; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yang K, 2010, J HERED, V101, P757, DOI 10.1093/jhered/esq078; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zabala G, 2003, GENETICS, V163, P295; Zabala G, 2007, CROP SCI, V47, pS113, DOI 10.2135/cropsci2006.12.0838tpg; Zabala G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111959; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	88	26	30	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159064	10.1371/journal.pone.0159064	http://dx.doi.org/10.1371/journal.pone.0159064			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404272	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508200032
J	Baruah, PS; Beauchemin, M; Hebert, J; Bertrand, R				Baruah, Prasamit Saurav; Beauchemin, Myriam; Hebert, Josee; Bertrand, Richard			Dynamic Bcl-xL (S49) and (S62) Phosphorylation/Dephosphorylation during Mitosis Prevents Chromosome Instability and Aneuploidy in Normal Human Diploid Fibroblasts	PLOS ONE			English	Article							INFLAMMATORY CYTOKINE SECRETION; CELL-CYCLE PROGRESSION; POLO-LIKE KINASES; FAMILY-MEMBERS; IN-VIVO; MITOCHONDRIAL APOPTOSIS; BUBR1 INSUFFICIENCY; GENE-EXPRESSION; BH3 DOMAIN; BCL-X(L)	Bcl-xL proteins undergo dynamic phosphorylation/dephosphorylation on Ser49 and Ser62 residues during mitosis. The expression of Bcl-xL(S49A), (S62A) and dual (S49/62A) phosphorylation mutants in tumor cells lead to severe mitotic defects associated with multipolar spindle, chromosome lagging and bridging, and micro-, bi- and multi-nucleated cells. Because the above observations were made in tumor cells which already display genomic instability, we now address the question: will similar effects occur in normal human diploid cells? We studied normal human diploid BJ foreskin fibroblast cells expressing Bcl-xL (wild type), (S49A), (S49D), (S62A), (S62D) and the dual-site (S49/62A) and (S49/62D) mutants. Cells expressing S49 and/or S62 phosphorylation mutants showed reduced kinetics of cell population doubling. These effects on cell population doubling kinetics correlated with early outbreak of senescence with no impact on the cell death rate. Senescent cells displayed typical senescence-associated phenotypes including high-level of senescence-associated beta-galactosidase activity, interleukin-6 (IL-6) secretion, tumor suppressor p53 and cyclin-dependent kinase inhibitor p21Waf1/Cip1 activation as well as gamma H2A.X-associated nuclear chromatin foci. Fluorescence in situ hybridization analysis and Giemsa-banded karyotypes revealed that the expression of Bcl-xL phosphorylation mutants in normal diploid BJ cells provoked chromosome instability and aneuploidy. These findings suggest that dynamic Bcl-xL(S49) and (S62) phosphorylation/dephosphorylation cycles are important in the maintenance of chromosome integrity during mitosis in normal cells. They could impact future strategies aiming to develop and identify compounds that could target not only the anti-apoptotic domain of Bcl-xL protein, but also its mitotic domain for cancer therapy.	[Baruah, Prasamit Saurav; Beauchemin, Myriam; Bertrand, Richard] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada; [Baruah, Prasamit Saurav; Beauchemin, Myriam; Bertrand, Richard] Inst Canc Montreal, Montreal, PQ, Canada; [Hebert, Josee] Hop Maisonneuve Rosemt, Ctr Rech, Quebec Leukemia Cell Bank, Montreal, PQ, Canada; [Hebert, Josee; Bertrand, Richard] Univ Montreal, Dept Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Bertrand, R (corresponding author), Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Montreal, PQ, Canada.; Bertrand, R (corresponding author), Inst Canc Montreal, Montreal, PQ, Canada.; Bertrand, R (corresponding author), Univ Montreal, Dept Med, Montreal, PQ, Canada.	richard.bertrand@umontreal.ca			Canadian Institutes of Health Research [MOP-97913]; Natural Sciences and Engineering Research Council of Canada [328207]; Cancer Research Network of Fonds de recherche du Quebec-Sante; Faculte des etudes superieures (Universite de Montreal, Canada); Fondation de l'Institut du cancer de Montreal (Canada)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cancer Research Network of Fonds de recherche du Quebec-Sante; Faculte des etudes superieures (Universite de Montreal, Canada); Fondation de l'Institut du cancer de Montreal (Canada)	This work was funded by Grant MOP-97913 from the Canadian Institutes of Health Research and Grant 328207 from the Natural Sciences and Engineering Research Council of Canada to RB, and a grant from the Cancer Research Network of Fonds de recherche du Quebec-Sante to JH. PSB received scholarships from the Faculte des etudes superieures (Universite de Montreal, Canada) and the Fondation de l'Institut du cancer de Montreal (Canada).	Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Basu A, 2003, FEBS LETT, V538, P41, DOI 10.1016/S0014-5793(03)00131-5; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Borner C, 1996, J BIOL CHEM, V271, P12695, DOI 10.1074/jbc.271.22.12695; Burri SH, 1999, INT J RADIAT ONCOL, V43, P423, DOI 10.1016/S0360-3016(98)00385-X; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Chang BS, 1997, EMBO J, V16, P968, DOI 10.1093/emboj/16.5.968; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Diaz JL, 1997, J BIOL CHEM, V272, P11350; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dumay A, 2006, ONCOGENE, V25, P3196, DOI 10.1038/sj.onc.1209344; Fan MY, 2000, J BIOL CHEM, V275, P29980, DOI 10.1074/jbc.M003776200; Fang W, 1996, IMMUNITY, V4, P291, DOI 10.1016/S1074-7613(00)80437-9; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Helmke C, 2016, ONCOGENE, V35, P135, DOI 10.1038/onc.2015.105; Huang DCS, 1997, EMBO J, V16, P4628, DOI 10.1093/emboj/16.15.4628; Janumyan YM, 2003, EMBO J, V22, P5459, DOI 10.1093/emboj/cdg533; Juin P, 2013, NAT REV CANCER, V13, P455, DOI 10.1038/nrc3538; Karczmarek-Borowska B, 2006, LUNG CANCER, V51, P61, DOI 10.1016/j.lungcan.2005.08.010; Krajewska M, 1996, CANCER RES, V56, P2422; Kumar S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/705745; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li HM, 2013, NAT CELL BIOL, V15, P773, DOI 10.1038/ncb2791; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Mallick S, 2013, HEAD NECK-J SCI SPEC, V35, P1448, DOI 10.1002/hed.23153; Morales CP, 1999, NAT GENET, V21, P115, DOI 10.1038/5063; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Poruchynsky MS, 1998, CANCER RES, V58, P3331; Qian J, 2004, ANAL BIOCHEM, V328, P131, DOI 10.1016/j.ab.2003.12.034; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Saintigny Y, 2001, EMBO J, V20, P2596, DOI 10.1093/emboj/20.10.2596; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schliekelman M, 2009, CANCER RES, V69, P45, DOI 10.1158/0008-5472.CAN-07-6330; Schmitt E, 2007, ONCOGENE, V26, P5851, DOI 10.1038/sj.onc.1210396; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sharma J, 2005, PANCREAS, V30, P337, DOI 10.1097/01.mpa.0000160282.64451.f1; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Talati C, 2016, CRIT REV ONCOL HEMAT, V98, P200, DOI 10.1016/j.critrevonc.2015.10.013; Tao ZF, 2014, ACS MED CHEM LETT, V5, P1088, DOI 10.1021/ml5001867; Wang JF, 2014, CELL CYCLE, V13, P1313, DOI 10.4161/cc.28293; Wang JF, 2012, CELL CYCLE, V11, P2159, DOI 10.4161/cc.20672; Wang JF, 2011, CELL SIGNAL, V23, P2030, DOI 10.1016/j.cellsig.2011.07.017; Wang QH, 2008, MOL CELL, V29, P488, DOI 10.1016/j.molcel.2007.12.029; Watanabe J, 2004, SURGERY, V135, P604, DOI 10.1016/j.surg.2003.11.015; Wiese C, 2002, CANCER RES, V62, P1279; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Wong H, 1996, EXP GERONTOL, V31, P311, DOI 10.1016/0531-5565(95)00025-9; Yamaguchi R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024102; Yang JS, 2011, ACTA HISTOCHEM, V113, P810, DOI 10.1016/j.acthis.2011.01.002; Zitouni S, 2014, NAT REV MOL CELL BIO, V15, P433, DOI 10.1038/nrm3819	57	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159091	10.1371/journal.pone.0159091	http://dx.doi.org/10.1371/journal.pone.0159091			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398719	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508100018
J	Verburg, PE; Tucker, G; Scheil, W; Erwich, JJHM; Dekker, GA; Roberts, CT				Verburg, Petra E.; Tucker, Graeme; Scheil, Wendy; Erwich, Jan Jaap H. M.; Dekker, Gus A.; Roberts, Claire Trelford			Sexual Dimorphism in Adverse Pregnancy Outcomes - A Retrospective Australian Population Study 1981-2011	PLOS ONE			English	Article							FETAL SEX; PRETERM BIRTH; PLACENTAL DYSFUNCTION; GESTATIONAL-AGE; GENDER; PREECLAMPSIA; HYPERTENSION; EXCESS; MALES	Objectives Sexual inequality starts in utero. The contribution of biological sex to the developmental origins of health and disease is increasingly recognized. The aim of this study was to assess and interpret sexual dimorphisms for three major adverse pregnancy outcomes which affect the health of the neonate, child and potentially adult. Methods Retrospective population-based study of 574,358 South Australian singleton live births during 1981-2011. The incidence of three major adverse pregnancy outcomes [preterm birth (PTB), pregnancy induced hypertensive disorders (PIHD) and gestational diabetes mellitus (GDM)] in relation to fetal sex was compared according to traditional and fetus-at-risk (FAR) approaches. Results The traditional approach showed male predominance for PTB [20-24 weeks: Relative Risk (RR) M/F 1.351, 95%-CI 1.274-1.445], spontaneous PTB [25-29 weeks: RR M/F 1.118, 95%-CI 1.044-1.197%], GDM [RR M/F 1.042, 95%-CI 1.011-1.074], overall PIHD [RR M/F 1.053, 95%-CI 1.034-1.072] and PIHD with term birth [RR M/F 1.074, 95%-CI 1.044-1.105]. The FAR approach showed that males were at increased risk for PTB [20-24 weeks: RR M/F 1.273, 95%-CI 1.087-1.490], for spontaneous PTB [25-29 weeks: RR M/F 1.269, 95%-CI 1.143-1.410] and PIHD with term birth [RR M/F 1.074, 95%-CI 1.044-1.105%]. The traditional approach demonstrated female predominance for iatrogenic PTB [25-29 weeks: RR M/F 0.857, 95%-CI 0.780-0.941] and PIHD associated with PTB [25-29 weeks: RR M/F 0.686, 95%-CI 0.581-0.811]. The FAR approach showed that females were at increased risk for PIHD with PTB [25-29 weeks: RR M/F 0.779, 95%-CI 0.648-0.937]. Conclusions This study confirms the presence of sexual dimorphisms and presents a coherent framework based on two analytical approaches to assess and interpret the sexual dimorphisms for major adverse pregnancy outcomes. The mechanisms by which these occur remain elusive, but sex differences in placental gene expression and function are likely to play a key role. Further research on sex differences in placental function and maternal adaptation to pregnancy is required to delineate the causal molecular mechanisms in sex-specific pregnancy outcome. Identifying these mechanisms may inform fetal sex specific tailored antenatal and neonatal care.	[Verburg, Petra E.; Dekker, Gus A.; Roberts, Claire Trelford] Univ Adelaide, Sch Med, Robinson Res Inst, Adelaide, SA, Australia; [Verburg, Petra E.; Erwich, Jan Jaap H. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynaecol, Groningen, Netherlands; [Verburg, Petra E.; Tucker, Graeme; Scheil, Wendy] SA Hlth, Epidemiol Branch, Adelaide, SA, Australia; [Tucker, Graeme; Scheil, Wendy] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Dekker, Gus A.] Lyell McEwin Hosp, Dept Obstet & Gynaecol, Elizabeth Vale, SA, Australia	Robinson Research Institute; University of Adelaide; University of Groningen; University of Adelaide; Lyell McEwin Hospital	Roberts, CT (corresponding author), Univ Adelaide, Sch Med, Robinson Res Inst, Adelaide, SA, Australia.	claire.roberts@adelaide.edu.au	Tucker, Graeme R/AAP-4228-2020	Roberts, Claire/0000-0002-9250-2192				Aibar L, 2012, J PERINAT MED, V40, P271, DOI 10.1515/jpm-2011-0137; Alzaim M, 2013, NUTR REV, V71, P158, DOI 10.1111/nure.12018; Asvold BO, 2014, HUM REPROD, V29, P1153, DOI 10.1093/humrep/deu068; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Brettell R, 2008, EUR J OBSTET GYN R B, V141, P123, DOI 10.1016/j.ejogrb.2008.07.030; Buckberry S, 2014, MOL HUM REPROD, V20, P810, DOI 10.1093/molehr/gau035; BYRNE J, 1987, AM J MED GENET, V26, P605, DOI 10.1002/ajmg.1320260315; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Colagiuri S, 2014, DIABETES RES CLIN PR, V103, P364, DOI 10.1016/j.diabres.2014.02.012; Cooperstock M, 1996, OBSTET GYNECOL, V88, P189, DOI 10.1016/0029-7844(96)00106-8; Di Renzo GC, 2007, GENDER MED, V4, P19, DOI 10.1016/S1550-8579(07)80004-0; Elsmen E, 2006, ACTA OBSTET GYN SCAN, V85, P1285, DOI 10.1080/00016340600578274; Eriksson JG, 2010, AM J HUM BIOL, V22, P330, DOI 10.1002/ajhb.20995; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Ghidini A, 2005, ACTA OBSTET GYN SCAN, V84, P547, DOI 10.1111/j.0001-6349.2005.00694.x; Ghidini A, 2005, BJOG-INT J OBSTET GY, V112, P140, DOI 10.1111/j.1471-0528.2004.00308.x; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; Illescas T, 2013, EUR J OBSTET GYN R B, V167, P14, DOI 10.1016/j.ejogrb.2012.10.023; Ingemarsson I, 2003, BJOG-INT J OBSTET GY, V110, P34, DOI 10.1016/S1470-0328(03)00022-3; Joseph K S, 2007, BMC Pregnancy Childbirth, V7, P4, DOI 10.1186/1471-2393-7-4; Khalil MM, 2013, LIBYAN J MED, V8, DOI 10.3402/ljm.v8i0.20008; Khong Y, 2011, BEST PRACT RES CL OB, V25, P301, DOI 10.1016/j.bpobgyn.2010.10.012; McLean A, 2001, VALIDATION 1994 S AU; Melamed N, 2010, J MATERN-FETAL NEO M, V23, P338, DOI 10.3109/14767050903300969; Muenchhoff M, 2014, J INFECT DIS, V209, pS120, DOI 10.1093/infdis/jiu232; Newbern D, 2011, CURR OPIN ENDOCRINOL, V18, P409, DOI 10.1097/MED.0b013e32834c800d; Redman CWG, 2010, AM J REPROD IMMUNOL, V63, P534, DOI 10.1111/j.1600-0897.2010.00831.x; Roberge S, 2011, J OBSTET GYNAECOL CA, V33, P216, DOI 10.1016/S1701-2163(16)34822-8; Roberts CT, 2010, PLACENTA, V31, pS47, DOI 10.1016/j.placenta.2010.01.001; Sheiner E, 2004, FETAL DIAGN THER, V19, P366, DOI 10.1159/000077967; Shiozaki A, 2011, J REPROD IMMUNOL, V89, P133, DOI 10.1016/j.jri.2010.12.011; Stark MJ, 2009, AM J PHYSIOL-REG I, V297, pR510, DOI 10.1152/ajpregu.00175.2009; Townsend EA, 2012, ENDOCR REV, V33, P1, DOI 10.1210/er.2010-0031; Tranquilli AL, 2012, PREGNANCY HYPERTENS, V2, P350, DOI [10.1016/j.preghy.2012.05.006, 10.1016/j.preghy.2012.04.146]; Vatten LJ, 2004, EARLY HUM DEV, V76, P47, DOI 10.1016/j.earlhumdev.2003.10.006; Walker MG, 2012, PLACENTA, V33, P568, DOI 10.1016/j.placenta.2012.03.011; Xiao L, 2014, DIABETIC MED, P1; YUDKIN PL, 1987, LANCET, V1, P1192; Zeitlin J, 2004, AM J OBSTET GYNECOL, V190, P1322, DOI 10.1016/j.ajog.2003.10.703; Zeitlin J, 2002, HUM REPROD, V17, P2762, DOI 10.1093/humrep/17.10.2762	40	46	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158807	10.1371/journal.pone.0158807	http://dx.doi.org/10.1371/journal.pone.0158807			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398996	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508100009
J	Jiang, D; Hao, GZ; Huang, LW; Zhang, D				Jiang, Dan; Hao, Guozhu; Huang, Liwen; Zhang, Dan			Use of Cusp Catastrophe for Risk Analysis of Navigational Environment: A Case Study of Three Gorges Reservoir Area	PLOS ONE			English	Article							SAFETY ASSESSMENT	A water traffic system is a huge, nonlinear, complex system, and its stability is affected by various factors. Water traffic accidents can be considered to be a kind of mutation of a water traffic system caused by the coupling of multiple navigational environment factors. In this study, the catastrophe theory, principal component analysis (PCA), and multivariate statistics are integrated to establish a situation recognition model for a navigational environment with the aim of performing a quantitative analysis of the situation of this environment via the extraction and classification of its key influencing factors; in this model, the natural environment and traffic environment are considered to be two control variables. The Three Gorges Reservoir area of the Yangtze River is considered as an example, and six critical factors, i.e., the visibility, wind, current velocity, route intersection, channel dimension, and traffic flow, are classified into two principal components: the natural environment and traffic environment. These two components are assumed to have the greatest influence on the navigation risk. Then, the cusp catastrophe model is employed to identify the safety situation of the regional navigational environment in the Three Gorges Reservoir area. The simulation results indicate that the situation of the navigational environment of this area is gradually worsening from downstream to upstream.	[Jiang, Dan; Hao, Guozhu; Huang, Liwen] Wuhan Univ Technol, Dept Nav, Wuhan, Hubei, Peoples R China; [Jiang, Dan; Hao, Guozhu; Huang, Liwen; Zhang, Dan] Key Lab Hubei Inland Shipping Technol, Wuhan, Hubei, Peoples R China; [Zhang, Dan] Chongqing Jiaotong Univ, Dept Nav, Chongqing, Peoples R China	Wuhan University of Technology; Chongqing Jiaotong University	Hao, GZ (corresponding author), Wuhan Univ Technol, Dept Nav, Wuhan, Hubei, Peoples R China.; Hao, GZ (corresponding author), Key Lab Hubei Inland Shipping Technol, Wuhan, Hubei, Peoples R China.	65518385@qq.com			National Natural Science Foundation of China [51379170]; Fundamental Research Funds for the Central Universities (Self-determined and innovative research funds of WUT); Fundamental Research Funds for the Central Universities [2014-JL-010]; Key Project in the National Science AMP; Technology Pillar Program [2015BAG20B05]; Fund of Hubei Inland Shipping Technology Key Laboratory [NHHY2014002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities (Self-determined and innovative research funds of WUT)(Fundamental Research Funds for the Central Universities); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Project in the National Science AMP; Technology Pillar Program; Fund of Hubei Inland Shipping Technology Key Laboratory	This work was financially supported by the National Natural Science Foundation of China (Grant No. 51379170) received by LWH, the Fundamental Research Funds for the Central Universities (Self-determined and innovative research funds of WUT), Fundamental Research Funds for the Central Universities (Grant No. 2014-JL-010) received by DJ, grants from the Key Project in the National Science & Technology Pillar Program (Grant No. 2015BAG20B05) received by LWH, and the Fund of Hubei Inland Shipping Technology Key Laboratory (No. NHHY2014002) received by DZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmat JF, 2009, OCEAN ENG, V36, P1278, DOI 10.1016/j.oceaneng.2009.07.003; [陈蜀喆 Chen Shuzhe], 2014, [中国航海, Journal of Navigation of China], V37, P36; Chen YH, 2015, MAR GEORESOUR GEOTEC, V33, P222, DOI 10.1080/1064119X.2013.836259; Girtler J, 2014, POL MARIT RES, V21, P9, DOI 10.2478/pomr-2014-0002; Hetherington C, 2006, J SAFETY RES, V37, P401, DOI 10.1016/j.jsr.2006.04.007; Kujala P, 2009, RELIAB ENG SYST SAFE, V94, P1349, DOI 10.1016/j.ress.2009.02.028; Liu Q, 2014, J WUHAN U TECHNOL TR, V38, P59; [刘文远 Liu Wenyuan], 2010, [中国安全科学学报, China Safety Science Journal], V20, P113; Lu CS, 2008, ACCIDENT ANAL PREV, V40, P594, DOI 10.1016/j.aap.2007.08.015; Mao CK, 2010, TOURISM MANAGE, V31, P855, DOI 10.1016/j.tourman.2009.09.003; Paulauskas V., 2006, TRANSPORT-VILNIUS, V21, P12, DOI [10.3846/16484142.2006.9638034, DOI 10.3846/16484142.2006.9638034]; Qu XB, 2012, TRANSPORT RES REC, P106, DOI 10.3141/2273-13; Wang JS, 2014, SAFETY SCI, V62, P46, DOI 10.1016/j.ssci.2013.08.002; [文元桥 Wen Yuanqiao], 2013, [中国安全科学学报, China Safety Science Journal（CSSJ）], V23, P32; Yang K., 2010, MIN SCI TECHNOL, V20, P71, DOI [10.1016/S1674-5264(09)60163-0, DOI 10.1016/S1674-5264(09)60163-0]; Yang K, 2015, J CHINA U MIN TECHNO, V15, P129; Yingluk Saerue, 2011, Information Technology Journal, V10, P585, DOI 10.3923/itj.2011.585.590; Zhang D, 2013, RELIAB ENG SYST SAFE, V118, P93, DOI 10.1016/j.ress.2013.04.006; Zhang YP, 2004, J HARBIN I TECHNOLOG, V1, P1; Zheng XP, 2010, SAFETY SCI, V48, P1236, DOI 10.1016/j.ssci.2010.07.003	20	6	7	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158482	10.1371/journal.pone.0158482	http://dx.doi.org/10.1371/journal.pone.0158482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391057	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400066
J	Ramkumar, G; Karthi, S; Muthusamy, R; Suganya, P; Natarajan, D; Kweka, EJ; Shivakumar, MS				Ramkumar, Govindaraju; Karthi, Sengodan; Muthusamy, Ranganathan; Suganya, Ponnusamy; Natarajan, Devarajan; Kweka, Eliningaya J.; Shivakumar, Muthugounder S.			Mosquitocidal Effect of Glycosmis pentaphylla Leaf Extracts against Three Mosquito Species (Diptera: Culicidae)	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; ANOPHELES-STEPHENSI; LARVICIDAL ACTIVITY; ESSENTIAL OILS; MALARIA; PLANT; REPELLENT; RUTACEAE; AEDES	Background The resistance status of malaria vectors to different classes of insecticides used for public health has raised concern for vector control programmes. Alternative compounds to supplement the existing tools are important to be searched to overcome the existing resistance and persistence of pesticides in vectors and the environment respectively. The mosquitocidal effects of Glycosmis pentaphylla using different solvents of acetone, methanol, chloroform and ethyl acetate extracts against three medically important mosquito vectors was conducted. Methods Glycosmis pentaphylla plant leaves were collected from Kolli Hills, India. The WHO test procedures for larval and adult bioassays were used to evaluate extracts against mosquito vectors, and the chemical composition of extracts identified using GC-MS analysis. Results The larvicidal and adulticidal activity of G. pentaphylla plant extracts clearly impacted the three species of major mosquitoes vectors. Acetone extracts had the highest larvicidal effect against An. stephensi, Cx. quinquefasciatus and Ae. aegypti with the LC50 and LC90 values of 0.0004, 138.54; 0.2669, 73.7413 and 0.0585, 303.746 mg/ml, respectively. The LC50 and LC90 adulticide values of G. pentaphylla leaf extracts in acetone, methanol, chloroform and ethyl acetate, solvents were as follows for Cx. quinquefasciatus, An. stephensi and Ae. Aegypti: 2.957, 5.458, 2.708, and 4.777, 3.449, 6.676 mg/ml respectively. The chemical composition of G. pentaphylla leaf extract has been found in 20 active compounds. Conclusions The plant leaf extracts of G. pentaphylla bioactive molecules which are effective and can be developed as an eco-friendly approach for larvicides and adulticidal mosquitoes vector control. Detailed identification and characterization of mosquitocidal effect of individual bioactive molecules ingredient may result into biodegradable effective tools for the control of mosquito vectors.	[Ramkumar, Govindaraju; Karthi, Sengodan; Muthusamy, Ranganathan; Suganya, Ponnusamy; Shivakumar, Muthugounder S.] Periyar Univ, Dept Biotechnol, Mol Entomol Lab, Salem 636011, Tamil Nadu, India; [Natarajan, Devarajan] Periyar Univ, Dept Biotechnol, Nat Drug Res Lab, Salem 636011, Tamil Nadu, India; [Kweka, Eliningaya J.] Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Mosquito Sect, POB 3024, Arusha, Tanzania; [Kweka, Eliningaya J.] Catholica Univ Hlth & Allied Sci, Dept Med Parasitol & Entomol, POB 1464, Mwanza, Tanzania	Periyar University; Periyar University	Kweka, EJ (corresponding author), Trop Pesticides Res Inst, Div Livestock & Human Dis Vector Control, Mosquito Sect, POB 3024, Arusha, Tanzania.; Kweka, EJ (corresponding author), Catholica Univ Hlth & Allied Sci, Dept Med Parasitol & Entomol, POB 1464, Mwanza, Tanzania.	pat.kweka@gmail.com	Karthi, Sengodan/D-5371-2015; Shivakumar, Muthugounder S./AAD-6241-2019; D., Natarajan/ABB-1036-2020; Govindaraju, Ramkumar/D-5331-2015; Muthusamy, Ranganathan/GOV-6650-2022	Shivakumar, Muthugounder S./0000-0002-1910-5510; Muthusamy, Ranganathan/0000-0002-2650-9791; Ramkumar, Govindaraju/0000-0001-7262-8428				Amer A, 2006, PARASITOL RES, V99, P466, DOI 10.1007/s00436-006-0182-3; Athikomkulchai S, 2006, CHEM PHARM BULL, V54, P262, DOI 10.1248/cpb.54.262; Bharati K, 2013, INDIAN J MED RES, V137, P36; Bowers William S., 1995, Insect Science and its Application, V16, P339; Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159; CDC, 2014, ED TRAINING; Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P465, DOI 10.1016/j.biortech.2007.11.060; CHOGO JB, 1981, J NAT PROD, V44, P308, DOI 10.1021/np50015a012; Chopra N, 1969, GLOSSARY INDIAN MED; Das A, 2012, ACTA TROP, V121, P267, DOI 10.1016/j.actatropica.2011.11.008; Das N. G., 2003, Journal of Vector Borne Diseases, V40, P49; FINNEY D J, 1971, P333; Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P874, DOI 10.1016/S1995-7645(10)60210-6; Khanna VG, 2011, PARASITOL RES, V109, P1373, DOI 10.1007/s00436-011-2384-6; Kilonzo B. S., 2001, Insect Science and its Application, V21, P89; Komalamisra Narumon, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1412; Kumar DS, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-14; Lee SE, AGR CHEM BIOTECHNOL, V44, P105; Liu SQ, 2000, SURVEY PESTICIDAL CO, P1098; Manjari MS, 2014, PARASITOL RES, V113, P2475, DOI 10.1007/s00436-014-3896-7; Mdoe F. P., 2014, Parasites and Vectors, V7; Murugan K, 2012, PARASITOL RES, V111, P1757, DOI 10.1007/s00436-012-3021-8; Nathan SS, 2005, ACTA TROP, V96, P47, DOI 10.1016/j.actatropica.2005.07.002; Okumu FO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-63; Quader MA, 1999, FITOTERAPIA, V70, P305, DOI 10.1016/S0367-326X(99)00028-3; Rajkumar S., 2005, African Journal of Biomedical Research, V8, P31; Sarwar M, 2009, PAK J BOT, V41, P3047; Seyoum A, 2003, TROP MED INT HEALTH, V8, P1005, DOI 10.1046/j.1360-2276.2003.01125.x; Sharma SK, 2012, INDIAN J MED RES, V135, P382; Suganya G, 2014, PARASITOL RES, V113, P875, DOI [10.1007/s00436-013-3718-3, 10.1007/s00436-014-3811-2]; Uddin S.N., 2006, TRADITIONAL USES ETH; WHO, 2005, GUID LAB FIELD TEST; WHO (World Health Organization), 1981, INSTR DET SUSC RES A	33	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158088	10.1371/journal.pone.0158088	http://dx.doi.org/10.1371/journal.pone.0158088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391146	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400028
J	Want, A; Gillespie, SR; Wang, Z; Gordon, R; Iomini, C; Ritch, R; Wolosin, JM; Bernstein, AM				Want, Andrew; Gillespie, Stephanie R.; Wang, Zheng; Gordon, Ronald; Iomini, Carlo; Ritch, Robert; Wolosin, J. Mario; Bernstein, Audrey M.			Autophagy and Mitochondrial Dysfunction in Tenon Fibroblasts from Exfoliation Glaucoma Patients	PLOS ONE			English	Article							PIGMENTED EPITHELIAL-CELLS; PSEUDOEXFOLIATION SYNDROME; ALZHEIMERS-DISEASE; SYSTEMIC DISORDER; PROTEIN; LC3; MICROTUBULES; TRAFFICKING; EXPRESSION; MATURATION	Purpose To test the hypothesis that autophagy dysfunction is involved in exfoliation syndrome (XFS), a systemic disorder of extracellular elastic matrices that causes a distinct form of human glaucoma. Methods Fibroblasts derived from tenon tissue discards (TFs) from filtration surgery to relieve intraocular pressure in XFS patients were compared against age-matched TFs derived from surgery in primary open-angle glaucoma (POAG) patients or from strabismus surgery. Differential interference contrast light, and electron microscopy were used to examine structural cell features. Immunocytochemistry was used to visualize LOXL1 and Fibulin-5, lysosomes, endosomes, Golgi, and microtubules. Light scatter, Cyto-ID (TM) and JC1 flow cytometry were used to measure relative cell size, autophagic flux rate and mitochondrial membrane potential (MMPT), respectively. Enhanced autophagy was induced by serum withdrawal. Results In culture, XFS-TFs were 1.38-fold larger (by light scatter ratio, p = 0.05), proliferated 42% slower (p = 0.026), and were morphologically distinct in 2D and 3D culture compared to their POAG counterparts. In extended 3D cultures, XFS-TFs accumulated 8-10 times more Fibulin-5 than the POAG-TFs, and upon serum withdrawal, there were marked deficiencies in relocation of endosomes and lysosomes to the perinuclear area. Correspondingly, the XFS-TFs displayed significant accumulation of the autophagasome marker LC3 II (3.9 fold increase compared to POAG levels, p = 0.0001) and autophagic flux rate as measured by Cyto-ID dye was 53% lower in XFS-TFs than in POAG-TFs (p = 0.01), indicating reduced clearance of autophagasomes. Finally the percent of cells with diminished MMPT was 3-8 times larger in the XFS-TFs than in POAG-TFs (p = 0.02). Conclusions Our results provide for the first time a link between XFS pathology to autophagy dysfunction, a major contributor to multiple age related diseases systemically throughout the body, in the brain and in the retina. A diminished capacity for degradation of denatured protein and aging cellular organelles may underpin the development of extracellular protein aggregates in XFS.	[Want, Andrew; Gillespie, Stephanie R.; Wang, Zheng; Iomini, Carlo; Wolosin, J. Mario; Bernstein, Audrey M.] Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA; [Gordon, Ronald] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY 10029 USA; [Gillespie, Stephanie R.; Bernstein, Audrey M.] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Ritch, Robert] New York Eye & Ear Infirm Mt Sinai, Einhorn Clin Res Ctr, New York, NY 10003 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York Eye & Ear Infirmary of Mount Sinai	Wolosin, JM; Bernstein, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Ophthalmol, New York, NY 10029 USA.; Bernstein, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	jmario.wolosin@mssm.edu; audrey.bernstein@mssm.edu		Bernstein, Audrey/0000-0002-2537-2594; wolosin, j. mario/0000-0002-6751-2794	Research to Prevent Blindness; MYS Family U.S. Charitable Foundation, Inc.; Bright Focus Foundation; Glaucoma Foundation; NIH-NEI [R01 EY024942, R01 EY018748, EY022639]; NIH [T32 GM062754]; NATIONAL EYE INSTITUTE [R01EY024942, R01EY014878, R01EY022639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM062754] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021838] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); MYS Family U.S. Charitable Foundation, Inc.; Bright Focus Foundation(BrightFocus Foundation); Glaucoma Foundation; NIH-NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by The Research to Prevent Blindness (AMB, JMW, and CI), The MYS Family U.S. Charitable Foundation, Inc., The Bright Focus Foundation, and The Glaucoma Foundation (AMB and JMW), NIH-NEI R01 EY024942 (AMB), NIH-NEI R01 EY018748 (JMW), NIH training grant T32 GM062754 (SRG), NIH-NEI EY022639 (CI). Microscopy and image analysis was performed at the Microscopy CORE. The authors would like to thank Leica and Mount Sinai's Microscopy CORE for providing access to the Leica TCS SP8 STED3X. The authors gratefully acknowledge the contribution of the surgeons who supplied surgical specimens: Dr. Celso Tello, (Manhattan Eye and Ear and Throat Hospital); Dr. Sung Chul Park (Manhattan Eye and Ear and Throat Hospital); Dr. Jeffrey Liebmann (Columbia University Medical Center); Dr. Brian Campollataro (New York Eye and Ear Infirmary of Mount Sinai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bojic L, 2005, GRAEF ARCH CLIN EXP, V243, P446, DOI 10.1007/s00417-004-1074-9; Bourdenx M, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00083; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; Cortes CJ, 2014, DRUG DISCOV TODAY, V19, P963, DOI 10.1016/j.drudis.2014.02.014; Cuervo AM, 2008, TRENDS GENET, V24, P604, DOI 10.1016/j.tig.2008.10.002; Divi RL, 2007, ENVIRON MOL MUTAGEN, V48, P179, DOI 10.1002/em.20245; Dutta D, 2015, METHOD CELL BIOL, V130, P127, DOI 10.1016/bs.mcb.2015.04.004; Elhawy E, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-22; Esteves AR, 2014, BBA-MOL BASIS DIS, V1842, P7, DOI 10.1016/j.bbadis.2013.10.003; Friedman LG, 2015, NEUROTHERAPEUTICS, V12, P94, DOI 10.1007/s13311-014-0320-z; Funk K. E., 2012, INT J ALZHEIMERS DIS, V2012, DOI DOI 10.1155/2012/752894; Furuta K, 1999, ARCH BIOCHEM BIOPHYS, V365, P75, DOI 10.1006/abbi.1999.1147; Guha S, 2014, ADV EXP MED BIOL, V801, P105, DOI 10.1007/978-1-4614-3209-8_14; Guha S, 2012, J NEUROCHEM, V122, P823, DOI 10.1111/j.1471-4159.2012.07804.x; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Haynes MK, 2009, J BIOMOL SCREEN, V14, P596, DOI 10.1177/1087057109335671; Huang B, 2009, ANNU REV BIOCHEM, V78, P993, DOI 10.1146/annurev.biochem.77.061906.092014; Kaarniranta Kai, 2010, Front Biosci (Elite Ed), V2, P1374; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kiselyov K, 2007, AUTOPHAGY, V3, P259, DOI 10.4161/auto.3906; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; KREIS TE, 1990, CELL MOTIL CYTOSKEL, V15, P67, DOI 10.1002/cm.970150202; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lopez-Lluch G, 2015, BIOGERONTOLOGY, V16, P599, DOI 10.1007/s10522-015-9585-9; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; Miglior S, 2015, PROG BRAIN RES, V221, P233, DOI 10.1016/bs.pbr.2015.06.007; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Mortensen M, 2010, P NATL ACAD SCI USA, V107, P832, DOI 10.1073/pnas.0913170107; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; O'Donovan TR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134676; Ovodenko B, 2007, INVEST OPHTH VIS SCI, V48, P1447, DOI 10.1167/iovs.06-0411; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; Ritch R, 2001, SURV OPHTHALMOL, V45, P265, DOI 10.1016/S0039-6257(00)00196-X; Ritch Robert, 2014, J Glaucoma, V23, pS1, DOI 10.1097/IJG.0000000000000119; Ritch R, 2001, CURR OPIN OPHTHALMOL, V12, P124, DOI 10.1097/00055735-200104000-00008; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Schlotzer-Schrehardt U, 2001, EXP EYE RES, V73, P765, DOI 10.1006/exer.2001.1084; SCHLOTZERSCHREHARDT U, 1994, AM J OPHTHALMOL, V118, P730, DOI 10.1016/S0002-9394(14)72552-8; SCHLOTZERSCHREHARDT UM, 1992, ARCH OPHTHALMOL-CHIC, V110, P1752, DOI 10.1001/archopht.1992.01080240092038; STREETEN BW, 1992, ARCH OPHTHALMOL-CHIC, V110, P1757, DOI 10.1001/archopht.1992.01080240097039; Sydor AM, 2015, TRENDS CELL BIOL, V25, P730, DOI 10.1016/j.tcb.2015.10.004; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tillement JP, 2014, CNS NEUROL DISORD-DR, V13, P593, DOI 10.2174/18715273113126660197; Trantow CM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001008; Trantow CM, 2009, INVEST OPHTH VIS SCI, V50, P1205, DOI 10.1167/iovs.08-2791; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang X, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-31; Whigham BT, 2011, SAUDI J OPHTHALMOL, V25, P347, DOI 10.1016/j.sjopt.2011.07.001; Wohlgemuth SE, 2014, J MOL CELL CARDIOL, V71, P62, DOI 10.1016/j.yjmcc.2014.03.007; Xu W, 2016, J CLIN INVEST, V126, P1815, DOI 10.1172/JCI82409; Zhou Y, 2013, J BIOMED RES, V27, P23, DOI 10.7555/JBR.27.20110142	54	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157404	10.1371/journal.pone.0157404	http://dx.doi.org/10.1371/journal.pone.0157404			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391778	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400008
J	Nagamine, K; Ishikawa, Y; Hoshizaki, S				Nagamine, Keisuke; Ishikawa, Yukio; Hoshizaki, Sugihiko			Insights into How Longicorn Beetle Larvae Determine the Timing of Metamorphosis: Starvation-Induced Mechanism Revisited	PLOS ONE			English	Article							PSACOTHEA-HILARIS PASCOE; MANDUCA-SEXTA L; TOBACCO HORNWORM; PREMATURE METAMORPHOSIS; COLEOPTERA; SIZE; DIAPAUSE; CERAMBYCIDAE; BEHAVIOR; HORMONE	Larvae of holometabolous insects must determine the timing of their metamorphosis. How they determine this timing has only been studied in detail for a few insect species. In a few species of Coleoptera, starvation is known to be a cue for metamorphosis, leading to the formation of smaller adults (starvation-induced pupation, SiP). We investigated the occurrence of SiP in the beetle Psacothea hilaris. When P. hilaris larvae were starved late in the feeding phase of the last (5th) instar, they exhibited typical SiP characterized by constancy of the time from food deprivation to pupation (TTP) irrespective of the body weight upon food deprivation or the length of prior feeding. In contrast, when larvae were starved early in the feeding phase, TTP decreased by roughly 1 day as the feeding became 1 day longer. The change in the response to starvation was estimated to occur on day 5.9 in the last instar. A series of refeeding experiments suggested that whereas SiP occurred readily in the larvae starved in the late feeding phase, activation of SiP was suspended until day 5.9 in the larvae starved early in the feeding phase. When P. hilaris larvae were fed continuously, they eventually ceased feeding spontaneously and pupated. The time length between spontaneous cessation of feeding and pupation was approximately equal to the TTP in SiP. This suggests that the same mechanism was activated by food deprivation in the late feeding phase and by spontaneous cessation of ad libitum feeding.	[Nagamine, Keisuke; Ishikawa, Yukio; Hoshizaki, Sugihiko] Univ Tokyo, Grad Sch Agr & Life Sci, Appl Entomol Lab, Dept Agr & Environm Biol, Tokyo, Japan	University of Tokyo	Nagamine, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Appl Entomol Lab, Dept Agr & Environm Biol, Tokyo, Japan.	ef10140@yahoo.co.jp	Ishikawa, Yukio/J-5676-2019	Ishikawa, Yukio/0000-0003-3067-2513				[Anonymous], 2014, R LANG ENV STAT COMP; Bocak L, 2014, SYST ENTOMOL, V39, P97, DOI 10.1111/syen.12037; DOMINICK OS, 1985, J EXP BIOL, V117, P45; Estes AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079061; Fox J, 2005, J BEHAV EDUC, V14, P1, DOI 10.1007/s10864-005-0957-0; FUJISHITA M, 1982, J INSECT PHYSIOL, V28, P961, DOI 10.1016/0022-1910(82)90113-5; Fukaya M, 2004, APPL ENTOMOL ZOOL, V39, P603, DOI 10.1303/aez.2004.603; Hatem NE, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0155-z; JONES D, 1981, J INSECT PHYSIOL, V27, P779, DOI 10.1016/0022-1910(81)90068-8; Jucker C., 2006, Bollettino di Zoologia Agraria e di Bachicoltura, V38, P187; Kemirembe K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044429; Koyama T, 2014, ELIFE, V3, DOI 10.7554/eLife.03091; Kusama T, 1984, LONGICORN BEETLES JA, P262; Lupi D., 2013, Bulletin OEPP, V43, P316, DOI 10.1111/epp.12045; Muggeo V.M., 2008, R NEWS, V8, P20; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Munyiri FN, 2005, GEN COMP ENDOCR, V144, P150, DOI 10.1016/j.ygcen.2005.05.006; Munyiri FN, 2004, J INSECT PHYSIOL, V50, P1075, DOI 10.1016/j.jinsphys.2004.09.009; Munyiri FN, 2003, APPL ENTOMOL ZOOL, V38, P509, DOI 10.1303/aez.2003.509; Nagamine K, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-539; Nijhout H.F., 1998, INSECT HORMONES, P280; Nijhout HF, 2008, DEV CELL, V15, P491, DOI 10.1016/j.devcel.2008.09.014; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; NIJHOUT HF, 1974, J EXP BIOL, V61, P481; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; ROUNTREE DB, 1986, J EXP BIOL, V120, P41; Sato T, 2001, APPL ENTOMOL ZOOL, V36, P189, DOI 10.1303/aez.2001.189; Sehnal F., 1985, P1; Shafiei M, 2001, PHYSIOL ENTOMOL, V26, P173, DOI 10.1046/j.1365-3032.2001.00231.x; Shintani Y, 1997, APPL ENTOMOL ZOOL, V32, P347, DOI 10.1303/aez.32.347; Shintani Y, 2003, J INSECT PHYSIOL, V49, P975, DOI 10.1016/S0022-1910(03)00167-7; Shintani Y, 1996, APPL ENTOMOL ZOOL, V31, P489; Shintani Y, 1998, ENTOMOL EXP APPL, V86, P41, DOI 10.1023/A:1003114926558; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556; Suzuki Y, 2013, P NATL ACAD SCI USA, V110, P12518, DOI 10.1073/pnas.1311405110; Terao M, 2015, ENTOMOL SCI, V18, P85, DOI 10.1111/ens.12084; TRUMAN JW, 1974, J EXP BIOL, V60, P371; Walsh AL, 2011, J INSECT PHYSIOL, V57, P809, DOI 10.1016/j.jinsphys.2011.03.009	38	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158831	10.1371/journal.pone.0158831	http://dx.doi.org/10.1371/journal.pone.0158831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27386861	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500053
J	Pincet, F; Adrien, V; Yang, R; Delacotte, J; Rothman, JE; Urbach, W; Tareste, D				Pincet, Frederic; Adrien, Vladimir; Yang, Rong; Delacotte, Jerome; Rothman, James E.; Urbach, Wladimir; Tareste, David			FRAP to Characterize Molecular Diffusion and Interaction in Various Membrane Environments	PLOS ONE			English	Article							SYNAPTIC VESICLE DOCKING; FLUORESCENCE RECOVERY; LIPID-BILAYERS; LATERAL MOBILITY; MODEL MEMBRANES; PROTEINS; DYNAMICS; DOMAINS; COMPLEX; FUSION	Fluorescence recovery after photobleaching (FRAP) is a standard method used to study the dynamics of lipids and proteins in artificial and cellular membrane systems. The advent of confocal microscopy two decades ago has made quantitative FRAP easily available to most laboratories. Usually, a single bleaching pattern/area is used and the corresponding recovery time is assumed to directly provide a diffusion coefficient, although this is only true in the case of unrestricted Brownian motion. Here, we propose some general guidelines to perform FRAP experiments under a confocal microscope with different bleaching patterns and area, allowing the experimentalist to establish whether the molecules undergo Brownian motion (free diffusion) or whether they have restricted or directed movements. Using in silico simulations of FRAP measurements, we further indicate the data acquisition criteria that have to be verified in order to obtain accurate values for the diffusion coefficient and to be able to distinguish between different diffusive species. Using this approach, we compare the behavior of lipids in three different membrane platforms (supported lipid bilayers, giant liposomes and sponge phases), and we demonstrate that FRAP measurements are consistent with results obtained using other techniques such as Fluorescence Correlation Spectroscopy (FCS) or Single Particle Tracking (SPT). Finally, we apply this method to show that the presence of the synaptic protein Munc 18-1 inhibits the interaction between the synaptic vesicle SNARE protein, VAMP2, and its partner from the plasma membrane, Syn1A.	[Pincet, Frederic; Adrien, Vladimir; Delacotte, Jerome; Urbach, Wladimir] Sorbonne Univ, Univ Paris 06, Ecole Normale Super, Lab Phys Stat,CNRS,UMR 8550, Paris, France; [Pincet, Frederic; Rothman, James E.] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Adrien, Vladimir] Univ Paris 05, Sorbonne Paris Cite, Lab Cristallog & RMN Biol, CNRS,UMR 8015, Paris, France; [Yang, Rong] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Urbach, Wladimir] Univ Paris 05, Sorbonne Paris Cite, UFR Biomed, Paris, France; [Tareste, David] Univ Paris Diderot, Sorbonne Paris Cite, Membrane Traff Hlth & Dis, INSERM,ERL U950, Paris, France; [Tareste, David] Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; Yale University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Columbia University; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite	Pincet, F (corresponding author), Sorbonne Univ, Univ Paris 06, Ecole Normale Super, Lab Phys Stat,CNRS,UMR 8550, Paris, France.; Pincet, F (corresponding author), Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.; Tareste, D (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Membrane Traff Hlth & Dis, INSERM,ERL U950, Paris, France.; Tareste, D (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Inst Jacques Monod, CNRS,UMR 7592, Paris, France.	pincet@lps.ens.fr; david.tareste@inserm.fr	Urbach, Wladimir/AAG-9004-2019; Adrien, Vladimir/HHM-9186-2022; Tareste, David/L-2639-2017; Delacotte, Jérôme/Q-2788-2018; URBACH, Wladimir/AAA-5969-2022; Tareste, David/P-9249-2019	Urbach, Wladimir/0000-0002-1673-6923; Tareste, David/0000-0002-8744-7598; Delacotte, Jérôme/0000-0001-9681-1200; URBACH, Wladimir/0000-0002-1673-6923; Tareste, David/0000-0002-8744-7598; PINCET, FREDERIC/0000-0002-4243-2157	ANR@RATION SynBioExo; ANR Blanc [ANR-12-BSV5-0002, ANR-12-BSV8-0010-ASSEMBLY]; ANR Jeunes Chercheurs [ANR-09-JCJC-0062-01]; AFM Trampoline [16799]; PhD Program "Frontieres du Vivant (FdV) - Cursus Bettencourt"; James Rothman's lab.	ANR@RATION SynBioExo(French National Research Agency (ANR)); ANR Blanc(French National Research Agency (ANR)); ANR Jeunes Chercheurs(French National Research Agency (ANR)); AFM Trampoline; PhD Program "Frontieres du Vivant (FdV) - Cursus Bettencourt"; James Rothman's lab.	This work was supported by the ANR@RATION SynBioExo to J.E.R.; by the ANR Blanc ANR-12-BSV5-0002 to F.P.; by the ANR Blanc ANR-12-BSV8-0010-ASSEMBLY to W.U.; by the ANR Jeunes Chercheurs ANR-09-JCJC-0062-01 and the AFM Trampoline 16799 to D.T.; V.A. is supported by funds from the PhD Program "Frontieres du Vivant (FdV) - Cursus Bettencourt". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rong Yang worked in James Rothman's lab at Columbia University as a post-doctoral research scientist from January 2005 to October 2006. Any research work performed by this author during this period was funded by James Rothman's lab. None of the work related to this manuscript was funded by Rong Yang's current employer, Adimab, LLC. This current employer did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DM, 1990, J PHYS CHEM-US, V94, P8683, DOI 10.1021/j100387a012; ANGELOVA MI, 1992, PROG COLL POL SCI S, V89, P127; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bacia K, 2004, J BIOL CHEM, V279, P37951, DOI 10.1074/jbc.M407020200; Blumenthal D, 2015, SCI REP-UK, V5, DOI 10.1038/srep11655; Bockmann RA, 2003, BIOPHYS J, V85, P1647, DOI 10.1016/S0006-3495(03)74594-9; Braeckmans K, 2003, BIOPHYS J, V85, P2240, DOI 10.1016/S0006-3495(03)74649-9; Braga J, 2004, MOL BIOL CELL, V15, P4749, DOI 10.1091/mbc.E04-06-0496; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Chan YHM, 2007, CURR OPIN CHEM BIOL, V11, P581, DOI 10.1016/j.cbpa.2007.09.020; DAVOUST J, 1982, EMBO J, V1, P1233, DOI 10.1002/j.1460-2075.1982.tb00018.x; Domanov YA, 2011, P NATL ACAD SCI USA, V108, P12605, DOI 10.1073/pnas.1102646108; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Gambin Y, 2010, J PHYS CHEM B, V114, P3559, DOI 10.1021/jp911354y; GORDON GW, 1995, BIOPHYS J, V68, P766, DOI 10.1016/S0006-3495(95)80251-1; Guo L, 2008, CHEMPHYSCHEM, V9, P721, DOI 10.1002/cphc.200700611; Ji H, 2010, BIOPHYS J, V99, P553, DOI 10.1016/j.bpj.2010.04.060; Jonsson P, 2008, BIOPHYS J, V95, P5334, DOI 10.1529/biophysj.108.134874; Kang M, 2015, PLOS ONE, DOI [10.1371/journal.pone.0127966, DOI 10.1371/JOURNAL.PONE.0127966PMID]; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Liang BY, 2014, BIOCHEMISTRY-US, V53, P1485, DOI 10.1021/bi401638u; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; Loren N, 2015, Q REV BIOPHYS, V48, P323, DOI 10.1017/S0033583515000013; Maldonado A, 1996, PHYS REV E, V54, P1774, DOI 10.1103/PhysRevE.54.1774; MARRA J, 1985, J COLLOID INTERF SCI, V107, P446, DOI 10.1016/0021-9797(85)90197-3; MERKEL R, 1989, J PHYS-PARIS, V50, P1535, DOI 10.1051/jphys:0198900500120153500; Merzlyakov M, 2006, LANGMUIR, V22, P10145, DOI 10.1021/la061976d; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Ostuni MA, 2014, BIOL OPEN, V3, P1173, DOI 10.1242/bio.20149845; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rayan G, 2014, BIOPHYS J, V107, P1129, DOI 10.1016/j.bpj.2014.07.016; Rayan G, 2010, SENSORS-BASEL, V10, P5927, DOI 10.3390/s100605927; Reffay M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005035; Richmond DL, 2011, P NATL ACAD SCI USA, V108, P9431, DOI 10.1073/pnas.1016410108; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Salome L, 1998, EUR BIOPHYS J BIOPHY, V27, P391, DOI 10.1007/s002490050146; Samsonov AV, 2001, BIOPHYS J, V81, P1486, DOI 10.1016/S0006-3495(01)75803-1; Seiffert S, 2005, J MICROSC-OXFORD, V220, P20, DOI 10.1111/j.1365-2818.2005.01512.x; Sezgin E, 2012, MOL MEMBR BIOL, V29, P144, DOI 10.3109/09687688.2012.700490; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOUMPASIS DM, 1983, BIOPHYS J, V41, P95, DOI 10.1016/S0006-3495(83)84410-5; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Staras K, 2013, J NEUROCHEM, V126, P213, DOI 10.1111/jnc.12240; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; Taulier N, 2000, BIOPHYS J, V78, P857, DOI 10.1016/S0006-3495(00)76643-4; Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2; Wawrezinieck L, 2005, BIOPHYS J, V89, P4029, DOI 10.1529/biophysj.105.067959; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042854; YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7; Zilly FE, 2006, PLOS BIOL, V4, P1789, DOI 10.1371/journal.pbio.0040330	55	55	54	3	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158457	10.1371/journal.pone.0158457	http://dx.doi.org/10.1371/journal.pone.0158457			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387979	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500020
J	Roberts, A; Austin, W; Evans, K; Bird, C; Schweizer, M; Darling, K				Roberts, Angela; Austin, William; Evans, Katharine; Bird, Clare; Schweizer, Magali; Darling, Kate			A New Integrated Approach to Taxonomy: The Fusion of Molecular and Morphological Systematics with Type Material in Benthic Foraminifera	PLOS ONE			English	Article							RIBOSOMAL DNA; GLOBAL DISTRIBUTION; SEQUENCES; DISTRIBUTIONS; PHYLOGENY; DIVERSITY; AMMONIA; REGION; MARSH	A robust and consistent taxonomy underpins the use of fossil material in palaeoenvironmental research and long-term assessment of biodiversity. This study presents a new integrated taxonomic protocol for benthic foraminifera by unequivocally reconciling the traditional taxonomic name to a specific genetic type. To implement this protocol, a fragment of the small subunit ribosomal RNA (SSU rRNA) gene is used in combination with 16 quantitative morphometric variables to fully characterise the benthic foraminiferal species concept of Elphidium williamsoni Haynes, 1973. A combination of live contemporary topotypic specimens, original type specimens and specimens of genetic outliers were utilised in this study. Through a series of multivariate statistical tests we illustrate that genetically characterised topotype specimens are morphologically congruent with both the holotype and paratype specimens of E. williamsoni Haynes, 1973. We present the first clear link between morphologically characterised type material and the unique SSU rRNA genetic type of E. williamsoni. This example provides a standard framework for the benthic foraminifera which bridges the current discontinuity between molecular and morphological lines of evidence, allowing integration with the traditional Linnaean roots of nomenclature to offer a new prospect for taxonomic stability.	[Roberts, Angela; Austin, William; Darling, Kate] Univ St Andrews, Sch Geog & Geosci, St Andrews KY16 9AL, Fife, Scotland; [Austin, William] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Evans, Katharine; Bird, Clare; Schweizer, Magali; Darling, Kate] Univ Edinburgh, Sch Geosci, W Mains Rd, Edinburgh EH9 3JW, Midlothian, Scotland; [Schweizer, Magali] Univ Angers, LPG BIAF Recent & Fossil Bioindicators, UMR CNRS 6112, 2 Bd Lavoisier, F-49045 Angers, France	University of St Andrews; UHI Millennium Institute; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); Universite d'Angers	Roberts, A (corresponding author), Univ St Andrews, Sch Geog & Geosci, St Andrews KY16 9AL, Fife, Scotland.	adr37@st-andrews.ac.uk	Evans, Katharine/L-1709-2013; Schweizer, Magali/F-9358-2014	Evans, Katharine/0000-0002-9819-1049; Schweizer, Magali/0000-0001-5115-1616; Bird, Clare/0000-0002-7500-5573	NERC [NE4/G018502/1, NE/G020310/1]; Carnegie Trust for the Universities of Scotland; Estuarine Coastal and Shelf Science Association; Swiss National Science Foundation (SNSF) [PA00P2_126226, PA00P2_142065]; Natural Environment Research Council [dml011000, 1147226, NE/G020310/1, NE/G018502/1] Funding Source: researchfish; NERC [dml011000, NE/G018502/1] Funding Source: UKRI	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Carnegie Trust for the Universities of Scotland; Estuarine Coastal and Shelf Science Association; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by NERC grant NE4/G018502/1 and NE/G020310/1 (Website: http://www.nerc.ac.uk). The authors also thank the following for their support: the Carnegie Trust for the Universities of Scotland (Website: http://www.carnegie-trust.org) and the Estuarine Coastal and Shelf Science Association (Website: http://www.ecsa-news.org). M.S. was also supported by the Swiss National Science Foundation (SNSF), fellowships for advanced researchers PA00P2_126226 and PA00P2_142065 (Website: http://www.snf.ch/en/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS T. D., 1965, CONTRIB CUSHMAN FOUND FORAMINIFERAL RES, V16, P55; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Brodniewicz I, 1965, RECENT SOME HOLOCENE; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; BUZAS MA, 1985, J PALEONTOL, V59, P1075; BUZAS MARTIN A., 1966, J PALEONTOL, V40, P585; Camacho SG, 2015, PALAEONTOL ELECTRON, V18, P1; Cushman JA, 1930, NONIONIDAE CAMERINID; Cushman JA, 1939, MONOGRAPH FORAMINIFE; Cushman JA, 1949, RECENT BELGIAN FORAM; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, MAR MICROPALEO UNPUB; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Ebach MC, 2011, ZOOTAXA, P67, DOI 10.11646/zootaxa.2742.1.5; Ertan KT, 2004, MAR MICROPALEONTOL, V53, P367, DOI 10.1016/j.marmicro.2004.08.001; Feyling-Hanssen RW, 1964, FORAMINIFERA LATE QU; Forey PL, 2004, PHILOS T R SOC B, V359, P639, DOI 10.1098/rstb.2003.1453; Garcia-Vallve S., DENDROUPGMA DENDROGR; Geoffrey Bowker, 1999, SORTING THINGS OUT C; Gooday AJ, 2012, ANNU REV MAR SCI, V4, P237, DOI 10.1146/annurev-marine-120709-142737; Grimm GW, 2009, USING MULTIPLE ANAL; GROSS O, 2001, PATRIMOINES NATURELS, V50, P60; Haake F-W, 1962, UNTERSUCHUNGEN FORAM; Habura A, 2008, LIMNOL OCEANOGR, V53, P1339, DOI 10.4319/lo.2008.53.4.1339; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haynes J.R., 1969, GEOL J, V6, P217, DOI DOI 10.1002/GJ.3350060207; Haynes J.R., 1973, CARDIGAN BAY RECENT; Hayward B. W, 1997, RECENT ELPHIDIIDAE F; Hayward BW, 2004, MAR MICROPALEONTOL, V50, P237, DOI 10.1016/S0377-8398(03)00074-4; Hayward BW, WORLD MODERN FORAMIN; Henderson A. S., 2002, PALAEONTOL ELECTRON, V4, P34; Hesemann, FORAMINIFERA GALLERY; Holzmann M, 2000, MICROPALEONTOLOGY, V46, P21; Holzmann Maria, 1998, Revue de Micropaleontologie, V41, P59, DOI 10.1016/S0035-1598(98)90098-8; Horton BP, 2007, MAR MICROPALEONTOL, V63, P169, DOI 10.1016/j.marmicro.2006.11.006; Horton BP, 2005, HOLOCENE, V15, P216, DOI 10.1191/0959683605hl787rp; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL, V4th; Jacob E, 1798, ADAMS ESSAYS MICROSC, P1; Kemp AC, 2011, J FORAMIN RES, V41, P114, DOI 10.2113/gsjfr.41.2.114; Langer MR, 2001, J MICROPALAEONTOL, V20, P183, DOI 10.1144/jm.20.2.183; Lejzerowicz F, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0283; Levy A., 1969, Revue Micropaleont., V12, P92; Lutze G. F., 1965, Meyniana, V15, P75; MILLER AAL, 1982, J FORAMIN RES, V12, P116, DOI 10.2113/gsjfr.12.2.116; Murray JW, 2007, MAR MICROPALEONTOL, V64, P163, DOI 10.1016/j.marmicro.2007.04.002; Murray JW, 2006, ECOLOGY AND APPLICATIONS OF BENTHIC FORAMINIFERA, P1, DOI 10.1017/CBO9780511535529; MURRAY JW, 1965, J MAR BIOL ASSOC UK, V45, P481, DOI 10.1017/S0025315400054965; National Center for Biotechnology Information, 2015, GENBANK OV; Pawlowski J, 2010, FORAMBARCODING MOL D; Pawlowski J, 2014, J FORAMIN RES, V44, P62, DOI 10.2113/gsjfr.44.1.62; Pillet L, 2013, MAR MICROPALEONTOL, V103, P1, DOI 10.1016/j.marmicro.2013.07.001; Pillet L, 2011, PROTIST, V162, P394, DOI 10.1016/j.protis.2010.10.001; Portner H.-O., 2022, CLIMATE CHANGE 2022; Roberts A, 2016, RECONCILING MOL MORP; Schweizer M, 2005, MAR MICROPALEONTOL, V57, P51, DOI 10.1016/j.marmicro.2005.07.001; Schweizer M, 2012, J FORAMIN RES, V42, P340, DOI 10.2113/gsjfr.42.4.340; Schweizer M, 2011, CR PALEVOL, V10, P95, DOI 10.1016/j.crpv.2011.01.003; Schweizer M, 2009, J FORAMIN RES, V39, P300, DOI 10.2113/gsjfr.39.4.300; Scott GH, 2011, MAR MICROPALEONTOL, V78, P96, DOI 10.1016/j.marmicro.2010.11.001; Sejrup HP, 2004, MAR MICROPALEONTOL, V53, P197, DOI 10.1016/j.marmicro.2004.05.009; TODD RUTH, 1961, CONTR CUSHMAN FOUND FORAMINIFERAL RES, V12, P5; Tsuchiya M, 2000, MICROPALEONTOLOGY, V46, P13; Tsuchiya M, 2008, MAR MICROPALEONTOL, V69, P212, DOI 10.1016/j.marmicro.2008.07.008; Waterton C., 2013, BARCODING NATURE SHI; WILKINSON IP, 1979, J PALEONTOL, V53, P628; Williamson W.C, 1858, RECENT FORAMINIFERA	66	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158754	10.1371/journal.pone.0158754	http://dx.doi.org/10.1371/journal.pone.0158754			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388271	Green Published, Green Submitted, gold			2022-12-26	WOS:000379811500042
J	Jakubec, D; Laskowski, RA; Vondrasek, J				Jakubec, David; Laskowski, Roman A.; Vondrasek, Jiri			Sequence-Specific Recognition of DNA by Proteins: Binding Motifs Discovered Using a Novel Statistical/Computational Analysis	PLOS ONE			English	Article							MOLECULAR ELECTROSTATIC POTENTIALS; SIDE-CHAIN INTERACTIONS; AMINO ACID INTERACTIONS; TRANSCRIPTION FACTORS; STRUCTURAL-ANALYSIS; CRYSTAL-STRUCTURE; BASE-PAIRS; DIELECTRIC MEDIUM; NUCLEIC-ACIDS; FORCE-FIELD	Decades of intensive experimental studies of the recognition of DNA sequences by proteins have provided us with a view of a diverse and complicated world in which few to no features are shared between individual DNA-binding protein families. The originally conceived direct readout of DNA residue sequences by amino acid side chains offers very limited capacity for sequence recognition, while the effects of the dynamic properties of the interacting partners remain difficult to quantify and almost impossible to generalise. In this work we investigated the energetic characteristics of all DNA residue-amino acid side chain combinations in the conformations found at the interaction interface in a very large set of protein-DNA complexes by the means of empirical potential-based calculations. General specificity-defining criteria were derived and utilised to look beyond the binding motifs considered in previous studies. Linking energetic favourability to the observed geometrical preferences, our approach reveals several additional amino acid motifs which can distinguish between individual DNA bases. Our results remained valid in environments with various dielectric properties.	[Jakubec, David; Vondrasek, Jiri] Inst Organ Chem & Biochem, Prague 6, Czech Republic; [Jakubec, David] Charles Univ Prague, Fac Sci, Dept Phys & Macromol Chem, Prague 2, Czech Republic; [Laskowski, Roman A.] EMBL EBI, Wellcome Trust Genome Campus, Cambridge, England	Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Charles University Prague; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute	Vondrasek, J (corresponding author), Inst Organ Chem & Biochem, Prague 6, Czech Republic.	jiri.vondrasek@uochb.cas.cz	Jakubec, David/O-7570-2017	Jakubec, David/0000-0003-4288-0344; Laskowski, Roman/0000-0001-5528-0087	Ministry of Education, Youth, and Sports of the Czech Republic (KONTAKT II programme) [LH11020]; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic [Z40550506]	Ministry of Education, Youth, and Sports of the Czech Republic (KONTAKT II programme); Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by the Ministry of Education, Youth, and Sports of the Czech Republic (KONTAKT II programme LH11020, http://www.msmt.cz/), and the Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic (research project No. Z40550506, http://www.uochb.cz/). Access to computing and storage facilities was provided by ELIXIR CZ and the National Grid Infrastructure MetaCentrum, administered under the programme "Projects of Large Infrastructure for Research, Development, and Innovations." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKINRIMISI EO, 1964, BIOCHEMISTRY-US, V3, P619, DOI 10.1021/bi00893a004; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Balasubramanian S, 2009, BIOPHYS J, V96, P2245, DOI 10.1016/j.bpj.2008.11.040; Battistini F, 2012, J MOL BIOL, V420, P8, DOI 10.1016/j.jmb.2012.03.026; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berka K, 2010, J CHEM THEORY COMPUT, V6, P2191, DOI 10.1021/ct100007y; Berka K, 2009, J CHEM THEORY COMPUT, V5, P982, DOI 10.1021/ct800508v; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; BONACCORSI R, 1972, THEOR CHIM ACTA, V24, P51, DOI 10.1007/BF00528310; Chocholousova J, 2006, J PHYS CHEM B, V110, P17240, DOI 10.1021/jp0627675; Contreras-Moreira B, 2010, NUCLEIC ACIDS RES, V38, pD91, DOI 10.1093/nar/gkp781; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; de Ruiter A, 2015, NUCLEIC ACIDS RES, V43, P708, DOI 10.1093/nar/gku1344; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; Dror I, 2014, NUCLEIC ACIDS RES, V42, P430, DOI 10.1093/nar/gkt862; FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868; Gaillard T, 2011, J CHEM THEORY COMPUT, V7, P3181, DOI 10.1021/ct200384r; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Hawkins GD, 1996, J PHYS CHEM-US, V100, P19824, DOI 10.1021/jp961710n; HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K; HEGDE RS, 1992, NATURE, V359, P505, DOI 10.1038/359505a0; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hobza P, 2002, J AM CHEM SOC, V124, P11802, DOI 10.1021/ja026759n; Hostas J, 2015, J CHEM THEORY COMPUT, V11, P4086, DOI 10.1021/acs.jctc.5b00398; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jakubec D, 2015, J CHEM THEORY COMPUT, V11, P1939, DOI 10.1021/ct501168n; Jones S, 1999, J MOL BIOL, V287, P877, DOI 10.1006/jmbi.1999.2659; Jurecka P, 2006, PHYS CHEM CHEM PHYS, V8, P1985, DOI 10.1039/b600027d; Kilic S, 2014, NUCLEIC ACIDS RES, V42, pD156, DOI 10.1093/nar/gkt1123; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; Kleinjung J, 2014, CURR OPIN STRUC BIOL, V25, P126, DOI 10.1016/j.sbi.2014.04.003; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; LUSTIG B, 1995, NUCLEIC ACIDS RES, V23, P4707, DOI 10.1093/nar/23.22.4707; Lustig B, 1997, NUCLEIC ACIDS RES, V25, P2562, DOI 10.1093/nar/25.13.2562; Mandel-Gutfreund Y, 1998, NUCLEIC ACIDS RES, V26, P2306, DOI 10.1093/nar/26.10.2306; Mirny LA, 2002, NUCLEIC ACIDS RES, V30, P1704, DOI 10.1093/nar/30.7.1704; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; Parker SCJ, 2009, SCIENCE, V324, P389, DOI 10.1126/science.1169050; PERAHIA D, 1978, THEOR CHIM ACTA, V48, P263, DOI 10.1007/BF00549025; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pichierri F, 1999, J AM CHEM SOC, V121, P6152, DOI 10.1021/ja984124b; Prabakaran P, 2001, BIOINFORMATICS, V17, P1027, DOI 10.1093/bioinformatics/17.11.1027; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Rohs R, 2009, CURR OPIN STRUC BIOL, V19, P171, DOI 10.1016/j.sbi.2009.03.002; SCHLITTER J, 1993, CHEM PHYS LETT, V215, P617, DOI 10.1016/0009-2614(93)89366-P; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SHAKKED Z, 1989, NATURE, V342, P456, DOI 10.1038/342456a0; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SINGH J, 1990, J MOL BIOL, V211, P595, DOI 10.1016/0022-2836(90)90268-Q; Singh J, 1992, ATLAS OF PROTEIN SID, VII; Singh J, 1992, ATLAS OF PROTEIN SID, VI; SMITH ML, 1995, ONCOGENE, V10, P1053; SPONER J, 1994, J PHYS CHEM-US, V98, P3161, DOI 10.1021/j100063a019; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; THOMAS PD, 1978, FEBS LETT, V96, P90, DOI 10.1016/0014-5793(78)81069-2; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Yang L, 2014, NUCLEIC ACIDS RES, V42, pD148, DOI 10.1093/nar/gkt1087; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	70	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158704	10.1371/journal.pone.0158704	http://dx.doi.org/10.1371/journal.pone.0158704			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384774	Green Submitted, gold, Green Published			2022-12-26	WOS:000379809400077
J	Moyer, AE; Zheng, WX; Schweitzer, MH				Moyer, Alison E.; Zheng, Wenxia; Schweitzer, Mary H.			Keratin Durability Has Implications for the Fossil Record: Results from a 10 Year Feather Degradation Experiment	PLOS ONE			English	Article							BETA BETA KERATINS; BACTERIAL-DEGRADATION; SOFT-TISSUE; EVOLUTION; BIRD; PRESERVATION; DECAY; DIVERSIFICATION; EPIDERMIS; ORIGIN	Keratinous 'soft tissue' structures (i.e. epidermally derived and originally non-biomineralized), include feathers, skin, claws, beaks, and hair. Despite their relatively common occurrence in the fossil record (second only to bone and teeth), few studies have addressed natural degradation processes that must occur in all organic material, including those keratinous structures that are incorporated into the rock record as fossils. Because feathers have high preservation potential and strong phylogenetic signal, in the current study we examine feathers subjected to different burial environments for a duration of similar to 10 years, using transmission electron microscopy (TEM) and in situ immunofluorescence (IF). We use morphology and persistence of specific immunoreactivity as indicators of preservation at the molecular and microstructural levels. We show that feather keratin is durable, demonstrates structural and microstructural integrity, and retains epitopes suitable for specific antibody recognition in even the harshest conditions. These data support the hypothesis that keratin antibody reactivity can be used to identify the nature and composition of epidermal structures in the rock record, and to address evolutionary questions by distinguishing between alpha- (widely distributed) and beta- (limited to sauropsids) keratin.	[Moyer, Alison E.; Zheng, Wenxia; Schweitzer, Mary H.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Schweitzer, Mary H.] North Carolina Museum Nat Sci, Raleigh, NC 27601 USA	University of North Carolina; North Carolina State University	Moyer, AE (corresponding author), North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.	aemoyer@ncsu.edu	schweitzer, mary h/A-6756-2010; Schweitzer, Mary/V-8143-2019	schweitzer, mary h/0000-0002-0427-3829; 	David and Lucile Packard Foundation; NSF INSPIRE program [EAR-1344198]; National Science Foundation Graduate Research Fellowship Program [DGE-1252376]; Directorate For Geosciences [1344198] Funding Source: National Science Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NSF INSPIRE program(National Science Foundation (NSF)); National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by grants to MHS from the David and Lucile Packard Foundation and the NSF INSPIRE program (EAR-1344198), and the National Science Foundation Graduate Research Fellowship Program (DGE-1252376) To AEM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibardi L, 2002, J EXP ZOOL, V293, P27, DOI 10.1002/jez.10145; Alibardi L, 2015, PROTOPLASMA, V252, P1529, DOI 10.1007/s00709-015-0782-9; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Briggs DEG, 1995, PALAIOS, V10, P539, DOI 10.2307/3515093; Cai CG, 2009, J IND MICROBIOL BIOT, V36, P875, DOI 10.1007/s10295-009-0565-4; Carvalho ID, 2015, BRAZ J GEOL, V45, P161, DOI 10.1590/23174889201500020001; Carvalho ID, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8141; Chen CF, 2015, ANNU REV ANIM BIOSCI, V3, P169, DOI 10.1146/annurev-animal-022513-114127; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; Collins MJ, 1998, THE GEOCHEMICAL FATE, P74, DOI [10.1021/bk-1998-0707.ch006, DOI 10.1021/BK-1998-0707.CH006]; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Dent BB, 2004, ENVIRON GEOL, V45, P576, DOI 10.1007/s00254-003-0913-z; EGLINTON G, 1991, PHILOS T ROY SOC B, V333, P315, DOI 10.1098/rstb.1991.0081; Eglinton G, 1991, PHILOS T R SOC LON B, V333, P327, DOI [10.1098/rstb.1991.0081, DOI 10.1098/RSTB.1991.0081]; Eliason CM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1505; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fraser RDB, 2008, J STRUCT BIOL, V162, P1, DOI 10.1016/j.jsb.2008.01.011; Fraser RDB, 2011, J STRUCT BIOL, V173, P391, DOI 10.1016/j.jsb.2010.09.020; Fujii T, 2008, J BIOL MACROMOL, V8, P48; Goldstein G, 2004, AUK, V121, P656, DOI 10.1642/0004-8038(2004)121[0656:BDOBAW]2.0.CO;2; Greenwold MJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0249-1; Greenwold MJ, 2013, J EXP ZOOL PART B, V320, P393, DOI 10.1002/jez.b.22514; Gunderson AR, 2008, J AVIAN BIOL, V39, P539, DOI 10.1111/j.0908-8857.2008.04413.x; Hitchcock E., 1841, SCENOGRAPHICAL GEOLO; Hitchcock E., 1841, ELEMENTARY GEOLOGY; Hitchcock E, 1841, 4 PARTS 1 EC GEOLOGY; Hitchcock E., 1841, SCI GEOLOGY; Holthaus KB, 2016, MOL BIOL EVOL, V33, P726, DOI 10.1093/molbev/msv265; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindgren J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13520; Lucas A., 1972, AVIAN ANATOMY INTEGU; Manning PL, 2013, J ANAL ATOM SPECTROM, V28, P1024, DOI 10.1039/c3ja50077b; Moyer AE, 2014, SCI REP-UK, V4, DOI [10.1038/srep04233, 10.1038/srep06191]; Navalon G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14864; Ng CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002748; NOTBOHM H, 1992, J PROTEIN CHEM, V11, P635, DOI 10.1007/BF01024964; O'Connor J, 2015, J ORNITHOL, V156, pS333, DOI 10.1007/s10336-015-1222-5; Osborn HF., 1911, AM MUSEUM J, V2, P7; Pacton M, 2007, GEOMICROBIOL J, V24, P571, DOI 10.1080/01490450701672042; Sawyer RH, 2003, J EXP ZOOL PART B, V298B, P57, DOI 10.1002/jez.b.26; Schweitzer MH, 2015, BIOESSAYS, V37, P1174, DOI 10.1002/bies.201500061; Schweitzer MH, 2011, ANNU REV EARTH PL SC, V39, P187, DOI 10.1146/annurev-earth-040610-133502; Schweitzer MH, 1999, J EXP ZOOL, V285, P146; Schweitzer MH, 1999, J VERTEBR PALEONTOL, V19, P712, DOI 10.1080/02724634.1999.10011183; Shawkey MD, 2015, J MORPHOL, V276, P378, DOI 10.1002/jmor.20347; Stettenheim PR, 2000, AM ZOOL, V40, P461, DOI 10.1668/0003-1569(2000)040[0461:TIMOMB]2.0.CO;2; Strasser B, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0360-y; Symondson WOC, 1999, INSECT BIOCHEM MOLEC, V29, P873, DOI 10.1016/S0965-1748(99)00063-6; Vinther J, 2015, BIOESSAYS, V37, P643, DOI 10.1002/bies.201500018; Westall F, 2001, PRECAMBRIAN RES, V106, P93, DOI 10.1016/S0301-9268(00)00127-3; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010	54	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157699	10.1371/journal.pone.0157699	http://dx.doi.org/10.1371/journal.pone.0157699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384819	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400021
J	Hirata, Y; Amigo, JM; Matsuzaka, Y; Yokota, R; Mushiake, H; Aihara, K				Hirata, Yoshito; Amigo, Jose M.; Matsuzaka, Yoshiya; Yokota, Ryo; Mushiake, Hajime; Aihara, Kazuyuki			Detecting Causality by Combined Use of Multiple Methods: Climate and Brain Examples	PLOS ONE			English	Article							STRUCTURAL EQUATION MODELS; PAST 800,000 YEARS; TIME-SERIES; CORTICOCORTICAL CONNECTIONS; COUPLING DIRECTIONS; GRANGER CAUSALITY; RECURRENCE PLOTS; SYSTEMS; NETWORK; PREDICTION	Identifying causal relations from time series is the first step to understanding the behavior of complex systems. Although many methods have been proposed, few papers have applied multiple methods together to detect causal relations based on time series generated from coupled nonlinear systems with some unobserved parts. Here we propose the combined use of three methods and a majority vote to infer causality under such circumstances. Two of these methods are proposed here for the first time, and all of the three methods can be applied even if the underlying dynamics is nonlinear and there are hidden common causes. We test our methods with coupled logistic maps, coupled Rossler models, and coupled Lorenz models. In addition, we show from ice core data how the causal relations among the temperature, the CH4 level, and the CO2 level in the atmosphere changed in the last 800,000 years, a conclusion also supported by irregularly sampled data analysis. Moreover, these methods show how three regions of the brain interact with each other during the visually cued, two-choice arm reaching task. Especially, we demonstrate that this is due to bottom up influences at the beginning of the task, while there exist mutual influences between the posterior medial prefrontal cortex and the presupplementary motor area. Based on our results, we conclude that identifying causality with an appropriate ensemble of multiple methods ensures the validity of the obtained results more firmly.	[Hirata, Yoshito; Yokota, Ryo; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan; [Amigo, Jose M.] Univ Miguel Hernandez, Ctr Invest Operat, Avda Univ S-N, Elche 03202, Spain; [Matsuzaka, Yoshiya; Mushiake, Hajime] Tohoku Univ, Sch Med, Dept Physiol, 2-1 Seiryo Machi Aoba Ku, Sendai, Miyagi 9808575, Japan	University of Tokyo; Universidad Miguel Hernandez de Elche; Tohoku University	Hirata, Y (corresponding author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan.	yoshito@sat.t.u-tokyo.ac.jp	Amigo, Jose/B-2217-2008; Hirata, Yoshito/L-9297-2018	Amigo, Jose/0000-0002-1642-1171; Hirata, Yoshito/0000-0002-9245-2543; Mushiake, Hajime/0000-0002-5130-4720	Aihara Innovative Mathematical Modelling Project of the Japanese Society for the Promotion of Science (JSPS); JSPS KAKENHI [15H05707]; CREST, JST; Spanish Ministry of Economy and Competitiveness [MTM2012-31698]; World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living Systems) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research [15H05871] Funding Source: KAKEN	Aihara Innovative Mathematical Modelling Project of the Japanese Society for the Promotion of Science (JSPS); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); CREST, JST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Spanish Ministry of Economy and Competitiveness(Spanish Government); World-Leading Innovative R&D on Science and Technology (FIRST Program); Council for Science and Technology Policy (CSTP)(Council for Science and Technology Policy (CSTP)); Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living Systems) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Aihara Innovative Mathematical Modelling Project of the Japanese Society for the Promotion of Science (JSPS), through its Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy (CSTP), and by the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living Systems) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and the Japan Agency for Medical Research and Development (AMED). This work was also partially supported by JSPS KAKENHI Grant Number 15H05707 and CREST, JST. J.M.A. was supported by the Spanish Ministry of Economy and Competitiveness, Project MTM2012-31698.	Arnhold J, 1999, PHYSICA D, V134, P419, DOI 10.1016/S0167-2789(99)00140-2; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Chen YH, 2004, PHYS LETT A, V324, P26, DOI 10.1016/j.physleta.2004.02.032; Chen ZT, 2013, NEURAL COMPUT, V25, P1605, DOI 10.1162/NECO_a_00444; DeGroot M.H., 2002, PROBABILITY STAT; Donges JF, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/48007; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; Feldhoff JH, 2012, PHYS LETT A, V376, P3504, DOI 10.1016/j.physleta.2012.10.008; Furl N, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00253; Gershenfeld N., 1999, NATURE MATH MODELING; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hirata Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016203; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Hoyer PO, 2008, INT J APPROX REASON, V49, P362, DOI 10.1016/j.ijar.2008.02.006; Hyvarinen A, 2013, J MACH LEARN RES, V14, P111; Hyvarinen A, 2010, J MACH LEARN RES, V11, P1709; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kang J, 2014, THEOR APPL CLIMATOL, V116, P537, DOI 10.1007/s00704-013-0960-7; Lo LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138596; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; LUPPINO G, 1990, EXP BRAIN RES, V82, P214; LUPPINO G, 1993, J COMP NEUROL, V338, P114, DOI 10.1002/cne.903380109; Ma HF, 2014, SCI REP-UK, V4, DOI 10.1038/srep07464; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Matsuzaka Y, 2012, P NATL ACAD SCI USA, V109, P4633, DOI 10.1073/pnas.1119971109; MAY RM, 1976, NATURE, V261, P459, DOI 10.1038/261459a0; MEES A, 1992, PHYS LETT A, V169, P41, DOI 10.1016/0375-9601(92)90802-S; Monetti R, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.022911; Nawrath J, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.038701; Palus M, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.046211; Palus M, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056211; Romano MC, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036211; Rosenblum MG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.045202; ROSSLER OE, 1976, PHYS LETT A, V57, P397, DOI 10.1016/0375-9601(76)90101-8; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; Schiff SJ, 1996, PHYS REV E, V54, P6708, DOI 10.1103/PhysRevE.54.6708; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Shimizu S, 2006, J MACH LEARN RES, V7, P2003; Shimizu S, 2014, J MACH LEARN RES, V15, P2629; Stark J, 1999, J NONLINEAR SCI, V9, P255, DOI 10.1007/s003329900072; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; van Nes EH, 2015, NAT CLIM CHANGE, V5, P445, DOI [10.1038/nclimate2568, 10.1038/NCLIMATE2568]; Vossel S, 2014, NEUROSCIENTIST, V20, P150, DOI 10.1177/1073858413494269; Winterhalder M, 2007, INT J BIFURCAT CHAOS, V17, P3735, DOI 10.1142/S0218127407019664; Zou Y, 2011, INT J BIFURCAT CHAOS, V21, P1099, DOI 10.1142/S0218127411029033	50	24	24	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158572	10.1371/journal.pone.0158572	http://dx.doi.org/10.1371/journal.pone.0158572			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380515	Green Published, gold			2022-12-26	WOS:000379798700034
J	Abert, C; Kontaxis, G; Martens, S				Abert, Christine; Kontaxis, Georg; Martens, Sascha			Accessory Interaction Motifs in the Atg19 Cargo Receptor Enable Strong Binding to the Clustered Ubiquitin-related Atg8 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLE TARGETING PATHWAY; SELECTIVE AUTOPHAGY; SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; LIR MOTIF; CYTOPLASM; YEAST; MECHANISM; FORM	Selective autophagy contributes to cellular homeostasis by delivering harmful material into the lysosomal system for degradation via vesicular intermediates referred to as autophagosomes. The cytoplasm-to-vacuole targeting pathway is a variant of selective autophagy in Saccharomyces cerevisiae during which hydrolases such as prApel are transported into the vacuole. In general, selectivity is achieved by autophagic cargo receptors that link the cargo to autophagosomal membranes because of their ability to simultaneously interact with the cargo and Atg8 proteins that coat the membrane. The Atg19 receptor contains multiple Atg8 interaction sites in its C terminus in addition to a canonical Atg8-interacting LC3-interacting region (LIR, with LC3 being a homolog of Atg8) motif, but their mode of interaction with Atg8 is unclear. Here we show, using a combination of NMR, microscopy-based interaction assays, and prApel processing experiments, that two additional sites interact with Atg8 in a LIR-like and thus mutually exclusive manner. We term these motifs accessory LIR motifs because their affinities are lower than that of the canonical LIR motif. Thus, one Atg19 molecule has the ability to interact with multiple Atg8 proteins simultaneously, resulting in a high-avidity interaction that may confer specific binding to the Atg8-coated autophagosomal membrane on which Atg8 is concentrated.	[Abert, Christine; Martens, Sascha] Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dept Biochem & Cell Biol, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria; [Kontaxis, Georg] Univ Vienna, Max F Perutz Labs, Dept Struct & Computat Biol, Campus Vienna Bioctr 5-1, A-1030 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Martens, S (corresponding author), Univ Vienna, Max F Perutz Labs, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria.	sascha.martens@univie.ac.at		Martens, Sascha/0000-0003-3786-8199	ERC [260304, 646653]; FWF [P25546-B20]; EMBO; DOC fellowship of the Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 25546] Funding Source: researchfish	ERC(European Research Council (ERC)European Commission); FWF(Austrian Science Fund (FWF)); EMBO(European Molecular Biology Organization (EMBO)); DOC fellowship of the Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by ERC Grants 260304 and 646653, by FWF Grant P25546-B20), by the EMBO Young Investigator Program, and by a DOC fellowship of the Austrian Academy of Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	BABA M, 1994, J CELL BIOL, V124, P903, DOI 10.1083/jcb.124.6.903; Birgisdottir AB, 2013, J CELL SCI, V126, P3237, DOI 10.1242/jcs.126128; HARDING TM, 1995, J CELL BIOL, V131, P591, DOI 10.1083/jcb.131.3.591; Ho KH, 2009, AUTOPHAGY, V5, P461, DOI 10.4161/auto.5.4.7696; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kumeta H, 2010, J BIOMOL NMR, V47, P237, DOI 10.1007/s10858-010-9420-1; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Randow F, 2014, CELL HOST MICROBE, V15, P404, DOI 10.1016/j.chom.2014.03.012; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Rozenknop A, 2011, J MOL BIOL, V410, P477, DOI 10.1016/j.jmb.2011.05.003; Sawa-Makarska J, 2014, NAT CELL BIOL, V16, P425, DOI 10.1038/ncb2935; Scott SV, 1996, P NATL ACAD SCI USA, V93, P12304, DOI 10.1073/pnas.93.22.12304; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Suzuki K, 2002, DEV CELL, V3, P815, DOI 10.1016/S1534-5807(02)00359-3; Wurzer B, 2015, ELIFE, V4, DOI 10.7554/eLife.08941; Yuga M, 2011, J BIOL CHEM, V286, P13704, DOI 10.1074/jbc.M110.173906; Zaffagnini G, 2016, J MOL BIOL, V428, P1714, DOI 10.1016/j.jmb.2016.02.004	26	12	12	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18799	18808		10.1074/jbc.M116.736892	http://dx.doi.org/10.1074/jbc.M116.736892			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402840	hybrid, Green Published			2022-12-26	WOS:000383242300017
J	Mollet, IG; Malm, HA; Wendt, A; Orho-Melander, M; Eliasson, L				Mollet, Ines Guerra; Malm, Helena Anna; Wendt, Anna; Orho-Melander, Marju; Eliasson, Lena			Integrator of Stress Responses Calmodulin Binding Transcription Activator 1 (Camta1) Regulates miR-212/miR-132 Expression and Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell (B-cell); cyclic AMP (cAMP); insulin secretion; microRNA (miRNA); pancreatic islet; transcription coactivator; transcription promoter; type 2 diabetes; calmodulin binding transcription activator 1 (Camta1); NK2 homeobox 2 (Nkx2-2)	PANCREATIC BETA-CELLS; B-CELLS; MICE LACKING; RISK LOCI; ISLET; NKX2.2; GENE; EXOCYTOSIS; PROTEINS; FAMILY	Altered microRNA profiles have been demonstrated in experimental models of type 2 diabetes, including in islets of the diabetic Goto-Kakizaki (GK) rat. Our bioinformatic analysis of conserved sequences in promoters of microRNAs, previously observed to be up-regulated in GK rat islets, revealed putative CGCG-core motifs on the promoter of the miR-212/miR-132 cluster, overexpression of which has been shown to increase insulin secretion. These motifs are possible targets of calmodulin binding transcription activators Camta1 and Camta2 that have been recognized as integrators of stress responses. We also identified putative NKE elements, possible targets of NK2 homeobox proteins like the essential islet transcription factor Nkx2-2. As Camtas can function as co-activators with NK2 proteins in other tissues, we explored the role of Camta1, Camta2, and Nkx2-2 in the regulation of the miR-212/miR-132 cluster and insulin secretion. We demonstrate that exposure of control Wistar or GK rat islets to 16.7 mm glucose increases miR-212/miR-132 expression but significantly less so in the GK rat. In addition, Camta1, Camta2, and Nkx2-2 were down-regulated in GK rat islets, and knockdown of Camta1 reduced miR-212/miR-132 promoter activity and miR-212/miR-132 expression, even under cAMP elevation. Knockdown of Camta1 decreased insulin secretion in INS-1 832/13 cells and Wistar rat islets but increased insulin content. Furthermore, knockdown of Camta1 reduced K+-induced insulin secretion and voltage-dependent Ca2+ currents. We also demonstrate Camta1 and Nkx2-2 protein interaction. These results indicate that Camta1 is required not only for expression of the miR-212/miR-132 cluster but at multiple levels for regulating beta cell insulin content and secretion.	[Mollet, Ines Guerra; Malm, Helena Anna; Wendt, Anna; Orho-Melander, Marju; Eliasson, Lena] Lund Univ, Dept Clin Sci, Clin Res Ctr, Jan Waldenstroms Gata 35, SE-20502 Malmo, Sweden	Lund University	Mollet, IG (corresponding author), Lund Univ, Dept Clin Sci, Clin Res Ctr, Jan Waldenstroms Gata 35, SE-20502 Malmo, Sweden.	inesmollet@gmail.com	Eliasson, Lena/E-9294-2012; Mollet, Ines Guerra/H-8526-2019	Eliasson, Lena/0000-0002-6467-5029; Mollet, Ines Guerra/0000-0002-1422-1336; Wendt, Anna/0000-0001-8807-5979	Vetenskapsradet Project Grant [2012-13147]; Linneus Grant [2006-237]; Strategic Research Grant [2009-1039]; Regional Support through ALF-Skane [ALFSKANE-450661]; Diabetesfonden Grant [DIA 2013-055]; Albert Pahlsson Foundation	Vetenskapsradet Project Grant; Linneus Grant; Strategic Research Grant; Regional Support through ALF-Skane; Diabetesfonden Grant; Albert Pahlsson Foundation	This work was supported by Vetenskapsradet Project Grant 2012-13147 (to L. E.), Linneus Grant 2006-237 (to Lund University Diabetes Centre), Strategic Research Grant 2009-1039 (to SFO-EXODIAB), Regional Support through ALF-Skane ALFSKANE-450661, Diabetesfonden Grant DIA 2013-055, and the Albert Pahlsson Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Aziz H, 2005, PLANTA MED, V71, P609, DOI 10.1055/s-2005-871265; AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; Anderson KR, 2009, J BIOL CHEM, V284, P31236, DOI 10.1074/jbc.M109.048694; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cauchi S, 2008, J MOL MED, V86, P341, DOI 10.1007/s00109-007-0295-x; Choi MS, 2005, J BIOL CHEM, V280, P40820, DOI 10.1074/jbc.M504616200; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; Doherty CJ, 2009, PLANT CELL, V21, P972, DOI 10.1105/tpc.108.063958; Doyle MJ, 2007, DEVELOPMENT, V134, P515, DOI 10.1242/dev.02763; Doyle MJ, 2007, DIABETES, V56, P1999, DOI 10.2337/db06-1766; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Eckardt NA, 2009, PLANT CELL, V21, P697, DOI 10.1105/tpc.109.210310; Eliasson L, 1997, J PHYSIOL-LONDON, V503, P399, DOI 10.1111/j.1469-7793.1997.399bh.x; Esguerra JLS, 2014, GENES-BASEL, V5, P1018, DOI 10.3390/genes5041018; Esguerra JLS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018613; Finkler A, 2007, FEBS LETT, V581, P3893, DOI 10.1016/j.febslet.2007.07.051; GARCIAFERNANDEZ J, 1991, P NATL ACAD SCI USA, V88, P7338, DOI 10.1073/pnas.88.16.7338; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Han JH, 2006, CELL, V127, P847, DOI 10.1016/j.cell.2006.09.030; Hao MM, 2005, J CELL SCI, V118, P5873, DOI 10.1242/jcs.02684; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huentelman MJ, 2007, HUM MOL GENET, V16, P1469, DOI 10.1093/hmg/ddm097; Jacovetti C, 2012, J CLIN INVEST, V122, P3541, DOI 10.1172/JCI64151; Keller DM, 2012, MOL ENDOCRINOL, V26, P989, DOI 10.1210/me.2011-1205; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Liu N, 2006, CURR OPIN CELL BIOL, V18, P715, DOI 10.1016/j.ceb.2006.10.003; Long CZ, 2014, P NATL ACAD SCI USA, V111, P11521, DOI 10.1073/pnas.1411251111; MacDonald PE, 2006, CELL METAB, V4, P283, DOI 10.1016/j.cmet.2006.08.011; Malm HA, 2016, MOL CELL ENDOCRINOL, V424, P23, DOI 10.1016/j.mce.2016.01.010; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Miller LA, 2011, PSYCHOGERIATRICS, V11, P135, DOI 10.1111/j.1479-8301.2011.00357.x; Mitsuda N, 2003, PLANT CELL PHYSIOL, V44, P975, DOI 10.1093/pcp/pcg137; Muller-Borer B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038454; Olofsson CS, 2002, PFLUG ARCH EUR J PHY, V444, P43, DOI 10.1007/s00424-002-0781-5; OSTENSON CG, 1993, DIABETOLOGIA, V36, P3, DOI 10.1007/BF00399086; Papizan JB, 2011, GENE DEV, V25, P2291, DOI 10.1101/gad.173039.111; PRICE M, 1993, J NEUROBIOL, V24, P1385, DOI 10.1002/neu.480241010; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; Raum JC, 2006, MOL CELL BIOL, V26, P5735, DOI 10.1128/MCB.00249-06; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Shang J, 2015, MOL ENDOCRINOL, V29, P1243, DOI 10.1210/me.2014-1335; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Song K, 2006, CELL, V125, P453, DOI 10.1016/j.cell.2006.02.048; Sussel L, 1998, DEVELOPMENT, V125, P2213; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang H, 2007, DIABETOLOGIA, V50, P348, DOI 10.1007/s00125-006-0490-2; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Yang TB, 2002, J BIOL CHEM, V277, P45049, DOI 10.1074/jbc.M207941200	55	18	19	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18440	18452		10.1074/jbc.M116.716860	http://dx.doi.org/10.1074/jbc.M116.716860			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402838	Green Published, hybrid			2022-12-26	WOS:000383241800034
J	Venetz, D; Koovely, D; Weder, B; Neri, D				Venetz, Dario; Koovely, Danil; Weder, Bruce; Neri, Dario			Targeted Reconstitution of Cytokine Activity upon Antigen Binding using Split Cytokine Antibody Fusion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibody; cancer; cytokine; immunotherapy; pharmacology; activity-on-demand; tumor targeting; split protein; activity reconstitution; interleukin-12	INTERLEUKIN-12 IL-12 P40; MONOCLONAL-ANTIBODY; IN-VIVO; COMPLEMENTATION ASSAYS; ANTITUMOR-ACTIVITY; CHOP CHEMOTHERAPY; ARMED ANTIBODIES; BREAST-CANCER; CELL LYMPHOMA; DELIVERY	The targeted assembly of antibody products upon antigen binding represents a novel strategy for the reconstitution of potent therapeutic activity at the site of disease, sparing healthy tissues. We demonstrate that interleukin-12, a heterodimeric pro-inflammatory cytokine consisting of the disulfide-linked p40 and p35 subunits, can be reconstituted by sequential reassembly of fusion proteins based on antibody fragments and interleukin-12 subunit mutants. Analysis of the immunostimulatory properties of interleukin-12 and its derivatives surprisingly revealed that the mutated p35 subunit partially retained the activity of the parental cytokine, whereas the p40 subunit alone was not able to stimulate T cells or natural killer cells. The concept of stepwise antibody-based reassembly of split cytokines could be useful for the development of other anticancer therapeutics with improved safety and tolerability.	[Venetz, Dario; Koovely, Danil; Weder, Bruce; Neri, Dario] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Venetz, D; Neri, D (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Vladimir Prelog Weg 1-5-10, CH-8093 Zurich, Switzerland.	dario.venetz@pharma.ethz.ch; dario.neri@pharma.ethz.ch	Neri, Dario/P-4368-2016	Neri, Dario/0000-0001-5234-7370; Weder, Bruce/0000-0001-5961-2544	ETH Zurich; Swiss National Science Foundation [310030B_163479/1]; Commission for Technology and Innovation [17072.1]; European Research Council [670603]	ETH Zurich(ETH Zurich); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission for Technology and Innovation; European Research Council(European Research Council (ERC)European Commission)	This research was supported by the ETH Zurich, the Swiss National Science Foundation (Project 310030B_163479/1), the Commission for Technology and Innovation (Project 17072.1), and the European Research Council (Project 670603). The authors declare that they have no conflicts of interest with the contents of this article.	Banaszek A, 2013, THESIS; Borsi L, 2003, BLOOD, V102, P4384, DOI 10.1182/blood-2003-04-1039; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Carnemolla B, 2002, BLOOD, V99, P1659, DOI 10.1182/blood.V99.5.1659; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Desnoyers LR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006682; DONOHUE JH, 1983, J IMMUNOL, V130, P2203; Eigentler TK, 2011, CLIN CANCER RES, V17, P7732, DOI 10.1158/1078-0432.CCR-11-1203; Gafner V, 2006, INT J CANCER, V119, P2205, DOI 10.1002/ijc.22101; Gallamini A, 2007, BLOOD, V110, P2316, DOI 10.1182/blood-2007-02-074641; Garcin G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4016; GILLESSEN S, 1995, EUR J IMMUNOL, V25, P200, DOI 10.1002/eji.1830250133; Gillies SD, 2013, PROTEIN ENG DES SEL, V26, P561, DOI 10.1093/protein/gzt045; Gollob JA, 2000, CLIN CANCER RES, V6, P1678; GUBLER U, 1991, P NATL ACAD SCI USA, V88, P4143, DOI 10.1073/pnas.88.10.4143; Halin C, 2002, NAT BIOTECHNOL, V20, P264, DOI 10.1038/nbt0302-264; Heinzel FP, 1997, J IMMUNOL, V158, P4381; Hess C, 2014, MEDCHEMCOMM, V5, P408, DOI 10.1039/c3md00360d; HOSTOMSKY Z, 1991, P NATL ACAD SCI USA, V88, P1148, DOI 10.1073/pnas.88.4.1148; Jalah R, 2013, J BIOL CHEM, V288, P6763, DOI 10.1074/jbc.M112.436675; Lauwerys BR, 2002, LUPUS, V11, P384, DOI 10.1191/0961203302lu213oa; Leonard JP, 1997, BLOOD, V90, P2541; Li J, 2008, ANAL BIOCHEM, V373, P389, DOI 10.1016/j.ab.2007.10.034; Lieschke GJ, 1997, NAT BIOTECHNOL, V15, P35, DOI 10.1038/nbt0197-35; LING P, 1995, J IMMUNOL, V154, P116; Morell M, 2009, FEBS LETT, V583, P1684, DOI 10.1016/j.febslet.2009.03.002; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Neri D, 2016, CURR OPIN IMMUNOL, V40, P96, DOI 10.1016/j.coi.2016.03.006; Pasche N, 2012, CLIN CANCER RES, V18, P4092, DOI 10.1158/1078-0432.CCR-12-0282; Pasche N, 2012, DRUG DISCOV TODAY, V17, P583, DOI 10.1016/j.drudis.2012.01.007; Pietras RJ, 1998, ONCOGENE, V17, P2235, DOI 10.1038/sj.onc.1202132; Remy I, 2007, BIOTECHNIQUES, V42, P137, DOI 10.2144/000112396; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; SCHOENHAUT DS, 1992, J IMMUNOL, V148, P3433; Shigehara K, 2003, CLIN EXP IMMUNOL, V132, P152, DOI 10.1046/j.1365-2249.2003.02105.x; Sommavilla R, 2010, PROTEIN ENG DES SEL, V23, P653, DOI 10.1093/protein/gzq038; Tassev DV, 2009, EXPERT OPIN BIOL TH, V9, P341, DOI 10.1517/14712590802715764 ; Topp MS, 2014, J CLIN ONCOL, V32, P4134, DOI 10.1200/JCO.2014.56.3247; VADHANRAJ S, 1987, NEW ENGL J MED, V317, P1545, DOI 10.1056/NEJM198712173172501; Venetz D, 2015, P NATL ACAD SCI USA, V112, P2000, DOI 10.1073/pnas.1416694112; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Versteegen RM, 2013, ANGEW CHEM INT EDIT, V52, P14112, DOI 10.1002/anie.201305969; Villa A, 2008, INT J CANCER, V122, P2405, DOI 10.1002/ijc.23408; Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Wu CY, 2000, J IMMUNOL, V165, P6221, DOI 10.4049/jimmunol.165.11.6221; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530; Zhang Z, 2003, CANCER RES, V63, P6453	50	15	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18139	18147		10.1074/jbc.M116.737734	http://dx.doi.org/10.1074/jbc.M116.737734			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402834	Green Published, hybrid			2022-12-26	WOS:000383241800008
J	Lori, L; Pasquo, A; Lori, C; Petrosino, M; Chiaraluce, R; Tallant, C; Knapp, S; Consalvi, V				Lori, Laura; Pasquo, Alessandra; Lori, Clorinda; Petrosino, Maria; Chiaraluce, Roberta; Tallant, Cynthia; Knapp, Stefan; Consalvi, Valerio			Effect of BET Missense Mutations on Bromodomain Function, Inhibitor Binding and Stability	PLOS ONE			English	Article							STAPHYLOCOCCAL NUCLEASE; TARGETING BROMODOMAINS; ACETYLATED CHROMATIN; STRUCTURAL-ANALYSIS; EPIGENETIC READERS; MIDLINE CARCINOMA; PROTEIN STABILITY; BRD4; CANCER; DISEASE	Lysine acetylation is an important epigenetic mark regulating gene transcription and chromatin structure. Acetylated lysine residues are specifically recognized by bromodomains, small protein interaction modules that read these modification in a sequence and acetylation dependent way regulating the recruitment of transcriptional regulators and chromatin remodelling enzymes to acetylated sites in chromatin. Recent studies revealed that bromodomains are highly druggable protein interaction domains resulting in the development of a large number of bromodomain inhibitors. BET bromodomain inhibitors received a lot of attention in the oncology field resulting in the rapid translation of early BET bromodomain inhibitors into clinical studies. Here we investigated the effects of mutations present as polymorphism or found in cancer on BET bromodomain function and stability and the influence of these mutants on inhibitor binding. We found that most BET missense mutations localize to peripheral residues in the two terminal helices. Crystal structures showed that the three dimensional structure is not compromised by these mutations but mutations located in close proximity to the acetyl-lysine binding site modulate acetyl-lysine and inhibitor binding. Most mutations affect significantly protein stability and tertiary structure in solution, suggesting new interactions and an alternative network of protein-protein interconnection as a consequence of single amino acid substitution. To our knowledge this is the first report studying the effect of mutations on bromodomain function and inhibitor binding.	[Lori, Laura; Lori, Clorinda; Petrosino, Maria; Chiaraluce, Roberta; Consalvi, Valerio] Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [Pasquo, Alessandra] SSPT BIOAG BIOTEC ENEA Casaccia ENEA, Rome, Italy; [Tallant, Cynthia; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium & Target Discovery Inst, Oxford, England; [Tallant, Cynthia; Knapp, Stefan] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany; [Tallant, Cynthia; Knapp, Stefan] Goethe Univ Frankfurt, Buchmann Inst Life Sci BMLS, Frankfurt, Germany	Sapienza University Rome; Italian National Agency New Technical Energy & Sustainable Economics Development; University of Oxford; Goethe University Frankfurt; Goethe University Frankfurt	Chiaraluce, R (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci A Rossi Fanelli, Rome, Italy.	roberta.chiaraluce@uniroma1.it	Knapp, Stefan/AAG-2347-2019; consalvi, valerio/F-1918-2011	Knapp, Stefan/0000-0001-5995-6494; Tallant, Cynthia/0000-0001-5645-435X	Regione Lazio [FILAS-RU-2014-1020]	Regione Lazio(Regione Lazio)	This work was supported by Regione Lazio (Prot. FILAS-RU-2014-1020).	Belkina AC, 2014, J LEUKOCYTE BIOL, V95, P451, DOI 10.1189/jlb.1112588; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Casadio R, 2011, HUM MUTAT, V32, P1161, DOI 10.1002/humu.21555; Choy N, 2003, J MOL BIOL, V334, P527, DOI 10.1016/j.jmb.2003.09.059; Dawson MA, 2012, NEW ENGL J MED, V367, P647, DOI 10.1056/NEJMra1112635; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engin HB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152929; Evans P., 2007, SCALA SCALE TOGETHER; Filippakopoulos P, 2014, NAT REV DRUG DISCOV, V13, P339, DOI 10.1038/nrd4286; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fish PV, 2012, J MED CHEM, V55, P9831, DOI 10.1021/jm3010515; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; French CA, 2004, J CLIN ONCOL, V22, P4135, DOI 10.1200/JCO.2004.02.107; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; Fuchs JE, 2015, J CHEM THEORY COMPUT, V11, P851, DOI 10.1021/ct500633u; Gaboriau DCA, 2015, BIOCHEM J, V466, P613, DOI 10.1042/BJ20141077; Gao M, 2015, STRUCTURE, V23, P1362, DOI 10.1016/j.str.2015.03.028; Geierhaas CD, 2007, PROTEIN SCI, V16, P125, DOI 10.1110/ps.062383807; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hewings DS, 2012, J MED CHEM, V55, P9393, DOI 10.1021/jm300915b; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Ishii H, 2005, DNA CELL BIOL, V24, P432, DOI 10.1089/dna.2005.24.432; Jung M, 2015, EPIGENOMICS-UK, V7, P487, DOI 10.2217/epi.14.91; Kiss RS, 2003, J BIOL CHEM, V278, P21952, DOI 10.1074/jbc.M302676200; Kucukkal TG, 2015, CURR OPIN STRUC BIOL, V32, P18, DOI 10.1016/j.sbi.2015.01.003; Kumar R, 2016, ONCOGENE, V35, P4423, DOI 10.1038/onc.2015.513; Lamonica JM, 2011, P NATL ACAD SCI USA, V108, pE159, DOI 10.1073/pnas.1102140108; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; LESLIE AGW, 2007, MOSFLM; Lori C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064824; Martin LJ, 2016, J MED CHEM, V59, P4462, DOI 10.1021/acs.jmedchem.5b01865; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishiyama A, 2006, MOL BIOL CELL, V17, P814, DOI 10.1091/mbc.E05-08-0729; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pasquo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032555; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Picaud S, 2013, CANCER RES, V73, P3336, DOI 10.1158/0008-5472.CAN-12-3292; Pradeep L, 2004, BIOCHEMISTRY-US, V43, P11393, DOI 10.1021/bi049320b; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Rowling PJE, 2010, J BIOL CHEM, V285, P20080, DOI 10.1074/jbc.M109.088922; ROYER CA, 1993, PROTEIN SCI, V2, P1844, DOI 10.1002/pro.5560021106; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SHORTLE D, 1995, ADV PROTEIN CHEM, V46, P217, DOI 10.1016/S0065-3233(08)60336-8; Sinha A, 2005, BIOCHEM J, V387, P257, DOI 10.1042/BJ20041793; Spudich G, 2000, BIOCHEMISTRY-US, V39, P11677, DOI 10.1021/bi000466u; Sutherell CL, 2016, J MED CHEM, V59, P5095, DOI 10.1021/acs.jmedchem.5b01997; Wrabl J, 1999, NAT STRUCT BIOL, V6, P876; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Zhou Ming, 2003, Ai Zheng, V22, P123; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	59	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159180	10.1371/journal.pone.0159180	http://dx.doi.org/10.1371/journal.pone.0159180			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403962	Green Published, gold			2022-12-26	WOS:000379508200041
J	Shi, YH; Quan, RF; Xie, SJ; Li, Q; Cao, GP; Zhuang, W; Zhang, L; Shao, RX; Yang, DS				Shi, Yihui; Quan, Renfu; Xie, Shangju; Li, Qiang; Cao, Guoping; Zhuang, Wei; Zhang, Liang; Shao, Rongxue; Yang, Disheng			Evaluation of a Novel HA/ZrO2-Based Porous Bioceramic Artificial Vertebral Body Combined with a rhBMP-2/Chitosan Slow-Release Hydrogel	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; ZIRCONIA; COMPOSITE; DELIVERY; RHBMP-2; MICROSPHERES; FUSION; BMP-2	A new HA/ZrO2-based porous bioceramic artificial vertebral body (AVB), carried a recombinant human bone morphogenetic protein-2 (rhBMP-2)/chitosan slow-release hydrogel was prepared to repair vertebral bone defect in beagles. An ionic cross-linking was used to prepare the chitosan hydrogel (CS gel) as the rhBMP-2 slow-release carrier. The vertebral body defects were implanted with the rhBMP-2-loaded AVB in group A, or a non-drug-loaded AVB in group B, or autologous iliac in group C. The encapsulation rate of rhBMP-2 in rhBMP-2-loaded CS gel was 91.88 +/- 1.53%, with a drug load of 39.84 +/- 2.34 ng/mg. At 6, 12, 24 weeks postoperatively, radiography showed that the bone calluses gradually increased with time in group A, where the artificial vertebral body had completely fused with host-bone at 24 weeks after surgery. In group C, an apparent bone remodeling was occurred in the early stages, and the graft-bone and host-bone had also fused completely at 24 weeks postoperatively. In group B, fusion occurred less than in groups A and C. At 24 weeks after surgery, micro-computed tomography (Micro-CT) revealed that the volume of newly-formed bone in group A was significantly more than in group B (p<0.05). At 24 weeks after surgery, ultra-compressive strengths of the operated segments were 14.03 +/- 1.66 MPa in group A, 8.62 +/- 1.24 MPa in group B, and 13.78 +/- 1.43 MPa in group C. Groups A and C were both significantly higher than group B (p<0.05). At 24 weeks postoperatively, the hard tissue sections showed that the AVB of group A had tightly fused with host bone, and that pores of the AVB had been filled with abundant nearly mature bone, and that the new bone structured similarly to a trabecular framework, which was similar to that in group C. In contrast, implant fusion of the AVB in group B was not as apparent as group A. In conclusion, the novel HA/ZrO2-based porous bioceramic AVB carried the rhBMP-2-loaded CS gel can promote the repair of bony defect, and induce bone tissue to grow into the pores, which may replace iliac bone grafts as commonly applied in clinical practice.	[Shi, Yihui; Zhang, Liang] Zhejiang Chinese Med Univ, Hangzhou, Zhejiang, Peoples R China; [Quan, Renfu; Xie, Shangju; Li, Qiang; Cao, Guoping; Zhuang, Wei] Zhejiang Chinese Med Univ, Affiliated JiangNan Hosp, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China; [Shao, Rongxue] Zhejiang Chinese Med Univ, Guangxing Hosp, Hangzhou, Zhejiang, Peoples R China; [Yang, Disheng] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang Chinese Medical University; Zhejiang University	Quan, RF (corresponding author), Zhejiang Chinese Med Univ, Affiliated JiangNan Hosp, Dept Orthoped, Hangzhou, Zhejiang, Peoples R China.	quanrenfu@126.com			Zhejiang Key Science and Technology Project [2014CO3031]; Public Welfare Technology and Social Development Project Zhejing Science and Technology Department [2012C33114]; Hanghou Key Science and Technology Project [20122513A14]	Zhejiang Key Science and Technology Project; Public Welfare Technology and Social Development Project Zhejing Science and Technology Department; Hanghou Key Science and Technology Project	The study of "Evaluation of a novel HA/ZrO<INF>2</INF>-based porous bioceramic artificial vertebral body combined with a rhBMP-2/chitosan slow-release hydrogel" was supported by Zhejiang Key Science and Technology Project (2014CO3031); Public Welfare Technology and Social Development Project (2012C33114) Zhejing Science and Technology Department and Hanghou Key Science and Technology Project (20122513A14). All funders above were belonging to government public welfare funder. There was no author and individual employed or contracted by the funders involved in this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarrategi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034117; Abarrategi A, 2009, ACTA BIOMATER, V5, P2633, DOI 10.1016/j.actbio.2009.02.031; Alt V, 2009, EUR SPINE J, V18, P800, DOI 10.1007/s00586-009-0935-7; Branemark PI, 1985, TISSUE INTEGRATED PR, P11; Chen L, 2014, J MATER SCI-MATER M, V25, P1709, DOI 10.1007/s10856-014-5194-4; Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006; Hannink G, 2013, J MATER SCI-MATER M, V24, P325, DOI 10.1007/s10856-012-4802-4; Jun SH, 2013, J MATER SCI-MATER M, V24, P773, DOI 10.1007/s10856-012-4822-0; Kim H, 2012, EUR SPINE J, V21, P1324, DOI 10.1007/s00586-011-2092-z; Kim S, 2012, ACTA BIOMATER, V8, P1768, DOI 10.1016/j.actbio.2012.01.009; Matsuno T, 2000, J MATER SCI LETT, V19, P573, DOI 10.1023/A:1006722110462; MOSEKILDE L, 1986, BONE, V7, P207, DOI 10.1016/8756-3282(86)90019-0; Muller U, 2006, EUR CELLS MATER, V11, P8, DOI 10.22203/eCM.v011a02; Nayak Y, 2008, J MATER SCI-MATER M, V19, P2437, DOI 10.1007/s10856-008-3371-z; OHGUSHI H, 1993, J BIOMED MATER RES, V27, P1401, DOI 10.1002/jbm.820271107; Patel ZS, 2008, ACTA BIOMATER, V4, P1126, DOI 10.1016/j.actbio.2008.04.002; Piva RH, 2015, SCANNING, V37, P372, DOI 10.1002/sca.21221; Quan R, 2006, JOURNAL OF BIOMATERI, V23, P123; Quan RF, 2008, J MATER SCI-MATER M, V19, P183, DOI 10.1007/s10856-006-0025-x; [全仁夫 Quan Renfu], 2012, [中华创伤杂志, Chinese Journal of Trauma], V28, P946; [全仁夫 QUAN RenJu], 2006, [中华创伤杂志, Chinese Journal of Traumatology], V22, P852; Rodgers MA, 2013, BMJ-BRIT MED J, V346, P398; Ruhe PQ, 2006, J MATER SCI-MATER M, V17, P919, DOI 10.1007/s10856-006-0181-z; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; Shi SS, 2009, J BIOMATER APPL, V23, P331, DOI 10.1177/0885328208090013; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2; Sollazzo V, 2008, DENT MATER, V24, P357, DOI 10.1016/j.dental.2007.06.003; Vaidya R, 2008, J SPINAL DISORD TECH, V21, P557, DOI 10.1097/BSD.0b013e31815ea897; Wang AH, 2009, J MICROENCAPSUL, V26, P593, DOI 10.3109/02652040802586167; [王玮 Wang Wei], 2011, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V15, P4611; Woo EJ, 2011, SPINE, V36, P1817, DOI 10.1097/BRS.0b013e31822e6028; Xie SJ, 2015, COMPOS INTERFACE, V22, P151, DOI 10.1080/15685543.2015.997174; Yusop A. H., 2012, INT J BIOMATER, DOI DOI 10.1155/2012/641430; [张敏 Zhang Min], 2006, [复合材料学报, Acta Materiae Compositae Sinica], V23, P115; Zhou S.H., 2007, CHINESE J TISSUE ENG, V11, P9688	36	4	5	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0157698	10.1371/journal.pone.0157698	http://dx.doi.org/10.1371/journal.pone.0157698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27400197	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508100003
J	Carlsson, E; Thwaite, JE; Jenner, DC; Spear, AM; Flick-Smith, H; Atkins, HS; Byrne, B; Ding, JL				Carlsson, Emil; Thwaite, Joanne E.; Jenner, Dominic C.; Spear, Abigail M.; Flick-Smith, Helen; Atkins, Helen S.; Byrne, Bernadette; Ding, Jeak Ling			Bacillus anthracis TIR Domain-Containing Protein Localises to Cellular Microtubule Structures and Induces Autophagy	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; INNATE IMMUNITY; BRUCELLA-MELITENSIS; RECEPTOR; SUBVERSION; MACROPHAGES; FAMILY; RECOGNITION; PROTECTION; INFECTION	Toll-like receptors (TLRs) recognise invading pathogens and mediate downstream immune signalling via Toll/IL-1 receptor (TIR) domains. TIR domain proteins (Tdps) have been identified in multiple pathogenic bacteria and have recently been implicated as negative regulators of host innate immune activation. A Tdp has been identified in Bacillus anthracis, the causative agent of anthrax. Here we present the first study of this protein, designated BaTdp. Recombinantly expressed and purified BaTdp TIR domain interacted with several human TIR domains, including that of the key TLR adaptor MyD88, although BaTdp expression in cultured HEK293 cells had no effect on TLR4- or TLR2-mediated immune activation. During expression in mammalian cells, BaTdp localised to microtubular networks and caused an increase in lipidated cytosolic microtubule-associated protein 1A/1B-light chain 3 (LC3), indicative of autophagosome formation. In vivo intra-nasal infection experiments in mice showed that a BaTdp knockout strain colonised host tissue faster with higher bacterial load within 4 days post-infection compared to the wild type B. anthracis. Taken together, these findings indicate that BaTdp does not play an immune suppressive role, but rather, its absence increases virulence. BaTdp present in wild type B. anthracis plausibly interact with the infected host cell, which undergoes autophagy in self-defence.	[Carlsson, Emil; Byrne, Bernadette] Imperial Coll London, Dept Life Sci, London, England; [Carlsson, Emil; Ding, Jeak Ling] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore, Singapore; [Thwaite, Joanne E.; Jenner, Dominic C.; Spear, Abigail M.; Flick-Smith, Helen; Atkins, Helen S.] Def Sci & Technol Lab, Salisbury, Wilts, England	Imperial College London; National University of Singapore; Defence Science & Technology Laboratory	Byrne, B (corresponding author), Imperial Coll London, Dept Life Sci, London, England.; Ding, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore, Singapore.	b.byrne@imperial.ac.uk; dbsdjl@nus.edu.sg	Ding, Jeak/H-8057-2012	Byrne, Bernadette/0000-0001-9598-9832	Imperial College International Joint Scholarship	Imperial College International Joint Scholarship	Funded by Imperial College International Joint Scholarship awarded to BB and JLD.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alaidarous M, 2014, J BIOL CHEM, V289, P654, DOI 10.1074/jbc.M113.523274; Askarian F, 2014, J INNATE IMMUN, V6, P485, DOI 10.1159/000357618; Beedham RJ, 2001, VACCINE, V19, P4409, DOI 10.1016/S0264-410X(01)00197-9; Bergman NH, 2007, INFECT IMMUN, V75, P3434, DOI 10.1128/IAI.01345-06; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Campoy E, 2009, CURR TOP MICROBIOL, V335, P227, DOI 10.1007/978-3-642-00302-8_11; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Carlsson E, 2016, BBA-MOL CELL RES, V1863, P244, DOI 10.1016/j.bbamcr.2015.11.021; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Chen CY, 2011, J CELL BIOL, V193, P769, DOI 10.1083/jcb.201008050; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; Felix C, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0053-y; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Huth JR, 1997, PROTEIN SCI, V6, P2359; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Kagan JC, 2014, NAT REV IMMUNOL, V14, P821, DOI 10.1038/nri3757; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kraemer Thomas Daniel, 2014, Int J Microbiol, V2014, P918143, DOI 10.1155/2014/918143; Narayanan KB, 2015, APOPTOSIS, V20, P196, DOI 10.1007/s10495-014-1073-1; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Niu H, 2008, CELL MICROBIOL, V10, P593, DOI 10.1111/j.1462-5822.2007.01068.x; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; Patterson Nicholas J, 2014, Front Microbiol, V5, P662, DOI 10.3389/fmicb.2014.00662; Peng J, 2010, EUR J IMMUNOL, V40, P1738, DOI 10.1002/eji.200940034; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Radhakrishnan Girish K, 2012, Biomol Concepts, V3, P571; Radhakrishnan GK, 2011, BIOCHEM J, V439, P79, DOI 10.1042/BJ20110577; Radhakrishnan GK, 2010, BIOCHEM BIOPH RES CO, V397, P59, DOI 10.1016/j.bbrc.2010.05.056; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rana RR, 2013, MED MICROBIOL IMMUN, V202, P1, DOI 10.1007/s00430-012-0253-2; Rana RR, 2011, MICROB PATHOGENESIS, V51, P89, DOI 10.1016/j.micpath.2011.05.004; REED L. J., 1938, AMER JOUR HYG, V27, P493; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Schnaith A, 2007, J BIOL CHEM, V282, P2695, DOI 10.1074/jbc.M609784200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shannon JG, 2003, INFECT IMMUN, V71, P3183, DOI 10.1128/IAI.71.6.3183-3189.2003; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Snyder GA, 2014, J BIOL CHEM, V289, P669, DOI 10.1074/jbc.M113.523407; Spear AM, 2012, MICROBIOL-SGM, V158, P1593, DOI 10.1099/mic.0.055012-0; Spear AM, 2009, TRENDS MICROBIOL, V17, P393, DOI 10.1016/j.tim.2009.06.005; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033	54	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158575	10.1371/journal.pone.0158575	http://dx.doi.org/10.1371/journal.pone.0158575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391310	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400081
J	Kupz, A; Zedler, U; Staber, M; Kaufmann, SHE				Kupz, Andreas; Zedler, Ulrike; Staeber, Manuela; Kaufmann, Stefan H. E.			A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent Reactivation	PLOS ONE			English	Article							CD8(+) T-CELLS; HUMAN-IMMUNODEFICIENCY-VIRUS; IN-VIVO; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE RECONSTITUTION; ANTI-IL-2 MAB; CUTTING EDGE; NK CELLS; IL-2; COMPLEXES	Infection with Mycobacterium tuberculosis (Mtb) is the leading cause of death in human immunodeficiency virus (HIV)(+) individuals, particularly in Sub-Saharan Africa. Management of this deadly co-infection is a significant global health challenge that is exacerbated by the lack of efficient vaccines against both Mtb and HIV, as well as the lack of reliable and robust animal models for Mtb/HIV co-infection. Here we describe a tractable and reproducible mouse model to study the reactivation dynamics of latent Mtb infection following the loss of CD4(+) T cells as it occurs in HIV-co-infected individuals. Whereas intradermally (i.d.) infected C57BL/6 mice contained Mtb within the local draining lymph nodes, depletion of CD4(+) cells led to progressive systemic spread of the bacteria and induction of lung pathology. To interrogate whether reactivation of Mtb after CD4(+) T cell depletion can be reversed, we employed interleukin (IL)-2/anti-IL-2 complex-mediated cell boost approaches. Although populations of non-CD4 lymphocytes, such as CD8(+) memory T cells, natural killer (NK) cells and double-negative (DN) T cells significantly expanded after IL-2/anti-IL-2 complex treatment, progressive development of bacteremia and pathologic lung alterations could not be prevented. These data suggest that the failure to reverse Mtb reactivation is likely not due to anergy of the expanded cell subsets and rather indicates a limited potential for IL-2-complex-based therapies in the management of Mtb/HIV co-infection.	[Kupz, Andreas; Zedler, Ulrike; Staeber, Manuela; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Kupz, Andreas] James Cook Univ, Ctr Biosecur & Trop Infect Dis, Australian Inst Trop Hlth & Med, Cairns, Qld, Australia	Max Planck Society; James Cook University	Kupz, A; Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany.	andreas.kupz@jcu.edu.au; kaufmann@mpiib-berlin.mpg.de	Kaufmann, Stefan HE/I-5454-2014	Kaufmann, Stefan HE/0000-0001-9866-8268; Kupz, Andreas/0000-0002-9259-7873	Max Planck Society; European Union [HEALTH-F4-2011-28087]; EU [643381]; National Health and Medical Research Council of Australia [APP1052764]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Union(European Commission); EU(European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Max Planck Society; the European Union's Seventh Framework Programme (EU FP7; http://www.aditecproject.eu/) project "ADITEC" (HEALTH-F4-2011-28087; and EU Horizon 2020 (http://www.horizont2020.de/) project "TBVAC 2020" (grant 643381) to SHEK; AK was supported by the National Health and Medical Research Council of Australia (https://www.nhmrc.gov.au/) through a CJ Martin Biomedical Early Career Fellowship (APP1052764). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Behr MA, 2014, LANCET INFECT DIS, V14, P250, DOI 10.1016/S1473-3099(13)70253-6; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; CARSON WE, 1994, J EXP MED, V180, P1395, DOI 10.1084/jem.180.4.1395; Dubois S, 2008, J IMMUNOL, V180, P2099, DOI 10.4049/jimmunol.180.4.2099; Duque-Correa MA, 2014, P NATL ACAD SCI USA, V111, pE4024, DOI 10.1073/pnas.1408839111; Epardaud M, 2008, CANCER RES, V68, P2972, DOI 10.1158/0008-5472.CAN-08-0045; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Gengenbacher M, 2012, FEMS MICROBIOL REV, V36, P514, DOI 10.1111/j.1574-6976.2012.00331.x; Hamilton SE, 2010, J IMMUNOL, V185, P6584, DOI 10.4049/jimmunol.1001215; Heyckendorf J, 2015, EMERG INFECT DIS, V21, P1685, DOI 10.3201/eid2109.150461; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Kamimura D, 2006, J IMMUNOL, V177, P306, DOI 10.4049/jimmunol.177.1.306; Kasprowicz VO, 2016, J INFECT DIS, V213, P628, DOI 10.1093/infdis/jiv455; Kovacs JA, 1996, NEW ENGL J MED, V335, P1350, DOI 10.1056/NEJM199610313351803; KOVACS JA, 1995, NEW ENGL J MED, V332, P567, DOI 10.1056/NEJM199503023320904; Ku CC, 2000, SCIENCE, V288, P675, DOI 10.1126/science.288.5466.675; Kupz A, 2016, J CLIN INVEST, V126, P2109, DOI 10.1172/JCI84978; Kupz A, 2013, P NATL ACAD SCI USA, V110, P2252, DOI 10.1073/pnas.1222047110; Kupz A, 2012, NAT IMMUNOL, V13, P162, DOI 10.1038/ni.2195; Lai RPJ, 2016, SEMIN IMMUNOPATHOL, V38, P185, DOI 10.1007/s00281-015-0532-2; Li XC, 2001, NAT MED, V7, P114, DOI 10.1038/83253; Thomas ZR, 2015, T ROY SOC TROP MED H, V109, P175, DOI 10.1093/trstmh/tru206; Molloy MJ, 2009, J IMMUNOL, V182, P4512, DOI 10.4049/jimmunol.0804175; Nishimura H, 1996, J IMMUNOL, V156, P663; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pawlowski A, 2012, PLOS PATHOG, V8, DOI [10.1371/jou rnal.ppat.1002464, DOI 10.1371/J0U]; Potash MJ, 2005, P NATL ACAD SCI USA, V102, P3760, DOI 10.1073/pnas.0500649102; Reece ST, 2010, J CLIN INVEST, V120, P3365, DOI 10.1172/JCI42796; Schneider BE, 2010, EUR J IMMUNOL, V40, P396, DOI 10.1002/eji.200939583; Sprent J, 2001, CURR OPIN IMMUNOL, V13, P248, DOI 10.1016/S0952-7915(00)00211-9; Stoklasek TA, 2006, J IMMUNOL, V177, P6072, DOI 10.4049/jimmunol.177.9.6072; Stonier SW, 2010, IMMUNOL LETT, V127, P85, DOI 10.1016/j.imlet.2009.09.009; Tomala J, 2013, ACS CHEM BIOL, V8, P871, DOI 10.1021/cb3007242; Tomala J, 2009, J IMMUNOL, V183, P4904, DOI 10.4049/jimmunol.0900284; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Votavova P, 2014, IMMUNOL LETT, V159, P1, DOI 10.1016/j.imlet.2014.01.017; Waithman J, 2008, J IMMUNOL, V180, P5789, DOI 10.4049/jimmunol.180.9.5789; WHO, 2014, GLOB TUB REP 2014; Zwirner NW, 2010, BIOFACTORS, V36, P274, DOI 10.1002/biof.107	42	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158849	10.1371/journal.pone.0158849	http://dx.doi.org/10.1371/journal.pone.0158849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391012	Green Published, Green Accepted, gold			2022-12-26	WOS:000380005400143
J	Mishra, P; Kaur, S; Sharma, AN; Jolly, RS				Mishra, Pradeep; Kaur, Suneet; Sharma, Amar Nath; Jolly, Ravinder S.			Characterization of an Indole-3-Acetamide Hydrolase from Alcaligenes faecalis subsp parafaecalis and Its Application in Efficient Preparation of Both Enantiomers of Chiral Building Block 2,3-Dihydro-1,4-Benzodioxin-2-Carboxylic Acid	PLOS ONE			English	Article							MOLECULAR-CLONING; PHENOXY ANALOGS; AMIDASE; POTENT; SERIES; 1,4-BENZODIOXANE; ANTAGONISTS; AFFINITY; AGONIST; MKC-242	Both the enantiomers of 2,3-dihydro-1,4-benzodioxin-2-carboxylic acid are valuable chiral synthons for enantiospecific synthesis of therapeutic agents such as (S)-doxazosin mesylate, WB 4101, MKC 242, 2,3-dihydro-2-hydroxymethyl-1,4-benzodioxin, and N-[2,4-oxo-1,3-thiazolidin-3-yl]-2,3-dihydro-1,4-benzodioxin-2-carboxamide. Pharmaceutical applications require these enantiomers in optically pure form. However, currently available methods suffer from one drawback or other, such as low efficiency, uncommon and not so easily accessible chiral resolving agent and less than optimal enantiomeric purity. Our interest in finding a biocatalyst for efficient production of enantiomerically pure 2,3-dihydro-1,4-benzodioxin-2-carboxylic acid lead us to discover an amidase activity from Alcaligenes faecalis subsp. parafaecalis, which was able to kinetically resolve 2,3-dihydro-1,4-benzodioxin-2-carboxyamide with E value of >200. Thus, at about 50% conversion, (R)-2,3-dihydro-1,4-benzodioxin-2-carboxylic acid was produced in >99% e.e. The remaining amide had (S)configuration and 99% e.e. The amide and acid were easily separated by aqueous (alkaline)-organic two phase extraction method. The same amidase was able to catalyse, albeit at much lower rate the hydrolysis of (S)-amide to (S)-acid without loss of e.e. The amidase activity was identified as indole-3-acetamide hydrolase (IaaH). IaaH is known to catalyse conversion of indole-3-acetamide (IAM) to indole-3-acetic acid (IAA), which is phytohormone of auxin class and is widespread among plants and bacteria that inhabit plant rhizosphere. IaaH exhibited high activity for 2,3-dihydro-1,4-benzodioxin-2-carboxamide, which was about 65% compared to its natural substrate, indole-3-acetamide. The natural substrate for IaaH indole-3-acetamide shared, at least in part a similar bicyclic structure with 2,3-dihydro-1,4-benzodioxin-2-carboxamide, which may account for high activity of enzyme towards this un-natural substrate. To the best of our knowledge this is the first application of IaaH in production of industrially important molecules.	[Mishra, Pradeep; Kaur, Suneet; Sharma, Amar Nath; Jolly, Ravinder S.] CSIR Inst Microbial Technol, Dept Bioorgan Chem, Sect 39, Chandigarh, India; [Kaur, Suneet] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Duke University	Jolly, RS (corresponding author), CSIR Inst Microbial Technol, Dept Bioorgan Chem, Sect 39, Chandigarh, India.	jolly@imtech.res.in	Kaur, Suneet/ABB-4807-2020	Kaur, Suneet/0000-0001-9271-8519	Council of Scientific and Industrial Research (CSIR), New Delhi, India [BSC0211]; CSIR, New Delhi, India [BSC0211]; CSIR	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Supra Institutional Project Grant BSC0211 from Council of Scientific and Industrial Research (CSIR), New Delhi, India to RSJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Supra Institutional Project Grant BSC0211 from CSIR, New Delhi, India. PM, SK and ANS acknowledge CSIR for award of Senior Research Fellowship. We acknowledge the technical help provided by Chander Prakash and Pradeep Patel.	Baoz N., 1994, Patent No. [US 5306638, 5306638]; Benz P, 2007, J CHEM TECHNOL BIOT, V82, P1087, DOI 10.1002/jctb.1795; Bolchi C, 2004, BIOORGAN MED CHEM, V12, P4937, DOI 10.1016/j.bmc.2004.06.040; Bolchi C, 2003, TETRAHEDRON-ASYMMETR, V14, P3779, DOI 10.1016/j.tetasy.2003.09.012; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAMPBELL SF, 1987, J MED CHEM, V30, P49, DOI 10.1021/jm00384a009; Chebrou H, 1996, BBA-PROTEIN STRUCT M, V1298, P285, DOI 10.1016/S0167-4838(96)00145-8; CHEN CS, 1982, J AM CHEM SOC, V104, P7294, DOI 10.1021/ja00389a064; Egorova K, 2004, APPL MICROBIOL BIOT, V65, P38, DOI 10.1007/s00253-004-1607-5; Faber K, 2012, COMPUTER PROGRAM DET; Fang QK, 2001, TETRAHEDRON-ASYMMETR, V12, P2169, DOI 10.1016/S0957-4166(01)00368-8; Fumagalli L, 2005, BIOORGAN MED CHEM, V13, P2547, DOI 10.1016/j.bmc.2005.01.034; Fumagalli L, 2012, EUR J MED CHEM, V58, P184, DOI 10.1016/j.ejmech.2012.09.049; KATRITZKY AR, 1989, SYNTHESIS-STUTTGART, P949; Khalilullah H, 2012, B KOREAN CHEM SOC, V33, P575, DOI 10.5012/bkcs.2012.33.2.575; Kuwabe S, 2001, J AM CHEM SOC, V123, P12202, DOI 10.1021/ja012046d; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin Y, 2013, BIOCHEMISTRY-US, V52, P690, DOI 10.1021/bi301242m; Ma S, 2006, ACTA PHARMACOL SIN, V27, P8; Masterson DS, 2009, TETRAHEDRON-ASYMMETR, V20, P1476, DOI 10.1016/j.tetasy.2009.05.037; Matsuda T, 1995, JPN J PHARMACOL, V69, P357, DOI 10.1254/jjp.69.357; Mehta Praveen Kumar B SK, 2013, EXTREMOPHILES, V17; Moon LS, 2009, THESIS; NELSON WL, 1979, J MED CHEM, V22, P1125, DOI 10.1021/jm00195a024; Neu D, 2007, FEBS J, V274, P3440, DOI 10.1111/j.1742-4658.2007.05876.x; Neumann S, 2002, ACTA CRYSTALLOGR D, V58, P333, DOI 10.1107/S0907444901020248; Pallavicini M, 2006, EUR J MED CHEM, V41, P1025, DOI 10.1016/j.ejmech.2006.04.004; Pollmann S, 2003, PHYTOCHEMISTRY, V62, P293, DOI 10.1016/S0031-9422(02)00563-0; Quaglia W, 2008, J MED CHEM, V51, P6359, DOI 10.1021/jm800461k; SCHRODER G, 1984, EUR J BIOCHEM, V138, P387, DOI 10.1111/j.1432-1033.1984.tb07927.x; SEKINE M, 1989, J BACTERIOL, V171, P1718, DOI 10.1128/jb.171.3.1718-1724.1989; Shen WL, 2012, APPL MICROBIOL BIOT, V94, P1007, DOI 10.1007/s00253-011-3704-6; Smith ME, 2012, CHEMCATCHEM, V4, P472, DOI 10.1002/cctc.201100490; Somboonthum P, 1997, NEUROPHARMACOLOGY, V36, P1733, DOI 10.1016/S0028-3908(97)00174-3; Torisu K, 2004, BIOORGAN MED CHEM, V12, P5361, DOI 10.1016/j.bmc.2004.07.048; Valoti E, 2001, J ORG CHEM, V66, P1018, DOI 10.1021/jo0008340; Verho O, 2015, J AM CHEM SOC, V137, P3996, DOI 10.1021/jacs.5b01031; Vorwerk SB, 2001, PLANTA, V212, P9; Wang YS, 2011, WORLD J MICROB BIOT, V27, P2885, DOI 10.1007/s11274-011-0769-4; 신승훈, 2002, Annals of Rehabilitation Medicine, V26, P1	41	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159009	10.1371/journal.pone.0159009	http://dx.doi.org/10.1371/journal.pone.0159009			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391673	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400189
J	Saunders, ME; Luck, GW				Saunders, Manu E.; Luck, Gary W.			Combining Costs and Benefits of Animal Activities to Assess Net Yield Outcomes in Apple Orchards	PLOS ONE			English	Article							CYDIA-POMONELLA L; LANDSCAPE COMPLEXITY; ECOSYSTEM SERVICES; FRUIT ABORTION; PAN TRAPS; POLLINATION; CROP; PEST; BIRDS; BIODIVERSITY	Diverse animal communities influence ecosystem function in agroecosystems through positive and negative plant-animal interactions. Yet, past research has largely failed to examine multiple interactions that can have opposing impacts on agricultural production in a given context. We collected data on arthropod communities and yield quality and quantity parameters (fruit set, yield loss and net outcomes) in three major apple-growing regions in south-eastern Australia. We quantified the net yield outcome (accounting for positive and negative interactions) of multiple animal activities (pollination, fruit damage, biological control) across the entire growing season on netted branches, which excluded vertebrate predators of arthropods, and open branches. Net outcome was calculated as the number of undamaged fruit at harvest as a proportion of the number of blossoms (i.e., potential fruit yield). Vertebrate exclusion resulted in lower levels of fruit set and higher levels of arthropod damage to apples, but did not affect net outcomes. Yield quality and quantity parameters (fruit set, yield loss, net outcomes) were not directly associated with arthropod functional groups. Model variance and significant differences between the ratio of pest to beneficial arthropods between regions indicated that complex relationships between environmental factors and multiple animal interactions have a combined effect on yield. Our results show that focusing on a single crop stage, species group or ecosystem function/service can overlook important complexity in ecological processes within the system. Accounting for this complexity and quantifying the net outcome of ecological interactions within the system, is more informative for research and management of biodiversity and ecosystem services in agricultural landscapes.	[Saunders, Manu E.; Luck, Gary W.] Charles Sturt Univ, Inst Land Water & Soc, POB 789, Albury, NSW 2640, Australia	Charles Sturt University	Saunders, ME (corresponding author), Charles Sturt Univ, Inst Land Water & Soc, POB 789, Albury, NSW 2640, Australia.	masaunders@csu.edu.au	Saunders, Manu E./H-4246-2019	Saunders, Manu E./0000-0003-0645-8277	Australian Research Council [DP140100709]	Australian Research Council(Australian Research Council)	This research was funded by Australian Research Council Discovery Grant DP140100709, awarded to G.W.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by an Australian Research Council Discovery Grant DP140100709 awarded to G.W.L. We thank orchard managers for providing access to orchards; R. Peisley provided field assistance; D. Nimmo provided helpful comments on statistical analyses; anonymous reviewers provided helpful comments to improve the manuscript.	Adler LS, 2001, ECOLOGY, V82, P2032, DOI 10.1890/0012-9658(2001)082[2032:DAIEOA]2.0.CO;2; Aguirre-Gutierrez J, 2015, DIVERS DISTRIB, V21, P1129, DOI 10.1111/ddi.12350; Anderies JM, 2006, ECOSYSTEMS, V9, P865, DOI 10.1007/s10021-006-0017-1; Bennett Andrew F., 1997, Pacific Conservation Biology, V3, P244; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Blitzer EJ, 2016, AGR ECOSYST ENVIRON, V221, P1, DOI 10.1016/j.agee.2016.01.004; Bone NJ, 2009, CROP PROT, V28, P675, DOI 10.1016/j.cropro.2009.03.021; Boreux V, 2013, P NATL ACAD SCI USA, V110, P8387, DOI 10.1073/pnas.1210590110; Bos MM, 2007, ECOL APPL, V17, P1841, DOI 10.1890/06-1763.1; Botes C, 2009, INT J PLANT SCI, V170, P151, DOI 10.1086/595291; BOYLE RMD, 1983, J HORTIC SCI, V58, P355, DOI 10.1080/00221589.1983.11515130; BROWN MW, 1995, J ECON ENTOMOL, V88, P127, DOI 10.1093/jee/88.1.127; Brown MW, 2001, ENVIRON ENTOMOL, V30, P415, DOI 10.1603/0046-225X-30.2.415; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Chapman T. F., 2007, Journal of the Royal Society of Western Australia, V90, P33; CHURCHILL D M, 1970, Australian Journal of Zoology, V18, P427, DOI 10.1071/ZO9700427; Classen A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3148; de Bello F, 2010, BIODIVERS CONSERV, V19, P2873, DOI 10.1007/s10531-010-9850-9; Dennis F. G. Jr., 1979, Horticultural Reviews, V1, P395; Dodds K, 2014, ORCHARD PLANT PROTEC; Garratt M.P.D., 2014, Journal of Pollination Ecology, V12, P9; Garratt MPD, 2014, AGR ECOSYST ENVIRON, V184, P34, DOI 10.1016/j.agee.2013.10.032; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Hamilton J., 2006, FLY INTERACTIVE ATLA; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Herrera CM, 2009, ANN BOT-LONDON, V103, P1415, DOI 10.1093/aob/mcp026; Jonsson M, 2015, J APPL ECOL, V52, P1274, DOI 10.1111/1365-2664.12489; KENDALL DA, 1973, J APPL ECOL, V10, P847, DOI 10.2307/2401873; Keogh R., 2010, POLLINATION AWARE RE; Koh LP, 2008, ECOL APPL, V18, P821, DOI 10.1890/07-1650.1; Leather SR, 2005, METH ECOL, P1, DOI 10.1002/9780470750513.ch1; Letourneau DK, 2012, J APPL ECOL, V49, P1405, DOI 10.1111/1365-2664.12001; Lindborg R, 2004, ECOLOGY, V85, P1840, DOI 10.1890/04-0367; Losada JM, 2013, SCI HORTIC-AMSTERDAM, V150, P283, DOI 10.1016/j.scienta.2012.11.031; Lundin O, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2243; Maas B, 2013, ECOL LETT, V16, P1480, DOI 10.1111/ele.12194; Macfadyen S, 2015, ECOL ENTOMOL, V40, P56, DOI 10.1111/een.12213; Macfadyen S, 2009, ECOL LETT, V12, P229, DOI 10.1111/j.1461-0248.2008.01279.x; MADSEN HF, 1966, CAN ENTOMOL, V98, P903, DOI 10.4039/Ent98903-9; Martin EA, 2015, PEERJ, V3, DOI 10.7717/peerj.1095; Martins KT, 2015, AGR ECOSYST ENVIRON, V200, P12, DOI 10.1016/j.agee.2014.10.018; McCall AC, 2006, ECOL LETT, V9, P1351, DOI 10.1111/j.1461-0248.2006.00975.x; Meehan TD, 2011, P NATL ACAD SCI USA, V108, P11500, DOI 10.1073/pnas.1100751108; Michener C.D., 2007, BEES WORLD, Vsecond; MOEED A, 1979, NEW ZEAL J ZOOL, V6, P475, DOI 10.1080/03014223.1979.10428389; Mols CMM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000202; Morrison EB, 2012, ECOLOGICAL APPL, V22, P1536; Ndang'ang'a PK, 2013, INT J PEST MANAGE, V59, P211, DOI 10.1080/09670874.2013.820005; Nicholls CI, 2013, AGRON SUSTAIN DEV, V33, P257, DOI 10.1007/s13593-012-0092-y; Peisley RK, SPRINGER SC IN PRESS; Puech C, 2014, AGR ECOSYST ENVIRON, V194, P48, DOI 10.1016/j.agee.2014.05.002; R Development Core Team, 2012, R LANG ENV STAT COMP; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Raymond L, 2014, AGR ECOSYST ENVIRON, V185, P99, DOI 10.1016/j.agee.2013.12.019; Rusch A, 2013, AGR ECOSYST ENVIRON, V166, P118, DOI 10.1016/j.agee.2011.05.004; Saunders ME, 2016, AMBIO, V45, P4, DOI 10.1007/s13280-015-0696-y; Saunders ME, 2013, J INSECT CONSERV, V17, P1011, DOI 10.1007/s10841-013-9584-6; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Sheffield Cory S., 2014, Journal of Pollination Ecology, V12, P120; Sheffield CS, 2005, ANN BOT-LONDON, V95, P583, DOI 10.1093/aob/mci058; SOLOMON ME, 1976, J APPL ECOL, V13, P341, DOI 10.2307/2401784; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Stevens NB, 2007, WHAT WASP THAT INTER; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; Tuell JK, 2009, ENTOMOL EXP APPL, V131, P93, DOI 10.1111/j.1570-7458.2009.00826.x; Vadkertiova R, 2012, CAN J MICROBIOL, V58, P1344, DOI 10.1139/cjm-2012-0468; Vandewalle M, 2010, BIODIVERS CONSERV, V19, P2921, DOI 10.1007/s10531-010-9798-9; Veres A, 2013, AGR ECOSYST ENVIRON, V166, P110, DOI 10.1016/j.agee.2011.05.027; Vicens N, 2000, ENVIRON ENTOMOL, V29, P235, DOI 10.1603/0046-225X(2000)029[0235:PEOOCA]2.0.CO;2; Vrdoljak SM, 2012, J INSECT CONSERV, V16, P345, DOI 10.1007/s10841-011-9420-9; WEARING CH, 1992, BIOCONTROL SCI TECHN, V2, P285, DOI 10.1080/09583159209355244; Winqvist C, 2011, J APPL ECOL, V48, P570, DOI 10.1111/j.1365-2664.2010.01950.x; Witzgall P, 2012, J CHEM ECOL, V38, P949, DOI 10.1007/s10886-012-0158-y; Wright JW, 2003, ECOLOGY, V84, P2062, DOI 10.1890/02-0676	74	8	8	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158618	10.1371/journal.pone.0158618	http://dx.doi.org/10.1371/journal.pone.0158618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391022	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400091
J	Weinheimer, I; Haikonen, T; Ala-Poikela, M; Moser, M; Streng, J; Rajamaki, ML; Valkonen, JPT				Weinheimer, Isabel; Haikonen, Tuuli; Ala-Poikela, Marjo; Moser, Mirko; Streng, Janne; Rajamaki, Minna-Liisa; Valkonen, Jari P. T.			Viral RNase3 Co-Localizes and Interacts with the Antiviral Defense Protein SGS3 in Plant Cells	PLOS ONE			English	Article							HELPER COMPONENT PROTEINASE; POTATO-VIRUS-A; SILENCING SUPPRESSOR; SIRNA BIOGENESIS; MOSAIC-VIRUS; ARABIDOPSIS; INFECTION; GENE; TRANSITIVITY; RECOGNITION	Sweet potato chlorotic stunt virus (SPCSV; family Closteroviridae) encodes a Class 1 RNase III endoribonuclease (RNase3) that suppresses post-transcriptional RNA interference (RNAi) and eliminates antiviral defense in sweetpotato plants (Ipomoea batatas). For RNAi suppression, RNase3 cleaves double-stranded small interfering RNAs (ds-siRNA) and long dsRNA to fragments that are too short to be utilized in RNAi. However, RNase3 can suppress only RNAi induced by sense RNA. Sense-mediated RNAi involves host suppressor of gene silencing 3 (SGS3) and RNA-dependent RNA polymerase 6 (RDR6). In this study, subcellular localization and host interactions of RNase3 were studied in plant cells. RNase3 was found to interact with SGS3 of sweetpotato and Arabidopsis thaliana when expressed in leaves, and it localized to SGS3/RDR6 bodies in the cytoplasm of leaf cells and protoplasts. RNase3 was also detected in the nucleus. Co-expression of RNase3 and SGS3 in leaf tissue enhanced the suppression of RNAi, as compared with expression of RNase3 alone. These results suggest additional mechanisms needed for efficient RNase3-mediated suppression of RNAi and provide new information about the subcellular context and phase of the RNAi pathway in which RNase3 realizes RNAi suppression.	[Weinheimer, Isabel; Haikonen, Tuuli; Ala-Poikela, Marjo; Streng, Janne; Rajamaki, Minna-Liisa; Valkonen, Jari P. T.] Univ Helsinki, Dept Agr Sci, Helsinki, Finland; [Moser, Mirko] Fdn Edmund Mach, San Michele, Italy; [Weinheimer, Isabel] Roche Diagnost GmbH, Penzberg, Germany; [Haikonen, Tuuli] Nat Resources Inst Finland Luke, Hort Prod Res, Piikkio, Finland; [Ala-Poikela, Marjo] Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA	University of Helsinki; Fondazione Edmund Mach; Roche Holding; Natural Resources Institute Finland (Luke); Idaho; University of Idaho	Rajamaki, ML (corresponding author), Univ Helsinki, Dept Agr Sci, Helsinki, Finland.	minna.rajamaki@helsinki.fi	Haikonen, Tuuli/AAY-6303-2020; Rajamäki, Minna-Liisa/AAY-5758-2020	Rajamäki, Minna-Liisa/0000-0002-7952-0433; Valkonen, Jari/0000-0002-3704-9911; Moser, Mirko/0000-0002-1936-984X; Haikonen, Tuuli/0000-0002-9631-9774	Academy of Finland [1134335, 1253126, 1276136]; Viikki Doctoral Program in Molecular Biosciences; Finnish Doctoral Program in Plant Sciences	Academy of Finland(Academy of Finland); Viikki Doctoral Program in Molecular Biosciences; Finnish Doctoral Program in Plant Sciences	This work was funded by the Academy of Finland (grants 1134335, 1253126 and 1276136 to JPTV), Viikki Doctoral Program in Molecular Biosciences (to IW), and the Finnish Doctoral Program in Plant Sciences (to TH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Ala-Poikela M, 2011, J VIROL, V85, P6784, DOI 10.1128/JVI.00485-11; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Chen H, 2015, VIROLOGY, V476, P395, DOI 10.1016/j.virol.2014.12.034; Cuellar WJ, 2009, P NATL ACAD SCI USA, V106, P10354, DOI 10.1073/pnas.0806042106; Du ZG, 2011, MOL PLANT PATHOL, V12, P808, DOI [10.1111/J.1364-3703.2011.00716.X, 10.1111/j.1364-3703.2011.00716.x]; Fukunaga R, 2009, EMBO J, V28, P545, DOI 10.1038/emboj.2009.2; Gall JG, 2003, NAT REV MOL CELL BIO, V4, P975, DOI 10.1038/nrm1262; Garcia-Ruiz H, 2010, PLANT CELL, V22, P481, DOI 10.1105/tpc.109.073056; Glick E, 2008, P NATL ACAD SCI USA, V105, P157, DOI 10.1073/pnas.0709036105; Guo HY, 2013, MOL PLANT MICROBE IN, V26, P927, DOI 10.1094/MPMI-02-13-0040-R; Haas G, 2008, EMBO J, V27, P2102, DOI 10.1038/emboj.2008.129; Haikonen T, 2013, MOL PLANT MICROBE IN, V26, P734, DOI 10.1094/MPMI-01-13-0023-R; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hoffer P, 2011, P NATL ACAD SCI USA, V108, P409, DOI 10.1073/pnas.1009805108; Jouannet V, 2012, EMBO J, V31, P1704, DOI 10.1038/emboj.2012.20; Karyeija RF, 2000, PHYTOPATHOLOGY, V90, P1250, DOI 10.1094/PHYTO.2000.90.11.1250; Kim SH, 2007, EMBO J, V26, P2169, DOI 10.1038/sj.emboj.7601674; Kreuze JF, 2005, J VIROL, V79, P7227, DOI 10.1128/JVI.79.11.7227-7238.2005; Kumakura N, 2009, FEBS LETT, V583, P1261, DOI 10.1016/j.febslet.2009.03.055; Mann KS, 2016, VIROLOGY, V490, P27, DOI 10.1016/j.virol.2016.01.003; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Muangsan N, 2004, PLANT J, V38, P1004, DOI 10.1111/j.1365-313X.2004.02103.x; Okano Y, 2014, PLANT CELL, V26, P2168, DOI 10.1105/tpc.113.120535; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pumplin N, 2013, NAT REV MICROBIOL, V11, P745, DOI 10.1038/nrmicro3120; Rajamaki ML, 2014, MOL PLANT MICROBE IN, V27, P1199, DOI 10.1094/MPMI-04-14-0109-R; Rajamaki ML, 2009, PLANT CELL, V21, P2485, DOI 10.1105/tpc.108.064147; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Weinheimer I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004711; Weinheimer I, 2014, J GEN VIROL, V95, P486, DOI 10.1099/vir.0.058693-0; Xie FL, 2012, PLANTA, V236, P101, DOI 10.1007/s00425-012-1591-4; Yoshikawa M, 2013, P NATL ACAD SCI USA, V110, P4117, DOI 10.1073/pnas.1217050110; Zamyatnin AA, 2006, PLANT J, V46, P145, DOI 10.1111/j.1365-313X.2006.02674.x; Zhang DP, 2008, CELL CYCLE, V7, P2268, DOI 10.4161/cc.7.14.6306	37	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159080	10.1371/journal.pone.0159080	http://dx.doi.org/10.1371/journal.pone.0159080			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391019	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400208
J	Jindrova, A; Tuma, J; Sladek, V				Jindrova, Alena; Tuma, Jan; Sladek, Vladimir			Impact of Non-Invasively Induced Motor Deficits on Tibial Cortical Properties in Mutant Lurcher Mice	PLOS ONE			English	Article							CROSS-SECTIONAL GEOMETRY; EARLY BRONZE-AGE; OSTEOCYTE MORPHOLOGY; BONE-STRUCTURE; BODY-SIZE; MOUSE; ADAPTATION; PURKINJE; DENSITY; SKILLS	It has been shown that Lurcher mutant mice have significantly altered motor abilities, regarding their motor coordination and muscular strength because of olivorecebellar degeneration. We assessed the response of the cross-sectional geometry and lacuno-canalicular network properties of the tibial mid-diaphyseal cortical bone to motor differences between Lurcher and wild-type (WT) male mice from the B6CBA strain. The first data set used in the cross-sectional geometry analysis consists of 16 mice of 4 months of age and 32 mice of 9 months of age. The second data set used in the lacunar-canalicular network analysis consists of 10 mice of 4 months of age. We compared two cross-sectional geometry and four lacunar-canalicular properties by I-region using the maximum and minimum second moment of area and anatomical orientation as well as H-regions using histological differences within a cross section. We identified inconsistent differences in the studied cross-sectional geometry properties between Lurcher and WT mice. The biggest significant difference between Lurcher and WT mice is found in the number of canaliculi, whereas in the other studied properties are only limited. Lurcher mice exhibit an increased number of canaliculi (p < 0.01) in all studied regions compared with the WT controls. The number of canaliculi is also negatively correlated with the distance from the centroid in the Lurcher and positively correlated in the WT mice. When the Lurcher and WT sample is pooled, the number of canaliculi and lacunar volume is increased in the posterior I-max region, and in addition, midcortical H-region exhibit lower number of canaliculi, lacuna to lacuna distance and increased lacunar volume. Our results indicate, that the importance of precise sample selection within cross sections in future studies is highlighted because of the histological heterogeneity of lacunar-canalicular network properties within the I-region and H-region in the mouse cortical bone.	[Jindrova, Alena; Sladek, Vladimir] Charles Univ Prague, Dept Anthropol & Human Genet, Fac Sci, Prague, Czech Republic; [Tuma, Jan] Charles Univ Prague, Fac Med Pilsen, Dept Pathophysiol, Plzen, Czech Republic; [Tuma, Jan] Charles Univ Prague, Fac Med Pilsen, Lab Neurodegenerat Disorders, Biomed Ctr, Plzen, Czech Republic	Charles University Prague; Charles University Prague; Charles University Prague	Jindrova, A (corresponding author), Charles Univ Prague, Dept Anthropol & Human Genet, Fac Sci, Prague, Czech Republic.	aja.jindrova@seznam.cz	Tuma, Jan/AFK-6976-2022; Tuma, Jan/AAG-5323-2022; Tuma, Jan/A-1572-2010	Tuma, Jan/0000-0002-7197-8482; Tuma, Jan/0000-0002-7197-8482; Tuma, Jan/0000-0002-7197-8482	Charles University Grant Agency [408911]	Charles University Grant Agency	This study was funded by the Charles University Grant Agency, grant number 408911 (AJ), http://www.cuni.cz/UK-33.html. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was funded by the Charles University Grant Agency, grant number 408911. We would like to thank Ondrej Sebesta for technical support and assistance in the high resolution confocal scanning of bone samples and the modification of the ImageJ macro for the CSG analyses of histological sections. We would also like to thank Eliska Makajevova, Jaroslav Roman and Veronika Sabolova for assistance in the preparation of bone samples and morphometric analyses. We also thank Sebastien Nogue for technical assistance.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Babuska V, 2015, CEREBELLUM, V14, P632, DOI 10.1007/s12311-015-0656-x; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Britz HM, 2012, BONE, V51, P913, DOI 10.1016/j.bone.2012.08.112; Brodt MD, 1999, J BONE MINER RES, V14, P2159, DOI 10.1359/jbmr.1999.14.12.2159; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Burr DB, 2002, BONE, V30, P781, DOI 10.1016/S8756-3282(02)00707-X; CADDY KWT, 1976, BRAIN RES, V111, P396, DOI 10.1016/0006-8993(76)90783-6; Carter Y, 2013, BONE, V52, P126, DOI 10.1016/j.bone.2012.09.010; Cendelin J, 2014, BEHAV BRAIN RES, V271, P218, DOI 10.1016/j.bbr.2014.06.023; Cendelin J, 2010, BEHAV BRAIN RES, V210, P8, DOI 10.1016/j.bbr.2010.01.035; Ciani C, 2009, BONE, V44, P1015, DOI 10.1016/j.bone.2009.01.376; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; FORTIER PA, 1987, EXP BRAIN RES, V66, P271, DOI 10.1007/bf00243304; FROST HM, 1982, METAB BONE DIS RELAT, V4, P217, DOI 10.1016/0221-8747(82)90031-5; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Hamrick MW, 2000, BONE, V27, P343, DOI 10.1016/S8756-3282(00)00339-2; Hartmann N, 2001, J CELL BIOCHEM, P222; Hilber P, 2004, BRAIN RES, V1003, P108, DOI 10.1016/j.brainres.2004.01.008; Hilber P, 2001, NEUROSCIENCE, V102, P615, DOI 10.1016/S0306-4522(00)00509-1; Hirose S, 2007, J BONE MINER METAB, V25, P374, DOI 10.1007/s00774-007-0764-x; Hora M, 2014, J HUM EVOL, V67, P19, DOI 10.1016/j.jhevol.2013.09.011; HUISKES R, 1982, J BIOMECH, V15, P65, DOI 10.1016/0021-9290(82)90036-7; Huiskes R, 2000, NATURE, V405, P704, DOI 10.1038/35015116; Jerome C, 2012, COMP ANATOMY HISTOLO, P53; Jindrova A, 2012, FOLIA ZOOL, V61, P340, DOI 10.25225/fozo.v61.i3.a1.2012; Kamioka H, 2001, BONE, V28, P145, DOI 10.1016/S8756-3282(00)00421-X; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; Kodama Y, 1999, BONE, V25, P183, DOI 10.1016/S8756-3282(99)00155-6; Krizkova A, 2004, BEHAV BRAIN RES, V150, P65, DOI 10.1016/S0166-4328(03)00247-X; Lalonde R, 1996, BEHAV BRAIN RES, V74, P213, DOI 10.1016/0166-4328(95)00164-6; LANYON LE, 1982, J BIOMECH, V15, P141, DOI 10.1016/0021-9290(82)90246-9; LeMarec N, 1997, EXP BRAIN RES, V116, P131, DOI 10.1007/PL00005733; Leroux A, 2002, GAIT POSTURE, V15, P64, DOI 10.1016/S0966-6362(01)00181-3; Longair M, 2011, BIOINFORMATICS; Mader KS, 2013, BONE, V57, P142, DOI 10.1016/j.bone.2013.06.026; Merzin M., 2008, APPL STEREOLOGICAL M; Nicolella DP, 2006, J BIOMECH, V39, P1735, DOI 10.1016/j.jbiomech.2005.04.032; O'Neill MC, 2004, J HUM EVOL, V47, P221, DOI 10.1016/j.jhevol.2004.07.002; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; PHILLIPS RITA J. S., 1960, JOUR GENET, V57, P35, DOI 10.1007/BF02985337; Polk JD, 2000, J HUM EVOL, V39, P297, DOI 10.1006/jhev.2000.0420; Porras-Garcia E, 2005, EUR J NEUROSCI, V21, P979, DOI 10.1111/j.1460-9568.2005.03940.x; Price C, 2005, J BONE MINER RES, V20, P1983, DOI 10.1359/JBMR.050707; Qing H, 2012, J BONE MINER RES, V27, P1018, DOI 10.1002/jbmr.1567; Robling AG, 2002, J BONE MINER RES, V17, P1545, DOI 10.1359/jbmr.2002.17.8.1545; ROUX W, 1881, KAMPF TEILE ORGANISM; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Ruff C, 2002, ANNU REV ANTHROPOL, V31, P211, DOI 10.1146/annurev.anthro.31.040402.085407; Ruff C.B., 2006, MOMENT MACRO NIH IMA; Ruff C. B, 2007, BIOL ANTHR HUMAN SKE, P183; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; RUFF CB, 1993, AM J PHYS ANTHROPOL, V91, P21, DOI 10.1002/ajpa.1330910103; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P359, DOI 10.1002/ajpa.1330600308; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sharma D, 2012, BONE, V51, P488, DOI 10.1016/j.bone.2012.05.014; SIMSKE SJ, 1992, J BIOMECH, V25, P489, DOI 10.1016/0021-9290(92)90089-J; Skedros JG, 2004, J MORPHOL, V259, P281, DOI 10.1002/jmor.10167; Skedros JG, 2003, ANAT REC PART A, V273A, P609, DOI 10.1002/ar.a.10073; Sladek V, 2007, AM J PHYS ANTHROPOL, V133, P669, DOI 10.1002/ajpa.20551; Sladek V, 2006, AM J PHYS ANTHROPOL, V130, P320, DOI 10.1002/ajpa.20372; STEINBERG ME, 1981, CLIN ORTHOP RELAT R, P52; Stout S, 2011, BONE HISTOLOGY ANTHR, P153; Styner M, 2014, BONE, V64, P39, DOI 10.1016/j.bone.2014.03.044; Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008; Sugawara Y, 2013, BONE, V52, P189, DOI 10.1016/j.bone.2012.09.033; Thullier F, 1997, DEV BRAIN RES, V100, P22, DOI 10.1016/S0165-3806(97)00010-2; Trinkaus E, 1999, J HUM EVOL, V37, P1, DOI 10.1006/jhev.1999.0295; Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5; van Hove RP, 2009, BONE, V45, P321, DOI 10.1016/j.bone.2009.04.238; Vatsa A, 2008, BONE, V43, P452, DOI 10.1016/j.bone.2008.01.030; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; WETTS R, 1982, BRAIN RES, V250, P358, DOI 10.1016/0006-8993(82)90431-0; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	76	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158877	10.1371/journal.pone.0158877	http://dx.doi.org/10.1371/journal.pone.0158877			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387489	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500057
J	Davidson, JA; Urban, T; Tong, SH; Twite, M; Woodruff, A; Wischmeyer, PE; Klawitter, J				Davidson, Jesse A.; Urban, Tracy; Tong, Suhong; Twite, Mark; Woodruff, Alan; Wischmeyer, Paul E.; Klawitter, Jelena			Alkaline Phosphatase, Soluble Extracellular Adenine Nucleotides, and Adenosine Production after Infant Cardiopulmonary Bypass	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; ACUTE KIDNEY INJURY; CONTROLLED-TRIAL; CARDIAC-SURGERY; GUT MICROBIOTA; IN-VIVO; INFLAMMATION; CHILDREN; COLITIS; SEPSIS	Rationale Decreased alkaline phosphatase activity after infant cardiac surgery is associated with increased post-operative cardiovascular support requirements. In adults undergoing coronary artery bypass grafting, alkaline phosphatase infusion may reduce inflammation. Mechanisms underlying these effects have not been explored but may include decreased conversion of extracellular adenine nucleotides to adenosine. Objectives 1) Evaluate the association between alkaline phosphatase activity and serum conversion of adenosine monophosphate to adenosine after infant cardiac surgery; 2) assess if inhibition/supplementation of serum alkaline phosphatase modulates this conversion. Methods and Research Pre/post-bypass serum samples were obtained from 75 infants <4 months of age. Serum conversion of 13C5-adenosine monophosphate to 13C5-adenosine was assessed with/without selective inhibition of alkaline phosphatase and CD73. Low and high concentration 13C5-adenosine monophosphate (simulating normal/stress concentrations) were used. Effects of alkaline phosphatase supplementation on adenosine monophosphate clearance were also assessed. Changes in serum alkaline phosphatase activity were strongly correlated with changes in 13C5-adenosine production with or without CD73 inhibition (r = 0.83; p<0.0001). Serum with low alkaline phosphatase activity (<= 80 U/L) generated significantly less 13C5-adenosine, particularly in the presence of high concentration 13C5-adenosine monophosphate (10.4 mu mol/L vs 12.9 mu mol/L; p = 0.0004). Inhibition of alkaline phosphatase led to a marked decrease in 13C5-adenosine production ( 11.9 mu mol/L vs 2.7 mu mol/L; p<0.0001). Supplementation with physiologic dose human tissue non-specific alkaline phosphatase or high dose bovine intestinal alkaline phosphatase doubled 13C5-adenosine monophosphate conversion to 13C5-adenosine (p<0.0001). Conclusions Alkaline phosphatase represents the primary serum ectonucleotidase after infant cardiac surgery and low post-operative alkaline phosphatase activity leads to impaired capacity to clear adenosine monophosphate. AP supplementation improves serum clearance of adenosine monophosphate to adenosine. These findings represent a potential therapeutic mechanism for alkaline phosphatase infusion during cardiac surgery. New and Noteworthy We identify alkaline phosphatase (AP) as the primary soluble ectonucleotidase in infants undergoing cardiopulmonary bypass and show decreased capacity to clear AMP when AP activity decreases post-bypass. Supplementation of AP ex vivo improves this capacity and may represent the beneficial therapeutic mechanism of AP infusion seen in phase 2 studies.	[Davidson, Jesse A.] Univ Colorado, Dept Pediat, Pediat Cardiol, Aurora, CO 80045 USA; [Urban, Tracy] Childrens Hosp Colorado, CCRO, Aurora, CO USA; [Tong, Suhong] Univ Colorado, Dept Biostat, Aurora, CO USA; [Twite, Mark; Wischmeyer, Paul E.; Klawitter, Jelena] Univ Colorado, Dept Anesthesiol, Aurora, CO USA; [Woodruff, Alan] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesia, Div Pediat Crit Care Med, Boston, MA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Harvard University; Boston Children's Hospital; Harvard Medical School	Davidson, JA (corresponding author), Univ Colorado, Dept Pediat, Pediat Cardiol, Aurora, CO 80045 USA.	jesse.davidson@childrenscolorado.org	Woodruff, MD, Alan G/AAM-3427-2021	Woodruff, MD, Alan G/0000-0003-2219-7660; Davidson, Jesse/0000-0001-9193-9803	National Institute of Health/Heart Lung and Blood Institute [1K23HL123634-01]; National Institute of Health/National Center for Advancing Translational Science Colorado Clinical and Translational Science Award [UL1 TR001082]; American Heart Association [13CRP17300016]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL123634] Funding Source: NIH RePORTER	National Institute of Health/Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Health/National Center for Advancing Translational Science Colorado Clinical and Translational Science Award; American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study is supported by National Institute of Health/Heart Lung and Blood Institute 1K23HL123634-01 (JAD), National Institute of Health/National Center for Advancing Translational Science Colorado Clinical and Translational Science Award Grant Number UL1 TR001082 (JAD), and American Heart Association 13CRP17300016 (JAD). Contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascione R, 2006, ANN THORAC SURG, V81, P97, DOI 10.1016/j.athoracsur.2005.06.038; Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010; Beumer C, 2003, J PHARMACOL EXP THER, V307, P737, DOI 10.1124/jpet.103.056606; Blinder JJ, 2012, J THORAC CARDIOV SUR, V143, P368, DOI 10.1016/j.jtcvs.2011.06.021; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Chen KT, 2010, AM J PHYSIOL-GASTR L, V299, pG467, DOI 10.1152/ajpgi.00364.2009; Cremer J, 1996, ANN THORAC SURG, V61, P1714, DOI 10.1016/0003-4975(96)00055-0; Davidson J, 2012, CRIT CARE, V16, DOI 10.1186/cc11483; de Jong PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035070; Ebrahimi F, 2011, J GASTROINTEST SURG, V15, P860, DOI 10.1007/s11605-010-1405-6; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Fiechter D, 2011, CARDIOL RES, V2, P236, DOI 10.4021/cr81w; Heemskerk S, 2009, CRIT CARE MED, V37, P417, DOI 10.1097/CCM.0b013e31819598af; Hoffman TM, 2003, CIRCULATION, V107, P996, DOI 10.1161/01.CIR.0000051365.81920.28; Kats S, 2009, RECENT PATENTS INFLA, V3, P214, DOI 10.2174/187221309789257388; Koyama I, 2002, CLIN BIOCHEM, V35, P455, DOI 10.1016/S0009-9120(02)00330-2; Lukas M, 2010, INFLAMM BOWEL DIS, V16, P1180, DOI 10.1002/ibd.21161; LUM G, 1989, CLIN CHEM, V35, P664; Malo MS, 2010, GUT, V59, P1476, DOI 10.1136/gut.2010.211706; MOSS DW, 1982, CLIN CHEM, V28, P2007; NEUTZE JM, 1974, AM HEART J, V88, P553, DOI 10.1016/0002-8703(74)90237-3; Newburger JW, 2006, CIRCULATION, V113, P183, DOI 10.1161/CIRCULATIONAHA.105.594804; Pavione MA, 2012, J THORAC CARDIOV SUR, V144, P178, DOI 10.1016/j.jtcvs.2011.12.029; Peters E, ALKALINE PHOSPHATASE; Petrovic-Djergovic D, 2012, J IMMUNOL, V188, P2387, DOI 10.4049/jimmunol.1003671; Pettengill M, 2013, J BIOL CHEM, V288, P27315, DOI 10.1074/jbc.M113.484212; Pickkers P, 2012, CRIT CARE, V16, DOI 10.1186/cc11159; Pike AF, 2013, BBA-MOL BASIS DIS, V1832, P2044, DOI 10.1016/j.bbadis.2013.07.016; Poelstra K, 1997, AM J PATHOL, V151, P1163; Poupon R, 2015, HEPATOLOGY, V61, P2080, DOI 10.1002/hep.27715; Ramasamy S, 2011, INFLAMM BOWEL DIS, V17, P532, DOI 10.1002/ibd.21377; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Rossano JW, 2012, J CARD FAIL, V18, P459, DOI 10.1016/j.cardfail.2012.03.001; Tuin A, 2009, GUT, V58, P379, DOI 10.1136/gut.2007.128868; Verweij WR, 2004, SHOCK, V22, P174, DOI 10.1097/01.shk.0000132485.05049.8a; Whitehouse JS, 2010, J SURG RES, V163, P79, DOI 10.1016/j.jss.2010.04.048; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	40	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158981	10.1371/journal.pone.0158981	http://dx.doi.org/10.1371/journal.pone.0158981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384524	gold, Green Submitted, Green Published			2022-12-26	WOS:000379809400095
J	Humer, E; Khol-Parisini, A; Metzler-Zebeli, BU; Gruber, L; Zebeli, Q				Humer, Elke; Khol-Parisini, Annabella; Metzler-Zebeli, Barbara U.; Gruber, Leonhard; Zebeli, Qendrim			Alterations of the Lipid Metabolome in Dairy Cows Experiencing Excessive Lipolysis Early Postpartum	PLOS ONE			English	Article							NONESTERIFIED FATTY-ACIDS; INSULIN-RESISTANCE; EARLY LACTATION; GLUCOSE-METABOLISM; SUBCLINICAL KETOSIS; BETA-OXIDATION; BODY CONDITION; DRY PERIOD; CARNITINE; PLASMA	A decrease in insulin sensitivity enhances adipose tissue lipolysis helping early lactation cows counteracting their energy deficit. However, excessive lipolysis poses serious health risks for cows, and its underlying mechanisms are not clearly understood. The present study used targeted ESI-LC-MS/MS-based metabolomics and indirect insulin sensitivity measurements to evaluate metabolic alterations in the serum of dairy cows of various parities experiencing variable lipolysis early postpartum. Thirty (12 primiparous and 18 multiparous) cows of Holstein Friesian and Simmental breeds, fed the same diet and kept under the same management conditions, were sampled at d 21 postpartum and classified as low (n = 10), medium (n = 8), and high (n = 12) lipolysis groups, based on serum concentration of nonesterified fatty acids. Overall, excessive lipolysis in the high group came along with impaired estimated insulin sensitivity and characteristic shifts in acylcarnitine, sphingomyelin, phosphatidylcholine and lysophospholipid metabolome profiles compared to the low group. From the detected phosphatidylcholines mainly those with diacyl-residues showed differences among lipolysis groups. Furthermore, more than half of the detected sphingomyelins were increased in cows experiencing high lipomobilization. Additionally, strong differences in serum acylcarnitines were noticed among lipolysis groups. The study suggests an altered serum phospholipidome in dairy cows associated with an increase in certain long-chain sphingomyelins and the progression of disturbed insulin function. In conclusion, the present study revealed 37 key metabolites as part of alterations in the synthesis or breakdown of sphingolipids and phospholipids associated with lowered estimated insulin sensitivity and excessive lipolysis in early-lactating cows.	[Humer, Elke; Khol-Parisini, Annabella; Zebeli, Qendrim] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Metzler-Zebeli, Barbara U.] Univ Vet Med Vienna, Univ Clin Swine, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Gruber, Leonhard] Agr Res & Educ Ctr Raumberg Gumpenstein, Inst Livestock Res, Irdning, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Zebeli, Q (corresponding author), Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria.	qendrim.zebeli@vetmeduni.ac.at		Humer, Elke/0000-0001-9776-0353	collaborative project ADDA (ADvancement of Dairying in Austria) of Austrian Research Promotion Agency (FFG) [843543]	collaborative project ADDA (ADvancement of Dairying in Austria) of Austrian Research Promotion Agency (FFG)	This research was supported by collaborative project ADDA (ADvancement of Dairying in Austria) of Austrian Research Promotion Agency (FFG), (Grant No. 843543) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Adewuyi AA, 2005, VET QUART, V27, P117, DOI 10.1080/01652176.2005.9695192; Almanza-Perez JC, 2010, BIOMED PHARMACOTHER, V64, P534, DOI 10.1016/j.biopha.2009.04.047; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Bell DH, 1981, LIPID METABOLISM LIV, P363; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BREMER J, 1983, PHYSIOL REV, V63, P1420, DOI 10.1152/physrev.1983.63.4.1420; Breukink H. J., 1997, Israel Journal of Veterinary Medicine, V52, P66; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chilliard Y, 2000, P NUTR SOC, V59, P127, DOI 10.1017/S002966510000015X; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Cozzi G, 2011, J DAIRY SCI, V94, P3895, DOI 10.3168/jds.2010-3687; De Koster JD, 2013, VET CLIN N AM-FOOD A, V29, P299, DOI 10.1016/j.cvfa.2013.04.002; Drackley JK., 2000, LIPID METABOLISM; Floegel A, 2013, DIABETES, V62, P639, DOI 10.2337/db12-0495; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; GENUTH SM, 1979, DIABETES, V28, P1083, DOI 10.2337/diab.28.12.1083; GfE (Gesellschaft fur Ernahrungsphysiologie), 2001, REC SUPPL EN NUTR DA; Gonzalez FD, 2011, J VET SCI, V12, P251, DOI 10.4142/jvs.2011.12.3.251; Gruffat D, 1996, REPROD NUTR DEV, V36, P375, DOI 10.1051/rnd:19960404; Grum DE, 1996, J DAIRY SCI, V79, P1850, DOI 10.3168/jds.S0022-0302(96)76553-0; Hammon HM, 2009, J DAIRY SCI, V92, P1554, DOI 10.3168/jds.2008-1634; Hanamatsu H, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.38; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2014, CELL METAB, V20, P703, DOI 10.1016/j.cmet.2014.10.017; Holtenius P, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-29; Humer E, 2016, ANIMAL; Imhasly S, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-122; Ingvartsen KL, 2000, J DAIRY SCI, V83, P1573, DOI 10.3168/jds.S0022-0302(00)75029-6; Inokuchi T, 1995, DIABETES RES CLIN PR, V30, P1, DOI 10.1016/0168-8227(95)01140-4; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lapierre H, 2012, J ANIM SCI, V90, P1708, DOI 10.2527/jas.2011-4645; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Li Y, 2014, VET QUART, V34, P152, DOI 10.1080/01652176.2014.962116; MARKUSFELD O, 1987, J DAIRY SCI, V70, P158, DOI 10.3168/jds.S0022-0302(87)79990-1; MCGARRY JD, 1975, P NATL ACAD SCI USA, V72, P4385, DOI 10.1073/pnas.72.11.4385; Meikle A, 2004, REPRODUCTION, V127, P727, DOI 10.1530/rep.1.00080; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Metzler-Zebeli BU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130553; Moore JH, 1981, LIPID METABOLISM MAM; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; Oberbach A, 2011, J PROTEOME RES, V10, P4769, DOI 10.1021/pr2005555; Oetzel GR, 2004, VET CLIN N AM-FOOD A, V20, P651, DOI 10.1016/j.cvfa.2004.06.006; Ospina PA, 2010, J DAIRY SCI, V93, P3595, DOI 10.3168/jds.2010-3074; Piepenbrink MS, 2003, J DAIRY SCI, V86, P1722, DOI 10.3168/jds.S0022-0302(03)73758-8; Pires JAA, 2007, J DAIRY SCI, V90, P2735, DOI 10.3168/jds.2006-759; PULLEN DL, 1990, J ANIM SCI, V68, P1395; Quesada I, 2008, J ENDOCRINOL, V199, P5, DOI 10.1677/JOE-08-0290; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Ramsay S L, 2007, Apparatus and method for analyzing a metabolite profile, Patent No. [EP 1875401 A211, 1875401]; Rico JE, 2015, J DAIRY SCI, V98, P7757, DOI 10.3168/jds.2015-9519; Sun LW, 2014, J DAIRY SCI, V97, P1552, DOI 10.3168/jds.2013-6757; Suthar VS, 2013, J DAIRY SCI, V96, P2925, DOI 10.3168/jds.2012-6035; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; van Dorland HA, 2009, J DAIRY SCI, V92, P1924, DOI 10.3168/jds.2008-1454; Wang-Sattler R, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.43; Weber C, 2013, J DAIRY SCI, V96, P165, DOI 10.3168/jds.2012-5574; WINTER SC, 1989, AM J DIS CHILD, V143, P1337, DOI 10.1001/archpedi.1989.02150230095030; Zeisel SH, 2001, CHOLINE, P513; Zhang HY, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-186; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	63	30	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158633	10.1371/journal.pone.0158633	http://dx.doi.org/10.1371/journal.pone.0158633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383746	gold, Green Published, Green Submitted			2022-12-26	WOS:000379809400069
J	Sepulveda, RD; Valdivia, N				Sepulveda, Roger D.; Valdivia, Nelson			Localised Effects of a Mega-Disturbance: Spatiotemporal Responses of Intertidal Sandy Shore Communities to the 2010 Chilean Earthquake	PLOS ONE			English	Article							ANALOGA STIMPSON 1857; BEACH ECOSYSTEMS; CRAB; MULTIVARIATE; ASSEMBLAGES; ORIENTATION; VARIABILITY; ABUNDANCE; ZONATION; BACI	Determining the effects of unpredictable disturbances on dynamic ecological systems is challenged by the paucity of appropriate temporal and spatial coverage of data. On 27 February 2010, an 8.8 Mw mega-earthquake and tsunami struck central Chile and caused coastal land-level changes, massive damage to coastal infrastructure, and widespread mortality of coastal organisms. Wave-exposed sandy beaches showed significant changes of species abundances from before to after the earthquake, but the highly dynamic biotic and abiotic conditions of these habitats make difficult to draw clear-cut conclusions from these patterns. Here, we analysed a beyond-BACI (Before-After Control-Impact) sampling design to test whether the effects of the Maule earthquake on sandy-shore species diversity, abundance, and structure were heterogeneous along the shore. Invertebrate species abundances were quantified before (i.e. February 2010) and after (i.e. March 2010, September 2010, and March 2011) the earthquake at three sandy shores randomly located within the earthquake rupture area and three sites within a "control" area located >400 km southward from epicentre. Immediately after the earthquake took place, the three sites located in the rupture area showed anomalous beach-profile uplifts that did not comply with the erosion (i.e. "negative" uplifts) that regularly occurs during late summer in the region. Species richness, abundance, and community structure significantly varied from before to after the strike, but these patterns of change varied among sites within both areas. Only the site with the strongest and persistent beach-profile uplift within the rupture area showed significant concomitant changes in species richness and community structure; after 13 months, this community showed a similar multivariate structure to the before-disturbance state. This site, in particular, was located in the section of the rupture area that received most of the impact of the after-earthquake tsunami. Therefore, our results suggest that the effects of the Maule mega-earthquake on the ecological communities were spatially heterogeneous and highly localised. We suggest that high mobility and other species' adaptations to the dynamic environmental conditions of sandy beaches might explain the comparatively high resilience of these assemblages. With this work we hope to motivate further experimental research on the role of individual- and population-level properties in the response of sandy-beach communities to interacting sources of disturbances.	[Sepulveda, Roger D.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile; [Sepulveda, Roger D.] Univ Simon Bolivar, South Amer Res Grp Coastal Ecosyst SARCE, Ctr Invest, Caracas, Venezuela; [Valdivia, Nelson] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Valdivia, Nelson] Univ Austral Chile, Ctr Invest FONDAP Dinam Ecosistemas Marinos Altas, Valdivia, Chile	Universidad Austral de Chile; Simon Bolivar University; Universidad Austral de Chile; Universidad Austral de Chile	Sepulveda, RD (corresponding author), Univ Austral Chile, Fac Ciencias, Inst Ciencias Ambientales & Evolut, Valdivia, Chile.; Sepulveda, RD (corresponding author), Univ Simon Bolivar, South Amer Res Grp Coastal Ecosyst SARCE, Ctr Invest, Caracas, Venezuela.	rogersepulveda@uach.cl	; Valdivia, Nelson/C-3613-2009	Sepulveda, Roger D./0000-0003-0226-5662; Valdivia, Nelson/0000-0002-5394-2072	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT [3100145, 1141037, DID-UACHS-2013-03]; Direccion de Investigacion y Desarrollo [DID-UACHS-2014-29]; Programa de Mejoramiento de la Calidad y Equidad de la Educacion Superior MECESUP [0805]	Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Direccion de Investigacion y Desarrollo; Programa de Mejoramiento de la Calidad y Equidad de la Educacion Superior MECESUP	This study was funded by Fondo Nacional de Desarrollo Cientifico y Tecnologico FONDECYT #3100145 and Direccion de Investigacion y Desarrollo DID-UACHS-2014-29 grants to R.D. Sepulveda, and supported by Programa de Mejoramiento de la Calidad y Equidad de la Educacion Superior MECESUP #0805, FONDECYT #1141037, and DID-UACHS-2013-03 grants to N. Valdivia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Brusca RC, 2003, INVERTEBRATES; Castilla JC, 2010, MAR ECOL PROG SER, V418, P17, DOI 10.3354/meps08830; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Defeo O, 2009, ESTUAR COAST SHELF S, V81, P1, DOI 10.1016/j.ecss.2008.09.022; Defeo O, 2013, GEOMORPHOLOGY, V199, P106, DOI 10.1016/j.geomorph.2013.04.013; Donohue I, 2013, ECOL LETT, V16, P421, DOI 10.1111/ele.12086; Dugan JE, 2010, SCIENCE, V329, P1146, DOI 10.1126/science.329.5996.1146-a; Fanini L, 2009, MAR ECOL PROG SER, V392, P133, DOI 10.3354/meps08219; Farias M, 2010, SCIENCE, V329, P916, DOI 10.1126/science.1192094; Gower J., 2005, ENCY BIOSTATISTICS, DOI DOI 10.1111/icad.12045; Jaramillo E, 2003, ESTUAR COAST SHELF S, V58, P177, DOI 10.1016/S0272-7714(03)00049-0; Jaramillo E, 1996, REV CHIL HIST NAT, V69, P641; Jaramillo E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035348; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Loreau M, 2003, P NATL ACAD SCI USA, V100, P12765, DOI 10.1073/pnas.2235465100; Madariaga R, 2010, SCIENCE, V328, P181, DOI 10.1126/science.1189197; McLachlan A., 2010, ECOLOGY SANDY SHORES, DOI DOI 10.1016/B978-0-12-372569-1.X5000-9; Menge BA, 2015, ECOL MONOGR, V85, P213, DOI 10.1890/14-0113.1; Munguia P, 2007, OECOLOGIA, V153, P533, DOI 10.1007/s00442-007-0762-7; Nel R, 2014, ESTUAR COAST SHELF S, V150, P1, DOI 10.1016/j.ecss.2014.07.016; Nybakken J., 2005, MARINE BIOL ECOLOGIC; Rodriguez JG, 2001, REV CHIL HIST NAT, V74, P885; Rossano C, 2009, ESTUAR COAST SHELF S, V85, P573, DOI 10.1016/j.ecss.2009.09.029; Scapini F, 2008, MAR ECOL-EVOL PERSP, V29, P19, DOI 10.1111/j.1439-0485.2007.00196.x; Scapini F, 2013, CRUSTACEANA, V86, P932, DOI 10.1163/15685403-00003206; Schlacher TA, 2008, MAR ECOL-EVOL PERSP, V29, P70, DOI 10.1111/j.1439-0485.2007.00204.x; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Subramoniam T, 2003, ADV MAR BIOL, V46, P91, DOI 10.1016/S0065-2881(03)46003-3; Terlizzi A, 2005, MAR ECOL PROG SER, V289, P27, DOI 10.3354/meps289027; Terlizzi A, 2007, MAR ECOL PROG SER, V332, P25, DOI 10.3354/meps332025; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; Valdivia N, 2014, MAR ECOL PROG SER, V497, P131, DOI 10.3354/meps10593; Veas R, 2013, MAR ENVIRON RES, V89, P9, DOI 10.1016/j.marenvres.2013.04.004; Veas R, 2014, MAR BIOL, V161, P2345, DOI 10.1007/s00227-014-2510-y; Veiga P, 2014, J SEA RES, V90, P1, DOI 10.1016/j.seares.2014.02.009; Vigny C, 2011, SCIENCE, V332, P1417, DOI 10.1126/science.1204132; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612	40	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157910	10.1371/journal.pone.0157910	http://dx.doi.org/10.1371/journal.pone.0157910			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383744	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400030
J	Stokesbury, MJW; Logan-Chesney, LM; McLean, MF; Buhariwalla, CF; Redden, AM; Beardsall, JW; Broome, JE; Dadswell, MJ				Stokesbury, Michael J. W.; Logan-Chesney, Laura M.; McLean, Montana F.; Buhariwalla, Colin F.; Redden, Anna M.; Beardsall, Jeffrey W.; Broome, Jeremy E.; Dadswell, Michael J.			Atlantic Sturgeon Spatial and Temporal Distribution in Minas Passage, Nova Scotia, Canada, a Region of Future Tidal Energy Extraction	PLOS ONE			English	Article							POPULATION CHARACTERISTICS; ACIPENSER-FULVESCENS; FISHWAY DESIGN; SUWANNEE RIVER; LAKE STURGEON; UNITED-STATES; HABITAT USE; INNER BAY; FUNDY; BASIN	In the Bay of Fundy, Atlantic sturgeon from endangered and threatened populations in the USA and Canada migrate through Minas Passage to enter and leave Minas Basin. A total of 132 sub-adult and adult Atlantic sturgeon were tagged in Minas Basin during the summers of 2010-2014 using pressure measuring, uniquely coded, acoustic transmitters with a four or eight year life span. The aim of this study was to examine spatial and seasonal distribution of sturgeon in Minas Passage during 2010-2014 and test the hypothesis that, when present, Atlantic sturgeon were evenly distributed from north to south across Minas Passage. This information is important as tidal energy extraction using in-stream, hydrokinetic turbines is planned for only the northern portion of Minas Passage. Electronic tracking data from a total of 740 sturgeon days over four years demonstrated that Atlantic sturgeon used the southern portion of Minas Passage significantly more than the northern portion. Sturgeon moved through Minas Passage at depths mostly between 15 and 45 m (n = 10,116; mean = 31.47 m; SD = 14.88). Sturgeon mean swimming depth was not significantly related to bottom depth and in deeper regions they swam pelagically. Sturgeon predominately migrated inward through Minas Passage during spring, and outward during late summer-autumn. Sturgeon were not observed in Minas Passage during winter 2012-2013 when monitoring receivers were present. This information will enable the estimation of encounters of Atlantic sturgeon with in-stream hydrokinetic turbines.	[Stokesbury, Michael J. W.; Logan-Chesney, Laura M.; McLean, Montana F.; Buhariwalla, Colin F.; Redden, Anna M.; Beardsall, Jeffrey W.; Broome, Jeremy E.; Dadswell, Michael J.] Acadia Univ, Dept Biol, Wolfville, NS, Canada	Acadia University	Stokesbury, MJW (corresponding author), Acadia Univ, Dept Biol, Wolfville, NS, Canada.	Michael.Stokesbury@AcadiaU.ca			National Science and Engineering Research Council of Canada; Offshore Energy and Environmental Research; Fundy Ocean Research Centre for Energy; Acadia Graduate Awards; Canada Research Chairs Program	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Offshore Energy and Environmental Research; Fundy Ocean Research Centre for Energy; Acadia Graduate Awards; Canada Research Chairs Program(Canada Research Chairs)	Research was funded by the National Science and Engineering Research Council of Canada grant to the Ocean Tracking Network Canada, Dr. Sara Iverson PI (http://www.nserc-crsng.gc.ca/). Research was funded by the National Science and Engineering Research Council of Canada Discovery Grant to MJWS (http://www.nserc-crsng.gc.ca/). Offshore Energy and Environmental Research, and Fundy Ocean Research Centre for Energy awards to AMR and MJWS (http://www.oera.ca/about-us/history-of-oeer-oetr/; http://fundyforce.ca/). Support was also provided by Acadia Graduate Awards to MFM, JWB, LMLC and CFB (http://www2.acadiau.ca/index.php). MJWS was supported by the Canada Research Chairs Program (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx).	Apostle R, 2013, J INT WILDLIFE LAW P, V16, P198; ASMFC (Atlantic States Marine Fisheries Commission), 1998, ATL STURG STOCK ASS; Beardsall JW, 2013, T AM FISH SOC, V142, P1202, DOI 10.1080/00028487.2013.806347; Benson RL, 2007, ENVIRON BIOL FISH, V79, P269, DOI 10.1007/s10641-006-9023-6; Bousf ield E. L., 1960, Bulletin National Museum of Canada, VNo. 166, P1; Bradford RG, 1992, CAN J ZOOL, V71, P56; Broome J, 2012, 107 AC CTR EST RES; Broome J. E., 2014, THESIS; Broome JE, 2015, P 3 MAR EN TECHN S M; Cheong TS, 2006, ENVIRON BIOL FISH, V77, P197, DOI 10.1007/s10641-006-9071-y; Coutant CC, 2000, T AM FISH SOC, V129, P351, DOI 10.1577/1548-8659(2000)129<0351:FBIRTP>2.0.CO;2; Dadswell M. J., 1987, AM FISHERIES SOC S, V1, P313; DADSWELL MJ, 1994, BIOL J LINN SOC, V51, P93, DOI 10.1111/j.1095-8312.1994.tb00947.x; DADSWELL MJ, 1986, FISHERIES, V11, P26, DOI 10.1577/1548-8446(1986)011<0026:PIOLTP>2.0.CO;2; DADSWELL MJ, 1979, CAN J ZOOL, V57, P2186, DOI 10.1139/z79-287; Dadswell MJ, 2006, FISHERIES, V31, P218, DOI 10.1577/1548-8446(2006)31[218:AROTSO]2.0.CO;2; Dadswell MJ., 1984, CAN TECH REP FISH AQ, V1256, P163; DFO (Department of Fisheries and Oceans Canada), 2009, 2009029 DFO CAN SCI; Erickson DL, 2011, J APPL ICHTHYOL, V27, P356, DOI 10.1111/j.1439-0426.2011.01690.x; Food and Drug Administration, 2012, FED REGISTER, V77, P2012; GORDON DC, 1983, CAN J FISH AQUAT SCI, V40, P1331, DOI 10.1139/f83-156; Greely J.R, 1963, MEM SEARS FOUND MAR, V1, P24; Hammar L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117756; Hammar L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084141; Karsten RH, 2008, P I MECH ENG A-J POW, V222, P493, DOI 10.1243/09576509JPE555; Keyser FM, 2016, CAN J FISH AQUAT SCI, V73, P1777, DOI 10.1139/cjfas-2016-0002; McLean MF, 2013, J APPL ICHTHYOL, V29, P503, DOI 10.1111/jai.12175; McLean MF, 2014, MAR ECOL PROG SER, V496, P59, DOI 10.3354/meps10555; Moore T., 1998, THESIS; O'Rourke F, 2010, RENEW SUST ENERG REV, V14, P3206, DOI 10.1016/j.rser.2010.07.039; Peake S, 1997, CAN J FISH AQUAT SCI, V54, P1361, DOI 10.1139/cjfas-54-6-1361; Redden A.M., 2014, P 2 INT C ENV INT MA; Rulifson RA, 2008, T AM FISH SOC, V137, P23, DOI 10.1577/T06-174.1; Scott W.B., 1988, CANADIAN B FISHERIES, V219; Secor DH, 2002, AM FISH S S, V28, P89; Stein AB, 2004, T AM FISH SOC, V133, P527, DOI 10.1577/T02-151.1; Stokesbury KDE, 2014, REV FISH SCI AQUAC, V22, P193, DOI 10.1080/23308249.2014.913005; Sulak KJ, 1999, J APPL ICHTHYOL, V15, P116, DOI 10.1111/j.1439-0426.1999.tb00220.x; Sulak KJ, 2002, J APPL ICHTHYOL, V18, P617, DOI 10.1046/j.1439-0426.2002.00401.x; Taylor DA, PLOS ONE, V11, DOI [10.1371/journal.pone.01524702016, DOI 10.1371/JOURNAL.PONE.01524702016]; Vennell R, 2010, J FLUID MECH, V663, P253, DOI 10.1017/S0022112010003502; Viehman HA, 2015, ESTUAR COAST, V38, pS215, DOI 10.1007/s12237-014-9776-7; Viehman HA, 2015, ESTUAR COAST, V38, pS241, DOI 10.1007/s12237-014-9767-8; WEBB PW, 1986, CAN J ZOOL, V64, P2137, DOI 10.1139/z86-328; Wirgin I, 2012, T AM FISH SOC, V141, P1389, DOI 10.1080/00028487.2012.700899; YEO RK, 1979, GEOSCI CAN, V6, P115	46	17	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158387	10.1371/journal.pone.0158387	http://dx.doi.org/10.1371/journal.pone.0158387			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383274	Green Published, gold			2022-12-26	WOS:000379809400046
J	Banares-Hidalgo, A; Perez-Gil, J; Estrada, P				Banares-Hidalgo, Angeles; Perez-Gil, Jesus; Estrada, Pilar			Conformational Stability of the NH2-Terminal Propeptide of the Precursor of Pulmonary Surfactant Protein SP-B	PLOS ONE			English	Article							ESCHERICHIA-COLI; RECOMBINANT FORM; IN-VITRO; AGGREGATION; XYLANASE; BINDING; MODEL	Assembly of pulmonary surfactant lipid-protein complexes depends on conformational changes coupled with proteolytic maturation of proSP-B, the precursor of pulmonary surfactant protein B (SP-B), along the surfactant biogenesis pathway in pneumocytes. Conformational destabilization of the N-terminal propeptide of proSP-B (SP-B-N) triggers exposure of the mature SP-B domain for insertion into surfactant lipids. We have studied the conformational stability during GdmCl- or urea-promoted unfolding of SP-B-N with trp fluorescence and circular dichroism spectroscopies. Binding of the intermediate states to bis-ANS suggests their molten globule-like character. Delta G(H2O)(0) was similar to 12.7 kJ center dot mol(-1) either with urea or GdmCl. None of the thermal transitions of SP-B-N detected by CD correspond to protein unfolding. Differential scanning calorimetry of SP-B-N evidenced two endothermic peaks involved in oligomer dissociation as confirmed with 2 M urea. Ionic strength was relevant since at 150 mM NaCl, the process originating the endotherm at the highest temperature was irreversible (T-m2 = 108.5 degrees C) with an activation energy of 703.8 kJ center dot mol(-1). At 500 mM NaCl the process became reversible (T-m2 = 114.4 degrees C) and data were fitted to the Non-two States model with two subpeaks. No free thiois in the propeptide could be titrated by DTNB with or without 5.7 M GdmCl, indicating disulfide bonds establishment.	[Banares-Hidalgo, Angeles; Perez-Gil, Jesus; Estrada, Pilar] Univ Complutense, Fac Biol, Dept Bioquim & Biol Mol 1, Ciudad Univ, E-28040 Madrid, Spain	Complutense University of Madrid	Perez-Gil, J (corresponding author), Univ Complutense, Fac Biol, Dept Bioquim & Biol Mol 1, Ciudad Univ, E-28040 Madrid, Spain.	jperezgil@bio.ucm.es	Perez-Gil, Jesus/H-3102-2019	Perez-Gil, Jesus/0000-0003-3587-7147	Spanish Ministry of Economy and Competition [BIO2012-30733, BIO2015-67930-R]; Regional Government of Madrid [P2013/MIT-2807]	Spanish Ministry of Economy and Competition(Spanish Government); Regional Government of Madrid	This research has been supported by grants from the Spanish Ministry of Economy and Competition (BIO2012-30733, BIO2015-67930-R), and the Regional Government of Madrid (P2013/MIT-2807).	Banares-Hidalgo A, 2008, J IND MICROBIOL BIOT, V35, P1367, DOI 10.1007/s10295-008-0437-3; Banares-Hidalgo A, 2014, BBA-BIOMEMBRANES, V1838, P1738, DOI 10.1016/j.bbamem.2014.03.016; Brasch F, 2004, AM J RESP CELL MOL, V30, P449, DOI 10.1165/rcmb.2003-0262OC; Burgos I, 2008, J PHYS CHEM B, V112, P14325, DOI 10.1021/jp804465c; Chapeaurouge A, 2002, J BIOL CHEM, V277, P16478, DOI 10.1074/jbc.M105232200; Chapeaurouge A, 2001, J BIOL CHEM, V276, P14861, DOI 10.1074/jbc.M009622200; Clarke J, 1998, CURR OPIN STRUC BIOL, V8, P112, DOI 10.1016/S0959-440X(98)80018-3; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; ELLMAN GL, 1958, ARCH BIOCHEM BIOPHYS, V74, P443, DOI 10.1016/0003-9861(58)90014-6; Fan DJ, 2009, BIOCHIM BIOPHYS ACTA, V1794, P994; Faull KF, 2000, ARCH BIOCHEM BIOPHYS, V376, P266, DOI 10.1006/abbi.2000.1714; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; FREIRE E, 1978, BIOPOLYMERS, V17, P463, DOI 10.1002/bip.1978.360170212; Gonzalez JM, 2005, P NATL ACAD SCI USA, V102, P1895, DOI 10.1073/pnas.0409517102; Gozdek A, 2008, ACTA BIOCHIM POL, V55, P57, DOI 10.18388/abp.2008_3201; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Guo SY, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1267, DOI 10.1023/B:BIRY.0000009143.92546.33; Ishimaru D, 2004, BIOPHYS J, V87, P2691, DOI 10.1529/biophysj.104.044685; Kuznetsova IM, 2004, J PROTEOME RES, V3, P485, DOI 10.1021/pr034094y; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lima LMTR, 2004, EUR J BIOCHEM, V271, P3580, DOI 10.1111/j.0014-2956.2004.04295.x; Lin S, 1996, J BIOL CHEM, V271, P19689, DOI 10.1074/jbc.271.33.19689; Lopez G, 2011, J IND MICROBIOL BIOT, V38, P113, DOI 10.1007/s10295-010-0836-0; Lyubarev AE, 2000, J THERM ANAL CALORIM, V62, P51, DOI 10.1023/A:1010102525964; Menendez M, 1995, EUR J BIOCHEM, V234, P887, DOI 10.1111/j.1432-1033.1995.887_a.x; Milardi D, 1996, BIOPHYS CHEM, V62, P95, DOI 10.1016/S0301-4622(96)02191-6; Nath D, 2001, EUR J BIOCHEM, V268, P5471, DOI 10.1046/j.0014-2956.2001.02485.x; Palacios A, 2006, ENZYME MICROB TECH, V40, P85, DOI 10.1016/j.enzmictec.2005.10.042; PAPPA HS, 1993, EUR J BIOCHEM, V212, P227, DOI 10.1111/j.1432-1033.1993.tb17654.x; PATTHY L, 1991, J BIOL CHEM, V266, P6035; Pfeil W., 1998, PROTEIN STABILITY FO; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; QI XY, 1994, J BIOL CHEM, V269, P16746; Radford SE, 2000, TRENDS BIOCHEM SCI, V25, P611, DOI 10.1016/S0968-0004(00)01707-2; REDFIELD C, 1994, NAT STRUCT BIOL, V1, P23, DOI 10.1038/nsb0194-23; Rosgen J, 1999, HDB THERMAL ANAL CAL, P65; SANCHEZRUIZ JM, 1992, BIOPHYS J, V61, P921, DOI 10.1016/S0006-3495(92)81899-4; Schiffer CA, 1996, CURR OPIN BIOTECH, V7, P428, DOI 10.1016/S0958-1669(96)80119-4; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TANFORD C, 1964, J AM CHEM SOC, V86, P2050, DOI 10.1021/ja01064a028; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2002, FEBS LETT, V514, P181, DOI 10.1016/S0014-5793(02)02359-1; Uversky VN, 1997, PROTEIN PEPTIDE LETT, V4, P355; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Yang L, 2010, J IMMUNOL, V184, P975, DOI 10.4049/jimmunol.0900650; Zhai YF, 2000, BBA-REV BIOMEMBRANES, V1469, P87, DOI 10.1016/S0304-4157(00)00003-4	48	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158430	10.1371/journal.pone.0158430	http://dx.doi.org/10.1371/journal.pone.0158430			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380171	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000379798700031
J	Lipovsek, S; Novak, T; Janzekovic, F; Weiland, N; Leitinger, G				Lipovsek, Saska; Novak, Tone; Janzekovic, Franc; Weiland, Nina; Leitinger, Gerd			Malpighian Tubule Cells in Overwintering Cave Crickets Troglophilus cavicola (Kollar, 1833) and T. neglectus Krauss, 1879 (Rhaphidophoridae, Ensifera)	PLOS ONE			English	Article							FINE-STRUCTURE; FAT-BODY; AUTOPHAGY; ORTHOPTERA; STARVATION; MIDGUT; TRANSPORT	During winter, cave cricket larvae undergo dormancy in subterranean habitats; this dormancy is termed diapause in second year Troglophilus cavicola larvae because they mature during this time, and termed quiescence in T. neglectus, because they mature after dormancy. Here we used electron microscopy to analyze ultrastructural changes in the epithelial cells in the Malpighian tubules (MTs) of T. cavicola during diapause, in order to compare them with previous findings on T. neglectus. Moreover, the autophagosomes were studied with immunofluorescence microscopy in both species. Although the basic ultrastructure of the cells was similar, specific differences appeared during overwintering. During this natural starvation period, the nucleus, rER, the Golgi apparatus and mitochondria did not show structural changes, and the spherites were exploited. The abundances of autophagic structures in both species increased during overwintering. At the beginning of overwintering, in both species and sexes, the rates of cells with autophagic structures (phagophores, autophagosomes, autolysosomes and residual bodies) were low, while their rates increased gradually towards the end of overwintering. Between sexes, in T. cavicola significant differences were found in the autophagosome abundances in the middle and at the end, and in T. neglectus at the end of overwintering. Females showed higher rates of autophagic cells than males, and these were more abundant in T. cavicola. Thus, autophagic processes in the MT epithelial cells induced by starvation are mostly parallel in diapausing T. cavicola and quiescent T. neglectus, but more intensive in diapausing females.	[Lipovsek, Saska] Univ Maribor, Fac Med, Maribor, Slovenia; [Lipovsek, Saska; Novak, Tone; Janzekovic, Franc; Weiland, Nina] Univ Maribor, Fac Nat Sci & Math, Dept Biol, Maribor, Slovenia; [Lipovsek, Saska] Univ Maribor, Fac Chem & Chem Engn, Maribor, Slovenia; [Leitinger, Gerd] Med Univ Graz, Inst Cell Biol Histol & Embryol, Res Unit Electron Microscop Tech, Graz, Austria	University of Maribor; University of Maribor; University of Maribor; Medical University of Graz	Leitinger, G (corresponding author), Med Univ Graz, Inst Cell Biol Histol & Embryol, Res Unit Electron Microscop Tech, Graz, Austria.	gerd.leitinger@medunigraz.at	Janžekovič, Franc/H-9096-2015	Leitinger, Gerd/0000-0002-5281-9830				Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Alberts B, 2008, MOL BIOL CELL, P813; Alberts B, 2004, ESSENTIAL CELL BIOL, P39; Alexiou S, 2013, PARNASSIANA ARCH, V1, P51; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Barth JMI, 2011, CELL DEATH DIFFER, V18, P915, DOI 10.1038/cdd.2010.157; Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512; Bradley T.J., 1985, P421; Bradley TJ, 2008, J EXP BIOL, V211, P835, DOI 10.1242/jeb.009589; Chopard L, 1983, BIOL ORTHOPTERES, P541; CHRISTIAN, 2008, HOHLE, V59, P48; Cooper GM, 2009, CELL MOL APPROACH, P309; Delakorda SL, 2009, ARTHROPOD STRUCT DEV, V38, P315, DOI 10.1016/j.asd.2009.02.001; Di Russo C., 1998, ENCY BIOSPELEOLOGICA, VII, P989; Di Russo Claudio, 2007, Journal of Orthoptera Research, V16, P67, DOI 10.1665/1082-6467(2007)16[67:TCCONT]2.0.CO;2; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Eskelinen Eeva-Liisa, 2008, V445, P11, DOI 10.1007/978-1-59745-157-4_2; GARRETT MA, 1988, J MORPHOL, V195, P313, DOI 10.1002/jmor.1051950306; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hazelton SR, 2001, J MORPHOL, V247, P80, DOI 10.1002/1097-4687(200101)247:1<80::AID-JMOR1004>3.0.CO;2-X; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Heller GH, 2004, FAUNA EUROPEA RHAPHI; Kalender Yusuf, 2002, Acta Zoologica Bulgarica, V54, P87; Karaman I, 2011, ZOOL J LINN SOC-LOND, V163, P1035, DOI 10.1111/j.1096-3642.2011.00738.x; Kaya S, 2013, BIOL J LINN SOC, V108, P335, DOI 10.1111/j.1095-8312.2012.02025.x; Ketmaier V, 2000, BELG J ZOOL, V130, P51; Khoa DB, 2012, INSECT MOL BIOL, V21, P473, DOI 10.1111/j.1365-2583.2012.01152.x; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kogler K, 1983, THESIS; Kristensen AR, 2008, MOL CELL PROTEOMICS, V7, P2419, DOI 10.1074/mcp.M800184-MCP200; LEROY YVELINE, 1967, ANN SPELEOL, V22, P659; Lipovsek S, 2016, PROTOPLASMA, V253, P457, DOI 10.1007/s00709-015-0824-3; Lipovsek S, 2014, ARTHROPOD STRUCT DEV, V43, P493, DOI 10.1016/j.asd.2014.06.001; Lipovsek S, 2011, ARTHROPOD STRUCT DEV, V40, P54, DOI 10.1016/j.asd.2010.09.002; Martoja R., 1984, P199; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Moog O, 1982, SITZ BER OSTERR MN 1, V191, P185; Novak T., 1983, MEM BIOSPEOL, V10, P127; Novak T, 2013, ACTA CARSOLOGICA, V42, P301; Pacheco CA, 2014, ENTOMOL ORNITHOL HER, V3, P2, DOI [DOI 10.4172/2161-0983.1000122, 10.4172/2161-0983.1000122]; Pal R, 2013, TISSUE CELL, V45, P312, DOI 10.1016/j.tice.2013.04.002; PANNABECKER T, 1995, ANNU REV ENTOMOL, V40, P493, DOI 10.1146/annurev.en.40.010195.002425; Pehani Spela, 1997, Entomologist, V116, P224; Pigino G, 2005, TISSUE CELL, V37, P223, DOI 10.1016/j.tice.2005.02.001; Remy P., 1931, Annales des Sciences Naturelles (Zoologie) Paris, V(10), P263; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Sbordoni V, 2004, ENCY CAVES KARST SCI, P451; Taylan MS, 2013, ZOOKEYS, P33, DOI 10.3897/zookeys.257.4133; Taylan S, 2012, ZOOTAXA, V3597, P33; Wheeler DE, 2003, ENCY INSECTS, P991; Yea SY, 1992, B I BASIC SCI INHA U, V13, P97	51	9	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158598	10.1371/journal.pone.0158598	http://dx.doi.org/10.1371/journal.pone.0158598			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379687	Green Submitted, gold, Green Published			2022-12-26	WOS:000379798700037
J	Vantangoli, MM; Madnick, SJ; Wilson, S; Boekelheide, K				Vantangoli, Marguerite M.; Madnick, Samantha J.; Wilson, Shelby; Boekelheide, Kim			Estradiol Exposure Differentially Alters Monolayer versus Microtissue MCF-7 Human Breast Carcinoma Cultures	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER CELLS; E-CADHERIN; GENE-EXPRESSION; ESTROGEN; PROLIFERATION; SNAIL; SLUG	The development of three-dimensional (3D) cultures is increasing, as they are able to provide the utility of in vitro models and the strength of testing in physiologically relevant systems. When cultured in a scaffold-free agarose hydrogel system, MCF-7 human breast carcinoma cells organize and develop into microtissues that contain a luminal space, in stark contrast to the flat morphology of MCF-7 two-dimensional (2D) monolayer cultures. Following exposure to 1nM E2, expression of typical estrogen-responsive genes, including progesterone receptor (PGR), PDZ containing domain 1 (PDZK1) and amphiregulin (AREG) is increased in both 2D and 3D cultures. When examining expression of other genes, particularly those involved in cell adhesion, there were large changes in 3D MCF-7 microtissues, with little to no change observed in the MCF-7 monolayer cultures. Together, these results indicate that while the initial estrogen-regulated transcriptional targets respond similarly in 2D and 3D cultures, there are large differences in activation of other pathways related to cell-cell interactions.	[Vantangoli, Marguerite M.; Madnick, Samantha J.; Wilson, Shelby; Boekelheide, Kim] Brown Univ, Dept Pathol & Lab Med, 70 Ship St, Providence, RI 02903 USA	Brown University	Boekelheide, K (corresponding author), Brown Univ, Dept Pathol & Lab Med, 70 Ship St, Providence, RI 02903 USA.	Kim_Boekelheide@brown.edu			National Institute of Environmental Health Sciences (NIEHS) Training Grant [T32 ES007272]; NIH [RO1 ES 020750]; Unilever; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007272, R01ES020750] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS) Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Unilever(Unilever); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Major support for this research was provided by the National Institute of Environmental Health Sciences (NIEHS) Training Grant T32 ES007272, Unilever, and the generous gift of Donna McGraw Weiss '89 and Jason Weiss, with additional support by NIH RO1 ES 020750. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors would like to thank Dr. Edward Dere for assistance with data analysis and visualization.; Major support for this research was provided NIEHS Training Grant T32 ES007272, Unilever, and the generous gift of Donna McGraw Weiss '89 and Jason Weiss, with additional support by NIH RO1 ES 020750. The authors would like to thank Dr. Edward Dere for assistance with data analysis and visualization.	[Anonymous], 2002, NORMAL TUMOR DERIVED; [Anonymous], 2007, MORPHOLOGIES BREAST; [Anonymous], 2003, FIBROBLAST BIOL 3 DI; [Anonymous], 1973, HUMAN CELL LINE PLEU; [Anonymous], 2007, DYNAMICS SELF ASSEMB; [Anonymous], 2004, USE 3 DIMENSIONAL BA; [Anonymous], 2003, MORPHOGENESIS ONCOGE; [Anonymous], 2005, MODELLING GLANDULAR; [Anonymous], 2007, 3 DIMENSIONAL CULTUR; [Anonymous], 1991, CONTROL MAMMARY EPIT; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Chambers A, 2010, J TOXICOL ENV HEAL B, V13, P546, DOI 10.1080/10937404.2010.538657; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Ghosh MG, 2000, CANCER RES, V60, P6367; Hajra KM, 2002, CANCER RES, V62, P1613; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Nguyen-Ngoc KV, 2012, P NATL ACAD SCI USA, V109, pE2595, DOI 10.1073/pnas.1212834109; Kohl M, 2007, SLQPCR FUNCTIONS ANA; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Napolitano AP, 2007, BIOTECHNIQUES, V43, P494, DOI 10.2144/000112591; Park SH, 2008, MOL ENDOCRINOL, V22, P2085, DOI 10.1210/me.2007-0512; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; R Core Team, 2012, R LANG ENV STAT COMP; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Scherbakov AM, 2012, J CELL BIOCHEM, V113, P2147, DOI 10.1002/jcb.24087; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suh Y, 2013, ONCOGENE, V32, P4873, DOI 10.1038/onc.2012.505; Vantangoli MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135426; Vendrell JA, 2004, J MOL ENDOCRINOL, V32, P397, DOI 10.1677/jme.0.0320397; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006	32	7	7	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157997	10.1371/journal.pone.0157997	http://dx.doi.org/10.1371/journal.pone.0157997			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379522	Green Submitted, Green Published, gold			2022-12-26	WOS:000379798700016
J	Bolognini, D; Moss, CE; Nilsson, K; Petersson, AU; Donnelly, I; Sergeev, E; Konig, GM; Kostenis, E; Kurowska-Stolarska, M; Miller, A; Dekker, N; Tobin, AB; Milligan, G				Bolognini, Daniele; Moss, Catherine E.; Nilsson, Karolina; Petersson, Annika U.; Donnelly, Iona; Sergeev, Eugenia; Koenig, Gabriele M.; Kostenis, Evi; Kurowska-Stolarska, Mariola; Miller, Ashley; Dekker, Niek; Tobin, Andrew B.; Milligan, Graeme			A Novel Allosteric Activator of Free Fatty Acid 2 Receptor Displays Unique G(i)-functional Bias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; FUNCTIONAL-CHARACTERIZATION; GUT MICROBIOTA; FFA2; PHARMACOLOGY; MECHANISM; AGONISTS; BINDING; LIGAND; GPR43	The short chain fatty acid receptor FFA2 is able to stimulate signaling via both G(i)- and G(q)/G(11)-promoted pathways. These pathways are believed to control distinct physiological end points but FFA2 receptor ligands appropriate to test this hypothesis have been lacking. Herein, we characterize AZ1729, a novel 142A2 regulator that acts as a direct allosteric agonist and as a positive allosteric modulator, increasing the activity of the endogenously produced short chain fatty acid propionate in G(i)-mediated pathways, but not at those transduced by G(q)/G(11). Using AZ1729 in combination with direct inhibitors of G(i) and G(q)/G(11) family G proteins demonstrated that although both arms contribute to propionate-mediated regulation of phospho-ERK1/2 MAP kinase signaling in FFA2-expressing 293 cells, the G(q)/G(11)-mediated pathway is predominant. We extend these studies by employing AZ1729 to dissect physiological FFA2 signaling pathways. The capacity of AZ1729 to act at FFA2 receptors to inhibit beta-adrenoreceptor agonist-promoted lipolysis in primary mouse adipocytes and to promote chemotaxis of isolated human neutrophils confirmed these as FFA2 processes mediated by G(i) signaling, whereas, in concert with blockade by the G(q)/G(11) inhibitor FR900359, the inability of AZ1729 to mimic or regulate propionate-mediated release of GLP-1 from mouse colonic preparations defined this physiological response as an end point transduced via activation of G(q)/G(11).	[Bolognini, Daniele; Moss, Catherine E.; Sergeev, Eugenia] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow G12 8QQ, Lanark, Scotland; [Moss, Catherine E.; Tobin, Andrew B.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Nilsson, Karolina] AstraZeneca, Cardiovasc & Metab Dis, Pepparedsleden 1, SE-43183 Molndal, Sweden; [Nilsson, Karolina] AstraZeneca, Resp Inflammatory & Autoimmune Dis Innovat Med &, Dept Med Chem, Pepparedsleden 1, SE-43183 Molndal, Sweden; [Dekker, Niek] AstraZeneca, Discovery Sci Reagents & Assay Dev, Pepparedsleden 1, SE-43183 Molndal, Sweden; [Donnelly, Iona; Miller, Ashley] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow G12 8QQ, Lanark, Scotland; [Kostenis, Evi] Univ Bonn, Mol Cellular & Pharmacobiol Sect, D-53115 Bonn, Germany; [Koenig, Gabriele M.] Univ Bonn, Inst Pharmaceut Biol, D-53115 Bonn, Germany; [Kurowska-Stolarska, Mariola] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Leicester; AstraZeneca; AstraZeneca; AstraZeneca; University of Glasgow; University of Bonn; University of Bonn; University of Glasgow	Milligan, G (corresponding author), Univ Glasgow, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk	Kurowska-Stolarska, Mariola/AAD-1683-2019; Bolognini, Daniele/AAF-7892-2020; Hodge, Daryl/AAL-2993-2021	Hodge, Daryl/0000-0003-2288-7020; Sergeev, Eugenia/0000-0001-8271-3693	Biotechnology and Biosciences Research Council [BB/L027887/1, BB/L02781X/1]; German Research Foundation (DFG) [FR900359, FOR2372]; BBSRC [BB/K019856/1, BB/K019856/2, BB/L02781X/1, BB/L027887/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L027887/1, BB/L02781X/1, 1653478, BB/K019856/1, BB/K019856/2] Funding Source: researchfish	Biotechnology and Biosciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Research Foundation (DFG)(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biosciences Research Council Grants BB/L027887/1 (to G. M. and A. M. M.) and BB/L02781X/1 (to A. B. T.) and German Research Foundation (DFG) (to G. M. K. and E K.) for isolation and characterization of FR900359 Grant FOR2372. N.D., K.N., and A. U. P. are employees of AstraZeneca.	Alvarez-Curto E., 2016, BIOCH PHARM; Ang ZW, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00028; Berg S., 2007, Int. Pat., Patent No. [WO2007120096, 2007120096]; Boerrigter G, 2012, CIRC-HEART FAIL, V5, P627, DOI 10.1161/CIRCHEARTFAILURE.112.969220; Bolognini D, 2016, MOL PHARMACOL, V89, P388, DOI 10.1124/mol.115.102301; Brown A. J., 2003, J BIOL; Busnelli M, 2012, J BIOL CHEM, V287, P3617, DOI 10.1074/jbc.M111.277178; Christopoulos A, 2014, MOL PHARMACOL, V86, P463, DOI 10.1124/mol.114.094342; Corbisier J, 2015, J BIOL CHEM, V290, P9542, DOI 10.1074/jbc.M114.596098; Dass NB, 2007, NEUROGASTROENT MOTIL, V19, P66, DOI 10.1111/j.1365-2982.2006.00853.x; den Besten G, 2013, AM J PHYSIOL-GASTR L, V305, pG900, DOI 10.1152/ajpgi.00265.2013; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Due-Hansen ME, 2016, ORG BIOMOL CHEM, V14, P430, DOI 10.1039/c5ob02129d; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Grundmann M, 2016, CELL CHEM BIOL, V23, P392, DOI 10.1016/j.chembiol.2016.02.014; Hii CS, 2004, J BIOL CHEM, V279, P49825, DOI 10.1074/jbc.M406892200; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Hudson BD, 2013, J BIOL CHEM, V288, P17296, DOI 10.1074/jbc.M113.455337; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Kenakin T, 2015, MOL PHARMACOL, V88, P1055, DOI 10.1124/mol.115.099770; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; Kenakin T, 2010, J RECEPT SIG TRANSD, V30, P313, DOI 10.3109/10799893.2010.503964; Keov P, 2011, NEUROPHARMACOLOGY, V60, P24, DOI 10.1016/j.neuropharm.2010.07.010; Kimura I, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00085; Langmead CJ, 2011, METHODS MOL BIOL, V746, P195, DOI 10.1007/978-1-61779-126-0_10; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Liu Y. P., 2015, J ADV CLIN PHARM, V1, P1, DOI DOI 10.1109/TCYB.2015.2388582; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; M'Kadmi C, 2015, J BIOL CHEM, V290, P27021, DOI 10.1074/jbc.M115.659250; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Milligan G, 2017, CHEM REV, V117, P67, DOI 10.1021/acs.chemrev.6b00056; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Mohammad S, 2015, CURR DRUG TARGETS, V16, P771, DOI 10.2174/1389450116666150408103557; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Park BO, 2016, EUR J PHARMACOL, V771, P1, DOI 10.1016/j.ejphar.2015.12.010; Pizzonero M, 2014, J MED CHEM, V57, P10044, DOI 10.1021/jm5012885; Possenti R, 2012, BIOCHEM J, V441, P511, DOI 10.1042/BJ20111165; Reimann F, 2008, CELL METAB, V8, P532, DOI 10.1016/j.cmet.2008.11.002; Rodrigues H. G., 2015, EUR J PHARM; Schmidt J, 2011, J BIOL CHEM, V286, P10628, DOI 10.1074/jbc.M110.210872; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Sergeev E, 2016, J BIOL CHEM, V291, P303, DOI 10.1074/jbc.M115.687939; Smith NJ, 2011, MOL PHARMACOL, V80, P163, DOI 10.1124/mol.110.070789; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Vinolo MAR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021205; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2	56	45	45	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18915	18931		10.1074/jbc.M116.736157	http://dx.doi.org/10.1074/jbc.M116.736157			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27385588	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000383242300028
J	Wesolowski, CA; Wesolowski, MJ; Babyn, PS; Wanasundara, SN				Wesolowski, Carl A.; Wesolowski, Michal J.; Babyn, Paul S.; Wanasundara, Surajith N.			Time Varying Apparent Volume of Distribution and Drug Half-Lives Following Intravenous Bolus Injections	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; PLASMA-CLEARANCE	We present a model that generalizes the apparent volume of distribution and half-life as functions of time following intravenous bolus injection. This generalized model defines a time varying apparent volume of drug distribution. The half-lives of drug remaining in the body vary in time and become longer as time elapses, eventually converging to the terminal half-life. Two example fit models were substituted into the general model: biexponential models from the least relative concentration error, and gamma variate models using adaptive regularization for least relative error of clearance. Using adult population parameters from 41 studies of the renal glomerular filtration marker Yb-169-DTPA, simulations of extracellular fluid volumes of 5, 10, 15 and 20 litres and plasma clearances of 40 and 100 ml/min were obtained. Of these models, the adaptively obtained gamma variate models had longer times to 95% of terminal volume and longer half-lives.	[Wesolowski, Carl A.; Wesolowski, Michal J.; Babyn, Paul S.; Wanasundara, Surajith N.] Univ Saskatchewan, Coll Med, Dept Med Imaging, Saskatoon, SK, Canada; [Wesolowski, Carl A.] Mem Univ Newfoundland, Dept Radiol, St John, NF, Canada	University of Saskatchewan; Memorial University Newfoundland	Wesolowski, CA (corresponding author), Univ Saskatchewan, Coll Med, Dept Med Imaging, Saskatoon, SK, Canada.; Wesolowski, CA (corresponding author), Mem Univ Newfoundland, Dept Radiol, St John, NF, Canada.	carl.wesolowski@usask.ca	Wesolowski, Carl A/C-1317-2010	Wesolowski, Carl A/0000-0003-0134-9346; Wanasundara, Surajith/0000-0003-0939-1039	Sylvia Fedoruk Canadian Centre for Nuclear Innovation [J2012-114]; College of Medicine of the University of Saskatchewan	Sylvia Fedoruk Canadian Centre for Nuclear Innovation; College of Medicine of the University of Saskatchewan	This work was supported by the Sylvia Fedoruk Canadian Centre for Nuclear Innovation (grant no. J2012-114), http://www.fedorukcentre.ca/, and the College of Medicine of the University of Saskatchewan, https://www.usask.ca/. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to express their gratitude to Dr. Charles D. Russell for making the patient data available. The authors express their gratitude especially to Dr. Richard C. Puetter and to Dr. Jane Alcorn for their contributions to previous submissions of this work. This work was supported by the Sylvia Fedoruk Canadian Centre for Nuclear Innovation (grant no. J2012-114) and the College of Medicine of the University of Saskatchewan. There was no additional external funding received for this study.	Becker R, 1991, Eur J Drug Metab Pharmacokinet, VSpec No 3, P15; BENET LZ, 1979, J PHARM SCI, V68, P1071, DOI 10.1002/jps.2600680845; Berezhkovskiy LM, 2007, J PHARM SCI-US, V96, P1638, DOI 10.1002/jps.20804; BROCHNERMORTENSEN J, 1981, SCAND J CLIN LAB INV, V41, P91, DOI 10.3109/00365518109092020; COLBURN WA, 1983, J PHARMACOKINET BIOP, V11, P389, DOI 10.1007/BF01058957; FLORIJN KW, 1994, KIDNEY INT, V46, P252, DOI 10.1038/ki.1994.267; Heiene RD, 1998, J VET INTERN MED, V12, P401, DOI 10.1111/j.1939-1676.1998.tb02143.x; NIAZI S, 1976, J PHARM SCI, V65, P452, DOI 10.1002/jps.2600650339; Orlando R, 1998, BRIT J CLIN PHARMACO, V46, P605; Perkinson AS, 2010, PHYSIOL MEAS, V31, P183, DOI 10.1088/0967-3334/31/2/005; RUSSELL CD, 1985, J NUCL MED, V26, P1243; Smith DA, 2015, J MED CHEM, V58, P5691, DOI 10.1021/acs.jmedchem.5b00201; Toutain PL, 2004, J VET PHARMACOL THER, V27, P441, DOI 10.1111/j.1365-2885.2004.00602.x; Toutain PL, 2004, J VET PHARMACOL THER, V27, P415, DOI 10.1111/j.1365-2885.2004.00605.x; Wada DR, 1998, CLIN PHARMACOKINET, V35, P1, DOI 10.2165/00003088-199835010-00001; Wanasundara SN, 2016, NUCL MED COMMUN, V37, P79, DOI 10.1097/MNM.0000000000000405; Wanasundara SN, 2015, NUCL MED COMMUN, V36, P392, DOI 10.1097/MNM.0000000000000255; Wesolowski CA, 2010, J NUCL MED S2, V51; Wesolowski CA, 2010, J PHARMACOKINET PHAR, V37, P435, DOI 10.1007/s10928-010-9167-z; Wesolowski CA, 2011, EUR J NUCL MED MOL I, V38, P2247, DOI 10.1007/s00259-011-1887-9; ZIERLER K, 1981, ANNU REV BIOPHYS BIO, V10, P531, DOI 10.1146/annurev.bb.10.060181.002531	21	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158798	10.1371/journal.pone.0158798	http://dx.doi.org/10.1371/journal.pone.0158798			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403663	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508200016
J	Szirovicza, L; Lopez, P; Kopena, R; Benko, M; Martin, J; Penzes, JJ				Szirovicza, Leonora; Lopez, Pilar; Kopena, Renata; Benko, Maria; Martin, Jose; Penzes, Judit J.			Random Sampling of Squamate Reptiles in Spanish Natural Reserves Reveals the Presence of Novel Adenoviruses in Lacertids (Family Lacertidae) and Worm Lizards (Amphisbaenia)	PLOS ONE			English	Article							DRAGONS POGONA-VITTICEPS; ADENO-LIKE VIRUS; INFECTION; EVOLUTION; ANTIBODIES; HEPATITIS; SEQUENCE; GENUS; PCR; DNA	Here, we report the results of a large-scale PCR survey on the prevalence and diversity of adenoviruses (AdVs) in samples collected randomly from free-living reptiles. On the territories of the Guadarrama Mountains National Park in Central Spain and of the Chafarinas Islands in North Africa, cloacal swabs were taken from 318 specimens of eight native species representing five squamate reptilian families. The healthy-looking animals had been captured temporarily for physiological and ethological examinations, after which they were released. We found 22 AdV-positive samples in representatives of three species, all from Central Spain. Sequence analysis of the PCR products revealed the existence of three hitherto unknown AdVs in 11 Carpetane rock lizards (Iberolacerta cyreni), nine Iberian worm lizards (Blanus cinereus), and two Iberian green lizards (Lacerta schreiberi), respectively. Phylogeny inference showed every novel putative virus to be a member of the genus Atadenovirus. This is the very first description of the occurrence of AdVs in amphisbaenian and lacertid hosts. Unlike all squamate atadenoviruses examined previously, two of the novel putative AdVs had A+T rich DNA, a feature generally deemed to mirror previous host switch events. Our results shed new light on the diversity and evolution of atadenoviruses.	[Szirovicza, Leonora; Benko, Maria; Penzes, Judit J.] Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, 21 Hungaria Krt, H-1143 Budapest, Hungary; [Lopez, Pilar; Kopena, Renata; Martin, Jose] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Jose Gutierrez Abascal 2, E-28006 Madrid, Spain	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Penzes, JJ (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, 21 Hungaria Krt, H-1143 Budapest, Hungary.	Judit.Penzes@iaf.inrs.ca	Lopez, Pilar/K-6221-2014; BENKO, Maria/A-4135-2008; Kopena, Renata/AAG-4392-2020; Martin, Jose/B-1073-2014	Lopez, Pilar/0000-0001-6577-1509; Martin, Jose/0000-0001-6648-3998; Kopena, Renata/0000-0001-7850-6472; Szirovicza, Leonora/0000-0003-1528-044X	Hungarian Scientific Research Fund (OTKA) [K100163];  [MICIIN-CGL2011-24150/BOS];  [MINECO-CGL2014-53523-P]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ; 	The authors gratefully acknowledge the financial support provided by the Hungarian Scientific Research Fund (OTKA grant K100163) and by the projects MICIIN-CGL2011-24150/BOS and MINECO CGL2014-53523-P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abbas MD, 2011, VET MICROBIOL, V150, P70, DOI 10.1016/j.vetmic.2011.01.010; Aderem A, 2000, CELL, V103, P993, DOI 10.1016/S0092-8674(00)00201-4; Ambinder RF, 1999, SEMIN CANCER BIOL, V9, P369, DOI 10.1006/scbi.1999.0137; Amo L, 2004, PARASITOL RES, V94, P290, DOI 10.1007/s00436-004-1212-7; Ascher JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060977; Ball I, 2014, VET J, V202, P176, DOI 10.1016/j.tvjl.2014.07.027; Ball I, 2014, J ZOO WILDLIFE MED, V45, P287, DOI 10.1638/2013-0143.1; Ball Inna, 2012, Journal of Herpetological Medicine and Surgery, V22, P12, DOI 10.5818/1529-9651-22.1-2.12; Behncke H, 2013, VET REC, V173, P248, DOI 10.1136/vr.101545; Benko M, 2003, CURR TOP MICROBIOL, V272, P3; Benko M, 2002, J VIROL, V76, P10056, DOI 10.1128/JVI.76.19.10056-10059.2002; Benko M, 1998, ARCH VIROL, V143, P829, DOI 10.1007/s007050050335; Benko M., 2011, SPRINGER INDEX VIRUS, P29; Dan A, 2003, ACTA VET HUNG, V51, P551, DOI 10.1556/AVet.51.2003.4.13; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Davison AJ, 2000, J GEN VIROL, V81, P2431, DOI 10.1099/0022-1317-81-10-2431; Doszpoly A, 2013, INFECT GENET EVOL, V17, P106, DOI 10.1016/j.meegid.2013.03.049; Farkas SL, 2008, MAGYAR ALLATORVOSOK, V130, P775; Farkas SL, 2008, VIRUS RES, V132, P132, DOI 10.1016/j.virusres.2007.11.009; Flajnik MF, 2000, CURR TOP MICROBIOL, V252, P233; FRYE FL, 1994, J ZOO WILDLIFE MED, V25, P167; Harrach B, 2000, ACTA VET HUNG, V48, P485, DOI 10.1556/004.48.2000.4.11; Harrach B., 2012, VIRUS TAXONOMY, P125, DOI DOI 10.1016/8978-0-12-384684-6.00009-4; HELDSTAB A, 1984, J ZOO ANIM MED, V15, P118, DOI 10.2307/20094703; Hess M, 1997, VIROLOGY, V238, P145, DOI 10.1006/viro.1997.8815; Hyndman T, 2011, AUST VET J, V89, P232, DOI 10.1111/j.1751-0813.2011.00712.x; JACOBSON ER, 1985, J AM VET MED ASSOC, V187, P1226; JACOBSON ER, 1986, J ZOO WILDLIFE MED, V17, P149, DOI 10.2307/20094810; JACOBSON ER, 1990, VET PATHOL, V27, P210, DOI 10.1177/030098589002700313; Judit P, 2011, MAGY ALLATORVOSOK, V133, P432; JUHASZ A, 1993, ARCH VIROL, V130, P429, DOI 10.1007/BF01309671; JULIAN AF, 1982, NEW ZEAL VET J, V30, P59, DOI 10.1080/00480169.1982.34880; Kinsel MJ, 1997, J ZOO WILDLIFE MED, V28, P498; Kovacs ER, 2010, J VIROL METHODS, V163, P262, DOI 10.1016/j.jviromet.2009.10.007; Krieg AM, 2003, SCAND J INFECT DIS, V35, P653, DOI 10.1080/00365540310015999; Kubiak M, 2013, VET REC, V172, P475, DOI 10.1136/vr.101087; Kubber-Heiss A, 2006, WIEN TIERARZTL MONAT, V93, P68; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Madsen T, 2007, EVOL ECOL, V21, P271, DOI 10.1007/s10682-006-9004-4; Mahapatra D, 2013, J ZOO WILDLIFE MED, V44, P220, DOI 10.1638/1042-7260-44.1.220; Marschang RE, 2011, VIRUSES-BASEL, V3, P2087, DOI 10.3390/v3112087; Marschang RE, 2003, P 6 INT C VET VIR VI, P152; OGAWA M, 1992, J VET MED B, V39, P732, DOI 10.1111/j.1439-0450.1992.tb01228.x; Papp T, 2009, VET MICROBIOL, V134, P233, DOI 10.1016/j.vetmic.2008.08.003; Parkin DB, 2009, INFECT GENET EVOL, V9, P501, DOI 10.1016/j.meegid.2009.01.010; Penzes JJ, 2015, J GEN VIROL, V96, P2769, DOI 10.1099/vir.0.000215; Penzes JJ, 2014, J VIROL, V88, P11304, DOI 10.1128/JVI.00306-14; Penzes JJ, 2014, ACTA VET HUNG, V62, P284, DOI 10.1556/AVet.2014.010; Perkins LEL, 2001, J VET DIAGN INVEST, V13, P365, DOI 10.1177/104063870101300418; Poss M, 2006, J VIROL, V80, P2728, DOI 10.1128/JVI.80.6.2728-2737.2006; Ramis A, 2000, J VET DIAGN INVEST, V12, P573, DOI 10.1177/104063870001200616; Raymond JT, 2003, J WILDLIFE DIS, V39, P431, DOI 10.7589/0090-3558-39.2.431; Rivera S, 2009, J VET DIAGN INVEST, V21, P415, DOI 10.1177/104063870902100402; SCHUMACHER J, 1994, J ZOO WILDLIFE MED, V25, P461; Shackelton LA, 2005, P NATL ACAD SCI USA, V102, P379, DOI 10.1073/pnas.0406765102; Staden R, 2000, Methods Mol Biol, V132, P115; Wellehan JFX, 2004, J VIROL, V78, P13366, DOI 10.1128/JVI.78.23.13366-13369.2004; Wozniak E. J., 2000, Journal of Herpetological Medicine and Surgery, V10, P4	59	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159016	10.1371/journal.pone.0159016	http://dx.doi.org/10.1371/journal.pone.0159016			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27399970	gold, Green Submitted, Green Published			2022-12-26	WOS:000379508100014
J	Larson, BA; Rockers, PC; Bonawitz, R; Sriruttan, C; Glencross, DK; Cassim, N; Coetzee, LM; Greene, GS; Chiller, TM; Vallabhaneni, S; Long, L; van Rensburg, C; Govender, NP				Larson, Bruce A.; Rockers, Peter C.; Bonawitz, Rachael; Sriruttan, Charlotte; Glencross, Deborah K.; Cassim, Naseem; Coetzee, Lindi M.; Greene, Gregory S.; Chiller, Tom M.; Vallabhaneni, Snigdha; Long, Lawrence; van Rensburg, Craig; Govender, Nelesh P.			Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa	PLOS ONE			English	Article							MORTALITY; CARE	Background In 2015 South Africa established a national cryptococcal antigenemia (CrAg) screening policy targeted at HIV-infected patients with CD4+ T-lymphocyte (CD4) counts <100 cells/mu l who are not yet on antiretroviral treatment (ART). Two screening strategies are included in national guidelines: reflex screening, where a CrAg test is performed on remnant blood samples from CD4 testing; and provider-initiated screening, where providers order a CrAg test after a patient returns for CD4 test results. The objective of this study was to compare costs and effectiveness of these two screening strategies. Methods We developed a decision analytic model to compare reflex and provider-initiated screening in terms of programmatic and health outcomes (number screened, number identified for preemptive treatment, lives saved, and discounted years of life saved) and screening and treatment costs (2015 USD). We estimated a base case with prevalence and other parameters based on data collected during CrAg screening pilot projects integrated into routine HIV care in Gauteng, Free State, and Western Cape Provinces. We conducted sensitivity analyses to explore how results change with underlying parameter assumptions. Results In the base case, for each 100,000 CD4 tests, the reflex strategy compared to the provider-initiated strategy has higher screening costs ($37,536 higher) but lower treatment costs ($55,165 lower), so overall costs of screening and treatment are $17,629 less with the reflex strategy. The reflex strategy saves more lives (30 lives, 647 additional years of life saved). Sensitivity analyses suggest that reflex screening dominates provider-initiated screening ( lower total costs and more lives saved) or saves additional lives for small additional costs (<$125 per life year) across a wide range of conditions (CrAg prevalence, patient and provider behavior, patient survival without treatment, and effectiveness of preemptive fluconazole treatment). Conclusions In countries with substantial numbers of people with untreated, advanced HIV disease such as South Africa, CrAg screening before initiation of ART has the potential to reduce cryptococcal meningitis and save lives. Reflex screening compared to provider-initiated screening saves more lives and is likely to be cost saving or have low additional costs per additional year of life saved.	[Larson, Bruce A.; Rockers, Peter C.; Bonawitz, Rachael] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Sriruttan, Charlotte; Govender, Nelesh P.] Natl Inst Communicable Dis, Ctr Opportunist Trop & Hosp Infect, Johannesburg, South Africa; [Glencross, Deborah K.; Cassim, Naseem; Coetzee, Lindi M.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Glencross, Deborah K.; Cassim, Naseem; Coetzee, Lindi M.; Long, Lawrence; van Rensburg, Craig; Govender, Nelesh P.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Long, Lawrence; van Rensburg, Craig] Wits Hlth Consortium, Hlth Econ & Epidemiol Off, Johannesburg, South Africa; [Greene, Gregory S.; Chiller, Tom M.; Vallabhaneni, Snigdha] Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA USA; [Bonawitz, Rachael] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA	Boston University; National Institute for Communicable Diseases (NICD); National Health Laboratory Service; University of Witwatersrand; University of Witwatersrand; Centers for Disease Control & Prevention - USA; Boston University	Larson, BA (corresponding author), Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA.	blarson@bu.edu	Govender, Nelesh/ABI-6429-2020; Cassim, Naseem/GLR-4911-2022; Cassim, Naseem/AFU-5522-2022	Cassim, Naseem/0000-0003-4389-2849; Cassim, Naseem/0000-0003-4389-2849; Larson, Bruce/0000-0002-9322-2387; Govender, Nelesh/0000-0001-7869-9462; Glencross, Deborah/0000-0001-7106-769X; Long, Lawrence/0000-0003-4986-4988	CDC Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118511] Funding Source: NIH RePORTER	CDC Foundation(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Boston University School of Public received a grant from the CDC Foundation, which provided support to BU and HE2RO related authors for completing this analysis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binnicker MJ, 2012, CLIN VACCINE IMMUNOL, V19, P1988, DOI 10.1128/CVI.00446-12; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Fox MP, 2012, TROP MED INT HEALTH, V17, P1235, DOI 10.1111/j.1365-3156.2012.03055.x; French N, 2002, AIDS, V16, P1031, DOI 10.1097/00002030-200205030-00009; Glencross DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114727; Govender NP, 2015, HIV MED, V16, P468, DOI 10.1111/hiv.12245; Govender NP, 2014, SAMJ S AFR MED J, V104, P896, DOI 10.7196/SAMJ.9070; Govender NP, PHASED IMPLEMENTATIO; Jarvis JN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069288; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Kaplan JE, 2015, JAIDS-J ACQ IMM DEF, V68, pS331, DOI 10.1097/QAI.0000000000000484; Kapoor SW, 2015, AIDS, V29, P2473, DOI 10.1097/QAD.0000000000000872; Larson BA, 2013, AIDS RES TREAT, V2013, DOI 10.1155/2013/941493; Larson Bruce A, 2013, Cost Eff Resour Alloc, V11, P18, DOI 10.1186/1478-7547-11-18; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Mathers CD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P45; Meiring ST, 2012, AIDS, V26, P2307, DOI 10.1097/QAD.0b013e3283570567; Meya David, 2015, Curr Trop Med Rep, V2, P81; Meya DB, 2010, CLIN INFECT DIS, V51, P448, DOI 10.1086/655143; Micol R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013856; National Institute of Communicable Diseases, 2015, MONTHL SURV REP 1 JA; National Institute of Communicable Diseases National Health Laboratory Service, 2014, GERMS SA ANN REP 201; Rajasingham R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001316; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Smith RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062213; South African National Department of Health, 2018, GUIDELINES IMPLEMENT; Vallabhaneni S, 2016, N LONGL SESS TITL CR; Wake RM, 2016, AIDS, V30, P339, DOI 10.1097/QAD.0000000000000967	30	25	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158986	10.1371/journal.pone.0158986	http://dx.doi.org/10.1371/journal.pone.0158986			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390864	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400181
J	Lim, I; Jung, Y; Kim, DY; Kim, KT				Lim, Ilgye; Jung, Youngseob; Kim, Do-Yeon; Kim, Kyong-Tai			HnRNP Q Has a Suppressive Role in the Translation of Mouse Cryptochrome1	PLOS ONE			English	Article							MAMMALIAN CIRCADIAN CLOCK; RNA-BINDING PROTEINS; MESSENGER-RNA; SUPRACHIASMATIC NUCLEUS; DEPENDENT TRANSLATION; FEEDBACK LOOPS; DEGRADATION; CRY; OSCILLATION; RHYTHMS	Precise regulation of gene expression is especially important for circadian timekeeping which is maintained by the proper oscillation of the mRNA and protein of clock genes and clock-controlled genes. As a main component of the core negative arm feedback loops in the circadian clock, the Cry1 gene contributes to the maintenance of behavioral and molecular rhythmicity. Despite the central role of Cry1, the molecular mechanisms regulating expression levels of Cry1 mRNA and protein are not well defined. In particular, the post-transcriptional regulation of Cry1 mRNA fate decisions is unclear. Here, we demonstrate that hnRNP Q binds to mCry1 mRNA via the 5'UTR. Furthermore, hnRNP Q inhibits the translation of mCry1 mRNA, leading to altered rhythmicity in the mCRY1 protein profile.	[Lim, Ilgye; Kim, Kyong-Tai] Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, Gyeongbuk, South Korea; [Lim, Ilgye] CHA Univ, Sch Med, Seongnam, South Korea; [Jung, Youngseob; Kim, Kyong-Tai] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea; [Kim, Do-Yeon] Kyungpook Natl Univ, Brain Sci & Engn Inst, Sch Dent, Dept Pharmacol, Daegu, South Korea	Pohang University of Science & Technology (POSTECH); Pochon Cha University; Pohang University of Science & Technology (POSTECH); Kyungpook National University	Kim, KT (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Life Sci, Pohang, Gyeongbuk, South Korea.; Kim, KT (corresponding author), Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, Gyeongbuk, South Korea.; Kim, DY (corresponding author), Kyungpook Natl Univ, Brain Sci & Engn Inst, Sch Dent, Dept Pharmacol, Daegu, South Korea.	dykim82@knu.ac.kr; ktk@postech.ac.kr		KIM, KYONG-TAI/0000-0001-7292-2627	"Cooperative Research Program for Agriculture Science & Technology Development" from Rural Development Administration [PJ01121602]; BK21 Plus - Ministry of Education [10Z20130012243]; POSCO (AP-TP, Green science), Korea	"Cooperative Research Program for Agriculture Science & Technology Development" from Rural Development Administration; BK21 Plus - Ministry of Education; POSCO (AP-TP, Green science), Korea	This work was carried out with the support of the "Cooperative Research Program for Agriculture Science & Technology Development (Project No. PJ01121602)" from Rural Development Administration, BK21 Plus funded by the Ministry of Education [10Z20130012243], and POSCO (AP-TP, Green science), Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand SN, 2013, J NEUROSCI, V33, P7145, DOI 10.1523/JNEUROSCI.4950-12.2013; Barinaga M, 2000, SCIENCE, V288, P943; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kim DY, 2011, NUCLEIC ACIDS RES, V39, P8901, DOI 10.1093/nar/gkr605; Kim DY, 2010, NUCLEIC ACIDS RES, V38, P7068, DOI 10.1093/nar/gkq569; Kim JH, 2003, MOL CELL BIOL, V23, P708, DOI 10.1128/MCB.23.2.708-720.2003; Kim TD, 2007, GENE DEV, V21, P797, DOI 10.1101/gad.1519507; Kim TD, 2005, MOL CELL BIOL, V25, P3232, DOI 10.1128/MCB.25.8.3232-3246.2005; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee KH, 2014, NUCLEIC ACIDS RES, V42, P3590, DOI 10.1093/nar/gkt1379; Lee KH, 2012, MOL CELL BIOL, V32, P717, DOI 10.1128/MCB.06177-11; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Ono D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2670; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Paz I, 2014, NUCLEIC ACIDS RES, V42, pW361, DOI 10.1093/nar/gku406; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Schmalen I, 2014, CELL, V157, P1203, DOI 10.1016/j.cell.2014.03.057; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shi GS, 2013, P NATL ACAD SCI USA, V110, P4750, DOI 10.1073/pnas.1302560110; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Woo KC, 2010, MOL CELL BIOL, V30, P197, DOI 10.1128/MCB.01154-09; Xing WM, 2013, NATURE, V496, P64, DOI 10.1038/nature11964; Xu H., 2015, BIOMED RES INT, V2015, P1, DOI DOI 10.1016/J.CECA.2015.02.006; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214	41	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159018	10.1371/journal.pone.0159018	http://dx.doi.org/10.1371/journal.pone.0159018			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392095	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400193
J	Rebelo, F; Franco-Sena, AB; Struchiner, CJ; Kac, G				Rebelo, Fernanda; Franco-Sena, Ana Beatriz; Struchiner, Claudio Jose; Kac, Gilberto			Changes in Maternal Plasma Adiponectin from Late Pregnancy to the Postpartum Period According to the Mode of Delivery: Results from a Prospective Cohort in Rio de Janeiro, Brazil	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TYPE-2 DIABETIC-PATIENTS; HUMAN-MILK ADIPONECTIN; SERUM ADIPONECTIN; WOMEN; WEIGHT; INSULIN; ASSOCIATIONS; POPULATION; ADIPOCYTES	Introduction Maternal plasma adiponectin is inversely related to insulin resistance, atherosclerosis and child health. However, little is known about its concentrations in the perinatal period, especially according to mode of delivery. Our aim is to evaluate the association between mode of delivery and changes in maternal plasma adiponectin from 3rd trimester of pregnancy to 30-45 days postpartum. Methods A cohort was recruited in Rio de Janeiro, Brazil, with four waves of follow-up: 5-13th, 22-26th, 30-36th gestational weeks and 30-45 days postpartum. Eligible subjects should be between 20-40 years of age, be free of chronic and infectious diseases and presenting with a singleton pregnancy. The mode of delivery was classified as vaginal (VD) or cesarean (CS). Plasma adiponectin concentration (mu g/mL) was measured using commercial ELISA kits. Statistical analyses included the Wilcoxon rank-sum test and the multiple linear mixed effects model. Results A total of 159 participated in the study. Median adiponectin concentrations were higher for the VD group (n = 99; 8.25, IQR: 5.85-11.90) than for the CS group (n = 60; 7.34, IQR: 4.36-9.76; p = 0.040) in the postpartum samples but were not different between the two groups in the 3rd trimester. Women who underwent CS had a lower rate of increase in adiponectin concentration from the 3rd trimester to 30-45 days postpartum compared to those who underwent VD (beta = -.15, 95% CI: -.28-.02, p = 0.030). Conclusion The CS procedure was associated with lower maternal circulating concentrations of adiponectin at 30-45 days postpartum, compared to the VD.	[Rebelo, Fernanda; Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth, Rio De Janeiro, RJ, Brazil; [Rebelo, Fernanda; Franco-Sena, Ana Beatriz; Kac, Gilberto] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Dept Social & Appl Nutr, Nutr Epidemiol Observ, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Kac, G (corresponding author), Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Dept Social & Appl Nutr, Nutr Epidemiol Observ, Rio De Janeiro, RJ, Brazil.	gilberto.kac@gmail.com	Rebelo, Fernanda/AAN-5125-2020; Struchiner, Claudio Jose/HGB-9492-2022; Kac, Gilberto/H-6862-2012; Struchiner, Claudio J/M-9360-2013	Kac, Gilberto/0000-0001-8603-9077; Struchiner, Claudio J/0000-0003-2114-847X; Rebelo, Fernanda/0000-0001-6207-5161	National Council for Scientific and Technological Development (CNPq) [471196/2010-0, 304182/2013-3]; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ) [E-26/111.400/2010, E-26/110.681/2012, E-26/112.181/2012, E-26/111.698/2013]; National School of Public Health; Brazilian Coordination for the Training of University Level Personnel (CAPES in the Portuguese acronym); CAPES; CNPq	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National School of Public Health; Brazilian Coordination for the Training of University Level Personnel (CAPES in the Portuguese acronym)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for this study was provided by the National Council for Scientific and Technological Development (CNPq, grant numbers: 471196/2010-0, 304182/2013-3) and the Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ, grant numbers: E-26/111.400/2010, E-26/110.681/2012, E-26/112.181/2012, E-26/111.698/2013). These agencies had no roles in the study design; collection, analysis and interpretation of the data; writing of the paper; or the decision to submit the paper for publication. FR received scholarships from the National School of Public Health and Brazilian Coordination for the Training of University Level Personnel (CAPES in the Portuguese acronym). ABFS received a scholarship from the CAPES. GK and CJS received scholarships from CNPq.; We would like to thank the funding agencies that have made possible the realization of this study. FR received scholarships from the National School of Public Health and Brazilian Coordination for the Training of University Level Personnel (CAPES in the Portuguese acronym). ABFS received a scholarship from the CAPES. GK and CJS received scholarships from CNPq. The authors have no conflicts of interest to report. We also thank Professor Michelle A. Williams and the Global Research and Training in Non-Communicable Diseases and Perinatal Epidemiology Group (Harvard T. H. Chan School of Public Health, Boston/MA) for the ideas and contributions that they provided for the improvement of the article.	Andreasson AN, 2012, AM J HUM BIOL, V24, P595, DOI 10.1002/ajhb.22279; Asai-Sato M, 2006, ENDOCR J, V53, P555, DOI 10.1507/endocrj.K06-026; Asayama K, 2003, OBES RES, V11, P1072, DOI 10.1038/oby.2003.147; Aso Y, 2006, DIABETES, V55, P1954, DOI 10.2337/db05-1525; Bowen JM, 2002, PLACENTA, V23, P257, DOI 10.1053/plac.2001.0782; Brown S, 1998, BRIT J OBSTET GYNAEC, V105, P156, DOI 10.1111/j.1471-0528.1998.tb10045.x; Catalano PM, 2006, DIABETOLOGIA, V49, P1677, DOI 10.1007/s00125-006-0264-x; Childbirth Connection, 2012, VAG CES BIRTH WHAT I; Cicarelli LM, 2005, MEDIAT INFLAMM, P96, DOI 10.1155/MI.2005.96; Eriksson B, 2010, BRIT J NUTR, V103, P50, DOI 10.1017/S0007114509991371; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; KAAPA P, 1993, ACTA OBSTET GYN SCAN, V72, P543, DOI 10.3109/00016349309058160; Kew S, 2014, DIABETES CARE, V37, P1998, DOI 10.2337/dc14-0087; Kishida K, 2014, BEST PRACT RES CL EN, V28, P119, DOI 10.1016/j.beem.2013.08.006; Ley SH, 2012, AM J CLIN NUTR, V95, P867, DOI 10.3945/ajcn.111.028431; Matyjaszek-Matuszek B, 2014, ANN AGR ENV MED, V21, P850, DOI 10.5604/12321966.1129945; Mazaki-Tovi S, 2011, GYNECOL ENDOCRINOL, V27, P725, DOI 10.3109/09513590.2010.500426; Merl V, 2005, INT J OBESITY, V29, P998, DOI 10.1038/sj.ijo.0802971; Mutlu B, 2011, J MATERN-FETAL NEO M, V24, P1367, DOI 10.3109/14767058.2010.548883; Newburg DS, 2010, J PEDIATR-US, V156, pS41, DOI 10.1016/j.jpeds.2009.11.020; *NIH, 2006, NIH STAT OF THE SCI, P1; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Ozarda Y, 2012, CLIN CHEM LAB MED, V50, P911, DOI 10.1515/cclm-2011-0724; Retnakaran R, 2007, DIABETIC MED, V24, P245, DOI 10.1111/j.1464-5491.2007.02077.x; Retnakaran R, 2010, DIABETOLOGIA, V53, P268, DOI 10.1007/s00125-009-1600-8; Savino F, 2012, ACTA PAEDIATR, V101, P1058, DOI 10.1111/j.1651-2227.2012.02744.x; Shand B, 2006, CLIN CHEM LAB MED, V44, P1264, DOI 10.1515/CCLM.2006.227; Domingues RMSM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00105113; Stefan N, 2002, J CLIN ENDOCR METAB, V87, P4652, DOI 10.1210/jc.2002-020694; Textor J, 2011, EPIDEMIOLOGY, V22, P745, DOI 10.1097/EDE.0b013e318225c2be; Vitoratos N, 2008, GYNECOL ENDOCRINOL, V24, P614, DOI 10.1080/09513590802342866; Woo JG, 2009, BREASTFEED MED, V4, P101, DOI 10.1089/bfm.2008.0137; Yuan GY, 2007, J ENDOCRINOL, V194, P275, DOI 10.1677/JOE-07-0133	34	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158886	10.1371/journal.pone.0158886	http://dx.doi.org/10.1371/journal.pone.0158886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391647	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400150
J	Chakrabarti, M; Klionsky, DJ; Ray, SK				Chakrabarti, Mrinmay; Klionsky, Daniel J.; Ray, Swapan K.			miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells	PLOS ONE			English	Article							OLIGOMER PROCYANIDINS; GRAPE SEEDS; IN-VITRO; EXPRESSION; DIFFERENTIATION; PROLIFERATION; INVASION; INDUCE; DEATH	Glioblastoma is the most common and malignant brain tumor in humans. It is a heterogeneous tumor harboring glioblastoma stem cells (GSC) and other glioblastoma cells that survive and sustain tumor growth in a hypoxic environment via induction of autophagy and resistance to apoptosis. So, a therapeutic strategy to inhibit autophagy and promote apoptosis could greatly help control growth of glioblastoma. We created hypoxia using sodium sulfite (SS) for induction of substantiated autophagy in human GSC and glioblastoma SNB19 cells. Induction of autophagy was confirmed by acridine orange (AO) staining and significant increase in Beclin-1 in autophagic cells. microRNA database (miRDB) search suggested that miR-30e could suppress the autophagy marker Beclin-1 and also inhibit the caspase activation inhibitors (AVEN and BIRC6). Pro-apoptotic effect of proanthocyanidin (PAC) has not yet been explored in glioblastoma cells. Combination of 50 nM miR-30e and 150 mu M PAC acted synergistically for inhibition of viability in both cells. This combination therapy most effectively altered expression of molecules for inhibition of autophagy and induced extrinsic and intrinsic pathways of apoptosis through suppression of AVEN and BIRC6. Collectively, combination of miR-30e and PAC is a promising therapeutic strategy to inhibit autophagy and increase apoptosis in GSC and SNB19 cells.	[Chakrabarti, Mrinmay; Ray, Swapan K.] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA	University of South Carolina System; University of South Carolina Columbia; University of Michigan System; University of Michigan	Ray, SK (corresponding author), Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	swapan.ray@uscmed.sc.edu	CHAKRABARTI, MRINMAY/M-5652-2019		University of South Carolina School of Medicine Research Development Fund (USC SOM RDF, Columbia, SC, USA); South Carolina Spinal Cord Injury Research Fund (Columbia, SC, USA) [SC SCIRF-2015-I-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	University of South Carolina School of Medicine Research Development Fund (USC SOM RDF, Columbia, SC, USA); South Carolina Spinal Cord Injury Research Fund (Columbia, SC, USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The present study was supported in part by the grants from University of South Carolina School of Medicine Research Development Fund (USC SOM RDF, Columbia, SC, USA) and South Carolina Spinal Cord Injury Research Fund (SC SCIRF-2015-I-01, Columbia, SC, USA) to SKR.	Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bhutia SK, 2010, CANCER RES, V70, P3667, DOI 10.1158/0008-5472.CAN-09-3647; BLOCK G, 1992, NUTR CANCER, V18, P1, DOI 10.1080/01635589209514201; Chakrabarti M, 2013, EXP CELL RES, V319, P1575, DOI 10.1016/j.yexcr.2013.02.025; Chakrabarti M, 2013, NEUROCHEM RES, V38, P420, DOI 10.1007/s11064-012-0936-5; Chakrabarti M, 2012, BRAIN RES, V1454, P1, DOI 10.1016/j.brainres.2012.03.017; Chen LH, 2011, BIOCHEM PHARMACOL, V81, P594, DOI 10.1016/j.bcp.2010.12.011; Chifenti Barbara, 2013, Clin Exp Reprod Med, V40, P33, DOI 10.5653/cerm.2013.40.1.33; DEMESQUITA HBB, 1991, INT J CANCER, V48, P540, DOI 10.1002/ijc.2910480411; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gallo S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.155; Hershkovitz-Rokah O, 2015, CANCER LETT, V356, P597, DOI 10.1016/j.canlet.2014.10.006; Jiang B, 2011, J BIOL INORG CHEM, V16, P267, DOI 10.1007/s00775-010-0723-1; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Meeran SM, 2009, CARCINOGENESIS, V30, P520, DOI 10.1093/carcin/bgp019; Mohan N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078958; Nandakumar V, 2008, CANC LETT, V375, P162; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Pintha K, 2015, BIOL PHARM BULL, V38, P571, DOI 10.1248/bpb.b14-00719; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Singh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027444; Sun Q, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-134; Tanabe F, 2011, AUTOPHAGY, V7, P1462, DOI 10.4161/auto.7.12.17892; Turcotte S, 2010, CURR OPIN CELL BIOL, V22, P246, DOI 10.1016/j.ceb.2009.12.007; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021539; Viry E, 2014, BIOCHEM PHARMACOL, V92, P31, DOI 10.1016/j.bcp.2014.07.006; Yamanaka-Tatematsu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076605; Zarzynska JM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/710345; Zhang FJ, 2010, PHARM BIOL, V48, P883, DOI 10.3109/13880200903311102; Zhang FJ, 2009, CHEM-BIOL INTERACT, V179, P419, DOI 10.1016/j.cbi.2008.12.017; Zhang Y, 2014, BIOCHEM PHARMACOL, V87, P562, DOI 10.1016/j.bcp.2013.12.004; Zheng HL, 2015, INT J ONCOL, V46, P708, DOI 10.3892/ijo.2014.2744; Zou ZY, 2012, J BIOL CHEM, V287, P4148, DOI 10.1074/jbc.M111.307405	38	22	22	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158537	10.1371/journal.pone.0158537	http://dx.doi.org/10.1371/journal.pone.0158537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388765	Green Published, Green Submitted, gold			2022-12-26	WOS:000379811500026
J	Rajora, OP; Eckert, AJ; Zinck, JWR				Rajora, Om P.; Eckert, Andrew J.; Zinck, John W. R.			Single-Locus versus Multilocus Patterns of Local Adaptation to Climate in Eastern White Pine (Pinus strobus, Pinaceae)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ADAPTIVE POPULATION DIFFERENTIATION; GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; CANDIDATE GENES; NUCLEOTIDE POLYMORPHISMS; PHENOTYPIC ASSOCIATIONS; POPULUS-TREMULA; NEUTRAL MARKERS; COLD-HARDINESS	Natural plant populations are often adapted to their local climate and environmental conditions, and populations of forest trees offer some of the best examples of this pattern. However, little empirical work has focused on the relative contribution of single-locus versus multilocus effects to the genetic architecture of local adaptation in plants/forest trees. Here, we employ eastern white pine (Pinus strobus) to test the hypothesis that it is the inter-genic effects that primarily drive climate-induced local adaptation. The genetic structure of 29 range-wide natural populations of eastern white pine was determined in relation to local climatic factors using both a reference set of SSR markers, and SNPs located in candidate genes putatively involved in adaptive response to climate. Comparisons were made between marker sets using standard single-locus outlier analysis, single-locus and multilocus environment association analyses and a novel implementation of Population Graphs. Magnitudes of population structure were similar between the two marker sets. Outlier loci consistent with diversifying selection were rare for both SNPs and SSRs. However, genetic distances based on the multilocus among population covariances (cGD) were significantly more correlated to climate, even after correcting for spatial effects, for SNPs as compared to SSRs. Coalescent simulations confirmed that the differences in mutation rates between SSRs and SNPs did not affect the topologies of the Population Graphs, and hence values of cGD and their correlations with associated climate variables. We conclude that the multilocus covariances among populations primarily reflect adaptation to local climate and environment in eastern white pine. This result highlights the complexity of the genetic architecture of adaptive traits, as well as the need to consider multilocus effects in studies of local adaptation.	[Rajora, Om P.; Zinck, John W. R.] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB, Canada; [Eckert, Andrew J.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA USA	University of New Brunswick; Virginia Commonwealth University	Rajora, OP (corresponding author), Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB, Canada.	Om.Rajora@unb.ca		Zinck, John/0000-0002-6116-3976	Natural Sciences and Engineering Research Council of Canada Discovery Grant [RGPIN 170651]; Canada Research Chair Program [CRC950-201869]	Natural Sciences and Engineering Research Council of Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair Program(Canada Research Chairs)	The research was funded and John W.R. Zinck was financially supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grant RGPIN 170651, and Canada Research Chair Program (CRC950-201869) funds to the Principal Investigator Om P. Rajora. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. John W.R. Zinck is currently affiliated with Athletigen Technologies Inc., which had no role whatsoever in the study or manuscript preparation.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Albert EM, 2013, ECOL LETT, V16, P86, DOI 10.1111/ele.12061; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bourret V, 2014, MOL ECOL, V23, P4444, DOI 10.1111/mec.12798; Bradburd GS, 2013, EVOLUTION, V67, P3258, DOI 10.1111/evo.12193; Buchert GP, 1997, CONSERV BIOL, V11, P747, DOI 10.1046/j.1523-1739.1997.96074.x; Burger R, 1999, GENETICS, V152, P807; Chhatre VE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097291; Coop G, 2014, ARXIV13077759; Coop G, 2010, GENETICS, V185, P1411, DOI 10.1534/genetics.110.114819; Csillery K, 2014, MOL ECOL, V23, P4696, DOI 10.1111/mec.12902; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Doyle J. J., 1987, PHYTOCHEM B, P11; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Dyer RJ, 2007, THEOR POPUL BIOL, V71, P71, DOI 10.1016/j.tpb.2006.07.001; Dyer Rodney J., 2015, Annual Review of Ecology Evolution and Systematics, V46, P327; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Eckert AJ, 2013, GENETICS, V195, P1353, DOI 10.1534/genetics.113.157198; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Endler J.A., 1986, Monographs in Population Biology, pviii; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; EXCOFFIER L, 1992, GENETICS, V131, P479; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; FOWLER D P, 1969, Silvae Genetica, V18, P123; GENYS JB, 1987, CAN J FOREST RES, V17, P228, DOI 10.1139/x87-039; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; GRATTAPAGLIA D, 2011, TREE GENET GENOMES, V7, P241, DOI DOI 10.1007/S11295-010-0328-4; Gugger PF, 2013, MOL ECOL, V22, P3598, DOI 10.1111/mec.12317; Hall D, 2007, EVOLUTION, V61, P2849, DOI 10.1111/j.1558-5646.2007.00230.x; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hancock AM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001375; Hancock AM, 2010, P NATL ACAD SCI USA, V107, P8924, DOI 10.1073/pnas.0914625107; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Holliday JA, 2012, G3-GENES GENOM GENET, V2, P1085, DOI 10.1534/g3.112.002733; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Howe GT, 2003, CAN J BOT, V81, P1247, DOI [10.1139/b03-141, 10.1139/B03-141]; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Joyce DG, 2013, FOREST ECOL MANAG, V295, P173, DOI 10.1016/j.foreco.2012.12.024; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Keller SR, 2012, MOL BIOL EVOL, V29, P3143, DOI 10.1093/molbev/mss121; Klutsch CFC, 2012, CONSERV GENET, V13, P21, DOI 10.1007/s10592-011-0259-0; Kremer A, 2012, HEREDITY, V108, P375, DOI 10.1038/hdy.2011.81; Kremer A, 1997, GENETICS, V145, P1229; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Krutovsky KV, 2005, GENETICS, V171, P2029, DOI 10.1534/genetics.105.044420; Latta RG, 2004, NEW PHYTOL, V161, P51, DOI 10.1046/j.1469-8137.2003.00920.x; Latta RG, 1998, AM NAT, V151, P283, DOI 10.1086/286119; Le Corre V, 2003, GENETICS, V164, P1205; Le Corre V, 2012, MOL ECOL, V21, P1548, DOI 10.1111/j.1365-294X.2012.05479.x; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Leips J, 2000, GENETICS, V155, P1773; LEWONTIN RC, 1973, GENETICS, V74, P175; Li P, 1997, CAN J FOREST RES, V27, P199, DOI 10.1139/cjfr-27-2-199; Ma XF, 2010, GENETICS, V186, P1033, DOI 10.1534/genetics.110.120873; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; MARONEK DM, 1974, FOREST SCI, V20, P135; Marquardt PE, 2007, CAN J FOREST RES, V37, P2652, DOI 10.1139/X07-114; Marquardt PE, 2004, MOL ECOL, V13, P3305, DOI 10.1111/j.1365-294X.2004.02341.x; Martinoia E, 2002, PLANTA, V214, P345, DOI 10.1007/s004250100661; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Mehes M, 2009, J PLANT ECOL-UK, V2, P143, DOI 10.1093/jpe/rtp016; Morgenstern EK, 1996, GEOGRAPHIC VARIATION; Nadeau S, 2015, AM J BOT, V102, P1342, DOI 10.3732/ajb.1500160; Namroud MC, 2008, MOL ECOL, V17, P3599, DOI 10.1111/j.1365-294X.2008.03840.x; Neale DB, 2011, NAT REV GENET, V12, P111, DOI 10.1038/nrg2931; Neale DB, 2004, TRENDS PLANT SCI, V9, P325, DOI 10.1016/j.tplants.2004.05.006; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; OHTA T, 1982, GENETICS, V101, P139; Pannell JR, 2014, NEW PHYTOL, V201, P417, DOI 10.1111/nph.12495; Pidugu SR, 2006, MOL ECOL NOTES, V6, P580, DOI 10.1111/j.1471-8286.2006.01286.x; Prunier J, 2012, MOL ECOL, V21, P4270, DOI 10.1111/j.1365-294X.2012.05691.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rajora OP, 2000, MOL ECOL, V9, P339, DOI 10.1046/j.1365-294x.2000.00886.x; Rajora OP, 1998, CAN J BOT, V76, P500, DOI 10.1139/cjb-76-3-500; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Storz JF, 2008, GENETICS, V180, P367, DOI 10.1534/genetics.108.088732; Walsh B, 1999, GENETICS ANAL QUANTI; Wang TL, 2010, ECOL APPL, V20, P153, DOI 10.1890/08-2257.1; Watling JI, 2012, ECOL MODEL, V246, P79, DOI 10.1016/j.ecolmodel.2012.07.018; Wegrzyn Jill L, 2008, Int J Plant Genomics, V2008, P412875, DOI 10.1155/2008/412875; Wendel G. W., 1990, USDA FOREST SERVICE, V654, P476; Wheeler NC, 2005, MOL BREEDING, V15, P145, DOI 10.1007/s11032-004-3978-9; Whitlock MC, 2011, MOL ECOL, V20, P1083, DOI 10.1111/j.1365-294X.2010.04996.x; Willyard A, 2008, MOL BIOL EVOL, V24, P90; Zinck JWR, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0624-1	94	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158691	10.1371/journal.pone.0158691	http://dx.doi.org/10.1371/journal.pone.0158691			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387485	gold, Green Submitted, Green Published			2022-12-26	WOS:000379811500037
J	Abdulhamid, SM; Abd Latiff, MS; Abdul-Salaam, G; Madni, SHH				Abdulhamid, Shafi'i Muhammad; Abd Latiff, Muhammad Shafie; Abdul-Salaam, Gaddafi; Madni, Syed Hamid Hussain			Secure Scientific Applications Scheduling Technique for Cloud Computing Environment Using Global League Championship Algorithm	PLOS ONE			English	Article							INFRASTRUCTURE; SEARCH	Cloud computing system is a huge cluster of interconnected servers residing in a datacenter and dynamically provisioned to clients on-demand via a front-end interface. Scientific applications scheduling in the cloud computing environment is identified as NP-hard problem due to the dynamic nature of heterogeneous resources. Recently, a number of metaheuristics optimization schemes have been applied to address the challenges of applications scheduling in the cloud system, without much emphasis on the issue of secure global scheduling. In this paper, scientific applications scheduling techniques using the Global League Championship Algorithm (GBLCA) optimization technique is first presented for global task scheduling in the cloud environment. The experiment is carried out using Cloud-Sim simulator. The experimental results show that, the proposed GBLCA technique produced remarkable performance improvement rate on the makespan that ranges between 14.44% to 46.41%. It also shows significant reduction in the time taken to securely schedule applications as parametrically measured in terms of the response time. In view of the experimental results, the proposed technique provides better-quality scheduling solution that is suitable for scientific applications task execution in the Cloud Computing environment than the MinMin, MaxMin, Genetic Algorithm (GA) and Ant Colony Optimization (ACO) scheduling techniques.	[Abdulhamid, Shafi'i Muhammad; Abd Latiff, Muhammad Shafie; Madni, Syed Hamid Hussain] Univ Teknol Malaysia, Fac Comp, Johor Baharu, Malaysia; [Abdulhamid, Shafi'i Muhammad] Fed Univ Technol, Dept Cyber Secur Sci, Minna, Nigeria; [Abdul-Salaam, Gaddafi] Kwame Nkuruma Univ Sci & Technol, Kumasi, Ghana	Universiti Teknologi Malaysia	Abdulhamid, SM (corresponding author), Univ Teknol Malaysia, Fac Comp, Johor Baharu, Malaysia.; Abdulhamid, SM (corresponding author), Fed Univ Technol, Dept Cyber Secur Sci, Minna, Nigeria.	shafii.abdulhamid@futminna.edu.ng	Abdulhamid, Shafi'i Muhammad/J-4288-2016; Abd Latiff, Muhammad Shafie/P-1648-2015; Madni, Hamid/AIC-1780-2022; Madni, Syed Hamid Hussain/AAF-6434-2019	Abdulhamid, Shafi'i Muhammad/0000-0001-9196-9447; Abd Latiff, Muhammad Shafie/0000-0002-0741-2257; Madni, Hamid/0000-0002-3816-1382; Madni, Syed Hamid Hussain/0000-0002-3816-1382				Abdulhamid S.I.M., 2014, ARPN J ENG APPL SCI, V9, P2528; Abdulhamid Shafi'I Muhammad, 2014, Journal of Theoretical and Applied Information Technology, V63, P10; Abdulhamid Shafii Muhammad, 2015, INDIAN J SCI TECHNOL, V8, P1; Abdulhamid SM, 2014, LEAGUE CHAMPIONSHIP, P381; Abdullahi M, 2016, FUTURE GENER COMP SY, V56, P640, DOI 10.1016/j.future.2015.08.006; Abrishami S, 2013, FUTURE GENER COMP SY, V29, P158, DOI 10.1016/j.future.2012.05.004; Aceto G, 2013, CLOUD MONITORING SUR; Achary R, 2015, ADV INTELL SYST, V321, P71, DOI 10.1007/978-3-319-11227-5_7; Alkhanak E. N., 2015, FUTURE GENERATION CO; Bala A, 2015, CONCURRENT ENG; Beegom ASA, 2015, LECT NOTES COMPUT SC, V8956, P356, DOI 10.1007/978-3-319-14977-6_38; Chen Zong-Gan, 2015, EV COMP CEC 2015 IEE; Cheng MY, 2014, COMPUT STRUCT, V139, P98, DOI 10.1016/j.compstruc.2014.03.007; Dutta D, 2011, GENETIC ALGORITHM AP, P422; Frincu ME, 2011, THESIS; Gasior Jakub, 2013, Algorithms and Architectures for Parallel Processing. 13th International Conference, ICA3PP 2013. Proceedings: LNCS 8285, P247, DOI 10.1007/978-3-319-03859-9_21; Geng J, 2015, NEUROCOMPUTING, V151, P1362, DOI 10.1016/j.neucom.2014.10.055; Guo-ning G, 2010, GENETIC SIMULATED AN, P60; Hao Yuan, 2014, Journal of Software, V9, P705, DOI 10.4304/jsw.9.3.705-708; Hazlewood V, 2015, PARALLEL WORKLOAD AR; Hu X, 2014, J COMPUTATIONAL INFO, V10, P8723; Jin G, 2015, J INFORM COMPUTATION, V12, P1045, DOI DOI 10.12733/jics20105450; Kashan HA, 2009, LEAGUE CHAMPIONSHIP, P43; Keshk Arabi E., 2014, International Journal of Intelligent Systems and Applications, V6, P25, DOI 10.5815/ijisa.2014.05.02; Kolodziej J, 2011, GENETIC ALGORITHMS E, P17; Kun Li, 2011, 2011 Sixth ChinaGrid Annual Conference (ChinaGrid), P3, DOI 10.1109/ChinaGrid.2011.17; Li H-H, 2015, P COMP PUBL 2015 GEN; Li JY, 2012, J PARALLEL DISTR COM, V72, P666, DOI 10.1016/j.jpdc.2012.02.002; Liu X.-F., 2014, P 2014 C GEN EV COMP; Madni S.H.H., 2016, INDIAN J SCI TECHNOL, V9; Madni SHH, J NETWORK COMPUTER A; Madni SHH, 2016, J NETW COMPUT APPL, V68, P173, DOI 10.1016/j.jnca.2016.04.016; MATHEW T, 2014, STUDY ANAL VARIOUS T, P658; Moharana S.S., 2013, INT J COMPUT SCI ENG, V2, P101; Moschakis IA, 2013, CONCURRENCY COMPUTAT; PAN Y, 2015, PLOS ONE, V10; Pandey S, 2010, INT CON ADV INFO NET, P400, DOI 10.1109/AINA.2010.31; Ramezani F, 2014, INT J PARALLEL PROG, V42, P739, DOI 10.1007/s10766-013-0275-4; Rodriguez MA, 2014, IEEE T CLOUD COMPUT, V2, P222, DOI 10.1109/TCC.2014.2314655; Shanahan HP, 2014, BIOINFORMATICS CLOUD; Sidhu J, 2015, INT J APPL ENG RES, V10; Smanchat S, 2015, FUTURE GENER COMP SY, V52, P1, DOI 10.1016/j.future.2015.04.019; SRIKANTH GU, 2015, INDIAN J SCI TECHN S, V8, P33; Tawfeek M, 2015, CLOUD TASK SCHEDULIN, P64; Tsai CW, 2014, IEEE T CLOUD COMPUT, V2, P236, DOI 10.1109/TCC.2014.2315797; Verma A, 2014, BICRITERIA PRIORITY, P1; Wu K., 2014, TUNABLE WORKFLOW SCH; Yang W, 2014, INT J GRID DISTRIBUT, V7; Yazar S, 2014, BENCHMARKING UNDEDIC; Yousif A, 2012, OPTIMIZING JOB SCHED, P97; Zhan ZH, 2015, ACM COMPUT SURV, V47, DOI 10.1145/2788397; Zhang W, 2014, MATHEMATICAL PROBLEM, V2014; Zhong SB, 2010, KEY ENG MATER, V439-440, P1487, DOI 10.4028/www.scientific.net/KEM.439-440.1487	53	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158102	10.1371/journal.pone.0158102	http://dx.doi.org/10.1371/journal.pone.0158102			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384239	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400034
J	Hontelez, JAC; Tanser, FC; Naidu, KK; Pillay, D; Barnighausen, T				Hontelez, Jan A. C.; Tanser, Frank C.; Naidu, Kevindra K.; Pillay, Deenan; Barnighausen, Till			The Effect of Antiretroviral Treatment on Health Care Utilization in Rural South Africa: A Population-Based Cohort Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; HIV TREATMENT; SERVICES; THERAPY; ACCESS; PREVENTION; COVERAGE; DELIVERY; LESSONS; PROGRAM	Background The effect of the rapid scale-up of vertical antiretroviral treatment (ART) programs for HIV in sub-Saharan Africa on the overall health system is under intense debate. Some have argued that these programs have reduced access for people suffering from diseases unrelated to HIV because ART programs have drained human and physical resources from other parts of the health system; others have claimed that the investments through ART programs have strengthened the general health system and the population health impacts of ART have freed up health care capacity for the treatment of diseases that are not related to HIV. To establish the population-level impact of ART programs on health care utilization in the public-sector health system, we compared trends in health care utilization among HIV-infected people receiving and not receiving ART with HIV-uninfected people during a period of rapid ART scale-up. Methods and Findings We used data from the Wellcome Trust Africa Centre for Population Health, which annually elicited information on health care utilization from all surveillance participants over the period 2009-2012 (N = 32,319). We determined trends in hospitalization, and public-sector and private-sector primary health care (PHC) clinic visits for HIV-infected and -uninfected people over a time period of rapid ART scale-up (2009-2012) in this community. We regressed health care utilization on HIV status and ART status in different calendar years, controlling for sex, age, and area of residence. The proportion of people who reported to have visited a public-sector primary health care (PHC) clinic in the last 6 months increased significantly over the period 2009-2012, for both HIV-infected people (from 59% to 67%; p<0.001), and HIV-uninfected people (from 41% to 47%; p<0.001). In contrast, the proportion of HIV-infected people visiting a private-sector PHC clinic declined from 22% to 12% p<0.001) and hospitalization rates declined from 128 to 82 per 1000 PY (p<0.001). For HIV-uninfected people, the proportion visiting a private-sector PHC clinic declined from 16% to 9%, and hospitalization rates declined from 78 to 44 per 1000 PY (p<0.001). After controlling for potential confounding factors, all trends remained of similar magnitude and significance. Conclusions Our results indicate that the ART scale-up in this high HIV prevalence community has shifted health care utilization from hospitals and private-sector primary care to public-sector primary care. Remarkably, this shift is observed for both HIV-infected and -uninfected populations, supporting and extending hypotheses of 'therapeutic citizenship' whereby HIV-infected patients receiving ART facilitate primary care access for family and community members. One explanation of our findings is that ART has improved the capacity or quality of primary care in this community and, as a consequence, increasingly met overall health care needs at the primary care level rather than at the secondary level. Future research needs to confirm this causal interpretation of our findings using qualitative work to understand causal mechanisms or quasi-experimental quantitative studies to increase the strength of causal inference.	[Hontelez, Jan A. C.; Tanser, Frank C.; Naidu, Kevindra K.; Pillay, Deenan; Barnighausen, Till] Univ KwaZulu Natal, Wellcome Trust Africa Ctr Populat Hlth, Mtubatuba, South Africa; [Hontelez, Jan A. C.; Barnighausen, Till] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Hontelez, Jan A. C.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Tanser, Frank C.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa; [Pillay, Deenan] UCL, Div Infect & Immun, London, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; Erasmus University Rotterdam; Erasmus MC; University of Kwazulu Natal; University of London; University College London	Hontelez, JAC (corresponding author), Univ KwaZulu Natal, Wellcome Trust Africa Ctr Populat Hlth, Mtubatuba, South Africa.; Hontelez, JAC (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA.; Hontelez, JAC (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	j.hontelez@erasmusmc.nl	Bärnighausen, Till/Y-2388-2019; Tanser, Frank/ABE-8326-2021	Tanser, Frank/0000-0001-9797-0000	Bill and Melinda Gates foundation from the HIV Modelling Consortium; Talent Scheme Veni research programme - Netherlands Organisation for Scientific Research (NWO); US National Institutes of Health, National Institute of Child Health and Human Development [R01 HD058482]; Wellcome Trust; American people through the United States Agency for International Development (USAID); President's Emergency Plan (PEPFAR) [674-A-00-08-0001-00]; Academy of Medical Sciences (AMS) [AMS-NAF2-Tanser] Funding Source: researchfish	Bill and Melinda Gates foundation from the HIV Modelling Consortium; Talent Scheme Veni research programme - Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); US National Institutes of Health, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); President's Emergency Plan (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS))	This study received funding from the Bill and Melinda Gates foundation through grants from the HIV Modelling Consortium. Jan Hontelez is supported by the Talent Scheme Veni research programme, which is financed by the Netherlands Organisation for Scientific Research (NWO). Till Barnighausen and Frank Tanser were supported by grant R01 HD058482 from the US National Institutes of Health, National Institute of Child Health and Human Development. The Africa Centre for Health and Population Studies received funding from the Wellcome Trust. The funding organizations had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation, review or approval of the manuscript. In addition, this study is made possible by the generous support of the American people through the United States Agency for International Development (USAID) and the President's Emergency Plan (PEPFAR) under the terms of Award No. 674-A-00-08-0001-00 for the Hlabisa Treatment and Care Programme. The opinions expressed herein are those of the authors and do not necessarily reflect the views of USAID or the United States Government.	Aday LA, 2006, DESIGNING CONDUCTING; Anekwe TD, 2015, VACCINE, V33, P5020, DOI 10.1016/j.vaccine.2015.04.072; Atun RA, 2008, DO VERTICAL STAND AL; Baernighausen T, 2011, NEW ENGL J MED, V364, P2181, DOI 10.1056/NEJMp1014255; Baltussen Rob, 2013, Cost Eff Resour Alloc, V11, P26, DOI 10.1186/1478-7547-11-26; Barnighausen T, 2013, LANCET; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Bor J, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001905; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bor J, 2012, HEALTH AFFAIR, V31, P1459, DOI 10.1377/hlthaff.2012.0407; Chimbindi N, 2013, 6 SA AIDS C 18 21 JU; Cooke GS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-585; Coovadia H, 2009, LANCET, V374, P817, DOI 10.1016/S0140-6736(09)60951-X; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; England R, 2009, LANCET, V374, P1674, DOI 10.1016/S0140-6736(09)61984-X; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Harris B, 2011, J PUBLIC HEALTH POL, V32, pS102, DOI 10.1057/jphp.2011.35; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Hontelez JAC, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-39; Hontelez Jan A C, 2012, AIDS, V26 Suppl 1, pS19; Hontelez JAC, 2011, AIDS, V25, P1665, DOI 10.1097/QAD.0b013e32834982ea; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Levine R, 2009, JAIDS-J ACQ IMM DEF, V52, pS3, DOI 10.1097/QAI.0b013e3181bbc807; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Maher D, 2010, B WORLD HEALTH ORGAN, V88, P943, DOI 10.2471/BLT.10.077891; Matoso MP, 2013, S AFR MED J, V103, P156; Matsubayashi T, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S9; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; McCoy D, 2005, AM J PUBLIC HEALTH, V95, P18, DOI 10.2105/AJPH.2004.040121; Meyer-Rath G, 2013, JAIDS-J ACQ IMM DEF, V62, P322, DOI 10.1097/QAI.0b013e31827e8785; Mills A, 2012, LANCET, V380, P126, DOI 10.1016/S0140-6736(12)60357-2; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; Naidoo S, 2012, J PUBLIC HEALTH-UK, V34, P149, DOI 10.1093/pubmed/fds008; Ndirangu J, 2009, TROP MED INT HEALTH, V14, P1383, DOI 10.1111/j.1365-3156.2009.02382.x; Nguyen VK, 2007, AIDS, V21, pS31, DOI 10.1097/01.aids.0000298100.48990.58; Nguyen VK, ANTIRETROVIRAL GLOBA, P124; Ooms G, 2007, PLOS MED, V4, P605, DOI 10.1371/journal.pmed.0040128; Piot P, 2009, LANCET, V374, P260, DOI 10.1016/S0140-6736(09)60321-4; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Starrs AM, 2009, LANCET, V374, P1674, DOI 10.1016/S0140-6736(09)61985-1; Suthar AB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001496; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; UNAIDS, 2014, REP GLOB AIDS EP 201; Walton DA, 2004, J PUBLIC HEALTH POL, V25, P137, DOI 10.1057/palgrave.jphp.3190013; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Health Organization, 2013, CONGUID UANT DRU; Wouters E, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-210; Yu DB, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-8; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158015	10.1371/journal.pone.0158015	http://dx.doi.org/10.1371/journal.pone.0158015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27384178	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400033
J	Samson, S; Basri, M; Masoumi, HRF; Malek, EA; Karjiban, RA				Samson, Shazwani; Basri, Mahiran; Masoumi, Hamid Reza Fard; Malek, Emilia Abdul; Karjiban, Roghayeh Abedi			An Artificial Neural Network Based Analysis of Factors Controlling Particle Size in a Virgin Coconut Oil-Based Nanoemulsion System Containing Copper Peptide	PLOS ONE			English	Article							ZNO NANOPARTICLES; NANO-EMULSIONS; OPTIMIZATION; FORMULATION; DELIVERY; EXTRACT; DESIGN; ACID	A predictive model of a virgin coconut oil (VCO) nanoemulsion system for the topical delivery of copper peptide (an anti-aging compound) was developed using an artificial neural network (ANN) to investigate the factors that influence particle size. Four independent variables including the amount of VCO, Tween 80:Pluronic F68 (T80:PF68), xanthan gum and water were the inputs whereas particle size was taken as the response for the trained network. Genetic algorithms (GA) were used to model the data which were divided into training sets, testing sets and validation sets. The model obtained indicated the high quality performance of the neural network and its capability to identify the critical composition factors for the VCO nanoemulsion. The main factor controlling the particle size was found out to be xanthan gum (28.56%) followed by T80:PF68 (26.9%), VCO (22.8%) and water (21.74%). The formulation containing copper peptide was then successfully prepared using optimum conditions and particle sizes of 120.7 nm were obtained. The final formulation exhibited a zeta potential lower than -25 mV and showed good physical stability towards centrifugation test, freeze-thaw cycle test and storage at temperature 25 degrees C and 45 degrees C.	[Samson, Shazwani; Basri, Mahiran; Masoumi, Hamid Reza Fard; Malek, Emilia Abdul; Karjiban, Roghayeh Abedi] Univ Putra Malaysia, Fac Sci, Dept Chem, Upm Serdang, Selangor, Malaysia	Universiti Putra Malaysia	Samson, S; Basri, M (corresponding author), Univ Putra Malaysia, Fac Sci, Dept Chem, Upm Serdang, Selangor, Malaysia.	dorawanie_89@yahoo.com; mahiran@science.upm.edu.my						Abdollahi Y, 2015, J IND ENG CHEM, V25, P168, DOI 10.1016/j.jiec.2014.10.029; Aghaeinejad-Meybodi A, 2015, J TAIWAN INST CHEM E, V48, P40, DOI 10.1016/j.jtice.2014.10.022; Arenillo SA, 2008, J HIGHER ED RES, V5, P190; Ba-Abbad MM, 2013, J IND ENG CHEM, V19, P99, DOI 10.1016/j.jiec.2012.07.010; Badhani B, 2015, RSC ADV, V5, P27540, DOI 10.1039/c5ra01911g; Catalogna M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044587; Chen SM, 2013, J EARTH SYST SCI, V122, P399, DOI 10.1007/s12040-013-0289-8; Choudhury AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077071; Ribeiro RCD, 2015, MOLECULES, V20, P2492, DOI 10.3390/molecules20022492; de Carvalho SM, 2013, IND CROP PROD, V49, P278, DOI 10.1016/j.indcrop.2013.04.054; Fadare DA, 2007, AFR J BIOTECHNOL, V6, P2184; Gibbs MS, 2003, MODSIM 2003: INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, VOLS 1-4, P789; Hadzir NM, 2013, AAPS PHARMSCITECH, V14, P456, DOI 10.1208/s12249-013-9929-1; Hamman JH, 2005, BIODRUGS, V19, P165, DOI 10.2165/00063030-200519030-00003; Kamariah L, 2008, J TROP AGR FOOD SCI, V36, P1; Kamble Meghana S., 2013, J BIOMED PHARM RES, V2, P100; Kiransan M, 2015, SPECTROCHIM ACTA A, V140, P465, DOI 10.1016/j.saa.2014.12.100; Kumar SN, 2015, EUR J PHARM SCI, V67, P97, DOI 10.1016/j.ejps.2014.10.014; Kumar P, 2014, TRANSPORT RES C-EMER, V40, P111, DOI 10.1016/j.trc.2014.01.006; Leelapornpisid P., 2014, INT J PHARM PHARM SC, V6, P313; Loong NC, 2014, IND CROP PROD, V59, P309, DOI 10.1016/j.indcrop.2014.05.042; Lupo MP, 2005, DERMATOL SURG, V31, P832; Mahdi ES, 2011, INT J NANOMED, V6, P2499, DOI 10.2147/IJN.S22337; Mansor T. S. T., 2012, International Food Research Journal, V19, P837; Marina AM, 2009, TRENDS FOOD SCI TECH, V20, P481, DOI 10.1016/j.tifs.2009.06.003; Marinkovski M, 2014, J SUPERCRIT FLUID, V92, P242; Masoumi HRF, 2013, SCI WORLD J, DOI 10.1155/2013/962083; Moghaddam MG, 2010, J BIOTECHNOL, V13, DOI [10.2225/vol13-issue3-fulltext-9, DOI 10.2225/VOL13-ISSUE3-FULLTEXT-9]; Mukherjee PK, 2011, PHYTOMEDICINE, V19, P64, DOI 10.1016/j.phymed.2011.10.003; Musharavati F., 2010, J ADV MAT MANUFACT E, V41, P140; Ngan CL, 2014, SCI WORLD J, DOI 10.1155/2014/219035; Pickart L, 2010, SOFW-J, V136, P10; Pickart L., 2012, J AGING RES CLIN PRA, V1, P13; Rebolleda S, 2015, FOOD CHEM, V167, P16, DOI 10.1016/j.foodchem.2014.06.097; Rezaee M, 2014, IND CROP PROD, V52, P506, DOI 10.1016/j.indcrop.2013.10.046; Sarkar A, 2015, AQUAT PR, V4, P1070, DOI 10.1016/j.aqpro.2015.02.135; Setya S, 2014, WORLD J, V3, P2214; Shilin M, 2013, INT J NANOMED, V8, P4045, DOI [10.2147/IJN.S47956, DOI 10.2147/IJN.S47956]; Tadros T, 2004, ADV COLLOID INTERFAC, V108, P303, DOI 10.1016/j.cis.2003.10.023; Tsai MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102850	40	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157737	10.1371/journal.pone.0157737	http://dx.doi.org/10.1371/journal.pone.0157737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383135	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400024
J	Li, AN; Zhang, YR; Zhao, ZD; Wang, MM; Zan, LS				Li, Anning; Zhang, Yaran; Zhao, Zhidong; Wang, Mingming; Zan, Linsen			Molecular Characterization and Transcriptional Regulation Analysis of the Bovine PDHB Gene	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE COMPLEX; INTRAMUSCULAR FAT-CONTENT; LONGISSIMUS MUSCLE; E1-BETA SUBUNIT; EXPRESSION; BINDING; PROTEIN; DEFICIENCY; PIGS; METABOLISM	The pyruvate dehydrogenase beta subunit (PDHB) is a subunit of pyruvate dehydrogenase (E1), which catalyzes pyruvate into acetyl-CoA and provides a linkage between the tricarboxylic acid cycle (TCA) and the glycolysis pathway. Previous studies demonstrated PDHB to be positively related to the intramuscular fat (IMF) content. However, the transcriptional regulation of PDHB remains unclear. In our present study, the cDNA of bovine PDHB was cloned and the genomic structure was analyzed. The phylogenetic tree showed bovine PDHB to be closely related to goat and sheep, and least related to chicken. Spatial expression pattern analysis revealed the products of bovine PDHB to be widely expressed with the highest level in the fat of testis. To understand the transcriptional regulation of bovine PDHB, 1899 base pairs (bp) of the 5'-regulatory region was cloned. Sequence analysis neither found consensus TATA-box nor CCAAT-box in the 5'-flanking region of bovine PDHB. However, a CpG island was predicted from nucleotides -284 to + 117. Serial deletion constructs of the 5'-flanking region, evaluated in dual-luciferase reporter assay, revealed the core promoter to be located 490bp upstream from the transcription initiation site (+ 1). Electrophoretic mobility shift assay (EMSA) and chromatin immunoprecipitation assay (ChIP) in combination with asite-directed mutation experiment indicated both myogenin (MYOG) and the CCAAT/enhancer-binding protein beta (C/EBP beta) to be important transcription factors for bovine PDHB in skeletal muscle cells and adipocytes. Our results provide an important basis for further investigation of the bovine PDHB function and regulation in cattle.	[Li, Anning; Zhang, Yaran; Zhao, Zhidong; Wang, Mingming; Zan, Linsen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China; [Zan, Linsen] Northwest A&F Univ, Natl Beef Cattle Improvement Ctr, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.; Zan, LS (corresponding author), Northwest A&F Univ, Natl Beef Cattle Improvement Ctr, Yangling 712100, Shaanxi, Peoples R China.	zanlinsen@163.com		Li, Anning/0000-0001-7695-161X	National Natural Science Foundation of China [31402042]; National 863 Program of China [2013AA102505]; Northwest A & F University Special Funds of Central Colleges Basic Scientific Research Operating Expenses [2014YB009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); Northwest A & F University Special Funds of Central Colleges Basic Scientific Research Operating Expenses	This research was funded by the National Natural Science Foundation of China (Grant No. 31402042), National 863 Program of China (Grant No. 2013AA102505) and the Northwest A & F University Special Funds of Central Colleges Basic Scientific Research Operating Expenses (Grant No. 2014YB009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was funded by the National Natural Science Foundation of China (Grant No. 31402042), National 863 Program of China (Grant No. 2013AA102505) and the Northwest A&F University Special Funds of Central Colleges Basic Scientific Research Operating Expenses (Grant No. 2014YB009).	Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; Cai Z, 2010, MOL CELL PROTEOMICS, V9, P2617, DOI 10.1074/mcp.M110.000661; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chow G, 2005, J BIOL CHEM, V280, P26904, DOI 10.1074/jbc.M413845200; Gerbens F, 2001, J ANIM SCI, V79, P347; Guo L, 2015, J BIOL CHEM, V290, P755, DOI 10.1074/jbc.R114.619957; Han Z, 2008, J BIOL CHEM, V283, P237, DOI 10.1074/jbc.M704748200; Hendrickson SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012862; Imbard A, 2011, MOL GENET METAB, V104, P507, DOI 10.1016/j.ymgme.2011.08.008; Kanda A, 2015, J BIOL CHEM; Kikuchi D, 2014, BIOCHEM BIOPH RES CO, V451, P288, DOI 10.1016/j.bbrc.2014.07.114; KOIKE K, 1990, P NATL ACAD SCI USA, V87, P5594, DOI 10.1073/pnas.87.15.5594; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Li A, 2015, J ANIM SCI, V93, P5144, DOI 10.2527/jas.2015-9378; Li AN, 2013, MAMM GENOME, V24, P72, DOI 10.1007/s00335-012-9440-0; Li AN, 2010, MOL GENET GENOMICS, V284, P185, DOI 10.1007/s00438-010-0558-z; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; Mercimek-Mahmutoglu S, 2015, EPILEPSIA; Okajima K, 2008, MOL GENET METAB, V93, P371, DOI 10.1016/j.ymgme.2007.10.135; Park SY, 2014, BIOCHEM BIOPH RES CO, V450, P1631, DOI 10.1016/j.bbrc.2014.07.061; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Patel MS, 2014, J BIOL CHEM, V289, P16615, DOI 10.1074/jbc.R114.563148; Platter WJ, 2005, J ANIM SCI, V83, P890; Prasad C, 2011, BRAIN DEV-JPN, V33, P856, DOI 10.1016/j.braindev.2011.08.003; Quintana E, 2009, J INHERIT METAB DIS; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Sasaki Y, 2006, ANIM GENET, V37, P40, DOI 10.1111/j.1365-2052.2005.01380.x; Serao NVL, 2011, J ANIM BREED GENET, V128, P28, DOI 10.1111/j.1439-0388.2010.00887.x; Sun WQ, 2015, LIFE SCI, V121, P97, DOI 10.1016/j.lfs.2014.11.030; TAYLOR SI, 1975, J BIOL CHEM, V250, P2028; Wang H, 2014, MOL BIOL REP, V41, P251, DOI 10.1007/s11033-013-2858-y; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]; Zheng AJ, 2014, J PROTEOMICS, V98, P271, DOI 10.1016/j.jprot.2013.12.021	36	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157445	10.1371/journal.pone.0157445	http://dx.doi.org/10.1371/journal.pone.0157445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379520	gold, Green Published, Green Submitted			2022-12-26	WOS:000379798700006
J	Fu, Q; Zhou, XY; Dong, Y; Huang, YH; Yang, JH; Oh, KW; Hu, ZZ				Fu, Qiang; Zhou, Xiaoyan; Dong, Yun; Huang, Yonghong; Yang, Jianhua; Oh, Ki-Wan; Hu, Zhenzhen			Decreased Caffeine-Induced Locomotor Activity via Microinjection of CART Peptide into the Nucleus Accumbens Is Linked to Inhibition of the pCaMKIIa-D3R Interaction	PLOS ONE			English	Article							AMPHETAMINE-REGULATED TRANSCRIPT; CONDITIONED PLACE PREFERENCE; D3 DOPAMINE-RECEPTORS; MESSENGER-RNA; GENE-EXPRESSION; PROTEIN-KINASE; CAMKII-ALPHA; RAT-BRAIN; COCAINE; CREB	The purpose of this study was to characterize the inhibitory modulation of cocaine-and amphetamine-regulated transcript (CART) peptides, particularly with respect to the function of the D-3 dopamine receptor (D3R), which is activated by its interaction with phosphorylated CaMKII alpha (pCaMKII alpha) in the nucleus accumbens (NAc). After repeated oral administration of caffeine (30 mg/kg) for five days, microinjection of CART peptide (0.08 mu M/0.5 mu l/hemisphere) into the NAc affected locomotor behavior. The pCaMKII alpha-D3R interaction, D3R phosphorylation and cAMP/PKA/phosphorylated CREB (pCREB) signaling pathway activity were measured in NAc tissues, and Ca2+ influx and pCaMKIIa levels were measured in cultured NAc neurons. We found that CART attenuated the caffeine-mediated enhancement of depolarization-induced Ca2+ influx and CaMKII alpha phosphorylation in cultured NAc neurons. Repeated microinjection of CART peptides into the NAc decreased the caffeine-induced enhancement of Ca2+ channels activity, pCaMKII alpha levels, the pCaMKII alpha-D3R interaction, D3R phosphorylation, cAMP levels, PKA activity and pCREB levels in the NAc. Furthermore, behavioral sensitization was observed in rats that received five-day administration of caffeine following microinjection of saline but not in rats that were treated with caffeine following microinjection of CART peptide. These results suggest that caffeine-induced CREB phosphorylation in the NAc was ameliorated by CART peptide due to its inhibition of D3R phosphorylation. These effects of CART peptides may play a compensatory role by inhibiting locomotor behavior in rats.	[Fu, Qiang] Nanchang Univ, Affiliated Hosp 4, Dept Respirat, Nanchang, Jiangxi, Peoples R China; [Fu, Qiang] Jiangxi Prov Peoples Hosp, Dept 2, Dept Respirat, Nanchang, Jiangxi, Peoples R China; [Zhou, Xiaoyan; Huang, Yonghong; Hu, Zhenzhen] Nanchang Univ, Coll Med, Dept Pathophysiol, Nanchang, Jiangxi, Peoples R China; [Dong, Yun] Jiangxi Tumor Hosp, Dept Breast Surg, Nanchang, Jiangxi, Peoples R China; [Yang, Jianhua] Nanchang Univ, Coll Med, Dept Physiol, Nanchang, Jiangxi, Peoples R China; [Oh, Ki-Wan] Chungbuk Natl Univ, Coll Pharm, Cheongju, South Korea	Nanchang University; Nanchang University; Nanchang University; Chungbuk National University	Hu, ZZ (corresponding author), Nanchang Univ, Coll Med, Dept Pathophysiol, Nanchang, Jiangxi, Peoples R China.	huzhenzhen@ncu.edu.cn			National Foundation of China [81201035]; Health and Family Planning Commission of Jiangxi province [2015A041]	National Foundation of China; Health and Family Planning Commission of Jiangxi province	This work was supported by the National Foundation of China (Grant no. 81201035, http://www.nsfc.gov.cn/, ZH) and the Health and Family Planning Commission of Jiangxi province (Grant no. 2015A041, http://www.jxwst.gov.cn/, ZH).	Ahlgren-Beekendorf JA, 2004, J RECEPT SIG TRANSD, V24, P117, DOI 10.1081/LRST-200029953; Avalos-Fuentes A, 2013, NEUROPHARMACOLOGY, V71, P273, DOI 10.1016/j.neuropharm.2013.04.010; Beaudry G, 2004, SYNAPSE, V51, P233, DOI 10.1002/syn.10302; Biala G, 2003, POL J PHARMACOL, V55, P327; Brunzell DH, 2009, NEUROPSYCHOPHARMACOL, V34, P1993, DOI 10.1038/npp.2009.11; Cai ZY, 2014, BRAIN RES, V1557, P101, DOI 10.1016/j.brainres.2014.02.024; Cappelletti S, 2015, CURR NEUROPHARMACOL, V13, P71, DOI 10.2174/1570159X13666141210215655; Carelli RM, 2002, PHYSIOL BEHAV, V76, P379, DOI 10.1016/S0031-9384(02)00760-6; Cho JH, 2015, NEUROPEPTIDES, V50, P1, DOI 10.1016/j.npep.2015.03.004; Connolly S, 2010, BIOCHEM BIOPH RES CO, V397, P152, DOI 10.1016/j.bbrc.2010.05.054; Couceyro PR, 2005, J PHARMACOL EXP THER, V315, P1091, DOI 10.1124/jpet.105.091678; Cruz-Trujillo R, 2013, NEUROPHARMACOLOGY, V67, P370, DOI 10.1016/j.neuropharm.2012.11.032; Dallvechia-Adams S, 2002, J COMP NEUROL, V448, P360, DOI 10.1002/cne.10268; de Lartigue G, 2007, J NEUROSCI, V27, P2876, DOI 10.1523/JNEUROSCI.5508-06.2007; DiRocco DP, 2009, J NEUROSCI, V29, P2393, DOI 10.1523/JNEUROSCI.4356-08.2009; Dominguez G, 2004, MOL BRAIN RES, V126, P22, DOI 10.1016/j.molbrainres.2004.02.027; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Ferre S, 2010, J ALZHEIMERS DIS, V20, pS35, DOI 10.3233/JAD-2010-1400; Hollander JA, 2010, NATURE, V466, P197, DOI 10.1038/nature09202; Hu ZZ, 2015, KOREAN J PHYSIOL PHA, V19, P89, DOI 10.4196/kjpp.2015.19.2.89; Hu ZZ, 2014, BEHAV PHARMACOL, V25, P32, DOI 10.1097/FBP.0000000000000016; Hubert GW, 2010, NEUROSCIENCE, V165, P179, DOI 10.1016/j.neuroscience.2009.10.013; Hunter RG, 2006, NEUROPHARMACOLOGY, V50, P858, DOI 10.1016/j.neuropharm.2005.12.007; Jaworski JN, 2007, NEUROPEPTIDES, V41, P65, DOI 10.1016/j.npep.2006.12.003; Jaworski JN, 2006, PEPTIDES, V27, P1993, DOI 10.1016/j.peptides.2006.03.034; Jaworski JN, 2003, J PHARMACOL EXP THER, V307, P1038, DOI 10.1124/jpet.103.052332; Jones DC, 2009, NEUROSCIENCE, V160, P339, DOI 10.1016/j.neuroscience.2009.02.051; Jones DC, 2006, J PHARMACOL EXP THER, V317, P454, DOI 10.1124/jpet.105.096123; Kaya E, 2016, SYNAPSE, V70, P283, DOI 10.1002/syn.21903; KIM HS, 1995, GEN PHARMACOL, V26, P1071, DOI 10.1016/0306-3623(94)00267-Q; Kimmel HL, 2000, J PHARMACOL EXP THER, V294, P784; Kurokawa K, 2011, NEUROSCIENCE, V176, P328, DOI 10.1016/j.neuroscience.2010.11.062; Lakatos A, 2002, MOL BRAIN RES, V104, P81, DOI 10.1016/S0169-328X(02)00321-2; Larson EB, 2015, J NEUROSCI, V35, P3537, DOI 10.1523/JNEUROSCI.1524-14.2015; Larson EB, 2011, J NEUROSCI, V31, P16447, DOI 10.1523/JNEUROSCI.3070-11.2011; Liu XY, 2009, NEURON, V61, P425, DOI 10.1016/j.neuron.2008.12.015; Loweth JA, 2008, NEUROSCI LETT, V444, P157, DOI 10.1016/j.neulet.2008.08.004; Loweth JA, 2013, J NEUROSCI, V33, P1411, DOI 10.1523/JNEUROSCI.4386-13.2013; Loweth JA, 2010, J NEUROSCI, V30, P939, DOI 10.1523/JNEUROSCI.4383-09.2010; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Moffett MC, 2011, SYNAPSE, V65, P1, DOI 10.1002/syn.20815; Newman AH, 2005, J MED CHEM, V48, P3663, DOI 10.1021/jm040190e; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Peng QH, 2014, NEUROCHEM INT, V75, P105, DOI 10.1016/j.neuint.2014.06.005; Salinas A, 2006, J NEUROCHEM, V97, P408, DOI 10.1111/j.1471-4159.2006.03745.x; Self DW, 1998, J NEUROSCI, V18, P1848; SHI WX, 1994, J NEUROSCI, V14, P4548	47	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159104	10.1371/journal.pone.0159104	http://dx.doi.org/10.1371/journal.pone.0159104			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404570	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508200035
J	Yarnoff, BO; Hoerger, TJ; Simpson, SA; Pavkov, ME; Burrows, NR; Shrestha, SS; Williams, DE; Zhuo, XH				Yarnoff, Benjamin O.; Hoerger, Thomas J.; Simpson, Siobhan A.; Pavkov, Meda E.; Burrows, Nilka R.; Shrestha, Sundar S.; Williams, Desmond E.; Zhuo, Xiaohui			The Cost-Effectiveness of Anemia Treatment for Persons with Chronic Kidney Disease	PLOS ONE			English	Article							ERYTHROPOIESIS-STIMULATING AGENTS; QUALITY-OF-LIFE; DARBEPOETIN ALPHA; HEMODIALYSIS; CKD; MORTALITY; THERAPY; STROKE; TRIAL; LEVEL	Background Although major guidelines uniformly recommend iron supplementation and erythropoietin stimulating agents (ESAs) for managing chronic anemia in persons with chronic kidney disease (CKD), there are differences in the recommended hemoglobin (Hb) treatment target and no guidelines consider the costs or cost-effectiveness of treatment. In this study, we explored the most cost-effective Hb target for anemia treatment in persons with CKD stages 3-4. Methods and Findings The CKD Health Policy Model was populated with a synthetic cohort of persons over age 30 with prevalent CKD stages 3-4 (i.e., not on dialysis) and anemia created from the 19992010 National Health and Nutrition Examination Survey. Incremental cost-effectiveness ratios (ICERs), computed as incremental cost divided by incremental quality adjusted life years (QALYs), were assessed for Hb targets of 10 g/dl to 13 g/dl at 0.5 g/dl increments. Targeting a Hb of 10 g/dl resulted in an ICER of $32,111 compared with no treatment and targeting a Hb of 10.5 g/dI resulted in an ICER of $32,475 compared with a Hb target of 10 g/dl. QALYs increased to 4.63 for a Hb target of 10 g/dl and to 4.75 for a target of 10.5 g/dl or 11 g/dl. Any treatment target above 11 g/dl increased medical costs and decreased QALYs. Conclusions In persons over age 30 with CKD stages 3-4, anemia treatment is most cost-effective when targeting a Hb level of 10.5 g/dl. This study provides important information for framing guidelines related to treatment of anemia in persons with CKD.	[Yarnoff, Benjamin O.; Hoerger, Thomas J.; Simpson, Siobhan A.] RTI Int, Res Triangle Pk, NC 27709 USA; [Pavkov, Meda E.; Burrows, Nilka R.; Shrestha, Sundar S.; Williams, Desmond E.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Zhuo, Xiaohui] Merck Res Labs, N Wales, PA USA	Research Triangle Institute; Centers for Disease Control & Prevention - USA; Merck & Company	Yarnoff, BO (corresponding author), RTI Int, Res Triangle Pk, NC 27709 USA.	byarnoff@rti.org		Yarnoff, Benjamin/0000-0002-5147-1588; Hoerger, Thomas/0000-0003-4154-7806	Centers for Disease Control and Prevention (CDC) [200-2008-27958]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported by funding (Contract #200-2008-27958) from the Centers for Disease Control and Prevention (CDC). The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of CDC. Xiaohui Zhuo is now employed by Merck Laboratories, but was employed by the Centers for Disease Control and Prevention while working on this project. The funder provided support in the form of salaries for authors BOY, TJH, SAS, MEP, NRB, SSS, DEW, and XZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ara R, 2008, VALUE HEALTH, V11, P1131, DOI 10.1111/j.1524-4733.2008.00352.x; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Blumberg N, 1996, AM J SURG, V171, P324, DOI 10.1016/S0002-9610(97)89635-3; Boulware LE, 2003, JAMA-J AM MED ASSOC, V290, P3101, DOI 10.1001/jama.290.23.3101; Centers for Medicare and Medicaid Services, 2012, MED PART B DRUG AV S; Clement FM, 2010, AM J KIDNEY DIS, V56, P1050, DOI 10.1053/j.ajkd.2010.07.015; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Finkelstein FO, 2009, CLIN J AM SOC NEPHRO, V4, P33, DOI 10.2215/CJN.00630208; Grosse Scott D, 2008, Expert Rev Pharmacoecon Outcomes Res, V8, P165, DOI 10.1586/14737167.8.2.165; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Hoerger TJ, 2015, AM J KIDNEY DIS, V65, P403, DOI 10.1053/j.ajkd.2014.09.023; Hoerger TJ, 2012, J AM SOC NEPHROL, V23, P2035, DOI 10.1681/ASN.2012040347; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P452, DOI 10.1053/j.ajkd.2009.11.016; Hoerger TJ, 2010, AM J KIDNEY DIS, V55, P463, DOI 10.1053/j.ajkd.2009.11.017; Kopple JD, 2001, AM J KIDNEY DIS, V37, pS66, DOI 10.1053/ajkd.2001.20748; Koulouridis I, 2013, AM J KIDNEY DIS, V61, P44, DOI 10.1053/j.ajkd.2012.07.014; Lawer EV, 2010, CLIN J AM SOC NEPHRO, V5, P667, DOI 10.2215/CJN.06020809; Leaf DE, 2009, KIDNEY INT, V75, P15, DOI 10.1038/ki.2008.414; Locatelli F, 2009, NEPHROL DIAL TRANSPL, V24, P348, DOI 10.1093/ndt/gfn653; Lu M, 2010, AM J HEMATOL, V85, P315, DOI 10.1002/ajh.21656; Meenan RT, 2007, MED DECIS MAKING, V27, P161, DOI 10.1177/0272989X06297388; National Institute for Health and Clinical Excellence, 2011, AN MAN PEOPL CHRON K; Nishio A, 2013, BLOOD PURIFICAT, V36, P29, DOI 10.1159/000350583; Palmer SC, 2010, ANN INTERN MED, V153, P23, DOI 10.7326/0003-4819-153-1-201007060-00252; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Quon P, 2012, HLTH OUTCOMES RES ME, V3, pe79, DOI DOI 10.1016/J.EHRM.2012.03.004; Singh AK, 2010, CURR OPIN NEPHROL HY, V19, P420, DOI 10.1097/MNH.0b013e32833cf1d6; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Skali H, 2011, CIRCULATION, V124, P2903, DOI 10.1161/CIRCULATIONAHA.111.030411; Tonelli M, 2003, KIDNEY INT, V64, P295, DOI 10.1046/j.1523-1755.2003.00079.x; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; Vlagopoulos PT, 2005, J AM SOC NEPHROL, V16, P3403, DOI 10.1681/ASN.2005030226; Weinstein MC, 1996, COST EFFECTIVENESS H	34	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0157323	10.1371/journal.pone.0157323	http://dx.doi.org/10.1371/journal.pone.0157323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404556	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508200002
J	Tanaka, S; Fujita, S; Kizawa, S; Morita, H; Ishizaka, N				Tanaka, Suguru; Fujita, Shu-ichi; Kizawa, Shun; Morita, Hideaki; Ishizaka, Nobukazu			Association between FGF23, alpha-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages	PLOS ONE			English	Article							GROWTH-FACTOR 23; LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR-DISEASE; SOLUBLE KLOTHO; HEART; PHOSPHATE; RECEPTOR; DEATH; POPULATION; FACTOR-23	Background Several experimental studies have demonstrated that fibroblast growth factor 23 (FGF23) may induce myocardial hypertrophy via pathways independent of a-Klotho, its co-factor in the induction of phosphaturia. On the other hand, few studies have clearly demonstrated the relationship between FGF23 level and left ventricular hypertrophy among subjects without chronic kidney disease (CKD; i.e., CKD stage G1 or G2). Purpose To investigate the data from 903 patients admitted to the cardiology department with various degrees of renal function, including 234 patients with CKD stage G1/G2. Methods and Results Serum levels of full-length FGF23 and a-Klotho were determined by enzyme immunoassay. After adjustment for sex, age, and estimated glomerular filtration rate (eGFR), the highest FGF23 tertile was significantly associated with left ventricular hypertrophy among patients with CKD stage G1/G2 and those with CKD stage G3a/G3b/G4 as compared with the lowest FGF23 tertile, and the association retained significance after further adjustment for serum levels of corrected calcium, inorganic phosphate, and C-reactive protein, as well as diuretic use, history of hypertension, and systolic blood pressure. FGF23 was also associated with low left ventricular ejection fraction among patients with CKD stage G1/G2 and those with CKD stage G3a/G3b/G4 after adjusting for age, sex, eGFR, corrected calcium, and inorganic phosphate. On the other hand, compared with the highest a-Klotho tertile, the lowest a-Klotho tertile was associated with left ventricular hypertrophy and systolic dysfunction only among patients with CKD stage G3b and stage G3a, respectively. Conclusions An association between FGF23 and cardiac hypertrophy and systolic dysfunction was observed among patients without CKD as well as those with CKD after multivariate adjustment. However, the association between alpha-Klotho and cardiac hypertrophy and systolic dysfunction was significant only among patients with CKD G3b and G3a, respectively.	[Tanaka, Suguru; Fujita, Shu-ichi; Kizawa, Shun; Morita, Hideaki; Ishizaka, Nobukazu] Osaka Med Coll, Dept Cardiol, Osaka, Japan	Osaka Medical College	Ishizaka, N (corresponding author), Osaka Med Coll, Dept Cardiol, Osaka, Japan.	ishizaka@osaka-med.ac.jp			Ministry of Education, Science, and Culture of Japan [15K09106]	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants in Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 15K09106) but there are no relationships with the company relating to employment, consultancy, patents, products in development or marketed products, and other categories that may potently the authors' adherence to all the PLOS ONE policies.; This work was supported in part by Grants in Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan (No. 15K09106) but there are no relationships with the company relating to employment, consultancy, patents, products in development or marketed products, and other categories that may potently our adherence to all the PLOS ONE policies. We are highly appreciative of Chieko Ohta, Yumiko Ohgami, and Megumi Hashimoto for their excellent technical assistance.	Andersen IA, 2016, NEPHROL DIAL TRANSPL, V31, P767, DOI 10.1093/ndt/gfv398; Bhattacharyya N, 2012, J BONE MINER RES, V27, P1132, DOI 10.1002/jbmr.1546; Brandenburg VM, 2014, ATHEROSCLEROSIS, V237, P53, DOI 10.1016/j.atherosclerosis.2014.08.037; Buiten MS, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-197; Chudek J, 2014, NEPHROL DIAL TRANSPL, V29, P1757, DOI 10.1093/ndt/gfu063; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grabner A, 2015, CELL METAB, V22, P1020, DOI 10.1016/j.cmet.2015.09.002; Gruson D, 2012, PEPTIDES, V37, P258, DOI 10.1016/j.peptides.2012.08.003; Gutierrez OM, 2009, CIRCULATION, V119, P2545, DOI 10.1161/CIRCULATIONAHA.108.844506; Hu MC, 2015, J AM SOC NEPHROL, V26, P1290, DOI 10.1681/ASN.2014050465; Imazu M, 2014, AM J PHYSIOL-HEART C, V307, pH1504, DOI 10.1152/ajpheart.00331.2014; Isakova T, 2013, PEDIATR NEPHROL, V28, P2035, DOI 10.1007/s00467-013-2515-7; Isakova T, 2011, KIDNEY INT, V79, P1370, DOI 10.1038/ki.2011.47; Ix JH, 2012, J AM COLL CARDIOL, V60, P200, DOI 10.1016/j.jacc.2012.03.040; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Leaf DE, 2016, KIDNEY INT, V89, P939, DOI 10.1016/j.kint.2015.12.035; Leifheit-Nestler M, 2016, NEPHROL DIAL TRANSPL, V31, P1088, DOI 10.1093/ndt/gfv421; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Navarro-Gonzalez JF, 2014, HEART, V100, P34, DOI 10.1136/heartjnl-2013-304746; Negishi K, 2010, CIRC J, V74, P2734, DOI 10.1253/circj.CJ-10-0355; Ozeki M, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-147; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; Rowell J, 2010, J CARDIOVASC TRANSL, V3, P516, DOI 10.1007/s12265-010-9208-4; Scialla JJ, 2014, NAT REV NEPHROL, V10, P268, DOI 10.1038/nrneph.2014.49; Seiler C, 2011, EUR HEART J, V32, P261, DOI [10.1093/eurheartj/ehq314, 10.1093/eurheartj/ehr215]; Seiler S, 2013, KIDNEY INT, V83, P121, DOI 10.1038/ki.2012.288; Semba RD, 2011, J AM GERIATR SOC, V59, P1596, DOI 10.1111/j.1532-5415.2011.03558.x; Sharma S, 2013, CLIN NEPHROL, V80, P313, DOI 10.5414/CN107991; Shibata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073184; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; van Breda F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128994; Wachtell K, 2000, HYPERTENSION, V35, P6, DOI 10.1161/01.HYP.35.1.6; Wolf M, 2014, CURR OPIN NEPHROL HY, V23, P411, DOI 10.1097/01.mnh.0000447020.74593.6f; Xie J, 2015, J AM SOC NEPHROL, V26, P1150, DOI 10.1681/ASN.2014040325; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Yamazaki Y, 2010, BIOCHEM BIOPH RES CO, V398, P513, DOI 10.1016/j.bbrc.2010.06.110; Yang K, 2015, J AM SOC NEPHROL, V26, P2434, DOI 10.1681/ASN.2014060543; 2000, NAT GENET, V26, P345, DOI DOI 10.1038/81664	42	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0156860	10.1371/journal.pone.0156860	http://dx.doi.org/10.1371/journal.pone.0156860			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27400031	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508100002
J	Chi, PC; Chang, SC; Yun, CH; Kuo, JY; Hung, CL; Hou, CJY; Liu, CY; Yang, FS; Wu, TH; Bezerra, HG; Yeh, HI				Chi, Po-Ching; Chang, Shun-Chuan; Yun, Chun-Ho; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Liu, Chia-Yuan; Yang, Fei-Shih; Wu, Tung-Hsin; Bezerra, Hiram G.; Yeh, Hung-I			The Associations between Various Ectopic Visceral Adiposity and Body Surface Electrocardiographic Alterations: Potential Differences between Local and Remote Systemic Effects	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; PERICARDIAL FAT; CARDIOVASCULAR-DISEASE; ABDOMINAL FAT; RISK SCORE; TISSUE; HEART; OBESITY; ATHEROSCLEROSIS; EXPRESSION	Background The associations between pericardial adiposity and altered atrial conduction had been demonstrated. However, data comparing differential effects of various body sites visceral adiposity on atrial and ventricular electrocardiographic alterations remains largely unknown. Methods and Results We assessed both peri-cardial fat (PCF) and peri-aortic visceral adiposity (TAT) using dedicated computed tomography (CT) software (Aquarius 3D Workstation, TeraRecon, San Mateo, CA, USA), with anthropometrics including body mass index (BMI) and biochemical data obtained. We further related PCF and TAT data to standardized 12-leads electrocardiogram (ECG), including P and QRS wave morphologies. Among 3,087 study subjects (mean age, 49.6 years; 28% women), we observed a linear association among greater visceral adiposity burden, leftward deviation of P and QRS axes, longer PR interval and widened QRS duration (all p< 0.001). These associations became attenuated after accounting for BMI and baseline clinical co-variates, with greater PCF remained independently associated with prolonged QRS duration (beta = 0.91 [ 95% CI: 0.52, 1.31] per 1-SD increase in PCF, p< 0.001). Finally, both PCF and TAT showed incremental value in identifying abnormally high PR interval (> 200ms, likelihood-ratio: 33.17 to 41.4 & 39.03 for PCF and TAT) and widened QRS duration (> 100ms, likelihood- ratio: 55.67 to 65.4 & 61.94 for PCF and TAT, all X-2 p< 0.05) when superimposed on age and BMI. Conclusion We show in our data greater visceral fat burden may have differential associations on several body surface electrocardiographic parameters. Compared to remote adiposity, those surrounding the heart tissue demonstrated greater influences on altered cardiac activation or conduction, indicating a possible local biological effect.	[Chi, Po-Ching; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan; [Chi, Po-Ching; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Mem Hosp, Med Res, Taipei, Taiwan; [Chi, Po-Ching; Chang, Shun-Chuan; Kuo, Jen-Yuan; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yeh, Hung-I] Mackay Med Coll, Dept Med, New Taipei, Taiwan; [Chi, Po-Ching; Yun, Chun-Ho; Hung, Chung-Lieh; Hou, Charles Jia-Yin] Nursing & Management Coll, Mackay Med, New Taipei, Taiwan; [Yun, Chun-Ho; Hung, Chung-Lieh; Hou, Charles Jia-Yin; Yang, Fei-Shih] Mackay Mem Hosp, Dept Radiol, Taipei, Taiwan; [Liu, Chia-Yuan] Mackay Mem Hosp, Dept Gastroenterol, Taipei, Taiwan; [Wu, Tung-Hsin] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei, Taiwan; [Bezerra, Hiram G.] Baptist Cardiac Vasc Inst, Cardiovasc MRI & CT Program, Miami, FL USA	Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Medical College; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Baptist Cardiac & Vascular Institute	Hung, CL; Yeh, HI (corresponding author), Mackay Mem Hosp, Div Cardiol, Dept Internal Med, Taipei, Taiwan.; Hung, CL; Yeh, HI (corresponding author), Mackay Mem Hosp, Med Res, Taipei, Taiwan.; Hung, CL; Yeh, HI (corresponding author), Mackay Med Coll, Dept Med, New Taipei, Taiwan.; Hung, CL (corresponding author), Nursing & Management Coll, Mackay Med, New Taipei, Taiwan.; Hung, CL (corresponding author), Mackay Mem Hosp, Dept Radiol, Taipei, Taiwan.	jotaro3791@gmail.com; yehmmc@mmc.edu.tw	Kuo, Jen-Yuan/AAX-5448-2021		National Science Council [NSC-101-2314-B-195-020, NSC103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3]; Mackay Memorial Hospital [10271, 10248, 10220, 10253, 10375, 10358, E-102003]; Taiwan Foundation for geriatric emergency and critical care	National Science Council(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital; Taiwan Foundation for geriatric emergency and critical care	This work was partly supported by grants of the National Science Council: NSC-101-2314-B-195-020, NSC103-2314-B-010-005-MY3, 103-2314-B-195-001-MY3, 101-2314-B-195 -020 -MY1, MOST 103-2314-B-195-006-MY3; Mackay Memorial Hospital: 10271, 10248, 10220, 10253, 10375, 10358, E-102003; Taiwan Foundation for geriatric emergency and critical care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; Al Chekakie MO, 2010, J AM COLL CARDIOL, V56, P784, DOI 10.1016/j.jacc.2010.03.071; Babcock MJ, 2011, OBESITY, V19, P179, DOI 10.1038/oby.2010.121; Bagi Z, 2014, CURR VASC PHARMACOL, V12, P453, DOI 10.2174/1570161112666140423221843; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Biernacka A, 2011, AGING DIS, V2, P158; Britton KA, 2013, OBESITY, V21, P1496, DOI 10.1002/oby.20166; Chamberlain AM, 2011, AM J CARDIOL, V107, P85, DOI 10.1016/j.amjcard.2010.08.049; Chao TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097472; Chiou CW, 1997, CIRCULATION, V95, P2573, DOI 10.1161/01.CIR.95.11.2573; Crendal E, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-95; Fitzgibbons TP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000582; FLEG JL, 1990, J GERONTOL, V45, pM95, DOI 10.1093/geronj/45.3.M95; Friedman DJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000477; Graner M, 2014, NUTR METAB CARDIOVAS, V24, P315, DOI 10.1016/j.numecd.2013.09.013; Guzzardi Maria A, 2011, Rev Diabet Stud, V8, P403, DOI 10.1900/RDS.2011.8.403; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Hense HW, 1998, J AM COLL CARDIOL, V32, P451, DOI 10.1016/S0735-1097(98)00240-X; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Iacobellis G, 2005, CYTOKINE, V29, P251, DOI 10.1016/j.cyto.2004.11.002; Iacobellis G, 2007, INT J CARDIOL, V115, P272, DOI 10.1016/j.ijcard.2006.04.016; James TN, 2001, PROG CARDIOVASC DIS, V43, P495, DOI 10.1053/pcad.2001.24598; Kaya Z, 2015, WIEN KLIN WOCHENSCHR, V127, P191, DOI 10.1007/s00508-015-0722-x; Lehman SJ, 2010, ATHEROSCLEROSIS, V210, P656, DOI 10.1016/j.atherosclerosis.2010.01.007; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Magnani JW, 2013, CIRC-ARRHYTHMIA ELEC, V6, P84, DOI 10.1161/CIRCEP.112.975342; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; MESSERLI FH, 1986, NEW ENGL J MED, V314, P378, DOI 10.1056/NEJM198602063140608; Narayanan K, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001654; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Rodriguez A, 2007, CURR PHARM DESIGN, V13, P2169; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Sacks HS, 2007, AM HEART J, V153, P907, DOI 10.1016/j.ahj.2007.03.019; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Shin SY, 2011, J CARDIOVASC ELECTR, V22, P647, DOI 10.1111/j.1540-8167.2010.01993.x; Spiroglou SG, 2010, J ATHEROSCLER THROMB, V17, P115; Thanassoulis G, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000885; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Yang FS, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-98; Yun CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061997; Yun CH, 2012, EUR J RADIOL, V81, P749, DOI 10.1016/j.ejrad.2011.01.035	43	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158300	10.1371/journal.pone.0158300	http://dx.doi.org/10.1371/journal.pone.0158300			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391045	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400040
J	Holcomb, N; Goswami, M; Han, SG; Clark, S; Orren, DK; Gairola, CG; Mellon, I				Holcomb, Nathaniel; Goswami, Mamta; Han, Sung Gu; Clark, Samuel; Orren, David K.; Gairola, C. Gary; Mellon, Isabel			Exposure of Human Lung Cells to Tobacco Smoke Condensate Inhibits the Nucleotide Excision Repair Pathway	PLOS ONE			English	Article							INDUCED DNA-DAMAGE; GROUP-C PROTEIN; CIGARETTE-SMOKE; MUTATIONAL HOTSPOTS; UBIQUITIN LIGASE; P53 MUTATION; DIOL EPOXIDE; XPA PROTEIN; CANCER; GENE	Exposure to tobacco smoke is the number one risk factor for lung cancer. Although the DNA damaging properties of tobacco smoke have been well documented, relatively few studies have examined its effect on DNA repair pathways. This is especially true for the nucleotide excision repair (NER) pathway which recognizes and removes many structurally diverse DNA lesions, including those introduced by chemical carcinogens present in tobacco smoke. The aim of the present study was to investigate the effect of tobacco smoke on NER in human lung cells. We studied the effect of cigarette smoke condensate (CSC), a surrogate for tobacco smoke, on the NER pathway in two different human lung cell lines; IMR-90 lung fibroblasts and BEAS-2B bronchial epithelial cells. To measure NER, we employed a slot-blot assay to quantify the introduction and removal of UV light-induced 6-4 photoproducts and cyclobutane pyrimidine dimers. We find a dose-dependent inhibition of 6-4 photoproduct repair in both cell lines treated with CSC. Additionally, the impact of CSC on the abundance of various NER proteins and their respective RNAs was investigated. The abundance of XPC protein, which is required for functional NER, is significantly reduced by treatment with CSC while the abundance of XPA protein, also required for NER, is unaffected. Both XPC and XPA RNA levels are modestly reduced by CSC treatment. Finally, treatment of cells with MG-132 abrogates the reduction in the abundance of XPC protein produced by treatment with CSC, suggesting that CSC enhances proteasome-dependent turnover of the protein that is mediated by ubiquitination. Together, these findings indicate that tobacco smoke can inhibit the same DNA repair pathway that is also essential for the removal of some of the carcinogenic DNA damage introduced by smoke itself, increasing the DNA damage burden of cells exposed to tobacco smoke.	[Holcomb, Nathaniel; Goswami, Mamta; Clark, Samuel; Orren, David K.; Gairola, C. Gary; Mellon, Isabel] Univ Kentucky, Dept Toxicol & Canc Biol, Markey Canc Ctr, Lexington, KY USA; [Han, Sung Gu] Konkuk Univ, Toxicol Lab, Dept Food Sci & Biotechnol Anim Resources, Coll Anim Biosci & Technol, Seoul, South Korea	University of Kentucky; Konkuk University	Mellon, I (corresponding author), Univ Kentucky, Dept Toxicol & Canc Biol, Markey Canc Ctr, Lexington, KY USA.	mellon@uky.edu		Holcomb, Nathaniel/0000-0002-8214-2613; Han, Sung Gu/0000-0002-1485-861X	Kentucky Lung Cancer Research Program; Lexington Cancer Foundation; NIH [T32ES007266]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007266] Funding Source: NIH RePORTER	Kentucky Lung Cancer Research Program; Lexington Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Support was provided by Kentucky Lung Cancer Research Program [http://kentuckylungcancer.org/] to IM and The Lexington Cancer Foundation [http://lexingtoncancerfoundation.org/] to IM and NIH Training Grant T32ES007266 to NH.	Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; AUTRUP JL, 1992, CHEM-BIOL INTERACT, V85, P141, DOI 10.1016/0009-2797(92)90058-S; Balansky R, 2010, INT J CANCER, V126, P1047, DOI 10.1002/ijc.24942; Barckhausen C, 2014, ONCOGENE, V33, P1964, DOI 10.1038/onc.2013.141; Bunick CG, 2006, BIOCHEMISTRY-US, V45, P14965, DOI 10.1021/bi061370o; Chen GS, 2010, ENVIRON MOL MUTAGEN, V51, P330, DOI 10.1002/em.20540; Coggins CRE, 2010, INHAL TOXICOL, V22, P974, DOI 10.3109/08958378.2010.501831; Curtin GM, 2004, TOXICOL SCI, V81, P14, DOI 10.1093/toxsci/kfh172; DeMarini DM, 2008, MUTAT RES-GEN TOX EN, V650, P15, DOI 10.1016/j.mrgentox.2007.09.006; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; EISENSTADT E, 1982, P NATL ACAD SCI-BIOL, V79, P1945, DOI 10.1073/pnas.79.6.1945; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; Foresta M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087984; Friedberg EC, 2000, MUTAT RES-DNA REPAIR, V459, P99, DOI 10.1016/S0921-8777(99)00068-3; GAIROLA C, 1982, MUTAT RES, V102, P123, DOI 10.1016/0165-1218(82)90113-6; Gibbons DL, 2014, MOL CANCER RES, V12, P3, DOI 10.1158/1541-7786.MCR-13-0539; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Gunz D, 1996, J BIOL CHEM, V271, P25089, DOI 10.1074/jbc.271.41.25089; Guo XQ, 2011, MUTAGENESIS, V26, P273, DOI 10.1093/mutage/geq083; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Han SG, 2016, ENVIRON MOL MUTAGEN, V57, P220, DOI 10.1002/em.22000; Hang B, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/709521; He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812; Hecht SS, 2005, CARCINOGENESIS, V26, P1488, DOI 10.1093/carcin/bgi148; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; Hecht SS, 2012, INT J CANCER, V131, P2724, DOI 10.1002/ijc.27816; Hess MT, 1997, MOL CELL BIOL, V17, P7069, DOI 10.1128/MCB.17.12.7069; Hollander MC, 2005, P NATL ACAD SCI USA, V102, P13200, DOI 10.1073/pnas.0503133102; HSU TC, 1991, MUTAT RES, V259, P67, DOI 10.1016/0165-1218(91)90110-8; Hutt JA, 2005, CARCINOGENESIS, V26, P1999, DOI 10.1093/carcin/bgi150; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Ide F, 2000, CARCINOGENESIS, V21, P1263, DOI 10.1093/carcin/21.6.1263; Ishikawa T, 2001, MUTAT RES-FUND MOL M, V477, P41, DOI 10.1016/S0027-5107(01)00094-X; Islami F, 2015, TRANSL LUNG CANCER R, V4, P327, DOI 10.3978/j.issn.2218-6751.2015.08.04; Islami F, 2015, CANCER CAUSE CONTROL, V26, P409, DOI 10.1007/s10552-014-0517-9; Jaiswal AS, 2013, NEOPLASIA, V15, P454, DOI 10.1593/neo.13176; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Kim SY, 2011, J BIOL CHEM, V286, P31932, DOI 10.1074/jbc.M111.267633; Koberle B, 2006, DNA REPAIR, V5, P641, DOI 10.1016/j.dnarep.2005.12.001; Kundu CN, 2007, ONCOGENE, V26, P1428, DOI 10.1038/sj.onc.1209925; Kwon MC, 2013, MOL ONCOL, V7, P165, DOI 10.1016/j.molonc.2013.02.010; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Luo LZ, 2004, MUTAT RES-FUND MOL M, V554, P375, DOI 10.1016/j.mrfmmm.2004.06.031; Matsumoto S, 2015, NUCLEIC ACIDS RES, V43, P1700, DOI 10.1093/nar/gkv038; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Mellon I, 2002, DNA REPAIR, V1, P531, DOI 10.1016/S1568-7864(02)00053-8; Meschini R, 2008, MUTAT RES-FUND MOL M, V637, P93, DOI 10.1016/j.mrfmmm.2007.07.005; Moktar A, 2011, INT J ONCOL, V39, P941, DOI 10.3892/ijo.2011.1106; Moktar A, 2009, INT J ONCOL, V35, P1297, DOI 10.3892/ijo_00000447; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; Muotri AR, 2002, CARCINOGENESIS, V23, P1039, DOI 10.1093/carcin/23.6.1039; Narayan S, 2004, ONCOGENE, V23, P5880, DOI 10.1038/sj.onc.1207792; Ng JMY, 2003, GENE DEV, V17, P1630, DOI 10.1101/gad.260003; Nik-Zainal S, 2015, MUTAGENESIS, V30, P763, DOI 10.1093/mutage/gev073; Nishi R, 2009, DNA REPAIR, V8, P767, DOI 10.1016/j.dnarep.2009.02.004; Nollen M, 2009, MOL NUTR FOOD RES, V53, P572, DOI 10.1002/mnfr.200800480; PILLSBURY HC, 1972, J ASSOC OFF ANA CHEM, V55, P636; Porter PC, 2005, DNA REPAIR, V4, P341, DOI 10.1016/j.dnarep.2004.10.007; Poulsen SL, 2013, J CELL BIOL, V201, P797, DOI 10.1083/jcb.201212075; Povlsen LK, 2012, NAT CELL BIOL, V14, P1089, DOI 10.1038/ncb2579; Puumalainen MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4695; Qiu JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115224; Quan TH, 1996, MOL CARCINOGEN, V16, P32, DOI 10.1002/(SICI)1098-2744(199605)16:1<32::AID-MC5>3.0.CO;2-Q; QUAN TH, 1995, MOL CARCINOGEN, V12, P91, DOI 10.1002/mc.2940120206; Renaud E, 2011, DNA REPAIR, V10, P835, DOI 10.1016/j.dnarep.2011.05.003; RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013; Scharer Orlando D, 2013, Cold Spring Harb Perspect Biol, V5, pa012609, DOI 10.1101/cshperspect.a012609; Smith ML, 2002, MUTAGENESIS, V17, P149, DOI 10.1093/mutage/17.2.149; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Talikka M, 2012, CRIT REV TOXICOL, V42, P877, DOI 10.3109/10408444.2012.725244; Tang MS, 2011, MOL NUTR FOOD RES, V55, P1291, DOI 10.1002/mnfr.201100148; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; USDHSS, 2014, HLTH CONSMOK 50 YE; van Cuijk L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8499; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Walaszek Z, 2007, INT J TOXICOL, V26, P345, DOI 10.1080/10915810701490422; Wang HT, 2012, J BIOL CHEM, V287, P12379, DOI 10.1074/jbc.M111.329623; Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684; Wang QE, 2007, NUCLEIC ACIDS RES, V35, P5338, DOI 10.1093/nar/gkm550; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; Witschi H, 2007, INT J TOXICOL, V26, P339, DOI 10.1080/10915810701490380; Yang MH, 2005, ENVIRON MOL MUTAGEN, V45, P374, DOI 10.1002/em.20097; Yeo JE, 2012, CHEM RES TOXICOL, V25, P2462, DOI 10.1021/tx3003033; Yoon JH, 2001, CANCER RES, V61, P7110; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb; Zhao B, 2006, NUCLEIC ACIDS RES, V34, P417, DOI 10.1093/nar/gkj446	94	11	12	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158858	10.1371/journal.pone.0158858	http://dx.doi.org/10.1371/journal.pone.0158858			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391141	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400145
J	Ni, LH; Zhao, ZL; Dorje, G; Ma, M				Ni, Lianghong; Zhao, Zhili; Dorje, Gaawe; Ma, Mi			The Complete Chloroplast Genome of Ye-Xing-Ba (Scrophularia dentata; Scrophulariaceae), an Alpine Tibetan Herb	PLOS ONE			English	Article							SEQUENCE; GLYCOSIDES	Scrophularia dentata is an important Tibetan medicinal plant and traditionally used for the treatment of exanthema and fever in Traditional Tibetan Medicine (TTM). However, there is little sequence and genomic information available for S. dentata. In this paper, we report the complete chloroplast genome sequence of S. dentata and it is the first sequenced member of the Sect. Tomiophyllum within Scrophularia (Scrophulariaceae). The gene order and organization of the chloroplast genome of S. dentata are similar to other Lamiales chloroplast genomes. The plastome is 152,553 bp in length and includes a pair of inverted repeats (IRs) of 25,523 bp that separate a large single copy (LSC) region of 84,058 bp and a small single copy (SSC) region of 17,449 bp. It has 38.0% GC content and includes 114 unique genes, of which 80 are protein-coding, 30 are transfer RNA, and 4 are ribosomal RNA. Also, it contains 21 forward repeats, 19 palindrome repeats and 41 simple sequence repeats (SSRs). The repeats and SSRs within S. dentata were compared with those of S. takesimensis and present certain discrepancies. The chloroplast genome of S. dentata was compared with other five publicly available Lamiales genomes from different families. All the coding regions and non-coding regions (introns and intergenic spacers) within the six chloroplast genomes have been extracted and analysed. Furthermore, the genome divergent hotspot regions were identified. Our studies could provide basic data for the alpine medicinal species conservation and molecular phylogenetic researches of Scrophulariaceae and Lamiales.	[Ni, Lianghong; Zhao, Zhili] Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China; [Dorje, Gaawe; Ma, Mi] Tibetan Tradit Med Coll, Lhasa, Peoples R China	Shanghai University of Traditional Chinese Medicine; University of Tibetan Medicine	Zhao, ZL (corresponding author), Shanghai Univ Tradit Chinese Med, Sch Pharm, Shanghai, Peoples R China.	zhilzhao@163.com		zhao, zhili/0000-0003-2127-4134	National Natural Science Foundation of China [81173654]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81173654). Professor Zhili Zhao received the funding in 2012 (https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cavalier-Smith T, 2002, CURR BIOL, V12, pR62, DOI 10.1016/S0960-9822(01)00675-3; Chen JH, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00447; Choi KS, 2014, MITOCHONDR DNA, P1; Choi KS, 2015, GENE, V572, P214, DOI 10.1016/j.gene.2015.07.020; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Curci PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120589; De las Rivas J, 2002, GENOME RES, V12, P567, DOI 10.1101/gr.209402; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gogniashvili M, 2015, GENET RESOUR CROP EV, V62, P1269, DOI 10.1007/s10722-015-0230-x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; HONG DY, 1983, ANN MO BOT GARD, V70, P701; Kong WW, 2015, COMM COM INF SC, V546, P1, DOI 10.1007/978-3-662-48558-3_1; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kurtz S, 1999, BIOINFORMATICS, V15, P426, DOI 10.1093/bioinformatics/15.5.426; Li Xi-wen, 2012, Yaoxue Xuebao, V47, P124; Liu Yang, 2013, Biomed Res Int, V2013, P839683, DOI 10.1155/2013/839683; Nazareno AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129930; Ni LH, 2016, GENE, V577, P281, DOI 10.1016/j.gene.2015.12.005; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Oxelman B, 2005, TAXON, V54, P411, DOI 10.2307/25065369; Qian J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057607; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Vieira LD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090618; Wang WY, 1991, TIBETAN MED, P333; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Williams AV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125768; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073053; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110656; Yao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129347; Yap JYS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128126; Yi DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035872; Zedane L, 2016, BIOL J LINN SOC, V117, P44, DOI 10.1111/bij.12509; Zhang LQ, 2015, FITOTERAPIA, V106, P72, DOI 10.1016/j.fitote.2015.08.005; Zhang LQ, 2014, FITOTERAPIA, V98, P84, DOI 10.1016/j.fitote.2014.07.005; Zhang LQ, 2013, J MOL STRUCT, V1049, P299, DOI 10.1016/j.molstruc.2013.05.039; Zhang TW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030531; Zhang Y, 2014, GENE, V549, P58, DOI 10.1016/j.gene.2014.07.041; Zhao ZL, 2010, J ETHNOPHARMACOL, V132, P122, DOI 10.1016/j.jep.2010.07.051; Zhao Z.-L., 1992, CHIN PHARM J, V27, P269; Zhong BQ, 1979, FLORA REIPUBLICAE PO, V67, P46	43	21	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158488	10.1371/journal.pone.0158488	http://dx.doi.org/10.1371/journal.pone.0158488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391235	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400068
J	Opiyo, MA; Hamer, GL; Lwetoijera, DW; Auckland, LD; Majambere, S; Okumu, FO				Opiyo, Mercy A.; Hamer, Gabriel L.; Lwetoijera, Dickson W.; Auckland, Lisa D.; Majambere, Silas; Okumu, Fredros O.			Using Stable Isotopes of Carbon and Nitrogen to Mark Wild Populations of Anopheles and Aedes Mosquitoes in South-Eastern Tanzania	PLOS ONE			English	Article							CULEX MOSQUITOS; DISPERSAL	Background Marking wild mosquitoes is important for understanding their ecology, behaviours and role in disease transmission. Traditional insect marking techniques include using fluorescent dyes, protein labels, radioactive labels and tags, but such techniques have various limitations; notably low marker retention and inability to mark wild mosquitoes at source. Stable isotopes are gaining wide spread use for non-invasive marking of arthropods, permitting greater understanding of mosquito dispersal and responses to interventions. We describe here a simple technique for marking naturally-breeding malaria and dengue vectors using stable isotopes of nitrogen (N-15) and carbon (C-13), and describe potential field applications. Methods We created man-made aquatic mosquito habitats and added either N-15-labelled potassium nitrate or C-13-labelled glucose, leaving non-adulterated habitats as controls. We then allowed wild mosquitoes to lay eggs in these habitats and monitored their development in situ. Pupae were collected promptly as they appeared and kept in netting cages. Emergent adults (in pools of similar to 4 mosquitoes/pool) and individually stored pupae were desiccated and analysed using Isotope Ratio Mass Spectrometry (IRMS). Findings Anopheles gambiae s.l and Aedes spp. from enriched C-13 and enriched N-15 larval habitats had significantly higher isotopic levels than controls (P = 0.005), and both isotopes produced sufficient distinction between marked and unmarked mosquitoes. Mean delta N-15 for enriched females and males were 275.6 +/- 65.1 and 248.0 +/- 54.6, while mean delta N-15 in controls were 2.1 +/- 0.1 and 3.9 +/- 1.7 respectively. Similarly, mean delta C-13 for enriched females and males were 36.08 +/- 5.28 and 38.5 +/- 6.86, compared to - 4.3 +/- 0.2 and - 7.9 +/- 3.6 in controls respectively. Mean delta N-15 and delta C-13 was significantly higher in any pool containing at least one enriched mosquito compared to pools with all unenriched mosquitoes, P<0.001. In all cases, there were variations in standardized isotopic ratios between mosquito species. Conclusion Enrichment of semi-natural mosquito larval habitats with stable isotopes of nitrogen and carbon resulted in effective marking of Anopheles and Aedes mosquitoes colonizing these habitats. This approach can significantly enhance studies on mosquito eco-physiology, dispersal, pathogen transmission and responses to control measures.	[Opiyo, Mercy A.; Lwetoijera, Dickson W.; Majambere, Silas; Okumu, Fredros O.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania; [Opiyo, Mercy A.; Majambere, Silas] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England; [Hamer, Gabriel L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Auckland, Lisa D.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Majambere, Silas] Innovat Vector Control Consortium, Liverpool, Merseyside, England; [Okumu, Fredros O.] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Parktown, South Africa	Ifakara Health Institute; Liverpool School of Tropical Medicine; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; University of Witwatersrand	Opiyo, MA (corresponding author), Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, Ifakara, Tanzania.; Opiyo, MA (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England.	mopiyo@ihi.or.tz			Bill & Melinda Gates Foundation [OPP52644]; Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine [WT102350/Z/13/Z]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine(Wellcome Trust)	This work was funded by Bill & Melinda Gates Foundation (Grant Numbers: OPP52644). Fredros Okumu was also supported by Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine (Grant number: WT102350/Z/13/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Nuru Nchimbi, Zuhura Kondo, Monica Mpingwa, and Andrew Kafwenji for assisting in field data collections. We also thank Japhet Kihonda for assisting in mosquito species identifications, Emmanuel Kaindoa for going over this manuscript and providing initial reviews on figures and results, and Brendan Roark and the Stable Isotope Geosciences Facility at Texas A&M University for sample analysis. This work was funded by Bill & Melinda Gates Foundation (Grant Numbers: OPP52644). Fredros Okumu was also supported by Wellcome Trust Intermediate Fellowship in Public Health and Tropical Medicine (Grant number: WT102350/Z/13/Z).	Chiu C, 2008, P NATL ACAD SCI USA, V105, P13116, DOI 10.1073/pnas.0804408105; Ciota AT, 2012, J MED ENTOMOL, V49, P35, DOI 10.1603/ME11077; Corp. I., 2012, IBM SPSS STAT WIND V; Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106; Dickens BL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-65; Gilbreath TM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-353; Gillies M, 1987, ANOPHELINAE AFRICA S; Guerra CA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-276; Hagler JR, 2001, ANNU REV ENTOMOL, V46, P511, DOI 10.1146/annurev.ento.46.1.511; Hamer GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002768; Hamer GL, 2012, J MED ENTOMOL, V49, P61, DOI 10.1603/ME11076; Hamer SA, 2015, J MED ENTOMOL, V52, P1043, DOI 10.1093/jme/tjv063; Head G, 2010, J APPL ECOL, V47, P583, DOI 10.1111/j.1365-2664.2010.01796.x; Helinski MEH, 2007, J EXP BIOL, V210, P1266, DOI 10.1242/jeb.002642; Hood-Nowotny R, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-6; Hood-Nowotny R, 2007, ENTOMOL EXP APPL, V124, P3, DOI 10.1111/j.1570-7458.2007.00572.x; Hood-Nowotny R, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.7901; IAEA, 2009, INT AT EN AG MAN US, P69; METZGER R, 1979, Angewandte Parasitologie, V20, P77; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Verhulst NO, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-200; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Winters AE, 2012, ECOL ENTOMOL, V37, P56, DOI 10.1111/j.1365-2311.2011.01337.x	23	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159067	10.1371/journal.pone.0159067	http://dx.doi.org/10.1371/journal.pone.0159067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392083	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400206
J	Zahonova, K; Fussy, Z; Obornik, M; Elias, M; Yurchenko, V				Zahonova, Kristina; Fussy, Zoltan; Obornik, Miroslav; Elias, Marek; Yurchenko, Vyacheslav			RuBisCO in Non-Photosynthetic Alga Euglena longa: Divergent Features, Transcriptomic Analysis and Regulation of Complex Formation	PLOS ONE			English	Article							A/B-BINDING-PROTEIN; CARBOXYLASE OXYGENASE; SMALL-SUBUNIT; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; POLYPROTEIN PRECURSOR; MECHANISTIC DIVERSITY; GENE REPLACEMENT; MESSENGER-RNA; LIGHT; EXPRESSION	Euglena longa, a close relative of the photosynthetic model alga Euglena gracilis, possesses an enigmatic non-photosynthetic plastid. Its genome has retained a gene for the large subunit of the enzyme RuBisCO (rbcL). Here we provide new data illuminating the putative role of RuBisCO in E. longa. We demonstrated that the E. longa RBCL protein sequence is extremely divergent compared to its homologs from the photosynthetic relatives, suggesting a possible functional shift upon the loss of photosynthesis. Similarly to E. gracilis, E. longa harbors a nuclear gene encoding the small subunit of RuBisCO (RBCS) as a precursor polyprotein comprising multiple RBCS repeats, but one of them is highly divergent. Both RBCL and the RBCS proteins are synthesized in E. longa, but their abundance is very low compared to E. gracilis. No RBCS monomers could be detected in E. longa, suggesting that processing of the precursor polyprotein is inefficient in this species. The abundance of RBCS is regulated post-transcriptionally. Indeed, blocking the cytoplasmic translation by cycloheximide has no immediate effect on the RBCS stability in photosynthetically grown E. gracilis, but in E. longa, the protein is rapidly degraded. Altogether, our results revealed signatures of evolutionary degradation (becoming defunct) of RuBisCO in E. longa and suggest that its biological role in this species may be rather unorthodox, if any.	[Zahonova, Kristina; Elias, Marek; Yurchenko, Vyacheslav] Univ Ostrava, Dept Biol & Ecol, Life Sci Res Ctr, Ostrava 70100, Czech Republic; [Zahonova, Kristina; Elias, Marek; Yurchenko, Vyacheslav] Univ Ostrava, Fac Sci, Inst Environm Technol, Ostrava 70100, Czech Republic; [Fussy, Zoltan; Obornik, Miroslav; Yurchenko, Vyacheslav] Biol Ctr ASCR, Inst Parasitol, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Obornik, Miroslav] Ctr Agaltech, Inst Microbiol ASCR, Trebon 37901, Czech Republic	University of Ostrava; University of Ostrava; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences	Yurchenko, V (corresponding author), Univ Ostrava, Dept Biol & Ecol, Life Sci Res Ctr, Ostrava 70100, Czech Republic.; Yurchenko, V (corresponding author), Univ Ostrava, Fac Sci, Inst Environm Technol, Ostrava 70100, Czech Republic.; Yurchenko, V (corresponding author), Biol Ctr ASCR, Inst Parasitol, Ceske Budejovice 37005, Czech Republic.	vyacheslav.yurchenko@osu.cz	Elias, Marek/D-6851-2014; Füssy, Zoltán/A-6025-2013; Obornik, Miroslav/G-9350-2014; Záhonová, Kristína/AAT-9188-2020; Yurchenko, Vyacheslav/E-4532-2013	Elias, Marek/0000-0003-0066-6542; Füssy, Zoltán/0000-0002-0820-6359; Záhonová, Kristína/0000-0002-5766-0267; Yurchenko, Vyacheslav/0000-0003-4765-3263	Czech Science Foundation [13-24983S, 13-33039S]; National Feasibility Programme I of the Czech Republic [TEWEP LO1208]; Czech Academy of Sciences; European Regional Development Fund [CZ.1.05/1.1.00/02.0068]	Czech Science Foundation(Grant Agency of the Czech Republic); National Feasibility Programme I of the Czech Republic; Czech Academy of Sciences(Czech Academy of Sciences); European Regional Development Fund(European Commission)	This study was supported by the Czech Science Foundation grants 13-24983S (to ME) and 13-33039S (to MO), the project TEWEP LO1208 of the National Feasibility Programme I of the Czech Republic, and by Czech Academy of Sciences fellowship (to ZF). The MS analysis was carried out at the Proteomics Core Facility of CEITEC - Central European Institute of Technology, ID number CZ.1.05/1.1.00/02.0068, financed by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Prof. Juraj Krajcovic (Comenius University in Bratislava, Slovakia) for providing cultures of both Euglena species and permission to use unpublished transcriptomic data generated in frame of a collaborative project. This study was supported by the Czech Science Foundation grants 13-24983S (to ME) and 13-33039S (to MO), the project TEWEP LO1208 of the National Feasibility Programme I of the Czech Republic (to KZ, ME, and VY), and by the Czech Academy of Sciences fellowship (to ZF). The MS analysis was carried out at the Proteomics Core Facility of CEITEC-Central European Institute of Technology, ID number CZ.1.05/1.1.00/02.0068, financed by the European Regional Development Fund.	Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; BASSHAM JA, 1950, J BIOL CHEM, V185, P781; Bennett MS, 2015, J EUKARYOT MICROBIOL, V62, P773, DOI 10.1111/jeu.12235; Busse I, 2003, INT J SYST EVOL MICR, V53, P617, DOI 10.1099/ijs.0.02295-0; CHAN RL, 1990, EMBO J, V9, P333, DOI 10.1002/j.1460-2075.1990.tb08115.x; CRAMER M, 1952, ARCH MIKROBIOL, V17, P384, DOI 10.1007/BF00410835; Dey S, 2015, J BIOL CHEM, V290, P30658, DOI 10.1074/jbc.M115.691295; Doyle CM, 2013, ARCH BIOCHEM BIOPHYS, V531, P44, DOI 10.1016/j.abb.2012.12.005; Durnford DG, 2006, EUKARYOT CELL, V5, P2079, DOI 10.1128/EC.00222-06; Enomoto T, 1997, PLANT CELL PHYSIOL, V38, P743, DOI 10.1093/oxfordjournals.pcp.a029229; Feiz L, 2014, PLANT J, V80, P862, DOI 10.1111/tpj.12686; Genkov T, 2010, J BIOL CHEM, V285, P19833, DOI 10.1074/jbc.M110.124230; Genkov T, 2009, J BIOL CHEM, V284, P30105, DOI 10.1074/jbc.M109.044081; Gockel G, 2000, PROTIST, V151, P347, DOI 10.1078/S1434-4610(04)70033-4; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Hauser T, 2015, NAT STRUCT MOL BIOL, V22, P720, DOI 10.1038/nsmb.3062; Hauser T, 2015, NAT PLANTS, V1, P1, DOI [10.1038/NPLANTS.2015.65, 10.1038/nplants.2015.65]; Imker HJ, 2008, BIOCHEMISTRY-US, V47, P11171, DOI 10.1021/bi801685f; Imker HJ, 2007, BIOCHEMISTRY-US, V46, P4077, DOI 10.1021/bi7000483; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Kanevski I, 1999, PLANT PHYSIOL, V119, P133, DOI 10.1104/pp.119.1.133; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; KELLER M, 1991, PLANT MOL BIOL, V17, P73, DOI 10.1007/BF00036807; Knight JRP, 2013, NUCLEIC ACIDS RES, V41, P4185, DOI 10.1093/nar/gkt129; Koziol AG, 2008, MOL BIOL EVOL, V25, P92, DOI 10.1093/molbev/msm232; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Leander BS, 2004, TRENDS MICROBIOL, V12, P251, DOI 10.1016/j.tim.2004.04.001; Lin MT, 2014, NATURE, V513, P547, DOI 10.1038/nature13776; MACHADO MA, 1990, PLANTA, V181, P91, DOI 10.1007/BF00202329; Manen JF, 2004, MOL PHYLOGENET EVOL, V33, P482, DOI 10.1016/j.ympev.2004.06.010; Marin B, 2003, PROTIST, V154, P99, DOI 10.1078/143446103764928521; Markunas CM, 2016, J EUKARYOT MICROBIOL, V63, P326, DOI 10.1111/jeu.12282; MUCHHAL US, 1992, PLANT MOL BIOL, V18, P287, DOI 10.1007/BF00034956; Nowitzki U, 2004, EUR J BIOCHEM, V271, P4123, DOI 10.1111/j.1432-1033.2004.04350.x; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Randle CP, 2005, AM J BOT, V92, P1575, DOI 10.3732/ajb.92.9.1575; Rice DW, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-31; RIKIN A, 1988, P NATL ACAD SCI USA, V85, P5117, DOI 10.1073/pnas.85.14.5117; SAILLAND A, 1986, PLANT MOL BIOL, V7, P213, DOI 10.1007/BF00021333; SIEMEISTER G, 1990, PLANT MOL BIOL, V14, P825, DOI 10.1007/BF00016515; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; van Lun M, 2014, J AM CHEM SOC, V136, P3165, DOI 10.1021/ja411579b; Vesteg M, 2009, J EUKARYOT MICROBIOL, V56, P159, DOI 10.1111/j.1550-7408.2008.00383.x; Watson GMF, 1997, FEMS MICROBIOL LETT, V146, P13, DOI 10.1016/S0378-1097(96)00417-X; Wheatley NM, 2014, J BIOL CHEM, V289, P7973, DOI 10.1074/jbc.M113.531236; Wolfe AD, 1998, MOL BIOL EVOL, V15, P1243, DOI 10.1093/oxfordjournals.molbev.a025853; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Yamaguchi A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-29; YOKOTA A, 1989, J BIOCHEM, V105, P400, DOI 10.1093/oxfordjournals.jbchem.a122676; Yurchenko V, 2006, MOL CELL BIOL, V26, P1786, DOI 10.1128/MCB.26.5.1786-1794.2006; Yurchenko V, 2008, BIOCHEM BIOPH RES CO, V366, P263, DOI 10.1016/j.bbrc.2007.11.136; Zahonova K, 2014, FEBS LETT, V588, P783, DOI 10.1016/j.febslet.2014.01.034; Zhang H, 2003, J PHYCOL, V39, P1160, DOI 10.1111/j.0022-3646.2003.03-055.x	61	19	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158790	10.1371/journal.pone.0158790	http://dx.doi.org/10.1371/journal.pone.0158790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391690	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400124
J	Yan, XY; Meng, WB; Wu, FF; Xu, AL; Chen, SW; Huang, SF				Yan, Xinyu; Meng, Wenbin; Wu, Fenfang; Xu, Anlong; Chen, Shangwu; Huang, Shengfeng			The Nuclear DNA Content and Genetic Diversity of Lampetra morii	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; VERTEBRATE GENOME; LAMPREY; EVOLUTION; PETROMYZONTIFORMES; INSIGHTS; HAGFISH; PETROMYZONIDAE; CHROMOSOMES; CYCLOSTOMES	We investigated the nuclear DNA content and genetic diversity of a river lamprey, the Korean lamprey Lampetra morii, which is distributed in the northeast of China. L. morii spends its whole life cycle in fresh water, and its adult size is relatively small (similar to 160 mm long) compared with that of other lampreys. The haploid nuclear DNA content of L. morii is 1.618 pg (approximately 1.582 Gb) in germline cells, and there is similar to 15% germline DNA loss in somatic cells. These values are significantly smaller than those of Petromyzon marinus, a lamprey with a published draft genome. The chromosomes of L. morii are small and acrocentric, with a diploid modal number of 2n = 132, lower than some other lampreys. Sequence and AFLP analyses suggest that the allelic polymorphism rate (similar to 0.14% based on examined nuclear and mitochondrial DNA sequences) of L. morii is much lower than that (similar to 2%) of P. marinus. Phylogenetic analysis based on a mitochondrial DNA fragment confirms that L. morii belongs to the genus Lampetra, which, together with the genus Lethenteron, forms a sister group to P. marinus. These genetic background data are valuable for subsequent genetic and genomic research on L. morii.	[Yan, Xinyu; Meng, Wenbin; Wu, Fenfang; Xu, Anlong; Chen, Shangwu; Huang, Shengfeng] Sun Yat Sen Univ, State Key Lab Biocontrol, Guangdong Key Lab Pharmaceut Funct Genes, Sch Life Sci, Guangzhou, Guangdong, Peoples R China; [Xu, Anlong] Beijing Univ Chinese Med, Beijing, Peoples R China	Sun Yat Sen University; Beijing University of Chinese Medicine	Huang, SF (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Guangdong Key Lab Pharmaceut Funct Genes, Sch Life Sci, Guangzhou, Guangdong, Peoples R China.	hshengf2@mail.sysu.edu.cn		Huang, Shengfeng/0000-0002-0968-1370	National Basic Research Program of China (973 Program) [2013CB835305]; National Natural Science Foundation of China [31171193]; National Supercomputer Center in Guangzhou; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Supercomputer Center in Guangzhou; Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund	This work was supported by the project of the National Basic Research Program of China (973 Program; No. 2013CB835305 to SH), the National Natural Science Foundation of China (No. 31171193 to SH), and National Supercomputer Center in Guangzhou and the Special Program for Applied Research on Super Computation of the NSFC-Guangdong Joint Fund (to SH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmone-Marsan P, 1997, ANIM GENET, V28, P418, DOI 10.1111/j.1365-2052.1997.00204.x; Barucchi VC, 2013, CYTOGENET GENOME RES, V141, P80, DOI 10.1159/000354098; Boehm T, 2012, ANNU REV IMMUNOL, V30, P203, DOI 10.1146/annurev-immunol-020711-075038; Caputo V, 2011, CHROMOSOME RES, V19, P481, DOI 10.1007/s10577-011-9197-4; Delarbre C, 2000, MOL BIOL EVOL, V17, P519, DOI 10.1093/oxfordjournals.molbev.a026332; Filcek KB, 2005, N AM J FISH MANAGE, V25, P502, DOI 10.1577/M03-206.1; HOWELL WM, 1971, EXPERIENTIA, V27, P222, DOI 10.1007/BF02145908; Huang SF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6896; Hwang DS, 2013, MITOCHONDR DNA, V24, P678, DOI 10.3109/19401736.2013.773989; Hwang DS, 2013, MITOCHONDR DNA, V24, P406, DOI 10.3109/19401736.2013.763246; Kasamatsu J, 2013, MICROBIOL IMMUNOL, V57, P1, DOI 10.1111/j.1348-0421.2012.00500.x; Kuraku S, 2006, ZOOL SCI, V23, P1053, DOI 10.2108/zsj.23.1053; Kuraku S, 2008, ZOOL SCI, V25, P960, DOI 10.2108/zsj.25.960; LEE WJ, 1995, GENETICS, V139, P873; Mehta TK, 2013, P NATL ACAD SCI USA, V110, P16044, DOI 10.1073/pnas.1315760110; Mejia O, 2004, GENETICA, V122, P325, DOI 10.1007/s10709-004-3127-8; NAKAI Y, 1991, CYTOGENET CELL GENET, V56, P196, DOI 10.1159/000133087; POTTER IC, 1981, GENETICA, V56, P149, DOI 10.1007/BF00055414; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; RASCH EM, 1971, CHROMOSOMA, V33, P1, DOI 10.1007/BF00326379; ROBINSON ES, 1975, EXPERIENTIA, V31, P912, DOI 10.1007/BF02358846; ROBINSON ES, 1981, EXPERIENTIA, V37, P239, DOI 10.1007/BF01991630; Semon M, 2012, CURR BIOL, V22, pR641, DOI 10.1016/j.cub.2012.06.022; Shimeld SM, 2012, DEVELOPMENT, V139, P2091, DOI 10.1242/dev.074716; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Smith JJ, 2012, CURR BIOL, V22, P1524, DOI 10.1016/j.cub.2012.06.028; Smith JJ, 2010, CHROMOSOMA, V119, P381, DOI 10.1007/s00412-010-0263-z; Smith JJ, 2009, P NATL ACAD SCI USA, V106, P11212, DOI 10.1073/pnas.0902358106; Suzuki A, 1999, CHROMOSOME SCI, P3; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; White MM, 2009, J MOL EVOL, V68, P715, DOI 10.1007/s00239-009-9246-1	31	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157494	10.1371/journal.pone.0157494	http://dx.doi.org/10.1371/journal.pone.0157494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388621	Green Submitted, Green Published, gold			2022-12-26	WOS:000379811500005
J	Huang, YH; Yang, HY; Huang, SW; Ou, G; Hsu, YF; Hsu, MJ				Huang, Yu-Han; Yang, Hung-Yu; Huang, Shiu-Wen; Ou, George; Hsu, Ya-Fen; Hsu, Ming-Jen			Interleukin-6 Induces Vascular Endothelial Growth Factor-C Expression via Src-FAK-STAT3 Signaling in Lymphatic Endothelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR LYMPHANGIOGENESIS; VEGF-C; METASTASIS; ANGIOGENESIS; PHOSPHORYLATION; PROGRESSION; INHIBITION; CARCINOMA; PATHWAY	Elevated serum interleukin-6 (IL-6) levels correlates with tumor grade and poor prognosis in cancer patients. IL-6 has been shown to promote tumor lymphangiogenesis through vascular endothelial growth factor-C (VEGF-C) induction in tumor cells. We recently showed that IL-6 also induced VEGF-C expression in lymphatic endothelial cells (LECs). However, the signaling mechanisms involved in IL-6-induces VEGF-C induction in LECs remain incompletely understood. In this study, we explored the causal role of focal adhesion kinase (FAK) in inducing VEGF-C expression in IL-6-stimulated murine LECs (SV-LECs). FAK signaling blockade by NSC 667249 (a FAK inhibitor) attenuated IL-6-induced VEGF-C expression and VEGF-C promoter-luciferase activities. IL-6's enhancing effects of increasing FAK, ERK1/2, p38MAPK, C/EBP beta, p65 and STAT3 phosphorylation as well as C/EBP beta-, kappa B- and STAT3-luciferase activities were reduced in the presence of NSC 667249. STAT3 knockdown by STAT3 siRNA abrogated IL-6's actions in elevating VEGF-C mRNA and protein levels. Moreover, Src-FAK signaling blockade reduced IL-6's enhancing effects of increasing STAT3 binding to the VEGF-C promoter region, cell migration and endothelial tube formation of SV-LECs. Together these results suggest that IL-6 increases VEGF-C induction and lymphangiogenesis may involve, at least in part, Src-FAK-STAT3 cascade in LECs.	[Huang, Yu-Han; Hsu, Ming-Jen] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Yang, Hung-Yu] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Cardiovasc Med, Taipei, Taiwan; [Yang, Hung-Yu] Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan; [Yang, Hung-Yu] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan; [Huang, Shiu-Wen] Natl Taiwan Univ, Coll Med, Grad Inst Pharmacol, Taipei, Taiwan; [Ou, George] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Hsu, Ya-Fen] Landseed Hosp, Dept Surg, Div Gen Surg, Taoyuan, Taiwan; [Hsu, Ming-Jen] Taipei Med Univ, Coll Med, Sch Med, Dept Pharmacol, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; National Taiwan University; University of British Columbia; Taipei Medical University	Hsu, MJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan.; Hsu, YF (corresponding author), Landseed Hosp, Dept Surg, Div Gen Surg, Taoyuan, Taiwan.; Hsu, MJ (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Pharmacol, Taipei, Taiwan.	yafen0505@gmail.com; aspirin@tmu.edu.tw		Hsu, Ming-Jen/0000-0001-9688-8494	Ministry of Science and Technology of Taiwan [MOST 102-2314-B-706-001, 103-2314-B-706-001]; Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan [102TMU-WFH-02-4]; Landseed Hospital, Taoyuan, Taiwan [LSH-2013-01]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan; Landseed Hospital, Taoyuan, Taiwan	This work was supported by grants (MOST 102-2314-B-706-001, 103-2314-B-706-001) from the Ministry of Science and Technology of Taiwan (https://www.most.gov.tw/), Y.F.H; grant (102TMU-WFH-02-4) from the Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan (http://wfh.tmu.edu.tw/), M.J.H; and grant (LSH-2013-01) from the Landseed Hospital, Taoyuan, Taiwan (http://www.landseedhospital.com.tw), Y.F.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183; Ando T., 2005, Lymphatic Research and Biology, V3, P105, DOI 10.1089/lrb.2005.3.105; Andreozzi F, 2007, MOL CELL BIOL, V27, P2372, DOI 10.1128/MCB.01340-06; Ara T, 2010, EUR J CANCER, V46, P1223, DOI 10.1016/j.ejca.2010.02.026; Barbier D, 2012, AM J RESP CELL MOL, V47, P149, DOI 10.1165/rcmb.2011-0405OC; Belluco C, 2000, ANN SURG ONCOL, V7, P133, DOI 10.1007/s10434-000-0133-7; Besser D, 1999, MOL CELL BIOL, V19, P1401; Buettner R, 2002, CLIN CANCER RES, V8, P945; Chang HL, 2013, BBA-GEN SUBJECTS, V1830, P4053, DOI 10.1016/j.bbagen.2013.04.011; Chang YF, 2015, ONCOTARGET, V6, P85, DOI 10.18632/oncotarget.2765; Che KF, 2012, MOL MED, V18, P1169, DOI 10.2119/molmed.2012.00103; Chelsky ZL, 2015, MOL PHARMACOL, V88, P524, DOI 10.1124/mol.115.099093; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Gu Y, 2008, CLIN EXP METASTAS, V25, P717, DOI 10.1007/s10585-008-9180-4; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hu J, 2014, EUR J CANCER, V50, P2336, DOI 10.1016/j.ejca.2014.06.005; Huang YH, 2014, ANGIOGENESIS, V17, P407, DOI 10.1007/s10456-013-9386-1; Jean C, 2014, J CELL BIOL, V204, P247, DOI 10.1083/jcb.201307067; Ji H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5944; Karpanen T, 2001, CANCER RES, V61, P1786; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Lee H, 2011, CANCER RES, V71, P3772, DOI 10.1158/0008-5472.CAN-10-3304; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liao WC, 2008, CLIN CANCER RES, V14, P428, DOI 10.1158/1078-0432.CCR-07-1032; Lin HH, 2011, J BIOL CHEM, V286, P3829, DOI 10.1074/jbc.M110.168831; Lin JM, 2005, CANCER RES, V65, P6901, DOI 10.1158/0008-5472.CAN-05-0408; Liu SX, 2007, MOL BIOL CELL, V18, P2169, DOI 10.1091/mbc.E06-12-1121; Luo Y, 2011, ONCOGENE, V30, P2098, DOI 10.1038/onc.2010.590; Maeng YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep20739; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Miyazaki T, 2015, CIRC RES, V116, P1170, DOI 10.1161/CIRCRESAHA.116.305363; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Nilsson MB, 2005, CANCER RES, V65, P10794, DOI 10.1158/0008-5472.CAN-05-0623; Oliver G, 2004, NAT REV IMMUNOL, V4, P35, DOI 10.1038/nri1258; Ou JJ, 2015, CANCER LETT, V358, P200, DOI 10.1016/j.canlet.2014.12.046; Qu ZX, 2015, CANCER RES, V75, P3209, DOI 10.1158/0008-5472.CAN-14-3042; Roberts N, 2006, CANCER RES, V66, P2650, DOI 10.1158/0008-5472.CAN-05-1843; Rokavec M, 2014, J CLIN INVEST, V124, P1853, DOI 10.1172/JCI73531; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; Schoppmann SF, 2010, ANN ONCOL, V21, P955, DOI 10.1093/annonc/mdp532; Semenza GL, 2013, ONCOGENE, V32, P4057, DOI 10.1038/onc.2012.578; Shackleford TJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2902; Shinriki S, 2011, J PATHOL, V225, P142, DOI 10.1002/path.2935; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Snyder M, 2014, J BIOL CHEM, V289, P30082, DOI 10.1074/jbc.M114.591719; Stacker SA, 2002, NAT REV CANCER, V2, P573, DOI 10.1038/nrc863; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Veikkola T, 2001, EMBO J, V20, P1223, DOI 10.1093/emboj/20.6.1223; Whyte J, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2361; Yadav A, 2011, MOL CANCER RES, V9, P1658, DOI 10.1158/1541-7786.MCR-11-0271; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang Q, 2008, J BIOL CHEM, V283, P13491, DOI 10.1074/jbc.M708055200	59	33	34	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158839	10.1371/journal.pone.0158839	http://dx.doi.org/10.1371/journal.pone.0158839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383632	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400088
J	Robins, MT; Lu, J; van Rijn, RM				Robins, Meridith T.; Lu, Julie; van Rijn, Richard M.			Unique Behavioral and Neurochemical Effects Induced by Repeated Adolescent Consumption of Caffeine-Mixed Alcohol in C57BL/6 Mice	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; ENERGY DRINK CONSUMPTION; NUCLEUS-ACCUMBENS; DELTA-FOSB; HIGH-RISK; LOCOMOTOR-ACTIVITY; RECEPTOR AGONIST; SEX-DIFFERENCES; DOPAMINE; COCAINE	The number of highly caffeinated products has increased dramatically in the past few years. Among these products, highly caffeinated energy drinks are the most heavily advertised and purchased, which has resulted in increased incidences of co-consumption of energy drinks with alcohol. Despite the growing number of adolescents and young adults reporting caffeine-mixed alcohol use, knowledge of the potential consequences associated with co-consumption has been limited to survey-based results and in-laboratory human behavioral testing. Here, we investigate the effect of repeated adolescent (post-natal days P35-61) exposure to caffeine-mixed alcohol in C57BL/6 mice on common drug-related behaviors such as locomotor sensitivity, drug reward and cross-sensitivity, and natural reward. To determine changes in neurological activity resulting from adolescent exposure, we monitored changes in expression of the transcription factor Delta FosB in the dopaminergic reward pathway as a sign of long-term increases in neuronal activity. Repeated adolescent exposure to caffeine-mixed alcohol exposure induced significant locomotor sensitization, desensitized cocaine conditioned place preference, decreased cocaine locomotor cross-sensitivity, and increased natural reward consumption. We also observed increased accumulation of Delta FosB in the nucleus accumbens following repeated adolescent caffeine-mixed alcohol exposure compared to alcohol or caffeine alone. Using our exposure model, we found that repeated exposure to caffeine-mixed alcohol during adolescence causes unique behavioral and neurochemical effects not observed in mice exposed to caffeine or alcohol alone. Based on similar findings for different substances of abuse, it is possible that repeated exposure to caffeine-mixed alcohol during adolescence could potentially alter or escalate future substance abuse as means to compensate for these behavioral and neurochemical alterations.	[Robins, Meridith T.; van Rijn, Richard M.] Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Lu, Julie] Univ Calif San Francisco, Dept Neurosci, San Francisco, CA 94158 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California San Francisco	van Rijn, RM (corresponding author), Purdue Univ, Coll Pharm, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	rvanrijn@purdue.edu	van Rijn, Richard M./I-8790-2019	van Rijn, Richard M./0000-0002-9957-1633; Robins, Meridith/0000-0003-0582-7907	Pathway to Independence grant [R00AA20539]; Alcoholic Beverage Medical Research Foundation/Foundation for Alcohol Research; Ralph W. and Grace M. Showalter Research Trust [207566]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R00AA020539] Funding Source: NIH RePORTER	Pathway to Independence grant; Alcoholic Beverage Medical Research Foundation/Foundation for Alcohol Research; Ralph W. and Grace M. Showalter Research Trust; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Richard M. van Rijn is supported by a Pathway to Independence grant for the National Institute on Alcohol Abuse and Alcoholism (R00AA20539), a grant from the Alcoholic Beverage Medical Research Foundation/Foundation for Alcohol Research (http://www.abmrf.org/) and a grant from the Ralph W. and Grace M. Showalter Research Trust (#207566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Richard M. van Rijn is supported by a Pathway to Independence grant for the National Institute on Alcohol Abuse and Alcoholism (R00AA20539) a grant from the Alcoholic Beverage Medical Research Foundation/Foundation for Alcohol Research and a grant from the Ralph W. and Grace M. Showalter Research Trust (#207566). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani W, 2004, BEHAV PHARMACOL, V15, P341, DOI 10.1097/00008877-200409000-00005; Adriani W, 2004, NEUROPSYCHOPHARMACOL, V29, P869, DOI 10.1038/sj.npp.1300366; [Anonymous], 2013, ENERGY DRINKS SHOTS; Arria AM, 2011, JAMA-J AM MED ASSOC, V305, P600, DOI 10.1001/jama.2011.109; Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P365, DOI 10.1111/j.1530-0277.2010.01352.x; Avci S, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2013.06.031; Bachmanov AA, 2001, CHEM SENSES, V26, P905, DOI 10.1093/chemse/26.7.905; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Berger AC, 2011, EMBO MOL MED, V3, P385, DOI 10.1002/emmm.201100144; Bobzean SAM, 2014, EXP NEUROL, V259, P64, DOI 10.1016/j.expneurol.2014.01.022; Bonar EE, 2015, ADDICT BEHAV, V43, P11, DOI 10.1016/j.addbeh.2014.11.023; Brache K, 2011, ADDICT BEHAV, V36, P1133, DOI 10.1016/j.addbeh.2011.07.003; CHEN JF, 1993, NEUROSCIENCE, V54, P669, DOI 10.1016/0306-4522(93)90238-B; Crawford CA, 2011, PSYCHOPHARMACOLOGY, V213, P43, DOI 10.1007/s00213-010-2011-8; Cunningham CL, 2006, NAT PROTOC, V1, P1662, DOI 10.1038/nprot.2006.279; De Vries TJ, 1998, NEUROREPORT, V9, P1763, DOI 10.1097/00001756-199806010-00017; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Do J, 2013, LEARN MEMORY, V20, P21, DOI 10.1101/lm.025015.111; Engle SE, 2013, MOL PHARMACOL, V84, P393, DOI 10.1124/mol.113.087346; Everitt BJ, 2013, NEUROSCI BIOBEHAV R, V37, P1946, DOI 10.1016/j.neubiorev.2013.02.010; Ferre Sergi, 2011, J Caffeine Res, V1, P153; Flaisher-Grinberg S, 2009, J NEUROSCI METH, V177, P44, DOI 10.1016/j.jneumeth.2008.09.018; Freet CS, 2015, PHYSIOL BEHAV, V149, P174, DOI 10.1016/j.physbeh.2015.06.009; Fritz BM, 2014, ALCOHOL CLIN EXP RES, V38, P2269, DOI 10.1111/acer.12472; Fuxe K, 2007, PHYSIOL BEHAV, V92, P210, DOI 10.1016/j.physbeh.2007.05.034; Garrett BE, 1997, PHARMACOL BIOCHEM BE, V57, P533, DOI 10.1016/S0091-3057(96)00435-2; Gladwin TE, 2011, DEV COGN NEUROS-NETH, V1, P364, DOI 10.1016/j.dcn.2011.06.008; Hansen ST, 2013, PHARMACOL BIOCHEM BE, V103, P582, DOI 10.1016/j.pbb.2012.10.010; Hilbert MLT, 2013, PHARMACOL BIOCHEM BE, V110, P168, DOI 10.1016/j.pbb.2013.07.008; Hnasko TS, 2007, J NEUROSCI, V27, P12484, DOI 10.1523/JNEUROSCI.3133-07.2007; HOOKS MS, 1993, PSYCHOPHARMACOLOGY, V111, P109, DOI 10.1007/BF02257416; Ikemoto S, 2002, NEUROSCIENCE, V113, P939, DOI 10.1016/S0306-4522(02)00247-6; Itzhak Y, 1999, BRAIN RES, V818, P204, DOI 10.1016/S0006-8993(98)01260-8; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Kovacs KM, 2005, ALCOHOL CLIN EXP RES, V29, P730, DOI 10.1097/01.ALC.0000164361.62346.D6; Lee B, 2009, J NEUROSCI, V29, P14734, DOI 10.1523/JNEUROSCI.3765-09.2009; Marczinski CA, 2014, ALCOHOL CLIN EXP RES, V38, P1822, DOI 10.1111/acer.12493; Martz ME, 2015, J ADOLESCENT HEALTH, V56, P557, DOI 10.1016/j.jadohealth.2015.01.019; May CE, 2015, ALCOHOL CLIN EXP RES, V39, P1443, DOI 10.1111/acer.12794; McLellan TM, 2012, NUTR REV, V70, P730, DOI 10.1111/j.1753-4887.2012.00525.x; Merritt KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078258; Miyake ER, 2015, ADDICT BEHAV, V43, P60, DOI 10.1016/j.addbeh.2014.12.009; Nestler EJ, 2001, P NATL ACAD SCI USA, V98, P11042, DOI 10.1073/pnas.191352698; Nestler EJ., 2013, J DRUG ALCOHOL RES, V2, P1; Novier A, 2015, PHARMACOL BIOCHEM BE, V133, P65, DOI 10.1016/j.pbb.2015.03.015; O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x; O'Neill CE, 2015, NEUROPSYCHOPHARMACOL, V40, P813, DOI 10.1038/npp.2014.278; Oteri A, 2007, ALCOHOL CLIN EXP RES, V31, P1677, DOI 10.1111/j.1530-0277.2007.00464.x; Peacock A, 2015, ALCOHOL CLIN EXP RES, V39, P733, DOI 10.1111/acer.12680; Peacock A, 2014, ADDICTION, V109, P1612, DOI 10.1111/add.12622; Peacock A, 2014, APPETITE, V76, P60, DOI 10.1016/j.appet.2014.01.003; Peacock A, 2013, APPETITE, V64, P1, DOI 10.1016/j.appet.2012.12.021; Perrotti LI, 2008, SYNAPSE, V62, P358, DOI 10.1002/syn.20500; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Spear L, 2000, ALCOHOL RES HEALTH, V24, P115; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Thiele TE, 2014, ALCOHOL, V48, P235, DOI 10.1016/j.alcohol.2013.08.005; Thompson D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011038; van Rijn RM, 2012, DRUG ALCOHOL DEPEN, V122, P156, DOI 10.1016/j.drugalcdep.2011.09.024; Van Swearingen AED, 2013, PSYCHOPHARMACOLOGY, V225, P707, DOI 10.1007/s00213-012-2860-4; Volkow ND, 2010, BIOESSAYS, V32, P748, DOI 10.1002/bies.201000042; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636	65	9	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158189	10.1371/journal.pone.0158189	http://dx.doi.org/10.1371/journal.pone.0158189			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380261	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700022
J	Zhong, H; Fazenbaker, C; Chen, C; Breen, S; Huang, J; Yao, X; Ren, P; Yao, Y; Herbst, R; Hollingsworth, RE				Zhong, H.; Fazenbaker, C.; Chen, C.; Breen, S.; Huang, J.; Yao, X.; Ren, P.; Yao, Y.; Herbst, R.; Hollingsworth, R. E.			Overproduction of IGF-2 drives a subset of colorectal cancer cells, which specifically respond to an anti-IGF therapeutic antibody and combination therapies	ONCOGENE			English	Article							GROWTH-FACTOR-I; FACTOR RECEPTOR; ANTITUMOR-ACTIVITY; FACTOR (IGF)-I; INSULIN; GENE; EXPRESSION; INHIBITOR; RISK; MECHANISMS	Colorectal cancer (CRC) is a heterogeneous disease with a broad spectrum of genetic and epigenetic changes. A comprehensive molecular characterization of CRC by The Cancer Genome Atlas Network detected the overexpression of the insulin-like growth factor 2 (IGF2) gene, encoding a ligand for the insulin-like growth factor 1 receptor (IGF-1R), in a subset of CRC tumors. In this study, we investigated the oncogenic potential of IGF-2 in IGF2-overexpressing CRC models and the efficacy of MEDI-573, an IGF-1/2-neutralizing antibody. We found that a subset of CRC cell lines express high IGF-2 levels owing to an increased DNA copy number and hypermethylation in the H19 promoter of the IGF2 gene. MEDI-573 efficiently neutralized IGF-2 and induced apoptosis, which resulted in significant tumor growth inhibition in CRC mouse models that express high levels of IGF-2. These effects were specific to CRCs overexpressing IGF-2, as MEDI-573 did not affect the growth CRC cell lines with normal levels. Moreover, blockade of IGF-2 by MEDI-573 modulated other signaling pathways, suggesting combination therapies with inhibitors of these pathways. Indeed, in vivo efficacy was significantly enhanced when MEDI-573 was used in combination with trastuzumab, AZD2014 (dual mTORC1/2i), AZD5363 (AKTi) and selumetinib (AZD6244/ARRY-142886, MEK1/2i) or cetuximab. These results demonstrate that overexpressed IGF-2 is the major tumorigenic driver in a subset of CRCs and encourage testing of MEDI-573, alone and in combinations, in IGF2-overexpressing CRC patients.	[Zhong, H.; Fazenbaker, C.; Chen, C.; Breen, S.; Herbst, R.; Hollingsworth, R. E.] MedImmune, Oncol Res, One MedImmune Way, Gaithersburg, MD 20878 USA; [Huang, J.; Yao, X.; Yao, Y.] MedImmune, Translat Sci, Gaithersburg, MD USA; [Ren, P.] MedImmune, Biostat, Gaithersburg, MD USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Hollingsworth, RE (corresponding author), MedImmune, Oncol Res, One MedImmune Way, Gaithersburg, MD 20878 USA.	hollingsworthr@medimmune.com			MedImmune	MedImmune(AstraZenecaMedimmune)	We thank Mohammed Dar, Parthiv Mahadevia, Dirk Mendel, Robert Sikorski, Teresa Klinowska, Sabina Cosulich, Barry Davies and Stephen Green for scientific input and manuscript review. This work was supported by MedImmune.	Abraham J, 2011, MOL CANCER THER, V10, P697, DOI 10.1158/1535-7163.MCT-10-0695; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Cheng YW, 2010, INT J CANCER, V127, P568, DOI 10.1002/ijc.25086; Cui HM, 1998, NAT MED, V4, P1276, DOI 10.1038/3260; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Davies BR, 2012, MOL CANCER THER, V11, P873, DOI 10.1158/1535-7163.MCT-11-0824-T; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fidler MJ, 2012, THER ADV MED ONCOL, V4, P51, DOI 10.1177/1758834011427576; Gao J, 2011, CANCER RES, V71, P1029, DOI 10.1158/0008-5472.CAN-10-2274; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Ghosh JC, 2008, J BIOL CHEM, V283, P5188, DOI 10.1074/jbc.M705904200; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Gualberto A, 2009, CURR DRUG TARGETS, V10, P923, DOI 10.2174/138945009789577945; Guichard SM, 2015, MOL CANCER THER, V14, P2508, DOI 10.1158/1535-7163.MCT-15-0365; Haluska P, 2014, CLIN CANCER RES, V20, P4747, DOI 10.1158/1078-0432.CCR-14-0114; Huang F, 2009, CANCER RES, V69, P161, DOI 10.1158/0008-5472.CAN-08-0835; LAHM H, 1994, INT J CANCER, V58, P452, DOI 10.1002/ijc.2910580325; LAHM H, 1992, BRIT J CANCER, V65, P341, DOI 10.1038/bjc.1992.69; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; Mazzoletti M, 2011, CANCER RES, V71, P4573, DOI 10.1158/0008-5472.CAN-10-4322; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakagawa H, 2001, P NATL ACAD SCI USA, V98, P591, DOI 10.1073/pnas.011528698; Ou DL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-2; Ravenel JD, 2001, JNCI-J NATL CANCER I, V93, P1698, DOI 10.1093/jnci/93.22.1698; REMACLEBONNET M, 1992, INT J CANCER, V52, P910, DOI 10.1002/ijc.2910520614; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Sciacca L, 1999, ONCOGENE, V18, P2471, DOI 10.1038/sj.onc.1202600; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shin DH, 2011, MOL CANCER THER, V10, P2437, DOI 10.1158/1535-7163.MCT-11-0235; Shiratsuchi I, 2011, ANTICANCER RES, V31, P2541; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Tran TN, 2014, J CLIN PATHOL, V67, P985, DOI 10.1136/jclinpath-2014-202347; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Wang Y, 2005, MOL CANCER THER, V4, P1214, DOI 10.1158/1535-7163.MCT-05-0048; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; Yuen JSP, 2008, EXPERT OPIN THER TAR, V12, P589, DOI 10.1517/14728222.12.5.589 ; Zanella ER, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010445; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zhao RH, 2008, CURR COLORECT CANC R, V4, P65, DOI 10.1007/s11888-008-0012-3; Zhong HH, 2014, MOL CANCER THER, V13, P2662, DOI 10.1158/1535-7163.MCT-14-0144	47	16	16	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 9	2017	36	6					797	806		10.1038/onc.2016.248	http://dx.doi.org/10.1038/onc.2016.248			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IX	27399333				2022-12-26	WOS:000394168200007
J	Granata, C; Oliveira, RSF; Little, JP; Renner, K; Bishop, DJ				Granata, Cesare; Oliveira, Rodrigo S. F.; Little, Jonathan P.; Renner, Kathrin; Bishop, David J.			Mitochondrial adaptations to high-volume exercise training are rapidly reversed after a reduction in training volume in human skeletal muscle	FASEB JOURNAL			English	Article						mitochondrial biogenesis; mitochondrial respiration; p53; PGC-1 alpha; PHF20	EXPRESSION; INTENSITY; PROTEIN; PGC-1-ALPHA; PERFORMANCE; BIOGENESIS; INTERVAL; IMPROVEMENTS; ACTIVATION; RESPONSES	Increased mitochondrial content and respiration have both been reported after exercise training. However, no study has directly compared how different training volumes influence mitochondrial respiration and markers of mitochondrial biogenesis. Ten healthy men performed high-intensity interval cycling during 3 consecutive training phases; 4 wk of normal-volume training (NVT; 3/wk), followed by 20 d of high-volume training (HVT; 2/d) and 2 wk of reduced-volume training (RVT; 5 sessions). Resting biopsy samples (vastus lateralis) were obtained at baseline and after each phase. No mitochondrial parameter changed after NVT. After HVT, mitochondrial respiration and citrate synthase activity (similar to 40-50%), as well as the protein content of electron transport system (ETS) subunits (similar to 10-40%), and that of peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1 alpha), NRF1, mitochondrial transcription factor A (TFAM), PHF20, and p53 (similar to 65-170%) all increased compared to baseline; mitochondrial specific respiration remained unchanged. After RVT, all the mitochondrial parameters measured except citrate synthase activity (similar to 36% above initial) were not significantly different compared to baseline (all P > 0.05). Our findings demonstrate that training volume is an important determinant of training-induced mitochondrial adaptations and highlight the rapid reversibility of human skeletal muscle to a reduction in training volume.	[Granata, Cesare; Oliveira, Rodrigo S. F.; Bishop, David J.] Victoria Univ, Coll Sport & Exercise Sci, Inst Sport Exercise & Act Living, PB140,Footscray Pk Campus, Melbourne, Vic 3011, Australia; [Little, Jonathan P.] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Renner, Kathrin] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany	Victoria University; University of British Columbia; University of British Columbia Okanagan; University of Regensburg	Bishop, DJ (corresponding author), Victoria Univ, Coll Sport & Exercise Sci, Inst Sport Exercise & Act Living, PB140,Footscray Pk Campus, Melbourne, Vic 3011, Australia.	david.bishop@vu.edu.au	Renner, Kathrin/H-3211-2013; Little, Jonathan P./T-4076-2019; Granata, Cesare/J-9738-2016; Bishop, David John/X-9826-2019	Little, Jonathan P./0000-0002-9796-2008; Granata, Cesare/0000-0002-3509-6001; Bishop, David John/0000-0002-6956-9188; Renner, Kathrin/0000-0002-7116-1368	ANZ-MASON foundation	ANZ-MASON foundation	The authors acknowledge the participants who took part in this research for their time and commitment. They also thank E. Brentnall (Victoria University, Melbourne, VIC, Australia) for her valuable help in data collection. This study was funded by a grant from the ANZ-MASON foundation provided to D.J.B. Data collection and analysis took place at Victoria University.	Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE672, DOI 10.1152/ajpendo.00043.2007; Baldwin J, 2000, MED SCI SPORT EXER, V32, P1648; Bartlett JD, 2015, EUR J SPORT SCI, V15, P3, DOI 10.1080/17461391.2014.920926; Bishop D, 2000, MED SCI SPORT EXER, V32, P1088, DOI 10.1097/00005768-200006000-00008; Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012; BOOTH FW, 1977, J BIOL CHEM, V252, P416; COSTILL DL, 1985, MED SCI SPORT EXER, V17, P339; Cui GF, 2012, NAT STRUCT MOL BIOL, V19, P916, DOI 10.1038/nsmb.2353; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907; Halson SL, 2004, J APPL PHYSIOL, V97, P1245, DOI 10.1152/japplphysiol.01368.2003; Halson SL, 2002, J APPL PHYSIOL, V93, P947, DOI 10.1152/japplphysiol.01164.2001; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jeppesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029391; Kadaja L, 2010, EXP CLIN CARDIOL, V15, pE116; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lehmann MJ, 1997, J SPORT MED PHYS FIT, V37, P7; Luden N, 2012, SCAND J MED SCI SPOR, V22, P662, DOI 10.1111/j.1600-0838.2011.01305.x; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; MADSEN K, 1993, J APPL PHYSIOL, V75, P1444, DOI 10.1152/jappl.1993.75.4.1444; MCCOY M, 1994, J APPL PHYSIOL, V77, P1532, DOI 10.1152/jappl.1994.77.3.1532; Meex RCR, 2010, DIABETES, V59, P572, DOI 10.2337/db09-1322; MOORE RL, 1987, J APPL PHYSIOL, V63, P1719, DOI 10.1152/jappl.1987.63.5.1719; Mujika Inigo, 2004, Sports Med, V34, P891, DOI 10.2165/00007256-200434130-00003; Ferraresso RLP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/935483; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Saleem A, 2011, EXERC SPORT SCI REV, V39, P199, DOI 10.1097/JES.0b013e31822d71be; SHEPLEY B, 1992, J APPL PHYSIOL, V72, P706, DOI 10.1152/jappl.1992.72.2.706; Tonkonogi M, 2000, J PHYSIOL-LONDON, V528, P379, DOI 10.1111/j.1469-7793.2000.00379.x; Vincent G, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00051; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wang CH, 2010, ANN NY ACAD SCI, V1201, P157, DOI 10.1111/j.1749-6632.2010.05625.x; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200	39	76	77	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3413	3423		10.1096/fj.201500100R	http://dx.doi.org/10.1096/fj.201500100R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27402675				2022-12-26	WOS:000384329800013
J	Feng, X; Liu, P; Zhou, X; Li, MT; Li, FL; Wang, Z; Meng, ZP; Sun, YP; Yu, Y; Xiong, Y; Yuan, HX; Guan, KL				Feng, Xu; Liu, Peng; Zhou, Xin; Li, Meng-Tian; Li, Fu-Long; Wang, Zhen; Meng, Zhipeng; Sun, Yi-Ping; Yu, Ying; Xiong, Yue; Yuan, Hai-Xin; Guan, Kun-Liang			Thromboxane A2 Activates YAP/TAZ Protein to Induce Vascular Smooth Muscle Cell Proliferation and Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO PATHWAY; CORONARY ANGIOPLASTY; TISSUE-GROWTH; NEOINTIMAL HYPERPLASIA; RECEPTOR ANTAGONIST; HYPERTENSIVE RATS; BALLOON INJURY; SIZE-CONTROL; F-ACTIN; A(2)	The thromboxane A2 receptor (TP) has been implicated in restenosis after vascular injury, which induces vascular smooth muscle cell (VSMC) migration and proliferation. However, the mechanism for this process is largely unknown. In this study, we report that TP signaling induces VSMC migration and proliferation through activating YAP/TAZ, two major downstream effectors of the Hippo signaling pathway. The TP-specific agonists [1S-[1 alpha,2 alpha(Z),3 beta(1E,3S*),4 alpha]]-7-[3-[3-hydroxy-4-(4-odophenoxy)-1-butenyl]-7-oxabicyclo[2.2.1]hept-2-yll-5-hep-tenoic acid (1-BOP) and 9,11-dideoxy-9 alpha,11 alpha-methanoepoxyprosta-5Z,13E-dien-l-oic acid (U-46619) induce YAP/TAZ activation in multiple cell lines, including VSMCs. YAP/TAZ activation induced by I-BOP is blocked by knockout of the receptor TP or knockdown of the downstream G proteins G alpha(12/13). Moreover, Rho inhibition or actin cytoskeleton disruption prevents I-BOP-induced YAP/TAZ activation. Importantly, TP activation promotes DNA synthesis and cell migration in VSMCs in a manner dependent on YAP/TAZ. Taken together, thromboxane A2 signaling activates YAP/TAZ to promote VSMC migration and proliferation, indicating YAP/TAZ as potential therapeutic targets for cardiovascular diseases.	[Feng, Xu; Liu, Peng; Zhou, Xin; Li, Meng-Tian; Li, Fu-Long; Wang, Zhen; Sun, Yi-Ping; Xiong, Yue; Yuan, Hai-Xin; Guan, Kun-Liang] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200032, Peoples R China; [Feng, Xu; Liu, Peng; Zhou, Xin; Li, Meng-Tian; Li, Fu-Long; Wang, Zhen; Sun, Yi-Ping; Xiong, Yue; Yuan, Hai-Xin; Guan, Kun-Liang] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Meng, Zhipeng; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92130 USA; [Meng, Zhipeng; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92130 USA; [Yu, Ying] Chinese Acad Sci, Key Lab Food Safety Res, Ctr Excellence Mol Cell Sci, Inst Nutr Sci,Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill	Xiong, Y; Yuan, HX; Guan, KL (corresponding author), Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200032, Peoples R China.; Xiong, Y; Yuan, HX; Guan, KL (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China.; Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92130 USA.; Guan, KL (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92130 USA.; Xiong, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	yxiong@email.unc.edu; yuanhaixin@fudan.edu.cn; kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; Zhou, Xin/AAD-6937-2019		National Natural Science Foundation of China [31570784]; National Institutes of Health [RO1GM067113, RO1CA068377, RO1CA163834, R35CA196878, RO1GM51586, RO1EY022611]; NATIONAL CANCER INSTITUTE [R35CA196878] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Natural Science Foundation of China Grant 31570784 (to H. X. Y.). K. L G. is a cofounder of Vivace Therapeutics Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grants RO1GM067113, RO1CA068377, and RO1CA163834. To whom correspondence may be addressed: E-mail: yxiong@email.unc.edu.; Supported by National Institutes of Health Grants R35CA196878, RO1GM51586, and RO1EY022611. To whom correspondence may be addressed. E-mail: kuguan@ucsd.edu.	Audoly LP, 2000, CIRCULATION, V101, P2833, DOI 10.1161/01.CIR.101.24.2833; Bauer J, 2014, BRIT J PHARMACOL, V171, P3115, DOI 10.1111/bph.12677; Belton O, 2000, CIRCULATION, V102, P840; Belton OA, 2003, CIRCULATION, V108, P3017, DOI 10.1161/01.CIR.0000104565.78013.AD; BRADEN GA, 1991, CIRCULATION, V84, P679, DOI 10.1161/01.CIR.84.2.679; Byrne A, 1997, ARTERIOSCL THROM VAS, V17, P3224, DOI 10.1161/01.ATV.17.11.3224; Cayatte AJ, 2000, ARTERIOSCL THROM VAS, V20, P1724, DOI 10.1161/01.ATV.20.7.1724; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Cicha I, 2005, ARTERIOSCL THROM VAS, V25, P1008, DOI 10.1161/01.ATV.0000162173.27682.7b; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Egan KM, 2005, CIRCULATION, V111, P334, DOI 10.1161/01.CIR.0000153386.95356.78; Fernandez BG, 2011, DEVELOPMENT, V138, P2337, DOI 10.1242/dev.063545; Fetalvero KM, 2006, AM J PHYSIOL-HEART C, V290, pH1337, DOI 10.1152/ajpheart.00936.2005; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; HAMBERG M, 1975, P NATL ACAD SCI USA, V72, P2994, DOI 10.1073/pnas.72.8.2994; HANASAKI K, 1990, BIOCHEM PHARMACOL, V40, P2535, DOI 10.1016/0006-2952(90)90096-4; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059; ISHIMITSU T, 1988, HYPERTENSION, V12, P46, DOI 10.1161/01.HYP.12.1.46; ISHIMITSU T, 1988, AM J HYPERTENS, V1, pS38, DOI 10.1093/ajh/1.3.38S; Kobayashi T, 2004, J CLIN INVEST, V114, P784, DOI 10.1172/JCI200421446; Lee HY, 2007, CIRC RES, V100, P372, DOI 10.1161/01.RES.0000257945.97958.77; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lv XB, 2015, EMBO REP, V16, P975, DOI 10.15252/embr.201439951; Marx SO, 2011, CIRC-CARDIOVASC INTE, V4, P104, DOI 10.1161/CIRCINTERVENTIONS.110.957332; Matsumae H, 2008, ARTERIOSCL THROM VAS, V28, P1077, DOI 10.1161/ATVBAHA.108.162362; Meng ZP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9357; Michels S, 2001, Semin Ophthalmol, V16, P201, DOI 10.1076/soph.16.4.201.10298; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Nakahata N, 2008, PHARMACOL THERAPEUT, V118, P18, DOI 10.1016/j.pharmthera.2008.01.001; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pakala R, 1997, CIRCULATION, V96, P2280; Pakala Rajbabu, 2004, Cardiovasc Radiat Med, V5, P20, DOI 10.1016/j.carrad.2003.12.002; PETERSON MB, 1986, AM HEART J, V111, P1, DOI 10.1016/0002-8703(86)90544-2; Pratico D, 2000, BLOOD, V96, P3823, DOI 10.1182/blood.V96.12.3823.h8003823_3823_3826; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Sansores-Garcia L, 2011, EMBO J, V30, P2325, DOI 10.1038/emboj.2011.157; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Ting HJ, 2012, J CARDIOVASC PHARM T, V17, P248, DOI 10.1177/1074248411424145; Wang XB, 2012, ARTERIOSCL THROM VAS, V32, P2662, DOI 10.1161/ATVBAHA.112.254730; Wennmann DO, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.476; Xie CQ, 2012, J BIOL CHEM, V287, P14598, DOI 10.1074/jbc.M111.329268; Yamagami S, 1999, JPN HEART J, V40, P791, DOI 10.1536/jhj.40.791; Yokota T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094895; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YG, 2015, DEV CELL, V34, P642, DOI 10.1016/j.devcel.2015.08.014; Zhou X, 2015, J CLIN INVEST, V125, P2123, DOI 10.1172/JCI79573	59	67	71	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18947	18958		10.1074/jbc.M116.739722	http://dx.doi.org/10.1074/jbc.M116.739722			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27382053	Green Published, hybrid			2022-12-26	WOS:000383242300030
J	Wessel, SR; Cornilescu, CC; Cornilescu, G; Metz, A; Leroux, M; Hu, KF; Sandler, SJ; Markley, JL; Keck, JL				Wessel, Sarah R.; Cornilescu, Claudia C.; Cornilescu, Gabriel; Metz, Alice; Leroux, Maxime; Hu, Kaifeng; Sandler, Steven J.; Markley, John L.; Keck, James L.			Structure and Function of the PriC DNA Replication Restart Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA helicase; DNA replication; DNA-protein interaction; nuclear magnetic resonance (NMR); protein-protein interaction; DNA replication restart; DnaB helicase; PriC; single-stranded DNA-binding protein	N-TERMINAL DOMAIN; ESCHERICHIA-COLI; BINDING PROTEIN; PRIMOSOME FACTOR; FORKS; INITIATION; COMPLEX; POLYMERASE; HELICASE; DYNAMICS	Collisions between DNA replication complexes (replisomes) and barriers such as damaged DNA or tightly bound protein complexes can dissociate replisomes from chromosomes prematurely. Replisomes must be reloaded under these circumstances to avoid incomplete replication and cell death. Bacteria have evolved multiple pathways that initiate DNA replication restart by recognizing and remodeling abandoned replication forks and reloading the replicative helicase. In vitro, the simplest of these pathways is mediated by the single-domain PriC protein, which, along with the DnaC helicase loader, can load the DnaB replicative helicase onto DNA bound by the single-stranded DNA (ssDNA)-binding protein (SSB). Previous biochemical studies have identified PriC residues that mediate interactions with ssDNA and SSB. However, the mechanisms by which PriC drives DNA replication restart have remained poorly defined due to the limited structural information available for PriC. Here, we report the NMR structure of full-length PriC from Cronobacter sakazakii. PriC forms a compact bundle of -helices that brings together residues involved in ssDNA and SSB binding at adjacent sites on the protein surface. Disruption of these interaction sites and of other conserved residues leads to decreased DnaB helicase loading onto SSB-bound DNA. We also demonstrate that PriC can directly interact with DnaB and the DnaB<bold>DnaC complex</bold>. These data lead to a model in which PriC acts as a scaffold for recruiting DnaB<bold>DnaC to SSB</bold>/ssDNA sites present at stalled replication forks.	[Wessel, Sarah R.; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1135 Biochem Sci Bldg,420 Henry Mall, Madison, WI 53706 USA; [Cornilescu, Claudia C.; Cornilescu, Gabriel; Hu, Kaifeng; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Cornilescu, Claudia C.; Cornilescu, Gabriel; Hu, Kaifeng; Markley, John L.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Metz, Alice; Leroux, Maxime; Sandler, Steven J.] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Hu, Kaifeng] Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, Grp Liquid State NMR, Kunming 650201, Yunnan, Peoples R China	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Massachusetts System; University of Massachusetts Amherst; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Keck, JL (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1135 Biochem Sci Bldg,420 Henry Mall, Madison, WI 53706 USA.	jlkeck@wisc.edu	Cornilescu, Gabriel/H-3113-2011; Cornilescu, Claudia/K-1981-2015	Cornilescu, Gabriel/0000-0002-1204-8904; Cornilescu, Claudia/0000-0002-2401-7806; Keck, James/0000-0002-5961-0220	NIGMS, National Institutes of Health [P41GM103399]; University of Wisconsin-Madison; National Institutes of Health [P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220]; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; United States Department of Agriculture; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR008438, S10RR002781, P41RR002301, S10RR029220, S10RR023438, S10RR025062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098885, T32GM007215, P41GM103399] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wisconsin-Madison; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Ken Satyshur for assistance with binding pocket volume analysis, Tricia Windgassen for assistance with two-hybrid experiments, and members of the Keck laboratory for critical reading of the manuscript. This study made use of the National Magnetic Resonance Facility at Madison, which is supported by NIGMS, National Institutes of Health, Grant P41GM103399 (old number: P41RR002301). Equipment was purchased with funds from the University of Wisconsin-Madison; National Institutes of Health Grants P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, and S10RR029220; National Science Foundation Grants DMB-8415048, OIA-9977486, and BIR-9214394; and the United States Department of Agriculture.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aramaki T, 2015, J BIOCHEM, V157, P529, DOI 10.1093/jb/mvv014; Aramaki T, 2013, PROTEIN SCI, V22, P1279, DOI 10.1002/pro.2314; Aramaki T, 2013, GENES CELLS, V18, P723, DOI 10.1111/gtc.12069; Arias-Palomo E, 2013, CELL, V153, P438, DOI 10.1016/j.cell.2013.03.006; Bhattacharyya B, 2014, P NATL ACAD SCI USA, V111, P1373, DOI 10.1073/pnas.1318001111; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fang LH, 1999, MOL CELL, V4, P541, DOI 10.1016/S1097-2765(00)80205-1; Fitzkee NC, 2010, J BIOMOL NMR, V48, P65, DOI 10.1007/s10858-010-9441-9; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; George NP, 2012, J BIOL CHEM, V287, P22123, DOI 10.1074/jbc.M112.367573; Grimwade JE, 2007, MOL MICROBIOL, V66, P428, DOI 10.1111/j.1365-2958.2007.05930.x; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; HILL TM, 1990, P NATL ACAD SCI USA, V87, P2481, DOI 10.1073/pnas.87.7.2481; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang YH, 2013, PROTEIN J, V32, P477, DOI 10.1007/s10930-013-9509-y; James P, 1996, GENETICS, V144, P1425; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Kim S, 1996, J BIOL CHEM, V271, P21406, DOI 10.1074/jbc.271.35.21406; Kim S, 1996, J BIOL CHEM, V271, P4315; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Kohlbacher O, 2000, BIOINFORMATICS, V16, P815, DOI 10.1093/bioinformatics/16.9.815; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; Ludlam AV, 2001, J BIOL CHEM, V276, P27345, DOI 10.1074/jbc.M101940200; Makowska-Grzyska M, 2010, MOL CELL, V37, P90, DOI 10.1016/j.molcel.2009.12.031; Marceau AH, 2011, EMBO J, V30, P4236, DOI 10.1038/emboj.2011.305; MARSZALEK J, 1994, J BIOL CHEM, V269, P4883; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Petzold C, 2015, J BIOL CHEM, V290, P14626, DOI 10.1074/jbc.M115.655134; Sandler SJ, 2000, GENETICS, V155, P487; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Schwieters CD, 2001, J MAGN RESON, V149, P239, DOI 10.1006/jmre.2001.2300; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Tian Y, 2014, J MAGN RESON, V243, P54, DOI 10.1016/j.jmr.2014.03.011; WAHLE E, 1989, J BIOL CHEM, V264, P2469; WAHLE E, 1989, J BIOL CHEM, V264, P2463; Wessel SR, 2013, J BIOL CHEM, V288, P17569, DOI 10.1074/jbc.M113.478156; Wuthrich K., 1986, NMR PROTEINS NUCL AC, V36, P180	44	9	9	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18384	18396		10.1074/jbc.M116.738781	http://dx.doi.org/10.1074/jbc.M116.738781			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382050	Green Published, hybrid			2022-12-26	WOS:000383241800029
J	Attane, C; Peyot, ML; Lussier, R; Zhang, DW; Joly, E; Madiraju, SRM; Prentki, M				Attane, Camille; Peyot, Marie-Line; Lussier, Roxane; Zhang, Dongwei; Joly, Erik; Madiraju, S. R. Murthy; Prentki, Marc			Differential Insulin Secretion of High-Fat Diet-Fed C57BL/6NN and C57BL/6NJ Mice: Implications of Mixed Genetic Background in Metabolic Studies	PLOS ONE			English	Article							NICOTINAMIDE NUCLEOTIDE TRANSHYDROGENASE; ADIPOSE TRIGLYCERIDE LIPASE; INBRED MOUSE STRAINS; INDUCED OBESITY; GLUCOSE-TOLERANCE; GENOMIC ANALYSIS; SUBSTRAINS; SUSCEPTIBILITY; TRAIT	Many metabolic studies employ tissue-specific gene knockout mice, which requires breeding of floxed gene mice, available mostly on C57BL/6N (NN) genetic background, with cre or Flp recombinase-expressing mice, available on C57BL/6J (JJ) background, resulting in the generation of mixed C57BL/6NJ (NJ) genetic background mice. Recent awareness of many genetic differences between NN and JJ strains including the deletion of nicotinamide nucleotide transhydrogenase (nnt), necessitates examination of the consequence of mixed NJ background on glucose tolerance, beta cell function and other metabolic parameters. Male mice with NN and NJ genetic background were fed with normal or high fat diets (HFD) for 12 weeks and glucose and insulin homeostasis were studied. Genotype had no effect on body weight and food intake in mice fed normal or high fat diets. Insulinemia in the fed and fasted states and after a glucose challenge was lower in HFD-fed NJ mice, even though their glycemia and insulin sensitivity were similar to NN mice. NJ mice showed mild glucose intolerance. Moreover, glucose-but not KCl-stimulated insulin secretion in isolated islets was decreased in HFD-fed NJ vs NN mice without changes in insulin content and beta cell mass. Under normal diet, besides reduced fed insulinemia, NN and NJ mice presented similar metabolic parameters. However, HFD-fed NJ mice displayed lower fed and fasted insulinemia and glucose-induced insulin secretion in vivo and ex vivo, as compared to NN mice. These results strongly caution against using unmatched mixed genetic background C57BL/6 mice for comparisons, particularly under HFD conditions.	[Prentki, Marc] CRCHUM, Montreal Diabet Res Ctr, Dept Biochem & Nutr, Montreal, PQ, Canada; Univ Montreal, Montreal, PQ, Canada; [Zhang, Dongwei] Beijing Univ Chinese Med, Diabet Res Ctr, Beijing, Peoples R China	Universite de Montreal; Universite de Montreal; Beijing University of Chinese Medicine	Prentki, M (corresponding author), CRCHUM, Montreal Diabet Res Ctr, Dept Biochem & Nutr, Montreal, PQ, Canada.	marc.prentki@umontreal.ca	Zhang, Dongwei/AAS-8384-2020	Zhang, Dongwei/0000-0002-7793-1482	Canadian Institutes of Health Research; Canadian Diabetes Association	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association	This study was supported by grants from the Canadian Institutes of Health Research to MP and SRMM. M.P. holds the Canada Research Chair in Diabetes and Metabolism. CA was supported by a fellowship from the Canadian Diabetes Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LC, 2012, OBESITY, V20, P1403, DOI 10.1038/oby.2012.36; Andrikopoulos S, 2005, J ENDOCRINOL, V187, P45, DOI 10.1677/joe.1.06333; Aston-Mourney K, 2007, DIABETOLOGIA, V50, P2476, DOI 10.1007/s00125-007-0814-x; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; Bourdi M, 2011, CHEM RES TOXICOL, V24, P794, DOI 10.1021/tx200143x; DIWAN BA, 1980, CANCER LETT, V9, P111, DOI 10.1016/0304-3835(80)90114-7; Fergusson G, 2014, MOL METAB, V3, P848, DOI 10.1016/j.molmet.2014.09.006; Fex M, 2007, J ENDOCRINOL, V194, P551, DOI 10.1677/JOE-07-0161; Fisher-Wellman KH, 2015, BIOCHEM J, V467, P271, DOI 10.1042/BJ20141447; Fontaine DA, 2016, DIABETES, V65, P25, DOI 10.2337/db15-0982; Freeman HC, 2006, DIABETES, V55, P2153, DOI 10.2337/db06-0358; Grottick AJ, 2005, MOL BRAIN RES, V139, P153, DOI 10.1016/j.molbrainres.2005.05.020; Heiker JT, 2014, PHYSIOL GENOMICS, V46, P377, DOI 10.1152/physiolgenomics.00014.2014; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; Kahle M, 2013, MOL METAB, V2, P435, DOI 10.1016/j.molmet.2013.07.009; KAKU K, 1988, DIABETES, V37, P707, DOI 10.2337/diabetes.37.6.707; Kern M, 2012, BIOCHEM BIOPH RES CO, V417, P717, DOI 10.1016/j.bbrc.2011.12.008; Kooptiwut S, 2002, ENDOCRINOLOGY, V143, P2085, DOI 10.1210/en.143.6.2085; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Mulligan MK, 2008, GENES BRAIN BEHAV, V7, P677, DOI 10.1111/j.1601-183X.2008.00405.x; Nicholson A, 2010, OBESITY, V18, P1902, DOI 10.1038/oby.2009.477; Peyot ML, 2009, J BIOL CHEM, V284, P16848, DOI 10.1074/jbc.M109.006650; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Rydstrom J, 2006, TRENDS BIOCHEM SCI, V31, P355, DOI 10.1016/j.tibs.2006.05.003; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Sluyter F, 1999, BEHAV BRAIN RES, V98, P39; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Tamarina NA, 2014, ISLETS, V6, DOI 10.4161/isl.27685; Toye AA, 2005, DIABETOLOGIA, V48, P675, DOI 10.1007/s00125-005-1680-z; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808; Wong N, 2010, ENDOCRINOLOGY, V151, P96, DOI 10.1210/en.2009-0887; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338	34	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159165	10.1371/journal.pone.0159165	http://dx.doi.org/10.1371/journal.pone.0159165			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403868	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508200040
J	Gerencser, AA; Mookerjee, SA; Jastroch, M; Brand, MD				Gerencser, Akos A.; Mookerjee, Shona A.; Jastroch, Martin; Brand, Martin D.			Measurement of the Absolute Magnitude and Time Courses of Mitochondrial Membrane Potential in Primary and Clonal Pancreatic Beta-Cells	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; OXIDATIVE-PHOSPHORYLATION; GLUCOSE SENSITIVITY; CA2+ CONCENTRATION; MOUSE ISLETS; B-CELLS; CALCIUM; ATP; METABOLISM; PLASMA	The aim of this study was to simplify, improve and validate quantitative measurement of the mitochondrial membrane potential (Delta psi M) in pancreatic beta-cells. This built on our previously introduced calculation of the absolute magnitude of Delta psi M in intact cells, using time-lapse imaging of the non-quench mode fluorescence of tetramethylrhodamine methyl ester and a bis-oxonol plasma membrane potential (Delta psi P) indicator Delta psi M is a central mediator of glucose-stimulated insulin secretion in pancreatic beta-cells Delta psi M is at the crossroads of cellular energy production and demand, therefore precise assay of its magnitude is a valuable tool to study how these processes interplay in insulin secretion. Dispersed islet cell cultures allowed cell type-specific, single-cell observations of cell-to-cell heterogeneity of Delta psi M and Delta psi P. Glucose addition caused hyperpolarization of Delta psi M and depolarization of Delta psi P. The hyperpolarization was a monophasic step increase, even in cells where the Delta psi P depolarization was biphasic. The biphasic response of Delta psi P was associated with a larger hyperpolarization of Delta psi M than the monophasic response. Analysis of the relationships between Delta psi P and Delta psi M revealed that primary dispersed beta-cells responded to glucose heterogeneously, driven by variable activation of energy metabolism. Sensitivity analysis of the calibration was consistent with beta-cells having substantial cell-to-cell variations in amounts of mitochondria, and this was predicted not to impair the accuracy of determinations of relative changes in Delta psi M and Delta psi P. Finally, we demonstrate a significant problem with using an alternative Delta psi M probe, rhodamine 123. In glucose-stimulated and oligomycin-inhibited beta-cells the principles of the rhodamine 123 assay were breached, resulting in misleading conclusions.	[Gerencser, Akos A.; Mookerjee, Shona A.; Jastroch, Martin; Brand, Martin D.] Buck Inst Res Aging, Novato, CA 94945 USA; [Gerencser, Akos A.] Image Analyst Software, Novato, CA 94945 USA; [Mookerjee, Shona A.] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Jastroch, Martin] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, Neuherberg, Germany; [Jastroch, Martin] Helmholtz Zentrum Munchen, German Diabet Ctr DZD, Neuherberg, Germany	Buck Institute for Research on Aging; Touro University California; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Gerencser, AA (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.; Gerencser, AA (corresponding author), Image Analyst Software, Novato, CA 94945 USA.	agerencser@buckinstitute.org	Jastroch, Martin/I-7494-2017; Brand, Martin D/A-9423-2012	Brand, Martin D/0000-0003-4418-6153	Buck Institute for Research on Aging	Buck Institute for Research on Aging	The study including salaries was funded by Buck Institute for Research on Aging internal funds to MDB. Image Analyst Software contributed to the study by computer software. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akhmedov D, 2010, FASEB J, V24, P4613, DOI 10.1096/fj.10-162222; Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Antinozzi PA, 2002, J BIOL CHEM, V277, P11746, DOI 10.1074/jbc.M108462200; Birket MJ, 2011, J CELL SCI, V124, P348, DOI 10.1242/jcs.072272; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brand MD, 1997, J EXP BIOL, V200, P193; Casimir M, 2009, BIOCHEM J, V424, P459, DOI 10.1042/BJ20090729; CHACON E, 1994, BIOPHYS J, V66, P942, DOI 10.1016/S0006-3495(94)80904-X; Detimary P, 1996, J BIOL CHEM, V271, P20559, DOI 10.1074/jbc.271.34.20559; DETIMARY P, 1995, J CLIN INVEST, V96, P1738, DOI 10.1172/JCI118219; Doliba NM, 2012, AM J PHYSIOL-ENDOC M, V302, pE87, DOI 10.1152/ajpendo.00218.2011; DUCHEN MR, 1993, BIOCHEM J, V294, P35, DOI 10.1042/bj2940035; Gerencser AA, 2001, CELL CALCIUM, V30, P311, DOI 10.1054/ceca.2001.0238; Gerencser AA, 2015, BIOCH J; Gerencser AA, 2016, MOL CELL, V61, P642, DOI 10.1016/j.molcel.2016.02.026; Gerencser AA, 2015, ENDOCRINOLOGY, V156, P3496, DOI 10.1210/en.2015-1552; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; GHOSH A, 1991, J BIOL CHEM, V266, P22887; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Gray JP, 2012, AM J PHYSIOL-ENDOC M, V303, pE191, DOI 10.1152/ajpendo.00465.2011; GRODSKY GM, 1972, J CLIN INVEST, V51, P2047, DOI 10.1172/JCI107011; HACKENBROCK CR, 1971, J CELL BIOL, V51, P123, DOI 10.1083/jcb.51.1.123; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Heart E, 2009, AM J PHYSIOL-ENDOC M, V296, pE1354, DOI 10.1152/ajpendo.90836.2008; HEIMBERG H, 1993, EMBO J, V12, P2873, DOI 10.1002/j.1460-2075.1993.tb05949.x; Henquin JC, 2006, DIABETES, V55, P3470, DOI 10.2337/db06-0868; HOEK JB, 1980, J BIOL CHEM, V255, P1458; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Huber HJ, 2009, J NEUROSCI METH, V176, P270, DOI 10.1016/j.jneumeth.2008.09.003; Huypens P, 2011, DIABETOLOGIA, V54, P135, DOI 10.1007/s00125-010-1923-5; Johnson D, 2007, DIABETES, V56, P1694, DOI 10.2337/db07-0026; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; Kindmark H, 2001, J BIOL CHEM, V276, P34530, DOI 10.1074/jbc.M102492200; Krippeit-Drews P, 2000, BIOCHEM BIOPH RES CO, V267, P179, DOI 10.1006/bbrc.1999.1921; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Metelkin E, 2009, FEBS J, V276, P6942, DOI 10.1111/j.1742-4658.2009.07394.x; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Nicholls DG, 2012, METHODS MOL BIOL, V810, P119, DOI 10.1007/978-1-61779-382-0_8; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; NICHOLLS DG, 2013, BIOENERGETICS; Nita II, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046649; Ohara-Imaizumi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015553; Panten U, 2013, METABOLISM, P1; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Rorsman P, 2011, PROG BIOPHYS MOL BIO, V107, P224, DOI 10.1016/j.pbiomolbio.2011.06.009; Schulz N, 2013, INT J MOL SCI, V14, P18989, DOI 10.3390/ijms140918989; SLATE DL, 1995, ANTICANCER RES, V15, P811; SMOLEN P, 1993, BIOPHYS J, V64, P1668, DOI 10.1016/S0006-3495(93)81539-X; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023	56	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159199	10.1371/journal.pone.0159199	http://dx.doi.org/10.1371/journal.pone.0159199			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404273	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508200043
J	Kurachi, M; Mikuni, M; Ishizaki, Y				Kurachi, Masashi; Mikuni, Masahiko; Ishizaki, Yasuki			Extracellular Vesicles from Vascular Endothelial Cells Promote Survival, Proliferation and Motility of Oligodendrocyte Precursor Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; EXOSOMES; BRAIN; DIFFERENTIATION; MIGRATION; MICROVESICLES; EXPRESSION; PERICYTES; MIR-219; ROLES	We previously examined the effect of brain microvascular endothelial cell (MVEC) transplantation on rat white matter infarction, and found that MVEC transplantation promoted remyelination of demyelinated axons in the infarct region and reduced apoptotic death of oligodendrocyte precursor cells (OPCs). We also found that the conditioned medium (CM) from cultured MVECs inhibited apoptosis of cultured OPCs. In this study, we examined contribution of extracellular vesicles (EVs) contained in the CM to its inhibitory effect on OPC apoptosis. Removal of EVs from the CM by ultracentrifugation reduced its inhibitory effect on OPC apoptosis. To confirm whether EVs derived from MVECs are taken up by cultured OPCs, we labeled EVs with PKH67, a fluorescent dye, and added them to OPC cultures. Many vesicular structures labeled with PKH67 were found within OPCs immediately after their addition. Next we examined the effect of MVEC-derived EVs on OPC behaviors. After 2 days in culture with EVs, there was significantly less pyknotic and more BrdU-positive OPCs when compared to control. We also examined the effect of EVs on motility of OPCs. OPCs migrated longer in the presence of EVs when compared to control. To examine whether these effects on cultured OPCs are shared by EVs from endothelial cells, we prepared EVs from conditioned media of several types of endothelial cells, and tested their effects on cultured OPCs. EVs from all types of endothelial cells we examined reduced apoptosis of OPCs and promoted their motility. Identification of the molecules contained in EVs from endothelial cells may prove helpful for establishment of effective therapies for demyelinating diseases.	[Kurachi, Masashi; Ishizaki, Yasuki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma, Japan; [Mikuni, Masahiko] Gunma Univ, Grad Sch Med, Dept Psychiat & Neurosci, Maebashi, Gunma, Japan	Gunma University; Gunma University	Ishizaki, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma, Japan.	yasukiishizaki@gunma-u.ac.jp	Ishizaki, Yasuki/AAB-1209-2020		Japan Society for the Promotion of Science [25122704, 15K15448]; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Japan Agency for Medical Research and Development (AMED)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	No. 25122704 from the Japan Society for the Promotion of Science (https://www.jsps.go.jp) to Y.I. No. 15K15448 from the Japan Society for the Promotion of Science (https://www.jsps.go.jp) to M.K. 'Integrated Research on Neuropsychiatric Disorders' carried out under the Strategic Research program for Brain Sciences (SRPBS) by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT, http://www.mext.go.jp) and Japan Agency for Medical Research and Development (AMED, http://www.amed.go.jp) to Y.I. and M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ms. Kao Abe (Department of Molecular and Cellular Neurobiology, Gunma University Graduate School of Medicine), and Ms. Yu Miyazaki (Department of Pharmacy, Takasaki University of Health and Welfare, Takasaki, Japan) for excellent technical assistance (cell culture and data analysis). We also thank for Bioresource Center at Gunma University Graduate School of Medicine. This work was partly supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to Y. Ishizaki (No. 25122704) and to M. Kurachi (No. 15K15448). A part of this study is the result of 'Integrated Research on Neuropsychiatric Disorders' carried out under the Strategic Research program for Brain Sciences (SRPBS) by the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and Japan Agency for Medical Research and Development (AMED).	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Atay SDC, EXOSOMES AND MICROVE, V1, DOI [10.5772/56180, DOI 10.5772/56180, 10. 5772/56180]; Barca-Mayo O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00013; BARRES BA, 1993, DEVELOPMENT, V118, P283; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Budde H, 2010, DEVELOPMENT, V137, P2127, DOI 10.1242/dev.050633; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; de Faria Omar Jr., 2012, Frontiers in Genetics, V3, P46, DOI 10.3389/fgene.2012.00046; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; Desmond DW, 2002, CEREBROVASC DIS, V13, P53, DOI 10.1159/000049151; Dugas JC, 2007, J NEUROSCI, V27, P6185, DOI 10.1523/JNEUROSCI.0628-07.2007; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Fitzpatrick JMK, 2015, INT J BIOCHEM CELL B, V65, P134, DOI 10.1016/j.biocel.2015.05.021; Fruhbeis C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00182; Fruhbeis C, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00119; Haqqani AS, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-4; Hayakawa K, 2011, J NEUROSCI, V31, P10666, DOI 10.1523/JNEUROSCI.1944-11.2011; Hu JG, 2009, J NEUROSCI RES, V87, P2854, DOI 10.1002/jnr.22111; Iijima K, 2015, J NEUROCHEM, V135, P539, DOI 10.1111/jnc.13262; Issa Razao, 2005, Angiogenesis, V8, P53, DOI 10.1007/s10456-005-5613-8; Kawikova I, 2015, BRAIN RES, V1617, P63, DOI 10.1016/j.brainres.2014.09.070; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Milner R, 1996, J NEUROSCI, V16, P7240; Miyamoto Y, 2008, J NEUROSCI, V28, P8326, DOI 10.1523/JNEUROSCI.1482-08.2008; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Puentes S, 2012, BRAIN RES, V1469, P43, DOI 10.1016/j.brainres.2012.06.042; Pusic AD, 2014, J NEUROIMMUNOL, V266, P12, DOI 10.1016/j.jneuroim.2013.10.014; Pusic AD, 2014, GLIA, V62, P284, DOI 10.1002/glia.22606; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Szabo C A, 1997, Neurobiology (Bp), V5, P1; Tilling T, 2002, CELL TISSUE RES, V310, P19, DOI 10.1007/s00441-002-0604-1; van Balkom BWM, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26760; VLODAVSKY I, 1987, J CELL PHYSIOL, V131, P402, DOI 10.1002/jcp.1041310312; Wang SS, 2009, CURR OPIN GENET DEV, V19, P205, DOI 10.1016/j.gde.2009.04.002; Xin HQ, 2013, J CEREBR BLOOD F MET, V33, P1711, DOI 10.1038/jcbfm.2013.152; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066	50	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159158	10.1371/journal.pone.0159158	http://dx.doi.org/10.1371/journal.pone.0159158			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403742	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508200039
J	Cellier, M; James, AL; Orenga, S; Perry, JD; Turnbull, G; Stanforth, SP				Cellier, Marie; James, Arthur L.; Orenga, Sylvain; Perry, John D.; Turnbull, Graeme; Stanforth, Stephen P.			The Synthesis of L-Alanyl and beta-Alanyl Derivatives of 2-Aminoacridone and Their Application in the Detection of Clinically-Important Microorganisms	PLOS ONE			English	Article							AMINOPEPTIDASE; 2-ARYLBENZOTHIAZOLE; NITROREDUCTASE; BENZOXAZOLE; BACTERIA	In clinical microbiology the speed with which pathogenic microorganisms may be detected has a direct impact on patient health. One important strategy used in the laboratory is the growth of cultures in the presence of an enzymatic substrate which, once transformed by the appropriate microbial enzyme, generates a detectable colour or fluorescence output. Such substrates have previously been prepared by our group and others and are available as commercial diagnostic kits, however they all suffer from some degree of diffusion when used in a solid growth medium. This diffusion complicates the detection and differentiation of species in polymicrobial cultures and so we sought to improve on our previous work. In this work we have prepared and evaluated a series of novel fluorogenic enzyme substrates based on N-substituted-2-aminoacridones. All of the prepared substrates were found to be suitable for the detection and differentiation of certain microorganisms, however those based on the 2-amino-10-benzylacridone core in particular showed no apparent diffusion when incorporated into solid growth media. On transformation these substrates generated brightly fluorescent colonies that are clearly contrasted with the background medium due to the difference in emission wavelength (lambda(em) 445-450 nm for the substrate, lambda(em) 550 nm for the product). Here we have shown that our L-alanyl aminopeptidase substrate, 2-(N-L-alanylamino)-10-benzylacridone, is particularly suited to the detection of Gram-negative bacteria, and our beta-alanyl aminopeptidase substrate, 2-(N-beta-alanylamino)-10-benzylacridone, to the detection of Pseudomonas aeruginosa and Serratia marcescens when grown on solid media incorporating these substrates. The resulting fluorophore shows no apparent diffusion from the colonies of interest, and the enhanced sensitivity offered by fluorescent emission may allow for the detection of these organisms as microcolonies using automated fluorescence microscopy.	[Cellier, Marie; Orenga, Sylvain] bioMerieux SA, Res & Dev Microbiol, La Balme Les Grottes, France; [James, Arthur L.; Turnbull, Graeme; Stanforth, Stephen P.] Northumbria Univ, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Perry, John D.] Freeman Rd Hosp, Dept Microbiol, Newcastle Upon Tyne, Tyne & Wear, England	Northumbria University; Newcastle Freeman Hospital; Newcastle University - UK	Turnbull, G (corresponding author), Northumbria Univ, Dept Appl Sci, Newcastle Upon Tyne, Tyne & Wear, England.	g.turnbull@northumbria.ac.uk	Orenga, Sylvain/AAE-5471-2020; Turnbull, Graeme/H-8457-2014	Turnbull, Graeme/0000-0003-2606-3387	bioMerieux, SA, France; Northumbria University, Faculty of Health and Life Sciences, UK; bioMerieux	bioMerieux, SA, France; Northumbria University, Faculty of Health and Life Sciences, UK; bioMerieux	Work reported in this paper was conducted as part of a co-funded PhD studentship between bioMerieux, SA, France and Northumbria University, Faculty of Health and Life Sciences, UK with assistance from the Freeman Hospital, Department of Microbiology, UK. bioMerieux staff (MC and SO) received funding in the form of salaries. JDP is employed by the Freeman Hospital, and receives funding from bioMerieux. The specific roles of these authors are articulated in the 'author contributions' section. bioMerieux staff also provided direction on study design and performed some analysis using the synthetic substrates described in this manuscript. Northumbria University provided facilities for synthesis and analysis (performed by GT under the direction of SPS and ALJ). Freeman Hospital staff (JDP) contributed to the study design and evaluation of the substrates.	Anderson RJ, 2008, BIOORG MED CHEM LETT, V18, P832, DOI 10.1016/j.bmcl.2007.11.018; BLANCHARD C, 1981, J HETEROCYCLIC CHEM, V18, P841, DOI 10.1002/jhet.5570180447; CARLONE GM, 1982, J CLIN MICROBIOL, V16, P1157, DOI 10.1128/JCM.16.6.1157-1159.1982; Cellier M, 2015, BIOORG MED CHEM LETT, V25, P5694, DOI 10.1016/j.bmcl.2015.10.099; Cellier M, 2014, BIOORGAN MED CHEM, V22, P1250, DOI 10.1016/j.bmc.2014.01.013; Cellier M, 2011, BIOORGAN MED CHEM, V19, P2903, DOI 10.1016/j.bmc.2011.03.043; Haughland R, 2002, HDB FLUORESCENT PROB; Laine L, 2009, J CYST FIBROS, V8, P143, DOI 10.1016/j.jcf.2008.11.003; London R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008609; Orenga S, 2009, J MICROBIOL METH, V79, P139, DOI 10.1016/j.mimet.2009.08.001; Perry JD, 2007, J APPL MICROBIOL, V103, P2046, DOI 10.1111/j.1365-2672.2007.03442.x; Reymond JL, 2009, CHEM COMMUN, P34, DOI 10.1039/b813732c; Steen AD, 2015, AQUAT MICROB ECOL, V75, P271, DOI 10.3354/ame01755; Vaiyapuri S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000796; Zaytsev AV, 2008, ORG BIOMOL CHEM, V6, P682, DOI 10.1039/b716978g	15	3	4	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158378	10.1371/journal.pone.0158378	http://dx.doi.org/10.1371/journal.pone.0158378			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391894	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000380005400048
J	Li, LP; Zhang, BG; Xiao, PG; Qi, YD; Zhang, Z; Liu, HT; Li, XJ; Wang, GP; Terwei, A				Li, Liping; Zhang, Bengang; Xiao, Peigen; Qi, Yaodong; Zhang, Zhao; Liu, Haitao; Li, Xiaojin; Wang, Guoping; Terwei, Andre			Patterns and Environmental Determinants of Medicinal Plant : Vascular Plant Ratios in Xinjiang, Northwest China	PLOS ONE			English	Article							GLOBAL PATTERNS; CONSERVATION; DIVERSITY; KNOWLEDGE; DISTRICT	With both a full collection of native vascular plant distributions and a full checklist of source plants of the Chinese Materia Medica (CMM), the Uygur Medicine (UM), and the Kazak Medicine (KM) for the Xinjiang region, we defined medicinal plant: vascular plant ratios (simplified as medicinal plant ratios hereafter) as the value of medicinal plant richness divided by vascular plant richness. We aimed to find whether the ratios are constant or change in different environments, which environmental variables determine medicinal plant ratios, and whether the ratios are more influenced by human or by natural environments. Finally, suggestions for medicinal plant conservation were addressed. We found that (1) medicinal plant ratios were not constant, and they were high in the Tarim Basin which was largely covered by desert, while they were relatively low in mountainous areas, especially in the Tianshan Mountains where the general species richness was high; (2) medicinal plant ratios were not significantly influenced by human activities, indicated by human population density distributions, but they were highly correlated with plant species richness and climate, i.e. ratios decreased with plant species richness and MAP, and were related quadratically with MAT; (3) CMM ratio and UM ratio were more influenced by plant richness than by climate, while KM ratio was more influenced by climate. We concluded that the percentages of plants used as medicines were not influenced by distances from human settlements, but were determined by species richness or climate. We suggest that (1), in general, the medicinal plant ratio could be a complementary indicator for medicinal plant conservation planning and (2), for the region of Xinjiang, not only high diversity areas, but also some extreme environments should be considered as compensation for a better protection of medicinal plants.	[Li, Liping] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Li, Liping; Zhang, Bengang; Xiao, Peigen; Qi, Yaodong; Zhang, Zhao; Liu, Haitao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Minist Educ,Key Lab Bioact Subst & Resources Util, Beijing, Peoples R China; [Zhang, Bengang; Liu, Haitao; Li, Xiaojin; Wang, Guoping] Xinjiang Inst Chinese & Ethn Med, Urumqi, Peoples R China; [Terwei, Andre] German Fed Inst Hydrol, Dept Ecol Interact, Koblenz, Germany	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Peking Union Medical College	Zhang, BG (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Med Plant Dev, Minist Educ,Key Lab Bioact Subst & Resources Util, Beijing, Peoples R China.; Zhang, BG (corresponding author), Xinjiang Inst Chinese & Ethn Med, Urumqi, Peoples R China.	bgzhang@implad.ac.cn	Li, Liping/C-2574-2011	Li, Liping/0000-0002-5550-1932	National Natural Science Foundation of China [81503183, 81560660]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by National Natural Science Foundation of China (81503183, 81560660). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KP, 2010, J MED PLANTS RES, V4, P235; Adnan M, 2012, ECON BOT, V66, P344, DOI 10.1007/s12231-012-9213-4; Akhtar N, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-25; Bhuwendra Singh, 2012, Journal of Forestry Research, V23, P145, DOI 10.1007/s11676-012-0245-5; Caniago I, 1998, ECON BOT, V52, P229, DOI 10.1007/BF02862141; China National Corporation of Traditional & Herbal Medicine, 1994, REC CHIN MED RES; Commissione Redactorum Florae Xinjiangensis, 1992, FLOR XINJ; Dhyani PP, 2005, CURR SCI INDIA, V88, P335; Editorial Committee of Chinese Physical Geography of the Chinese Academy of Sciences, 1984, CHIN PHYS GEOGR CLIM; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Ghimire SK, 2008, J APPL ECOL, V45, P41, DOI 10.1111/j.1365-2664.2007.01375.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoareau L., 1999, ELECTRON J BIOTECHN, V2, P3; Huang Lin-fang, 2013, Yaoxue Xuebao, V48, P580; Huang LQ, 2005, RES INFORM TRADITION, V7; Kala CP, 2004, BIODIVERS CONSERV, V13, P453, DOI 10.1023/B:BIOC.0000006511.67354.7f; Kandari L. S., 2011, Journal of Forestry Research (Harbin), V22, P403, DOI 10.1007/s11676-011-0110-y; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Law W, 2007, BIODIVERS CONSERV, V16, P1747, DOI 10.1007/s10531-006-9057-2; Li JZ, 1995, RESOURCES TRADITIONA, V1, P11; Li LP, 2015, CHIN HERB MED, V7, P45, DOI 10.1016/S1674-6384(15)60019-3; Li LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066450; Li LiPing, 2011, Ganhanqu Yanjiu (Arid Zone Research), V28, P1, DOI 10.3724/SP.J.1148.2011.00001; Lopez-Pujol J, 2006, BIODIVERS CONSERV, V15, P3983, DOI 10.1007/s10531-005-3015-2; MANANDHAR NP, 1995, J ETHNOPHARMACOL, V48, P1, DOI 10.1016/0378-8741(95)01269-J; Manish Mishra, 2013, International Research Journal of Biological Sciences, V2, P1; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pei SJ, 2010, BIODIVERS CONSERV, V19, P2619, DOI 10.1007/s10531-010-9862-5; R Core Team, 2021, R LANGUAGE ENV STAT; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; Rokaya MB, 2012, J MT SCI-ENGL, V9, P201, DOI 10.1007/s11629-012-2144-9; Sang WG, 2011, BIOSCIENCE, V61, P720, DOI 10.1525/bio.2011.61.9.11; Shaheen H, 2012, PAK J BOT, V44, P739; Shinwari ZK, 2011, PAK J BOT, V43, P5; Shrestha PM, 2003, J ETHNOPHARMACOL, V86, P81, DOI 10.1016/S0378-8741(03)00051-5; Sivasankari Balayogan, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P975, DOI 10.1016/S2221-1691(13)60188-4; Stangeland T, 2008, J ETHNOPHARMACOL, V117, P290, DOI 10.1016/j.jep.2008.02.008; State Administration of Traditional Chinese Medicine-Chinese Materia Medica Editorial Board, 2005, CHIN MAT MED UIGH CA; Tang JL, 2008, LANCET, V372, P1938, DOI 10.1016/S0140-6736(08)61354-9; The State Key Laboratory of Resources and Environment Information System Institute of Geographic Sciences and Natural Resources Research Chinese Academy of Sciences, 1996, CHIN POP 1 4000000; Verpoorte R, 2014, J ETHNOPHARMACOL, V158, P447, DOI 10.1016/j.jep.2014.10.038; Wang R., 2008, MATERIA MED KAZAK NA; Wang XJ, 2012, WORLD SCI TECHNOLOGY, V14, P1904; Zhang HX, 2014, BIOL CONSERV, V177, P165, DOI 10.1016/j.biocon.2014.07.005; Zhao ZZ, 2012, J ETHNOPHARMACOL, V140, P476, DOI 10.1016/j.jep.2012.01.048; Zheng XL, 2013, J ETHNOPHARMACOL, V148, P964, DOI 10.1016/j.jep.2013.05.051; Zhu GQ, 2014, CHECKLIST MED PLANTS	47	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158405	10.1371/journal.pone.0158405	http://dx.doi.org/10.1371/journal.pone.0158405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391239	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400055
J	Chen, C; Zeger, S; Breysse, P; Katz, J; Checkley, W; Curriero, FC; Tielsch, JM				Chen, Chen; Zeger, Scott; Breysse, Patrick; Katz, Joanne; Checkley, William; Curriero, Frank C.; Tielsch, James M.			Estimating Indoor PM2.5 and CO Concentrations in Households in Southern Nepal: The Nepal Cookstove Intervention Trials	PLOS ONE			English	Article							PARTICULATE MATTER; AIR-POLLUTION; HEALTH; EXPOSURES; CHILDREN; QUALITY	High concentrations of household air pollution (HAP) due to biomass fuel usage with unvented, insufficient combustion devices are thought to be an important health risk factor in South Asia population. To better characterize the indoor concentrations of particulate matter (PM2.5) and carbon monoxide (CO), and to understand their impact on health in rural southern Nepal, this study analyzed daily monitoring data collected with DataRAM pDR-1000 and LASCAR CO data logger in 2980 households using traditional biomass cookstove indoor through the Nepal Cookstove Intervention Trial-Phase I between March 2010 and October 2011. Daily average PM2.5 and CO concentrations collected in area near stove were 1,376 (95% CI, 1,331-1,423) mu g/m(3) and 10.9 (10.5-11.3) parts per million (ppm) among households with traditional cookstoves. The 95th percentile, hours above 100 mu g/m(3) for PM2.5 or 6ppm for CO, and hours above 1000 mu g/m(3) for PM2.5 or 9ppm for CO were also reported. An algorithm was developed to differentiate stove-influenced (SI) periods from non-stove-influenced (non-SI) periods in monitoring data. Average stove-influenced concentrations were 3,469 (3,350-3,588) mu g/m(3) for PM2.5 and 21.8 (21.1-22.6) ppm for CO. Dry season significantly increased PM2.5 concentration in all metrics; wood was the cleanest fuel for PM2.5 and CO, while adding dung into the fuel increased concentrations of both pollutants. For studies in rural southern Nepal, CO concentration is not a viable surrogate for PM2.5 concentrations based on the low correlation between these measures. In sum, this study filled a gap in knowledge on HAP in rural Nepal using traditional cookstoves and revealed very high concentrations in these households.	[Chen, Chen; Breysse, Patrick] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Zeger, Scott] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Katz, Joanne; Checkley, William] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Checkley, William] Johns Hopkins Sch Med, Dept Med, Div Pulm & Crit Care, Baltimore, MD USA; [Curriero, Frank C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Tielsch, James M.] George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Global Hlth, Washington, DC 20052 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; George Washington University	Tielsch, JM (corresponding author), George Washington Univ, Sch Publ Hlth, Milken Inst, Dept Global Hlth, Washington, DC 20052 USA.	jtielsch@gwu.edu	Chen, Chen/X-1025-2019	Chen, Chen/0000-0002-0632-946X; Zeger, Scott/0000-0001-8907-1603; Checkley, William/0000-0003-1106-8812; Katz, Joanne/0000-0002-5997-7823	National Institute of Environmental Health Sciences, United States National Institutes of Health [ES015558]; Thrasher Research Fund [02830-4]; Global Alliance for Clean Cookstoves of the United Nations Foundation [UNF-12-380]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015558] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Thrasher Research Fund; Global Alliance for Clean Cookstoves of the United Nations Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	National Institute of Environmental Health Sciences, United States National Institutes of Health (ES015558) (JT), the Thrasher Research Fund (02830-4) (JT), and the Global Alliance for Clean Cookstoves of the United Nations Foundation (UNF-12-380) (JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was performed with financial support from the National Institute of Environmental Health Sciences, United States National Institutes of Health (ES015558), the Thrasher Research Fund (02830-4), and the Global Alliance for Clean Cookstoves of the United Nations Foundation (UNF-12-380).	Clark ML, 2013, ENVIRON HEALTH PERSP, V121, P1120, DOI 10.1289/ehp.1206429; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Dutta K, 2007, ENERGY SUSTAIN DEV, V11, P19, DOI DOI 10.1016/S0973-0826(08)60397-X; Edwards RD, 2007, INDOOR AIR, V17, P189, DOI 10.1111/j.1600-0668.2007.00465.x; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; Gurley ES, 2013, INDOOR AIR, V23, P379, DOI 10.1111/ina.12038; Gurung A, 2013, ENVIRON RES, V124, P54, DOI 10.1016/j.envres.2013.03.007; Intensive Study and Research Center Pvt. Ltd, 2014, DISTR VDC PROF NEP 2; Johansson TB, 2012, GLOB EN ASS GEA; Kurmi OP, 2011, THORAX, V66, P724, DOI 10.1136/thx.2010.144717; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McCracken JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055670; Mukhopadhyay R, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI [10.3402/gha.v5i0.19016, 10.3402/gha.v510.19016]; Naeher LP, 2001, ENVIRON SCI TECHNOL, V35, P575, DOI 10.1021/es991225g; Northcross A, 2010, J ENVIRON MONITOR, V12, P873, DOI 10.1039/b916068j; Shrestha IL, 2005, INT J OCCUP ENV HEAL, V11, P150, DOI 10.1179/oeh.2005.11.2.150; Soneja S, 2014, INT J ENV RES PUB HE, V11, P6400, DOI 10.3390/ijerph110606400; Thermo Electron Corporation, 2003, MODEL PDR 1000AN 120; Tielsch JM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1271; Wallace L, 2006, ATMOS ENVIRON, V40, P399, DOI 10.1016/j.atmosenv.2005.08.042; Wallace LA, 2011, J EXPO SCI ENV EPID, V21, P49, DOI 10.1038/jes.2010.15; WHO, 2014, WHO GUID IND AIR QUA; Wolrd Health Organization, 2010, WHO GUID IND AIR QUA; World Health Organization, 2006, AIR QUAL GUID GLOB U; Wu CF, 2005, J EXPO ANAL ENV EPID, V15, P99, DOI 10.1038/sj.jea.7500351	25	29	29	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157984	10.1371/journal.pone.0157984	http://dx.doi.org/10.1371/journal.pone.0157984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389398	gold, Green Published, Green Submitted			2022-12-26	WOS:000379811500010
J	Han, K; Hwang, E; Park, JB				Han, Kyungdo; Hwang, Eunkyung; Park, Jun-Beom			Association between Consumption of Coffee and the Prevalence of Periodontitis: The 2008-2010 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							GREEN TEA CONSUMPTION; BONE-MINERAL DENSITY; INSULIN-RESISTANCE; METABOLIC SYNDROME; TOOTH LOSS; ADULTS; WOMEN; CAFFEINE; DISEASE; RISK	Background This study was performed to assess the relationship between the consumption of coffee and periodontitis using nationally representative data. Methods The data from the Korea National Health and Nutrition Examination Survey were used; the analysis in this study was confined to a total of 16,730 respondents over 19 years old who had no missing values for the consumption of coffee or outcome variables. A community periodontal index greater than or equal to code 3 was defined as periodontal disease. Results Consumption of coffee was significantly higher in the individuals with periodontitis in males. The odds ratios of the percentage of individuals with periodontitis tended to increase with the consumption of coffee. Adjusted odds ratios and their 95% confidence intervals of the male participants were 1, 1.131(0.792-1.617), 1.161(0.857-1.573), 1.053(0.805-1.379), 1.299(1.007-1.676), and 1.458(1.141-1.862) for once per month or less, once per month<x <= 3 times per week, three times per week<x <= 6 times per week, once per day, twice per day, and three or more per day, respectively. Conclusions Consumption of coffee may be considered an independent risk indicator of periodontal disease in Korean male adults, and we suggest that the periodontal health of male may benefit from reduction of coffee consumption.	[Han, Kyungdo] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea; [Hwang, Eunkyung] Myongji Univ, Bangmok Coll Gen Educ, Seoul, South Korea; [Park, Jun-Beom] Catholic Univ Korea, Coll Med, Dept Periodont, Seoul, South Korea	Catholic University of Korea; Myongji University; Catholic University of Korea	Park, JB (corresponding author), Catholic Univ Korea, Coll Med, Dept Periodont, Seoul, South Korea.	jbassoonis@yahoo.co.kr	Park, Jun-Beom/I-8201-2019	Park, Jun-Beom/0000-0002-8915-1555	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information Communication Technology (ICT) & Future Planning (Seoul, Republic of Korea) [NRF-2014R1A1A1003106]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, Information Communication Technology (ICT) & Future Planning (Seoul, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, Information Communication Technology (ICT) & Future Planning (NRF-2014R1A1A1003106) (Seoul, Republic of Korea).; This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, Information and Communication Technology & Future Planning (NRF-2014R1A1A1003106). The authors have stated explicitly that there are no conflicts of interest in connection with this article.	Bae J, 2015, RHEUMATOL INT, V35, P327, DOI 10.1007/s00296-014-3061-8; Bernabe E, 2014, J DENT, V42, P952, DOI 10.1016/j.jdent.2014.04.011; Bezerra JP, 2008, J PERIODONTOL, V79, P2356, DOI [10.1902/jop.2008.080204, 10.1902/jop.2008.080204 ]; Broderick Pamela, 2004, J Okla State Med Assoc, V97, P538; Budhathoki S, 2015, INT J CANCER, V137, P463, DOI 10.1002/ijc.29390; Choi EJ, 2014, KOREAN J FAM MED, V35, P11, DOI 10.4082/kjfm.2014.35.1.11; Choi HM, 2015, J PERIODONTOL, V86, P866, DOI 10.1902/jop.2015.150025; Chun YH, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-84; Chung JH, 2016, J PERIODONTOL, P1; de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003; Duarte PM, 2015, J EVID-BASED DENT PR, V15, P77, DOI 10.1016/j.jebdp.2015.03.010; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Han K, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002791; Han K, 2016, MATURITAS, V85, P73, DOI 10.1016/j.maturitas.2015.12.010; Han K, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001839; Hong JW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002864; Ikeda M, 2010, SCAND J CLIN LAB INV, V70, P171, DOI 10.3109/00365511003650165; Islam SKMA, 2015, ENDOCR J, V62, P981, DOI 10.1507/endocrj.EJ15-0350; Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11; Jeon JY, 2013, DIABETES METAB J, V37, P349, DOI 10.4093/dmj.2013.37.5.349; Kamagata-Kiyoura Y, 1999, J PERIODONTOL, V70, P283, DOI 10.1902/jop.1999.70.3.283; Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007; Kim J, 2012, J ACAD NUTR DIET, V112, P246, DOI 10.1016/j.jada.2011.10.005; Kim SY, 2014, KOREAN J FAM MED, V35, P1, DOI 10.4082/kjfm.2014.35.1.1; Kim Y. H., 2013, CLIN ORAL INVEST; Kim YH, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0142-3; Koyama Y, 2010, PREV MED, V50, P173, DOI 10.1016/j.ypmed.2010.01.010; Lee JK, 2015, EUR J ENDOCRINOL, V172, P595, DOI 10.1530/EJE-14-0805; Lee JH, 2016, KOREAN J FAM MED, V37, P7, DOI 10.4082/kjfm.2016.37.1.7; Lim HS, 2015, FOOD ADDIT CONTAM A, V32, P1786, DOI 10.1080/19440049.2015.1077396; Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x; Macedo Rander Moreira, 2015, Braz. Dent. J., V26, P175, DOI 10.1590/0103-6440201300219; Machida T, 2014, NUTRIENTS, V6, P4476, DOI 10.3390/nu6104476; MARKKANEN H, 1978, COMMUNITY DENT ORAL, V6, P240, DOI 10.1111/j.1600-0528.1978.tb01158.x; Ng N, 2014, J PERIODONTOL, V85, P1042, DOI 10.1902/jop.2013.130179; Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008; Oh JY, 2007, KOREAN J FAM MED, V28, P532; Park JB, 2014, J PERIODONTOL, V85, P1521, DOI 10.1902/jop.2014.130782; Sakamoto W, 2001, BONE, V28, P332, DOI 10.1016/S8756-3282(00)00444-0; Setiawan VW, 2015, GASTROENTEROLOGY, V148, P118, DOI 10.1053/j.gastro.2014.10.005; Tan EK, 2003, J NEUROL SCI, V216, P163, DOI 10.1016/j.jns.2003.07.006; Tanaka Keiko, 2008, Fukuoka Acta Medica, V99, P80; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Yi JR, 2016, ARCH ORAL BIOL, V64, P51, DOI 10.1016/j.archoralbio.2015.12.009; Zuccarello D, 2014, GENE, V535, P286, DOI 10.1016/j.gene.2013.11.016	45	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158845	10.1371/journal.pone.0158845	http://dx.doi.org/10.1371/journal.pone.0158845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387296	gold, Green Published, Green Submitted			2022-12-26	WOS:000379811500055
J	Puig, J; Sanchez-Gonzalez, J; Blasco, G; Daunis-i-Estadella, P; Federau, C; Alberich-Bayarri, A; Biarnes, C; Nael, K; Essig, M; Jain, R; Wintermark, M; Pedraza, S				Puig, Josep; Sanchez-Gonzalez, Javier; Blasco, Gerard; Daunis-i-Estadella, Pepus; Federau, Christian; Alberich-Bayarri, Angel; Biarnes, Carles; Nael, Kambiz; Essig, Marco; Jain, Rajan; Wintermark, Max; Pedraza, Salvador			Intravoxel Incoherent Motion Metrics as Potential Biomarkers for Survival in Glioblastoma	PLOS ONE			English	Article							CEREBRAL BLOOD-VOLUME; DIFFUSION-WEIGHTED MRI; PERFUSION-RELATED PARAMETERS; INITIAL CLINICAL-EXPERIENCE; BRAIN PERFUSION; BOLUS TRACKING; TUMOR GRADE; GLIOMAS; CONTRAST; MODEL	Objective Intravoxel incoherent motion (IVIM) is an MRI technique with potential applications in measuring brain tumor perfusion, but its clinical impact remains to be determined. We assessed the usefulness of IVIM-metrics in predicting survival in newly diagnosed glioblastoma. Methods Fifteen patients with glioblastoma underwent MRI including spin-echo echo-planar DWI using 13 b-values ranging from 0 to 1000 s/mm(2). Parametric maps for diffusion coefficient (D), pseudodiffusion coefficient (D*), and perfusion fraction (f) were generated for contrast-enhancing regions (CER) and non-enhancing regions (NCER). Regions of interest were manually drawn in regions of maximum f and on the corresponding dynamic susceptibility contrast images. Prognostic factors were evaluated by Kaplan-Meier survival and Cox proportional hazards analyses. Results We found that f(CER) and D*(CER) correlated with rCBF(CER). The best cutoffs for 6-month survival were f(CER)>9.86% and D*(CER)>21.712 x 10(-3)mm(2)/s (100% sensitivity, 71.4% specificity, 100% and 80% positive predictive values, and 80% and 100% negative predictive values; AUC: 0.893 and 0.857, respectively). Treatment yielded the highest hazard ratio (5.484; 95% CI: 1.162-25.88; AUC: 0.723; P = 0.031); f(CER) combined with treatment predicted survival with 100% accuracy. Conclusions The IVIM-metrics f(CER) and D*(CER) are promising biomarkers of 6-month survival in newly diagnosed glioblastoma.	[Puig, Josep; Blasco, Gerard; Biarnes, Carles; Pedraza, Salvador] Hosp Univ Dr Josep Trueta, Imaging Res Unit, IDI, Girona Biomed Res Inst IDIBGI, Girona, Spain; [Sanchez-Gonzalez, Javier] Philips Healthcare Iber, Madrid, Spain; [Daunis-i-Estadella, Pepus] Univ Girona, Dept Comp Sci Appl Math & Stat, Girona, Spain; [Federau, Christian] CHU Vaudois, Dept Diagnost & Intervent Radiol, Lausanne, Switzerland; [Federau, Christian; Wintermark, Max] Univ Lausanne, Lausanne, Switzerland; [Federau, Christian; Wintermark, Max] Stanford Univ, Dept Radiol, Neuroradiol Div, Palo Alto, CA 94304 USA; [Alberich-Bayarri, Angel] La Fe Polytech & Univ Hosp, Biomed Imaging Res Grp GIBI230, La Fe Hlth Res Inst, Valencia, Spain; [Nael, Kambiz] Icahn Sch Med Mt Sinai, Dept Radiol, New York, NY 10029 USA; [Essig, Marco] Univ Manitoba, Dept Radiol, Winnipeg, MB, Canada; [Jain, Rajan] NYU, Div Neuroradiol, Dept Radiol, Langone Med Ctr, New York, NY USA	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Philips; Philips Healthcare; Universitat de Girona; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Stanford University; Icahn School of Medicine at Mount Sinai; University of Manitoba; New York University; NYU Langone Medical Center	Puig, J (corresponding author), Hosp Univ Dr Josep Trueta, Imaging Res Unit, IDI, Girona Biomed Res Inst IDIBGI, Girona, Spain.	jpuigalcantara@idibgi.org	Daunis-i-Estadella, Pepus/B-9082-2011; pedraza, salvador/AAC-1728-2019; Alberich-Bayarri, Angel/E-3822-2010	Daunis-i-Estadella, Pepus/0000-0001-6134-9255; pedraza, salvador/0000-0003-2517-4413; Alberich-Bayarri, Angel/0000-0002-5932-2392; essig, marco/0000-0002-7964-2297; Jain, Rajan/0000-0002-4879-0457; Sanchez-Gonzalez, Javier/0000-0003-1427-3870; Blasco, Gerard/0000-0002-5302-0625	Philips Healthcare Iberica	Philips Healthcare Iberica	The authors received no specific funding for this work. Javier Sanchez-Gonzalez is employed by Philips Healthcare Iberica. Philips Healthcare Iberica provided support in the form of salary for author Javier Sanchez-Gonzalez, but this company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Andreou A, 2013, EUR RADIOL, V23, P428, DOI 10.1007/s00330-012-2604-1; ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Bisdas S, 2014, NMR BIOMED, V27, P1184, DOI 10.1002/nbm.3172; Bisdas S, 2013, NEURORADIOLOGY, V55, P1189, DOI 10.1007/s00234-013-1229-7; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Calamante F, 2002, STROKE, V33, P1146, DOI 10.1161/01.STR.0000014208.05597.33; Carroll TJ, 2003, RADIOLOGY, V227, P593, DOI 10.1148/radiol.2272020092; Cha S, 2002, RADIOLOGY, V223, P11, DOI 10.1148/radiol.2231010594; Chandarana H, 2012, INVEST RADIOL, V47, P688, DOI 10.1097/RLI.0b013e31826a0a49; Federau C, 2014, AM J NEURORADIOL, V35, P256, DOI 10.3174/ajnr.A3686; Federau C, 2015, NMR BIOMED, V28, P9, DOI 10.1002/nbm.3223; Federau C, 2014, J MAGN RESON IMAGING, V39, P624, DOI 10.1002/jmri.24195; Federau C, 2012, RADIOLOGY, V265, P874, DOI 10.1148/radiol.12120584; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Goldbrunner RH, 2000, J NEURO-ONCOL, V50, P53, DOI 10.1023/A:1006462504447; Grech-Sollars M, 2015, NMR BIOMED, V28, P468, DOI 10.1002/nbm.3269; Hakyemez B, 2010, CLIN RADIOL, V65, P15, DOI 10.1016/j.crad.2009.09.005; Hu YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07208; Iima M, 2014, INVEST RADIOL, V49, P485, DOI 10.1097/RLI.0000000000000040; Jain R, 2011, AM J NEURORADIOL, V32, P388, DOI 10.3174/ajnr.A2280; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Kim HS, 2014, AM J NEURORADIOL, V35, P490, DOI 10.3174/ajnr.A3719; Knutsson L, 2010, MAGN RESON MATER PHY, V23, P1, DOI 10.1007/s10334-009-0190-2; Koh DM, 2011, AM J ROENTGENOL, V196, P1351, DOI 10.2214/AJR.10.5515; Kono K, 2001, AM J NEURORADIOL, V22, P1081; LATOUR LL, 1994, P NATL ACAD SCI USA, V91, P1229, DOI 10.1073/pnas.91.4.1229; Law M, 2003, AM J NEURORADIOL, V24, P1989; Law M, 2008, RADIOLOGY, V247, P490, DOI 10.1148/radiol.2472070898; Le Bihan D, 2013, RADIOLOGY, V268, P318, DOI 10.1148/radiol.13130420; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Liu CL, 2013, EUR J RADIOL, V82, pE782, DOI 10.1016/j.ejrad.2013.08.006; More J. J., 1980, ANL8074, VIII; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Niendorf T, 1996, MAGN RESON MED, V36, P847, DOI 10.1002/mrm.1910360607; Olson JJ, 2009, J NEURO-ONCOL, V93, P1, DOI 10.1007/s11060-009-9838-z; Ostergaard L, 1998, J CEREBR BLOOD F MET, V18, P935, DOI 10.1097/00004647-199809000-00002; Pang YX, 2013, MAGN RESON MED, V69, P553, DOI 10.1002/mrm.24277; Paulson ES, 2008, RADIOLOGY, V249, P601, DOI 10.1148/radiol.2492071659; Pope WB, 2005, AM J NEURORADIOL, V26, P2466; Prince MR, 2009, J MAGN RESON IMAGING, V30, P1298, DOI 10.1002/jmri.21973; Rock K, 2012, BRIT J RADIOL, V85, pE729, DOI 10.1259/bjr/83796755; Ronning PA, 2012, NEURO-ONCOLOGY, V14, P1178, DOI 10.1093/neuonc/nos153; Sasaki M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112866; Shin JH, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790783; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Sumi M, 2013, AM J NEURORADIOL, V34, P410, DOI 10.3174/ajnr.A3227; Sumi M, 2012, RADIOLOGY, V263, P770, DOI 10.1148/radiol.12111248; Wang LL, 2014, EUR RADIOL, V24, P1914, DOI 10.1007/s00330-014-3176-z; Weber MA, 2010, INVEST RADIOL, V45, P755, DOI 10.1097/RLI.0b013e3181ec9db0; Wirestam R, 2001, ACTA RADIOL, V42, P123, DOI 10.1080/028418501127346459; Yuan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087024	52	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158887	10.1371/journal.pone.0158887	http://dx.doi.org/10.1371/journal.pone.0158887			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387822	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500059
J	Wang, L; Liu, GH; Fu, SJ; Xu, LZ; Zhao, K; Zhang, CM				Wang, Lu; Liu, Guohua; Fu, Shujun; Xu, Lingzhong; Zhao, Kun; Zhang, Caiming			Retinal Image Enhancement Using Robust Inverse Diffusion Equation and Self-Similarity Filtering	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; FUNDUS IMAGES; VISUAL IMPAIRMENT; SHOCK FILTERS; RISK-FACTORS; DIAGNOSIS; RESTORATION; PREVALENCE; ALGORITHMS; FEATURES	As a common ocular complication for diabetic patients, diabetic retinopathy has become an important public health problem in the world. Early diagnosis and early treatment with the help of fundus imaging technology is an effective control method. In this paper, a robust inverse diffusion equation combining a self-similarity filtering is presented to detect and evaluate diabetic retinopathy using retinal image enhancement. A flux corrected transport technique is used to control diffusion flux adaptively, which eliminates overshoots inherent in the Laplacian operation. Feature preserving denoising by the self-similarity filtering ensures a robust enhancement of noisy and blurry retinal images. Experimental results demonstrate that this algorithm can enhance important details of retinal image data effectively, affording an opportunity for better medical interpretation and subsequent processing.	[Wang, Lu; Xu, Lingzhong] Shandong Univ, Sch Publ Hlth, Jinan 250012, Peoples R China; [Liu, Guohua] Shandong Univ, Qilu Childrens Hosp, Dept Ophthalmol, Jinan 250022, Peoples R China; [Fu, Shujun] Shandong Univ, Sch Math, Jinan 250100, Peoples R China; [Zhao, Kun] Shandong Univ, Hosp 2, Dept Med Imaging, Jinan 250033, Peoples R China; [Zhang, Caiming] Shandong Univ Finance & Econ, Sch Comp Sci & Technol, Jinan 250061, Peoples R China; [Zhang, Caiming] Shandong Univ, Sch Comp Sci & Technol, Jinan 250101, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University of Finance & Economics; Shandong University	Fu, SJ (corresponding author), Shandong Univ, Sch Math, Jinan 250100, Peoples R China.	shujunfu@163.com			National Natural Science Foundation of China [61272239, 61070094, 61020106001]; NSFC Joint Fund with Guangdong [U1201258]; Science and Technology Development Project of Shandong Province of China [2014GGX101024]; Fundamental Research Funds of Shandong University [2014JC012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NSFC Joint Fund with Guangdong(National Natural Science Foundation of Guangdong Province); Science and Technology Development Project of Shandong Province of China; Fundamental Research Funds of Shandong University	The research has been supported in part by the National Natural Science Foundation of China (61272239, 61070094, 61020106001); the NSFC Joint Fund with Guangdong (U1201258); the Science and Technology Development Project of Shandong Province of China (2014GGX101024); and the Fundamental Research Funds of Shandong University (2014JC012).	Abbas Q, 2013, INT J INNOV COMPUT I, V9, P3731; Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; ALVAREZ L, 1994, SIAM J NUMER ANAL, V31, P590, DOI 10.1137/0731032; Aubert G., 2006, MATH PROBLEMS IMAGE, DOI 10.1007/978-0-387-44588-5; Azzopardi G, 2015, MED IMAGE ANAL, V19, P46, DOI 10.1016/j.media.2014.08.002; Bernardes R, 2011, OPHTHALMOLOGICA, V226, P161, DOI 10.1159/000329597; Buades A, 2005, MULTISCALE MODEL SIM, V4, P490, DOI 10.1137/040616024; Chang HB, 2015, OPT ENG, V54, DOI 10.1117/1.OE.54.1.013107; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Foracchia M, 2005, MED IMAGE ANAL, V9, P179, DOI 10.1016/j.media.2004.07.001; Fu S, 2010, ELECTRON LETT, V46, P907, DOI 10.1049/el.2010.0027; Fu SJ, 2007, NEUROCOMPUTING, V70, P883, DOI 10.1016/j.neucom.2006.10.035; Fu SJ, 2011, SCI CHINA INFORM SCI, V54, P1184, DOI 10.1007/s11432-011-4239-2; Giancardo L, 2012, MED IMAGE ANAL, V16, P216, DOI 10.1016/j.media.2011.07.004; Gonzalez R.C, 2007, DIGITAL IMAGE PROCES, V3rd; Gordois A, 2012, GLOB PUBLIC HEALTH, V7, P465, DOI 10.1080/17441692.2011.634815; Kyari F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1299; Mookiah MRK, 2013, COMPUT BIOL MED, V43, P2136, DOI 10.1016/j.compbiomed.2013.10.007; Noronha K, 2013, J MED IMAG HEALTH IN, V3, P280, DOI 10.1166/jmihi.2013.1169; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; OSHER S, 1990, SIAM J NUMER ANAL, V27, P919, DOI 10.1137/0727053; Patton N, 2006, PROG RETIN EYE RES, V25, P99, DOI 10.1016/j.preteyeres.2005.07.001; Patwari MB, 2013, INT J ENG, V2, P395; Quellec G, 2011, IEEE T MED IMAGING, V30, P523, DOI 10.1109/TMI.2010.2089383; Rampal H., 2013, P WORLD C MED PHYS B, P900; Ravishankar S, 2009, PROC CVPR IEEE, P210, DOI 10.1109/CVPRW.2009.5206763; Reza AM, 2004, J VLSI SIG PROC SYST, V38, P35, DOI 10.1023/B:VLSI.0000028532.53893.82; Rodrigues P, 2010, THESIS; Sepasian M, 2008, P WORLD C ENG COMP S, P22; Setiawan A. W., 2013, ICT SMART SOC ICISS, P1, DOI [10.1109/ICTSS.2013.6588092, DOI 10.1109/ICTSS.2013.6588092]; Shujun Fu, 2008, 2008 9th International Conference on Signal Processing (ICSP 2008), P1231, DOI 10.1109/ICOSP.2008.4697353; Tariq A., 2010, 2010 IEEE Symposium on Industrial Electronics and Applications (ISIEA 2010), P423, DOI 10.1109/ISIEA.2010.5679430; Walter T, 2002, IEEE T MED IMAGING, V21, P1236, DOI 10.1109/TMI.2002.806290; Xue WF, 2014, IEEE T IMAGE PROCESS, V23, P4850, DOI 10.1109/TIP.2014.2355716; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yu H, 2012, IEEE T INF TECHNOL B, V16, P644, DOI 10.1109/TITB.2012.2198668; Zheng YJ, 2014, MED IMAGE ANAL, V18, P903, DOI 10.1016/j.media.2013.09.009	37	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158480	10.1371/journal.pone.0158480	http://dx.doi.org/10.1371/journal.pone.0158480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388503	Green Published, Green Submitted, gold			2022-12-26	WOS:000379811500024
J	Rohner, F; Leyvraz, M; Konan, AG; Esso, LJCE; Wirth, JP; Norte, A; Adiko, AF; Bonfoh, B; Aaron, GJ				Rohner, Fabian; Leyvraz, Magali; Konan, Amoin G.; Esso, Lasme J. C. E.; Wirth, James P.; Norte, Augusto; Adiko, Adiko F.; Bonfoh, Bassirou; Aaron, Grant J.			The Potential of Food Fortification to Add Micronutrients in Young Children and Women of Reproductive Age - Findings from a Cross-Sectional Survey in Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; VITAMIN-A; QUANTIFICATION; VALIDATION; TOOL	Poor micronutrient intakes are a major contributing factor to the high burden of micronutrient deficiencies in Cote d'Ivoire. Large-scale food fortification is considered a cost-effective approach to deliver micronutrients, and fortification of salt (iodine), wheat flour (iron and folic acid), and vegetable oil (vitamin A) is mandatory in Cote d'Ivoire. A cross-sectional survey on households with at least one child 6-23 months was conducted to update coverage figures with adequately fortified food vehicles in Abidjan, the capital of and largest urban community in Cote d'Ivoire, and to evaluate whether additional iron and vitamin A intake is sufficient to bear the potential to reduce micronutrient malnutrition. Information on demographics and food consumption was collected, along with samples of salt and oil. Wheat flour was sampled from bakeries and retailers residing in the selected clusters. In Abidjan, 86% and 97% of salt and vegetable oil samples, respectively, were adequately fortified, while only 32% of wheat flour samples were adequately fortified, but all samples contained some added iron. There were no major differences in additional vitamin A and iron intake between poor and non-poor households. For vitamin A in oil, the additional percentage of the recommended nutrient intake was 27% and 40% for children 6-23 months and women of reproductive age, respectively, while for iron from wheat flour, only 13% and 19% could be covered. Compared to previous estimates, coverage has remained stable for salt and wheat flour, but improved for vegetable oil. Fortification of vegetable oil clearly provides a meaningful additional amount of vitamin A. This is not currently the case for iron, due to the low fortification levels. Iron levels in wheat flour should be increased and monitored, and additional vehicles should be explored to add iron to the Ivorian diet.	[Rohner, Fabian; Wirth, James P.; Norte, Augusto] GroundWork, Flaesch, Switzerland; [Leyvraz, Magali; Aaron, Grant J.] Global Alliance Improved Nutr, Geneva, Switzerland; [Konan, Amoin G.; Esso, Lasme J. C. E.; Adiko, Adiko F.; Bonfoh, Bassirou] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Konan, Amoin G.; Esso, Lasme J. C. E.; Adiko, Adiko F.] Univ Felix Houphouet Boigny, Abidjan, Cote Ivoire; [Bonfoh, Bassirou] Univ Basel, Swiss Trop & Publ Hlth Inst, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute	Rohner, F (corresponding author), GroundWork, Flaesch, Switzerland.	fabian@groundworkhealth.org	Rohner, Fabian/I-5088-2019	Rohner, Fabian/0000-0003-0579-6952; Wirth, James P/0000-0002-4733-0379; Rios-Leyvraz, Magali/0000-0003-0455-197X	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Participating respondents are kindly thanked for their time committed to complete the interviews. The field teams are acknowledged for their efforts in conducting the high-quality data collection. Bradley Woodruff provided some greatly appreciated statistical advice. Valentin B. Kone helped prepare survey supplies and coordinate training logistics. This survey was funded by the Bill & Melinda Gates Foundation.	Alkire S, 2014, WORLD DEV, V59, P251, DOI 10.1016/j.worlddev.2014.01.026; [Anonymous], 2011, CIRCULAR AUTORISATIO; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Blencowe H, 2010, INT J EPIDEMIOL, V39, P110, DOI 10.1093/ije/dyq028; Copenhagen consensus, 2012, 3 COP CONS OUTC DOC; Dimova R, 2012, RIGHT PRICE RICE COT; Dubresson A, 1989, EC RURALE, V190, P3; FAO and WHO, 2004, JOINT FAO WHO EXP CO; Food and Agriculture Organization of the United Nations (FAO), 2005, FOOD NUTR BULL, V26, P166; Gaber S, 2013, GLOB PUBLIC HEALTH, V8, P698, DOI 10.1080/17441692.2013.791334; Helen Keller International Institut National de la Sante Publique Global Allliance for Improved Nutrition, 2010, UNPUB; Hess SY, 2013, FOOD NUTR BULL, V34, P21, DOI 10.1177/156482651303400104; INS, 2014, REC GEN POP HAB 2014; Institut National de la Statistique (INS) et ICF International, 2012, ENQ DEM SANT IND MUL; International HK, 2006, ET CONS FAR BLE TREN; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Laillou A, 2013, FOOD NUTR BULL, V34, pS124, DOI 10.1177/15648265130342S114; Renaud C, 2013, INT J VITAM NUTR RES, V83, P122, DOI 10.1024/0300-9831/a000154; Rivera JA, 2008, CHALLENGE HUNGER MAL; Rohner F., 2013, PUBLIC HEALTH NUTR, V15, P1; Rohner F, 2012, FOOD NUTR BULL, V33, pS330, DOI 10.1177/15648265120334S309; Rohner F, 2011, INT J VITAM NUTR RES, V81, P335, DOI 10.1024/0300-9831/a000081; West CE, 1997, FOOD CONSUMPTION NUT; World Health Organization, 2007, WHOIVB0807	24	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158552	10.1371/journal.pone.0158552	http://dx.doi.org/10.1371/journal.pone.0158552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384762	Green Published, gold, Green Accepted			2022-12-26	WOS:000379809400058
J	Metwally, AM; El-Din, EMS; Shehata, MA; Shaalan, A; El Etreby, LA; Kandeel, WA; Shaaban, SY; Rabah, TM				Metwally, Ammal M.; El-Din, Ebtissam M. Salah; Shehata, Manal A.; Shaalan, Ashraf; El Etreby, Lobna A.; Kandeel, Wafaa A.; Shaaban, Sanaa Y.; Rabah, Thanaa M.			Early Life Predictors of Socio-Emotional Development in a Sample of Egyptian Infants	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; BEHAVIOR; BRAIN; CHILDREN; ZINC; OUTCOMES; CONTEXT; SERUM; RISK	Introduction Emotional problems are amongst the most critical concerns to be intentionally handled to enhance the wellbeing and development of children. Objective To determine the predictors of socio-emotional development of Egyptian infants related to infant feeding practices, aspects of infant and maternal health and socioeconomic status. Subjects and Methods A cross-sectional comparative study included 322 breast fed, 240 bottle fed and 93 mixed fed infants, from 6-24 months of age, who were enrolled in the Well-Baby Clinic of the National Research Centre and from pediatric outpatient facilities in urban Cairo. Assessment of socio-emotional development was performed using Bayley Scales of Infant and Toddler Development (Bayley III). Detailed maternal and infant history was recorded. Levels of serum zinc, copper, iron, vitamin B12 and complete blood count (CBC) were assessed in a subsample of 193 infants. Results The risk of having below average socio-emotional composite score was nearly two and half times among formula-fed infants than among breast-fed infants. By binary logistical regression analysis, predictors of below average socio-emotional score were a lower serum zinc value, being formula fed during the first half-year and introduction of complementary food before the age of six months (p< 0.05). Conclusion Exclusive breastfeeding and to a lesser extent mixed feeding during the first half year is correlated with above average socio-emotional development. Maternal education and zinc status were also determinants of better infant mental health. Our endeavors ought to be directed towards integrated interventions addressing multiple risks to children's development.	[Metwally, Ammal M.; El Etreby, Lobna A.; Rabah, Thanaa M.] Natl Res Ctr, Div Med, Dept Community Med Res, Giza, Egypt; [El-Din, Ebtissam M. Salah; Shehata, Manal A.] Natl Res Ctr, Dept Child Hlth, Div Med, Giza, Egypt; [Shaalan, Ashraf; Kandeel, Wafaa A.] Natl Res Ctr, Dept Biol Anthropol, Div Med, Giza, Egypt; [Shaaban, Sanaa Y.] Ain Shams Univ, Dept Pediat, Fac Med, Cairo, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Ain Shams University	Shehata, MA (corresponding author), Natl Res Ctr, Dept Child Hlth, Div Med, Giza, Egypt.	dr_manalabdelkader@hotmail.com	Metwally, Ammal M/A-1531-2016; Salah El-Din, Ebtissam/ABH-2327-2021; Al-Tohamy, Muhammad/B-4273-2016; Shehata, Manal/P-4319-2015	Metwally, Ammal M/0000-0003-0575-5202; Salah El-Din, Ebtissam/0000-0002-3331-8977; Rabah, Thanaa/0000-0002-4383-9450; Al-Tohamy, Muhammad/0000-0001-9368-2570; Shehata, Manal/0000-0001-8749-7010				Allen MC, 2005, AVERYS DIS NEWBORN, P1026; [Anonymous], 2005, CHILD DEV, V76, P795; [Anonymous], 2004, TECHN CONS ASS IR ST; Aylward GP, 2002, MENT RETARD DEV D R, V8, P234, DOI 10.1002/mrdd.10043; Bayley N, 1993, BAYLEY SCALES INFANT; Behrman RE, 2007, PRETERM BIRTH CAUSES; BELL JG, 1987, AM J DIS CHILD, V141, P1128, DOI 10.1001/archpedi.1987.04460100106041; BENDERSKY M, 1994, DEV PSYCHOL, V30, P484, DOI 10.1037/0012-1649.30.4.484; Bornstein MH, 2003, MON PARENT, P29; Bryan J, 2004, NUTR REV, V62, P295, DOI 10.1301/nr.2004.aug.295-306; Bystrova K, 2009, BIRTH-ISS PERINAT C, V36, P97, DOI 10.1111/j.1523-536X.2009.00307.x; Center on the Developing Child at Harvard University, 2010, FDN LIF HLTH AR BUIL; Chilton M, 2007, INDIAN J MED RES, V126, P262; Chou PP, 1987, METHODS CLIN CHEM, P596; CIOMS/WHO, 1993, INT ETH GUID BIOM RE; Damon W., 2006, HDB CHILD PSYCHOL, V3, P226; DARLING N, 1993, PSYCHOL BULL, V113, P487, DOI 10.1037/0033-2909.113.3.487; De Boo HA, 2006, AUST NZ J OBSTET GYN, V46, P4, DOI 10.1111/j.1479-828X.2006.00506.x; Easterbrooks MA, 2012, HDB PSYCHOL; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; Emde R. N., 2005, ZERO 3 DIAGNOSTIC CL; Fergusson DM, 1999, PAEDIATR PERINAT EP, V13, P144; Folio RM., 2000, PEABODY DEV MOTOR SC, V2; Forns J, 2012, GAC SANIT, V26, P397, DOI 10.1016/j.gaceta.2011.10.011; Gardner JMM, 2005, AM J CLIN NUTR, V82, P399, DOI 10.1093/ajcn/82.2.399; Ghosh M, 2008, INDIAN J PEDIATR, V75, P685, DOI 10.1007/s12098-008-0129-z; Goodman E, 2005, J ADOLESCENT HEALTH, V37, P484, DOI 10.1016/j.jadohealth.2004.11.126; Gross J.J., 2014, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Hess SY, 2007, FOOD NUTR BULL, V28, pS403, DOI 10.1177/15648265070283S303; Hinshaw-Fuselier S, 2009, HDB INFANT MENTAL HL; Jain A, 2002, PEDIATRICS, V109, P1044, DOI 10.1542/peds.109.6.1044; Jansen J, 2008, DEV REV, V28, P503, DOI 10.1016/j.dr.2008.07.001; Kelsey JL., 1996, METHODS OBSERVATIONA; Kramer MS, 2008, PEDIATRICS, V121, pE435, DOI 10.1542/peds.2007-1248; Lozoff B, 1998, CHILD DEV, V69, P24, DOI 10.1111/j.1467-8624.1998.tb06130.x; Lozoff B, 1996, J PEDIATR-US, V129, P382, DOI 10.1016/S0022-3476(96)70070-7; Lucas-Thompson RG, 2010, PSYCHOL BULL, V136, P915, DOI 10.1037/a0020875; LUKEMAN D, 1993, J CHILD PSYCHOL PSYC, V34, P837, DOI 10.1111/j.1469-7610.1993.tb01093.x; Marquis GS, 2005, ENCY EARLY CHILDHOOD, P1; McCrory C, 2013, MATERN CHILD HLTH J, V17, P1680, DOI 10.1007/s10995-012-1182-9; McNeilly AS, 1985, MATERNAL NUTRITION L, P1; Moore T, 2012, J PEDIATR-US, V160, P553, DOI 10.1016/j.jpeds.2011.09.047; Murray R. K., 2011, HARPERS ILLUSTRATED; Narvaez D, 2013, EARLY CHILD RES Q, V28, P759, DOI 10.1016/j.ecresq.2013.07.003; OSKI FA, 1980, AM J DIS CHILD, V134, P459, DOI 10.1001/archpedi.1980.02130170009004; PAHO, 2003, GUID PRINC COMPL FEE; Parlakian R., 2003, ABCS PROMOTING SCH R; Perry BD, 1995, INFANT MENT HEALTH J, V16, P271, DOI 10.1002/1097-0355(199524)16:4<271::AID-IMHJ2280160404>3.0.CO;2-B; Posada G, 2002, DEV PSYCHOL, V38, P67, DOI 10.1037//0012-1649.38.1.67; Prado EL, 2012, ALIVE THRIVE TECHNIC; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Quinn KP, 1998, J EMOT BEHAV DISORD, V7, P54; Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689; Raver CC, 2004, CHILD DEV, V75, P346, DOI 10.1111/j.1467-8624.2004.00676.x; Reynolds A, 2001, PEDIATR CLIN N AM, V48, P159, DOI 10.1016/S0031-3955(05)70291-1; Richter Linda, 2004, IMPORTANCE CAREGIVER; Roy A, 2009, ENVIRON HEALTH PERSP, V117, P1607, DOI 10.1289/ehp.0900625; Saarni C., 1998, P237; Morris AS, 2007, SOC DEV, V16, P361, DOI 10.1111/j.1467-9507.2007.00389.x; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; Shonkoff J.P., 2000, NEURONS NEIGHBORHOOD; Swain JE, 2007, J CHILD PSYCHOL PSYC, V48, P262, DOI 10.1111/j.1469-7610.2007.01731.x; TAYLOR A, 1981, CLIN CHIM ACTA, V110, P83, DOI 10.1016/0009-8981(81)90304-1; The World Health Organization, 2008, FOOD NUTR B, V29; Thompson R.A., 2008, HDB ATTACHMENT THEOR, V2nd ed., P348; Thompson RA, 2010, MORAL PERSONALITY ID; Tomasello M, 2007, DEVELOPMENTAL SCI, V10, P121, DOI 10.1111/j.1467-7687.2007.00573.x; von der Lippe AL, 1999, INT J BEHAV DEV, V23, P703, DOI 10.1080/016502599383766; Wachs TD, 2009, CHILD HLTH ED, V1, P107; Wachs Theodore D., 2005, Food and Nutrition Bulletin, V26, pS159; Walker SP, INEQUALITY EARLY CHI; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WALTER T, 1989, PEDIATRICS, V84, P7; WHO, 2011, WHO TECH REP SER, V959, P1; WHO/UNICEF, 1998, WHONUT981 UNICEF; WHO-AIMS, 2006, REP MENT HLTH SYST E; Williams KR, 2003, J INTELL DISABIL RES, V47, P291, DOI 10.1046/j.1365-2788.2003.00491.x; World Health Organization,, 2012, RISKS MENT HLTH OV V; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization (WHO), 2001, 542 WHO WHA, V54.2; ZEITLIN MF, 1995, EARLY HUM DEV, V41, P97, DOI 10.1016/0378-3782(94)01612-S; Zimmerman I.L., 2002, PRESCHOOL LANGUAGE S	82	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158086	10.1371/journal.pone.0158086	http://dx.doi.org/10.1371/journal.pone.0158086			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379907	Green Published, gold, Green Submitted			2022-12-26	WOS:000379798700019
J	Palanisamy, A; Friese, MB; Cotran, E; Moller, L; Boyd, JD; Crosby, G; Culley, DJ				Palanisamy, Arvind; Friese, Matthew B.; Cotran, Emily; Moller, Ludde; Boyd, Justin D.; Crosby, Gregory; Culley, Deborah J.			Prolonged Treatment with Propofol Transiently Impairs Proliferation but Not Survival of Rat Neural Progenitor Cells In Vitro	PLOS ONE			English	Article							TERM COGNITIVE IMPAIRMENT; CARE-UNIT PATIENTS; ADULT NEUROGENESIS; DENTATE GYRUS; STEM-CELLS; CRITICAL ILLNESS; AGED RATS; HIPPOCAMPAL-NEURONS; SPATIAL MEMORY; A RECEPTOR	Neurocognitive dysfunction is common in survivors of intensive care. Prolonged sedation has been implicated but the mechanisms are unclear. Neurogenesis continues into adulthood and is implicated in learning. The neural progenitor cells (NPC) that drive neurogenesis have receptors for the major classes of sedatives used clinically, suggesting that interruption of neurogenesis may partly contribute to cognitive decline in ICU survivors. Using an in vitro system, we tested the hypothesis that prolonged exposure to propofol concentration- and duration-dependently kills or markedly decreases the proliferation of NPCs. NPCs isolated from embryonic day 14 Sprague-Dawley rat pups were exposed to 0, 2.5, or 5.0 mu g/ mL of propofol, concentrations consistent with deep clinical anesthesia, for either 4 or 24 hours. Cells were assayed for cell death and proliferation either immediately following propofol exposure or 24 hours later. NPC death and apoptosis were measured by propidium iodine staining and cleaved caspase-3 immunocytochemistry, respectively, while proliferation was measured by EdU incorporation. Staurosporine (1 mu M for 6h) was used as a positive control for cell death. Cells were analyzed with unbiased high-throughput immunocytochemistry. There was no cell death at either concentration of propofol or duration of exposure. Neither concentration of propofol impaired NPC proliferation when exposure lasted 4 h, but when exposure lasted 24 h, propofol had an anti-proliferative effect at both concentrations (P < 0.0001, propofol vs. control). However, this effect was transient; proliferation returned to baseline 24 h after discontinuation of propofol (P = 0.37, propofol vs. control). The transient but reversible suppression of NPC proliferation, absence of cytotoxicity, and negligible effect on the neural stem cell pool pool suggest that propofol, even in concentrations used for clinical anesthesia, has limited impact on neural progenitor cell biology.	[Palanisamy, Arvind; Friese, Matthew B.; Cotran, Emily; Crosby, Gregory; Culley, Deborah J.] Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA; [Moller, Ludde] Uppsala Univ, Fac Pharm, Dept Pharmaceut Biosci, Uppsala, Sweden; [Boyd, Justin D.] Harvard Med Sch, LDDN, Harvard NeuroDiscovery Ctr, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Uppsala University; Harvard University	Palanisamy, A (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA USA.	apalanisamy@bwh.harvard.edu	Crosby, Gregory/N-6578-2019	Friese, Matthew/0000-0001-7410-285X; Boyd, Justin/0000-0002-5197-4724	NIH [GM088817]; NIH T32 training grant [5T32GM007592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088817, T32GM007592] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T32 training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH GM088817 to GC, and NIH grant to DC. MBF was supported by a NIH T32 training grant (5T32GM007592) to the Harvard Medical School Department of Anesthesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Marcie A. Glicksman, PhD, Director, Leads Discovery, Laboratory for Drug Discovery in Neurodegeneration (LDDN), Harvard NeuroDiscovery Center, Harvard Medical School, Brigham & Women's Hospital, Cambridge, MA for her helpful comments and advice on high-content screening. The work was supported by NIH GM088817 to GC. MBF was supported by a NIH T32 training grant (5T32GM007592) to the Harvard Medical School Department of Anesthesia	Aimone JB, 2011, NEURON, V70, P589, DOI 10.1016/j.neuron.2011.05.010; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Barr J, 2001, ANESTHESIOLOGY, V95, P324, DOI 10.1097/00000542-200108000-00011; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Brann JH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00182; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Casati A, 1999, ANESTH ANALG, V88, P917, DOI 10.1097/00000539-199904000-00043; Cattano D, 2008, ANESTH ANALG, V106, P1712, DOI 10.1213/ane.0b013e318172ba0a; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Creeley C, 2013, BRIT J ANAESTH, V110, P29, DOI 10.1093/bja/aet173; Culley DJ, 2013, BRIT J ANAESTH, V110, P19, DOI 10.1093/bja/aet169; Culley DJ, 2011, ANESTHESIOLOGY, V115, P754, DOI 10.1097/ALN.0b013e318223b78b; Culley DJ, 2004, ANESTHESIOLOGY, V100, P309, DOI 10.1097/00000542-200402000-00020; Djaiani G, 2016, ANESTHESIOLOGY, V124, P362, DOI 10.1097/ALN.0000000000000951; Dong CX, 2012, CRIT CARE MED, V40, P2407, DOI 10.1097/CCM.0b013e318253563c; Drew LJ, 2013, LEARN MEMORY, V20, P710, DOI 10.1101/lm.026542.112; Encinas JM, 2012, BEHAV BRAIN RES, V227, P433, DOI 10.1016/j.bbr.2011.10.010; Erasso DM, 2013, BRAIN RES, V1530, P1, DOI 10.1016/j.brainres.2013.07.035; Erasso DM, 2012, BRAIN RES, V1441, P38, DOI 10.1016/j.brainres.2011.11.025; Feliciano DM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018846; Fiset P, 1999, J NEUROSCI, V19, P5506; Fredriksson A, 2007, ANESTHESIOLOGY, V107, P427, DOI 10.1097/01.anes.0000278892.62305.9c; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Gunther ML, 2007, CRIT CARE CLIN, V23, P491, DOI 10.1016/j.ccc.2007.07.001; Hopkins RO, 2012, AM J RESP CRIT CARE, V186, P1220, DOI 10.1164/rccm.201206-1022CP; Hughes CG, 2011, ANESTH ANALG, V112, P1212, DOI 10.1213/ANE.0b013e318215366d; Iwakiri H, 2005, ANESTH ANALG, V100, P107, DOI 10.1213/01.ANE.0000139358.15909.EA; Kempermann G, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018929; Kim WR, 2012, BEHAV BRAIN RES, V227, P470, DOI 10.1016/j.bbr.2011.07.012; Krzisch M, 2013, ANESTHESIOLOGY, V118, P602, DOI 10.1097/ALN.0b013e3182815948; Lee IH, 2008, ANESTH ANALG, V107, P1211, DOI 10.1213/ane.0b013e31817ee879; Li Y, 2012, P NATL ACAD SCI USA, V109, P4290, DOI 10.1073/pnas.1120754109; Liu F, 2014, NEUROTOXICOLOGY, V42, P49, DOI 10.1016/j.neuro.2014.03.011; Lonardo NW, 2014, AM J RESP CRIT CARE, V189, P1383, DOI 10.1164/rccm.201312-2291OC; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Marin-Burgin A, 2012, BEHAV BRAIN RES, V227, P391, DOI 10.1016/j.bbr.2011.07.001; Masica Andrew L, 2007, Am J Geriatr Pharmacother, V5, P218, DOI 10.1016/j.amjopharm.2007.10.005; Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mongiat LA, 2011, EUR J NEUROSCI, V33, P1055, DOI 10.1111/j.1460-9568.2011.07603.x; Pallotto M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00166; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Patel SB, 2012, AM J RESP CRIT CARE, V185, P486, DOI 10.1164/rccm.201102-0273CI; Pearn ML, 2012, ANESTHESIOLOGY, V116, P352, DOI 10.1097/ALN.0b013e318242a48c; Rigouzzo A, 2008, ANESTH ANALG, V106, P1109, DOI 10.1213/ane.0b013e318164f388; Sakamoto M, 2014, J NEUROSCI, V34, P5788, DOI 10.1523/JNEUROSCI.0674-14.2014; Sall JW, 2012, ANESTHESIOLOGY, V117, P1080, DOI 10.1097/ALN.0b013e31826f8d86; Sall JW, 2009, ANESTHESIOLOGY, V110, P826, DOI 10.1097/ALN.0b013e31819b62e2; Shyr MH, 1997, ANESTH ANALG, V84, P1344, DOI 10.1097/00000539-199706000-00031; SHYR MH, 1995, NEUROSCI LETT, V184, P212, DOI 10.1016/0304-3940(94)11209-2; Spahr-Schopfer I, 2000, ANESTHESIOLOGY, V92, P1408, DOI 10.1097/00000542-200005000-00032; Stratmann G, 2009, ANESTHESIOLOGY, V110, P834, DOI 10.1097/ALN.0b013e31819c463d; Tao T, 2013, J NEUROSURG ANESTH, V25, P299, DOI 10.1097/ANA.0b013e31828baa93; Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335; Twaroski DM, 2015, ANESTHESIOLOGY, V123, P1067, DOI 10.1097/ALN.0000000000000857; Vivar C, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00015; Wang DD, 2009, J PHYSIOL-LONDON, V587, P1873, DOI 10.1113/jphysiol.2008.167635; Wang JW, 2015, GENET MOL RES, V14, P14920, DOI 10.4238/2015.November.18.57; Woon FL, 2012, AM J RESP CRIT CARE, V186, P333, DOI 10.1164/rccm.201112-2261OC; Wunsch H, 2009, CRIT CARE MED, V37, P3031, DOI 10.1097/CCM.0b013e3181b02eff; Zhong YL, 2014, CELL BIOCHEM FUNCT, V32, P720, DOI 10.1002/cbf.3077; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274; Zou WW, 2013, MOL MED REP, V7, P1123, DOI 10.3892/mmr.2013.1298	64	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158058	10.1371/journal.pone.0158058	http://dx.doi.org/10.1371/journal.pone.0158058			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379684	gold, Green Published, Green Submitted			2022-12-26	WOS:000379798700017
J	Stein, R; Kapplusch, F; Heymann, MC; Russ, S; Staroske, W; Hedrich, CM; Rosen-Wolff, A; Hofmann, SR				Stein, Robert; Kapplusch, Franz; Heymann, Michael Christian; Russ, Susanne; Staroske, Wolfgang; Hedrich, Christian Michael; Roesen-Wolff, Angela; Hofmann, Sigrun Ruth			Enzymatically Inactive Procaspase 1 stabilizes the ASC Pyroptosome and Supports Pyroptosome Spreading during Cell Division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						caspase 1 (CASP1); imaging; inflammasome; IL-1; NLRP3; ASC; IL-1; apoptosis-associated speck-like protein containing a CARD; interleukin 1-converting enzyme; pyroptosome	NF-KAPPA-B; NLRP3 INFLAMMASOME ACTIVATION; CONTAINING APAF1-LIKE PROTEIN; REGULATES ACTIVATION; MURINE MACROPHAGES; CONVERTING-ENZYME; CUTTING EDGE; ADAPTER ASC; CASPASE-1; DEATH	Caspase-1 is a key player during the initiation of pro-inflammatory innate immune responses, activating pro-IL-1 in so-called inflammasomes. A subset of patients with recurrent febrile episodes and systemic inflammation of unknown origin harbor mutations in CASP1 encoding caspase-1. CASP1 variants result in reduced enzymatic activity of caspase-1 and impaired IL-1 secretion. The apparent paradox of reduced IL-1 secretion but systemic inflammation led to the hypothesis that CASP1 mutations may result in variable protein interaction clusters, thus activating alternative signaling pathways. To test this hypothesis, we established and characterized an in vitro system of transduced immortalized murine macrophages expressing either WT or enzymatically inactive (p.C284A) procaspase-1 fusion reporter proteins. Macrophages with variant p.C284A caspase-1 did not secrete IL-1 and exhibited reduced inflammatory cell death, referred to as pyroptosis. Caspase-1 and apoptosis-associated speck-like protein containing a CARD (ASC) formed cytosolic macromolecular complexes (so-called pyroptosomes) that were significantly increased in number and size in cells carrying the p.C284A caspase-1 variant compared with WT caspase-1. Furthermore, enzymatically inactive caspase-1 interacted with ASC longer and with increased intensity compared with WT caspase-1. Applying live cell imaging, we documented for the first time that pyroptosomes containing enzymatically inactive variant p.C284A caspase-1 spread during cell division. In conclusion, variant p.C284A caspase-1 stabilizes pyroptosome formation, potentially enhancing inflammation by two IL-1-independent mechanisms: pyroptosomes convey an enhanced inflammatory stimulus through the recruitment of additional proteins (such as RIP2, receptor interacting protein kinase 2), which is further amplified through pyroptosome and cell division.	[Stein, Robert; Kapplusch, Franz; Heymann, Michael Christian; Russ, Susanne; Hedrich, Christian Michael; Roesen-Wolff, Angela; Hofmann, Sigrun Ruth] Tech Univ Dresden, Med Fak Carl Gustav Carus, Dept Pediat, D-01307 Dresden, Germany; [Staroske, Wolfgang] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Hofmann, SR (corresponding author), Univ Hosp Carl Gustav Carus, Dept Pediat, Fetscherstr 74, D-01307 Dresden, Germany.	sigrun.hofmann@uniklinikum-dresden.de	Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020	Stein, Robert/0000-0003-0896-9943; Hedrich, Christian/0000-0002-1295-6179	German Research Foundation (DFG) [KFO249, HO4510/1-2, RO/471-11]; Else Kroner Fresenius Stiftung (Else-Kroner-Promotionskolleg); Else Kroner Fresenius Stiftung (EKFS Foundation)	German Research Foundation (DFG)(German Research Foundation (DFG)); Else Kroner Fresenius Stiftung (Else-Kroner-Promotionskolleg); Else Kroner Fresenius Stiftung (EKFS Foundation)	This work was supported by German Research Foundation (DFG) Grants KFO249, TP2, HO4510/1-2 (to S. R. H.) and TP1 and RO/471-11 (to A. R. W.) and the Else Kroner Fresenius Stiftung (Else-Kroner-Promotionskolleg, EKFS Foundation) (to R. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Aachoui Y, 2013, CURR OPIN MICROBIOL, V16, P319, DOI 10.1016/j.mib.2013.04.004; Abdelaziz DHA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00018; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; BLASI E, 1987, EUR J IMMUNOL, V17, P1491, DOI 10.1002/eji.1830171016; Broz P, 2016, CELL RES, V26, P859, DOI 10.1038/cr.2016.67; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Broz P, 2015, NATURE, V526, P642, DOI 10.1038/nature15632; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Dick MS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11929; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandez DJ, 2015, BIOL CHEM, V396, P193, DOI 10.1515/hsz-2014-0253; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Hauenstein AV, 2015, CURR OPIN STRUC BIOL, V31, P75, DOI 10.1016/j.sbi.2015.03.014; Heymann M. C., 2011, J GENET SYNDR GENE S, V3, P1; Heymann MC, 2015, CLIN IMMUNOL, V160, P172, DOI 10.1016/j.clim.2015.05.011; Heymann MC, 2014, J IMMUNOL, V192, P4379, DOI 10.4049/jimmunol.1203524; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kayalar C, 1996, P NATL ACAD SCI USA, V93, P2234, DOI 10.1073/pnas.93.5.2234; Kersse K, 2011, J BIOL CHEM, V286, P35874, DOI 10.1074/jbc.M111.242321; Kolly L, 2009, J IMMUNOL, V183, P4003, DOI 10.4049/jimmunol.0802173; Lakowicz J. R., 2010, PRINCIPLES FLUORESCE, P367; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; Lu A, 2015, FEBS J, V282, P435, DOI 10.1111/febs.13133; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Luksch H, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0520-5; Luksch H, 2013, HUM MUTAT, V34, P122, DOI 10.1002/humu.22169; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martin BN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5977; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Misawa T, 2013, NAT IMMUNOL, V14, P454, DOI 10.1038/ni.2550; Ruhl S, 2015, EUR J IMMUNOL, V45, P2927, DOI 10.1002/eji.201545772; Sarkar A, 2006, J IMMUNOL, V176, P4979, DOI 10.4049/jimmunol.176.8.4979; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Stoffels M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00054; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Taxman DJ, 2011, J BIOL CHEM, V286, P19605, DOI 10.1074/jbc.M111.221077; Wang L, 2002, J BIOL CHEM, V277, P29874, DOI 10.1074/jbc.M203915200; WILSON KP, 1994, NATURE, V370, P270, DOI 10.1038/370270a0; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Zhang L, 2014, HEPATOB PANCREAT DIS, V13, P138, DOI 10.1016/S1499-3872(14)60024-2	54	9	9	3	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18419	18429		10.1074/jbc.M116.718668	http://dx.doi.org/10.1074/jbc.M116.718668			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402835	Green Published, hybrid			2022-12-26	WOS:000383241800032
J	Ferguson, R; Subramanian, V				Ferguson, Ross; Subramanian, Vasanta			PA6 Stromal Cell Co-Culture Enhances SH-SY5Y and VSC4.1 Neuroblastoma Differentiation to Mature Phenotypes	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NEURO-BLASTOMA CELLS; EMBRYONIC STEM-CELLS; DOPAMINERGIC-NEURONS; HUMAN ANGIOGENIN; RETINOIC ACID; LINE; GROWTH; IMMUNOGLOBULINS; VARIANTS	Neuroblastoma cell lines such as SH-SY5Y have been used for modelling neurodegenerative diseases and for studying basic mechanisms in neuroscience. Since neuroblastoma cells proliferate and generally do not express markers of mature or functional neurons, we exploited a co-culture system with the stromal cell line PA6 to better induce differentiation to a more physiologically relevant status. We found that co-culture of the neuroblastoma cell lines in the presence of neural inducers such retinoic acid was able to generate a high proportion of quiescent neurons with very long neurites expressing differentiation markers. The co-culture system additionally cuts short the time taken to produce a more mature phenotype. We also show the application of this system to study proteins implicated in motor neuron disease.	[Ferguson, Ross; Subramanian, Vasanta] Univ Bath, Dept Biol & Biochem, Bath, Avon, England	University of Bath	Subramanian, V (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.	V.Subramanian@bath.ac.uk			NC3Rs-National Centre for the Replacement, Refinement and Reduction of Animals in Research [G0900786]; NC3R'S, UK; National Centre for the Replacement [G0900786/1] Funding Source: researchfish	NC3Rs-National Centre for the Replacement, Refinement and Reduction of Animals in Research; NC3R'S, UK; National Centre for the Replacement	This work was funded by a NC3Rs-National Centre for the Replacement, Refinement and Reduction of Animals in Research, grant to VS, grant number G0900786, http://www.nc3rs.org.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to gratefully acknowledge the Developmental Studies Hybridoma Bank, Iowa, USA, for the 2H3 and rat 401 monoclonal antibodies and the NC3R'S, UK, for funding.	ADEM A, 1987, DEV BRAIN RES, V33, P235, DOI 10.1016/0165-3806(87)90156-8; ALEXIANU ME, 1994, J NEUROCHEM, V63, P2365; BIEDLER JL, 1973, CANCER RES, V33, P2643; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; CICCARONE V, 1989, CANCER RES, V49, P219; Constantinescu R, 2007, J NEURAL TRANSM-SUPP, P17; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Greenway MJ, 2004, NEUROLOGY, V63, P1936, DOI 10.1212/01.WNL.0000144344.39103.F6; Guloglu MO, 2014, J NEUROSCI RES, V92, P564, DOI 10.1002/jnr.23355; Inoka S, 2007, FASEB J, V21, P912; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Knaryan VH, 2014, J NEUROCHEM, V130, P280, DOI 10.1111/jnc.12629; KODAMA HA, 1982, J CELL PHYSIOL, V112, P83, DOI 10.1002/jcp.1041120113; Korecka JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063862; Kwon YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085736; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Lyuh E, 2007, GROWTH HORM IGF RES, V17, P315, DOI 10.1016/j.ghir.2007.03.002; PAHLMAN S, 1983, CELL DIFFER DEV, V12, P165, DOI 10.1016/0045-6039(83)90006-4; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; Presgraves SP, 2004, NEUROTOX RES, V5, P579, DOI 10.1007/bf03033178; Razavi S, 2013, BIOCHEM BIOPH RES CO, V440, P381, DOI 10.1016/j.bbrc.2013.09.069; ROSS RA, 1983, J NATL CANCER I, V71, P741; SMITH RG, 1994, P NATL ACAD SCI USA, V91, P3393, DOI 10.1073/pnas.91.8.3393; Storch A, 2000, J NEUROCHEM, V75, P2259, DOI 10.1046/j.1471-4159.2000.0752259.x; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095; Thiyagarajan N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2126; Vazin T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006606; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Zeng XM, 2004, STEM CELLS, V22, P925, DOI 10.1634/stemcells.22-6-925	30	11	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159051	10.1371/journal.pone.0159051	http://dx.doi.org/10.1371/journal.pone.0159051			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391595	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400201
J	Nogusa, S; Slifker, MJ; Ingram, JP; Thapa, RJ; Balachandran, S				Nogusa, Shoko; Slifker, Michael J.; Ingram, Justin P.; Thapa, Roshan J.; Balachandran, Siddharth			RIPK3 Is Largely Dispensable for RIG-I-Like Receptor- and Type I Interferon-Driven Transcriptional Responses to Influenza A Virus in Murine Fibroblasts	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; PROGRAMMED NECROSIS; NLRP3 INFLAMMASOME; RECOGNITION; ACTIVATION; PROTEIN; SIGNAL; IRF-7; CELL	The kinase RIPK3 is a key regulator of cell death responses to a growing number of viral and microbial agents. We have found that influenza A virus (IAV)-mediated cell death is largely reliant on RIPK3 and that RIPK3-deficient mice are notably more susceptible to lethal infection by IAV than their wild-type counterparts. Recent studies demonstrate that RIPK3 also participates in regulating gene transcription programs during host pro-inflammatory and innate-immune responses, indicating that this kinase is not solely an inducer of cell death and that RIPK3-driven transcriptional responses may collaborate with cell death in promoting clearance of IAV. Here, we carried out DNA microarray analyses to determine the contribution of RIPK3 to the IAV-elicited host transcriptional response. We report that RIPK3 does not contribute significantly to the RLR-activated transcriptome or to the induction of type I IFN genes, although, interestingly, IFN-beta production at a post-transcriptional step was modestly attenuated in IAV-infected ripk3(-/-) fibroblasts. Overall, RIPK3 regulated the expression of <5% of the IAV-induced transcriptome, and no genes were found to be obligate RIPK3 targets. IFN-beta signaling was also found to be largely normal in the absence of RIPK3. Together, these results indicate that RIPK3 is not essential for the host antiviral transcriptional response to IAV in murine fibroblasts.	[Nogusa, Shoko; Ingram, Justin P.; Thapa, Roshan J.; Balachandran, Siddharth] Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Slifker, Michael J.] Fox Chase Canc Ctr, Dept Bioinformat & Biostat, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Balachandran, S (corresponding author), Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	siddharth.balachandran@fccc.edu			National Institutes of Health [CA168621, AI113469]; National Institutes of Health Cancer Center Support Grant [P30CA006927]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA168621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113469] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants CA168621 and AI113469 to SB. Additional funds were provided by National Institutes of Health Cancer Center Support Grant P30CA006927 and an appropriation from the Commonwealth of Pennsylvania (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Vishva Dixit for providing ripk3<SUP>-/-</SUP> mice, and to Luis Sigal for supplying mavs<SUP>-/-</SUP> and ifnar1<SUP>-/-</SUP> mice. We also thank John Bertin and Peter Gough for RIPK3 inhibitor GSK'872 and Paul Thomas for PR8-Delta NS1 virus. We gratefully acknowledge Yuesheng Li and Suraj Peri for processing microarray samples, and for bioinformatic support, respectively. This work was supported by National Institutes of Health grants CA168621 and AI113469 to SB. Additional funds were provided by National Institutes of Health Cancer Center Support Grant P30CA006927 and an appropriation from the Commonwealth of Pennsylvania (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Basagoudanavar SH, 2011, J VIROL, V85, P2599, DOI 10.1128/JVI.02213-10; Chen P., 2013, J APPL CHEM, V2013, P1, DOI DOI 10.1155/2013/424253; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Kang TB, 2014, METHOD ENZYMOL, V545, P67, DOI 10.1016/B978-0-12-801430-1.00003-2; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Krug RM, 2015, CURR OPIN VIROL, V12, P1, DOI 10.1016/j.coviro.2015.01.007; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Nogusa S, 2016, CELL HOST M IN PRESS; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sridharan H, 2014, TRENDS MICROBIOL, V22, P199, DOI 10.1016/j.tim.2014.01.005; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Wang XQ, 2014, NAT IMMUNOL, V15, P1126, DOI 10.1038/ni.3015; Weinlich R, 2014, MOL CELL, V56, P469, DOI 10.1016/j.molcel.2014.11.001; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	29	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158774	10.1371/journal.pone.0158774	http://dx.doi.org/10.1371/journal.pone.0158774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391363	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400121
J	Shin, SY; Kim, T; Seo, DW; Sohn, CH; Kim, SH; Ryoo, SM; Lee, YS; Lee, JH; Kim, WY; Lim, KS				Shin, Soo-Yong; Kim, Taerim; Seo, Dong-Woo; Sohn, Chang Hwan; Kim, Sung-Hoon; Ryoo, Seung Mok; Lee, Yoon-Seon; Lee, Jae Ho; Kim, Won Young; Lim, Kyoung Soo			Correlation between National Influenza Surveillance Data and Search Queries from Mobile Devices and Desktops in South Korea	PLOS ONE			English	Article							TWITTER	Background Digital surveillance using internet search queries can improve both the sensitivity and timeliness of the detection of a health event, such as an influenza outbreak. While it has recently been estimated that the mobile search volume surpasses the desktop search volume and mobile search patterns differ from desktop search patterns, the previous digital surveillance systems did not distinguish mobile and desktop search queries. The purpose of this study was to compare the performance of mobile and desktop search queries in terms of digital influenza surveillance. Methods and Results The study period was from September 6, 2010 through August 30, 2014, which consisted of four epidemiological years. Influenza-like illness (ILI) and virologic surveillance data from the Korea Centers for Disease Control and Prevention were used. A total of 210 combined queries from our previous survey work were used for this study. Mobile and desktop weekly search data were extracted from Naver, which is the largest search engine in Korea. Spearman's correlation analysis was used to examine the correlation of the mobile and desktop data with ILI and virologic data in Korea. We also performed lag correlation analysis. We observed that the influenza surveillance performance of mobile search queries matched or exceeded that of desktop search queries over time. The mean correlation coefficients of mobile search queries and the number of queries with an r-value of >= 0.7 equaled or became greater than those of desktop searches over the four epidemiological years. A lag correlation analysis of up to two weeks showed similar trends. Conclusion Our study shows that mobile search queries for influenza surveillance have equaled or even become greater than desktop search queries over time. In the future development of influenza surveillance using search queries, the recognition of changing trend of mobile search data could be necessary.	[Shin, Soo-Yong; Lee, Jae Ho] Asan Med Ctr, Dept Biomed Informat, Seoul 138736, South Korea; [Kim, Taerim; Seo, Dong-Woo; Sohn, Chang Hwan; Ryoo, Seung Mok; Lee, Yoon-Seon; Lee, Jae Ho; Kim, Won Young; Lim, Kyoung Soo] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul 138736, South Korea; [Kim, Sung-Hoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Anesthesiol & Pain Med, Seoul 138736, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Seo, DW (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Emergency Med, Seoul 138736, South Korea.	leiseo@gmail.com		Ryoo, Seung Mok/0000-0002-2436-3311				Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0; Baeza-Yates R, 2007, STUDY MOBILE SEARCH, DOI DOI 10.1109/IZS.2008.4497268; Bernardo TM, 2013, J MED INTERNET RES, V15, P239, DOI 10.2196/jmir.2740; Broniatowski DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083672; Brownstein J.S., 2010, NEW ENGL J MED, V362, P1731, DOI DOI 10.1056/NEJMSR1002707; Cho S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081422; Church K, 2008, P 10; Church K., 2011, P INT C HUMAN COMPUT, P67, DOI [DOI 10.1145/2037373.2037385, 10.1145/2037373.2037385]; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Generous N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003892; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Hulth A, 2011, EURO SURVEILL, V16; Hulth A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-252; Irvin CB, 2003, ANN EMERG MED, V41, P447, DOI 10.1067/mem.2003.104; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kamvar M, 2009, COMPUTERS IPHONES MO; Kamvar M, 2006, LARGE SCALE STUDY WI; Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506; Li J, 2009, GOOD ABANDONMENT MOB; McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581; Milinovich GJ, 2014, LANCET INFECT DIS, V14, P160, DOI 10.1016/S1473-3099(13)70244-5; Morse SS, 2012, BIOSECUR BIOTERROR, V10, P6, DOI 10.1089/bsp.2011.0088; Nagar R, 2014, J MED INTERNET RES, V16, P260, DOI 10.2196/jmir.3416; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Santillana M, 2014, AM J PREV MED, V47, P341, DOI 10.1016/j.amepre.2014.05.020; Santos JC, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-S1-S6; Seo Dong-Woo, 2014, J Med Internet Res, V16, pe289, DOI 10.2196/jmir.3680; Soler MS, 2011, LANCET, V378, P1833, DOI 10.1016/S0140-6736(11)60834-9; Valdivia A, 2010, EURO SURVEILL, V15	30	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158539	10.1371/journal.pone.0158539	http://dx.doi.org/10.1371/journal.pone.0158539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391028	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400078
J	Wilson, D; Moehlis, J				Wilson, Dan; Moehlis, Jeff			Toward a More Efficient Implementation of Antifibrillation Pacing	PLOS ONE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; CARDIAC TISSUE; VENTRICULAR-TACHYCARDIA; ATRIAL-FIBRILLATION; EXCITABLE MEDIA; SPIRAL WAVES; TRANSTHORACIC DEFIBRILLATION; BIDOMAIN EQUATIONS; MONOPHASIC SHOCKS; HEART	We devise a methodology to determine an optimal pattern of inputs to synchronize firing patterns of cardiac cells which only requires the ability to measure action potential durations in individual cells. In numerical bidomain simulations, the resulting synchronizing inputs are shown to terminate spiral waves with a higher probability than comparable inputs that do not synchronize the cells as strongly. These results suggest that designing stimuli which promote synchronization in cardiac tissue could improve the success rate of defibrillation, and point towards novel strategies for optimizing antifibrillation pacing.	[Wilson, Dan; Moehlis, Jeff] Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Wilson, D (corresponding author), Univ Calif Santa Barbara, Dept Mech Engn, Santa Barbara, CA 93106 USA.	dan.d.wilson8@gmail.com			National Science Foundation [NSF-1363243]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation, NSF-1363243 (http://www.nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for this work by National Science Foundation Grant NSF-1363243 is gratefully acknowledged.	Ambrosi CM, 2011, HEART RHYTHM, V8, P101, DOI 10.1016/j.hrthm.2010.10.018; [Anonymous], 2008, INTRO PROBABILITY TH; Bell N, 2013, CUSP GENERIC PARALLE; Bilge AK, 2006, PACE, V29, P619, DOI 10.1111/j.1540-8159.2006.00409.x; Bittihn P, 2010, PHILOS T R SOC A, V368, P2221, DOI 10.1098/rsta.2010.0038; Cherry EM, 2008, J THEOR BIOL, V254, P674, DOI 10.1016/j.jtbi.2008.06.030; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; Cysyk J, 2008, BIOPHYS J, V94, P1533, DOI 10.1529/biophysj.107.116244; Dillon SM, 1998, J CARDIOVASC ELECTR, V9, P529, DOI 10.1111/j.1540-8167.1998.tb01847.x; DiMarco JP, 2003, NEW ENGL J MED, V349, P1836, DOI 10.1056/NEJMra035432; Dosdall DJ, 2010, ANNU REV BIOMED ENG, V12, P233, DOI [10.1146/annurev-bioeng-070909-105305, 10.1146/armurev-bioeng-070909-105305]; Dreyfus S. E., 1962, APPL DYNAMIC PROGRAM; Duncan OD, 1955, AM J SOCIOL, V60, P493, DOI 10.1086/221609; Efimov IR, 2004, CIRC RES, V95, P21, DOI 10.1161/01.RES.0000130529.18016.35; Epstein AE, 1998, CIRCULATION, V98, P1517, DOI 10.1161/01.CIR.98.15.1517; ERMENTROUT GB, 1991, J MATH BIOL, V29, P195, DOI 10.1007/BF00160535; Faddy SC, 2003, RESUSCITATION, V58, P9, DOI 10.1016/S0300-9572(03)00077-7; Fast VG, 1998, CIRC RES, V82, P375, DOI 10.1161/01.RES.82.3.375; Fenton FH, 2009, CIRCULATION, V120, P467, DOI 10.1161/CIRCULATIONAHA.108.825091; Fishler MG, 2000, IEEE T BIO-MED ENG, V47, P59, DOI 10.1109/10.817620; Gray RA, 2005, P NATL ACAD SCI USA, V102, P4672, DOI 10.1073/pnas.0407860102; Hooks DA, 2002, CIRC RES, V91, P331, DOI 10.1161/01.RES.0000031957.70034.89; HOPPENSTEADT F, 1997, WEAKLY CONNECTED NEU; Ichinose N, 1998, INT J BIFURCAT CHAOS, V8, P2375, DOI 10.1142/S021812749800190X; IDEKER RE, 1995, PACE, V18, P512, DOI 10.1111/j.1540-8159.1995.tb02562.x; Jacq F, 2009, GEN HOSP PSYCHIAT, V31, P266, DOI 10.1016/j.genhosppsych.2009.01.003; Karma A, 1994, CHAOS, V4, P461, DOI 10.1063/1.166024; Keener JP, 1998, CHAOS, V8, P234, DOI 10.1063/1.166300; Kirk DE., 1998, OPTIMAL CONTROL THEO; Kroll MW, 2007, J INTERV CARD ELECTR, V18, P247, DOI 10.1007/s10840-007-9095-z; KROLL MW, 1994, PACE, V17, P1782, DOI 10.1111/j.1540-8159.1994.tb03746.x; Kuck KH, 2000, CIRCULATION, V102, P748, DOI 10.1161/01.CIR.102.7.748; Laughner JI, 2012, AM J PHYSIOL-HEART C, V303, pH753, DOI 10.1152/ajpheart.00404.2012; Li DS, 1999, CIRCULATION, V100, P87, DOI 10.1161/01.CIR.100.1.87; Li WW, 2009, HEART RHYTHM, V6, P1020, DOI 10.1016/j.hrthm.2009.03.015; Luther S, 2011, NATURE, V475, P235, DOI 10.1038/nature10216; PLONSEY R, 1986, MED BIOL ENG COMPUT, V24, P130, DOI 10.1007/BF02443925; PLONSEY R, 1982, BIOPHYS J, V39, P309, DOI 10.1016/S0006-3495(82)84521-9; Rabinovitch A, 1999, CHAOS, V9, P880, DOI 10.1063/1.166460; Ripplinger CM, 2006, AM J PHYSIOL-HEART C, V291, pH184, DOI 10.1152/ajpheart.01300.2005; ROTH BJ, 1994, IEEE T BIO-MED ENG, V41, P232, DOI 10.1109/10.284941; Roth BJ, 1997, IEEE T BIO-MED ENG, V44, P326, DOI 10.1109/10.563303; Rush S, 1978, BIOMEDICAL ENG IEEE, P389, DOI [10.1109/TBME.1978.326270, DOI 10.1109/TBME.1978.326270]; Schneider T, 2000, CIRCULATION, V102, P1780; Spach MS, 2007, CIRC RES, V101, P743, DOI 10.1161/CIRCRESAHA.107.163956; SPACH MS, 1986, CIRC RES, V58, P356, DOI 10.1161/01.RES.58.3.356; Suzuki T, 2010, PACE, V33, P1455, DOI 10.1111/j.1540-8159.2010.02887.x; Sweeney MO, 2004, PACE, V27, P1292, DOI 10.1111/j.1540-8159.2004.00622.x; Swerdlow CD, 1996, CIRCULATION, V94, P2278, DOI 10.1161/01.CIR.94.9.2278; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Thomas SA, 2006, AM J CRIT CARE, V15, P389; Trayanova N, 1998, J ELECTROCARDIOL, V31, P23, DOI 10.1016/S0022-0736(98)90274-6; Trayanova N, 2001, PHILOS T ROY SOC A, V359, P1327, DOI 10.1098/rsta.2001.0834; Trayanova N., 2009, CARDIAC BIOELECTRIC, P85; Vigmond EJ, 2008, PROG BIOPHYS MOL BIO, V96, P3, DOI 10.1016/j.pbiomolbio.2007.07.012; Walcott GP, 2003, RESUSCITATION, V59, P59, DOI 10.1016/S0300-9572(03)00161-8; Wathen MS, 2004, CIRCULATION, V110, P2591, DOI 10.1161/01.CIR.0000145610.64014.E4; Wilson D, 2015, SIAM REV, V57, P201, DOI 10.1137/140952478; Wilson D, 2014, SIAM J APPL DYN SYST, V13, P944, DOI 10.1137/130942851; Wilson D, 2014, SIAM J APPL DYN SYST, V13, P276, DOI 10.1137/120901702; Winfree AT., 1980, GEOMETRY BIOL TIME; Winter J, 2000, AM J CARDIOL, V86, p71K, DOI 10.1016/S0002-9149(00)01294-7	62	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158239	10.1371/journal.pone.0158239	http://dx.doi.org/10.1371/journal.pone.0158239			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391010	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400039
J	Zhuang, L; Ma, Y; Wang, Q; Zhang, J; Zhu, C; Zhang, L; Xu, XP				Zhuang, Lin; Ma, Yan; Wang, Qian; Zhang, Jing; Zhu, Chen; Zhang, Lu; Xu, Xiaoping			Atg3 Overexpression Enhances Bortezomib-Induced Cell Death in SKM-1 Cell	PLOS ONE			English	Article							RISK MYELODYSPLASTIC SYNDROME; UBIQUITIN-PROTEASOME SYSTEM; DOUBLE-EDGED-SWORD; SELECTIVE AUTOPHAGY; PROTECTIVE AUTOPHAGY; POOR-PROGNOSIS; CANCER CELLS; PROTEIN; RESISTANCE; APOPTOSIS	Background Myelodysplastic syndrome (MDS) is a group of heterogeneous hematopoietic stem cell malignancies with a high risk of transformation into acute myeloid leukemia (AML). Clonal evolutions are significantly associated with transformation to AML. According to a gene expression microarray, atg3 is downregulated in MDS patients progressing to leukemia, but less is known about the function of Atg3 in the survival and death of MSD/AML cells. Moreover, the role of autophagy as a result of bortezomib treatment is controversial. The current study was designed to investigate the function of Atg3 in SKM-1 cells and to study the effect of Atg3 on cell viability and cell death following bortezomib treatment. Methods Four leukemia cell lines (SKM-1, THP-1, NB4 and K562) and two healthy patients' bone marrow cells were analyzed for Atg3 expression via qRT-PCR and Western blotting analysis. The role of Atg3 in SKM-1 cell survival and cell death was analyzed by CCK-8 assay, trypan blue exclusion assay, DAPI staining and Annexin V/PI dual staining with or without bortezomib treatment. Western blotting analysis was used to detect proteins in autophagic and caspase signaling pathways. Electron microscopy was used to observe ultrastructural changes after Atg3 overexpression. Results Downregulation of Atg3 expression was detected in four leukemia cell lines compared with healthy bone marrow cells. Atg3 mRNA was significantly decreased in MDS patients' bone marrow cells. Overexpression of Atg3 in SKM-1 cells resulted in AKT-mTOR-dependent autophagy, a significant reduction in cell proliferation and increased cell death, which could be overcome by the autophagy inhibitor 3-MA. SKM-1 cells overexpressing Atg3 were hypersensitive to bortezomib treatment at different concentrations via autophagic cell death and enhanced sensitivity to apoptosis in the SKM-1 cell line. Following treatment with 3-MA, the sensitivity of Atg3-overexpressing cells to bortezomib treatment was reduced. Atg3 knockdown blocked cell growth inhibition and cell death induced by bortezomib. Conclusion Our preliminary study of Atg3 in the high-risk MDS cell line suggests that Atg3 might be possibly a critical regulator of autophagic cell death and a gene target for therapeutic interventions in MDS.	[Zhuang, Lin; Ma, Yan; Wang, Qian; Zhang, Jing; Zhu, Chen; Zhang, Lu; Xu, Xiaoping] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Hematol, Shanghai, Peoples R China	Fudan University	Xu, XP (corresponding author), Fudan Univ, Huashan Hosp, Shanghai Med Coll, Dept Hematol, Shanghai, Peoples R China.	xpxu1111@163.com			Natural Science Foundation of China [81070404, 81100340]; Shanghai Municipal Commission of Health and Family Planning [15GWZK0801]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning	The project was financially supported by a grant from the Natural Science Foundation of China (Grant No.81070404 and 81100340) and Shanghai Municipal Commission of Health and Family Planning (Grant No. 15GWZK0801). The funders had a role in study design, data collection and analysis, decision to publish.	Alimena G, 2011, LEUKEMIA RES, V35, P504, DOI 10.1016/j.leukres.2010.08.021; Chang L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.415; Chen S, 2014, BLOOD, V124, P2687, DOI 10.1182/blood-2014-03-564534; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Dayyani F, 2010, CANCER-AM CANCER SOC, V116, P2174, DOI 10.1002/cncr.24984; Fang J, 2012, BLOOD, V120, P858, DOI 10.1182/blood-2012-02-407999; Fulda S, 2015, ONCOGENE, V34, P5105, DOI 10.1038/onc.2014.458; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gao ZH, 2010, AUTOPHAGY, V6, P126, DOI 10.4161/auto.6.1.10928; Heras-Sandoval D, 2014, CELL SIGNAL, V26, P2694, DOI 10.1016/j.cellsig.2014.08.019; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Jabbour E, 2013, AM J HEMATOL, V88, P831, DOI 10.1002/ajh.23513; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Ma Y, 2013, MOL BIOL REP, V40, P469, DOI 10.1007/s11033-012-2082-1; Min H, 2014, CANCER CHEMOTH PHARM, V74, P167, DOI 10.1007/s00280-014-2451-7; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Mortensen M, 2011, AUTOPHAGY, V7, P1069, DOI 10.4161/auto.7.9.15886; Natarajan-Ame S, 2012, BRIT J HAEMATOL, V158, P232, DOI 10.1111/j.1365-2141.2012.09153.x; Oral O, 2012, APOPTOSIS, V17, P810, DOI 10.1007/s10495-012-0735-0; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Radoshevich L, 2010, CELL, V142, P590, DOI 10.1016/j.cell.2010.07.018; Raza A, 2012, NAT REV CANCER, V12, P849, DOI 10.1038/nrc3321; Sahasrabuddhe AA, 2015, IMMUNOL REV, V263, P224, DOI 10.1111/imr.12236; Schreiber A, 2014, BBA-MOL CELL RES, V1843, P163, DOI 10.1016/j.bbamcr.2013.03.019; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Terpos E, 2007, LEUKEMIA RES, V31, P559, DOI 10.1016/j.leukres.2006.05.018; Wang H, 2010, CANCER GENET CYTOGEN, V196, P159, DOI 10.1016/j.cancergencyto.2009.09.015; Wang L, 2014, MOL BIOL REP, V41, P2093, DOI 10.1007/s11033-014-3058-0; Wertz IE, 2014, CURR OPIN CHEM BIOL, V23, P71, DOI 10.1016/j.cbpa.2014.10.011; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Yoo BH, 2015, AUTOPHAGY, V11, P1230, DOI 10.1080/15548627.2015.1056968; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang MJ, 2015, ONCOTARGET, V6, P8567, DOI 10.18632/oncotarget.3251; Zhao Z, 2015, CANCER LETT, V358, P17, DOI 10.1016/j.canlet.2014.11.046	39	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158761	10.1371/journal.pone.0158761	http://dx.doi.org/10.1371/journal.pone.0158761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391105	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400118
J	Vallerand, D; Massonnet, G; Kebir, F; Gentien, D; Maciorowski, Z; De la Grange, P; Sigal-Zafrani, B; Richardson, M; Humbert, S; Thuleau, A; Assayag, F; de Plater, L; Nicolas, A; Scholl, S; Marangoni, E; Weigand, S; Roman-Roman, S; Savina, A; Decaudin, D				Vallerand, David; Massonnet, Gerald; Kebir, Fatima; Gentien, David; Maciorowski, Zofia; De la Grange, Pierre; Sigal-Zafrani, Brigitte; Richardson, Marion; Humbert, Sandrine; Thuleau, Aurelie; Assayag, Franck; de Plater, Ludmilla; Nicolas, Andre; Scholl, Suzy; Marangoni, Elisabetta; Weigand, Stefan; Roman-Roman, Sergio; Savina, Ariel; Decaudin, Didier			Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization	PLOS ONE			English	Article							SUPPRESSES GROWTH; TUMOR XENOGRAFTS; MOUSE MODELS; EXPRESSION; STROMA; MICROENVIRONMENT; ESTABLISHMENT; PROGRESSION; METASTASIS; IMPACT	Drug discovery efforts have focused on the tumor microenvironment in recent years. However, few studies have characterized the stroma component in patient-derived xenografts (PDXs) and genetically engineered mouse models (GEMs). In this study, we characterized the stroma in various models of breast cancer tumors in mice. We performed transcriptomic and flow cytometry analyses on murine populations for a series of 25 PDXs and the two most commonly used GEMs (MMTV-PyMT and MMTV-erBb2). We sorted macrophages from five models. We then profiled gene expression in these cells, which were also subjected to flow cytometry for phenotypic characterization. Hematopoietic cell composition, mostly macrophages and granulocytes, differed between tumors. Macrophages had a specific polarization phenotype related to their M1/M2 classification and associated with the expression of genes involved in the recruitment, invasion and metastasis processes. The heterogeneity of the stroma component of the models studied suggests that tumor cells modify their microenvironment to satisfy their needs. Our observations suggest that such models are of relevance for preclinical studies.	[Vallerand, David; Massonnet, Gerald; Thuleau, Aurelie; Assayag, Franck; de Plater, Ludmilla; Marangoni, Elisabetta; Decaudin, Didier] PSL Univ, Inst Curie, Lab Preclin Invest, Translat Res Dept, Paris, France; [Vallerand, David; Savina, Ariel] Inst Roche, Boulogne, France; [Kebir, Fatima; Sigal-Zafrani, Brigitte; Richardson, Marion; Nicolas, Andre] Inst Curie, Dept Pathol, Boulogne, France; [Gentien, David] PSL Univ, Inst Curie, Platform Mol Biol Facil, Paris, France; [Maciorowski, Zofia] PSL Univ, Inst Curie, Flow Cytometry Core Facil, Paris, France; [De la Grange, Pierre] Inst Univ Hematol, GenoSplice Technol, Paris, France; [Sigal-Zafrani, Brigitte] PSL Univ, Inst Curie, INSERM, U830, Paris, France; [Humbert, Sandrine] PSL Univ, Inst Curie, INSERM, CNRS UMR3306,U1005, Orsay, France; [Scholl, Suzy; Decaudin, Didier] Inst Curie, Dept Med Oncol, Orsay, France; [Weigand, Stefan] Roche Diagnost GmbH, Penzberg, Germany; [Roman-Roman, Sergio; Decaudin, Didier] PSL Univ, Inst Curie, Translat Res Dept, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Roche Holding; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Decaudin, D (corresponding author), PSL Univ, Inst Curie, Lab Preclin Invest, Translat Res Dept, Paris, France.; Decaudin, D (corresponding author), Inst Curie, Dept Med Oncol, Orsay, France.; Decaudin, D (corresponding author), PSL Univ, Inst Curie, Translat Res Dept, Paris, France.	didier.decaudin@curie.net	Gentien, David/O-9356-2019; Humbert, Sandrine/S-2981-2016; Gentien, David/L-7757-2017; Roman-Roman, Sergio/K-9993-2014; Marangoni, Elisabetta/GSO-3945-2022	Gentien, David/0000-0001-8317-5188; Roman-Roman, Sergio/0000-0001-6459-2613; Marangoni, Elisabetta/0000-0002-3337-6448; Humbert, Sandrine/0000-0002-9501-2658	ROCHE laboratories; ROCHE laboratories (CIFRE PhD grant) [2010/0553]; CIFRE PhD grant from Roche [2010/0553]	ROCHE laboratories; ROCHE laboratories (CIFRE PhD grant); CIFRE PhD grant from Roche	David Vallerand was paid by ROCHE laboratories and a part of experiments was supported by ROCHE laboratories (CIFRE PhD grant 2010/0553). Stefan Weigand and Ariel Savina were employed by Roche Diagnostics GmbH. Pierre De La Grange was employed by GenoSplice Technology. The specific roles of these authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We would like to thank the staff of our laboratory for their contribution to this study. We also thank the Department of Pathology of the Institut Curie for assistance with pathology studies. We thank Sophie Grondin, Annick Viguier, Benoit Albaud, and Frederic Lemoine for their advice and technical support. We also thank the staff of the Institut Curie animal facility. We thank Prof. Dominique Bellet for his generosity in sharing his laboratory facilities at the Faculty of Pharmacy of Paris Descartes University with us. Finally, we thank Dr Nathalie Varoqueaux, Dr Emilie Vinolo and Dr Sebastian Amigorena for their careful review of the manuscript. This work was supported by CIFRE PhD grant 2010/0553 from Roche.	Aharinejad S, 2004, CANCER RES, V64, P5378, DOI 10.1158/0008-5472.CAN-04-0961; Bergamaschi A, 2009, MOL ONCOL, V3, P469, DOI 10.1016/j.molonc.2009.07.003; Chaudary Naz, 2012, Cancers (Basel), V4, P821, DOI 10.3390/cancers4030821; Coffelt SB, 2009, BBA-REV CANCER, V1796, P11, DOI 10.1016/j.bbcan.2009.02.004; Cottu P, 2011, BREAST CANC RES TREA; Davies E, 2010, J LEUKOCYTE BIOL, V88, P529, DOI 10.1189/jlb.0909648; de la Grange P, 2005, NUCLEIC ACIDS RES, V33, P4276, DOI 10.1093/nar/gki738; de la Grange P, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-180; de la Grange P, 2010, NUCLEIC ACIDS RES, V38, P2825, DOI 10.1093/nar/gkq008; de Plater L, 2010, BRIT J CANCER, V103, P1192, DOI 10.1038/sj.bjc.6605900; Decaudin D, 2011, ANTI-CANCER DRUG, V22, P827, DOI 10.1097/CAD.0b013e3283475f70; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; Doedens AL, 2010, CANCER RES, V70, P7465, DOI 10.1158/0008-5472.CAN-10-1439; Engels B, 2012, SEMIN CANCER BIOL, V22, P41, DOI 10.1016/j.semcancer.2011.12.008; Garber K, 2009, J NATL CANCER I, V101, P6, DOI 10.1093/jnci/djn481; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Houghton AM, 2006, CANCER RES, V66, P6149, DOI 10.1158/0008-5472.CAN-04-0297; Howell A, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2435; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Kaler P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011700; Kim IS, 2010, BIOCHEM BIOPH RES CO, V394, P443, DOI 10.1016/j.bbrc.2010.03.070; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li XQ, 2012, CURR PHARM DESIGN, V18, P2404, DOI 10.2174/13816128112092404; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; LUCCHINI F, 1992, CANCER LETT, V64, P203, DOI 10.1016/0304-3835(92)90044-V; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Nemati F, 2010, CLIN CANCER RES, V16, P2352, DOI 10.1158/1078-0432.CCR-09-3066; Petit V, 2013, LAB INVEST, V93, P611, DOI 10.1038/labinvest.2013.44; Petrillo LA, 2012, BREAST CANCER RES TR, V135, P913, DOI 10.1007/s10549-012-2226-y; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Reinheckel T, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00133; Reyal F, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3095; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Tovey MG, 1996, J LEUKOCYTE BIOL, V59, P512, DOI 10.1002/jlb.59.4.512; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	45	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157670	10.1371/journal.pone.0157670	http://dx.doi.org/10.1371/journal.pone.0157670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388901	Green Submitted, Green Published, gold			2022-12-26	WOS:000379811500007
J	O'Beirne, SL; Salit, J; Rodriguez-Flores, JL; Staudt, MR; Khalil, CA; Fakhro, KA; Robay, A; Ramstetter, MD; Al-Azwani, IK; Malek, JA; Zirie, M; Jayyousi, A; Badii, R; Al-Marri, AA; Chiuchiolo, MJ; Al-Shakaki, A; Chidiac, O; Gharbiah, M; Bener, A; Stadler, D; Hackett, NR; Mezey, JG; Crystal, RG				O'Beirne, Sarah L.; Salit, Jacqueline; Rodriguez-Flores, Juan L.; Staudt, Michelle R.; Khalil, Charbel Abi; Fakhro, Khalid A.; Robay, Amal; Ramstetter, Monica D.; Al-Azwani, Iman K.; Malek, Joel A.; Zirie, Mahmoud; Jayyousi, Amin; Badii, Ramin; Al-Marri, Ajayeb Al-Nabet; Chiuchiolo, Maria J.; Al-Shakaki, Alya; Chidiac, Omar; Gharbiah, Maey; Bener, Abdulbari; Stadler, Dora; Hackett, Neil R.; Mezey, Jason G.; Crystal, Ronald G.			Type 2 Diabetes Risk Allele Loci in the Qatari Population	PLOS ONE			English	Article							GENETIC ARCHITECTURE; VARIANTS; SUSCEPTIBILITY; ASSOCIATION; LINKAGE; OBESITY; DISEASE; TCF7L2; COMMON	Background The prevalence of type 2 diabetes (T2D) is increasing in the Middle East. However, the genetic risk factors for T2D in the Middle Eastern populations are not known, as the majority of studies of genetic risk for T2D are in Europeans and Asians. Methods All subjects were >= 3 generation Qataris. Cases with T2D (n = 1,124) and controls (n = 590) were randomly recruited and assigned to the 3 known Qatari genetic subpopulations [Bedouin (Q1), Persian/South Asian (Q2) and African (Q3)]. Subjects underwent genotyping for 37 single nucleotide polymorphisms (SNPs) in 29 genes known to be associated with T2D in Europeans and/or Asian populations, and an additional 27 tag SNPs related to these susceptibility loci. Pre-study power analysis suggested that with the known incidence of T2D in adult Qataris (22%), the study population size would be sufficient to detect significant differences if the SNPs were risk factors among Qataris, assuming that the odds ratio (OR) for T2D SNPs in Qatari's is greater than or equal to the SNP with highest known OR in other populations. Results Haplotype analysis demonstrated that Qatari haplotypes in the region of known T2D risk alleles in Q1 and Q2 genetic subpopulations were similar to European haplotypes. After Benjamini-Hochberg adjustment for multiple testing, only two SNPs (rs7903146 and rs4506565), both associated with transcription factor 7-like 2 (TCF7L2), achieved statistical significance in the whole study population. When T2D subjects and control subjects were assigned to the known 3 Qatari subpopulations, and analyzed individually and with the Q1 and Q2 genetic subpopulations combined, one of these SNPs (rs4506565) was also significant in the admixed group. No other SNPs associated with T2D in all Qataris or individual genetic subpopulations. Conclusions With the caveats of the power analysis, the European/Asian T2D SNPs do not contribute significantly to the high prevalence of T2D in the Qatari population, suggesting that the genetic risks for T2D are likely different in Qataris compared to Europeans and Asians.	[O'Beirne, Sarah L.; Salit, Jacqueline; Rodriguez-Flores, Juan L.; Staudt, Michelle R.; Ramstetter, Monica D.; Chiuchiolo, Maria J.; Hackett, Neil R.; Mezey, Jason G.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY USA; [O'Beirne, Sarah L.; Crystal, Ronald G.] Weill Cornell Med Coll, Div Pulm & Crit Care Med, Dept Med, New York, NY USA; [Khalil, Charbel Abi; Fakhro, Khalid A.; Robay, Amal; Al-Azwani, Iman K.; Malek, Joel A.; Al-Shakaki, Alya; Chidiac, Omar; Gharbiah, Maey] Weill Cornell Med Coll Qatar, Dept Med Genet, Doha, Qatar; [Fakhro, Khalid A.] Sidra Med Res Ctr, Div Translat Med, Doha, Qatar; [Ramstetter, Monica D.; Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Zirie, Mahmoud; Jayyousi, Amin] Hamad Med Corp, Dept Med, Doha, Qatar; [Badii, Ramin; Al-Marri, Ajayeb Al-Nabet] Hamad Med Corp, Lab Med & Pathol, Doha, Qatar; [Bener, Abdulbari] Hamad Med Corp, Dept Med Stat & Epidemiol, Doha, Qatar; [Stadler, Dora] Weill Cornell Med Coll Qatar, Dept Med, Doha, Qatar	Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Sidra Medical & Research Center; Cornell University; Hamad Medical Corporation; Hamad Medical Corporation; Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Khalil, CA (corresponding author), Weill Cornell Med Coll Qatar, Dept Med Genet, Doha, Qatar.	geneticmedicine@med.cornell.edu	BENER, ABDULBARİ/AAC-4436-2020; O'Beirne, Sarah/K-1214-2016; Rodriguez-Flores, Juan L/AAJ-7565-2020; Abi Khalil, Charbel/J-6813-2012	O'Beirne, Sarah/0000-0003-2876-0258; Rodriguez-Flores, Juan L/0000-0002-0394-8062; Abi Khalil, Charbel/0000-0002-1428-6324; Staudt, Michelle/0000-0002-3364-0894	Qatar Foundation; Weill Cornell Medical College in Qatar; Qatar National Research Foundation [NPRP 09-741-3-193, 09-740-3-192, NPRP 5-436-3-116]	Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF)); Weill Cornell Medical College in Qatar(Qatar National Research Fund (QNRF)); Qatar National Research Foundation(National Research Foundation of Korea)	These studies were supported, in part, by The Qatar Foundation and the Weill Cornell Medical College in Qatar and Qatar National Research Foundation NPRP 09-741-3-193, 09-740-3-192 and NPRP 5-436-3-116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank N. Mohamed for editorial assistance. These studies were supported, in part, by The Qatar Foundation and the Weill Cornell Medical College in Qatar and Qatar National Research Foundation NPRP 09-741-3-193, 09-740-3-192 and NPRP 5-436-3-116.	Agarwala V, 2013, NAT GENET, V45, P1418, DOI 10.1038/ng.2804; Al-Daghri NM, 2014, CLIN ENDOCRINOL, V80, P532, DOI 10.1111/cen.12187; Almawi WY, 2013, DIABETES RES CLIN PR, V102, P117, DOI 10.1016/j.diabres.2013.09.001; Alsmadi O, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-72; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bener A, 2005, CROAT MED J, V46, P302; Billings LK, 2010, ANN NY ACAD SCI, V1212, P59, DOI 10.1111/j.1749-6632.2010.05838.x; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bonnefond A, 2015, CELL METAB, V21, P357, DOI 10.1016/j.cmet.2014.12.020; Cauchi S, 2012, DIABETES METAB, V38, P316, DOI 10.1016/j.diabet.2012.02.003; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ezzidi I, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-33; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goddard KAB, 2000, AM J HUM GENET, V66, P216, DOI 10.1086/302727; Grarup N, 2014, DIABETOLOGIA, V57, P1528, DOI 10.1007/s00125-014-3270-4; Gu S, 2007, EUR J HUM GENET, V15, P302, DOI 10.1038/sj.ejhg.5201751; Haiman CA, 2012, DIABETES, V61, P1642, DOI 10.2337/db11-1296; Hara K, 2014, BIOCHEM BIOPH RES CO, V452, P213, DOI 10.1016/j.bbrc.2014.08.012; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Omberg L, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-49; Popkin BM, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0631-4; Prasad RB, 2015, GENES-BASEL, V6, P87, DOI 10.3390/genes6010087; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodriguez-Flores JL, 2016, GENOME RES, V26, P151, DOI 10.1101/gr.191478.115; Rodriguez-Flores JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047614; Shao WJ, 2013, DIABETES, V62, P789, DOI 10.2337/db12-0365; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tomei S, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0459-3; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Xu J, 2012, GENET MOL RES, V11, P1592, DOI 10.4238/2012.May.24.1; Zhou YD, 2014, HUM MOL GENET, V23, P6419, DOI 10.1093/hmg/ddu359	42	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0156834	10.1371/journal.pone.0156834	http://dx.doi.org/10.1371/journal.pone.0156834			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383215	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400007
J	Souza, ALA; Faria, RX; Calabrese, KS; Hardoim, DJ; Taniwaki, N; Alves, LA; De Simone, SG				Souza, Andre L. A.; Faria, Robson X.; Calabrese, Katia S.; Hardoim, Daiane J.; Taniwaki, Noemi; Alves, Luiz A.; De Simone, Salvatore G.			Temporizin and Temporizin-1 Peptides as Novel Candidates for Eliminating Trypanosoma cruzi	PLOS ONE			English	Article							FORMS ION CHANNELS; HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; CHAGAS-DISEASE; MEMBRANE-PERMEABILIZATION; PLASMA-MEMBRANE; LIPID BILAYER; IN-VITRO; GRAMICIDIN; ANTIBACTERIAL	Tropical diseases caused by parasitic infections continue to cause socioeconomic distress worldwide. Among these, Chagas disease has become a great concern because of globalization. Caused by Trypanosoma cruzi, there is an increasing need to discover new, more effective methods to manage infections that minimize disease onset. Antimicrobial peptides represent a possible solution to this challenge. As effector molecules of the innate immune response against pathogens, they are the first line of defense found in all multi-cellular organisms. In amphibians, temporins are a large family of antimicrobial peptides found in skin secretions. Their functional roles and modes of action present unique properties that indicate possible candidates for therapeutic applications. Here, we investigated the trypanocide activity of temporizin and temporizin-1. Temporizin is an artificial, hybrid peptide containing the N-terminal region of temporin A, the pore-forming region of gramicidin and a C-terminus consisting of alternating leucine and lysine. Temporizin-1 is a modification of temporizin with a reduction in the region responsible for insertion into membranes. Their activities were evaluated in a cell permeabilization assay by flow cytometry, an LDH release assay, electron microscopy, an MTT assay and patch clamp experiments. Both temporizin and temporizin-1 demonstrated toxicity against T. cruzi with temporizin displaying slightly more potency. At concentrations up to 100 mu g/ml, both peptides exhibited low toxicity in J774 cells, a macrophage lineage cell line, and no toxicity was observed in mouse primary peritoneal macrophages. In contrast, the peptides showed some toxicity in rat adenoma GH3 cells and Jurkat human lymphoma cells with temporizin-1 displaying lower toxicity. In summary, a shortened form of the hybrid temporizin peptide, temporizin-1, was efficient at killing T. cruzi and it has low toxicity in wild-type mammalian cells. These data suggest that temporizin-1 might be a candidate for Chagas disease therapy.	[Souza, Andre L. A.; De Simone, Salvatore G.] Fiocruz MS, Natl Inst Sci & Technol Innovat Neglected Dis INC, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, RJ, Brazil; [Souza, Andre L. A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Expt & Computat Biochem Pharmaceut, Rio De Janeiro, RJ, Brazil; [Faria, Robson X.] Fiocruz MS, Inst Oswaldo Cruz, Lab Toxoplasmosis & Other Protozoosis, Rio De Janeiro, RJ, Brazil; [Calabrese, Katia S.; Hardoim, Daiane J.] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunomodulat & Protozool, Rio De Janeiro, RJ, Brazil; [Taniwaki, Noemi] Fiocruz MS, Adolfo Lutz Inst, Elect Microscopy Sect, Sao Paulo, SP, Brazil; [Alves, Luiz A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Cellular Commun, Rio De Janeiro, RJ, Brazil; [De Simone, Salvatore G.] Univ Fed Fluminense, Inst Biol, Dept Cellular & Mol Biol, Niteroi, RJ, Brazil	Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Instituto Adolfo Lutz; Fundacao Oswaldo Cruz; Universidade Federal Fluminense	Faria, RX (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Toxoplasmosis & Other Protozoosis, Rio De Janeiro, RJ, Brazil.	robson.xavier@gmail.com	De-Simone, Salvatore/I-2989-2013; Calabrese, Katia S/V-2631-2018	De-Simone, Salvatore/0000-0002-2172-656X; Hardoim, Daiana de Jesus/0000-0002-2272-2472	CNPq; FAPERJ; CAPES V/Fiocruz CNPq; PAPES VI/CNPq; Oswaldo Cruz Institute	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES V/Fiocruz CNPq; PAPES VI/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Institute	This work was supported by grants from CNPq, FAPERJ, CAPES V/Fiocruz CNPq, PAPES VI/CNPq and Oswaldo Cruz Institute.	Adade CM, 2013, TOXICON, V69, P227, DOI 10.1016/j.toxicon.2013.03.011; AGAWA Y, 1991, J BIOL CHEM, V266, P20218; Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; ANDREU D, 1992, FEBS LETT, V296, P190, DOI 10.1016/0014-5793(92)80377-S; Angelique L, 2015, MOLECULES, V20, P15392, DOI 10.3390/molecules200815392; Aquila M, 2012, PATCH CLAMP TECHNIQU; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; Bartel LC, 2007, HUM EXP TOXICOL, V26, P781, DOI 10.1177/0960327107084540; Bern C, 2008, CURR OPIN INFECT DIS, V21, P476, DOI 10.1097/QCO.0b013e32830ef5b6; Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171; Bezzerri V, 2014, J PEPT SCI, V20, P822, DOI 10.1002/psc.2674; Bhunia A, 2011, J BIOL CHEM, V286, P24394, DOI 10.1074/jbc.M110.189662; BRADBURY AF, 1991, TRENDS BIOCHEM SCI, V16, P112, DOI 10.1016/0968-0004(91)90044-V; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Capone R, 2010, BIOPHYS J, V98, P2644, DOI 10.1016/j.bpj.2010.02.024; Cerecetto Hugo, 2002, Current Topics in Medicinal Chemistry, V2, P1187, DOI 10.2174/1568026023393066; CLARK DP, 1994, J BIOL CHEM, V269, P10849; Conlon JM, 2009, BBA-BIOMEMBRANES, V1788, P1556, DOI 10.1016/j.bbamem.2008.09.018; Conlon JM, 2004, BBA-PROTEINS PROTEOM, V1696, P1, DOI 10.1016/j.bbapap.2003.09.004; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P549, DOI 10.1590/S0074-02762009000400002; Croft A M, 2006, J R Army Med Corps, V152, P156; CRUCIANI RA, 1992, EUR J PHARM-MOLEC PH, V226, P287, DOI 10.1016/0922-4106(92)90045-W; D'Elia C, 2005, REV SOC BRAS MED TRO, V38, P7, DOI 10.1590/S0037-86822005000100002; Da Silveira JF, 1991, BIOCHIM BIOPHYS ACTA, V644, P341; David JM, 2015, J KIDNEY CANCER VHL, V2, P15, DOI 10.15586/jkcvhl.2015.21; deAndrade ALSS, 1996, LANCET, V348, P1407, DOI 10.1016/S0140-6736(96)04128-1; Deane L. M., 1964, Revista Brasileira de Malariologia, V16, P27; Delespaux V, 2007, DRUG RESIST UPDATE, V10, P30, DOI 10.1016/j.drup.2007.02.004; Dias J. C. P., 1984, Memorias do Instituto Oswaldo Cruz, V79, P85, DOI 10.1590/S0074-02761984000500017; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Dixit R, 2008, ACTA TROP, V106, P75, DOI 10.1016/j.actatropica.2008.01.001; Eggimann GA, 2015, MOLECULES, V20, P2775, DOI 10.3390/molecules20022775; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; ELLIS JA, 1993, VET PARASITOL, V50, P143, DOI 10.1016/0304-4017(93)90015-F; Fabbro DL, 2007, REV SOC BRAS MED TRO, V40, P1, DOI 10.1590/S0037-86822007000100001; Faria RX, 2009, AM J PHYSIOL-CELL PH, V297, pC28, DOI 10.1152/ajpcell.00476.2008; Faria RX, 2005, AM J PHYSIOL-CELL PH, V288, pC260, DOI 10.1152/ajpcell.00215.2004; Fieck A, 2010, EXP PARASITOL, V125, P342, DOI 10.1016/j.exppara.2010.02.016; Garcia S, 2005, ANTIMICROB AGENTS CH, V4; Grieco P, 2013, BBA-BIOMEMBRANES, V1828, P652, DOI 10.1016/j.bbamem.2012.08.027; Grieco P, 2011, J PEPT SCI, V17, P358, DOI 10.1002/psc.1350; KAGAN BL, 1990, P NATL ACAD SCI USA, V87, P210, DOI 10.1073/pnas.87.1.210; KETCHEM RR, 1993, SCIENCE, V261, P1457, DOI 10.1126/science.7690158; Kim H, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1111/CHS0.12019; KOEPPE RE, 1995, BIOCHEMISTRY-US, V34, P9299, DOI 10.1021/bi00029a004; KREIL G, 1994, CIBA F SYMP, V186, P77; LENT H, 1979, Bulletin of the American Museum of Natural History, V163, P123; Leuschner C, 2003, BREAST CANCER RES TR, V78, P17, DOI 10.1023/A:1022169525521; Lombana A, 2014, J PEPT SCI, V20, P563, DOI 10.1002/psc.2654; Madison AN, 2007, INFECT IMMUN, V75, P4780, DOI 10.1128/IAI.00557-07; Mahalka AK, 2009, BBA-BIOMEMBRANES, V1788, P1600, DOI 10.1016/j.bbamem.2009.04.012; Mangoni ML, 2016, CURR TOP MED CHEM, V16, P54, DOI 10.2174/1568026615666150703121403; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Mookherjee N, 2007, CELL MOL LIFE SCI, V64, P922, DOI 10.1007/s00018-007-6475-6; Paulmann M, 2012, J BIOL CHEM, V287, P8434, DOI 10.1074/jbc.M111.332270; Pinto EG, 2013, EXP PARASITOL, V135, P655, DOI 10.1016/j.exppara.2013.09.016; Quigley EP, 2000, J MEMBRANE BIOL, V174, P207, DOI 10.1007/s002320001045; Rinaldi AC, 2002, BIOCHEM J, V368, P91, DOI 10.1042/BJ20020806; Rodrigues CO, 2001, J EUKARYOT MICROBIOL, V48, P588, DOI 10.1111/j.1550-7408.2001.tb00195.x; Saint N, 2002, BBA-BIOMEMBRANES, V1564, P359, DOI 10.1016/S0005-2736(02)00470-4; Sato H, 2006, BBA-BIOMEMBRANES, V1758, P1245, DOI 10.1016/j.bbamem.2006.02.021; Simmaco M, 1998, SCAND J IMMUNOL, V48, P357; Simmaco M, 1996, EUR J BIOCHEM, V242, P788, DOI 10.1111/j.1432-1033.1996.0788r.x; Song C, 2013, P NATL ACAD SCI USA, V110, P4586, DOI 10.1073/pnas.1214739110; SPECTOR AA, 1985, J LIPID RES, V26, P1015; STANKOVIC CJ, 1990, ANAL BIOCHEM, V184, P100, DOI 10.1016/0003-2697(90)90019-6; Tempone AG, 2007, LETT DRUG DES DISCOV, V4, P67; Urbina JA, 2003, TRENDS PARASITOL, V19, P495, DOI 10.1016/j.pt.2003.09.001; WARNOCK DE, 1993, J BIOL CHEM, V268, P10145; Wilkinson SR, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001252; YAMADA K, 1994, BIOCHEM J, V298, P623, DOI 10.1042/bj2980623; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 2009, CURR OPIN INVEST DR, V10, P164	74	14	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157673	10.1371/journal.pone.0157673	http://dx.doi.org/10.1371/journal.pone.0157673			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384541	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400019
J	Summers, JA; Harper, AR; Feasley, CL; Van-Der-Wel, H; Byrum, JN; Hermann, M; West, CM				Summers, Jody A.; Harper, Angelica R.; Feasley, Christa L.; Van-Der-Wel, Hanke; Byrum, Jennifer N.; Hermann, Marcela; West, Christopher M.			Identification of Apolipoprotein A-I as a Retinoic Acid-binding Protein in the Eye	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORM DEPRIVATION MYOPIA; HUMAN SERUM-ALBUMIN; VITAMIN-A; CHOLESTEROL TRANSPORT; CELLULAR CHOLESTEROL; MASS-SPECTROMETRY; HUMAN-PLASMA; QUANTIFICATION; CHICKEN; RAT	All-trans-retinoic acid may be an important molecular signal in the postnatal control of eye size. The goal of this study was to identify retinoic acid-binding proteins secreted by the choroid and sclera during visually guided ocular growth. Following photoaffinity labeling with all-trans-[11,12-H-3]retinoic acid, the most abundant labeled protein detected in the conditioned medium of choroid or sclera had an apparent M-r of 27,000 Da. Following purification and mass spectrometry, the M-r 27,000 band was identified as apolipoprotein A-I. Affinity capture of the radioactive M-r 27,000 band by anti-chick apolipoprotein A-I antibodies confirmed its identity as apolipoprotein A-I. Photoaffinity labeling and fluorescence quenching experiments demonstrated that binding of retinoic acid to apolipoprotein A-I is 1) concentration-dependent, 2) selective for all-trans-retinoic acid, and 3) requires the presence of apolipoprotein A-I-associated lipids for retinoid binding. Expression of apolipoprotein A-I mRNA and protein synthesis were markedly up regulated in choroids of chick eyes during the recovery from induced myopia, and apolipoprotein A-I mRNA was significantly increased in choroids following retinoic acid treatment. Together, these data suggest that apolipoprotein A-I may participate in a regulatory feedback mechanism with retinoic acid to control the action of retinoic acid on ocular targets during postnatal ocular growth.	[Summers, Jody A.; Harper, Angelica R.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St, Oklahoma City, OK 73104 USA; [Feasley, Christa L.; Van-Der-Wel, Hanke; Byrum, Jennifer N.; West, Christopher M.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Feasley, Christa L.] Thermo Fisher Sci, W Palm Beach, FL 33407 USA; [Van-Der-Wel, Hanke; West, Christopher M.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Hermann, Marcela] Med Univ Vienna, Dept Med Biochem, Max F Perutz Labs, Dr Bohr Gasse 9-2, A-1030 Vienna, Austria	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Thermo Fisher Scientific; University System of Georgia; University of Georgia; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Summers, JA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 975 NE 10th St, Oklahoma City, OK 73104 USA.	Jody-summers@ouhsc.edu		Hermann, Marcela/0000-0003-2298-4269	National Institutes of Health [EY09391, GM037539]; University of Oklahoma Health Sciences Center (OUHSC); OUHSC Department of Biochemistry and Molecular Biology; OUHSC Vice President's Office for Research; Herzfelder'sche Familienstiftung; NATIONAL EYE INSTITUTE [R01EY009391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Oklahoma Health Sciences Center (OUHSC); OUHSC Department of Biochemistry and Molecular Biology; OUHSC Vice President's Office for Research; Herzfelder'sche Familienstiftung; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants EY09391 (to J. A. S.) and GM037539 (to C. M. W.); the University of Oklahoma Health Sciences Center (OUHSC), which funded the Oklahoma Center for Medical Glycobiology (to C. M. W.) in association with the OUHSC Department of Biochemistry and Molecular Biology and the OUHSC Vice President's Office for Research; and the Herzfelder'sche Familienstiftung (to M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arbuckle JL, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-23; BAILEY JS, 1988, J BIOL CHEM, V263, P9326; Bay?n A., 2007, OPHTHALMOLOGY, V17, P1; Belgacem O, 2007, BIOLOGICALS, V35, P43, DOI 10.1016/j.biologicals.2006.01.004; BERNSTEIN PS, 1995, P NATL ACAD SCI USA, V92, P654, DOI 10.1073/pnas.92.3.654; Bertrand E, 2006, MOL CELL PROTEOMICS, V5, P2158, DOI 10.1074/mcp.M600073-MCP200; Chen Y, 1996, J BIOL CHEM, V271, P20507, DOI 10.1074/jbc.271.34.20507; COGAN U, 1976, EUR J BIOCHEM, V65, P71, DOI 10.1111/j.1432-1033.1976.tb10390.x; Dolgin E, 2015, NATURE, V519, P276, DOI 10.1038/519276a; During A, 2007, J LIPID RES, V48, P2283, DOI 10.1194/jlr.M700263-JLR200; Eckhoff C., 1990, J LIPID RES, V31, P1445; FIELDING CJ, 1995, J LIPID RES, V36, P211; FIORELLA PD, 1991, J BIOL CHEM, V266, P16572; FOGH K, 1993, ARCH BIOCHEM BIOPHYS, V300, P751, DOI 10.1006/abbi.1993.1104; Fox G., 1978, BIOCHIM BIOPHYS ACTA, V537, P358; Gaus K, 2004, FASEB J, V18, P574, DOI 10.1096/fj.03-0486fje; HARA H, 1991, J BIOL CHEM, V266, P3080; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Heroux M. S., 2014, PHYSIOL GENOMICS, V46, P467; Illing M, 1997, J BIOL CHEM, V272, P10303, DOI 10.1074/jbc.272.15.10303; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Jones LA, 2007, INVEST OPHTH VIS SCI, V48, P3524, DOI 10.1167/iovs.06-1118; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; Kaptein A, 1997, J LIPID RES, V38, P2273; Karnaukhova E, 2007, BIOCHEM PHARMACOL, V73, P901, DOI 10.1016/j.bcp.2006.11.023; KELLEY JL, 1980, COMP BIOCHEM PHYS B, V65, P239, DOI 10.1016/0305-0491(80)90008-5; KEMMINK J, 1995, BIOCHEMISTRY-US, V34, P12630, DOI 10.1021/bi00039a019; Kiss RS, 1999, BIOCHEMISTRY-US, V38, P4327, DOI 10.1021/bi982597p; KISS RS, 1993, BIOCHEMISTRY-US, V32, P7872, DOI 10.1021/bi00082a006; KURLANDSKY SB, 1995, J BIOL CHEM, V270, P17850, DOI 10.1074/jbc.270.30.17850; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUCIANI MF, 1994, GENOMICS, V21, P150, DOI 10.1006/geno.1994.1237; McFadden SA, 2004, VISION RES, V44, P643, DOI 10.1016/j.visres.2003.11.002; Mertz JR, 2000, EXP EYE RES, V70, P519, DOI 10.1006/exer.1999.0813; N'soukpoe-Kossi CN, 2007, INT J BIOL MACROMOL, V40, P484, DOI 10.1016/j.ijbiomac.2006.11.005; NAPOLI JL, 1986, J BIOL CHEM, V261, P3592; NAPOLI JL, 1985, J LIPID RES, V26, P387; Neele DM, 1999, BIOCHEM PHARMACOL, V58, P263, DOI 10.1016/S0006-2952(99)00105-7; NIMPF J, 1988, J LIPID RES, V29, P657; Norton TT, 2013, EXP EYE RES, V114, P48, DOI 10.1016/j.exer.2013.05.004; NORTON TT, 1995, VISION RES, V35, P1271, DOI 10.1016/0042-6989(94)00243-F; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; NOY N, 1992, BIOCHIM BIOPHYS ACTA, V1106, P159, DOI 10.1016/0005-2736(92)90234-D; Ong DE, 2000, BBA-PROTEIN STRUCT M, V1482, P209, DOI 10.1016/S0167-4838(00)00156-4; Oram J. F., 2000, J BIOL CHEM, V275, P34508; PETERSON PA, 1971, J BIOL CHEM, V246, P7544; Rada JA, 2000, INVEST OPHTH VIS SCI, V41, P2050; RADA JA, 1991, DEV BIOL, V147, P303, DOI 10.1016/0012-1606(91)90288-E; Rada JA, 2001, CURR EYE RES, V22, P121, DOI 10.1076/ceyr.22.2.121.5525; Rada JAS, 2012, INVEST OPHTH VIS SCI, V53, P1649, DOI 10.1167/iovs.11-8444; Rengarajan K, 2001, BIOCHEM BIOPH RES CO, V284, P268, DOI 10.1006/bbrc.2001.4960; Rose KA, 2008, OPHTHALMOLOGY, V115, P1279, DOI 10.1016/j.ophtha.2007.12.019; ROSS AC, 1980, J LIPID RES, V21, P100; Seko Y, 1998, OPHTHALMIC RES, V30, P361, DOI 10.1159/000055496; SHACKELFORD JE, 1983, J BIOL CHEM, V258, P7175; Siegwart JT, 2011, OPTOMETRY VISION SCI, V88, pE365, DOI 10.1097/OPX.0b013e31820b053d; Smith EL, 2011, OPTOMETRY VISION SCI, V88, P1029, DOI 10.1097/OPX.0b013e3182279cfa; Summers JA, 2015, INVEST OPHTH VIS SCI, V56; Sun H, 2012, BBA-MOL CELL BIOL L, V1821, P99, DOI 10.1016/j.bbalip.2011.06.010; Sundaram M, 1998, BIOCHEM J, V334, P155, DOI 10.1042/bj3340155; Tanaka T, 1997, J BIOL CHEM, V272, P15789, DOI 10.1074/jbc.272.25.15789; Troilo D, 2006, INVEST OPHTH VIS SCI, V47, P1768, DOI 10.1167/iovs.05-0298; Vachali PP, 2013, ARCH BIOCHEM BIOPHYS, V539, P181, DOI 10.1016/j.abb.2013.07.008; YANCEY PG, 1995, BIOCHEMISTRY-US, V34, P7955, DOI 10.1021/bi00024a021; ZOLFAGHARI R, 1994, J LIPID RES, V35, P1985	67	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18991	19005		10.1074/jbc.M116.725523	http://dx.doi.org/10.1074/jbc.M116.725523			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402828	hybrid, Green Published			2022-12-26	WOS:000383242300034
J	Hayase, T				Hayase, Tamaki			Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor	PLOS ONE			English	Article							CANNABINOID CB1 RECEPTOR; ELEVATED PLUS-MAZE; INHIBITOR SODIUM-BUTYRATE; MOUSE FORCED SWIM; WORKING-MEMORY; ACETYLCHOLINE-RECEPTORS; INDUCED ACTIVATION; ANXIOLYTIC-LIKE; IMMOBILIZATION STRESS; ANTAGONIST RIMONABANT	Like various stressors, the addictive use of nicotine (NC) is associated with emotional symptoms such as anxiety and depression, although the underlying mechanisms have not yet been fully elucidated due to the complicated involvement of target neurotransmitter systems. In the elicitation of these emotional symptoms, the fundamental involvement of epigenetic mechanisms such as histone acetylation has recently been suggested. Furthermore, among the interacting neurotransmitter systems implicated in the effects of NC and stressors, the endocannabinoid (ECB) system is considered to contribute indispensably to anxiety and depression. In the present study, the epigenetic involvement of histone acetylation induced by histone deacetylase (HDAC) inhibitors was investigated in anxiety-and depression- related behavioral alterations caused by NC and/or immobilization stress (IM). Moreover, based on the contributing roles of the ECB system, the interacting influence of ECB ligands on the effects of HDAC inhibitors was evaluated in order to examine epigenetic therapeutic interventions. Anxiety-like (elevated plus-maze test) and depression-like (forced swimming test) behaviors, which were observed in mice treated with repeated (4 days) NC (subcutaneous 0.8 mg/kg) and/or IM (10 min), were blocked by the HDAC inhibitors sodium butyrate (SB) and valproic acid (VA). The cannabinoid type 1 (CB1) agonist ACPA (arachidonylcyclopropylamide; AC) also antagonized these behaviors. Conversely, the CB1 antagonist SR 141716A (SR), which counteracted the effects of AC, attenuated the anxiolytic-like effects of the HDAC inhibitors commonly in the NC and/or IM groups. SR also attenuated the antidepressant-like effects of the HDAC inhibitors, most notably in the IM group. From these results, the combined involvement of histone acetylation and ECB system was shown in anxiety-and depression-related behaviors. In the NC treatment groups, the limited influence of SR against the HDAC inhibitor-induced antidepressant-like effects may reflect the characteristic involvement of histone acetylation within the NC-related neurotransmitter systems other than the ECB system.	[Hayase, Tamaki] Kyoto Univ, Dept Legal Med, Kyoto 6068501, Japan	Kyoto University	Hayase, T (corresponding author), Kyoto Univ, Dept Legal Med, Kyoto 6068501, Japan.	thayase@mri.biglobe.ne.jp						Alves SH, 2004, BEHAV PHARMACOL, V15, P37, DOI 10.1097/00008877-200402000-00005; Anderson SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048665; Andreasen JT, 2011, J PSYCHOPHARMACOL, V25, P1134, DOI 10.1177/0269881110391831; Andreasen JT, 2009, BEHAV PHARMACOL, V20, P286, DOI 10.1097/FBP.0b013e32832c713e; ARMARIO A, 1991, PHARMACOL BIOCHEM BE, V39, P373, DOI 10.1016/0091-3057(91)90194-7; Aronson KR, 2008, ANN BEHAV MED, V36, P259, DOI 10.1007/s12160-008-9068-1; Balerio GN, 2006, PSYCHOPHARMACOLOGY, V184, P504, DOI 10.1007/s00213-005-0251-9; Bambico FR, 2012, PROG NEURO-PSYCHOPH, V38, P88, DOI 10.1016/j.pnpbp.2012.02.006; Benekareddy M, 2011, BIOL PSYCHIAT, V70, P1024, DOI 10.1016/j.biopsych.2011.08.005; Biala G, 2009, J PHYSIOL PHARMACOL, V60, P113; Biala G, 2006, LIFE SCI, V79, P81, DOI 10.1016/j.lfs.2005.12.043; Braida D, 2007, EUR J PHARMACOL, V555, P156, DOI 10.1016/j.ejphar.2006.10.038; Bruijnzeel AW, 2012, NEUROSCI BIOBEHAV R, V36, P1418, DOI 10.1016/j.neubiorev.2012.02.015; Castino MR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124796; Chegini HR, 2014, BEHAV BRAIN RES, V261, P114, DOI 10.1016/j.bbr.2013.12.007; Chen YW, 2012, NEUROSCIENCE, V206, P155, DOI 10.1016/j.neuroscience.2011.12.009; Childs E, 2009, PSYCHOPHARMACOLOGY, V203, P1, DOI 10.1007/s00213-008-1359-5; Choi D, 2015, INT J PSYCHOPHYSIOL, V98, P470, DOI 10.1016/j.ijpsycho.2015.10.005; Cippitelli A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028142; CLARKE PBS, 1990, CIBA F SYMP, V152, P153; Cohen A, 2009, PSYCHOPHARMACOLOGY, V204, P541, DOI 10.1007/s00213-009-1486-7; D'Addario C, 2013, FEBS J, V280, P1905, DOI 10.1111/febs.12125; DEANGELIS L, 1995, PHARMACOL BIOCHEM BE, V52, P329, DOI 10.1016/0091-3057(95)00100-B; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Dyrvig M, 2012, BRAIN RES BULL, V88, P507, DOI 10.1016/j.brainresbull.2012.05.004; Edwards AC, 2011, NICOTINE TOB RES, V13, P677, DOI 10.1093/ntr/ntr058; Egashira N, 2008, EUR J PHARMACOL, V589, P117, DOI 10.1016/j.ejphar.2008.03.046; Faraday MM, 1999, PHARMACOL BIOCHEM BE, V62, P273, DOI 10.1016/S0091-3057(98)00159-2; Faraday MM, 2003, PHARMACOL BIOCHEM BE, V74, P325, DOI 10.1016/S0091-3057(02)00999-1; Faravelli C, 2012, CURR PHARM DESIGN, V18, P5663, DOI 10.2174/138161212803530907; Ferland CL, 2014, ENDOCRINOLOGY, V155, P2942, DOI 10.1210/en.2013-1918; File SE, 1996, PHARMACOL BIOCHEM BE, V54, P3, DOI 10.1016/0091-3057(95)02175-2; FILE SE, 1988, NEUROPSYCHOBIOLOGY, V20, P82, DOI 10.1159/000118478; File SE, 2000, PHARMACOL BIOCHEM BE, V66, P65, DOI 10.1016/S0091-3057(00)00198-2; Fisher DJ, 2012, BRAIN RES, V1429, P72, DOI 10.1016/j.brainres.2011.10.029; Fokos S, 2010, J PSYCHOPHARMACOL, V24, P767, DOI 10.1177/0269881109104904; Gagliano H, 2014, NEUROPHARMACOLOGY, V79, P75, DOI 10.1016/j.neuropharm.2013.10.031; Gangarossa G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019415; Gilbert DG, 1997, PSYCHOPHARMACOLOGY, V130, P197, DOI 10.1007/s002130050229; Gold PW, 2015, MOL PSYCHIATR, V20, P32, DOI 10.1038/mp.2014.163; Gonzalez-Aparicio R, 2014, NEUROBIOL DIS, V62, P416, DOI 10.1016/j.nbd.2013.10.008; Gozen O, 2013, SYNAPSE, V67, P545, DOI 10.1002/syn.21659; Griebel G, 2005, BIOL PSYCHIAT, V57, P261, DOI 10.1016/j.biopsych.2004.10.032; Grundey J, 2015, PSYCHOPHARMACOLOGY, V232, P2491, DOI 10.1007/s00213-015-3880-7; Grundey J, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00186; Gundersen BB, 2009, NEUROPHARMACOLOGY, V57, P67, DOI 10.1016/j.neuropharm.2009.04.008; Haring M, 2007, NEUROSCIENCE, V146, P1212, DOI 10.1016/j.neuroscience.2007.02.021; Haring M, 2013, NEUROPHARMACOLOGY, V65, P83, DOI 10.1016/j.neuropharm.2012.09.002; Haring M, 2012, NEUROSCIENCE, V204, P145, DOI 10.1016/j.neuroscience.2011.12.035; Hale MW, 2012, CELL MOL NEUROBIOL, V32, P695, DOI 10.1007/s10571-012-9827-1; Haller J, 2007, EUR J NEUROSCI, V25, P2445, DOI 10.1111/j.1460-9568.2007.05476.x; Han A, 2014, NEUROPHARMACOLOGY, V81, P292, DOI 10.1016/j.neuropharm.2014.02.017; Harrist A, 2004, SYNAPSE, V54, P200, DOI 10.1002/syn.20081; Hayase T, 2000, Nihon Arukoru Yakubutsu Igakkai Zasshi, V35, P402; Hayase T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-76; Hayase T, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-20; Hayase Tamaki, 2011, BMC Pharmacology, V11, P6, DOI 10.1186/1471-2210-11-6; Hayase T, 2011, J TOXICOL SCI, V36, P31, DOI 10.2131/jts.36.31; Hermann H, 2002, NEUROSCIENCE, V109, P451, DOI 10.1016/S0306-4522(01)00509-7; Hill MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2591, DOI 10.1038/sj.npp.1301092; Hill MN, 2004, EUR J PHARMACOL, V499, P291, DOI 10.1016/j.ejphar.2004.06.069; Hsu HR, 2007, EUR J PHARMACOL, V566, P124, DOI 10.1016/j.ejphar.2007.03.040; Hughes JR, 2007, NICOTINE TOB RES, V9, P315, DOI 10.1080/14622200701188919; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji SJ, 2014, BRAIN RES, V1577, P77, DOI 10.1016/j.brainres.2014.06.035; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kaplan GB, 2011, PHARMACOL BIOCHEM BE, V99, P217, DOI 10.1016/j.pbb.2011.01.009; Kelsey JE, 2009, BEHAV BRAIN RES, V203, P304, DOI 10.1016/j.bbr.2009.04.035; Kinlein SA, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00031; Kobayashi H, 2012, NEUROSCI RES, V72, P355, DOI 10.1016/j.neures.2011.12.009; Kotlyar M, 2011, NICOTINE TOB RES, V13, P492, DOI 10.1093/ntr/ntr011; Lanfumey L, 2008, NEUROSCI BIOBEHAV R, V32, P1174, DOI 10.1016/j.neubiorev.2008.04.006; Leventhal AM, 2013, DRUG ALCOHOL DEPEN, V133, P324, DOI 10.1016/j.drugalcdep.2013.06.015; Li S, 2006, PHARMACOL BIOCHEM BE, V85, P324, DOI 10.1016/j.pbb.2006.08.015; Liu D, 2014, EXP BIOL MED, V239, P330, DOI 10.1177/1535370213513987; Loughlin SE, 2006, J COMP NEUROL, V497, P575, DOI 10.1002/cne.20999; Lutfy K, 2006, J NEUROCHEM, V99, P1321, DOI 10.1111/j.1471-4159.2006.04217.x; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Mannucci C, 2011, NICOTINE TOB RES, V13, P239, DOI 10.1093/ntr/ntq242; Marco EM, 2004, BEHAV PHARMACOL, V15, P21, DOI 10.1097/00008877-200402000-00003; McEwen BS, 2012, NEUROPHARMACOLOGY, V62, P3, DOI 10.1016/j.neuropharm.2011.07.014; McLaughlin RJ, 2012, NEUROSCIENCE, V204, P134, DOI 10.1016/j.neuroscience.2011.07.052; McMahon LR, 2007, EUR J PHARMACOL, V569, P70, DOI 10.1016/j.ejphar.2007.04.054; Melis M, 2008, J NEUROSCI, V28, P13985, DOI 10.1523/JNEUROSCI.3221-08.2008; Mineur YS, 2016, NEUROPSYCHOPHARMACOL, V41, P1579, DOI 10.1038/npp.2015.316; Mineur YS, 2013, P NATL ACAD SCI USA, V110, P3573, DOI 10.1073/pnas.1219731110; Molteni R, 2010, J PSYCHOPHARMACOL, V24, P595, DOI 10.1177/0269881108099815; Moonat S, 2013, BIOL PSYCHIAT, V73, P763, DOI 10.1016/j.biopsych.2013.01.012; Morilak DA, 2005, PROG NEURO-PSYCHOPH, V29, P1214, DOI 10.1016/j.pnpbp.2005.08.007; MORSE DE, 1989, PSYCHOPHARMACOLOGY, V98, P539, DOI 10.1007/BF00441956; Nestler EJ, 2014, NEUROPHARMACOLOGY, V76, P259, DOI 10.1016/j.neuropharm.2013.04.004; Newman MB, 2001, PROG NEURO-PSYCHOPH, V25, P609, DOI 10.1016/S0278-5846(00)00178-0; Nikolaus S, 2010, REV NEUROSCIENCE, V21, P119; Nikolaus S, 2009, BEHAV BRAIN RES, V204, P32, DOI 10.1016/j.bbr.2009.06.009; Ookubo M, 2013, J PSYCHIATR RES, V47, P1204, DOI 10.1016/j.jpsychires.2013.05.028; Papadopoulos A, 2011, EUR NEUROPSYCHOPHARM, V21, P316, DOI 10.1016/j.euroneuro.2010.05.005; Parrott AC, 2004, PSYCHOL REP, V94, P33; Pastor V, 2011, J NEUROCHEM, V116, P636, DOI 10.1111/j.1471-4159.2010.07149.x; Patel S, 2004, ENDOCRINOLOGY, V145, P5431, DOI 10.1210/en.2004-0638; Pathak G, 2015, NEUROPHARMACOLOGY, V95, P434, DOI 10.1016/j.neuropharm.2015.04.026; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PETRAGLIA F, 1986, NEUROENDOCRINOLOGY, V44, P320, DOI 10.1159/000124663; Philip NS, 2010, PSYCHOPHARMACOLOGY, V212, P1, DOI 10.1007/s00213-010-1932-6; Picciotto MR, 2008, PROG NEUROBIOL, V84, P329, DOI 10.1016/j.pneurobio.2007.12.005; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; Picciotto MR, 2002, NEUROREPORT, V13, P1097, DOI 10.1097/00001756-200207020-00006; Popik P, 2005, EUR J PHARMACOL, V515, P128, DOI 10.1016/j.ejphar.2005.04.009; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prini P, 2013, 36 C NAZ SOC IT FARM; Prior H, 2004, HIPPOCAMPUS, V14, P135, DOI 10.1002/hipo.10166; Rey AA, 2012, NEUROPSYCHOPHARMACOL, V37, P2624, DOI 10.1038/npp.2012.123; Richards JM, 2011, BIOL PSYCHOL, V88, P1, DOI 10.1016/j.biopsycho.2011.06.009; Riebe CJ, 2011, STRESS, V14, P384, DOI 10.3109/10253890.2011.586753; Rubino T, 2007, NEUROPSYCHOPHARMACOL, V32, P2036, DOI 10.1038/sj.npp.1301330; Sadri-Vakili G, 2007, HUM MOL GENET, V16, P1293, DOI 10.1093/hmg/ddm078; Sailaja BS, 2012, P NATL ACAD SCI USA, V109, pE3687, DOI 10.1073/pnas.1209990110; Scherma M, 2008, CNS NEUROL DISORD-DR, V7, P468, DOI 10.2174/187152708786927859; Schiltz CA, 2007, BIOL PSYCHIAT, V61, P127, DOI 10.1016/j.biopsych.2006.03.002; Schmidt HD, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012047; Schmuckermair C, 2013, NEUROPSYCHOPHARMACOL, V38, P1234, DOI 10.1038/npp.2013.21; Shingo AS, 2005, J NEURAL TRANSM, V112, P1475, DOI 10.1007/s00702-005-0370-2; Spencer SJ, 2004, EUR J NEUROSCI, V20, P1008, DOI 10.1111/j.1460-9568.2004.03569.x; Steiner MA, 2008, PSYCHONEUROENDOCRINO, V33, P54, DOI 10.1016/j.psyneuen.2007.09.008; STOLERMAN IP, 1991, TRENDS PHARMACOL SCI, V12, P467, DOI 10.1016/0165-6147(91)90638-9; Stone EA, 2007, PROG NEURO-PSYCHOPH, V31, P1196, DOI 10.1016/j.pnpbp.2007.04.010; Subbanna S, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu028; Suemaru K, 2006, PHYSIOL BEHAV, V88, P545, DOI 10.1016/j.physbeh.2006.05.007; Suri D, 2014, INT J NEUROPSYCHOPH, V17, P289, DOI 10.1017/S1461145713001004; Takahashi E, 2008, EUR J PHARMACOL, V589, P149, DOI 10.1016/j.ejphar.2008.05.020; Takahashi RN, 2005, NEUROSCI LETT, V380, P270, DOI 10.1016/j.neulet.2005.01.049; Takamura N, 2014, PROG NEURO-PSYCHOPH, V50, P116, DOI 10.1016/j.pnpbp.2013.12.011; Taylor G, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1151; Terzian AL, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00049; Turner JR, 2011, NICOTINE TOB RES, V13, P48, DOI 10.1093/ntr/ntq206; Umka J, 2010, NEUROSCIENCE, V166, P15, DOI 10.1016/j.neuroscience.2009.11.073; Vialou V, 2013, ANNU REV PHARMACOL, V53, P59, DOI 10.1146/annurev-pharmtox-010611-134540; Viveros MP, 2007, BEHAV PHARMACOL, V18, P375, DOI 10.1097/FBP.0b013e3282d28fb4; Waddington CH, 2012, INT J EPIDEMIOL, V41, P10, DOI 10.1093/ije/dyr184; West R, 1997, AM J PSYCHIAT, V154, P1589, DOI 10.1176/ajp.154.11.1589; Wong CCY, 2011, ADDICTION, V106, P480, DOI 10.1111/j.1360-0443.2010.03321.x; World Health Organization, 2019, WHO REPORT GLOBAL TO; World Health Organization-WHO, 2013, WHO REP GLOB TOB EP; Xing B, 2013, BEHAV BRAIN RES, V243, P261, DOI 10.1016/j.bbr.2013.01.019; YOSHIDA T, 1994, PHYSIOL BEHAV, V55, P53, DOI 10.1016/0031-9384(94)90009-4	144	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158950	10.1371/journal.pone.0158950	http://dx.doi.org/10.1371/journal.pone.0158950			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27404492	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508200023
J	Korbut, R; Mehrdana, F; Kania, PW; Larsen, MH; Frees, D; Dalsgaard, I; Jorgensen, LV				Korbut, Rozalia; Mehrdana, Foojan; Kania, Per Walter; Larsen, Marianne Halberg; Frees, Dorte; Dalsgaard, Inger; Jorgensen, Louise von Gersdorff			Antigen Uptake during Different Life Stages of Zebrafish (Danio rerio) Using a GFP-Tagged Yersinia ruckeri	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; INNATE IMMUNE-RESPONSE; RAINBOW-TROUT; AEROMONAS-SALMONICIDA; MODEL ORGANISM; GILL CELLS; IN-VITRO; SYSTEM; PROTEIN; TRANSPARENT	Immersion-vaccines (bacterins) are routinely used for aquacultured rainbow trout to protect against Yersinia ruckeri (Yr). During immersion vaccination, rainbow trout take up and process the antigens, which induce protection. The zebrafish was used as a model organism to study uptake mechanisms and subsequent antigen transport in fish. A genetically modified Yr was developed to constitutively express green fluorescent protein (GFP) and was used for bacterin production. Larval, juvenile and adult transparent zebrafish (tra:nac mutant) received a bath in the bacterin for up to 30 minutes. Samples were taken after 1 min, 15 min, 30 min, 2 h, 12 h and 24 h. At each sampling point fish were used for live imaging of the uptake using a fluorescence stereomicroscope and for immunohistochemistry (IHC). In adult fish, the bacterin could be traced within 30 min in scale pockets, skin, oesophagus, intestine and fins. Within two hours post bath (pb) Yr-antigens were visible in the spleen and at 24 h in liver and kidney. Bacteria were associated with the gills, but uptake at this location was limited. Antigens were rarely detected in the blood and never in the nares. In juvenile fish uptake of the bacterin was seen in the intestine 30 min pb and in the nares 2 hpb but never in scale pockets. Antigens were detected in the spleen 12 hpb. Zebrafish larvae exhibited major Yr uptake only in the mid-intestine enterocytes 24 hpb. The different life stages of zebrafish varied with regard to uptake locations, however the gut was consistently a major uptake site. Zebrafish and rainbow trout tend to have similar uptake mechanisms following immersion or bath vaccination, which points towards zebrafish as a suitable model organism for this aquacultured species.	[Korbut, Rozalia; Mehrdana, Foojan; Kania, Per Walter; Jorgensen, Louise von Gersdorff] Univ Copenhagen, Dept Vet Dis Biol, Lab Aquat Pathobiol, Frederiksberg, Denmark; [Larsen, Marianne Halberg; Frees, Dorte] Univ Copenhagen, Dept Vet Dis Biol, Food Safety & Zoonoses, Frederiksberg, Denmark; [Dalsgaard, Inger] Tech Univ Denmark, Natl Vet Inst, Sect Bacteriol & Pathol, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen; Technical University of Denmark	Jorgensen, LV (corresponding author), Univ Copenhagen, Dept Vet Dis Biol, Lab Aquat Pathobiol, Frederiksberg, Denmark.	lvgj@sund.ku.dk		Larsen, Marianne Halberg/0000-0001-6242-6937; Dalsgaard, Inger/0000-0003-2066-1060; Jorgensen, Louise von Gersdorff/0000-0002-6005-3249; Frees, Dorte/0000-0003-4946-2890	Danish Council for Independent Research, Technology and Production Sciences, LVGJ; Villum Foundation, Denmark [VKR022858]; Villum Fonden [00007220] Funding Source: researchfish	Danish Council for Independent Research, Technology and Production Sciences, LVGJ; Villum Foundation, Denmark; Villum Fonden(Villum Fonden)	This work was supported by the Danish Council for Independent Research, Technology and Production Sciences, (http://ufm.dk/en/research-and-innovation/councils-and-commissions/the-danish-council-for-independent-research) LVGJ. Grant no. VKR022858 to Kurt Buchmann from the Villum Foundation, Denmark. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 2000, DEV DYNAM, V219, P155, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1052>3.3.CO;2-B; Berghmans S, 2005, BIOTECHNIQUES, V39, P227, DOI 10.2144/05392RV02; Cantas L, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-37; Chettri JK, 2012, DEV COMP IMMUNOL, V36, P463, DOI 10.1016/j.dci.2011.08.014; Chettri JK, 2013, VET IMMUNOL IMMUNOP, V154, P42, DOI 10.1016/j.vetimm.2013.04.001; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Ellis A.E, 1988, FISH VACCINATION; Encinas P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-518; FERGUSON HW, 1976, J COMP PATHOL, V86, P377, DOI 10.1016/0021-9975(76)90005-0; Fishman MC, 2001, SCIENCE, V294, P1290, DOI 10.1126/science.1066652; Fortineau N, 2000, RES MICROBIOL, V151, P353, DOI 10.1016/S0923-2508(00)00158-3; Fuiman LA, 1998, COPEIA, P602, DOI 10.2307/1447790; Gomez-Requeni P, 2011, COMP BIOCHEM PHYS D, V6, P178, DOI 10.1016/j.cbd.2011.02.002; Handy RD, 2011, J FISH BIOL, V79, P821, DOI 10.1111/j.1095-8649.2011.03080.x; Harmache A, 2006, J VIROL, V80, P3655, DOI 10.1128/JVI.80.7.3655-3659.2006; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; JOHNSON KA, 1982, J FISH DIS, V5, P207, DOI 10.1111/j.1365-2761.1982.tb00475.x; Jorgensen LV, 2011, J FISH DIS, V34, P749, DOI 10.1111/j.1365-2761.2011.01291.x; Khimmakthong U, 2013, MICROB PATHOGENESIS, V59-60, P33, DOI 10.1016/j.micpath.2013.03.001; Krauss J, 2013, BIOL OPEN, V2, P703, DOI 10.1242/bio.20135132; Kwok KWH, 2012, AQUAT TOXICOL, V120, P59, DOI 10.1016/j.aquatox.2012.04.012; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; LaPatra S, 2015, VACCINE, V33, P771, DOI 10.1016/j.vaccine.2014.12.055; Ledent V, 2002, DEVELOPMENT, V129, P597; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Lin B, 2007, MOL IMMUNOL, V44, P295, DOI 10.1016/j.molimm.2006.03.001; Lister JA, 1999, DEVELOPMENT, V126, P3757; Lu AJ, 2014, FISH SHELLFISH IMMUN, V36, P229, DOI 10.1016/j.fsi.2013.11.007; Ludwig M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001269; McCollum CW, 2011, BIRTH DEFECTS RES C, V93, P67, DOI 10.1002/bdrc.20210; Meeker ND, 2008, DEV COMP IMMUNOL, V32, P745, DOI 10.1016/j.dci.2007.11.011; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Novoa B, 2006, VACCINE, V24, P5806, DOI 10.1016/j.vaccine.2006.05.015; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; Ohtani M, 2014, PLOS ONE, V9; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Rendueles O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002815; Ribas L, 2014, REV AQUACULT, V6, P209, DOI 10.1111/raq.12041; ROBOHM RA, 1995, FISH SHELLFISH IMMUN, V5, P137, DOI 10.1016/S1050-4648(05)80023-3; Rodriguez I, 2008, FISH SHELLFISH IMMUN, V25, P239, DOI 10.1016/j.fsi.2008.05.002; Ruyra A, 2014, VACCINE, V32, P3955, DOI 10.1016/j.vaccine.2014.05.010; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; TATNER MF, 1984, J FISH BIOL, V25, P95, DOI 10.1111/j.1095-8649.1984.tb04854.x; TORROBA M, 1993, HISTOL HISTOPATHOL, V8, P363; Traver D, 2003, ADV IMMUNOL, V81, P253; Ulloa PE, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00313; Ulloa PE, 2011, REV FISH BIOL FISHER, V21, P649, DOI 10.1007/s11160-011-9203-0; Uribe C, 2011, VET MED-CZECH, V56, P486, DOI 10.17221/3294-VETMED; Volff JN, 2005, HEREDITY, V94, P280, DOI 10.1038/sj.hdy.6800635; WALKER C, 1983, GENETICS, V103, P125; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Yoder JA, 2002, MICROBES INFECT, V4, P1469, DOI 10.1016/S1286-4579(02)00029-1; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; ZAPATA AG, 1987, J FISH BIOL, V31, P209, DOI 10.1111/j.1095-8649.1987.tb05315.x; Zhang ZH, 2012, FISH SHELLFISH IMMUN, V33, P36, DOI 10.1016/j.fsi.2012.03.031; Zon LI, 2005, NAT REV DRUG DISCOV, V4, P35, DOI 10.1038/nrd1606	58	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158968	10.1371/journal.pone.0158968	http://dx.doi.org/10.1371/journal.pone.0158968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404564	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508200024
J	Priller, JPR; Reid, S; Konein, P; Dietrich, P; Sonnewald, S				Priller, Johannes Peter Roman; Reid, Stephen; Konein, Patrick; Dietrich, Petra; Sonnewald, Sophia			The Xanthomonas campestris pv. vesicatoria Type-3 Effector XopB Inhibits Plant Defence Responses by Interfering with ROS Production	PLOS ONE			English	Article							PSEUDOMONAS-SYRINGAE EFFECTOR; APOPLASTIC OXIDATIVE BURST; NADPH OXIDASE RBOHD; ARABIDOPSIS INNATE IMMUNITY; SALICYLIC-ACID; III EFFECTORS; MOLECULAR CHARACTERIZATION; PATHOGEN INTERACTIONS; MICROBE INTERACTIONS; BACTERIAL PATHOGENS	The bacterial pathogen Xanthomonas campestris pv. vesicatoria 85-10 (Xcv) translocates about 30 type-3 effector proteins (T3Es) into pepper plants (Capsicum annuum) to suppress plant immune responses. Among them is XopB which interferes with PTI, ETI and sugar-mediated defence responses, but the underlying molecular mechanisms and direct targets are unknown so far. Here, we examined the XopB-mediated suppression of plant defence responses in more detail. Infection of susceptible pepper plants with Xcv lacking xopB resulted in delayed symptom development compared to Xcv wild type infection concomitant with an increased formation of salicylic acid (SA) and expression of pathogenesis-related (PR) genes. Expression of xopB in Arabidopsis thaliana promoted the growth of the virulent Pseudomonas syringae pv. tomato (Pst) DC3000 strain. This was paralleled by a decreased SA-pool and a lower induction of SA-dependent PR gene expression. The expression pattern of early flg22-responsive marker genes indicated that MAPK signalling was not altered in the presence of XopB. However, XopB inhibited the flg22-triggered burst of reactive oxygen species (ROS). Consequently, the transcript accumulation of AtOXI1, a ROS-dependent marker gene, was reduced in xopB-expressing Arabidopsis plants as well as callose deposition. The lower ROS production correlated with a low level of basal and flg22-triggered expression of apoplastic peroxidases and the NADPH oxidase RBOHD. Conversely, deletion of xopB in Xcv caused a higher production of ROS in leaves of susceptible pepper plants. Together our results demonstrate that XopB modulates ROS responses and might thereby compromise plant defence.	[Priller, Johannes Peter Roman; Reid, Stephen; Konein, Patrick; Sonnewald, Sophia] Univ Erlangen Nurnberg, Div Biochem, Dept Biol, Erlangen, Germany; [Dietrich, Petra] Univ Erlangen Nurnberg, Div Mol Plant Physiol, Dept Biol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Sonnewald, S (corresponding author), Univ Erlangen Nurnberg, Div Biochem, Dept Biol, Erlangen, Germany.	sophia.sonnewald@fau.de		Priller, Josef/0000-0001-7596-0979	Deutsche Forschungsgemeinschaft [SFB796]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by a grant from the Deutsche Forschungsgemeinschaft to SS in the frame of collaborative research centre "reprogramming of host cells by microbial effectors" (SFB796; http://www.dfg.de/en/research_funding/programmes/list/projectdetails/index.jsp?id=52732026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Arnold DL, 2001, PHYSIOL MOL PLANT P, V58, P55, DOI 10.1006/pmpp.2000.0315; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Biemelt S, 2006, J PLANT PHYSIOL, V163, P307, DOI 10.1016/j.jplph.2005.10.011; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Block A, 2005, PLANT PHYSIOL, V138, P1481, DOI 10.1104/pp.105.059246; Block A, 2008, CURR OPIN PLANT BIOL, V11, P396, DOI 10.1016/j.pbi.2008.06.007; Block A, 2014, NEW PHYTOL, V201, P1358, DOI 10.1111/nph.12626; Blume B, 2000, PLANT CELL, V12, P1425, DOI 10.1105/tpc.12.8.1425; Boldt R, 2001, J PLANT PHYSIOL, V158, P1591, DOI 10.1078/0176-1617-00571; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bolouri Moghaddam MR, 2012, J EXP BOT, V63, P3989, DOI 10.1093/jxb/ers129; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Caddick MX, 1998, NAT BIOTECHNOL, V16, P177, DOI 10.1038/nbt0298-177; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Choi HW, 2007, PLANT PHYSIOL, V145, P890, DOI 10.1104/pp.107.103325; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collmer A, 2009, PLANT PHYSIOL, V150, P1623, DOI 10.1104/pp.109.140327; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Deslandes L, 2012, TRENDS PLANT SCI, V17, P644, DOI 10.1016/j.tplants.2012.06.011; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dubiella U, 2013, P NATL ACAD SCI USA, V110, P8744, DOI 10.1073/pnas.1221294110; Engelsdorf T, 2013, PLANT PHYSIOL, V162, P225, DOI 10.1104/pp.112.209676; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Ferreira SJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-93; Gao XQ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003127; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Guo M, 2009, MOL PLANT MICROBE IN, V22, P1069, DOI 10.1094/MPMI-22-9-1069; Hao HQ, 2014, PLANT CELL, V26, P1729, DOI 10.1105/tpc.113.122358; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Herbers K, 1996, PLANT CELL, V8, P793, DOI 10.1105/tpc.8.5.793; Herbers K, 1996, FEBS LETT, V397, P239, DOI 10.1016/S0014-5793(96)01183-0; HOFGEN R, 1990, PLANT SCI, V66, P221, DOI 10.1016/0168-9452(90)90207-5; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kadota Y, 2015, PLANT CELL PHYSIOL, V56, P1472, DOI 10.1093/pcp/pcv063; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Kocal N, 2008, PLANT PHYSIOL, V148, P1523, DOI 10.1104/pp.108.127977; Li L, 2014, CELL HOST MICROBE, V15, P329, DOI 10.1016/j.chom.2014.02.009; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Liu YK, 2016, PLANT CELL REP, V35, P995, DOI 10.1007/s00299-016-1950-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Mammarella ND, 2015, PHYTOCHEMISTRY, V112, P110, DOI 10.1016/j.phytochem.2014.07.010; Munkvold KR, 2009, MOL PLANT PATHOL, V10, P777, DOI 10.1111/j.1364-3703.2009.00586.x; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Noel L, 2001, MOL MICROBIOL, V41, P1271, DOI 10.1046/j.1365-2958.2001.02567.x; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; O'Brien JA, 2012, PLANT PHYSIOL, V158, P2013, DOI 10.1104/pp.111.190140; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Proels RK, 2014, MOL PLANT PATHOL, V15, P858, DOI 10.1111/mpp.12139; Ranf S, 2008, PLANT J, V53, P287, DOI 10.1111/j.1365-313X.2007.03342.x; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Rodriguez-Herva JJ, 2012, CELL MICROBIOL, V14, P669, DOI 10.1111/j.1462-5822.2012.01749.x; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; Schulze S, 2012, NEW PHYTOL, V195, P894, DOI 10.1111/j.1469-8137.2012.04210.x; Segonzac C, 2011, PLANT PHYSIOL, V156, P687, DOI 10.1104/pp.110.171249; Silhavy D, 2002, EMBO J, V21, P3070, DOI 10.1093/emboj/cdf312; Sinha AK, 2002, PLANT PHYSIOL, V128, P1480, DOI 10.1104/pp.010771; Smith JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004578; Smith JM, 2014, PLANT PHYSIOL, V164, P440, DOI 10.1104/pp.113.229179; Sonnewald S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051763; Sun Y, 2009, SCIENCE, V342, P403; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Torres MA, 2005, NAT GENET, V37, P1130, DOI 10.1038/ng1639; Tsuda K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000772; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Voll LM, 2012, NEW PHYTOL, V195, P189, DOI 10.1111/j.1469-8137.2012.04129.x; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Xu J, 2014, PLANT J, V77, P222, DOI 10.1111/tpj.12382; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhang J, 2010, MOL PLANT, V3, P783, DOI 10.1093/mp/ssq035; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007	84	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159107	10.1371/journal.pone.0159107	http://dx.doi.org/10.1371/journal.pone.0159107			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398933	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508100020
J	Anzai, J; Nagayasu-Tanaka, T; Terashima, A; Asano, T; Yamada, S; Nozaki, T; Kitamura, M; Murakami, S				Anzai, Jun; Nagayasu-Tanaka, Toshie; Terashima, Akio; Asano, Taiji; Yamada, Satoru; Nozaki, Takenori; Kitamura, Masahiro; Murakami, Shinya			Long-term Observation of Regenerated Periodontium Induced by FGF-2 in the Beagle Dog 2-Wall Periodontal Defect Model	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; GUIDED TISSUE REGENERATION; INTRA-BONY DEFECTS; IMPLANTATION; STIMULATION; MATURATION; THERAPY; CELLS; BFGF	The long-term stability and qualitative characteristics of periodontium regenerated by FGF-2 treatment were compared with normal physiological healing tissue controls in a Beagle dog 2-wall periodontal defect model 13 months after treatment by assessing tissue histology and three-dimensional microstructure using micro-computed tomography (mu CT). After FGF-2 (0.3%) or vehicle treatment at the defect sites, serial changes in the bone mineral content (BMC) were observed using periodic X-ray imaging. Tissues were harvested at 13 months, evaluated histomorphometrically, and the cortical bone volume and trabecular bone structure of the newly formed bone were analyzed using mu CT. FGF-2 significantly increased the BMC of the defect area at 2 months compared with that of the control group, and this difference was unchanged through 13 months. The cortical bone volume was significantly increased by FGF-2, but there was no difference between the groups in trabecular bone structure. Bone maturation was occurring in both groups because of the lower cortical volume and denser trabecular bone than what is found in intact bone. FGF-2 also increased the area of newly formed bone as assessed histomorphometrically, but the ratios of trabecular bone in the defect area were similar between the control and FGF-2 groups. These results suggest that FGF-2 stimulates neogenesis of alveolar bone that is of similar quality to that of the control group. The lengths of the regenerated periodontal ligament and cementum, measured as the distance from the defect bottom to the apical end of the gingival epithelium, and height and area of the newly formed bone in the FGF-2 group were larger than those in the control group. The present study demonstrated that, within the limitation of artificial periodontal defect model, the periodontal tissue regenerated by FGF-2 was maintained for 13 months after treatment and was qualitatively equivalent to that generated through the physiological healing process.	[Anzai, Jun; Nagayasu-Tanaka, Toshie; Terashima, Akio; Asano, Taiji] Kaken Pharmaceut Co LTD, Drug Res Ctr, Dept Pharmacol, Yamashina Ku, Kyoto, Japan; [Nagayasu-Tanaka, Toshie; Yamada, Satoru; Nozaki, Takenori; Kitamura, Masahiro; Murakami, Shinya] Osaka Univ, Grad Sch Dent, Dept Periodontol, Suita, Osaka, Japan	Kaken Pharmaceutical Co Ltd; Osaka University	Murakami, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Periodontol, Suita, Osaka, Japan.	ipshinya@dent.osaka-u.ac.jp		Murakami, Shinya/0000-0002-5230-452X	Kaken Pharmaceutical Co., LTD.	Kaken Pharmaceutical Co., LTD.(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Kaken Pharmaceutical Co., LTD. The funder provided support in the form of salaries for authors [JA, TNT, ST, AT, and TA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Anzai J, 2010, BIOCHEM BIOPH RES CO, V403, P345, DOI 10.1016/j.bbrc.2010.11.032; Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x; BERGLUNDH T, 1991, J CLIN PERIODONTOL, V18, P616, DOI 10.1111/j.1600-051X.1991.tb00099.x; Bouxsein ML, 2003, OSTEOPOROSIS INT, V14, pS118, DOI 10.1007/s00198-003-1489-x; Eickholz P, 2007, J PERIODONTOL, V78, P37, DOI 10.1902/jop.2007.060097; GOTTLOW J, 1993, J PERIODONTOL, V64, P1157, DOI 10.1902/jop.1993.64.11s.1157; Graziani F, 2005, J CLIN PERIODONTOL, V32, P905, DOI 10.1111/j.1600-051X.2005.00789.x; Hidaka T, 2012, ARCH ORAL BIOL, V57, P830, DOI 10.1016/j.archoralbio.2011.12.003; Huja SS, 2008, J MORPHOL, V269, P138, DOI 10.1002/jmor.10582; Kallai I, 2011, NAT PROTOC, V6, P105, DOI 10.1038/nprot.2010.180; Kim TG, 2009, J CLIN PERIODONTOL, V36, P589, DOI 10.1111/j.1600-051X.2009.01420.x; Kinoshita A, 1997, J PERIODONTOL, V68, P103, DOI 10.1902/jop.1997.68.2.103; Kitamura M, 2016, J BONE MINER RES, V31, P806, DOI 10.1002/jbmr.2738; Kitamura M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002611; Laurell L, 2006, J CLIN PERIODONTOL, V33, P596, DOI 10.1111/j.1600-051X.2006.00951.x; Lee JS, 2012, J CLIN PERIODONTOL, V39, P466, DOI 10.1111/j.1600-051X.2012.01862.x; Muller R, 2009, NAT REV RHEUMATOL, V5, P373, DOI 10.1038/nrrheum.2009.107; Murakami S, 2003, J PERIODONTAL RES, V38, P97, DOI 10.1034/j.1600-0765.2003.00640.x; Murakami S, 1999, J PERIODONTAL RES, V34, P425, DOI 10.1111/j.1600-0765.1999.tb02277.x; Nagayasu-Tanaka T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131870; Nakamura K, 1997, J ORTHOPAED RES, V15, P307, DOI 10.1002/jor.1100150222; NAKAMURA T, 1995, ENDOCRINOLOGY, V136, P1276, DOI 10.1210/en.136.3.1276; Nevins M, 2005, J PERIODONTOL, V76, P2205, DOI 10.1902/jop.2005.76.12.2205; NYMAN S, 1982, J CLIN PERIODONTOL, V9, P290, DOI 10.1111/j.1600-051X.1982.tb02095.x; Park JC, 2012, J CLIN PERIODONTOL, V39, P565, DOI 10.1111/j.1600-051X.2012.01868.x; Pun S, 2000, BONE, V27, P197, DOI 10.1016/S8756-3282(00)00312-4; Sculean A, 2015, PERIODONTOL 2000, V68, P7, DOI 10.1111/prd.12091; Seo BM, 2004, LANCET, V364, P149, DOI 10.1016/S0140-6736(04)16627-0; Shirakata Y, 2010, J CLIN PERIODONTOL, V37, P374, DOI 10.1111/j.1600-051X.2010.01539.x; Slotte C, 2007, J CLIN PERIODONTOL, V34, P977, DOI 10.1111/j.1600-051X.2007.01138.x; Stavropoulos A, 2004, J CLIN PERIODONTOL, V31, P939, DOI 10.1111/j.1600-051X.2004.00586.x; Takayama S, 2001, J DENT RES, V80, P2075, DOI 10.1177/00220345010800121001; Takeda K, 2005, TISSUE ENG, V11, P1618, DOI 10.1089/ten.2005.11.1618	33	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158485	10.1371/journal.pone.0158485	http://dx.doi.org/10.1371/journal.pone.0158485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391131	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400067
J	Bhushan, C; Chong, MQ; Choi, S; Joshi, AA; Haldar, JP; Damasio, H; Leahy, RM				Bhushan, Chitresh; Chong, Minqi; Choi, Soyoung; Joshi, Anand A.; Haldar, Justin P.; Damasio, Hanna; Leahy, Richard M.			Temporal Non-Local Means Filtering Reveals Real-Time Whole-Brain Cortical Interactions in Resting fMRI	PLOS ONE			English	Article							HUMAN CONNECTOME PROJECT; FUNCTIONAL CONNECTIVITY; ARTIFACT REMOVAL; STATE FMRI; NETWORK; MRI; PARCELLATIONS; RESOLUTION; STRATEGY; IMAGES	Intensity variations over time in resting BOLD fMRI exhibit spatial correlation patterns consistent with a set of large scale cortical networks. However, visualizations of this data on the brain surface, even after extensive preprocessing, are dominated by local intensity fluctuations that obscure larger scale behavior. Our novel adaptation of non-local means (NLM) filtering, which we refer to as temporal NLM or tNLM, reduces these local fluctuations without the spatial blurring that occurs when using standard linear filtering methods. We show examples of tNLM filtering that allow direct visualization of spatio-temporal behavior on the cortical surface. These results reveal patterns of activity consistent with known networks as well as more complex dynamic changes within and between these networks. This ability to directly visualize brain activity may facilitate new insights into spontaneous brain dynamics. Further, temporal NLM can also be used as a preprocessor for resting fMRI for exploration of dynamic brain networks. We demonstrate its utility through application to graph-based functional cortical parcellation. Simulations with known ground truth functional regions demonstrate that tNLM filtering prior to parcellation avoids the formation of false parcels that can arise when using linear filtering. Application to resting fMRI data from the Human Connectome Project shows significant improvement, in comparison to linear filtering, in quantitative agreement with functional regions identified independently using task-based experiments as well as in test-retest reliability.	[Bhushan, Chitresh; Chong, Minqi; Choi, Soyoung; Joshi, Anand A.; Haldar, Justin P.; Leahy, Richard M.] Univ So Calif, Signal & Image Proc Inst, Los Angeles, CA USA; [Choi, Soyoung] Univ So Calif, Neurosci Grad Program, Los Angeles, CA USA; [Damasio, Hanna] Univ So Calif, Brain & Creat Inst Dornsife Coll Letters Arts & S, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California	Leahy, RM (corresponding author), Univ So Calif, Signal & Image Proc Inst, Los Angeles, CA USA.	leahy@sipi.usc.edu	Joshi, Anand/AAA-8378-2020; Bhushan, Chitresh/AAG-3305-2020; Haldar, Justin P/B-4983-2008	Joshi, Anand/0000-0002-9582-3848; Bhushan, Chitresh/0000-0002-2935-2515; Haldar, Justin P/0000-0002-1838-0211; Choi, So Young/0000-0001-7165-4691	National Institutes of Health [R01 NS089212, R01 NS074980, R01 EB009048]; 16 NIH Institutes and Centers [1U54MH091657]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089212, R01NS074980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 16 NIH Institutes and Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Clinical Center (CC)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health grants R01 NS089212, R01 NS074980 and R01 EB009048.; Data were provided [in part] by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. This research was supported by NIH grants R01 NS089212, R01 NS074980 and R01 EB009048.	Angenent S, 1999, IEEE T MED IMAGING, V18, P700, DOI 10.1109/42.796283; [Anonymous], 2014, WU MINN HCP 500 SUBJ; ANTROBUS JS, 1970, T NEW YORK ACAD SCI, V32, P242, DOI 10.1111/j.2164-0947.1970.tb02056.x; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; Bernier M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00715; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, NEUROIMAGE, V37, P1091, DOI 10.1016/j.neuroimage.2007.01.010; Chambers MC, 2015, I S BIOMED IMAGING, P1364, DOI 10.1109/ISBI.2015.7164129; Coupe P, 2008, IEEE T MED IMAGING, V27, P425, DOI 10.1109/TMI.2007.906087; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Duna J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081390; Faro S. H., 2006, FUNCTIONAL MRI BASIC; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Fransson P, 2002, NEUROIMAGE, V16, P977, DOI 10.1006/nimg.2002.1079; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726; Gibbons J.D., 2003, NONPARAMETRIC STAT I, V4th; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Joshi AA, 2009, IEEE T IMAGE PROCESS, V18, P1358, DOI 10.1109/TIP.2009.2016163; Kelly RE, 2010, J NEUROSCI METH, V189, P233, DOI 10.1016/j.jneumeth.2010.03.028; Khullar S, 2011, NEUROIMAGE, V54, P2867, DOI 10.1016/j.neuroimage.2010.10.063; Kruggel F, 1999, NEUROIMAGE, V10, P530, DOI 10.1006/nimg.1999.0490; Kundu P, 2013, P NATL ACAD SCI USA, V110, P16187, DOI 10.1073/pnas.1301725110; Li BJ, 2011, NEUROIMAGE, V58, P442, DOI 10.1016/j.neuroimage.2011.01.085; Manjon JV, 2008, MED IMAGE ANAL, V12, P514, DOI 10.1016/j.media.2008.02.004; Manjon JV, 2009, INT J BIOMED IMAGING, V2009, DOI 10.1155/2009/756897; Mikl M, 2008, MAGN RESON IMAGING, V26, P490, DOI 10.1016/j.mri.2007.08.006; Pruim RHR, 2015, NEUROIMAGE, V112, P267, DOI 10.1016/j.neuroimage.2015.02.064; Raichle ME, 2011, BRAIN CONNECT, V1, P3, DOI 10.1089/brain.2011.0019; Rydell J, 2008, IEEE J-STSP, V2, P891, DOI 10.1109/JSTSP.2008.2007826; Seo S, 2011, I S BIOMED IMAGING, P372, DOI 10.1109/ISBI.2011.5872426; Seo S, 2010, LECT NOTES COMPUT SC, V6363, P505; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Smith SM, 2013, TRENDS COGN SCI, V17, P666, DOI 10.1016/j.tics.2013.09.016; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Song X, 2006, IEEE IMAGE PROC, P2857, DOI 10.1109/ICIP.2006.313025; St-Jean S, 2014, JOINT ANN M ISMRM ES, P758; Thirion B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00167; Tohka J, 2008, NEUROIMAGE, V39, P1227, DOI 10.1016/j.neuroimage.2007.10.013; Triantafyllou C, 2006, NEUROIMAGE, V32, P551, DOI 10.1016/j.neuroimage.2006.04.182; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Essen DC, 2012, CEREB CORTEX, V22, P2241, DOI 10.1093/cercor/bhr291; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Wiest-Daessle N, 2008, LECT NOTES COMPUT SC, V5242, P171, DOI 10.1007/978-3-540-85990-1_21; Wig GS, 2014, NEUROIMAGE, V93, P276, DOI 10.1016/j.neuroimage.2013.07.035; Wink AM, 2004, IEEE T MED IMAGING, V23, P374, DOI 10.1109/TMI.2004.824234; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Xing XX, 2013, 19 ANN M ORG HUM BRA, P2030; Yu SX, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P313, DOI 10.1109/iccv.2003.1238361; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111; Zuo XN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026703	57	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158504	10.1371/journal.pone.0158504	http://dx.doi.org/10.1371/journal.pone.0158504			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391481	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400071
J	Kwiatek, M; Majka, M; Majka, J; Belter, J; Suchowilska, E; Wachowska, U; Wiwart, M; Wisniewska, H				Kwiatek, Michal; Majka, Maciej; Majka, Joanna; Belter, Jolanta; Suchowilska, Elzbieta; Wachowska, Urszula; Wiwart, Marian; Wisniewska, Halina			Intraspecific Polymorphisms of Cytogenetic Markers Mapped on Chromosomes of Triticum polonicum L.	PLOS ONE			English	Article							FUSARIUM HEAD BLIGHT; IN-SITU HYBRIDIZATION; RIBOSOMAL-RNA GENES; GENOME DIFFERENTIATION; TETRAPLOID WHEAT; B-GENOME; POLYPLOID WHEATS; BREAD WHEAT; EVOLUTION; AEGILOPS	Triticum genus encloses several tetraploid species that are used as genetic stocks for expanding the genetic variability of wheat (Triticum aestivum L.). Although the T. aestivum (2n = 6x = 42, AABBDD) and T. durum (2n = 4x = 28, AABB) karyotypes were well examined by chromosome staining, Giemsa C-banding and FISH markers, other tetraploids are still poorly characterized. Here, we established and compared the fluorescence in situ hybridization (FISH) patterns on chromosomes of 20 accessions of T. polonicum species using different repetitive sequences from BAC library of wheat 'Chinese Spring'. The chromosome patterns of Polish wheat were compared to tetraploid (2n = 4x = 28, AABB) Triticum species: T. durum, T. diccocon and T. turanicum, as well. A combination of pTa-86, pTa-535 and pTa-713 probes was the most informative among 6 DNA probes tested. Probe pTa-k374, which is similar to 28S rDNA sequence enabled to distinguish signal size and location differences, as well as rDNA loci elimination. Furthermore, pTa-465 and pTa-k566 probes are helpful for the detection of similar organized chromosomes. The polymorphisms of signals distribution were observed in 2A, 2B, 3B, 5B, 6A and 7B chromosomes. Telomeric region of the short arm of 6B chromosome was the most polymorphic. Our work is novel and contributes to the understanding of T. polonicum genome organization which is essential to develop successful advanced breeding strategies for wheat. Collection and characterization of this germplasm can contribute to the wheat biodiversity safeguard.	[Kwiatek, Michal; Majka, Maciej; Majka, Joanna; Belter, Jolanta; Wisniewska, Halina] Polish Acad Sci, Inst Plant Genet, Strzeszynska 34, PL-60479 Poznan, Poland; [Suchowilska, Elzbieta; Wiwart, Marian] Univ Warmia & Mazury, Dept Plant Breeding & Seed Prod, Pl Lodzki 3, PL-10727 Olsztyn, Poland; [Wachowska, Urszula] Univ Warmia & Mazury, Dept Entomol Phytopathol & Mol Diagnost, Pl Lodzki 3, PL-10727 Olsztyn, Poland	Polish Academy of Sciences; Institute of Plant Genetics of the Polish Academy of Sciences; University of Warmia & Mazury; University of Warmia & Mazury	Kwiatek, M (corresponding author), Polish Acad Sci, Inst Plant Genet, Strzeszynska 34, PL-60479 Poznan, Poland.	mkwi@igr.poznan.pl	Wiwart, Marian/ABC-4518-2020; Majka, Maciej/ABG-2805-2020; Wiwart, Marian/AAC-6367-2021; Kwiatek, Michał T./ABG-5673-2020	Wiwart, Marian/0000-0003-2693-7021; Majka, Maciej/0000-0002-5039-9465; Kwiatek, Michał T./0000-0001-9442-3124; Suchowilska, Elzbieta/0000-0002-8999-6742; Majka, Joanna/0000-0001-9918-2980; Wachowska, Urszula/0000-0002-9043-6128	National Science Centre [SONATA6-2013/11/D/NZ9/02719]	National Science Centre(National Science Centre, Poland)	This work was supported by grant from the National Science Centre (SONATA6-2013/11/D/NZ9/02719).	Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Badaeva ED, 2010, RUSS J GENET+, V46, P769, DOI 10.1134/S102279541007001X; Badaeva ED, 2004, PLANT SYST EVOL, V246, P45, DOI 10.1007/s00606-003-0072-4; Badaeva ED, 1996, GENOME, V39, P1150, DOI 10.1139/g96-145; Badaeva ED, 2002, PLANT SYST EVOL, V231, P163, DOI 10.1007/s006060200018; Badaeva ED, 2015, CYTOGENET GENOME RES, V146, P71, DOI 10.1159/000433458; Buerstmayr H, 2003, EUPHYTICA, V130, P17, DOI 10.1023/A:1022324727780; Cuadrado A, 2000, THEOR APPL GENET, V101, P711, DOI 10.1007/s001220051535; Cuadrado A, 2008, GENOME, V51, P809, DOI 10.1139/G08-065; Dean M, 2007, J CEREAL SCI, V46, P188, DOI 10.1016/j.jcs.2007.06.007; DUBCOVSKY J, 1995, GENETICS, V140, P1367; Dvorak J, LINNEAN, P127; Dvorak J, 2006, MOL BIOL EVOL, V23, P1386, DOI 10.1093/molbev/msl004; Endo TR, 1996, J HERED, V87, P295, DOI 10.1093/oxfordjournals.jhered.a023003; FLAVELL RB, 1974, BIOCHEM GENET, V12, P257, DOI 10.1007/BF00485947; GERLACH WL, 1980, NUCLEIC ACIDS RES, V8, P4851, DOI 10.1093/nar/8.21.4851; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; GILL BS, 1974, P NATL ACAD SCI USA, V71, P4086, DOI 10.1073/pnas.71.10.4086; Goral T, 2015, PLANT PATHOLOGY J, V31, P226, DOI 10.5423/PPJ.OA.03.2015.0038; Grausgruber H, 2005, FIELD CROP RES, V91, P319, DOI 10.1016/j.fcr.2004.08.001; Guo X, 2014, PLANT CELL, V26, P4311, DOI 10.1105/tpc.114.129841; Heckmann S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5979; Heslop-Harrison JS, 2000, PLANT CELL, V12, P617, DOI 10.1105/tpc.12.5.617; JIANG JM, 1994, CHROMOSOMA, V103, P179, DOI 10.1007/BF00368010; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; Ksiazczyk T, 2011, J APPL GENET, V52, P305, DOI 10.1007/s13353-011-0048-y; Kubalakova M, 2005, GENETICS, V170, P823, DOI 10.1534/genetics.104.039180; Kwiatek M, 2016, PROTOPLASMA, V253, P329, DOI 10.1007/s00709-015-0813-6; Kwiatek M, 2015, J APPL GENET, V56, P163, DOI 10.1007/s13353-014-0264-3; Levy AA, 2002, PLANT PHYSIOL, V130, P1587, DOI 10.1104/pp.015727; LUKASZEWSKI AJ, 1995, CEREAL RES COMMUN, V23, P9; Matsuoka Y, 2004, THEOR APPL GENET, V109, P1710, DOI 10.1007/s00122-004-1806-6; Miller JD, 1998, CAN J PLANT PATHOL, V20, P95; MUKAI Y, 1993, CHROMOSOMA, V102, P88, DOI 10.1007/BF00356025; Oliver RE, 2008, CROP SCI, V48, P213, DOI 10.2135/cropsci2007.03.0129; Pedersen C, 1997, GENOME, V40, P589, DOI 10.1139/g97-077; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Rozen S, 2000, Methods Mol Biol, V132, P365; Salina EA, 2006, GENOME, V49, P1023, DOI 10.1139/G06-050; Salina EA, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-99; Salina EA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-414; Sears E.R., 1954, MISSOURI AGR EXPT ST, V572, P1; Stack RW, 2002, CROP SCI, V42, P637, DOI 10.2135/cropsci2002.0637; Wendel JF, 2000, PLANT MOL BIOL, V42, P225, DOI 10.1023/A:1006392424384; Wisniewska H, 2013, J APPL GENET, V54, P435, DOI 10.1007/s13353-013-0171-z; Wisniewska Halina, 2005, Journal of Applied Genetics, V46, P35; Wiwart M, 2013, GENET RESOUR CROP EV, V60, P2359, DOI 10.1007/s10722-013-0004-2; Zaharieva MZ, 2010, GENET RESOUR CROP EV, V57, P937, DOI 10.1007/s10722-010-9572-6; Zhang P, 2004, CHROMOSOMA, V112, P288, DOI 10.1007/s00412-004-0273-9; Zohary D, 2000, DOMESTICATION PLANTS, V3, P316	51	13	13	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158883	10.1371/journal.pone.0158883	http://dx.doi.org/10.1371/journal.pone.0158883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391447	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400148
J	Mather, AE; Reeve, R; Mellor, DJ; Matthews, L; Reid-Smith, RJ; Dutil, L; Haydon, DT; Reid, SWJ				Mather, Alison E.; Reeve, Richard; Mellor, Dominic J.; Matthews, Louise; Reid-Smith, Richard J.; Dutil, Lucie; Haydon, Daniel T.; Reid, Stuart W. J.			Detection of Rare Antimicrobial Resistance Profiles by Active and Passive Surveillance Approaches	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; FOOD ANIMALS; SALMONELLA; TYPHIMURIUM; ENVIRONMENT; DISEASE	Antimicrobial resistance (AMR) surveillance systems are generally not specifically designed to detect emerging resistances and usually focus primarily on resistance to individual drugs. Evaluating the diversity of resistance, using ecological metrics, allows the assessment of sampling protocols with regard to the detection of rare phenotypes, comprising combinations of resistances. Surveillance data of phenotypic AMR of Canadian poultry Salmonella Heidelberg and swine Salmonella Typhimurium var. 5- were used to contrast active (representative isolates derived from healthy animals) and passive (diagnostic isolates) surveillance and assess their suitability for detecting emerging resistance patterns. Although in both datasets the prevalences of resistance to individual antimicrobials were not significantly different between the two surveillance systems, analysis of the diversity of entire resistance phenotypes demonstrated that passive surveillance of diagnostic isolates detected more unique phenotypes. Whilst the most appropriate surveillance method will depend on the relevant objectives, under the conditions of this study, passive surveillance of diagnostic isolates was more effective for the detection of rare and therefore potentially emerging resistance phenotypes.	[Mather, Alison E.; Reeve, Richard; Mellor, Dominic J.; Matthews, Louise; Haydon, Daniel T.; Reid, Stuart W. J.] Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland; [Mather, Alison E.; Mellor, Dominic J.; Reid, Stuart W. J.] Univ Glasgow, Sch Vet Med, Glasgow, Lanark, Scotland; [Reeve, Richard; Matthews, Louise; Haydon, Daniel T.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Reid-Smith, Richard J.] Publ Hlth Agcy Canada, Guelph, ON, Canada; [Reid-Smith, Richard J.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Dutil, Lucie] Publ Hlth Agcy Canada, St Hyacinthe, PQ, Canada; [Mather, Alison E.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Reid, Stuart W. J.] Univ London, Royal Vet Coll, Hatfield, Herts, England	University of Glasgow; University of Glasgow; University of Glasgow; Public Health Agency of Canada; University of Guelph; Public Health Agency of Canada; University of Cambridge; University of London; University of London Royal Veterinary College	Mather, AE (corresponding author), Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Glasgow, Lanark, Scotland.; Mather, AE (corresponding author), Univ Glasgow, Sch Vet Med, Glasgow, Lanark, Scotland.	am2382@cam.ac.uk	Reeve, Richard/K-9918-2015; Matthews, Louise/E-2913-2013	Reeve, Richard/0000-0003-2589-8091; Matthews, Louise/0000-0003-4420-8367	William Stewart Fellowship whilst at the University of Glasgow; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/M014088/1, BB/E010326/1, BB/L004070/1]; National Science Foundation [BB/L004070/1, BB/K01126X/1, BB/F015313/1, DEB1216040]; EU [264639]; BBSRC [BB/K01126X/1, BB/F015313/1, BB/M014088/1, BB/J020567/1, BB/L004070/1, BB/E010326/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K01126X/1, BB/F015313/1, BB/L004070/1, BB/E010326/1, BB/M014088/1, BB/J020567/1] Funding Source: researchfish	William Stewart Fellowship whilst at the University of Glasgow; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation(National Science Foundation (NSF)); EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	AEM was supported by the William Stewart Fellowship whilst at the University of Glasgow, and is currently supported by Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/M014088/1; RR is supported by BBSRC grant BB/E010326/1 and BB/L004070/1; LM is supported by BB/K01126X/1, BB/L004070/1, BB/F015313/1, National Science Foundation DEB1216040 and an EUfunded Marie Curie Initial Training Network (MCITN) program (NEMATODE SYSTEM HEALTH project (FP7-PEOPLE-2010-ITN-ID: 264639)). The funders played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aarestrup FM, 2004, J VET MED B, V51, P380, DOI 10.1111/j.1439-0450.2004.00775.x; Afema JA, 2015, ZOONOSES PUBLIC HLTH, V62, P506, DOI 10.1111/zph.12172; Anderson RM, 1999, NAT MED, V5, P147, DOI 10.1038/5507; [Anonymous], CLSI PERF STAND ANT; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bax R, 2001, CLIN MICROBIOL INFEC, V7, P316, DOI 10.1046/j.1198-743x.2001.00239.x; Beal RK, 2004, VET IMMUNOL IMMUNOP, V100, P151, DOI 10.1016/j.vetimm.2004.04.005; Brant R, 2010, CONFIDENCE INTERVALS; Canton R, 2005, CLIN MICROBIOL INFEC, V11, P3, DOI 10.1111/j.1469-0691.2005.01081.x; Caprioli A, 2000, MONITORING ANTIBIOTI, P295; Critchley IA, 2004, CLIN MICROBIOL INFEC, V10, P502, DOI 10.1111/j.1469-0691.2004.00911.x; Doherr MG, 2001, PHILOS T R SOC B, V356, P1097, DOI 10.1098/rstb.2001.0898; Fluit AC, 2006, CLIN MICROBIOL INFEC, V12, P410, DOI 10.1111/j.1469-0691.2006.01406.x; Gill J, 2000, EMERG INFECT DIS, V6, P30; Hadorn DC, 2008, VET RES, V39, DOI 10.1051/vetres:2008033; Hall BG, 2004, DRUG RESIST UPDATE, V7, P111, DOI 10.1016/j.drup.2004.02.003; Harrell, 2010, HMISC HARRELL MISCEL; Hawkey PM, 2008, J ANTIMICROB CHEMOTH, V62, pI1, DOI 10.1093/jac/dkn241; Johnson AP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0080; Johnson JM, 2005, CAN VET J, V46, P141; Laupland KB, 2007, CLIN INVEST MED, V30, pE159, DOI 10.25011/cim.v30i4.1777; Lewis D, 2002, J ANTIMICROB CHEMOTH, V49, P3, DOI 10.1093/jac/49.1.3; Livermore DM, 1998, BRIT MED J, V317, P614, DOI 10.1136/bmj.317.7159.614; Masterton RG, 2000, J ANTIMICROB CHEMOTH, V46, P53, DOI 10.1093/jac/46.suppl_2.53; Mather AE, 2012, P ROY SOC B-BIOL SCI, V279, P1630, DOI 10.1098/rspb.2011.1975; McEwan S. A., 2006, ANTIMICROBIAL RESIST, P397; Perencevich EN, 2004, CLIN INFECT DIS, V38, P1108, DOI 10.1086/382886; Perron GG, 2007, INFECT GENET EVOL, V7, P223, DOI 10.1016/j.meegid.2006.09.003; Poppe C, 2001, MICROB DRUG RESIST, V7, P197, DOI 10.1089/10766290152045084; Rempel OR, 2009, EPIDEMIOL INFECT, V137, P1665, DOI 10.1017/S0950268809990100; Renyi A., 1961, P 4 BERK S MATH STAT, P547; Sahm DF, 1997, INFECT DIS CLIN N AM, V11, P767, DOI 10.1016/S0891-5520(05)70389-5; Shannon KP, 2002, J ANTIMICROB CHEMOTH, V49, P201, DOI 10.1093/jac/49.1.201; Tapsall John W, 2003, Commun Dis Intell Q Rep, V27 Suppl, pS70; Vergison A, 2006, PEDIATRICS, V118, pE801, DOI 10.1542/peds.2005-3195; Wales AD, 2009, VET REC, V165, P648, DOI 10.1136/vr.165.22.648; WHO-AGISAR, 2010, WHO ADV GROUP INT SU	37	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158515	10.1371/journal.pone.0158515	http://dx.doi.org/10.1371/journal.pone.0158515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391966	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400075
J	Sun, RS; Yang, YQ; Ran, XZ; Yang, T				Sun, Renshan; Yang, Yongqiang; Ran, Xinze; Yang, Tao			Calcium Influx of Mast Cells Is Inhibited by Aptamers Targeting the First Extracellular Domain of Orai1	PLOS ONE			English	Article							ACTIVATED CA2+ CHANNELS; CRAC CHANNEL; IL-2 PRODUCTION; T-LYMPHOCYTES; ION CHANNELS; RELEASE	Using the systematic evolution of ligands by exponential enrichment (SELEX) method, we identified oligonucleotides that bind to the first extracellular domain of the Orai1 protein with high affinities and high specificities. These ligands were isolated from a random singlestrand DNA (ssDNA) library with 40 randomized sequence positions, using synthesized peptides with amino acid sequences identical to the first extracellular domain of the Orai1 protein as the targets for SELEX selection. Seven aptamers were obtained after 12 rounds of SELEX. An enzyme-linked oligonucleotide assay (ELONA) was performed to determine the affinities of the aptamers. Aptamer Y1 had the highest affinity (Kd = 1.72x10(-8) mol/L) and was selected for functional experiments in mast cells. Using LAD2 cells with the human high-affinity IgE receptor and Ca2+ release activation channel (CRAC), we demonstrated that Aptamer Y1 blocked IgE-mediated beta-hexosaminidase release from cells triggered by biotin-IgE and streptavidin. A specific binding assay showed that Aptamer Y1 not only bound the Orai1 peptide specifically but also that the Orai1 peptide did not bind significantly to other random oligonucleotide molecules. Furthermore, Aptamer Y1 regulation of intracellular Ca2+ mobilization was investigated by probing intracellular Ca2+ with a Fluo-4-AM fluorescent probe. We found that Aptamer Y1 inhibits Ca2+ influx into antigen-activated mast cells. These results indicate that the target of Aptamer Y1 in the degranulation pathway is upstream of Ca2+ influx. Therefore, these oligonucleotide agents represent a novel class of CRAC inhibitors that may be useful in the fight against allergic diseases.	[Sun, Renshan; Yang, Yongqiang; Yang, Tao] Third Mil Med Univ, Daping Hosp, Inst Battle Surg, Dept Dermatol, Chongqing 400042, Peoples R China; [Ran, Xinze] Third Mil Med Univ, Coll Mil Prevent Med, Inst Combined Injury, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Sun, RS (corresponding author), Third Mil Med Univ, Daping Hosp, Inst Battle Surg, Dept Dermatol, Chongqing 400042, Peoples R China.	pharma3061@163.com			National Natural Science Foundation of China [81571569]; National Natural Science Foundation of P.R. China [81571569]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81571569).; We thank Dr. Wei Sun for experimental assistance with laser confocal microscopy and providing helpful advice that contributed to this work, in the Third Military Medical University, China. This work was supported by the National Natural Science Foundation of P.R. China (Grants No. 81571569).	CHUNG SC, 1994, BRIT J PHARMACOL, V113, P861, DOI 10.1111/j.1476-5381.1994.tb17072.x; Derler I, 2012, FRONT BIOSCI-LANDMRK, V17, P1304, DOI 10.2741/3988; Di Capite JL, 2011, CURR OPIN ALLERGY CL, V11, P33, DOI 10.1097/ACI.0b013e32834232b0; Di Sabatino A, 2009, J IMMUNOL, V183, P3454, DOI 10.4049/jimmunol.0802887; Fahrner M, 2013, CHANNELS, V7, P330, DOI 10.4161/chan.26742; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Ishikawa J, 2003, J IMMUNOL, V170, P4441, DOI 10.4049/jimmunol.170.9.4441; Muik M, 2012, CELL MOL LIFE SCI, V69, P4163, DOI 10.1007/s00018-012-1072-8; Ni J, 2012, CANCER METAST REV, V31, P779, DOI 10.1007/s10555-012-9389-1; Ni X, 2011, CURR MED CHEM, V18, P4206, DOI 10.2174/092986711797189600; Nonaka Y, 2013, ANAL CHEM, V85, P1132, DOI 10.1021/ac303023d; Pan Q, 2014, MOL THER, V22, P940, DOI 10.1038/mt.2014.31; Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Rice LV, 2013, EUR J PHARMACOL, V704, P49, DOI 10.1016/j.ejphar.2013.02.022; Rysavy Noel M, 2014, Bioarchitecture, V4, P127, DOI 10.1080/19490992.2014.995516; Sutovska M, 2013, ADV EXP MED BIOL, V756, P39, DOI 10.1007/978-94-007-4549-0_6; Tabarzad M, 2016, PROTEIN J, V35, P81, DOI 10.1007/s10930-016-9653-2; Tang XL, 2014, J INFECTION, V69, P569, DOI 10.1016/j.jinf.2014.05.015; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang BD, 2012, INT ARCH ALLERGY IMM, V159, P23, DOI 10.1159/000335178; Zhang BD, 2011, J ALLERGY CLIN IMMUN, V127, P1522, DOI 10.1016/j.jaci.2011.02.005; Zhu J, 2014, IET NANOBIOTECHNOL, V8, P2, DOI 10.1049/iet-nbt.2013.0028	27	15	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158223	10.1371/journal.pone.0158223	http://dx.doi.org/10.1371/journal.pone.0158223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390850	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400038
J	Yaish, MW; Al-Lawati, A; Jana, GA; Patankar, HV; Glick, BR				Yaish, Mahmoud W.; Al-Lawati, Abbas; Jana, Gerry Aplang; Patankar, Himanshu Vishwas; Glick, Bernard R.			Impact of Soil Salinity on the Structure of the Bacterial Endophytic Community Identified from the Roots of Caliph Medic (Medicago truncatula)	PLOS ONE			English	Article							GROWTH-PROMOTING BACTERIA; PHOENIX-DACTYLIFERA L.; PSEUDOMONAS-PUTIDA UW4; 16S RIBOSOMAL-RNA; PLANT-GROWTH; SP-NOV.; 1-AMINOCYCLOPROPANE-1-CARBOXYLATE DEAMINASE; BONFERRONI PROCEDURE; MULTIPLE TESTS; SALT TOLERANCE	In addition to being a forage crop, Caliph medic (Medicago truncatula) is also a model legume plant and is used for research focusing on the molecular characterization of the interaction between rhizobia and plants. However, the endophytic microbiome in this plant is poorly defined. Endophytic bacteria play a role in supplying plants with the basic requirements necessary for growth and development. Moreover, these bacteria also play a role in the mechanism of salinity stress adaptation in plants. As a prelude to the isolation and utilization of these bacteria in Caliph medic farming, 41 bacterial OTUs were identified in this project from within the interior of the roots of this plant by pyrosequencing of the small ribosomal subunit gene (16S rDNA) using a cultivation-independent approach. In addition, the differential abundance of these bacteria was studied following exposure of the plants to salinity stress. About 29,064 high-quality reads were obtained from the sequencing of six libraries prepared from control and salinity-treated tissues. Statistical analysis revealed that the abundance of similar to 70% of the OTUs was significantly (p <= 0.05) altered in roots that were exposed to salinity stress. Sequence analysis showed a similarity between some of the identified species and other, known, growth-promoting bacteria, marine and salt-stressed soil-borne bacteria, and nitrogen-fixing bacterial isolates. Determination of the amendments to the bacterial community due to salinity stress in Caliph medic provides a crucial step toward developing an understanding of the association of these endophytes, under salt stress conditions, in this model plant. To provide direct evidence regarding their growth promoting activity, a group of endophytic bacteria were isolated from inside of plant roots using a cultivation-dependent approach. Several of these isolates were able to produce ACC-deaminase, ammonia and IAA; and to solubilize Zn+2 and PO4-3. This data is consistent with the predicted occurrence (based on cultivation-independent techniques) of these bacteria and provides some insight into the importance of the endophytic bacteria in Caliph medic when grown under normal and saline conditions.	[Yaish, Mahmoud W.; Al-Lawati, Abbas; Jana, Gerry Aplang; Patankar, Himanshu Vishwas] Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman; [Glick, Bernard R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	Sultan Qaboos University; University of Waterloo	Yaish, MW (corresponding author), Sultan Qaboos Univ, Dept Biol, Coll Sci, Muscat, Oman.	myaish@squ.edu.om	Yaish, Mahmoud W/F-7168-2014; Patankar, Himanshu/L-9643-2019	Yaish, Mahmoud W/0000-0002-5171-3014; Patankar, Himanshu/0000-0001-6739-2895; Jana, Gerry Aplang/0000-0002-0314-2392	Ministry of Agriculture and Fisheries; College of Science, Sultan Qaboos University, Oman	Ministry of Agriculture and Fisheries; College of Science, Sultan Qaboos University, Oman	This work was supported by the Ministry of Agriculture and Fisheries and the College of Science, Sultan Qaboos University, Oman. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Ministry of Agriculture and Fisheries and the College of Science, Sultan Qaboos University, Oman for funding this research project. Authors would like to thank Dr. Aliya Al-Ansari for the help in the bioinformatics analysis.	Ahn SJ, 1996, NUCLEIC ACIDS RES, V24, P2623, DOI 10.1093/nar/24.13.2623; Al-Lawati A, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15018299; Ali S, 2014, PLANT PHYSIOL BIOCH, V80, P160, DOI 10.1016/j.plaphy.2014.04.003; Barker D. G., 1990, Plant Molecular Biology Reporter, V8, P40, DOI 10.1007/BF02668879; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chapman H.D., 1962, SOIL SCI SOC AM J, V93, P68, DOI [DOI 10.1097/00010694-196201000-00015, 10.12691/wjar-4-2-4, DOI 10.2136/SSSAJ1963.03615995002700010004X]; Cheng ZY, 2007, CAN J MICROBIOL, V53, P912, DOI 10.1139/W07-050; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Dong YM, 2003, APPL ENVIRON MICROB, V69, P1783, DOI 10.1128/AEM.69.3.1783-1790.2003; FURUKAWA K, 1989, J BACTERIOL, V171, P5467, DOI 10.1128/jb.171.10.5467-5472.1989; Gamalero E, 2010, J APPL MICROBIOL, V108, P236, DOI 10.1111/j.1365-2672.2009.04414.x; Gao W, 2013, ANTON LEEUW INT J G, V103, P485, DOI 10.1007/s10482-012-9830-z; Glick BR, 2004, ADV APPL MICROBIOL, V56, P291, DOI 10.1016/S0065-2164(04)56009-4; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Glick BR, 2012, PLANT GROWTH PROMOTI; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Gower JC, 1985, ENCY STAT SC, V5, P3; Gu J, 2007, INT J SYST EVOL MICR, V57, P250, DOI 10.1099/ijs.0.64522-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Han YL, 2015, J MICROBIOL BIOTECHN, V25, P1119, DOI 10.4014/jmb.1412.12053; HATTORI M, 1986, ANAL BIOCHEM, V152, P232, DOI 10.1016/0003-2697(86)90403-3; Ramirez-Bahena MH, 2013, INT J SYST EVOL MICR, V63, P1760, DOI 10.1099/ijs.0.041368-0; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Howieson J, 2004, SOIL BIOL BIOCHEM, V36, P1261, DOI 10.1016/j.soilbio.2004.04.008; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jha B, 2012, PLANT SOIL, V356, P265, DOI 10.1007/s11104-011-0877-9; Jiang SM, 2008, MAR BIOL, V153, P945, DOI 10.1007/s00227-007-0866-y; Johnston-Monje D, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0233-3; Kem MP, 2015, BIOCHEMISTRY-US, V54, P744, DOI 10.1021/bi5013673; Khalifa AYZ, 2016, SAUDI J BIOL SCI, V23, P79, DOI 10.1016/j.sjbs.2015.06.008; Kloepper JW, 1996, BIOSCIENCE, V46, P406, DOI 10.2307/1312874; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lane D.J., 1991, NUCL ACID TECHNIQUES, P125; LIM HS, 1991, APPL ENVIRON MICROB, V57, P510, DOI 10.1128/AEM.57.2.510-516.1991; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; Magurran AE, 2013, MEASURING BIOL DIVER; Marques APGC, 2010, SOIL BIOL BIOCHEM, V42, P1229, DOI 10.1016/j.soilbio.2010.04.014; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Metternicht G., 2008, REMOTE SENSING SOIL; Moradi A, 2011, AFR J MICROBIOL RES, V5, P144; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nogi Y, 2014, INT J SYST EVOL MICR, V64, P1149, DOI 10.1099/ijs.0.058321-0; Oggerin M, 2011, INT J SYST EVOL MICR, V61, P1757, DOI 10.1099/ijs.0.032805-0; Pan E, 2012, ORG LETT, V14, P2390, DOI 10.1021/ol300806e; Peel MD, 2004, CROP SCI, V44, P2049, DOI 10.2135/cropsci2004.2049; Pei AY, 2010, APPL ENVIRON MICROB, V76, P3886, DOI 10.1128/AEM.02953-09; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Pikovskaya R.I., 1948, MIKROBIOLOGIYA, V17, pe370; Pini F, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-78; Postnikova OA, 2013, PLANT CELL PHYSIOL, V54, P1041, DOI 10.1093/pcp/pct056; Rashid S, 2012, APPL SOIL ECOL, V61, P217, DOI 10.1016/j.apsoil.2011.09.011; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; SARGENT MG, 1980, J GEN MICROBIOL, V116, P511; Sauvetre A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00083; Setia R, 2013, SCI TOTAL ENVIRON, V465, P267, DOI 10.1016/j.scitotenv.2012.08.028; Siddikee MA, 2011, PLANT PHYSIOL BIOCH, V49, P427, DOI 10.1016/j.plaphy.2011.01.015; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Spain AM, 2009, ISME J, V3, P992, DOI 10.1038/ismej.2009.43; Stajkovic O., 2009, Botanica Serbica, V33, P107; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Suarez C, 2014, INT J SYST EVOL MICR, V64, P481, DOI 10.1099/ijs.0.054817-0; Suarez R, 2008, MOL PLANT MICROBE IN, V21, P958, DOI 10.1094/MPMI-21-7-0958; Szilagyi-Zecchin VJ, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0026-y; Szymanska Sonia, 2013, Ecological Questions, V18, P9, DOI 10.2478/ecoq-2013-0001; Tewari S, 2014, CURR MICROBIOL, V69, P484, DOI 10.1007/s00284-014-0612-x; Timmusk S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096086; Trujillo ME, 2010, ISME J, V4, P1265, DOI 10.1038/ismej.2010.55; Vurukonda SSKP, 2016, MICROBIOL RES, V184, P13, DOI 10.1016/j.micres.2015.12.003; Wang Y, 2008, INT J SYST EVOL MICR, V58, P2065, DOI 10.1099/ijs.0.65436-0; Widada J, 2002, CHEMOSPHERE, V49, P485, DOI 10.1016/S0045-6535(02)00334-X; Xu J, 2014, ISOLATION ASSESSMENT; Yaish MW, 2015, GENET MOL RES, V14, P9943, DOI 10.4238/2015.August.19.30; Yaish MW, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00348; Yaish MW, 2015, ANTON LEEUW INT J G, V107, P1519, DOI 10.1007/s10482-015-0445-z; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Zhang H, 2008, MOL PLANT MICROBE IN, V21, P737, DOI 10.1094/MPMI-21-6-0737; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao BS, 2010, INT J SYST EVOL MICR, V60, P1125, DOI 10.1099/ijs.0.013201-0	81	58	60	3	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159007	10.1371/journal.pone.0159007	http://dx.doi.org/10.1371/journal.pone.0159007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391592	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400188
J	Zhang, GF; Lovei, GL; Wu, X; Wan, FH				Zhang, Gui Fen; Lovei, Gabor L.; Wu, Xia; Wan, Fang Hao			Presence of Native Prey Does Not Divert Predation on Exotic Pests by Harmonia axyridis in Its Indigenous Range	PLOS ONE			English	Article							FRANKLINIELLA-OCCIDENTALIS PERGANDE; CLASSICAL BIOLOGICAL-CONTROL; BEMISIA-TABACI; ALTERNATIVE PREY; NATURAL ENEMIES; INVERTEBRATE PREDATORS; HEMIPTERA ALEYRODIDAE; APPARENT COMPETITION; PALLAS COLEOPTERA; MOLECULAR MARKERS	In China, two invasive pests, Bemisia tabaci MEAM1 (Gennadius) and Frankliniella occidentalis (Pergande), often co-occur with the native pest, Aphis gossypii (Glover), on plants of Malvaceae and Cucurbitaceae. All three are preyed on by the native ladybird, Harmonia axyridis (Pallas); however, the native predator might be expected to prefer native prey to the exotic ones due to a shared evolutionary past. In order to clarify whether the presence of native prey affected the consumption of these two invasive species by the native predator, field-cage experiments were conducted. A duplex qPCR was used to simultaneously detect both non-native pests within the gut of the predator. H. axyridis readily accepted both invasive prey species, but preferred B. tabaci. With all three prey species available, H. axyridis consumption of B. tabaci was 39.3 +/- 2.2% greater than consumption of F. occidentalis. The presence of A. gossypii reduced (by 59.9% on B. tabaci, and by 60.6% on F. occidentalis), but did not stop predation on the two exotic prey when all three were present. The consumption of B. tabaci was similar whether it was alone or together with A. gossypii. However, the presence of aphids reduced predation on the invasive thrips. Thus, some invasive prey may be incorporated into the prey range of a native generalist predator even in the presence of preferred native prey.	[Zhang, Gui Fen; Lovei, Gabor L.; Wu, Xia; Wan, Fang Hao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Lovei, Gabor L.] Aarhus Univ, Dept Agroecol, Flakkebjerg Res Ctr, Slagelse, Denmark; [Wan, Fang Hao] Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Shandong, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Aarhus University; Qingdao Agricultural University	Zhang, GF; Wan, FH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.; Wan, FH (corresponding author), Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Shandong, Peoples R China.	zhangguifen@caas.cn; wanfanghao@caas.cn	Lövei, Gabor L./B-7763-2008	Lövei, Gabor L./0000-0002-6467-9812	National Natural Science Foundation of China [30971967, 31572067]; National Basic Research Program of China [2009CB119200]; Commonwealth Special Fund for the Agricultural Industry [201103026, 201303019, 201409061]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Commonwealth Special Fund for the Agricultural Industry	This study was supported by the National Natural Science Foundation of China (30971967, 31572067) to GFZ; the National Basic Research Program of China (2009CB119200) to FHW; and the Commonwealth Special Fund for the Agricultural Industry (201103026, 201303019, 201409061) to GFZ and FHW. GFZ and FHW prepared the manuscript.	Agusti N, 2003, MOL ECOL, V12, P3467, DOI 10.1046/j.1365-294X.2003.02014.x; Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Bailey SF, 1940, J ECON ENTOMOL, V33, P133, DOI 10.1093/jee/33.1.133; Berkvens N, 2008, BIOCONTROL, V53, P211, DOI 10.1007/s10526-007-9130-0; Bompard A, 2013, POPUL ECOL, V55, P433, DOI 10.1007/s10144-013-0371-8; Caraguel CGB, 2011, J VET DIAGN INVEST, V23, P2, DOI 10.1177/104063871102300102; Carlsson NOL, 2009, FRONT ECOL ENVIRON, V7, P525, DOI 10.1890/080093; Chailleux A, 2014, PEST MANAG SCI, V70, P1769, DOI 10.1002/ps.3916; Colares F, 2015, J ECON ENTOMOL, V108, P2546, DOI 10.1093/jee/tov235; Colares F, 2015, BIOL CONTROL, V90, P16, DOI 10.1016/j.biocontrol.2015.05.009; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; DeBach P, 1964, BIOL CONTROL INSECT; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; Desneux N, 2008, B ENTOMOL RES, V98, P631, DOI 10.1017/S0007485308006238; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Elton C. S., 1958, ECOLOGY INVASIONS AN; Enkegaard A, 2001, ENTOMOL EXP APPL, V101, P81, DOI 10.1023/A:1019230603364; Gariepy TD, 2007, J APPL ENTOMOL, V131, P225, DOI 10.1111/j.1439-0418.2007.01145.x; Gomez-Polo P, 2014, J PEST SCI, V87, P371, DOI 10.1007/s10340-013-0550-6; HAN Y, 1997, EC INSECT FAUNA CHIN, P263; Harper GL, 2005, MOL ECOL, V14, P819, DOI [10.1111/j.1365-294X.2005.02442.x, 10.1111/j.1365-294x.2005.02442.x]; Harwood JD, 2007, MOL ECOL, V16, P4390, DOI 10.1111/j.1365-294X.2007.03482.x; Hoddle MS, 2004, CONSERV BIOL, V18, P38, DOI 10.1111/j.1523-1739.2004.00249.x; Hodek I., 1996, ECOLOGY COCCINELLIDA; Hodek Ivo, 2012, P141; HOLLINGSWORTH RG, 1994, J ECON ENTOMOL, V87, P293, DOI 10.1093/jee/87.2.293; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; HOLT RD, 1994, ANNU REV ECOL SYST, V25, P495, DOI 10.1146/annurev.es.25.110194.002431; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; HOWARTH FG, 1991, ANNU REV ENTOMOL, V36, P485, DOI 10.1146/annurev.en.36.010191.002413; Jaworski CC, 2015, J PEST SCI, V88, P793, DOI 10.1007/s10340-015-0698-3; Jaworski CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082231; Jensen K, 2012, P ROY SOC B-BIOL SCI, V279, P2212, DOI 10.1098/rspb.2011.2410; Jensen Sten E., 2000, Integrated Pest Management Reviews, V5, P131, DOI 10.1023/A:1009600426262; Jiao XG, 2014, J PEST SCI, V87, P629, DOI 10.1007/s10340-014-0594-2; Kenis M., 2008, HARMONIA AXYRIDIS IN; Kirk WDJ, 2003, AGR FOREST ENTOMOL, V5, P301, DOI 10.1046/j.1461-9563.2003.00192.x; Koch R L, 2003, J Insect Sci, V3, P32; Levine JM, 2004, ECOL LETT, V7, P975, DOI 10.1111/j.1461-0248.2004.00657.x; Liu HC, 1989, CHINESE J BIOL CONT, V2, P92; Lockwood JL, 2007, INVASION ECOLOGY; Lovei GL, 2012, TRENDS ECOL EVOL, V27, P2, DOI 10.1016/j.tree.2011.10.009; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Mayntz D, 2005, SCIENCE, V307, P111, DOI 10.1126/science.1105493; Michaud JP, 2008, ENTOMOL EXP APPL, V126, P40, DOI 10.1111/j.1570-7458.2007.00636.x; Michaud JP, 2002, ENVIRON ENTOMOL, V31, P827, DOI 10.1603/0046-225X-31.5.827; Michaud JP, 2005, EUR J ENTOMOL, V102, P385, DOI 10.14411/eje.2005.055; Michaud JP, 2002, ANN ENTOMOL SOC AM, V95, P531, DOI 10.1603/0013-8746(2002)095[0531:CBCACR]2.0.CO;2; Moreno-Ripoll R, 2014, J PEST SCI, V87, P133, DOI 10.1007/s10340-013-0522-x; MURDOCH WW, 1985, AM NAT, V125, P344, DOI 10.1086/284347; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Nedved O, 2008, EUR J ENTOMOL, V105, P431, DOI 10.14411/eje.2008.055; O'Gorman EJ, 2009, P NATL ACAD SCI USA, V106, P13393, DOI 10.1073/pnas.0903682106; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Pettersson Jan, 2012, P444; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Rao Q, 2012, J INTEGR AGR, V11, P321, DOI 10.1016/S2095-3119(12)60016-1; SAS Institute Inc, 2006, P US MAN VERS 8; Schmidt JM, 2014, MOL ECOL, V23, P3777, DOI 10.1111/mec.12734; Seo Mi Ja, 2000, Korean Journal of Applied Entomology, V39, P59; SILVER ARJ, 1995, PESTIC SCI, V43, P21, DOI 10.1002/ps.2780430104; Simberloff D, 1996, ECOLOGY, V77, P1965, DOI 10.2307/2265693; Sint D, 2012, METHODS ECOL EVOL, V3, P898, DOI 10.1111/j.2041-210X.2012.00215.x; Symondson WOC, 2002, ANNU REV ENTOMOL, V47, P561, DOI 10.1146/annurev.ento.47.091201.145240; van Steenis M., 1995, THESIS; Wang Na, 2007, Acta Agriculturae Zhejiangensis, V19, P346; Wang Su, 2007, Yingyong Shengtai Xuebao, V18, P2117; XU RM, 1984, Z ANGEW ENTOMOL, V97, P305; Yang R., 2009, RES BIOL INVASIONS C, P10; Zappala L, 2013, J PEST SCI, V86, P635, DOI 10.1007/s10340-013-0531-9; Zhang GF, 2012, J APPL ENTOMOL, V136, P410, DOI 10.1111/j.1439-0418.2011.01661.x; Zhang GF, 2007, ENTOMOL EXP APPL, V123, P81, DOI 10.1111/j.1570-7458.2007.00528.x; Zhang GF, 2007, MOL ECOL NOTES, V7, P947, DOI 10.1111/j.1471-8286.2007.01819.x; Zhang GF, 2014, ENTOMOL EXP APPL, V150, P66, DOI 10.1111/eea.12134; Zhang GF, 2011, ENVIRON ENTOMOL, V40, P140, DOI 10.1603/EN10135; [张友军 Zhang Youjun], 2011, [植物保护, Plant Protection], V37, P1; 张友军, 2003, [植物保护, Plant Protection], V29, P58	79	2	4	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159048	10.1371/journal.pone.0159048	http://dx.doi.org/10.1371/journal.pone.0159048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391468	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400200
J	Jones, K; Ballesteros, A; Mentink-Kane, M; Warren, J; Rattila, S; Malech, H; Kang, E; Dveksler, G				Jones, Karlie; Ballesteros, Angela; Mentink-Kane, Margaret; Warren, James; Rattila, Shemona; Malech, Harry; Kang, Elizabeth; Dveksler, Gabriela			PSG9 Stimulates Increase in FoxP3(+) Regulatory T-Cells through the TGF-beta 1 Pathway	PLOS ONE			English	Article							LATENT TGF-BETA; PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN; GROWTH-FACTOR-BETA; TRANSCRIPTION FACTOR FOXP3; GLYCOPROTEIN 1 PSG1; CUTTING EDGE; EXPRESSION; ACTIVATION; RECEPTOR; SURFACE	The pregnancy-specific glycoproteins (PSGs) are a family of proteins secreted by the syncytiotrophoblast of the placenta and are the most abundant trophoblastic proteins in maternal blood during the third trimester. The human PSG family consists of 10 protein-coding genes, some of which have a possible role in maintaining maternal immune tolerance to the fetus. PSG9 was reported as a potential predictive biomarker of pre-eclampsia, a serious complication of pregnancy that has been related to immunological dysfunction at the fetal-maternal interface. Therefore, we hypothesized that PSG9 may have an immunoregulatory role during pregnancy. We found that PSG9 binds to LAP and activates the latent form of TGF-beta 1. In addition, PSG9 induces the secretion of TGF-beta 1 from macrophages but not from CD4(+) T-cells. TGF-beta 1 is required for the ex vivo differentiation of regulatory T-cells and, consistent with the ability of PSG9 to activate this cytokine, we observed that PSG9 induces the differentiation of FoxP3(+) regulatory T-cells from naive murine and human T-cells. Cytokines that are associated with inflammatory responses were also reduced in the supernatants of T-cells treated with PSG9, suggesting that PSG9, through its activation of TGF beta-1, could be a potent inducer of immune tolerance.	[Jones, Karlie; Malech, Harry; Kang, Elizabeth] NIAID, NIH, Bethesda, MD USA; [Ballesteros, Angela] NIDCD, NIH, Bethesda, MD USA; [Mentink-Kane, Margaret; Warren, James; Rattila, Shemona; Dveksler, Gabriela] USUHS, Dept Pathol, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Dveksler, G (corresponding author), USUHS, Dept Pathol, Bethesda, MD USA.	gabriela.dveksler@usuhs.edu		Malech, Harry/0000-0001-5874-5775; Ballesteros Morcillo, Angela/0000-0001-5796-6875	USUHS [R0742495]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Z-A1-00-0989]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000988, ZIAAI000644, ZIAAI000989] Funding Source: NIH RePORTER	USUHS; Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the USUHS intramural award R0742495 to GD and the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) under intramural project number Z-A1-00-0989 supported the research reported in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Bailly S, 1997, J BIOL CHEM, V272, P16329, DOI 10.1074/jbc.272.26.16329; Ballesteros A, 2015, J BIOL CHEM, V290, P4422, DOI 10.1074/jbc.M114.597518; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blankley RT, 2013, MOL CELL PROTEOMICS; Blois SM, 2014, MUCOSAL IMMUNOL, V7, P348, DOI 10.1038/mi.2013.53; Camolotto S, 2010, PLACENTA, V31, P312, DOI 10.1016/j.placenta.2010.01.004; Chang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061701; Chatterjee P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00253; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Coghill JM, 2011, BLOOD, V117, P3268, DOI 10.1182/blood-2010-12-290403; Duan W, 2011, J IMMUNOL, V187, P6499, DOI 10.4049/jimmunol.1101398; Dumont BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075949; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gandhi R, 2010, J IMMUNOL, V184, P4620, DOI 10.4049/jimmunol.0903329; Han KL, 2013, J IMMUNOL, V190, P458, DOI 10.4049/jimmunol.1201325; HORNE CHW, 1976, EXPERIENTIA, V32, P1197, DOI 10.1007/BF01927624; Jurisicova A, 1999, HUM REPROD, V14, P1852, DOI 10.1093/humrep/14.7.1852; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lisboa FA, 2011, J BIOL CHEM, V286, P7577, DOI 10.1074/jbc.M110.161810; Lu LF, 2006, NATURE, V442, P997, DOI 10.1038/nature05010; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Martinez FF, 2013, AM J REPROD IMMUNOL, V69, P383, DOI 10.1111/aji.12089; Murphy-Ullrich JE, 2000, CYTOKINE GROWTH F R, V11, P59, DOI 10.1016/S1359-6101(99)00029-5; OLSEN A, 1994, GENOMICS, V23, P659, DOI 10.1006/geno.1994.1555; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; Radaev S, 2010, J BIOL CHEM, V285, P14806, DOI 10.1074/jbc.M109.079921; Falcon CR, 2014, AM J REPROD IMMUNOL, V72, P527, DOI 10.1111/aji.12307; SALEM HT, 1981, BRIT J OBSTET GYNAEC, V88, P371, DOI 10.1111/j.1471-0528.1981.tb00999.x; Shanley DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057491; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; TEGLUND S, 1995, BIOCHEM BIOPH RES CO, V211, P656, DOI 10.1006/bbrc.1995.1862; Todorovic V, 2005, INT J BIOCHEM CELL B, V37, P38, DOI 10.1016/j.biocel.2004.03.011; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; TOWLER CM, 1976, BRIT J OBSTET GYNAEC, V83, P775, DOI 10.1111/j.1471-0528.1976.tb00743.x; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wakabayashi Y, 2011, J BIOL CHEM, V286, P35456, DOI 10.1074/jbc.M111.236794; Wakefield LM, 1989, GROWTH FACTORS, V1, P203, DOI 10.3109/08977198908997997; WURZ H, 1981, J PERINAT MED, V9, P67, DOI 10.1515/jpme.1981.9.2.67; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200	52	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158050	10.1371/journal.pone.0158050	http://dx.doi.org/10.1371/journal.pone.0158050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389696	Green Published, gold			2022-12-26	WOS:000379811500012
J	Papp-Kadar, V; Szabo, JE; Nyiri, K; Vertessy, BG				Papp-Kadar, Veronika; Szabo, Judit Eszter; Nyiri, Kinga; Vertessy, Beata G.			In Vitro Analysis of Predicted DNA-Binding Sites for the Stl Repressor of the Staphylococcus aureus SaPIBov1 Pathogenicity Island	PLOS ONE			English	Article							ESCHERICHIA-COLI; HORIZONTAL TRANSFER; HELPER PHAGE; DUTPASE; PROTEIN; EXPRESSION; MECHANISM; URACIL; INHIBITION; MUTATIONS	The regulation model of the Staphylococcus aureus pathogenicity island SaPIbov1 transfer was recently reported. The repressor protein Stl obstructs the expression of SaPI proteins Str and Xis, latter which is responsible for mobilization initiation. Upon Phi 11 phage infection of S. aureus. phage dUTPase activates the SaPI transfer via Stl-dUTPase complex formation. Our aim was to predict the binding sites for the Stl repressor within the S. aureus pathogenicity island DNA sequence. We found that Stl was capable to bind to three 23-mer oligonucleotides, two of those constituting sequence segments in the stl-str, while the other corresponding to sequence segment within the str-xis intergenic region. Within these oligonucleotides, mutational analysis revealed that the predicted binding site for the Stl protein exists as a palindromic segment in both intergenic locations. The palindromes are built as 6-mer repeat sequences involved in Stl binding. The 6-mer repeats are separated by a 5 oligonucleotides long, nonspecific sequence. Future examination of the interaction between Stl and its binding sites in vivo will provide a molecular explanation for the mechanisms of gene repression and gene activation exerted simultaneously by the Stl protein in regulating transfer of the SaPIbov1 pathogenicity island in S. aureus.	[Papp-Kadar, Veronika; Szabo, Judit Eszter; Nyiri, Kinga; Vertessy, Beata G.] Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, H-1111 Budapest, Hungary; [Papp-Kadar, Veronika; Szabo, Judit Eszter; Nyiri, Kinga; Vertessy, Beata G.] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Lab Genome Metab & Repair, H-1117 Budapest, Hungary	Budapest University of Technology & Economics; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Vertessy, BG (corresponding author), Budapest Univ Technol & Econ, Dept Appl Biotechnol & Food Sci, H-1111 Budapest, Hungary.; Vertessy, BG (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Lab Genome Metab & Repair, H-1117 Budapest, Hungary.	vertessy@mail.bme.hu	Vertessy, Beata G/H-6202-2012	Vertessy, Beata G./0000-0002-1288-2982	National Institute for Research and Innovation (NKFIH) [OTKA NK 84008, OTKA K109486]; Baross program of the New Hungary Development Plan [OMFB-00266/2010 REG-KM-09-1- 2009-0050, 3DSTRUCT]; Hungarian Academy of Sciences [TTK IF-28/ 2012]; MedinProt program of the Hungarian Academy of Sciences; European Commission FP7 BioStruct-X project [283570]; ICGEB Research Grant [CRP/HUN14-01]	National Institute for Research and Innovation (NKFIH); Baross program of the New Hungary Development Plan; Hungarian Academy of Sciences(Hungarian Academy of Sciences); MedinProt program of the Hungarian Academy of Sciences; European Commission FP7 BioStruct-X project; ICGEB Research Grant	This work was supported by grants from the National Institute for Research and Innovation (NKFIH) (OTKA NK 84008, OTKA K109486), the Baross program of the New Hungary Development Plan (3DSTRUCT, OMFB-00266/2010 REG-KM-09-1- 2009-0050), the Hungarian Academy of Sciences (TTK IF-28/ 2012), the MedinProt program of the Hungarian Academy of Sciences, the European Commission FP7 BioStruct-X project (contract No. 283570), and CRP/HUN14-01 ICGEB Research Grant to BGV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Tormo-Mas MA, 2010, NATURE, V465, P779, DOI 10.1038/nature09065; Atalla Heba, 2011, Animal Health Research Reviews, V12, P33, DOI 10.1017/S1466252311000065; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Baldo AM, 1999, J VIROL, V73, P7710, DOI 10.1128/JVI.73.9.7710-7721.1999; Brown NL, 2003, FEMS MICROBIOL REV, V27, P145, DOI 10.1016/S0168-6445(03)00051-2; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Carr JF, 2015, J BACTERIOL, V197, P2981, DOI 10.1128/JB.00219-15; Chen CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063210; Dearborn Altaira D, 2012, Bacteriophage, V2, P70; Fraunholz M, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00775-13; Godovikova V, 2015, APPL ENVIRON MICROB, V81, P6496, DOI 10.1128/AEM.01541-15; Golding GR, 2012, J BACTERIOL, V194, P6627, DOI 10.1128/JB.01680-12; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hirmondo R, 2015, DNA REPAIR, V30, P21, DOI 10.1016/j.dnarep.2015.03.005; Hochschild A, 2009, CURR OPIN STRUC BIOL, V19, P79, DOI 10.1016/j.sbi.2008.12.008; Ladner RD, 2001, CURR PROTEIN PEPT SC, V2, P361, DOI 10.2174/1389203013380991; Lari SU, 2006, DNA REPAIR, V5, P1407, DOI 10.1016/j.dnarep.2006.06.009; Larsson G, 1996, J BIOL CHEM, V271, P24010, DOI 10.1074/jbc.271.39.24010; Leveles I, 2013, ACTA CRYSTALLOGR D, V69, P2298, DOI 10.1107/S0907444913021136; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Liu YF, 2001, P NATL ACAD SCI USA, V98, P6877, DOI 10.1073/pnas.121013398; MAAS WK, 1994, MICROBIOL REV, V58, P631, DOI 10.1128/MMBR.58.4.631-640.1994; Mahdi LK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-769; MANIATIS T, 1975, CELL, V5, P109, DOI 10.1016/0092-8674(75)90018-5; McClure MA, 2001, CURR PROTEIN PEPT SC, V2, P313, DOI 10.2174/1389203013381062; Mir-Sanchis I, 2012, MOL MICROBIOL, V85, P833, DOI 10.1111/j.1365-2958.2012.08145.x; Muha V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002738; Nagy GN, 2014, FEBS J, V281, P4207, DOI 10.1111/febs.12941; Nemeth-Pongracz V, 2007, NUCLEIC ACIDS RES, V35, P495, DOI 10.1093/nar/gkl1074; Nguyen M, 2015, INFECT IMMUN, V83, P130, DOI 10.1128/IAI.02467-14; Nickels BE, 2002, J MOL BIOL, V324, P17, DOI 10.1016/S0022-2836(02)01043-4; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Nyri K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139086; Pecsi I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037461; Santillan M, 2001, P NATL ACAD SCI USA, V98, P1364, DOI 10.1073/pnas.98.4.1364; Solovjev V, 2011, METAGENOMICITAPP, P61; Szabo JE, 2014, NUCLEIC ACIDS RES, V42, P11912, DOI 10.1093/nar/gku882; Tallent SM, 2007, J BACTERIOL, V189, P7520, DOI 10.1128/JB.00738-07; THUKRAL SK, 1991, MOL CELL BIOL, V11, P1566, DOI 10.1128/MCB.11.3.1566; Toth J, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706230200; Ubeda C, 2008, MOL MICROBIOL, V67, P493, DOI 10.1111/j.1365-2958.2007.06027.x; Vertessy BG, 2009, ACCOUNTS CHEM RES, V42, P97, DOI 10.1021/ar800114w; Wang YJ, 2010, MOL BIOL REP, V37, P3991, DOI 10.1007/s11033-010-0058-6	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158793	10.1371/journal.pone.0158793	http://dx.doi.org/10.1371/journal.pone.0158793			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388898	Green Accepted, Green Published, gold			2022-12-26	WOS:000379811500047
J	Ambrosis, N; Boyd, CD; O'Toole, GA; Fernandez, J; Sisti, F				Ambrosis, Nicolas; Boyd, Chelsea D.; O'Toole, George A.; Fernandez, Julieta; Sisti, Federico			Homologs of the LapD-LapG c-di-GMP Effector System Control Biofilm Formation by Bordetella bronchiseptica	PLOS ONE			English	Article							PSEUDOMONAS-FLUORESCENS PF0-1; ADENYLATE-CYCLASE TOXIN; RESPIRATORY-TRACT; MECHANISM; INFECTION; VIRULENCE; PERTUSSIS; MOTILITY; PROTEASE	Biofilm formation is important for infection by many pathogens. Bordetella bronchiseptica causes respiratory tract infections in mammals and forms biofilm structures in nasal epithelium of infected mice. We previously demonstrated that cyclic di-GMP is involved in biofilm formation in B. bronchiseptica. In the present work, based on their previously reported function in Pseudomonas fluorescens, we identified three genes in the B. bronchiseptica genome likely involved in c-di-GMP-dependent biofilm formation: brtA, lapD and lapG. Genetic analysis confirmed a role for BrtA, LapD and LapG in biofilm formation using microtiter plate assays, as well as scanning electron and fluorescent microscopy to analyze the phenotypes of mutants lacking these proteins. In vitro and in vivo studies showed that the protease LapG of B. bronchiseptica cleaves the N-terminal domain of BrtA, as well as the LapA protein of P. fluorescens, indicating functional conservation between these species. Furthermore, while BrtA and LapG appear to have little or no impact on colonization in a mouse model of infection, a B. bronchiseptica strain lacking the LapG protease has a significantly higher rate of inducing a severe disease outcome compared to the wild type. These findings support a role for c-di-GMP acting through BrtA/LapD/LapG to modulate biofilm formation, as well as impact pathogenesis, by B. bronchiseptica	[Ambrosis, Nicolas; Fernandez, Julieta; Sisti, Federico] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, IBBM,CCT,CONICET La Plata, La Plata, Buenos Aires, Argentina; [Boyd, Chelsea D.; O'Toole, George A.] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Hanover, NH USA; [Boyd, Chelsea D.] NIAID, Div Extramural Act, Sci Review Program, Rockville, MD USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Dartmouth College; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fernandez, J; Sisti, F (corresponding author), Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, IBBM,CCT,CONICET La Plata, La Plata, Buenos Aires, Argentina.	julietafernandez3@gmail.com; federico.sisti@gmail.com	Sisti, Federico/GOV-3334-2022	Sisti, Federico/0000-0001-7548-0422; Fernandez, Julieta/0000-0001-7803-5885; Ambrosis, Nicolas/0000-0002-5299-3425	NIH [R01-AI097307]; NSF [MCB-9984521]; CONICET; PICT [2013-0092]; PIP [0092, 0486]; CONICET doctoral fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); PICT(ANPCyT); PIP; CONICET doctoral fellowship	This work was supported by NIH grant R01-AI097307 and NSF grant MCB-9984521 to GAO, and International Cooperation grants (2012 and 2013) from CONICET to FS and JF, PICT 2013-0092, PIP No 0092 and PIP No 0486 to FS and JF. NA was supported by CONICET doctoral fellowship.	AKERLEY BJ, 1992, J BACTERIOL, V174, P980, DOI 10.1128/jb.174.3.980-990.1992; Bakas L, 1998, BBA-BIOMEMBRANES, V1368, P225, DOI 10.1016/S0005-2736(97)00181-8; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Boyd CD, 2012, J BACTERIOL, V194, P4406, DOI 10.1128/JB.00642-12; Chatterjee D, 2012, J BACTERIOL, V194, P4415, DOI 10.1128/JB.00640-12; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; GOODNOW RA, 1980, MICROBIOL REV, V44, P722, DOI 10.1128/MMBR.44.4.722-738.1980; Harvill ET, 1999, INFECT IMMUN, V67, P1493, DOI 10.1128/IAI.67.3.1493-1500.1999; Harvill ET, 2000, INFECT IMMUN, V68, P6720, DOI 10.1128/IAI.68.12.6720-6728.2000; Inatsuka CS, 2005, P NATL ACAD SCI USA, V102, P18578, DOI 10.1073/pnas.0507910102; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; Mishra M, 2005, J BACTERIOL, V187, P1474, DOI 10.1128/JB.187.4.1474-1484.2005; Navarro MVAS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000588; Newell PD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000587; Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106; Nicholson TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049166; Nishikawa S, 2016, MICROBIOL IMMUNOL, V60, P93, DOI 10.1111/1348-0421.12356; Ryan RP, 2013, MICROBIOL-SGM, V159, P1286, DOI 10.1099/mic.0.068189-0; Serra DO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028811; Sisti F, 2002, INFECT IMMUN, V70, P1791, DOI 10.1128/IAI.70.4.1791-1798.2002; Sisti F, 2013, MICROBIOL-SGM, V159, P869, DOI 10.1099/mic.0.064345-0; Skinner JA, 2004, J IMMUNOL, V173, P1934, DOI 10.4049/jimmunol.173.3.1934; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Subrini O, 2013, J BIOL CHEM, V288, P32585, DOI 10.1074/jbc.M113.508838; Whiteley CG, 2015, BIOTECHNOL ADV, V33, P124, DOI 10.1016/j.biotechadv.2014.11.010	26	12	12	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158752	10.1371/journal.pone.0158752	http://dx.doi.org/10.1371/journal.pone.0158752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380521	Green Published, gold			2022-12-26	WOS:000379798700044
J	Samol, A; Gones, M; Zumhagen, S; Bruns, HJ; Paul, M; Vahlhaus, C; Waltenberger, J; Schulze-Bahr, E; Eckardt, L; Monnig, G				Samol, Alexander; Goenes, Mehmet; Zumhagen, Sven; Bruns, Hans-Juergen; Paul, Matthias; Vahlhaus, Christian; Waltenberger, Johannes; Schulze-Bahr, Eric; Eckardt, Lars; Moennig, Gerold			Improved Clinical Risk Stratification in Patients with Long QT Syndrome? Novel Insights from Multi-Channel ECGs	PLOS ONE			English	Article							REPOLARIZATION; DISPERSION; PHENOTYPE; GENOTYPE; INDEX; DEATH	Background We investigated whether multichannel ECG-recordings are useful to risk-stratify patients with congenital long-QT syndrome (LQTS) for risk of sudden cardiac death under optimized medical treatment. Methods In 34 LQTS-patients ( 11 male; age 31 +/- 13 years, QTc 478 +/- 51ms; LQT1 n = 8, LQT2 n = 15) we performed a standard 12-channel ECG and a 120-channel body surface potential mapping. The occurrence of clinical events (CE; syncope, torsade de pointes (TdP), sudden cardiac arrest (SCA)) was documented and correlated with different ECG-parameters in all lead positions. Results Seven patients developed TdP, four survived SCA and 12 experienced syncope. 12/34 had at least one CE. CE was associated with a longer QTc-interval (519 +/- 43ms vs. 458 +/- 42ms; p = 0.001), a lower T-wave integral (TWI) on the left upper chest (-1.2 +/- 74.4mV*ms vs. 63.0 +/- 29.7mV*ms; p = 0.001), a lower range of T-wave amplitude (TWA) in the region of chest lead V8 (0.10 +/- 0.08mV vs. 0.18 +/- 0.07mV; p = 0.008) and a longer T-peak-T-end time (TpTe) in lead V1 (98 +/- 23ms vs. 78 +/- 26ms; p = 0.04). Receiver-operating-characteristic (ROC) analyses revealed a sensitivity of 96% and a specificity of 75% ( area under curve (AUC) 0.89 +/- 0.06, p = 0.001) at a cut-off value of 26.8mV*ms for prediction of CE by TWI, a sensitivity of 86% and a specificity of 83% at a cut-off value of 0.11mV (AUC 0.83 +/- 0.09, p = 0.002) for prediction of CE by TWA and a sensitivity of 83% and a specificity of 73% at a cut-off value of 87ms ( AUC 0.80 +/- 0.07, p = 0.005) for prediction of CE by TpTe. Conclusions Occurrence of CE in LQTS-patients seems to be associated with a prolonged, low-amplitude T-wave.	[Samol, Alexander; Bruns, Hans-Juergen; Paul, Matthias; Vahlhaus, Christian; Waltenberger, Johannes] Univ Hosp Munster, Div Cardiol, Dept Cardiovasc Med, Munster, Germany; [Goenes, Mehmet; Zumhagen, Sven; Eckardt, Lars; Moennig, Gerold] Univ Hosp Munster, Div Electrophysiol, Dept Cardiovasc Med, Munster, Germany; [Zumhagen, Sven; Paul, Matthias; Schulze-Bahr, Eric] Univ Hosp Munster, Inst Genet Heart Dis IfGH, Dept Cardiovasc Med, Munster, Germany; [Samol, Alexander] Johannes Wesling Hosp Minden, Dept Cardiol & Crit Care Med, Minden, Germany; [Vahlhaus, Christian] Klinikum Leer, Dept Cardiol & Angiol, Leer, Germany	University of Munster; University of Munster; University of Munster; Ruhr University Bochum	Samol, A (corresponding author), Univ Hosp Munster, Div Cardiol, Dept Cardiovasc Med, Munster, Germany.; Samol, A (corresponding author), Johannes Wesling Hosp Minden, Dept Cardiol & Crit Care Med, Minden, Germany.	Alexander.Samol@muehlenkreiskliniken.de	Paul, Matthias/AAI-3187-2021; Samol, Alexander/AAB-9187-2020					DEAMBROGGI L, 1986, CIRCULATION, V74, P1334, DOI 10.1161/01.CIR.74.6.1334; Goldenberg I, 2011, J AM COLL CARDIOL, V57, P51, DOI 10.1016/j.jacc.2010.07.038; Goldenberg I, 2010, J CARDIOVASC ELECTR, V21, P893, DOI 10.1111/j.1540-8167.2010.01737.x; Gupta P, 2008, J ELECTROCARDIOL, V41, P567, DOI 10.1016/j.jelectrocard.2008.07.016; Hobbs JB, 2006, JAMA-J AM MED ASSOC, V296, P1249, DOI 10.1001/jama.296.10.1249; Kaufman ES, 2008, HEART RHYTHM, V5, P831, DOI 10.1016/j.hrthm.2008.02.029; Kies P, 2011, EUR J NUCL MED MOL I, V38, P1899, DOI 10.1007/s00259-011-1852-7; Lubinski A, 1998, PACE, V21, P172, DOI 10.1111/j.1540-8159.1998.tb01083.x; MITCHELL LB, 1992, CIRCULATION, V86, P383, DOI 10.1161/01.CIR.86.2.383; Monnig G, 2006, EUR HEART J, V27, P2074, DOI 10.1093/eurheartj/ehl159; Moss Arthur J, 2002, Card Electrophysiol Rev, V6, P311, DOI 10.1023/A:1016301730302; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Samol A, 2013, EUROPACE, V15, P582, DOI 10.1093/europace/eus311; Schulze-Bahr Eric, 2003, Hum Mutat, V21, P651, DOI 10.1002/humu.9144; Schwartz PJ, 2006, J INTERN MED, V259, P39, DOI 10.1111/j.1365-2796.2005.01583.x; Schwartz PJ, 2005, NAT CLIN PRACT CARD, V2, P346, DOI 10.1038/ncpcardio0239; SCHWARTZ PJ, 1985, EUR HEART J, V6, P103, DOI 10.1093/eurheartj/6.suppl_D.103; SCHWARTZ PJ, 1985, AM HEART J, V109, P399, DOI 10.1016/0002-8703(85)90626-X; Takenaka K, 2003, CIRCULATION, V107, P838, DOI 10.1161/01.CIR.0000048142.85076.A2; Vijayakumar R, 2014, CIRCULATION, V130, P1936, DOI 10.1161/CIRCULATIONAHA.114.011359; Yamaguchi M, 2003, CLIN SCI, V105, P671, DOI 10.1042/CS20030010; Zhang L, 2000, CIRCULATION, V102, P2849; Zumhagen Sven, 2012, Herzschrittmacherther Elektrophysiol, V23, P211, DOI 10.1007/s00399-012-0232-8	23	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158085	10.1371/journal.pone.0158085	http://dx.doi.org/10.1371/journal.pone.0158085			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379800	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700018
J	Jiang, QF; Liu, ZQ; Zhou, Z; Wang, LL; Wang, LL; Yue, F; Wang, JJ; Wang, H; Song, LS				Jiang, Qiufen; Liu, Zhaoqun; Zhou, Zhi; Wang, Lingling; Wang, Leilei; Yue, Feng; Wang, Jingjing; Wang, Hao; Song, Linsheng			Transcriptional activation and translocation of ancient NOS during immune response	FASEB JOURNAL			English	Article						nitric oxide synthase; NF-kappa B; STAT	NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; NERVOUS-SYSTEM; TNF-ALPHA; MOLECULAR CHARACTERIZATION; CRASSOSTREA-GIGAS; PROTEIN-KINASES; INDUCIBLE-TYPE; EXPRESSION; CELLS	NOS is the key component of the NO system, which plays an indispensable role in many physiologic and immunologic processes; however, the process that underlies the activation of ancient NOSs and their functions remains unclear. Expression of Crassostrea gigas NOS (CgNOS) mRNA in hemocytes was examined after stimulating oysters with LPS and TNF-alpha Expression level of CgNOS mRNA was increased significantly, by 2.61-fold (P < 0.05), at 24 h poststimulation. A positive CgNOS signal was detected via immunoprecipitation, and only one protein was detected in oyster hemocytes. Shifting and supershifting bands were observed in EMSAs between the CgNOS promoter and the transcription factors CgNF-kappa B1 and Cg-signal transducer and activator of transcription (STAT). CgNF-kappa B1 was detected in the nucleus only at 12 h, whereas CgSTAT was observed in the cytoplasm and nucleus at 12 and 24 h. Expression levels of tyrosine-protein kinase receptor Tie-1, phosphatidylinositide phosphatase SAC2, phosphatidylinositol-4-phosphate 5-kinase type-1, diacylglycerol kinase , LPS-induced TNF-alpha factor-like protein, cAMP-dependent transcription factor-2, NF-kappa B1, and STAT6 were significantly elevated in a transcriptome analysis after 12 h of LPS and TNF-alpha stimulation. An immunoreactive CgNOS signal was observed in both the cell membrane and cytoplasm at 12 h, whereas it was mainly localized to the cytoplasm at 24 h post-LPS and -TNF-alpha stimulation. These findings revealed that CgNOS could be transcriptionally activated by CgNF-kappa B1 and CgSTAT via the PI3K-Akt pathway, similar to what occurs for iNOS, but CgNOS translocated to the cytoplasm, similar to neuronal NOS, to modulate downstream signals during an immune defense. These results collectively provide crucial knowledge about the evolution of NOS structure and function.	[Jiang, Qiufen; Liu, Zhaoqun; Zhou, Zhi; Wang, Lingling; Wang, Leilei; Yue, Feng; Wang, Jingjing; Wang, Hao] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Jiang, Qiufen; Liu, Zhaoqun; Wang, Leilei; Yue, Feng; Wang, Jingjing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Lingling; Song, Linsheng] Dalian Ocean Univ, Key Lab Mariculture & Stock Enhancement North Chi, Minist Agr, Dalian, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Dalian Ocean University; Ministry of Agriculture & Rural Affairs	Wang, LL (corresponding author), Chinese Acad Sci, Inst Oceanol, 7 Nanhai Rd, Qingdao 266071, Peoples R China.	wanglingling@ms.qdio.ac.cn	Yue, Feng/S-6565-2017		Chinese Ministry of Science and Technology [2014AA093501]; National Science Foundation of China [31530069]; earmarked funds for Modern Agro-Industry Technology Research System [CARS-48]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked funds for Modern Agro-Industry Technology Research System	This research was supported by the High Technology Project (863 Project, No. 2014AA093501) from the Chinese Ministry of Science and Technology, Grant 31530069 from National Science Foundation of China, and earmarked funds for Modern Agro-Industry Technology Research System (CARS-48). The authors thank Dr. Qiang Gao for his guidance on the operations of the equipment and Dr. Dahai Gao and Dr. Zhanhui Hou for help in the bioinformatical analysis. The authors declare no competing financial interests.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andreakis N, 2011, MOL BIOL EVOL, V28, P163, DOI 10.1093/molbev/msq179; Barcia R., 2008, ISJ, V5, P43; Bhat NR, 2002, J BIOL CHEM, V277, P29584, DOI 10.1074/jbc.M204994200; Bi XL, 2005, INT IMMUNOPHARMACOL, V5, P185, DOI 10.1016/j.intimp.2004.08.008; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Caivano M, 1998, FEBS LETT, V429, P249, DOI 10.1016/S0014-5793(98)00578-X; Chan ED, 1999, J IMMUNOL, V162, P415; Cioni C, 2012, J COMP NEUROL, V520, P364, DOI 10.1002/cne.22729; Cole AG, 2002, J EXP BIOL, V205, P3143; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Fujie S, 2005, J NEUROBIOL, V62, P14, DOI 10.1002/neu.20046; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058453; Geller DA, 1998, CANCER METAST REV, V17, P7, DOI 10.1023/A:1005940202801; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GILBERT RS, 1993, J CELL PHYSIOL, V157, P128, DOI 10.1002/jcp.1041570117; Groves JT, 2000, CURR OPIN CHEM BIOL, V4, P687, DOI 10.1016/S1367-5931(00)00146-0; Hedgecock D, 2007, P NATL ACAD SCI USA, V104, P2313, DOI 10.1073/pnas.0610880104; Jiang QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069158; Jiang QF, 2013, FISH SHELLFISH IMMUN, V34, P100, DOI 10.1016/j.fsi.2012.10.011; Kizaki T, 2001, BIOCHEM BIOPH RES CO, V289, P1031, DOI 10.1006/bbrc.2001.6123; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; KOIDE M, 1993, J BIOL CHEM, V268, P24959; Korneev SA, 1998, J NEUROBIOL, V35, P65, DOI 10.1002/(SICI)1097-4695(199804)35:1<65::AID-NEU6>3.0.CO;2-9; Korneev SA, 2005, J NEUROSCI, V25, P1188, DOI 10.1523/JNEUROSCI.4671-04.2005; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lee SJ, 1998, J BIOL CHEM, V273, P27430, DOI 10.1074/jbc.273.42.27430; Li HX, 2008, CYTOKINE, V41, P1, DOI 10.1016/j.cyto.2007.09.016; Li L, 2004, MAR BIOTECHNOL, V6, P26, DOI 10.1007/s10126-003-0001-0; Marcus JS, 2003, GLIA, V41, P152, DOI 10.1002/glia.10168; MESSMER UK, 1994, CELL SIGNAL, V6, P17; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Miller BW, 1997, AM J PHYSIOL-CELL PH, V273, pC130, DOI 10.1152/ajpcell.1997.273.1.C130; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Naude PJW, 2011, FEBS J, V278, P888, DOI 10.1111/j.1742-4658.2011.08017.x; Oess S, 2006, BIOCHEM J, V396, P401, DOI 10.1042/BJ20060321; OGURA T, 1993, BIOCHEM BIOPH RES CO, V193, P1014, DOI 10.1006/bbrc.1993.1726; Perez-Sala D, 2001, AM J PHYSIOL-RENAL, V280, pF466, DOI 10.1152/ajprenal.2001.280.3.F466; Peri F, 2010, BIOCHEM SOC T, V38, P1390, DOI 10.1042/BST0381390; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; Roszer T, 2010, CELL TISSUE RES, V342, P191, DOI 10.1007/s00441-010-1063-8; Scheinker V, 2005, BIOCHEM BIOPH RES CO, V338, P1204, DOI 10.1016/j.bbrc.2005.10.069; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Smith P. K., 1989, GOOGLE PATENTS; Stasiv Y, 2004, GENE DEV, V18, P1812, DOI 10.1101/gad.298004; Stasiv Y, 2001, J BIOL CHEM, V276, P42241, DOI 10.1074/jbc.M105066200; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225; Weisz A, 1996, BIOCHEM J, V316, P209, DOI 10.1042/bj3160209; Wright B, 2006, BIOL CELL, V98, P265, DOI 10.1042/BC20050066; Yao Y, 2003, MOL PHARMACOL, V63, P383, DOI 10.1124/mol.63.2.383; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang Y, 2011, FISH SHELLFISH IMMUN, V30, P954, DOI 10.1016/j.fsi.2011.01.031	62	14	15	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3527	3540		10.1096/fj.201500193RR	http://dx.doi.org/10.1096/fj.201500193RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27402673				2022-12-26	WOS:000384329800022
J	Zanphorlin, LM; Lima, TB; Wong, MJ; Balbuena, TS; Minetti, CASA; Remeta, DP; Young, JC; Barbosa, LRS; Gozzo, FC; Ramos, CHI				Zanphorlin, Leticia M.; Lima, Tatiani B.; Wong, Michael J.; Balbuena, Tiago S.; Minetti, Conceicao A. S. A.; Remeta, David P.; Young, Jason C.; Barbosa, Leandro R. S.; Gozzo, Fabio C.; Ramos, Carlos H. I.			Heat Shock Protein 90 kDa (Hsp90) Has a Second Functional Interaction Site with the Mitochondrial Import Receptor Tom70	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE-SCATTERING; SPECTROMETRY; CHAPERONES; RESOLUTION; COMPLEXES; BINDING; LIGAND; HSP70	To accomplish its crucial role, mitochondria require proteins that are produced in the cytosol, delivered by cytosolic Hsp90, and translocated to its interior by the translocase outer membrane (TOM) complex. Hsp90 is a dimeric molecular chaperone and its function is modulated by its interaction with a large variety of co-chaperones expressed within the cell. An important family of co-chaperones is characterized by the presence of one TPR (tetratricopeptide repeat) domain, which binds to the C-terminal MEEVD motif of Hsp90. These include Tom70, an important component of the TOM complex. Despite a wealth of studies conducted on the relevance of Tom 70 center dot Hsp90 complex formation, there is a dearth of information regarding the exact molecular mode of interaction. To help fill this void, we have employed a combined experimental strategy consisting of cross-linking/mass spectrometry to investigate binding of the C-terminal Hsp90 domain to the cytosolic domain of Tom70. This approach has identified a novel region of contact between C-Hsp90 and Tom70, a finding that is confirmed by probing the corresponding peptides derived from cross-linking experiments via isothermal titration calorimetry and mitochondrial import assays. The data generated in this study are combined to input constraints for a molecular model of the Hsp90/Tom70 interaction, which has been validated by small angle x-ray scattering, hydrogen/deuterium exchange, and mass spectrometry. The resultant model suggests that only one of the MEEVD motifs within dimeric Hsp90 contacts Tom70. Collectively, our findings provide significant insight on the mechanisms by which preproteins interact with Hsp90 and are translocated via Tom70 to the mitochondria.	[Zanphorlin, Leticia M.; Lima, Tatiani B.; Gozzo, Fabio C.; Ramos, Carlos H. I.] Univ Campinas UNICAMP, Inst Chem, BR-13083970 Campinas, SP, Brazil; [Wong, Michael J.; Young, Jason C.] McGill Univ, Dept Biochem, Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada; [Balbuena, Tiago S.] State Univ Sao Paulo, Coll Agr & Vet Sci, BR-14884900 Sao Paulo, Brazil; [Minetti, Conceicao A. S. A.; Remeta, David P.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Barbosa, Leandro R. S.] Univ Sao Paulo, Inst Fis, BR-05508090 Sao Paulo, SP, Brazil	Universidade Estadual de Campinas; McGill University; Universidade Estadual Paulista; Rutgers State University New Brunswick; Universidade de Sao Paulo	Ramos, CHI (corresponding author), Univ Campinas UNICAMP, Inst Chem, BR-13083970 Campinas, SP, Brazil.	cramos@iqm.unicamp.br	Minetti, Conceicao/AGD-6419-2022; Balbuena, Tiago Santana/B-7971-2012; Minetti, Conceicao/B-5077-2009; Barbosa, Leandro Ramos Souza/GRJ-9680-2022; Barbosa, Tiago M./ABE-6789-2020; Lima, Tatiani Brenelli/A-3454-2017; Barbosa, Leandro Ramos Souza/E-6577-2012; Ramos, CH/C-1571-2012; Barbosa, L. R. S./AAN-7787-2020	Minetti, Conceicao/0000-0002-9682-2898; Minetti, Conceicao/0000-0002-9682-2898; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Barbosa, Tiago M./0000-0001-7071-2116; Barbosa, Leandro Ramos Souza/0000-0001-5997-2160; Ramos, CH/0000-0002-7246-9081; Lima, Tatiani Brenelli de/0000-0003-4869-0592; Balbuena, Tiago/0000-0002-1053-0254; Remeta, David/0000-0002-4142-0904	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant FAPESP [2012/50161-8]; Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq); FAPESP; Canadian Institutes of Health Research [MOP-130332]; INBEB (Instituto Nacional de Biologia Estrutural e Bioimagem)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); INBEB (Instituto Nacional de Biologia Estrutural e Bioimagem)	This work was supported in part by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant FAPESP 2012/50161-8, Ministerio da Ciencia e Tecnologia/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT/CNPq), and fellowships from FAPESP and the Canadian Institutes of Health Research (MOP-130332). The authors declare they have no conflict of interest with the contents of this article.; Supported by INBEB (Instituto Nacional de Biologia Estrutural e Bioimagem).	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BARBOSA LRS, 2013, PROTEINS SOLUTION IN, P49; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; da Sava V. C., 2012, J PROTEOMICS, V75, P2790; da Silva VCH, 2013, PLANT PHYSIOL BIOCH, V68, P16, DOI 10.1016/j.plaphy.2013.03.015; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Engen JR, 2003, ANALYST, V128, P623, DOI 10.1039/b212800b; Fan ACY, 2011, J BIOL CHEM, V286, P32208, DOI 10.1074/jbc.M111.280446; Fan ACY, 2011, PROTEIN PEPTIDE LETT, V18, P122; Fan ACY, 2010, BIOCHEM J, V429, P553, DOI 10.1042/BJ20091855; Gava LM, 2011, ARCH BIOCHEM BIOPHYS, V513, P119, DOI 10.1016/j.abb.2011.06.015; Graf Christian, 2014, Front Mol Biosci, V1, P4, DOI 10.3389/fmolb.2014.00004; Guinier A., 1955, SMALL ANGLE SCATTERI; Hammersley AP, 1996, HIGH PRESSURE RES, V14, P235, DOI 10.1080/08957959608201408; Kahraman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073411; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Li Jing, 2013, Biomed J, V36, P106, DOI 10.4103/2319-4170.113230; Li JZ, 2010, ACTA CRYSTALLOGR F, V66, P985, DOI 10.1107/S1744309110025522; Li JX, 2009, J BIOL CHEM, V284, P23852, DOI 10.1074/jbc.M109.023986; Lima DB, 2015, J PROTEOMICS, V129, P51, DOI 10.1016/j.jprot.2015.01.013; Makhnevych T., 2012, CELL RES, V1823, P674; Mayer MP, 2015, MOL CELL, V58, P8, DOI 10.1016/j.molcel.2015.02.022; Melin J, 2015, BBA-MOL CELL RES, V1853, P1850, DOI 10.1016/j.bbamcr.2015.04.021; Millson SH, 2008, BIOCHEM J, V413, P261, DOI 10.1042/BJ20080105; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Rhangoo M. K, 2007, BIOL CELL, V18, P3414; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1988, ACTA CRYSTALLOGR A, V44, P244, DOI 10.1107/S0108767387011255; Tiroli-Cepeda AO, 2014, J PROTEOMICS, V104, P48, DOI 10.1016/j.jprot.2014.02.004; Tsutakawa SE, 2007, J STRUCT BIOL, V158, P214, DOI 10.1016/j.jsb.2006.09.008; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wales TE, 2006, J MOL BIOL, V357, P1592, DOI 10.1016/j.jmb.2006.01.075; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zanphorlin LM, 2014, BBA-GEN SUBJECTS, V1840, P3145, DOI 10.1016/j.bbagen.2014.06.008; Zhang YL, 1998, ANAL BIOCHEM, V261, P139, DOI 10.1006/abio.1998.2738	40	24	24	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18620	18631		10.1074/jbc.M115.710137	http://dx.doi.org/10.1074/jbc.M115.710137			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402847	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000383242300003
J	Meyer, MB; Benkusky, NA; Sen, B; Rubin, J; Pike, JW				Meyer, Mark B.; Benkusky, Nancy A.; Sen, Buer; Rubin, Janet; Pike, J. Wesley			Epigenetic Plasticity Drives Adipogenic and Osteogenic Differentiation of Marrow-derived Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipocyte; cell differentiation; ChIP-sequencing (ChIP-seq); histone modification; mesenchymal stem cells (MSCs); osteoblast	VITAMIN-D-RECEPTOR; TRANSCRIPTION FACTOR-BINDING; BONE-MARROW; 1,25-DIHYDROXYVITAMIN D-3; GENE-EXPRESSION; PPAR-GAMMA; SIGNALING PATHWAY; FAT ACCUMULATION; CIRCADIAN CLOCK; ADIPOSE-TISSUE	Terminal differentiation of multipotent stem cells is achieved through a coordinated cascade of activated transcription factors and epigenetic modifications that drive gene transcription responsible for unique cell fate. Within the mesenchymal lineage, factors such as RUNX2 and PPAR are indispensable for osteogenesis and adipogenesis, respectively. We therefore investigated genomic binding of transcription factors and accompanying epigenetic modifications that occur during osteogenic and adipogenic differentiation of mouse bone marrow-derived mesenchymal stem cells (MSCs). As assessed by ChIP-sequencing and RNA-sequencing analyses, we found that genes vital for osteogenic identity were linked to RUNX2, C/EBP, retinoid X receptor, and vitamin D receptor binding sites, whereas adipocyte differentiation favored PPAR, retinoid X receptor, C/EBP, and C/EBP binding sites. Epigenetic marks were clear predictors of active differentiation loci as well as enhancer activities and selective gene expression. These marrow-derived MSCs displayed an epigenetic pattern that suggested a default preference for the osteogenic pathway; however, these patterns were rapidly altered near the Adipoq, Cidec, Fabp4, Lipe, Plin1, Pparg, and Cebpa genes during adipogenic differentiation. Surprisingly, we found that these cells also exhibited an epigenetic plasticity that enabled them to trans-differentiate from adipocytes to osteoblasts (and vice versa) after commitment, as assessed by staining, gene expression, and ChIP-quantitative PCR analysis. The osteogenic default pathway may be subverted during pathological conditions, leading to skeletal fragility and increased marrow adiposity during aging, estrogen deficiency, and skeletal unloading. Taken together, our data provide an increased mechanistic understanding of the epigenetic programs necessary for multipotent differentiation of MSCs that may prove beneficial in the development of therapeutic strategies.	[Meyer, Mark B.; Benkusky, Nancy A.; Pike, J. Wesley] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Sen, Buer; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC 27514 USA	University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill	Pike, JW (corresponding author), Univ Wisconsin, Dept Biochem, Hector F Deluca Biochem Labs, Rm 543D,433 Babcock Dr, Madison, WI 53706 USA.	pike@biochem.wisc.edu			National Institutes of Health [DK-072281, AR-066616]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR066616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK-072281 (to J. W. P.) and AR-066616 (to J. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARBOUR NC, 1993, MOL ENDOCRINOL, V7, P1307, DOI 10.1210/me.7.10.1307; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bieszczad KM, 2015, J NEUROSCI, V35, P13124, DOI 10.1523/JNEUROSCI.0914-15.2015; Boonyatecha N, 2012, MOL IMMUNOL, V51, P255, DOI 10.1016/j.molimm.2012.03.017; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Case N, 2013, BONE, V52, P454, DOI 10.1016/j.bone.2012.08.122; Case N, 2010, J ORTHOP RES, V28, P1531, DOI 10.1002/jor.21156; Case N, 2010, J CELL BIOCHEM, V110, P545, DOI 10.1002/jcb.22574; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chen JQ, 2013, J BONE MINER RES, V28, P1160, DOI 10.1002/jbmr.1834; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhanasekaran M, 2013, CELL BIOCHEM FUNCT, V31, P612, DOI 10.1002/cbf.2948; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hakelien AM, 2014, STEM CELLS, V32, P2780, DOI 10.1002/stem.1759; Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606; Huang DW, 2008, BIOINFORMATION, V2, P428; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Kaneko I, 2015, FASEB J, V29, P4023, DOI 10.1096/fj.14-269811; Kim S, 2007, J STEROID BIOCHEM, V103, P430, DOI 10.1016/j.jsbmb.2006.12.020; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2010, ADV EXP MED BIOL, V658, P43, DOI 10.1007/978-1-4419-1050-9_5; Kondo M, 2015, ARTHRITIS RHEUMATOL, V67, P1250, DOI 10.1002/art.39036; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Lin CS, 2013, HISTOL HISTOPATHOL, V28, P1109, DOI 10.14670/HH-28.1109; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Madsen MS, 2014, MOL CELL BIOL, V34, P939, DOI 10.1128/MCB.01344-13; Masri S, 2012, ANN NY ACAD SCI, V1264, P103, DOI 10.1111/j.1749-6632.2012.06649.x; Matthews D. G., 2015, J STEROID BIOCHEM, DOI [10.1016/j.jsbmb.2015.1009.1035, DOI 10.1016/J.JSBMB.2015.1009.1035]; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Meyer M. B., 2015, J STEROID BIOCHEM, DOI [10.1016/j.jsbmb.2015.1009.1001, DOI 10.1016/J.JSBMB.2015.1009.1001]; Meyer MB, 2006, MOL ENDOCRINOL, V20, P1447, DOI 10.1210/me.2006-0031; Meyer MB, 2015, J BIOL CHEM, V290, P11093, DOI 10.1074/jbc.M115.648394; Meyer MB, 2014, J BIOL CHEM, V289, P19539, DOI 10.1074/jbc.M114.578104; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Meyer MB, 2012, MOL ENDOCRINOL, V26, P37, DOI 10.1210/me.2011-1109; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Meyer MB, 2010, J BIOL CHEM, V285, P15599, DOI 10.1074/jbc.M110.119958; Nakahata Y, 2007, CURR OPIN CELL BIOL, V19, P230, DOI 10.1016/j.ceb.2007.02.016; Narvaez CJ, 2009, ENDOCRINOLOGY, V150, P651, DOI 10.1210/en.2008-1118; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nielsen R, 2014, METHOD ENZYMOL, V537, P261, DOI 10.1016/B978-0-12-411619-1.00014-8; Ortiz-Gonzalez XR, 2004, CURR NEUROVASC RES, V1, P207, DOI 10.2174/1567202043362342; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Peng T, 2015, CLIN LAB, V61, P1171, DOI 10.7754/Clin.Lab.2015.150217; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rojas A, 2015, J BIOL CHEM, V290, P28329, DOI 10.1074/jbc.M115.657825; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; SATO M, 1988, J CELL PHYSIOL, V135, P545, DOI 10.1002/jcp.1041350326; Schwartz AV, 2013, J CLIN ENDOCR METAB, V98, P2294, DOI 10.1210/jc.2012-3949; Sen B, 2015, STEM CELLS, V33, P3065, DOI 10.1002/stem.2090; Siersbaek R, 2014, CELL REP, V7, P1434, DOI 10.1016/j.celrep.2014.04.043; St John HC, 2015, BONE, V72, P81, DOI 10.1016/j.bone.2014.11.010; St John HC, 2014, MOL ENDOCRINOL, V28, P1150, DOI 10.1210/me.2014-1091; Styner M, 2014, BONE, V64, P39, DOI 10.1016/j.bone.2014.03.044; Styner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051613; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Thompson B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148619; Thompson WR, 2015, SCI REP-UK, V5, DOI 10.1038/srep11049; Tong J, 2011, MECH AGEING DEV, V132, P552, DOI 10.1016/j.mad.2011.09.004; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trudel G, 2009, J APPL PHYSIOL, V107, P540, DOI 10.1152/japplphysiol.91530.2008; Visweswaran M, 2015, INT J BIOCHEM CELL B, V68, P139, DOI 10.1016/j.biocel.2015.09.008; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Wu H, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r52; Yeung DKW, 2005, J MAGN RESON IMAGING, V22, P279, DOI 10.1002/jmri.20367; Zella LA, 2010, MOL ENDOCRINOL, V24, P128, DOI 10.1210/me.2009-0140	73	102	105	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17829	17847		10.1074/jbc.M116.736538	http://dx.doi.org/10.1074/jbc.M116.736538			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27402842	hybrid, Green Published			2022-12-26	WOS:000383241300029
J	Mizukami, K; Raj, K; Osborne, C; Giger, U				Mizukami, Keijiro; Raj, Karthik; Osborne, Carl; Giger, Urs			Cystinuria Associated with Different SLC7A9 Gene Variants in the Cat	PLOS ONE			English	Article							ACUTE INTERMITTENT PORPHYRIA; CANINE CYSTINURIA; UROLITH-CENTER; MUTATIONS; SLC3A1; IDENTIFICATION; DIAGNOSIS; PATTERNS; DOMINANT; BREEDS	Cystinuria is a classical inborn error of metabolism characterized by a selective proximal renal tubular defect affecting cystine, ornithine, lysine, and arginine (COLA) reabsorption, which can lead to uroliths and urinary obstruction. In humans, dogs and mice, cystinuria is caused by variants in one of two genes, SLC3A1 and SLC7A9, which encode the rBAT and b(o,+) AT subunits of the b(o,+) basic amino acid transporter system, respectively. In this study, exons and flanking regions of the SLC3A1 and SLC7A9 genes were sequenced from genomic DNA of cats (Felis catus) with COLAuria and cystine calculi. Relative to the Felis catus-6.2 reference genome sequence, DNA sequences from these affected cats revealed 3 unique homozygous SLC7A9 missense variants: one in exon 5 (p.Asp236Asn) from a non-purpose-bred medium-haired cat, one in exon 7 (p. Val294Glu) in a Maine Coon and a Sphinx cat, and one in exon 10 (p.Thr392Met) from a non-purpose-bred long-haired cat. A genotyping assay subsequently identified another cystinuric domestic medium-haired cat that was homozygous for the variant originally identified in the purebred cats. These missense variants result in deleterious amino acid substitutions of highly conserved residues in the b(o,+) AT protein. A limited population survey supported that the variants found were likely causative. The remaining 2 sequenced domestic short-haired cats had a heterozygous variant at a splice donor site in intron 10 and a homozygous single nucleotide variant at a branchpoint in intron 11 of SLC7A9, respectively. This study identifies the first SLC7A9 variants causing feline cystinuria and reveals that, as in humans and dogs, this disease is genetically heterogeneous in cats.	[Mizukami, Keijiro; Raj, Karthik; Giger, Urs] Univ Penn, Sch Vet Med, Med Genet Sect, Philadelphia, PA 19104 USA; [Osborne, Carl] Univ Minnesota, Coll Vet Med, Vet Clin Sci, St Paul, MN 55108 USA	University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities	Giger, U (corresponding author), Univ Penn, Sch Vet Med, Med Genet Sect, Philadelphia, PA 19104 USA.	giger@vet.upenn.edu		Raj, Karthik/0000-0001-7736-1101	National Institutes of Health [OD 010939]; Japan Society for the Promotion of Science	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was in part supported by a grant from the National Institutes of Health (https://www.nih.gov/) OD 010939 and a Postdoctoral Fellowship for Research Abroad from Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-ab/) to KM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasan H, 2012, JAVMA-J AM VET MED A, V240, P842, DOI 10.2460/javma.240.7.842; Brons AK, 2013, J VET INTERN MED, V27, P1400, DOI 10.1111/jvim.12176; BUSH M, 1978, J AM VET MED ASSOC, V173, P1159; Chatzikyriakidou A, 2005, GENET TEST, V9, P175, DOI 10.1089/gte.2005.9.175; Clavero S, 2013, VET J, V198, P720, DOI 10.1016/j.tvjl.2013.10.008; Clavero S, 2010, HUM MOL GENET, V19, P584, DOI 10.1093/hmg/ddp525; den Dunnen J, 2016, NOMENCLATURE DESCRIP; Di Perna M, 2008, GENET TEST, V12, P351, DOI 10.1089/gte.2007.0113; DIBARTOLA SP, 1991, J AM VET MED ASSOC, V198, P102; Dong CL, 2015, HUM MOL GENET, V24, P2125, DOI 10.1093/hmg/ddu733; Duran M., 2008, LAB GUIDE METHODS BI, DOI DOI 10.1007/978-3-540-76698-8_5; Eggermann T, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-19; Espino M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137277; Feliubadalo L, 2003, HUM MOL GENET, V12, P2097, DOI 10.1093/hmg/ddg228; Fernandez E, 2002, AM J PHYSIOL-RENAL, V283, pF540, DOI 10.1152/ajprenal.00071.2002; Font-Llitjos M, 2005, J MED GENET, V42, P58, DOI 10.1136/jmg.2004.022244; Frousios K, 2013, GENOMICS, V102, P223, DOI 10.1016/j.ygeno.2013.06.005; Giger U, 2014, P 2014 AM COLL VET I; Henthorn PS, 2006, COLD SPRING HARB MON, V44, P349; Henthorn PS, 2000, HUM GENET, V107, P295; Houston DM, 2009, CAN VET J, V50, P1263; JACKSON OF, 1979, J COMP PATHOL, V89, P39, DOI 10.1016/0021-9975(79)90006-9; Kurushima JD, 2013, ANIM GENET, V44, P311, DOI 10.1111/age.12008; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MH, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0510-7; Li G, 2016, G3-GENES GENOM GENET, V6, P1607, DOI 10.1534/g3.116.028746; Li Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104452; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lipinski MJ, 2008, GENOMICS, V91, P12, DOI 10.1016/j.ygeno.2007.10.009; Livrozet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102700; Lulich JP, 2013, VET REC, V172, P363, DOI 10.1136/vr.101056; Menotti-Raymond M, 2008, GENOMICS, V91, P1, DOI 10.1016/j.ygeno.2007.08.008; Mizukami K, 2015, J VET INTERN MED, V29, P120, DOI 10.1111/jvim.12501; MORRIS JG, 1985, J NUTR, V115, P524, DOI 10.1093/jn/115.4.524; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Nwaokorie EE, 2013, JAVMA-J AM VET MED A, V242, P1099, DOI 10.2460/javma.242.8.1099; Osborne C, 2001, P 19 FOR AM COLL VET, P794; Osborne CA, 1999, FELINE PRACT, V27, pS31; Osborne CA, 2009, VET CLIN N AM-SMALL, V39, P65, DOI 10.1016/j.cvsm.2008.09.005; Osborne CA, 2009, VET CLIN N AM-SMALL, V39, P183, DOI 10.1016/j.cvsm.2008.09.011; Palacin M, 2013, THE ONLINE METABOLIC; Peters T, 2003, HUM MOL GENET, V12, P2109, DOI 10.1093/hmg/ddg189; Sahota A, 2014, UROLOGY, V84, DOI 10.1016/j.urology.2014.07.043; SMITH A, 1977, MED J AUSTRALIA, V2, P153, DOI 10.5694/j.1326-5377.1977.tb99112.x; Tordiffe ASW, 2012, J ZOO WILDLIFE MED, V43, P649, DOI 10.1638/2011-0236R1.1; Ulrich LK, 1996, VET CLIN N AM-SMALL, V26, P393, DOI 10.1016/S0195-5616(96)50218-4; Wong KA, 2015, BJU INT, V116, P109, DOI 10.1111/bju.12894	47	10	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159247	10.1371/journal.pone.0159247	http://dx.doi.org/10.1371/journal.pone.0159247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404572	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508200046
J	Bautista, CA; Park, HJ; Mazur, CM; Aaron, RK; Bilgen, B				Bautista, Catherine A.; Park, Hee Jun; Mazur, Courtney M.; Aaron, Roy K.; Bilgen, Bahar			Effects of Chondroitinase ABC-Mediated Proteoglycan Digestion on Decellularization and Recellularization of Articular Cartilage	PLOS ONE			English	Article							ADULT STEM-CELLS; EXTRACELLULAR-MATRIX; BIOLOGIC SCAFFOLDS; CHONDROGENIC DIFFERENTIATION; ENGINEERED CARTILAGE; GROWTH-FACTORS; TISSUE; BONE; DEFECTS; KNEE	Articular cartilage has a limited capacity to heal itself and thus focal defects often result in the development of osteoarthritis. Current cartilage tissue engineering strategies seek to regenerate injured tissue by creating scaffolds that aim to mimic the unique structure and composition of native articular cartilage. Decellularization is a novel strategy that aims to preserve the bioactive factors and 3D biophysical environment of the native extracellular matrix while removing potentially immunogenic factors. The purpose of this study was to develop a procedure that can enable decellularization and recellularization of intact articular cartilage matrix. Full-thickness porcine articular cartilage plugs were decellularized with a series of freeze-thaw cycles and 0.1% (w/v) sodium dodecyl sulfate detergent cycles. Chondroitinase ABC (ChABC) was applied before the detergent cycles to digest glycosaminoglycans in order to enhance donor chondrocyte removal and seeded cell migration. Porcine synovium-derived mesenchymal stem cells were seeded onto the decellularized cartilage scaffolds and cultured for up to 28 days. The optimized decellularization protocol removed 94% of native DNA per sample wet weight, while collagen content and alignment were preserved. Glycosaminoglycan depletion prior to the detergent cycles increased removal of nuclear material. Seeded cells infiltrated up to 100 mu m into the cartilage deep zone after 28 days in culture. ChABC treatment enhances decellularization of the relatively dense, impermeable articular cartilage by reducing glycosaminoglycan content. ChABC treatment did not appear to affect cell migration during recellularization under static, in vitro culture, highlighting the need for more dynamic seeding methods.	[Bautista, Catherine A.; Mazur, Courtney M.] Brown Univ, Ctr Biomed Engn, Providence, RI 02912 USA; [Park, Hee Jun] Brown Univ, Div Biol & Med, Providence, RI 02912 USA; [Aaron, Roy K.; Bilgen, Bahar] Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Warren Alpert Brown Med Sch, Providence, RI 02903 USA; [Bilgen, Bahar] Providence VA Med Ctr, Providence, RI USA	Brown University; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Bilgen, B (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Orthopaed, Warren Alpert Brown Med Sch, Providence, RI 02903 USA.; Bilgen, B (corresponding author), Providence VA Med Ctr, Providence, RI USA.	bahar_bilgen@brown.edu	Bilgen, Bahar/B-3096-2009	Bilgen, Bahar/0000-0002-7395-2315; Bautista, Catherine/0000-0002-4923-3249	Department of Veterans Affairs, Rehabilitation RD Service [IK2 RX000760]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008155] Funding Source: NIH RePORTER; Veterans Affairs [IK2RX000760] Funding Source: NIH RePORTER	Department of Veterans Affairs, Rehabilitation RD Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	BB was funded by the Department of Veterans Affairs, Rehabilitation R&D Service, Grant No. IK2 RX000760 (http://www.research.va.gov/services/rrd.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JL, 2012, MOL BIOL CELL, V23, P3731, DOI 10.1091/mbc.E12-03-0172; [Anonymous], 2014, ONE WAY ANOVA POSTHO; Asanbaeva A, 2007, ARTHRITIS RHEUM, V56, P188, DOI 10.1002/art.22298; ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304; Bautista C, 2015, 61 ANN M ORTH RES SO; Benders KEM, 2013, TRENDS BIOTECHNOL, V31, P169, DOI 10.1016/j.tibtech.2012.12.004; Bian LM, 2009, TISSUE ENG PT A, V15, P2065, DOI 10.1089/ten.tea.2008.0495; Bilgen B, 2009, TISSUE ENG PT A, V15, P3261, DOI [10.1089/ten.tea.2008.0273, 10.1089/ten.TEA.2008.0273]; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; Carey James L, 2012, J Bone Joint Surg Am, V94, pe80, DOI 10.2106/JBJS.L.00319; Cheng CW, 2014, BIOTECHNOL ADV, V32, P462, DOI 10.1016/j.biotechadv.2013.12.012; Cheng NC, 2009, TISSUE ENG PT A, V15, P231, DOI 10.1089/ten.tea.2008.0253; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Davies-Tuck ML, 2008, OSTEOARTHR CARTILAGE, V16, P337, DOI 10.1016/j.joca.2007.07.005; Demange M, 2012, CURR REV MUSCULOSKE, V5, P229, DOI 10.1007/s12178-012-9132-0; Diekman BO, 2010, TISSUE ENG PT A, V16, P523, DOI 10.1089/ten.TEA.2009.0398; Elder BD, 2010, NEUROSURGERY, V66, P722, DOI 10.1227/01.NEU.0000367616.49291.9F; Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033; Farr J, 2011, CLIN ORTHOP RELAT R, V469, P2696, DOI 10.1007/s11999-010-1764-z; Fermor HL, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5517-0; Frisbie DD, 1999, VET SURG, V28, P242, DOI 10.1053/jvet.1999.0242; Gao Y, 2014, BIOMED RES INT; Ghanavi P, 2012, CELL TISSUE RES, V347, P643, DOI 10.1007/s00441-012-1323-x; Gong YY, 2011, BIOMATERIALS, V32, P2265, DOI 10.1016/j.biomaterials.2010.11.078; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156; Juran CM, 2015, TISSUE ENG PT A, V21, P829, DOI [10.1089/ten.tea.2014.0250, 10.1089/ten.TEA.2014.0250]; Katta J, 2008, P I MECH ENG H, V222, P1, DOI 10.1243/09544119JEIM325; Keane TJ, 2015, METHODS, V84, P25, DOI 10.1016/j.ymeth.2015.03.005; Keane TJ, 2012, BIOMATERIALS, V33, P1771, DOI 10.1016/j.biomaterials.2011.10.054; Kheir E, 2011, J BIOMED MATER RES A, V99A, P283, DOI 10.1002/jbm.a.33171; Krych AJ, 2012, J BONE JOINT SURG AM, V94A, P971, DOI 10.2106/JBJS.K.00815; Kuo J, 2010, J BIOMECH, V43, P1316, DOI 10.1016/j.jbiomech.2010.01.020; Kwon JS, 2013, INT J PHARMACEUT, V454, P183, DOI 10.1016/j.ijpharm.2013.06.023; Laasanen MS, 2003, BIORHEOLOGY, V40, P133; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lee YHD, 2014, CARTILAGE, V5, P145, DOI 10.1177/1947603514529445; Luo L, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/1596047; Luo L, 2016, J MECH BEHAV BIOMED, V55, P21, DOI 10.1016/j.jmbbm.2015.10.002; Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002; Mazur C, 2014, 60 ANN M ORTH RES SO; Mollon B, 2013, OSTEOARTHR CARTILAGE, V21, P1824, DOI 10.1016/j.joca.2013.08.024; Murphy MK, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4409; Natoli RM, 2009, TISSUE ENG PT A, V15, P3119, DOI 10.1089/ten.TEA.2008.0478; Ng KW, 2011, ANN BIOMED ENG, V39, P2491, DOI 10.1007/s10439-011-0356-8; Pallante AL, 2012, J BONE JOINT SURG AM, V94A, P1984, DOI 10.2106/JBJS.K.00439; Pearle AD, 2005, CLIN SPORT MED, V24, P1, DOI 10.1016/j.csm.2004.08.007; Peretti GM, 2000, TISSUE ENG, V6, P567, DOI 10.1089/107632700750022206; Schlie-Wolter S, 2013, EXP CELL RES, V319, P1553, DOI 10.1016/j.yexcr.2013.03.016; SCHMIDT MB, 1990, J ORTHOPAED RES, V8, P353, DOI 10.1002/jor.1100080307; Schwarz S, 2015, J TISSUE ENG REGEN M, V9, pE239, DOI 10.1002/term.1650; Sutherland AJ, 2015, ADV HEALTHC MATER, V4, DOI 10.1002/adhm.201400165; Tan LJ, 2012, J BIOMATER APPL, V26, P877, DOI 10.1177/0885328210389504; Utomo L, 2015, BIOMED MATER, V10, DOI 10.1088/1748-6041/10/1/015010; Vinardell T, 2009, ANN BIOMED ENG, V37, P2556, DOI 10.1007/s10439-009-9791-1; Wang ZJ, 2014, GENET MOL RES, V13, P4599, DOI 10.4238/2014.June.18.2; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Yang Q, 2014, SCI WORLD J, DOI 10.1155/2014/127084; Yang ZQ, 2010, TISSUE ENG PART C-ME, V16, P865, DOI [10.1089/ten.tec.2009.0444, 10.1089/ten.TEC.2009.0444]; Zhang ZZ, 2015, ACS APPL MATER INTER, V7, P15294, DOI 10.1021/acsami.5b03129; Zhao YH, 2013, CHINESE MED J-PEKING, V126, P3130, DOI 10.3760/cma.j.issn.0366-6999.20130212; Zheng XF, 2011, J MATER SCI-MATER M, V22, P693, DOI 10.1007/s10856-011-4248-0	62	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158976	10.1371/journal.pone.0158976	http://dx.doi.org/10.1371/journal.pone.0158976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391810	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400177
J	Lee, KH; Nam, H; Jeong, DE; Kim, SS; Song, HJ; Pyeon, HJ; Kang, K; Hong, SC; Nam, DH; Joo, KM				Lee, Kee Hang; Nam, Hyun; Jeong, Da Eun; Kim, Sung Soo; Song, Hye Jin; Pyeon, Hee Jang; Kang, Kyeongjin; Hong, Seung-Cheol; Nam, Do-Hyun; Joo, Kyeung Min			Sensitive Tumorigenic Potential Evaluation of Adult Human Multipotent Neural Cells Immortalized by hTERT Gene Transduction	PLOS ONE			English	Article							STEM-CELL; STRUCTURAL VARIATION; MODELS; TRANSLATION; PROTEIN; BONE	Stem cells and therapeutic genes are emerging as a new therapeutic approach to treat various neurodegenerative diseases with few effective treatment options. However, potential formation of tumors by stem cells has hampered their clinical application. Moreover, adequate preclinical platforms to precisely test tumorigenic potential of stem cells are controversial. In this study, we compared the sensitivity of various animal models for in vivo stem cell tumorigenicity testing to identify the most sensitive platform. Then, tumorigenic potential of adult human multipotent neural cells (ahMNCs) immortalized by the human telomerase reverse transcriptase (hTERT) gene was examined as a stem cell model with therapeutic genes. When human glioblastoma (GBM) cells were injected into adult (4-6-week-old) Balb/c-nu, adult NOD/SCID, adult NOG, or neonate (1-2-week-old) NOG mice, the neonate NOG mice showed significantly faster tumorigenesis than that of the other groups regardless of intracranial or subcutaneous injection route. Two kinds of ahMNCs (682TL and 779TL) were primary cultured from surgical samples of patients with temporal lobe epilepsy. Although the ahMNCs were immortalized by lentiviral hTERT gene delivery (hTERT-682TL and hTERT-779TL), they did not form any detectable masses, even in the most sensitive neonate NOG mouse platform. Moreover, the hTERT-ahMNCs had no gross chromosomal abnormalities on a karyotype analysis. Taken together, our data suggest that neonate NOG mice could be a sensitive animal platform to test tumorigenic potential of stem cell therapeutics and that ahMNCs could be a genetically stable stem cell source with little tumorigenic activity to develop regenerative treatments for neurodegenerative diseases.	[Lee, Kee Hang; Jeong, Da Eun; Kim, Sung Soo; Hong, Seung-Cheol; Nam, Do-Hyun; Joo, Kyeung Min] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea; [Nam, Hyun; Nam, Do-Hyun] Sungkyunkwan Univ, Dept Neurosurg, Samsung Med Ctr, Seoul, South Korea; [Song, Hye Jin; Pyeon, Hee Jang; Kang, Kyeongjin; Joo, Kyeung Min] Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Seoul, South Korea; [Lee, Kee Hang; Nam, Hyun; Jeong, Da Eun; Kim, Sung Soo; Song, Hye Jin; Pyeon, Hee Jang; Hong, Seung-Cheol; Nam, Do-Hyun; Joo, Kyeung Min] Samsung Med Ctr, Res Inst Future Med, Stem Cell & Regenerat Med Ctr, Seoul 06351, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung Medical Center	Joo, KM (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.; Joo, KM (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Anat & Cell Biol, Seoul, South Korea.; Joo, KM (corresponding author), Samsung Med Ctr, Res Inst Future Med, Stem Cell & Regenerat Med Ctr, Seoul 06351, South Korea.	kmjoo@skku.edu			Ministry of Food and Drug Safety [14172MFDS974]; National Research Foundation [NRF-2013R1A1A2058169]	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea); National Research Foundation	This research was supported by grants from Ministry of Food and Drug Safety in 2014 (14172MFDS974) and National Research Foundation (NRF-2013R1A1A2058169). KMJ received grants, which supported salary, materials and fees for equipment. The URL of Ministry of Food and Drug Safety is (http://www.mfds.go.kr/index.do). The URL of National Research Foundation is (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none).; This research was supported by grants from Ministry of Food and Drug Safety in 2014 (14172MFDS974) and National Research Foundation (NRF-2013R1A1A2058169).	Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Bocker W, 2008, J CELL MOL MED, V12, P1347, DOI [10.1111/j.1582-4934.2008.00299.x, 10.1111/j.1582-4934.2008.0299.x]; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Bullwinkel J, 2006, J CELL PHYSIOL, V206, P624, DOI 10.1002/jcp.20494; Chen B, 2009, BRAIN RES, V1284, P1, DOI 10.1016/j.brainres.2009.05.100; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Denton PW, 2011, AIDS REV, V13, P135; Drost J, 2015, NATURE, V521, P43, DOI 10.1038/nature14415; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flammang TJ, 1997, REGUL TOXICOL PHARM, V26, P230, DOI 10.1006/rtph.1997.1125; FOGH J, 1977, JNCI-J NATL CANCER I, V59, P221, DOI 10.1093/jnci/59.1.221; Frey-Vasconcells J, 2012, STEM CELL TRANSL MED, V1, P353, DOI 10.5966/sctm.2012-0018; Fuentealba LC, 2015, CELL, V161, P1644, DOI 10.1016/j.cell.2015.05.041; GANICK DJ, 1980, INT ARCH ALLER A IMM, V62, P330, DOI 10.1159/000232530; Goldring CEP, 2011, CELL STEM CELL, V8, P618, DOI 10.1016/j.stem.2011.05.012; Gupta B, 2007, CANCER IMMUNOL IMMUN, V56, P1215, DOI 10.1007/s00262-006-0273-0; Hahn WC, 2001, ANN MED, V33, P123, DOI 10.3109/07853890109002067; Harding J, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt171; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Joo KM, 2013, CELL REP, V3, P260, DOI 10.1016/j.celrep.2012.12.013; Joo KM, 2013, EXP NEUROL, V240, P168, DOI 10.1016/j.expneurol.2012.11.021; Kanemura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085336; Kawamata S, 2015, J CLIN MED, V4, P159, DOI 10.3390/jcm4010159; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lee HJ, 2010, J NEUROSCI RES, V88, P3282, DOI 10.1002/jnr.22474; Lindvall O, 2010, J CLIN INVEST, V120, P29, DOI 10.1172/JCI40543; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Lunn JS, 2011, ANN NEUROL, V70, P353, DOI 10.1002/ana.22487; Marei HES, 2015, J CELL PHYSIOL, V230, P116, DOI 10.1002/jcp.24688; Martino G, 2011, PHYSIOL REV, V91, P1281, DOI 10.1152/physrev.00032.2010; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McClain RM, 2001, TOXICOL PATHOL, V29, P128, DOI 10.1080/019262301753178537; Nam H, 2015, WORLD J STEM CELLS, V7, P126, DOI 10.4252/wjsc.v7.i1.126; Nombela-Arrieta C, 2011, NAT REV MOL CELL BIO, V12, P126, DOI 10.1038/nrm3049; Oh JE, 2011, J BIOL CHEM, V286, P38757, DOI 10.1074/jbc.M111.244939; PIETRA G, 1959, NATURE, V183, P1689, DOI 10.1038/1831689a0; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reddel RR, 2000, CARCINOGENESIS, V21, P477, DOI 10.1093/carcin/21.3.477; Roy NS, 2007, NAT PROTOC, V2, P2815, DOI 10.1038/nprot.2007.402; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Urraca N, 2015, STEM CELL RES, V15, P722, DOI 10.1016/j.scr.2015.11.004; Wilson R, 2015, STEM CELL TRANSL MED, V4, P905, DOI 10.5966/sctm.2014-0196; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042	51	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158639	10.1371/journal.pone.0158639	http://dx.doi.org/10.1371/journal.pone.0158639			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391353	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400095
J	Marczok, S; Bortz, B; Wang, C; Pospisil, H				Marczok, Stefanie; Bortz, Birgit; Wang, Chong; Pospisil, Heike			Comprehensive Analysis of Genome Rearrangements in Eight Human Malignant Tumor Tissues	PLOS ONE			English	Article							CHROMOSOMAL FRAGILE SITES; COPY-NUMBER ALTERATIONS; LI-FRAUMENI-SYNDROME; COLORECTAL-CANCER; DNA-REPLICATION; INSTABILITY; ADAMS; P53	Carcinogenesis is a complex multifactorial, multistage process, but the precise mechanisms are not well understood. In this study, we performed a genome-wide analysis of the copy number variation (CNV), breakpoint region (BPR) and fragile sites in 2,737 tumor samples from eight tumor entities and in 432 normal samples. CNV detection and BPR identification revealed that BPRs tended to accumulate in specific genomic regions in tumor samples whereas being dispersed genome-wide in the normal samples. Hotspots were observed, at which segments with similar alteration in copy number were overlapped along with BPRs adjacently clustered. Evaluation of BPR occurrence frequency showed that at least one was detected in about and more than 15% of samples for each tumor entity while BPRs were maximal in 12% of the normal samples. 127 of 2,716 tumor-relevant BPRs (termed 'common BPRs') exhibited also a noticeable occurrence frequency in the normal samples. Colocalization assessment identified 20,077 CNV-affecting genes and 169 of these being known tumor-related genes. The most noteworthy genes are KIAA0513 important for immunologic, synaptic and apoptotic signal pathways, intergenic non-coding RNA RP11-115C21.2 possibly acting as oncogene or tumor suppressor by changing the structure of chromatin, and ADAM32 likely importance in cancer cell proliferation and progression by ectodomain-shedding of diverse growth factors, and the well-known tumor suppressor gene p53. The BPR distributions indicate that CNV mutations are likely non-random in tumor genomes. The marked recurrence of BPRs at specific regions supports common progression mechanisms in tumors. The presence of hotspots together with common BPRs, despite its small group size, imply a relation between fragile sites and cancer-gene alteration. Our data further suggest that both protein-coding and non-coding genes possessing a range of biological functions might play a causative or functional role in tumor biology. This research enhances our understanding of the mechanisms for tumorigenesis and progression.	[Marczok, Stefanie; Bortz, Birgit; Wang, Chong; Pospisil, Heike] Univ Appl Sci Wildau, High Performance Comp Life Sci, Inst Appl Biosci, Wildau, Germany	University of Applied Sciences Wildau	Pospisil, H (corresponding author), Univ Appl Sci Wildau, High Performance Comp Life Sci, Inst Appl Biosci, Wildau, Germany.	pospisil@th-wildau.de			Europaischer Fonds fur regionale Entwicklung, State Brandenburg [EFRE 1416689]; Bundesministerium fur Bildung und Forschung in the project "Prediction and modeling of hybrid performance and yield gain in oilseed rape by systems biology" [PROGReSs - 031A297G]	Europaischer Fonds fur regionale Entwicklung, State Brandenburg; Bundesministerium fur Bildung und Forschung in the project "Prediction and modeling of hybrid performance and yield gain in oilseed rape by systems biology"(Federal Ministry of Education & Research (BMBF))	Funding for S. Marczok and B. Bortz was provided by a grant of the Europaischer Fonds fur regionale Entwicklung, EFRE 1416689, State Brandenburg (www.esf.brandenburg.de); and by the Bundesministerium fur Bildung und Forschung in the project "Prediction and modeling of hybrid performance and yield gain in oilseed rape by systems biology" (PROGReSs - 031A297G) (www.bmbf.de).	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], 2009, AFFYMETRIX, V2, P1; [Anonymous], RAW DAT DOWNL AFFYME; Bernstein C., 2013, NEW RES DIRECTIONS D; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bose P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101607; Bougeard G, 2008, J MED GENET, V45, P535, DOI 10.1136/jmg.2008.057570; Brocker Chad N., 2009, Human Genomics, V4, P43; de Andrade M, 2011, HUM HERED, V71, P221, DOI 10.1159/000328843; Dillon LW, 2010, CURR GENOMICS, V11, P326, DOI 10.2174/138920210791616699; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Frohlich C, 2013, BIOCHEM J, V452, P97, DOI 10.1042/BJ20121558; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Gratias S, 2007, CANCER RES, V67, P408, DOI 10.1158/0008-5472.CAN-06-1317; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Gutschner T, 2012, RNA BIOL, V9, P703, DOI 10.4161/rna.20481; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Karimpour-Fard Anis, 2010, Hum Genomics, V4, P421; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lauriat TL, 2006, BRAIN RES, V1121, P1, DOI 10.1016/j.brainres.2006.08.099; Le Scouarnec S, 2012, HEREDITY, V108, P75, DOI 10.1038/hdy.2011.100; Li WL, 2013, PHYSIOL GENOMICS, V45, P1, DOI 10.1152/physiolgenomics.00082.2012; Li YD, 2012, HUM MOL GENET, V21, P4957, DOI 10.1093/hmg/dds340; Mahfouz EM, 2014, CENT EUR J PUBL HEAL, V22, P215, DOI 10.21101/cejph.a3919; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; McAllister HA, 1978, ATLAS TUMOR PATHOL, P46; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Neuvial P, 2011, SPR HBK COMPU STAT, P225, DOI 10.1007/978-3-642-16345-6_11; Nordman J, 2012, DEVELOPMENT, V139, P455, DOI 10.1242/dev.061838; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Ruijs MWG, 2010, J MED GENET, V47, P421, DOI 10.1136/jmg.2009.073429; Shlien A, 2008, P NATL ACAD SCI USA, V105, P11264, DOI 10.1073/pnas.0802970105; Silva AG, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-63; Standfuss C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-380; Stewart B, 2014, WORLD CANC REPORT 20; Thys RG, 2015, CURR GENOMICS, V16, P60, DOI 10.2174/1389202916666150114223205; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yang RX, 2014, CARCINOGENESIS, V35, P315, DOI 10.1093/carcin/bgt344; Zarrei M, 2015, NAT REV GENET, V16, P172, DOI 10.1038/nrg3871; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308	51	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158995	10.1371/journal.pone.0158995	http://dx.doi.org/10.1371/journal.pone.0158995			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391163	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400184
J	Park, EY; Kim, EH; Kim, CY; Kim, MH; Choung, JS; Oh, YS; Moon, HS; Jun, HS				Park, Eun-Young; Kim, Eung-Hwi; Kim, Chul-Young; Kim, Mi-Hwi; Choung, Jin-Seung; Oh, Yoon-Sin; Moon, Hong-Sub; Jun, Hee-Sook			Angelica dahurica Extracts Improve Glucose Tolerance through the Activation of GPR119	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; GLYCEMIC CONTROL; TYPE-2; AGONISTS; FURANOCOUMARINS; PATHOGENESIS; ROOTS	G protein-coupled receptor (GPR) 119 is expressed in pancreatic beta-cells and intestinal L cells, and is involved in glucose-stimulated insulin secretion and glucagon-like peptide-1 (GLP-1) release, respectively. Therefore, the development of GPR119 agonists is a potential treatment for type 2 diabetes. We screened 1500 natural plant extracts for GPR119 agonistic actions and investigated the most promising extract, that from Angelica dahurica (AD), for hypoglycemic actions in vitro and in vivo. Human GPR119 activation was measured in GeneBLAzer T-Rex GPR119-CRE-bla CHO-K1 cells; intracellular cAMP levels and insulin secretion were measured in INS-1 cells; and GLP-1 release was measured in GLUTag cells. Glucose tolerance tests and serum plasma insulin levels were measured in normal C57BL6 mice and diabetic db/db mice. AD extract-treated cells showed significant increases in GPR119 activation, intracellular cAMP levels, GLP-1 levels and glucose-stimulated insulin secretion as compared with controls. In normal mice, a single treatment with AD extract improved glucose tolerance and increased insulin secretion. Treatment with multiple doses of AD extract or n-hexane fraction improved glucose tolerance in diabetic db/db mice. Imperatorin, phellopterin and isoimperatorin were identified in the active fraction of AD extract. Among these, phellopterin activated GPR119 and increased active GLP-1 and insulin secretion in vitro and enhanced glucose tolerance in normal and db/db mice. We suggest that phellopterin might have a therapeutic potential for the treatment of type 2 diabetes.	[Park, Eun-Young; Moon, Hong-Sub] Mokpo Natl Univ, Coll Pharm, Muan Gun 534729, Jeonnam, South Korea; [Kim, Eung-Hwi; Kim, Mi-Hwi; Choung, Jin-Seung; Oh, Yoon-Sin; Jun, Hee-Sook] Gachon Univ, Lee Gil Ya Canc & Diabet Inst, 7-45 Songdo Dong, Inchon 406840, South Korea; [Kim, Chul-Young] Hanyang Univ, Coll Pharm, Ansan 426791, Kyeonggi, South Korea; [Oh, Yoon-Sin; Jun, Hee-Sook] Gil Hosp, Gachon Med Res Inst, Inchon, South Korea; [Jun, Hee-Sook] Gachon Univ, Coll Pharm, 7-45 Songdo Dong, Inchon 406840, South Korea; [Jun, Hee-Sook] Gachon Univ, Gachon Inst Pharmaceut Sci, 7-45 Songdo Dong, Inchon 406840, South Korea	Mokpo National University; Gachon University; Hanyang University; Gachon University; Gachon University; Gachon University	Jun, HS (corresponding author), Gachon Univ, Lee Gil Ya Canc & Diabet Inst, 7-45 Songdo Dong, Inchon 406840, South Korea.; Jun, HS (corresponding author), Gil Hosp, Gachon Med Res Inst, Inchon, South Korea.; Jun, HS (corresponding author), Gachon Univ, Coll Pharm, 7-45 Songdo Dong, Inchon 406840, South Korea.; Jun, HS (corresponding author), Gachon Univ, Gachon Inst Pharmaceut Sci, 7-45 Songdo Dong, Inchon 406840, South Korea.	hsjun@gachon.ac.kr	오, 윤신/AAS-2225-2020	Jun, Hee-Sook/0000-0002-1166-4932; Oh, Yoon Sin/0000-0003-3995-4429	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI12C1564]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C1564).	Amer Diabet Assoc, 2009, DIABETES CARE, V32, pS13, DOI 10.2337/dc09-S013; Ban HS, 2003, PLANTA MED, V69, P408, DOI 10.1055/s-2003-39702; Chu ZL, 2008, ENDOCRINOLOGY, V149, P2038, DOI 10.1210/en.2007-0966; Chu ZL, 2007, ENDOCRINOLOGY, V148, P2601, DOI 10.1210/en.2006-1608; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; Fyfe MCT, 2008, EXPERT OPIN DRUG DIS, V3, P403, DOI 10.1517/17460441.3.4.403; Jones RM, 2009, EXPERT OPIN THER PAT, V19, P1339, DOI 10.1517/13543770903153878; KIM C M, 1991, Archives of Pharmacal Research (Seoul), V14, P87, DOI 10.1007/BF02857821; Kim YK, 2007, PHYTOTHER RES, V21, P288, DOI 10.1002/ptr.2043; Lechner D, 2004, PHYTOCHEMISTRY, V65, P331, DOI 10.1016/j.phytochem.2003.11.010; Liu DP, 2011, MOLECULES, V16, P6339, DOI 10.3390/molecules16086339; Ohishi T, 2012, EXPERT OPIN INV DRUG, V21, P321, DOI 10.1517/13543784.2012.657797; Overton HA, 2008, BRIT J PHARMACOL, V153, pS76, DOI 10.1038/sj.bjp.0707529; Overton HA, 2006, CELL METAB, V3, P167, DOI 10.1016/j.cmet.2006.02.004; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Russell-Jones D, 2012, CLIN ENDOCRINOL, V77, P489, DOI 10.1111/j.1365-2265.2012.04483.x; Seo WD, 2013, J FUNCT FOODS, V5, P1421, DOI 10.1016/j.jff.2013.05.011; Shalaby NMM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/480545; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; TAYLOR SI, 1994, DIABETES, V43, P735, DOI 10.2337/diab.43.6.735; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Zhang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063861	23	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158796	10.1371/journal.pone.0158796	http://dx.doi.org/10.1371/journal.pone.0158796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391814	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400125
J	Singh, AK; Paritosh, K; Kant, U; Burma, PK; Pental, D				Singh, Amarjeet Kumar; Paritosh, Kumar; Kant, Uma; Burma, Pradeep Kumar; Pental, Deepak			High Expression of Cry1Ac Protein in Cotton (Gossypium hirsutum) by Combining Independent Transgenic Events that Target the Protein to Cytoplasm and Plastids	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; BACILLUS-THURINGIENSIS TOXINS; FIELD-EVOLVED RESISTANCE; IN-VITRO REGENERATION; BT-COTTON; INSECT RESISTANCE; CRYSTAL-PROTEIN; PYRAMIDING BT; FULL-LENGTH; GENE	Transgenic cotton was developed using two constructs containing a truncated and codon-modified cry1Ac gene (1,848 bp), which was originally characterized from Bacillus thuringiensis subspecies kurstaki strain HD73 that encodes a toxin highly effective against many lepidopteran pests. In Construct I, the cry1Ac gene was cloned under FMVde, a strong constitutively expressing promoter, to express the encoded protein in the cytoplasm. In Construct II, the encoded protein was directed to the plastids using a transit peptide taken from the cotton rbcSIb gene. Genetic transformation experiments with Construct I resulted in a single copy insertion event in which the Cry1Ac protein expression level was 2-2.5 times greater than in the Bacillus thuringiensis cotton event Mon 531, which is currently used in varieties and hybrids grown extensively in India and elsewhere. Another high expression event was selected from transgenics developed with Construct II. The Cry protein expression resulting from this event was observed only in the green plant parts. No transgenic protein expression was observed in the non-green parts, including roots, seeds and non-green floral tissues. Thus, leucoplasts may lack the mechanism to allow entry of a protein tagged with the transit peptide from a protein that is only synthesized in tissues containing mature plastids. Combining the two events through sexual crossing led to near additive levels of the toxin at 4-5 times the level currently used in the field. The two high expression events and their combination will allow for effective resistance management against lepidopteran insect pests, particularly Helicoverpa armigera, using a high dosage strategy.	[Singh, Amarjeet Kumar; Paritosh, Kumar; Kant, Uma; Pental, Deepak] Univ Delhi, Ctr Genet Manipulat Crop Plants, South Campus,Benito Juarez Rd, New Delhi 110021, India; [Burma, Pradeep Kumar] Univ Delhi, Dept Genet, South Campus,Benito Juarez Rd, New Delhi 110021, India	University of Delhi; University of Delhi	Pental, D (corresponding author), Univ Delhi, Ctr Genet Manipulat Crop Plants, South Campus,Benito Juarez Rd, New Delhi 110021, India.	depental@gmail.com		paritosh, kumar/0000-0001-6250-7112	Department of Biotechnology, Government of India [BT/AB/NP/07/98, BA/AB/NP/07/Cotton/2005]; Indian Council of Agricultural Research, Government of India [ICAR-NPTC/EFC/XII Plan]; J. C. Bose Fellowship (Department of Science and Technology, Government of India)	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Council of Agricultural Research, Government of India(Indian Council of Agricultural Research (ICAR)); J. C. Bose Fellowship (Department of Science and Technology, Government of India)(Department of Science & Technology (India))	Research work was supported by grants from the Department of Biotechnology, Government of India (1999-2009, from grant number "BT/AB/NP/07/98" and "BA/AB/NP/07/Cotton/2005") and the Indian Council of Agricultural Research, Government of India (2015-onwards, from grant number "ICAR-NPTC/EFC/XII Plan"). DP acknowledges award of a J. C. Bose Fellowship (Department of Science and Technology, Government of India). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DP acknowledges award of a J. C. Bose Fellowship (Department of Science and Technology, Government of India). We thank Dr. Paresh Verma, (Shriram Bioseed Genetics, India) for providing seeds of the BioCot lines.	Acharjee S, 2010, PLANT SCI, V178, P333, DOI 10.1016/j.plantsci.2010.02.001; Adamczyk JJ, 2009, TRANSGENIC RES, V18, P143, DOI 10.1007/s11248-008-9198-z; ADANG MJ, 1985, GENE, V36, P289, DOI 10.1016/0378-1119(85)90184-2; Akin DS, 2010, MIDSOUTH ENTOMOL, V4, P1; Bates SL, 2005, NAT BIOTECHNOL, V23, P57, DOI 10.1038/nbt1056; BENFEY PN, 1989, EMBO J, V8, P2195, DOI 10.1002/j.1460-2075.1989.tb08342.x; Carriere Y, 2015, NAT BIOTECHNOL, V33, P161, DOI 10.1038/nbt.3099; Carriere Y, 2010, EVOL APPL, V3, P561, DOI 10.1111/j.1752-4571.2010.00129.x; Cattaneo MG, 2006, P NATL ACAD SCI USA, V103, P7571, DOI 10.1073/pnas.0508312103; Chakrabarti SK, 1998, J INVERTEBR PATHOL, V72, P336, DOI 10.1006/jipa.1998.4786; Chaudhary B, 2003, PLANT CELL REP, V21, P955, DOI 10.1007/s00299-003-0613-x; Choudhary B., 2015, ISAAA SERIES BIOTECH; Crickmore N., 2016, BACILLUS THURINGIENS; Cui JJ, 2011, J ECON ENTOMOL, V104, P673, DOI 10.1603/EC09228; DALE EC, 1991, P NATL ACAD SCI USA, V88, P10558, DOI 10.1073/pnas.88.23.10558; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Dong HZ, 2007, J AGRON CROP SCI, V193, P21, DOI 10.1111/j.1439-037X.2006.00240.x; Edge J. M., 2001, Journal of Cotton Science, V5, P121; Falck-Zepeda J. B., 2000, Agribusiness (New York), V16, P21, DOI 10.1002/(SICI)1520-6297(200024)16:1&lt;21::AID-AGR3&gt;3.0.CO;2-F; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P8693, DOI 10.1093/nar/15.21.8693; Gatehouse JA, 2008, PLANT PHYSIOL, V146, P881, DOI 10.1104/pp.107.111096; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Greenplate JT, 1999, J ECON ENTOMOL, V92, P1377, DOI 10.1093/jee/92.6.1377; Gryspeirt A, 2012, TOXINS, V4, P810, DOI 10.3390/toxins4100810; Gupta GP, 2004, INDIAN J AGR SCI, V74, P548; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; HOFTE H, 1989, MICROBIOL REV, V53, P242; James C., 2014, ISAAA BRIEF; Kanoria S, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-85; Kathage J, 2012, P NATL ACAD SCI USA, V109, P11652, DOI 10.1073/pnas.1203647109; KAY R, 1987, SCIENCE, V236, P1299, DOI 10.1126/science.236.4806.1299; Kiani S, 2013, J BIOTECHNOL, V166, P88, DOI 10.1016/j.jbiotec.2013.04.011; Klumper W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111629; Kranthi KR, 2005, CURR SCI INDIA, V89, P291; Kumar M, 2009, J BIOTECHNOL, V140, P143, DOI 10.1016/j.jbiotec.2009.01.005; Kumar S, 2005, J INVERTEBR PATHOL, V88, P83, DOI 10.1016/j.jip.2004.09.002; Kumar S, 1998, PLANT CELL REP, V18, P59, DOI 10.1007/s002990050532; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li HM, 2013, TRENDS PLANT SCI, V18, P360, DOI 10.1016/j.tplants.2013.04.003; Li LB, 2014, ACTA PHYSIOL PLANT, V36, P2717, DOI 10.1007/s11738-014-1642-5; Liao CY, 2002, J INVERTEBR PATHOL, V80, P55, DOI 10.1016/S0022-2011(02)00035-6; Liu FY, 2010, PEST MANAG SCI, V66, P155, DOI 10.1002/ps.1849; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Maiti IB, 1997, TRANSGENIC RES, V6, P143, DOI 10.1023/A:1018477705019; Moar WJ, 2007, SCIENCE, V318, P1561, DOI 10.1126/science.1151313; Olsen KM, 2005, J ECON ENTOMOL, V98, P1007, DOI 10.1603/0022-0493-98.3.1007; OMIRULLEH S, 1993, PLANT MOL BIOL, V21, P415, DOI 10.1007/BF00028800; Palma L, 2014, TOXINS, V6, P3296, DOI 10.3390/toxins6123296; Paritosh K, 2013, PLANT MOL BIOL REP, V31, P1176, DOI 10.1007/s11105-013-0576-1; PERLAK FJ, 1990, BIO-TECHNOL, V8, P939, DOI 10.1038/nbt1090-939; Perlak FJ, 2001, PLANT J, V27, P489, DOI 10.1046/j.1365-313X.2001.01120.x; Rawat P, 2011, J BIOSCIENCES, V36, P363, DOI 10.1007/s12038-011-9074-5; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Soberon M, 2015, BT RESISTANCE CHARAC; Strizhov N, 1996, P NATL ACAD SCI USA, V93, P15012, DOI 10.1073/pnas.93.26.15012; TABASHNIK BE, 1982, ENVIRON ENTOMOL, V11, P1137, DOI 10.1093/ee/11.6.1137; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Teng YS, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001416; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; Wang Q, 2016, SCI CHINA LIFE SCI, V59, P172, DOI 10.1007/s11427-015-4920-6; Wu JH, 2011, TRANSGENIC RES, V20, P963, DOI 10.1007/s11248-011-9483-0; Yan XX, 2006, FEBS LETT, V580, P6509, DOI 10.1016/j.febslet.2006.10.057; Yu J, 2014, NUCLEIC ACIDS RES, V42, pD1229, DOI 10.1093/nar/gkt1064; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207	67	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158603	10.1371/journal.pone.0158603	http://dx.doi.org/10.1371/journal.pone.0158603			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391960	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400087
J	Urso, K; Charles, JF; Shull, GE; Aliprantis, AO; Balestrieri, B				Urso, Katia; Charles, Julia F.; Shull, Gary E.; Aliprantis, Antonios O.; Balestrieri, Barbara			Anion Exchanger 2 Regulates Dectin-1-Dependent Phagocytosis and Killing of Candida albicans	PLOS ONE			English	Article							NF-KAPPA-B; AE2 CL-/HCO3-EXCHANGER; C-TYPE LECTIN; INNATE IMMUNITY; HOST-DEFENSE; RECOGNITION; ACTIVATION; DECTIN-2; RECEPTOR; MACROPHAGES	Anion exchanger 2 (Ae2; gene symbol, Slc4a2) is a plasma membrane Cl-/HCO3- exchanger expressed in the gastrointestinal tract, kidney and bone. We have previously shown that Ae2 is required for the function of osteoclasts, bone resorbing cells of the macrophage lineage, to maintain homeostatic cytoplasmic pH and electroneutrality during acid secretion. Macrophages require endosomal acidification for pathogen killing during the process known as phagocytosis. Chloride is thought to be the principal ion responsible for maintaining electroneutrality during organelle acidification, but whether Cl-/HCO3- exchangers such as Ae2 contribute to macrophage function is not known. In this study we investigated the role of Ae2 in primary macrophages during phagocytosis. We find that Ae2 is expressed in macrophages where it regulates intracellular pH and the binding of Zymosan, a fungal cell wall derivative. Surprisingly, the transcription and surface expression of Dectin- 1, the major phagocytic receptor for Candida albicans (C. albicans) and Zymosan, is reduced in the absence of Ae2. As a consequence, Zymosan-induced Tnfa expression is also impaired in Ae2-deficient macrophages. Similar to Ae2 deficiency, pharmacological alkalinization of lysosomal pH with bafilomycin A decreases both Dectin-1 mRNA and cell surface expression. Finally, Ae2-deficient macrophages demonstrate defective phagocytosis and killing of the human pathogenic fungus C. albicans. Our results strongly suggest that Ae2 is a critical factor in the innate response to C. albicans. This study represents an important contribution to a better understanding of how Dectin-1 expression and fungal clearance is regulated.	[Urso, Katia; Charles, Julia F.; Aliprantis, Antonios O.; Balestrieri, Barbara] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Urso, Katia; Charles, Julia F.; Aliprantis, Antonios O.; Balestrieri, Barbara] Harvard Med Sch, Boston, MA 02115 USA; [Shull, Gary E.] Univ Cincinnati, Coll Med, Dept Mol Genet, Cincinnati, OH USA; [Balestrieri, Barbara] Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Jeff & Penny Vinik Ctr Allerg Dis Res, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University System of Ohio; University of Cincinnati; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Balestrieri, B (corresponding author), Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.; Balestrieri, B (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Balestrieri, B (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Jeff & Penny Vinik Ctr Allerg Dis Res, Boston, MA 02115 USA.	bbalestrieri@partners.org	Balestrieri, Barbara/Y-2547-2018	Balestrieri, Barbara/0000-0002-0323-3278; Charles, Julia/0000-0002-5875-314X	National Institute of Health [R01HL113071, R01AR060363, K08AR062590]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR062590, R01AR060363] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institute of Health grants R01HL113071, R01AR060363, K08AR062590. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama TE, 2002, MOL CELL BIOL, V22, P2607, DOI 10.1128/MCB.22.8.2607-2619.2002; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aliprantis AO, 2008, J CLIN INVEST, V118, P3775, DOI 10.1172/JCI35711; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Alper SL, 2009, J EXP BIOL, V212, P1672, DOI 10.1242/jeb.029454; Balestrieri B, 2006, J BIOL CHEM, V281, P6691, DOI 10.1074/jbc.M508314200; Balestrieri B, 2009, J IMMUNOL, V182, P4891, DOI 10.4049/jimmunol.0803776; Bi LK, 2010, J BIOL CHEM, V285, P25969, DOI 10.1074/jbc.M110.131300; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Concepcion AR, 2014, EUR J IMMUNOL, V44, P1341, DOI 10.1002/eji.201344218; Coury F, 2013, P NATL ACAD SCI USA, V110, P2163, DOI 10.1073/pnas.1206392110; Davis JT, 2010, CHEM SOC REV, V39, P3843, DOI 10.1039/b926164h; Davis JT, 2009, NAT CHEM, V1, P138, DOI [10.1038/NCHEM.178, 10.1038/nchem.178]; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Frische S, 2004, AM J PHYSIOL-RENAL, V286, pF1163, DOI 10.1152/ajprenal.00409.2003; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gawenis LR, 2010, AM J PHYSIOL-GASTR L, V298, pG493, DOI 10.1152/ajpgi.00178.2009; Gawenis LR, 2004, J BIOL CHEM, V279, P30531, DOI 10.1074/jbc.M403779200; Gilbert AS, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a019661; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; GORDON AH, 1980, NATURE, V286, P79, DOI 10.1038/286079a0; Greenblatt MB, 2010, J EXP MED, V207, P923, DOI 10.1084/jem.20092531; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; HISHIKAWA T, 1991, J CELL BIOL, V115, P59, DOI 10.1083/jcb.115.1.59; Kerscher B, 2013, INT IMMUNOL, V25, P271, DOI 10.1093/intimm/dxt006; Khan NS, 2016, J IMMUNOL, V196, P2249, DOI 10.4049/jimmunol.1401545; KIMURA M, 1994, AM J PHYSIOL-REG I, V267, pR1596, DOI 10.1152/ajpregu.1994.267.6.R1596; Kullberg BJ, 2015, NEW ENGL J MED, V373, P1445, DOI 10.1056/NEJMra1315399; Lecanda J, 2000, BIOCHEM BIOPH RES CO, V276, P117, DOI 10.1006/bbrc.2000.3439; Mansour MK, 2013, J BIOL CHEM, V288, P16043, DOI 10.1074/jbc.M113.473223; McGreal EP, 2006, GLYCOBIOLOGY, V16, P422, DOI 10.1093/glycob/cwj077; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Medina JF, 2000, BIOCHEM BIOPH RES CO, V267, P228, DOI 10.1006/bbrc.1999.1951; Naumann K, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/283649; Netea MG, 2006, J CLIN INVEST, V116, P1642, DOI 10.1172/JCI27114; Netea MG, 2015, NAT REV IMMUNOL, V15, P630, DOI 10.1038/nri3897; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Recalde S, 2006, AM J PATHOL, V169, P165, DOI 10.2353/ajpath.2006.051096; Saijo S, 2011, INT IMMUNOL, V23, P467, DOI 10.1093/intimm/dxr046; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Sato K, 2006, J BIOL CHEM, V281, P38854, DOI 10.1074/jbc.M606542200; Sato M, 2003, J IMMUNOL, V171, P417, DOI 10.4049/jimmunol.171.1.417; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; van Vugt MJ, 1999, BLOOD, V94, P808, DOI 10.1182/blood.V94.2.808.414k31_808_817; Wongchana W, 2015, J IMMUNOL, V195, P5337, DOI 10.4049/jimmunol.1401770; Wu J, 2008, P NATL ACAD SCI USA, V105, P16934, DOI 10.1073/pnas.0808763105	49	4	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158893	10.1371/journal.pone.0158893	http://dx.doi.org/10.1371/journal.pone.0158893			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391897	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400152
J	Zhang, XQ; Wang, J; Wang, B; Chen, S; Fu, QH; Sun, K				Zhang, Xiaoqing; Wang, Jian; Wang, Bo; Chen, Sun; Fu, Qihua; Sun, Kun			A Novel Missense Mutation of GATA4 in a Chinese Family with Congenital Heart Disease	PLOS ONE			English	Article							VENTRICULAR SEPTAL-DEFECT; TETRALOGY; FALLOT; REGULATOR; GENE	Background Congenital heart disease (CHD) is the most prevalent type of birth defect in human, with high morbidity in infant. Several genes essential for heart development have been identified. GATA4 is a pivotal transcription factor that can regulate the cardiac development. Many GATA4 mutations have been identified in patients with different types of CHD. Aims In this study, the NKX2-5, HAND1 and GATA4 coding regions were sequenced in a family spanning three generations in which seven patients had CHD. Disease-causing potential variation in this family was evaluated by bioinformatics programs and the transcriptional activity of mutant protein was analyzed by the dual luciferase reporter assay. Results A novel GATA4 mutation, c.C931T (p.R311W), was identified and co-segregated with the affected patients in this family. The bioinformatics programs predicted this heterozygous mutation to be deleterious and the cross-species alignment of GATA4 sequences showed that the mutation occurred within a highly conserved amino acid. Even though it resided in the nuclear localization signal domain, the mutant protein didn't alter its intracellular distribution. Nevertheless, further luciferase reporter assay demonstrated that the p.R311W mutation reduced the ability of GATA4 to activate its downstream target gene. Conclusions Our study identified a novel mutation in GATA4 that likely contributed to the CHD in this family. This finding expanded the spectrum of GATA4 mutations and underscored the pathogenic correlation between GATA4 mutations and CHD.	[Zhang, Xiaoqing; Wang, Jian; Wang, Bo; Fu, Qihua] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Lab Med, Shanghai, Peoples R China; [Chen, Sun; Sun, Kun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Cardiol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Fu, QH (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Lab Med, Shanghai, Peoples R China.; Sun, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Pediat Cardiol, Shanghai, Peoples R China.	qfu@shsmu.edu.cn; drsunkun@xinhuamed.com.cn	Fu, Qihua/AAW-9989-2020		National Natural Science Foundation of China [81371893]; Innovation Program of Shanghai Municipal Education Commission [13ZZ086]; Shanghai Municipality Health Bureau [20114y072]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Shanghai Municipality Health Bureau	This work was supported by the National Natural Science Foundation of China (No. 81371893 to QF), the Innovation Program of Shanghai Municipal Education Commission (No. 13ZZ086 to QF), the research fund of Shanghai Municipality Health Bureau (No. 20114y072 to JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburawi EH, 2015, TRENDS CARDIOVAS MED, V25, P291, DOI 10.1016/j.tcm.2014.11.007; Agnihotri S, 2011, J EXP MED, V208, P689, DOI 10.1084/jem.20102099; Bruneau BG, 2008, NATURE, V451, P943, DOI 10.1038/nature06801; Chen MW, 2010, PEDIATR CARDIOL, V31, P85, DOI 10.1007/s00246-009-9576-1; Epstein JA, 2005, CIRCULATION, V112, P592, DOI 10.1161/CIRCULATIONAHA.104.479857; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Goldmuntz E, 2001, CIRCULATION, V104, P2565, DOI 10.1161/hc4601.098427; Heineke J, 2007, J CLIN INVEST, V117, P3198, DOI 10.1172/JCI32573; Latinkic BV, 2003, DEVELOPMENT, V130, P3865, DOI 10.1242/dev.00599; Liu XY, 2011, INT J MOL MED, V28, P17, DOI 10.3892/ijmm.2011.638; Lu CX, 2016, INT J MOL MED, V37, P445, DOI 10.3892/ijmm.2015.2436; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; NORA JJ, 1968, CIRCULATION, V38, P604, DOI 10.1161/01.CIR.38.3.604; Philips AS, 2007, J BIOL CHEM, V282, P24915, DOI 10.1074/jbc.M701789200; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Pu WT, 2004, DEV BIOL, V275, P235, DOI 10.1016/j.ydbio.2004.08.008; Shah G S, 2008, Kathmandu Univ Med J (KUMJ), V6, P33; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; van der Bom T, 2011, NAT REV CARDIOL, V8, P50, DOI 10.1038/nrcardio.2010.166; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wang E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062138; Wang J, 2011, PATHOLOGY, V43, P322, DOI 10.1097/PAT.0b013e32834635a9; Wang J, 2012, DNA CELL BIOL, V31, P1610, DOI 10.1089/dna.2012.1814; Wang XK, 2014, MOL MED REP, V9, P695, DOI 10.3892/mmr.2013.1847; Wang XK, 2013, CARDIOL YOUNG, V23, P394, DOI 10.1017/S1047951112001035; Wu GH, 2012, TRANSL RES, V159, P376, DOI 10.1016/j.trsl.2011.10.012; Yang YQ, 2013, HUM MUTAT, V34, P1662, DOI 10.1002/humu.22434; Yang YQ, 2012, PEDIATR CARDIOL, V33, P539, DOI 10.1007/s00246-011-0146-y	29	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158904	10.1371/journal.pone.0158904	http://dx.doi.org/10.1371/journal.pone.0158904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391137	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400158
J	Wang, N; Guo, XY; Yan, Z; Wang, W; Chen, B; Ge, F; Ye, BP				Wang, Na; Guo, Xinyan; Yan, Zheng; Wang, Wei; Chen, Biao; Ge, Feng; Ye, Boping			A Comprehensive Analysis on Spread and Distribution Characteristic of Antibiotic Resistance Genes in Livestock Farms of Southeastern China	PLOS ONE			English	Article							MANURE APPLICATION; SOILS ADJACENT; WASTE-WATER; ABUNDANCE; SULFONAMIDE; BACTERIA; LAGOONS; COSELECTION; PREVALENCE; TOLERANCE	The pollution of antibiotic resistance genes (ARGs) in livestock farms is a problem which need to be paid more attention to, due to the severe resistance dissemination and the further human health risk. In this study, all the relevant exposure matrices (manure, soil and water) of sixteen animal farms in Southeastern China were sampled to determine twenty-two ARGs conferring resistance to five major classes of antibiotics including tetracyclines, sulfonamides, quinolones, aminoglycosides, and macrolides. The results showed that the spread property of sul genes was most extensive and strong, followed by tet and erm genes. The abundance of tet genes expressing ribosomal protection proteins (tetM, tetO, tetQ, tetT and tetW) was higher than that expressing efflux pump proteins (tetA, tetC, tetE and tetG) in each type of samples. The high abundance and frequency of ermB gene in the matrices should be paid more attention, because macrolides is a major medicine for human use. For manures, it was found that the similar ARGs distribution rules were existing in poultry manure or porcine manure samples, despite of the different origins of these two types of livestock farms. Meanwhile, it was interesting that the distribution rule of tet genes in animal manure was nearly the same as all the ARGs. For soils, the result of nonmetric multi-dimensional scaling (NMDS) analysis showed that the pollution of ARGs in the soils fertilized by poultry and cattle manures were more substantial in northern Jiangsu, but no significant ARGs diversity was observed among porcine manured soils of five different regions. Furthermore, most ARGs showed significant positive relationships with environmental variables such as concentration of sulfonamides, tetracyclines, Cu, Zn and total organic carbon (TOC). The pollution profile and characteristics of so many ARGs in livestock farms can provide significative foundation for the regulation and legislation of antibiotics in China.	[Wang, Na; Guo, Xinyan; Wang, Wei; Ge, Feng] Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China; [Wang, Na; Guo, Xinyan] Minist Environm Protect China, Key Lab Pesticide Environm Assessment & Pollut Co, Nanjing 210042, Jiangsu, Peoples R China; [Chen, Biao; Ye, Boping] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Jiangsu, Peoples R China; [Yan, Zheng] Chinese Soc Environm Sci, Beijing 100082, Peoples R China	China Pharmaceutical University	Ge, F (corresponding author), Minist Environm Protect China, Nanjing Inst Environm Sci, Nanjing 210042, Jiangsu, Peoples R China.; Ye, BP (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing 210009, Jiangsu, Peoples R China.	gefeng@nies.org; yebp@cpu.edu.cn			Commonwealth and Environmental Protection Project - MEP [201309031]; Natural Science Foundation of China [21507037]; Fundamental Research Funds for NIES "Source apportionment research of antibiotics pollution in typical drinking water resource"	Commonwealth and Environmental Protection Project - MEP; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for NIES "Source apportionment research of antibiotics pollution in typical drinking water resource"	The authors would like to acknowledge the financial support from 2013 Commonwealth and Environmental Protection Project granted by the MEP (201309031), the Natural Science Foundation of China (no. 21507037), and the Fundamental Research Funds for NIES in 2016 "Source apportionment research of antibiotics pollution in typical drinking water resource".	Berg J, 2010, ENVIRON SCI TECHNOL, V44, P8724, DOI 10.1021/es101798r; Boxall ABA, 2010, HANDB EXP PHARMACOL, V199, P291, DOI 10.1007/978-3-642-10324-7_12; Brooks JP, 2014, WATER RES, V57, P96, DOI 10.1016/j.watres.2014.03.017; Byrne-Bailey KG, 2009, ANTIMICROB AGENTS CH, V53, P696, DOI 10.1128/AAC.00652-07; Chen BA, 2015, ENVIRON SCI POLLUT R, V22, P13950, DOI 10.1007/s11356-015-4636-y; Chen F, 2011, ENVIRON POLLUT, V159, P1490, DOI 10.1016/j.envpol.2011.03.016; Cheng WX, 2013, ENVIRON INT, V61, P1, DOI 10.1016/j.envint.2013.08.023; Durso LM, 2014, CURR OPIN MICROBIOL, V19, P37, DOI 10.1016/j.mib.2014.05.019; Fahrenfeld N, 2014, ENVIRON SCI TECHNOL, V48, P2643, DOI 10.1021/es404988k; Fernandez-Calvino D, 2013, SOIL BIOL BIOCHEM, V57, P953, DOI 10.1016/j.soilbio.2012.08.017; Gao PP, 2012, WATER RES, V46, P2355, DOI 10.1016/j.watres.2012.02.004; Guo XY, 2016, J ENVIRON SCI HEAL B, V51, P383, DOI 10.1080/03601234.2016.1142743; Heuer H, 2011, CURR OPIN MICROBIOL, V14, P236, DOI 10.1016/j.mib.2011.04.009; Hsu JT, 2014, J HAZARD MATER, V277, P34, DOI 10.1016/j.jhazmat.2014.02.016; Huerta B, 2013, SCI TOTAL ENVIRON, V456, P161, DOI 10.1016/j.scitotenv.2013.03.071; Icgen B, 2014, B ENVIRON CONTAM TOX, V93, P735, DOI 10.1007/s00128-014-1383-6; Jensen LB, 2002, ENVIRON INT, V28, P487, DOI 10.1016/S0160-4120(02)00076-4; Joy SR, 2014, SCI TOTAL ENVIRON, V481, P69, DOI 10.1016/j.scitotenv.2014.02.027; Knapp CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027300; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Ling ZH, 2013, J ENVIRON SCI, V25, P1656, DOI 10.1016/S1001-0742(12)60223-X; McIntosh D, 2008, J ANTIMICROB CHEMOTH, V61, P1221, DOI 10.1093/jac/dkn123; McKinney CW, 2010, ENVIRON SCI TECHNOL, V44, P6102, DOI 10.1021/es9038165; Peak N, 2007, ENVIRON MICROBIOL, V9, P143, DOI 10.1111/j.1462-2920.2006.01123.x; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Pruden A, 2013, ENVIRON HEALTH PERSP, V121, P878, DOI 10.1289/ehp.1206446; Scientific Committee on Emerging and Newly Identified Health Risks, 2009, ASS ANT RES EFF BIOC; Shi Y, 2012, B ENVIRON CONTAM TOX, V9, P857; Smith MS, 2004, APPL ENVIRON MICROB, V70, P7372, DOI 10.1128/AEM.70.12.7372-7377.2004; Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P7397, DOI 10.1021/es101657s; Su HC, 2014, SCI TOTAL ENVIRON, V490, P708, DOI 10.1016/j.scitotenv.2014.05.060; Wang N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112626; Wardwell LH, 2009, GEOMICROBIOL J, V26, P238, DOI [10.1080/01490450902891854, 10.1080/01490450902889072]; Wu N, 2010, ENVIRON SCI TECHNOL, V44, P6933, DOI 10.1021/es1007802; Yuan CG, 2004, ENVIRON INT, V30, P769, DOI 10.1016/j.envint.2004.01.001; Zhang QQ, 2015, ENVIRON SCI TECHNOL, V49, P6772, DOI 10.1021/acs.est.5b00729	36	79	88	11	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0156889	10.1371/journal.pone.0156889	http://dx.doi.org/10.1371/journal.pone.0156889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388166	Green Published, gold			2022-12-26	WOS:000379811500001
J	Chen, WH; Niu, SX; Ma, X; Zhang, P; Gao, Y; Fan, Y; Pang, HG; Gong, HJ; Shen, DL; Gu, LY; Zhang, Y; Zhang, X				Chen, Weihao; Niu, Shaoxi; Ma, Xin; Zhang, Peng; Gao, Yu; Fan, Yang; Pang, Haigang; Gong, Huijie; Shen, Donglai; Gu, Liangyou; Zhang, Yu; Zhang, Xu			RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FARNESYLTRANSFERASE INHIBITORS; PROTEIN EXPRESSION; UP-REGULATION; LUNG-CANCER; RAS; INVASION; TRANSFORMATION; APOPTOSIS; SURVIVAL	This study aims to investigate the biological role of RhoB in clear cell renal cell carcinoma (ccRCC). The expression of RhoB was examined in specimens of patients and cell lines by Western blot and Immunohistochemistry. The correlation between RhoB expression and clinicopathologic variables was also analyzed. The effects of RhoB on cell proliferation, cell cycle, cell apoptosis, and invasion/migration were detected by over-expression and knockdown of RhoB level in ccRCC cells via plasmids and RNAi. The results showed that RhoB was low-expressed in ccRCC surgical specimens and cell lines compared with adjacent normal renal tissues and normal human renal proximal tubular epithelial cell lines (HKC), and its protein expression level was significantly associated with the tumor pathologic parameter embracing tumor size(P = 0.0157), pT stage(P = 0.0035), TNM stage(P = 0.0024) and Fuhrman tumor grade(P = 0.0008). Further, over-expression of RhoB remarkably inhibited the cancer cell proliferation, colony formation and promoted cancer cell apoptosis, and aslo reduced the invasion and migration ability of ccRCC cells. Interestingly, up-regulation of RhoB could induce cell cycle arrest in G2/M phase and led to cell cycle regulators(CyclineB1, CDK1) and pro-apoptotic protein(casp3, casp9) aberrant expression. Moreover, knockdown of RhoB in HKC cells promoted cell proliferation and migration. Taken together, our study indicates that RhoB expression is decreased in ccRCC carcinogenesis and progression. Up-regulation of RhoB significantly inhibits ccRCC cell malignant phenotype. These findings show that RhoB may play a tumor suppressive role in ccRCC cells, raising its potential value in futural therapeutic target for the patients of ccRCC.	[Chen, Weihao; Niu, Shaoxi; Ma, Xin; Zhang, Peng; Gao, Yu; Fan, Yang; Pang, Haigang; Gong, Huijie; Shen, Donglai; Gu, Liangyou; Zhang, Yu; Zhang, Xu] Chinese Peoples Liberat Army, Gen Hosp, Mil Postgrad Med Coll, State Key Lab Kidney Dis,Dept Urol, Beijing, Peoples R China; [Chen, Weihao] Gen Hosp Navy, Dept Urol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital; Sixth Medical Center of Chinese PLA General Hospital	Zhang, X (corresponding author), Chinese Peoples Liberat Army, Gen Hosp, Mil Postgrad Med Coll, State Key Lab Kidney Dis,Dept Urol, Beijing, Peoples R China.	xzhang@tjh.tjmu.edu.cn			National High Technology Research and Development Program of China [2014AA020607]; NGH Innovation Fostering Fund [CXPY201423]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); NGH Innovation Fostering Fund	This work was supported by the National High Technology Research and Development Program of China (2014AA020607) to XM and NGH Innovation Fostering Fund (CXPY201423). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnane J, 2002, CLIN CANCER RES, V8, P2225; Bastien L, 2009, BJU INT, V103, P1334, DOI 10.1111/j.1464-410X.2009.08454.x; Bellizzi A, 2008, INT J MOL MED, V22, P25; Bellovin DI, 2006, ONCOGENE, V25, P6959, DOI 10.1038/sj.onc.1209682; Boone B, 2009, J CUTAN PATHOL, V36, P629, DOI 10.1111/j.1600-0560.2008.01117.x; Bousquet E, 2009, CANCER RES, V69, P6092, DOI 10.1158/0008-5472.CAN-08-4147; Calvayrac O, 2014, CLIN CANCER RES, V20, P6541, DOI 10.1158/1078-0432.CCR-14-0506; Campbell D, 2007, CLIN J AM SOC NEPHRO, V2, P211, DOI 10.2215/CJN.00300107; Chen YX, 2006, J STEROID BIOCHEM, V101, P179, DOI 10.1016/j.jsbmb.2006.06.030; Chen Z, 2000, J BIOL CHEM, V275, P17974, DOI 10.1074/jbc.C000145200; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; FRITZ G, 1995, J BIOL CHEM, V270, P25172, DOI 10.1074/jbc.270.42.25172; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Hu TH, 2013, ONCOL REP, V30, P1707, DOI 10.3892/or.2013.2608; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang K, 2004, ONCOGENE, V23, P1136, DOI 10.1038/sj.onc.1207236; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Kamasani U, 2004, CANCER RES, V64, P8389, DOI 10.1158/0008-5472.CAN-04-2437; Kamasani U, 2003, CANCER BIOL THER, V2, P273; Karakiewicz PI, 2007, J CLIN ONCOL, V25, P1316, DOI 10.1200/JCO.2006.06.1218; Karnoub AE, 2004, BREAST CANCER RES TR, V84, P61, DOI 10.1023/B:BREA.0000018427.84929.5c; Kim BK, 2011, CARCINOGENESIS, V32, P254, DOI 10.1093/carcin/bgq244; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Liu YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078417; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Marlow LA, 2009, CANCER RES, V69, P1536, DOI 10.1158/0008-5472.CAN-08-3718; Mazieres J, 2004, CLIN CANCER RES, V10, P2742, DOI 10.1158/1078-0432.CCR-03-0149; Prendergast GC, 2001, NAT REV CANCER, V1, P162, DOI 10.1038/35101096; Prendergast GC, 2001, HISTOL HISTOPATHOL, V16, P269, DOI 10.14670/HH-16.269; Ren J, 2011, BRIT J CANCER, V105, P1905, DOI 10.1038/bjc.2011.492; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Sato N, 2007, INT J CANCER, V120, P543, DOI 10.1002/ijc.22328; Vishnu P, 2012, GYNECOL ONCOL, V124, P589, DOI 10.1016/j.ygyno.2011.11.019; Wang DA, 2005, J BIOL CHEM, V280, P19243, DOI 10.1074/jbc.M411472200; ZALCMAN G, 1995, ONCOGENE, V10, P1935; Zhou JT, 2011, INT J CANCER, V128, P1057, DOI 10.1002/ijc.25445	40	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157599	10.1371/journal.pone.0157599	http://dx.doi.org/10.1371/journal.pone.0157599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384222	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400016
J	Lin, PC; Yang, YF; Tyan, YC; Hsiao, ESL; Chu, PC; Lee, CT; Lee, JC; Chen, YMA; Liao, PC				Lin, Peng-Chan; Yang, Yi-Fang; Tyan, Yu-Chang; Hsiao, Eric S. L.; Chu, Po-Chen; Lee, Chung-Ta; Lee, Jenq-Chang; Chen, Yi-Ming Arthur; Liao, Pao-Chi			Identification of Phosphorylated Cyclin-Dependent Kinase 1 Associated with Colorectal Cancer Survival Using Label-Free Quantitative Analyses	PLOS ONE			English	Article							CELL-CYCLE; MASS-SPECTROMETRY; PHOSPHOPEPTIDE ENRICHMENT; CARCINOEMBRYONIC ANTIGEN; MEMBRANE-PROTEINS; WEE1 KINASE; IN-VIVO; PROGNOSIS; PHOSPHOPROTEOMICS; CHROMATOGRAPHY	Colorectal cancer is the most common form of cancer in the world, and the five-year survival rate is estimated to be almost 90% in the early stages. Therefore, the identification of potential biomarkers to assess the prognosis of early stage colorectal cancer patients is critical for further clinical treatment. Dysregulated tyrosine phosphorylation has been found in several diseases that play a significant regulator of signaling in cellular pathways. In this study, this strategy was used to characterize the tyrosine phosphoproteome of colorectal cell lines with different progression abilities (SW480 and SW620). We identified a total of 280 phosphotyrosine (pTyr) peptides comprising 287 pTyr sites from 261 proteins. Label-free quantitative analysis revealed the differential level of a total of 103 pTyr peptides between SW480 and SW620 cells. We showed that cyclin-dependent kinase I (CDK1) pTyr15 level in SW480 cells was 3.3-fold greater than in SW620 cells, and these data corresponded with the label-free mass spectrometry-based proteomic quantification analysis. High level CDK1 pTyr15 was associated with prolonged disease-free survival for stage II colorectal cancer patients (n = 79). Taken together, our results suggest that the CDK1 pTyr15 protein is a potential indicator of the progression of colorectal cancer.	[Lin, Peng-Chan] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Yang, Yi-Fang; Hsiao, Eric S. L.; Liao, Pao-Chi] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ, Dept Med Imaging & Radiol Sci, Kaohsiung, Taiwan; [Tyan, Yu-Chang; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Tyan, Yu-Chang] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Tyan, Yu-Chang; Chen, Yi-Ming Arthur] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chu, Po-Chen] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Lee, Chung-Ta] Natl Cheng Kung Univ, Coll Med, Dept Pathol, Tainan, Taiwan; [Lee, Jenq-Chang] Natl Cheng Kung Univ, Coll Med, Dept Surg, Tainan, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University	Liao, PC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan, Taiwan.	liaopc@mail.ncku.edu.tw			National Cheng Kung University, Taiwan [NCKUH-10105014]; Ministry of Science and Technology, Taiwan (MOST) [103-2811-M-006-021, 103-2113-M-006-003-MY3, 100-2113-M-006-002-MY3, 102-2352-B-006-003]; National Science Council, Taiwan (NSC) [99-2923-M-006-001]; Kaohsiung Medical University; Aim for the Top 500 Universities grant; Aim for the Top Universities Grant [KMU-TP104E12]	National Cheng Kung University, Taiwan; Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan); National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University; Aim for the Top 500 Universities grant; Aim for the Top Universities Grant	This study was supported by grants from the National Cheng Kung University, Taiwan (NCKUH-10105014); the Ministry of Science and Technology, Taiwan (MOST 103-2811-M-006-021, 103-2113-M-006-003-MY3, 100-2113-M-006-002-MY3, 102-2352-B-006-003); the National Science Council, Taiwan (NSC 99-2923-M-006-001); and Kaohsiung Medical University, Aim for the Top 500 Universities grant and Aim for the Top Universities Grant, No. KMU-TP104E12.; The authors thank the Tissue Bank of National Cheng Kung University Hospital for providing tissue samples. This study was supported by grants from the National Cheng Kung University, Taiwan (NCKUH-10105014), the Ministry of Science and Technology, Taiwan(MOST103-2811-M-006-021, 103-2113-M-006-003-MY3, 100-2113-M-006-002-MY3, 102-2352-B-006-003), the National Science Council, Taiwan (NSC 99-2923-M-006-001), Kaohsiung Medical University, Aim for the Top 500 Universities grant and Aim for the Top Universities Grant, No. KMU-TP104E12.	Aggarwal C, 2013, ANN ONCOL, V24, P420, DOI 10.1093/annonc/mds336; Barascu A, 2006, INT J BIOCHEM CELL B, V38, P196, DOI 10.1016/j.biocel.2005.08.015; Bellew M, 2006, BIOINFORMATICS, V22, P1902, DOI 10.1093/bioinformatics/btl276; Bianco C, 2006, CLIN CANCER RES, V12, P5158, DOI 10.1158/1078-0432.CCR-06-0274; Blacken GR, 2007, ANAL CHEM, V79, P5449, DOI 10.1021/ac070790w; Boersema PJ, 2010, MOL CELL PROTEOMICS, V9, P84, DOI 10.1074/mcp.M900291-MCP200; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130; Chiu KH, 2011, J PROTEOME RES, V10, P1110, DOI 10.1021/pr1008724; COHEN AM, 1991, CANCER, V67, P1859, DOI 10.1002/1097-0142(19910401)67:7<1859::AID-CNCR2820670707>3.0.CO;2-A; Ding VMY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017538; Duffy MJ, 2001, CLIN CHEM, V47, P624; Fauzee NJS, 2012, PATHOL ONCOL RES, V18, P191, DOI 10.1007/s12253-011-9428-1; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GIBBS JB, 1994, CELL, V79, P193, DOI 10.1016/0092-8674(94)90189-9; Gilmore JM, 2012, ANAL BIOANAL CHEM, V402, P711, DOI 10.1007/s00216-011-5466-5; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Hashimoto O, 2003, MOL CARCINOGEN, V36, P171, DOI 10.1002/mc.10111; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Henriksson ML, 2011, AM J PATHOL, V178, P1387, DOI 10.1016/j.ajpath.2010.12.008; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Imanishi SY, 2007, MOL CELL PROTEOMICS, V6, P1380, DOI 10.1074/mcp.M600480-MCP200; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Kettenbach AN, 2011, ANAL CHEM, V83, P7635, DOI 10.1021/ac201894j; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li J, 2002, RADIAT RES, V157, P322, DOI 10.1667/0033-7587(2002)157[0322:WTTIGP]2.0.CO;2; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; Marcantonio M, 2008, MOL CELL PROTEOMICS, V7, P645, DOI 10.1074/mcp.M700383-MCP200; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; McKinley ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080207; McLeod HL, 1999, BRIT J CANCER, V79, P191, DOI 10.1038/sj.bjc.6690033; Mir SE, 2010, CANCER CELL, V18, P244, DOI 10.1016/j.ccr.2010.08.011; MOERTEL CG, 1986, CANCER, V58, P603, DOI 10.1002/1097-0142(19860801)58:3<603::AID-CNCR2820580302>3.0.CO;2-K; Montoya A, 2011, METHODS, V54, P370, DOI 10.1016/j.ymeth.2011.02.004; Morandell S, 2006, PROTEOMICS, V6, P4047, DOI 10.1002/pmic.200600058; Nita-Lazar A, 2008, PROTEOMICS, V8, P4433, DOI 10.1002/pmic.200800231; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Phipps AI, 2013, BRIT J CANCER, V108, P1757, DOI 10.1038/bjc.2013.118; Potapova TA, 2009, MOL BIOL CELL, V20, P1737, DOI 10.1091/mbc.E08-07-0771; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Savitski MM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003830; Smits VAJ, 2001, BBA-GENE STRUCT EXPR, V1519, P1, DOI 10.1016/S0167-4781(01)00204-4; Squire CJ, 2005, STRUCTURE, V13, P541, DOI 10.1016/j.str.2004.12.017; Sugimoto K, 2013, DIGEST SURG, V30, P368, DOI 10.1159/000355444; Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200; Sung WW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-951; Suzuki O, 2006, J AM COLL SURGEONS, V202, P732, DOI 10.1016/j.jamcollsurg.2006.02.007; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Wang MC, 2015, ANAL BIOANAL CHEM, V407, P1343, DOI 10.1007/s00216-014-8352-0; Wang YL, 2001, CANCER RES, V61, P8211; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Welburn JPI, 2007, J BIOL CHEM, V282, P3173, DOI 10.1074/jbc.M609151200; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Wu HY, 2007, J PROTEOME RES, V6, P1812, DOI 10.1021/pr060631d; Wu HY, 2010, J PROTEOME RES, V9, P4102, DOI 10.1021/pr1006153; Wu HY, 2009, ANAL CHEM, V81, P7778, DOI 10.1021/ac9013435; Yang TH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S16-S10; Zeestraten ECM, 2012, BRIT J CANCER, V106, P133, DOI 10.1038/bjc.2011.504	65	5	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158844	10.1371/journal.pone.0158844	http://dx.doi.org/10.1371/journal.pone.0158844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383761	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400089
J	Martino, S; Jamme, M; Deligny, C; Busson, M; Loiseau, P; Azoulay, E; Galicier, L; Pene, F; Provot, F; Dossier, A; Saheb, S; Veyradier, A; Coppo, P				Martino, Suella; Jamme, Mathieu; Deligny, Christophe; Busson, Marc; Loiseau, Pascale; Azoulay, Elie; Galicier, Lionel; Pene, Frederic; Provot, Francois; Dossier, Antoine; Saheb, Samir; Veyradier, Agnes; Coppo, Paul		French Reference Ctr Thrombotic Mi	Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; SEVERE ADAMTS13 DEFICIENCY; MICROANGIOPATHIES REFERENCE CENTER; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DISPARITIES; EXPERIENCE; ASSOCIATION; INVOLVEMENT; RITUXIMAB; DIAGNOSIS	Black people are at increased risk of thrombotic thrombocytopenic purpura (TTP). Whether clinical presentation of TTP in Black patients has specific features is unknown. We assessed here differences in TTP presentation and outcome between Black and White patients. Clinical presentation was comparable between both ethnic groups. However, prognosis differed with a lower death rate in Black patients than in White patients (2.7% versus 11.6%, respectively, P = .04). Ethnicity, increasing age and neurologic involvement were retained as risk factors for death in a multivariable model (P < .05 all). Sixty-day overall survival estimated by the Kaplan-Meier curves and compared with the Log-Rank test confirmed that Black patients had a better survival than White patients (P = .03). Salvage therapies were similarly performed between both groups, suggesting that disease severity was comparable. The comparison of HLA-DRB1*11, -DRB1*04 and -DQB1*03 allele frequencies between Black patients and healthy Black individuals revealed no significant difference. However, the protective allele against TTP, HLA-DRB1*04, was dramatically decreased in Black individuals in comparison with White individuals. Black people with TTP may have a better survival than White patients despite a comparable disease severity. A low natural frequency of HLA-DRB1*04 in Black ethnicity may account for the greater risk of TTP in this population.	[Martino, Suella; Coppo, Paul] Hop St Antoine, AP HP, Serv Hematol, Paris, France; [Martino, Suella; Jamme, Mathieu; Azoulay, Elie; Galicier, Lionel; Pene, Frederic; Provot, Francois; Dossier, Antoine; Saheb, Samir; Veyradier, Agnes; Coppo, Paul] Hop St Antoine, AP HP, Ctr Reference Microangiopathies Thrombot, Paris, France; [Martino, Suella; Jamme, Mathieu; Azoulay, Elie; Galicier, Lionel; Pene, Frederic; Provot, Francois; Dossier, Antoine; Saheb, Samir; Veyradier, Agnes; Coppo, Paul] Univ Paris 06, Paris, France; [Deligny, Christophe] CHU Ft de France, Serv Med Interne, Fort De France, Martinique, France; [Busson, Marc; Loiseau, Pascale] Hop St Louis, Sorbonne Paris Cite, Lab Jean Dausset Immunol & Histocompatibilite, AP HP, Paris, France; [Busson, Marc; Loiseau, Pascale] Hop St Louis, Sorbonne Paris Cite, INSERM, UMRS 1160, Paris, France; [Azoulay, Elie; Galicier, Lionel; Veyradier, Agnes] Univ Paris Diderot, Paris, France; [Azoulay, Elie] Hop St Louis, AP HP, Serv Reanimat Med, Paris, France; [Galicier, Lionel] Hop St Louis, AP HP, Serv Immunol Clin, Paris, France; [Pene, Frederic] Hop Cochin, AP HP, Serv Reanimat Med, Paris, France; [Pene, Frederic] Univ Paris 05, Paris, France; [Provot, Francois] Hop Albert Calmette, Serv Nephrol, Lille, France; [Dossier, Antoine] Hop Bichat Claude Bernard, AP HP, Serv Med Interne, Paris, France; [Saheb, Samir] Hop La Pitie Salpetriere, Serv Med Interne 1, Paris, France; [Veyradier, Agnes] Hop Lariboisiere, AP HP, Serv Hematol Biol, Paris, France; [Coppo, Paul] Univ Paris 06, Sorbonne Univ, Paris, France; [Coppo, Paul] Inst Gustave Roussy, INSERM, U1009, Villejuif, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; CHU Martinique; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy	Coppo, P (corresponding author), Hop St Antoine, AP HP, Serv Hematol, Paris, France.; Coppo, P (corresponding author), Hop St Antoine, AP HP, Ctr Reference Microangiopathies Thrombot, Paris, France.; Coppo, P (corresponding author), Univ Paris 06, Paris, France.; Coppo, P (corresponding author), Univ Paris 06, Sorbonne Univ, Paris, France.; Coppo, P (corresponding author), Inst Gustave Roussy, INSERM, U1009, Villejuif, France.	paul.coppo@aphp.fr	Dossier, Antoine/AGG-9850-2022; Herbrecht, Raoul/AAT-1763-2021	Herbrecht, Raoul/0000-0002-9381-4876; Stepanian, Alain/0000-0002-2942-0901; Saheb, Samir/0000-0002-7764-6016; Pene, Frederic/0000-0003-3639-3849				Benhamou Y, 2015, J THROMB HAEMOST, V13, P293, DOI 10.1111/jth.12790; Benhamou Y, 2012, HAEMATOL-HEMATOL J, V97, P1181, DOI 10.3324/haematol.2011.049676; Cataland SR, 2009, EUR J HAEMATOL, V83, P559, DOI 10.1111/j.1600-0609.2009.01331.x; Coppo P, 2004, MEDICINE, V83, P233, DOI 10.1097/01.md.0000133622.03370.07; Coppo P, 2010, J THROMB HAEMOST, V8, P856, DOI 10.1111/j.1538-7836.2010.03772.x; Coppo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010208; Ferrari S, 2007, BLOOD, V109, P2815, DOI 10.1182/blood-2006-02-006064; Franchini M, 2008, BLOOD TRANSFUS-ITALY, V6, P127, DOI 10.2450/2008.0055-07; Froissart A, 2012, CRIT CARE MED, V40, P104, DOI 10.1097/CCM.0b013e31822e9d66; Greenberg AJ, 2012, LEUKEMIA, V26, P609, DOI 10.1038/leu.2011.368; Hovinga JAK, 2010, BLOOD, V115, P1500, DOI 10.1182/blood-2009-09-243790; Hughes C, 2009, J THROMB HAEMOST, V7, P529, DOI 10.1111/j.1538-7836.2009.03285.x; John ML, 2012, ANN HEMATOL, V91, P507, DOI 10.1007/s00277-011-1384-z; JOSEPH G, 1994, AM J HEMATOL, V47, P189, DOI 10.1002/ajh.2830470308; Klaus C, 2004, BLOOD, V103, P4514, DOI 10.1182/blood-2003-12-4165; Miller CH, 2003, J THROMB HAEMOST, V1, P2191, DOI 10.1046/j.1538-7836.2003.00367.x; Molokhia M, 2003, HUM GENET, V112, P310, DOI 10.1007/s00439-002-0883-3; Molokhia M, 2001, LANCET, V357, P1414, DOI 10.1016/S0140-6736(00)04580-3; Rhew EY, 2009, TRANSL RES, V153, P51, DOI 10.1016/j.trsl.2008.11.006; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; Scully M, 2010, J THROMB HAEMOST, V8, P257, DOI 10.1111/j.1538-7836.2009.03692.x; Scully M, 2008, BRIT J HAEMATOL, V142, P819, DOI 10.1111/j.1365-2141.2008.07276.x; Scully M, 2012, BRIT J HAEMATOL, V158, P323, DOI 10.1111/j.1365-2141.2012.09167.x; Scully M, 2011, BLOOD, V118, P1746, DOI 10.1182/blood-2011-03-341131; Terrell DR, 2010, AM J HEMATOL, V85, P844, DOI 10.1002/ajh.21833; Tersteeg C, 2014, CIRCULATION, V129, P1320, DOI 10.1161/CIRCULATIONAHA.113.006727; van den Born BJH, 2006, J HYPERTENS, V24, P2299, DOI 10.1097/01.hjh.0000249710.21146.38; Wohner N, 2012, THROMB RES, V129, pE41, DOI 10.1016/j.thromres.2011.11.021	28	26	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0156679	10.1371/journal.pone.0156679	http://dx.doi.org/10.1371/journal.pone.0156679			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383202	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400006
J	Fratini, S; Ragionieri, L; Cannicci, S				Fratini, Sara; Ragionieri, Lapo; Cannicci, Stefano			Demographic History and Reproductive Output Correlates with Intraspecific Genetic Variation in Seven Species of Indo-Pacific Mangrove Crabs	PLOS ONE			English	Article							PERISESARMA-GUTTATUM BRACHYURA; SCYLLA-SERRATA CRUSTACEA; POPULATION-STRUCTURE; INHACA ISLAND; ADAPTIVE SIGNIFICANCE; DECAPOD CRUSTACEANS; SEQUENCE DIVERSITY; LAND CRAB; SAR-UANLE; MITOCHONDRIAL	The spatial distribution and the amount of intraspecific genetic variation of marine organisms are strongly influenced by many biotic and abiotic factors. Comparing biological and genetic data characterizing species living in the same habitat can help to elucidate the processes driving these variation patterns. Here, we present a comparative multispecies population genetic study on seven mangrove crabs co-occurring in the West Indian Ocean characterized by planktotrophic larvae with similar pelagic larval duration. Our main aim was to investigate whether a suite of biological, behavioural and ecological traits could affect genetic diversities of the study species in combination with historical demographic parameters. As possible current explanatory factors, we used the intertidal micro-habitat colonised by adult populations, various parameters of individual and population fecundity, and the timing of larval release. As the genetic marker, we used partial sequences of cytochrome oxidase subunit I gene. Genetic and ecological data were collected by the authors and/or gathered from primary literature. Permutational multiple regression models and ANOVA tests showed that species density and their reproductive output in combination with historical demographic parameters could explain the intraspecific genetic variation indexes across the seven species. In particular, species producing consistently less eggs per spawning event showed higher values of haplotype diversity. Moreover, Tajima's D parameters well explained the recorded values for haplotype diversity and average gamma st. We concluded that current intraspecific gene diversities in crabs inhabiting mangrove forests were affected by population fecundity as well as past demographic history. The results were also discussed in terms of management and conservation of fauna in the Western Indian Ocean mangroves.	[Fratini, Sara; Cannicci, Stefano] Univ Florence, Dept Biol, Florence, Italy; [Ragionieri, Lapo] Univ Cologne, Inst Zool, Funct Peptid, Cologne, Germany; [Cannicci, Stefano] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China; [Cannicci, Stefano] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	University of Florence; University of Cologne; University of Hong Kong; University of Hong Kong	Fratini, S (corresponding author), Univ Florence, Dept Biol, Florence, Italy.	sarafratini@unifi.it	Cannicci, Stefano/N-8512-2019	Cannicci, Stefano/0000-0002-6544-0213; Fratini, Sara/0000-0002-5754-8830; Ragionieri, Lapo/0000-0003-0099-2719	FIRB project (Italian MIUR) [RBAU01H5C3_001]; PUMPSEA project; Cannicci ex 60% project (Italian MIUR); 6th Framework Program of the EC [INCO-CT2004-510863]	FIRB project (Italian MIUR)(Ministry of Education, Universities and Research (MIUR)); PUMPSEA project; Cannicci ex 60% project (Italian MIUR)(Ministry of Education, Universities and Research (MIUR)); 6th Framework Program of the EC(European Commission)	Support was provided by FIRB project (Italian MIUR), no RBAU01H5C3_001, PUMPSEA project, 6th Framework Program of the EC, INCO-CT2004-510863, and Cannicci ex 60% project (Italian MIUR).	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Arndt A, 1998, MOL ECOL, V7, P1053, DOI 10.1046/j.1365-294x.1998.00429.x; Avise J, 2004, MOL MARKERS NATURAL; Avise JC, 2000, PHYLOGEOGRAPHY HIST; Barber PH, 2006, EVOLUTION, V60, P1825; Bartolini F, 2011, MAR ENVIRON RES, V71, P53, DOI 10.1016/j.marenvres.2010.10.002; Becker BJ, 2007, P NATL ACAD SCI USA, V104, P3267, DOI 10.1073/pnas.0611651104; BRICK RW, 1974, AQUACULTURE, V3, P231, DOI 10.1016/0044-8486(74)90074-X; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Cannicci S, 2008, AQUAT BOT, V89, P186, DOI 10.1016/j.aquabot.2008.01.009; Cannicci S, 2011, MAR ECOL PROG SER, V430, P121, DOI 10.3354/meps08954; Cannicci S, 2009, ESTUAR COAST SHELF S, V84, P305, DOI 10.1016/j.ecss.2009.04.021; Carvalho GR, 1998, ITAL J ZOOL, V65, P21, DOI 10.1080/11250009809386791; Chen T., 2012, THESIS; Christy JH, 2011, INTEGR COMP BIOL, V51, P62, DOI 10.1093/icb/icr013; Clarke KR, 2006, PRIMER V 6 USER MANU; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; Collin R, 2001, MOL ECOL, V10, P2249, DOI 10.1046/j.1365-294X.2001.01372.x; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; Crisp D.J., 1978, NATO Conference Series IV Marine Sciences, V2, P257; Dahdouh-Guebas F, 1999, B MAR SCI, V64, P291; Dahdouh-Guebas F., 2002, Wetlands Ecology and Management, V10, P179, DOI 10.1023/A:1020133110407; Davis JA, 2004, J WORLD AQUACULT SOC, V35, P121, DOI 10.1111/j.1749-7345.2004.tb01068.x; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Emmerson WD, 2001, HYDROBIOLOGIA, V449, P221, DOI 10.1023/A:1017506917996; EMMERSON WD, 1994, J CRUSTACEAN BIOL, V14, P568, DOI 10.2307/1549002; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FELDER DL, 1994, J CRUSTACEAN BIOL, V14, P191, DOI 10.2307/1548900; Flores AAV, 2002, J CRUSTACEAN BIOL, V22, P143, DOI 10.1651/0278-0372(2002)022[0143:SMRCAJ]2.0.CO;2; Flowers JM, 2002, EVOLUTION, V56, P1445, DOI 10.1111/j.0014-3820.2002.tb01456.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FORWARD RB, 1987, B MAR SCI, V41, P165; Fratini S, 2002, J EXP MAR BIOL ECOL, V272, P103, DOI 10.1016/S0022-0981(02)00052-7; Fratini S, 2011, J ETHOL, V29, P481, DOI 10.1007/s10164-011-0282-0; Fratini S, 2010, ESTUAR COAST SHELF S, V86, P51, DOI 10.1016/j.ecss.2009.10.009; Fu YX, 1997, GENETICS, V147, P915; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; GIFFORD CA, 1962, BIOL BULL, V123, P207, DOI 10.2307/1539516; Gopurenko D, 1999, MAR BIOL, V134, P227, DOI 10.1007/s002270050541; Gourlan AT, 2008, EARTH PLANET SC LETT, V267, P353, DOI 10.1016/j.epsl.2007.11.054; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Guzman BE, 2011, ITAL J ZOOL, V78, P444, DOI 10.1080/11250003.2011.576403; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hartnoll RG, 2010, CRUSTACEANA MONOGR, V11, P153; Hauser L, 2008, FISH FISH, V9, P333, DOI 10.1111/j.1467-2979.2008.00299.x; HEDGECOCK D, 1986, B MAR SCI, V39, P550; HILL BJ, 1979, MAR BIOL, V55, P209, DOI 10.1007/BF00396820; HILL BJ, 1994, MAR BIOL, V120, P379, DOI 10.1007/BF00680211; HILL BJ, 1982, MAR BIOL, V69, P117, DOI 10.1007/BF00396967; HILL BJ, 1975, MAR BIOL, V32, P119, DOI 10.1007/BF00388505; HILL BJ, 1976, MAR BIOL, V34, P109, DOI 10.1007/BF00390752; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Hudson RR, 2000, GENETICS, V155, P2011; Garcia-Merchan VH, 2012, MOL PHYLOGENET EVOL, V62, P664, DOI 10.1016/j.ympev.2011.11.009; KANNUPANDI T, 1980, INDIAN J MAR SCI, V9, P271; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; Kawane M, 2008, MAR BIOL, V156, P193, DOI 10.1007/s00227-008-1076-y; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; KIMURA M, 1964, GENETICS, V49, P561; Kristensen E, 2006, LIMNOL OCEANOGR, V51, P1557, DOI 10.4319/lo.2006.51.4.1557; LAGO RP, 1993, J CRUSTACEAN BIOL, V13, P745, DOI 10.2307/1549105; LAGO RP, 1989, S AFR J ZOOL, V24, P199; Lee HJE, 2009, MOL ECOL, V18, P2165, DOI 10.1111/j.1365-294X.2009.04169.x; LI WH, 1977, GENETICS, V85, P331; MICHELI F, 1991, MAR BIOL, V111, P247, DOI 10.1007/BF01319706; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; MITTON JB, 1989, EVOLUTION, V43, P1712, DOI 10.1111/j.1558-5646.1989.tb02621.x; MORGAN SG, 1987, J EXP MAR BIOL ECOL, V113, P71, DOI 10.1016/0022-0981(87)90083-9; Naderloo R, 2016, ZOOL ANZ, V262, P10, DOI 10.1016/j.jcz.2016.03.010; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nei M, 1982, Prog Clin Biol Res, V103 Pt A, P167; Nei M, 1987, MOL EVOLUTIONARY BIO; Ong KS, 1964, IPFC P, P135; Palumbi SR, 2004, ANNU REV ENV RESOUR, V29, P31, DOI 10.1146/annurev.energy.29.062403.102254; Papadopoulos Isabelle, 2002, Wetlands Ecology and Management, V10, P249, DOI 10.1023/A:1020183931789; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Paula J, 2004, J PLANKTON RES, V26, P1163, DOI 10.1093/plankt/fbh106; Paula J, 2003, ESTUAR COAST SHELF S, V56, P325, DOI 10.1016/S0272-7714(02)00165-8; Paula J, 2001, MAR ECOL PROG SER, V215, P251, DOI 10.3354/meps215251; Penha-Lopes G, 2009, J EXP MAR BIOL ECOL, V381, P25, DOI 10.1016/j.jembe.2009.08.009; POUPIN J., 2010, BIODIVERSITE INDO PA; Ragionieri L, 2015, HYDROBIOLOGIA, V749, P183, DOI 10.1007/s10750-014-2165-1; Ragionieri L, 2010, ESTUAR COAST SHELF S, V86, P179, DOI 10.1016/j.ecss.2009.11.002; Ragionieri L, 2009, MOL PHYLOGENET EVOL, V52, P825, DOI 10.1016/j.ympev.2009.04.008; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roman J, 2006, P ROY SOC B-BIOL SCI, V273, P2453, DOI 10.1098/rspb.2006.3597; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schneider S, 1999, GENETICS, V152, P1079; Schubart CD, 2006, B FR PECHE PISCIC, P1019, DOI 10.1051/kmae:2006008; Schubart CD, 1998, NATURE, V393, P363, DOI 10.1038/30724; Shanks AL, 2003, ECOL APPL, V13, pS159; Shanks AL, 2008, BIOL BULL, V216, P373; Silva IC, 2010, MAR BIOL, V157, P1113, DOI 10.1007/s00227-010-1393-9; Silva IC, 2010, BIOL J LINN SOC, V99, P28, DOI 10.1111/j.1095-8312.2009.01338.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Simoni R, 2013, MAR BIOL, V160, P2483, DOI 10.1007/s00227-013-2243-3; Skov MW, 2005, ECOLOGY, V86, P1164, DOI 10.1890/04-0917; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAJIMA F, 1984, MOL BIOL EVOL, V1, P269; TAJIMA F, 1989, GENETICS, V123, P585; TEMPLETON AR, 1993, AM ANTHROPOL, V95, P51, DOI 10.1525/aa.1993.95.1.02a00030; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; VANNINI M, 1981, MONIT ZOOL ITAL, V14, P57, DOI 10.1080/03749444.1981.10736614; VANNINI M, 1981, MONIT ZOOL ITAL, V14, P199, DOI 10.1080/03749444.1981.10736622; Wares JP, 2010, EVOLUTION, V64, P1136, DOI 10.1111/j.1558-5646.2009.00870.x; Wolcott T.G., 1988, P55, DOI 10.1017/CBO9780511753428.004; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yuhara T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084720; ZAYKIN DV, 1993, J HERED, V84, P152, DOI 10.1093/oxfordjournals.jhered.a111304	117	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158582	10.1371/journal.pone.0158582	http://dx.doi.org/10.1371/journal.pone.0158582			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379532	Green Published, gold			2022-12-26	WOS:000379798700036
J	Yeh, CH; Chen, PC; Chen, CH; Hsu, CF; Huang, RL; Ding, DC; Chu, TY				Yeh, Ching-Hua; Chen, Pao-Chu; Chen, Chiu-Hua; Hsu, Che-Fang; Huang, Rui-Len; Ding, Dah-Ching; Chu, Tang-Yuan			Platelet-Derived Growth Factor in the Ovarian Follicle Attracts the Stromal Cells of the Fallopian Tube Fimbriae	PLOS ONE			English	Article							SEROUS CARCINOMA; CANCER; MIGRATION; CARCINOGENESIS; CYTOKINES; GUIDANCE; FLUID	During human ovulation, the fallopian tube fimbriae must move to the ovulation site to catch the oocyte. As the tissue-of-origin of the majority of ovarian high-grade serous carcinoma (HGSC), the fallopian tube fimbriae carrying a precursor cancer lesion may also approach the ovulatory site for metastasis. We hypothesize that platelet-derived growth factor (PDGF) in mature follicle fluid (FF) attracts the migration of PDGFR-expressing fimbriae toward the ovulating follicle. We observed that more PDGFR-beta was expressed in the distal part than in the proximal parts of the fallopian tube, particularly in stromal cells in the lamina propria. The stromal cells, but not the epithelial cells, from normal fimbriae and fallopian tube HGSC were highly chemotactic to mature FF. The chemotactic activities were positively correlated with PDGF-BB and estradiol levels in FF and were abolished by a blocking antibody of PDGFR-beta and by tyrosine kinase inhibitor imatinib. When PDGF-BB/AB was depleted from the FF, more than 80% of chemotaxis activities were diminished. This study suggests an ovarian follicle-directed and PDGF-dependent attraction of fallopian tube fimbriae before ovulation. The same mechanism may also be crucial for the ovarian homing of HGSC, which largely originates in the fimbriae.	[Yeh, Ching-Hua; Chen, Chiu-Hua; Hsu, Che-Fang; Ding, Dah-Ching; Chu, Tang-Yuan] Tzu Chi Gen Hosp, Cerv Canc Prevent Ctr, Hualien 970, Taiwan; [Chen, Pao-Chu; Chu, Tang-Yuan] Tzu Chi Gen Hosp, Dept Obstet & Gynecol, Hualien 970, Taiwan; [Huang, Rui-Len] Taipei Med Univ, Dept Obstet & Gynecol, Shuang Ho Hosp, New Taipei, Taiwan; [Chen, Pao-Chu; Chu, Tang-Yuan] Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Taipei Medical University; Shuang Ho Hospital; Tzu Chi University	Chu, TY (corresponding author), Tzu Chi Gen Hosp, Cerv Canc Prevent Ctr, Hualien 970, Taiwan.; Chu, TY (corresponding author), Tzu Chi Gen Hosp, Dept Obstet & Gynecol, Hualien 970, Taiwan.; Chu, TY (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan.	hidrchu@gmail.com	DING, DAH-CHING/Y-3592-2019	Huang, Rui Lan/0000-0001-6458-4672; Hsu, Che-Fang/0000-0002-8024-9150; Chu, Tang-Yuan/0000-0003-2717-2681	National Science Council of Taiwan, R.O.C. [NSC 99-2628-B303-001]; Buddhist Tzu Chi General Hospital, Hualien, Taiwan [TCRD-I102-01-01]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Buddhist Tzu Chi General Hospital, Hualien, Taiwan	Funded by a grant from the National Science Council of Taiwan, R.O.C. (NSC 99-2628-B303-001) and an intramural grant from Buddhist Tzu Chi General Hospital, Hualien, Taiwan (TCRD-I102-01-01).; This study was supported by a grant of the National Science Council of Taiwan, ROC (NSC 99-2628-B-303-001) and an intramural grant of Tzu Chi General Hospital, Hualien, Taiwan TCRD-I102-01-01). The authors are grateful to the in vitro fertilization-ET team of Tzu Chi General Hospital for providing FF for this study, and to Miss Rui-Len Huang of Taipei Medical University Shuang Ho Hospital for technique assistance.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Das A, 2011, J ASSIST REPROD GEN, V28, P677, DOI 10.1007/s10815-011-9580-2; Dubeau L, 2013, ANN ONCOL, V24, P28, DOI 10.1093/annonc/mdt308; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; EDWARDS RG, 1975, J REPROD FERTIL, P121; Gordon J D, 1995, Obstet Gynecol Surv, V50, P688, DOI 10.1097/00006254-199509000-00024; Gordts Stephan, 2002, Reprod Biomed Online, V4 Suppl 3, P10; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Hasegawa A, 2009, J REPROD IMMUNOL, V83, P40, DOI 10.1016/j.jri.2009.09.002; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Huang HS, 2015, CARCINOGENESIS, V36, P1419, DOI 10.1093/carcin/bgv132; Karst Alison M, 2011, F1000 Med Rep, V3, P22, DOI 10.3410/M3-22; Karst AM, 2011, P NATL ACAD SCI USA, V108, P7547, DOI 10.1073/pnas.1017300108; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Ledee N, 2008, HUM REPROD, V23, P2001, DOI 10.1093/humrep/den192; Lousse JC, 2008, FERTIL STERIL, V90, P833, DOI 10.1016/j.fertnstert.2007.12.049; Marquez RT, 2005, CLIN CANCER RES, V11, P6116, DOI 10.1158/1078-0432.CCR-04-2509; Nagel M, 2004, DEVELOPMENT, V131, P2727, DOI 10.1242/dev.01141; Nik NN, 2014, ANNU REV PATHOL-MECH, V9, P27, DOI 10.1146/annurev-pathol-020712-163949; Overton C, 1996, HUM REPROD, V11, P380, DOI 10.1093/HUMREP/11.2.380; Perets R, 2013, CANCER CELL, V24, P751, DOI 10.1016/j.ccr.2013.10.013; Pinkas H, 2008, MOL HUM REPROD, V14, P199, DOI 10.1093/molehr/gan011; Seidman JD, 2011, GYNECOL ONCOL, V120, P470, DOI 10.1016/j.ygyno.2010.11.020; Tangkijvanich P, 2002, EXP CELL RES, V281, P140, DOI 10.1006/excr.2002.5657; Wan ACA, 2016, TRENDS BIOTECHNOL, V34, P711, DOI 10.1016/j.tibtech.2016.02.015	26	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158266	10.1371/journal.pone.0158266	http://dx.doi.org/10.1371/journal.pone.0158266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379403	Green Submitted, gold, Green Published			2022-12-26	WOS:000379798700025
J	Deligny, A; Dierker, T; Dagalv, A; Lundequist, A; Eriksson, I; Nairn, AV; Moremen, KW; Merry, CLR; Kjellen, L				Deligny, Audrey; Dierker, Tabea; Dagalv, Anders; Lundequist, Anders; Eriksson, Inger; Nairn, Alison V.; Moremen, Kelley W.; Merry, Catherine L. R.; Kjellen, Lena			NDST2 (N-Deacetylase/N-Sulfotransferase-2) Enzyme Regulates Heparan Sulfate Chain Length	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEACETYLASE/N-SULFOTRANSFERASE 1; EMBRYONIC STEM-CELLS; MICE DEFICIENT; N-SULFATION; BIOSYNTHESIS; MOUSE; PROTEOGLYCANS; EXPRESSION; GLYCOSAMINOGLYCAN; DIFFERENTIATION	Analysis of heparan sulfate synthesized by HEK 293 cells overexpressing murine NDST1 and/or NDST2 demonstrated that the amount of heparan sulfate was increased in NDST2-but not in NDST1-overexpressing cells. Altered transcript expression of genes encoding other biosynthetic enzymes or proteoglycan core proteins could not account for the observed changes. However, the role of NDST2 in regulating the amount of heparan sulfate synthesized was confirmed by analyzing heparan sulfate content in tissues isolated from Ndst2(-/-) mice, which contained reduced levels of the polysaccharide. Detailed disaccharide composition analysis showed no major structural difference between heparan sulfate from control and Ndst2(-/-) tissues, with the exception of heparan sulfate from spleen where the relative amount of trisulfated disaccharides was lowered in the absence of NDST2. In vivo transcript expression levels of the heparan sulfate-polymerizing enzymes Ext1 and Ext2 were also largely unaffected by NDST2 levels, pointing to a mode of regulation other than increased gene transcription. Size estimation of heparan sulfate polysaccharide chains indicated that increased chain lengths in NDST2-overexpressing cells alone could explain the increased heparan sulfate content. A model is discussed where NDST2-specific substrate modification stimulates elongation resulting in increased heparan sulfate chain length.	[Deligny, Audrey; Dierker, Tabea; Dagalv, Anders; Lundequist, Anders; Eriksson, Inger; Merry, Catherine L. R.; Kjellen, Lena] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, SE-75123 Uppsala, Sweden; [Nairn, Alison V.; Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Merry, Catherine L. R.] Univ Nottingham, Ctr Biomol Sci, Wolfson Ctr Stem Cells Tissue Engn & Modelling, Nottingham NG7 2RD, England	Uppsala University; University System of Georgia; University of Georgia; University of Nottingham	Kjellen, L (corresponding author), Biomed Ctr, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	lena.kjellen@imbim.uu.se	Moremen, Kelley/AAD-4661-2019	merry, catherine/0000-0002-3490-2809; Nairn, Alison/0000-0002-4453-7593	Swedish Research Council; Swedish Cancer Society; Stiftelsen for Proteoglykanforskning; DAAD, German Academic Exchange Service; International Academic Fellowship from Leverhulme Trust; National Institutes of Health [GM103490]; EPSRC [EP/J013854/1] Funding Source: UKRI; MRC [G0701165, G0902170] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103490] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [978724] Funding Source: researchfish; Engineering and Physical Sciences Research Council [1169153, EP/J013854/1] Funding Source: researchfish; Medical Research Council [G0701165, G0902170] Funding Source: researchfish; National Centre for the Replacement [NC/N001583/1] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Stiftelsen for Proteoglykanforskning; DAAD, German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); International Academic Fellowship from Leverhulme Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement	This work was supported by grants from the Swedish Research Council (to L.K.), the Swedish Cancer Society (to L.K.), Stiftelsen for Proteoglykanforskning (to L.K.), and DAAD, German Academic Exchange Service (to T. D.), an International Academic Fellowship from the Leverhulme Trust (to C. L. R. M.), and National Institutes of Health Grant GM103490 (to K. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Barkefors I, 2011, J BIOL CHEM, V286, P24189, DOI 10.1074/jbc.M110.212209; Bengtsson J, 2003, BIOCHEMISTRY-US, V42, P2110, DOI 10.1021/bi026928g; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Carlsson Pernilla, 2012, Handb Exp Pharmacol, P23, DOI 10.1007/978-3-642-23056-1_2; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Cheung WF, 1996, BIOCHEMISTRY-US, V35, P5250, DOI 10.1021/bi952325b; Dagalv A, 2015, METHODS MOL BIOL, V1229, P189, DOI 10.1007/978-1-4939-1714-3_17; Dagalv A, 2011, J BIOL CHEM, V286, P44433, DOI 10.1074/jbc.M111.303891; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Fan GP, 2000, FEBS LETT, V467, P7, DOI 10.1016/S0014-5793(00)01111-X; Foley EM, 2010, PROG MOL BIOL TRANSL, V93, P213, DOI 10.1016/S1877-1173(10)93010-X; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Forsberg M, 2012, J BIOL CHEM, V287, P10853, DOI 10.1074/jbc.M111.337030; Gasimli L, 2014, BBA-GEN SUBJECTS, V1840, P1993, DOI 10.1016/j.bbagen.2014.01.007; Grobe K, 2005, DEVELOPMENT, V132, P3777, DOI 10.1242/dev.01935; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Kreuger J, 2012, J HISTOCHEM CYTOCHEM, V60, P898, DOI 10.1369/0022155412464972; Kusche-Gullberg M, 1998, J BIOL CHEM, V273, P11902, DOI 10.1074/jbc.273.19.11902; Lawrence R, 2008, NAT METHODS, V5, P291, DOI 10.1038/nmeth0408-291; Le Jan S, 2012, ARTERIOSCL THROM VAS, V32, P1255, DOI 10.1161/ATVBAHA.111.240622; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Ledin J, 2006, J BIOL CHEM, V281, P35727, DOI 10.1074/jbc.M604113200; Li BYZ, 2011, METHODS MOL BIOL, V690, P285, DOI 10.1007/978-1-60761-962-8_19; Li FC, 2011, J CELL BIOL, V192, P691, DOI 10.1083/jcb.201008087; LIDHOLT K, 1992, BIOCHEM J, V287, P21, DOI 10.1042/bj2870021; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lindahl U, 2013, J INTERN MED, V273, P555, DOI 10.1111/joim.12061; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Petersen F, 1999, J BIOL CHEM, V274, P12376, DOI 10.1074/jbc.274.18.12376; PETTERSSON I, 1991, J BIOL CHEM, V266, P8044; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pikas DS, 2000, BIOCHEMISTRY-US, V39, P4552, DOI 10.1021/bi992524l; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Ringvall M, 2010, PROG MOL BIOL TRANSL, V93, P35, DOI 10.1016/S1877-1173(10)93003-2; ROBINSON HC, 1978, J BIOL CHEM, V253, P6687; Ronnberg E, 2012, METHODS MOL BIOL, V836, P201, DOI 10.1007/978-1-61779-498-8_14; Roy A, 2014, J BIOL CHEM, V289, P237, DOI 10.1074/jbc.M112.435156; Sheng JZ, 2011, J BIOL CHEM, V286, P19768, DOI 10.1074/jbc.M111.224311; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Vives RR, 2014, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00331; Xian XJ, 2010, CELL TISSUE RES, V339, P31, DOI 10.1007/s00441-009-0829-3; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314	45	23	23	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18600	18607		10.1074/jbc.M116.744433	http://dx.doi.org/10.1074/jbc.M116.744433			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27387504	Green Published, hybrid			2022-12-26	WOS:000383242300001
J	Lofruthe, N; Gallitz, I; Traeger, L; Baumer, N; Schulze, I; Kuhlmann, T; Muller-Tidow, C; Steinbicker, AU				Lofruthe, Niklas; Gallitz, Inka; Traeger, Lisa; Baeumer, Nicole; Schulze, Isabell; Kuhlmann, Tanja; Mueller-Tidow, Carsten; Steinbicker, Andrea U.			Intravenous Iron Carboxymaltose as a Potential Therapeutic in Anemia of Inflammation	PLOS ONE			English	Article							MOUSE MODEL; PEPTIDE HEPCIDIN; INTERLEUKIN-6; TRANSFUSION; FERROPORTIN; EXPRESSION; EFFICACY; GENE; MICE	Intravenous iron supplementation is an effective therapy in iron deficiency anemia (IDA), but controversial in anemia of inflammation (AI). Unbound iron can be used by bacteria and viruses for their replication and enhance the inflammatory response. Nowadays available high molecular weight iron complexes for intravenous iron substitution, such as ferric carboxymaltose, might be useful in AI, as these pharmaceuticals deliver low doses of free iron over a prolonged period of time. We tested the effects of intravenous iron carboxymaltose in murine AI: Wild-type mice were exposed to the heat-killed Brucella abortus (BA) model and treated with or without high molecular weight intravenous iron. 4h after BA injection followed by 2h after intravenous iron treatment, inflammatory cytokines were upregulated by BA, but not enhanced by iron treatment. In long term experiments, mice were fed a regular or an iron deficient diet and then treated with intravenous iron or saline 14 days after BA injection. Iron treatment in mice with BA-induced AI was effective 24h after iron administration. In contrast, mice with IDA (on iron deficiency diet) prior to BA-IA required 7d to recover from AI. In these experiments, inflammatory markers were not further induced in iron-treated compared to vehicle-treated BA-injected mice. These results demonstrate that intravenous iron supplementation effectively treated the murine BA-induced AI without further enhancement of the inflammatory response. Studies in humans have to reveal treatment options for AI in patients.	[Lofruthe, Niklas; Gallitz, Inka; Traeger, Lisa; Steinbicker, Andrea U.] Univ Munster, Univ Hosp Muenster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany; [Baeumer, Nicole; Schulze, Isabell; Mueller-Tidow, Carsten] Univ Hosp Muenster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany; [Kuhlmann, Tanja] Univ Munster, Univ Hosp Muenster, Inst Neuropathol, Munster, Germany; [Mueller-Tidow, Carsten] Univ Hosp Halle, Dept Med Hematol & Oncol 4, Halle, Germany	University of Munster; University of Munster; University of Munster; Martin Luther University Halle Wittenberg	Steinbicker, AU (corresponding author), Univ Munster, Univ Hosp Muenster, Dept Anesthesiol Intens Care & Pain Med, Munster, Germany.	andrea.steinbicker@ukmuenster.de	Müller-Tidow, Carsten/O-7207-2018	Müller-Tidow, Carsten/0000-0002-7166-5232; Steinbicker, Andrea U./0000-0002-5237-961X	"Innovative Medical Research" Muenster Medical School, Muenster University [IMF ST 111206]; German Research Foundation (Deutsche Forschungsgemeinschaft) [STE 1894/4-1]	"Innovative Medical Research" Muenster Medical School, Muenster University; German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by grants from "Innovative Medical Research" Muenster Medical School, Muenster University (IMF ST 111206) and from the German Research Foundation (Deutsche Forschungsgemeinschaft) STE 1894/4-1 (AUS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from "Innovative Medical Research" Muenster Medical School, Muenster University (IMF ST 111206) and from the German Research Foundation (Deutsche Forschungsgemeinschaft) STE 1894/4-1 (AUS).	Baumer N, 2011, J BIOL CHEM, V286, P28210, DOI 10.1074/jbc.M110.203471; Bothwell, 1980, METHODS HEMATOLOGY, V1, P90; Brown CO, 2012, BIOCHEM J, V444, P515, DOI 10.1042/BJ20112019; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Gardenghi S, 2014, BLOOD, V123, P1137, DOI 10.1182/blood-2013-08-521625; Geisser P, 2010, PHARMACEUTICS, V3, P12; Heming N, 2012, CRIT CARE MED, V40, P2141, DOI 10.1097/CCM.0b013e31824e6713; Kim A, 2014, BLOOD, V123, P1129, DOI 10.1182/blood-2013-08-521419; Lin L, 2007, BLOOD, V110, P2182, DOI 10.1182/blood-2007-04-087593; Litton E, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4822; McCranor BJ, 2014, BLOOD CELL MOL DIS, V52, P126, DOI 10.1016/j.bcmd.2013.09.004; Michels K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004998; Nairz M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00152; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2014, HEMATOL ONCOL CLIN N, V28, P671, DOI 10.1016/j.hoc.2014.04.005; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Prince OD, 2012, HAEMATOL-HEMATOL J, V97, P1648, DOI 10.3324/haematol.2011.053397; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Song SNJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4323; Steinbicker AU, 2013, NUTRIENTS, V5, P3034, DOI 10.3390/nu5083034; Steinbicker AU, 2011, BLOOD, V118, P4224, DOI 10.1182/blood-2011-03-339952; Steinbicker AU, 2011, BLOOD, V117, P4915, DOI 10.1182/blood-2010-10-313064; Valenti L, 2011, ARTERIOSCL THROM VAS, V31, P683, DOI 10.1161/ATVBAHA.110.214858; Ward DM, 2012, BBA-MOL CELL RES, V1823, P1426, DOI 10.1016/j.bbamcr.2012.03.004	29	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158599	10.1371/journal.pone.0158599	http://dx.doi.org/10.1371/journal.pone.0158599			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404499	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508200012
J	Idelevich, EA; Becker, K; Schmitz, J; Knaack, D; Peters, G; Kock, R				Idelevich, Evgeny A.; Becker, Karsten; Schmitz, Janne; Knaack, Dennis; Peters, Georg; Koeck, Robin			Evaluation of an Automated System for Reading and Interpreting Disk Diffusion Antimicrobial Susceptibility Testing of Fastidious Bacteria	PLOS ONE			English	Article							VIDEO READER SYSTEM; ZONE READER; OSIRIS	Results of disk diffusion antimicrobial susceptibility testing depend on individual visual reading of inhibition zone diameters. Therefore, automated reading using camera systems might represent a useful tool for standardization. In this study, the ADAGIO automated system (Bio-Rad) was evaluated for reading disk diffusion tests of fastidious bacteria. 144 clinical isolates (68 beta-haemolytic streptococci, 28 Streptococcus pneumoniae, 18 viridans group streptococci, 13 Haemophilus influenzae, 7 Moraxella catarrhalis, and 10 Campylobacter jejuni) were tested on Mueller-Hinton agar supplemented with 5% defibrinated horse blood and 20 mg/L beta-NAD (MH-F, Oxoid) according to EUCAST. Plates were read manually with a ruler and automatically using the ADAGIO system. Inhibition zone diameters, indicated by the automated system, were visually controlled and adjusted, if necessary. Among 1548 isolate-antibiotic combinations, comparison of automated vs. manual reading yielded categorical agreement (CA) without visual adjustment of the automatically determined zone diameters in 81.4%. In 20% (309 of 1548) of tests it was deemed necessary to adjust the automatically determined zone diameter after visual control. After adjustment, CA was 94.8%; very major errors (false susceptible interpretation), major errors (false resistant interpretation) and minor errors (false categorization involving intermediate result), calculated according to the ISO 20776-2 guideline, accounted to 13.7% (13 of 95 resistant results), 3.3% (47 of 1424 susceptible results) and 1.4% (21 of 1548 total results), respectively, compared to manual reading. The ADAGIO system allowed for automated reading of disk diffusion testing in fastidious bacteria and, after visual validation of the automated results, yielded good categorical agreement with manual reading.	[Idelevich, Evgeny A.; Becker, Karsten; Knaack, Dennis; Peters, Georg; Koeck, Robin] Univ Hosp Munster, Inst Med Microbiol, Munster, Germany; [Schmitz, Janne] Univ Hosp Munster, Inst Hyg, Munster, Germany	University of Munster; University of Munster	Idelevich, EA (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Germany.	evgeny.idelevich@ukmuenster.de	Becker, Karsten/O-2302-2018; Köck, Robin/AAC-1552-2019	Becker, Karsten/0000-0002-6391-1341; 				Andrews JM, 2000, J ANTIMICROB CHEMOTH, V46, P535, DOI 10.1093/jac/46.4.535; [Anonymous], 2007, ISOFDIS 20776 22007; Croxatto A, 2016, CLIN MICROBIOL INFEC, V22, P217, DOI 10.1016/j.cmi.2015.09.030; European Committee on Antimicrobial Susceptibility Testing, 2014, BREAKP TABL INT MICS; Geiss HK, 2000, DIAGN MICR INFEC DIS, V37, P151, DOI 10.1016/S0732-8893(00)00132-2; Hombach M, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-225; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Kolbert M, 2004, CLIN MICROBIOL INFEC, V10, P416, DOI 10.1111/j.1469-0691.2004.00885.x; Korgenski EK, 1998, J CLIN MICROBIOL, V36, P302, DOI 10.1128/JCM.36.1.302-304.1998; Lestari ES, 2008, J MICROBIOL METH, V75, P177, DOI 10.1016/j.mimet.2008.05.020; Medeiros AA, 2000, J CLIN MICROBIOL, V38, P1688, DOI 10.1128/JCM.38.4.1688-1693.2000; Nijs A, 2003, J CLIN MICROBIOL, V41, P3627, DOI 10.1128/JCM.41.8.3627-3630.2003; Sanchez MA, 2001, CLIN MICROBIOL INFEC, V7, P352, DOI 10.1046/j.1198-743x.2001.00274.x; The European Committee on Antimicrobial Susceptibility Testing, 2014, EUCAST DISK DIFF MET; van Belkum A, 2013, J CLIN MICROBIOL, V51, P2018, DOI 10.1128/JCM.00313-13	15	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159183	10.1371/journal.pone.0159183	http://dx.doi.org/10.1371/journal.pone.0159183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391898	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400217
J	Tiwari, A; Lemke, J; Altmueller, J; Thiele, H; Glaus, E; Fleischhauer, J; Nurnberg, P; Neidhardt, J; Berger, W				Tiwari, Amit; Lemke, Johannes; Altmueller, Janine; Thiele, Holger; Glaus, Esther; Fleischhauer, Johannes; Nuernberg, Peter; Neidhardt, John; Berger, Wolfgang			Identification of Novel and Recurrent Disease-Causing Mutations in Retinal Dystrophies Using Whole Exome Sequencing (WES): Benefits and Limitations	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE BESTROPHINOPATHY; DOMINANT RETINITIS-PIGMENTOSA; SPLICING FACTOR PRP8; MISSENSE SUBSTITUTIONS; MACULAR DEGENERATION; PROTEIN FUNCTION; DOMAIN; VARIANTS; GENES; BRR2	Inherited retinal dystrophies (IRDs) are Mendelian diseases with tremendous genetic and phenotypic heterogeneity. Identification of the underlying genetic basis of these dystrophies is therefore challenging. In this study we employed whole exome sequencing (WES) in 11 families with IRDs and identified disease-causing variants in 8 of them. Sequence analysis of about 250 IRD-associated genes revealed 3 previously reported disease-associated variants in RHO, BEST1 and RP1. We further identified 5 novel pathogenic variants in RPGRIP1 (p.Ser964Profs*37), PRPF8 (p.Tyr2334Leufs*51), CDHR1 (p.Pro133Arg and c.439-17G>A) and PRPF31 (p.Glu183_Met193dup). In addition to confirming the power of WES in genetic diagnosis of IRDs, we document challenges in data analysis and show cases where the underlying genetic causes of IRDs were missed by WES and required additional techniques. For example, the mutation c.439-17G>A in CDHR1 would be rated unlikely applying the standardWES analysis. Only transcript analysis in patient fibroblasts confirmed the pathogenic nature of this variant that affected splicing of CDHR1 by activating a cryptic splice-acceptor site. In another example, a 33-base pair duplication in PRPF31 missed by WES could be identified only via targeted analysis by Sanger sequencing. We discuss the advantages and challenges of using WES to identify mutations in heterogeneous diseases like IRDs.	[Tiwari, Amit; Lemke, Johannes; Glaus, Esther; Neidhardt, John; Berger, Wolfgang] Univ Zurich, Inst Med Mol Genet, Wagistr 12, CH-8952 Schlieren, Switzerland; [Altmueller, Janine; Thiele, Holger; Nuernberg, Peter] Univ Cologne, CCG, Weyertal 115b, D-50931 Cologne, Germany; [Fleischhauer, Johannes] Univ Zurich Hosp, Dept Ophthalmol, Frauenklin Str 24, CH-8091 Zurich, Switzerland; [Nuernberg, Peter] Univ Cologne, CMMC, Robert Koch Str 21, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Berger, Wolfgang] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Berger, Wolfgang] Univ Zurich, Neurosci Ctr Zurich ZNZ, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Berger, Wolfgang] Swiss Fed Inst Technol, Neurosci Ctr Zurich ZNZ, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Lemke, Johannes] Univ Clin Leipzig, Inst Human Genet, Leipzig AoR, Philipp Rosenthal Str 55, D-04103 Leipzig, Germany; [Neidhardt, John] Carl von Ossietzky Univ Oldenburg, Fac Med & Hlth Sci, Human Genet, D-26129 Oldenburg, Germany; [Berger, Wolfgang] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-26111 Oldenburg, Germany	University of Cologne; University of Zurich; University Zurich Hospital; University of Cologne; University of Cologne; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Leipzig University; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Tiwari, A (corresponding author), Univ Zurich, Inst Med Mol Genet, Wagistr 12, CH-8952 Schlieren, Switzerland.	tiwari@medmolgen.uzh.ch	Neidhardt, John/J-4310-2017; Thiele, Holger/ABE-6792-2020	Thiele, Holger/0000-0002-0169-998X; Neidhardt, John/0000-0002-9205-8394	Swiss National Science Foundation [320030_138507]; Velux Stiftung, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Stiftung, Switzerland	This study was funded by a grant from the Swiss National Science Foundation (Grant Number: 320030_138507) to WB and JN and from Velux Stiftung, Switzerland to WB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aldahmesh MA, 2009, MOL VIS, V15, P2464; Audo I, 2012, HUM MUTAT, V33, P73, DOI 10.1002/humu.21640; Berger W, 2010, PROG RETIN EYE RES, V29, P335, DOI 10.1016/j.preteyeres.2010.03.004; Beryozkin A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13187; Boon CJF, 2009, PROG RETIN EYE RES, V28, P187, DOI 10.1016/j.preteyeres.2009.04.002; Consugar MB, 2015, GENET MED, V17, P253, DOI 10.1038/gim.2014.172; Corton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065574; Davidson AE, 2011, INVEST OPHTH VIS SCI, V52, P3730, DOI 10.1167/iovs.10-6707; Dietrich K, 2002, BRIT J OPHTHALMOL, V86, P328, DOI 10.1136/bjo.86.3.328; Ellingford JM, 2016, J MED GENET, V53, P761, DOI 10.1136/jmedgenet-2016-103837; Glaus E, 2011, MOL THER, V19, P936, DOI 10.1038/mt.2011.7; Glockle N, 2014, EUR J HUM GENET, V22, P99, DOI 10.1038/ejhg.2013.72; Huang L, 2016, EXP EYE RES, V146, P252, DOI 10.1016/j.exer.2016.03.015; Johnson AA, 2015, INVEST OPHTH VIS SCI, V56, P4619, DOI 10.1167/iovs.15-16910; Kramer F, 2000, EUR J HUM GENET, V8, P286, DOI 10.1038/sj.ejhg.5200447; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; MacDonald IM, 2012, OPHTHALMIC GENET, V33, P123, DOI 10.3109/13816810.2011.592172; Maeder C, 2009, NAT STRUCT MOL BIOL, V16, P42, DOI 10.1038/nsmb.1535; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Nikopoulos K, 2015, SCI REP-UK, V5, DOI 10.1038/srep13902; Payne A, 2000, INVEST OPHTH VIS SCI, V41, P4069; Pena V, 2007, MOL CELL, V25, P615, DOI 10.1016/j.molcel.2007.01.023; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Stone EA, 2005, GENOME RES, V15, P978, DOI 10.1101/gr.3804205; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Villegas Jacob, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2803s71; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Xu Y, 2014, HUM GENET, V133, P1255, DOI 10.1007/s00439-014-1460-2; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Zhang LD, 2007, PROTEIN SCI, V16, P1024, DOI 10.1110/ps.072872007; Zhao L, 2015, HUM GENET, V134, P217, DOI 10.1007/s00439-014-1512-7	41	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158692	10.1371/journal.pone.0158692	http://dx.doi.org/10.1371/journal.pone.0158692			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391102	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000380005400105
J	Tschinkel, WR; Seal, JN				Tschinkel, Walter R.; Seal, Jon N.			Bioturbation by the Fungus-Gardening Ant, Trachymyrmex septentrionalis	PLOS ONE			English	Article							GRASS-CUTTING ANT; ACROMYRMEX-HEYERI; NEST ARCHITECTURE; SOIL PROPERTIES; HYMENOPTERA; FORMICIDAE; PHYLOGEOGRAPHY; PREFERENCE; AUSTRALIA; EVOLUTION	Soil invertebrates such as ants are thought to be important manipulators of soils in temperate and tropical ecosystems. The fungus gardening ant, Trachymyrmex septentrionalis, is an important agent of biomantling, that is, of depositing soil excavated from below onto the surface, and has been suggested as an agent of bioturbation (moving soil below ground) as well. The amount of bioturbation by this ant was quantified by planting queenright colonies in sand columns consisting of 5 layers of different colored sand. The amount of each color of sand deposited on the surface was determined from April to November 2015. In November, colonies were excavated and the color and amount of sand deposited below ground (mostly as backfill in chambers) was determined. Extrapolated to one ha, T. septentrionalis deposited 800 kg of sand per annum on the surface, and an additional 200 kg (17% of the total excavated) below ground. On average, this mixes 1.3% of the sand from other layers within the top meter of soil per millennium, but this mixing is unlikely to be homogeneous, and probably occurs as "hotspots" in both horizontal and vertical space. Such mixing is discussed as a challenge to sediment dating by optically stimulated luminescence (OSL).	[Tschinkel, Walter R.] Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA; [Seal, Jon N.] Univ Texas Tyler, Ctr Environm Biodivers & Conservat, Dept Biol, Tyler, TX 75799 USA	State University System of Florida; Florida State University; University of Texas System; University of Texas at Tyler	Tschinkel, WR (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	tschinkel@bio.fsu.edu	Seal, Jon/M-7396-2018	Seal, Jon/0000-0001-8013-1438	National Science Foundation [IOS 1021632, DEB 1354629]; Division Of Integrative Organismal Systems [1552822] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by National Science Foundation grant No. IOS 1021632 and DEB 1354629. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the competent and cheerful technical help of Tyler Murdock, Nicholas Hanley and Daniel Dominguez. This work was supported in part by National Science Foundation grant No. IOS 1021632 and DEB 1354629. We thank the US Forest Service, Apalachicola National Forest for permits to carry out this research project in the national forest.	Bateman MD, 2003, QUATERNARY SCI REV, V22, P1169, DOI 10.1016/S0277-3791(03)00019-2; Bollazzi M, 2002, INSECT SOC, V49, P153, DOI 10.1007/s00040-002-8295-x; Bollazzi M, 2008, OECOLOGIA, V158, P165, DOI 10.1007/s00442-008-1113-z; Bollazzi M, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.13701; Bucher EH, 2004, BIOTROPICA, V36, P327, DOI 10.1646/04005; Cerda A, 2008, J APPL ENTOMOL, V132, P306, DOI 10.1111/j.1439-0418.2008.01267.x; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; DEBRUYN LAL, 1994, AUST J SOIL RES, V32, P555, DOI 10.1071/SR9940555; Dorn RI, 2014, GEOLOGY, V42, P771, DOI 10.1130/G35825.1; ELDRIDGE DJ, 1994, AUST J SOIL RES, V32, P323, DOI 10.1071/SR9940323; Farji Brener AG, 2004, J VEG SCI, V15, P823; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Forrest B, 2003, QUATERNARY SCI REV, V22, P1279, DOI 10.1016/S0277-3791(03)00028-3; Gabet EJ, 2003, ANNU REV EARTH PL SC, V31, P249, DOI 10.1146/annurev.earth.31.100901.141314; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; HAINES B, 1983, Tropical Ecology, V24, P85; Halfen AF, 2010, 19 WORLD C SOIL SCI; Humphreys G.S., 1998, 16 WORLD C SOIL SCI; HUNTLEY DJ, 1985, NATURE, V313, P105, DOI 10.1038/313105a0; JOHNSON DL, 1990, SOIL SCI, V149, P84, DOI 10.1097/00010694-199002000-00004; Johnson DL, 2010, 19 WORLD C SOIL SCI; King JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075843; Licht HHD, 2010, EVOLUTION, V64, P2055, DOI 10.1111/j.1558-5646.2010.00948.x; McGlynn TP, 2012, ANNU REV ENTOMOL, V57, P291, DOI 10.1146/annurev-ento-120710-100708; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Mikheyev AS, 2008, MOL ECOL, V17, P4480, DOI 10.1111/j.1365-294X.2008.03940.x; Moser JC, 2006, ANN ENTOMOL SOC AM, V99, P891, DOI 10.1603/0013-8746(2006)99[891:CEAMOA]2.0.CO;2; Moutinho P, 2003, ECOLOGY, V84, P1265, DOI 10.1890/0012-9658(2003)084[1265:IOLANO]2.0.CO;2; Mueller UG, 2011, P NATL ACAD SCI USA, V108, P4053, DOI 10.1073/pnas.1015806108; Myers R.L., 1990, P150; Nkem JN, 2000, PEDOBIOLOGIA, V44, P609, DOI 10.1078/S0031-4056(04)70075-X; Phillips JD, 2007, CATENA, V70, P92, DOI 10.1016/j.catena.2006.08.002; Pielstrom S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057040; Richards PJ, 2011, EARTH SURF PROC LAND, V36, P1240, DOI 10.1002/esp.2149; Richards PJ, 2009, EARTH-SCI REV, V96, P92, DOI 10.1016/j.earscirev.2009.06.004; Rink WJ, 2013, J ARCHAEOL SCI, V40, P2217, DOI 10.1016/j.jas.2012.11.006; Robins R, 2011, ENVIRON ARCHAEOL, V16, P151, DOI 10.1179/174963111X13110803261010; Roces F, 2000, INSECT SOC, V47, P348, DOI 10.1007/PL00001728; Rodrigues K. F., 2013, THESIS; Scott JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009922; Seal JN, 2007, PHYSIOL ENTOMOL, V32, P8, DOI 10.1111/j.1365-3032.2006.00534.x; Seal JN, 2006, ANN ENTOMOL SOC AM, V99, P673, DOI 10.1603/0013-8746(2006)99[673:CPOTFA]2.0.CO;2; Seal JN, 2015, BIOL J LINN SOC, V114, P689, DOI 10.1111/bij.12426; Seal JN, 2010, INSECT CONSERV DIVER, V3, P134, DOI 10.1111/j.1752-4598.2010.00085.x; Tschinkel WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139922; Tschinkel WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120407; Tschinkel WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112981; TSCHINKEL WR, 1974, ENVIRON ENTOMOL, V3, P667, DOI 10.1093/ee/3.4.667; Tschinkel WR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.21; Tschinkel WR, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.9; Tschinkel WR, 2003, PALAEOGEOGR PALAEOCL, V192, P321, DOI 10.1016/S0031-0182(02)00690-9; Tschinkel WR, 2011, J INSECT SCI; Whitford WG, 2000, INVERTEBRATES AS WEB-MASTERS IN ECOSYSTEMS, P25, DOI 10.1079/9780851993942.0025; Wilkinson MT, 2009, EARTH-SCI REV, V97, P257, DOI 10.1016/j.earscirev.2009.09.005	54	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158920	10.1371/journal.pone.0158920	http://dx.doi.org/10.1371/journal.pone.0158920			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391485	Green Published, gold			2022-12-26	WOS:000380005400162
J	van Lummel, RC; Walgaard, S; Maier, AB; Ainsworth, E; Beek, PJ; van Dieen, JH				van Lummel, Rob C.; Walgaard, Stefan; Maier, Andrea B.; Ainsworth, Erik; Beek, Peter J.; van Dieen, Jaap H.			The Instrumented Sit-to-Stand Test (iSTS) Has Greater Clinical Relevance than the Manually Recorded Sit-to-Stand Test in Older Adults	PLOS ONE			English	Article							PHYSICAL PERFORMANCE-MEASURES; BODY FIXED SENSOR; FUNCTIONAL STATUS; CHAIR; ACCELEROMETERS; PREDICTOR; MOVEMENTS; ACCURACY; STRENGTH; BREAKING	Background The ability to rise from sitting to standing is critical to an individual's quality of life, as it is a prerequisite for functional independence. The purpose of the current study was to examine the hypothesis that test durations as assessed with the instrumented repeated Sit-To-Stand (STS) show stronger associations with health status, functional status and daily physical activity of older adults than manually recorded test durations. Methods In 63 older participants (mean age 83 +/- 6.9 years, 51 female), health status was assessed using the European Quality of Life questionnaire and functional status was assessed using the physical function index of the of the RAND-36. Physical performance was measured using a wearable sensor-based STS test. From this test, durations, sub-durations and kinematics of the STS movements were estimated and analysed. In addition, physical activity was measured for one week using an activity monitor and episodes of lying, sitting, standing and locomotion were identified. Associations between STS parameters with health status, functional status and daily physical activity were assessed. Results The manually recorded STS times were not significantly associated with health status (p = 0.457) and functional status (p = 0.055), whereas the instrumented STS times were (both p = 0.009). The manually recorded STS durations showed a significant association to daily physical activity for mean sitting durations (p = 0.042), but not for mean standing durations (p = 0.230) and mean number of locomotion periods (p = 0.218). Furthermore, durations of the dynamic sit-to-stand phase of the instrumented STS showed more significant associations with health status, functional status and daily physical activity (all p = 0.001) than the static phases standing and sitting (p = 0.043-0.422). Conclusions As hypothesized, instrumented STS durations were more strongly associated with participant health status, functional status and physical activity than manually recorded STS durations in older adults. Furthermore, instrumented STS allowed assessment of the dynamic phases of the test, which were likely more informative than the static sitting and standing phases.	[van Lummel, Rob C.; Walgaard, Stefan; Ainsworth, Erik] McRoberts BV, Raamweg 43, NL-2596 HN The Hague, Netherlands; [van Lummel, Rob C.; Maier, Andrea B.; Beek, Peter J.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Maier, Andrea B.] Univ Melbourne, Royal Melbourne Hosp, Dept Med & Aged Care, Melbourne, Vic 3010, Australia	Vrije Universiteit Amsterdam; Royal Melbourne Hospital; University of Melbourne	van Lummel, RC (corresponding author), McRoberts BV, Raamweg 43, NL-2596 HN The Hague, Netherlands.; van Lummel, RC (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	r.vanlummel@mcroberts.nl	van Dieen, Jaap/B-3937-2013; Maier, Andrea/W-7060-2019; Maier, Andrea B./Q-5548-2019	van Dieen, Jaap/0000-0002-7719-5585; Maier, Andrea/0000-0001-7206-1724; Beek, Peter/0000-0002-0917-8548	Netherlands Organization for Scientific Research (NWO TOP NIG grant) [91209021]; Innovation Fund of Agis/Achmea (Innovatiefonds grant) [499256]; Dutch health insurance company	Netherlands Organization for Scientific Research (NWO TOP NIG grant)(Netherlands Organization for Scientific Research (NWO)); Innovation Fund of Agis/Achmea (Innovatiefonds grant); Dutch health insurance company	This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO TOP NIG grant 91209021) for the development of a novel instrument to support fall prevention in extramural care, as well as a grant from the Innovation Fund of Agis/Achmea (Innovatiefonds grant 499256), a Dutch health insurance company. The aim was to develop a fall prevention program for inhabitants of a care home and the community. These funding organizations had no involvement with the contents of the study.	Benatti FB, 2015, MED SCI SPORT EXER, V47, P2053, DOI 10.1249/MSS.0000000000000654; BOHANNON RW, 1995, PERCEPT MOTOR SKILL, V80, P163, DOI 10.2466/pms.1995.80.1.163; Boonstra MC, 2006, J BIOMECH, V39, P354, DOI 10.1016/j.jbiomech.2004.11.021; Buford TW, 2010, AGEING RES REV, V9, P369, DOI 10.1016/j.arr.2010.04.004; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Dijkstra B, 2008, AGE AGEING, V37, P436, DOI 10.1093/ageing/afn097; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Foldvari M, 2000, J GERONTOL A-BIOL, V55, pM192, DOI 10.1093/gerona/55.4.M192; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fryback DG, 2007, MED CARE, V45, P1162, DOI 10.1097/MLR.0b013e31814848f1; Giansanti D, 2006, PHYSIOL MEAS, V27, P713, DOI 10.1088/0967-3334/27/8/006; Glenn JM, 2015, J GERIATR PHYS THER, V71270, P1; Gray M, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-145; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1989, J GERONTOL, V44, pM141, DOI 10.1093/geronj/44.5.M141; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; HODGE WA, 1986, P NATL ACAD SCI USA, V83, P2879, DOI 10.1073/pnas.83.9.2879; Hortobagyi T, 2003, J GERONTOL A-BIOL, V58, P453; Hughes MA, 1996, J BIOMECH, V29, P1509, DOI 10.1016/0021-9290(96)00083-8; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Jones SE, 2013, THORAX, V68, P1015, DOI 10.1136/thoraxjnl-2013-203576; Millor N, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-86; Najafi B, 2002, IEEE T BIO-MED ENG, V49, P843, DOI 10.1109/TBME.2002.800763; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; Pai Y, 1990, MED SCI SPORTS EXERC; Penninx BWJH, 2000, J GERONTOL A-BIOL, V55, pM691, DOI 10.1093/gerona/55.11.M691; Rabinovich RA, 2013, EUR RESPIR J, V42, P1205, DOI 10.1183/09031936.00134312; Regterschot GRH, 2015, GAIT POSTURE, V41, P935, DOI 10.1016/j.gaitpost.2015.03.350; RILEY PO, 1991, J BIOMECH, V24, P77, DOI 10.1016/0021-9290(91)90328-K; Rolland Y, 2006, EUR J EPIDEMIOL, V21, P113, DOI 10.1007/s10654-005-5458-x; Rosenberg IH, 1997, J NUTR, V127, P990; SCHENKMAN M, 1990, PHYS THER, V70, P638, DOI 10.1093/ptj/70.10.638; Schwenk M, 2012, PHYSIOL MEAS, V33, P1931, DOI 10.1088/0967-3334/33/11/1931; SKELTON DA, 1994, AGE AGEING, V23, P371, DOI 10.1093/ageing/23.5.371; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Van Hees VT, 2009, MED SCI SPORT EXER, V41, P810, DOI 10.1249/MSS.0b013e31818ff636; Van Lummel RC, 2013, GAIT POSTURE, V38, P153, DOI 10.1016/j.gaitpost.2012.10.008; van Lummel RC, 2012, PHYSIOL MEAS, V33, P1855, DOI 10.1088/0967-3334/33/11/1855; van Lummel RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151881; van Lummel RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144048; Van Remoortel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039198; van Schooten KS, 2015, J AGING PHYS ACTIV, V23, P9, DOI [10.1123/japa.2013-0103, 10.1123/JAPA.2013-0103]; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williamson R, 2001, MED BIOL ENG COMPUT, V39, P294, DOI 10.1007/BF02345283; Zijlstra A., 2012, J NEUROENG REHABIL, V9, P1, DOI DOI 10.HTT0S://D0I.0RG/10.1186/1743-0003-9-75	49	47	47	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157968	10.1371/journal.pone.0157968	http://dx.doi.org/10.1371/journal.pone.0157968			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391082	Green Published, gold			2022-12-26	WOS:000380005400027
J	Huang, PP; Brusman, LE; Iyer, AK; Webster, NJG; Mellon, PL				Huang, Polly P.; Brusman, Liza E.; Iyer, Anita K.; Webster, Nicholas J. G.; Mellon, Pamela L.			A Novel Gonadotropin-Releasing Hormone 1 (Gnrh1) Enhancer-Derived Noncoding RNA Regulates Gnrh1 Gene Expression in GnRH Neuronal Cell Models	PLOS ONE			English	Article							INTEGRATIVE GENOMICS VIEWER; HOMEODOMAIN PROTEINS; GT1-7 CELLS; TRANSCRIPTION; CHROMATIN; INFERTILITY; PROMOTER; ELEMENTS; REVEALS; OCT-1	Gonadotropin-releasing hormone (GnRH), a neuropeptide released from a small population of neurons in the hypothalamus, is the central mediator of the hypothalamic-pituitarygonadal axis, and is required for normal reproductive development and function. Evolutionarily conserved regulatory elements in the mouse, rat, and human Gnrh1 gene include three enhancers and the proximal promoter, which confer Gnrh1 gene expression specifically in GnRH neurons. In immortalized mouse hypothalamic GnRH (GT1-7) neurons, which show pulsatile GnRH release in culture, RNA sequencing and RT-qPCR revealed that expression of a novel long noncoding RNA at Gnrh1 enhancer 1 correlates with high levels of GnRH mRNA expression. In GT1-7 neurons, which contain a transgene carrying 3 kb of the rat Gnrh1 regulatory region, both the mouse and rat Gnrh1 enhancer-derived noncoding RNAs (GnRH-E1 RNAs) are expressed. We investigated the characteristics and function of the endogenous mouse GnRH-E1 RNA. Strand-specific RT-PCR analysis of GnRH-E1 RNA in GT1-7 cells revealed GnRH-E1 RNAs that are transcribed in the sense and antisense directions from distinct 5' start sites, are 3' polyadenylated, and are over 2 kb in length. These RNAs are localized in the nucleus and have a half-life of over 8 hours. In GT1-7 neurons, siRNA knockdown of mouse GnRH-E1 RNA resulted in a significant decrease in the expression of the Gnrh1 primary transcript and Gnrh1 mRNA. Over-expression of either the sense or antisense mouse GnRH-E1 RNA in immature, migratory GnRH (GN11) neurons, which do not express either GnRH-E1 RNA or GnRH mRNA, induced the transcriptional activity of co-transfected rat Gnrh1 gene regulatory elements, where the induction requires the presence of the rat Gnrh1 promoter. Together, these data indicate that GnRH-E1 RNA is an inducer of Gnrh1 gene expression. GnRH-E1 RNA may play an important role in the development and maturation of GnRH neurons.	[Huang, Polly P.; Brusman, Liza E.; Iyer, Anita K.; Mellon, Pamela L.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Webster, Nicholas J. G.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Huang, Polly P.; Brusman, Liza E.; Iyer, Anita K.; Webster, Nicholas J. G.; Mellon, Pamela L.] Univ Calif San Diego, Ctr Reprod Sci & Med, La Jolla, CA 92093 USA; [Iyer, Anita K.] Illumina Inc, 5200 Illumina Way, San Diego, CA 92122 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Illumina	Mellon, PL (corresponding author), Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA.; Mellon, PL (corresponding author), Univ Calif San Diego, Ctr Reprod Sci & Med, La Jolla, CA 92093 USA.	pmellon@ucsd.edu	Webster, Nick/AAI-8410-2021	Mellon, Pamela/0000-0002-8856-0410	National Institutes of Health [R01 HD082567, R01 HD072754, R01 HD020377, R01 CA196853, U54 CA155435, P30 DK063491, P42 ES101337]; National Institutes of Health, Specialized Cooperative Centers Program in Reproduction and Infertility Research [U54 HD012303]; Veterans Affairs [101BX002709]; Endocrine Society;  [P30 CA023100];  [T32 DK007541];  [F32 HD058427];  [T32 DK007494]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007203, P50HD012303, R01HD082567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, Specialized Cooperative Centers Program in Reproduction and Infertility Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); Endocrine Society; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants R01 HD082567, R01 HD072754, and R01 HD020377 (to P.L.M.) and by the National Institutes of Health through a cooperative agreement (U54 HD012303) as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research (P.L.M. and N.J. G.W.). This work was also supported by National Institutes of Health grants R01 CA196853 and U54 CA155435 and Veterans Affairs grant 101BX002709 (N.J.G.W.). P.L.M. and N.J.G.W. were partially supported by P30 DK063491 and P30 CA023100, and P.L.M. was partially supported by P42 ES101337. P.P.H. was partially supported by T32 DK007541. L.E.B. was partially supported by the Endocrine Society. A.K.I. was partially supported by F32 HD058427 and T32 DK007494. Additional grants: National Institutes of Health R01 HD020377 to Pamela L. Mellon, National Institutes of Health P30 DK063491 to Pamela L. Mellon and Nicholas J. G. Webster, and National Institutes of Health P42 ES101337 to Pamela L. Mellon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Caley DP, 2010, THESCIENTIFICWORLDJO, V10, P90, DOI 10.1100/tsw.2010.7; Chappell PE, 2003, J NEUROSCI, V23, P11202; CLARK ME, 1995, MOL CELL BIOL, V15, P6169; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Eraly SA, 1998, MOL ENDOCRINOL, V12, P469, DOI 10.1210/me.12.4.469; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Givens ML, 2005, J BIOL CHEM, V280, P19156, DOI 10.1074/jbc.M502004200; Givens ML, 2004, MOL ENDOCRINOL, V18, P2950, DOI 10.1210/me.2003-0437; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hoffmann HM, 2016, J NEUROSCI, V36, P3506, DOI 10.1523/JNEUROSCI.2723-15.2016; Iyer AK, 2011, MOL ENDOCRINOL, V25, P460, DOI 10.1210/me.2010-0403; Iyer AK, 2010, MOL ENDOCRINOL, V24, P1949, DOI 10.1210/me.2010-0156; Kaiser UB, 2005, ENDOCRINE, V26, P277, DOI 10.1385/ENDO:26:3:277; Kelley CG, 2002, MOL ENDOCRINOL, V16, P2413, DOI 10.1210/me.2002-0189; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kinsey-Jones JS, 2005, J NEUROENDOCRINOL, V17, P541, DOI 10.1111/j.1365-2826.2005.01341.x; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Lai F, 2014, CURR OPIN GENET DEV, V25, P38, DOI 10.1016/j.gde.2013.11.017; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Larder R, 2011, J NEUROSCI, V31, P426, DOI 10.1523/JNEUROSCI.1688-10.2011; Lawson MA, 1998, MOL CELL ENDOCRINOL, V140, P157, DOI 10.1016/S0303-7207(98)00044-6; Lawson MA, 1996, MOL CELL BIOL, V16, P3596; Lawson MA, 1998, MOL ENDOCRINOL, V12, P364, DOI 10.1210/me.12.3.364; Lawson MA, 2002, ENDOCRINOLOGY, V143, P1404, DOI 10.1210/en.143.4.1404; Layman LC, 2003, ENDOCRIN METAB CLIN, V32, P549, DOI 10.1016/S0889-8529(03)00040-9; Maamar H, 2013, GENE DEV, V27, P1260, DOI 10.1101/gad.217018.113; Maggi R, 2000, ENDOCRINOLOGY, V141, P2105, DOI 10.1210/en.141.6.2105; Melgar MF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r113; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Mercer TR, 2013, NAT STRUCT MOL BIOL, V20, P300, DOI 10.1038/nsmb.2480; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Nelson SB, 2000, MOL ENDOCRINOL, V14, P1509, DOI 10.1210/me.14.9.1509; Novaira HJ, 2011, J NEUROSCI, V31, P3336, DOI 10.1523/JNEUROSCI.5419-10.2011; Orom UA, 2011, CURR OPIN GENET DEV, V21, P194, DOI 10.1016/j.gde.2011.01.020; Pnueli L, 2015, P NATL ACAD SCI USA, V112, P4369, DOI 10.1073/pnas.1414841112; RADOVICK S, 1991, P NATL ACAD SCI USA, V88, P3402, DOI 10.1073/pnas.88.8.3402; Rave-Harel N, 2004, J BIOL CHEM, V279, P30287, DOI 10.1074/jbc.M402960200; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sun M, 2015, ENDOCR REV, V36, P25, DOI 10.1210/er.2014-1034; Swaab DF, 1997, ACTA PAEDIATR, V86, P50; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tobet SA, 2006, ENDOCRINOLOGY, V147, P1159, DOI 10.1210/en.2005-1275; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tsai PS, 2006, NAT CLIN PRACT ENDOC, V2, P160, DOI 10.1038/ncpendmet0119; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; WEINER RI, 1993, HUM REPROD, V8, P13, DOI 10.1093/humrep/8.suppl_2.13; WETSEL WC, 1991, ENDOCRINOLOGY, V129, P1584, DOI 10.1210/endo-129-3-1584; WETSEL WC, 1992, P NATL ACAD SCI USA, V89, P4149, DOI 10.1073/pnas.89.9.4149; WHYTE DB, 1995, MOL ENDOCRINOL, V9, P467, DOI 10.1210/me.9.4.467; Zhen SJ, 1997, J BIOL CHEM, V272, P12620, DOI 10.1074/jbc.272.19.12620	56	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158597	10.1371/journal.pone.0158597	http://dx.doi.org/10.1371/journal.pone.0158597			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389022	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500028
J	Niu, SY; Wang, YL; Zhao, ZL; Deng, MJ; Cao, L; Yang, L; Fan, GQ				Niu, Suyan; Wang, Yuanlong; Zhao, Zhenli; Deng, Minjie; Cao, Lin; Yang, Lu; Fan, Guoqiang			Transcriptome and Degradome of microRNAs and Their Targets in Response to Drought Stress in the Plants of a Diploid and Its Autotetraploid Paulownia australis	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; ABSCISIC-ACID; REGULATED MICRORNAS; ARABIDOPSIS; TOLERANCE; SALT; EXPRESSION; GENE; MIRNAS; OVEREXPRESSION	MicroRNAs (miRNAs) are small, non-coding RNAs that play vital roles in plant growth, development, and stress response. Increasing numbers of studies aimed at discovering miRNAs and analyzing their functions in plants are being reported. In this study, we investigated the effect of drought stress on the expression of miRNAs and their targets in plants of a diploid and derived autotetraploid Paulownia australis. Four small RNA (sRNA) libraries and four degradome libraries were constructed from diploid and autotetraploid P. australis plants treated with either 75% or 25% relative soil water content. A total of 33 conserved and 104 novel miRNAs (processing precision value > 0.1) were identified, and 125 target genes were identified for 36 of the miRNAs by using the degradome sequencing. Among the identified miRNAs, 54 and 68 were differentially expressed in diploid and autotetraploid plants under drought stress (25% relative soil water content), respectively. The expressions of miRNAs and target genes were also validated by quantitative real-time PCR. The results showed that the relative expression trends of the randomly selected miRNAs were similar to the trends predicted by Illumina sequencing. And the correlations between miRNAs and their target genes were also analyzed. Furthermore, the functional analysis showed that most of these miRNAs and target genes were associated with plant development and environmental stress response. This study provided molecular evidence for the possible involvement of certain miRNAs in the drought response and/or tolerance in P. australis, and certain level of differential expression between diploid and autotetraploid plants.	[Niu, Suyan; Wang, Yuanlong; Zhao, Zhenli; Deng, Minjie; Cao, Lin; Yang, Lu; Fan, Guoqiang] Henan Agr Univ, Inst Paulownia, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China; [Niu, Suyan; Wang, Yuanlong; Zhao, Zhenli; Deng, Minjie; Cao, Lin; Yang, Lu; Fan, Guoqiang] Henan Agr Univ, Coll Forestry, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China.; Fan, GQ (corresponding author), Henan Agr Univ, Coll Forestry, 95 Wenhua Rd, Zhengzhou 450002, Henan, Peoples R China.	zlxx64@126.com	Zhou, Man/S-4256-2016		National Natural Science Foundation of China [30271082, 30571496, U1204309]; Outstanding Talents Project 347 of Henan Province [122101110700]; Transformation Project of the National Agricultural Scientific and Technological Achievement of China [2012GB2D000271]; Science and Technology Innovation Team Project of Zhengzhou City, China [121PCXTD515]; Outstanding Talents Project of Henan Province [122101110700]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Talents Project 347 of Henan Province; Transformation Project of the National Agricultural Scientific and Technological Achievement of China; Science and Technology Innovation Team Project of Zhengzhou City, China; Outstanding Talents Project of Henan Province	This study was funded by the National Natural Science Foundation of China (grant number 30271082, 30571496, U1204309), by the Outstanding Talents Project 347 of Henan Province (grant number 122101110700), by the Transformation Project of the National Agricultural Scientific and Technological Achievement of China (grant number 2012GB2D000271), and by the Science and Technology Innovation Team Project of Zhengzhou City, China (grant number 121PCXTD515). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank the editor and reviewers for their thoughtful comments for improving our manuscript. We also thank Dr. Xiu-Qing Li of Agriculture and Agri-Food Canada for internal review of the revised manuscript. This study was funded by the National Natural Science Foundation of China (Grant number 30271082, 30571496, U1204309), by the Outstanding Talents Project of Henan Province (Grant number 122101110700), by the Transformation Project of the National Agricultural Scientific and Technological Achievement of China (Grant number 2012GB2D000271), and by the Science and Technology Innovation Team Project of Zhengzhou City, China (Grant number 121PCXTD515).	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Anssour S, 2009, ANN BOT-LONDON, V103, P1207, DOI 10.1093/aob/mcp058; Ates S, 2008, AFR J BIOTECHNOL, V7, P4153; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Cartolano M, 2007, NAT GENET, V39, P901, DOI 10.1038/ng2056; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai XY, 2007, PLANT PHYSIOL, V143, P1739, DOI 10.1104/pp.106.094532; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dong YP, 2014, INT J MOL SCI, V15, P4583, DOI 10.3390/ijms15034583; Fan GQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140590; Fan GQ, 2014, BIOCHIMIE, V102, P68, DOI 10.1016/j.biochi.2014.02.008; Fan GuoQiang, 2009, Journal of Northwest A & F University - Natural Science Edition, V37, P83; Geddy R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-130; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; GIRAUDAT J, 1994, PLANT MOL BIOL, V26, P1557, DOI 10.1007/BF00016490; Goettel W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086153; GOFFEAU A, 2004, CHEMISTRY, V1, P1; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuang HH, 2005, PLANT J, V44, P37, DOI 10.1111/j.1365-313X.2005.02506.x; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Kwak PB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-457; Leitch IJ, 1997, TRENDS PLANT SCI, V2, P470, DOI 10.1016/S1360-1385(97)01154-0; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li JJ, 2001, PLANT CELL, V13, P2269, DOI 10.1105/tpc.13.10.2269; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li XQ, 2016, CURR ISSUES MOL BIOL, V20, P29; Liao Y, 2008, PLANTA, V228, P225, DOI 10.1007/s00425-008-0731-3; Liu HH, 2008, RNA, V14, P836, DOI 10.1261/rna.895308; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Man MZ, 2000, BIOINFORMATICS, V16, P953, DOI 10.1093/bioinformatics/16.11.953; Marechal A, 2010, NEW PHYTOL, V186, P299, DOI 10.1111/j.1469-8137.2010.03195.x; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Newman SM, 1997, AGROFOREST SYST, V39, P23, DOI 10.1023/A:1005938310106; Ni ZY, 2012, BIOCHEM BIOPH RES CO, V427, P330, DOI 10.1016/j.bbrc.2012.09.055; Niu SY, 2016, MOL GENET GENOMICS, V291, P181, DOI 10.1007/s00438-015-1102-y; Niu SY, 2014, PLANT CELL TISS ORG, V119, P457, DOI 10.1007/s11240-014-0546-9; Niu SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106736; Niu SuYan, 2013, Scientia Silvae Sinicae, V49, P77; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pang MX, 2011, J PLANT PHYSIOL, V168, P824, DOI 10.1016/j.jplph.2010.10.006; Peng XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032997, 10.1371/journal.pone.0040120]; Rao KVM, 2006, PHYSIOLOGY AND MOLECULAR BIOLOGY OF STRESS TOLERANCE IN PLANTS, P1; Ren YY, 2012, FUNCT INTEGR GENOMIC, V12, P327, DOI 10.1007/s10142-012-0271-6; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Ruan MB, 2009, GENOMICS, V94, P263, DOI 10.1016/j.ygeno.2009.07.002; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Song J.B., 2016, PLANT GENE, V5, P56, DOI [10.1016/j.plgene.2015.12.001, DOI 10.1016/J.PLGENE.2015.12.001]; Song JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125427; Song JB, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-210; Song JB, 2012, PLANT CELL PHYSIOL, V53, P1283, DOI 10.1093/pcp/pcs080; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; TANG R C, 1980, Southern Journal of Applied Forestry, V4, P19; Valliyodan B, 2006, CURR OPIN PLANT BIOL, V9, P189, DOI 10.1016/j.pbi.2006.01.019; Wang D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-44; Wang M, 2013, GENE, V530, P26, DOI 10.1016/j.gene.2013.08.009; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang X.S., 2013, J HENAN AGR U, V46, P646; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhou M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28700; Zhou M, 2013, PLANT PHYSIOL, V161, P1375, DOI 10.1104/pp.112.208702; Zhou X, 2007, BIOTECHNOLOGY AND SUSTAINABLE AGRICULTURE 2006 AND BEYOND, P471, DOI 10.1007/978-1-4020-6635-1_78; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zhou ZS, 2012, J EXP BOT, V63, P4597, DOI 10.1093/jxb/ers136	83	2	2	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158750	10.1371/journal.pone.0158750	http://dx.doi.org/10.1371/journal.pone.0158750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388154	gold, Green Submitted, Green Published			2022-12-26	WOS:000379811500041
J	Cohen, TJ; Constance, BH; Hwang, AW; James, M; Yuan, CX				Cohen, Todd J.; Constance, Brian H.; Hwang, Andrew W.; James, Michael; Yuan, Chao-Xing			Intrinsic Tau Acetylation Is Coupled to Auto-Proteolytic Tau Fragmentation	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; TERMINALLY CLEAVED TAU; ALZHEIMERS-DISEASE; ACETYLTRANSFERASE ACTIVITY; IN-VITRO; HISTONE ACETYLTRANSFERASE; TRANSGENIC MICE; POSTTRANSLATIONAL MODIFICATIONS; LYSINE PROPIONYLATION; PROTEIN ACETYLATION	Tau proteins are abnormally aggregated in a range of neurodegenerative tauopathies including Alzheimer's disease (AD). Recently, tau has emerged as an extensively post-translationally modified protein, among which lysine acetylation is critical for normal tau function and its pathological aggregation. Here, we demonstrate that tau isoforms have different propensities to undergo lysine acetylation, with auto-acetylation occurring more prominently within the lysine-rich microtubule-binding repeats. Unexpectedly, we identified a unique intrinsic property of tau in which auto-acetylation induces proteolytic tau cleavage, thereby generating distinct N- and C-terminal tau fragments. Supporting a catalytic reaction-based mechanism, mapping and mutagenesis studies showed that tau cysteines, which are required for acetyl group transfer, are also essential for auto-proteolytic tau processing. Further mass spectrometry analysis identified the C-terminal 2nd and 4th microtubule binding repeats as potential sites of auto-cleavage. The identification of acetylationmediated auto-proteolysis provides a new biochemical mechanism for tau self-regulation and warrants further investigation into whether auto-catalytic functions of tau are implicated in AD and other tauopathies.	[Cohen, Todd J.; Constance, Brian H.] Univ N Carolina, Neurosci Ctr, Dept Neurol, Chapel Hill, NC 27599 USA; [Cohen, Todd J.; Constance, Brian H.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Hwang, Andrew W.; James, Michael] Univ Penn, Sch Med, Inst Aging, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Hwang, Andrew W.; James, Michael] Univ Penn, Sch Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; [Yuan, Chao-Xing] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Cohen, TJ (corresponding author), Univ N Carolina, Neurosci Ctr, Dept Neurol, Chapel Hill, NC 27599 USA.; Cohen, TJ (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	toddcohen@neurology.unc.edu			Alzheimer's Association [NIRG-14-321219]; National Institutes of Health [UL1TR001111]; University of Pennsylvania Alzheimer's Disease Core Center (ADCC) [P30-AG010124-25]; National Center for Advancing Translational Sciences (NCATS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Alzheimer's Disease Core Center (ADCC); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Alzheimer's Association grant NIRG-14-321219 (TJC) (http://www.alz.org); the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through Grant Award Number UL1TR001111 (TJC) (https://ncats.nih.gov); and the University of Pennsylvania Alzheimer's Disease Core Center (ADCC) grant P30-AG010124-25. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoury E, 2013, ANGEW CHEM INT EDIT, V52, P3511, DOI 10.1002/anie.201208290; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Arai T, 2004, ANN NEUROL, V55, P72, DOI 10.1002/ana.10793; Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Barten DM, 2011, J ALZHEIMERS DIS, V24, P127, DOI 10.3233/JAD-2011-110161; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; Cohen TJ, 2013, NAT STRUCT MOL BIOL, V20, P756, DOI 10.1038/nsmb.2555; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Congdon EE, 2012, AUTOPHAGY, V8, P609, DOI 10.4161/auto.19048; Crowe A, 2013, J BIOL CHEM, V288, P11024, DOI 10.1074/jbc.M112.436006; Dormeyer W, 2005, MOL CELL PROTEOMICS, V4, P1226, DOI 10.1074/mcp.M500047-MCP200; Dormeyer W, 2003, ANAL BIOANAL CHEM, V376, P994, DOI 10.1007/s00216-003-2058-z; DUPRET JM, 1992, J BIOL CHEM, V267, P7381; Garg S, 2011, NEUROBIOL AGING, V32, P1, DOI 10.1016/j.neurobiolaging.2010.09.008; Ghanta S, 2013, CRIT REV BIOCHEM MOL, V48, P561, DOI 10.3109/10409238.2013.838204; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hochgrafe K, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0204-4; Hosokawa M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052389; Irwin DJ, 2012, BRAIN, V135, P807, DOI 10.1093/brain/aws013; Kamah A, 2014, BIOCHEMISTRY-US, V53, P3020, DOI 10.1021/bi500006v; Karanam B, 2006, J BIOL CHEM, V281, P40292, DOI 10.1074/jbc.M608813200; Khlistunova I, 2006, J BIOL CHEM, V281, P1205, DOI 10.1074/jbc.M507753200; Lewis JD, 2011, MOL PLANT PATHOL, V12, P928, DOI [10.1111/J.1364-3703.2011.00719.X, 10.1111/j.1364-3703.2011.00719.x]; Lu L, 2011, CELL RES, V21, P1182, DOI 10.1038/cr.2011.71; Luo Y, 2014, J PHYS CHEM LETT, V5, P3026, DOI 10.1021/jz501457f; Matsumoto SE, 2015, HUM MOL GENET, V24, P6403, DOI 10.1093/hmg/ddv351; Meredith JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076523; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Mittal R, 2010, J BIOL CHEM, V285, P19927, DOI 10.1074/jbc.M110.126581; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; O'Leary JC, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-45; Olia AS, 2015, ACS CHEM BIOL, V10, P2034, DOI 10.1021/acschembio.5b00342; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Payton M, 2001, MICROBIOL-SGM, V147, P1137, DOI 10.1099/00221287-147-5-1137; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; Sinclair JC, 2000, NAT STRUCT BIOL, V7, P560; Soeda Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10216; Sokolow S, 2015, J NEUROCHEM, V133, P368, DOI 10.1111/jnc.12991; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; Ustun S, 2015, PLANT PHYSIOL, V168, P107, DOI 10.1104/pp.15.00132; Wagner GR, 2013, J BIOL CHEM, V288, P29036, DOI 10.1074/jbc.M113.486753; Wagshal D, 2015, J NEUROL NEUROSUR PS, V86, P244, DOI 10.1136/jnnp-2014-308004; Wang JD, 2010, J BIOL CHEM, V285, P11458, DOI 10.1074/jbc.M109.087585; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Wang YP, 2009, HUM MOL GENET, V18, P4153, DOI 10.1093/hmg/ddp367; Watanabe A, 2004, J NEUROCHEM, V90, P1302, DOI 10.1111/j.1471-4159.2004.02611.x; Wischik CM, 2015, J ALZHEIMERS DIS, V44, P705, DOI 10.3233/JAD-142874; Wray S, 2008, J NEUROCHEM, V105, P2343, DOI 10.1111/j.1471-4159.2008.05321.x; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yang C, 2012, J BIOL CHEM, V287, P34917, DOI 10.1074/jbc.M112.359356; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhang K, 2009, J PROTEOME RES, V8, P900, DOI 10.1021/pr8005155	56	23	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158470	10.1371/journal.pone.0158470	http://dx.doi.org/10.1371/journal.pone.0158470			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383765	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400050
J	Conway, TM; Hoffmann, LJ; Breitbarth, E; Strzepek, RF; Wolff, EW				Conway, Tim M.; Hoffmann, Linn J.; Breitbarth, Eike; Strzepek, Robert F.; Wolff, Eric W.			The Growth Response of Two Diatom Species to Atmospheric Dust from the Last Glacial Maximum	PLOS ONE			English	Article							SOUTHERN-OCEAN PHYTOPLANKTON; NATURAL IRON FERTILIZATION; EAST ANTARCTICA ICE; LIGHT INTERACTIONS; FLOW-INJECTION; TRACE-ELEMENTS; SILICIC-ACID; CO2 CHANGE; CARBON; CLIMATE	Relief of iron (Fe) limitation in the surface Southern Ocean has been suggested as one driver of the regular glacial-interglacial cycles in atmospheric carbon dioxide (CO2). The proposed cause is enhanced deposition of Fe-bearing atmospheric dust to the oceans during glacial intervals, with consequent effects on export production and the carbon cycle. However, understanding the role of enhanced atmospheric Fe supply in biogeochemical cycles is limited by knowledge of the fluxes and 'bioavailability' of atmospheric Fe during glacial intervals. Here, we assess the effect of Fe fertilization by dust, dry-extracted from the Last Glacial Maximum portion of the EPICA Dome C Antarctic ice core, on the Antarctic diatom species Eucampia antarctica and Proboscia inermis. Both species showed strong but differing reactions to dust addition. E. antarctica increased cell number (3880 vs. 786 cells mL(-1)), chlorophyll a (51 vs. 3.9 mu g mL(-1)) and particulate organic carbon (POC; 1.68 vs. 0.28 mu g mL(-1)) production in response to dust compared to controls. P. inermis did not increase cell number in response to dust, but chlorophyll a and POC per cell both strongly increased compared to controls (39 vs. 15 and 2.13 vs. 0.95 ng cell(-1) respectively). The net result of both responses was a greater production of POC and chlorophyll a, as well as decreased Si:C and Si:N incorporation ratios within cells. However, E, antarctica decreased silicate uptake for the same nitrate and carbon uptake, while P. inermis increased carbon and nitrate uptake for the same silicate uptake. This suggests that nutrient utilization changes in response to Fe addition could be driven by different underlying mechanisms between different diatom species. Enhanced supply of atmospheric dust to the surface ocean during glacial intervals could therefore have driven nutrient-utilization changes which could permit greater carbon fixation for lower silica utilization. Additionally, both species responded more strongly to lower amounts of direct Fe chloride addition than they did to dust, suggesting that not all the Fe released from dust was in a bioavailable form available for uptake by diatoms.	[Conway, Tim M.; Wolff, Eric W.] British Antarct Survey, Cambridge, England; [Conway, Tim M.; Wolff, Eric W.] Univ Cambridge, Dept Earth Sci, Cambridge, England; [Conway, Tim M.] Swiss Fed Inst Technol, Dept Earth Sci, Zurich, Switzerland; [Hoffmann, Linn J.; Breitbarth, Eike; Strzepek, Robert F.] Univ Otago, Dept Chem, Dunedin, New Zealand; [Conway, Tim M.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Hoffmann, Linn J.] Univ Otago, Dept Bot, Dunedin, New Zealand; [Breitbarth, Eike] REZO Water Energy, Dunedin, New Zealand; [Strzepek, Robert F.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Cambridge; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Otago; State University System of Florida; University of South Florida; University of Otago; Australian National University	Conway, TM (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	conway.tm@gmail.com	Wolff, Eric W/D-7925-2014; Wolff, Eric/AAB-1097-2021; Strzepek, Robert Francis/A-1216-2011; Hoffmann, Linn/J-3761-2019; Strzepek, Robert/GQH-8703-2022	Wolff, Eric W/0000-0002-5914-8531; Wolff, Eric/0000-0002-5914-8531; Strzepek, Robert Francis/0000-0002-6442-7121; Hoffmann, Linn/0000-0003-0242-4686; Conway, Tim/0000-0002-3069-9786	Natural Environment Research Council studentship; Royal Society Research Professorship [RP120096]; German Research Foundation [HO-4217, BR-3794]; NERC [bas0100034] Funding Source: UKRI; Natural Environment Research Council [bas0100034] Funding Source: researchfish	Natural Environment Research Council studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society Research Professorship; German Research Foundation(German Research Foundation (DFG)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council studentship to TMC (http://www.nerc.ac.uk/), Royal Society Research Professorship to EWW (https://royalsociety.org/) RP120096, LJH and EB were funded by German Research Foundation grants HO-4217 and BR-3794 (http://www.dfg.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achterberg EP, 2001, ANAL CHIM ACTA, V442, P1, DOI 10.1016/S0003-2670(01)01091-1; Achterberg EP, 2013, GEOPHYS RES LETT, V40, P921, DOI 10.1002/grl.50221; Adkins JF, 2013, PALEOCEANOGRAPHY, V28, P539, DOI 10.1002/palo.20046; Allen CS, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001055; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Boutron C. F., 1985, ANN GLACIOL, V7, P7; Bowie AR, 1998, ANAL CHIM ACTA, V361, P189, DOI 10.1016/S0003-2670(98)00015-4; Boyd P.W., 2000, CHANGING OCEAN CARBO, p[61, 107]; Boyle E, 1998, NATURE, V393, P733, DOI 10.1038/31585; Breitbarth E, 2010, BIOGEOSCIENCES, V7, P1075, DOI 10.5194/bg-7-1075-2010; Browning TJ, 2014, GEOPHYS RES LETT, V41, P2851, DOI 10.1002/2014GL059364; Browning TJ, 2014, BIOGEOSCIENCES, V11, P463, DOI 10.5194/bg-11-463-2014; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; BURCKLE LH, 1983, MICROPALEONTOLOGY, V29, P6, DOI 10.2307/1485648; Cavender-Bares KK, 1999, LIMNOL OCEANOGR, V44, P237, DOI 10.4319/lo.1999.44.2.0237; Chever F, 2010, BIOGEOSCIENCES, V7, P455, DOI 10.5194/bg-7-455-2010; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Conway T, 2010, THESIS; Conway TM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8850; Croot PL, 2000, ELECTROANAL, V12, P565, DOI 10.1002/(SICI)1521-4109(200005)12:8<565::AID-ELAN565>3.0.CO;2-L; Croot PL, 2002, ANAL CHIM ACTA, V466, P261, DOI 10.1016/S0003-2670(02)00596-2; Currie KI, 2011, BIOGEOCHEMISTRY, V104, P23, DOI 10.1007/s10533-009-9355-3; Cutter GA, 2012, LIMNOL OCEANOGR-METH, V10, P425, DOI 10.4319/lom.2012.10.425; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; DEANGELIS M, 1987, NATURE, V325, P318, DOI 10.1038/325318a0; Duggen S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL027522; Eldridge ML, 2004, AQUAT MICROB ECOL, V35, P79, DOI 10.3354/ame035079; Falkowski P.G., 1992, OCEANOGRAPHY, V5, P84, DOI [DOI 10.5670/OCEANOG.1992.14, 10.5670/oceanog.1992.14]; Fischer AC, 2007, MAR CHEM, V107, P533, DOI 10.1016/j.marchem.2007.08.004; Franck VM, 2005, LIMNOL OCEANOGR, V50, P825, DOI 10.4319/lo.2005.50.3.0825; Franck VM, 2003, MAR ECOL PROG SER, V252, P15, DOI 10.3354/meps252015; Franck VM, 2000, DEEP-SEA RES PT II, V47, P3315; Gabrielli P, 2005, ATMOS ENVIRON, V39, P6420, DOI 10.1016/j.atmosenv.2005.07.025; Gaspari V, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024352; Gervais F, 2002, LIMNOL OCEANOGR, V47, P1324, DOI 10.4319/lo.2002.47.5.1324; Grasshoff K., 1983, METHODS SEAWATER ANA, P125; Green SE, 2006, DEEP-SEA RES PT II, V53, P620, DOI 10.1016/j.dsr2.2006.01.022; GREENE RM, 1994, LIMNOL OCEANOGR, V39, P1061, DOI 10.4319/lo.1994.39.5.1061; Hendry KR, 2014, QUATERNARY SCI REV, V89, P13, DOI 10.1016/j.quascirev.2014.01.019; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Hoffmann LJ, 2007, BIOGEOSCIENCES, V4, P569, DOI 10.5194/bg-4-569-2007; Hoffmann LJ, 2012, MAR CHEM, V132, P28, DOI 10.1016/j.marchem.2012.02.003; Hoffmann LJ, 2006, LIMNOL OCEANOGR, V51, P1217, DOI 10.4319/lo.2006.51.3.1217; Hutchins DA, 1998, NATURE, V393, P561, DOI 10.1038/31203; Jaccard SL, 2013, SCIENCE, V339, P1419, DOI 10.1126/science.1227545; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Knap A., 1996, 19 JGOFS UNESCO; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Kohfeld KE, 2009, GLACIAL INTERGLACIAL; Kolbowski J, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P825; Lambert F, 2008, NATURE, V452, P616, DOI 10.1038/nature06763; Landschutzer P, 2015, SCIENCE, V349, P1221, DOI 10.1126/science.aab2620; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Mahowald NM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002402; Marteel A, 2008, EARTH PLANET SC LETT, V272, P579, DOI 10.1016/j.epsl.2008.05.021; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez-Garcia A, 2014, SCIENCE, V343, P1347, DOI 10.1126/science.1246848; Martinez-Garcia A, 2011, NATURE, V476, P312, DOI 10.1038/nature10310; Mawji E, 2015, MAR CHEM, V177, P1, DOI 10.1016/j.marchem.2015.04.005; MILLERO FJ, 1987, GEOCHIM COSMOCHIM AC, V51, P793, DOI 10.1016/0016-7037(87)90093-7; Millero FJ, 1998, EARTH PLANET SC LETT, V154, P323, DOI 10.1016/S0012-821X(97)00179-9; Moore CM, 2007, DEEP-SEA RES PT II, V54, P2045, DOI 10.1016/j.dsr2.2007.06.011; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pollard RT, 2009, NATURE, V457, P577, DOI 10.1038/nature07716; Rothlisberger R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020338; Sarthou G, 2008, DEEP-SEA RES PT II, V55, P734, DOI 10.1016/j.dsr2.2007.12.033; Schlosser C, 2011, MAR CHEM, V127, P48, DOI 10.1016/j.marchem.2011.07.008; Sedwick PN, 2000, J GEOPHYS RES-OCEANS, V105, P11321, DOI 10.1029/2000JC000256; Shatova O, 2016, J EXP MAR BIO ECOL I; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; STAUBER JL, 1987, MAR BIOL, V94, P511, DOI 10.1007/BF00431397; Strzepek RF, 2012, LIMNOL OCEANOGR, V57, P1182, DOI 10.4319/lo.2012.57.4.1182; Strzepek RF, 2011, LIMNOL OCEANOGR, V56, P1983, DOI 10.4319/lo.2011.56.6.1983; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Tagliabue A, 2012, BIOGEOSCIENCES, V9, P2333, DOI 10.5194/bg-9-2333-2012; Takeda S, 1998, NATURE, V393, P774, DOI 10.1038/31674; Throndsen J., 1978, PHYTOPLANKTON MANUAL, P69; Timmermans KR, 2004, LIMNOL OCEANOGR, V49, P2141, DOI 10.4319/lo.2004.49.6.2141; Timmermans KR, 2001, LIMNOL OCEANOGR, V46, P260, DOI 10.4319/lo.2001.46.2.0260; Visser F, 2003, J PHYCOL, V39, P1085, DOI 10.1111/j.0022-3646.2003.03-023.x; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Willmott V, 2010, ANTARCT SCI, V22, P3, DOI 10.1017/S095410200999037X; Wolff EW, 2006, NATURE, V440, P491, DOI 10.1038/nature04614; Zhang HN, 1996, MAR CHEM, V52, P17, DOI 10.1016/0304-4203(95)00076-3; Ziegler M, 2013, NAT GEOSCI, V6, P457, DOI [10.1038/NGEO1782, 10.1038/ngeo1782]	91	3	3	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158553	10.1371/journal.pone.0158553	http://dx.doi.org/10.1371/journal.pone.0158553			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384948	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000379809400059
J	Atef, ME; Anand-Srivastava, MB				Atef, Mohammed Emehdi; Anand-Srivastava, Madhu B.			Role of PKC delta in Enhanced Expression of Gq alpha/PLC beta 1 Proteins and VSMC Hypertrophy in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; KINASE-C-DELTA; GROWTH-FACTOR RECEPTOR; ANGIOTENSIN-II; OXIDATIVE STRESS; NADPH OXIDASE; SHR ROLE; INCREASED PROLIFERATION; ACTIVATION MECHANISMS; VASCULAR HYPERTROPHY	Gq alpha signaling has been implicated in cardiac hypertrophy. In addition, angiotensin II (Ang II) was also shown to induce its hypertrophic effect through Gqa and PKC delta activation. We recently showed the role of enhanced expression of Gq alpha/PLC beta 1 proteins in vascular smooth muscle cell (VSMC) hypertrophy, however, the role of PKCd in VSMC hypertrophy in animal model is still lacking. The present study was therefore undertaken to examine the role of PKCd and the associated signaling mechanisms in VSMC hypertrophy using 16-week-old spontaneously hypertensive rats (SHR). VSMC from 16-week-old SHR exhibited enhanced phosphorylation of PKC delta-Tyr(311) and increased protein synthesis, marker of hypertrophy, as compared to WKY rats which was attenuated by rottlerin, an inhibitor of PKCd. In addition, knocking down of PKCd by PKC delta-siRNA also attenuated enhanced protein synthesis in VSMC from SHR. Furthermore, rottlerin attenuated the increased production of superoxide anion, NAD(P) H oxidase activity, increased expression of Gqa, phospholipase C(PLC)beta 1, insulin like growth factor-1 receptor (IGF-1R) and epidermal growth factor receptor ( EGFR) proteins in VSMC from SHR. In addition, the enhanced phosphorylation of c-Src, PKC delta-Tyr(311), IGF-1R, EGFR and ERK1/2 exhibited by VSMC from SHR was also attenuated by rottlerin. These results suggest that VSMC from SHR exhibit enhanced activity of PKCd and that PKCd is the upstream molecule of reactive oxygen species (ROS) and contributes to the enhanced expression of Gqa and PLC beta 1 proteins and resultant VSMC hypertrophy involving c-Src, growth factor receptor transactivation and MAP kinase signaling.	[Atef, Mohammed Emehdi; Anand-Srivastava, Madhu B.] Univ Montreal, Dept Mol & Integrat Physiol, Fac Med, Montreal, PQ, Canada	Universite de Montreal	Anand-Srivastava, MB (corresponding author), Univ Montreal, Dept Mol & Integrat Physiol, Fac Med, Montreal, PQ, Canada.	Madhu.anand-srivastava@umontreal.ca			Canadian Institutes of Health Research (CIHR) [MOP-53074]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	MBAS was funded by a grant from the Canadian Institutes of Health Research (CIHR) (MOP-53074).	ANANDSRIVASTAVA MB, 1982, BIOCHEM BIOPH RES CO, V108, P213, DOI 10.1016/0006-291X(82)91853-8; ANDREA JE, 1992, HYPERTENSION, V20, P585, DOI 10.1161/01.HYP.20.5.585; Atef ME, 2011, FASEB J, V25, P1009; Atef ME, 2016, AM J PHYSIOL-HEART C, V310, pH608, DOI 10.1152/ajpheart.00659.2015; Atef ME, 2014, AM J PHYSIOL-CELL PH, V307, pC97, DOI 10.1152/ajpcell.00337.2013; Bankers-Fulbright JL, 2001, J CELL PHYSIOL, V189, P306, DOI 10.1002/jcp.10022; Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; Berra-Romani R, 2008, AM J PHYSIOL-CELL PH, V295, pC779, DOI 10.1152/ajpcell.00173.2008; Braun MU, 2004, MOL CELL BIOCHEM, V262, P135, DOI 10.1023/B:MCBI.0000038229.23132.9f; Chen CH, 2001, J MOL CELL CARDIOL, V33, P581, DOI 10.1006/jmcc.2000.1330; Chen QW, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-52; CLERK A, 1994, J BIOL CHEM, V269, P32848; Delafontaine P, 2004, ARTERIOSCL THROM VAS, V24, P435, DOI 10.1161/01.ATV.0000105902.89459.09; Dempsey EC, 2000, AM J PHYSIOL-LUNG C, V279, pL429, DOI 10.1152/ajplung.2000.279.3.L429; Dreux AC, 2006, ATHEROSCLEROSIS, V186, P38, DOI 10.1016/j.atherosclerosis.2005.06.038; Fan CY, 2005, BIOCHEM J, V390, P761, DOI 10.1042/BJ20050287; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Frank GD, 2002, MOL ENDOCRINOL, V16, P367, DOI 10.1210/me.16.2.367; Fukuda N, 1999, ARTERIOSCL THROM VAS, V19, P1210, DOI 10.1161/01.ATV.19.5.1210; Gavi S, 2006, TRENDS ENDOCRIN MET, V17, P46, DOI 10.1016/j.tem.2006.01.006; Greene MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085848; Ha H, 2001, AM J KIDNEY DIS, V38, pS204, DOI 10.1053/ajkd.2001.27446; Hall KJ, 2007, BIOCHEM J, V406, P501, DOI 10.1042/BJ20070244; Hsieh HL, 2008, BBA-MOL CELL RES, V1783, P1563, DOI 10.1016/j.bbamcr.2008.03.016; Hsieh HL, 2009, ARTERIOSCL THROM VAS, V29, P1594, DOI 10.1161/ATVBAHA.109.185801; Katz M, 2007, BBA-MOL CELL RES, V1773, P1161, DOI 10.1016/j.bbamcr.2007.01.002; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Koide Y, 2003, HYPERTENS RES, V26, P421, DOI 10.1291/hypres.26.421; KORSGAARD N, 1993, HYPERTENSION, V22, P523, DOI 10.1161/01.HYP.22.4.523; Larroque-Cardoso P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.47; Lee IT, 2013, BIOCHEM PHARMACOL, V85, P954, DOI 10.1016/j.bcp.2012.12.016; Leszczynski D, 1996, LIFE SCI, V58, P599, DOI 10.1016/0024-3205(95)02329-1; Li CH, 2003, FASEB J, V17, P2106, DOI 10.1096/fj.03-0150fje; Li WQ, 1998, MOL CELL BIOL, V18, P5888, DOI 10.1128/MCB.18.10.5888; Li Y, 2006, CARDIOVASC RES, V72, P464, DOI 10.1016/j.cardiores.2006.08.012; Li YA, 2010, AM J PHYSIOL-HEART C, V299, pH1959, DOI 10.1152/ajpheart.00526.2010; Liebmann C, 2001, CELL SIGNAL, V13, P777, DOI 10.1016/S0898-6568(01)00192-9; Lu MH, 2003, CLIN EXP HYPERTENS, V25, P413, DOI 10.1081/CEH-120024985; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; Lv P, 2012, CIRC RES, V111, P697, DOI 10.1161/CIRCRESAHA.112.272013; Maioli E, 2012, SCI WORLD J, DOI 10.1100/2012/350826; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Nakashima H, 2008, HYPERTENSION, V51, P232, DOI 10.1161/HYPERTENSIONAHA.107.101253; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Ohanian V, 1996, CIRC RES, V78, P806, DOI 10.1161/01.RES.78.5.806; Reeves EP, 1999, BIOCHEM J, V344, P859, DOI 10.1042/0264-6021:3440859; Ringshausen I, 2006, LEUKEMIA, V20, P514, DOI 10.1038/sj.leu.2404113; Ron D, 1999, FASEB J, V13, P1658, DOI 10.1096/fasebj.13.13.1658; Saha S, 2008, CAN J PHYSIOL PHARM, V86, P190, DOI 10.1139/Y08-012; Sandoval YHG, 2011, CELL SIGNAL, V23, P354, DOI 10.1016/j.cellsig.2010.10.005; SASAGURI T, 1993, EXP CELL RES, V208, P311, DOI 10.1006/excr.1993.1251; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Talior I, 2005, AM J PHYSIOL-ENDOC M, V288, pE405, DOI 10.1152/ajpendo.00378.2004; Uchiyama K, 2009, EUR J PHARM SCI, V38, P504, DOI 10.1016/j.ejps.2009.09.016; Zhang DH, 2007, J PHARMACOL EXP THER, V322, P913, DOI 10.1124/jpet.107.124669; Zhang MJ, 2016, HISTOCHEM CELL BIOL, V145, P119, DOI 10.1007/s00418-015-1386-3; Zhu BH, 2001, ENDOCRINOLOGY, V142, P3598, DOI 10.1210/en.142.8.3598	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157955	10.1371/journal.pone.0157955	http://dx.doi.org/10.1371/journal.pone.0157955			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379421	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700015
J	Daryadel, A; Haubitz, M; Figueiredo, M; Steubl, D; Roos, M; Mader, A; Hettwer, S; Wagner, CA				Daryadel, Arezoo; Haubitz, Monika; Figueiredo, Marta; Steubl, Dominik; Roos, Marcel; Maeder, Armin; Hettwer, Stefan; Wagner, Carsten A.			The C-Terminal Fragment of Agrin (CAF), a Novel Marker of Renal Function, Is Filtered by the Kidney and Reabsorbed by the Proximal Tubule	PLOS ONE			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; NEUROMUSCULAR-JUNCTION; HEPARAN-SULFATE; NEUROTRYPSIN; EXPRESSION; CLEAVAGE; BIOMARKER; CELLS	Agrin, a multidomain proteoglycan and neurotrypsin, a neuronal serine protease, are important for forming (neuromuscular) synapses. Proteolytical activity of neurotrypsin produces a C-terminal fragment of agrin, termed CAF, of approximately 22 kDA molecular size which also circulates in blood. The presence of CAF in urine suggests either glomerular filtration or secretion into urine. Blood levels of CAF have been identified as a potential novel marker of kidney function. Here we describe that several nephron segments in the mouse kidney express agrin and neutrotrypsin in addition to the localization of both protein in the glomerulum. Agrin mRNA and protein was detected in almost all nephron segments and mRNA abundance was highest in the inner medullary collecting duct. Neurotrypsin mRNA was mostly detected in the thick ascending limb of the loop of Henle, the distal convoluted tubule, and the inner medullary collecting duct. Moreover, we show that the proximal tubule absorbs injected recombinant CAF by a process shared with receptor-mediated and fluid phase endocytosis. Co-injection of CAF with recombinant human transferrin, a substrate of the receptor-mediated endocytic pathway as well as with FITC-labelled dextran (10 kDa), a marker of fluid phase endocytosis, showed partial colocalization of CAF with both markers. Further colocalization of CAF with the lysosomal marker cathepsin B suggested degradation of CAF by the lysosome in the proximal tubule. Thus, the murine kidney expresses agrin and neurotrypsin in nephron segments beyond the glomerulum. CAF is filtered by the glomerulum and is reabsorbed by endocytosis by the proximal tubule. Thus, impaired kidney function could impair glomerular clearance of CAF and thereby increase circulating CAF levels.	[Daryadel, Arezoo; Figueiredo, Marta; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Daryadel, Arezoo; Figueiredo, Marta; Wagner, Carsten A.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Haubitz, Monika; Maeder, Armin; Hettwer, Stefan] Neurotune AG, Schlieren, Switzerland; [Steubl, Dominik; Roos, Marcel] Klinikum Rechts Der Isar, Dept Nephrol, Munich, Germany	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Technical University of Munich	Wagner, CA (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.; Wagner, CA (corresponding author), Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland.	Wagnerca@access.uzh.ch		Wagner, Carsten/0000-0002-9874-8898; Haubitz, Monika/0000-0001-7660-401X	EU FP7 EUROSTAR grant ("Early Diagnosis and Monitoring of Renal Diseases") [E! 6038]; Swiss Commission for Technology and Innovation [15622.1 PFLS-LS]	EU FP7 EUROSTAR grant ("Early Diagnosis and Monitoring of Renal Diseases"); Swiss Commission for Technology and Innovation	This study has been supported by an EU FP7 EUROSTAR grant ("Early Diagnosis and Monitoring of Renal Diseases, E! 6038 KIDNEY") to D. Steubl, M. Roos, A. Mader, S. Hettwer, and C.A. Wagner, and a grant from the Swiss Commission for Technology and Innovation ("CTI no. 15622.1 PFLS-LS") to A. Mader, S. Hettwer, and C.A. Wagner.	[Anonymous], 2015, DIAGN PROD INF; Bacic D, 2006, KIDNEY INT, V69, P495, DOI 10.1038/sj.ki.5000148; Barik A, 2014, DEV NEUROBIOL, V74, P828, DOI 10.1002/dneu.22190; Bolliger MF, 2010, J CELL SCI, V123, P3944, DOI 10.1242/jcs.072090; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; Christensen EI, 2012, COMPR PHYSIOL, V2, P805, DOI 10.1002/cphy.c100073; Christensen EI, 2009, PFLUG ARCH EUR J PHY, V458, P1039, DOI 10.1007/s00424-009-0685-8; Devetzis V, 2015, PLOS ONE IN PRESS; Drey M, 2015, CLIN LAB, V61, P69, DOI 10.7754/Clin.Lab.2014.140724; Eusebio A, 2003, NEUROMUSCULAR DISORD, V13, P408, DOI 10.1016/S0960-8966(03)00036-1; Frischknecht R, 2014, PROG BRAIN RES, V214, P81, DOI 10.1016/B978-0-444-63486-3.00004-9; Goldberg S, 2009, NEPHROL DIAL TRANSPL, V24, P2044, DOI 10.1093/ndt/gfn758; Groffen AJ, 1998, J HISTOCHEM CYTOCHEM, V46, P19, DOI 10.1177/002215549804600104; Groffen AJA, 1998, EUR J BIOCHEM, V254, P123, DOI 10.1046/j.1432-1327.1998.2540123.x; Harvey SJ, 2007, AM J PATHOL, V171, P139, DOI 10.2353/ajpath.2007.061116; HATAE T, 1986, CELL TISSUE RES, V246, P271, DOI 10.1007/BF00215889; Hettwer S, 2013, EXP GERONTOL, V48, P69, DOI 10.1016/j.exger.2012.03.002; Matsumoto-Miyai K, 2009, CELL, V136, P1161, DOI 10.1016/j.cell.2009.02.034; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Mohebbi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055286; Nielsen R, 2007, P NATL ACAD SCI USA, V104, P5407, DOI 10.1073/pnas.0700330104; Raats CJI, 1998, J BIOL CHEM, V273, P17832, DOI 10.1074/jbc.273.28.17832; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Stephan A, 2008, FASEB J, V22, P1861, DOI 10.1096/fj.07-100008; Steubl D, 2015, CLIN CHEM LAB MED; Steubl D, 2015, INT UROL NEPHROL, V47, P391, DOI 10.1007/s11255-014-0852-5; Steubl D, 2014, TRANSL RES, V164, P392, DOI 10.1016/j.trsl.2014.05.005; Steubl D, 2013, AM J NEPHROL, V38, P501, DOI 10.1159/000356969; Suh JH, 2013, NAT REV NEPHROL, V9, P470, DOI 10.1038/nrneph.2013.109; Wijnhoven TJM, 2007, J AM SOC NEPHROL, V18, P823, DOI 10.1681/ASN.2006070692	31	10	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157905	10.1371/journal.pone.0157905	http://dx.doi.org/10.1371/journal.pone.0157905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380275	Green Published, gold, Green Accepted			2022-12-26	WOS:000379798700012
J	Costabile, BK; Kim, YK; Iqbal, J; Zuccaro, MV; Wassef, L; Narayanasamy, S; Curley, RW; Harrison, EH; Hussain, MM; Quadro, L				Costabile, Brianna K.; Kim, Youn-Kyung; Iqbal, Jahangir; Zuccaro, Michael V.; Wassef, Lesley; Narayanasamy, Sureshbabu; Curley, Robert W., Jr.; Harrison, Earl H.; Hussain, M. Mahmood; Quadro, Loredana			beta-Apo-10 '-carotenoids Modulate Placental Microsomal Triglyceride Transfer Protein Expression and Function to Optimize Transport of Intact beta-Carotene to the Embryo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carotenoid; metabolism; placenta; retinoid; vitamin A; apocarotenoid	RETINOIC ACID RECEPTORS; VITAMIN-A; LIPID-METABOLISM; GENE-EXPRESSION; X-RECEPTOR; P19 CELLS; APO-B; TRANSCRIPTION; PROVITAMIN; CLEAVAGE	beta-Carotene is an important source of vitamin A for the mammalian embryo, which depends on its adequate supply to achieve proper organogenesis. In mammalian tissues, beta-carotene 15,15-oxygenase (BCO1) converts beta-carotene to retinaldehyde, which is then oxidized to retinoic acid, the biologically active form of vitamin A that acts as a transcription factor ligand to regulate gene expression. beta-Carotene can also be cleaved by beta-carotene 9,10-oxygenase (BCO2) to form beta-apo-10-carotenal, a precursor of retinoic acid and a transcriptional regulator per se. The mammalian embryo obtains beta-carotene from the maternal circulation. However, the molecular mechanisms that enable its transfer across the maternal-fetal barrier are not understood. Given that beta-carotene is transported in the adult bloodstream by lipoproteins and that the placenta acquires, assembles, and secretes lipoproteins, we hypothesized that the aforementioned process requires placental lipoprotein biosynthesis. Here we show that beta-carotene availability regulates transcription and activity of placental microsomal triglyceride transfer protein as well as expression of placental apolipoprotein B, two key players in lipoprotein biosynthesis. We also show that beta-apo-10-carotenal mediates the transcriptional regulation of microsomal triglyceride transfer protein via hepatic nuclear factor 4 and chicken ovalbumin upstream promoter transcription factor I/II. Our data provide the first in vivo evidence of the transcriptional regulatory activity of beta-apocarotenoids and identify microsomal triglyceride transfer protein and its transcription factors as the targets of their action. This study demonstrates that beta-carotene induces a feed-forward mechanism in the placenta to enhance the assimilation of beta-carotene for proper embryogenesis.	[Costabile, Brianna K.; Kim, Youn-Kyung; Zuccaro, Michael V.; Wassef, Lesley; Quadro, Loredana] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; [Costabile, Brianna K.; Kim, Youn-Kyung; Zuccaro, Michael V.; Wassef, Lesley; Quadro, Loredana] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Costabile, Brianna K.; Kim, Youn-Kyung; Zuccaro, Michael V.; Wassef, Lesley; Quadro, Loredana] Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Iqbal, Jahangir; Hussain, M. Mahmood] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA; [Narayanasamy, Sureshbabu; Curley, Robert W., Jr.] Ohio State Univ, Coll Pharm, 500 W 12th Ave, Columbus, OH 43210 USA; [Narayanasamy, Sureshbabu; Harrison, Earl H.] Ohio State Univ, Dept Human Nutr, Columbus, OH 43210 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Quadro, L (corresponding author), Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.; Quadro, L (corresponding author), Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA.; Quadro, L (corresponding author), Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08901 USA.; Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA.; Hussain, MM (corresponding author), Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA.	mahmood.hussain@downstate.edu; quadro@aesop.rutgers.edu	NARAYANASAMY, SURESHBABU/AAN-6604-2021; Iqbal, Jahangir/B-3903-2014; Zuccaro, Michael/HGC-5116-2022; Harrison, Earl H/AAN-5378-2021; Zuccaro, Michael/HDN-0529-2022	Iqbal, Jahangir/0000-0002-9021-2271; Narayanasamy, Sureshbabu/0000-0002-5846-3230	National Institutes of Health [R01HD057493, R01HD057493-02S1, R01HD057493-05S1, R01HD833331, R01HL95924, R01DK81879, R01HL049879]; Veterans Affairs Merit Award [BX001728]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057493, R01HD083331] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049879, R01HL095924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081879, R01DK101251] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Award(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by National Institutes of Health Grants R01HD057493, R01HD057493-02S1, R01HD057493-05S1, and R01HD833331 (to L. Q.); R01HL95924 and R01DK81879 (to M. M. H.); and R01HL049879 (to E. H. H. and R. W. C.) and by Veterans Affairs Merit Award BX001728 (to M. M. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Amengual J, 2013, J BIOL CHEM, V288, P34081, DOI 10.1074/jbc.M113.501049; Amengual J, 2011, FASEB J, V25, P948, DOI 10.1096/fj.10-173906; Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; Bakillah A, 2000, BIOCHEMISTRY-US, V39, P4892, DOI 10.1021/bi9924009; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Dai K, 2012, J LIPID RES, V53, P901, DOI 10.1194/jlr.M025130; Dai KZ, 2010, ARTERIOSCL THROM VAS, V30, P568, DOI 10.1161/ATVBAHA.109.198135; dela Sena C, 2014, J BIOL CHEM, V289, P13661, DOI 10.1074/jbc.M114.557710; Dimenstein R, 1996, BIOL NEONATE, V69, P230, DOI 10.1159/000244315; Dolle P., 2015, RETINOIDS BIOL BIOCH, P309; ERDMAN JW, 1993, ANN NY ACAD SCI, V691, P76, DOI 10.1111/j.1749-6632.1993.tb26159.x; Eroglu A, 2013, J LIPID RES, V54, P1719, DOI 10.1194/jlr.R039537; Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142; Eroglu A, 2010, ARCH BIOCHEM BIOPHYS, V504, P11, DOI 10.1016/j.abb.2010.07.025; Fisher EA, 2012, BBA-MOL CELL BIOL L, V1821, P778, DOI 10.1016/j.bbalip.2012.02.001; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; Ginsberg HN, 1998, ENDOCRIN METAB CLIN, V27, P503, DOI 10.1016/S0889-8529(05)70023-2; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; Hussain MM, 2011, CLIN LIPIDOL, V6, P293, DOI 10.2217/CLP.11.21; Kamper M, 2015, BIOCHIMIE, V112, P121, DOI 10.1016/j.biochi.2015.03.002; Kim YK, 2011, FASEB J, V25, P1641, DOI 10.1096/fj.10-175448; LADIAS JAA, 1992, J BIOL CHEM, V267, P15849; Lee SA, 2014, AM J PHYSIOL-HEART C, V307, pH1675, DOI 10.1152/ajpheart.00548.2014; Li R, 2011, BIOCHEM BIOPH RES CO, V406, P268, DOI 10.1016/j.bbrc.2011.02.031; Lobo GP, 2012, BBA-MOL CELL BIOL L, V1821, P78, DOI 10.1016/j.bbalip.2011.04.010; Madsen EM, 2004, J BIOL CHEM, V279, P55271, DOI 10.1074/jbc.M411404200; Marceau G, 2007, VITAM HORM, V75, P97, DOI 10.1016/S0083-6729(06)75004-X; Nadeau V, 2014, DEVELOPMENT, V141, P2825, DOI 10.1242/dev.107409; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Panariello L, 1996, J BIOL CHEM, V271, P25524, DOI 10.1074/jbc.271.41.25524; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; Pickens BS, 2013, J CELL PHYSIOL, V228, P791, DOI 10.1002/jcp.24228; Qian A, 2000, BIOCHEM BIOPH RES CO, V276, P837, DOI 10.1006/bbrc.2000.3549; Rava P, 2005, J LIPID RES, V46, P1779, DOI 10.1194/jlr.D400043-JLR200; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Rhinn M, 2011, P NATL ACAD SCI USA, V108, P16687, DOI 10.1073/pnas.1103877108; Roder K, 2007, BIOCHEM SOC T, V35, P1211, DOI 10.1042/BST0351211; Simmons DG, 2008, DEVELOPMENT, V135, P2083, DOI 10.1242/dev.020099; Spiegler E, 2012, BBA-MOL CELL BIOL L, V1821, P88, DOI 10.1016/j.bbalip.2011.05.003; Sun J, 2014, J BIOL CHEM, V289, P33118, DOI 10.1074/jbc.M114.610501; Topletz AR, 2015, MOL PHARMACOL, V87, P430, DOI 10.1124/mol.114.096784; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Wang CX, 2015, ARCH BIOCHEM BIOPHYS, V572, P2, DOI 10.1016/j.abb.2015.01.009; Wassef L, 2013, ARCH BIOCHEM BIOPHYS, V539, P223, DOI 10.1016/j.abb.2013.07.004; Wassef L, 2015, J NUTR, V145, P1408, DOI 10.3945/jn.114.207043; Wassef L, 2012, J NUTR, V142, P1456, DOI 10.3945/jn.112.162677; Wassef L, 2011, J BIOL CHEM, V286, P32198, DOI 10.1074/jbc.M111.253070; WITTMAACK FM, 1995, ENDOCRINOLOGY, V136, P340, DOI 10.1210/en.136.1.340; Ziouzenkova O, 2007, MOL ENDOCRINOL, V21, P77, DOI 10.1210/me.2006-0225	55	26	27	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18525	18535		10.1074/jbc.M116.738336	http://dx.doi.org/10.1074/jbc.M116.738336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402843	Green Published, hybrid			2022-12-26	WOS:000383241800042
J	Kim, MO; Ryu, HW; Choi, JH; Son, TH; Oh, SR; Lee, HS; Yuk, HJ; Cho, S; Kang, JS; Lee, CW; Lee, J; Lee, CK; Hong, ST; Lee, SU				Kim, Mun Ock; Ryu, Hyung Won; Choi, Ji-Hee; Son, Tae Hyun; Oh, Sei-Ryang; Lee, Hyun-Sun; Yuk, Heung Joo; Cho, Sungchan; Kang, Jong Soon; Lee, Chang Woo; Lee, Jinhyuk; Lee, Chong-Kil; Hong, Sung-Tae; Lee, Su Ui			Anti-Obesity Effects of Spiramycin In Vitro and In Vivo	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; AMPK; OBESITY; ADIPOGENESIS; ENERGY; METABOLISM	The effects of spiramycin on adipogenesis and high fat diet (HFD)-induced obesity were investigated. Potential mechanisms contributing to these effects were elucidated. The inhibitory effect of spiramycin on adipocyte differentiation was assessed using 3T3-L1 preadipocyte cells, in which several parameters involved in AMPK signal pathways and lipid metabolism were examined. To further investigate the pharmacological effects of spiramycin in vivo, we examined several obesity-related parameters in HFD-induced obese mice. Spiramycin significantly inhibited preadipocyte differentiation by attenuating intracellular lipid accumulation. Spiramycin also reduced the expression of adipogenic master regulators (PPAR gamma, C/EBP alpha, and SREBP1c) and their downstream target genes (FAS, aP2, and GLUT4) in 3T3-L1 cells. In addition, AMPK phosphorylation was increased by spiramycin treatment in 3T3-L1 cells during early differentiation. Notably, HFD-induced obese mice administered spiramycin showed substantial decreases in body weight gain, serum leptin levels, adipose tissue mass, and hepatic lipid accumulation. Moreover, the decreased levels of GPT and GOT in the serum indicated that spiramycin attenuated hepatic injury caused by HFD. Taken together, these results demonstrate for the first time that spiramycin effectively attenuates HFD-induced obesity and hepatic steatosis by inhibiting adipogenesis.	[Kim, Mun Ock; Ryu, Hyung Won; Choi, Ji-Hee; Son, Tae Hyun; Oh, Sei-Ryang; Lee, Hyun-Sun; Yuk, Heung Joo; Lee, Su Ui] Korea Res Inst Biosci & Biotechnol, Nat Med Res Ctr, 30 Yeongudanji Ro, Cheongju 28116, Chungbuk, South Korea; [Cho, Sungchan] Korea Res Inst Biosci & Biotechnol, Anticanc Agent Res Ctr, 30 Yeongudanji Ro, Cheongju 28116, Chungbuk, South Korea; [Kang, Jong Soon; Lee, Chang Woo] Korea Res Inst Biosci & Biotechnol, Bioevaluat Ctr, 30 Yeongudanji Ro, Cheongju 28116, Chungbuk, South Korea; [Lee, Jinhyuk] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr KOBIC, 125 Gwahak Ro, Yuseong 34141, Daejeon, South Korea; [Son, Tae Hyun; Lee, Chong-Kil] Chungbuk Natl Univ, Coll Pharm, Cheongju 28644, South Korea; [Hong, Sung-Tae] Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungbuk National University; Korea Advanced Institute of Science & Technology (KAIST)	Lee, SU (corresponding author), Korea Res Inst Biosci & Biotechnol, Nat Med Res Ctr, 30 Yeongudanji Ro, Cheongju 28116, Chungbuk, South Korea.; Hong, ST (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 34141, South Korea.	mogwai@kaist.ac.kr; iamsuui@kribb.re.kr	Yuk, Heung Joo/T-5882-2019	Kang, Jong Soon/0000-0001-7698-0162; Hong, Sung-Tae/0000-0001-5981-4859	Korea Research Institute of Bioscience and Biotechnology Research Initiative Program [KGM1221622]; Basic Science Research Program of the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning [NRF-2013R1A1A3008189, 2013R1A1A3009382]; NRF of Korea Grant - Korean Government [35B-2011-1-C00033]	Korea Research Institute of Bioscience and Biotechnology Research Initiative Program; Basic Science Research Program of the National Research Foundation (NRF) - Ministry of Science, ICT and Future Planning; NRF of Korea Grant - Korean Government	This work was supported by grants from the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program (KGM1221622) and the Basic Science Research Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2013R1A1A3008189 and 2013R1A1A3009382). This research was also supported by an NRF of Korea Grant funded by the Korean Government (35B-2011-1-C00033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez JA, 2014, ADV NUTR, V5, P71, DOI 10.3945/an.113.004705; Ballinger A, 2002, EUR J PHARMACOL, V440, P109, DOI 10.1016/S0014-2999(02)01422-X; Benoit SC, 2004, RECENT PROG HORM RES, V59, P267, DOI 10.1210/rp.59.1.267; Chen SF, 2011, CAN J PHYSIOL PHARM, V89, P793, DOI 10.1139/Y11-077; Choi KM, 2014, J NUTR BIOCHEM, V25, P201, DOI 10.1016/j.jnutbio.2013.10.007; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Fernandez-Veledo S, 2013, IUBMB LIFE, V65, P572, DOI 10.1002/iub.1170; Giri S, 2006, NUTR METAB, V3, DOI 10.1186/1743-7075-3-31; Ha SK, 2011, J COMP PATHOL, V145, P88, DOI 10.1016/j.jcpa.2010.11.011; He Y, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/481580; Henriksen BS, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-29; Hwang JT, 2009, NEW BIOTECHNOL, V26, P17, DOI 10.1016/j.nbt.2009.03.005; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim WS, 2009, AM J PHYSIOL-ENDOC M, V296, pE812, DOI 10.1152/ajpendo.90710.2008; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Lafontan M, 2014, DIABETES METAB, V40, P16, DOI 10.1016/j.diabet.2013.08.002; Lee H, 2011, INT J MOL MED, V28, P65, DOI 10.3892/ijmm.2011.674; Lee YK, 2009, J AGR FOOD CHEM, V57, P305, DOI 10.1021/jf802737z; Lefterova MI, 2014, TRENDS ENDOCRIN MET, V25, P293, DOI 10.1016/j.tem.2014.04.001; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Matejkova O, 2004, FEBS LETT, V569, P245, DOI 10.1016/j.febslet.2004.06.002; Misra P, 2008, EXPERT OPIN THER TAR, V12, P91, DOI 10.1517/14728222.12.1.91; Poulsen SM, 2000, J MOL BIOL, V304, P471, DOI 10.1006/jmbi.2000.4229; Ragab SMM, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0087-1; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Scioli MG, 2014, INT J MOL SCI, V15, P6517, DOI 10.3390/ijms15046517; Shan TZ, 2013, FASEB J, V27, P277, DOI 10.1096/fj.12-211516; Vivarelli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150913	32	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158632	10.1371/journal.pone.0158632	http://dx.doi.org/10.1371/journal.pone.0158632			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398599	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508100005
J	Kunert, R; Willems, RM; Hagoort, P				Kunert, Richard; Willems, Roel M.; Hagoort, Peter			An Independent Psychometric Evaluation of the PROMS Measure of Music Perception Skills	PLOS ONE			English	Article							ABILITY	The Profile of Music Perception Skills (PROMS) is a recently developed measure of perceptual music skills which has been shown to have promising psychometric properties. In this paper we extend the evaluation of its brief version to three kinds of validity using an individual difference approach. The brief PROMS displays good discriminant validity with working memory, given that it does not correlate with backward digit span (r = .04). Moreover, it shows promising criterion validity (association with musical training (r = .45), musicianship status (r = .48), and self-rated musical talent (r = .51)). Finally, its convergent validity, i.e. relation to an unrelated measure of music perception skills, was assessed by correlating the brief PROMS to harmonic closure judgment accuracy. Two independent samples point to good convergent validity of the brief PROMS (r = .36; r = .40). The same association is still significant in one of the samples when including self-reported music skill in a partial correlation (r(partial) = .30; r(partial) = .17). Overall, the results show that the brief version of the PROMS displays a very good pattern of construct validity. Especially its tuning subtest stands out as a valuable part for music skill evaluations in Western samples. We conclude by briefly discussing the choice faced by music cognition researchers between different musical aptitude measures of which the brief PROMS is a well evaluated example.	[Kunert, Richard; Hagoort, Peter] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Kunert, Richard; Willems, Roel M.; Hagoort, Peter] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Willems, Roel M.] Radboud Univ Nijmegen, Ctr Language Studies, Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen; Radboud University Nijmegen	Kunert, R (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.; Kunert, R (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	RiKunert@gmail.com	Hagoort, Peter/B-7417-2012	Willems, Roel/0000-0002-4963-5387; Kunert, Richard/0000-0002-0203-2108	Dutch science organization; Max Planck Society	Dutch science organization; Max Planck Society(Max Planck Society)	This study was financially supported by a Dutch science organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek: www.nwo.nl/) Spinoza Prize awarded to PH and a PhD grant from the Max Planck Society (www.mpg.de) to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Brown S, 2013, PSYCHOL MUSIC, V41, P229, DOI 10.1177/0305735611425896; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Gingras B, 2015, PHILOS T R SOC B, V370, P76, DOI 10.1098/rstb.2014.0092; Gordon Edwin, 1989, ADV MEASURES MUSIC A; Groth-Marnat G, 2001, CA CH AD PS, P29; Hansen M, 2013, PSYCHOL MUSIC, V41, P779, DOI 10.1177/0305735612452186; Kunert R, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150685; Law LNC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052508; Macnamara BN, 2014, PSYCHOL SCI, V25, P1608, DOI 10.1177/0956797614535810; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; Pasinski AC, 2016, PSYCHON B REV, V23, P1553, DOI 10.3758/s13423-015-0998-x; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00030; Schaal NK, 2014, MUSIC SCI, V18, P423, DOI 10.1177/1029864914541851; Seashore C. E., 1960, MEASURES MUSICAL TAL; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Ullen F, 2014, PERS INDIV DIFFER, V63, P87, DOI 10.1016/j.paid.2014.01.057; Wallentin M, 2010, LEARN INDIVID DIFFER, V20, P188, DOI 10.1016/j.lindif.2010.02.004; Westen D, 2003, J PERS SOC PSYCHOL, V84, P608, DOI 10.1037/0022-3514.84.3.608	21	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159103	10.1371/journal.pone.0159103	http://dx.doi.org/10.1371/journal.pone.0159103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DQ9CN	27398805	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508100019
J	Barker, JC; Guerra, C; Gonzalez-Vargas, MJ; Hoeft, KS				Barker, Judith C.; Guerra, Claudia; Gonzalez-Vargas, M. Judy; Hoeft, Kristin S.			Acceptability of Salt Fluoridation in a Rural Latino Community in the United States: An Ethnographic Study	PLOS ONE			English	Article							ORAL-HEALTH; LOW-INCOME; WATER-USE; PREFERENCES; SERVICES; BELIEFS; MIGRANT; FOOD	Compared to other population groups in the United States, caries (tooth decay) is a disproportionately prevalent disease among Latino populations, especially among low-income and rural sub-groups and children under five years of age. Fluoride is a primary preventive for caries. While water fluoridation is a major and effective public health means for delivering fluoride on a mass scale, it does not reach many rural areas or population groups such as Latinos who eschew drinking water from municipal sources. This study examines the acceptability to such groups of salt fluoridation, an alternate means of delivering fluoride long used on a global scale. An ethnographic study in California's rural Central Valley was performed. Thirty individual interviews and 5 focus groups (N = 61) were conducted in Spanish to investigate low-income Latino migrant caregivers' experiences, views and understandings of domestic salt, oral health, caries prevention and fluoride. Audio data were transcribed, translated, coded and thematically analyzed. Table salt was readily available and frequently consumed. Both adult and child daily sodium consumption was high. Despite a general feeling that it was good, and present in dentifrices or dietary supplements, most participants had little knowledge about fluoride. Concerns were raised about cardio-vascular and other possibly deleterious effects if an increase in salt consumption occurred because fluoridated salt was viewed as having 'extra' benefits. Once informed about fluoride's safety and role in caries prevention, most participants expressed willingness to use fluoridated salt, especially if it benefitted children. Reassurance about its safety and benefits, and demonstration of its taste, were important aspects of acceptance. Taste was paramount. Participants would not consume more fluoridated salt than their current salt as that would result in unpleasant changes in food flavor and taste. While salt fluoridation is acceptable, the feasibility of producing and distributing fluoridated salt in the United States is, however, complex and challenging.	[Barker, Judith C.; Guerra, Claudia; Hoeft, Kristin S.] Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA; [Hoeft, Kristin S.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Hoeft, Kristin S.] Univ Calif San Francisco, Dept Prevent & Restorat Dent Sci, San Francisco, CA 94143 USA; [Guerra, Claudia] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Community Educ & Outreach Pasick Res Grp, San Francisco, CA 94143 USA; [Gonzalez-Vargas, M. Judy] Univ Calif San Francisco, Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Barker, Judith C.; Guerra, Claudia; Hoeft, Kristin S.] Univ Calif San Francisco, Ctr Address Childrens Oral Hlth Dispar, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barker, JC (corresponding author), Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA.; Barker, JC (corresponding author), Univ Calif San Francisco, Ctr Address Childrens Oral Hlth Dispar, San Francisco, CA 94143 USA.	Judith.Barker@ucsf.edu			National Institute of Dental and Craniofacial Research (NIDCR) [U54 DE019285]	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	All authors received funding from the National Institute of Dental and Craniofacial Research (NIDCR; www.nidcr.nih.gov) through grant number U54 DE019285. The authors also acknowledge assistance with publication costs from the University of California San Francisco (UCSF) Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADA, 2005, FLUOR FACTS; ADA Division of Communication, 2003, J Am Dent Assoc, V134, P1287; Adams SH, 2009, J PUBLIC HEALTH DENT, V69, P217, DOI 10.1111/j.1752-7325.2009.00125.x; Allen Lindsay, 2006, GUIDELINES FOOD FORT; American Academy of Pediatric Dentistry (AAPD), POL EARL CHILDH CAR; American Dental Association (ADA), 2015, ADA NEWS; [Anonymous], 2007, NAT I HLTH APPL RES; Banoczy J, 2009, MILK FLUORIDATION FOR THE PREVENTION OF DENTAL CARIES, P19; Barker JC., 2008, BMC ORAL HEALTH, V8, P8, DOI DOI 10.1186/1472-6831-8-8; Beltran-Aguilar Eugenio D., 2005, Morbidity and Mortality Weekly Report, V54, P1; Bernard R.H., 2005, RES METHODS ANTHR QU; Cagetti MG, 2013, ACTA ODONTOL SCAND, V71, P381, DOI 10.3109/00016357.2012.690447; Hernandez-Guerrero JC, 2008, J PUBLIC HEALTH DENT, V68, P242, DOI 10.1111/j.1752-7325.2008.00084.x; Casamassimo PS, 2009, J AM DENT ASSOC, V140, P650, DOI 10.14219/jada.archive.2009.0250; Centers for Disease Control and Prevention, 1999, MMWR, V48, P933; Centers for Disease Control and Prevention (CDC), 2012 COMM WAT FLUOR; Charmaz K., 2003, STRATEGIES QUALITATI, V2nd ed., P249; Cortes DE, 2013, AM J PREV MED, V44, pS267, DOI 10.1016/j.amepre.2012.11.012; Espelid I, 2009, EUR ARCH PAEDIATR DE, V10, P149, DOI 10.1007/BF03262676; Estupinan-Day S, 2005, SCI PUBLICATION, V615; Finlayson Tracy L, 2014, J Dent Oral Craniofac Epidemiol, V2, P15; Finlayson TL, 2010, J PUBLIC HEALTH DENT, V70, P292, DOI 10.1111/j.1752-7325.2010.00184.x; Flores G, 2008, PEDIATRICS, V121, pE286, DOI 10.1542/peds.2007-1243; Food US and Drug Administration, 2010, CONS UPD LOW SALT YO; Food US and Drug Administration (FDA), 2010, BOTTL WAT EV KEEP IT; Gooch B, 2015, PUBLIC HEALTH REP, V130, P318, DOI 10.1177/003335491513000408; Hansen E, 2003, J HEALTH CARE POOR U, V14, P153, DOI 10.1177/1049208903014002001; Henney JE, 2010, STRATEGIES TO REDUCE SODIUM INTAKE IN THE UNITED STATES, P1; Hobson WL, 2007, ARCH PEDIAT ADOL MED, V161, P457, DOI 10.1001/archpedi.161.5.457; Hoeft KS, 2015, APPETITE, V87, P1, DOI 10.1016/j.appet.2014.11.031; Holmes Seth, 2013, FRESH FRUIT BROKEN B; Horton S, 2009, COMMUNITY DENT HLTH, V26, P216, DOI 10.1922/CDH_2320Horton06; Horton S, 2008, J PUBLIC HEALTH DENT, V68, P22, DOI 10.1111/j.1752-7325.2007.00078.x; Horton SB, 2010, ANN ANTHROPL PRACT, V34, P68, DOI 10.1111/j.1556-4797.2010.01052.x; International Food Information Council Foundation, 2014, FOOS INS IS FOOD FOR; International Food Information Council Foundation, 2014, FOOD INS FOOD PORT T; Isong IA, 2012, PEDIATRICS, V130, P306, DOI 10.1542/peds.2011-0838; Koreishi S, 2012, PUBLIC HLTH SOCIAL J, P85; Leung AM, 2012, NUTRIENTS, V4, P1740, DOI 10.3390/nu4111740; del Valle LML, 2005, J DENT CHILD, V72, P61; Lukes S, 2006, DENT SERVICES MIGRAN, V22; Mapes LV, 2000, SEATTLE TIMES; Marin G, 1991, RES HISPANIC POPULAT; Marino R, 2012, COMMUNITY DENT HLTH, V29, P302, DOI 10.1922/CDH_2893Marino07; Marthaler Thomas M, 2005, Schweiz Monatsschr Zahnmed, V115, P785; Marthaler TM, 2005, INT DENT J, V55, P351; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Milgrom P, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-38; MOBED K, 1992, WESTERN J MED, V157, P367; Morgan DL, 1999, FOCUS GROUPS QUALITA; Moss M, 2013, SUGAR SALT FAT; National Center for Chronic Disease Prevention and Health Promotion, 2009, COMM WAT FLUOR OTH F; National Center for Chronic Disease Prevention and Health Promotion, 2009, NAT OR HLTH SURV SYS; National Center for Farmworker Health, 2013, FARMW OCC HLTH SAF; Pan American Health Organization, 1986, SCI PUBLICATION, V501; Penn State Extension, 2012, FOOD HLTH HOM FOOD P; Penn State Extension, FOOD HLTH HOM FOOD P; Peretz Benjamin, 2003, Pediatr Dent, V25, P114; Perez-Escamilla R, 2009, J AM DIET ASSOC, V109, P988, DOI 10.1016/j.jada.2009.03.014; Pollick HF, 2013, J CALIF DENT ASSOC, P400; Pollick HF, 2013, J CALIF DENT ASSOC, V41, P471; Pollick Howard F, 2013, J Calif Dent Assoc, V41, P395; Quandt S, 2007, J IMMIG MIN HLTH, V9; Sampaio FC, 2011, MONOGR ORAL SCI, V22, P133, DOI 10.1159/000325161; Scherzer T, 2011, J PUBLIC HEALTH DENT, V71, P79, DOI 10.1111/j.1752-7325.2011.00242.x; Scherzer T, 2010, J PUBLIC HEALTH DENT, V70, P337, DOI 10.1111/j.1752-7325.2010.00193.x; Semba RD, 2012, J NUTR, V142, p143S, DOI 10.3945/jn.110.137745; Sriraman NK, 2009, PEDIATR DENT, V31, P310; Stewart DCL, 2002, J PUBLIC HEALTH DENT, V62, P84, DOI 10.1111/j.1752-7325.2002.tb03427.x; Stoecklin-Marois MT, 2011, J AGRIC SAF HEALTH, V17, P291, DOI 10.13031/2013.39803; Strauss A., 1990, BASICS QUALITATIVE R; Surgeon General. U.S. Department of Health and Human Services. National Institute of Dental and Craniofacial Research (U.S.), 2000, OR HLTH AM REP SURG; Swan MA, 2010, PEDIATR DENT, V32, P400; Telleen S, 2012, J PUBLIC HEALTH DENT, V72, P8, DOI 10.1111/j.1752-7325.2011.00275.x; The Hispanic Institute (THI), 2013, OB HISP AM BIGG CHAL; US Census Bureau data, POV THRESH POV THRES; Vallejos-Sanchez AA, 2006, ACTA ODONTOL SCAND, V64, P209, DOI 10.1080/00016350600555537; VanDerslice J, 2011, AM J PUBLIC HEALTH, V101, pS109, DOI 10.2105/AJPH.2011.300189; Villarejo D, 2003, ANNU REV PUBL HEALTH, V24, P175, DOI 10.1146/annurev.publhealth.24.100901.140901; Weintraub JA, 2013, J PUBLIC HEALTH DENT, V73, P311, DOI 10.1111/jphd.12029; Weissman AM, 1997, AM J PUBLIC HEALTH, V87, P1379, DOI 10.2105/AJPH.87.8.1379-a; Wespi HJ, 1986, SCI PUBLICATION, V501; Williams BL, 2001, J EXPO ANAL ENV EPID, V11, P510, DOI 10.1038/sj.jea.7500192; Yengopal V, 2010, SADJ, V65, P60; Yeung C Albert, 2011, Evid Based Dent, V12, P17, DOI 10.1038/sj.ebd.6400776; Yeung C Albert, 2008, Evid Based Dent, V9, P39, DOI 10.1038/sj.ebd.6400578	86	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158540	10.1371/journal.pone.0158540	http://dx.doi.org/10.1371/journal.pone.0158540			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391112	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400079
J	Hidalgo, J; Latorre, P; Carrodeguas, JA; Velazquez-Campoy, A; Sancho, J; Lopez-Buesa, P				Hidalgo, Jorge; Latorre, Pedro; Alberto Carrodeguas, Jose; Velazquez-Campoy, Adrian; Sancho, Javier; Lopez-Buesa, Pascual			Inhibition of Pig Phosphoenolpyruvate Carboxykinase Isoenzymes by 3-Mercaptopicolinic Acid and Novel Inhibitors	PLOS ONE			English	Article							DIABETES-MELLITUS; GTP; GLUCONEOGENESIS; PCK1	There exist two isoforms of cytosolic phosphoenolpyruvate carboxykinase (PEPCK-C) in pig populations that differ in a single amino acid (Met139Leu). The isoenzymes have different kinetic properties, affecting more strongly the K-m and V-max of nucleotides. They are associated to different phenotypes modifying traits of considerable economic interest. In this work we use inhibitors of phosphoenolpyruvate carboxykinase activity to search for further differences between these isoenzymes. On the one hand we have used the well-known inhibitor 3-mercaptopicolinic acid. Its inhibition patterns were the same for both isoenzymes: a three-fold decrease of the K-i values for GTP in 139Met and 139Leu (273 and 873 mu M, respectively). On the other hand, through screening of a chemical library we have found two novel compounds with inhibitory effects of a similar magnitude to that of 3-mercaptopicolinic acid but with less solubility and specificity. One of these novel compounds, (N'1-({5-[1-methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl]-2-thienyl}methylidene)-2,4-dichlorobenzene-1-carbohydrazide), exhibited significantly different inhibitory effects on either isoenzyme: it enhanced threefold the apparent K-m value for GTP in 139Met, whereas in 139Leu, it reduced it from 99 to 69 mu M. The finding of those significant differences in the binding of GTP reinforces the hypothesis that the Met139Leu substitution affects strongly the nucleotide binding site of PEPCK-C.	[Hidalgo, Jorge; Latorre, Pedro; Lopez-Buesa, Pascual] Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain; [Hidalgo, Jorge; Latorre, Pedro; Alberto Carrodeguas, Jose; Velazquez-Campoy, Adrian; Sancho, Javier; Lopez-Buesa, Pascual] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, BIFI IQFR CSIC Joint Unit, Zaragoza, Spain; [Alberto Carrodeguas, Jose; Velazquez-Campoy, Adrian; Sancho, Javier] Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol, Zaragoza, Spain; [Alberto Carrodeguas, Jose; Velazquez-Campoy, Adrian; Sancho, Javier] Univ Zaragoza, Fac Ciencias, Celular, Zaragoza, Spain; [Alberto Carrodeguas, Jose; Velazquez-Campoy, Adrian; Sancho, Javier] IIS Aragon, Zaragoza, Spain; [Velazquez-Campoy, Adrian] Govt Aragon, Fdn ARAID, Zaragoza, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; University of Zaragoza; University of Zaragoza	Lopez-Buesa, P (corresponding author), Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain.; Lopez-Buesa, P (corresponding author), Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, BIFI IQFR CSIC Joint Unit, Zaragoza, Spain.	plopezbu@unizar.es	Román, Pedro Ángel Latorre/K-1052-2019; Velazquez-Campoy, Adrian/E-7946-2012; Sancho, javier/AAA-1225-2019	Velazquez-Campoy, Adrian/0000-0001-5702-4538; Sancho, javier/0000-0002-2879-9200; Latorre Muro, Pedro/0000-0002-6794-3535; Hidalgo, Jorge/0000-0002-6041-0963	Fundacion La Caixa;  [AGL2008-01487ALI];  [DGA-IAF FITE2012/2013];  [UZ2014-CIE-03];  [AGL2015-66177];  [BFU2013-47064-P];  [BIO2014-57314-REDT];  [PI078/08]	Fundacion La Caixa(La Caixa Foundation); ; ; ; ; ; ; 	This study was supported by research grants AGL2008-01487ALI (www.mineco.gob.es), DGA-IAF FITE2012/2013 (www.aragob.es), and UZ2014-CIE-03 (www.unizar.es) to P.L.B., AGL2015-66177 to P.L.B. and J.A.C., and grants BFU2013-47064-P (www.micinn.es), BIO2014-57314-REDT (www.mineco.gob.es) and PI078/08 to J.S. P.L. was supported by a predoctoral fellowship of Fundacion La Caixa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balan MD, 2015, BIOCHEMISTRY-US, V54, P5878, DOI 10.1021/acs.biochem.5b00822; Beale EG, 2007, CELL BIOCHEM BIOPHYS, V48, P89, DOI 10.1007/s12013-007-0025-6; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Case CL, 2007, BBA-GEN SUBJECTS, V1770, P1576, DOI 10.1016/j.bbagen.2007.07.012; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Cremades N, 2009, ACS CHEM BIOL, V4, P928, DOI 10.1021/cb900166q; Foley LH, 2003, BIOORG MED CHEM LETT, V13, P3607, DOI 10.1016/S0960-894X(03)00722-4; Hakimi P, 2007, J BIOL CHEM, V282, P32844, DOI 10.1074/jbc.M706127200; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; LAGUNAS R, 1983, EUR J BIOCHEM, V137, P479, DOI 10.1111/j.1432-1033.1983.tb07851.x; Latorre P, 2016, SCI REP-UK, V6, DOI 10.1038/srep19617; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Lyne PD, 2002, DRUG DISCOV TODAY, V7, P1047, DOI 10.1016/S1359-6446(02)02483-2; Pey AL, 2008, J CLIN INVEST, V118, P2858, DOI 10.1172/JCI34355; ROBINSON BH, 1975, FEBS LETT, V58, P12, DOI 10.1016/0014-5793(75)80214-6; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Stiffin RM, 2008, BIOCHEMISTRY-US, V47, P2099, DOI 10.1021/bi7020662; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; VUILLEUMIER S, 1993, BIOCHEMISTRY-US, V32, P10303, DOI 10.1021/bi00090a005; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yang JQ, 2009, J BIOL CHEM, V284, P27031, DOI 10.1074/jbc.R109.040535; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Zhang P, 2014, P NATL ACAD SCI USA, V111, P10684, DOI 10.1073/pnas.1411026111	25	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159002	10.1371/journal.pone.0159002	http://dx.doi.org/10.1371/journal.pone.0159002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391465	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400187
J	Huang, Q; Wei, HF; Wu, ZP; Li, L; Yao, LF; Sun, ZW; Li, L; Lin, ZJ; Xu, W; Han, S; Cao, WJ; Xu, YF; Song, DW; Yang, XH; Xiao, JR				Huang, Quan; Wei, Haifeng; Wu, Zhipeng; Li, Lin; Yao, Liangfang; Sun, Zhengwang; Li, Lei; Lin, Zaijun; Xu, Wei; Han, Shuai; Cao, Wenjiao; Xu, Yunfei; Song, Dianwen; Yang, Xinghai; Xiao, Jianru			Preferentially Expressed Antigen of Melanoma Prevents Lung Cancer Metastasis	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; E-CADHERIN; PRAME EXPRESSION; TUMOR-GROWTH; INHIBITION; MIGRATION; INVASION; MODEL	Lung cancer is the most common cause of cancer death worldwide. The poor survival rate is largely due to the extensive local invasion and metastasis. However, the mechanisms underlying the invasion and metastasis of lung cancer cells remain largely elusive. In this study, we examined the role of preferentially expressed antigen of melanoma (PRAME) in lung cancer metastasis. Our results show that PRAME is downregulated in lung adenocarcinoma and lung bone metastasis compared with normal human lung. Knockdown of PRAME decreases the expression of E-Cadherin and promotes the proliferation, invasion, and metastasis of lung cancer cells by regulating multiple critical genes, most of which are related to cell migration, including MMP1, CCL2, CTGF, and PLAU. Clinical data analysis reveals that the expression of MMP1 correlates with the clinical features and outcome of lung adenocarcinoma. Taken together, our data demonstrate that PRAME plays a role in preventing the invasion and metastasis of lung adenocarcinoma and novel diagnostic or therapeutic strategies can be developed by targeting PRAME.	[Huang, Quan; Yao, Liangfang; Li, Lei] East China Normal Univ, Sch Life Sci, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, 500 Dongchuan Rd, Shanghai 200241, Peoples R China; [Huang, Quan; Wei, Haifeng; Wu, Zhipeng; Li, Lin; Sun, Zhengwang; Li, Lei; Lin, Zaijun; Xu, Wei; Han, Shuai; Song, Dianwen; Yang, Xinghai; Xiao, Jianru] Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Oncol, 415 Fengyang Rd, Shanghai 200003, Peoples R China; [Cao, Wenjiao] China Welf Inst IPMCH, Int Peace Matern & Child Hlth Hosp, Shanghai, Peoples R China; [Xu, Yunfei] Tongji Univ, Peoples Hosp 10, Dept Urol, Shanghai, Peoples R China	East China Normal University; Naval Medical University; Tongji University	Wei, HF; Song, DW; Yang, XH; Xiao, JR (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Orthoped Oncol, 415 Fengyang Rd, Shanghai 200003, Peoples R China.; Xu, YF (corresponding author), Tongji Univ, Peoples Hosp 10, Dept Urol, Shanghai, Peoples R China.	weihaifeng_sh@sina.com; yunfei_sh@sina.com; dianwen_sh@sina.com; xinghai_cz@sohu.com; xiaojianru_sh@163.com	Xiao, Jian/GYU-4351-2022					Aikawa T, 2006, MOL CANCER THER, V5, P1108, DOI 10.1158/1535-7163.MCT-05-0516; Bankovic J, 2010, LUNG CANCER, V67, P151, DOI 10.1016/j.lungcan.2009.04.010; Banyard J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-387; Bonapace L, 2014, NATURE, V515, DOI 10.1038/nature13862; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Epping MT, 2008, BRIT J CANCER, V99, P398, DOI 10.1038/sj.bjc.6604494; Finger EC, 2014, ONCOGENE, V33, P1093, DOI 10.1038/onc.2013.47; Ikeda H, 1997, IMMUNITY, V6, P199, DOI 10.1016/S1074-7613(00)80426-4; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Lin TS, 2004, ONCOL REP, V12, P717; Liu H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-583; Liu KC, 2011, ONCOL REP, V26, P177, DOI 10.3892/or.2011.1264; Liu YN, 2005, ONCOGENE, V24, P8277, DOI 10.1038/sj.onc.1208991; McDowall MD, 2009, NUCLEIC ACIDS RES, V37, pD651, DOI 10.1093/nar/gkn870; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Rosol TJ, 2003, CANCER-AM CANCER SOC, V97, P748, DOI 10.1002/cncr.11150; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Simmons J. K., 2014, Veterinary Sciences, V1, P16; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sunami E, 2000, Oncologist, V5, P108, DOI 10.1634/theoncologist.5-2-108; Szczepanski MJ, 2013, BIOMARK MED, V7, P575, DOI 10.2217/bmm.13.68; Tan PX, 2012, BIOCHEM BIOPH RES CO, V419, P801, DOI 10.1016/j.bbrc.2012.02.110; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wenger C, 1999, ONCOGENE, V18, P1073, DOI 10.1038/sj.onc.1202395; Xie D, 2001, CANCER RES, V61, P8917	34	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0149640	10.1371/journal.pone.0149640	http://dx.doi.org/10.1371/journal.pone.0149640			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391090	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400001
J	Swetnam, TL; O'Connor, CD; Lynch, AM				Swetnam, Tyson L.; O'Connor, Christopher D.; Lynch, Ann M.			Tree Morphologic Plasticity Explains Deviation from Metabolic Scaling Theory in Semi-Arid Conifer Forests, Southwestern USA	PLOS ONE			English	Article							SANTA-CATALINA MOUNTAINS; SIZE DISTRIBUTIONS; ALLOMETRIC EQUATIONS; PINALENO MOUNTAINS; CARBON STOCKS; MODEL; TEMPERATURE; COMPETITION; MORTALITY; ARIZONA	A significant concern about Metabolic Scaling Theory (MST) in real forests relates to consistent differences between the values of power law scaling exponents of tree primary size measures used to estimate mass and those predicted by MST. Here we consider why observed scaling exponents for diameter and height relationships deviate from MST predictions across three semi-arid conifer forests in relation to: (1) tree condition and physical form, (2) the level of inter-tree competition (e.g. open vs closed stand structure), (3) increasing tree age, and (4) differences in site productivity. Scaling exponent values derived from non-linear least-squares regression for trees in excellent condition (n = 381) were above the MST prediction at the 95% confidence level, while the exponent for trees in good condition were no different than MST (n = 926). Trees that were in fair or poor condition, characterized as diseased, leaning, or sparsely crowned had exponent values below MST predictions (n = 2,058), as did recently dead standing trees (n = 375). Exponent value of the mean-tree model that disregarded tree condition (n = 3,740) was consistent with other studies that reject MST scaling. Ostensibly, as stand density and competition increase trees exhibited greater morphological plasticity whereby the majority had characteristically fair or poor growth forms. Fitting by least-squares regression biases the mean-tree model scaling exponent toward values that are below MST idealized predictions. For 368 trees from Arizona with known establishment dates, increasing age had no significant impact on expected scaling. We further suggest height to diameter ratios below MST relate to vertical truncation caused by limitation in plant water availability. Even with environmentally imposed height limitation, proportionality between height and diameter scaling exponents were consistent with the predictions of MST.	[Swetnam, Tyson L.] Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA; [O'Connor, Christopher D.; Lynch, Ann M.] US Forest Serv, Rocky Mt Res Stn, Missoula, MT USA; [Lynch, Ann M.] Univ Arizona, Tree Ring Res Lab, Tucson, AZ 85721 USA	University of Arizona; United States Department of Agriculture (USDA); United States Forest Service; University of Arizona	Swetnam, TL (corresponding author), Univ Arizona, Sch Nat Resources & Environm, Tucson, AZ USA.	tswetnam@email.arizona.edu	Swetnam, Tyson/Q-4216-2018	Swetnam, Tyson/0000-0002-6639-7181	USFS Region 3 Office; Coronado National Forest; Rocky Mountain Research Station, U.S. Forest Service through Research Joint Venture Agreement [07-JV-11221615-317]; University of Arizona; Nature Conservancy; Critical Zone Observatory (NSF Award) [0724958]; USDA Forest Service, Rocky Mountain Research Station [07-JV-11221615-317]; U.S. Forest Service; United States National Park Service, Valles Caldera National Preserve	USFS Region 3 Office; Coronado National Forest; Rocky Mountain Research Station, U.S. Forest Service through Research Joint Venture Agreement; University of Arizona; Nature Conservancy; Critical Zone Observatory (NSF Award); USDA Forest Service, Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); United States National Park Service, Valles Caldera National Preserve	The Santa Catalina field work and TL Swetnam were funded by the USFS Region 3 Office and the Coronado National Forest. The Pinaleno Demography Project, AM Lynch, and CD O'Connor were funded by the Rocky Mountain Research Station, U.S. Forest Service through Research Joint Venture Agreement 07-JV-11221615-317, the Coronado National Forest, University of Arizona, and the Nature Conservancy. The Valles Caldera field work and TL Swetnam were funded by the Critical Zone Observatory (NSF Award #0724958).; The research, analysis and other work documented in this publication was partially funded by the USDA Forest Service, Rocky Mountain Research Station, through Agreement # 07-JV-11221615-317 in cooperation with the U.S. Forest Service, Coronado National Forest, and the United States National Park Service, Valles Caldera National Preserve; however the findings, conclusions, and views expressed are those of the authors and do not necessarily represent the views of the U.S. Forest Service or National Park Service. Additional funding and support was provided by the USFS Region 3 Office, the Coronado National Forest, and the Critical Zone Observatory (NSF Award #0724958). Pinaleno lidar data were analyzed by the USFS Remote Sensing and Application Center (RSAC): Tom Mellin, Denise Laes, and Brent Mitchell. Pinaleno plot data were collected by USFS Personnel: Craig Wilcox, and Matt Littrell; University of Arizona personnel: Don Falk, Jesse Minor, Rebecca Minor, Laura Marshall, Alex Arizpe, Josh Farella, Jacquie Dewar, Ben Schippers, Anastasia Rabin, Kyle Miller, Alicia Durnin and Andrew McIntyre. Valles Caldera plot data were collected by Scott Compton of the Valles Caldera Preserve; Jon Pelletier, Shirley Papuga, Joshua Conver, and Kristine Nelson of the University of Arizona CZO. The Santa Catalina plot data were collected by Alicia Durnham, Anastasia Rabin, Benjamin Schippers, Jacquie Dewar, Jesse Minor, Joshua Conver, Kyle Miller, and Shane Cook.	[Anonymous], 2013, MATLAB R2013A; APPLEQUIST M. B., 1958, JOUR FOREST, V56, P141; Bentley LP, 2013, ECOL LETT, V16, P1069, DOI 10.1111/ele.12127; Brohman R, 2014, WO67 USDA FOR SERV E; Brown PM, 2008, INT J WILDLAND FIRE, V17, P28, DOI 10.1071/WF07023; Brown PM, 2008, ECOL APPL, V18, P1984, DOI 10.1890/07-1337.1; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chojnacky DC, 2014, FORESTRY, V87, P129, DOI 10.1093/forestry/cpt053; Clarke A, 2006, FUNCT ECOL, V20, P405, DOI 10.1111/j.1365-2435.2006.01109.x; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Coomes DA, 2007, J ECOL, V95, P1084, DOI 10.1111/j.1365-2745.2007.01280.x; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2011, J ECOL, V99, P748, DOI 10.1111/j.1365-2745.2011.01811.x; Coomes DA, 2009, J ECOL, V97, P1369, DOI 10.1111/j.1365-2745.2009.01571.x; Duncanson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep17153; Duncanson LI, 2015, GLOBAL ECOL BIOGEOGR, V24, P1465, DOI 10.1111/geb.12371; Duursma RA, 2003, FOREST ECOL MANAG, V186, P373, DOI 10.1016/S0378-1127(03)00307-4; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Ernest SKM, 2003, ECOL LETT, V6, P990, DOI 10.1046/j.1461-0248.2003.00526.x; ESRI, 2011, ARCGIS DESKT REL 10; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Grissino-Mayer, 2001, TREE-RING RES, V57, P205, DOI DOI 10.1016/J.DENDRO.2010.12.002; GrissinoMayer HD, 1995, USDA ROCKY, V264, P399; Heyerdahl EK, 2011, GTRRMRS261 USDA FOR; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Jenkins J. C., 2004, NE319 USDA FOR SERV, DOI [10.2737/NE-GTR-319, DOI 10.2737/NE-GTR-319]; Jenkins JC, 2003, FOREST SCI, V49, P12; Kempes CP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020551; Kerkhoff AJ, 2007, BIOSCIENCE, V57, P489, DOI 10.1641/B570606; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; Lines ER, 2012, GLOBAL ECOL BIOGEOGR, V21, P1017, DOI 10.1111/j.1466-8238.2011.00746.x; Liu FJ, 2008, ECOHYDROLOGY, V1, P239, DOI 10.1002/eco.22; Lutz JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036131; Mascaro J, 2011, REMOTE SENS ENVIRON, V115, P3770, DOI 10.1016/j.rse.2011.07.019; McDowell N, 2002, OECOLOGIA, V132, P12, DOI 10.1007/s00442-002-0904-x; McDowell NG, 2015, NAT CLIM CHANGE, V5, P669, DOI [10.1038/nclimate2641, 10.1038/NCLIMATE2641]; McDowell NG, 2002, TREE PHYSIOL, V22, P763, DOI 10.1093/treephys/22.11.763; Miles PD, 2009, NRS38, V38, P39; Muldavin E, 2006, VEGETATION MAP VALLE; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; Navar J, 2009, FOREST ECOL MANAG, V257, P427, DOI 10.1016/j.foreco.2008.09.028; Navar-Chaidez J. de J., 2010, Tropical and Subtropical Agroecosystems, V12, P507; NIERING WA, 1984, VEGETATIO, V58, P3; O'Connor C.D., ECOLOGICAL IN PRESS; O'Connor CD, 2015, FOREST ECOL MANAG, V336, P148, DOI 10.1016/j.foreco.2014.10.021; O'Connor CD, 2014, FOREST ECOL MANAG, V329, P264, DOI 10.1016/j.foreco.2014.06.032; Pelletier JD, 2013, J GEOPHYS RES-EARTH, V118, P741, DOI 10.1002/jgrf.20046; Price CA, 2007, ECOLOGY, V88, P1132, DOI 10.1890/06-1158; Price CA, 2007, P NATL ACAD SCI USA, V104, P13204, DOI 10.1073/pnas.0702242104; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Purves DW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000870; Rasmussen C, 2012, HYDROL EARTH SYST SC, V16, P725, DOI 10.5194/hess-16-725-2012; Rasmussen C, 2015, VADOSE ZONE J, V14, DOI 10.2136/vzj2014.07.0102; Rasmussen C, 2011, BIOGEOCHEMISTRY, V102, P15, DOI 10.1007/s10533-010-9476-8; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Savage VM, 2010, P NATL ACAD SCI USA, V107, P22722, DOI 10.1073/pnas.1012194108; Savage VM, 2004, AM NAT, V163, P429, DOI 10.1086/381872; Shea K, 2004, ECOL LETT, V7, P491, DOI 10.1111/j.1461-0248.2004.00600.x; Shinozaki K, 1964, JPN J ECOL, V14, P97, DOI DOI 10.18960/SEITAI.14.3_97; Shinozaki K, 1964, JAPANESE J ECOL, V14, P133, DOI DOI 10.18960/SEITAI.14.4_133; Shreve, 1915, VEGETATION DESERT MO; Sillett SC, 2010, FOREST ECOL MANAG, V259, P976, DOI 10.1016/j.foreco.2009.12.003; Smith DD, 2014, NEW PHYTOL, V201, P217, DOI 10.1111/nph.12487; Smith T. M., 1993, P272; Speer JH, 2010, FUNDAMENTALS TREE RI; Sperry JS, 2012, FUNCT ECOL, V26, P1054, DOI 10.1111/j.1365-2435.2012.02022.x; Stephenson NL, 2014, NATURE, V507, P90, DOI 10.1038/nature12914; Stokes M.A., 1968, INTRO TREE RING DATI; Suding KN, 2001, ECOLOGY, V82, P2133, DOI 10.2307/2680221; Swetnam TL, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00384.1; Swetnam T. L., 2013, THESIS; Swetnam TL, 2014, FOREST ECOL MANAG, V330, P271, DOI 10.1016/j.foreco.2014.07.011; Swetnam TL, 2014, FOREST ECOL MANAG, V323, P158, DOI 10.1016/j.foreco.2014.03.016; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106; WHITTAKER RH, 1975, ECOLOGY, V56, P771, DOI 10.2307/1936291; YAMAGUCHI DK, 1991, CAN J FOREST RES, V21, P414, DOI 10.1139/x91-053	79	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157582	10.1371/journal.pone.0157582	http://dx.doi.org/10.1371/journal.pone.0157582			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391084	gold, Green Submitted, Green Published			2022-12-26	WOS:000380005400014
J	Triplett, LR; Shidore, T; Long, J; Miao, JM; Wu, SC; Han, Q; Zhou, CH; Ishihara, H; Li, JY; Zhao, BY; Leach, JE				Triplett, Lindsay R.; Shidore, Teja; Long, John; Miao, Jiamin; Wu, Shuchi; Han, Qian; Zhou, Changhe; Ishihara, Hiromichi; Li, Jianyong; Zhao, Bingyu; Leach, Jan E.			AvrRxo1 Is a Bifunctional Type III Secreted Effector and Toxin-Antitoxin System Component with Homologs in Diverse Environmental Contexts	PLOS ONE			English	Article							RESISTANCE; BACTERIA; REVEALS; GENE; DIVERGENCE; SEQUENCE; MAIZE	Toxin-antitoxin (TA) systems are ubiquitous bacterial systems that may function in genome maintenance and metabolic stress management, but are also thought to play a role in virulence by helping pathogens survive stress. We previously demonstrated that the Xanthomonas oryzae pv. oryzicola protein AvrRxo1 is a type III-secreted virulence factor that has structural similarities to the zeta family of TA toxins, and is toxic to plants and bacteria in the absence of its predicted chaperone Arc1. In this work, we confirm that AvrRxo1 and its binding partner Arc1 function as a TA system when expressed in Escherichia coli. Sequences of avrRxo1 homologs were culled from published and newly generated phytopathogen genomes, revealing that avrRxo1:arc1 modules are rare or frequently inactivated in some species and highly conserved in others. Cloning and functional analysis of avrRxo1 from Acidovorax avenae, A. citrulli, Burkholderia andropogonis, Xanthomonas translucens, and Xanthomonas euvesicatoria showed that some AvrRxo1 homologs share the bacteriostatic and Rxo1-mediated cell death triggering activities of AvrRxo1 from X. oryzae. Additional distant putative homologs of avrRxo1 and arc1 were identified in genomic or metagenomic sequence of environmental bacteria with no known pathogenic role. One of these distant homologs was cloned from the filamentous soil bacterium Cystobacter fuscus. avrRxo1 from C. fuscus caused watersoaking and triggered Rxo1-dependent cell collapse in Nicotiana benthamiana, but no growth suppression in E. coli was observed. This work confirms that a type III effector can function as a TA system toxin, and illustrates the potential of microbiome data to reveal new environmental origins or reservoirs of pathogen virulence factors.	[Triplett, Lindsay R.; Shidore, Teja] Connecticut Agr Expt Stn, Dept Plant Pathol & Ecol, New Haven, CT 06504 USA; [Long, John; Ishihara, Hiromichi; Leach, Jan E.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Long, John; Ishihara, Hiromichi; Leach, Jan E.] Colorado State Univ, Program Plant Mol Biol, Ft Collins, CO 80523 USA; [Miao, Jiamin; Wu, Shuchi; Zhou, Changhe; Zhao, Bingyu] Virginia Polytech Inst & State Univ, Dept Hort, Blacksburg, VA 24061 USA; [Han, Qian; Li, Jianyong] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA; [Han, Qian] Hainan Univ, Lab Trop Vet Med & Vector Biol, Coll Agr, Haikou 570228, Hainan, Peoples R China	Connecticut Agricultural Experiment Station; Colorado State University; Colorado State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Hainan University	Triplett, LR (corresponding author), Connecticut Agr Expt Stn, Dept Plant Pathol & Ecol, New Haven, CT 06504 USA.	lindsay.triplett@ct.gov	Han, Qian/J-8696-2014; LI, JIAN/GRY-2197-2022; li, jian/GSE-0245-2022; Han, Qian/AAS-2134-2020	Han, Qian/0000-0001-6245-5252; Wu, Shuchi/0000-0001-9578-4626	Agriculture and Food Research Initiative Competitive grant of the USDA National Institute of Food and Agriculture [2014-67013-21564]; National Science Foundation [IOS-0845283]	Agriculture and Food Research Initiative Competitive grant of the USDA National Institute of Food and Agriculture; National Science Foundation(National Science Foundation (NSF))	This project was supported by the Agriculture and Food Research Initiative Competitive grant no. 2014-67013-21564 of the USDA National Institute of Food and Agriculture (nifa.usda.gov) to LRT and JEL and National Science Foundation (nsf.gov) grant no. IOS-0845283 to BZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by the Agriculture and Food Research Initiative Competitive Grant no. 2014-67013-21564 of the USDA National Institute of Food and Agriculture to L.R.T., and J.E.L. and National Science Foundation grant no. IOS-0845283 to B.Z.	Arbing MA, 2010, STRUCTURE, V18, P996, DOI 10.1016/j.str.2010.04.018; Audoly G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026528; Brown BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000706; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; de Lange O, 2015, NUCLEIC ACIDS RES, V43, P10065, DOI 10.1093/nar/gkv1053; Eckshtain-Levi N, 2014, PHYTOPATHOLOGY, V104, P1152, DOI 10.1094/PHYTO-12-13-0350-R; Han Q, 2015, STRUCTURE, V23, P1900, DOI 10.1016/j.str.2015.06.030; He XS, 2015, P NATL ACAD SCI USA, V112, P244, DOI 10.1073/pnas.1419038112; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Liu HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113875; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; McCann HC, 2008, NEW PHYTOL, V177, P33, DOI 10.1111/j.1469-8137.2007.02293.x; Mutschler H, 2011, J MOL MED, V89, P1183, DOI 10.1007/s00109-011-0797-4; Mutschler H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001033; Nelson WC, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00713; Norton JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002954; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; REIMERS PJ, 1991, PHYSIOL MOL PLANT P, V38, P39, DOI 10.1016/S0885-5765(05)80141-9; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Sberro H, 2013, MOL CELL, V50, P136, DOI 10.1016/j.molcel.2013.02.002; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Singletary LA, 2009, J BACTERIOL, V191, P7456, DOI 10.1128/JB.00963-09; Sletvold H, 2008, PLASMID, V60, P75, DOI 10.1016/j.plasmid.2008.04.002; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Triplett LR, 2011, APPL ENVIRON MICROB, V77, P3930, DOI 10.1128/AEM.00028-11; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Wilson K., 2001, CURR PROTOC MOL BIOL, V71, P27, DOI [10.1002/0471142727.mb0204s56, DOI 10.1002/0471142727.MB0204S56]; Wonni I, 2014, PHYTOPATHOLOGY, V104, P520, DOI 10.1094/PHYTO-07-13-0213-R; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhao BY, 2004, MOL PLANT MICROBE IN, V17, P771, DOI 10.1094/MPMI.2004.17.7.771; Zielenkiewicz U, 2005, J BACTERIOL, V187, P6094, DOI 10.1128/JB.187.17.6094-6105.2005	37	27	27	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158856	10.1371/journal.pone.0158856	http://dx.doi.org/10.1371/journal.pone.0158856			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391081	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400144
J	Wang, JJ; Lv, Y; Zhang, Y; Zheng, DX; Zhao, YL; Castellan, D; Liu, HL; Wang, ZL				Wang, Jingjing; Lv, Yan; Zhang, Yi; Zheng, Dongxia; Zhao, Yunling; Castellan, David; Liu, Hualei; Wang, Zhiliang			Genomic Characterizations of a Newcastle Disease Virus Isolated from Ducks in Live Bird Markets in China	PLOS ONE			English	Article							NORTHEASTERN UNITED-STATES; AVIAN INFLUENZA; HEMAGGLUTININ-NEURAMINIDASE; PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; EASTERN CHINA; WATERFOWL; SURVEILLANCE; GENOTYPE; SEQUENCE	One class I Newcastle disease virus (NDV), designated as duck/Guangxi/1261/2015 (GX1261), was isolated from asymptomatic ducks in live bird markets (LBM) from southern China during the national active surveillance for NDVs in 2015. The complete genome length of GX1261 isolate was 15,198 nucleotides with the gene order of 3'-NP-P-M-F-HN-L5'. The motif at the cleavage site of F protein was (112)ERQER/L-117, which was typical of low virulence NDV. Several mutations were identified in the functional domains of F and HN proteins, including fusion peptide, heptad repeat region, transmembrane domains and neutralizing epitopes. Phylogenetic analysis based on the complete F gene revealed that the isolate was clustered into sub-genotype 1c in class I, and showed a high level of similarity with the strains isolated from waterfowl in the United States of America. This is the first report of this kind of virus in the mainland of China. These results demonstrated that GX1261-like viruses might exist in asymptomatic waterfowl, and remain undetected or unidentified. Thus, more investigation needs to be done in order to identify the source of the virus. This study revealed the genetic and phylogenetic characteristics of GX1261 isolate and could help us to better understand the epidemiological context of class I NDV in China.	[Wang, Jingjing; Lv, Yan; Zheng, Dongxia; Zhao, Yunling; Liu, Hualei; Wang, Zhiliang] China Anim Hlth & Epidemiol Ctr, OIE Reference Lab Newcastle Dis, Qingdao 266032, Peoples R China; [Zhang, Yi] China Anim Hlth & Epidemiol Ctr, OIE Collaborating Ctr Vet Epidemiol & Publ Hlth, Qingdao 266032, Peoples R China; [Castellan, David] DM Castellan Int Vet Consulting, Niagara Falls, ON, Canada	China Animal Health & Epidemiology Center; China Animal Health & Epidemiology Center	Liu, HL; Wang, ZL (corresponding author), China Anim Hlth & Epidemiol Ctr, OIE Reference Lab Newcastle Dis, Qingdao 266032, Peoples R China.	hualeiliuwy@163.com; zlwang111@163.com			Chinese Special Fund for Agro-scientific Research in the Public Interest [201303033]; DM Castellan International Veterinary Consulting	Chinese Special Fund for Agro-scientific Research in the Public Interest; DM Castellan International Veterinary Consulting	This work was supported by the Chinese Special Fund for Agro-scientific Research in the Public Interest (201303033). DM Castellan International Veterinary Consulting provided support in the form of salaries for author David Castellan, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aldous EW, 2010, AVIAN PATHOL, V39, P519, DOI 10.1080/03079457.2010.530938; Alexander DJ, 2009, NEWCASTLE DIS OIE TE; Bulaga LL, 2003, AVIAN DIS, V47, P996, DOI 10.1637/0005-2086-47.s3.996; CHAMBERS P, 1986, J GEN VIROL, V67, P475, DOI 10.1099/0022-1317-67-3-475; Cho SH, 2008, J CLIN MICROBIOL, V46, P1541, DOI 10.1128/JCM.00187-08; Cho SH, 2007, VIRUS GENES, V35, P293, DOI 10.1007/s11262-007-0078-z; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; Diel DG, 2012, INFECT GENET EVOL, V12, P1770, DOI 10.1016/j.meegid.2012.07.012; Dimitrov KM, 2016, INFECT GENET EVOL, V39, P22, DOI 10.1016/j.meegid.2016.01.008; Guo HB, 2013, ARCH VIROL, V158, P1121, DOI 10.1007/s00705-012-1572-8; Hu SL, 2010, VET MICROBIOL, V140, P92, DOI 10.1016/j.vetmic.2009.07.029; Jindal N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-191; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; King DJ, 1997, AVIAN DIS, V41, P683, DOI 10.2307/1592161; Liu XW, 2009, AVIAN PATHOL, V38, P377, DOI 10.1080/03079450903183637; MCGINNES LW, 1995, VIROLOGY, V212, P398, DOI 10.1006/viro.1995.1497; Meng CC, 2012, ARCH VIROL, V157, P869, DOI 10.1007/s00705-012-1248-4; Pfitzer S, 2000, AVIAN DIS, V44, P655, DOI 10.2307/1593107; Romer-Oberdorfer A, 2006, AVIAN DIS, V50, P259, DOI 10.1637/7471-111505R.1; Seal BS, 2005, VET MICROBIOL, V106, P7, DOI 10.1016/j.vetmic.2004.11.013; Senne DA, 2003, AVIAN DIS, V47, P898, DOI 10.1637/0005-2086-47.s3.898; Shengqing Y, 2002, VIROLOGY, V301, P206, DOI 10.1006/viro.2002.1539; Snoeck CJ, 2013, J CLIN MICROBIOL, V51, P2250, DOI 10.1128/JCM.00684-13; Takakuwa H, 1998, JPN J VET RES, V45, P207; TOYODA T, 1989, VIROLOGY, V169, P273, DOI 10.1016/0042-6822(89)90152-9; Umali DV, 2014, VIRUS GENES, V49, P89, DOI 10.1007/s11262-014-1075-7; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]; Zhu J, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0211-2	28	14	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158771	10.1371/journal.pone.0158771	http://dx.doi.org/10.1371/journal.pone.0158771			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391305	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400120
J	Carey, JR; Liedo, P; Xu, C; Wang, JL; Muller, HG; Su, YR; Vaupel, JW				Carey, James R.; Liedo, Pablo; Xu, Cong; Wang, Jane-Ling; Mueller, Hans-Georg; Su, Yu-Ru; Vaupel, James W.			Diet Shapes Mortality Response to Trauma in Old Tephritid Fruit Flies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; STRESS RESISTANCE; REPRODUCTION; INJURY	Despite the importance of trauma in healthspan and lifespan in humans as well as in non-human species, with one important exception the literature in both gerontology and ecology contains virtually no experimental demographic studies concerned with trauma in any species. We used dietary manipulation [full diet (F) versus sugar-only (S)] to produce four levels of frailty in 55-day old tephritid fruit flies (Anastrepha ludens) that were then subject to the trauma of cage transfer stress (n = 900/sex in each of the 4 treatments). The key results included the following: (1) there is a trauma effect caused by the transfer that depends on previous diet before transfer, new diet after transfer and gender of the fly; (2) males are more vulnerable than females; (3) if initial diet was F, flies are relatively immune against the trauma, and the subsequent diet (F or S) does not matter; (4) however if initial diet was S, then the effect of the trauma depends largely on the diet after the transfer; (5) flies transferred from S to F diets do very well in terms of remaining longevity (i.e. greatest remaining longevity), while flies transferred from S to S diet do poorly (i.e. shortest remaining longevity). We discuss both the strengths and weaknesses of this study and implications of the results.	[Carey, James R.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Carey, James R.] Univ Calif Berkeley, Ctr Econ & Demog Aging, Berkeley, CA 94720 USA; [Liedo, Pablo] El Colegio Frontera Sur ECOSUR, Tapachula, Chiapas, Mexico; [Xu, Cong] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA USA; [Wang, Jane-Ling; Mueller, Hans-Georg] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Su, Yu-Ru] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA; [Vaupel, James W.] Max Planck Inst Demog Res, Konrad Zuse Str 1, Rostock, Germany	University of California System; University of California Davis; University of California System; University of California Berkeley; El Colegio de la Frontera Sur (ECOSUR); Stanford University; University of California System; University of California Davis; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; Max Planck Society	Carey, JR (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.; Carey, JR (corresponding author), Univ Calif Berkeley, Ctr Econ & Demog Aging, Berkeley, CA 94720 USA.	jrcarey@ucdavis.edu	Liedo, Pablo/E-9313-2010	Liedo, Pablo/0000-0002-0004-1721; Xu, Cong/0000-0002-8047-0488; Vaupel, James/0000-0003-0783-3905	Max Planck Institute for Demographic Research; NIA/NIH [P01 AG 022500-01]; NATIONAL INSTITUTE ON AGING [P01AG022500] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023313] Funding Source: NIH RePORTER; Division Of Mathematical Sciences [1512975] Funding Source: National Science Foundation	Max Planck Institute for Demographic Research; NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work received research support from the Max Planck Institute for Demographic Research and NIA/NIH grant P01 AG 022500-01.	[Anonymous], 2014, HORMESIS HLTH DIS; Carey JR, 2007, EXP GERONTOL, V42, P166, DOI 10.1016/j.exger.2006.10.002; Carey JR, 1998, SCIENCE, V281, P996, DOI 10.1126/science.281.5379.996; Criddle LM, 2009, ADV EMERG NURS J, V31, P323, DOI 10.1097/TME.0b013e3181bd2a67; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Katzenberger RJ, 2013, P NATL ACAD SCI USA, V110, pE4152, DOI 10.1073/pnas.1316895110; Mair W, 2003, SCIENCE, V301, P1731, DOI 10.1126/science.1086016; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; Roach DA, 2014, ANNU REV ECOL EVOL S, V45, P421, DOI 10.1146/annurev-ecolsys-120213-091730; Semenchenko GV, 2004, BIOGERONTOLOGY, V5, P17, DOI 10.1023/B:BGEN.0000017681.46326.9e; Sepulveda S, 2008, EXP GERONTOL, V43, P136, DOI 10.1016/j.exger.2007.10.006; Tatar M, 2009, J GERONTOL A-BIOL, V64, P161, DOI 10.1093/gerona/gln067	12	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158468	10.1371/journal.pone.0158468	http://dx.doi.org/10.1371/journal.pone.0158468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383645	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400049
J	Liu, GZ; Zhao, YS; Gowda, M; Longin, CFH; Reif, JC; Mette, MF				Liu, Guozheng; Zhao, Yusheng; Gowda, Manje; Longin, C. Friedrich H.; Reif, Jochen C.; Mette, Michael F.			Predicting Hybrid Performances for Quality Traits through Genomic-Assisted Approaches in Central European Wheat	PLOS ONE			English	Article							SEPTORIA-TRITICI BLOTCH; BREAD-MAKING QUALITY; HARD WINTER-WHEAT; 1 PSY1 GENES; COMMON WHEAT; FUNCTIONAL MARKERS; GRAIN HARDNESS; SELECTION ACCURACY; BAKING QUALITY; HEADING TIME	Bread-making quality traits are central targets for wheat breeding. The objectives of our study were to (1) examine the presence of major effect QTLs for quality traits in a Central European elite wheat population, (2) explore the optimal strategy for predicting the hybrid performance for wheat quality traits, and (3) investigate the effects of marker density and the composition and size of the training population on the accuracy of prediction of hybrid performance. In total 135 inbred lines of Central European bread wheat (Triticum aestivum L.) and 1,604 hybrids derived from them were evaluated for seven quality traits in up to six environments. The 135 parental lines were genotyped using a 90k single-nucleotide polymorphism array. Genome-wide association mapping initially suggested presence of several quantitative trait loci (QTLs), but cross-validation rather indicated the absence of major effect QTLs for all quality traits except of 1000-kernel weight. Genomic selection substantially outperformed marker-assisted selection in predicting hybrid performance. A resampling study revealed that increasing the effective population size in the estimation set of hybrids is relevant to boost the accuracy of prediction for an unrelated test population.	[Liu, Guozheng; Zhao, Yusheng; Reif, Jochen C.; Mette, Michael F.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Breeding Res, Stadt Seeland, Germany; [Gowda, Manje; Longin, C. Friedrich H.] Univ Hohenheim, State Plant Breeding Inst, Stuttgart, Germany; [Gowda, Manje] Int Maize & Wheat Improvement Ctr CIMMYT, Nairobi, Kenya; [Mette, Michael F.] King Abdullah Univ Sci & Technol, Ctr Desert Agr, Thuwal, Saudi Arabia	Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University Hohenheim; CGIAR; International Maize & Wheat Improvement Center (CIMMYT); King Abdullah University of Science & Technology	Reif, JC (corresponding author), Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Breeding Res, Stadt Seeland, Germany.	reif@ipk-gatersleben.de	Gowda, Manje/AAG-2251-2019; Zhao, Yusheng/U-1883-2019; Gowda, Manje/AAH-4207-2019	Gowda, Manje/0000-0003-4434-6364; Zhao, Yusheng/0000-0001-6783-5182; Reif, Jochen/0000-0002-6742-265X	Bundesministerium fur Bildung und Forschung [FKZ0315945D]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	The wheat data set for this research was generated within the HYWHEAT project funded by Bundesministerium fur Bildung und Forschung (Grant ID: FKZ0315945D). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSCOMBE FJ, 1963, TECHNOMETRICS, V5, P141, DOI 10.2307/1266059; Bentley AR, 2014, THEOR APPL GENET, V127, P2619, DOI 10.1007/s00122-014-2403-y; BERNARDO R, 1994, CROP SCI, V34, P20, DOI 10.2135/cropsci1994.0011183X003400010003x; Bordes J, 2014, MOL BREEDING, V33, P755, DOI 10.1007/s11032-013-0004-0; Bundessortenamt, 2000, RICHTL DURCHF LANDW; Butler DG, 2018, ASREML R REFERENCE M; Carter AH, 2012, THEOR APPL GENET, V124, P1079, DOI 10.1007/s00122-011-1770-x; Chen F, 2012, MOL BREEDING, V29, P371, DOI 10.1007/s11032-011-9553-2; El-Feki WM, 2013, CROP SCI, V53, P1953, DOI 10.2135/cropsci2012.12.0674; Falconer D. S., 1996, INTRO QUANTITATIVE G; Freund W, 2006, FUTURE FLOUR COMPEND, P101; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Giroux MJ, 1997, THEOR APPL GENET, V95, P857, DOI 10.1007/s001220050636; Giroux MJ, 1998, P NATL ACAD SCI USA, V95, P6262, DOI 10.1073/pnas.95.11.6262; Gowda M, 2014, HEREDITY, V112, P552, DOI 10.1038/hdy.2013.139; Groos C, 2004, J CEREAL SCI, V40, P93, DOI 10.1016/j.jcs.2004.08.006; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; He XY, 2008, THEOR APPL GENET, V116, P213, DOI 10.1007/s00122-007-0660-8; He XY, 2007, THEOR APPL GENET, V115, P47, DOI 10.1007/s00122-007-0539-8; He XY, 2009, MOL BREEDING, V23, P553, DOI 10.1007/s11032-009-9255-1; Heffner EL, 2011, PLANT GENOME-US, V4, P65, DOI [10.3835/plantgenome2010.12.0029, 10.3835/plantgenome.2010.12.0029]; Heffner EL, 2011, CROP SCI, V51, P2597, DOI 10.2135/cropsci2011.05.0253; Heffner EL, 2009, CROP SCI, V49, P1, DOI 10.2135/cropsci2008.08.0512; Henderson C. R, 1984, APPL LINEAR MODELS A; Heslot N, 2015, CROP SCI, V55, P1, DOI 10.2135/cropsci2014.03.0249; HOLM S, 1979, SCAND J STAT, V6, P65; Ishikawa G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111337; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; LANDE R, 1990, GENETICS, V124, P743; Liang D, 2010, EUPHYTICA, V172, P235, DOI 10.1007/s10681-009-0054-x; Liu YN, 2012, THEOR APPL GENET, V125, P1, DOI 10.1007/s00122-012-1829-3; Longin CFH, 2015, THEOR APPL GENET, V128, P1297, DOI 10.1007/s00122-015-2505-1; Longin CFH, 2013, THEOR APPL GENET, V126, P2791, DOI 10.1007/s00122-013-2172-z; Longin CFH, 2012, THEOR APPL GENET, V125, P1087, DOI 10.1007/s00122-012-1967-7; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Miedaner T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-858; Mirdita V, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1628-8; Moreau L, 2004, EUPHYTICA, V137, P111, DOI 10.1023/B:EUPH.0000040508.01402.21; Muhleisen J, 2014, THEOR APPL GENET, V127, P309, DOI 10.1007/s00122-013-2219-1; Ortiz R, 2008, AGR ECOSYST ENVIRON, V126, P46, DOI 10.1016/j.agee.2008.01.019; PAYNE PI, 1987, J SCI FOOD AGR, V40, P51, DOI 10.1002/jsfa.2740400108; Peterson CJ, 1998, EUPHYTICA, V100, P157, DOI 10.1023/A:1018361502435; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Reif JC, 2011, THEOR APPL GENET, V123, P283, DOI 10.1007/s00122-011-1583-y; Reif JC, 2011, THEOR APPL GENET, V122, P961, DOI 10.1007/s00122-010-1502-7; Schrag TA, 2009, MAYDICA, V54, P353; Schrag TA, 2010, THEOR APPL GENET, V120, P451, DOI 10.1007/s00122-009-1208-x; SHEWRY PR, 1995, BIO-TECHNOL, V13, P1185, DOI 10.1038/nbt1195-1185; SINGH NK, 1985, THEOR APPL GENET, V71, P79, DOI 10.1007/BF00278258; STRAM DO, 1994, BIOMETRICS, V50, P1171, DOI 10.2307/2533455; Sun DJ, 2005, MOL BREEDING, V16, P209, DOI 10.1007/s11032-005-6618-0; Technow F, 2012, THEOR APPL GENET, V125, P1181, DOI 10.1007/s00122-012-1905-8; ter Braak CJF, 2005, GENETICS, V170, P1435, DOI 10.1534/genetics.105.040469; Utz HF, 2000, GENETICS, V154, P1839; Wang JW, 2009, HEREDITAS, V146, P208, DOI 10.1111/j.1601-5223.2009.02132.x; Wang LH, 2009, THEOR APPL GENET, V118, P525, DOI 10.1007/s00122-008-0918-9; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wheat Marketing Center, 2008, WHEAT FLOUR TEST MET; Whittaker JC, 2000, GENET RES, V75, P249, DOI 10.1017/S0016672399004462; Xu SZ, 2003, GENETICS, V163, P789; Xu YB, 2005, PLANT MOL BIOL, V59, P7, DOI 10.1007/s11103-004-4681-2; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191; Yang FP, 2009, EUPHYTICA, V165, P445, DOI 10.1007/s10681-008-9745-y; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; Zhang YL, 2009, CROP PASTURE SCI, V60, P587, DOI 10.1071/CP08392; Zhao Y, 2014, HEREDITY, V112, P638, DOI 10.1038/hdy.2014.1; Zhao Y, 2015, GENOME BASED ESTABLI; Zhao YS, 2015, P NATL ACAD SCI USA, V112, P15624, DOI 10.1073/pnas.1514547112; Zhao YS, 2015, PLANT BREEDING, V134, P1, DOI 10.1111/pbr.12231; Zhao YS, 2013, J EXP BOT, V64, P4453, DOI 10.1093/jxb/ert259; Zhao YS, 2013, CROP SCI, V53, P802, DOI 10.2135/cropsci2012.08.0463; Zheng SS, 2010, EUPHYTICA, V176, P357, DOI 10.1007/s10681-010-0215-y; Zhong SB, 2006, PHYTOPATHOLOGY, V96, P993, DOI 10.1094/PHYTO-96-0993; [No title captured]	76	35	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158635	10.1371/journal.pone.0158635	http://dx.doi.org/10.1371/journal.pone.0158635			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383841	gold, Green Published, Green Submitted			2022-12-26	WOS:000379809400070
J	Luis, AR; Couchinho, MN; dos Santos, ME				Luis, Ana Rita; Couchinho, Miguel N.; dos Santos, Manuel E.			A Quantitative Analysis of Pulsed Signals Emitted by Wild Bottlenose Dolphins	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; ECHOLOCATION CLICKS; ACOUSTIC REPERTOIRE; BEHAVIOR; CALLS; CAPTURE; SPINNER; WHALES; RANGE; PREY	Common bottlenose dolphins (Tursiops truncatus), produce a wide variety of vocal emissions for communication and echolocation, of which the pulsed repertoire has been the most difficult to categorize. Packets of high repetition, broadband pulses are still largely reported under a general designation of burst-pulses, and traditional attempts to classify these emissions rely mainly in their aural characteristics and in graphical aspects of spectrograms. Here, we present a quantitative analysis of pulsed signals emitted by wild bottlenose dolphins, in the Sado estuary, Portugal (2011-2014), and test the reliability of a traditional classification approach. Acoustic parameters (minimum frequency, maximum frequency, peak frequency, duration, repetition rate and inter-click-interval) were extracted from 930 pulsed signals, previously categorized using a traditional approach. Discriminant function analysis revealed a high reliability of the traditional classification approach (93.5% of pulsed signals were consistently assigned to their aurally based categories). According to the discriminant function analysis (Wilk's A = 0.11, F-3,F-2.41 = 282.75, P < 0.001), repetition rate is the feature that best enables the discrimination of different pulsed signals (structure coefficient = 0.98). Classification using hierarchical cluster analysis led to a similar categorization pattern: two main signal types with distinct magnitudes of repetition rate were clustered into five groups. The pulsed signals, here described, present significant differences in their time-frequency features, especially repetition rate (P < 0.001), inter-click-interval (P < 0.001) and duration (P < 0.001). We document the occurrence of a distinct signal type-short burst-pulses, and highlight the existence of a diverse repertoire of pulsed vocalizations emitted in graded sequences. The use of quantitative analysis of pulsed signals is essential to improve classifications and to better assess the contexts of emission, geographic variation and the functional significance of pulsed signals.	[Luis, Ana Rita; Couchinho, Miguel N.; dos Santos, Manuel E.] ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Luis, Ana Rita; Couchinho, Miguel N.; dos Santos, Manuel E.] Ctr Portugues Estudo Mamiferos Marinhos, Projecto Delfim, Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA)	Luis, AR (corresponding author), ISPA Inst Univ, MARE Marine & Environm Sci Ctr, Lisbon, Portugal.; Luis, AR (corresponding author), Ctr Portugues Estudo Mamiferos Marinhos, Projecto Delfim, Lisbon, Portugal.	aluis@ispa.pt	Luís, Ana Rita/AAJ-9395-2020	Luís, Ana Rita/0000-0002-2075-1974; dos Santos, Manuel/0000-0001-8225-9398	Fundacao para a Ciencia e Tecnologia (FCT) [UID/MAR/04292/2013]; Troia-Natura S.A. [24052/4141/2010/RNES];  [SFRH / BD / 90037 / 2012]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Troia-Natura S.A.; 	This study had the support of Fundacao para a Ciencia e Tecnologia (FCT), through the strategic project UID/MAR/04292/2013 granted to MARE, and the grant awarded to ARL (SFRH / BD / 90037 / 2012). Troia-Natura S.A. funded the data collection in 2011, through the project 24052/4141/2010/RNES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizpurua O, 2014, J EXP BIOL, V217, P3318, DOI 10.1242/jeb.104992; Akamatsu T, 1998, J ACOUST SOC AM, V104, P2511, DOI 10.1121/1.423757; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Anonymous, 2008, P401, DOI 10.1007/978-0-387-78365-9_10; Au W. W., 1993, SONAR DOLPHINS; Au WWL, 2004, ACOUST PHYS+, V50, P454, DOI 10.1134/1.1776224; Baumann-Pickering S, 2010, J ACOUST SOC AM, V128, P2212, DOI 10.1121/1.3479549; Bidelman GM, 2014, NEUROSCI LETT, V572, P53, DOI 10.1016/j.neulet.2014.04.037; Blomquist C., 2004, ECHOLOCATION BATS DO, P425; Buscaino G, 2015, MAR MAMMAL SCI, V31, P891, DOI 10.1111/mms.12194; Caldwell M.C., 1990, P199; Caldwell M. C., 1967, Quarterly Los Angeles County Museum, V5, P12; CALDWELL MC, 1965, NATURE, V207, P434, DOI 10.1038/207434a0; Connor RC, 1996, BEHAVIOUR, V133, P643, DOI 10.1163/156853996X00404; Deaux EC, 2013, BEHAVIOUR, V150, P75, DOI 10.1163/1568539X-00003038; Diaz Lopez B., 2009, DOLPHINS ANATOMY BEH, P1; dos Santos Manuel E., 1995, P325; dos Santos ME., 2004, ECHOLOCATION BATS DO, P386; DOSSANTOS ME, 1990, NATO ADV SCI I A-LIF, V196, P585; Finneran JJ, 2013, J ACOUST SOC AM, V133, P1796, DOI 10.1121/1.4788997; Gage N, 2006, BRAIN RES, V1069, P166, DOI 10.1016/j.brainres.2005.11.023; Green S., 1979, SOCIAL BEHAV COMMUNI, P73, DOI DOI 10.1007/978-1-4615-9116-0_3; Gridley T, 2015, BIOACOUSTICS, V24, P153, DOI 10.1080/09524622.2015.1014851; Griffiths SR, 2013, BEHAV PROCESS, V98, P58, DOI 10.1016/j.beproc.2013.05.007; Hauser MD., 1996, COMMUNICATION; Herman LM, 2002, COGNITIVE ANIMAL, P275; Herzing Denise L., 1996, Aquatic Mammals, V22, P61; Herzing DL, 2015, DOLPHIN COMMUNICATION AND COGNITION: PAST, PRESENT, AND FUTURE, P1; Herzing DL, 2000, SPR HDB AUD, V12, P225; Herzing DL., 2015, ANIM BEHAV COGNIT, V2, P14, DOI [10.12966/abc.02.02.2015, DOI 10.12966/ABC.02.02.2015]; Janik VM, 2013, J COMP PHYSIOL A, V199, P479, DOI 10.1007/s00359-013-0817-7; Janik VM, 2000, J COMP PHYSIOL A, V186, P673, DOI 10.1007/s003590000120; Janik VM, 2000, SCIENCE, V289, P1355, DOI 10.1126/science.289.5483.1355; Janik VM, 2000, P ROY SOC B-BIOL SCI, V267, P923, DOI 10.1098/rspb.2000.1091; Keenan S, 2013, ANIM BEHAV, V85, P109, DOI 10.1016/j.anbehav.2012.10.014; King SL, 2015, ANIM COGN, V18, P969, DOI 10.1007/s10071-015-0851-7; Lammers MO, 2015, DOLPHIN COMMUNICATION AND COGNITION: PAST, PRESENT, AND FUTURE, P107; Lammers MO, 2003, J ACOUST SOC AM, V114, P1629, DOI 10.1121/1.1596173; LILLY JC, 1961, SCIENCE, V133, P1689, DOI 10.1126/science.133.3465.1689; Madsen PT, 2007, AQUAT BIOL, V1, P141, DOI 10.3354/ab00014; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Murray SO, 1998, J ACOUST SOC AM, V104, P1679, DOI 10.1121/1.424380; Overstrom N.A., 1983, Zoo Biology, V2, P93, DOI 10.1002/zoo.1430020203; Quick NJ, 2008, J COMP PSYCHOL, V122, P305, DOI 10.1037/0735-7036.122.3.305; Ridgway SH, 2014, J EXP BIOL, V217, P2910, DOI 10.1242/jeb.100511; Ridgway S. H., 1991, J ACOUST SOC AM, V90, P2335, DOI [10.1121/1.402199, DOI 10.1121/1.402199]; Sayigh LS, 2007, ANIM BEHAV, V74, P1631, DOI 10.1016/j.anbehav.2007.02.018; Simard Peter, 2008, Aquatic Mammals, V34, P464, DOI 10.1578/AM.34.4.2008.464; Supin AY, 1995, HEARING RES, V92, P38, DOI 10.1016/0378-5955(95)00194-8; Tinsley H.E., 2000, HDB MULTIVARIATE STA, DOI DOI 10.1016/B978-012691360-6/50016-1; Van Parijs SM, 2000, J ACOUST SOC AM, V108, P1938, DOI 10.1121/1.1289667; Wahlberg M, 2011, J ACOUST SOC AM, V130, P2263, DOI 10.1121/1.3624822; Watkins W. A., 1968, MARINE BIOACOUSTICS, V2, P15, DOI DOI 10.1575/1912/2726; Wilson E.O., 1975, P1	54	16	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157781	10.1371/journal.pone.0157781	http://dx.doi.org/10.1371/journal.pone.0157781			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383211	Green Published, gold			2022-12-26	WOS:000379809400025
J	Chen, JY; Liu, JH; Wu, HDI; Lin, KH; Chang, KC; Liou, YM				Chen, Jan-Yow; Liu, Jiung-Hsiun; Wu, Hong-Dar Isaac; Lin, Kuo-Hung; Chang, Kuan-Cheng; Liou, Ying-Ming			Transforming Growth Factor-beta 1 T869C Gene Polymorphism Is Associated with Acquired Sick Sinus Syndrome via Linking a Higher Serum Protein Level	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; NODE DYSFUNCTION; SCN5A MUTATION; HUMAN GENOME; CHANNEL; OVEREXPRESSION; BRADYCARDIA; MECHANISMS; ARRHYTHMIA; DISEASE	Background Familial sick sinus syndrome is associated with gene mutations and dysfunction of ion channels. In contrast, degenerative fibrosis of the sinus node tissue plays an important role in the pathogenesis of acquired sick sinus syndrome. There is a close relationship between transforming growth factor-beta 1 mediated cardiac fibrosis and acquired arrhythmia. It is of interest to examine whether transforming growth factor-beta 1 is involved in the pathogenesis of acquired sick sinus syndrome. Methods Overall, 110 patients with acquired SSS and 137 age/gender-matched controls were screened for transforming growth factor-beta 1 and cardiac sodium channel gene polymorphisms using gene sequencing or restriction fragment length polymorphism methods. An enzyme-linked immunosorbent assay was used to determine the serum level of transforming growth factor-beta 1. Results Two transforming growth factor-beta 1 gene polymorphisms (C-509T and T+869C) and one cardiac sodium channel gene polymorphism (H588R) have been identified. The C-dominant CC/CT genotype frequency of T869C was significantly higher in acquired sick sinus syndrome patients than in controls (OR 2.09, 95% CI 1.16-3.75, P = 0.01). Consistently, the level of serum transforming growth factor-beta 1 was also significantly greater in acquired sick sinus syndrome group than in controls (5.3 +/- 3.4 ng/ml vs. 3.7 +/- 2.4 ng/ml, P = 0.01). In addition, the CC/CT genotypes showed a higher transforming growth factor-beta 1 serum level than the TT genotype (4.25 +/- 2.50 ng/ml vs. 2.71 +/- 1.76 ng/ml, P = 0.028) in controls. Conclusion Transforming growth factor-beta 1 T869C polymorphism, correlated with high serum transforming growth factor-beta 1 levels, is associated with susceptibility to acquired sick sinus syndrome.	[Chen, Jan-Yow; Lin, Kuo-Hung; Chang, Kuan-Cheng] China Med Univ Hosp, Dept Med, Div Cardiol, Taichung, Taiwan; [Chen, Jan-Yow; Liou, Ying-Ming] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Chen, Jan-Yow; Liu, Jiung-Hsiun; Lin, Kuo-Hung; Chang, Kuan-Cheng] China Med Univ, Sch Med, Taichung, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Dept Appl Math, Taichung, Taiwan; [Wu, Hong-Dar Isaac] Natl Chung Hsing Univ, Inst Stat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; National Chung Hsing University; China Medical University Taiwan; National Chung Hsing University; National Chung Hsing University	Liou, YM (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan.	ymlion@dragon.nchu.edu.tw		Liou, Ying-Ming/0000-0002-8190-7629	Taiwan National Science Council (NSC) (Ministry of Science and Technology) [NSC 101-2314-B-039-042]	Taiwan National Science Council (NSC) (Ministry of Science and Technology)	This study was supported by funding (NSC 101-2314-B-039-042) from Taiwan National Science Council (Ministry of Science and Technology) (https://www.most.gov.tw/en/public). JYC received the funding.	Adan V, 2003, AM FAM PHYSICIAN, V67, P1725; Ardlie KG, 2002, NAT REV GENET, V3, P299, DOI 10.1038/nrg777; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Chen JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029951; Chen LY, 2007, CLIN PHARMACOL THER, V81, P35, DOI 10.1038/sj.clpt.6100016; Dobrzynski H, 2007, CIRCULATION, V115, P1921, DOI 10.1161/CIRCULATIONAHA.106.616011; DUFF JL, 1995, CARDIOVASC RES, V30, P511, DOI 10.1016/0008-6363(95)00088-7; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gramley F, 2010, INT J CARDIOL, V143, P405, DOI 10.1016/j.ijcard.2009.03.110; Gregoratos G, 2003, CIRCULATION, V108, pE143, DOI 10.1161/01.CIR.0000102938.55119.EC; Hao XJ, 2011, CIRC-ARRHYTHMIA ELEC, V4, P397, DOI 10.1161/CIRCEP.110.960807; Hein L, 1997, P NATL ACAD SCI USA, V94, P6391, DOI 10.1073/pnas.94.12.6391; Herrmann S, 2011, CARDIOVASC RES, V92, P179, DOI 10.1093/cvr/cvr205; Holm H, 2011, NAT GENET, V43, P316, DOI 10.1038/ng.781; Jones SA, 2007, CIRCULATION, V115, P1183, DOI 10.1161/CIRCULATIONAHA.106.663070; Kasi VS, 2007, AM J PHYSIOL-HEART C, V293, pH182, DOI 10.1152/ajpheart.00684.2006; Lamas GA, 2000, AM HEART J, V140, P541, DOI 10.1067/mhj.2000.109652; Lau DH, 2011, CURR OPIN CARDIOL, V26, P55, DOI 10.1097/HCO.0b013e32834138f4; Li X, 2008, J CLIN LAB ANAL, V22, P164, DOI 10.1002/jcla.20236; Makita N, 2005, HEART RHYTHM, V2, P1128, DOI 10.1016/j.hrthm.2005.06.032; Mangrum JM, 2000, NEW ENGL J MED, V342, P703, DOI 10.1056/NEJM200003093421006; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; Milanesi R, 2006, NEW ENGL J MED, V354, P151, DOI 10.1056/NEJMoa052475; Nielsen JC, 2011, EUR HEART J, V32, P686, DOI 10.1093/eurheartj/ehr022; Peng LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067738; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; RUBENSTEIN JJ, 1972, CIRCULATION, V46, P5, DOI 10.1161/01.CIR.46.1.5; Shah R, 2006, HUM GENET, V119, P61, DOI 10.1007/s00439-005-0112-y; Stieber J, 2004, TRENDS CARDIOVAS MED, V14, P23, DOI 10.1016/j.tcm.2003.09.006; Susianti H, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-514; Tellez JO DH, 2006, J MOL CELL CARDIOL, V40, P1; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Wu CH, 2013, HEART RHYTHM, V10, P10, DOI 10.1016/j.hrthm.2012.09.016; Yamada Y, 2000, ARTHRITIS RHEUM, V43, P452, DOI 10.1002/1529-0131(200002)43:2<452::AID-ANR28>3.0.CO;2-C; Zhang H, 2007, AM J PHYSIOL-HEART C, V292, pH165, DOI 10.1152/ajpheart.01101.2005	36	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158676	10.1371/journal.pone.0158676	http://dx.doi.org/10.1371/journal.pone.0158676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380173	Green Published, gold, Green Submitted			2022-12-26	WOS:000379798700041
J	Hostetler, CM; Phillips, TJ; Ryabinin, AE				Hostetler, Caroline M.; Phillips, Tamara J.; Ryabinin, Andrey E.			Methamphetamine Consumption Inhibits Pair Bonding and Hypothalamic Oxytocin in Prairie Voles	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS DOPAMINE; MICROTUS-OCHROGASTER; PARTNER PREFERENCE; MONOGAMOUS RODENT; SEX-DIFFERENCES; MOUSE-BRAIN; DRUG; AMPHETAMINE; VASOPRESSIN; BEHAVIOR	Methamphetamine (MA) abuse has been linked to violence, risk-taking behaviors, decreased sexual inhibition, and criminal activity. It is important to understand mechanisms underlying these drug effects for prevention and treatment of MA-associated social problems. Previous studies have demonstrated that experimenter-administered amphetamine inhibits pair bonding and increases aggression in monogamous prairie voles. It is not currently known whether similar effects on social behaviors would be obtained under conditions during which the drug is voluntarily (actively) administered. The current study investigated whether MA drinking affects pair bonding and what neurocircuits are engaged. In Experiment 1, we exposed male and female voles to 4 days each of 20 and 40 mg/L MA under a continuous 2-bottle choice (2BC) procedure. Animals were housed either singly or in mesh-divided cages with a social partner. Voles consumed MA in a drinking solution, but MA drinking was not affected by either sex or housing condition. In Experiment 2, we investigated whether MA drinking disrupts social bonding by measuring aggression and partner preference formation following three consecutive days of 18-hour/day access to 100 mg/L MA in a 2BC procedure. Although aggression toward a novel opposite-sex animal was not affected by MA exposure, partner preference was inhibited in MA drinking animals. Experiment 3 examined whether alterations in hypothalamic neuropeptides provide a potential explanation for the inhibition of partner preference observed in Experiment 2. MA drinking led to significant decreases in oxytocin, but not vasopressin, in the paraventricular nucleus of the hypothalamus. These experiments are the first investigation into how voluntary pre-exposure to MA affects the development of social attachment in a socially monogamous species and identify potential neural circuits involved in these effects.	[Hostetler, Caroline M.; Phillips, Tamara J.; Ryabinin, Andrey E.] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA; [Hostetler, Caroline M.; Phillips, Tamara J.] Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA; [Phillips, Tamara J.; Ryabinin, Andrey E.] Oregon Hlth & Sci Univ, Methamphetamine Abuse Res Ctr, Portland, OR 97201 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System; Oregon Health & Science University	Hostetler, CM (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97201 USA.; Hostetler, CM (corresponding author), Vet Affairs Portland Hlth Care Syst, Portland, OR 97239 USA.	Caroline.Hostetler@gmail.com		Ryabinin, Andrey/0000-0003-4662-3775	National Institutes of Health [RO1 AA019793, P50DA018165]; Department of Veterans Affairs; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA019793] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	Funding was provided by National Institutes of Health RO1 AA019793 (to AER), Department of Veterans Affairs (to TJP), and National Institutes of Health P50DA018165 (to TJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anacker AMJ, 2014, P NATL ACAD SCI USA, V111, P6052, DOI 10.1073/pnas.1320879111; Anacker AMJ, 2011, ADDICT BIOL, V16, P92, DOI 10.1111/j.1369-1600.2010.00234.x; Anderson Peter D, 2012, J Pharm Pract, V25, P41, DOI 10.1177/0897190011431150; Aragona BJ, 2006, NAT NEUROSCI, V9, P133, DOI 10.1038/nn1613; Aragona BJ, 2007, NEUROSCI LETT, V418, P190, DOI 10.1016/j.neulet.2007.03.019; Bales KL, 2013, BIOL PSYCHIAT, V74, P180, DOI 10.1016/j.biopsych.2012.08.025; Becker JB, 2008, FRONT NEUROENDOCRIN, V29, P36, DOI 10.1016/j.yfrne.2007.07.003; CARTER CS, 1995, NEUROSCI BIOBEHAV R, V19, P303; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Cho MM, 1999, BEHAV NEUROSCI, V113, P1071, DOI 10.1037/0735-7044.113.5.1071; CUNNINGHAM CL, 1992, ANN NY ACAD SCI, V654, P431, DOI 10.1111/j.1749-6632.1992.tb25989.x; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; Deng XL, 2007, BIOL PSYCHIAT, V61, P1235, DOI 10.1016/j.biopsych.2006.09.010; Deng XL, 2001, MOL BRAIN RES, V93, P64, DOI 10.1016/S0169-328X(01)00184-X; DeVries AC, 1997, CAN J ZOOL, V75, P295, DOI 10.1139/z97-037; Eastwood EC, 2014, ADDICT BIOL, V19, P370, DOI 10.1111/adb.12003; Fattore L, 2008, WOMENS HEALTH, V4, P51, DOI 10.2217/17455057.4.1.51; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; Gobrogge KL, 2009, P NATL ACAD SCI USA, V106, P19144, DOI 10.1073/pnas.0908620106; Grilly DM, 2001, PSYCHOPHARMACOLOGY, V153, P155, DOI 10.1007/s002130000580; Hammock EAD, 2005, SCIENCE, V308, P1630, DOI 10.1126/science.1111427; Hammock EAD, 2002, EUR J NEUROSCI, V16, P399, DOI 10.1046/j.1460-9568.2002.02083.x; Harkness JH, 2015, NEUROPSYCHOPHARMACOL, V40, P2175, DOI 10.1038/npp.2015.61; Hemby SE, 1997, PSYCHOPHARMACOLOGY, V133, P7, DOI 10.1007/s002130050365; Hostetler CM, 2012, PSYCHOPHARMACOLOGY, V224, P121, DOI 10.1007/s00213-012-2836-4; Hostetler CM, 2012, NEUROSCIENCE; Knafo A, 2008, GENES BRAIN BEHAV, V7, P266, DOI 10.1111/j.1601-183X.2007.00341.x; Liu Y, 2011, J NEUROSCI, V31, P7960, DOI 10.1523/JNEUROSCI.1006-11.2011; Liu Y, 2010, P NATL ACAD SCI USA, V107, P1217, DOI 10.1073/pnas.0911998107; Lynch WJ, 2006, EXP CLIN PSYCHOPHARM, V14, P34, DOI 10.1037/1064-1297.14.1.34; McCutcheon JE, 2011, J NEUROSCI, V31, P5737, DOI 10.1523/JNEUROSCI.0350-11.2011; McFarland K, 2003, J NEUROSCI, V23, P3531; McKetin R, 2014, ADDICTION, V109, P798, DOI 10.1111/add.12474; Phillips TJ, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00327; Quality CfBHSa, 2015, NSDUH SER H, VH-50; Ryabinin AE, 2000, ACTA NEUROBIOL EXP, V60, P547; Semple SJ, 2002, J SUBST ABUSE TREAT, V22, P149, DOI 10.1016/S0740-5472(02)00223-4; Shabani S, 2011, GENES BRAIN BEHAV, V10, P625, DOI 10.1111/j.1601-183X.2011.00700.x; Shabani S, 2012, NEUROPHARMACOLOGY, V62, P2169, DOI 10.1016/j.neuropharm.2012.01.002; Shi X, PLOS ONE; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; Wheeler JM, 2009, GENES BRAIN BEHAV, V8, P758, DOI 10.1111/j.1601-183X.2009.00522.x; WILLIAMS JR, 1994, J NEUROENDOCRINOL, V6, P247, DOI 10.1111/j.1365-2826.1994.tb00579.x; Young KA, 2014, J NEUROSCI, V34, P8499, DOI 10.1523/JNEUROSCI.4275-13.2014; Young KA, 2011, BRAIN RES, V1367, P213, DOI 10.1016/j.brainres.2010.09.109; Young LJ, 2004, NAT NEUROSCI, V7, P1048, DOI 10.1038/nn1327; Zanos P, 2014, PHARMACOL BIOCHEM BE, V119, P72, DOI 10.1016/j.pbb.2013.05.009; Zhu JPQ, 2006, NEUROTOXICOLOGY, V27, P131, DOI 10.1016/j.neuro.2005.05.014	48	7	8	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158178	10.1371/journal.pone.0158178	http://dx.doi.org/10.1371/journal.pone.0158178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380172	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700021
J	Koh, HB; Scruggs, AM; Huang, SK				Koh, Hailey B.; Scruggs, Anne M.; Huang, Steven K.			Transforming Growth Factor-1 Increases DNA Methyltransferase 1 and 3a Expression through Distinct Post-transcriptional Mechanisms in Lung Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; DNA methylation; DNA methyltransferase; fibroblast; glycogen synthase kinase 3 (GSK-3); mammalian target of rapamycin (mTOR); transforming growth factor beta (TGF-B); ubiquitylation (ubiquitination); DNMT1; DNMT3a	INDUCED PULMONARY-FIBROSIS; FOCAL ADHESION KINASE; ZINC-FINGER PROTEINS; BETA TGF-BETA; PROSTAGLANDIN E-2; MYOFIBROBLAST DIFFERENTIATION; TUMOR-SUPPRESSOR; DNMT1 STABILITY; BREAST-CANCER; T-CELLS	DNA methylation is a fundamental epigenetic mark that plays a critical role in differentiation and is mediated by the actions of DNA methyltransferases (DNMTs). TGF-1 is one of the most potent inducers of fibroblast differentiation, and although many of its actions on fibroblasts are well described, the ability of TGF-1 to modulate DNA methylation in mesenchymal cells is less clear. Here, we examine the ability of TGF-1 to modulate the expression of various DNMTs in primary lung fibroblasts (CCL210). TGF-1 increased the protein expression, but not RNA levels, of both DNMT1 and DNMT3a. The increases in DNMT1 and DNMT3a were dependent on TGF-1 activation of focal adhesion kinase and PI3K/Akt. Activation of mammalian target of rapamycin complex 1 by Akt resulted in increased protein translation of DNMT3a. In contrast, the increase in DNMT1 by TGF-1 was not dependent on new protein synthesis and instead was due to decreased protein degradation. TGF-1 treatment led to the phosphorylation and inactivation of glycogen synthase kinase-3, which resulted in inhibition of DNMT1 ubiquitination and proteosomal degradation. The phosphorylation and inactivation of glycogen synthase kinase-3 was dependent on mammalian target of rapamycin complex 1. These results demonstrate that TGF-1 increases expression of DNMT1 and DNMT3a through different post-transcriptional mechanisms. Because DNA methylation is critical to many processes including development and differentiation, for which TGF-1 is known to be crucial, the ability of TGF-1 to increase expression of both DNMT1 and DNMT3a demonstrates a novel means by which TGF-1 may regulate DNA methylation in these cells.	[Koh, Hailey B.; Scruggs, Anne M.; Huang, Steven K.] Univ Michigan, Div Pulm & Crit Care Med, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Huang, SK (corresponding author), 6301 MSRB IIII,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	stehuang@umich.edu			NHLBI, National Institutes of Health [HL119289, HL127203]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL127203, R56HL119289] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES017885] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by Grants HL119289 and HL127203 from the NHLBI, National Institutes of Health (to S. K. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agoston AT, 2005, J BIOL CHEM, V280, P18302, DOI 10.1074/jbc.M501675200; Aschner Y, 2016, AM J RESP CELL MOL, V54, P647, DOI 10.1165/rcmb.2015-0391TR; Azizi M, 2014, CANCER BIOL THER, V15, P419, DOI 10.4161/cbt.27630; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bechtel W, 2010, NAT MED, V16, P544, DOI 10.1038/nm.2135; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; Chen TL, 2013, INHAL TOXICOL, V25, P525, DOI 10.3109/08958378.2013.809393; De Marzo AM, 1999, CANCER RES, V59, P3855; Diaz A, 1998, EXP CELL RES, V241, P222, DOI 10.1006/excr.1998.4050; Domingo-Gonzalez R, 2015, AM J PHYSIOL-LUNG C, V308, pL86, DOI 10.1152/ajplung.00283.2014; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Esteve PO, 2011, NAT STRUCT MOL BIOL, V18, P42, DOI 10.1038/nsmb.1939; Esteve PO, 2009, P NATL ACAD SCI USA, V106, P5076, DOI 10.1073/pnas.0810362106; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Garrison G, 2013, AM J RESP CELL MOL, V48, P550, DOI 10.1165/rcmb.2012-0262OC; Gorelik G, 2007, J IMMUNOL, V179, P5553, DOI 10.4049/jimmunol.179.8.5553; Harding P, 2006, KIDNEY INT, V69, P1578, DOI 10.1038/sj.ki.5000323; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Hodge David R., 2007, Cancer Genomics & Proteomics, V4, P387; Horowitz JC, 2007, CELL SIGNAL, V19, P761, DOI 10.1016/j.cellsig.2006.10.001; Huang S, 2007, AM J PHYSIOL-LUNG C, V292, pL405, DOI 10.1152/ajplung.00232.2006; Huang SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107055; Huang SK, 2012, FASEB J, V26, P3703, DOI 10.1096/fj.11-203323; Huang SK, 2010, AM J PATHOL, V177, P2245, DOI 10.2353/ajpath.2010.100446; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jeltsch A, 2014, TRENDS BIOCHEM SCI, V39, P310, DOI 10.1016/j.tibs.2014.05.002; Jinawath A, 2005, BIOCHEM J, V385, P557, DOI 10.1042/BJ20040684; Jurkowska RZ, 2011, CHEMBIOCHEM, V12, P206, DOI 10.1002/cbic.201000195; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Kimura H, 2003, NUCLEIC ACIDS RES, V31, P3101, DOI 10.1093/nar/gkg406; Kishikawa S, 2002, EUR J BIOCHEM, V269, P2961, DOI 10.1046/j.1432-1033.2002.02972.x; Lang UE, 2013, ONCOGENE, V32, P4557, DOI 10.1038/onc.2012.457; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Li CR, 2013, J BIOL CHEM, V288, P19127, DOI 10.1074/jbc.M113.453357; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li M, 2011, J CLIN INVEST, V121, P277, DOI 10.1172/JCI42090; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Li YP, 2010, EXP GERONTOL, V45, P312, DOI 10.1016/j.exger.2009.12.008; Lin RK, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-46; Lin RK, 2010, CANCER RES, V70, P5807, DOI 10.1158/0008-5472.CAN-09-4161; Lin RK, 2010, J CLIN INVEST, V120, P521, DOI 10.1172/JCI40706; Martin M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-435; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Neveu WA, 2015, AM J PHYSIOL-CELL PH, V309, pC616, DOI 10.1152/ajpcell.00086.2015; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pan XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060335; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pathania R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7910; Peng LR, 2011, MOL CELL BIOL, V31, P4720, DOI 10.1128/MCB.06147-11; QUDDUS J, 1993, J CLIN INVEST, V92, P38, DOI 10.1172/JCI116576; Rabinovich EI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033770; Sanders YY, 2012, AM J RESP CRIT CARE, V186, P525, DOI 10.1164/rccm.201201-0077OC; Shamma A, 2013, MOL CELL BIOL, V33, P3113, DOI 10.1128/MCB.01597-12; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Soltani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039736; Sun LD, 2007, CELL SIGNAL, V19, P2255, DOI 10.1016/j.cellsig.2007.06.014; SZYF M, 1991, J BIOL CHEM, V266, P10027; Tabish AM, 2015, METHODS MOL BIOL, V1315, P201, DOI 10.1007/978-1-4939-2715-9_15; Thannickal VJ, 2003, J BIOL CHEM, V278, P12384, DOI 10.1074/jbc.M208544200; Thomas PE, 2007, AM J PHYSIOL-LUNG C, V293, pL417, DOI 10.1152/ajplung.00489.2006; Wang HZ, 2011, J IMMUNOL, V186, P5217, DOI 10.4049/jimmunol.1002513; Wettlaufer SH, 2016, AM J RESP CELL MOL, V54, P114, DOI 10.1165/rcmb.2014-0468OC; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Zhang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025168; Zhou Q, 2008, MOL CANCER RES, V6, P873, DOI 10.1158/1541-7786.MCR-07-0330	70	17	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19287	19298		10.1074/jbc.M116.723080	http://dx.doi.org/10.1074/jbc.M116.723080			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27405758	Green Published, hybrid			2022-12-26	WOS:000383242800010
J	Murai, Y; Yotsumoto, Y				Murai, Yuki; Yotsumoto, Yuko			Timescale- and Sensory Modality-Dependency of the Central Tendency of Time Perception	PLOS ONE			English	Article							TEMPORAL BISECTION; INTERVAL; DURATION; MEMORY; CLOCK; RANGE; DISCRIMINATION; MECHANISMS; ATTENTION; STIMULI	When individuals are asked to reproduce intervals of stimuli that are intermixedly presented at various times, longer intervals are often underestimated and shorter intervals overestimated. This phenomenon may be attributed to the central tendency of time perception, and suggests that our brain optimally encodes a stimulus interval based on current stimulus input and prior knowledge of the distribution of stimulus intervals. Two distinct systems are thought to be recruited in the perception of sub-and supra-second intervals. Sub-second timing is subject to local sensory processing, whereas supra-second timing depends on more centralized mechanisms. To clarify the factors that influence time perception, the present study investigated how both sensory modality and timescale affect the central tendency. In Experiment 1, participants were asked to reproduce sub-or supra-second intervals, defined by visual or auditory stimuli. In the sub-second range, the magnitude of the central tendency was significantly larger for visual intervals compared to auditory intervals, while visual and auditory intervals exhibited a correlated and comparable central tendency in the supra-second range. In Experiment 2, the ability to discriminate sub-second intervals in the reproduction task was controlled across modalities by using an interval discrimination task. Even when the ability to discriminate intervals was controlled, visual intervals exhibited a larger central tendency than auditory intervals in the sub-second range. In addition, the magnitude of the central tendency for visual and auditory sub-second intervals was significantly correlated. These results suggest that a common modality-independent mechanism is responsible for the supra-second central tendency, and that both the modality-dependent and modality-independent components of the timing system contribute to the central tendency in the sub-second range.	[Murai, Yuki; Yotsumoto, Yuko] Univ Tokyo, Dept Life Sci, Tokyo, Japan; [Murai, Yuki] Japan Soc Promot Sci, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science	Yotsumoto, Y (corresponding author), Univ Tokyo, Dept Life Sci, Tokyo, Japan.	cyuko@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science [25119003, 16H03749, 14J03550]; Grants-in-Aid for Scientific Research [16H03749] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) Grant-in-Aid for Scientific Research on Innovative Areas (25119003) for YY, Grant-in-Aid for Scientific Research(B) (16H03749) for YY, and Grant-in-Aid for JSPS Fellows (14J03550) for YM.	Acerbi L, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002771; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Cheng RK, 2008, BRAIN RES, V1237, P167, DOI 10.1016/j.brainres.2008.08.062; Cicchini GM, 2012, J NEUROSCI, V32, P1056, DOI 10.1523/JNEUROSCI.3411-11.2012; Filippopoulos PC, 2013, PSYCHOL RES-PSYCH FO, V77, P708, DOI 10.1007/s00426-012-0464-6; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Grondin S, 2014, ADV EXP MED BIOL, V829, P17, DOI 10.1007/978-1-4939-1782-2_2; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Gu BM, 2011, LECT NOTES ARTIF INT, V6789, P67, DOI 10.1007/978-3-642-21478-3_6; Hayashi MJ, 2014, J COGNITIVE NEUROSCI, V26, P1685, DOI 10.1162/jocn_a_00580; Heron J, 2012, P ROY SOC B-BIOL SCI, V279, P690, DOI 10.1098/rspb.2011.1131; Hollingworth H. L., 1910, J PHILOS PSYCHOL SCI, V7, P461, DOI [10.2307/2012819, DOI 10.2307/2012819]; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Kanai R, 2011, EXP BRAIN RES, V209, P465, DOI 10.1007/s00221-011-2577-3; Karmarkar UR, 2007, NEURON, V53, P427, DOI 10.1016/j.neuron.2007.01.006; KEELE SW, 1985, ACTA PSYCHOL, V60, P173, DOI 10.1016/0001-6918(85)90054-X; Kuroda T, 2014, ACTA PSYCHOL, V149, P134, DOI 10.1016/j.actpsy.2013.11.013; Lejeune H, 2009, EUR J COGN PSYCHOL, V21, P941, DOI 10.1080/09541440802453006; Levy JM, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00044; Lewis PA, 2009, PHILOS T R SOC B, V364, P1897, DOI 10.1098/rstb.2009.0020; Lewis PA, 2006, TRENDS COGN SCI, V10, P401, DOI 10.1016/j.tics.2006.07.006; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; MECK WH, 1985, J EXP PSYCHOL ANIM B, V11, P52, DOI 10.1037/0097-7403.11.1.52; Merchant H, 2008, J NEUROPHYSIOL, V99, P939, DOI 10.1152/jn.01225.2007; Merchant H, 2013, ANNU REV NEUROSCI, V36, P313, DOI 10.1146/annurev-neuro-062012-170349; Murai Yuki, 2016, Front Integr Neurosci, V10, P12, DOI 10.3389/fnint.2016.00012; Noulhiane M, 2009, EUR J COGN PSYCHOL, V21, P18, DOI 10.1080/09541440701825981; Ortega L, 2014, ATTEN PERCEPT PSYCHO, V76, P1485, DOI 10.3758/s13414-014-0663-x; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Penney TB, 2000, J EXP PSYCHOL HUMAN, V26, P1770, DOI 10.1037//0096-1523.26.6.1770; Petzschner FH, 2015, TRENDS COGN SCI, V19, P285, DOI 10.1016/j.tics.2015.03.002; Petzschner FH, 2011, J NEUROSCI, V31, P17220, DOI 10.1523/JNEUROSCI.2028-11.2011; Rammsayer TH, 2014, ACTA PSYCHOL, V147, P68, DOI 10.1016/j.actpsy.2013.05.004; Rattat AC, 2012, BEHAV RES METHODS, V44, P67, DOI 10.3758/s13428-011-0135-3; Ryan LJ, 2011, J COGN PSYCHOL, V23, P157, DOI 10.1080/20445911.2011.477812; Shi ZH, 2016, CURR OPIN BEHAV SCI, V8, P200, DOI [10.1016/j.cobeha.2016.02.014, 10.1163/9789004307339_002]; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Stauffer CC, 2012, PSYCHOL RES-PSYCH FO, V76, P20, DOI 10.1007/s00426-011-0333-8; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Tse PU, 2004, PERCEPT PSYCHOPHYS, V66, P1171, DOI 10.3758/BF03196844; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P289; Wearden JH, 2003, TIME AND MIND II: INFORMATION PROCESSING PERSPECTIVES, P21; Wiener M, 2015, NEUROIMAGE, V113, P268, DOI 10.1016/j.neuroimage.2015.03.054; Wiener M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100803; Wiener M, 2010, NEUROIMAGE, V49, P1728, DOI 10.1016/j.neuroimage.2009.09.064	50	16	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158921	10.1371/journal.pone.0158921	http://dx.doi.org/10.1371/journal.pone.0158921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27404269	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508200021
J	Selton-Suty, C; Delahaye, F; Tattevin, P; Federspiel, C; Le Moing, V; Chirouze, C; Nazeyrollas, P; Vernet-Garnier, V; Bernard, Y; Chocron, S; Obadia, JF; Alla, F; Hoen, B; Duval, X				Selton-Suty, Christine; Delahaye, Francois; Tattevin, Pierre; Federspiel, Claire; Le Moing, Vincent; Chirouze, Catherine; Nazeyrollas, Pierre; Vernet-Garnier, Veronique; Bernard, Yvette; Chocron, Sidney; Obadia, Jean-Francois; Alla, Francois; Hoen, Bruno; Duval, Xavier		AEPEI	Symptomatic and Asymptomatic Neurological Complications of Infective Endocarditis: Impact on Surgical Management and Prognosis	PLOS ONE			English	Article							CEREBROVASCULAR COMPLICATIONS; CARDIAC-SURGERY; DIAGNOSIS; EMBOLISM	Objectives Symptomatic neurological complications (NC) are a major cause of mortality in infective endocarditis (IE) but the impact of asymptomatic complications is unknown. We aimed to assess the impact of asymptomatic NC (AsNC) on the management and prognosis of IE. Methods From the database of cases collected for a population-based study on IE, we selected 283 patients with definite left-sided IE who had undergone at least one neuroimaging procedure (cerebral CT scan and/or MRI) performed as part of initial evaluation. Results Among those 283 patients, 100 had symptomatic neurological complications (SNC) prior to the investigation, 35 had an asymptomatic neurological complications (AsNC), and 148 had a normal cerebral imaging (NoNC). The rate of valve surgery was 43% in the 100 patients with SNC, 77% in the 35 with AsNC, and 54% in the 148 with NoNC (p<0.001). In-hospital mortality was 42% in patients with SNC, 8.6% in patients with AsNC, and 16.9% in patients with NoNC (p<0.001). Among the 135 patients with NC, 95 had an indication for valve surgery (71%), which was performed in 70 of them (mortality 20%) and not performed in 25 (mortality 68%). In a multivariate adjusted analysis of the 135 patients with NC, age, renal failure, septic shock, and IE caused by S. aureus were independently associated with in-hospital and 1-year mortality. In addition SNC was an independent predictor of 1-year mortality. Conclusions The presence of NC was associated with a poorer prognosis when symptomatic. Patients with AsNC had the highest rate of valve surgery and the lowest mortality rate, which suggests a protective role of surgery guided by systematic neuroimaging results.	[Selton-Suty, Christine] CHU Nancy Brabois, Cardiol, F-54511 Nancy, France; [Delahaye, Francois] Univ Lyon 1, Hospices Civils Lyon, Hop Cardiol Louis Pradel, Lyon, France; [Tattevin, Pierre] Ctr Hosp Univ, Malad Infectieuses & Reanim Med, Rennes, France; [Federspiel, Claire] Ctr Hosp Dept Vendee, Cardiol, La Roche Sur Yon, France; [Le Moing, Vincent] Univ Montpellier, Inst Rech Dev, Ctr Hosp Reg Univ, Malad Infectieuses & Trop,UMI 233, Montpellier, France; [Chirouze, Catherine] Univ Franche Comte, Ctr Hosp Univ, Malad Infectieuses & Trop, Lab Chronoenvironm UMR 6249, Besancon, France; [Nazeyrollas, Pierre] Ctr Hosp Univ, Cardiol, Reims, France; [Vernet-Garnier, Veronique] Ctr Hosp Univ, Microbiol, Reims, France; [Bernard, Yvette] Ctr Hosp Univ, Cardiol, Besancon, France; [Chocron, Sidney] Ctr Hosp Univ, Chirurg Card, Besancon, France; [Obadia, Jean-Francois] Hop Louis Pradel Chirurg Cardiothorac & Transplan, UCBL1, Lab Physiol Lyon Nord, Uninte INSERM Cardioprotect 886, Lyon, France; [Alla, Francois] Univ Paris 05, Apemac, EA4360, Univ Lorraine,INSERM,CIC EC,CIE6, Nancy, France; [Hoen, Bruno] Ctr Hosp Univ, Malad Infectieuses & Trop, Point A Pitre, France; [Duval, Xavier] Univ Paris Diderot Paris 7, Hop Univ Bichat, AP HP, Inserm IAME U1137,UFR Med Bichat,Inserm CIC 1425, Paris, France	CHU de Nancy; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Rennes; CHD Vendee; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CHU de Montpellier; Universite de Franche-Comte; CHU Besancon; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Reims; Universite de Franche-Comte; CHU Besancon; Universite de Franche-Comte; CHU Besancon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lorraine; CHU Guadeloupe; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Selton-Suty, C (corresponding author), CHU Nancy Brabois, Cardiol, F-54511 Nancy, France.	c.suty-selton@chu-nancy.fr	Vernet-Garnier, Véronique/P-5729-2016; Carmen, Team3/Y-7384-2019; alla, francois/D-2295-2014	Carmen, Team3/0000-0002-3614-0924; Le Moing, Vincent/0000-0002-9529-2792; alla, francois/0000-0002-5793-7190; Selton-Suty, Christine/0000-0003-4129-5784; Lab, Carmen/0000-0002-5935-3236	Ministere de la Sante (FR); Programme Hospitalier de Recherche Clinique; Association pour l'Enseignement de la Therapeutique; Societe de Pathologie Infectieuse de Langue Francaise; Societe Francaise de Microbiologie; Societe Nationale Francaise de Medecine Interne; Societe de Reanimation de Langue Francaise; Societe Francaise de Gerontologie; Societe Francaise de Cardiologie; Societe Francaise de Chirurgie Thoracique et Cardiovasculaire; Societe Francaise d'Anesthesie-Reanimation; Federation Francaise de Cardiologie	Ministere de la Sante (FR); Programme Hospitalier de Recherche Clinique; Association pour l'Enseignement de la Therapeutique; Societe de Pathologie Infectieuse de Langue Francaise; Societe Francaise de Microbiologie; Societe Nationale Francaise de Medecine Interne; Societe de Reanimation de Langue Francaise; Societe Francaise de Gerontologie; Societe Francaise de Cardiologie; Societe Francaise de Chirurgie Thoracique et Cardiovasculaire; Societe Francaise d'Anesthesie-Reanimation; Federation Francaise de Cardiologie	This work was supported by Ministere de la Sante (FR), and Programme Hospitalier de Recherche Clinique 2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was scientifically supported by the following French professional organizations: Association pour l'Enseignement de la Therapeutique, Societe de Pathologie Infectieuse de Langue Francaise, Societe Francaise de Microbiologie, Societe Nationale Francaise de Medecine Interne, Societe de Reanimation de Langue Francaise, Societe Francaise de Gerontologie, Societe Francaise de Cardiologie, Societe Francaise de Chirurgie Thoracique et Cardiovasculaire, Societe Francaise d'Anesthesie-Reanimation, and Federation Francaise de Cardiologie.	Barsic B, 2013, CLIN INFECT DIS, V56, P209, DOI 10.1093/cid/cis878; Cooper HA, 2009, CIRCULATION, V120, P585, DOI 10.1161/CIRCULATIONAHA.108.834432; Duval X, 2010, ANN INTERN MED, V152, P497, DOI 10.7326/0003-4819-152-8-201004200-00006; Garcia-Cabrera E, 2013, CIRCULATION, V127, P2272, DOI 10.1161/CIRCULATIONAHA.112.000813; Goulenok T, 2013, CEREBROVASC DIS, V35, P327, DOI 10.1159/000348317; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Habib G, 2009, EUR HEART J, V30, P2369, DOI 10.1093/eurheartj/ehp285; Kang DH, 2012, NEW ENGL J MED, V366, P2466, DOI 10.1056/NEJMoa1112843; Lee SJ, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-30; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Meshaal MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118616; Misfeld M, 2014, J THORAC CARDIOV SUR, V147, P1837, DOI 10.1016/j.jtcvs.2013.10.076; Pruitt AA, 2013, CURR TREAT OPTION NE, V15, P465, DOI 10.1007/s11940-013-0235-8; Selton-Suty C, 2012, CLIN INFECT DIS, V54, P1230, DOI 10.1093/cid/cis199; Snygg-Martin U, 2008, CLIN INFECT DIS, V47, P23, DOI 10.1086/588663; Thuny F, 2007, EUR HEART J, V28, P1155, DOI 10.1093/eurheartj/ehm005; Thuny F, 2012, LANCET, V379, P965, DOI 10.1016/S0140-6736(11)60755-1	17	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158522	10.1371/journal.pone.0158522	http://dx.doi.org/10.1371/journal.pone.0158522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27400273	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508100004
J	Groendahl, S; Fink, P				Groendahl, Sophie; Fink, Patrick			The Effect of Diet Mixing on a Nonselective Herbivore	PLOS ONE			English	Article							COMPLEMENTARY RESOURCES; GENERALIST HERBIVORES; INSECT HERBIVORE; FOOD; GROWTH; FITNESS; SELECTION; QUALITY; CYANOBACTERIUM; INFOCHEMICALS	The balanced-diet hypothesis states that a diverse prey community is beneficial to consumers due to resource complementarity among the prey species. Nonselective consumer species cannot differentiate between prey items and are therefore not able to actively regulate their diet intake. We thus wanted to test whether the balanced-diet hypothesis is applicable to nonselective consumers. We conducted a laboratory experiment in which a nonselective model grazer, the freshwater gastropod Lymnaea stagnalis, was fed benthic green algae as single species or as a multi-species mixture and quantified the snails' somatic growth rates and shell lengths over a seven-week period. Gastropods fed the mixed diet were found to exhibit a higher somatic growth rate than the average of the snails fed single prey species. However, growth on the multi-species mixture did not exceed the growth rate obtained on the best single prey species. Similar results were obtained regarding the animals' shell height increase over time. The mixed diet did not provide the highest growth rate, which confirms our hypothesis. We thus suggest that the balanced-diet hypothesis is less relevant for non-selective generalist consumers, which needs to be considered in estimates of secondary production.	[Groendahl, Sophie; Fink, Patrick] Univ Cologne, Inst Zool, Workgrp Aquat Chem Ecol, Cologne, Nrw, Germany; [Fink, Patrick] Univ Dusseldorf, Inst Zoomorphol & Cell Biol, Dusseldorf, Nrw, Germany	University of Cologne; Heinrich Heine University Dusseldorf	Groendahl, S (corresponding author), Univ Cologne, Inst Zool, Workgrp Aquat Chem Ecol, Cologne, Nrw, Germany.	sgroenda@uni-koeln.de	Fink, Patrick/A-5901-2009	Fink, Patrick/0000-0002-5927-8977	Deutsche Forschungsgemeinschaft (DFG) [FI 1548/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft (DFG), Grant FI 1548/5-1, http://www.dfg.de/, PF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle N, 2005, FRESHWATER BIOL, V50, P369, DOI 10.1111/j.1365-2427.2004.01325.x; Alva-Martinez AF, 2007, AQUAT ECOL, V41, P579, DOI 10.1007/s10452-007-9115-1; Araya RG, 2012, AQUACULTURE, V364, P272, DOI 10.1016/j.aquaculture.2012.08.036; Armitage P. D., 2012, CHIRONOMIDAE BIOL EC; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; BERGMAN E, 1994, ECOLOGY, V75, P1233, DOI 10.2307/1937449; Bernays EA, 1997, ECOLOGY, V78, P1157, DOI 10.1890/0012-9658(1997)078[1157:IHDRFB]2.0.CO;2; BERNAYS EA, 1994, ECOLOGY, V75, P1997, DOI 10.2307/1941604; Boenigk J, 2002, AQUAT MICROB ECOL, V27, P195, DOI 10.3354/ame027195; Camacho FA, 2006, LIMNOL OCEANOGR, V51, P1870, DOI 10.4319/lo.2006.51.4.1870; CARMICHAEL WW, 1986, ADV BOT RES, V12, P47, DOI 10.1016/S0065-2296(08)60193-7; CHUNG TK, 1991, J NUTR, V121, P979, DOI 10.1093/jn/121.7.979; COLLINS M, 1978, MICROBIOL REV, V42, P725, DOI 10.1128/MMBR.42.4.725-746.1978; Coogan SCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105719; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; Dame R.F., 2011, ECOLOGY MARINE BIVAL; Dawes C J, 1966, LIGHT ELECT MICROSCO; DEARING MD, 1992, ECOLOGY, V73, P845, DOI 10.2307/1940162; DeMott WR, 2010, ECOLOGY, V91, P540, DOI 10.1890/08-2103.1; DeMott WR, 1998, ECOLOGY, V79, P2463, DOI 10.2307/176836; Dillon R. T., 2000, ECOLOGY FRESHWATER M, DOI 10.1017/CBO9780511542008; FENCHEL T, 1975, MAR BIOL, V30, P119, DOI 10.1007/BF00391586; Fink P, 2006, OIKOS, V115, P484, DOI 10.1111/j.2006.0030-1299.14951.x; Foster GG, 1999, MAR BIOL, V134, P307, DOI 10.1007/s002270050548; Franzke A, 2010, ECOL ENTOMOL, V35, P126, DOI 10.1111/j.1365-2311.2009.01168.x; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Gamfeldt L, 2005, ECOL LETT, V8, P696, DOI 10.1111/j.1461-0248.2005.00765.x; HABDIJA I, 1995, INT REV GES HYDROBIO, V80, P103, DOI 10.1002/iroh.19950800113; Hagele BF, 1999, OECOLOGIA, V119, P521, DOI 10.1007/s004420050815; Hillebrand H, 1999, LIMNOL OCEANOGR, V44, P440, DOI 10.4319/lo.1999.44.2.0440; Kennish R, 1996, OECOLOGIA, V105, P22, DOI 10.1007/BF00328787; Khait R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082391; Lampert W, 2011, DAPHNIA DEV MODEL OR; Lampert W, 1996, FUNCTIONAL ECOLOGY, P631; Lefcheck JS, 2013, ECOLOGY, V94, P565, DOI 10.1890/12-0192.1; LIMA SL, 1986, ANIM BEHAV, V34, P536, DOI 10.1016/S0003-3472(86)80122-1; LOBEL PS, 1981, MAR BIOL, V64, P173, DOI 10.1007/BF00397106; LOPEZ GR, 1978, OECOLOGIA, V32, P263, DOI 10.1007/BF00345106; Moelzner J, 2015, OIKOS, V124, P1603, DOI 10.1111/oik.02069; Moelzner J, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00246.1; Moelzner J, 2014, J ANIM ECOL, V83, P1007, DOI 10.1111/1365-2656.12220; PENNINGS SC, 1993, ECOLOGY, V74, P879, DOI 10.2307/1940813; Raubenheimer D, 2006, ANIM BEHAV, V71, P1253, DOI 10.1016/j.anbehav.2005.07.024; RAUBENHEIMER D, 1992, ECOLOGY, V73, P1012, DOI 10.2307/1940176; RAUBENHEIMER D, 1993, ANIM BEHAV, V45, P953, DOI 10.1006/anbe.1993.1114; Senior AM, 2015, AM NAT, V186, P649, DOI 10.1086/683182; Senior AM, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004111; Simpson SJ, 2015, ANNU REV ENTOMOL, V60, P293, DOI 10.1146/annurev-ento-010814-020917; Unsicker SB, 2008, OECOLOGIA, V156, P313, DOI 10.1007/s00442-008-0973-6; Valiela I, 1995, MARINE ECOLOGICAL PR; VanDonk E, 1997, LIMNOL OCEANOGR, V42, P357; von Elert E, 1997, LIMNOL OCEANOGR, V42, P1796, DOI 10.4319/lo.1997.42.8.1796; WATANABE JM, 1984, OECOLOGIA, V62, P47, DOI 10.1007/BF00377371; WEST L, 1986, ECOLOGY, V67, P798, DOI 10.2307/1937702; WESTOBY M, 1978, AM NAT, V112, P627, DOI 10.1086/283303; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; Zotin AA, 2009, BIOL BULL+, V36, P455, DOI 10.1134/S1062359009050057	57	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158924	10.1371/journal.pone.0158924	http://dx.doi.org/10.1371/journal.pone.0158924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391787	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400164
J	Guo, DD; Liu, F; Tu, YH; He, BX; Gao, Y; Guo, ML				Guo, Dan-Dan; Liu, Fei; Tu, Yan-Hua; He, Bei-Xuan; Gao, Yue; Guo, Mei-Li			Expression Patterns of Three UGT Genes in Different Chemotype Safflower Lines and under MeJA Stimulus Revealed Their Potential Role in Flavonoid Biosynthesis	PLOS ONE			English	Article							NOMENCLATURE UPDATE; MOLECULAR-CLONING; GLYCOSYLTRANSFERASES; GLUCOSYLTRANSFERASE; QUINOCHALCONES; GLYCOSYLATION; NICOTIFLORIN; FLORETS	Safflower (Carthamus tinctorius L.) has received a significant amount of attention as a medicinal plant in China. Flavonoids are the dominant active medical compounds. UDP-glycosyltransferase plays an essential role in the biosynthesis and storage of flavonoids in safflower. In this study, 45 UGT unigenes were screened from our transcriptomic database of safflower. Among them, 27 UGT unigenes were predicted to own a complete open reading frame with various pI and Mw. The phylogenetic tree showed that CtUGT3 and CtUGT16 were classified under the UGT71 subfamily involved in metabolite process, whereas CtUGT25 has high identities with PoUGT both catalyzing the glycosylation of flavonoids and belonging to the UGT90 subfamily. cDNA microarray exhibited that the three UGT genes displayed temporal difference in two chemotype safflower lines. To functionally characterize UGT in safflower, CtUGT3, CtUGT16 and CtUGT25 were cloned and analyzed. Subcellular localization suggested that the three UGTs might be located in the cell cytoplasm and chloroplast. The expression pattern showed that the three UGTs were all suppressed in two lines responsive to methyl jasmonate induction. The co-expression relation of expression pattern and metabolite accumulation demonstrated that CtUGT3 and CtUGT25 were positively related to kaempferol-3-O-beta-D-glucoside and CtUGT16 was positively related to quercetin-3-O-beta-D-glucoside in yellow line, whereas CtUGT3 and CtUGT25 were positively related to quercetin-3-O-beta-D-glucoside in white line. This study indicates that the three CtUGTs play a significant and multiple role in flavonoids biosynthesis with presenting different functional characterization in two safflower lines.	[Guo, Dan-Dan; Liu, Fei; Tu, Yan-Hua; He, Bei-Xuan; Gao, Yue; Guo, Mei-Li] Second Mil Med Univ, Coll Pharm, Dept Pharmacognosy, Shanghai 200433, Peoples R China	Naval Medical University	Gao, Y; Guo, ML (corresponding author), Second Mil Med Univ, Coll Pharm, Dept Pharmacognosy, Shanghai 200433, Peoples R China.	gaoyue2000@hotmail.com; mlguo@126.com			Natural Science Foundation of China [81173484, 81473300]; Shanghai Natural Science Foundation [13ZR1448200]; "863" High Technology Project [2008AA02Z137]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); "863" High Technology Project(National High Technology Research and Development Program of China)	This work was supported by a grant from Natural Science Foundation of China (81173484 and 81473300), Shanghai Natural Science Foundation (13ZR1448200) and "863" High Technology Project (2008AA02Z137).	Ahmed A, 2006, J AM CHEM SOC, V128, P14224, DOI 10.1021/ja064686s; Bock KW, 2015, BIOCHEM PHARMACOL, V8; Bowles D, 2005, CURR OPIN PLANT BIOL, V8, P254, DOI 10.1016/j.pbi.2005.03.007; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Brazier-Hicks M, 2009, J BIOL CHEM, V284, P17926, DOI 10.1074/jbc.M109.009258; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen QY, 2015, PLANT CELL REP, V34, P1761, DOI 10.1007/s00299-015-1822-9; Chen S, 2011, PLANT CELL REP, V30, P1593, DOI 10.1007/s00299-011-1070-6; Dixon RA, 1999, TRENDS PLANT SCI, V4, P394, DOI 10.1016/S1360-1385(99)01471-5; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gandia-Herrero F, 2008, PLANT J, V56, P963, DOI 10.1111/j.1365-313X.2008.03653.x; Gecgel U, 2007, J AM OIL CHEM SOC, V84, P47, DOI 10.1007/s11746-006-1007-3; He L-S, 2013, PLOS ONE, V8; Hu L, 2015, PLOS ONE, V10; Jiang JS, 2010, ORG LETT, V12, P1196, DOI 10.1021/ol902971w; Jones P, 2003, J BIOL CHEM, V278, P43910, DOI 10.1074/jbc.M303523200; Kazuma K, 2000, BIOSCI BIOTECH BIOCH, V64, P1588, DOI 10.1271/bbb.64.1588; Kim JH, 2006, PLANT SCI, V170, P897, DOI 10.1016/j.plantsci.2005.12.013; Ko JH, 2006, PLANT CELL REP, V25, P741, DOI 10.1007/s00299-006-0119-4; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li RP, 2006, BIOL PHARM BULL, V29, P1868, DOI 10.1248/bpb.29.1868; Li RP, 2006, J ETHNOPHARMACOL, V107, P143, DOI 10.1016/j.jep.2006.04.024; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Lim EK, 2003, GLYCOBIOLOGY, V13, P139, DOI 10.1093/glycob/cwg017; Liu Z, 2015, BMC PLANT BIOL, V15; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Mackenzie PI, 1997, PHARMACOGENETICS, V7, P255, DOI 10.1097/00008571-199708000-00001; Masada S, 2009, PLANT CELL PHYSIOL, V50, P1401, DOI 10.1093/pcp/pcp088; Modolo LV, 2007, PLANT MOL BIOL, V64, P499, DOI 10.1007/s11103-007-9167-6; Naoumkina M, 2007, P NATL ACAD SCI USA, V104, P17909, DOI 10.1073/pnas.0708697104; Ono E, 2010, PLANT CELL, V22, P2856, DOI 10.1105/tpc.110.074625; Reddy NRR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129422; Shahin A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-640; Suzuki H, 2005, PLANTA, V220, P696, DOI 10.1007/s00425-004-1387-2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Trapero A, 2012, PLANT PHYSIOL, V159, P1335, DOI 10.1104/pp.112.198069; Vogt T, 2000, TRENDS PLANT SCI, V5, P380, DOI 10.1016/S1360-1385(00)01720-9; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; WeymouthWilson AC, 1997, NAT PROD REP, V14, P99, DOI 10.1039/np9971400099; Williams C, 1994, FLAVONOIDS ADV RES 1; Xie KB, 2014, ORG LETT, V16, P4874, DOI 10.1021/ol502380p; Zhou XD, 2014, J ETHNOPHARMACOL, V151, P27, DOI 10.1016/j.jep.2013.10.050	43	10	17	6	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158159	10.1371/journal.pone.0158159	http://dx.doi.org/10.1371/journal.pone.0158159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391785	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400034
J	Marin, V; Rosso, N; Dal Ben, M; Raseni, A; Boschelle, M; Degrassi, C; Nemeckova, I; Nachtigal, P; Avellini, C; Tiribelli, C; Gazzin, S				Marin, Veronica; Rosso, Natalia; Dal Ben, Matteo; Raseni, Alan; Boschelle, Manuela; Degrassi, Cristina; Nemeckova, Ivana; Nachtigal, Petr; Avellini, Claudio; Tiribelli, Claudio; Gazzin, Silvia			An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis	PLOS ONE			English	Article							HEPATIC STEATOSIS; HIGH-FRUCTOSE; BODY-WEIGHT; DIET; CHILDREN; ADOLESCENTS; METABOLISM; OBESITY; GENDER; MOUSE	Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) are the hepatic manifestations of the metabolic syndrome; worrisome is the booming increase in pediatric age. To recreate the full spectrum of juvenile liver pathology and investigate the gender impact, male and female C57Bl/6 mice were fed with high fat diet plus fructose in the drinking water (HFHC) immediately after weaning (equal to 3-years old human), and disease progression followed for 16 weeks, until adults (equal to 30-years old human). 100% of subjects of both genders on HFHC diet developed steatosis in 4weeks, and some degree of fibrosis in 8weeks, with the 86% of males and 15% of females presenting a stage 2 fibrosis at 16weeks. Despite a similar final liver damage both groups, a sex difference in the pathology progression was observed. Alterations in glucose homeostasis, dyslipidemia, hepatomegaly and obese phenotype were evident from the very beginning in males with an increased hepatic inflammatory activity. Conversely, such alterations were present in females only at the end of the HFHC diet (with the exception of insulin resistance and the hepatic inflammatory state). Interestingly, only females showed an altered hepatic redox state. This juvenile model appears a good platform to unravel the underlying gender dependent mechanisms in the progression from NAFLD to NASH, and to characterize novel therapeutic approaches.	[Marin, Veronica; Rosso, Natalia; Dal Ben, Matteo; Tiribelli, Claudio; Gazzin, Silvia] Fdn Italiana Fegato, AREA Sci Pk, Trieste, Italy; [Raseni, Alan; Boschelle, Manuela] IRCCS Osped Burlo Garofolo Pediat Hosp, Clin Chem Lab, Trieste, Italy; [Degrassi, Cristina] Med Res Inst, AREA Sci Pk, Trieste, Italy; [Nemeckova, Ivana; Nachtigal, Petr] Charles Univ Prague, Dept Biol & Med Sci, Fac Pharm Hradec Kralove, Heyrovskeho 1203, Hradec Kralove 50005, Czech Republic; [Avellini, Claudio] Azienda Osped Univ Santa Maria Misericordia, Dip Anat & Patol, Udine, Italy; [Tiribelli, Claudio] Univ Trieste, Dept Med Sci, Trieste, Italy	IRCCS Burlo Garofolo; Charles University Prague; Hospital Santa Maria della Misericordia; University of Trieste	Gazzin, S (corresponding author), Fdn Italiana Fegato, AREA Sci Pk, Trieste, Italy.	silvia.gazzin@csf.units.it	Nachtigal, Petr/S-8022-2017; Nemeckova, Ivana/T-6610-2017; Rosso, Natalia/K-9035-2016; Dal Ben, Matteo/N-6658-2015; Tiribelli, Claudio/A-4716-2014	Nachtigal, Petr/0000-0001-9568-7295; Nemeckova, Ivana/0000-0002-9795-8471; Rosso, Natalia/0000-0002-4251-3547; Dal Ben, Matteo/0000-0001-9294-2107; Tiribelli, Claudio/0000-0001-6596-7595	Italian National Grant MIUR [Art.13 D.LGS 297/99]; Fondazione Italiana Fegato, ONLUS	Italian National Grant MIUR(Ministry of Education, Universities and Research (MIUR)); Fondazione Italiana Fegato, ONLUS	The present work was funded by Italian National Grant MIUR - Art.13 D.LGS 297/99 - Progetto Nutrizione e Salute (NR, VM, SG); and in part by an in-house grant from Fondazione Italiana Fegato, ONLUS (MDB, CT).	Akagiri S, 2008, J CLIN BIOCHEM NUTR, V42, P150, DOI 10.3164/jcbn.2008022; Alini Schultz, 2014, J DIABETES METAB DIS, V1; Altunkaynak BZ, 2007, SAUDI MED J, V28, P891; Anstee QM, 2011, LIVER INT, V31, P440, DOI 10.1111/j.1478-3231.2011.02463.x; Bellentani S, 2010, DIGEST DIS, V28, P155, DOI 10.1159/000282080; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Escola-Gil JC, 2011, ARTERIOSCL THROM VAS, V31, P2493, DOI 10.1161/ATVBAHA.111.236075; Della Corte C, 2012, J ADOLESCENT HEALTH, V51, P305, DOI 10.1016/j.jadohealth.2012.01.010; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Feldstein AE, 2009, GUT, V58, P1538, DOI 10.1136/gut.2008.171280; Fu JF, 2009, WORLD J GASTROENTERO, V15, P912, DOI 10.3748/wjg.15.912; Ganz M, 2014, WORLD J GASTROENTERO, V20, P8525, DOI 10.3748/wjg.v20.i26.8525; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Giorgio V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-40; Hewitt KN, 2004, ENDOCRINOLOGY, V145, P1842, DOI 10.1210/en.2003-1369; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x; Kamada Y, 2011, AM J PHYSIOL-GASTR L, V301, pG1031, DOI 10.1152/ajpgi.00211.2011; Keyamura Y, 2015, BIOL PHARM BULL, V38, P785, DOI 10.1248/bpb.b14-00775; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Ko JS, 2009, DIGEST DIS SCI, V54, P2225, DOI 10.1007/s10620-009-0949-3; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Larter CZ, 2008, J GASTROEN HEPATOL, V23, P1635, DOI 10.1111/j.1440-1746.2008.05543.x; LEY CJ, 1992, AM J CLIN NUTR, V55, P950, DOI 10.1093/ajcn/55.5.950; Lichtenstein AH, 2000, ATHEROSCLEROSIS, V150, P227, DOI 10.1016/S0021-9150(99)00504-3; Loomba R, 2009, HEPATOLOGY, V50, P1282, DOI 10.1002/hep.23119; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Louet Jean-Francois, 2004, Curr Atheroscler Rep, V6, P180, DOI 10.1007/s11883-004-0030-9; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Machado MV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127991; de Castro UGM, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-136; Nobili V, 2006, HEPATOLOGY, V44, P458, DOI 10.1002/hep.21262; Patton HM, 2006, J PEDIATR GASTR NUTR, V43, P413, DOI 10.1097/01.mpg.0000239995.58388.56; Pettersson US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046057; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roberts EA, 2007, J HEPATOL, V46, P1133, DOI 10.1016/j.jhep.2007.03.003; Rosso N, 2014, WORLD J GASTROENTERO, V20, P9038, DOI 10.3748/wjg.v20.i27.9038; Sanches SCL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/574832; Schwimmer JB, 2005, PEDIATRICS, V115, pE561, DOI 10.1542/peds.2004-1832; Schwinnner JB, 2005, HEPATOLOGY, V42, P641, DOI 10.1002/hep.20842; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; Suzuki D, 2005, J GASTROEN HEPATOL, V20, P327, DOI 10.1111/j.1440-1746.2005.03724.x; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Takahashi Y, 2011, HEPATOL RES, V41, P1066, DOI 10.1111/j.1872-034X.2011.00855.x	47	31	32	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158817	10.1371/journal.pone.0158817	http://dx.doi.org/10.1371/journal.pone.0158817			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391242	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400133
J	Nahidiazar, L; Agronskaia, AV; Broertjes, J; van den Broek, B; Jalink, K				Nahidiazar, Leila; Agronskaia, Alexandra V.; Broertjes, Jorrit; van den Broek, Bram; Jalink, Kees			Optimizing Imaging Conditions for Demanding Multi-Color Super Resolution Localization Microscopy	PLOS ONE			English	Article							SINGLE-MOLECULE FLUORESCENCE; OXYGEN SCAVENGING SYSTEM; SUPERRESOLUTION MICROSCOPY; PROBES; DYES	Single Molecule Localization super-resolution Microscopy (SMLM) has become a powerful tool to study cellular architecture at the nanometer scale. In SMLM, single fluorophore labels are made to repeatedly switch on and off ("blink"), and their exact locations are determined by mathematically finding the centers of individual blinks. The image quality obtainable by SMLM critically depends on efficacy of blinking (brightness, fraction of molecules in the on-state) and on preparation longevity and labeling density. Recent work has identified several combinations of bright dyes and imaging buffers that work well together. Unfortunately, different dyes blink optimally in different imaging buffers, and acquisition of good quality 2- and 3-color images has therefore remained challenging. In this study we describe a new imaging buffer, OxEA, that supports 3-color imaging of the popular Alexa dyes. We also describe incremental improvements in preparation technique that significantly decrease lateral-and axial drift, as well as increase preparation longevity. We show that these improvements allow us to collect very large series of images from the same cell, enabling image stitching, extended 3D imaging as well as multi-color recording.	[Nahidiazar, Leila; van den Broek, Bram; Jalink, Kees] Netherlands Canc Inst, Dept Cell Biol, Cell Biophys Grp, Amsterdam, Netherlands; [Agronskaia, Alexandra V.] Univ Utrecht, Mol Biophys Grp, Utrecht, Netherlands; [Broertjes, Jorrit; Jalink, Kees] Univ Amsterdam, Fac Sci, Amsterdam, Netherlands; [Jalink, Kees] Univ Amsterdam, Swammerdam Inst Life Sci, Mol Cytol, Van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands	Netherlands Cancer Institute; Utrecht University; University of Amsterdam; University of Amsterdam	Jalink, K (corresponding author), Netherlands Canc Inst, Dept Cell Biol, Cell Biophys Grp, Amsterdam, Netherlands.; Jalink, K (corresponding author), Univ Amsterdam, Fac Sci, Amsterdam, Netherlands.; Jalink, K (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Mol Cytol, Van Leeuwenhoek Ctr Adv Microscopy, Amsterdam, Netherlands.	k.jalink@nki.nl		Jalink, Kees/0000-0001-7019-3440	Stichting Technische Wetenschappen [STW12150]	Stichting Technische Wetenschappen	Support was provided by grant# STW12150 from the Stichting Technische Wetenschappen [http://www.stw.nl/en/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CE, 2008, BIOPHYS J, V94, P1826, DOI 10.1529/biophysj.107.117689; Altman RB, 2012, NAT METHODS, V9, P68, DOI [10.1038/nmeth.1774, 10.1038/NMETH.1774]; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/NMETH.1768, 10.1038/nmeth.1768]; Enderlein J, 2012, RECENT DEV GSDIM MIC, V8228, DOI [10.1117/12.912748, DOI 10.1117/12.912748]; Engelhardt J, 2011, NANO LETT, V11, P209, DOI 10.1021/nl103472b; FONTIJN R, 1995, EXP CELL RES, V216, P199, DOI 10.1006/excr.1995.1025; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Groussard C, 2000, J APPL PHYSIOL, V89, P169, DOI 10.1152/jappl.2000.89.1.169; Ha T, 2012, ANNU REV PHYS CHEM, V63, P595, DOI 10.1146/annurev-physchem-032210-103340; Ho Kwei-Chi, 2003, Am J Clin Oncol, V26, pe86, DOI 10.1097/00000421-200308000-00029; Hoogendoorn E, 2014, SCI REP-UK, V4, DOI 10.1038/srep03854; Liu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep13017; Nahidiazar L, 2015, J CELL SCI, V128, P3714, DOI 10.1242/jcs.171892; Olivier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069004; Olivier N, 2013, BIOMED OPT EXPRESS, V4, P885, DOI 10.1364/BOE.4.000885; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Pereira PM, 2015, METHOD CELL BIOL, V125, P95, DOI 10.1016/bs.mcb.2014.10.004; Prakash K, 2015, P NATL ACAD SCI USA, V112, P14635, DOI 10.1073/pnas.1516928112; Shi XH, 2010, ANAL CHEM, V82, P6132, DOI 10.1021/ac1008749; van de Linde S, 2010, J BIOTECHNOL, V149, P260, DOI 10.1016/j.jbiotec.2010.02.010; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Vogelsang J, 2010, CHEMPHYSCHEM, V11, P2475, DOI 10.1002/cphc.201000189; Vogelsang J, 2009, P NATL ACAD SCI USA, V106, P8107, DOI 10.1073/pnas.0811875106; Widengren J, 2007, J PHYS CHEM A, V111, P429, DOI 10.1021/jp0646325	24	91	91	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158884	10.1371/journal.pone.0158884	http://dx.doi.org/10.1371/journal.pone.0158884			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391487	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400149
J	Rodriguez-Viera, L; Perera, E; Martos-Sitcha, JA; Perdomo-Morales, R; Casuso, A; Montero-Alejo, V; Garcia-Galano, T; Martinez-Rodriguez, G; Mancera, JM				Rodriguez-Viera, Leandro; Perera, Erick; Antonio Martos-Sitcha, Juan; Perdomo-Morales, Rolando; Casuso, Antonio; Montero-Alejo, Vivian; Garcia-Galano, Tsai; Martinez-Rodriguez, Gonzalo; Miguel Mancera, Juan			Molecular, Biochemical, and Dietary Regulation Features of alpha-Amylase in a Carnivorous Crustacean, the Spiny Lobster Panulirus argus	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; DIGESTIVE ENZYME-ACTIVITIES; PHENOLOXIDASE ACTIVITY; CARBOHYDRATE SOURCES; GENE POLYMORPHISM; FORMULATED DIETS; EVOLUTION; EXPRESSION; TRYPSIN; GROWTH	Alpha-amylases are ubiquitously distributed throughout microbials, plants and animals. It is widely accepted that omnivorous crustaceans have higher alpha-amylase activity and number of isoforms than carnivorous, but contradictory results have been obtained in some species, and carnivorous crustaceans have been less studied. In addition, the physiological meaning of alpha-amylase polymorphism in crustaceans is not well understood. In this work we studied alpha-amylase in a carnivorous lobster at the gene, transcript, and protein levels. It was showed that alpha-amylase isoenzyme composition (i.e., phenotype) in lobster determines carbohydrate digestion efficiency. Most frequent alpha-amylase phenotype has the lowest digestion efficiency, suggesting this is a favoured trait. We revealed that gene and intron loss have occurred in lobster alpha-amylase, thus lobsters express a single 1830 bp cDNA encoding a highly conserved protein with 513 amino acids. This protein gives rise to two isoenzymes in some individuals by glycosylation but not by limited proteolysis. Only the glycosylated isoenzyme could be purified by chromatography, with biochemical features similar to other animal amylases. High carbohydrate content in diet down-regulates a-amylase gene expression in lobster. However, high alpha-amylase activity occurs in lobster gastric juice irrespective of diet and was proposed to function as an early sensor of the carbohydrate content of diet to regulate further gene expression. We concluded that gene/isoenzyme simplicity, post-translational modifications and low Km, coupled with a tight regulation of gene expression, have arose during evolution of alpha-amylase in the carnivorous lobster to control excessive carbohydrate digestion in the presence of an active alpha-amylase.	[Rodriguez-Viera, Leandro; Casuso, Antonio; Garcia-Galano, Tsai] Univ Havana, Ctr Marine Res, Havana, Cuba; [Perera, Erick; Antonio Martos-Sitcha, Juan; Martinez-Rodriguez, Gonzalo] CSIC, Inst Ciencias Marinas Andalucia, ICMAN, Cadiz, Spain; [Perdomo-Morales, Rolando; Montero-Alejo, Vivian] Ctr Pharmaceut Res & Dev, Dept Biochem, Havana, Cuba; [Rodriguez-Viera, Leandro; Miguel Mancera, Juan] Univ Cadiz, Dept Biol, Cadiz, Spain; [Perera, Erick] CSIC, IATS, Dept Fish Physiol & Biotechnol, Control Food Intake Grp, Castellon de La Plana, Spain; [Antonio Martos-Sitcha, Juan] CSIC, IATS, Nutrigen & Fish Growth Endocrinol Grp, Castellon de La Plana, Spain	Universidad de la Habana; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS)	Rodriguez-Viera, L (corresponding author), Univ Havana, Ctr Marine Res, Havana, Cuba.; Perera, E (corresponding author), CSIC, Inst Ciencias Marinas Andalucia, ICMAN, Cadiz, Spain.; Rodriguez-Viera, L (corresponding author), Univ Cadiz, Dept Biol, Cadiz, Spain.; Perera, E (corresponding author), CSIC, IATS, Dept Fish Physiol & Biotechnol, Control Food Intake Grp, Castellon de La Plana, Spain.	leandro@cim.uh.cu; erick.perera@icman.csic.es	Rodriguez-Viera, Leandro/AAA-8942-2020; Martos-Sitcha, Juan Antonio/L-6140-2014; MARTINEZ-RODRIGUEZ, GONZALO/A-2564-2009; Perdomo-Morales, Rolando/AAC-8280-2020; Rodriguez-Viera, Leandro/AAD-3149-2020; Perera, Erick/E-9908-2018; Montero-Alejo, Vivian/AAY-1316-2020	Rodriguez-Viera, Leandro/0000-0002-2392-0075; Martos-Sitcha, Juan Antonio/0000-0002-0151-7250; MARTINEZ-RODRIGUEZ, GONZALO/0000-0003-3379-580X; Perdomo-Morales, Rolando/0000-0001-5598-6864; Rodriguez-Viera, Leandro/0000-0002-2392-0075; Perera, Erick/0000-0001-6108-1340; Montero-Alejo, Vivian/0000-0002-0089-7925	International Foundation for Science [A/4306-2]; Escuela Internacional de Doctorado en Agroalimentacion	International Foundation for Science(International Foundation for Science); Escuela Internacional de Doctorado en Agroalimentacion	This work was partially supported by International Foundation for Science (http://www.ifs.se/) through project no. A/4306-2 granted to EP, and Escuela Internacional de Doctorado en Agroalimentacion (http://www.ceia3.es/eida3) fellowship granted to LRV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; BENKEL BF, 1987, P NATL ACAD SCI USA, V84, P1337, DOI 10.1073/pnas.84.5.1337; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Castro PF, 2012, J CRUSTACEAN BIOL, V32, P607, DOI 10.1163/193724012X634206; Celis-Guerrero LE, 2004, MAR BIOTECHNOL, V6, P262, DOI 10.1007/s10126-003-0032-6; Chow S, 2011, MAR BIOTECHNOL, V13, P305, DOI 10.1007/s10126-010-9301-3; Cox C, 1997, MAR FRESHWATER RES, V48, P671, DOI 10.1071/MF97198; Da Lage JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019673; DaLage JL, 1996, J MOL EVOL, V43, P334, DOI 10.1007/PL00006093; Darnis S, 1999, BBA-PROTEIN STRUCT M, V1430, P281, DOI 10.1016/S0167-4838(99)00011-4; Del Toro MDAN, 2006, J EXP ZOOL PART A, V305A, P645, DOI 10.1002/jez.a.318; Dojnov B, 2008, COMP BIOCHEM PHYS B, V149, P153, DOI 10.1016/j.cbpb.2007.09.009; Douglas SE, 2000, AQUACULTURE, V190, P247, DOI 10.1016/S0044-8486(00)00398-7; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FRIED M, 1987, DIGEST DIS SCI, V32, P1097, DOI 10.1007/BF01300195; Froystad MK, 2006, COMP BIOCHEM PHYS A, V145, P479, DOI 10.1016/j.cbpa.2006.08.003; GAUTHIER SF, 1982, J NUTR, V112, P1718, DOI 10.1093/jn/112.9.1718; Gella FJ, 1997, CLIN CHIM ACTA, V259, P147, DOI 10.1016/S0009-8981(96)06481-9; German DP, 2010, PHYSIOL BIOCHEM ZOOL, V83, P1, DOI 10.1086/648510; Grossman G.L., 1993, Insect Molecular Biology, V1, P223, DOI 10.1111/j.1365-2583.1993.tb00095.x; Guarna MM, 1995, COMP BIOCHEM PHYS B, V112, P619, DOI 10.1016/0305-0491(95)00099-2; Hasan K, 2008, BIOLOGIA, V63, P1044, DOI 10.2478/s11756-008-0167-z; HICKEY DA, 1981, BIOCHEM GENET, V19, P783, DOI 10.1007/BF00484009; Hirtz C, 2005, PROTEOMICS, V5, P4597, DOI 10.1002/pmic.200401316; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HUGHES BL, 1994, POULTRY SCI, V73, P953, DOI 10.3382/ps.0730953; Huvet A, 2008, ANIM GENET, V39, P662, DOI 10.1111/j.1365-2052.2008.01776.x; Huvet A, 2012, COMP BIOCHEM PHYS B, V163, P96, DOI 10.1016/j.cbpb.2012.05.003; Inomata N, 1997, MOL BIOL EVOL, V14, P942, DOI 10.1093/oxfordjournals.molbev.a025837; Inomata N, 1995, J MOL EVOL, V41, P1076, DOI 10.1007/BF00173189; Inomata N, 2008, GENE, V412, P102, DOI 10.1016/j.gene.2008.01.023; Janecek S, 2002, BIOLOGIA, V57, P29; JANECEK S, 1995, PROTEIN ENG, V8, P809, DOI 10.1093/protein/8.8.809; Johnston D, 2005, BIOL BULL-US, V208, P36, DOI 10.2307/3593099; Johnston DJ, 2003, MAR BIOL, V143, P1071, DOI 10.1007/s00227-003-1154-0; Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeMoullac G, 1997, J EXP MAR BIOL ECOL, V208, P107, DOI 10.1016/S0022-0981(96)02671-8; LIPCIUS RN, 1982, MAR BIOL, V68, P241, DOI 10.1007/BF00409591; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombrana M, 2005, COMP BIOCHEM PHYS B, V142, P56, DOI 10.1016/j.cbpc.2005.05.017; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYLE WG, 1983, J CRUSTACEAN BIOL, V3, P208, DOI 10.2307/1548257; Martinez G, 1998, BIOTECHNIQUES, V24, P238, DOI 10.2144/98242bm14; MARX JM, 1985, B MAR SCI, V36, P423; MCCOMMAS S, 1990, BIOCHEM GENET, V28, P585, DOI 10.1007/BF00553951; Moreau Y, 2001, COMP BIOCHEM PHYS B, V128, P543, DOI 10.1016/S1096-4959(00)00358-4; O'Rorke R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042757; Perdomo-Morales R, 2007, FISH SHELLFISH IMMUN, V23, P1187, DOI 10.1016/j.fsi.2007.04.001; Perera E, 2008, COMP BIOCHEM PHYS B, V151, P250, DOI 10.1016/j.cbpb.2008.07.005; Perera E, 2008, COMP BIOCHEM PHYS B, V150, P247, DOI 10.1016/j.cbpb.2008.03.009; Perera E, 2015, REV AQUACULT, V7, P243, DOI 10.1111/raq.12066; Perera E, 2012, BIOL BULL-US, V222, P158, DOI 10.1086/BBLv222n2p158; Perera E, 2010, AQUACULTURE, V310, P178, DOI 10.1016/j.aquaculture.2010.10.009; Perera E, 2010, FEBS J, V277, P3489, DOI 10.1111/j.1742-4658.2010.07751.x; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Prudence M, 2006, ANIM GENET, V37, P348, DOI 10.1111/j.1365-2052.2006.01481.x; Quinn G.P., 2002, EXPT DESIGN DATA ANA; Rodriguez-Viera L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108875; Saunders MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036580; SAVOIE L, 1986, J FOOD SCI, V51, P494, DOI 10.1111/j.1365-2621.1986.tb11164.x; Simon CJ, 2011, AQUACULT NUTR, V17, P613, DOI 10.1111/j.1365-2095.2011.00861.x; Simon CJ, 2009, AQUACULTURE, V294, P271, DOI 10.1016/j.aquaculture.2009.06.023; Simon CJ, 2009, AQUACULTURE, V290, P275, DOI 10.1016/j.aquaculture.2009.02.026; SMITH VJ, 1991, DEV COMP IMMUNOL, V15, P251, DOI 10.1016/0145-305X(91)90018-T; SVENSSON B, 1994, PLANT MOL BIOL, V25, P141, DOI 10.1007/BF00023233; Takashima S, 2012, ADV BIOL CHEM, V2, P10; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tsuji A, 2014, FEBS OPEN BIO, V4, P560, DOI 10.1016/j.fob.2014.06.002; VANWORMHOUDT A, 1995, BIOCHEM SYST ECOL, V23, P139, DOI 10.1016/0305-1978(94)00090-4; VanWormhoudt A, 1996, J MOL EVOL, V42, P543, DOI 10.1007/BF02352284; Wang M, 2014, MAR FRESHWATER RES, V65, P337, DOI 10.1071/MF13048; Williams KC, 2007, AQUACULTURE, V263, P1, DOI 10.1016/j.aquaculture.2006.10.019; WOJTOWICZ MB, 1972, COMP BIOCHEM PHYSIOL, V42, P295, DOI 10.1016/0305-0491(72)90274-X; ZACHARIUS RM, 1969, ANAL BIOCHEM, V30, P148, DOI 10.1016/0003-2697(69)90383-2; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhang Z, 2003, J MOL EVOL, V56, P121, DOI 10.1007/s00239-002-2384-3; Zoltowska K, 2001, ACTA BIOCHIM POL, V48, P763	82	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158919	10.1371/journal.pone.0158919	http://dx.doi.org/10.1371/journal.pone.0158919			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391425	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400161
J	Vallet, A; Locatelli, B; Levrel, H; Perez, CB; Imbach, P; Carmona, NE; Manlay, R; Oszwald, J				Vallet, Ameline; Locatelli, Bruno; Levrel, Harold; Brenes Perez, Christian; Imbach, Pablo; Carmona, Natalia Estrada; Manlay, Raphael; Oszwald, Johan			Dynamics of Ecosystem Services during Forest Transitions in Reventazon, Costa Rica	PLOS ONE			English	Article							LAND-USE CHANGE; BIODIVERSITY CONSERVATION; CLIMATE-CHANGE; TRADE-OFFS; COVER; SYNERGIES; IMPLEMENTATION; HETEROGENEITY; ADAPTATION; FRAMEWORK	The forest transition framework describes the temporal changes of forest areas with economic development. A first phase of forest contraction is followed by a second phase of expansion once a turning point is reached. This framework does not differentiate forest types or ecosystem services, and describes forests regardless of their contribution to human well-being. For several decades, deforestation in many tropical regions has degraded ecosystem services, such as watershed regulation, while increasing provisioning services from agriculture, for example, food. Forest transitions and expansion have been observed in some countries, but their consequences for ecosystem services are often unclear. We analyzed the implications of forest cover change on ecosystem services in Costa Rica, where a forest transition has been suggested. A review of literature and secondary data on forest and ecosystem services in Costa Rica indicated that forest transition might have led to an ecosystem services transition. We modeled and mapped the changes of selected ecosystem services in the upper part of the Reventazon watershed and analyzed how supply changed over time in order to identify possible transitions in ecosystem services. The modeled changes of ecosystem services is similar to the second phase of a forest transition but no turning point was identified, probably because of the limited temporal scope of the analysis. Trends of provisioning and regulating services and their tradeoffs were opposite in different spatial subunits of our study area, which highlights the importance of scale in the analysis of ecosystem services and forest transitions. The ecosystem services transition framework proposed in this study is useful for analyzing the temporal changes of ecosystem services and linking socio-economic drivers to ecosystem services demand at different scales.	[Vallet, Ameline; Levrel, Harold] Univ Paris Saclay, Ecole Ponts ParisTech, EHESS, CIRED,AgroParisTech,Cirad,CNRS, Nogent Sur Marne, France; [Vallet, Ameline; Locatelli, Bruno] CIRAD, Res Unit Forests & Soc, Montpellier, France; [Vallet, Ameline; Locatelli, Bruno] CIFOR, Lima, Peru; [Brenes Perez, Christian; Imbach, Pablo] CATIE, Turrialba, Costa Rica; [Carmona, Natalia Estrada] Biovers Int, Montpellier, France; [Manlay, Raphael] AgroParisTech, Unite Mixte Rech Eco&Sols, Montpellier, France; [Oszwald, Johan] Univ Rennes 2, Unite Mixte Rech CNRS 6554, LETG Rennes COSTEL, Rennes, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CIRAD; Ecole des Ponts ParisTech; UDICE-French Research Universities; Universite Paris Saclay; CIRAD; CGIAR; Center for International Forestry Research (CIFOR); Alliance; Bioversity International; AgroParisTech; Universite Rennes 2	Vallet, A (corresponding author), Univ Paris Saclay, Ecole Ponts ParisTech, EHESS, CIRED,AgroParisTech,Cirad,CNRS, Nogent Sur Marne, France.; Vallet, A (corresponding author), CIRAD, Res Unit Forests & Soc, Montpellier, France.; Vallet, A (corresponding author), CIFOR, Lima, Peru.	A.Vallet@cgiar.org	Locatelli, Bruno/C-9957-2009; Manlay, Raphaël J./C-8986-2011; CARMONA, NATALIA ESTRADA/AAN-7794-2020; Vallet, Améline/F-4037-2018	Locatelli, Bruno/0000-0003-2983-1644; Manlay, Raphaël J./0000-0003-0482-8457; CARMONA, NATALIA ESTRADA/0000-0003-4329-5470; Vallet, Améline/0000-0002-2731-0098; Levrel, Harold/0000-0002-4611-3639; Imbach, Pablo/0000-0003-4078-6063	International Climate Initiative IKI of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety; Norwegian Agency for Development Cooperation; CGIAR Research Program on Forests, Trees and Agroforestry CRP-FTA; CGIAR Fund	International Climate Initiative IKI of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety; Norwegian Agency for Development Cooperation; CGIAR Research Program on Forests, Trees and Agroforestry CRP-FTA(CGIAR); CGIAR Fund(CGIAR)	The International Climate Initiative IKI of the German Federal Ministry for the Environment, Nature Conservation, Building and Nuclear Safety (http://www.international-climate-initiative.com/en/) [AV and BL], the Norwegian Agency for Development Cooperation (https://www.norad.no/en/front/) [BL], and the CGIAR Research Program on Forests, Trees and Agroforestry CRP-FTA (http://foreststreesagroforestry.org/) with financial support from the CGIAR Fund [AV and BL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 2010, EV REC FOR MUND INF; [Anonymous], 2014, R LANG ENV STAT COMP; Arriagada R, 2009, 200907 LAT AM CAR EN; Arroyo-Mora JP, 2005, AGR ECOSYST ENVIRON, V106, P27, DOI 10.1016/j.agee.2004.07.002; Bagstad KJ, 2013, ECOSYST SERV, V5, pE40, DOI 10.1016/j.ecoser.2013.07.007; Bagstad KJ, 2013, ECOSYST SERV, V5, pE27, DOI 10.1016/j.ecoser.2013.07.004; Balthazar V, 2015, ECOL INDIC, V48, P63, DOI 10.1016/j.ecolind.2014.07.043; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bank World, 2000, COST RIC FOR POL LAN; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; Bienabe E, 2006, FOREST POLICY ECON, V9, P335, DOI 10.1016/j.forpol.2005.10.002; Bray DB, 2010, LANDSC SER, V10, P85, DOI 10.1007/978-1-4020-9656-3_5; Bremer LL, 2010, BIODIVERS CONSERV, V19, P3893, DOI 10.1007/s10531-010-9936-4; Brenes Perez C, 2009, ANALISIS MULTITEMPOR; Brockett CD, 2002, LAT AM RES REV, V37, P7; Calvo-Alvarado J, 2009, FOREST ECOL MANAG, V258, P931, DOI 10.1016/j.foreco.2008.10.035; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Carreno L, 2012, AGR ECOSYST ENVIRON, V154, P68, DOI 10.1016/j.agee.2011.05.019; Castro R, 2000, ENVIRON MONIT ASSESS, V61, P75, DOI 10.1023/A:1006366118268; Chadzon R L, 2016, AMBIO, V45, P538, DOI DOI 10.1007/913280-016-0772-Y; Daniels AE, 2009, REFORESTING LANDSCAP, P227; de Groot D, 2014, LINK BIODIVERSITY EC; Dearing JA, 2012, P NATL ACAD SCI USA, V109, pE1111, DOI 10.1073/pnas.1118263109; DeFries R, 2010, LAND USE POLICY, V27, P130, DOI 10.1016/j.landusepol.2009.07.003; ESRI, 2013, ARCGIS; Estrada Carmona N., 2009, IDENTIFICACION AREAS; FAO, 1989, 2 FAO; Farley KA, 2007, ANN ASSOC AM GEOGR, V97, P755, DOI 10.1111/j.1467-8306.2007.00581.x; Florian EM, 2008, ZONA CAFETALERA CORR; Geneletti D, 2013, ENVIRON IMPACT ASSES, V40, P25, DOI 10.1016/j.eiar.2012.12.003; Goldstein JH, 2012, P NATL ACAD SCI USA, V109, P7565, DOI 10.1073/pnas.1201040109; Grainger A, 2010, LANDSC SER, V10, P15, DOI 10.1007/978-1-4020-9656-3_2; Haase D, 2012, ECOL SOC, V17, DOI 10.5751/ES-04853-170322; Hall JM, 2012, LANDSCAPE ECOL, V27, P1135, DOI 10.1007/s10980-012-9755-y; HARRIS S A, 1973, Arctic and Alpine Research, V5, pA187; Harrison PA, 2014, ECOSYST SERV, V9, P191, DOI 10.1016/j.ecoser.2014.05.006; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HIJMANS RJ, 2015, GEOGRAPHIC DATA ANAL; Holland RA, 2011, BIODIVERS CONSERV, V20, P3285, DOI 10.1007/s10531-011-0113-1; IMN MINAET, 2011, EST CUENC HIDR COST; INEC, 2012, 10 CENS NAC POBL 6 V; ITCR, 2004, DIG ATL COST RIC CD; Kleinn C, 2002, ENVIRON MONIT ASSESS, V73, P17, DOI 10.1023/A:1012659129083; Kull CA, 2007, SOC NATUR RESOUR, V20, P723, DOI 10.1080/08941920701329702; Lambin EF, 2010, LAND USE POLICY, V27, P108, DOI 10.1016/j.landusepol.2009.09.003; Leh MDK, 2013, AGR ECOSYST ENVIRON, V165, P6, DOI 10.1016/j.agee.2012.12.001; Locatelli B, 2014, ENVIRON CONSERV, V41, P27, DOI 10.1017/S0376892913000234; Locatelli B, 2011, REG ENVIRON CHANGE, V11, P393, DOI 10.1007/s10113-010-0149-x; Locatelli B, 2011, FORESTS, V2, P431, DOI 10.3390/f2010431; Locatelli B, 2009, FOREST ECOL MANAG, V258, P1864, DOI 10.1016/j.foreco.2009.01.015; Martinez ML, 2009, FOREST ECOL MANAG, V258, P1856, DOI 10.1016/j.foreco.2009.02.023; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Maes J, 2012, BIOL CONSERV, V155, P1, DOI 10.1016/j.biocon.2012.06.016; Maitre D. C. L., 2009, ECOSYSTEM SERVICES L, P14; Marchamalo M, 2007, ECOL ECON, V63, P740, DOI 10.1016/j.ecolecon.2007.01.006; MATHER AS, 1992, AREA, V24, P367; Mather AS, 1998, AREA, V30, P117, DOI 10.1111/j.1475-4762.1998.tb00055.x; Mendoza-Gonzalez G, 2012, ECOL ECON, V82, P23, DOI 10.1016/j.ecolecon.2012.07.018; Meyfroidt P., 2009, REFORESTING LANDSCAP, P315; Moran-Ordonez A, 2013, ECOSYSTEMS, V16, P765, DOI 10.1007/s10021-013-9649-0; Murrieta Arevalo E., 2006, CARACTERIZACION COBE; NASA LP DAAC, 2011, ASTER GLOB DIG EL MO; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Nelson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014327; Nemec KT, 2013, BIODIVERS CONSERV, V22, P1, DOI 10.1007/s10531-012-0406-z; Pagella TF, 2014, LANDSCAPE ECOL, V29, P383, DOI 10.1007/s10980-013-9983-9; Pagiola S., 2006, PAYMENTS ENV SERVICE; Perz SG, 2007, PROF GEOGR, V59, P105, DOI 10.1111/j.1467-9272.2007.00594.x; Polasky S, 2011, ENVIRON RESOUR ECON, V48, P219, DOI 10.1007/s10640-010-9407-0; Pramova E, 2012, CLIM POLICY, V12, P393, DOI 10.1080/14693062.2011.647848; PREVDA, 2008, PLAN CUENC REV PAR 2; Putz FE, 2010, BIOTROPICA, V42, P10, DOI 10.1111/j.1744-7429.2009.00567.x; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Redo DJ, 2012, P NATL ACAD SCI USA, V109, P8839, DOI 10.1073/pnas.1201664109; Renard D, 2015, P NATL ACAD SCI USA, V112, P13411, DOI 10.1073/pnas.1502565112; Rounsevell MDA, 2010, BIODIVERS CONSERV, V19, P2823, DOI 10.1007/s10531-010-9838-5; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Rudel TK, 2009, REFORESTING LANDSCAP; SADER SA, 1988, BIOTROPICA, V20, P11, DOI 10.2307/2388421; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Sanchez-Azofeifa GA, 2007, CONSERV BIOL, V21, P1165, DOI 10.1111/j.1523-1739.2007.00751.x; Sharp R, 2014, INVEST 3 1 0 USERS G; Stem CJ, 2003, SOC NATUR RESOUR, V16, P387, DOI 10.1080/08941920309177; Swallow BM, 2009, ENVIRON SCI POLICY, V12, P504, DOI 10.1016/j.envsci.2008.11.003; Turner MG, 2013, LANDSCAPE ECOL, V28, P1081, DOI 10.1007/s10980-012-9741-4; Vignola R, 2010, DECISION MAKING FARM, P1132, DOI [10.1016/j.landusepol.2010.03.003, DOI 10.1016/J.LANDUSEP0L.2010.03.003]; Wang WJ, 2014, ENVIRON SCI POLICY, V44, P62, DOI 10.1016/j.envsci.2014.07.004; Willemen L, 2012, J ENVIRON MANAGE, V100, P86, DOI 10.1016/j.jenvman.2012.01.022; Wischmeier W. H., 1978, AGR HDB, V537, DOI DOI 10.1016/j.geomorph.2007.03.001; Wolff S, 2015, ECOL INDIC, V55, P159, DOI 10.1016/j.ecolind.2015.03.016; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Yackulic CB, 2011, ECOL SOC, V16, DOI 10.5751/ES-04275-160315; Zhang W, 2011, ENVIRON CONSERV, V38, P406, DOI 10.1017/S0376892911000555; Zomer R., 2006, CARBON LAND WATER GL	95	11	11	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158615	10.1371/journal.pone.0158615	http://dx.doi.org/10.1371/journal.pone.0158615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27390869	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400090
J	Thakur, JS; Jeet, G; Pal, A; Singh, S; Singh, A; Deepti, SS; Lal, M; Gupta, S; Prasad, R; Jain, S; Saran, R				Thakur, J. S.; Jeet, Gursimer; Pal, Arnab; Singh, Shavinder; Singh, Amarjit; Deepti, S. S.; Lal, Mohan; Gupta, Sanjay; Prasad, Rajender; Jain, Sanjay; Saran, Rajiv			Profile of Risk Factors for Non-Communicable Diseases in Punjab, Northern India: Results of a State-Wide STEPS Survey	PLOS ONE			English	Article							SERUM TOTAL CHOLESTEROL; REFERENCE INTERVALS; PHYSICAL-ACTIVITY; LDL-CHOLESTEROL; HDL-CHOLESTEROL; SOUTH-ASIA; TRIGLYCERIDES; PREVALENCE; PATTERNS; OBESITY	Background Efforts to assess the burden of non-communicable diseases risk factors has improved in low and middle-income countries after political declaration of UN High Level Meeting on NCDs. However, lack of reliable estimates of risk factors distribution are leading to delay in implementation of evidence based interventions in states of India. Methods A STEPS Survey, comprising all the three steps for assessment of risk factors of NCDs, was conducted in Punjab state during 2014-15. A statewide multistage sample of 5,127 residents, aged 18-69 years, was taken. STEPS questionnaire version 3.1 was used to collect information on behavioral risk factors, followed by physical measurements and blood and urine sampling for biochemical profile. Results Tobacco and alcohol consumption were observed in 11.3% (20% men and 0.9% women) and 15% (27% men and 0.3% women) of the population, respectively. Low levels of physical activity were recorded among 31% (95% CI: 26.7-35.5) of the participants. The prevalence of overweight and obesity was 28.6% (95% CI: 26.3-30.9) and 12.8% (95% CI: 11.2-14.4) respectively. Central obesity was higher among women (69.3%, 95% CI: 66.5-72.0) than men (49.5%, 95% CI: 45.3-53.7). Prevalence of hypertension in population was 40.1% (95% CI: 37.3-43.0). The mean sodium intake in grams per day for the population was 7.4 gms (95% CI: 7.2-7.7). The prevalence of diabetes (hyperglycemia), hypertriglyceridemia and hypercholesterolemia was 14.3% (95% CI: 11.7-16.8), 21.6% (95% CI: 18.5-25.1) and 16.1% (95% CI: 13.1-19.2), respectively. In addition, 7% of the population aged 40-69 years had a cardiovascular risk of >= 30% over a period of next 10 years. Conclusion We report high prevalence of risk factors of chronic non-communicable diseases among adults in Punjab. There is an urgent need to implement population, individual and programme wide prevention and control interventions to lower the serious consequences of NCDs.	[Thakur, J. S.; Jeet, Gursimer] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Pal, Arnab; Prasad, Rajender] Post Grad Inst Med Educ & Res, Dept Biochem, Chandigarh, India; [Singh, Shavinder] Christian Med Coll & Hosp, Dept Community Med, Ludhiana, Punjab, India; [Singh, Amarjit] Govt Med Coll, Dept Community Med, Patiala, Punjab, India; [Deepti, S. S.; Lal, Mohan] Govt Med Coll, Dept Community Med, Amritsar, Punjab, India; [Gupta, Sanjay] Guru Gobind Singh Med Coll, Dept Community Med, Faridkot, India; [Jain, Sanjay] Post Grad Inst Med Educ & Res, Dept Internal Med, Chandigarh, India; [Saran, Rajiv] Univ Michigan, Dept Internal Med & Epidemiol, Ann Arbor, MI 48109 USA	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; University of Michigan System; University of Michigan	Thakur, JS (corresponding author), Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India.	jsthakur64@gmail.com	Pal, Arnab/B-6024-2012; Pal, Arnab/AAK-7311-2021	Pal, Arnab/0000-0002-0850-3118; Pal, Arnab/0000-0002-0850-3118; Jain, Sanjay K/0000-0002-9241-3114; /0000-0003-3727-9941	National Health Mission, Punjab, India; National Health Mission (Punjab), Ministry of Health and Family Welfare, Government of India	National Health Mission, Punjab, India; National Health Mission (Punjab), Ministry of Health and Family Welfare, Government of India	National Health Mission, Punjab, India, JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate the support from Department of Health and Family welfare, Punjab especially Professor. KK Talwar, Advisor (Health), Government of Punjab, Ms. Vini Mahajan, IAS, Principal Secretary, Department of Health and Family Welfare and Mr. Hussan Lal, IAS, Secretary, Medical Education and Mission Director, National Health Mission, Punjab for their guidance and support for the project in conducting the study. Contributions by Biosense Pvt. Limited are acknowledged. We would like to thanks the members of Technical Advisory Committee and chairperson Prof. SK Jindal who provided technical oversight for the designing and implementation of survey. In addition inputs from advisors from University of Michigan were valuable. We sincerely acknowledge the financial support by National Health Mission (Punjab), Ministry of Health and Family Welfare, Government of India and technical support of WHO with special thanks to Dr. Dhirendra N Sinha, Regional Advisor (NCD and Tobacco Surveillance), WHO-SEARO and Dr. Lubna Bhatti, Epidemiologist, Prevention of Non-communicable Diseases (PND), World Health Organization, Geneva.	Anjana RM, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-26; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bhagyalaxmi A, 2013, J HEALTH POPUL NUTR, V31, P78; Devi BN, 2014, INDIAN J BASIC APPL, V4, P487; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Government of India, 2013, DISTR LEV HOUS FAC S; Institute for Health Metrics and Evaluation, 2010, GLOB BURD DIS STUD P; Jalali MT, 2013, INDIAN J CLIN BIOCHE, V28, P277, DOI 10.1007/s12291-012-0268-x; Jayawardena R, 2013, OBESITY FACTS, V6, P405, DOI 10.1159/000355598; Jayawardena R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-380; Kar SS, 2010, NATL MED J INDIA, V23, P206; Kaur V, 2012, INDIAN J CLIN BIOCHE, V27, P290, DOI 10.1007/s12291-012-0208-9; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kumar Rajesh, 2006, Indian Heart J, V58, P126; Kumaresan Kuppusamy, 2015, International Journal of Medicine and Public Health, V5, P253; Malati T, 2009, INDIAN J CLIN BIOCHE, V24, P343, DOI 10.1007/s12291-009-0063-5; [Ministry of Health and Family Welfare National Centre for Disease Control Government of India], 2015, INT DIS SURV PROGR; [Ministry of Health and Family Welfare Government of India International Institute for Population Sciences], 2009, GLOB AD TOB SURV GAT; Misra A, 2009, J Assoc Physicians India, V57, P163; Msyamboza KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020316; National Institute of Medical Statistics Indian Council of Medical Research (ICMR), 2009, IDSP NONC DIS RISK F; Nongkynrih Baridalyne, 2008, J Assoc Physicians India, V56, P165; PGIMER, 2014, BURD NCD RISK FACT P; Prinja S, 2012, INDIAN J MED RES, V136, P722; Registrar General of India, 2013, REP MED CERT CAUS DE; SGPC, 2006, SIKH REH MAR; Shah B, 2010, INDIAN J MED RES, V132, P634; Suryanarayana M.H., 2011, INEQUALITY ADJUSTED, P31; Thakur J, 2014, BURDEN NCD RISK FACT; Thakur J S, 2008, Int J Environ Res Public Health, V5, P399; Thakur Js, 2016, Asian Pac J Cancer Prev, V17, P791; Thomas MB, 2014, GLOBAL HEALTH ACTION, V7, P98, DOI 10.3402/gha.v7.22938; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; World Health Organaisation, 2014, TIM LEST STEPS NONC, P2; World Health Organisation, 2014, BHUT NONC DIS RISK F, P2; World Health Organization, 2005, WHO STEPS SURV MAN W; Zaman MM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1938-4; Zendejas B, 2013, SURGERY, V153, P160, DOI 10.1016/j.surg.2012.06.025	40	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157705	10.1371/journal.pone.0157705	http://dx.doi.org/10.1371/journal.pone.0157705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389020	gold, Green Published, Green Submitted			2022-12-26	WOS:000379811500008
J	Fujio, K; Obata, H; Kawashima, N; Nakazawa, K				Fujio, Kimiya; Obata, Hiroki; Kawashima, Noritaka; Nakazawa, Kimitaka			The Effects of Temporal and Spatial Predictions on Stretch Reflexes of Ankle Flexor and Extensor Muscles While Standing	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; TIBIALIS ANTERIOR MUSCLE; AUTOMATIC POSTURAL RESPONSES; SUPPORT-SURFACE; LEG MUSCLES; ELECTROMYOGRAPHIC RESPONSES; CORTICOSPINAL PATHWAYS; STANCE PERTURBATION; HUMAN WALKING; LOWER-LIMB	The purpose of the present study was to investigate how stretch reflex (SR) responses in the ankle extensor (soleus: SOL) and flexor (tibialis anterior: TA) muscles would be modulated with temporal and/or spatial predictions of external perturbations and whether their effects are specific to the standing posture. SR responses in the SOL/TA were elicited by imposing quick ankle toes-up/toes-down rotations while standing upright and in the supine position. We designed four experimental conditions based on pre-information about perturbations: no information (No Cue), the timing of the perturbation onset (TIM), the direction of the perturbation (DIR), and both the timing and direction of the perturbation (TIM/DIR). Each condition was separated and its order was counterbalanced. In the SR of TA evoked by toes-down rotation, integrated electromyography activities of the late component were significantly reduced in the TIM and TIM/DIR conditions as compared with those in the No Cue and DIR conditions. The occurrence rate of late SR components that reflects how often the reflex response was observed was also lower in the TIM and TIM/DIR conditions as compared with that in the No Cue and DIR conditions. On the other hand, no significant changes were seen among the four conditions in the early SR component in the TA and both SR components in the SOL. The same results in the occurrence rate were found in the supine position. The present results suggest (1) only temporal predictions have a remarkable effect on the SR excitability of the TA, and (2) this effect is independent of posture.	[Fujio, Kimiya; Obata, Hiroki; Nakazawa, Kimitaka] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Sports Sci Lab, Tokyo, Japan; [Kawashima, Noritaka] Res Inst Natl Rehabil Ctr Persons Disabil, Dept Rehabil Movement Funct, Tokorozawa, Saitama, Japan	University of Tokyo	Fujio, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Sports Sci Lab, Tokyo, Japan.	fujiokimiya@yahoo.co.jp						ACKERMANN H, 1991, NEUROSCI LETT, V127, P242, DOI 10.1016/0304-3940(91)90803-2; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319; BECKLEY DJ, 1991, ELECTROEN CLIN NEURO, V81, P353, DOI 10.1016/0168-5597(91)90024-R; BROUWER B, 1995, ELECTROMYOGR MOTOR C, V97, P49, DOI 10.1016/0924-980X(94)00265-9; Burleigh A, 1996, J NEUROPHYSIOL, V75, P1619, DOI 10.1152/jn.1996.75.4.1619; Carpenter MG, 2004, J NEUROPHYSIOL, V92, P3255, DOI 10.1152/jn.01139.2003; Carpenter MG, 1999, EXP BRAIN RES, V129, P93, DOI 10.1007/s002210050940; Chong RKY, 1999, EXP BRAIN RES, V124, P513, DOI 10.1007/s002210050647; Christensen LOD, 2001, J PHYSIOL-LONDON, V531, P545, DOI 10.1111/j.1469-7793.2001.0545i.x; CORNA S, 1995, J PHYSIOL-LONDON, V484, P803, DOI 10.1113/jphysiol.1995.sp020705; DIENER HC, 1991, EXP BRAIN RES, V84, P219; DIETZ V, 1992, PHYSIOL REV, V72, P33, DOI 10.1152/physrev.1992.72.1.33; Geertsen SS, 2010, J PHYSIOL-LONDON, V588, P2391, DOI 10.1113/jphysiol.2010.190678; Gilles M, 1999, EXP BRAIN RES, V124, P137, DOI 10.1007/s002210050607; Gruneberg C, 2005, J NEUROPHYSIOL, V94, P3143, DOI 10.1152/jn.00538.2004; HAMMOND PH, 1956, BRIT MED BULL, V12, P214, DOI 10.1093/oxfordjournals.bmb.a069553; HANSEN PD, 1988, EXP BRAIN RES, V73, P627, DOI 10.1007/BF00406622; Haridas C, 2005, BRAIN RES, V1062, P48, DOI 10.1016/j.brainres.2005.09.003; Honeycutt CF, 2009, J NEUROPHYSIOL, V101, P2751, DOI 10.1152/jn.91040.2008; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; Hudson HM, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00033; Jackson ND, 2009, J ELECTROMYOGR KINES, V19, P75, DOI 10.1016/j.jelekin.2007.06.016; Kimura T, 2003, NEUROSCI LETT, V347, P25, DOI 10.1016/S0304-3940(03)00612-8; McChesney JW, 1996, EXP BRAIN RES, V108, P315; MOORE SP, 1988, EXP BRAIN RES, V73, P648, DOI 10.1007/BF00406624; Musienko P, 2012, J NEUROPHYSIOL, V107, P2072, DOI 10.1152/jn.00730.2011; Nakazawa K, 2003, NEUROSCI LETT, V338, P53, DOI 10.1016/S0304-3940(02)01353-8; Nakazawa K, 2009, J ELECTROMYOGR KINES, V19, P782, DOI 10.1016/j.jelekin.2008.01.002; NARDONE A, 1990, EXP BRAIN RES, V80, P323; NASHNER LM, 1976, EXP BRAIN RES, V26, P59; Petersen N, 1998, J PHYSIOL-LONDON, V512, P267, DOI 10.1111/j.1469-7793.1998.267bf.x; ROTHWELL JC, 1986, EXP BRAIN RES, V63, P197; ROTHWELL JC, 1980, NATURE, V286, P496, DOI 10.1038/286496a0; Schieppati M, 1997, J PHYSIOL-LONDON, V503, P691, DOI 10.1111/j.1469-7793.1997.691bg.x; SCHIEPPATI M, 1995, J PHYSIOL-LONDON, V487, P787, DOI 10.1113/jphysiol.1995.sp020918; Taube W, 2006, J APPL PHYSIOL, V101, P420, DOI 10.1152/japplphysiol.01447.2005; TOFT E, 1989, EXP BRAIN RES, V74, P213; van Doornik J, 2004, EXP BRAIN RES, V157, P403, DOI 10.1007/s00221-004-1966-2; WOOLLACOTT MH, 1984, EXP BRAIN RES, V55, P263; YAMAMOTO C, 1989, EXP BRAIN RES, V77, P12; Zuur AT, 2009, J PHYSIOL-LONDON, V587, P1669, DOI 10.1113/jphysiol.2009.169367	42	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158721	10.1371/journal.pone.0158721	http://dx.doi.org/10.1371/journal.pone.0158721			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27385043	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400079
J	Fulgione, A; Nocerino, N; Iannaccone, M; Roperto, S; Capuano, F; Roveri, N; Lelli, M; Crasto, A; Calogero, A; Pilloni, AP; Capparelli, R				Fulgione, Andrea; Nocerino, Nunzia; Iannaccone, Marco; Roperto, Sante; Capuano, Federico; Roveri, Norberto; Lelli, Marco; Crasto, Antonio; Calogero, Armando; Pilloni, Argenia Paola; Capparelli, Rosanna			Lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling - In Vivo - the Helicobacter pylori Infection	PLOS ONE			English	Article							ADSORPTION; ERADICATION; ANTIBODIES; INCREASES	Background The resistance of Helicobacter pylori to the antibiotic therapy poses the problem to discover new therapeutic approaches. Recently it has been stated that antibacterial, immunomodulatory, and antioxidant properties of lactoferrin are increased when this protein is surface-linked to biomimetic hydroxyapatite nanocrystals. Objective Based on these knowledge, the aim of the study was to investigate the efficacy of lactoferrin delivered by biomimetic hydroxyapatite nanoparticles with cell free supernatant from probiotic Lactobacillus paracasei as an alternative therapy against Helicobacter pylori infection. Methods Antibacterial and antinflammatory properties, humoral antibody induction, histopathological analysis and absence of side effects were evaluated in both in vitro and in vivo studies. Results The tests carried out have been demonstrated better performance of lactoferrin delivered by biomimetic hydroxyapatite nanoparticles combined with cell free supernatant from probiotic Lactobacillus paracasei compared to both lactoferrin and probiotic alone or pooled. Conclusion These findings indicate the effectiveness and safety of our proposed therapy as alternative treatment for Helicobacter pylori infection.	[Fulgione, Andrea; Nocerino, Nunzia; Iannaccone, Marco; Crasto, Antonio; Capparelli, Rosanna] Univ Naples Federico II, Dept Agr, Naples, Italy; [Roperto, Sante] Univ Naples Federico II, Dept Vet Med & Anim Prod, Div Infect Dis, Naples, Italy; [Capuano, Federico] Ist Zooprofilatt Sperimentale Mezzogiorno, Dept Food Inspect, Naples, Italy; [Roveri, Norberto; Lelli, Marco] Univ Bologna, Dept Chem G Ciamician, Alma Mater Studiorum, LEBSC, Bologna, Italy; [Calogero, Armando] Univ Naples Federico II, Adv Biomed Sci Dept, Naples, Italy; [Pilloni, Argenia Paola] Univ Naples 2, Dept Expt Med, Div Clin Bacteriol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; IZS del Mezzogiorno; University of Bologna; University of Naples Federico II; Universita della Campania Vanvitelli	Capparelli, R (corresponding author), Univ Naples Federico II, Dept Agr, Naples, Italy.; Roperto, S (corresponding author), Univ Naples Federico II, Dept Vet Med & Anim Prod, Div Infect Dis, Naples, Italy.	sante.roperto@unina.it; capparel@unina.it	Capparelli, Rosanna/Q-3144-2017; Iannaccone, Marco/K-7559-2016; Fulgione, Andrea/AAK-9332-2021	Capparelli, Rosanna/0000-0001-8614-6251; Iannaccone, Marco/0000-0002-2283-6613; Fulgione, Andrea/0000-0002-8646-5073; roperto, sante/0000-0001-6210-5519; CALOGERO, Armando/0000-0003-2315-0610	RINAME Project [RBAP114AMK]; Interuniversity Consortium for Research on Chemistry of Metals in Biological Systems; Qualifu project; Chemical Center Srl; P.O.R. Campania F.S.E. (Percorsi universitari finalizzati alla incentivazione della ricerca scientifica, dell'innovazione e del trasferimento tecnologico - Tipologia progettuale: "Dottorati in Azienda" CUP) [E65E12000150006]; "Fondazione con il Sud" ("Biosensori piezoelettrici a risposta in tempo reale per applicazioni ambientali e agro-alimentari") [2011-PDR-18]	RINAME Project; Interuniversity Consortium for Research on Chemistry of Metals in Biological Systems; Qualifu project; Chemical Center Srl; P.O.R. Campania F.S.E. (Percorsi universitari finalizzati alla incentivazione della ricerca scientifica, dell'innovazione e del trasferimento tecnologico - Tipologia progettuale: "Dottorati in Azienda" CUP); "Fondazione con il Sud" ("Biosensori piezoelettrici a risposta in tempo reale per applicazioni ambientali e agro-alimentari")	Funded by RBAP114AMK, RINAME Project (funds for selected research topics), the Interuniversity Consortium for Research on Chemistry of Metals in Biological Systems, Qualifu project, Chemical Center Srl and P.O.R. Campania F.S.E. 2007/2013 (Percorsi universitari finalizzati alla incentivazione della ricerca scientifica, dell'innovazione e del trasferimento tecnologico - Tipologia progettuale: "Dottorati in Azienda" CUP E65E12000150006) for financial support. Dr. Marco Iannaccone was supported by research funding from "Fondazione con il Sud" (Project no. 2011-PDR-18, "Biosensori piezoelettrici a risposta in tempo reale per applicazioni ambientali e agro-alimentari").; The authors wish to thank Filomena Di Ruocco for technical assistance. In addition, they thank the RBAP114AMK, RINAME Project (funds for selected research topics), the Interuniversity Consortium for Research on Chemistry of Metals in Biological Systems, Qualifu project, Chemical Center Srl and P.O.R. Campania F.S.E. 2007/2013 (Percorsi universitari finalizzati alla incentivazione della ricerca scientifica, dell'innovazione e del trasferimento tecnologico-Tipologia progettuale: "Dottorati in Azienda" CUP E65E12000150006) for financial support. Dr. Marco Iannaccone was supported by research funding from "Fondazione con il Sud" (Project no. 2011-PDR-18, "Biosensori piezoelettrici a risposta in tempo reale per applicazioni ambientali e agro-alimentari")	Adlerova L, 2008, VET MED-CZECH, V53, P457, DOI 10.17221/1978-VETMED; Behnsen J, 2013, COLD SPRING HARB PER, P3; Berlutti F, 2006, BIOCHEM CELL BIOL, V84, P351, DOI 10.1139/O06-039; Bermudez-Brito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043197; Brown JC, 2011, J APPL MICROBIOL, V110, P139, DOI 10.1111/j.1365-2672.2010.04870.x; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Capparelli R, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-61; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; Delcenserie V, 2008, CURR ISSUES MOL BIOL, V10, P37; Delgado S, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00766; Drago L, 2011, RIV IMMUNOLOGIA ALLE, V3, P25; Drago-Serrano ME, 2010, IMMUNOL LETT, V134, P35, DOI 10.1016/j.imlet.2010.08.007; Huang XL, 2010, POSTGRAD MED J, V86, P272, DOI 10.1136/pgmj.2009.089987; Iafisco M, 2011, DALTON T, V40, P820, DOI 10.1039/c0dt00714e; Iafisco M, 2012, NANOSCALE, V4, P206, DOI 10.1039/c1nr11147g; Isolauri E, 2008, J CLIN GASTROENTEROL, V42, pS91, DOI 10.1097/MCG.0b013e3181639a98; Kanyshkova TG, 2001, BIOCHEMISTRY-MOSCOW+, V66, P1, DOI 10.1023/A:1002817226110; Kikuchi Shogo, 2002, Gastric Cancer, V5, P6, DOI 10.1007/s101200200001; Mikula M, 2003, J MICROBIOL METH, V55, P351, DOI 10.1016/S0167-7012(03)00166-0; Neng L, 2011, J BASIC MICROB, V53, P147; Nocerino N, 2014, INT J NANOMED, V9, P1175, DOI 10.2147/IJN.S55060; Olokoba A B, 2013, Niger Med J, V54, P1, DOI 10.4103/0300-1652.108884; Palazzo B, 2007, ADV FUNCT MATER, V17, P2180, DOI 10.1002/adfm.200600361; Palazzo B, 2009, ACTA BIOMATER, V5, P1241, DOI 10.1016/j.actbio.2008.10.024; Pan F, 2008, BIOINTERPHASES, V3, pFB36, DOI 10.1116/1.2965135; Papastergiou Vasilios, 2014, World J Gastrointest Pathophysiol, V5, P392, DOI 10.4291/wjgp.v5.i4.392; Pepe Giacomo, 2013, J Amino Acids, V2013, P939804, DOI 10.1155/2013/939804; Rocco A, 2006, ANN ONCOL, V17, pVII103, DOI 10.1093/annonc/mdl961; ROZALSKA B, 1993, FEMS IMMUNOL MED MIC, V7, P145; Ruggiero Paolo, 2014, World J Gastrointest Pathophysiol, V5, P384, DOI 10.4291/wjgp.v5.i4.384; Salama NR, 2013, NAT REV MICROBIOL, V11, P385, DOI 10.1038/nrmicro3016; Servin AL, 2003, BEST PRACT RES CL GA, V17, P741, DOI 10.1016/S1521-6918(03)00052-0; Sherman BC, 2004, United States patent, Patent No. [US 6713495, 6713495]; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Zhang MH, 2013, WORLD J MICROB BIOT, V29, P499, DOI 10.1007/s11274-012-1203-2; Zheng X, 2013, REV ESP ENFERM DIG, V105, P445, DOI 10.4321/s1130-01082013000800002	37	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158646	10.1371/journal.pone.0158646	http://dx.doi.org/10.1371/journal.pone.0158646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384186	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400072
J	Gonzalez, E; Salvo, A; Defago, MT; Valladares, G				Gonzalez, Ezequiel; Salvo, Adriana; Teresa Defago, Maria; Valladares, Graciela			A Moveable Feast: Insects Moving at the Forest-Crop Interface Are Affected by Crop Phenology and the Amount of Forest in the Landscape	PLOS ONE			English	Article							NATURAL ENEMIES; BIOLOGICAL-CONTROL; AGRICULTURAL LANDSCAPES; ECOSYSTEM SERVICES; DIVERSITY; PEST; FRAGMENTATION; CONSERVATION; BIODIVERSITY; PARASITISM	Edges have become prevailing habitats, mainly as a result of habitat fragmentation and agricultural expansion. The interchange of functionally relevant organisms like insects occurs through these edges and can influence ecosystem functioning in both crop and non-crop habitats. However, very few studies have focused on the directionality of insect movement through edges, and the role of crop and non-crop amount has been ignored. Using bidirectional flight interception traps we investigated interchange of herbivore, natural enemy, pollinator and detritivore insects between native forest fragments and soybean crops, simultaneously considering movement direction, forest cover in the landscape and crop phenology. In total, 52,173 specimens and 877 morphospecies were collected. We found that, within most functional and taxonomic groups, movement intensity was similar (richness and/or abundance) between directions, whereas a predominantly forest-to-crop movement characterized natural enemies. Insect movement was extensively affected by crop phenology, decreasing during crop senescence, and was enhanced by forest cover particularly at senescence. Mainly the same herbivore species moved to and from the forest, but different natural enemy species predominated in each direction. Finally, our analyses revealed greater forest contribution to natural enemy than to herbivore communities in the crop, fading with distance to the forest in both groups. By showing that larger amounts of forest lead to richer insect interchange, in both directions and in four functional groups, our study suggests that allocation to natural and cultivated habitats at landscape level could influence functioning of both systems. Moreover, natural enemies seemed to benefit more than pests from natural vegetation, with natural enemy spillover from forests likely contributing to pest control in soybean fields. Thus consequences of insect interchange seem to be mostly positive for the agroecosystem, although consequences for the natural system deserve further study.	[Gonzalez, Ezequiel; Salvo, Adriana; Teresa Defago, Maria; Valladares, Graciela] Ctr Invest Entomol Cordoba, Inst Multidisplinario Biol Vegetal CONICET UNC, Cordoba, Argentina		Gonzalez, E (corresponding author), Ctr Invest Entomol Cordoba, Inst Multidisplinario Biol Vegetal CONICET UNC, Cordoba, Argentina.	ezenofx@gmail.com	Gonzalez, Ezequiel/ABA-5941-2021; González, Ezequiel/ABH-7378-2020	González, Ezequiel/0000-0003-0411-1771	Consejo Nacional de Ciencia y Tecnica-Argentina [PIP 112 201201 00662]; Secretaria de Ciencia y Tecnica de la Provincia de Cordoba-Argentina	Consejo Nacional de Ciencia y Tecnica-Argentina; Secretaria de Ciencia y Tecnica de la Provincia de Cordoba-Argentina	Consejo Nacional de Ciencia y Tecnica-Argentina (Grant number: PIP 112 201201 00662). Website: http://www.conicet.gob.ar/.GV and AS received the funding. Secretaria de Ciencia y Tecnica de la Provincia de Cordoba-Argentina. Website: http://www.unc.edu.ar/investigacion. AS and GV received the funding.	Aizen Marcelo A, 2009, Ecol. austral, V19, P45; Barton K, 2020, MUMIN MULTIMODEL INF; Bates D. M., 2007, LME4 LINEAR MIXED EF; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Boiteau G, 2000, J ECON ENTOMOL, V93, P630, DOI 10.1603/0022-0493-93.3.630; BOLDT PE, 1975, J ECON ENTOMOL, V68, P480, DOI 10.1093/jee/68.4.480; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chaplin-Kramer R, 2011, ECOL LETT, V14, P922, DOI 10.1111/j.1461-0248.2011.01642.x; Clough Y, 2005, J BIOGEOGR, V32, P2007, DOI 10.1111/j.1365-2699.2005.01367.x; Collinge SK, 2002, LANDSCAPE ECOL, V17, P647, DOI 10.1023/A:1021536302195; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Diaz A, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.8101; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Duelli P, 2003, BASIC APPL ECOL, V4, P129, DOI 10.1078/1439-1791-00140; DUELLI P, 1990, BIOL CONSERV, V54, P193, DOI 10.1016/0006-3207(90)90051-P; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; FEHR WR, 1971, CROP SCI, V11, P929, DOI 10.2135/cropsci1971.0011183X001100060051x; Fischer J, 2014, CONSERV LETT, V7, P149, DOI 10.1111/conl.12084; Frost CM, 2015, ECOLOGY, V96, P193, DOI 10.1890/14-0696.1; Gonzalez E, 2015, INSECT CONSERV DIVER, V8, P359, DOI 10.1111/icad.12117; Gustafson EJ, 1996, ECOLOGY, V77, P94, DOI 10.2307/2265659; Hendrickx F, 2007, J APPL ECOL, V44, P340, DOI 10.1111/j.1365-2664.2006.01270.x; HERRERA CM, 1990, OIKOS, V58, P277, DOI 10.2307/3545218; HOUSE GJ, 1985, SOIL TILL RES, V5, P351, DOI 10.1016/S0167-1987(85)80003-9; Lee JC, 2001, J APPL ECOL, V38, P472, DOI 10.1046/j.1365-2664.2001.00602.x; Letourneau DK, 2011, ECOL APPL, V21, P9, DOI 10.1890/09-2026.1; LEWIS T, 1969, J APPL ECOL, V6, P443, DOI 10.2307/2401510; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Luti R., 1979, GEOGRAFIA FISICA PRO, P297; Macfadyen S, 2015, AGR ECOSYST ENVIRON, V200, P110, DOI 10.1016/j.agee.2014.11.012; Macfadyen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059659; Marasas ME, 2001, APPL SOIL ECOL, V18, P61, DOI 10.1016/S0929-1393(01)00148-2; MAY RM, 1973, ECOLOGY, V54, P315, DOI 10.2307/1934339; McKone M, 2001, CONSERV BIOL, V15, P1315, DOI 10.1046/j.1523-1739.2001.99399.x; Milfont MD, 2013, ENVIRON CHEM LETT, V11, P335, DOI 10.1007/s10311-013-0412-8; Missa O, 2009, J INSECT CONSERV, V13, P103, DOI 10.1007/s10841-007-9130-5; MOERICKE V., 1951, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V3, P23; Moreno ML, 2014, ACTA OECOL, V60, P26, DOI 10.1016/j.actao.2014.07.002; Nams VO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021886; Norris RF, 2000, WEED SCI, V48, P94, DOI 10.1614/0043-1745(2000)048[0094:IBWAPA]2.0.CO;2; Obrist MK, 2010, BIODIVERS CONSERV, V19, P2201, DOI 10.1007/s10531-010-9832-y; Perovic DJ, 2010, BIOL CONTROL, V52, P263, DOI 10.1016/j.biocontrol.2009.09.014; Pineda E, 2005, CONSERV BIOL, V19, P400, DOI 10.1111/j.1523-1739.2005.00531.x; Pinheiro J., 2019, NLME LINEAR NONLINEA; R Core Team, 2018, R LANG ENV STAT COMP; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Rossetti MR, 2013, J INSECT CONSERV, V17, P1137, DOI 10.1007/s10841-013-9594-4; Roubik D., 1995, POLLINATION CULTIVAT; Samways MJ, 2007, ANNU REV ENTOMOL, V52, P465, DOI 10.1146/annurev.ento.52.110405.091317; Schellhorn NA, 2014, ANNU REV ENTOMOL, V59, P559, DOI 10.1146/annurev-ento-011613-161952; Schmidt MH, 2008, J BIOGEOGR, V35, P157, DOI 10.1111/j.1365-2699.2007.01774.x; Fenoglio MS, 2012, ECOLOGY, V93, P2407, DOI 10.1890/11-2043.1; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Southwood TRE, 2000, ECOLOGICAL METHODS; Squires SE, 2009, BIOL CONSERV, V142, P203, DOI 10.1016/j.biocon.2008.10.015; Steffan-Dewenter I, 2001, P ROY SOC B-BIOL SCI, V268, P1685, DOI 10.1098/rspb.2001.1737; Thies C, 2003, OIKOS, V101, P18, DOI 10.1034/j.1600-0706.2003.12567.x; THOMPSON JN, 1991, ANNU REV ENTOMOL, V36, P65, DOI 10.1146/annurev.en.36.010191.000433; Thorbek P, 2004, J APPL ECOL, V41, P526, DOI 10.1111/j.0021-8901.2004.00913.x; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Tscharntke T, 1998, J APPL ECOL, V35, P708, DOI 10.1046/j.1365-2664.1998.355343.x; Tscharntke T, 2007, BIOL CONTROL, V43, P294, DOI 10.1016/j.biocontrol.2007.08.006; Valladares G, 2006, CONSERV BIOL, V20, P212, DOI 10.1111/j.1523-1739.2006.00337.x; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; Van EMDEN H. F., 1965, JAPPLECOL, V2, P171, DOI 10.2307/2401703; Wissinger SA, 1997, BIOL CONTROL, V10, P4, DOI 10.1006/bcon.1997.0543; Zak MR, 2008, ENVIRON MANAGE, V42, P181, DOI 10.1007/s00267-008-9101-y; Zak MR, 2004, BIOL CONSERV, V120, P589, DOI 10.1016/j.biocon.2004.03.034; Zhang W, 2007, ECOL ECON, V64, P253, DOI 10.1016/j.ecolecon.2007.02.024; Zuur Alain F., 2009, P1	78	32	32	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158836	10.1371/journal.pone.0158836	http://dx.doi.org/10.1371/journal.pone.0158836			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383505	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400087
J	Shih, SC; Ho, TC; Chen, SL; Tsao, YP				Shih, Shou-Chuan; Ho, Tsung-Chuan; Chen, Show-Li; Tsao, Yeou-Ping			Pigment Epithelium Derived Factor Peptide Protects Murine Hepatocytes from Carbon Tetrachloride-Induced Injury	PLOS ONE			English	Article							ACUTE LIVER-INJURY; CELL-DEATH; APOPTOSIS; IDENTIFICATION; RECEPTOR; BINDING; DAMAGE; MICE; NECROSIS; SURVIVAL	Fibrogenesis is induced by repeated injury to the liver and reactive regeneration and leads eventually to liver cirrhosis. Pigment epithelium derived factor (PEDF) has been shown to prevent liver fibrosis induced by carbon tetrachloride (CCl4). A 44 amino acid domain of PEDF (44-mer) was found to have a protective effect against various insults to several cell types. In this study, we investigated the capability of synthetic 44-mer to protect against liver injury in mice and in primary cultured hepatocytes. Acute liver injury, induced by CCl4, was evident from histological changes, such as cell necrosis, inflammation and apoptosis, and a concomitant reduction of glutathione (GSH) and GSH redox enzyme activities in the liver. Intraperitoneal injection of the 44-mer into CCl4-treated mice abolished the induction of AST and ALT and markedly reduced histological signs of liver injury. The 44-mer treatment can reduce hepatic oxidative stress as evident from lower levels of lipid hydroperoxide, and higher levels of GSH. CCl4 caused a reduction of Bcl-xL, PEDF and PPAR gamma, which was markedly restored by the 44-mer treatment. Consequently, the 44-mer suppressed liver fibrosis induced by repeated CCl4 injury. Furthermore, our observations in primary culture of rat hepatocytes showed that PEDF and the 44-mer protected primary rat hepatocytes against apoptosis induced by serum deprivation and TGF-beta 1. PEDF/44-mer induced cell protective STAT3 phosphorylation. Pharmacological STAT3 inhibition prevented the antiapoptotic action of PEDF/44-mer. Among several PEDF receptor candidates that may be responsible for hepatocyte protection, we demonstrated that PNPLA2 was essential for PEDF/44-mer-mediated STAT3 phosphorylation and antiapoptotic activity by using siRNA to selectively knockdown PNPLA2. In conclusion, the PEDF 44-mer protects hepatocytes from single and repeated CCl4 injury. This protective effect may stem from strengthening the counter oxidative stress capacity and induction of hepatoprotective factors.	[Shih, Shou-Chuan] Mackay Med Coll, New Taipei, Taiwan; [Shih, Shou-Chuan] Mackay Mem Hosp, Dept Internal Med, Taipei, Taiwan; [Ho, Tsung-Chuan; Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Tsao, Yeou-Ping] Mackay Mem Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Show-Li] Natl Taiwan Univ, Sch Med, Dept Microbiol, Taipei, Taiwan	Mackay Medical College; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; National Taiwan University	Shih, SC (corresponding author), Mackay Med Coll, New Taipei, Taiwan.; Shih, SC (corresponding author), Mackay Mem Hosp, Dept Internal Med, Taipei, Taiwan.; Tsao, YP (corresponding author), Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.; Tsao, YP (corresponding author), Mackay Mem Hosp, Dept Ophthalmol, Taipei, Taiwan.	shihshou@gmail.com; yptsao@yahoo.com			Ministry of Science and Technology, Taiwan [MOST 104-2314-B-195-006-MY3]; Mackay Memorial Hospital [MMH-E-105-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital	This work was supported by grants from the Ministry of Science and Technology, Taiwan (MOST 104-2314-B-195-006-MY3) and Mackay Memorial Hospital (MMH-E-105-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral J, 2010, INVEST OPHTH VIS SCI, V51, P1318, DOI 10.1167/iovs.09-4455; Bansal MB, 2005, J HEPATOL, V42, P548, DOI 10.1016/j.jhep.2004.11.043; Banumathi E, 2010, EXP EYE RES, V90, P89, DOI 10.1016/j.exer.2009.09.014; Barbato DL, 2014, CELL DEATH DIFFER, V21, P113, DOI 10.1038/cdd.2013.137; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Bilak MM, 2002, J NEUROSCI, V22, P9378; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Canbay A, 2003, HEPATOLOGY, V38, P1188, DOI 10.1053/jhep.2003.50472; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; Cao W, 1999, J NEUROSCI RES, V57, P789, DOI 10.1002/(SICI)1097-4547(19990915)57:6<789::AID-JNR4>3.3.CO;2-D; Chung C, 2008, J HEPATOL, V48, P471, DOI 10.1016/j.jhep.2007.10.012; Chung CH, 2009, GASTROENTEROLOGY, V136, P331, DOI 10.1053/j.gastro.2008.09.065; CZAJA MJ, 1995, GASTROENTEROLOGY, V108, P1849, DOI 10.1016/0016-5085(95)90149-3; Filleur S, 2005, CANCER RES; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Gao X, 2014, SCI REP-UK, V4, DOI 10.1038/srep05637; He SQ, 2006, LIVER TRANSPLANT, V12, P1869, DOI 10.1002/lt.21001; Ho TC, 2015, AM J PHYSIOL-CELL PH, V309, pC159, DOI 10.1152/ajpcell.00344.2014; Ho TC, 2013, STEM CELLS, V31, P1775, DOI 10.1002/stem.1393; Ho TC, 2010, AM J PATHOL, V177, P1798, DOI 10.2353/ajpath.2010.091085; Horiguchi N, 2010, HEPATOLOGY, V51, P1724, DOI 10.1002/hep.23532; Huang GJ, 2013, FOOD CHEM, V141, P3020, DOI 10.1016/j.foodchem.2013.03.061; Kawaguchi T, 2010, AM J PATHOL, V176, P168, DOI 10.2353/ajpath.2010.090242; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; KORNBRUST DJ, 1984, TOXICOL APPL PHARM, V72, P388, DOI 10.1016/0041-008X(84)90115-7; Lee JY, 2004, ARCH PHARM RES, V27, P340, DOI 10.1007/BF02980070; Mandal P, 2010, HEPATOLOGY, V51, P1420, DOI 10.1002/hep.23427; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Martin H, 2003, J NUTR, V133, P2505, DOI 10.1093/jn/133.8.2505; Matsumoto K, 2004, HEPATOLOGY, V40, P252, DOI 10.1002/hep.20259; Moriya K, 2012, HEPATOLOGY, V56, P311, DOI 10.1002/hep.25624; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; OBERHAMMER FA, 1992, P NATL ACAD SCI USA, V89, P5408, DOI 10.1073/pnas.89.12.5408; Ogata N, 2001, CURR EYE RES, V22, P245, DOI 10.1076/ceyr.22.4.245.5506; Park K, 2011, MOL CELL BIOL, V31, P3038, DOI 10.1128/MCB.01211-10; Sabir SM, 2008, J ETHNOPHARMACOL, V120, P226, DOI 10.1016/j.jep.2008.08.017; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Schattenberg JM, 2012, AM J PHYSIOL-GASTR L, V303, pG498, DOI 10.1152/ajpgi.00525.2011; Shi JL, 1996, HEPATOLOGY, V24, P1256; Son G, 2007, AM J PHYSIOL-GASTR L, V293, pG631, DOI 10.1152/ajpgi.00185.2007; Subramanian P, 2013, J BIOL CHEM, V288, P23928, DOI 10.1074/jbc.M113.487884; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Tsai TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095443; Unterlauft JD, 2014, EXP EYE RES, V127, P206, DOI 10.1016/j.exer.2014.08.004; Wang K, 2010, LAB INVEST, V90, P257, DOI 10.1038/labinvest.2009.129; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Yang BY, 2015, MOLECULES, V20, P12250, DOI 10.3390/molecules200712250; Zhang SX, 2006, J MOL ENDOCRINOL, V37, P1, DOI 10.1677/jme.1.02008	48	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157647	10.1371/journal.pone.0157647	http://dx.doi.org/10.1371/journal.pone.0157647			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384427	gold, Green Submitted, Green Published			2022-12-26	WOS:000379809400018
J	Xia, H; Huang, WX; Xiong, J; Tao, T; Zheng, XG; Wei, HB; Yue, YX; Chen, L; Luo, LJ				Xia, Hui; Huang, Weixia; Xiong, Jie; Tao, Tao; Zheng, Xiaoguo; Wei, Haibin; Yue, Yunxia; Chen, Liang; Luo, Lijun			Adaptive Epigenetic Differentiation between Upland and Lowland Rice Ecotypes Revealed by Methylation-Sensitive Amplified Polymorphism	PLOS ONE			English	Article							ORYZA-SATIVA L.; DNA METHYLATION; COLD STRESS; ADAPTATION; RESPONSES; PLANTS; POPULATIONS; INHERITANCE; ARABIDOPSIS; DIVERGENCE	The stress-induced epimutations could be inherited over generations and play important roles in plant adaption to stressful environments. Upland rice has been domesticated in water-limited environments for thousands of years and accumulated drought-induced epimutations of DNA methylation, making it epigenetically differentiated from lowland rice. To study the epigenetic differentiation between upland and lowland rice ecotypes on their drought-resistances, the epigenetic variation was investigated in 180 rice landraces under both normal and osmotic conditions via methylation-sensitive amplified polymorphism (MSAP) technique. Great alterations (52.9 similar to 54.3% of total individual-locus combinations) of DNA methylation are recorded when rice encountering the osmotic stress. Although the general level of epigenetic differentiation was very low, considerable level of FST (0.134 similar to 0.187) was detected on the highly divergent epiloci (HDE). The HDE detected in normal condition tended to stay at low levels in upland rice, particularly the ones de-methylated in responses to osmotic stress. Three out of four selected HDE genes differentially expressed between upland and lowland rice under normal or stressed conditions. Moreover, once a gene at HDE was up-/down-regulated in responses to the osmotic stress, its expression under the normal condition was higher/lower in upland rice. This result suggested expressions of genes at the HDE in upland rice might be more adaptive to the osmotic stress. The epigenetic divergence and its influence on the gene expression should contribute to the higher drought-resistance in upland rice as it is domesticated in the water-limited environment.	[Xia, Hui; Huang, Weixia; Xiong, Jie; Tao, Tao; Zheng, Xiaoguo; Wei, Haibin; Yue, Yunxia; Chen, Liang; Luo, Lijun] Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China; [Huang, Weixia; Xiong, Jie; Tao, Tao; Zheng, Xiaoguo; Yue, Yunxia; Luo, Lijun] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Huazhong Agricultural University	Luo, LJ (corresponding author), Shanghai Agrobiol Gene Ctr, Shanghai, Peoples R China.; Luo, LJ (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	lijun@sagc.org.cn	Xia, Hui/L-7129-2019	Xia, Hui/0000-0003-2446-5171	Natural Science Foundation of China [31200279]; Project of Shanghai Talent Youth of Agriculture [2121555]; Project of Subject Construction, Shanghai Academy of Agricultural Sciences [SAAS-2015 (07)]; National High-Tech Research and Development Program of China (863 Plan) [2014AA10A603, 2014AA10A604]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Shanghai Talent Youth of Agriculture; Project of Subject Construction, Shanghai Academy of Agricultural Sciences; National High-Tech Research and Development Program of China (863 Plan)(National High Technology Research and Development Program of China)	This research was supported by Natural Science Foundation of China (Grant No. 31200279) by HX, Project of Shanghai Talent Youth of Agriculture, 2015 (Grant No. 2121555) by HX, Project of Subject Construction, Shanghai Academy of Agricultural Sciences, 2015 (Grant No. SAAS-2015 (07)) by LJL, and the National High-Tech Research and Development Program of China (863 Plan)(Grant No. 2014AA10A603, 2014AA10A604) by LJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto K, 2007, ANN BOT-LONDON, V100, P205, DOI 10.1093/aob/mcm110; Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Becker C, 2011, NATURE, V12, P480; Becker C, 2012, CURR OPIN PLANT BIOL, V15, P562, DOI 10.1016/j.pbi.2012.08.004; Bernier J, 2008, J SCI FOOD AGR, V88, P927, DOI 10.1002/jsfa.3153; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Colaneri AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059878; Ding Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1732; Fan HH, 2013, ACTA PHYSIOL PLANT, V35, P2445, DOI 10.1007/s11738-013-1278-x; Feng QiZhi, 2012, Australian Journal of Crop Science, V6, P877; Gao GZ, 2014, BREEDING SCI, V64, P125, DOI 10.1270/jsbbs.64.125; Gao LX, 2010, PLANT CELL ENVIRON, V33, P1820, DOI 10.1111/j.1365-3040.2010.02186.x; Gayacharan, 2013, PHYSIOL MOL BIOL PLA, V19, P379, DOI 10.1007/s12298-013-0176-4; Herrera CM, 2014, MOL ECOL, V23, P1085, DOI 10.1111/mec.12679; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Holeski LM, 2012, TRENDS ECOL EVOL, V27, P618, DOI 10.1016/j.tree.2012.07.011; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Kinoshita T, 2014, PLANT CELL PHYSIOL, V55, P1859, DOI 10.1093/pcp/pcu125; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Li X, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-300; Lira-Medeiros CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010326; Liu HZ, 2008, GENE, V420, P57, DOI 10.1016/j.gene.2008.05.006; Lyu J, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-160; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Ou XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041143; Paun O, 2010, MOL BIOL EVOL, V27, P2465, DOI 10.1093/molbev/msq150; Richards EJ, 2011, CURR OPIN PLANT BIOL, V14, P204, DOI 10.1016/j.pbi.2011.03.009; Rico L, 2014, PLANT BIOLOGY, V16, P419, DOI 10.1111/plb.12049; Rois AS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-205; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Sahu PP, 2013, PLANT CELL REP, V32, P1151, DOI 10.1007/s00299-013-1462-x; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Schulz B, 2014, MOL ECOL, V23, P3523, DOI 10.1111/mec.12835; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; Shan XH, 2013, J PLANT BIOL, V56, P32, DOI 10.1007/s12374-012-0251-3; Shea N, 2011, J EVOLUTION BIOL, V24, P1178, DOI 10.1111/j.1420-9101.2011.02235.x; Steimer A, 2004, CURR OPIN PLANT BIOL, V7, P11, DOI 10.1016/j.pbi.2003.11.008; Verhoeven KJF, 2010, NEW PHYTOL, V185, P1108, DOI 10.1111/j.1469-8137.2009.03121.x; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Wenzel MA, 2014, MOL ECOL, V23, P4256, DOI 10.1111/mec.12833; Xia H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106352; Yu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055772; Zhang XJ, 2013, PLANT PHYSIOL BIOCH, V67, P189, DOI 10.1016/j.plaphy.2013.03.013; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010; Zhao W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112869; Zheng XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080253	49	20	21	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157810	10.1371/journal.pone.0157810	http://dx.doi.org/10.1371/journal.pone.0157810			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380174	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700011
J	Dejene, SW; Heitkonig, IMA; Prins, HHT; Lemma, FA; Mekonnen, DA; Alemu, ZE; Kelkay, TZ; de Boer, WF				Dejene, Sintayehu W.; Heitkonig, Ignas M. A.; Prins, Herbert H. T.; Lemma, Fitsum A.; Mekonnen, Daniel A.; Alemu, Zelalem E.; Kelkay, Tessema Z.; de Boer, Willem F.			Risk Factors for Bovine Tuberculosis (bTB) in Cattle in Ethiopia	PLOS ONE			English	Article							LIVESTOCK/WILDLIFE INTERFACE AREAS; MYCOBACTERIUM-BOVIS; INDIGENOUS CATTLE; PREVALENCE; MANAGEMENT; INFECTION; EPIDEMIOLOGY; TRANSHUMANT; INSPECTION; HUSBANDRY	Bovine tuberculosis (bTB) infection is generally correlated with individual cattle's age, sex, body condition, and with husbandry practices such as herd composition, cattle movement, herd size, production system and proximity to wildlife-including bTB maintenance hosts. We tested the correlation between those factors and the prevalence of bTB, which is endemic in Ethiopia's highland cattle, in the Afar Region and Awash National Park between November 2013 and April 2015. A total of 2550 cattle from 102 herds were tested for bTB presence using the comparative intradermal tuberculin test (CITT). Data on herd structure, herd movement, management and production system, livestock transfer, and contact with wildlife were collected using semi-structured interviews with cattle herders and herd owners. The individual overall prevalence of cattle bTB was 5.5%, with a herd prevalence of 46%. Generalized Linear Mixed Models with a random herd-effect were used to analyse risk factors of cattle reactors within each herd. The older the age of the cattle and the lower the body condition the higher the chance of a positive bTB test result, but sex, lactation status and reproductive status were not correlated with bTB status. At herd level, General Linear Models showed that pastoral production systems with transhumant herds had a higher bTB prevalence than sedentary herds. A model averaging analysis identified herd size, contact with wildlife, and the interaction of herd size and contact with wildlife as significant risk factors for bTB prevalence in cattle. A subsequent Structural Equation Model showed that the probability of contact with wildlife was influenced by herd size, through herd movement. Larger herds moved more and grazed in larger areas, hence the probability of grazing in an area with wildlife and contact with either infected cattle or infected wildlife hosts increased, enhancing the chances for bTB infection. Therefore, future bTB control strategies in cattle in pastoral areas should consider herd size and movement as important risk factors.	[Dejene, Sintayehu W.; Heitkonig, Ignas M. A.; Prins, Herbert H. T.; de Boer, Willem F.] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Dejene, Sintayehu W.; Alemu, Zelalem E.; Kelkay, Tessema Z.] Haramaya Univ, Coll Agr & Environm Sci, Dire Dawa, Ethiopia; [Lemma, Fitsum A.; Mekonnen, Daniel A.] Haramaya Univ, Coll Vet Med, Dire Dawa, Ethiopia	Wageningen University & Research; Haramaya University; Haramaya University	Dejene, SW (corresponding author), Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands.; Dejene, SW (corresponding author), Haramaya Univ, Coll Agr & Environm Sci, Dire Dawa, Ethiopia.	sintekal@gmail.com		Prins, Herbert/0000-0003-1131-5107; Heitkonig, Ignas/0000-0001-7771-3111	NUFFIC through Wageningen University	NUFFIC through Wageningen University	The authors are grateful to NUFFIC for the financial support of the PhD scholarship through Wageningen University for the first author. The authors thank Haramaya University for the logistical support.	Afar National Regional State, 2009, AF NAT REG STAT PROG; Ameni G., 2003, International Journal of Applied Research in Veterinary Medicine, V1, P17; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; [Anonymous], [No title captured]; Asseged B, 2004, TROP ANIM HEALTH PRO, V36, P537, DOI 10.1023/B:TROP.0000040934.32330.44; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Bernard F, 2005, PREV VET MED, V67, P267, DOI 10.1016/j.prevetmed.2004.11.002; Boland F, 2010, PREV VET MED, V93, P153, DOI 10.1016/j.prevetmed.2009.09.021; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Caron A, 2003, ECOL APPL, V13, P1338, DOI 10.1890/02-5266; Central Statistical Agency, 2008, STAT B, V388; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Cleaveland S, 2001, PHILOS T R SOC B, V356, P991, DOI 10.1098/rstb.2001.0889; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Cook AJC, 1996, BRIT VET J, V152, P37, DOI 10.1016/S0007-1935(96)80084-4; Corner LAL, 2006, VET MICROBIOL, V112, P303, DOI 10.1016/j.vetmic.2005.11.015; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Davies J, 2007, J DEV STUD, V43, P490, DOI 10.1080/00220380701204422; De Garine-Wichatitsky M, 2013, EPIDEMIOL INFECT, V141, P1342, DOI 10.1017/S0950268813000708; de Lisle GW, 2002, REV SCI TECH OIE, V21, P317, DOI 10.20506/rst.21.2.1339; De Vos V, 2001, ONDERSTEPOORT J VET, V68, P119; Ethiopian Meteorological Agency, 2013, MEAN MONTHL RAINF 19; Faye B., 2005, PREV VET MED, V67, p267 , DOI DOI 10.1016/J.PREVETMED.2004.11.002; Fetene T, 2009, TROP ANIM HEALTH PRO, V41, P273, DOI 10.1007/s11250-008-9186-6; Franks P, 2003, AWASH CONSERVATION D, P1; Gopal R, 2006, VET REC, V159, P265, DOI 10.1136/vr.159.9.265; Gumi B, 2011, TROP ANIM HEALTH PRO, V43, P1081, DOI 10.1007/s11250-010-9777-x; Hermandez J, J AM VET MED ASS, V213, P851; Huang ZYX, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0624; Humblet MF, 2009, VET RES, V40, DOI 10.1051/vetres/2009033; Inangolet FO, 2008, TROP ANIM HEALTH PRO, V40, P501, DOI 10.1007/s11250-007-9126-x; Johnston WT, 2011, INT J INFECT DIS, V15, pE833, DOI 10.1016/j.ijid.2011.08.004; Kaneene JB, 2002, J AM VET MED ASSOC, V221, P837, DOI 10.2460/javma.2002.221.837; Kassa B., 2005, J RURAL DEVELOP, V28, p[2, 185]; Katale BZ, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-267; Kazwala RR, 2001, VET RES COMMUN, V25, P609, DOI 10.1023/A:1012757011524; Keet DF, 2001, ONDERSTEPOORT J VET, V68, P225; Mamo G, 2013, J VET MED ANIM HLTH, V5, P171; Marangon S, 1998, PREV VET MED, V34, P87, DOI 10.1016/S0167-5877(97)00087-1; Menzies FD, 2000, VET J, V160, P92, DOI 10.1053/tvjl.2000.0482; Mfinanga S G M, 2004, East Afr Med J, V81, P171; Moritz M, 2013, HUM ECOL, V41, P205, DOI 10.1007/s10745-012-9546-8; Munyeme M, 2009, TROP ANIM HEALTH PRO, V41, P345, DOI 10.1007/s11250-008-9195-5; Munyeme M, 2008, PREV VET MED, V85, P317, DOI 10.1016/j.prevetmed.2008.03.006; Munyeme M, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-21; Nieminen P.L., 2013, EPIDEMIOLOGY BIOSTAT, V10, P1, DOI DOI 10.2427/8854; NOLAN A, 1994, VET MICROBIOL, V40, P179, DOI 10.1016/0378-1135(94)90054-X; O'Brien DJ, 2011, VET MICROBIOL, V151, P23, DOI 10.1016/j.vetmic.2011.02.022; Office International des Epizooties, 2009, TERR MAN BOV TUB; Oloya J, 2007, PREV VET MED, V80, P318, DOI 10.1016/j.prevetmed.2007.03.004; Preston DL, 2012, ECOLOGY, V93, P1254, DOI 10.1890/11-1821.1; Prins Herbert H.T., 2000, Conservation Biology Series (Dordrecht), V12, P51; Rahman M. A., 2008, Bangladesh Journal of Veterinary Medicine, V6, P175; Regassa A, 2008, VET J, V178, P119, DOI 10.1016/j.tvjl.2007.06.019; Reilly LA, 2007, PREV VET MED, V80, P129, DOI 10.1016/j.prevetmed.2007.02.002; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Sitters J, 2009, BIOL CONSERV, V142, P738, DOI 10.1016/j.biocon.2008.12.001; Skuce Robin A, 2012, Vet Med Int, V2012, P621210, DOI 10.1155/2012/621210; Teklu A, 2004, REV SCI TECH OIE, V23, P957, DOI 10.20506/rst.23.3.1534; Thrusfield M., 2005, VET EPIDEMIOLOGY; Tschopp R, 2010, J WILDLIFE DIS, V46, P753, DOI 10.7589/0090-3558-46.3.753; Tschopp R, 2009, PREV VET MED, V89, P205, DOI 10.1016/j.prevetmed.2009.02.006	63	31	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159083	10.1371/journal.pone.0159083	http://dx.doi.org/10.1371/journal.pone.0159083			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404387	Green Submitted, gold, Green Published			2022-12-26	WOS:000379508200033
J	Brousseau, L; Postolache, D; Lascoux, M; Drouzas, AD; Kallman, T; Leonarduzzi, C; Liepelt, S; Piotti, A; Popescu, F; Roschanski, AM; Zhelev, P; Fady, B; Vendramin, GG				Brousseau, Louise; Postolache, Dragos; Lascoux, Martin; Drouzas, Andreas D.; Kallman, Thomas; Leonarduzzi, Cristina; Liepelt, Sascha; Piotti, Andrea; Popescu, Flaviu; Roschanski, Anna M.; Zhelev, Peter; Fady, Bruno; Vendramin, Giovanni Giuseppe			Local Adaptation in European Firs Assessed through Extensive Sampling across Altitudinal Gradients in Southern Europe	PLOS ONE			English	Article							ABIES-ALBA MILL.; PINUS-PINASTER AIT.; POPULATION-STRUCTURE; GENE-FREQUENCY; CLIMATE-CHANGE; GENOMIC SCANS; LINKAGE DISEQUILIBRIUM; CONTRASTING PATTERNS; NUCLEOTIDE DIVERSITY; QUANTITATIVE TRAITS	Background Local adaptation is a key driver of phenotypic and genetic divergence at loci responsible for adaptive traits variations in forest tree populations. Its experimental assessment requires rigorous sampling strategies such as those involving population pairs replicated across broad spatial scales. Methods A hierarchical Bayesian model of selection (HBM) that explicitly considers both the replication of the environmental contrast and the hierarchical genetic structure among replicated study sites is introduced. Its power was assessed through simulations and compared to classical 'within-site' approaches (FDIST, BAYESCAN) and a simplified, within-site, version of the model introduced here (SBM). Results HBM demonstrates that hierarchical approaches are very powerful to detect replicated patterns of adaptive divergence with low false-discovery (FDR) and false-non-discovery (FNR) rates compared to the analysis of different sites separately through within-site approaches. The hypothesis of local adaptation to altitude was further addressed by analyzing replicated Abies alba population pairs (low and high elevations) across the species' southern distribution range, where the effects of climatic selection are expected to be the strongest. For comparison, a single population pair from the closely related species A. cephalonica was also analyzed. The hierarchical model did not detect any pattern of adaptive divergence to altitude replicated in the different study sites. Instead, idiosyncratic patterns of local adaptation among sites were detected by within-site approaches. Conclusion Hierarchical approaches may miss idiosyncratic patterns of adaptation among sites, and we strongly recommend the use of both hierarchical (multi-site) and classical (within-site) approaches when addressing the question of adaptation across broad spatial scales.	[Brousseau, Louise; Fady, Bruno] INRA, Domaine St Paul, URFM Ecol Forets Mediterraneennes UR629, Site Agroparc CS,Site Agroparc CS 40509, F-84914 Avignon 9, France; [Brousseau, Louise; Postolache, Dragos; Leonarduzzi, Cristina; Piotti, Andrea; Vendramin, Giovanni Giuseppe] Natl Res Council IBBR CNR, Div Florence, Inst Biosci & BioResources, Via Madonna Piano 10, I-50019 Sesto Fiorentino, FI, Italy; [Postolache, Dragos] Scuola Super Sant Anna, Piazza Martiri Liberta 33, I-56127 Pisa, Italy; [Postolache, Dragos; Popescu, Flaviu] Natl Inst Forest Res & Dev INCDS, Res Stn Simeria, Str Biscaria 1, Simeria 335900, Romania; [Lascoux, Martin; Kallman, Thomas] Uppsala Univ, Dept Ecol & Genet, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Lascoux, Martin; Kallman, Thomas] Uppsala Univ, Sci Life Lab, S-75236 Uppsala, Sweden; [Drouzas, Andreas D.] Aristotle Univ Thessaloniki, Sch Biol, GR-54124 Thessaloniki, Greece; [Leonarduzzi, Cristina] Natl 3 Res Council Corso Calatafimi, Div Palermo, Inst Biosci & BioResources, Natl Res Council IBBR CNR, I-90129 Palermo, PA, Italy; [Liepelt, Sascha; Roschanski, Anna M.] Univ Marburg, Fac Biol, Conservat Biol, Karl von Frisch Str, D-35032 Marburg, Germany; [Roschanski, Anna M.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Genebank Collect North, Inselstr 9, D-23999 Malchow Poel, Germany; [Zhelev, Peter] Univ Forestry, 10 Kl Ohridsky Blvd, Sofia 1797, Bulgaria	INRAE; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Scuola Superiore Sant'Anna; National Research & Development Institute in Forestry "Marin Dracea"; Uppsala University; Uppsala University; Aristotle University of Thessaloniki; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Philipps University Marburg; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; University of Forestry - Bulgaria	Brousseau, L (corresponding author), INRA, Domaine St Paul, URFM Ecol Forets Mediterraneennes UR629, Site Agroparc CS,Site Agroparc CS 40509, F-84914 Avignon 9, France.; Brousseau, L (corresponding author), Natl Res Council IBBR CNR, Div Florence, Inst Biosci & BioResources, Via Madonna Piano 10, I-50019 Sesto Fiorentino, FI, Italy.	louise.brousseau.ecogenomix@gmail.com	Brousseau, Louise/E-5346-2015; Zhelev, Petar/ABG-4248-2020; Piotti, Andrea/C-1304-2009; Liepelt, Sascha/H-1047-2011; Postolache, Dragos/P-4587-2014	Brousseau, Louise/0000-0003-2769-2767; Zhelev, Petar/0000-0002-4273-3400; Piotti, Andrea/0000-0002-3324-5325; Liepelt, Sascha/0000-0001-6529-2882; Postolache, Dragos/0000-0001-5250-8752; Drouzas, Andreas/0000-0001-5234-3572	ERAnet BiodivERsA project 'LinkTree' [ANR-08-Biodiversa-006-06]; ERAnet BiodivERsA project 'TipTree' [ANR-12-EBID-0003]; COST Action [FP 1202]; Italian MIUR project 'Biodiversitalia' [RBAP10A2T4]; 'Young Scientist Contract' (INRA, CJS)	ERAnet BiodivERsA project 'LinkTree'; ERAnet BiodivERsA project 'TipTree'; COST Action(European Cooperation in Science and Technology (COST)); Italian MIUR project 'Biodiversitalia'; 'Young Scientist Contract' (INRA, CJS)	Funding was provided by the ERAnet BiodivERsA project 'LinkTree' (ANR-08-Biodiversa-006-06), the ERAnet BiodivERsA project 'TipTree' (ANR-12-EBID-0003) and COST Action FP 1202. GGV was also supported by a grant by the Italian MIUR project 'Biodiversitalia' (RBAP10A2T4). LB was funded by a 'Young Scientist Contract' (INRA, CJS).r Funding was provided by the ERAnet BiodivERsA project 'LinkTree' (ANR-08-Biodiversa-006-06), the ERAnet BiodivERsA project 'TipTree' (ANR-12-EBID-0003) and COST Action FP 1202. GGV was also supported by a grant by the Italian MIUR project 'Biodiversitalia' (RBAP10A2T4). LB was funded by a 'Young Scientist Contract' (INRA, CJS). We thank Frederic Jean, Norbert Turion, Olivier Gilg (UEFM, INRA Avignon), Carlo Urbinati, Valeria Gallucci, Alma Piermattei and Emidia Santini (Universita Politecnica delle Marche) for their help with fieldwork. The Ente Parco Nazionale del Gran Sasso e Monti della Laga kindly granted permission for sampling and logistic support. We also thank Etienne Klein (BioSP, INRA Avignon) for its critical review of the hierarchical Bayesian model. Last, we thank EuroGeo-graphics for the administrative boundaries of the European basemap used in Fig 1.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Alberto FJ, 2013, GENETICS, V195, P495, DOI 10.1534/genetics.113.153783; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Alizoti PG, 2003, EUFORGENT TECHNICAL; Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; Bazin E, 2010, GENETICS, V185, P587, DOI 10.1534/genetics.109.112391; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Beaumont MA, 2004, NAT REV GENET, V5, P251, DOI 10.1038/nrg1318; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bella E, 2015, PLANT SYST EVOL, V301, P749, DOI 10.1007/s00606-014-1113-x; Brousseau L, 2013, ANN BOT-LONDON, V112, P1169, DOI 10.1093/aob/mct176; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Callister AN, 2008, TREE GENET GENOMES, V4, P237, DOI 10.1007/s11295-007-0104-2; Carlson JE, 2011, EVOLUTION, V65, P108, DOI 10.1111/j.1558-5646.2010.01131.x; Carnegie AJ, 2004, CAN J FOREST RES, V34, P2314, DOI [10.1139/x04-114, 10.1139/X04-114]; Chambel MR, 2007, ANN FOREST SCI, V64, P87, DOI 10.1051/forest:2006092; Chen J, 2012, GENETICS, V191, P865, DOI 10.1534/genetics.112.140749; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Corander J, 2003, GENETICS, V163, P367; Cordell S, 1998, OECOLOGIA, V113, P188, DOI 10.1007/s004420050367; Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796; Csillery K, 2014, MOL ECOL, V23, P4696, DOI 10.1111/mec.12902; De Mita S, 2013, MOL ECOL, V22, P1383, DOI 10.1111/mec.12182; de Villemereuil P, 2014, MOL ECOL, V23, P2006, DOI 10.1111/mec.12705; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Eckert AJ, 2010, MOL ECOL, V19, P3789, DOI 10.1111/j.1365-294X.2010.04698.x; Ekberg I., 1979, HOLARCTIC ECOL, V2, P255, DOI [10.1111/j.1600-0587.1979.tb01297.x, DOI 10.1111/J.1600-0587.1979.TB01297.X]; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Eveno E, 2008, MOL BIOL EVOL, V25, P417, DOI 10.1093/molbev/msm272; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fahrmeir L, 2001, J ROY STAT SOC C-APP, V50, P201, DOI 10.1111/1467-9876.00229; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2014, BIORXIV; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Gaggiotti OE, 2010, MOL ECOL RESOUR, V10, P821, DOI 10.1111/j.1755-0998.2010.02873.x; Genovese C, 2002, J ROY STAT SOC B, V64, P499, DOI 10.1111/1467-9868.00347; Gompert Z, 2011, GENETICS, V187, P903, DOI 10.1534/genetics.110.124693; Gonzalez-Martinez SC, 2002, HEREDITY, V89, P199, DOI 10.1038/sj.hdy.6800114; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hermisson J, 2009, HEREDITY, V103, P283, DOI 10.1038/hdy.2009.101; Heschel MS, 2005, AM J BOT, V92, P37, DOI 10.3732/ajb.92.1.37; Heuertz M, 2006, GENETICS, V174, P2095, DOI 10.1534/genetics.106.065102; HODGE GR, 1992, SILVAE GENET, V41, P252; Huber CD, 2014, MOL BIOL EVOL, V31, P3026, DOI 10.1093/molbev/msu247; Jensen JD, 2016, MOL ECOL, V25, P1, DOI 10.1111/mec.13493; Jump AS, 2006, MOL ECOL, V15, P3469, DOI 10.1111/j.1365-294X.2006.03027.x; Kallman T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095306; Kovmutak A., 1985, STUDY SPECIES HYDRID; Kremer A, 2012, HEREDITY, V108, P375, DOI 10.1038/hdy.2011.81; Kremer A, 2014, FUNCT ECOL, V28, P22, DOI 10.1111/1365-2435.12169; Kremer A, 2012, ECOL LETT, V15, P378, DOI 10.1111/j.1461-0248.2012.01746.x; Kumar N, 2006, PHOTOSYNTH RES, V88, P63, DOI 10.1007/s11120-005-9028-6; LEWONTIN RC, 1973, GENETICS, V74, P175; Li JR, 2012, MOL ECOL, V21, P28, DOI 10.1111/j.1365-294X.2011.05308.x; Liepelt S, 2009, REV PALAEOBOT PALYNO, V153, P139, DOI 10.1016/j.revpalbo.2008.07.007; Lotterhos KE, 2014, MOL ECOL, V23, P2178, DOI 10.1111/mec.12725; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Manel S, 2010, MOL ECOL, V19, P3824, DOI 10.1111/j.1365-294X.2010.04716.x; Mimura M, 2010, J EVOLUTION BIOL, V23, P249, DOI 10.1111/j.1420-9101.2009.01910.x; Montesinos-Navarro A, 2011, NEW PHYTOL, V189, P282, DOI 10.1111/j.1469-8137.2010.03479.x; Mosca E, 2012, MOL ECOL, V21, P5530, DOI 10.1111/mec.12043; Mosca E, 2014, NEW PHYTOL, V201, P180, DOI 10.1111/nph.12476; Mosca E, 2012, EVOL APPL, V5, P762, DOI 10.1111/j.1752-4571.2012.00256.x; Namroud MC, 2010, J MOL EVOL, V70, P371, DOI 10.1007/s00239-010-9335-1; Narum SR, 2011, MOL ECOL RESOUR, V11, P184, DOI 10.1111/j.1755-0998.2011.02987.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; Parent C, 2011, PLANT CELL ENVIRON, V34, P14; Parry ML, 2007, CLIMATE CHANGE 2007; Pavy N, 2012, HEREDITY, V108, P273, DOI 10.1038/hdy.2011.72; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Pineda-Garcia F, 2011, PLANT CELL ENVIRON, V34, P1536, DOI 10.1111/j.1365-3040.2011.02351.x; Pluess AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033636; Poncet BN, 2010, MOL ECOL, V19, P2896, DOI 10.1111/j.1365-294X.2010.04696.x; Pritchard JK, 2000, GENETICS, V155, P945; Prunier J, 2011, MOL ECOL, V20, P1702, DOI 10.1111/j.1365-294X.2011.05045.x; Rehfeldt GE, 2014, FOREST ECOL MANAG, V324, P147, DOI 10.1016/j.foreco.2014.02.040; Richardson BA, 2009, INT J PLANT SCI, V170, P1120, DOI 10.1086/605870; ROBERTSON A, 1975, GENETICS, V81, P775; Roschanski AM, 2016, MOL ECOL, V25, P776, DOI 10.1111/mec.13516; Roschanski AM, 2013, APPL PLANT SCI, V1, DOI 10.3732/apps.1200179; Saenz-Romero C, 2006, FOREST ECOL MANAG, V229, P340, DOI 10.1016/j.foreco.2006.04.014; Sagnard F, 2002, FOREST ECOL MANAG, V157, P175, DOI 10.1016/S0378-1127(00)00664-2; Sarkar SK, 2006, ANN STAT, V34, P394, DOI 10.1214/009053605000000778; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Silva JCE, 2001, CAN J FOREST RES, V31, P1887, DOI 10.1139/cjfr-31-11-1887; Siol M, 2010, NEW PHYTOL, V188, P313, DOI 10.1111/j.1469-8137.2010.03401.x; SLATKIN M, 1991, GENETICS, V127, P627; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; Stephens M, 2009, NAT REV GENET, V10, P681, DOI 10.1038/nrg2615; Storz JF, 2005, MOL ECOL, V14, P671, DOI 10.1111/j.1365-294X.2005.02437.x; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Vilas A, 2012, J EVOLUTION BIOL, V25, P1364, DOI 10.1111/j.1420-9101.2012.02526.x; Voltas J, 2008, TREES-STRUCT FUNCT, V22, P759, DOI 10.1007/s00468-008-0236-5; Wolf H., 2003, EUFORGEN TECHNICAL G	102	23	23	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158216	10.1371/journal.pone.0158216	http://dx.doi.org/10.1371/journal.pone.0158216			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392065	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400037
J	Emmons, S; Kobourov, S; Gallant, M; Borner, K				Emmons, Scott; Kobourov, Stephen; Gallant, Mike; Borner, Katy			Analysis of Network Clustering Algorithms and Cluster Quality Metrics at Scale	PLOS ONE			English	Article								Overview Notions of community quality underlie the clustering of networks. While studies surrounding network clustering are increasingly common, a precise understanding of the realtionship between different cluster quality metrics is unknown. In this paper, we examine the relationship between stand-alone cluster quality metrics and information recovery metrics through a rigorous analysis of four widely-used network clustering algorithms-Louvain, Infomap, label propagation, and smart local moving. We consider the stand-alone quality metrics of modularity, conductance, and coverage, and we consider the information recovery metrics of adjusted Rand score, normalized mutual information, and a variant of normalized mutual information used in previous work. Our study includes both synthetic graphs and empirical data sets of sizes varying from 1,000 to 1,000,000 nodes. Cluster Quality Metrics We find significant differences among the results of the different cluster quality metrics. For example, clustering algorithms can return a value of 0.4 out of 1 onmodularity but score 0 out of 1 on information recovery. We find conductance, though imperfect, to be the stand-alone quality metric that best indicates performance on the information recovery metrics. Additionally, our study shows that the variant of normalized mutual information used in previous work cannot be assumed to differ only slightly from traditional normalized mutual information. Network Clustering Algorithms Smart local moving is the overall best performing algorithm in our study, but discrepancies between cluster evaluation metrics prevent us from declaring it an absolutely superior algorithm. Interestingly, Louvain performed better than Infomap in nearly all the tests in our study, contradicting the results of previous work in which Infomap was superior to Louvain. We find that although label propagation performs poorly when clusters are less clearly defined, it scales efficiently and accurately to large graphs with well-defined clusters.	[Emmons, Scott; Gallant, Mike; Borner, Katy] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Kobourov, Stephen] Univ Arizona, Dept Comp Sci, Tucson, AZ 85721 USA; [Borner, Katy] Indiana Univ, Indiana Univ Network Sci Inst, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; University of Arizona; Indiana University System; Indiana University Bloomington	Emmons, S (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	sremmons@indiana.edu	Kobourov, Stephen G/A-3016-2008	Kobourov, Stephen G/0000-0002-0477-2724	National Institutes of Health; Lilly Endowment, Inc.; Indiana METACyt Initiative	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lilly Endowment, Inc.; Indiana METACyt Initiative	This research was partially funded by the National Institutes of Health. This research was supported in part by Lilly Endowment, Inc., through its support for the Indiana University Pervasive Technology Institute, and in part by the Indiana METACyt Initiative. The Indiana METACyt Initiative at IU is also supported in part by Lilly Endowment, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by Lilly Endowment, Inc., through its support for the Indiana University Pervasive Technology Institute, and in part by the Indiana METACyt Initiative. The Indiana METACyt Initiative at IU is also supported in part by Lilly Endowment, Inc.	Almeida H, 2011, LECT NOTES ARTIF INT, V6911, P44, DOI 10.1007/978-3-642-23780-5_13; [Anonymous], EUROVIS SHORT PAPERS; [Anonymous], P 19 ACM INT C INF K; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Bastian M., 2009, 3 INT AAAI C WEBL SO; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brandes U, 2003, LECT NOTES COMPUT SC, V2832, P568; Correll M, 2014, IEEE T VIS COMPUT GR, V20, P2142, DOI 10.1109/TVCG.2014.2346298; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Franke R, 2016, PHYSICA A, V461, P384, DOI 10.1016/j.physa.2016.05.063; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Grnwald P.D., 2005, ADV MINIMUM DESCRIPT; Hintze JL, 1998, AM STAT, V52, P181, DOI 10.2307/2685478; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Kheirkhahzadeh M, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032309; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Leskovec J, 2005, LECT NOTES ARTIF INT, V3721, P133; McAuley J, 2012, LECT NOTES COMPUT SC, V7575, P828, DOI 10.1007/978-3-642-33765-9_59; Meila M, 2007, J MULTIVARIATE ANAL, V98, P873, DOI 10.1016/j.jmva.2006.11.013; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; Ronhovde P, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046114; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rotta R., 2011, J EXP ALGORITHMICS, V16, p2.1, DOI DOI 10.1145/1963190.1970376; Schaeffer SE, 2007, COMPUT SCI REV, V1, P27, DOI 10.1016/j.cosrev.2007.05.001; Schaub MT, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.026112; Schaub MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032210; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Tibely G, 2008, PHYSICA A, V387, P4982, DOI 10.1016/j.physa.2008.04.024; Vinh NX, 2010, J MACH LEARN RES, V11, P2837; Waltman L, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40829-0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang J, 2015, KNOWL INF SYST, V42, P181, DOI 10.1007/s10115-013-0693-z	39	95	95	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159161	10.1371/journal.pone.0159161	http://dx.doi.org/10.1371/journal.pone.0159161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391786	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400216
J	Klein, N; Sander, PM; Krahl, A; Scheyer, TM; Houssaye, A				Klein, Nicole; Sander, P. Martin; Krahl, Anna; Scheyer, Torsten M.; Houssaye, Alexandra			Diverse Aquatic Adaptations in Nothosaurus spp. (Sauropterygia)-Inferences from Humeral Histology and Microanatomy	PLOS ONE			English	Article							LONG-BONE HISTOLOGY; LOWER MUSCHELKALK; LIFE-STYLE; WINTERSWIJK; SKELETOCHRONOLOGY; EOSAUROPTERYGIA; NETHERLANDS; EVOLUTION; REPTILIA; AMNIOTES	Mid-diaphyseal cortical bone tissue in humeri of Nothosaurus spp. consists of coarse parallel-fibered bone, finer and higher organized parallel-fibered bone, and lamellar bone. Vascular canals are mainly arranged longitudinally and radially in a dominantly radial system. Blood vessels are represented by simple vascular canals, incompletely lined primary osteons, and fully developed primary osteons. Nothosaurus spp. shows a variety of diaphyseal microanatomical patterns, ranging from thick to very thin-walled cortices. In the early Anisian (Lower Muschelkalk), small- and large-bodied Nothosaurus spp. generally exhibit bone mass increase (BMI). In the middle to late Anisian (Middle Muschelkalk) small-bodied nothosaurs retain BMI whereas larger-bodied forms tend to show a decrease in bone mass (BMD). During the latest Anisian to early Ladinian (Upper Muschelkalk), small-and few large-bodied nothosaurs retain BMI, whereas the majority of large-bodied forms exhibit BMD. The stratigraphically youngest nothosaurs document five microanatomical categories, two of which are unique among marine amniotes: One consists of a very heterogeneously distributed spongy periosteal organization, the other of very thin-walled cortices. The functional significance of the two unique microanatomical specializations seen in large-bodied nothosaurs is the reduction of bone mass, which minimizes inertia of the limbs, and thus saves energy during locomotion. Transitions between the various microanatomical categories are rather gradual. Our results suggest that small-bodied Nothosaurus marchicus and other, not further assignable small-bodied nothosaurs seem to have been bound to near-shore, shallow marine environments throughout their evolution. Some large-bodied Nothosaurus spp. followed the same trend but others became more active swimmers and possibly inhabited open marine environments. The variety of microanatomical patterns may be related to taxonomic differences, developmental plasticity, and possibly sexual dimorphism. Humeral microanatomy documents the diversification of nothosaur species into different environments to avoid intraclade competition as well as competition with other marine reptiles. Nothosaur microanatomy indicates that knowledge of processes involved in secondary aquatic adaptation and their interaction are more complex than previously believed.	[Klein, Nicole] Staatliches Museum Nat Kunde Stuttgart, Rosenstein 1, D-70191 Stuttgart, Germany; [Sander, P. Martin] Univ Bonn, Div Paleontol, Steinmann Inst, Nussallee 8, D-53115 Bonn, Germany; [Krahl, Anna] Ruhr Univ Bochum, Fac Mech Engn, Biomech Res Grp, Univ Str 150, D-44801 Bochum, Germany; [Scheyer, Torsten M.] Univ Zurich, Palaeontol Inst & Museum, Karl Schmid Str 4, CH-8006 Zurich, Switzerland; [Houssaye, Alexandra] Museum Natl Hist Nat, UMR CNRS 7179, Dept Ecol & Gest Biodiversite, 57 Rue Cuvier CP-55, F-75000 Paris, France	University of Bonn; Ruhr University Bochum; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN)	Klein, N (corresponding author), Staatliches Museum Nat Kunde Stuttgart, Rosenstein 1, D-70191 Stuttgart, Germany.	nicole.klein@smns-bw.de		Scheyer, Torsten M./0000-0002-6301-8983; Krahl, Anna/0000-0003-1806-2907	French National Research agency [ANR-13-PDOC-0011]; Swiss National Science Foundation (SNSF) [31003A_149506]; Deutsche Forschungsgemeinsschaft [WI1398/8-1]; SNSF [31003A_149506]; DFG [WI1389/8-1]	French National Research agency(French National Research Agency (ANR)); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Deutsche Forschungsgemeinsschaft(German Research Foundation (DFG)); SNSF(Swiss National Science Foundation (SNSF)); DFG(German Research Foundation (DFG))	The French National Research agency (ANR-13-PDOC-0011; http://www.agence-nationalerecherche.fr/?Project=ANR-13-PDOC-0011); Swiss National Science Foundation (SNSF grant no. 31003A_149506; http://www.snf.ch/en/funding/careers/snsf-professorships/Pages/default.aspx); Deutsche Forschungsgemeinsschaft (WI1398/8-1, http://gepris.dfg.de/gepris/projekt/270835314). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge O. Dulfer (StIPB), Ch. Wimmer-Pfeil (SMNS), and J. Hugi (formerly PIMUZ) for the production of the thin sections. C. Klug (PIMUZ), H. Furrer (formerly PIMUZ), H. Hagdorn (MHI), N. Hauschke (IGWH), P. Havlik (GPIT), R. Schoch (SMNS), and D. Schwarz-Wings (MfN) kindly gave permission for the histological sampling of nothosaur bones. H. Hagdorn (MHI), R. Bottcher (SMNS), and D. Seegis helped with Upper Muschelkalk stratigraphy. M. Laurin (CNRS) is acknowledged for discussion on Bone Profiler. M. Rasser and R. Baumann (both SMNS) provided technical support. A. H. acknowledges financial support from the ANR-13-PDOC-0011. T.M.S. acknowledges support of SNSF grant no. 31003A_149506. AK acknowledges financial support from the DFG (WI1389/8-1). We are grateful to the helpful comments of M. Laurin, one anonymous reviewer, and of the academic editor A. Farke.	Albers PCH, 2011, NETH J GEOSCI, V90, P15, DOI 10.1017/S0016774600000639; [Anonymous], 2000, HDB PALEOHERPETOLOGY; Bickelmann C, 2008, J VERTEBR PALEONTOL, V28, P326, DOI 10.1671/0272-4634(2008)28[326:APSAIH]2.0.CO;2; Braun J., 1985, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V169, P307; BUFFRENIL VD, 1980, B SOC ZOOL FR, V105, P355; Canoville A, 2010, BIOL J LINN SOC, V100, P384, DOI 10.1111/j.1095-8312.2010.01431.x; CARROLL RL, 1985, PHILOS T ROY SOC B, V309, P343, DOI 10.1098/rstb.1985.0091; De Buffrenil V, 2000, J HERPETOL, V34, P414, DOI 10.2307/1565365; de Buffrenil V, 2008, J MORPHOL, V269, P533, DOI 10.1002/jmor.10604; de Buffrenil Vivian, 1992, Revue de Paleobiologie, V11, P397; de Buffrenil V, 2010, J MAMM EVOL, V17, P101, DOI 10.1007/s10914-010-9130-1; de Ricqles Armand, 2001, P289; Digby KH, 1916, J ANAT PHYSIOL, V50, P187; FELDKAMP SD, 1987, J ZOOL, V212, P43, DOI 10.1111/j.1469-7998.1987.tb05113.x; Francillon-Vieillot H., 1990, P471; Girondot M, 2003, J VERTEBR PALEONTOL, V23, P458, DOI 10.1671/0272-4634(2003)023[0458:BPATTQ]2.0.CO;2; GRAY DJ, 1969, AM J ANAT, V124, P431, DOI 10.1002/aja.1001240403; Gray NM, 2007, ANAT REC, V290, P638, DOI 10.1002/ar.20533; Hanni K, 2004, GATTUNG CERESIOSAURU; Hayashi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059146; Houssaye A, 2016, BIOL J LINN SOC, V117, P350, DOI 10.1111/bij.12660; Houssaye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095637; Houssaye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076741; Houssaye A, 2013, BIOL J LINN SOC, V108, P3, DOI 10.1111/j.1095-8312.2012.02002.x; Houssaye A, 2013, BIOL REV, V88, P117, DOI 10.1111/j.1469-185X.2012.00243.x; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Huene F.von., 1944, Neues Jahrbuch fuer Mineralogie Geologie und Palaeontologie Stuttgart, VB 7-9, P223; Hugi J, 2012, J HERPETOL, V46, P312, DOI 10.1670/11-071; Hugi Jasmina, 2011, Swiss Journal of Palaeontology, V130, P297, DOI 10.1007/s13358-011-0023-6; Hugi J, 2011, CR PALEVOL, V10, P413, DOI 10.1016/j.crpv.2011.03.009; KLEIN N, 2016, Patent No. 201615; Klein N, 2008, PALEOBIOLOGY, V34, P247, DOI 10.1666/0094-8373(2008)034[0247:OSITLB]2.0.CO;2; Klein N, 2007, SP PALAEONT, P169; Klein N, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1163712; Klein N, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140440; Klein N, 2015, PALAEONTOL Z, V89, P961, DOI 10.1007/s12542-015-0273-5; Klein N, 2015, CONTRIB ZOOL, V84, P59, DOI 10.1163/18759866-08401005; Klein N, 2012, PALAEONTOL Z, V86, P389, DOI 10.1007/s12542-012-0137-1; Klein N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011613; Klein N, 2009, ACTA PALAEONTOL POL, V54, P589, DOI 10.4202/app.2008.0083; Klein N, 2009, FOSS REC, V12, P121, DOI 10.1002/mmng.200900002; Konietzko-Meier D, 2013, NETH J GEOSCI, V92, P97, DOI 10.1017/S0016774600000020; Krahl A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-123; Laurin M, 2016, CR PALEVOL, V15, P115, DOI 10.1016/j.crpv.2015.01.001; Laurin M, 2011, CR PALEVOL, V10, P381, DOI 10.1016/j.crpv.2011.02.003; Meyer Hvon, 1847, SAURIER MUSCHELKALKS; Meyer Hvon, 1842, NEUES JB MINERALOGIE, V1842, P184; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Peyer B., 1939, ABHANDLUNGEN SCHWEIZ, V62:, P1; Rieppel, 1994, FIELDIANA GEOL, V28, P1, DOI DOI 10.5962/BHL.TITLE.3399; Rieppel O, 2002, ZOOL J LINN SOC-LOND, V135, P33, DOI 10.1046/j.1096-3642.2002.00019.x; Rieppel O., 1996, FIELDIANA GEOLOGY, V34, P1; Rieppel Olivier, 2001, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V263, P137; SANDER PM, 1990, ANN SCI NAT ZOOL, V11, P213; Sander PM., 1999, GEOWISSENSCHAFTLICHE, V2, P103; Shelton CD, 2013, T EARTH SCI, V103, P217, DOI DOI 10.1017/S175569101300025X]; SUES HD, 1987, ZOOL J LINN SOC-LOND, V90, P109, DOI 10.1111/j.1096-3642.1987.tb01351.x; TSCHANZ K, 1989, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V208, P153; Voeten DFAE, 2015, PALAEONTOL Z, V89, P943, DOI 10.1007/s12542-014-0250-4; Watson DMS, 1924, P ZOOL SOC LOND, V1924, P885; Wiffen J, 1995, GEOBIOS-LYON, V28, P625, DOI 10.1016/S0016-6995(95)80216-9; Zhang QY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4973	62	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158448	10.1371/journal.pone.0158448	http://dx.doi.org/10.1371/journal.pone.0158448			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391607	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000380005400059
J	Tedeschi, GJ; Cummins, SE; Anderson, CM; Anthenelli, RM; Zhuang, YL; Zhu, SH				Tedeschi, Gary J.; Cummins, Sharon E.; Anderson, Christopher M.; Anthenelli, Robert M.; Zhuang, Yue-Lin; Zhu, Shu-Hong			Smokers with Self-Reported Mental Health Conditions: A Case for Screening in the Context of Tobacco Cessation Services	PLOS ONE			English	Article							SMOKING-CESSATION; PRIMARY-CARE; PSYCHIATRIC-DISORDERS; UNITED-STATES; DRUG-USE; DEPRESSION; ILLNESS; QUITLINE; ALCOHOL; PEOPLE	Background People with mental health conditions (MHC) smoke at high rates and many die prematurely from smoking-related illnesses. Smoking cessation programs, however, generally do not screen for MHC. This study examined the utility of MHC screening in a large tobacco quitline to determine whether self-reported MHC predicts service utilization and quitting behaviors. Methods & Findings A brief set of question on MHC was embedded in the routine intake of a state quitline, and 125,261 smokers calling from June 2012 to September 2015 were asked the questions. Quit attempt rate and 6-month success rate were analyzed for a random subset of participants. Overall, 52.2% of smokers reported at least one MHC. Demographic patterns like gender or ethnic difference in self-reported MHC were similar to that in the general population. Depression disorder was reported most often (38.6%), followed by anxiety disorder (33.8%), bipolar disorder (17.0%), drug/alcohol abuse (11.9%), and schizophrenia (7.9%). Among those reporting any MHC, about two-thirds reported more than 1 MHC. Smokers with MHC received more counseling than smokers with no MHC. Quit attempt rates were high for all three groups (>70%). The probability of relapse was greater for those with more than one MHC than for those with one MHC (p<0.005), which in turn was greater than those with no MHC (p<.01). The six-month prolonged abstinence rates for the three conditions were, 21.8%, 28.6%, and 33.7%, respectively. The main limitation of this study is the use of a non-validated self-report question to assess MHC, even though it appears to be useful for predicting quitting behavior. Conclusions Smokers with MHC actively seek treatment to quit. Smoking cessation services can use a brief set of questions to screen for MHC to help identify smokers in need of more intensive treatment to quit smoking.	[Tedeschi, Gary J.; Cummins, Sharon E.; Anderson, Christopher M.; Zhuang, Yue-Lin; Zhu, Shu-Hong] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Cummins, Sharon E.; Zhu, Shu-Hong] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Anthenelli, Robert M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhu, SH (corresponding author), Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA.; Zhu, SH (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.	szhu@ucsd.edu	Zhu, Shu-Hong/AAF-5164-2019	Tedeschi, Gary/0000-0001-5121-7064; Cummins, Sharon/0000-0003-3481-8436	California Department of Public Health (CDPH) [CDPH-09-13058, CDPH-14-10611]; First 5 California Children and Family Commission [CCFC-7235, CCFC-7318]; National Institutes of Health (NIAAA) [U01 AA013641]	California Department of Public Health (CDPH); First 5 California Children and Family Commission; National Institutes of Health (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Moores Cancer Center and Department of Family Medicine & Public Health staff contributions to the manuscript supported by the California Department of Public Health (CDPH), www.cdph.ca.gov, Contract #CDPH-09-13058 and CDPH-14-10611, and First 5 California Children and Family Commission, www.ccfc.ca.gov, Contract #CCFC-7235 and CCFC-7318. Dr. Anthenelli's contributions supported in part by the National Institutes of Health (NIAAA), www.niaaa.nih.gov, Grant # U01 AA013641 (INIA Stress Consortium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CM, 2007, TOB CONTROL, V16, pI81, DOI 10.1136/tc.2007.020701; Aubin HJ, 2012, NEUROSCI BIOBEHAV R, V36, P271, DOI 10.1016/j.neubiorev.2011.06.007; Bahorik AL, 2014, PSYCHOL MED, V44, P61, DOI 10.1017/S0033291713000548; Bowden CL, 2001, PSYCHIAT SERV, V52, P51, DOI 10.1176/appi.ps.52.1.51; Campion J., 2008, ADV PSYCHIAT TREAT, V14, P217, DOI [DOI 10.1192/APT.BP.108.005710, 10.1192/apt.bp.108.005710]; Cerimele JM, 2014, J AM BOARD FAM MED, V27, P399, DOI 10.3122/jabfm.2014.03.130252; Chu J.P., 2011, ONLINE READINGS PSYC, V3, P2307, DOI [10.9707/2307-0919.1026, DOI 10.9707/2307-0919.1026]; Druss BG, 2011, MED CARE, V49, P599, DOI 10.1097/MLR.0b013e31820bf86e; Gfroerer J, 2013, MMWR-MORBID MORTAL W, V62, P81; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Hebert KK, 2011, AM J PREV MED, V40, P47, DOI 10.1016/j.amepre.2010.09.030; Himelhoch S, 2003, AM J PSYCHIAT, V160, P2228, DOI 10.1176/appi.ajp.160.12.2228; Hormes JM, 2012, AIDS CARE, V24, P420, DOI 10.1080/09540121.2011.608795; Kerkvliet JL, 2015, NICOTINE TOB RES, V17, P735, DOI 10.1093/ntr/ntu239; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lawrence D, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-285; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; Lembke A, 2016, TOB CONTROL, V25, P261, DOI 10.1136/tobaccocontrol-2014-052215; Lukowski AV, 2015, NICOTINE TOB RES, V17, P924, DOI 10.1093/ntr/ntu252; Meyer F, 2009, J AFFECT DISORDERS, V112, P174, DOI 10.1016/j.jad.2008.04.022; Mitchell AJ, 2007, BRIT J GEN PRACT, V57, P144; Morral AR, 2000, DRUG ALCOHOL DEPEN, V57, P193, DOI 10.1016/S0376-8716(99)00048-4; Morris Chad D, 2009, J Am Psychiatr Nurses Assoc, V15, P32, DOI 10.1177/1078390308330050; North American Quitline Consortium, 2011, MDS STAND OPT QUEST; Olfson M, 2015, JAMA PSYCHIAT, V72, P1172, DOI 10.1001/jamapsychiatry.2015.1737; Parks J., 2006, MORBIDITY MORTALITY; Phillips KM, 2004, PROF PSYCHOL-RES PR, V35, P281, DOI 10.1037/0735-7028.35.3.281; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; Rogers E, 2014, AM J PUBLIC HEALTH, V104, P90, DOI 10.2105/AJPH.2013.301584; SAS Institute Inc, 2014, SAS 9 4 LANG REF; Saul J, 2013, RESULTS 2012 NAQC AN; Schroeder SA, 2010, ANNU REV PUBL HEALTH, V31, P297, DOI 10.1146/annurev.publhealth.012809.103701; Siru R, 2009, ADDICTION, V104, P719, DOI 10.1111/j.1360-0443.2009.02545.x; Stockwell T, 2004, ADDICTION, V99, P1024, DOI 10.1111/j.1360-0443.2004.00815.x; Substance Abuse and Mental Health Services Administration, 2013, RES 2012 NAT SURV DR; Thorndike A N, 2001, Nicotine Tob Res, V3, P85, DOI 10.1080/14622200020032132; Tidey JW, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4065; Trosclair A, 2010, ADDICT BEHAV, V35, P438, DOI 10.1016/j.addbeh.2009.12.011; Vickerman KA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/817298; Williams JM, 2013, AM J PUBLIC HEALTH, V103, P1549, DOI 10.2105/AJPH.2013.301232; Zhu SH, 2002, NEW ENGL J MED, V347, P1087, DOI 10.1056/NEJMsa020660; ZHU SH, 1995, PROF PSYCHOL-RES PR, V26, P624, DOI 10.1037/0735-7028.26.6.624; Zhu SH, 1996, J COUNS DEV, V75, P93, DOI 10.1002/j.1556-6676.1996.tb02319.x; Zhu SH, 1996, J CONSULT CLIN PSYCH, V64, P202, DOI 10.1037/0022-006X.64.1.202; Ziedonis DM, 2003, CURR OPIN PSYCHIATR, V16, P305, DOI 10.1097/01.yco.0000069086.26384.5f; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	46	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159127	10.1371/journal.pone.0159127	http://dx.doi.org/10.1371/journal.pone.0159127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391334	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400212
J	Toro, R; Perez-Serra, A; Campuzano, O; Moncayo-Arlandi, J; Allegue, C; Iglesias, A; Mangas, A; Brugada, R				Toro, Rocio; Perez-Serra, Alexandra; Campuzano, Oscar; Moncayo-Arlandi, Javier; Allegue, Catarina; Iglesias, Anna; Mangas, Alipio; Brugada, Ramon			Familial Dilated Cardiomyopathy Caused by a Novel Frameshift in the BAG3 Gene	PLOS ONE			English	Article							HEART-FAILURE; MUTATION; PROTEIN; LOCI	Background Dilated cardiomyopathy, a major cause of chronic heart failure and cardiac transplantation, is characterized by left ventricular or biventricular heart dilatation. In nearly 50% of cases the pathology is inherited, and more than 60 genes have been reported as disease-causing. However, in 30% of familial cases the mutation remains unidentified even after comprehensive genetic analysis. This study clinically and genetically assessed a large Spanish family affected by dilated cardiomyopathy to search for novel variations. Methods and Results Our study included a total of 100 family members. Clinical assessment was performed in alive, and genetic analysis was also performed in alive and 1 deceased relative. Genetic screening included resequencing of 55 genes associated with sudden cardiac death, and Sanger sequencing of main disease-associated genes. Genetic analysis identified a frame-shift variation in BAG3 (p.H243Tfr*64) in 32 patients. Genotype-phenotype correlation identified substantial heterogeneity in disease expression. Of 32 genetic carriers (one deceased), 21 relatives were clinically affected, and 10 were asymptomatic. Seventeen of the symptomatic genetic carriers exhibited proto-diastolic septal knock by echocardiographic assessment. Conclusions We report p.H243Tfr*64_BAG3 as a novel pathogenic variation responsible for familial dilated cardiomyopathy. This variation correlates with a more severe phenotype of the disease, mainly in younger individuals. Genetic analysis in families, even asymptomatic individuals, enables early identification of individuals at risk and allows implementation of preventive measures.	[Toro, Rocio; Mangas, Alipio] Sch Med, Dept Med, Cadiz, Spain; [Perez-Serra, Alexandra; Campuzano, Oscar; Moncayo-Arlandi, Javier; Allegue, Catarina; Iglesias, Anna; Brugada, Ramon] Univ Girona, IDIBGI, Cardiovasc Genet Ctr, Girona, Spain; [Campuzano, Oscar; Brugada, Ramon] Univ Girona, Sch Med, Dept Med Sci, Girona, Spain; [Brugada, Ramon] Univ Girona, Hosp Josep Trueta, Cardiac Genet Unit, Girona, Spain	Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Universitat de Girona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta	Brugada, R (corresponding author), Univ Girona, IDIBGI, Cardiovasc Genet Ctr, Girona, Spain.; Brugada, R (corresponding author), Univ Girona, Sch Med, Dept Med Sci, Girona, Spain.; Brugada, R (corresponding author), Univ Girona, Hosp Josep Trueta, Cardiac Genet Unit, Girona, Spain.	ramon@brugada.org	campuzano, oscar/J-1968-2014; Toro, Rocio/AEU-8689-2022; Mangas, Alipio/AAN-2722-2020	campuzano, oscar/0000-0001-5298-5276; Toro, Rocio/0000-0003-3136-1776; Mangas, Alipio/0000-0002-5402-6674; ALLEGUE TOSCANO, CATARINA/0000-0002-5121-3159; Moncayo-Arlandi, Javier/0000-0002-3564-4063	Obra Social "la Caixa"	Obra Social "la Caixa"(La Caixa Foundation)	This work was supported by Obra Social "la Caixa". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinrinade O, 2015, EUR HEART J, V36, P2327, DOI 10.1093/eurheartj/ehv253; Arimura T, 2011, HUM MUTAT, V32, P1481, DOI 10.1002/humu.21603; Bruch C, 2003, J AM SOC ECHOCARDIOG, V16, P1031, DOI 10.1016/S0894-7317(03)00634-5; Cuenca S, 2016, THE JOURNAL OF HEART; De Backer J, 2005, Eur J Echocardiogr, V6, P243, DOI 10.1016/j.euje.2004.09.010; De Marco M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.8; De Marco M, 2014, JACC-HEART FAIL, V2, P673, DOI 10.1016/j.jchf.2014.05.012; Fatkin D, 2011, CIRC-CARDIOVASC GENE, V4, P342, DOI 10.1161/CIRCGENETICS.110.958918; Feldman AM, 2014, J CELLULAR PHYSL; Flachskampf FA, 2007, HERZ, V32, P89, DOI 10.1007/s00059-007-2960-9; Franaszczyk M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-192; Garnier S, 2015, INT J CARDIOL, V189, P105, DOI 10.1016/j.ijcard.2015.04.003; Gupta P, 2010, BASIC RES CARDIOL, V105, P365, DOI 10.1007/s00395-010-0085-4; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Hershberger RE, 2011, J AM COLL CARDIOL, V57, P1641, DOI 10.1016/j.jacc.2011.01.015; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Hishiya A, 2010, CIRC RES, V107, P1220, DOI 10.1161/CIRCRESAHA.110.225649; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Knezevic T, 2015, HEART FAIL REV, V20, P423, DOI 10.1007/s10741-015-9487-6; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; Morales A, 2013, CURR CARDIOL REP, V15, DOI 10.1007/s11886-013-0375-1; Norton N, 2011, AM J HUM GENET, V88, P273, DOI 10.1016/j.ajhg.2011.01.016; Odgerel Z, 2010, NEUROMUSCULAR DISORD, V20, P438, DOI 10.1016/j.nmd.2010.05.004; Perez-Serra A, 2015, J CARD FAIL, V21, P217, DOI 10.1016/j.cardfail.2014.12.003; Selcen D, 2009, ANN NEUROL, V65, P83, DOI 10.1002/ana.21553; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; van Rijsingen IAW, 2012, J AM COLL CARDIOL, V59, P493, DOI 10.1016/j.jacc.2011.08.078; Villard E, 2011, EUR HEART J, V32, P1065, DOI 10.1093/eurheartj/ehr105	31	26	27	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158730	10.1371/journal.pone.0158730	http://dx.doi.org/10.1371/journal.pone.0158730			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391596	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400110
J	Dziewit, L; Radlinska, M				Dziewit, Lukasz; Radlinska, Monika			Two Inducible Prophages of an Antarctic Pseudomonas sp ANT_H14 Use the Same Capsid for Packaging Their Genomes - Characterization of a Novel Phage Helper-Satellite System	PLOS ONE			English	Article							ESCHERICHIA-COLI DEFICIENT; PATHOGENICITY ISLAND; CHROMOSOMAL ISLANDS; LAMBDOID PHAGE; HIM MUTANTS; BACTERIOPHAGE; DNA; TEMPERATE; GENES; INTEGRATION	Two novel prophages phi AH14a and phi AH14b of a psychrotolerant Antarctic bacterium Pseudomonas sp. ANT_H14 have been characterized. They were simultaneously induced with mitomycin C and packed into capsids of the same size and protein composition. The genome sequences of phi AH14a and phi AH14b have been determined. phi AH14b, the phage with a smaller genome (16,812 bp) seems to parasitize phi AH14a (55,060 bp) and utilizes its capsids, as only the latter encodes a complete set of structural proteins. Both viruses probably constitute a phage helper-satellite system, analogous to the P2-P4 duo. This study describes the architecture and function of the phi AH14a and phi AH14b genomes. Moreover, a functional analysis of a phi AH14a-encoded lytic enzyme and a DNA methyltransferase was performed. In silico analysis revealed the presence of the homologs of phi AH14a and phi AH14b in other Pseudomonas genomes, which may suggest that helper-satellite systems related to the one described in this work are common in pseudomonads.	[Dziewit, Lukasz] Univ Warsaw, Inst Microbiol, Dept Bacterial Genet, Fac Biol, Warsaw, Poland; [Radlinska, Monika] Univ Warsaw, Inst Microbiol, Dept Virol, Fac Biol, Warsaw, Poland	University of Warsaw; University of Warsaw	Radlinska, M (corresponding author), Univ Warsaw, Inst Microbiol, Dept Virol, Fac Biol, Warsaw, Poland.	m.radlinska@biol.uw.edu.pl	Dziewit, Lukasz/L-1131-2016	Dziewit, Lukasz/0000-0002-5057-2811; Radlinska, Monika/0000-0001-6818-8685	National Science Centre, Poland [DEC-2013/09/D/NZ8/03046]; European Union-the European Regional Development Fund [POIG.02.02.00-14-024/08-00]	National Science Centre, Poland(National Science Centre, Poland); European Union-the European Regional Development Fund	This work was supported by the National Science Centre, Poland (grant number DEC-2013/09/D/NZ8/03046). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Krzysztof Skowronek for useful comments and critical reading of the manuscript. This work was supported by the National Science Centre, Poland (grant no. DEC-2013/09/D/NZ8/03046). Library construction and phage genomes assembly was carried out at the DNA Sequencing and Oligonucleotide Synthesis Laboratory IBB PAS using the CePT infrastructure financed by the European Union-the European Regional Development Fund [Innovative economy 2007-13, Agreement POIG.02.02.00-14-024/08-00].	Al-Hasani K, 2001, MICROB PATHOGENESIS, V30, P1, DOI 10.1006/mpat.2000.0404; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Tormo MA, 2008, J BACTERIOL, V190, P2434, DOI 10.1128/JB.01349-07; Asadulghani M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000408; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bandyopadhyay K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-34; Belcaid M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S9-S10; Bishop AL, 2005, J BACTERIOL, V187, P2469, DOI 10.1128/JB.187.7.2469-2482.2005; Bobay LM, 2014, P NATL ACAD SCI USA, V111, P12127, DOI 10.1073/pnas.1405336111; BUTKUS V, 1987, NUCLEIC ACIDS RES, V15, P7091, DOI 10.1093/nar/15.17.7091; Byrne M, 2005, GENE, V346, P187, DOI 10.1016/j.gene.2004.11.001; CALENDAR R, 1981, VIROLOGY, V113, P20, DOI 10.1016/0042-6822(81)90133-1; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Catalano CE, 2000, CELL MOL LIFE SCI, V57, P128, DOI 10.1007/s000180050503; Ceyssens PJ, 2010, FUTURE MICROBIOL, V5, P1041, DOI 10.2217/FMB.10.66; Christie GE, 2012, VIROLOGY, V434, P210, DOI 10.1016/j.virol.2012.10.028; Di Lallo G, 2014, J BASIC MICROB, V54, P1210, DOI 10.1002/jobm.201300951; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Drozdz M, 2012, NUCLEIC ACIDS RES, V40, P2119, DOI 10.1093/nar/gkr1039; Dziewit L, 2014, J VIROL, V88, P13111, DOI 10.1128/JVI.01875-14; Frigols B, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005609; Garcia P, 2008, APPL ENVIRON MICROB, V74, P7552, DOI 10.1128/AEM.01709-08; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; HENTHORN KS, 1995, J BACTERIOL, V177, P3185, DOI 10.1128/jb.177.11.3185-3190.1995; Hernandez-Sanchez J, 2008, ARCH VIROL, V153, P1271, DOI 10.1007/s00705-008-0111-0; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hulo N, 2004, NUCLEIC ACIDS RES, V32, pD134, DOI 10.1093/nar/gkh044; INOUYE S, 1991, SCIENCE, V252, P969, DOI 10.1126/science.1709758; Santamaria RI, 2014, APPL ENVIRON MICROB, V80, P446, DOI 10.1128/AEM.02256-13; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Jung K, 2012, CURR OPIN MICROBIOL, V15, P118, DOI 10.1016/j.mib.2011.11.009; Keen Eric C, 2014, Bacteriophage, V4, pe28365; KIRBY JE, 1994, J BACTERIOL, V176, P2068, DOI 10.1128/jb.176.7.2068-2081.1994; Kropinski AM, 2000, J BACTERIOL, V182, P6066, DOI 10.1128/JB.182.21.6066-6074.2000; Kropinski AM, 2009, ENVIRON MICROBIOL, V11, P2775, DOI 10.1111/j.1462-2920.2009.01970.x; Kumar Ritesh, 2013, Subcell Biochem, V61, P81, DOI 10.1007/978-94-007-4525-4_4; Kung VL, 2010, MICROBIOL MOL BIOL R, V74, P621, DOI 10.1128/MMBR.00027-10; Laanto E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00829; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Latino L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093777; Leplae R, 2004, NUCLEIC ACIDS RES, V32, pD45, DOI 10.1093/nar/gkh084; LINDQVIST BH, 1993, MICROBIOL REV, V57, P683, DOI 10.1128/MMBR.57.3.683-702.1993; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Lopes A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1027; Lynch KH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-599; MARVIK OJ, 1994, VIROLOGY, V205, P51, DOI 10.1006/viro.1994.1619; MOZOLA MA, 1985, VIROLOGY, V140, P313, DOI 10.1016/0042-6822(85)90368-X; MOZOLA MA, 1985, VIROLOGY, V140, P328, DOI 10.1016/0042-6822(85)90369-1; Nilssen O, 1996, VIROLOGY, V219, P432, DOI 10.1006/viro.1996.0269; Niu YD, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0494-5; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Penades JR, 2015, ANNU REV VIROL, V2, P181, DOI 10.1146/annurev-virology-031413-085446; PIERSON LS, 1987, J MOL BIOL, V196, P487, DOI 10.1016/0022-2836(87)90026-X; Ram G, 2012, P NATL ACAD SCI USA, V109, P16300, DOI 10.1073/pnas.1204615109; Refardt D, 2011, ISME J, V5, P1451, DOI 10.1038/ismej.2011.30; Rice SA, 2009, ISME J, V3, P271, DOI 10.1038/ismej.2008.109; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Sambrook J., 2001, MOL CLONING LAB MANU; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schubert RA, 2007, GENE DEV, V21, P2461, DOI 10.1101/gad.1584907; Sepulveda-Robles O, 2012, APPL ENVIRON MICROB, V78, P4510, DOI 10.1128/AEM.00065-12; SHORE D, 1978, P NATL ACAD SCI USA, V75, P400, DOI 10.1073/pnas.75.1.400; Silby MW, 2011, FEMS MICROBIOL REV, V35, P652, DOI 10.1111/j.1574-6976.2011.00269.x; SIX EW, 1991, VIROLOGY, V182, P34, DOI 10.1016/0042-6822(91)90645-R; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Summer EJ, 2004, J MOL BIOL, V340, P49, DOI 10.1016/j.jmb.2004.04.053; Svenningsen SL, 2005, P NATL ACAD SCI USA, V102, P4465, DOI 10.1073/pnas.0409839102; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Uc-Mass A, 2004, VIROLOGY, V329, P425, DOI 10.1016/j.virol.2004.09.005; Vostrov AA, 1996, J BACTERIOL, V178, P1484, DOI 10.1128/jb.178.5.1484-1486.1996; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Wang XX, 2009, ISME J, V3, P1164, DOI 10.1038/ismej.2009.59; Webb JS, 2004, J BACTERIOL, V186, P8066, DOI 10.1128/JB.186.23.8066-8073.2004; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Wietzorrek A, 2006, J BACTERIOL, V188, P1419, DOI 10.1128/JB.188.4.1419-1436.2006; Yeo CC, 1998, PLASMID, V40, P203, DOI 10.1006/plas.1998.1365; Young R, 2002, J MOL MICROB BIOTECH, V4, P21; Zhang N, 1999, MOL GEN GENET, V262, P659, DOI 10.1007/s004380051128; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	84	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158889	10.1371/journal.pone.0158889	http://dx.doi.org/10.1371/journal.pone.0158889			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387973	gold, Green Published, Green Submitted			2022-12-26	WOS:000379811500060
J	Zador, Z; Sperrin, M; King, AT				Zador, Zsolt; Sperrin, Matthew; King, Andrew T.			Predictors of Outcome in Traumatic Brain Injury: New Insight Using Receiver Operating Curve Indices and Bayesian Network Analysis	PLOS ONE			English	Article							HEAD-INJURY; VALIDATION; MORTALITY; DESIGN; MODELS; CRASH; COMA	Background Traumatic brain injury remains a global health problem. Understanding the relative importance of outcome predictors helps optimize our treatment strategies by informing assessment protocols, clinical decisions and trial designs. In this study we establish importance ranking for outcome predictors based on receiver operating indices to identify key predictors of outcome and create simple predictive models. We then explore the associations between key outcome predictors using Bayesian networks to gain further insight into predictor importance. Methods We analyzed the corticosteroid randomization after significant head injury (CRASH) trial database of 10008 patients and included patients for whom demographics, injury characteristics, computer tomography (CT) findings and Glasgow Outcome Scale (GCS) were recorded (total of 13 predictors, which would be available to clinicians within a few hours following the injury in 6945 patients). Predictions of clinical outcome (death or severe disability at 6 months) were performed using logistic regression models with 5-fold cross validation. Predictive performance was measured using standardized partial area (pAUC) under the receiver operating curve (ROC) and we used Delong test for comparisons. Variable importance ranking was based on pAUC targeted at specificity (pAUC(SP)) and sensitivity (pAUC(SE)) intervals of 90-100%. Probabilistic associations were depicted using Bayesian networks. Results Complete AUC analysis showed very good predictive power (AUC = 0.8237, 95% CI: 0.8138-0.8336) for the complete model. Specificity focused importance ranking highlighted age, pupillary, motor responses, obliteration of basal cisterns/3rd ventricle and midline shift. Interestingly when targeting model sensitivity, the highest-ranking variables were age, severe extracranial injury, verbal response, hematoma on CT and motor response. Simplified models, which included only these key predictors, had similar performance (pAUC(SP) = 0.6523, 95% CI: 0.6402-0.6641 and pAUC(SE) = 0.6332, 95% CI: 0.62-0.6477) compared to the complete models (pAUC(SP) = 0.6664, 95% CI: 0.6543-0.679, pAUC(SE) = 0.6436, 95% CI: 0.6289-0.6585, de Long p value 0.1165 and 0.3448 respectively). Bayesian networks showed the predictors that did not feature in the simplified models were associated with those that did. Conclusion We demonstrate that importance based variable selection allows simplified predictive models to be created while maintaining prediction accuracy. Variable selection targeting specificity confirmed key components of clinical assessment in TBI whereas sensitivity based ranking suggested extracranial injury as one of the important predictors. These results help refine our approach to head injury assessment, decision-making and outcome prediction targeted at model sensitivity and specificity. Bayesian networks proved to be a comprehensive tool for depicting probabilistic associations for key predictors giving insight into why the simplified model has maintained accuracy.	[Zador, Zsolt; King, Andrew T.] Salford Royal Fdn Trust, Dept Neurosurg, Salford, Greater Manches, England; [Zador, Zsolt] Univ Manchester, Ctr Vasc & Stroke Res, Inst Cardiovasc Sci, Manchester, Lancs, England; [Sperrin, Matthew] Univ Manchester, Manchester Acad Hlth Sci Ctr, Hlth eRes Ctr, Farr Inst, Manchester, Lancs, England	Salford Royal NHS Foundation Trust; University of Manchester; University of Manchester	Zador, Z (corresponding author), Salford Royal Fdn Trust, Dept Neurosurg, Salford, Greater Manches, England.; Zador, Z (corresponding author), Univ Manchester, Ctr Vasc & Stroke Res, Inst Cardiovasc Sci, Manchester, Lancs, England.	zadzso@gmail.com	King, Andrew/AAR-1656-2020	Sperrin, Matthew/0000-0002-5351-9960; Zador, Zsolt/0000-0001-9767-3372; King, Andrew/0000-0002-6546-7248	National Institute for Health and Research; University of Manchester's Health eResearch Centre (HeRC) - Medical Research Council Grant [MR/K006665/1]; Medical Research Council [MC_PC_13042, MR/K006665/1] Funding Source: researchfish; National Institute for Health Research [CL-2014-06-004] Funding Source: researchfish; MRC [MR/K006665/1] Funding Source: UKRI	National Institute for Health and Research; University of Manchester's Health eResearch Centre (HeRC) - Medical Research Council Grant; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ZZ is an Academic Clinical Lecturer Funded by the National Institute for Health and Research. MS is supported by the University of Manchester's Health eResearch Centre (HeRC) funded by the Medical Research Council Grant MR/K006665/1.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; [Anonymous], 2021, LANG ENV STAT COMP; Bateman DE, 2001, J NEUROL NEUROSUR PS, V71, P13; Cai ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120805; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Edwards P, 2005, LANCET, V365, P1957; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Heinzelmann M, 1996, INJURY, V27, P345, DOI 10.1016/0020-1383(95)00223-5; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Korb K.B., 2004, COM SCI DAT; Lecky F, 2015, EMERG MED J, V32, P906, DOI 10.1136/emermed-2015-205460; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MCCLISH DK, 1989, MED DECIS MAKING, V9, P190, DOI 10.1177/0272989X8900900307; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nagarajan R, 2013, BAYESIAN NETWORKS R; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Patel HC, 2010, ACTA NEUROCHIR, V152, P1353, DOI 10.1007/s00701-010-0666-x; Perdue PW, 1998, J TRAUMA, V45, P805, DOI 10.1097/00005373-199810000-00034; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sesen MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082349; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; TEASDALE G, 1974, LANCET, V2, P81; The CRASH trial management group, 2001, BMC Emerg Med, V1, P1; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; van Leeuwen N, 2012, NEUROSURGERY, V70, P811, DOI 10.1227/NEU.0b013e318235d640; Wong George K C, 2011, J Emerg Trauma Shock, V4, P346, DOI 10.4103/0974-2700.83861; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032	39	27	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158762	10.1371/journal.pone.0158762	http://dx.doi.org/10.1371/journal.pone.0158762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388421	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500043
J	Markunas, CA; Wilcox, AJ; Xu, ZL; Joubert, BR; Harlid, S; Panduri, V; Haberg, SE; Nystad, W; London, SJ; Sandler, DP; Lie, RT; Wade, PA; Taylor, JA				Markunas, Christina A.; Wilcox, Allen J.; Xu, Zongli; Joubert, Bonnie R.; Harlid, Sophia; Panduri, Vijayalakshmi; Haberg, Siri E.; Nystad, Wenche; London, Stephanie J.; Sandler, Dale P.; Lie, Rolv T.; Wade, Paul A.; Taylor, Jack A.			Maternal Age at Delivery Is Associated with an Epigenetic Signature in Both Newborns and Adults	PLOS ONE			English	Article							DNA METHYLATION CHANGES; DEVELOPMENTAL ORIGINS; NORWEGIAN MOTHER; CHILD COHORT; PREGNANCY; EXPRESSION; SMOKING; RISK; PERSPECTIVE; POPULATION	Offspring of older mothers are at increased risk of adverse birth outcomes, childhood cancers, type 1 diabetes, and neurodevelopmental disorders. The underlying biologic mechanisms for most of these associations remain obscure. One possibility is that maternal aging may produce lasting changes in the epigenetic features of a child's DNA. To test this, we explored the association of mothers' age at pregnancy with methylation in her offspring, using blood samples from 890 Norwegian newborns and measuring DNA methylation at more than 450,000 CpG sites across the genome. We examined replication of a maternal-age finding in an independent group of 1062 Norwegian newborns, and then in 200 US middle-aged women. Older maternal age was significantly associated with reduced methylation at four adjacent CpGs near the 2nd exon of KLHL35 in newborns (p-values ranging from 3x10(-6) to 8x10(-7)). These associations were replicated in the independent set of newborns, and replicated again in women 40 to 60 years after their birth. This study provides the first example of parental age permanently affecting the epigenetic profile of offspring. While the specific functions of the affected gene are unknown, this finding opens the possibility that a mother's age at pregnancy could affect her child's health through epigenetic mechanisms.	[Markunas, Christina A.; Wilcox, Allen J.; Xu, Zongli; Joubert, Bonnie R.; London, Stephanie J.; Sandler, Dale P.; Taylor, Jack A.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Harlid, Sophia; Panduri, Vijayalakshmi; Wade, Paul A.; Taylor, Jack A.] NIEHS, Epigenet & Stem Cell Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Haberg, Siri E.; Nystad, Wenche; Lie, Rolv T.] Norwegian Inst Publ Hlth, Oslo, Norway; [Lie, Rolv T.] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Markunas, Christina A.] RTI Int, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Norwegian Institute of Public Health (NIPH); University of Bergen; Research Triangle Institute	Taylor, JA (corresponding author), NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA.; Taylor, JA (corresponding author), NIEHS, Epigenet & Stem Cell Biol Lab, NIH, Res Triangle Pk, NC 27709 USA.	taylor@niehs.nih.gov	Harlid, Sophia/AAJ-5809-2021; Wade, Paul A/D-2374-2019; London, Stephanie/C-3734-2019; Wilcox, Allen J/C-7723-2019; taylor, jack a/C-7154-2019	Harlid, Sophia/0000-0001-8540-6891; Wade, Paul A/0000-0002-6042-357X; London, Stephanie/0000-0003-4911-5290; Wilcox, Allen J/0000-0002-3376-1311; taylor, jack a/0000-0001-5303-6398; Sandler, Dale/0000-0002-6776-0018; xu, zongli/0000-0002-9034-8902; Joubert, Bonnie/0000-0001-7952-1180; Markunas, Christina/0000-0003-3401-733X	Intramural Research Program of the NIH, National Institute of Environmental Health Science, Sister Study [Z01 ES044005]; Intramural Research Program of the NIH, National Institute of Environmental Health Science, MoBa [Z01-ES-49019]; Intramural Research Program of the NIH, National Institute of Environmental Health Science, Norway Facial Clefts Study; Norwegian Ministry of Health; Ministry of Education and Research; NIH/NIEHS [N01-ES-75558]; NIH/NINDS [1 UO1 NS 047537-01]; Norwegian Research Council/FUGE [151918/S10]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101965, ZIAES049032, ZIAES044005, ZIAES044003, ZIAES049033, ZIAES049019, ZIAES049027] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Environmental Health Science, Sister Study; Intramural Research Program of the NIH, National Institute of Environmental Health Science, MoBa; Intramural Research Program of the NIH, National Institute of Environmental Health Science, Norway Facial Clefts Study; Norwegian Ministry of Health; Ministry of Education and Research; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Norwegian Research Council/FUGE(Research Council of Norway); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (http://www.niehs.nih.gov/, Z01 ES044005, Sister Study (DPS); Z01-ES-49019, MoBa (SJL); Norway Facial Clefts Study (AJW)). The Norwegian Mother and Child Cohort Study is supported by the Norwegian Ministry of Health and the Ministry of Education and Research (https://www.regjeringen.no/en/dep/kd/id586/), NIH/NIEHS (http://www.niehs.nih.gov/, contract no N01-ES-75558), NIH/NINDS (http://www.ninds.nih.gov/, grant no. 1 UO1 NS 047537-01), and the Norwegian Research Council/FUGE (http://www.forskningsradet.no/prognett-fuge/Home_page/1226993493114, grant no. 151918/S10 (WN)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins RM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-47; Cardwell CR, 2010, DIABETES, V59, P486, DOI 10.2337/db09-1166; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Grether JK, 2009, AM J EPIDEMIOL, V170, P1118, DOI 10.1093/aje/kwp247; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Haberg SE, 2011, J ALLERGY CLIN IMMUN, V127, P262, DOI 10.1016/j.jaci.2010.10.004; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Harlid S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118757; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Jenkins TG, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004458; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jolly M, 2000, HUM REPROD, V15, P2433, DOI 10.1093/humrep/15.11.2433; Joubert BR, 2014, CANCER EPIDEM BIOMAR, V23, P1007, DOI 10.1158/1055-9965.EPI-13-1256; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Kenny LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056583; Khalil A, 2013, ULTRASOUND OBST GYN, V42, P634, DOI 10.1002/uog.12494; Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170; Markunas CA, 2014, ENVIRON HEALTH PERSP, V122, P1147, DOI 10.1289/ehp.1307892; Milekic MH, 2014, MOL PSYCHIAT; Morris MR, 2011, ONCOGENE, V30, P1390, DOI 10.1038/onc.2010.525; Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x; Seoud MAF, 2002, AM J PERINAT, V19, P1, DOI 10.1055/s-2002-20175; Shelton JF, 2010, AUTISM RES, V3, P30, DOI 10.1002/aur.116; Shitani M, 2012, TUMOR BIOL, V33, P1307, DOI 10.1007/s13277-012-0378-3; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353; Venables WN., 2002, MODERN APPL STAT S 4; Waterland RA, 2007, ANNU REV NUTR, V27, P363, DOI 10.1146/annurev.nutr.27.061406.093705; Wilcox AJ, 2007, BMJ-BRIT MED J, V334, P464, DOI 10.1136/bmj.39079.618287.0B; Xu ZL, 2014, CARCINOGENESIS, V35, P356, DOI 10.1093/carcin/bgt391; Yip BH, 2006, INT J EPIDEMIOL, V35, P1495, DOI 10.1093/ije/dyl177; Yue MX, 2012, J ASSIST REPROD GEN, V29, P643, DOI 10.1007/s10815-012-9780-4	34	43	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0156361	10.1371/journal.pone.0156361	http://dx.doi.org/10.1371/journal.pone.0156361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383059	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400003
J	Hughes, N; Sciberras, E; Goldfeld, S				Hughes, Nathan; Sciberras, Emma; Goldfeld, Sharon			Family and Community Predictors of Comorbid Language, Socioemotional and Behavior Problems at School Entry	PLOS ONE			English	Article							CHILDREN; DIFFICULTIES; CHILDHOOD; MALTREATMENT; DISORDERS; STRENGTHS; HEALTH; SKILLS	Objectives To identify the prevalence and family and community-level predictors of comorbid speech-language difficulties and socioemotional and behavioral (SEB) difficulties across a population of children at school entry. Methods The School Entry Health Questionnaire is a parent survey of children's health and wellbeing, completed by all children starting school in Victoria, Australia (N = 53256). It includes parental report of speech-language difficulties, the Strengths and Difficulties Questionnaire (behavior), and numerous family and community variables. Following univariate analysis, family and community risk characteristics were entered into a multinomial logistic regression model to identify the associated relative risk of comorbid speech/language and SEB needs. The influence of experiencing multiple risk factors was also examined. Results 20.4% (n = 10,868) began school with either speech-language or SEB difficulties, with 3.1% (n = 1670) experiencing comorbid needs. Five factors predicted comorbidity: the child having witnessed violence; a history of parent mental illness; living in more deprived communities; and the educational attainment of each parent (independently). The relative risk of comorbidity was 6.1 (95% Confidence Interval: 3.9, 9.7) when a child experienced four or more risk factors, compared to those with no risk factors. Conclusions The risk of comorbidity in early childhood is associated with a range of family and community factors, and elevated by the presence of multiple factors. Children growing up in families experiencing multiple, complex needs are therefore at heightened risk of the early development of difficulties likely to impact upon schooling. Early identification of these children offers opportunities for appropriate and timely health and education intervention.	[Hughes, Nathan; Sciberras, Emma; Goldfeld, Sharon] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Hughes, Nathan] Univ Birmingham, Birmingham, W Midlands, England; [Hughes, Nathan; Goldfeld, Sharon] Univ Melbourne, Melbourne, Vic, Australia; [Sciberras, Emma] Deakin Univ, Melbourne, Vic, Australia; [Sciberras, Emma; Goldfeld, Sharon] Royal Childrens Hosp, Melbourne, Vic, Australia	Murdoch Children's Research Institute; University of Birmingham; University of Melbourne; Deakin University; Royal Children's Hospital Melbourne	Goldfeld, S (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Goldfeld, S (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.; Goldfeld, S (corresponding author), Royal Childrens Hosp, Melbourne, Vic, Australia.	sharon.goldfeld@rch.org.au	; Hughes, Nathan/O-8600-2014	Sciberras, Emma/0000-0003-2812-303X; Hughes, Nathan/0000-0002-5859-808X; Goldfeld, Sharon/0000-0001-6520-7094	Marie Curie International Outgoing Fellowship from the European Commission [PIOF-GA-2012-331494]; Australian National Health and Medical Research Council [1037159]; Australian National Health and Medical Research Council Career Development Fellowship [1082922]; NHMRC [1023493]	Marie Curie International Outgoing Fellowship from the European Commission; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	NH is funded by a Marie Curie International Outgoing Fellowship from the European Commission (grant number PIOF-GA-2012-331494). ES is funded through an Early Career Fellowship in Population Health from the Australian National Health and Medical Research Council (1037159). SG is funded through an Australian National Health and Medical Research Council Career Development Fellowship (1082922). The authors also acknowledge the support of the NHMRC-funded Centre of Research Excellence in Child Language (1023493).	Allen G., 2011, EARLY INTERVENTION N; Anda RF, 1999, JAMA-J AM MED ASSOC, V282, P1652, DOI 10.1001/jama.282.17.1652; Australian Bureau of Statistics, 2006, INF PAP INTR SOC IND; Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x; Benner GJ, 2002, J EMOT BEHAV DISORD, V10, P43, DOI 10.1177/106342660201000105; Bishop DVM, 2014, PSYCHOL PRESS CLASS, P1; Carpenter JL, 2011, EARLY CHILD DEV CARE, V181, P1021, DOI 10.1080/03004430.2010.509795; CHRISTOPOULOS C, 1987, J MARRIAGE FAM, V49, P611, DOI 10.2307/352206; Clegg J, 2015, J CHILD PSYCHOL PSYC, V56, P67, DOI 10.1111/jcpp.12281; Corso PS, 2008, AM J PUBLIC HEALTH, V98, P1094, DOI 10.2105/AJPH.2007.119826; Department for Communities and Local Government, 2014, UND TROUBL FAM; Department of Human Services, 2012, FAM MULT COMPL NEEDS; Dube S. R., 2006, Journal of Adolescent Health, V38, DOI 10.1016/j.jadohealth.2005.06.006; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Egger HL, 2006, J CHILD PSYCHOL PSYC, V47, P313, DOI 10.1111/j.1469-7610.2006.01618.x; FITZGERALD HE, 1993, CHILD DEV, V64, P110, DOI 10.2307/1131440; Fuchs S, 2013, CHILD PSYCHIAT HUM D, V44, P493, DOI 10.1007/s10578-012-0343-9; Gilliam W, 2000, EARLY CHILD DEV CARE, V162, P9, DOI DOI 10.1080/0300443001620102; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Hartas D, 2011, BRIT J SPEC EDUC, V38, P83, DOI 10.1111/j.1467-8578.2011.00507.x; Hawes DJ, 2004, AUST NZ J PSYCHIAT, V38, P644, DOI 10.1111/j.1440-1614.2004.01427.x; Massa J, 2008, INT J LANG COMM DIS, V43, P99, DOI 10.1080/13682820701261827; Mok PLH, 2014, J CHILD PSYCHOL PSYC, V55, P516, DOI 10.1111/jcpp.12190; Morris K., 2008, THINK FAMILY LIT REV; Nelson JR, 2005, J SPEC EDUC, V39, P97; Pike A, 2006, INT J BEHAV DEV, V30, P55, DOI 10.1177/0165025406062124; Plomin R, 2002, J CHILD PSYCHOL PSYC, V43, P619, DOI 10.1111/1469-7610.00051; Rankin J, 2004, M COMPLEX NEEDS FUTU; Reilly S, 2010, PEDIATRICS, V126, pE1530, DOI 10.1542/peds.2010-0254; RUTTER M, 1979, CHILD DEV, V50, P283, DOI 10.2307/1129404; St Clair MC, 2011, J COMMUN DISORD, V44, P186, DOI 10.1016/j.jcomdis.2010.09.004; State of Victoria Department of Education, 2015, SCH ENTR HLTH QUEST; Tomblin JB, 2012, TOP LANG DISORD, V32, P198, DOI 10.1097/TLD.0b013e318261c264	33	9	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158802	10.1371/journal.pone.0158802	http://dx.doi.org/10.1371/journal.pone.0158802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3JE	27379668	Green Published, Green Accepted, gold			2022-12-26	WOS:000379798700047
J	Pietrocola, G; Nobile, G; Gianotti, V; Zapotoczna, M; Foster, TJ; Geoghegan, JA; Speziale, P				Pietrocola, Giampiero; Nobile, Giulia; Gianotti, Valentina; Zapotoczna, Marta; Foster, Timothy J.; Geoghegan, Joan A.; Speziale, Pietro			Molecular Interactions of Human Plasminogen with Fibronectin-binding Protein B (FnBPB), a Fibrinogen/Fibronectin-binding Protein from Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; cell surface protein; fibrinogen; plasminogen; Staphylococcus aureus (S; aureus); tissue plasminogen activator (tPA)	STREPTOCOCCUS-PNEUMONIAE; SURFACE PROTEIN; AFFINITY-CHROMATOGRAPHY; BORRELIA-BURGDORFERI; CRYSTAL-STRUCTURE; BIOFILM FORMATION; CLUMPING FACTOR; HUMAN PLASMA; A-DOMAIN; FIBRINOGEN	Staphylococcus aureus is a commensal bacterium that has the ability to cause superficial and deep-seated infections. Like several other invasive pathogens, S. aureus can capture plasminogen from the human host where it can be converted to plasmin by host plasminogen activators or by endogenously expressed staphylokinase. This study demonstrates that sortase-anchored cell wall-associated proteins are responsible for capturing the bulk of bound plasminogen. Two cell wall-associated proteins, the fibrinogen- and fibronectin-binding proteins A and B, were found to bind plasminogen, and one of them, FnBPB, was studied in detail. Plasminogen captured on the surface of S. aureus- or Lactococcus lactis-expressing FnBPB could be activated to the potent serine protease plasmin by staphylokinase and tissue plasminogen activator. Plasminogen bound to recombinant FnBPB with a K-D of 0.532 m as determined by surface plasmon resonance. Plasminogen binding did not to occur by the same mechanism through which FnBPB binds to fibrinogen. Indeed, FnBPB could bind both ligands simultaneously indicating that their binding sites do not overlap. The N3 subdomain of FnBPB contains the full plasminogen-binding site, and this includes, at least in part, two conserved patches of surface-located lysine residues that were recognized by kringle 4 of the host protein.	[Pietrocola, Giampiero; Nobile, Giulia; Gianotti, Valentina; Speziale, Pietro] Univ Pavia, Dept Mol Med, Biochem Unit, Viale Taramelli 3-B, I-27100 Pavia, Italy; [Zapotoczna, Marta; Foster, Timothy J.; Geoghegan, Joan A.] Univ Dublin, Trinity Coll, Sch Genet & Microbiol, Dept Microbiol,Moyne Inst Prevent Med, Dublin 2, Ireland	University of Pavia; Trinity College Dublin	Speziale, P (corresponding author), Univ Pavia, Dept Mol Med, Biochem Unit, Viale Taramelli 3-B, I-27100 Pavia, Italy.; Geoghegan, JA (corresponding author), Univ Dublin, Trinity Coll Dublin, Sch Microbiol & Genet, Dept Microbiol,Moyne Inst Prevent Med, Dublin 2, Ireland.	geoghegj@tcd.ie; pspeziale@unipv.it	Zapotoczna, M./E-6874-2015	Zapotoczna, M./0000-0001-5971-1163; PIETROCOLA, GIAMPIERO/0000-0002-7069-8155	Fondazione CARIPLO Grant [2009-3546]; European Union [634588]	Fondazione CARIPLO Grant(Fondazione Cariplo); European Union(European Commission)	This work was supported by Fondazione CARIPLO Grant Vaccines 2009-3546 (to P. S.) and European Union's Horizon 2020 Research and Innovation Program Grant 634588. The authors declare that they have no conflicts of interest with the contents of this article.	Agarwal V, 2013, J BIOL CHEM, V288, P6849, DOI 10.1074/jbc.M112.405530; Antikainen J, 2007, FEMS IMMUNOL MED MIC, V51, P526, DOI 10.1111/j.1574-695X.2007.00330.x; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2013, INT J MED MICROBIOL, V303, P452, DOI 10.1016/j.ijmm.2013.06.002; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; BREMELL T, 1990, ARTHRITIS RHEUM, V33, P1739, DOI 10.1002/art.1780331120; Burke FM, 2011, FEBS J, V278, P2359, DOI 10.1111/j.1742-4658.2011.08159.x; Burke FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-160; Buscetta M, 2016, MOL MICROBIOL, V101, P27, DOI 10.1111/mmi.13357; CASTELLINO FJ, 1981, METHOD ENZYMOL, V80, P365; Chavakis T, 2005, BLOOD, V105, P1036, DOI 10.1182/blood-2004-01-0166; CHRISTENSEN U, 1992, BIOCHEM J, V285, P419, DOI 10.1042/bj2850419; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; Deivanayagam CCS, 2002, EMBO J, V21, P6660, DOI 10.1093/emboj/cdf619; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Duboscq C, 1997, THROMB RES, V86, P505, DOI 10.1016/S0049-3848(97)00099-6; Fitzgerald JR, 2006, MOL MICROBIOL, V59, P212, DOI 10.1111/j.1365-2958.2005.04922.x; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Fulde M, 2011, BIOCHEM J, V434, P523, DOI 10.1042/BJ20101121; Furuya H, 2011, MICROBIOL IMMUNOL, V55, P855, DOI 10.1111/j.1348-0421.2011.00392.x; Geoghegan JA, 2013, J BACTERIOL, V195, P2675, DOI 10.1128/JB.02128-12; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; Keane FM, 2007, MOL MICROBIOL, V63, P711, DOI 10.1111/j.1365-2958.2006.05552.x; Koch TK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047638; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Loof TG, 2015, MICROBIOL-SGM, V161, P621, DOI 10.1099/mic.0.000019; Loughman A, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-74; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; McCourt J, 2014, FEMS MICROBIOL LETT, V353, P157, DOI 10.1111/1574-6968.12424; Mulcahy ME, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003092; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; O'Connell DP, 1998, J BIOL CHEM, V273, P6821, DOI 10.1074/jbc.273.12.6821; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; Onder O, 2012, J BIOL CHEM, V287, P16860, DOI 10.1074/jbc.M111.290775; Palmqvist N, 2005, J INFECT DIS, V191, P791, DOI 10.1086/427663; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; Peetermans M., 2015, CRIT REV MICROBIOL, V2015, P1; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Roche FM, 2004, J BIOL CHEM, V279, P38433, DOI 10.1074/jbc.M402122200; Roche FM, 2003, MICROBIOL-SGM, V149, P2759, DOI 10.1099/mic.0.26412-0; Rooijakkers SHM, 2005, MICROBES INFECT, V7, P476, DOI 10.1016/j.micinf.2004.12.014; Salazar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112730; Sambrook J., 1989, MOL CLONING LAB MANU, P175; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; SHERERTZ RJ, 1993, J INFECT DIS, V167, P98, DOI 10.1093/infdis/167.1.98; Six A, 2015, MOL MICROBIOL, V97, P1209, DOI 10.1111/mmi.13097; Speziale P, 2008, NAT PROTOC, V3, P525, DOI 10.1038/nprot.2008.12; VALI Z, 1982, J BIOL CHEM, V257, P2104; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; Vazquez V, 2011, J BIOL CHEM, V286, P29797, DOI 10.1074/jbc.M110.214981; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Wang XX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0060872, 10.1371/currents.flu.3679b56a3a5313dc7c043fb944c6f138]; Wiles KG, 2010, J BIOL CHEM, V285, P21153, DOI 10.1074/jbc.M110.107730	59	34	35	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18148	18162		10.1074/jbc.M116.731125	http://dx.doi.org/10.1074/jbc.M116.731125			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27387503	Green Published, hybrid			2022-12-26	WOS:000383241800009
J	Tillman, TS; Alvarez, FJD; Reinert, NJ; Liu, C; Wang, DW; Xu, Y; Xiao, KH; Zhang, PJ; Tang, P				Tillman, Tommy S.; Alvarez, Frances J. D.; Reinert, Nathan J.; Liu, Chuang; Wang, Dawei; Xu, Yan; Xiao, Kunhong; Zhang, Peijun; Tang, Pei			Functional Human 7 Nicotinic Acetylcholine Receptor (nAChR) Generated from Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cys-loop receptor; electron microscopy (EM); ion channel; nicotinic acetylcholine receptors (nAChR); recombinant protein expression; 7nAChR; 7 nAChR; pLGICs; pentameric ligand-gated ion channels	GATED ION-CHANNEL; ALPHA-BUNGAROTOXIN RECEPTORS; X-RAY-STRUCTURE; THERAPEUTIC TARGET; ALLOSTERIC MODULATION; RECOMBINANT PROTEINS; 5-HT3 RECEPTOR; EXPRESSION; CELLS; MEMBRANE	Human Cys-loop receptors are important therapeutic targets. High-resolution structures are essential for rational drug design, but only a few are available due to difficulties in obtaining sufficient quantities of protein suitable for structural studies. Although expression of proteins in E. coli offers advantages of high yield, low cost, and fast turnover, this approach has not been thoroughly explored for full-length human Cys-loop receptors because of the conventional wisdom that E. coli lacks the specific chaperones and post-translational modifications potentially required for expression of human Cys-loop receptors. Here we report the successful production of full-length wild type human 7nAChR from E. coli. Chemically induced chaperones promote high expression levels of well-folded proteins. The choice of detergents, lipids, and ligands during purification determines the final protein quality. The purified 7nAChR not only forms pentamers as imaged by negative-stain electron microscopy, but also retains pharmacological characteristics of native 7nAChR, including binding to bungarotoxin and positive allosteric modulators specific to 7nAChR. Moreover, the purified 7nAChR injected into Xenopus oocytes can be activated by acetylcholine, choline, and nicotine, inhibited by the channel blockers QX-222 and phencyclidine, and potentiated by the 7nAChR specific modulators PNU-120596 and TQS. The successful generation of functional human 7nAChR from E. coli opens a new avenue for producing mammalian Cys-loop receptors to facilitate structure-based rational drug design.	[Tillman, Tommy S.; Reinert, Nathan J.; Xu, Yan; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA 15260 USA; [Alvarez, Frances J. D.; Liu, Chuang; Xu, Yan; Zhang, Peijun] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Wang, Dawei; Xu, Yan; Xiao, Kunhong; Tang, Pei] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Tang, Pei] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tang, P (corresponding author), Univ Pittsburgh, 2049 Biomed Sci Tower 3,3501 Fifth Ave, Pittsburgh, PA 15260 USA.	ptang@pitt.edu	Xiao, Kunhong/AAG-4275-2020	Xiao, Kunhong/0000-0002-1069-1226; Reinert, Nathan/0000-0001-6764-5522; Tang, Pei/0000-0002-2869-2737	National Institutes of Health [R01GM66358]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049202, R01GM066358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM66358 (to P. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; Aztiria EM, 2000, NEUROCHEM RES, V25, P171, DOI 10.1023/A:1007512121082; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bondarenko V, 2014, BBA-BIOMEMBRANES, V1838, P1389, DOI 10.1016/j.bbamem.2013.12.018; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Caina JA, 2014, J PROTEOMICS, V97, P265, DOI 10.1016/j.jprot.2013.08.012; Cheng H, 2015, ACTA PHARMACOL SIN, V36, P1013, DOI 10.1038/aps.2015.34; CONNOLLY J, 1992, BRIT J PHARMACOL, V105, P657, DOI 10.1111/j.1476-5381.1992.tb09035.x; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Csardi G, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005206; CUEVAS J, 1994, BRIT J PHARMACOL, V111, P663, DOI 10.1111/j.1476-5381.1994.tb14789.x; Dascal N., 2001, CURR PROTOC NEUROSCI; de Marco A, 2005, CELL STRESS CHAPERON, V10, P329, DOI 10.1379/CSC-139R.1; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Dineley KT, 2000, J BIOL CHEM, V275, P13974, DOI 10.1074/jbc.275.18.13974; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Fabian-Fine R, 2001, J NEUROSCI, V21, P7993, DOI 10.1523/JNEUROSCI.21-20-07993.2001; Fryer JD, 1999, J PHARMACOL EXP THER, V288, P88; Gill JK, 2011, P NATL ACAD SCI USA, V108, P5867, DOI 10.1073/pnas.1017975108; GREEN WN, 1995, TRENDS NEUROSCI, V18, P280, DOI 10.1016/0166-2236(95)93915-K; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Kahsai AW, 2014, NAT PROTOC, V9, P1301, DOI 10.1038/nprot.2014.075; Labriola JM, 2013, J BIOL CHEM, V288, P11294, DOI 10.1074/jbc.M113.458133; Li SX, 2011, NAT NEUROSCI, V14, P1253, DOI 10.1038/nn.2908; Lynch JW, 2006, CURR OPIN INVEST DR, V7, P48; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Miledi Ricardo, 2006, V322, P347; Millar NS, 2008, MOL MEMBR BIOL, V25, P279, DOI 10.1080/09687680802035675; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Molinari EJ, 1998, EUR J PHARMACOL, V347, P131, DOI 10.1016/S0014-2999(98)00084-3; Moraga-Cid G, 2015, P NATL ACAD SCI USA, V112, P2865, DOI 10.1073/pnas.1417864112; MORALES A, 1995, P NATL ACAD SCI USA, V92, P8468, DOI 10.1073/pnas.92.18.8468; Mowrey DD, 2013, J BIOL CHEM, V288, P35793, DOI 10.1074/jbc.M113.508333; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Peng JH, 2005, J PHARMACOL EXP THER, V313, P24, DOI 10.1124/jpet.104.079004; Qin HJ, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-51; Rakhilin S, 1999, J CELL BIOL, V146, P203; Rangwala F, 1997, J NEUROSCI, V17, P8201; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thompson AJ, 2007, EXPERT OPIN THER TAR, V11, P527, DOI 10.1517/14728222.11.4.527; Tillman TS, 2014, J BIOL CHEM, V289, P13851, DOI 10.1074/jbc.M113.524611; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wu J, 2016, TRENDS PHARMACOL SCI, V37, P562, DOI 10.1016/j.tips.2016.03.005; Zdanowski R, 2015, CENT EUR J IMMUNOL, V40, P373, DOI 10.5114/ceji.2015.54602	56	5	5	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18276	18282		10.1074/jbc.M116.729970	http://dx.doi.org/10.1074/jbc.M116.729970			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27385587	hybrid, Green Published			2022-12-26	WOS:000383241800020
J	Anand, S; Madhubala, R				Anand, Sneha; Madhubala, Rentala			Twin Attributes of Tyrosyl-tRNA Synthetase of Leishmania donovani: A HOUSEKEEPING PROTEIN TRANSLATION ENZYME AND A MIMIC OF HOST CHEMOKINE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; chemokine; cytokine; drug action; Leishmania; ELR peptide motif; fisetin; moonlighting	NEUTROPHIL GRANULOCYTES; IMMUNE EVASION; TNF-ALPHA; RECRUITMENT; SECRETION; INTERLEUKIN-8; INFLAMMATION; GENERATION; INHIBITION; RECEPTOR	Aminoacyl-tRNA synthetases (aaRSs) are housekeeping enzymes essential for protein synthesis. Apart from their parent aminoacylation activity, several aaRSs perform non-canonical functions in diverse biological processes. The present study explores the twin attributes of Leishmania tyrosyl-tRNA synthetase (LdTyrRS) namely, aminoacylation, and as a mimic of host CXC chemokine. Leishmania donovani is a protozoan parasite. Its genome encodes a single copy of tyrosyl-tRNA synthetase. We first tested the canonical aminoacylation role of LdTyrRS. The recombinant protein was expressed, and its kinetic parameters were determined by aminoacylation assay. To study the physiological role of LdTyrRS in Leishmania, gene deletion mutations were attempted via targeted gene replacement. The heterozygous mutants showed slower growth kinetics and exhibited attenuated virulence. LdTyrRS appears to be an essential gene as the chromosomal null mutants did not survive. Our data also highlights the non-canonical function of L. donovani tyrosyl-tRNA synthetase. We show that LdTyrRS protein is present in the cytoplasm and exits from the parasite cytoplasm into the extracellular medium. The released LdTyrRS functions as a neutrophil chemoattractant. We further show that LdTyrRS specifically binds to host macrophages with its ELR (Glu-Leu-Arg) peptide motif. The ELR-CXCR2 receptor interaction mediates this binding. This interaction triggers enhanced secretion of the proinflammatory cytokines TNF- and IL-6 by host macrophages. Our data indicates a possible immunomodulating role of LdTyrRS in Leishmania infection. This study provides a platform to explore LdTyrRS as a potential target for drug development	[Anand, Sneha; Madhubala, Rentala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Madhubala, R (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	rentala@outlook.com		madhubala, rentala/0000-0002-0034-399X; Anand, Sneha/0000-0002-6461-9174	Department of Biotechnology, Government of India [102/IFD/SAN/3321/2014-15]; University Grants Commission, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission, India(University Grants Commission, India)	This work was supported in part by Department of Biotechnology, Government of India Grant 102/IFD/SAN/3321/2014-15 (to R. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of funding from the University Grants Commission, India.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Aga E, 2002, J IMMUNOL, V169, P898, DOI 10.4049/jimmunol.169.2.898; Arena A, 1997, MICROBIOLOGICA, V20, P233; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Bhatt TK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1522; Brown MV, 2010, VASC PHARMACOL, V52, P21, DOI 10.1016/j.vph.2009.11.009; de Moura MC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001398; Cecilio P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00480; Cestari I, 2013, MOL CELL BIOL, V33, P4872, DOI 10.1128/MCB.00711-13; Cestari I, 2013, J BIOMOL SCREEN, V18, P490, DOI 10.1177/1087057112465980; Chandrasekar B, 2003, J BIOL CHEM, V278, P4675, DOI 10.1074/jbc.M207006200; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Darveau A., 1995, METH NEUROSCI, V26, P77, DOI DOI 10.1016/S1043-9471(06)80084-4; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Duque GA, 2014, J IMMUNOL, V193, P2363, DOI 10.4049/jimmunol.1303043; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Gadelha FR, 2013, EXP PARASITOL, V133, P287, DOI 10.1016/j.exppara.2012.12.007; Gowri VS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-621; GRAVES DT, 1995, CRIT REV ORAL BIOL M, V6, P109, DOI 10.1177/10454411950060020101; Griffin GK, 2012, J IMMUNOL, V188, P6287, DOI 10.4049/jimmunol.1200385; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Gupta G, 2013, ADV APPL MICROBIOL, V82, P155, DOI 10.1016/B978-0-12-407679-2.00005-3; Gupta G, 2009, J INFECT DIS, V200, P1300, DOI 10.1086/605895; Hurrell BP, 2016, TRENDS PARASITOL, V32, P392, DOI 10.1016/j.pt.2016.02.003; Hurrell BP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004929; Jia H, 2003, PROTEIN EXPRES PURIF, V27, P104, DOI 10.1016/S1046-5928(02)00576-4; Kane MM, 2001, J IMMUNOL, V166, P1141, DOI 10.4049/jimmunol.166.2.1141; Kansal S, 2012, J ANTIMICROB CHEMOTH, V67, P2650, DOI 10.1093/jac/dks286; KAPLER GM, 1990, MOL CELL BIOL, V10, P1084, DOI 10.1128/MCB.10.3.1084; Karam MC, 2006, EXP PARASITOL, V113, P168, DOI 10.1016/j.exppara.2006.01.003; Kawa S, 1997, FEBS LETT, V420, P196, DOI 10.1016/S0014-5793(97)01516-0; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; KIJIMA S, 1968, J BIOCHEM-TOKYO, V63, P434, DOI 10.1093/oxfordjournals.jbchem.a128795; Krobitsch S, 1998, J BIOL CHEM, V273, P6488, DOI 10.1074/jbc.273.11.6488; Lambertz U, 2012, J LEUKOCYTE BIOL, V91, P887, DOI 10.1189/jlb.0611326; Larson ET, 2011, J MOL BIOL, V409, P159, DOI 10.1016/j.jmb.2011.03.026; Laskay T, 2003, TRENDS MICROBIOL, V11, P210, DOI 10.1016/S0966-842X(03)00075-1; Laufs H, 2002, INFECT IMMUN, V70, P826, DOI 10.1128/IAI.70.2.826-835.2002; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Matte C, 2002, J INFECT DIS, V185, P673, DOI 10.1086/339260; McCall LI, 2010, MOL MICROBIOL, V77, P518, DOI 10.1111/j.1365-2958.2010.07229.x; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Ribeiro-Gomes FL, 2014, INFECT IMMUN, V82, P2713, DOI 10.1128/IAI.01600-13; Ribeiro-Gomes FL, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00059; Rolao N, 2004, ACTA TROP, V90, P123, DOI 10.1016/j.actatropica.2003.09.010; Sajish M, 2015, NATURE, V519, P370, DOI 10.1038/nature14028; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; Stillie R, 2009, J LEUKOCYTE BIOL, V86, P529, DOI 10.1189/jlb.0208125; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Taylor SC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/361590; Thalhofer CJ, 2011, INFECT IMMUN, V79, P108, DOI 10.1128/IAI.00338-10; van Zandbergen G, 2002, INFECT IMMUN, V70, P4177, DOI 10.1128/IAI.70.8.4177-4184.2002; Vieira SM, 2009, BRIT J PHARMACOL, V158, P779, DOI 10.1111/j.1476-5381.2009.00367.x; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wenzel UA, 2012, FASEB J, V26, P29, DOI 10.1096/fj.11-184895	63	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17754	17771		10.1074/jbc.M116.727107	http://dx.doi.org/10.1074/jbc.M116.727107			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27382051	Green Published, hybrid			2022-12-26	WOS:000383241300024
J	Joseph, TT; Mincer, JS				Joseph, Thomas T.; Mincer, Joshua S.			Common Internal Allosteric Network Links Anesthetic Binding Sites in a Pentameric Ligand-Gated Ion Channel	PLOS ONE			English	Article							GENERAL-ANESTHETICS; TRANSMEMBRANE DOMAIN; DYNAMICS; ACETYLCHOLINE; PROPOFOL; KETAMINE; RECEPTOR; MODULATION; MECHANISMS; SIMULATION	General anesthetics bind reversibly to ion channels, modifying their global conformational distributions, but the underlying atomic mechanisms are not completely known. We examine this issue by way of the model protein Gloeobacter violaceous ligand-gated ion channel (GLIC) using computational molecular dynamics, with a coarse-grained model to enhance sampling. We find that in flooding simulations, both propofol and a generic particle localize to the crystallographic transmembrane anesthetic binding region, and that propofol also localizes to an extracellular region shared with the crystallographic ketamine binding site. Subsequent simulations to probe these binding modes in greater detail demonstrate that ligand binding induces structural asymmetry in GLIC. Consequently, we employ residue interaction correlation analysis to describe the internal allosteric network underlying the coupling of ligand and distant effector sites necessary for conformational change. Overall, the results suggest that the same allosteric network may underlie the actions of various anesthetics, regardless of binding site.	[Joseph, Thomas T.; Mincer, Joshua S.] Icahn Sch Med Mt Sinai, Dept Anesthesiol, New York, NY 10029 USA; [Mincer, Joshua S.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA	Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Mincer, JS (corresponding author), Icahn Sch Med Mt Sinai, Dept Anesthesiol, New York, NY 10029 USA.; Mincer, JS (corresponding author), James J Peters Vet Affairs Med Ctr, Bronx, NY USA.	joshua.mincer@mountsinai.org	Mincer, Joshua/B-4785-2008	Mincer, Joshua/0000-0002-2482-3154	Eliasberg Clinical Scientist Training Program of the Department of Anesthesiology at Icahn School of Medicine at Mount Sinai; National Science Foundation's XSEDE program [TG-MCB140093]; Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai	Eliasberg Clinical Scientist Training Program of the Department of Anesthesiology at Icahn School of Medicine at Mount Sinai; National Science Foundation's XSEDE program; Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai	Support to T.T.J. is acknowledged from the Eliasberg Clinical Scientist Training Program of the Department of Anesthesiology at Icahn School of Medicine at Mount Sinai. Computational resources on the Stampede computer cluster at the Texas Advanced Computing Center, University of Texas, were supplied through the National Science Foundation's XSEDE program (allocation TG-MCB140093). This work was supported in part through the computational resources and staff expertise provided by the Department of Scientific Computing at the Icahn School of Medicine at Mount Sinai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraini JH, 2014, ANESTHESIOLOGY, V121, P1018, DOI 10.1097/ALN.0000000000000435; Ahmad S, 2010, J R SOC INTERFACE, V7, pS423, DOI 10.1098/rsif.2010.0190.focus; Bojak I, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00022; Brannigan G, 2010, P NATL ACAD SCI USA, V107, P14122, DOI 10.1073/pnas.1008534107; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Carswell CL, 2015, STRUCTURE, V23, P1655, DOI 10.1016/j.str.2015.06.020; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Chen QA, 2010, BIOPHYS J, V99, P1801, DOI 10.1016/j.bpj.2010.07.023; Chen YH, 2006, J BIOL CHEM, V281, P18184, DOI 10.1074/jbc.M600349200; Demerdash ONA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000531; Fourati Z, 2015, ACTA CRYSTALLOGR D, V71, P454, DOI 10.1107/S1399004714026698; Ghosh B, 2013, J BIOL CHEM, V288, P17420, DOI 10.1074/jbc.M113.464040; Hendrickx JFA, 2008, ANESTH ANALG, V107, P494, DOI 10.1213/ane.0b013e31817b859e; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Howard RJ, 2014, PHARMACOL REV, V66, P396, DOI 10.1124/pr.113.007468; Joseph TT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002693; Kong YF, 2007, STRUCTURE, V15, P611, DOI 10.1016/j.str.2007.04.002; Kong YF, 2009, PROTEINS, V74, P145, DOI 10.1002/prot.22139; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; Lee U, 2013, ANESTHESIOLOGY, V118, P1264, DOI 10.1097/ALN.0b013e31829103f5; Li XY, 2014, EUR BIOPHYS J BIOPHY, V43, P623, DOI 10.1007/s00249-014-0992-7; Liu RY, 2012, ANESTH ANALG, V114, P947, DOI 10.1213/ANE.0b013e31824c4def; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Mowrey D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064326; Mowrey D, 2013, J AM CHEM SOC, V135, P2172, DOI 10.1021/ja307275v; Negami T, 2014, J COMPUT CHEM, V35, P1835, DOI 10.1002/jcc.23693; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Pan JJ, 2012, STRUCTURE, V20, P1463, DOI 10.1016/j.str.2012.08.009; Pan JJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1703; Periole Xavier, 2013, Methods Mol Biol, V924, P533, DOI 10.1007/978-1-62703-017-5_20; Prevost MS, 2013, J MED CHEM, V56, P4619, DOI 10.1021/jm400374q; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Tieleman DP, 2001, PROTEINS, V44, P63, DOI 10.1002/prot.1073; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Velisetty P, 2014, J BIOL CHEM, V289, P3013, DOI 10.1074/jbc.M113.523050; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Willenbring D, 2011, BIOPHYS J, V101, P1905, DOI 10.1016/j.bpj.2011.09.026; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810	43	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158795	10.1371/journal.pone.0158795	http://dx.doi.org/10.1371/journal.pone.0158795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403526	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508200015
J	Kolbeneva, MG; Alexandrov, YI				Kolbeneva, Marina G.; Alexandrov, Yuri I.			Mental Reactivation and Pleasantness Judgment of Experience Related to Vision, Hearing, Skin Sensations, Taste and Olfaction	PLOS ONE			English	Article							NERVOUS-SYSTEM RESPONSES; VISUAL WORD RECOGNITION; AGE-OF-ACQUISITION; MODALITY-EXCLUSIVITY; LEXICAL DECISION; CATEGORY SIZE; FREQUENCY; EMOTIONS; LANGUAGE; IMAGERY	Language acquisition is based on our knowledge about the world and forms through multiple sensory-motor interactions with the environment. We link the properties of individual experience formed at different stages of ontogeny with the phased development of sensory modalities and with the acquisition of words describing the appropriate forms of sensitivity. To test whether early-formed experience related to skin sensations, olfaction and taste differs from later-formed experience related to vision and hearing, we asked Russian-speaking participants to categorize or to assess the pleasantness of experience mentally reactivated by sense-related adjectives found in common dictionaries. It was found that categorizing adjectives in relation to vision, hearing and skin sensations took longer than categorizing adjectives in relation to olfaction and taste. In addition, experience described by adjectives predominantly related to vision, hearing and skin sensations took more time for the pleasantness judgment and generated less intense emotions than that described by adjectives predominantly related to olfaction and taste. Interestingly the dynamics of skin resistance corresponded to the intensity and pleasantness of reported emotions. We also found that sense-related experience described by early-acquired adjectives took less time for the pleasantness judgment and generated more intense and more positive emotions than that described by later-acquired adjectives. Correlations were found between the time of the pleasantness judgment of experience, intensity and pleasantness of reported emotions, age of acquisition, frequency, imageability and length of sense-related adjectives. All in all these findings support the hypothesis that early-formed experience is less differentiated than later-formed experience.	[Kolbeneva, Marina G.; Alexandrov, Yuri I.] Russian Acad Sci, Inst Psychol, VB Shvyrkov Lab Neuronal Bases Mind, Moscow, Russia; [Alexandrov, Yuri I.] Natl Res Univ, Higher Sch Econ, Dept Psychol, Moscow, Russia	Institute of Psychology of Russian Academy of Sciences; Russian Academy of Sciences; HSE University (National Research University Higher School of Economics)	Kolbeneva, MG (corresponding author), Russian Acad Sci, Inst Psychol, VB Shvyrkov Lab Neuronal Bases Mind, Moscow, Russia.	kolbenevamarina@mail.ru	Alexandrov, Yuri/O-6826-2015; Kolbeneva, Marina G./AAD-2163-2022	Alexandrov, Yuri/0000-0002-2644-3016; Kolbeneva, Marina/0000-0002-6171-2162	Russian Science Foundation [14-28-00229]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation grant # 14-28-00229. URL: http://xn-m1afn.xn-p1ai/node/8. MK and YA received this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDROV LI, 1993, ALCOHOL, V10, P213, DOI 10.1016/0741-8329(93)90038-P; Alexandrov Y.I., 2009, DEV THEORY DIFFERENT, P17; Alexandrov Y.I., 1999, NEURONAL BASES PSYCH, V8, P201, DOI [10.1142/9789814313254_0017, DOI 10.1142/9789814313254_0017]; Alexandrov YI, 2005, COGNITIVE BRAIN RES, V25, P387, DOI 10.1016/j.cogbrainres.2005.08.006; Alexandrov YI, 2001, ACTA PHYSIOL SCAND, V171, P87, DOI 10.1046/j.1365-201x.2001.171001087.x; Alexandrov YI, 1989, PHYSL SIGNIFICANCE A; Alexandrov YI, 1995, 3 INT C, P5; Alexandrov YI, 2008, SOC SCI INFORM, V47, P419, DOI 10.1177/0539018408092580; Alexandrov YI, 2007, INT J PSYCHOPHYSIOL, V65, P261, DOI 10.1016/j.ijpsycho.2007.05.004; Alexopoulos T, 2007, J EXP SOC PSYCHOL, V43, P1010, DOI 10.1016/j.jesp.2006.10.017; ANOKHIN KV, 1991, BRAIN RES, V544, P101, DOI 10.1016/0006-8993(91)90890-8; ANOKHIN KV, 2000, CONC ADV BRAIN RES, V2, P53; Anokhin P K, 1978, PHILOS ASPECTS THEOR; Anokhin P. K., 1973, BIOL NEUROPHYSIOLOGY; [Anonymous], 2000, CONC ADV BRAIN RES; Baars BJ, 2003, J CONSCIOUSNESS STUD, V10, P100; BALABAN PM, 1993, EUR J NEUROSCI, V5, P768, DOI 10.1111/j.1460-9568.1993.tb00541.x; Barsalou LW, 2003, TRENDS COGN SCI, V7, P84, DOI 10.1016/S1364-6613(02)00029-3; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; Bensafi M, 2002, CHEM SENSES, V27, P703, DOI 10.1093/chemse/27.8.703; BERNTSON GG, 1993, ANN NY ACAD SCI, V702, P75, DOI 10.1111/j.1749-6632.1993.tb17243.x; Bird H, 2001, BEHAV RES METH INS C, V33, P73, DOI 10.3758/BF03195349; Blass EM, 1980, NEURAL MECHANISMS GO, P461; Bloom P, 1997, TRENDS COGN SCI, V1, P9, DOI 10.1016/S1364-6613(97)01006-1; BOCK M, 1986, PSYCHOL RES-PSYCH FO, V48, P107, DOI 10.1007/BF00309324; BOUCHER J, 1969, J VERB LEARN VERB BE, V8, P1, DOI 10.1016/S0022-5371(69)80002-2; Boucsein W., 1992, ELECTRODERMAL ACTIVI; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Briesemeister BB, 2012, SAGE OPEN, V2, DOI 10.1177/2158244012466558; Brysbaert M, 2000, EUR J COGN PSYCHOL, V12, P65, DOI 10.1080/095414400382208; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Catmur C, 2013, NEUROSCI LETT, V540, P21, DOI 10.1016/j.neulet.2012.10.001; Chernigovskaya TV, 2003, SPEAKING COLORS ODOR, P227; Chiarello C, 1999, BEHAV RES METH INS C, V31, P603, DOI 10.3758/BF03200739; Chuprikova NI, 1997, PSYCHOL MENTAL DEV P; COLLINS AM, 1970, J VERB LEARN VERB BE, V9, P432, DOI 10.1016/S0022-5371(70)80084-6; Connell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033321; Connell L, 2010, COGNITION, V115, P1, DOI 10.1016/j.cognition.2009.10.005; Cuccio V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115381; D'Hondt F, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00033; DAVIDSON RJ, 1992, PSYCHOL SCI, V3, P21, DOI 10.1111/j.1467-9280.1992.tb00250.x; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Dawson ME, 2000, HDB PSYCHOPHYSIOLOGY; de Gelder B, 2000, TRENDS COGN SCI, V4, P126, DOI 10.1016/S1364-6613(00)01470-4; Dementienko VV., 2000, HUMAN PHYSL, V26, P232, DOI DOI 10.1007/BF02760098; Dennett D.C., 1996, UNDERSTANDING CONSCI; Distel H, 1999, CHEM SENSES, V24, P191, DOI 10.1093/chemse/24.2.191; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; Edelman GM, 2003, P NATL ACAD SCI USA, V100, P5520, DOI 10.1073/pnas.0931349100; Eilola TM, 2011, INT J BILINGUAL, V15, P353, DOI 10.1177/1367006910379263; Estes Z, 2008, COGNITION, V108, P557, DOI 10.1016/j.cognition.2008.03.003; Estes Z, 2008, EMOTION, V8, P441, DOI 10.1037/1528-3542.8.4.441; EVGENYEVA A.P., 1999, DICT RUSSIAN LANGUAG; Farrow TFD, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00349; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Gerhand S, 1999, MEM COGNITION, V27, P592, DOI 10.3758/BF03211553; Ghyselinck M, 2004, ACTA PSYCHOL, V115, P43, DOI 10.1016/j.actpsy.2003.11.002; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Goldberg RF, 2006, J NEUROSCI, V26, P4917, DOI 10.1523/JNEUROSCI.5389-05.2006; Goldfield E.C., 1995, EMERGENT FORMS ORIGI; Gostev AA., 1992, HUMAN IMAGINATIVE SP; Gottlieb G., 1971, BIOPSYCHOLOGY DEV, P67; Hajcak G, 2004, BRAIN COGNITION, V56, P189, DOI 10.1016/j.bandc.2003.11.001; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; HERZ RS, 1992, CHEM SENSES, V17, P519, DOI 10.1093/chemse/17.5.519; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hoffman P, 2013, NEUROPSYCHOLOGIA, V51, P14, DOI 10.1016/j.neuropsychologia.2012.11.009; HYMAN R, 1953, J EXP PSYCHOL, V45, P188, DOI 10.1037/h0056940; Izura C., 2002, PSICOLOGICA, V23, P245; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Karpov LP, 1986, NEURONS BEHAV SYSTEM, P206; Khalfa S, 2002, NEUROSCI LETT, V328, P145, DOI 10.1016/S0304-3940(02)00462-7; Khayutin SN, 1997, PHYSL GEN BIOL REV, V12, P1; Kosslyn SM, 2005, COGN NEUROPSYCHOL, V22, P333, DOI 10.1080/02643290442000130; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Kousta ST, 2009, COGNITION, V112, P473, DOI 10.1016/j.cognition.2009.06.007; Laeng B, 2002, COGNITIVE SCI, V26, P207, DOI 10.1016/S0364-0213(01)00065-9; Lakoff George, 2003, METAPHOR WE LIVE BY; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LEVENSON RW, 1990, PSYCHOPHYSIOLOGY, V27, P363, DOI 10.1111/j.1469-8986.1990.tb02330.x; Levinson SC, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0302; LIBET B, 1993, NEUROPHYSIOLOGY CONS; Lickliter R, 2000, PSYCHOL BULL, V126, P260, DOI 10.1037/0033-2909.126.2.260; Liu YY, 2007, BEHAV RES METHODS, V39, P192, DOI 10.3758/BF03193147; Lynott D, 2009, BEHAV RES METHODS, V41, P558, DOI 10.3758/BRM.41.2.558; Mahon BZ, 2009, ANNU REV PSYCHOL, V60, P27, DOI 10.1146/annurev.psych.60.110707.163532; Mahon BZ, 2005, COGN NEUROPSYCHOL, V22, P480, DOI 10.1080/02643290442000446; Marchenko OP, 2009, THESIS; Marchenko OP, 2008, 3 INT C COGN SCI JUN, V1, P103; Maturana H., 1978, BIOL COGNITION; MERZLYAKOVA A.K., 2003, TYPES SEMANTIC VARIA; Meschyan G, 2002, MEM COGNITION, V30, P262, DOI 10.3758/BF03195287; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Mirabella G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035403; New B, 2006, PSYCHON B REV, V13, P45, DOI 10.3758/BF03193811; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Osgood C, 1975, MEASUREMENT MEANING; Panksepp J., 2000, EVOLUTION COGNITION, V6, P108, DOI DOI 10.1146/ANNUREV.AN.18.100189.0; Panksepp J., 2000, CONSCIOUSNESS EMOTIO, V1, P15, DOI [10.1075/ce.1.1.04pan, DOI 10.1075/CE.1.1.04PAN]; Pavlenko A, 2012, INT J PSYCHOL, V47, P405, DOI 10.1080/00207594.2012.743665; Peeters G., 1990, EUROPEAN REV SOCIAL, V1, P33, DOI [10.1080/14792779108401856, DOI 10.1080/14792779108401856]; Pieron H., 1967, FEELINGS EMOTIONS, P117; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Robin O, 1999, CHEM SENSES, V24, P327, DOI 10.1093/chemse/24.3.327; Rousmans S, 2000, CHEM SENSES, V25, P709, DOI 10.1093/chemse/25.6.709; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; SCHMALHAUSEN II, 1960, EVOLUTION, V14, P509, DOI 10.2307/2405999; SCHNEIRLA TC, 1959, NEBR SYM MOTIV, V7, P1; Schrauf R.W., 2004, J MULTILING MULTICUL, V25, P266, DOI [DOI 10.1080/01434630408666532, 10.1080/01434630408666532]; SHVYRKOV VB, 1990, MACHINERY OF THE MIND, P337; Shvyrkov VB, 1995, INTRO OBJECTIVE PSYC; Silvert L, 2004, INT J PSYCHOPHYSIOL, V53, P135, DOI 10.1016/j.ijpsycho.2004.03.005; Slobin D. I., 1979, PSYCHOLINGUISTICS; Spadacenta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104349; Spivey MJ, 2001, PSYCHOL RES-PSYCH FO, V65, P235, DOI 10.1007/s004260100059; Stadthagen-Gonzalez H, 2006, BEHAV RES METHODS, V38, P598, DOI 10.3758/BF03193891; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Tomasello M, 2008, JEAN NICOD LECT, P1; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Tugade MM, 2004, J PERS, V72, P1161, DOI 10.1111/j.1467-6494.2004.00294.x; Turner JE, 1998, MEM COGNITION, V26, P1282, DOI 10.3758/BF03201200; UEXKULL JAKOB VON, 1957, INSTINCTIVE BEHAV DE, P5, DOI DOI 10.1515/SEMI.1992.89.4.319; Usher M, 2002, J MATH PSYCHOL, V46, P704, DOI 10.1006/jmps.2002.1420; van Dantzig S, 2011, BEHAV RES METHODS, V43, P145, DOI 10.3758/s13428-010-0038-8; Viinikainen M, 2010, HUM BRAIN MAPP, V31, P1030, DOI 10.1002/hbm.20915; Vygotsky L.S., 1987, COLLECTED WORKS LS V, P43; WALLEY AC, 1992, MEM COGNITION, V20, P171, DOI 10.3758/BF03197166; Waxman SR, 2001, COGNITIVE PSYCHOL, V43, P217, DOI 10.1006/cogp.2001.0764; WERNER H, 1956, AM ANTHROPOL, V58, P866, DOI 10.1525/aa.1956.58.5.02a00070; WIERZBICKA A, 1986, STUD LANG, V10, P353, DOI 10.1075/sl.10.2.05wie; WILKINS AJ, 1971, J VERB LEARN VERB BE, V10, P382, DOI 10.1016/S0022-5371(71)80036-1; Wilson E. O., 1998, CONSILIENCE UNITY KN; WINTON WM, 1984, J EXP SOC PSYCHOL, V20, P195, DOI 10.1016/0022-1031(84)90047-7; Wismeijer DA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00105; Yeshurun Y, 2010, ANNU REV PSYCHOL, V61, P219, DOI 10.1146/annurev.psych.60.110707.163639; Zajonc R., 2004, FEELINGS EMOTIONS AM, P194; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zevin JD, 2002, J MEM LANG, V47, P1, DOI 10.1006/jmla.2001.2834; Zwaan RA, 2006, J EXP PSYCHOL GEN, V135, P1, DOI 10.1037/0096-3445.135.1.1	143	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159036	10.1371/journal.pone.0159036	http://dx.doi.org/10.1371/journal.pone.0159036			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CN	27400090	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508100015
J	Barbar, SD; Pauchard, LA; Bruyere, R; Bruillard, C; Hayez, D; Croisier, D; Pugin, J; Charles, PE				Barbar, Saber-Davide; Pauchard, Laure-Anne; Bruyere, Remi; Bruillard, Caroline; Hayez, Davy; Croisier, Delphine; Pugin, Jerome; Charles, Pierre-Emmanuel			Mechanical Ventilation Alters the Development of Staphylococcus aureus Pneumonia in Rabbit	PLOS ONE			English	Article							TIDAL-VOLUME VENTILATION; TOLL-LIKE RECEPTOR-2; LUNG INJURY; NOSOCOMIAL PNEUMONIA; GENE-EXPRESSION; PRESSURE; BACTEREMIA; ACTIVATION; CYTOKINES; IMPACT	Ventilator-associated pneumonia (VAP) is common during mechanical ventilation (MV). Beside obvious deleterious effects on muco-ciliary clearance, MV could adversely shift the host immune response towards a pro-inflammatory pattern through toll-like receptor (TLRs) up-regulation. We tested this hypothesis in a rabbit model of Staphylococcus aureus VAP. Pneumonia was caused by airway challenge with S. aureus, in either spontaneously breathing (SB) or MV rabbits (n = 13 and 17, respectively). Pneumonia assessment regarding pulmonary and systemic bacterial burden, as well as inflammatory response was done 8 and 24 hours after S. aureus challenge. In addition, ex vivo stimulations of whole blood taken from SB or MV rabbits (n = 7 and 5, respectively) with TLR2 agonist or heat-killed S. aureus were performed. Data were expressed as mean +/- standard deviation. After 8 hours of infection, lung injury was more severe in MV animals (1.40 +/- 0.33 versus [vs] 2.40 +/- 0.55, p = 0.007), along with greater bacterial concentrations (6.13 +/- 0.63 vs. 4.96 +/- 1.31 colony forming units/gram, p = 0.002). Interleukin (IL)-8 and tumor necrosis factor (TNF)-alpha serum concentrations reached higher levels in MV animals (p = 0.010). Whole blood obtained from MV animals released larger amounts of cytokines if stimulated with TLR2 agonist or heat-killed S. aureus (e.g., TNF-alpha: 1656 +/- 166 vs. 1005 +/- 89; p = 0.014). Moreover, MV induced TLR2 overexpression in both lung and spleen tissue. MV hastened tissue injury, impaired lung bacterial clearance, and promoted a systemic inflammatory response, maybe through TLR2 overexpression.	[Barbar, Saber-Davide; Pauchard, Laure-Anne; Bruyere, Remi; Bruillard, Caroline; Charles, Pierre-Emmanuel] Univ Bourgogne, INRA, UMR 1347, Lab Ventilat Immunite Poumon,Pole Microbiol Envir, Dijon, France; [Hayez, Davy; Croisier, Delphine] Vivexia SARL, Gemeaux, France; [Pugin, Jerome] Univ Hosp Geneva, Intens Care Lab, CH-1211 Geneva 14, Switzerland; [Pugin, Jerome] Fac Med, Dept Microbiol & Mol Med, CH-1211 Geneva 14, Switzerland	INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; University of Geneva; University of Geneva	Charles, PE (corresponding author), Univ Bourgogne, INRA, UMR 1347, Lab Ventilat Immunite Poumon,Pole Microbiol Envir, Dijon, France.	pierre-emmanuel.charles@chu-dijon.fr		Barbar, Saber Davide/0000-0002-5089-8088; Charles, Pierre-Emmanuel/0000-0002-0201-9544; Croisier, Delphine/0000-0002-8744-5832	Pfizer; "Vivexia" company	Pfizer(Pfizer); "Vivexia" company	PEC received a grant from Pfizer, namely the ASPIRE competitive grant in 2011.DCB and DH received support from the "Vivexia" company in the form of salaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Bouadma L, 2004, CRIT CARE MED, V32, P1563, DOI 10.1097/01.CCM.0000129674.25259.D4; Bouadma L, 2010, CRIT CARE MED, V38, P789, DOI 10.1097/CCM.0b013e3181ce21af; Bregeon F, 2005, ANESTHESIOLOGY, V102, P331; Broccard A, PRONE POSITIONING AT; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Charles PE, 2005, CRIT CARE MED, V33, P1029, DOI 10.1097/01.CCM.0000163404.35338.72; Charles PE, 2004, INTENS CARE MED, V30, P2263, DOI 10.1007/s00134-004-2442-y; Charles PE, 2002, CRIT CARE MED, V30, P2278, DOI 10.1097/00003246-200210000-00016; Charles PE, 2011, CRIT CARE, V15, DOI 10.1186/cc10330; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Christaki E, 2014, VIRULENCE, V5, P57, DOI 10.4161/viru.26514; Croisier-Bertin D, 2014, ANTIMICROB AGENTS CH, V58, P1855, DOI 10.1128/AAC.01707-13; Dhanireddy S, 2006, LAB INVEST, V86, P790, DOI 10.1038/labinvest.3700440; Droemann D, 2003, HISTOCHEM CELL BIOL, V119, P103, DOI 10.1007/s00418-003-0497-4; Dunzendorfer S, 2004, CIRC RES, V95, P684, DOI 10.1161/01.RES.0000143900.19798.47; Elson G, 2007, BLOOD, V109, P1574, DOI 10.1182/blood-2006-06-032961; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Hess DR, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.014; Hillman NH, 2007, AM J RESP CRIT CARE, V176, P575, DOI 10.1164/rccm.200701-051OC; Hilmi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096416; Kajikawa O, 2005, GENE, V344, P193, DOI 10.1016/j.gene.2004.09.032; Kuipers MT, 2011, CRIT CARE, V15, DOI 10.1186/cc10437; Ladoire S, 2013, ANESTHESIOLOGY; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luna CM, 1999, CHEST, V116, P1075, DOI 10.1378/chest.116.4.1075; Magret M, 2011, CRIT CARE, V15, DOI 10.1186/cc10036; Mourgeon E, 2000, AM J PHYSIOL-LUNG C, V279, pL699, DOI 10.1152/ajplung.2000.279.4.L699; Murphy DB, 2000, AM J RESP CRIT CARE, V162, P27, DOI 10.1164/ajrccm.162.1.9908110; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Oudin S, 2002, AM J RESP CELL MOL, V27, P107, DOI 10.1165/ajrcmb.27.1.4766; Ricard JD, 2001, AM J RESP CRIT CARE, V163, P1176, DOI 10.1164/ajrccm.163.5.2006053; Rubinstein E, 2008, CLIN INFECT DIS, V46, pS378, DOI 10.1086/533594; Neto AS, 2014, INTENS CARE MED, V40, P950, DOI 10.1007/s00134-014-3318-4; Neto AS, 2014, CURR OPIN CRIT CARE, V20, P25, DOI 10.1097/MCC.0000000000000044; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; Summers C, 2014, THORAX, V69, P623, DOI 10.1136/thoraxjnl-2013-204742; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Torres A, 2009, INTENS CARE MED, V35, P9, DOI 10.1007/s00134-008-1336-9; Tremblay L, 1997, J CLIN INVEST, V99, P944, DOI 10.1172/JCI119259; Valenza F, 2003, CRIT CARE MED, V31, P1993, DOI 10.1097/01.CCM.0000070401.65534.F9; Vaneker M, 2008, ANESTHESIOLOGY, V109, P465, DOI 10.1097/ALN.0b013e318182aef1; Villar J, 2010, INTENS CARE MED, V36, P1049, DOI 10.1007/s00134-010-1799-3; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; Wunderink RG, 2012, CLIN INFECT DIS, V54, P621, DOI 10.1093/cid/cir895; Xiang M, 2010, MOL MED, V16, P69, DOI 10.2119/molmed.2009.00097	48	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158799	10.1371/journal.pone.0158799	http://dx.doi.org/10.1371/journal.pone.0158799			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391952	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400126
J	Burke, GR				Burke, Gaelen R.			Analysis of Genetic Variation across the Encapsidated Genome of Microplitis demolitor Bracovirus in Parasitoid Wasps	PLOS ONE			English	Article							PSEUDOPLUSIA-INCLUDENS; PHYLOGENETIC ANALYSIS; HOST SPECIALIZATION; CHELONUS-INANITUS; MANDUCA-SEXTA; TRADE-OFFS; S2 CELLS; DNA; POLYDNAVIRUS; REPLICATION	Insect parasitoids must complete part of their life cycle within or on another insect, ultimately resulting in the death of the host insect. One group of parasitoid wasps, the 'microgastroid complex' (Hymenoptera: Braconidae), engage in an association with beneficial symbiotic viruses that are essential for successful parasitism of hosts. These viruses, known as Bracoviruses, persist in an integrated form in the wasp genome, and activate to replicate in wasp ovaries during development to ultimately be delivered into host insects during parasitism. The lethal nature of host-parasitoid interactions, combined with the involvement of viruses in mediating these interactions, has led to the hypothesis that Bracoviruses are engaged in an arms race with hosts, resulting in recurrent adaptation in viral (and host) genes. Deep sequencing was employed to characterize sequence variation across the encapsidated Bracovirus genome within laboratory and field populations of the parasitoid wasp species Microplitis demolitor. Contrary to expectations, there was a paucity of evidence for positive directional selection among virulence genes, which generally exhibited signatures of purifying selection. These data suggest that the dynamics of host-parasite interactions may not result in recurrent rounds of adaptation, and that adaptation may be more variable in time than previously expected.	[Burke, Gaelen R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Burke, GR (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	grburke@uga.edu			National Institutes of Health [F32 AI096552]; University of Georgia Research Foundation; Georgia Agricultural Experiment Station	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Research Foundation; Georgia Agricultural Experiment Station	This work was supported by the National Institutes of Health (F32 AI096552), the University of Georgia Research Foundation, and the Georgia Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguileta G, 2010, MOL ECOL, V19, P292, DOI 10.1111/j.1365-294X.2009.04454.x; ALBRECHT U, 1994, J GEN VIROL, V75, P3353, DOI 10.1099/0022-1317-75-12-3353; Andolfatto P, 2008, GENETICS, V180, P1767, DOI 10.1534/genetics.108.091850; Beck M, 2003, VIROLOGY, V314, P521, DOI 10.1016/S0042-6822(03)00463-X; Beck M, 2005, J VIROL, V79, P1861, DOI 10.1128/JVI.79.3.1861-1870.2005; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Beck MH, 2007, VIROLOGY, V359, P179, DOI 10.1016/j.virol.2006.09.002; Beckage NE, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P163, DOI 10.1016/B978-0-12-384858-1.00013-8; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bezier A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0047; Bitra K, 2016, VIROLOGY, V492, P259, DOI 10.1016/j.virol.2016.02.023; Bitra K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002722; Burke GR, 2015, J VIROL, V89, P9511, DOI 10.1128/JVI.01388-15; Burke GR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004660; Burke GR, 2014, MOL ECOL, V23, P890, DOI 10.1111/mec.12648; Burke Gaelen R., 2012, Insects, V3, P91, DOI 10.3390/insects3010091; Burke GR, 2012, J VIROL, V86, P3293, DOI 10.1128/JVI.06434-11; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Desjardins CA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r183; Drezen JM, 2003, J INSECT PHYSIOL, V49, P407, DOI 10.1016/S0022-1910(03)00058-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Henry LM, 2008, EVOLUTION, V62, P689, DOI 10.1111/j.1558-5646.2007.00316.x; Herniou EA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0051; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Ikeda M, 2013, VIROLOGY, V435, P1, DOI 10.1016/j.virol.2012.10.016; Jancek S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064432; Kofler R, 2011, BIOINFORMATICS, V27, P3435, DOI 10.1093/bioinformatics/btr589; Kofler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015925; Kraaijeveld AR, 1998, PARASITOLOGY, V116, pS29, DOI 10.1017/S0031182000084924; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawrence PO, 2005, J INSECT PHYSIOL, V51, P99, DOI 10.1016/j.jinsphys.2004.12.012; Lee DF, 2000, J VIROL, V74, P11873, DOI 10.1128/JVI.74.24.11873-11880.2000; Lewis S.E., 2002, GENOME BIOL, V3, pRESEARCH0082, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; Marti D, 2003, J GEN VIROL, V84, P1141, DOI 10.1099/vir.0.18832-0; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Miller LK, 1997, BACULOVIRUSES, P217, DOI DOI 10.1007/978; Murphy N, 2008, MOL PHYLOGENET EVOL, V47, P378, DOI 10.1016/j.ympev.2008.01.022; Narasimhan V, 2016, BIOINFORMATICS; Pasquier-Barre F, 2002, J GEN VIROL, V83, P2035, DOI 10.1099/0022-1317-83-8-2035; Pichon A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501150; Quicke D. L. J., 1997, PARASITIC WASPS; Rodriguez JJ, 2013, INSECT CONSERV DIVER, V6, P530, DOI 10.1111/icad.12003; Serbielle C, 2009, BIOL CHEM, V390, P493, DOI 10.1515/BC.2009.061; SHENEFELT RD, 1973, HYMENOPTERORUM CATAL, P669; SHEPARD M, 1983, ENVIRON ENTOMOL, V12, P641, DOI 10.1093/ee/12.3.641; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Strand MR, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P149, DOI 10.1016/B978-0-12-384858-1.00012-6; STRAND MR, 1991, J INSECT PHYSIOL, V37, P839, DOI 10.1016/0022-1910(91)90080-J; STRAND MR, 1991, ARCH INSECT BIOCHEM, V18, P131, DOI 10.1002/arch.940180302; TAJIMA F, 1989, GENETICS, V123, P585; Teakle R.E., 1991, HELIOTHIS RES METHOD, P22; Thiem Suzanne M., 2009, Virologica Sinica, V24, P436, DOI 10.1007/s12250-009-3058-8; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Webb BA, 2005, COMPREHENSIVE MOL IN, V6, P323, DOI DOI 10.1016/B0-44-451924-6/00086-7; Whitfield JB, 1998, ANNU REV ENTOMOL, V43, P129, DOI 10.1146/annurev.ento.43.1.129; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	64	3	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158846	10.1371/journal.pone.0158846	http://dx.doi.org/10.1371/journal.pone.0158846			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390861	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400142
J	Czerniawski, R; Slugocki, L; Kowalska-Goralska, M				Czerniawski, Robert; Slugocki, Lukasz; Kowalska-Goralska, Monika			Diurnal Changes of Zooplankton Community Reduction Rate at Lake Outlets and Related Environmental Factors	PLOS ONE			English	Article							ST-LAWRENCE-RIVER; FISH PREDATION; VERTICAL-DISTRIBUTION; BIOTIC FACTORS; STREAM; PLANKTON; ROTIFERS; WATER; DRIFT; DIEL	The reduced zooplankton abundance at the outlet sections of lakes depends on the occurrence of preying fry. Therefore, light conditions can play a major role in the drift of zooplankton along river outlets. The aim of this study was to determine the influence of diurnal light conditions on the decline of zooplankton densities at lake outlets. Photosynthetically active radiation (PAR) levels were measured to determine their effect on the rate of reduced zooplankton abundance. Cladocerans and copepods showed a significantly greater reduction in abundance than rotifers and nauplii. A significant positive relationship was observed between the PAR levels and the reduced abundance of Asplanchna sp., small cladocerans, large cladocerans and Copepoda at the lake outlets. Among the rotifers, small pelagic rotifers drifted the farthest at all hours of the day. Large crustaceans, especially the large cladocerans and copepodites and adult copepods, had the lowest chance of dispersing over a wide area. Our results indicate that light conditions play an important role in the reduction of zooplankton abundance at lake outlets and have an indirect influence on the downstream food web.	[Czerniawski, Robert; Slugocki, Lukasz] Univ Szczecin, Dept Gen Zool, Szczecin, Poland; [Czerniawski, Robert; Slugocki, Lukasz] Univ Szczecin, Ctr Mol Biol & Biotechnol, Szczecin, Poland; [Kowalska-Goralska, Monika] Wroclaw Univ Environm & Life Sci, Dept Hydrobiol & Aquaculture, Wroclaw, Poland	University of Szczecin; University of Szczecin; Wroclaw University of Environmental & Life Sciences	Czerniawski, R (corresponding author), Univ Szczecin, Dept Gen Zool, Szczecin, Poland.; Czerniawski, R (corresponding author), Univ Szczecin, Ctr Mol Biol & Biotechnol, Szczecin, Poland.	czerniawski@univ.szczecin.pl	Kowalska-Góralska, Monika/A-1312-2017; Sługocki, Łukasz/T-2320-2019	Kowalska-Góralska, Monika/0000-0001-9614-2000; Sługocki, Łukasz/0000-0003-0064-006X; czerniawski, robert/0000-0001-7785-087X	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW)	This publication was supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018.; Publication supported by Wroclaw Centre of Biotechnology, programme The Leading National Research Centre (KNOW) for years 2014-2018.	Akopian M, 1999, J PLANKTON RES, V21, P285, DOI 10.1093/plankt/21.2.285; Allan J D, 2007, STREAM ECOLOGY STRUC, V2nd; Basu BK, 1997, J PLANKTON RES, V19, P237, DOI 10.1093/plankt/19.2.237; Campbell CE, 2002, CAN J ZOOL, V80, P997, DOI 10.1139/Z02-077; Casper AF, 2007, RIVER RES APPL, V23, P73, DOI 10.1002/rra.966; Chang KH, 2008, LIMNOLOGY, V9, P125, DOI 10.1007/s10201-008-0244-6; CHRISTOFFERSEN K, 1993, LIMNOL OCEANOGR, V38, P561, DOI 10.4319/lo.1993.38.3.0561; Cobbaert D, 2010, HYDROBIOLOGIA, V644, P103, DOI 10.1007/s10750-010-0100-7; Czerniawski R, 2011, J APPL ICHTHYOL, V27, P984, DOI 10.1111/j.1439-0426.2011.01761.x; Czerniawski R, 2014, INT REV HYDROBIOL, V99, P300, DOI 10.1002/iroh.201301674; Czerniawski R, 2013, OCEANOL HYDROBIOL ST, V42, P123, DOI 10.2478/s13545-013-0065-z; Czerniawski R, 2013, BIOLOGIA, V68, P448, DOI 10.2478/s11756-013-0170-x; Czerniawski R, 2012, POL J ECOL, V60, P323; Czerniawski R, 2012, OCEANOL HYDROBIOL ST, V41, P46, DOI 10.2478/s13545-012-0006-2; Czerniawski R, 2011, CENT EUR J BIOL, V6, P659, DOI 10.2478/s11535-011-0024-x; Czerniawski R, 2010, CENT EUR J BIOL, V5, P240, DOI 10.2478/s11535-009-0062-9; Czerniawski R, 2010, HYDROBIOLOGIA, V638, P137, DOI 10.1007/s10750-009-0036-y; DEPAGGI SJ, 1995, HYDROBIOLOGIA, V310, P87, DOI 10.1007/BF00015526; Fontaneto D, 2005, HYDROBIOLOGIA, V542, P131, DOI 10.1007/s10750-004-5495-6; GLIWICZ ZM, 1986, ECOLOGY, V67, P883, DOI 10.2307/1939811; Hieber M, 2003, FRESHWATER BIOL, V48, P1078, DOI 10.1046/j.1365-2427.2003.01073.x; Hoffman JC, 2001, FRESHWATER BIOL, V46, P759, DOI 10.1046/j.1365-2427.2001.00716.x; HUTCHINSON BP, 1971, T AM FISH SOC, V100, P325, DOI 10.1577/1548-8659(1971)100<325:TEOFPO>2.0.CO;2; Jack JD, 2002, J PLANKTON RES, V24, P119, DOI 10.1093/plankt/24.2.119; Karabin A, 2005, HYDROBIOLOGIA, V546, P381, DOI 10.1007/s10750-005-4280-5; Lair N, 2006, RIVER RES APPL, V22, P567, DOI 10.1002/rra.923; Maier G, 2011, J LIMNOL, V70, P145, DOI 10.4081/jlimnol.2011.145; Mehner T, 2000, FRESHWATER BIOL, V45, P253, DOI 10.1046/j.1365-2427.2000.00551.x; Nielsen D, 2005, HYDROBIOLOGIA, V543, P101, DOI 10.1007/s10750-004-6946-9; Pourriot R, 1997, HYDROBIOLOGIA, V345, P143, DOI 10.1023/A:1002935807795; Radwan S., 2004, FRESHWATER FAUNA POL; Richardson WB, 1997, HYDROBIOLOGIA, V354, P141, DOI 10.1023/A:1003048431234; Romare P, 1999, LIMNOL OCEANOGR, V44, P1655, DOI 10.4319/lo.1999.44.7.1655; Rybak J. I., 2010, PLANKTONIC CRUSTACEA; Schram MD, 1998, J FRESHWATER ECOL, V13, P47, DOI 10.1080/02705060.1998.9663590; Sluss TD, 2008, FRESHWATER BIOL, V53, P1999, DOI 10.1111/j.1365-2427.2008.02023.x; TAYLOR BE, 1980, AM SOC LIMNOL OCEANO, V3, P377; Thorp JH, 2002, FRESHWATER BIOL, V47, P107, DOI 10.1046/j.1365-2427.2002.00787.x; Walks DJ, 2004, FRESHWATER BIOL, V49, P745, DOI 10.1111/j.1365-2427.2004.01220.x; Wissel B, 2003, LIMNOL OCEANOGR, V48, P1965, DOI 10.4319/lo.2003.48.5.1965; ZARET TM, 1976, LIMNOL OCEANOGR, V21, P804, DOI 10.4319/lo.1976.21.6.0804; Zhou SC, 2008, INT REV HYDROBIOL, V93, P297, DOI 10.1002/iroh.200711038	42	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158837	10.1371/journal.pone.0158837	http://dx.doi.org/10.1371/journal.pone.0158837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392017	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400140
J	Kivlin, SN; Hawkes, CV				Kivlin, Stephanie N.; Hawkes, Christine V.			Temporal and Spatial Variation of Soil Bacteria Richness, Composition, and Function in a Neotropical Rainforest	PLOS ONE			English	Article							MICROBIAL COMMUNITY STRUCTURE; MULTIPLE SEQUENCE ALIGNMENT; FUNGAL COMMUNITIES; ENZYME-ACTIVITIES; PLANT DIVERSITY; CLIMATE-CHANGE; DECOMPOSITION; RESPONSES; MOISTURE; DYNAMICS	The high diversity of tree species has traditionally been considered an important controller of belowground processes in tropical rainforests. However, soil water availability and resources are also primary regulators of soil bacteria in many ecosystems. Separating the effects of these biotic and abiotic factors in the tropics is challenging because of their high spatial and temporal heterogeneity. To determine the drivers of tropical soil bacteria, we examined tree species effects using experimental tree monocultures and secondary forests at La Selva Biological Station in Costa Rica. A randomized block design captured spatial variation and we sampled at four dates across two years to assess temporal variation. We measured bacteria richness, phylogenetic diversity, community composition, biomass, and functional potential. All bacteria parameters varied significantly across dates. In addition, bacteria richness and phylogenetic diversity were affected by the interaction of vegetation type and date, whereas bacteria community composition was affected by the interaction of vegetation type and block. Shifts in bacteria community richness and composition were unrelated to shifts in enzyme function, suggesting physiological overlap among taxa. Based on the observed temporal and spatial heterogeneity, our understanding of tropical soil bacteria will benefit from additional work to determine the optimal temporal and spatial scales for sampling. Understanding spatial and temporal variation will facilitate prediction of how tropical soil microbes will respond to future environmental change.	[Kivlin, Stephanie N.; Hawkes, Christine V.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Hawkes, CV (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	chawkes@austin.utexas.edu		Hawkes, Christine/0000-0002-1043-9469	National Science Foundation [DEB-1119169]; Division Of Environmental Biology [1119169] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The material is based upon work supported by the National Science Foundation under Grant No. DEB-1119169 to CVH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank R. Bedoya, F. Cascante, M. Hernandez, E. Paniagua, and M. Sanchez for assistance with fieldwork. Previous versions of this manuscript were improved by comments from K. DeAngelis, C. Looby, T. Miki, and two anonymous reviewers. The material is based upon work supported by the National Science Foundation under Grant No. DEB-1119169 to CVH. Soils were collected under Conagebio permit No. R-005-2012.	Acosta-Martinez V, 2007, APPL SOIL ECOL, V35, P35, DOI 10.1016/j.apsoil.2006.05.012; Allison SD, 2005, SOIL BIOL BIOCHEM, V37, P937, DOI 10.1016/j.soilbio.2004.09.014; Allison SD, 2011, SOIL BIOL, V22, P229, DOI 10.1007/978-3-642-14225-3_12; Allison SD, 2009, SOIL BIOL BIOCHEM, V41, P293, DOI 10.1016/j.soilbio.2008.10.032; ALVARADO G, 1990, TECNOLOGIA MARCHA, V10, P11; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; [Anonymous], 1996, SOIL MICROBIOLOGY BI; Barberan A, 2015, ECOL LETT, V18, P1397, DOI 10.1111/ele.12536; Bedoya R., 2009, PLANTACIONES FORESTA; Berlemont R, 2013, APPL ENVIRON MICROB, V79, P1545, DOI 10.1128/AEM.03305-12; Bonferroni C. E., 1936, PUBBL R I SUPER SCI, V8, P1; Bouskill N, 2016, FRONTIERS MICROBIOLO, P7; Bouskill N.J., 2016, FRONTIERS MICROBIOLO, V7; Bouskill NJ, 2013, ISME J, V7, P384, DOI 10.1038/ismej.2012.113; Brabcova V, 2016, NEW PHYTOL, V210, P1369, DOI 10.1111/nph.13849; Brockett BFT, 2012, SOIL BIOL BIOCHEM, V44, P9, DOI 10.1016/j.soilbio.2011.09.003; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carney KM, 2006, MICROB ECOL, V52, P226, DOI 10.1007/s00248-006-9115-z; Carney KM, 2005, ECOSYSTEMS, V8, P928, DOI 10.1007/s10021-005-0047-0; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Cleveland CC, 2010, ECOLOGY, V91, P2313, DOI 10.1890/09-1582.1; Dickie IA, 2010, NEW PHYTOL, V188, P916, DOI 10.1111/j.1469-8137.2010.03473.x; Eaton WD, 2012, TROP ECOL, V53, P207; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Espeleta JF, 2007, ECOL MONOGR, V77, P377, DOI 10.1890/06-1257.1; Evans SE, 2014, ECOL LETT, V17, P155, DOI 10.1111/ele.12206; Feng X, 2013, NAT CLIM CHANGE, V3, P811, DOI [10.1038/nclimate1907, 10.1038/NCLIMATE1907]; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; FRIESE CF, 1991, AGR ECOSYST ENVIRON, V34, P87, DOI 10.1016/0167-8809(91)90096-G; GONZALEZ JE, 1994, FOREST ECOL MANAG, V70, P159, DOI 10.1016/0378-1127(94)90083-3; Hall SJ, 2013, GLOBAL CHANGE BIOL, V19, P2804, DOI 10.1111/gcb.12229; Hall SJ, 2013, ECOSYSTEMS, V16, P576, DOI 10.1007/s10021-012-9631-2; Jones SE, 2010, P NATL ACAD SCI USA, V107, P5881, DOI 10.1073/pnas.0912765107; Kaiser C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9960; Karmalkar AV, 2011, CLIM DYNAM, V37, P605, DOI 10.1007/s00382-011-1099-9; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kivlin SN, 2016, ENVIRON MICROBIOL, V18, P4662, DOI 10.1111/1462-2920.13342; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Locey KJ, 2016, P NATL ACAD SCI USA, V113, P5970, DOI 10.1073/pnas.1521291113; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Mirarab S, 2015, J COMPUT BIOL, V22, P377, DOI 10.1089/cmb.2014.0156; Mueller RC, 2014, ISME J, V8, P1548, DOI 10.1038/ismej.2013.253; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; NEWSTROM LE, 1994, BIOTROPICA, V26, P141, DOI 10.2307/2388804; Nusslein K, 1999, APPL ENVIRON MICROB, V65, P3622; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Placella SA, 2012, P NATL ACAD SCI USA, V109, P10931, DOI 10.1073/pnas.1204306109; Powers JS, 1997, FOREST ECOL MANAG, V99, P43, DOI 10.1016/S0378-1127(97)00193-X; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2020, R LANG ENV STAT COMP; Raich JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100275; Ramirez KS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1988; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Russell AE, 2007, SOIL SCI SOC AM J, V71, P1389, DOI 10.2136/sssaj2006.0069; Russell AE, 2010, ECOL APPL, V20, P1087, DOI 10.1890/09-0635.1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Scott-Denton LE, 2006, GLOBAL CHANGE BIOL, V12, P205, DOI 10.1111/j.1365-2486.2005.01064.x; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Slik JWF, 2013, GLOBAL ECOL BIOGEOGR, V22, P1261, DOI 10.1111/geb.12092; Smith AP, 2015, GLOBAL CHANGE BIOL, V21, P3532, DOI 10.1111/gcb.12947; Stocker T F, 2013, CLIM CHANG 2013 PHYS; Stone MM, 2014, SOIL BIOL BIOCHEM, V75, P237, DOI 10.1016/j.soilbio.2014.04.017; Treseder KK, 2007, GLOBAL CHANGE BIOL, V13, P78, DOI 10.1111/j.1365-2486.2006.01279.x; Tripathi BM, 2012, MICROB ECOL, V64, P474, DOI 10.1007/s00248-012-0028-8; Tucker CM, 2017, BIOL REV, V92, P698, DOI 10.1111/brv.12252; Urbanova M, 2015, SOIL BIOL BIOCHEM, V84, P53, DOI 10.1016/j.soilbio.2015.02.011; Vandecar KL, 2011, SOIL SCI SOC AM J, V75, P1520, DOI 10.2136/sssaj2010.0390; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Wallenstein MD, 2009, GLOBAL CHANGE BIOL, V15, P1631, DOI 10.1111/j.1365-2486.2008.01819.x; Waring BG, 2016, NEW PHYTOL, V209, P845, DOI 10.1111/nph.13654; Waring BG, 2015, P ROY SOC B-BIOL SCI, V282, P91, DOI 10.1098/rspb.2015.1001; Waring BG, 2015, MICROB ECOL, V69, P843, DOI 10.1007/s00248-014-0436-z; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; Zimmerman AE, 2013, ISME J, V7, P1187, DOI 10.1038/ismej.2012.176	80	22	22	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159131	10.1371/journal.pone.0159131	http://dx.doi.org/10.1371/journal.pone.0159131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391450	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400213
J	Liu, GQ; Qiu, XH; Cao, L; Zhang, Y; Zhan, ZB; Han, RC				Liu, Guiqing; Qiu, Xuehong; Cao, Li; Zhang, Yi; Zhan, Zubing; Han, Richou			Evaluation of Reference Genes for Reverse Transcription Quantitative PCR Studies of Physiological Responses in the Ghost Moth, Thitarodes armoricanus (Lepidoptera, Hepialidae)	PLOS ONE			English	Article							TIME RT-PCR; INTERNAL CONTROL GENES; CORDYCEPS-SINENSIS; EXPRESSION ANALYSIS; SACCHAROMYCES-CEREVISIAE; ENTOMOPATHOGENIC FUNGUS; OPHIOCORDYCEPS-SINENSIS; HOUSEKEEPING GENES; BEAUVERIA-BASSIANA; PUI LEPIDOPTERA	Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) is the sensitive method to quantify the expression levels of target genes on the basis of endogenous control. An appropriate reference gene set for normalization is essential for reliable results. The ghost moth, Thitarodes armoricanus, a host species of a medicinal fungus, Ophiocordyceps sinensis, is an economically important member of the Lepidoptera. Recent studies have focused on the mechanism of adaptation of this species to its high-altitude environment and host immune response to O. sinensis infection and RT-qPCR is commonly used in these studies to decipher the genetic basis of physiological functions. However, a thorough assessment of candidate reference genes in the genus Thitarodes is lacking. Here, the expression levels of eight candidate reference genes (ACT, EF, EIF4A, GAPDH, G6PDH, RPL13A, TUB and 18S) in T. armoricanus at different developmental stages and in different body parts of the seventh instar larvae were analyzed, along with larvae kept under low temperatures, larvae exposed to two fungal infections and larvae fed different diets. Three established software programs-Bestkeeper, geNorm and NormFinder-were employed to calculate variation among the treatments. The results revealed that the best-suited reference genes differed across the treatments, with EF, EIF4A and GAPDH found to be the best suited for the different developmental stages and larvae body parts; EF, EIF4A and RPL13A found to be the best suited for low-temperature challenge; and EF, EIF4A and TUB found to be the best suited for the fungal infections and dietary treatments. This study thus further contributes to the establishment of an accurate method for normalizing RT-qPCR results for T. armoricanus and serves as a reference for gene expression studies of related insect species.	[Han, Richou] Guangdong Inst Appl Biol Resources, Guangdong Key Lab IPM Agr, Guangzhou, Guangdong, Peoples R China; Guangdong Inst Appl Biol Resources, Publ Lab Wild Anim Conservat & Utilizat, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences	Han, RC (corresponding author), Guangdong Inst Appl Biol Resources, Guangdong Key Lab IPM Agr, Guangzhou, Guangdong, Peoples R China.	hanrc@gdei.gd.cn			Guangdong Provincial Science and Technology Project [2015B070701019]; Environment Construction and Capacity Building of GDAS' Research Platform [2016GDASPT-0107]; Guangzhou science and technology plan projects [201604020030]	Guangdong Provincial Science and Technology Project; Environment Construction and Capacity Building of GDAS' Research Platform; Guangzhou science and technology plan projects	This work was supported by Guangdong Provincial Science and Technology Project (No. 2015B070701019) http://pro.gdstc.gov.cn/egrantweb/RCH preparation of the manuscript, Environment Construction and Capacity Building of GDAS' Research Platform (No. 2016GDASPT-0107) http://www.gdas.gd.cn/RCH preparation of the manuscript, and Guangzhou science and technology plan projects (201604020030) http://www.gzsi.gov.cn/LC preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Buenz EJ, 2005, J ETHNOPHARMACOL, V96, P19, DOI 10.1016/j.jep.2004.09.029; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Concha C, 2012, INSECT MOL BIOL, V21, P169, DOI 10.1111/j.1365-2583.2011.01123.x; Coulson DTR, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-46; Dowling CM, 2016, F1000 RES, V156, P9; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; FENG MG, 1994, BIOCONTROL SCI TECHN, V4, P3, DOI 10.1080/09583159409355309; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Ji DB, 2009, PHYTOTHER RES, V23, P116, DOI 10.1002/ptr.2576; Kirsch R, 2011, P ROY SOC B, P1; Koh JH, 2003, BIOL PHARM BULL, V26, P84, DOI 10.1248/bpb.26.84; Koppelkamm A, 2010, INT J LEGAL MED, V124, P371, DOI 10.1007/s00414-010-0433-9; Kylee J, 2011, PLOS ONE, V6; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Meng Q, 2015, INSECT BIOCHEM MOLEC, V64, P1, DOI 10.1016/j.ibmb.2015.06.014; Nadai C, 2015, INT J FOOD MICROBIOL, V215, P49, DOI 10.1016/j.ijfoodmicro.2015.08.012; Nijhof AM, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-112; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Perez R, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-79; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Ponton F, 2011, J INSECT PHYSIOL, V57, P840, DOI 10.1016/j.jinsphys.2011.03.014; Rangel DEN, 2008, MYCOL RES, V112, P1355, DOI 10.1016/j.mycres.2008.04.011; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Selvey S, 2001, MOL CELL PROBE, V15, P307, DOI 10.1006/mcpr.2001.0376; Shen GM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-76; Simmons J, 2013, INSECT MOL BIOL, V22, P62, DOI 10.1111/imb.12003; Sun ZX, 2012, ARCH INSECT BIOCHEM, V80, P1, DOI 10.1002/arch.20456; Sun ZX, 2011, J INSECT PHYSIOL, V57, P1660, DOI 10.1016/j.jinsphys.2011.08.019; Sung GH, 2007, STUD MYCOL, P5, DOI 10.3114/sim.2007.57.01; Svitkin YV, 2001, RNA, V7, P1743; Szabo A, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r59; Tao Z, 2015, J ECON ENTOMOL, P1; Teng XL, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.6001; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XL, 2011, ZOOKEYS, P43, DOI 10.3897/zookeys.127.802; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Wu WJ, 2015, GENE, V574, P95, DOI 10.1016/j.gene.2015.07.084; Wu YL, 2006, PHYTOTHER RES, V20, P646, DOI 10.1002/ptr.1921; Wu YL, 2005, PLANTA MED, V71, P381, DOI 10.1055/s-2005-864111; Yuan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086503; Zeng XQ, 2015, P NATL ACAD SCI USA, V112, P1095, DOI 10.1073/pnas.1423628112; Zhang GQ, 2006, APPL MICROBIOL BIOT, V72, P1152, DOI 10.1007/s00253-006-0411-9; Zhang SD, 2015, GENE, V555, P393, DOI 10.1016/j.gene.2014.11.038; Zhao DJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-631; Zhou XW, 2014, CRIT REV BIOTECHNOL, V34, P233, DOI 10.3109/07388551.2013.791245; Zhu J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-172; Zhu W, 2016, J INSECT PHYSIOL, V85, P76, DOI 10.1016/j.jinsphys.2015.11.008; Zou ZW, 2011, CRYOLETTERS, V32, P225	54	24	28	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159060	10.1371/journal.pone.0159060	http://dx.doi.org/10.1371/journal.pone.0159060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392023	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400205
J	Qu, YY; Hui, J; Wang, LM; Tang, N; Zhong, H; Liu, YM; Li, Z; Feng, Q; He, F				Qu, Yuan-yuan; Hui, Jing; Wang, La-mei; Tang, Na; Zhong, Hua; Liu, Yong-min; Li, Zhen; Feng, Qian; He, Fang			Reduced Expression of the Extracellular Calcium-Sensing Receptor (CaSR) Is Associated with Activation of the Renin-Angiotensin System (RAS) to Promote Vascular Remodeling in the Pathogenesis of Essential Hypertension	PLOS ONE			English	Article							BLOOD-PRESSURE; ENDOTHELIAL-CELLS; CALCIMIMETICS; ALDOSTERONE; MODULATION; RATS	The proliferation of vascular smooth muscle cells (VSMCs), remodeling of the vasculature, and the renin-angiotensin system (RAS) play important roles in the development of essential hypertension (EH), which is defined as high blood pressure (BP) in which secondary causes, such as renovascular disease, are absent. The calcium-sensing receptor (CaSR) is involved in the regulation of BP. However, the underlying mechanisms by which the CaSR regulates BP are poorly understood. In the present study, the role of the CaSR in EH was investigated using male spontaneously hypertensive rats (SHRs) and rat and human plasma samples. The percentages of medial wall thickness to external diameter (WT%), total vessel wall cross-sectional area to the total area (WA%) of thoracic arteries, as well as the percentage of wall area occupied by collagen to total vessel wall area (CA%) were determined. Tissue protein expression and plasma concentrations of the CaSR, cyclic adenosine monophosphate (cAMP), renin, and angiotensin II (Ang II) were additionally assessed. WT%, WA%, and CA% were found to increase with increasing BP, whereas the plasma concentration of CaSR was found to decrease. With increasing BP, the levels of smooth muscle actin and calponin decreased, whereas those of osteopontin and proliferating cell nuclear antigen increased. The CaSR level negatively correlated with the levels of cAMP and Ang II, but positively correlated with those of renin. Our data suggest that reduced expression of the CaSR is correlated with activation of the RAS, which induces increased vascular remodeling and VSMC proliferation, and thereby associated with EH in the SHR model and in the Han Chinese population. Our findings provide new insights into the pathogenesis of EH.	[Qu, Yuan-yuan; Hui, Jing; Tang, Na; Zhong, Hua; Liu, Yong-min; Li, Zhen; Feng, Qian; He, Fang] Shihezi Univ, Dept Pathophysiol, Key Lab Educ, Minist Xinjiang Endem & Ethn Dis,Coll Med, Shihezi, Peoples R China; [Qu, Yuan-yuan] Shihezi Univ, Dept Emergency & Crit Care Med, Affiliated Hosp 1, Coll Med, Shihezi 832008, Peoples R China; [Wang, La-mei] Shihezi Univ, Coll Med, Ctr Med Funct Expt, Shihezi, Peoples R China	Shihezi University; Shihezi University; Shihezi University	He, F (corresponding author), Shihezi Univ, Dept Pathophysiol, Key Lab Educ, Minist Xinjiang Endem & Ethn Dis,Coll Med, Shihezi, Peoples R China.	fangf2002shz@126.com	Liu, Yong/GWQ-6163-2022		National Natural Science Foundation of China [31560287]; Science & Technology Research and Development Program of Shihezi University [2014ZRKXYQ22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Research and Development Program of Shihezi University	This project was supported by grants from National Natural Science Foundation of China (No. 31560287) and the Science & Technology Research and Development Program of Shihezi University (2014ZRKXYQ22).	Atchison DK, 2010, AM J PHYSIOL-REG I, V299, pR1020, DOI 10.1152/ajpregu.00238.2010; AYACHI S, 1979, METABOLISM, V28, P1234, DOI 10.1016/0026-0495(79)90136-7; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; CHURCHILL PC, 1985, AM J PHYSIOL, V249, pF175, DOI 10.1152/ajprenal.1985.249.2.F175; Cow D, 1911, J PHYSIOL-LONDON, V42, P125; Davies E, 1999, HYPERTENSION, V33, P703, DOI 10.1161/01.HYP.33.2.703; GENEST J, 1975, CAN MED ASSOC J, V113, P421; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Kang G, 2015, KOREAN J PHYSIOL PHA, V19, P467, DOI 10.4196/kjpp.2015.19.5.467; Laragh John H., 1995, P1813; Liang Xiao, 2012, Shengli Xuebao, V64, P289; Molostvov G, 2007, AM J PHYSIOL-RENAL, V293, pF946, DOI 10.1152/ajprenal.00474.2006; Nijenhuis T, 2005, J CLIN INVEST, V115, P1651, DOI 10.1172/JCI24134; Ogata H, 2003, J AM SOC NEPHROL, V14, P959, DOI 10.1097/01.ASN.0000056188.23717.E5; Ortiz-Capisano MC, 2013, AM J PHYSIOL-RENAL, V304, pF248, DOI 10.1152/ajprenal.00451.2012; Rybczynska A, 2010, J PHYSIOL PHARMACOL, V61, P163; Rybczynska A, 2006, J ENDOCRINOL, V191, P189, DOI 10.1677/joe.1.06924; Saito M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03822; Smajilovic S, 2006, BIOCHEM BIOPH RES CO, V348, P1215, DOI 10.1016/j.bbrc.2006.07.192; Smajilovic S, 2011, BRIT J PHARMACOL, V164, P884, DOI 10.1111/j.1476-5381.2011.01317.x; Strom A, 2004, J VASC RES, V41, P314, DOI 10.1159/000079205; Svetkey LP, 2011, AM J HYPERTENS, V24, P209, DOI 10.1038/ajh.2010.223; Tang N, 2014, MED SCI MONITOR, V20, P2508, DOI 10.12659/MSM.892861; Wang R, 2003, EUR J BIOCHEM, V270, P2680, DOI 10.1046/j.1432-1033.2003.03645.x; Weston AH, 2011, ACTA PHYSIOL, V203, P127, DOI 10.1111/j.1748-1716.2010.02249.x; Weston AH, 2005, CIRC RES, V97, P391, DOI 10.1161/01.RES.0000178787.59594.a0; Yang Y-L, 2015, J RENIN-ANGIO-ALDO S; Yi B, 2012, GENE, V492, P354, DOI 10.1016/j.gene.2011.11.010	28	14	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157456	10.1371/journal.pone.0157456	http://dx.doi.org/10.1371/journal.pone.0157456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391973	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400010
J	Sanchez-Iglesias, S; Unruh-Pinheiro, A; Guillin-Amarelle, C; Gonzalez-Mendez, B; Ruiz-Riquelme, A; Rodriguez-Canete, BL; Rodriguez-Garcia, S; Guillen-Navarro, E; Domingo-Jimenez, R; Araujo-Vilar, D				Sanchez-Iglesias, Sofia; Unruh-Pinheiro, Alexander; Guillin-Amarelle, Cristina; Gonzalez-Mendez, Blanca; Ruiz-Riquelme, Alejandro; Leticia Rodriguez-Canete, Blanca; Rodriguez-Garcia, Silvia; Guillen-Navarro, Encarnacion; Domingo-Jimenez, Rosario; Araujo-Vilar, David			Skipped BSCL2 Transcript in Celia's Encephalopathy (PELD): New Insights on Fatty Acids Involvement, Senescence and Adipogenesis	PLOS ONE			English	Article							SEIP CONGENITAL LIPODYSTROPHY; ENDOPLASMIC-RETICULUM STRESS; DOCOSAHEXAENOIC ACID; DROPLET MORPHOLOGY; ARACHIDONIC-ACID; GENE-EXPRESSION; ER STRESS; CELLS; PROTEIN; YEAST	Objective PELD (Progressive Encephalopathy with or without Lipodystrophy or Celia's Encephalopathy) is a fatal and rare neurodegenerative syndrome associated with the BSCL2 mutation c.985C>T, that results in an aberrant transcript without the exon 7 (Celia seipin). The aim of this study was to evaluate both the process of cellular senescence and the effect of unsaturated fatty acids on preadipocytes from a homozygous c.985C>T patient. Also, the role of aberrant seipin isoform on adipogenesis was studied in adipose-derived human mesenchymal stem cells. Material and methods Cellular senescence was evaluated using beta-galactosidase staining of preadipocytes obtained from a homozygous c.985C>T patient. Moreover, these cells were cultured during 24 hours with Intralipid, a soybean oil-based commercial lipid emulsion. The expression of the different BSCL2 transcripts was measured by qPCR. Adipose-derived human mesenchymal stem cells were differentiated to a fat lineage using StemPRO adipogenesis kit, and the expression of BSCL2 transcripts and several adipogenesis-related genes was measured by qPCR. Results the treatment of preadipocytes with unsaturated fatty acids significantly reduced the expression of the BSCL2 transcript without exon 7 by 34 to 63%. On the other hand, at least in preadipocytes, this mutation does not disturb cellular senescence rate. Finally, during adipocyte differentiation of adipose-derived human mesenchymal stem cells, the expression of adipogenic genes (PPARG, LPIN1, and LPL) increased significantly over 14 days, and noteworthy is that the BSCL2 transcript without exon 7 was differentially expressed by 332 to 723% when compared to day 0, suggesting an underlying role in adipogenesis. Conclusions our results suggest that Celia seipin is probably playing an underestimated role in adipocyte maturation, but not in senescence, and its expression can be modified by exogenous factors as fatty acids.	[Sanchez-Iglesias, Sofia; Unruh-Pinheiro, Alexander; Guillin-Amarelle, Cristina; Gonzalez-Mendez, Blanca; Ruiz-Riquelme, Alejandro; Leticia Rodriguez-Canete, Blanca; Rodriguez-Garcia, Silvia; Araujo-Vilar, David] Univ Santiago de Compostela, Thyroid & Metab Dis Unit UETeM, Dept Med, Ctr Res Mol Med & Chron Dis CIMUS IDIS, Santiago De Compostela, Spain; [Guillen-Navarro, Encarnacion] Hosp Clin Univ Virgen de la Arrixaca, Div Pediat, Unit Med Genet & Dysmorphol, Murcia, Spain; [Domingo-Jimenez, Rosario] Hosp Clin Univ Virgen de la Arrixaca, Div Pediat, Sect Neuropediat, Murcia, Spain	Universidade de Santiago de Compostela; Hospital Clinico Universitario Virgen de la Arrixaca; Hospital Clinico Universitario Virgen de la Arrixaca	Araujo-Vilar, D (corresponding author), Univ Santiago de Compostela, Thyroid & Metab Dis Unit UETeM, Dept Med, Ctr Res Mol Med & Chron Dis CIMUS IDIS, Santiago De Compostela, Spain.	david.araujo@usc.es	Sánchez-Iglesias, Sofía/L-2644-2014; Riquelme, Alejandro Ruiz/AAG-7010-2019; araujo-vilar, david/L-1267-2014; Guillén Navarro, Encarna/AFU-6717-2022; Rodriguez-Garcia, Silvia/L-7893-2015	Sánchez-Iglesias, Sofía/0000-0003-3887-0573; Riquelme, Alejandro Ruiz/0000-0001-6581-7132; Guillén Navarro, Encarna/0000-0002-2915-7381; Rodriguez-Garcia, Silvia/0000-0001-5479-0237; Domingo-Jimenez, Rosario/0000-0001-5115-194X	Instituto de Salud Carlos III; European Regional Development Fund; Conselleria de Industria, Xunta de Galicia [10PXIB208013PR]; Asociacion Espanola de Familiares y Afectados de Lipodistrofias (AELIP); FEDER [PI10/02873, PI13/00314];  [ISCIII/PI13/00314/Cofinanciado FEDER]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund(European Commission); Conselleria de Industria, Xunta de Galicia(Xunta de Galicia); Asociacion Espanola de Familiares y Afectados de Lipodistrofias (AELIP); FEDER(European Commission); 	This work was supported by the Instituto de Salud Carlos III and the European Regional Development Fund, FEDER (grants number PI10/02873 and PI13/00314, http://www.isciii.es/), ISCIII/PI13/00314/Cofinanciado FEDER and by the Conselleria de Industria, Xunta de Galicia (grant number 10PXIB208013PR, http://www.xunta.es/). SRG was awarded a Research Fellowship, granted by the Asociacion Espanola de Familiares y Afectados de Lipodistrofias (AELIP, http://www.aelip.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOURRE JM, 1989, J NUTR, V119, P1880, DOI 10.1093/jn/119.12.1880; Boutet E, 2009, BIOCHIMIE, V91, P796, DOI 10.1016/j.biochi.2009.01.011; Cartwright BR, 2015, MOL BIOL CELL, V26, P726, DOI 10.1091/mbc.E14-08-1303; Cartwright BR, 2012, J LIPID RES, V53, P1042, DOI 10.1194/jlr.R023754; Casanas-Sanchez V, 2014, J NEUROCHEM, V131, P470, DOI 10.1111/jnc.12833; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chen WQ, 2009, ENDOCRINOLOGY, V150, P4552, DOI 10.1210/en.2009-0236; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, J LIPID RES, V52, P2136, DOI 10.1194/jlr.M017566; Ghosh N, 2007, ENDOCRINOLOGY, V148, P1359, DOI 10.1210/en.2006-0750; Gluckman PD, 2009, PRINCIPLES EVOLUTION; GORDON N, 1987, BRAIN DEV-JPN, V9, P571, DOI 10.1016/S0387-7604(87)80087-6; Gordon N, 1997, BRAIN DEV-JPN, V19, P165, DOI 10.1016/S0387-7604(96)00560-8; Guillen-Navarro E, 2013, J MED GENET, V50, P401, DOI 10.1136/jmedgenet-2013-101525; Hamosh M, 1998, BIOL NEONATE, V74, P106, DOI 10.1159/000014017; Harvey KA, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0005-6; Holtta-Vuori M, 2013, HUM MOL GENET, V22, P1157, DOI 10.1093/hmg/dds523; Innis SM, 2007, J NUTR, V137, P855, DOI 10.1093/jn/137.4.855; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Ito D, 2007, ANN NEUROL, V61, P237, DOI 10.1002/ana.21070; Ito D, 2009, BRAIN, V132, P8, DOI 10.1093/brain/awn216; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundin C, 2006, FEBS LETT, V580, P2281, DOI 10.1016/j.febslet.2006.03.040; Magre J, 2001, NAT GENET, V28, P365, DOI 10.1038/ng585; Panganiban RAM, 2013, INT J RADIAT BIOL, V89, P656, DOI 10.3109/09553002.2012.711502; Patwardhan GA, 2014, BBA-MOL CELL BIOL L, V1841, P1571, DOI 10.1016/j.bbalip.2014.08.017; Payne VA, 2008, DIABETES, V57, P2055, DOI 10.2337/db08-0184; Perez MA, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-25; Reardon HT, 2013, PROSTAG LEUKOTR ESS, V88, P15, DOI 10.1016/j.plefa.2012.02.003; Ruiz-Riquelme A, 2015, NEUROBIOLOGY DIS; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tian Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001364; Van Maldergem L, 2002, J MED GENET, V39, P722, DOI 10.1136/jmg.39.10.722; Victoria B, 2010, DIABETIC MED, V27, P1178, DOI 10.1111/j.1464-5491.2010.03052.x; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wei SH, 2014, J NEUROCHEM, V129, P328, DOI 10.1111/jnc.12638; Wei SH, 2013, J NEUROCHEM, V124, P478, DOI 10.1111/jnc.12099; Wijendran V, 2013, PROSTAG LEUKOTR ESS, V89, P345, DOI 10.1016/j.plefa.2013.08.004; Wolinski H, 2011, J CELL SCI, V124, P3894, DOI 10.1242/jcs.091454; Yagi T, 2011, HUM MOL GENET, V20, P3831, DOI 10.1093/hmg/ddr304; Yang WL, 2013, BIOCHEM J, V452, P37, DOI 10.1042/BJ20121870	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158874	10.1371/journal.pone.0158874	http://dx.doi.org/10.1371/journal.pone.0158874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391332	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400147
J	Albanna, W; Conzen, C; Weiss, M; Clusmann, H; Fuest, M; Mueller, M; Brockmann, MA; Vilser, W; Schmidt-Trucksass, A; Hoellig, A; Seiz, M; Thome, C; Kotliar, K; Schubert, GA				Albanna, Walid; Conzen, Catharina; Weiss, Miriam; Clusmann, Hans; Fuest, Matthias; Mueller, Marguerite; Brockmann, Marc Alexander; Vilser, Walthard; Schmidt-Trucksass, Arno; Hoellig, Anke; Seiz, Marcel; Thome, Claudius; Kotliar, Konstantin; Schubert, Gerrit Alexander			Retinal Vessel Analysis (RVA) in the Context of Subarachnoid Hemorrhage - A Proof of Concept Study	PLOS ONE			English	Article							ATHEROSCLEROSIS RISK; MICROVASCULAR ABNORMALITIES; CEREBRAL AUTOREGULATION; COMMUNITIES; STATEMENT; ISCHEMIA; ANALYZER; EYE	Background Timely detection of impending delayed cerebral ischemia after subarachnoid hemorrhage (SAH) is essential to improve outcome, but poses a diagnostic challenge. Retinal vessels as an embryological part of the intracranial vasculature are easily accessible for analysis and may hold the key to a new and non-invasive monitoring technique. This investigation aims to determine the feasibility of standardized retinal vessel analysis (RVA) in the context of SAH. Methods In a prospective pilot study, we performed RVA in six patients awake and cooperative with SAH in the acute phase (day 2-14) and eight patients at the time of follow-up (mean 4.6 +/- 1.7months after SAH), and included 33 age-matched healthy controls. Data was acquired using a manoeuvrable Dynamic Vessel Analyzer (Imedos Systems UG, Jena) for examination of retinal vessel dimension and neurovascular coupling. Results Image quality was satisfactory in the majority of cases (93.3%). In the acute phase after SAH, retinal arteries were significantly dilated when compared to the control group (124.2 +/- 4.3MU vs 110.9 +/- 11.4MU, p<0.01), a difference that persisted to a lesser extent in the later stage of the disease (122.7 +/- 17.2MU, p<0.05). Testing for neurovascular coupling showed a trend towards impaired primary vasodilation and secondary vasoconstriction (p = 0.08, p = 0.09 resp.) initially and partial recovery at the time of follow-up, indicating a relative improvement in a time-dependent fashion. Conclusion RVA is technically feasible in patients with SAH and can detect fluctuations in vessel diameter and autoregulation even in less severely affected patients. Preliminary data suggests potential for RVA as a new and non-invasive tool for advanced SAH monitoring, but clinical relevance and prognostic value will have to be determined in a larger cohort.	[Albanna, Walid; Conzen, Catharina; Weiss, Miriam; Clusmann, Hans; Hoellig, Anke; Schubert, Gerrit Alexander] Rhein Westfal TH Aachen, Dept Neurosurg, Aachen, Germany; [Fuest, Matthias] Rhein Westfal TH Aachen, Dept Ophthalmol, Aachen, Germany; [Mueller, Marguerite; Brockmann, Marc Alexander] Rhein Westfal TH Aachen, Dept Diagnost & Intervent Neuroradiol, Aachen, Germany; [Vilser, Walthard] IMEDOS Syst UG, Jena, Germany; [Schmidt-Trucksass, Arno] Univ Basel, Dept Exercise & Hlth Sci, Basel, Switzerland; [Seiz, Marcel] Heidelberg Univ, Univ Med Mannheim, Dept Neurosurg, Mannheim, Germany; [Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria; [Kotliar, Konstantin] FH Aachen Univ Appl Sci, Dept Med Engn & Technomath, Aachen, Germany	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; University of Basel; Ruprecht Karls University Heidelberg; Medical University of Innsbruck	Schubert, GA (corresponding author), Rhein Westfal TH Aachen, Dept Neurosurg, Aachen, Germany.	gerrit.schubert@me.com	Fuest, Matthias/AAC-8858-2020; Schubert, Gerrit Alexander/Q-9192-2017; Weiss, Miriam/AAJ-8845-2020; Schmidt-Trucksäss, Arno/I-7673-2015	Schubert, Gerrit Alexander/0000-0001-9135-6042; Weiss, Miriam/0000-0001-8820-0805; Schmidt-Trucksäss, Arno/0000-0002-4662-3911; Albanna, Walid/0000-0001-9986-8739; Kotliar, Konstantin/0000-0003-2087-957X	START-Program of the Faculty of Medicine, RWTH Aachen University	START-Program of the Faculty of Medicine, RWTH Aachen University	This research program is supported by the START-Program of the Faculty of Medicine, RWTH Aachen University. One of the authors [WV], is affiliated to IMEDOS Systems, employed as CEO of the company. IMEDOS Systems provided the utilized imaging device for research purposes only. IMEDOS Systems gave technical instruction and support for the imaging device. The funder provided support in the form of research material, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Particularly in view of the constructional setup of the imaging device, the authors would like to express our gratitude for the invaluable practical support that was generously provided by Mrs Jasmin Dell'Anna and Professor Klaus Radermacher (Faculty of Medical Engineering, Helmholtz-Institute for Biomedical Engineering, RWTH Aachen University).	Balbi M, 2017, J CEREBR BLOOD F MET, V37, P178, DOI 10.1177/0271678X15621253; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Budohoski KP, 2013, J CEREBR BLOOD F MET, V33, P449, DOI 10.1038/jcbfm.2012.189; Chen HI, 2011, NEUROSURGERY, V69, P53, DOI 10.1227/NEU.0b013e3182191451; Cooper LS, 2006, STROKE, V37, P82, DOI 10.1161/01.STR.0000195134.04355.e5; Couper DJ, 2002, AM J OPHTHALMOL, V133, P78, DOI 10.1016/S0002-9394(01)01315-0; Dengler J, 2011, INTENS CARE MED, V37, P1809, DOI 10.1007/s00134-011-2316-z; Derdeyn CP, 2002, BRAIN, V125, P595, DOI 10.1093/brain/awf047; Friedrich B, 2014, J CEREBR BLOOD F MET, V34, P1422, DOI 10.1038/jcbfm.2014.96; Garhofer G., 2012, OCULAR BLOOD FLOW, P101; Garhofer G, 2010, ACTA OPHTHALMOL, V88, P717, DOI 10.1111/j.1755-3768.2009.01587.x; Heitmar R, 2011, INVEST OPHTH VIS SCI, V52, P6199, DOI 10.1167/iovs.10-6628; Horn P, 2001, CEREBROVASC DIS, V12, P197, DOI 10.1159/000047704; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Koide M, 2013, ACTA NEUROCHIR SUPPL, V115, P167, DOI 10.1007/978-3-7091-1192-5_32; Koide M, 2012, P NATL ACAD SCI USA, V109, pE1387, DOI 10.1073/pnas.1121359109; Kotliar KE, 2004, GRAEF ARCH CLIN EXP, V242, P377, DOI 10.1007/s00417-003-0847-x; Kotliar KE, 2011, MICROVASC RES, V81, P123, DOI 10.1016/j.mvr.2010.11.007; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Polak K, 2000, BRIT J OPHTHALMOL, V84, P1285, DOI 10.1136/bjo.84.11.1285; Vajkoczy P, 2003, J NEUROSURG, V98, P1227, DOI 10.3171/jns.2003.98.6.1227; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Vilser W, 2002, Biomed Tech (Berl), V47 Suppl 1 Pt 2, P682, DOI 10.1515/bmte.2002.47.s1b.682; White H, 2006, INTENS CARE MED, V32, P981, DOI 10.1007/s00134-006-0173-y; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Wong TY, 2001, LANCET, V358, P1134, DOI 10.1016/S0140-6736(01)06253-5	27	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158781	10.1371/journal.pone.0158781	http://dx.doi.org/10.1371/journal.pone.0158781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388619	Green Published, Green Submitted, gold			2022-12-26	WOS:000379811500045
J	Leem, YE; Jeong, HJ; Kim, HJ; Koh, J; Kang, K; Bae, GU; Cho, H; Kang, JS				Leem, Young-Eun; Jeong, Hyeon-Ju; Kim, Hyun-Ji; Koh, Jewoo; Kang, KyeongJin; Bae, Gyu-Un; Cho, Hana; Kang, Jong-Sun			Cdo Regulates Surface Expression of Kir2.1 K+ Channel in Myoblast Differentiation	PLOS ONE			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; RECTIFYING POTASSIUM CHANNEL; MYOGENIC DIFFERENTIATION; TERMINAL DIFFERENTIATION; P38-ALPHA/BETA MAPK; SIGNALING PATHWAY; GOLGI EXPORT; RECEPTOR CDO; ER EXPORT; PROTEIN	A potassium channel Kir2.1-associated membrane hyperpolarization is required for myogenic differentiation. However the molecular regulatory mechanisms modulating Kir2.1 channel activities in early stage of myogenesis are largely unknown. A cell surface protein, Cdo functions as a component of multiprotein cell surface complexes to promote myogenesis. In this study, we report that Cdo forms a complex with Kir2.1 during myogenic differentiation, and is required for the channel activity by enhancing the surface expression of Kir2.1 in the early stage of differentiation. The expression of a constitutively active form of the upstream kinase for p38MAPK, MKK6(EE) can restore Kir2.1 activities in Cdo-depleted C2C12 cells, while the treatment with a p38MAPK inhibitor, SB203580 exhibits a similar effect of Cdo depletion on Kir2.1 surface expression. Furthermore, Cdo(-/-) primary myoblasts, which display a defective differentiation program, exhibit a defective Kir2.1 activity. Taken together, our results suggest that a promyogenic Cdo signaling is critical for Kir2.1 activities in the induction of myogenic differentiation.	[Leem, Young-Eun; Jeong, Hyeon-Ju; Kang, Jong-Sun] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea; [Kim, Hyun-Ji; Koh, Jewoo; Cho, Hana] Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon, South Korea; [Kang, KyeongJin] Sungkyunkwan Univ, Sch Med, Dept Anat, Suwon, South Korea; [Leem, Young-Eun; Jeong, Hyeon-Ju; Kim, Hyun-Ji; Koh, Jewoo; Kang, KyeongJin; Cho, Hana; Kang, Jong-Sun] Samsung Biomed Res Inst, Suwon, South Korea; [Bae, Gyu-Un] Sookmyung Womens Univ, Res Ctr Cell Fate Control, Seoul, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sookmyung Women's University	Kang, JS (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea.; Cho, H (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon, South Korea.; Cho, H; Kang, JS (corresponding author), Samsung Biomed Res Inst, Suwon, South Korea.	hanacho@skku.edu; kangj01@skku.edu		Cho, Hana/0000-0002-9394-8671	National Research Foundation of Korea (NRF) grant - Korea Government (MSIP) [NRF-2011-0017315, NRF-2013M3A9B1069776]; Samsung Biomedical Research Institute	National Research Foundation of Korea (NRF) grant - Korea Government (MSIP); Samsung Biomedical Research Institute(Samsung)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea Government (MSIP) (NRF-2011-0017315 to JSK) (NRF-2013M3A9B1069776 to JSK). Samsung Biomedical Research Institute provided support in the form of salaries for authors YEL, HJJ, HJK, JK, KJK, HC and JSK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abmayr SM, 2012, DEVELOPMENT, V139, P641, DOI 10.1242/dev.068353; Bae GU, 2010, MOL BIOL CELL, V21, P2399, DOI 10.1091/mbc.E09-12-1011; Bae GU, 2009, MOL CELL BIOL, V29, P4130, DOI 10.1128/MCB.00199-09; Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627; Boyer SB, 2009, J CELL PHYSIOL, V218, P385, DOI 10.1002/jcp.21610; Braun T, 2011, NAT REV MOL CELL BIO, V12, P349, DOI 10.1038/nrm3118; Cabane C, 2003, AM J PHYSIOL-CELL PH, V284, pC658, DOI 10.1152/ajpcell.00078.2002; Chae KS, 2005, NEUROSCIENCE, V135, P1013, DOI 10.1016/j.neuroscience.2005.06.060; Chae KS, 2005, J NEUROCHEM, V94, P367, DOI 10.1111/j.1471-4159.2005.03201.x; Cole F, 2004, DEV CELL, V7, P843, DOI 10.1016/j.devcel.2004.10.009; de Angelis L, 2005, DEV BIOL, V283, P171, DOI 10.1016/j.ydbio.2005.04.009; FAKLER B, 1994, NEURON, V13, P1413, DOI 10.1016/0896-6273(94)90426-X; Fischer-Lougheed J, 2001, J CELL BIOL, V153, P677, DOI 10.1083/jcb.153.4.677; Hinard V, 2008, DEVELOPMENT, V135, P859, DOI 10.1242/dev.011387; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Hoger JH, 2002, P NATL ACAD SCI USA, V99, P7780, DOI 10.1073/pnas.102184999; Jones SVP, 2003, MOL PHARMACOL, V64, P987, DOI 10.1124/mol.64.4.987; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kang JS, 2004, J CELL BIOL, V167, P493, DOI 10.1083/jcb.200405039; Kim S, 2007, DEV CELL, V12, P571, DOI 10.1016/j.devcel.2007.02.019; Klein H, 1999, J MEMBRANE BIOL, V167, P43, DOI 10.1007/s002329900470; Konig S, 2004, J BIOL CHEM, V279, P28187, DOI 10.1074/jbc.M313932200; Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479; Krauss RS, 2005, J CELL SCI, V118, P2355, DOI 10.1242/jcs.02397; Lee HJ, 2012, MOL BIOL CELL, V23, P1376, DOI 10.1091/mbc.E11-07-0634; Leem YE, 2011, CELL SIGNAL, V23, P2021, DOI 10.1016/j.cellsig.2011.07.016; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; Leyland ML, 2004, J BIOL CHEM, V279, P43427, DOI 10.1074/jbc.M407575200; Liu JH, 1998, J PHYSIOL-LONDON, V510, P467, DOI 10.1111/j.1469-7793.1998.467bk.x; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; Ma DH, 2011, CELL, V145, P1102, DOI 10.1016/j.cell.2011.06.007; Massarwa R, 2007, DEV CELL, V12, P557, DOI 10.1016/j.devcel.2007.01.016; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; Tran P, 2012, J BIOL CHEM, V287, P11602, DOI 10.1074/jbc.M112.351601; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Ruppersberg JP, 1996, NEUROPHARMACOLOGY, V35, P887, DOI 10.1016/0028-3908(96)00092-5; Ruppersberg JP, 2000, PFLUG ARCH EUR J PHY, V441, P1, DOI 10.1007/s004240000380; Sampson LJ, 2003, J BIOL CHEM, V278, P41988, DOI 10.1074/jbc.M307479200; SARGIACOMO M, 1989, J MEMBRANE BIOL, V107, P277, DOI 10.1007/BF01871942; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tong YH, 2001, J GEN PHYSIOL, V117, P103, DOI 10.1085/jgp.117.2.103; Wischmeyer E, 1998, J BIOL CHEM, V273, P34063, DOI 10.1074/jbc.273.51.34063; Wischmeyer E, 1996, P NATL ACAD SCI USA, V93, P5819, DOI 10.1073/pnas.93.12.5819; Wu ZG, 2000, MOL CELL BIOL, V20, P3951, DOI 10.1128/MCB.20.11.3951-3964.2000; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhang W, 2006, DEV CELL, V10, P657, DOI 10.1016/j.devcel.2006.04.005	54	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158707	10.1371/journal.pone.0158707	http://dx.doi.org/10.1371/journal.pone.0158707			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380411	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700043
J	Betapudi, V; Shukla, M; Alluri, R; Merkulov, S; McCrae, KR				Betapudi, Venkaiah; Shukla, Meenal; Alluri, Ravi; Merkulov, Sergei; McCrae, Keith R.			Novel role for p56/Lck in regulation of endothelial cell survival and angiogenesis	FASEB JOURNAL			English	Article						apoptosis; kininogen; p53; tyrosine protein kinase Lck	MOLECULAR-WEIGHT KININOGEN; TYROSINE KINASE LCK; SRC-FAMILY KINASES; PLASMINOGEN-ACTIVATOR; BINDING-PROTEIN; CYTOKERATIN 1; VASCULAR-PERMEABILITY; SIGNAL-TRANSDUCTION; TUBE FORMATION; APOPTOSIS	Previous studies have demonstrated that cleaved high-molecular-weight kininogen (HKa) induces endothelial apoptosis and inhibits angiogenesis and have suggested that this occurs through inhibition of Src family kinases. This study assessed the role of tyrosine-protein kinase Lck (p56/Lck) in this pathway. We analyzed early events leading to apoptosis of human endothelial cells exposed to HKa. The role of p56/Lck was investigated using short interfering (si) RNA knockdown and lentivirus expression in assays of endothelial tube formation, sprouting of neovessels from murine aorta, and angiogenesis in Matrigel plugs. HKa stimulated expression and phosphorylation of p56/Lck. siRNA knockdown of p56/Lck promoted endothelial proliferation and blocked HKa-induced apoptosis and activation of p53, Bax, and Bak. Lentivirus expression of p56/Lck in endothelial cells induced apoptosis and blocked tube formation. Expression of p56/Lck in murine aortic rings blocked sprouting angiogenesis. Lentivirus expressing p56/Lck blocked angiogenesis in Matrigel plugs, while p56/Lck short hairpin RNA inhibited the antiangiogenic effect of HKa. Scrambled siRNAs and empty lentiviral vectors were used in all experiments. Apoptosis of proliferating endothelial cells and inhibition of angiogenesis by HKa requires p56/Lck. This suggests a novel role for p56/Lck in regulation of endothelial cell survival and angiogenesis.	[Betapudi, Venkaiah; Shukla, Meenal; Alluri, Ravi; Merkulov, Sergei; McCrae, Keith R.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [McCrae, Keith R.] Cleveland Clin, Taussig Canc Inst, R4-018,9500 Euclid Ave, Cleveland, OH 44195 USA; [Betapudi, Venkaiah] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	McCrae, KR (corresponding author), Cleveland Clin, Taussig Canc Inst, R4-018,9500 Euclid Ave, Cleveland, OH 44195 USA.	mccraek@ccf.org			U.S. National Institutes of Health National Heart, Lung, and Blood Institute [R01-HL098796]	U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grant R01-HL098796 (to K.R.M.).	ADAMIS AP, 1993, BIOCHEM BIOPH RES CO, V193, P631, DOI 10.1006/bbrc.1993.1671; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Belka C, 2003, ONCOGENE, V22, P176, DOI 10.1038/sj.onc.1206103; Berg NN, 1997, J IMMUNOL, V159, P1753; Bhagwat SS, 2009, PURINERG SIGNAL, V5, P107, DOI 10.1007/s11302-008-9117-z; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886; Cao DJ, 2004, CIRC RES, V94, P1227, DOI 10.1161/01.RES.0000126567.75232.46; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chavakis T, 2000, BLOOD, V96, P514; Colman RW, 1997, J CLIN INVEST, V100, P1481, DOI 10.1172/JCI119669; Colman RW, 2000, BLOOD, V95, P543, DOI 10.1182/blood.V95.2.543; Cooper JC, 2010, INT J ONCOL, V36, P1201, DOI 10.3892/ijo_00000603; Creedon Helen, 2012, Critical Reviews in Oncogenesis, V17, P145; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Goldmann WH, 2002, CELL BIOL INT, V26, P567, DOI 10.1006/cbir.2002.0900; Gorska MM, 2012, BLOOD, V119, P1399, DOI 10.1182/blood-2011-04-350686; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Gruber C, 2004, BIOCHEM PHARMACOL, V67, P1859, DOI 10.1016/j.bcp.2004.01.026; Guo YL, 2005, J THROMB HAEMOST, V3, P670, DOI 10.1111/j.1538-7836.2005.01218.x; Hardwick JM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008722; Harr MW, 2010, CELL DEATH DIFFER, V17, P1381, DOI 10.1038/cdd.2010.25; Hasan AAK, 1998, P NATL ACAD SCI USA, V95, P3615, DOI 10.1073/pnas.95.7.3615; Herwald H, 1996, J BIOL CHEM, V271, P13040, DOI 10.1074/jbc.271.22.13040; Ion G, 2006, CELL SIGNAL, V18, P1887, DOI 10.1016/j.cellsig.2006.02.007; Joseph K, 1999, CLIN IMMUNOL, V92, P246, DOI 10.1006/clim.1999.4753; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kapoor M, 2000, ONCOGENE, V19, P358, DOI 10.1038/sj.onc.1203300; Kim MJ, 2008, BIOCHEM BIOPH RES CO, V370, P353, DOI 10.1016/j.bbrc.2008.03.084; Laham LE, 2000, ONCOGENE, V19, P3961, DOI 10.1038/sj.onc.1203738; Liu YC, 2008, AM J PHYSIOL-CELL PH, V295, pC257, DOI 10.1152/ajpcell.00569.2007; Liu Y, 2008, EXP CELL RES, V314, P774, DOI 10.1016/j.yexcr.2007.10.008; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; Mahdi F, 2004, J BIOL CHEM, V279, P16621, DOI 10.1074/jbc.M313850200; Mancuso P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114713; Martin MW, 2010, EXPERT OPIN THER PAT, V20, P1573, DOI 10.1517/13543776.2010.517749; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; MOORE GL, 1981, BIOCHEM MED METAB B, V26, P167, DOI 10.1016/0006-2944(81)90043-0; Novak J, 2014, MOL IMMUNOL, V57, P302, DOI 10.1016/j.molimm.2013.10.010; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Ostergaard HL, 1998, J BIOL CHEM, V273, P5692, DOI 10.1074/jbc.273.10.5692; Papatriantafyllou M, 2013, NAT REV IMMUNOL, V13, P222, DOI 10.1038/nri3429; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Park SI, 2007, EXPERT OPIN THER TAR, V11, P1207, DOI 10.1517/14728222.11.9.1207; Pixley RA, 2011, THROMB HAEMOSTASIS, V105, P1053, DOI 10.1160/TH10-09-0591; Prager GW, 2012, HAMOSTASEOLOGIE, V32, P105, DOI 10.5482/ha-1163; Renne T, 2000, J BIOL CHEM, V275, P33688, DOI 10.1074/jbc.M000313200; Salmond RJ, 2005, J IMMUNOL, V175, P6498, DOI 10.4049/jimmunol.175.10.6498; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Sen B., 2011, J SIGNAL TRANSDUCT, V2011; Shi MJ, 2006, MOL CANCER RES, V4, P39, DOI 10.1158/1541-7786.MCR-05-0202; Shibuya M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009092; Sun DY, 2006, BLOOD, V107, P4714, DOI 10.1182/blood-2005-09-3584; Svec A, 2008, PATHOL RES PRACT, V204, P785, DOI 10.1016/j.prp.2008.06.006; Umemura H, 2011, J GASTROENTEROL, V46, P577, DOI 10.1007/s00535-010-0369-3; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com; Zhang JC, 2002, CAN J PHYSIOL PHARM, V80, P85, DOI 10.1139/Y02-011; Zhang W, 2011, BLOOD, V118	64	10	10	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3515	3526		10.1096/fj.201500040	http://dx.doi.org/10.1096/fj.201500040			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27402674	Green Published			2022-12-26	WOS:000384329800021
J	Tong, SL; Lin, YB; Lu, S; Wang, MT; Bogdanov, M; Zheng, L				Tong, Shuilong; Lin, Yibin; Lu, Shuo; Wang, Meitian; Bogdanov, Mikhail; Zheng, Lei			Structural Insight into Substrate Selection and Catalysis of Lipid Phosphate Phosphatase PgpB in the Cell Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatase; phosphatidylglycerol; phospholipid metabolism; protein-lipid interaction; X-ray crystallography; lipid phosphate dephosphorylation; substrate selectivity	ESCHERICHIA-COLI PGPB; X-RAY-STRUCTURE; AUTOINDUCTION; ACTIVATION; PROTEINS; SYSTEM; GENE	PgpB belongs to the lipid phosphate phosphatase protein family and is one of three bacterial integral membrane phosphatases catalyzing dephosphorylation of phosphatidylglycerol phosphate (PGP) to generate phosphatidylglycerol. Although the structure of its apo form became recently available, the mechanisms of PgpB substrate binding and catalysis are still unclear. We found that PgpB was inhibited by phosphatidylethanolamine (PE) in a competitive mode in vitro. Here we report the crystal structure of the lipid-bound form of PgpB. The structure shows that a PE molecule is stabilized in a membrane-embedded tunnel formed by TM3 and the PSGH fingerprint peptide near the catalytic site, providing structural insight into PgpB substrate binding mechanism. Noteworthy, in silico docking of varied lipid phosphates exhibited similar substrate binding modes to that of PE, and the residues in the lipid tunnel appear to be important for PgpB catalysis. The catalytic triad in the active site is essential for dephosphorylating substrates lysophosphatidic acid, phosphatidic acid, or sphingosine-1-phosphate but surprisingly not for the native substrate PGP. Remarkably, residue His-207 alone is sufficient to hydrolyze PGP, indicating a specific catalytic mechanism for PgpB in PG biosynthesis. We also identified two novel sensor residues, Lys-93 and Lys-97, on TM3. Our data show that Lys-97 is essential for the recognition of lyso-form substrates. Modification at the Lys-93 position may alter substrate specificity of lipid phosphate phosphatase proteins in prokaryotes versus eukaryotes. These studies reveal new mechanisms of lipid substrate selection and catalysis by PgpB and suggest that the enzyme rests in a PE-stabilized state in the bilayer.	[Tong, Shuilong; Lin, Yibin; Lu, Shuo; Bogdanov, Mikhail; Zheng, Lei] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA; [Wang, Meitian] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Zheng, L (corresponding author), Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, 6431 Fannin St, Houston, TX 77030 USA.	lei.zheng@uth.tmc.edu	Bogdanov, Mikhail/J-3695-2017; Lin, B.Y./AAA-7774-2020; Crystal, Boy/Q-3005-2019	Crystal, Boy/0000-0003-0608-7875; Wang, Meitian/0000-0002-5340-3036	National Institute of General Medical Sciences [R01GM098572, R01GM097290]; American Heart Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097290, R01GM098572] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of General Medical Sciences Grants R01GM098572 and R01GM097290 (to L. Z.). This work was also supported by American Heart Association postdoctoral fellowships (to S. T.) The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brindley DN, 2009, J LIPID RES, V50, pS225, DOI 10.1194/jlr.R800055-JLR200; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Fan JP, 2014, P NATL ACAD SCI USA, V111, P7636, DOI 10.1073/pnas.1403097111; Havriluk T, 2008, ANAL BIOCHEM, V373, P392, DOI 10.1016/j.ab.2007.08.037; Hong H, 2011, J AM CHEM SOC, V133, P11389, DOI 10.1021/ja204524c; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Lu YH, 2011, J BIOL CHEM, V286, P5506, DOI 10.1074/jbc.M110.199265; Makde RD, 2007, BIOCHEMISTRY-US, V46, P2079, DOI 10.1021/bi062180g; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Meijberg W, 2002, J MOL BIOL, V319, P839, DOI 10.1016/S0022-2836(02)00342-X; Messerschmidt A, 1996, P NATL ACAD SCI USA, V93, P392, DOI 10.1073/pnas.93.1.392; MOZHAROV AD, 1985, FEBS LETT, V186, P103, DOI 10.1016/0014-5793(85)81348-X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Pierrugues O, 2001, J BIOL CHEM, V276, P20300, DOI 10.1074/jbc.M009726200; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Stukey J, 1997, PROTEIN SCI, V6, P469; Tanyi JL, 2003, CLIN CANCER RES, V9, P3534; Touze T, 2008, J BIOL CHEM, V283, P16573, DOI 10.1074/jbc.M800394200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; Weyand M, 1999, J MOL BIOL, V293, P595, DOI 10.1006/jmbi.1999.3179; WINN SI, 1981, PHILOS T ROY SOC B, V293, P121, DOI 10.1098/rstb.1981.0066	35	19	19	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18342	18352		10.1074/jbc.M116.737874	http://dx.doi.org/10.1074/jbc.M116.737874			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27405756	Green Published, hybrid			2022-12-26	WOS:000383241800026
J	Yadav, PK; Rajasekharan, R				Yadav, Pradeep Kumar; Rajasekharan, Ram			Misregulation of a DDHD Domain-containing Lipase Causes Mitochondrial Dysfunction in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; gene regulation; metabolism; mitochondria; phospholipid; AFT1; 2 transcription factors; Barth syndrome; DDHD domain; YOR022C; hereditary spastic paraplegia	HEREDITARY SPASTIC PARAPLEGIA; SACCHAROMYCES-CEREVISIAE; BARTH-SYNDROME; PHOSPHOLIPASE A(1); LIPID-METABOLISM; CARDIOLIPIN; MEMBRANE; PROTEIN; MUTANT; PHOSPHATIDYLGLYCEROL	The DDHD domain-containing proteins, which belong to the intracellular phospholipase A(1) (iPLA(1)) family, have been predicted to be involved in phospholipid metabolism, lipid trafficking, membrane turnover, and signaling. Defective cardiolipin (CL), phosphatidylethanolamine, and phosphatidylglycerol remodeling cause Barth syndrome and mitochondrial dysfunction. Here, we report that Yor022c is a Ddl1 (DDHD domain-containing lipase 1) that hydrolyzes CL, phosphatidylethanolamine, and phosphatidylglycerol. Ddl1 has been implicated in the remodeling of mitochondrial phospholipids and CL degradation. Our data also suggested that the accumulation of monolysocardiolipin is deleterious to the cells. We show that Aft1 and Aft2 transcription factors antagonistically regulate the DDL1 gene. This study reveals that the misregulation of DDL1 by Aft1/2 transcription factors alters CL metabolism and causes mitochondrial dysfunction in the cells. In humans, mutations in the DDHD1 and DDHD2 genes cause specific types of hereditary spastic paraplegia (SPG28 and SPG54, respectively), and the yeast DDL1-defective strain produces similar phenotypes of hereditary spastic paraplegia (mitochondrial dysfunction and defects in lipid metabolism). Therefore, the DDL1-defective strain could be a good model system for understanding hereditary spastic paraplegia.	Cent Food Technol Res Inst, CSIR, Dept Lipid Sci, Lipid Ctr, Mysore 570020, Karnataka, India; Cent Food Technol Res Inst, CSIR, Acad Sci & Innovat Res, Mysore 570020, Karnataka, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Rajasekharan, R (corresponding author), Cent Food Technol Res Inst, CSIR, Mysore 570020, Karnataka, India.	ram@cftri.com	Rajasekharan, Ram/R-2257-2019; Yadav, Pradeep Kumar/GZA-4317-2022	Rajasekharan, Ram/0000-0002-2124-6013; Yadav, Pradeep/0000-0002-4777-4914; Ram, Rajasekharan/0000-0002-4114-0654	Council of Scientific and Industrial Research (CSIR), New Delhi, India; CSIR, New Delhi; J. C. Bose National Fellowship	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); J. C. Bose National Fellowship	This study was supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India under the 12th 5-year plan project (LIPIC). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from CSIR, New Delhi.; Recipient of the J. C. Bose National Fellowship. To whom correspondence should be addressed: Central Food Technological Research Institute, Council of Scientific and Industrial Research, Mysore 570020, Karnataka, India. Tel.: 91-821-2517760; Fax: 91-821-2516308; E-mail: ram@cftri.com.	Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Berthelet S, 2010, GENETICS, V185, P1111, DOI 10.1534/genetics.110.117531; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Dimmer KS, 2006, PHYSIOLOGY, V21, P233, DOI 10.1152/physiol.00010.2006; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gonzalez M, 2013, EUR J HUM GENET, V21, P1214, DOI 10.1038/ejhg.2013.29; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; HIGGS HN, 1994, P NATL ACAD SCI USA, V91, P9574, DOI 10.1073/pnas.91.20.9574; Huang H, 2015, REDOX BIOL, V5, P169, DOI 10.1016/j.redox.2015.04.011; Inloes JM, 2014, P NATL ACAD SCI USA, V111, P14924, DOI 10.1073/pnas.1413706111; Inoue H, 2012, BBA-MOL CELL RES, V1823, P930, DOI 10.1016/j.bbamcr.2012.02.002; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Laha S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-83; Lev S, 2004, EXP CELL RES, V297, P1, DOI 10.1016/j.yexcr.2004.02.033; Lewandowska A, 2006, BBA-MOL CELL RES, V1763, P141, DOI 10.1016/j.bbamcr.2006.01.007; Nakajima K, 2002, J BIOL CHEM, V277, P11329, DOI 10.1074/jbc.M111092200; Nie J, 2010, BBA-MOL CELL BIOL L, V1801, P438, DOI 10.1016/j.bbalip.2009.12.002; Oganesyan N, 2007, PROTEIN EXPRES PURIF, V52, P280, DOI 10.1016/j.pep.2006.09.015; Pokorna L, 2016, BBA-BIOENERGETICS, V1857, P34, DOI 10.1016/j.bbabio.2015.10.004; Poor CB, 2014, P NATL ACAD SCI USA, V111, P4043, DOI 10.1073/pnas.1318869111; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; ROSE M, 1983, METHOD ENZYMOL, V101, P167; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Schlame M, 2003, J AM COLL CARDIOL, V42, P1994, DOI 10.1016/j.jacc.2003.06.015; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Schuiki I, 2009, IUBMB LIFE, V61, P151, DOI 10.1002/iub.159; Simons B, 2012, METABOLITES, V2, P195, DOI 10.3390/metabo2010195; Tamaki H, 2007, J BIOL CHEM, V282, P34288, DOI 10.1074/jbc.M704509200; Tamura Y, 2012, J BIOL CHEM, V287, P15205, DOI 10.1074/jbc.M111.338665; Tani Katsuko, 2012, Biomol Concepts, V3, P471, DOI 10.1515/bmc-2012-0014; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; Vijayakumar A, 2016, PLANT PHYSIOL, V170, P180, DOI 10.1104/pp.15.01615; Vreken P, 2000, BIOCHEM BIOPH RES CO, V279, P378, DOI 10.1006/bbrc.2000.3952; Yadav KK, 2015, MOL MICROBIOL, V98, P456, DOI 10.1111/mmi.13133; Yamashita A, 2010, BBA-MOL CELL BIOL L, V1801, P711, DOI 10.1016/j.bbalip.2010.03.012; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487	44	17	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18562	18581		10.1074/jbc.M116.733378	http://dx.doi.org/10.1074/jbc.M116.733378			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402848	Green Published, hybrid			2022-12-26	WOS:000383241800045
J	Kloten, V; Schlensog, M; Eschenbruch, J; Gasthaus, J; Tiedemann, J; Mijnes, J; Heide, T; Braunschweig, T; Knuchel, R; Dahl, E				Kloten, Vera; Schlensog, Martin; Eschenbruch, Julian; Gasthaus, Janina; Tiedemann, Janina; Mijnes, Jolein; Heide, Timon; Braunschweig, Till; Knuechel, Ruth; Dahl, Edgar			Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer	PLOS ONE			English	Article							REGULATED GENE 2; CELL-LINES; PROMOTER METHYLATION; MOLECULAR PORTRAITS; PROGNOSTIC MARKER; TGF-BETA; RECEPTOR; TUMOR; CD24; RECURRENCE	NDRG2, a member of the N-myc downstream-regulated gene family, is thought to be a putative tumor suppressor gene with promising clinical impact in breast cancer. Since breast cancer comprises heterogeneous intrinsic subtypes with distinct clinical outcomes we investigated the pivotal role of NDRG2 in basal-type breast cancers. Based on subtype classified tumor (n = 45) and adjacent normal tissues (n = 17) we examined NDRG2 mRNA expression and CpG-hypermethylation, whose significance was further validated by independent data sets from The Cancer Genome Atlas (TCGA). In addition, NDRG2 protein expression was evaluated immunohistochemically using a tissue micro array (TMA, n = 211). In vitro, we investigated phenotypic effects caused by NDRG2 silencing in the basal A-like HCC1806 as well as NDRG2 over-expression in basal A-like BT20 compared to luminal-type MCF7 breast cancer cells. Our tissue collections demonstrated an overall low NDRG2 mRNA expression in breast cancer subtypes compared to normal breast tissue in line with an increased CpG-hypermethylation in breast cancer tissue. Independent TCGA data sets verified a significant (P<0.001) expression loss of NDRG2 in breast tumors. Of interest, basal-like tumors more frequently retained abundant NDRG2 expression concordant with a lower CpG-hypermethylation. Unexpectedly, basal-like breast cancer revealed an association of NDRG2 expression with unfavorable patients' outcome. In line with this observation, in vitro experiments demonstrated reduced proliferation and migration rates (similar to 20%) in HCC1806 cells following NDRG2 silencing. In contrast, NDRG2 over-expressing luminal-type MCF7 cells demonstrated a 26% decreased proliferation rate. Until now, this is the first study investigating the putative role of NDRG2 in depth in basal-type breast cancer. Our data indicate that the described putative tumor suppressive function of NDRG2 may be confined to luminal-and basal B-type breast cancers.	[Kloten, Vera; Schlensog, Martin; Eschenbruch, Julian; Gasthaus, Janina; Tiedemann, Janina; Mijnes, Jolein; Heide, Timon; Braunschweig, Till; Knuechel, Ruth; Dahl, Edgar] Rhein Westfal TH Aachen, Fac Med, Inst Pathol, Mol Oncol Grp, Aachen, Germany	RWTH Aachen University	Kloten, V (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Pathol, Mol Oncol Grp, Aachen, Germany.	vkloten@ukaachen.de	Braunschweig, Till/AAO-5725-2020	Braunschweig, Till/0000-0001-9166-2912; Eschenbruch, Julian/0000-0002-3430-3590; Gasthaus, Janina/0000-0003-0890-6141				Bertucci F, 2008, INT J CANCER, V123, P236, DOI 10.1002/ijc.23518; Boulkroun S, 2005, PFLUG ARCH EUR J PHY, V451, P388, DOI 10.1007/s00424-005-1410-x; Boulkroun S, 2002, J BIOL CHEM, V277, P31506, DOI 10.1074/jbc.M200272200; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Dahl E, 2006, CLIN CANCER RES, V12, P3950, DOI 10.1158/1078-0432.CCR-05-2090; Foletta VC, 2009, J PHYSIOL-LONDON, V587, P1619, DOI 10.1113/jphysiol.2008.167882; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeschke J, 2012, EPIGENETICS-US, V7, P701, DOI 10.4161/epi.20445; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim MJ, 2014, MOL CELLS, V37, P759, DOI 10.14348/molcells.2014.0232; Kim MJ, 2014, CANCER LETT, V354, P33, DOI 10.1016/j.canlet.2014.06.023; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kristiansen G, 2011, J BIOL CHEM; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Li Y, 2011, J BIOL CHEM, V286, P32289, DOI 10.1074/jbc.M111.247825; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Liu N, 2008, NUCLEIC ACIDS RES, V36, P5335, DOI 10.1093/nar/gkn504; Liu N, 2007, BIOCHEM BIOPH RES CO, V358, P164, DOI 10.1016/j.bbrc.2007.04.089; Ma J, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3628; Ma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032368; Ma YL, 2014, BRAIN RES, V1569, P1, DOI 10.1016/j.brainres.2014.04.036; Malaterre J, 2007, FRONT BIOSCI-LANDMRK, V12, P492, DOI 10.2741/2077; Nakahata S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4393; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Noetzel E, 2012, ONCOGENE, V31, P2101, DOI 10.1038/onc.2011.403; Noetzel E, 2010, ONCOGENE, V29, P4814, DOI 10.1038/onc.2010.229; Oh SS, 2012, CARCINOGENESIS, V33, P1882, DOI 10.1093/carcin/bgs211; Okuda T, 2008, J HISTOCHEM CYTOCHEM, V56, P175, DOI 10.1369/jhc.7A7323.2007; PAGET S, 1989, CANCER METAST REV, V8, P98; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Reed AEM, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0519-x; Shen L, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2013.48; Shon SK, 2009, BIOCHEM BIOPH RES CO, V385, P198, DOI 10.1016/j.bbrc.2009.05.038; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Song SP, 2012, MED ONCOL, V29, P1879, DOI 10.1007/s12032-011-0110-y; Takeichi T, 2011, NEUROCHEM INT, V59, P21, DOI 10.1016/j.neuint.2011.03.019; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Veeck J, 2008, ONCOGENE, V27, P865, DOI 10.1038/sj.onc.1210669; Volk-Draper LD, 2012, NEOPLASIA, V14, P926, DOI 10.1593/neo.12956; Yamamura A, 2013, BIOCHEM BIOPH RES CO, V441, P102, DOI 10.1016/j.bbrc.2013.10.010; Yau C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2753; Zheng J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-251; Zheng J, 2010, ASIAN PAC J CANCER P, V11, P1817	48	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159073	10.1371/journal.pone.0159073	http://dx.doi.org/10.1371/journal.pone.0159073			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27400234	Green Submitted, gold, Green Published			2022-12-26	WOS:000379508100016
J	Yang, L; Xia, LP; Wang, Y; Hong, SD; Chen, HY; Liang, SB; Peng, PJ; Chen, Y				Yang, Lin; Xia, Liangping; Wang, Yan; Hong, Shaodong; Chen, Haiyang; Liang, Shaobo; Peng, Peijian; Chen, Yong			Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; EPSTEIN-BARR-VIRUS; NEOADJUVANT CHEMOTHERAPY; SERUM-ALBUMIN; CANCER; OUTCOMES; INFLAMMATION; CYTOKINES	Background Poor nutritional status is associated with progression and advanced disease in patients with cancer. The prognostic nutritional index (PNI) may represent a simple method of assessing host immunonutritional status. This study was designed to investigate the prognostic value of the PNI for distant metastasis-free survival (DMFS) in patients with nasopharyngeal carcinoma (NPC). Methods A training cohort of 1,168 patients with non-metastatic NPC from two institutions was retrospectively analyzed. The optimal PNI cutoff value for DMFS was identified using the online tool "Cutoff Finder". DMFS was analyzed using stratified and adjusted analysis. Propensity score-matched analysis was performed to balance baseline characteristics between the high and low PNI groups. Subsequently, the prognostic value of the PNI for DMFS was validated in an external validation cohort of 756 patients with NPC. The area under the receiver operating characteristics curve (AUC) was calculated to compare the discriminatory ability of different prognostic scores. Results The optimal PNI cutoff value was determined to be 51. Low PNI was significantly associated with poorer DMFS than high PNI in univariate analysis (P<0.001) as well as multivariate analysis (P<0.001) before propensity score matching. In subgroup analyses, PNI could also stratify different risks of distant metastases. Propensity score-matched analyses confirmed the prognostic value of PNI, excluding other interpretations and selection bias. In the external validation cohort, patients with high PNI also had significantly lower risk of distant metastases than those with low PNI (Hazards Ratios, 0.487; P<0.001). The PNI consistently showed a higher AUC value at 1-year (0.780), 3-year (0.793) and 5-year (0.812) in comparison with other prognostic scores. Conclusion PNI, an inexpensive and easily assessable inflammatory index, could aid clinicians in developing individualized treatment and follow-up strategies for patients with non-metastatic NPC.	[Yang, Lin; Xia, Liangping; Wang, Yan; Hong, Shaodong; Chen, Yong] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China; [Yang, Lin; Xia, Liangping; Wang, Yan; Hong, Shaodong; Chen, Yong] State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China; [Yang, Lin; Xia, Liangping; Wang, Yan; Hong, Shaodong; Chen, Yong] Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [Chen, Haiyang] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou, Guangdong, Peoples R China; [Liang, Shaobo] First Hosp Foshan, Foshan, Peoples R China; [Peng, Peijian] Sun Yat Sen Univ, Affiliated Hosp 5, Zhuhai, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Chen, Y (corresponding author), Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China.; Chen, Y (corresponding author), State Key Lab Oncol Southern China, Guangzhou, Guangdong, Peoples R China.; Chen, Y (corresponding author), Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	chenyong@sysucc.org.cn	Chen, Yongming/E-3656-2015	Chen, Yongming/0000-0003-2843-5543				Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Ceze N, 2011, CANCER CHEMOTH PHARM, V68, P1305, DOI 10.1007/s00280-011-1610-3; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chang ET, 2006, CANCER EPIDEM BIOMAR, V15, P1765, DOI 10.1158/1055-9965.EPI-06-0353; Chang JTC, 2005, INT J RADIAT ONCOL, V62, P501, DOI 10.1016/j.ijrobp.2004.09.057; Chaves MR, 2010, ONCOLOGIST, V15, P523, DOI 10.1634/theoncologist.2009-0283; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112581; Chen YP, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0006-x; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Guigay J, 2006, ANN ONCOL, V17, pX304, DOI 10.1093/annonc/mdl278; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Hong SD, 2015, TUMOR BIOL, V36, P3389, DOI 10.1007/s13277-014-2973-y; Ikeya T, 2015, J CANCER RES CLIN, V141, P307, DOI 10.1007/s00432-014-1799-8; Koehne CH, 2004, SEMIN ONCOL, V31, P12, DOI 10.1053/j.seminoncol.2004.03.041; Lai SZ, 2011, INT J RADIAT ONCOL, V80, P661, DOI 10.1016/j.ijrobp.2010.03.024; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Lee AWM, 2012, RADIOTHER ONCOL, V104, P272, DOI 10.1016/j.radonc.2012.08.001; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; LIEBOWITZ D, 1994, SEMIN ONCOL, V21, P376; Lien YC, 2004, J GASTROINTEST SURG, V8, P1041, DOI 10.1016/j.gassur.2004.09.033; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Migita K, 2013, ANN SURG ONCOL, V20, P2647, DOI 10.1245/s10434-013-2926-5; Okabayashi T, 2008, J GASTROEN HEPATOL, V23, P1869, DOI 10.1111/j.1440-1746.2008.05504.x; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Peerawong T, 2012, ASIAN PAC J CANCER P, V13, P5805, DOI 10.7314/APJCP.2012.13.11.5805; Qiu WZ, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-015-0076-9; ROTHSCHILD MA, 1988, HEPATOLOGY, V8, P385, DOI 10.1002/hep.1840080234; Sarmiento MPCB, 2014, CHIN J CANCER, V33, P159, DOI 10.5732/cjc.013.10010; Tang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122965; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Tsujimoto H, 2010, GASTRIC CANCER, V13, P212, DOI 10.1007/s10120-010-0568-x; Wei KR, 2014, CHIN J CANCER, V33, P381, DOI 10.5732/cjc.014.10086; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Xu LY, 2010, RADIOTHER ONCOL, V96, P94, DOI 10.1016/j.radonc.2010.04.006; Yao ZH, 2013, J CANCER RES CLIN, V139, P2117, DOI 10.1007/s00432-013-1523-0; ZHENG X, 1994, ACTA OTO-LARYNGOL, V114, P98, DOI 10.3109/00016489409126024	38	41	44	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158853	10.1371/journal.pone.0158853	http://dx.doi.org/10.1371/journal.pone.0158853			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27399281	gold, Green Submitted, Green Published			2022-12-26	WOS:000379508100011
J	Boudellioua, I; Saidi, R; Hoehndorf, R; Martin, MJ; Solovyev, V				Boudellioua, Imane; Saidi, Rabie; Hoehndorf, Robert; Martin, Maria J.; Solovyev, Victor			Prediction of Metabolic Pathway Involvement in Prokaryotic UniProtKB Data by Association Rule Mining	PLOS ONE			English	Article							ANNOTATION; ALGORITHM	The widening gap between known proteins and their functions has encouraged the development of methods to automatically infer annotations. Automatic functional annotation of proteins is expected to meet the conflicting requirements of maximizing annotation coverage, while minimizing erroneous functional assignments. This trade-off imposes a great challenge in designing intelligent systems to tackle the problem of automatic protein annotation. In this work, we present a system that utilizes rule mining techniques to predict metabolic pathways in prokaryotes. The resulting knowledge represents predictive models that assign pathway involvement to UniProtKB entries. We carried out an evaluation study of our system performance using cross-validation technique. We found that it achieved very promising results in pathway identification with an F-1-measure of 0.982 and an AUC of 0.987. Our prediction models were then successfully applied to 6.2 million UniProtKB/TrEMBL reference proteome entries of prokaryotes. As a result, 663,724 entries were covered, where 436,510 of them lacked any previous pathway annotations.	[Boudellioua, Imane; Hoehndorf, Robert] KAUST, Comp Elect & Math Sci & Engn Div CEMSE, CBRC, Thuwal, Saudi Arabia; [Saidi, Rabie; Martin, Maria J.] European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England; [Solovyev, Victor] Softberry Inc, 116 Radio Circle,Suite 400, Mt Kisco, NY 10549 USA	King Abdullah University of Science & Technology; European Molecular Biology Laboratory (EMBL)	Saidi, R (corresponding author), European Bioinformat Inst EMBL EBI, European Mol Biol Lab, Cambridge, England.	rsaidi@ebi.ac.uk	Boudellioua, Imane/AAG-1041-2019; Hoehndorf, Robert/H-6127-2019; Martín, María/HDL-9512-2022; Hoehndorf, Robert/A-9943-2011; Solovyev, Victor/C-4614-2013	Hoehndorf, Robert/0000-0001-8149-5890; Hoehndorf, Robert/0000-0001-8149-5890; Martin, Maria-Jesus/0000-0001-5454-2815; Solovyev, Victor/0000-0001-8885-493X; Saidi, Rabie/0000-0002-0449-5253	King Abdullah University of Science and Technology; BBSRC [BB/N004876/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/N004876/1] Funding Source: researchfish	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	IB, RH and VS were supported by funding provided by the King Abdullah University of Science and Technology.	Agrawal R., 1994, VLDB, P487, DOI DOI 10.1007/BF02948845; Agrawal R., 1994, P 20 INT C VER LARG, P487; Artamonova II, 2005, BIOINFORMATICS, V21, P49, DOI 10.1093/bioinformatics/bti1206; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Bebek G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-335; Biswas Margaret, 2002, Brief Bioinform, V3, P285, DOI 10.1093/bib/3.3.285; Bodenreider O, 2005, P PAC S BIOC, P104; Borgelt C, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P395; Borgelt C., 2004, CEUR WORKSHOP P, V126; Borgelt C., 2003, P FIMI IEEE ICDM WOR; BOUKER S, 2012, IEEE 24 INT C TOOLS, P658, DOI DOI 10.1109/ICTAI.2012.94; Bouker S, 2014, INT J ARTIF INTELL T, V23, DOI 10.1142/S0218213014600112; Brin S., 1997, SIGMOD REC, P265, DOI [DOI 10.1145/253262.253327, 10.1145/253260.253327]; Button WG, 2003, J CHEM INF COMP SCI, V43, P1371, DOI 10.1021/ci0202739; Campbell NA, 2002, BIOLOGY, V1; Chen XJ, 2011, BIOINFORMATICS, V27, P649, DOI 10.1093/bioinformatics/btq714; Chen Y, 2009, AM J PATHOL, V175, P2676, DOI 10.2353/ajpath.2009.080945; Chibucos MC, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau075; Chiu SH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-304; Creighton C, 2003, BIOINFORMATICS, V19, P79, DOI 10.1093/bioinformatics/19.1.79; Dale JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-15; Hou BK, 2004, J IND MICROBIOL BIOT, V31, P261, DOI 10.1007/s10295-004-0144-7; Jaworska J, 2002, SAR QSAR ENVIRON RES, V13, P307, DOI 10.1080/10629360290002794; Karp PD, 2011, STAND GENOMIC SCI, V5, P424, DOI 10.4056/sigs.1794338; Kirsch A, 2009, PODS'09: PROCEEDINGS OF THE TWENTY-EIGHTH ACM SIGMOD-SIGACT-SIGART SYMPOSIUM ON PRINCIPLES OF DATABASE SYSTEMS, P117, DOI 10.1145/1559795.1559814; Klopman G, 1997, J CHEM INF COMP SCI, V37, P329, DOI 10.1021/ci9601123; Kretschmann E, 2001, BIOINFORMATICS, V17, P920, DOI 10.1093/bioinformatics/17.10.920; Moller S, 1999, BIOINFORMATICS, V15, P219, DOI 10.1093/bioinformatics/15.3.219; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; National Human Genome Research Institute, BIOL PATHW; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pedruzzi I, 2013, NUCLEIC ACIDS RES, V41, pD584, DOI 10.1093/nar/gks1157; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Silberberg Y, 2012, J COMPUT BIOL, V19, P163, DOI 10.1089/cmb.2011.0264; Wu CH, 2002, NUCLEIC ACIDS RES, V30, P35, DOI 10.1093/nar/30.1.35	35	10	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158896	10.1371/journal.pone.0158896	http://dx.doi.org/10.1371/journal.pone.0158896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390860	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400155
J	Delaney, JR; Stupack, DG				Delaney, Joe Ryan; Stupack, Dwayne G.			Whole Genome Pathway Analysis Identifies an Association of Cadmium Response Gene Loss with Copy Number Variation in Mutant p53 Bearing Uterine Endometrial Carcinomas	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; MUTATIONAL LANDSCAPE; CARBONIC-ANHYDRASE; METALLOTHIONEIN 1A; CANCER GENOMICS; AUTOPHAGY GENE; MESSENGER-RNA; STRAND BREAKS; COMPLEX; CELLS	Background Massive chromosomal aberrations are a signature of advanced cancer, although the factors promoting the pervasive incidence of these copy number alterations (CNAs) are poorly understood. Gatekeeper mutations, such as p53, contribute to aneuploidy, yet p53 mutant tumors do not always display CNAs. Uterine Corpus Endometrial Carcinoma (UCEC) offers a unique system to begin to evaluate why some cancers acquire high CNAs while others evolve another route to oncogenesis, since about half of p53 mutant UCEC tumors have a relatively flat CNA landscape and half have 20-90% of their genome altered in copy number. Methods We extracted copy number information from 68 UCEC genomes mutant in p53 by the GIS-TIC2 algorithm. GO term pathway analysis, via GOrilla, was used to identify suppressed pathways. Genes within these pathways were mapped for focal or wide distribution. Deletion hotspots were evaluated for temporal incidence. Results Multiple pathways contributed to the development of pervasive CNAs, including developmental, metabolic, immunological, cell adhesion and cadmium response pathways. Surprisingly, cadmium response pathway genes are predicted as the earliest loss events within these tumors: in particular, the metallothionein genes involved in heavy metal sequestration. Loss of cadmium response genes were associated with copy number changes and poorer prognosis, contrasting with 'copy number flat' tumors which instead exhibited substantive mutation. Conclusion Metallothioneins are lost early in the development of high CNA endometrial cancer, providing a potential mechanism and biological rationale for increased incidence of endometrial cancer with cadmium exposure. Developmental and metabolic pathways are altered later in tumor progression.	[Delaney, Joe Ryan; Stupack, Dwayne G.] Rebecca & John UCSD Moores Canc Ctr, Div Gynecol Oncol, Dept Reprod Med, La Jolla, CA USA		Stupack, DG (corresponding author), Rebecca & John UCSD Moores Canc Ctr, Div Gynecol Oncol, Dept Reprod Med, La Jolla, CA USA.	dstupack@ucsd.edu			NCI grants [CA107263, T32CA121938]	NCI grants	This work was supported by NCI grants CA107263 (DGS) and T32CA121938 (JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JU, 2015, NATURE, V527, pS108, DOI 10.1038/527S108a; Adams SV, 2014, ENVIRON HEALTH PERSP, V122, P594, DOI 10.1289/ehp.1307054; Akesson A, 2008, CANCER RES, V68, P6435, DOI 10.1158/0008-5472.CAN-08-0329; Apostolova MD, 2006, TOXICOL SCI, V89, P465, DOI 10.1093/toxsci/kfj035; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Burke WM, 2014, GYNECOL ONCOL, V134, P393, DOI 10.1016/j.ygyno.2014.06.003; Cho YA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0075087, 10.1371/journal.pone.0081560]; Choe H, 2002, J MOL BIOL, V324, P691, DOI 10.1016/S0022-2836(02)01131-2; Cline MS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02652; Coddou C, 2005, TOXICOL APPL PHARM, V202, P121, DOI 10.1016/j.taap.2004.06.015; Davoli T, 2013, CELL, V155, P948, DOI 10.1016/j.cell.2013.10.011; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eriksen KT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100815; Fogal V, 2010, MOL CELL BIOL, V30, P1303, DOI 10.1128/MCB.01101-09; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; GOERING PL, 1984, TOXICOL APPL PHARM, V74, P321, DOI 10.1016/0041-008X(84)90285-0; Guyot E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142590; Haldsrud R, 2009, J TOXICOL ENV HEAL A, V72, P155, DOI 10.1080/15287390802538964; Hartwig A, 2013, METAL IONS LIFE SCI, V11, P491, DOI 10.1007/978-94-007-5179-8_15; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kawano Y, 2011, GYNECOL OBSTET INVES, V71, P240, DOI 10.1159/000319615; Klaassen CD, 2009, TOXICOL APPL PHARM, V238, P215, DOI 10.1016/j.taap.2009.03.026; Kladney RD, 2010, CANCER RES, V70, P8937, DOI 10.1158/0008-5472.CAN-10-1646; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Larson J, 2010, TOXICOL LETT, V199, P166, DOI 10.1016/j.toxlet.2010.08.020; LEE MJ, 1995, ARCH TOXICOL, V69, P590, DOI 10.1007/s002040050218; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; LITTEFIELD NA, 1994, CELL BIOL TOXICOL, V10, P127, DOI 10.1007/BF00756493; Liu XQ, 2009, CANCER LETT, V286, P217, DOI 10.1016/j.canlet.2009.05.030; Liu Y, 2013, J CELL PHYSIOL, V228, P78, DOI 10.1002/jcp.24108; Liu Y, 2016, NATURE, V531, P471, DOI 10.1038/nature17157; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; NATARAJAN AT, 1993, MUTAT RES, V287, P113, DOI 10.1016/0027-5107(93)90150-E; Nordberg M, 2000, CELL MOL BIOL, V46, P451; Pinter TBJ, 2015, BIOCHEM J, V471, P347, DOI 10.1042/BJ20150676; Pinter TBJ, 2014, BIOCHEMISTRY-US, V53, P6276, DOI 10.1021/bi5008673; Prickett TD, 2014, J INVEST DERMATOL, V134, P2390, DOI 10.1038/jid.2014.190; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Quintas-Cardama A, 2009, BLOOD, V113, P1619, DOI 10.1182/blood-2008-03-144790; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rampias T, 2014, NAT MED, V20, P1199, DOI 10.1038/nm.3678; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sadik NAH, 2008, J BIOCHEM MOL TOXIC, V22, P345, DOI 10.1002/jbt.20247; SHIMADA T, 1976, MUTAT RES, V40, P389, DOI 10.1016/0165-1218(76)90038-0; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wang Z, 1996, TOXICOL APPL PHARM, V139, P115, DOI 10.1006/taap.1996.0149; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Xue W, 2012, P NATL ACAD SCI USA, V109, P8212, DOI 10.1073/pnas.1206062109; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang XF, 2013, MOL CELL PROTEOMICS, V12, P3199, DOI 10.1074/mcp.M113.029413; Zhu J, 2007, CANCER CELL, V12, P23, DOI 10.1016/j.ccr.2007.06.004	62	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159114	10.1371/journal.pone.0159114	http://dx.doi.org/10.1371/journal.pone.0159114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391266	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400211
J	Ding, XL; Hu, J; Zhang, HY; Xu, YX				Ding, Xiaolin; Hu, Jin; Zhang, Hanying; Xu, Yinxue			Genetic Variants in the STMN1 Transcriptional Regulatory Region Affect Promoter Activity and Fear Behavior in English Springer Spaniels	PLOS ONE			English	Article							SCG10 MESSENGER-RNA; PHYLOGENETIC CONSERVATION; STARTLING STIMULI; STATHMIN FAMILY; BINDING LECTIN; ADULT-RAT; PROTEIN; EXPRESSION; AMYGDALA; ANXIETY	Stathmin 1 (STMN1) is a neuronal growth-associated protein that is involved in microtubule dynamics and plays an important role in synaptic outgrowth and plasticity. Given that STMN1 affects fear behavior, we hypothesized that genetic variations in the STMN1 transcriptional regulatory region affect gene transcription activity and control fear behavior. In this study, two single nucleotide polymorphisms (SNPs), g.-327A > Gand g.-125C > T, were identified in 317 English Springer Spaniels. A bioinformatics analysis revealed that both were loci located in the canine STMN1 putative promoter region and affected transcription factor binding. A statistical analysis revealed that the TT genotype at g.-125C > T produced a significantly greater fear level than that of the CC genotype (P < 0.05). Furthermore, the H4H4 (GTGT) haplotype combination was significantly associated with canine fear behavior (P < 0.01). Using serially truncated constructs of the STMN1 promoters and the luciferase reporter, we found that a 395 bp (-312 nt to + 83 nt) fragment constituted the core promoter region. The luciferase assay also revealed that the H4 (GT) haplotype promoter had higher activity than that of other haplotypes. Overall, our results suggest that the two SNPs in the canine STMN1 promoter region could affect canine fear behavior by altering STMN1 transcriptional activity.	[Ding, Xiaolin; Hu, Jin; Xu, Yinxue] Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China; [Zhang, Hanying] Nanjing Sanhome Pharmaceut Co LTD, Dept Pharmacol, R&D Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Xu, YX (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Dept Anim Genet Breeding & Reprod, Nanjing, Jiangsu, Peoples R China.	xuyinxue@njau.edu.cn						Alanentalo T, 2006, GENE EXPR PATTERNS, V6, P162, DOI 10.1016/j.modgep.2005.06.012; Alcaidinho J, 2014, NORD C HUM COMP INT; Araujo JA, 2013, J VET BEHAV, V8, P204, DOI 10.1016/j.jveb.2012.10.008; Banham AH, 2001, CANCER RES, V61, P8820; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Brauer AU, 2001, NEUROSCIENCE, V102, P515, DOI 10.1016/S0306-4522(00)00471-1; Brocke B, 2010, AM J MED GENET B, V153B, P243, DOI 10.1002/ajmg.b.30989; Capparelli R, 2008, IMMUNOGENETICS, V60, P157, DOI 10.1007/s00251-008-0284-4; Chorley BN, 2008, MUTAT RES-REV MUTAT, V659, P147, DOI 10.1016/j.mrrev.2008.05.001; Conley MJ, 2014, APPL ANIM BEHAV SCI, V156, P62, DOI 10.1016/j.applanim.2014.03.008; Ehlis AC, 2011, AM J MED GENET B, V156B, P291, DOI 10.1002/ajmg.b.31161; Fallin D, 2001, GENOME RES, V11, P143, DOI 10.1101/gr.148401; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fu Y, 2014, ANIM GENET, V45, P373, DOI 10.1111/age.12148; GODDARD ME, 1985, BEHAV GENET, V15, P69, DOI 10.1007/BF01071933; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; Hafler BP, 2008, BRAIN RES, V1222, P42, DOI 10.1016/j.brainres.2008.04.072; Hayashi K, 2006, J NEUROCHEM, V99, P237, DOI 10.1111/j.1471-4159.2006.04113.x; HOSHINO S, 1992, HUM IMMUNOL, V33, P98, DOI 10.1016/0198-8859(92)90059-V; Hu J, 2015, GENE, V574, P204, DOI 10.1016/j.gene.2015.08.008; Hydbring-Sandberg E, 2004, J ENDOCRINOL, V180, P439, DOI 10.1677/joe.0.1800439; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; JONES RB, 1992, ANIM BEHAV, V43, P1021, DOI 10.1016/0003-3472(92)90015-2; King T, 2003, APPL ANIM BEHAV SCI, V82, P45, DOI 10.1016/S0168-1591(03)00040-6; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; Ley J, 2007, APPL ANIM BEHAV SCI, V104, P71, DOI 10.1016/j.applanim.2006.03.021; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Madsen HO, 1998, J IMMUNOL, V161, P3169; Martel G, 2008, P NATL ACAD SCI USA, V105, P14620, DOI 10.1073/pnas.0807507105; Martel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030942; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; Morrow M, 2015, J VET BEHAV, V10, P286, DOI 10.1016/j.jveb.2015.03.002; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Pan Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058795; PESCHANSKI M, 1993, J COMP NEUROL, V337, P655, DOI 10.1002/cne.903370410; Radosta-Huntley L, 2007, APPL ANIM BEHAV SCI, V105, P330, DOI 10.1016/j.applanim.2006.11.005; Ruefenacht S, 2002, APPL ANIM BEHAV SCI, V79, P113, DOI 10.1016/S0168-1591(02)00134-X; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; Stephenson AH, 2006, LIFE SCI, V79, P1221, DOI 10.1016/j.lfs.2006.03.042; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Tiira K, 2014, APPL ANIM BEHAV SCI, V155, P82, DOI 10.1016/j.applanim.2014.03.007; van den Berg L, 2004, GENE, V326, P131, DOI 10.1016/j.gene.2003.10.028; Walczak M, 2014, J VET BEHAV, V6, pe13; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Wang YL, 1999, J BIOL CHEM, V274, P22095, DOI 10.1074/jbc.274.31.22095; Wang YL, 2001, BIOCHEM J, V355, P45, DOI 10.1042/0264-6021:3550045; Wilsson E, 1998, APPL ANIM BEHAV SCI, V58, P151, DOI 10.1016/S0168-1591(97)00093-2; Wilsson E, 2012, APPL ANIM BEHAV SCI, V141, P158, DOI 10.1016/j.applanim.2012.08.012; Yu SG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131572; Zhang LN, 2015, BIOMED REP, V3, P28, DOI 10.3892/br.2014.386; Zovkic IB, 2013, NEUROPSYCHOPHARMACOL, V38, P77, DOI 10.1038/npp.2012.79	57	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158756	10.1371/journal.pone.0158756	http://dx.doi.org/10.1371/journal.pone.0158756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390866	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400116
J	Hu, KM; Lou, LX; Tian, W; Pan, T; Ye, J; Zhang, SZ				Hu, Kaimin; Lou, Lixia; Tian, Wei; Pan, Tao; Ye, Juan; Zhang, Suzhan			The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment	PLOS ONE			English	Article							MORTALITY-RATES; PATTERNS	Breast cancer is a worldwide threat to female health with patient outcomes varying widely. The exact correlation between global outcomes of breast cancer and the national socioeconomic status is still undetermined. Mortality-to-incidence ratio (MIR) of breast cancer was calculated with the contemporary age standardized incidence and mortality rates for countries with data available at GLOBOCAN 2012 database. The MIR matched national human development indexes (HDIs) and health system attainments were respectively obtained from Human Development Report and World Health Report. Correlation analysis, regression analysis, and Tukey-Kramer post hoc test were used to explore the effects of HDI and health system attainment on breast cancer MIR. Our results demonstrated that breast cancer MIR was inversely correlated with national HDI (r = -.950; P < .001) and health system attainment (r = -.898; P < .001). Countries with very high HDI had significantly lower MIRs than those with high, medium and low HDI (P < .001). Liner regression model by ordinary least squares also indicated negative effects of both HDI (adjusted R-2 = .903, standardize beta = -.699, P < .001) and health system attainment (adjusted R-2 = .805, standardized beta = -.009; P < .001), with greater effects in developing countries identified by quantile regression analysis. It is noteworthy that significant health care disparities exist among countries in accordance with the discrepancy of HDI. Policies should be made in less developed countries, which are more likely to obtain worse outcomes in female breast cancer, that in order to improve their comprehensive economic strength and optimize their health system performance.	[Hu, Kaimin; Tian, Wei; Pan, Tao; Zhang, Suzhan] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Inst Canc, Hangzhou, Zhejiang, Peoples R China; [Lou, Lixia; Ye, Juan] Zhejiang Univ, Coll Med, Affiliated Hosp 2, Dept Ophthalmol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zhang, SZ (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 2, Inst Canc, Hangzhou, Zhejiang, Peoples R China.	zhangscy@tom.com			Zhejiang Provincial Natural Science Foundation of China [LQ13H160015, LQ14H160010]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The work was supported by Zhejiang Provincial Natural Science Foundation of China (LQ13H160015 and LQ14H160010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Corbex M, 2014, EUR J CANCER, V50, P1808, DOI 10.1016/j.ejca.2014.03.016; Coughlin SS, 2009, CANCER EPIDEMIOL, V33, P315, DOI 10.1016/j.canep.2009.10.003; de Kruijf EM, 2014, MOL ONCOL, V8, P1014, DOI 10.1016/j.molonc.2014.03.022; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; El Mistiri M, 2015, ANN EPIDEMIOLOGY; GLOBOCAN, 2012, EST CANC INC MORT PR; Gonzaga CMR, 2014, BREAST, V23, P180, DOI 10.1016/j.breast.2014.01.006; Institute NC, 1975, SEER CANC STAT REV; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kantelhardt EJ, 2015, CURR OPIN OBSTET GYN, V27, P108, DOI 10.1097/GCO.0000000000000139; Katzke VA, 2015, CANCER J, V21, P104, DOI 10.1097/PPO.0000000000000101; KOENKER R, 1978, ECONOMETRICA, V46, P33, DOI 10.2307/1913643; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Pace LE, 2014, JAMA-J AM MED ASSOC, V311, P1327, DOI 10.1001/jama.2014.1398; Patel AR, 2012, J UROLOGY, V187, P1978, DOI 10.1016/j.juro.2012.01.121; PINNEAU SR, 1966, PERCEPT MOTOR SKILL, V23, P1209, DOI 10.2466/pms.1966.23.3f.1209; Programme UND, HUM DEV REP 2013 RIS; ROSENTHAL R, 1968, PSYCHOL REP, V22, P570, DOI 10.2466/pr0.1968.22.2.570; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Swan J, 2003, CANCER, V97, P1528, DOI 10.1002/cncr.11208; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; TUKEY JW, 1949, BIOMETRICS, V5, P99, DOI 10.2307/3001913; Vostakolaei FA, 2011, EUR J PUBLIC HEALTH, V21, P573, DOI 10.1093/eurpub/ckq120; World Health Organization, 2000, WORLD HLTH REP 2000	30	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158951	10.1371/journal.pone.0158951	http://dx.doi.org/10.1371/journal.pone.0158951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391077	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400170
J	Lee, JE; Yang, HK; Hwang, JM				Lee, Ji Eun; Yang, Hee Kyung; Hwang, Jeong-Min			Surgical Outcomes of Inferior Oblique Myectomy in Unilateral Congenital Superior Oblique Palsy with or without Trochlear Nerve	PLOS ONE			English	Article							MUSCLE MYECTOMY; RECESSION; SURGERY	Objectives To compare the surgical outcomes of inferior oblique (IO) myectomy in congenital superior oblique palsy (SOP) according to the presence of the trochlear nerve identified with high-resolution MRI. Data Extraction Forty-one congenital SOP patients without a trochlear nerve (absent group) and 23 patients with a trochlear nerve (present group) who underwent IO myectomy as the primary surgical treatment were retrospectively reviewed. "Motor success" was defined as postoperative ipsilateral hypertropia <= 4 prism diopter (PD). "Head tilt improvement" was regarded as postoperative angle of head tilt < 5 degrees (degrees). Success rates for motor alignment and head tilt improvement, cumulative probabilities of success, and factors influencing surgical responses were evaluated. Results The cumulative probabilities of motor success at 2 years after IO myectomy were 92% in patients with a trochlear nerve and 86% in patients without a trochlear nerve (P = 0.138). The cumulative probabilities of undercorrection and recurrence of hypertropia after 2 years were 0% in the present group versus 21% in the absent group (P = 0.014). The cumulative probabilities of persistent head tilt after 2 years were 14% in the present group and 20% in the absent group (P = 0.486). A younger age at operation was associated with reduced probabilities of motor success and head tilt improvement (P = 0.009, P = 0.022 respectively). A greater preoperative angle of head tilt was associated with persistent head tilt after surgery (P = 0.038). Conclusions Congenital SOP without a trochlear nerve had a higher risk of hypertropia undercorrection after IO myectomy compared to patients with a trochlear nerve. A younger age at operation and larger preoperative head tilt was related to poor outcomes.	[Lee, Ji Eun; Yang, Hee Kyung; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea	Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Ophthalmol, Seongnam, South Korea.	hjm@snu.ac.kr						Ashishi M, 1999, CLIN STRABISMUS MANA, P19; Bahl RS, 2013, BRIT J OPHTHALMOL, V97, P184, DOI 10.1136/bjophthalmol-2012-301485; Caca I, 2012, J PEDIAT OPHTH STRAB, V49, P103, DOI 10.3928/01913913-20110628-01; Choi BS, 2010, AM J NEURORADIOL, V31, P1076, DOI 10.3174/ajnr.A1992; De Angelis D, 1999, AM J OPHTHALMOL, V128, P485, DOI 10.1016/S0002-9394(99)00225-1; ELLIS F D, 1976, International Ophthalmology Clinics, V16, P127, DOI 10.1097/00004397-197601630-00012; Ellis FJ, 1998, OPHTHALMOLOGY, V105, P544, DOI 10.1016/S0161-6420(98)93041-X; Ghazawy S, 2007, J AAPOS, V11, P601, DOI 10.1016/j.jaapos.2007.06.011; GUYTON DL, 1981, OPHTHALMOLOGY, V88, P1035; Helveston E M, 1996, Trans Am Ophthalmol Soc, V94, P315; Isenberg SJ, 1999, CLIN STRABISMUS MANA, P453; Khawam E, 2000, Binocul Vis Strabismus Q, V15, P331; Kim JH, 2012, GRAEF ARCH CLIN EXP, V250, P151, DOI 10.1007/s00417-010-1580-x; Kim JH, 2010, OPHTHALMOLOGY, V117, P2208, DOI 10.1016/j.ophtha.2010.02.017; Kim JH, 2010, BRIT J OPHTHALMOL, V94, P346, DOI 10.1136/bjo.2009.161398; Knapp P, 1971, Am Orthopt J, V21, P29; KNAPP P, 1976, International Ophthalmology Clinics, V16, P137, DOI 10.1097/00004397-197601630-00013; Kushner BJ, 2009, J AAPOS, V13, P132, DOI 10.1016/j.jaapos.2008.10.012; Lau FHS, 2009, BRIT J OPHTHALMOL, V93, P1616, DOI 10.1136/bjo.2008.156687; Lee DS, 2014, INVEST OPHTH VIS SCI, V55, P8571, DOI 10.1167/iovs.14-15323; Maruo T, 1996, JPN J OPHTHALMOL, V40, P235; Molinari A, 2009, J AAPOS, V13, P571, DOI 10.1016/j.jaapos.2009.08.015; Muchnick R S, 1998, J AAPOS, V2, P340, DOI 10.1016/S1091-8531(98)90031-3; REYNOLDS JD, 1984, ARCH OPHTHALMOL-CHIC, V102, P1503; Scott W E, 1986, Trans New Orleans Acad Ophthalmol, V34, P15; Shipman T, 2003, EYE, V17, P1013, DOI 10.1038/sj.eye.6700488; Simons B D, 1998, Binocul Vis Strabismus Q, V13, P273; TOOSI SH, 1979, AM J OPHTHALMOL, V88, P602, DOI 10.1016/0002-9394(79)90522-1; Yang HK, 2012, OPHTHALMOLOGY, V119, P170, DOI 10.1016/j.ophtha.2011.06.038; Yanyali A, 2001, Strabismus, V9, P83, DOI 10.1076/stra.9.2.83.702; 안재환, 2010, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V51, P76	31	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0156872	10.1371/journal.pone.0156872	http://dx.doi.org/10.1371/journal.pone.0156872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391445	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400005
J	Li, JL; Zhou, P; Li, L; Zhang, Y; Shao, Y; Tang, L; Tian, SM				Li, Jiale; Zhou, Ping; Li, Lan; Zhang, Yan; Shao, Yang; Tang, Li; Tian, Shuangming			Effects of Cationic Microbubble Carrying CD/TK Double Suicide Gene and alpha(V)beta(3) Integrin Antibody in Human Hepatocellular Carcinoma HepG2 Cells	PLOS ONE			English	Article							IN-VIVO; ULTRASOUND DESTRUCTION; NEUTRAL MICROBUBBLES; CANCER-THERAPY; DELIVERY; ANGIOGENESIS; TRANSFECTION; LIVER; APOPTOSIS; DISEASES	Objective Hepatocellular carcinoma (HCC), mostly derived from hepatitis or cirrhosisis, is one of the most common types of liver cancer. T-cell mediated immune response elicited by CD/TK double suicide gene has shown a substantial antitumor effect in HCC. Integrin alpha(V)beta(3) over expresssion has been suggested to regulate the biology behavior of HCC. In this study, we investigated the strategy of incorporating CD/TK double suicide gene and anti-alpha(V)beta(3) integrin monoclonal antibodies into cationic microbubbles (CMBs(alpha v beta 3)), and evaluated its killing effect in HCC cells. Methods To improve the transfection efficiency of targeted CD/TK double suicide gene, we adopted cationic microbubbles (CMBs), a cationic delivery agent with enhanced DNA-carrying capacity. The ultrasound and high speed shearing method was used to prepare the non-targeting cationic microbubbles (CMBs). Using the biotin-avidin bridge method, alpha(V)beta(3) integrin antibody was conjugated to CMBs, and CMBs(av beta 3) was generated to specifically target to HepG2 cells. The morphology and physicochemical properties of the CMBs(alpha v beta 3) was detected by optical microscope and zeta detector. The conjugation of plasmid and the antibody in CMBs(alpha v beta 3) were examined by immunofluorescent microscopy and flow cytometry. The binding capacities of CMBs(alpha v beta 3) and CMBs to HCC HepG2 and normal L-02 cells were compared using rosette formation assay. To detect EGFP fluorescence and examine the transfection efficiencies of CMBs(alpha v beta 3) and CMBs in HCC cells, fluorescence microscope and contrast-enhanced sonography were adopted. mRNA and protein level of CD/TK gene were detected by RT-PCR and Western blot, respectively. To evaluate the anti-tumor effect of CMBs(alpha v beta 3), HCC cells with CMBs(alpha v beta 3) were exposed to 5-flurocytosine / ganciclovir (5-FC/GCV). Then, cell cycle distribution after treatment were detected by PI staining and flow cytometry. Apoptotic cells death were detected by optical microscope and assessed by MTT assay and TUNEL-staining assay. Results CMBs(alpha v beta 3) had a regular shape and good dispersion. Compared to CMBs, CMBs(alpha v beta 3) had more stable concentrations of alpha(V)beta(3) ligand and pEGFP-KDRP-CD/TK, and CMBs(alpha v beta 3) was much sticker to HepG2 HCC cells than normal liver L-02cells. Moreover, after exposed to anti-alpha(V)beta(3) monoclonal antibody, the adhesion of CMBs(alpha v beta 3) to HepG2 cells and L-02 cells were significantly reduced. Also, CMBs(alpha v beta 3) demonstrated a substantially higher efficiency in pEGFP-KDRP-CD/TK plasmid transfection in HepG2 cells than CMBs. In addition, CMBs(alpha v beta 3) could significantly facilitate 5-FC/GCV-induced cell cycle arrest in S phase. Moreover, treatment of 5-FC/GCV combined with CMBs(alpha v beta 3) resulted in a marked apoptotic cell death in HepG2 and SK-Herp-1 HCC cells. In vitro, treatment of 5-FC/GCV combined with CMBs(alpha v beta 3) suppresed cell proliferation. In nude mice model, 5-FU + GCV combined with plasmid + CMBs(alpha v beta 3) were able to significantly suppress tumor volumes. Conclusion Through biotin-avidinmediation system, CMBs(alpha v beta 3) were successfully generated to specifically target HCC HepG2 cells. More importantly, CMBs(alpha v beta 3) could significantly facilitate 5-FC/GCV-induced cell cycle arrest and apoptotic cell death in HepG2 cells. Our study demonstrated a potential strategy that could be translated clinically to improve liver tumor gene delivery.	[Li, Jiale; Zhou, Ping; Li, Lan; Zhang, Yan; Shao, Yang; Tian, Shuangming] Cent S Univ, Xiangya Hosp 3, Dept Ultrasound, Changsha, Hunan, Peoples R China; [Tang, Li] Corp Pk Doral, MDFLOW Syst, Doral, FL USA	Central South University	Zhou, P (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Ultrasound, Changsha, Hunan, Peoples R China.	zhouping1000@hotmail.com	li, jia/GVT-7587-2022		National Natural Science Foundation of China [81271680]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from National Natural Science Foundation of China (81271680) and PZ received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our work was funded by a grant from National Natural Science Foundation of China (81271680) and PingZhou received the funding.And PingZhou was the person making decisions to publish.	Barry MA, 2009, CURR OPIN MOL THER, V11, P411; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chang SF, 2013, ULTRASON SONOCHEM, V20, P171, DOI 10.1016/j.ultsonch.2012.06.015; Christiansen JP, 2003, ULTRASOUND MED BIOL, V29, P1759, DOI 10.1016/S0301-5629(03)00976-1; Cui K, 2014, DNA CELL BIOL, V33, P301, DOI 10.1089/dna.2013.2229; Fujii H, 2011, EUR HEART J, V32, P2075, DOI 10.1093/eurheartj/ehq475; Gao Feng, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P1255; Gao Y, 2011, INT J NANOMED, V6, P1017, DOI 10.2147/IJN.S17040; Hu ZY, 2008, INT J CANCER, V123, P2418, DOI 10.1002/ijc.23752; Kluza E, 2010, NANO LETT, V10, P52, DOI 10.1021/nl902659g; Kojima Y, 2009, J SURG RES, V157, pE63, DOI 10.1016/j.jss.2008.12.016; Li QM, 2002, WORLD J GASTROENTERO, V8, P994; Li XH, 2012, ULTRASONICS, V52, P186, DOI 10.1016/j.ultras.2011.08.002; Lindner JR, 2000, CIRCULATION, V102, P2745, DOI 10.1161/01.CIR.102.22.2745; Panje CM, 2012, THERANOSTICS, V2, P1078, DOI 10.7150/thno.4240; Phillips LC, 2010, J VASC RES, V47, P270, DOI 10.1159/000258905; Pralhad T, 2003, J PHARM PHARMACOL, V55, P1045, DOI 10.1211/0022357021819; Sheldrake HM, 2009, CURR CANCER DRUG TAR, V9, P519, DOI 10.2174/156800909788486713; Song S, 2011, GENE THER, V18, P1006, DOI 10.1038/gt.2011.34; Sun L, 2013, BIOMATERIALS, V34, P2107, DOI 10.1016/j.biomaterials.2012.11.041; Suzuki J, 2010, J AM COLL CARDIOL, V55, P904, DOI 10.1016/j.jacc.2009.09.054; Touraine RL, 1998, HUM GENE THER, V9, P2385, DOI 10.1089/hum.1998.9.16-2385; Vassaux G, 2004, EXPERT OPIN BIOL TH, V4, P519; Villanueva FS, 1998, CIRCULATION, V98, P1, DOI 10.1161/01.CIR.98.1.1; Vongchan P, 2011, ANTICANCER RES, V31, P4067; Wang DS, 2012, RADIOLOGY, V264, P721, DOI 10.1148/radiol.12112368; Wei KR, 2014, CHIN J CANCER, V33, P388, DOI 10.5732/cjc.014.10088; Willmann JK, 2008, RADIOLOGY, V248, P936, DOI 10.1148/radiol.2483072231; Xu G, 2001, CLIN CANCER RES, V7, P3314	30	12	17	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158592	10.1371/journal.pone.0158592	http://dx.doi.org/10.1371/journal.pone.0158592			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391603	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400084
J	Petrushanko, IY; Lobachev, VM; Kononikhin, AS; Makarov, AA; Devred, F; Kovacic, H; Kubatiev, AA; Tsvetkov, PO				Petrushanko, Irina Yu; Lobachev, Vladimir M.; Kononikhin, Alexey S.; Makarov, Alexander A.; Devred, Francois; Kovacic, Herve; Kubatiev, Aslan A.; Tsvetkov, Philipp O.			Oxidation of Ca2+-Binding Domain of NADPH Oxidase 5 (NOX5): Toward Understanding the Mechanism of Inactivation of NOX5 by ROS	PLOS ONE			English	Article							METHIONINE RESIDUES; TARGET-SITE; CALMODULIN; BINDING; CALCIUM; PROTEIN; ANTIOXIDANTS; CALORIMETRY; PEPTIDE; DISEASE	NOX5 protein, one of the most active generators of reactive oxygen species (ROS), plays an important role in many processes, including regulation of cell growth, death and differentiation. Because of its central role in ROS generation, it needs to be tightly regulated to guarantee cellular homeostasis. Contrary to other members of NADPH-oxidases family, NOX5 has its own regulatory calcium-binding domain and thus could be activated directly by calcium ions. While several mechanisms of activation have been described, very little is known about the mechanisms that could prevent the overproduction of ROS by NOX5. In the present study using calorimetric methods and circular dichroism we found that oxidation of cysteine and methionine residues of NOX5 decreases binding of Ca2+ ions and perturbs both secondary and tertiary structure of protein. Our data strongly suggest that oxidation of calcium-binding domain of NOX5 could be implicated in its inactivation, serving as a possible defense mechanism against oxidative stress.	[Petrushanko, Irina Yu; Lobachev, Vladimir M.; Makarov, Alexander A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Vavilov St 32, Moscow 119991, Russia; [Kononikhin, Alexey S.] Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Moscow Region, Russia; [Devred, Francois; Kovacic, Herve; Tsvetkov, Philipp O.] Aix Marseille Univ, INSERM, UMR S CRO2 911, Fac Pharm, F-13385 Marseille, France; [Kubatiev, Aslan A.; Tsvetkov, Philipp O.] RAMS, Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Moscow Institute of Physics & Technology; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Russian Academy of Medical Sciences; Institute of General Pathology & Pathophysiology, RAMS	Tsvetkov, PO (corresponding author), Aix Marseille Univ, INSERM, UMR S CRO2 911, Fac Pharm, F-13385 Marseille, France.; Tsvetkov, PO (corresponding author), RAMS, Inst Gen Pathol & Pathophysiol, Moscow 125315, Russia.	philipp.tsvetkov@univ-amu.fr	Kubatiev, Aslan/AAF-8186-2021; kovacic, hervé/ABF-2451-2020; Makarov, Alexander/P-5279-2016; Kononikhin, Alexey/L-3171-2013; Devred, Francois/AAO-6337-2020	Devred, Francois/0000-0001-5990-8898	Russian Science Foundation [14-14-01152]; European Union [627524]	Russian Science Foundation(Russian Science Foundation (RSF)); European Union(European Commission)	The analysis of alpha-helical content and thermal denaturation of NOX5-EF as well as analysis of NOX5-EF oxidation level were supported by the Russian Science Foundation (grant #14-14-01152). Funding was also provided by European Union Seventh Framework Programme [FP7/2007-2013] Marie Curie Actions FP7-PEOPLE-2013-IIF#627524 (http://ec.europa.eu/research/participants/portal/desktop/en/opportunities/fp7/calls/fp7-people-2013-iif.html) for data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research leading to these results has received funding from the European Union Seventh Framework Programme [FP7/2007-2013] under Grant Agreement FIT no627524. The analysis of alpha-helical content and thermal denaturation of NOX5-EF as well as analysis of NOX5-EF oxidation level were supported by the Russian Science Foundation (grant #14-14-01152). We would like to thank Dr. Svetlana Gorokhova for helpful discussions and Dr. Jos Cox for providing plasmid for protein purification. Microcalorimetry experiments were performed in Timone Microcalorimetry Platform, Marseille.	Audran E, 2013, BBA-MOL CELL RES, V1833, P1720, DOI 10.1016/j.bbamcr.2013.01.008; Baladi S, 2001, PROTEIN SCI, V10, P771, DOI 10.1110/ps.40601; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Chen F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088405; Doroshow JH, 2014, NAT REV CLIN ONCOL, V11, P649, DOI 10.1038/nrclinonc.2014.158; El Jamali A, 2008, FREE RADICAL BIO MED, V44, P868, DOI 10.1016/j.freeradbiomed.2007.11.020; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI [10.1089/ars.2009.2587, 10.1089/ARS.2009.2587]; Garnier C, 1998, BIOCHEM BIOPH RES CO, V249, P197, DOI 10.1006/bbrc.1998.9108; Hill TJ, 2000, BIOCHEMISTRY-US, V39, P7284, DOI 10.1021/bi000139m; Indeykina MI, 2011, ANAL CHEM, V83, P3205, DOI 10.1021/ac103213j; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Kawahara T, 2011, BIOCHEMISTRY-US, V50, P2013, DOI 10.1021/bi1020088; Krause KH, 2004, JPN J INFECT DIS, V57, pS28; Lafitte D, 2002, BBA-PROTEINS PROTEOM, V1600, P105, DOI 10.1016/S1570-9639(02)00450-8; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Liang XW, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-21; Roman AY, 2016, CAN J MICROBIOL, V62, P123, DOI 10.1139/cjm-2015-0580; Schulz E, 2008, J AM COLL CARDIOL, V52, P1810, DOI 10.1016/j.jacc.2008.08.040; Thomson J.A., 2004, BIOCALORIMETRY, P35; Tirone F, 2007, FEBS LETT, V581, P1202, DOI 10.1016/j.febslet.2007.02.047; Tirone F, 2010, BIOCHEMISTRY-US, V49, P761, DOI 10.1021/bi901846y; Tsvetkov F O, 2010, Mol Biol (Mosk), V44, P938; Tsvetkov PO, 1999, J BIOL CHEM, V274, P18161, DOI 10.1074/jbc.274.26.18161; Tsvetkov PO, 2005, BIOCHIMIE, V87, P473, DOI 10.1016/j.biochi.2004.11.020; Tsvetkov PO, PROTEIN SEQUENCE ANA; Van Patten SM, 1999, J BIOL CHEM, V274, P10268, DOI 10.1074/jbc.274.15.10268; Weyemi U, 2015, RADIAT RES, V183, P262, DOI 10.1667/RR13799.1; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	32	22	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158726	10.1371/journal.pone.0158726	http://dx.doi.org/10.1371/journal.pone.0158726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391469	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400109
J	Wang, SS; Lei, T; Zhang, M				Wang, Shanshan; Lei, Ting; Zhang, Man			The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer	PLOS ONE			English	Article							P-GLYCOPROTEIN; EPIGALLOCATECHIN GALLATE; CISPLATIN RESISTANCE; DRUG-RESISTANCE; MOLECULAR-MECHANISMS; GINSENOSIDE RH-2; PROTEIN MRP; EXPRESSION; CELLS; INHIBITION	Chemotherapy is an important strategy for the treatment of bladder cancer. However, the main problem limiting the success of chemotherapy is the development of multidrug resistance (MDR). To improve the management of bladder cancer, it is an urgent matter to search for strategies to reverse MDR. We chose three kinds of herbal medicines including ginsenoside Rh2, (-)-Epigallocatechin gallate (EGCG) and Tetramethylpyrazine (TMP) to detect their effects on bladder cancer. Reversal effects of these three herbal medicines for drug resistance in adriamycin (ADM)-resistant Pumc-91 cells (Pumc-91/ADM) were assessed by Cell Counting Kit-8 (CCK-8) cell proliferation assay system. The mechanisms of reversal effect for TMP were explored in Pumc-91/ADM and T24/DDP cells. After Pumc91/ADM and T24/DDP cells were treated with TMP, cell cycle distribution analysis was performed by flow cytometry. The expression of MRP1, GST, BCL-2, LRP and TOPO-II was evaluated using quantitative real-time polymerase chain reaction (qRT-PCR), immunefluorescence assay and western blot. It was observed that TMP was capable of enhancing the cytotoxicity of anticancer agents on Pumc-91/ADM cells in response to ADM, however Rh2 and EGCG were unable to. The reversal effect of TMP was also demonstrated in T24/DDP cells. Moreover, the treatment with TMP in Pumc-91/ADM and T24/DDP cells led to an increased of G1 phase accompanied with a concomitant decrease of cell numbers in S phase. Compared to the control group, an obvious decrease of MRP1, GST, BCL-2 and an increase of TOPO-II were shown in TMP groups with a dose-dependency in mRNA and protein levels. However, there was no difference on LRP expression between TMP groups and the control group. TMP could effectively reverse MDR of Pumc-91/ADM and T24/DDP cells and its mechanisms might be correlated with the alteration of MRP1, GST, BCL-2 and TOPO-II. TMP might be a potential candidate for reversing drug resistance in bladder cancer chemotherapy.	[Wang, Shanshan; Lei, Ting; Zhang, Man] Capital Med Univ, Beijing Shijitan Hosp, Clin Lab Med, Beijing, Peoples R China; [Wang, Shanshan; Lei, Ting; Zhang, Man] Beijing Key Lab Urinary Cellular Mol Diagnost, Beijing, Peoples R China	Capital Medical University	Zhang, M (corresponding author), Capital Med Univ, Beijing Shijitan Hosp, Clin Lab Med, Beijing, Peoples R China.; Zhang, M (corresponding author), Beijing Key Lab Urinary Cellular Mol Diagnost, Beijing, Peoples R China.	mzhang99@aliyun.com			Beijing Administration of traditional Chinese medical [2014-ZYJ04]; Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics [Z151100001615060]	Beijing Administration of traditional Chinese medical; Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics	This study was funded by Beijing Administration of traditional Chinese medical (2014-ZYJ04) and Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics (Z151100001615060). Man Zhang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Beijing Administration of traditional Chinese medical (2014-ZYJ04) and Beijing Key Laboratory of Urinary Cellular Molecular Diagnostics (Z151100001615060).	Arantes-Rodrigues R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/791406; Atkins CD, 2012, NEW ENGL J MED, V367, P380, DOI 10.1056/NEJMc1206002; Bode AM, 2004, MUTAT RES-FUND MOL M, V555, P33, DOI 10.1016/j.mrfmmm.2004.05.018; Cervello M, 2006, WORLD J GASTROENTERO, V12, P5113; Chen L, 2009, BIOCHEM BIOPH RES CO, V386, P374, DOI 10.1016/j.bbrc.2009.06.042; Chen ZS, 1999, MOL PHARMACOL, V55, P921; Chisholm K, 2004, ANTI-CANCER DRUG, V15, P889, DOI 10.1097/00001813-200410000-00010; Cullen KJ, 2003, CANCER RES, V63, P8097; Diestra JE, 2003, J UROLOGY, V170, P1383, DOI 10.1097/01.ju.0000074710.96154.c9; Fei XF, 2002, ACTA PHARMACOL SIN, V23, P315; Fu YS, 2008, NEURO-ONCOLOGY, V10, P139, DOI 10.1215/15228517-2007-051; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gruber BM, 2010, MED SCI MONITOR, V16, pBR45; Hapke G, 2001, CANCER METAST REV, V20, P109, DOI 10.1023/A:1013116826788; HASEGAWA S, 1995, BRIT J CANCER, V71, P907, DOI 10.1038/bjc.1995.177; Hoffmann AC, 2010, NEOPLASIA, V12, P628, DOI 10.1593/neo.10402; Hong L, 2005, MOL CANCER THER, V4, P1936, DOI 10.1158/1535-7163.MCT-05-0182; Huang F, 2014, EXP THER MED, V7, P1611, DOI 10.3892/etm.2014.1662; Ishikawa Y, 2010, BIOL PHARM BULL, V33, P504, DOI 10.1248/bpb.33.504; Jacobs BL, 2010, CA-CANCER J CLIN, V60, P244, DOI 10.3322/caac.20077; Jia WWG, 2004, CAN J PHYSIOL PHARM, V82, P431, DOI 10.1139/Y04-049; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kellner U, 2002, LANCET ONCOL, V3, P235, DOI 10.1016/S1470-2045(02)00715-5; Khodadadian M, 2009, LUNG CANCER, V66, P48, DOI 10.1016/j.lungcan.2009.01.006; Khoshyomn S, 2000, PEDIATR NEUROSURG, V33, P123, DOI 10.1159/000028993; KIKUCHI Y, 1991, ANTI-CANCER DRUG, V2, P63, DOI 10.1097/00001813-199102000-00009; Kim HS, 2004, ARCH PHARM RES, V27, P429, DOI 10.1007/BF02980085; Kim KC, 2014, KOREAN J PHYSIOL PHA, V18, P61, DOI 10.4196/kjpp.2014.18.1.61; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Lee KY, 1996, CANCER LETT, V110, P193, DOI 10.1016/S0304-3835(96)04502-8; Li WM, 2010, BASIC CLIN PHARMACOL, V106, P45, DOI 10.1111/j.1742-7843.2009.00470.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Nakata H, 1998, JPN J CANCER RES, V89, P733, DOI 10.1111/j.1349-7006.1998.tb03278.x; Palaniyandi Kanagaraj, 2011, Int J Biochem Mol Biol, V2, P155; Park OJ, 2004, TOXICOL LETT, V150, P43, DOI 10.1016/j.toxlet.2003.06.001; Patel J, 2001, Pharmacogenomics, V2, P401, DOI 10.1517/14622416.2.4.401; Qian F, 2005, BIOMED PHARMACOTHER, V59, P64, DOI 10.1016/j.biopha.2005.01.002; Rioja J, 2011, BJU INT, V107, P1833, DOI 10.1111/j.1464-410X.2010.09653.x; Sakamoto M, 2001, Hum Cell, V14, P305; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scheffer GL, 2000, CURR OPIN ONCOL, V12, P550, DOI 10.1097/00001622-200011000-00007; Serretta V, 2003, J CANCER RES CLIN, V129, P472, DOI 10.1007/s00432-003-0455-5; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tada Y, 2002, INT J CANCER, V98, P630, DOI 10.1002/ijc.10246; Wang XB, 2010, ONCOL REP, V23, P211, DOI 10.3892/or_00000625; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Xiong L, 2007, AM J CHINESE MED, V35, P1011, DOI 10.1142/S0192415X07005478; Xu HW, 2010, J INT MED RES, V38, P34, DOI 10.1177/147323001003800104; Xu N, 2012, BIOCHEM BIOPH RES CO, V425, P468, DOI 10.1016/j.bbrc.2012.07.127; Zhang Min, 2009, J MED RES, V38, P70; Zhao HX, 2014, RADIOTHER ONCOL, V110, P132, DOI 10.1016/j.radonc.2013.10.014; Zhao M, 2015, IMMUNOASSAYS CLIN ME, V22, P338	55	24	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157759	10.1371/journal.pone.0157759	http://dx.doi.org/10.1371/journal.pone.0157759			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391608	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400020
J	Zakrzewska, M; Fendler, W; Zakrzewski, K; Sikorska, B; Grajkowska, W; Dembowska-Baginska, B; Filipek, I; Stefanczyk, L; Liberski, PP				Zakrzewska, Magdalena; Fendler, Wojciech; Zakrzewski, Krzysztof; Sikorska, Beata; Grajkowska, Wieslawa; Dembowska-Baginska, Bozenna; Filipek, Iwona; Stefanczyk, Lukasz; Liberski, Pawel P.			Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; INTRACRANIAL EPENDYMOMA; DRUG-RESISTANCE; CLUSTER; CANCER; CLASSIFICATION; METASTASIS; MIR-17-5P; GENES; ROLES	Background Ependymal tumors are the third most common group of brain tumors in children, accounting for about 10% of all primary brain neoplasms. According to the current WHO classification, they comprise four entities with the most frequent ependymoma and anaplastic ependymoma. The most of pediatric tumors are located within the posterior fossa, with a tendency to infiltrate the vital brain structures. This limits surgical resection and poses a considerable clinical problem. Moreover, there are no appropriate outcome prognostic factors besides the extent of surgical resection. Despite definition of molecular subgroups, the majority of childhood ependymomas present a balanced genome, which makes it difficult to establish molecular prognostic factors. Methods The purpose of our study was to explore whether miRNA expression could be used as prognostic markers in pediatric infratentorial ependymomas. We also performed a mRNA expression pattern analysis of NELL2 and LAMA2 genes, with immunohistochemical illustrations of representative cases. The miRNA and mRNA expression was measured in 53 pediatric infratentorial ependymomas using a real-time quantitative PCR. Results Three miRNAs were shown to efficiently differentiate between grade II and III ependymomas: miR-17-5p, miR-19a-3p, and miR-106b-5p. Survival analysis showed that the probabilities of overall (p = 0.036) and event-free survival (p = 0.002) were reduced with higher than median miRNA expression levels of miR-17-5p. Using multivariate analysis adjusted for patient's age, sex, tumor grade and localization, we showed statistically significant associations with event-free survival (p = 0004) and borderline statistical significance with overall survival (p = 0.057) for miR-17-5p. Correlation analysis of miR-19a, miR-17-5p, miR-106b revealed that their expression levels were significantly correlated with EZH2 expression, suggested marker of PFA ependymomas. Furthermore, lower expression level of LAMA2 mRNA was shown to be associated with an increased risk of death in covariate-adjusted analyses. Conclusions Our data provide a better understanding of pediatric ependymoma and suggests the presence of plausible molecular biomarkers connected with the outcome.	[Zakrzewska, Magdalena; Sikorska, Beata; Liberski, Pawel P.] Med Univ Lodz, Dept Mol Pathol & Neuropathol, Lodz, Poland; [Fendler, Wojciech] Med Univ Lodz, Dept Biostat & Translat Med, Lodz, Poland; [Zakrzewski, Krzysztof] Polish Mother Mem Hosp Res Inst, Dept Neurosurg, Lodz, Poland; [Grajkowska, Wieslawa] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Grajkowska, Wieslawa] Polish Acad Sci, Dept Expt & Clin Neuropathol, M Mossakowski Med Res Ctr, Warsaw, Poland; [Dembowska-Baginska, Bozenna; Filipek, Iwona] Childrens Mem Hlth Inst, Dept Pediat Oncol, Warsaw, Poland; [Stefanczyk, Lukasz] Third Municipal Hosp Lodz, Lodz, Poland	Medical University Lodz; Medical University Lodz; Polish Mother's Memorial Hospital - Research Institute; Children's Memorial Health Institute; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; Children's Memorial Health Institute	Zakrzewska, M (corresponding author), Med Univ Lodz, Dept Mol Pathol & Neuropathol, Lodz, Poland.	magdalena.zakrzewska@umed.lodz.pl	Fendler, Wojciech Maksymilian/S-9592-2016; Zakrzewska, Magdalena/S-9308-2016; Fendler, Wojciech/AAG-7020-2019; Sikorska, Beata/H-7138-2016	Fendler, Wojciech Maksymilian/0000-0002-5083-9168; Zakrzewska, Magdalena/0000-0001-5826-7726; Fendler, Wojciech/0000-0002-5083-9168; Sikorska, Beata/0000-0002-6166-0729; Grajkowska, Wieslawa/0000-0001-8318-5781; Liberski, Pawel P./0000-0001-6507-4682; Dembowska-Baginska, Bozenna/0000-0002-3845-5380; Zakrzewski, Krzysztof/0000-0001-5454-1783; Filipek, Iwona/0000-0003-2867-2696	Polish NCN grant [2011/01/B/NZ4/03573]	Polish NCN grant	Work was supported by the Polish NCN grant No. 2011/01/B/NZ4/03573.	Akhavan A, 2012, CANCER RES, V72, P2578, DOI 10.1158/0008-5472.CAN-11-3732; Araki A, 2014, NEURO-ONCOLOGY, V16, P23; Birks DK, 2011, PEDIATR BLOOD CANCER, V56, P211, DOI 10.1002/pbc.22723; Chen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118003; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Chua JH, 2009, CURR OPIN MOL THER, V11, P189; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-234; Costa FF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025114; Ellison DW, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-7; Ellison DW, 2016, WHO CLASSIFICATION T, V4; Fan MY, 2014, BREAST CANCER RES TR, V146, P487, DOI 10.1007/s10549-014-3040-5; Fang LK, 2014, ONCOTARGET, V5, P2974, DOI 10.18632/oncotarget.1614; Fang Y, 2015, J BIOL RES-THESSALON, V22, DOI 10.1186/s40709-015-0035-2; Godfraind C, 2009, CHILD NERV SYST, V25, P1185, DOI 10.1007/s00381-008-0804-4; Gyongyosi B, 2014, J HISTOCHEM CYTOCHEM, V62, P547, DOI 10.1369/0022155414537277; Kleinman CL, 2014, NAT GENET, V46, P39, DOI 10.1038/ng.2849; Li AM, 2015, CANCER-AM CANCER SOC, V121, P1499, DOI 10.1002/cncr.29198; Lourdusamy A, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0206-2; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Mao SS, 2014, FEBS J, V281, P1144, DOI 10.1111/febs.12680; Mathis SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105710; Mc Lendon RE, 2007, WHO CLASSIFICATION T, P74; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Niibori-Nambu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059558; Pajtler Kristian W, 2015, Oncoscience, V2, P827; Pajtler KW, 2015, CANCER CELL, V27, P728, DOI 10.1016/j.ccell.2015.04.002; Ridley L, 2008, NEURO-ONCOLOGY, V10, P675, DOI 10.1215/15228517-2008-036; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Spencer Peter, 2012, Frontiers in Genetics, V3, P192, DOI 10.3389/fgene.2012.00192; Srinivasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017438; Tan WQ, 2014, WORLD J GASTROENTERO, V20, P5962, DOI 10.3748/wjg.v20.i20.5962; Tena-Suck ML., 2015, J HISTOL HISTOPATHOL, V2, P17, DOI [10.7243/2055-091X-2-17, DOI 10.7243/2055-091X-2-17]; Tihan T, 2008, MODERN PATHOL, V21, P165, DOI 10.1038/modpathol.3800999; Wani K, 2012, ACTA NEUROPATHOL, V123, P727, DOI 10.1007/s00401-012-0941-4; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007; Yeh TS, 2014, ANN SURG, V259, P346, DOI 10.1097/SLA.0000000000000223; Zheng JJ, 2013, HEPATO-GASTROENTEROL, V60, P549, DOI 10.5754/hge12754	37	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158464	10.1371/journal.pone.0158464	http://dx.doi.org/10.1371/journal.pone.0158464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390862	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400064
J	Zhou, Y; Wu, Y; Qin, Y; Liu, L; Wan, J; Zou, LY; Zhang, QY; Zhu, JD; Mi, MT				Zhou, Yong; Wu, Ying; Qin, Yu; Liu, Lei; Wan, Jing; Zou, Lingyun; Zhang, Qianyong; Zhu, Jundong; Mi, Mantian			Ampelopsin Improves Insulin Resistance by Activating PPAR. and Subsequently Up-Regulating FGF21-AMPK Signaling Pathway	PLOS ONE			English	Article							SKELETAL-MUSCLE CELLS; BREAST-CANCER CELLS; GROWTH-FACTOR 21; RECEPTOR-GAMMA; ANTIDIABETIC ACTIONS; ENERGY-METABOLISM; PARTIAL AGONIST; GLUCOSE-UPTAKE; AMPK; AKT	Ampelopsin (APL), a major bioactive constituent of Ampelopsis grossedentata, exerts a number of biological effects. Here, we explored the anti-diabetic activity of APL and elucidate the underlying mechanism of this action. In palmitate-induced insulin resistance of L6 myotubes, APL treatment markedly up-regulated phosphorylated insulin receptor substrate-1 and protein kinase B, along with a corresponding increase of glucose uptake capacity. APL treatment also increased expressions of fibroblast growth factor (FGF21) and phosphorylated adenosine 5'-monophosphate -activated protein kinase (p-AMPK), however inhibiting AMPK by Compound C or AMPK siRNA, or blockage of FGF21 by FGF21 siRNA, obviously weakened APL -induced increases of FGF21 and p-AMPK as well as glucose uptake capacity in palmitate -pretreated L6 myotubes. Furthermore, APL could activate PPAR. resulting in increases of glucose uptake capacity and expressions of FGF21 and p-AMPK in palmitate -pretreated L6 myotubes, whereas all those effects were obviously abolished by addition of GW9662, a specific inhibitor of peroxisome proliferator-activated receptor -gamma (PPAR.), and PPAR gamma siRNA. Using molecular modeling and the luciferase reporter assays, we observed that APL could dock with the catalytic domain of PPAR. and dose-dependently up-regulate PPAR. activity. In summary, APL maybe a potential agonist of PPAR. and promotes insulin sensitization by activating PPAR. and subsequently regulating FGF21-AMPK signaling pathway. These results provide new insights into the protective health effects of APL, especially for the treatment of Type 2 diabetesmellitus.	[Zhou, Yong; Wu, Ying; Qin, Yu; Liu, Lei; Wan, Jing; Zhang, Qianyong; Zhu, Jundong; Mi, Mantian] Third Mil Med Univ, Res Ctr Nutr & Food Safety, Inst Mil Prevent Med, Chongqing Key Lab Nutr & Food Safety,Res Ctr Med, Chongqing 400038, Peoples R China; [Zou, Lingyun] Third Mil Med Univ, Coll Basic Med Sci, Chongqing 400038, Peoples R China	Army Medical University; Army Medical University	Mi, MT (corresponding author), Third Mil Med Univ, Res Ctr Nutr & Food Safety, Inst Mil Prevent Med, Chongqing Key Lab Nutr & Food Safety,Res Ctr Med, Chongqing 400038, Peoples R China.	mantian_mi@163.com			"12th Five year plan" for National Key Technology Research and Development Program of China [2012BAI35B02]	"12th Five year plan" for National Key Technology Research and Development Program of China	This work was supported by the "12th Five year plan" for National Key Technology Research and Development Program of China (grant number: 2012BAI35B02). Prof. Mantian MI received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; ARCHINTERNMED, 2010, ARCH INTERN MED, V170, P1191, DOI DOI 10.1001/ARCHINTERNMED.2010.207; Atanasov AG, 2013, BBA-GEN SUBJECTS, V1830, P4813, DOI 10.1016/j.bbagen.2013.06.021; Avior Y, 2013, FOOD FUNCT, V4, P831, DOI 10.1039/c3fo60063g; Babu PVA, 2013, J NUTR BIOCHEM, V24, P1777, DOI 10.1016/j.jnutbio.2013.06.003; Badeau RM, 2014, ANN MED, V46, P18, DOI 10.3109/07853890.2013.853369; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Dostalova I, 2009, PHYSIOL RES, V58, P1, DOI 10.33549/physiolres.931610; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Goto T, 2013, MOL NUTR FOOD RES, V57, P20, DOI 10.1002/mnfr.201200522; Huang WW, 2013, INT J ONCOL, V42, P2069, DOI 10.3892/ijo.2013.1909; Izumiya Y, 2008, FEBS LETT, V582, P3805, DOI 10.1016/j.febslet.2008.10.021; Kim B, 2015, J BIOL CHEM, V290, P19146, DOI 10.1074/jbc.M115.636852; Kim JH, 2015, ARCH PHARM RES, V38, P302, DOI 10.1007/s12272-015-0559-x; Liu HJ, 2015, J PHARMACOL EXP THER, V353, P573, DOI 10.1124/jpet.115.223107; Mashili F, 2013, DIABETES, V62, P457, DOI 10.2337/db12-0337; Meshkani R, 2014, CELL BIOCHEM FUNCT, V32, P683, DOI 10.1002/cbf.3072; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Ohashi M, 2015, BIOORG MED CHEM LETT, V25, P2639, DOI 10.1016/j.bmcl.2015.04.076; Park SY, 2014, KOREAN J PHYSIOL PHA, V18, P255, DOI 10.4196/kjpp.2014.18.3.255; Piemontese L, 2015, EUR J MED CHEM, V90, P583, DOI 10.1016/j.ejmech.2014.11.044; Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216; Qiang L, 2012, CELL, V148, P397, DOI 10.1016/j.cell.2012.01.020; Rathmann W, 2004, DIABETES CARE, V27, P2568, DOI 10.2337/diacare.27.10.2568; Ribas F, 2014, BIOCHEM J, V463, P191, DOI 10.1042/BJ20140403; Shen Y, 2012, J NEUROSCI, V32, P390, DOI 10.1523/JNEUROSCI.4639-11.2012; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Xie Q, 2014, GENE CHROMOSOME CANC, V53, P422, DOI 10.1002/gcc.22154; Xie XN, 2015, BBA-GEN SUBJECTS, V1850, P62, DOI 10.1016/j.bbagen.2014.09.027; Yu LF, 2010, CURR TOP MED CHEM, V10, P397, DOI 10.2174/156802610790980611; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang HT, 2013, EUR J PHARMACOL, V718, P235, DOI 10.1016/j.ejphar.2013.08.026; Zhou Y, 2014, CANCER SCI, V105, P1279, DOI 10.1111/cas.12494; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089021; Zou D, 2014, MED SCI SPORT EXER, V46, P2077, DOI 10.1249/MSS.0000000000000336	37	17	22	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159191	10.1371/journal.pone.0159191	http://dx.doi.org/10.1371/journal.pone.0159191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391974	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400218
J	Guglielmi, V; Maresca, L; Lanzillo, C; Marinoni, GM; D'Adamo, M; Di Roma, M; Preziosi, P; Bellia, A; Calo, L; Sbraccia, P				Guglielmi, Valeria; Maresca, Luciano; Lanzillo, Chiara; Marinoni, Giorgia Michela; D'Adamo, Monica; Di Roma, Mauro; Preziosi, Paolo; Bellia, Alfonso; Calo, Leonardo; Sbraccia, Paolo			Relationship between Regional Fat Distribution and Hypertrophic Cardiomyopathy Phenotype	PLOS ONE			English	Article							EPICARDIAL ADIPOSE-TISSUE; CARDIOVASCULAR MAGNETIC-RESONANCE; LEFT-VENTRICULAR MASS; CLINICAL PRESENTATION; HEART-ASSOCIATION; TASK-FORCE; OBESITY; DISEASE; DIAGNOSIS; RISK	Background Hypertrophic cardiomyopathy (HCM), the most common genetic heart disease, is characterized by heterogeneous phenotypic expression. Body mass index has been associated with LV mass and heart failure symptoms in HCM. The aim of our study was to investigate whether regional (trunk, appendicular, epicardial) fat distribution and extent could be related to hypertrophy severity and pattern in HCM. Methods Cardiovascular magnetic resonance was performed in 32 subjects with echocardiography-based diagnosis of HCM (22M/10F, 57.2 +/- 12.6 years) characterized by predominant hypertrophy at the interventricular septum (IVS). Regional fat distribution was assessed by dual-energy X-ray absorptiometry. Results Gender differences were detected in maximum IVS thickness (M: 18.3 +/- 3.8 mm vs. F: 14.3 +/- 4 mm, p = 0.012), right ventricle (RV) systolic function (M: 61.3 +/- 6.7%; F: 67.5 +/- 6.3%, p = 0.048), indexed RV end-diastolic (M: 64.8 +/- 16.3 ml/m(2); F: 50.7 +/- 15.5 ml/m(2), p = 0.04) and end-systolic volumes (M: 24.3 +/- 8.3 ml/m(2); F: 16.7 +/- 7.4 ml/m(2), p = 0.04). After adjusting for age and gender, maximum IVS thickness was associated with truncal fat (Tr-FAT) (beta = 0.43, p = 0.02), but not with either appendicular or epicardial fat. Epicardial fat resulted independently associated with NT-proBNP levels (beta = 0.63, p = 0.04). Late Gadolinium Enhancement-positive subjects displayed greater maximum IVS thickness (p = 0.02), LV mass index (p = 0.015) and NT-proBNP levels (p = 0.04), but no associations with fat amount or distribution were observed. Conclusion Truncal, but not appendicular or epicardial fat amount, seems to be related with maximum IVS thickness, the hallmark feature in our cohort of HCM patients. Further prospective researches are needed to assess a potential causative effect of central adiposity on HCM phenotype.	[Guglielmi, Valeria; Marinoni, Giorgia Michela; D'Adamo, Monica; Bellia, Alfonso; Sbraccia, Paolo] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy; [Maresca, Luciano; Di Roma, Mauro; Preziosi, Paolo] Policlin Casilino, Dept Diagnost Imaging, Rome, Italy; [Lanzillo, Chiara; Calo, Leonardo] Policlin Casilino, Dept Cardiol, Rome, Italy	University of Rome Tor Vergata	Sbraccia, P (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy.	sbraccia@med.uniroma2.it	D'Adamo, Monica/AAL-4676-2020; bellia, alfonso/AIA-9860-2022; Calo, Leonardo/R-1892-2016	D'Adamo, Monica/0000-0002-1673-1591; Calo, Leonardo/0000-0002-6062-5286; Guglielmi, Valeria/0000-0002-6912-7814	Ministero dell'Istruzione, dell'Universita e della Ricerca [2010329EKE_003]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by a grant from the Ministero dell'Istruzione, dell'Universita e della Ricerca (prot. 2010329EKE_003) to PS.; We gratefully acknowledge Amleto Alberico, Stefano Bonetti, Gianluca Campo e Giorgio Sebastiano for technical assistance in MRI scan execution. We are also grateful to Stefano Coppa and Luca Colangeli, students in Medicine, for their help in collecting clinical data. This work was supported by a grant from the Ministero dell'Istruzione, dell'Universita e della Ricerca (prot. 2010329EKE_003).	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; Arad M, 2005, CIRCULATION, V112, P2805, DOI 10.1161/CIRCULATIONAHA.105.547448; Canepa M, 2013, AM J CARDIOL, V112, P1182, DOI 10.1016/j.amjcard.2013.05.070; Choudhury L, 2002, J AM COLL CARDIOL, V40, P2156, DOI 10.1016/S0735-1097(02)02602-5; CIRO E, 1983, CIRCULATION, V67, P1227, DOI 10.1161/01.CIR.67.6.1227; [Criteria Committee New York Heart Association], 1979, NOM CRIT DIAGN DIS H, pxiii; Danias PG, 2003, J CARDIOV MAGN RESON, V5, P431, DOI 10.1081/JCMR-120022259; Doesch C, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-40; Elliott P, 2004, LANCET, V363, P1881, DOI 10.1016/S0140-6736(04)16358-7; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Fluchter S, 2007, OBESITY, V15, P870, DOI 10.1038/oby.2007.591; Fox CS, 2009, CIRCULATION, V119, P1586, DOI 10.1161/CIRCULATIONAHA.108.828970; Gaborit B, 2012, OBESITY, V20, P1200, DOI 10.1038/oby.2011.283; Gersh BJ, 2011, J AM COLL CARDIOL, V58, P2703, DOI 10.1016/j.jacc.2011.10.825; Green JJ, 2012, JACC-CARDIOVASC IMAG, V5, P370, DOI 10.1016/j.jcmg.2011.11.021; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guglielmi V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103381; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Iacobellis G, 2004, AM J CARDIOL, V94, P1084, DOI 10.1016/j.amjcard.2004.06.075; Kankaanpaa M, 2006, J CLIN ENDOCR METAB, V91, P4689, DOI 10.1210/jc.2006-0584; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Leonardi S, 2009, EUR HEART J, V30, P2003, DOI 10.1093/eurheartj/ehp152; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2004, AM J MED, V116, P63, DOI 10.1016/j.amjmed.2003.10.012; Maron MS, 2011, CIRCULATION, V124, P40, DOI 10.1161/CIRCULATIONAHA.110.985812; Maron MS, 2006, CIRCULATION, V114, P2232, DOI 10.1161/CIRCULATIONAHA.106.644682; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McKenna WJ, 1997, HEART, V77, P130, DOI 10.1136/hrt.77.2.130; Muhib S, 2013, INT HEART J, V54, P297, DOI 10.1536/ihj.54.297; Neeland IJ, 2013, CIRC-CARDIOVASC IMAG, V6, P800, DOI 10.1161/CIRCIMAGING.113.000532; Olivotto I, 2005, J AM COLL CARDIOL, V46, P480, DOI 10.1016/j.jacc.2005.04.043; Olivotto I, 2008, J AM COLL CARDIOL, V52, P559, DOI 10.1016/j.jacc.2008.04.047; Olivotto I, 2013, J AM COLL CARDIOL, V62, P449, DOI 10.1016/j.jacc.2013.03.062; Olivotto I, 2012, CIRC-HEART FAIL, V5, P535, DOI 10.1161/CIRCHEARTFAILURE.112.967026; Olivotto I, 2009, J CARDIOVASC TRANSL, V2, P349, DOI 10.1007/s12265-009-9137-2; Ouwens DM, 2010, J CELL MOL MED, V14, P2223, DOI 10.1111/j.1582-4934.2010.01141.x; Piran S, 2012, J AM COLL CARDIOL, V60, P283, DOI 10.1016/j.jacc.2012.05.005; Rider OJ, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-9; Seferovic PM, 2015, EUR HEART J, V36, P1718, DOI 10.1093/eurheartj/ehv134; Smith SC, 2011, J AM COLL CARDIOL, V58, P2432, DOI 10.1016/j.jacc.2011.10.824; Tsybouleva N, 2004, CIRCULATION, V109, P1284, DOI 10.1161/01.CIR.0000121426.43044.2B; Venteclef N, 2015, EUR HEART J, V36, P795, DOI 10.1093/eurheartj/eht099; Wang LB, 2010, ANN INTERN MED, V152, P513, DOI 10.7326/0003-4819-152-8-201004200-00008; Watkins H, 2008, HEART, V94, P1264, DOI 10.1136/hrt.2008.154104; Watkins H, 2011, NEW ENGL J MED, V364, P1643, DOI 10.1056/NEJMra0902923; Yndestad A, 2004, CIRCULATION, V109, P1379, DOI 10.1161/01.CIR.0000120704.97934.41	51	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158892	10.1371/journal.pone.0158892	http://dx.doi.org/10.1371/journal.pone.0158892			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388274	Green Submitted, Green Published, gold			2022-12-26	WOS:000379811500062
J	Lam, RS; O'Brien-Simpson, NM; Holden, JA; Lenzo, JC; Fong, SB; Reynolds, EC				Lam, Roselind S.; O'Brien-Simpson, Neil M.; Holden, James A.; Lenzo, Jason C.; Fong, Shao B.; Reynolds, Eric C.			Unprimed, M1 and M2 Macrophages Differentially Interact with Porphyromonas gingivalis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALTERNATIVE ACTIVATION; PERIODONTAL-DISEASE; SUBGINGIVAL PLAQUE; MOUSE MACROPHAGES; CELL-DEATH; LIPOPOLYSACCHARIDE; VIRULENCE; RESPONSES; INTERLEUKIN-4	Porphyromonas gingivalis is a keystone pathogen in the development of chronic periodontitis. Tissue macrophages are amongst the first immune cells to respond to bacteria and depending on the cytokine profile at the infection site, macrophages are primed to react to infection in different ways. Priming of naive macrophages with IFN-gamma produces a classical pro-inflammatory, antibacterial M1 macrophage after TLR ligation, whereas priming with IL-4 induces an anti-inflammatory tissue-repair M2 phenotype. Previous work has shown that M1 are preferentially generated in gingival tissue following infection with P. gingivalis. However, few studies have investigated the interactions of macrophage subsets with P. gingivalis cells. The aim of this study was to determine the ability of naive, M1 and M2 macrophages to phagocytose P. gingivalis and investigate how this interaction affects both the bacterial cell and the macrophage. M1 and M2 macrophages were both found to have enhanced phagocytic capacity compared with that of naive macrophages, however only the naive and M1 macrophages were able to produce a respiratory burst in order to clear the bacteria from the phagosome. P. gingivalis was found to persist in naive and M2, but not M1 macrophages for 24 hours. Phagocytosis of P. gingivalis also induced high levels of TNF-alpha, IL-12 and iNOS in M1 macrophages, but not in naive or M2 macrophages. Furthermore, infection of macrophages with P. gingivalis at high bacteria to macrophage ratios, while inducing an inflammatory response, was also found to be deleterious to macrophage longevity, with high levels of apoptotic cell death found in macrophages after infection. The activation of M1 macrophages observed in this study may contribute to the initiation and maintenance of a pro-inflammatory state during chronic periodontitis.	[Lam, Roselind S.; O'Brien-Simpson, Neil M.; Holden, James A.; Lenzo, Jason C.; Fong, Shao B.; Reynolds, Eric C.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Inst Bio21, Melbourne, Vic, Australia	University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Inst Bio21, Melbourne, Vic, Australia.	e.reynolds@unimelb.edu	O'Brien-Simpson, Neil/B-2901-2009	O'Brien-Simpson, Neil/0000-0001-8462-5603; Fong, Shao/0000-0002-0065-7884; Lenzo, Jason/0000-0002-0564-9250	Australian Government, Department of Industry, Innovation and Science [20080108]	Australian Government, Department of Industry, Innovation and Science(Australian GovernmentDepartment of Industry, Innovation and Science)	Supported by the Australian Government, Department of Industry, Innovation and Science Grant ID 20080108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], HOST PARASITE INTERA; Balce DR, 2011, BLOOD, V118, P4199, DOI 10.1182/blood-2011-01-328906; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bodet C, 2005, MICROBES INFECT, V7, P448, DOI 10.1016/j.micinf.2004.11.021; Byrne SJ, 2009, ORAL MICROBIOL IMMUN, V24, P469, DOI 10.1111/j.1399-302X.2009.00544.x; Chapple CC, 1998, J PATHOL, V186, P281; DEBINSKI W, 1995, J BIOL CHEM, V270, P16775, DOI 10.1074/jbc.270.28.16775; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Fink SL, 2007, CELL MICROBIOL, V9, P2562, DOI 10.1111/j.1462-5822.2007.01036.x; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gemmell E, 2001, J PERIODONTAL RES, V36, P92, DOI 10.1034/j.1600-0765.2001.360205.x; Gordon S, 1998, RES IMMUNOL, V149, P685, DOI 10.1016/S0923-2494(99)80039-X; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Griffen AL, 1999, J CLIN MICROBIOL, V37, P4028, DOI 10.1128/JCM.37.12.4028-4033.1999; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Holden JA, 2014, INFECT IMMUN, V82, P4190, DOI 10.1128/IAI.02325-14; Igboin CO, 2009, J CLIN MICROBIOL, V47, P3073, DOI 10.1128/JCM.00569-09; Jones KJ, 2010, J PERIODONTOL, V81, P1850, DOI 10.1902/jop.2010.100226; Komiya A, 2000, J PERIODONTOL, V71, P760, DOI 10.1902/jop.2000.71.5.760; Lam RS, 2014, J IMMUNOL, V193, P2349, DOI 10.4049/jimmunol.1400853; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lappin DF, 2000, J PERIODONTAL RES, V35, P369, DOI 10.1034/j.1600-0765.2000.035006369.x; Lenzo JC, 2016, INFECT IMMUN, DOI [10.1128/IAI.01482-15, DOI 10.1128/IAI.01482-15]; Linden GJ, 2013, J CLIN PERIODONTOL, V40, pS8, DOI [10.1902/jop.2013.1340010, 10.1111/jcpe.12064]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mathur A, 1996, J PERIODONTAL RES, V31, P489, DOI 10.1111/j.1600-0765.1996.tb01414.x; MCKEE AS, 1986, INFECT IMMUN, V52, P349, DOI 10.1128/IAI.52.2.349-355.1986; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Moraco AH, 2014, SEMIN IMMUNOL, V26, P497, DOI 10.1016/j.smim.2014.10.001; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nakao R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026163; Nishimura F, 2003, J PERIODONTOL, V74, P97, DOI 10.1902/jop.2003.74.1.97; O'Brien-Simpson NM, 2000, INFECT IMMUN, V68, P2704, DOI 10.1128/IAI.68.5.2704-2712.2000; O'Brien-Simpson NM, 2003, CURR PROTEIN PEPT SC, V4, P409, DOI 10.2174/1389203033487009; Offenbacher S, 1998, Ann Periodontol, V3, P233, DOI 10.1902/annals.1998.3.1.233; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Slocum C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004215; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tam V, 2009, INFECT IMMUN, V77, P1451, DOI 10.1128/IAI.01377-08; Tonetti MS, 2013, J CLIN PERIODONTOL, V40, pS24, DOI 10.1111/jcpe.12089; Varin A, 2010, BLOOD, V115, P353, DOI 10.1182/blood-2009-08-236711; Veith PD, 2014, J PROTEOME RES, V13, P2420, DOI 10.1021/pr401227e; Wang M, 2007, J IMMUNOL, V179, P2349, DOI 10.4049/jimmunol.179.4.2349; Wiebe C B, 2000, J Can Dent Assoc, V66, P594; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; YAHARA I, 1982, J CELL BIOL, V92, P69, DOI 10.1083/jcb.92.1.69; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; Yu T, 2016, J PERIODONTOL, V87, P1092, DOI 10.1902/jop.2016.160081; Zhou Q, 2005, INFECT IMMUN, V73, P935, DOI 10.1128/IAI.73.2.935-943.2005	55	46	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158629	10.1371/journal.pone.0158629	http://dx.doi.org/10.1371/journal.pone.0158629			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383471	Green Published, gold			2022-12-26	WOS:000379809400067
J	Waruru, A; Muttai, H; Ng'ang'a, L; Ackers, M; Kim, A; Miruka, F; Erick, O; Okonji, J; Ayuaya, T; Schwarcz, S				Waruru, Anthony; Muttai, Hellen; Ng'ang'a, Lucy; Ackers, Marta; Kim, Andrea; Miruka, Fredrick; Erick, Opiyo; Okonji, Julie; Ayuaya, Tolbert; Schwarcz, Sandra			Positive Predictive Value of the WHO Clinical and Immunologic Criteria to Predict Viral Load Failure among Adults on First, or Second-Line Antiretroviral Therapy in Kenya	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; DRIED BLOOD SPOTS; PLASMA; RNA	Routine HIV viral load (VL) monitoring is the standard of care for persons receiving antiretroviral therapy (ART) in developed countries. Although the World Health Organization recommends annual VL monitoring of patients on ART, recognizing difficulties in conducting routine VL testing, the WHO continues to recommend targeted VL testing to confirm treatment failure for persons who meet selected immunologic and clinical criteria. Studies have measured positive predictive value (PPV), negative predictive value, sensitivity and specificity of these criteria among patients receiving first-line ART but not specifically among those on second-line or subsequent regimens. Between 2008 and 2011, adult ART patients in Nyanza, Kenya who met national clinical or immunologic criteria for treatment failure received targeted VL testing. We calculated PPV and 95% confidence intervals (CI) of these criteria to detect virologic treatment failure among patients receiving a) first-line ART, b) second/subsequent ART, and c) any regimen. Of 12,134 patient specimens tested, 2,874 (23.7%) were virologically confirmed as treatment failures. The PPV for 2,834 first-line ART patients who met either the clinical or immunologic criteria for treatment failure was 34.4% (95% CI 33.2-35.7), 33.1% (95% CI 24.7-42.3) for the 40 patients on second-line/subsequent regimens, and 33.4%(95% CI 33.1-35.6) for any ART. PPV, regardless of criteria, for first-line ART patients was lowest among patients over 44 years old and highest for patients aged 15 to 34 years. PPV of immunological and clinical criteria for correctly identifying treatment failure was similarly low for adult patients receiving either first-line or second-line/subsequent ART regimens. Our data confirm the inadequacy of clinical and immunologic criteria to correctly identify treatment failure and support the implementation of routine VL testing.	[Waruru, Anthony; Muttai, Hellen; Ng'ang'a, Lucy; Miruka, Fredrick] CDC, US Ctr Dis Control & Prevent, Nairobi, Kenya; [Ackers, Marta; Kim, Andrea] CDC, US Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Erick, Opiyo; Okonji, Julie; Ayuaya, Tolbert] Kenya Govt Med Res Ctr, Kisumu, Kenya; [Schwarcz, Sandra] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Schwarcz, Sandra] Univ Calif San Francisco, San Francisco, CA 94143 USA	Centers for Disease Control & Prevention - USA; Kenya Medical Research Institute; San Francisco Department of Public Health; University of California System; University of California San Francisco	Waruru, A (corresponding author), CDC, US Ctr Dis Control & Prevent, Nairobi, Kenya.	awaruru@cdc.gov	Waruru, Anthony/U-7217-2019; Muttai, Hellen/ABH-7164-2020	Waruru, Anthony/0000-0002-4281-6345; Simangan, Mon Erick/0000-0002-2480-245X	University of California San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S. [NIMH R25MH064712]; NIH Office of AIDS Research-supported OCTAVE Project; NIMH [R25MH064712-08]; Fogarty International Center AITRP Program [D43TW00003]; US President's Emergency Plan for AIDS Relief from US Centers for Disease Control and Prevention, Division of Global HIV and TB [3U19C1000323]; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	University of California San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S.; NIH Office of AIDS Research-supported OCTAVE Project; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fogarty International Center AITRP Program; US President's Emergency Plan for AIDS Relief from US Centers for Disease Control and Prevention, Division of Global HIV and TB; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Support for this work was provided by the University of California San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S. NIMH R25MH064712, The NIH Office of AIDS Research-supported OCTAVE Project, NIMH-supported UCSF ITAPS Program (R25MH064712-08), the Fogarty International Center AITRP Program (D43TW00003), and the US President's Emergency Plan for AIDS Relief through cooperative agreement (3U19C1000323) from the US Centers for Disease Control and Prevention, Division of Global HIV and TB.; This publication was made possible by support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through cooperative agreement 3U19C1000323from the U.S. Centers for Disease Control and Prevention (CDC), Division of Global HIV/AIDS (DGHA)	[Anonymous], 2017, 2013 UNAIDS REP GLOB; Chaiwarith R, 2007, INT J INFECT DIS, V11, P413, DOI 10.1016/j.ijid.2006.11.003; Fiscus SA, 1998, J CLIN MICROBIOL, V36, P258, DOI 10.1128/JCM.36.1.258-260.1998; Garrido C, 2009, J CLIN MICROBIOL, V47, P1031, DOI 10.1128/JCM.02099-08; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Johannessen A, 2009, CLIN INFECT DIS, V49, P976, DOI 10.1086/605502; Keiser O, 2009, TROP MED INT HEALTH, V14, P1220, DOI 10.1111/j.1365-3156.2009.02338.x; Laurent C, 2011, LANCET INFECT DIS, V11, P825, DOI 10.1016/S1473-3099(11)70168-2; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Meya D, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-3; Moore DM, 2008, JAIDS-J ACQ IMM DEF, V49, P477, DOI 10.1097/QAI.0b013e318186eb18; National AIDS and STI Control Program, 2014, KEN AIDS IND SURV 20; National AIDS and STI Control Programme, 2014, GUIDELINES USE ANTIR; National AIDS and STI Control Programme, 2011, GUID ANT THER KEN; Office of U.S. Global AIDS Coordinator and the Bureau of Public Affairs USSD, ANN REP C PRES EM PL; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Rewari BB, 2010, JAIDS-J ACQ IMM DEF, V55, P610, DOI 10.1097/QAI.0b013e3181f43a31; Reynolds SJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-381; Roche Molecular Systems Inc, 1996, ROCH MOL DIAGN; Rutherford GW, 2013, 7 INT AIDS SOC IAS C; Schmitz ME, 2014, INT AIDS SOC C MELB; Stata Coorporation, 1985, STAT; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x	23	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158881	10.1371/journal.pone.0158881	http://dx.doi.org/10.1371/journal.pone.0158881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383834	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400090
J	Gujjula, R; Veeraiah, S; Kumar, K; Thakur, SS; Mishra, K; Kaur, R				Gujjula, Rahul; Veeraiah, Sangeetha; Kumar, Kundan; Thakur, Suman S.; Mishra, Krishnaveni; Kaur, Rupinder			Identification of Components of the SUMOylation Machinery in Candida glabrata: ROLE OF THE DESUMOYLATION PEPTIDASE CgUlp2 IN VIRULENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adhesion; biofilm; microbial pathogenesis; small ubiquitin-like modifier (SUMO); sumoylation; C; glabrata; Epa adhesins; SUMO peptidase; fungal pathogenesis; SUMO ligase	PROTEIN SUMOYLATION; CONJUGATING ENZYME; SUMO ISOPEPTIDASE; TELOMERE LENGTH; ADHESINS; LIGASE; EPIDEMIOLOGY; ULL1/SIZ1; VIRULENCE; ADHERENCE	Regulation of protein function by reversible post-translational modification, SUMOylation, is widely conserved in the eukaryotic kingdom. SUMOylation is essential for cell growth, division, and adaptation to stress in most organisms, including fungi. As these are key factors in determination of fungal virulence, in this study, we have investigated the importance of SUMOylation in the human pathogen, Candida glabrata. We identified the enzymes involved in small ubiquitin-like modifier conjugation and show that there is strong conservation between Saccharomyces cerevisiae and C. glabrata. We demonstrate that SUMOylation is an essential process and that adaptation to stress involves changes in global SUMOylation in C. glabrata. Importantly, loss of the deSUMOylating enzyme CgUlp2 leads to highly reduced small ubiquitin-like modifier protein levels, and impaired growth, sensitivity to multiple stress conditions, reduced adherence to epithelial cells, and poor colonization of specific tissues in mice. Our study thus demonstrates a key role for protein SUMOylation in the life cycle and pathobiology of C. glabrata.	[Kaur, Rupinder] Ctr DNA Fingerprinting & Diagnost, Bldg 7,Gruhakalpa 5-4-399-B, Hyderabad 500001, Andhra Pradesh, India; [Veeraiah, Sangeetha; Mishra, Krishnaveni] Univ Hyderabad, Sch Life Sci, Dept Biochem, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India; [Kumar, Kundan] Manipal Univ, Grad Studies Program, Manipal 576104, Karnataka, India; [Thakur, Suman S.] Habsiguda, Ctr Cellular & Mol Biol, Hyderabad 500007, Andhra Pradesh, India; [Gujjula, Rahul] Auroras Degree & PG Coll, Dept Biochem, Hyderabad 500020, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); University of Hyderabad; Manipal Academy of Higher Education (MAHE); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Kaur, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Bldg 7,Gruhakalpa 5-4-399-B, Hyderabad 500001, Andhra Pradesh, India.; Mishra, K (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Prof CR Rao Rd, Hyderabad 500046, Andhra Pradesh, India.	krishnaveni.mishra@gmail.com; rkaur@cdfd.org.in		Thakur, Suman/0000-0001-5928-8836; Kumar, Kundan/0000-0002-5467-9384	Department of Biotechnology, Government of India [BT/PR7388/MED/29/650/2012, BT/PR7123/BRB/10/1149/ 2012, BT/PR11752/BRB/10/685/2009, BT/PR5145/MED/29/470/2012]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, Government of India, Grants BT/PR7388/MED/29/650/2012 and BT/PR7123/BRB/10/1149/ 2012 (to R. K.), BT/PR11752/BRB/10/685/2009 (to K. M.), and BT/PR5145/MED/29/470/2012 (to R. K., K. M., and S. T.). The authors declare that they have no conflicts of interest with the contents of this article.	Abu Irqeba A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087306; Ben-Ami R, 2011, J INFECT DIS, V204, P626, DOI 10.1093/infdis/jir351; Borah S, 2014, ANTIMICROB AGENTS CH, V58, P5976, DOI 10.1128/AAC.02786-14; Borah S, 2011, J BIOL CHEM, V286, P34311, DOI 10.1074/jbc.M111.264671; Bowman SM, 2006, BIOESSAYS, V28, P799, DOI 10.1002/bies.20441; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Castano I, 2005, MOL MICROBIOL, V55, P1246, DOI 10.1111/j.1365-2958.2004.04465.x; Cormack BP, 1999, SCIENCE, V285, P578, DOI 10.1126/science.285.5427.578; Cormack BP, 1999, GENETICS, V151, P979; D'Ambrosio LM, 2014, CURR BIOL, V24, P361, DOI 10.1016/j.cub.2013.12.038; Darst RP, 2008, MOL CELL BIOL, V28, P1361, DOI 10.1128/MCB.01291-07; de Groot PWJ, 2013, EUKARYOT CELL, V12, P470, DOI 10.1128/EC.00364-12; De las Penas A, 2003, GENE DEV, V17, P2245, DOI 10.1101/gad.1121003; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Djordjevic D, 2002, APPL ENVIRON MICROB, V68, P2950, DOI 10.1128/AEM.68.6.2950-2958.2002; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Frieman MB, 2002, MOL MICROBIOL, V46, P479, DOI 10.1046/j.1365-2958.2002.03166.x; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hannan A, 2015, NUCLEIC ACIDS RES, V43, P10213, DOI 10.1093/nar/gkv842; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Harting R, 2013, MOL MICROBIOL, V90, P1125, DOI 10.1111/mmi.12421; Iraqui I, 2005, MOL MICROBIOL, V55, P1259, DOI 10.1111/j.1365-2958.2004.04475.x; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kaur R, 2007, P NATL ACAD SCI USA, V104, P7628, DOI 10.1073/pnas.0611195104; Klevay MJ, 2008, DIAGN MICR INFEC DIS, V60, P273, DOI 10.1016/j.diagmicrobio.2007.10.001; Leach MD, 2011, MOL BIOL CELL, V22, P687, DOI 10.1091/mbc.E10-07-0632; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Montagna MT, 2014, EUR REV MED PHARMACO, V18, P661; Moran C, 2010, AM J INFECT CONTROL, V38, P78, DOI 10.1016/j.ajic.2009.06.014; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Pappas PG, 2010, CLIN INFECT DIS, V50, P1101, DOI 10.1086/651262; Pasupala N, 2012, EUKARYOT CELL, V11, P452, DOI 10.1128/EC.05243-11; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller M, 2012, DIAGN MICR INFEC DIS, V74, P323, DOI 10.1016/j.diagmicrobio.2012.10.003; Pfaller MA, 2011, ANTIMICROB AGENTS CH, V55, P561, DOI 10.1128/AAC.01079-10; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodrigues CF, 2014, EUR J CLIN MICROBIOL, V33, P673, DOI 10.1007/s10096-013-2009-3; Sydorskyy Y, 2010, MOL CELL BIOL, V30, P4452, DOI 10.1128/MCB.00335-10; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Takahashi Y, 2001, J BIOL CHEM, V276, P48973, DOI 10.1074/jbc.M109295200; Takahashi Y, 2008, CELL CYCLE, V7, P1738, DOI 10.4161/cc.7.12.6156; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Walker LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000040; Wang YG, 2009, J CELL SCI, V122, P4249, DOI 10.1242/jcs.050542; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	58	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19573	19589		10.1074/jbc.M115.706044	http://dx.doi.org/10.1074/jbc.M115.706044			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27382059	Green Published, hybrid			2022-12-26	WOS:000383242800032
J	Fresco, VM; Kern, CB; Mohammadi, M; Twal, WO				Fresco, Victor M.; Kern, Christine B.; Mohammadi, Moosa; Twal, Waleed O.			Fibulin-1 Binds to Fibroblast Growth Factor 8 with High Affinity EFFECTS ON EMBRYO SURVIVAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRANIAL NEURAL CREST; EXTRACELLULAR-MATRIX; MOLECULAR-CLONING; CELL-MIGRATION; FGF8; FIBRONECTIN; MORPHOGENESIS; EXPRESSION; DELETION; SITES	Fibulin-1 (FBLN1) is a member of a growing family of extracellular matrix glycoproteins that includes eight members and is involved in cellular functions such as adhesion, migration, and differentiation. FBLN1 has also been implicated in embryonic heart and valve development and in the formation of neural crest derived structures, including aortic arch, thymus, and cranial nerves. Fibroblast growth factor 8 (FGF8) is a member of a large family of growth factors, and its functions include neural crest cell (NCC) maintenance, specifically NCC migration as well as patterning of structures formed from NCC such as outflow tract and cranial nerves. In this report, we sought to investigate whether FBLN1 and FGF8 have cooperative roles in vivo given their influence on the development of the same NCC-derived structures. Surface plasmon resonance binding data showed that FBLN1 binds tightly to FGF8 and prevents its enzymatic degradation by ADAM17. Moreover, overexpression of FBLN1 up-regulates FGF8 gene expression, and down-regulation of FBLN1 by siRNA inhibits FGF8 expression. The generation of a double mutant Fbln1 and mice (Fbln1(-/-) and Fgf8(-/-)) showed that haplo-insufficiency (Fbln1(+/-) and Ffg8(+/-)) resulted in increased embryonic mortality compared with single heterozygote crosses. The mortality of the FGF8/Fbln1 double heterozygote embryos occurred between 14.5 and 16.5 days post-coitus. In conclusion, FBLN1/FGF8 interaction plays a role in survival of vertebrate embryos, and reduced levels of both proteins resulted in added mortality in utero. The FBLN1/FGF8 interaction may also be involved in the survival of neural crest cell population during development.	[Twal, Waleed O.] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave,MSC 508, Charleston, SC 29425 USA; [Mohammadi, Moosa] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA	Medical University of South Carolina; New York University	Twal, WO (corresponding author), Med Univ South Carolina, Dept Regenerat Med & Cell Biol, 173 Ashley Ave,MSC 508, Charleston, SC 29425 USA.	twalwo@musc.edu	kasaei, fahime/T-7197-2018	Twal, Waleed/0000-0002-2888-4544; Kern, Christine/0000-0001-7955-8979; Mohammadi, Moosa/0000-0003-2434-9437	National Institutes of Health from NHLBI [R01 HL09506, P01 HL52813]; NIGMS [P30 GM103342]; National Institutes of Health [HL121382]; NIDCR [R01 DE-13686]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121382, F32HL009506, P01HL052813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103342] Funding Source: NIH RePORTER	National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01 HL09506 and P01 HL52813 from NHLBI and Grant P30 GM103342 from NIGMS (to South Carolina COBRE for Developmentally Based Cardiovascular Diseases). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grant HL121382.r Supported by NIDCR Grant R01 DE-13686.	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155; BALBONA K, 1992, J BIOL CHEM, V267, P20120; BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047; BOCKMAN DE, 1989, ANAT RECORD, V225, P209, DOI 10.1002/ar.1092250306; Castoldi M, 2002, BIOCHEM J, V362, P41, DOI 10.1042/0264-6021:3620041; Cooley MA, 2008, DEV BIOL, V319, P336, DOI 10.1016/j.ydbio.2008.04.029; Cooley MA, 2011, BIOL EXTRACELL MATR, P337, DOI 10.1007/978-3-642-16555-9_10; Draper BW, 2003, DEVELOPMENT, V130, P4639, DOI 10.1242/dev.00671; Farley AM, 2013, DEVELOPMENT, V140, P2015, DOI 10.1242/dev.087320; Frank DU, 2002, DEVELOPMENT, V129, P4591; Ghosh AK, 1996, CELL GROWTH DIFFER, V7, P1425; Goh KL, 1997, DEVELOPMENT, V124, P4309; GREENBERG JH, 1981, DEV BIOL, V87, P259, DOI 10.1016/0012-1606(81)90149-4; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Kern CB, 2006, DEV DYNAM, V235, P2238, DOI 10.1002/dvdy.20838; Kubota Y, 2004, CURR BIOL, V14, P2011, DOI 10.1016/j.cub.2004.10.047; Lee NV, 2005, J BIOL CHEM, V280, P34796, DOI 10.1074/jbc.M506980200; LORENZI MV, 1995, ONCOGENE, V10, P2051; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; Mittal A, 2013, DEV BIOL, V381, P73, DOI 10.1016/j.ydbio.2013.06.010; Moon AM, 2006, DEV CELL, V10, P71, DOI 10.1016/j.devcel.2005.12.003; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; Pan Y, 2014, MATRIX BIOL, V35, P253, DOI 10.1016/j.matbio.2013.10.013; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Phillips BT, 2001, DEV BIOL, V235, P351, DOI 10.1006/dbio.2001.0297; Pietri T, 2004, DEVELOPMENT, V131, P3871, DOI 10.1242/dev.01264; ROVASIO RA, 1983, J CELL BIOL, V96, P462, DOI 10.1083/jcb.96.2.462; Sato A, 2011, DEV BIOL, V354, P18, DOI 10.1016/j.ydbio.2011.03.010; SPENCE SG, 1992, DEV BIOL, V151, P473, DOI 10.1016/0012-1606(92)90186-K; Tran H, 1997, MATRIX BIOL, V15, P479, DOI 10.1016/S0945-053X(97)90021-4; Tran H, 1997, J BIOL CHEM, V272, P22600, DOI 10.1074/jbc.272.36.22600; Twal WO, 2015, MATRIX BIOL, V43, P97, DOI 10.1016/j.matbio.2015.01.021; Twal WO, 2001, J CELL SCI, V114, P4587; Vitelli F, 2002, DEVELOPMENT, V129, P4605; Wang C, 2006, MOL BIOL CELL, V17, P3075, DOI 10.1091/mbc.E05-11-1087; WILSON DI, 1993, J MED GENET, V30, P852, DOI 10.1136/jmg.30.10.852; ZHANG HY, 1993, DIFFERENTIATION, V52, P211, DOI 10.1111/j.1432-0436.1993.tb00633.x; Zhang R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136518; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	40	7	7	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18730	18739		10.1074/jbc.M115.702761	http://dx.doi.org/10.1074/jbc.M115.702761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402846	Green Published, hybrid			2022-12-26	WOS:000383242300011
J	Sullivan, LC; Berry, R; Sosnin, N; Widjaja, JML; Deuss, FA; Balaji, GR; LaGruta, NL; Mirams, M; Trapani, JA; Rossjohn, J; Brooks, AG; Andrews, DM				Sullivan, Lucy C.; Berry, Richard; Sosnin, Natasha; Widjaja, Jacqueline M. L.; Deuss, Felix A.; Balaji, Gautham R.; LaGruta, Nicole L.; Mirams, Michiko; Trapani, Joseph A.; Rossjohn, Jamie; Brooks, Andrew G.; Andrews, Daniel M.			Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; HLA-G; CRYSTAL-STRUCTURE; ANTIGEN PRESENTATION; NK CELLS; PEPTIDE CONFORMATION; STRUCTURAL BASIS; BINDING; EXPRESSION; CIS	Murine natural killer (NK) cells are regulated by the interaction of Ly49 receptors with major histocompatibility complex class I molecules (MHC-I). Although the ligands for inhibitory Ly49 were considered to be restricted to classical MHC (MHC-La), we have shown that the non-classical MHC molecule (MHC-Ib) H2-M3 was a ligand for the inhibitory Ly49A. Here we establish that another MHC-Ib, H2-Q10, is a bona fide ligand for the inhibitory Ly49C receptor. H2-Q10 bound to Ly49C with a marginally lower affinity (similar to-5 mu m) than that observed between Ly49C and MHC-Ia (H-2K(b)/H-2D(d), both similar to 1 mu m), and this recognition could be prevented by cis interactions with H-2K in situ. To understand the molecular details underpinning Ly49. MHC-Ib recognition, we determined the crystal structures of H2-Q10 and Ly49C bound H2-Q10. Unliganded H2-Q10 adopted a classical MHC-I fold and possessed a peptide-binding groove that exhibited features similar to those found in MHC-Ia, explaining the diverse peptide binding repertoire of H2-Q10. Ly49C bound to H2-Q10 underneath the peptide binding platform to a region that encompassed residues from the alpha 1, alpha 2, and alpha 3 domains, as well as the associated beta 2-microglobulin subunit. This docking mode was conserved with that previously observed for Ly490H-2K(b). Indeed, structure-guided mutation of Ly49C indicated that Ly49C center dot H2-Q10 and Ly49C center dot H-2K(b) possess similar energetic footprints focused around residues located within the Ly49C beta 4-stand and L5 loop, which contact the underside of the peptide-binding platform floor. Our data provide a structural basis for Ly49 center dot MHC-Ib recognition and demonstrate that MHC-Ib represent an extended family of ligands for Ly49 molecules.	[Sullivan, Lucy C.; Widjaja, Jacqueline M. L.; LaGruta, Nicole L.; Mirams, Michiko; Brooks, Andrew G.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Berry, Richard; Deuss, Felix A.; Balaji, Gautham R.; LaGruta, Nicole L.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia; [Berry, Richard; Deuss, Felix A.; Balaji, Gautham R.; LaGruta, Nicole L.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Berry, Richard; Deuss, Felix A.; Balaji, Gautham R.; Rossjohn, Jamie] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Sosnin, Natasha; Trapani, Joseph A.] Peter MacCallum Canc Ctr, Canc Cell Death Lab, East Melbourne, Vic 3000, Australia; [Trapani, Joseph A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Parkville, Vic 3010, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Andrews, Daniel M.] Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Melbourne, Vic 3004, Australia	University of Melbourne; Monash University; Monash University; Monash University; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Cardiff University; Monash University	Brooks, AG (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.; Andrews, DM (corresponding author), Monash Univ, Cent Clin Sch, Dept Immunol & Pathol, Burnet Inst, Level 6,89 Commercial Rd, Melbourne, Vic 3004, Australia.	jamie.rossjohn@monash.edu; agbrooks@unimelb.edu.au; dan.andrews@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Trapani, Joseph/0000-0003-0983-1532; Sosnin, Natasha/0000-0003-0481-3386; Deuss, Felix/0000-0002-0386-4336; Balaji, Gautham/0000-0002-7436-4689; Sullivan, Lucy/0000-0003-2907-4989; Brooks, Andrew/0000-0002-4085-9683; Andrews, Dan/0000-0002-5896-7885; berry, richard/0000-0001-7043-0469; La Gruta, Nicole/0000-0001-5358-9363	National Health and Medical Research Council (NHMRC); Sylvia and Charles Viertel Charitable Foundation; NHMRC Australia	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Charitable Foundation; NHMRC Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) Career Development Awards (to L. C. S., R. B, and D. M. A.), the Sylvia and Charles Viertel Charitable Foundation (to N. L L), and by an NHMRC Australia Fellowship (to J. R.). The authors declare that they have no conflicts of interest with the contents of this article.	Andrews DM, 2012, NAT IMMUNOL, V13, P1171, DOI 10.1038/ni.2468; Back J, 2009, IMMUNITY, V31, P598, DOI 10.1016/j.immuni.2009.07.007; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; Bessoles S, 2013, J IMMUNOL, V191, P5044, DOI 10.4049/jimmunol.1301971; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Clements CS, 2005, P NATL ACAD SCI USA, V102, P3360, DOI 10.1073/pnas.0409676102; COSMAN D, 1982, P NATL ACAD SCI-BIOL, V79, P4947, DOI 10.1073/pnas.79.16.4947; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Dimasi N, 2005, IMMUNOL CELL BIOL, V83, P1, DOI 10.1111/j.1440-1711.2005.01301.x; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; Goodridge JP, 2013, J IMMUNOL, V191, P3553, DOI 10.4049/jimmunol.1300081; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; He XL, 2001, STRUCTURE, V9, P1213, DOI 10.1016/S0969-2126(01)00689-X; Hoare HL, 2008, J MOL BIOL, V377, P1297, DOI 10.1016/j.jmb.2008.01.098; Hoare HL, 2006, NAT IMMUNOL, V7, P256, DOI 10.1038/ni1312; Ishitani A, 2003, J IMMUNOL, V171, P1376, DOI 10.4049/jimmunol.171.3.1376; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KIM S., 2008, P WORLD C ENG 2008 W, V1, P1, DOI DOI 10.1109/IEDM.2008.4796617; Kowiel M, 2014, ACTA CRYSTALLOGR D, V70, P3290, DOI 10.1107/S1399004714024572; KRESS M, 1983, CELL, V34, P189, DOI 10.1016/0092-8674(83)90149-6; LEE N, 1995, IMMUNITY, V3, P591, DOI 10.1016/1074-7613(95)90130-2; LeMaoult J, 2003, TISSUE ANTIGENS, V62, P273, DOI 10.1034/j.1399-0039.2003.00143.x; LEW AM, 1986, J IMMUNOL, V136, P254; MADDEN DR, 1993, CELL, V75, P693, DOI 10.1016/0092-8674(93)90490-H; Morandi F, 2011, BLOOD, V118, P5840, DOI 10.1182/blood-2011-05-352393; Morandi F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011763; O'Callaghan CA, 1998, MOL CELL, V1, P531, DOI 10.1016/S1097-2765(00)80053-2; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Rajagopalan S, 2014, CELL MOL IMMUNOL, V11, P460, DOI 10.1038/cmi.2014.53; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Saunders PM, 2015, IMMUNOL REV, V267, P148, DOI 10.1111/imr.12319; Scarpellino L, 2007, J IMMUNOL, V178, P1277, DOI 10.4049/jimmunol.178.3.1277; SHAWAR SM, 1994, ANNU REV IMMUNOL, V12, P839, DOI 10.1146/annurev.immunol.12.1.839; Takada T, 2003, GENOME RES, V13, P589, DOI 10.1101/gr.975303; Tormo J, 1999, NATURE, V402, P623, DOI 10.1038/45170; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; WANG CR, 1995, CELL, V82, P655, DOI 10.1016/0092-8674(95)90037-3; Zappacosta F, 2000, J IMMUNOL, V164, P1906, DOI 10.4049/jimmunol.164.4.1906	42	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18740	18752		10.1074/jbc.M116.737130	http://dx.doi.org/10.1074/jbc.M116.737130			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27385590	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000383242300012
J	Li, MH; Leng, TD; Feng, XC; Yang, T; Simon, RP; Xiong, ZG				Li, Ming-Hua; Leng, Tian-Dong; Feng, Xue-Chao; Yang, Tao; Simon, Roger P.; Xiong, Zhi-Gang			Modulation of Acid-sensing Ion Channel 1a by Intracellular pH and Its Role in Ischemic Stroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acid sensing ion channel (ASIC); brain; electrophysiology; ischemia; patch clamp	FOCAL CEREBRAL-ISCHEMIA; HIPPOCAMPAL-NEURONS; THERAPEUTIC TARGETS; CATION CHANNELS; ACTIVATED CURRENTS; TRANSIENT ISCHEMIA; EXTRACELLULAR PH; NERVOUS-SYSTEM; BRAIN-INJURY; RAT-BRAIN	An important contributor to brain ischemia is known to be extracellular acidosis, which activates acid-sensing ion channels (ASICs), a family of proton-gated sodium channels. Lines of evidence suggest that targeting ASICs may lead to novel therapeutic strategies for stroke. Investigations of the role of ASICs in ischemic brain injury have naturally focused on the role of extracellular pH in ASIC activation. By contrast, intracellular pH (pH(i)) has received little attention. This is a significant gap in our understanding because the ASIC response to extracellular pH is modulated by pH(i), and activation of ASICs by extracellular protons is paradoxically enhanced by intracellular alkalosis. Our previous studies show that acidosis-induced cell injury in in vitro models is attenuated by intracellular acidification. However, whether pH(i) affects ischemic brain injury in vivo is completely unknown. Furthermore, whereas ASICs in native neurons are composed of different subunits characterized by distinct electrophysiological/pharmacological properties, the subunit-dependent modulation of ASIC activity by pH(i) has not been investigated. Using a combination of in vitro and in vivo ischemic brain injury models, electrophysiological, biochemical, and molecular biological approaches, we show that the intracellular alkalizing agent quinine potentiates, whereas the intracellular acidifying agent propionate inhibits, oxygen-glucose deprivation-induced cell injury in vitro and brain ischemia-induced infarct volume in vivo. Moreover, we find that the potentiation of ASICs by quinine depends on the presence of the ASIC1a, ASIC2a subunits, but not ASIC1b, ASIC3 subunits. Furthermore, we have determined the amino acids in ASIC1a that are involved in the modulation of ASICs by pH(i).	[Li, Ming-Hua] Oregon Hlth & Sci Univ, Dept Neurol Surg, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Leng, Tian-Dong; Yang, Tao; Simon, Roger P.; Xiong, Zhi-Gang] Morehouse Sch Med, Dept Neurobiol, Inst Neurosci, Atlanta, GA 30310 USA; [Feng, Xue-Chao] Northeast Normal Univ, Inst Cytol & Genet, Minist Educ, Key Lab Mol Epigenet, Changchun 130000, Peoples R China	Oregon Health & Science University; Morehouse School of Medicine; Northeast Normal University - China	Li, MH (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol Surg, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Xiong, ZG (corresponding author), Morehouse Sch Med, Dept Neurobiol, 720 Westview Dr SW, Atlanta, GA 30310 USA.	limin@ohsu.edu; zxiong@msm.edu		feng, xuechao/0000-0003-2444-3757	American Heart Association [13SDG14590005]; National Institutes of Health [R01NS066027, U54NS08932]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS083932, R01NS066027] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by American Heart Association Grant 13SDG14590005 (to M. H. L.) and National Institutes of Health Grants R01NS066027 and U54NS08932 (to Z. G. X.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Back T, 2000, ANN NEUROL, V47, P485, DOI 10.1002/1531-8249(200004)47:4<485::AID-ANA12>3.3.CO;2-#; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Benveniste M, 2005, NEW ENGL J MED, V352, P85, DOI 10.1056/NEJMcibr045010; BLOMQVIST P, 1982, ACTA PHYSIOL SCAND, V116, P103, DOI 10.1111/j.1748-1716.1982.tb10606.x; Bonnet U, 2000, NEUROPHARMACOLOGY, V39, P2067, DOI 10.1016/S0028-3908(00)00033-2; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; BUSA WB, 1984, AM J PHYSIOL, V246, pR409, DOI 10.1152/ajpregu.1984.246.4.R409; Chen XM, 2007, J PHYSIOL-LONDON, V579, P657, DOI 10.1113/jphysiol.2006.120733; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHESLER M, 1990, PROG NEUROBIOL, V34, P401, DOI 10.1016/0301-0082(90)90034-E; CHOPP M, 1990, J CEREBR BLOOD F MET, V10, P860, DOI 10.1038/jcbfm.1990.142; Chu XP, 2012, CURR DRUG TARGETS, V13, P263, DOI 10.2174/138945012799201685; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; Chu XP, 2003, J PHYSIOL-LONDON, V550, P385, DOI 10.1113/jphysiol.2003.043091; Collins A, 2005, J CELL PHYSIOL, V202, P76, DOI 10.1002/jcp.20093; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; DEITMER JW, 1980, J PHYSIOL-LONDON, V304, P471, DOI 10.1113/jphysiol.1980.sp013337; Dixon DB, 1996, VISION RES, V36, P3925, DOI 10.1016/S0042-6989(96)00129-0; ERECINSKA M, 1989, J CEREBR BLOOD F MET, V9, P2, DOI 10.1038/jcbfm.1989.2; Frey EN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071733; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Joeres N, 2016, SCI REP-UK, V6, DOI 10.1038/srep27647; Johnson MB, 2001, J CEREBR BLOOD F MET, V21, P734, DOI 10.1097/00004647-200106000-00011; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; KATSURA K, 1991, J CEREBR BLOOD F MET, V11, P597, DOI 10.1038/jcbfm.1991.109; KATSURA K, 1992, EUR J NEUROSCI, V4, P166, DOI 10.1111/j.1460-9568.1992.tb00863.x; Krauson AJ, 2016, J BIOL CHEM, V291, P11407, DOI 10.1074/jbc.M115.702316; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Krishtal O, 2015, NEUROPHARMACOLOGY, V94, P4, DOI 10.1016/j.neuropharm.2014.12.014; Kweon HJ, 2013, BMB REP, V46, P295, DOI 10.5483/BMBRep.2013.46.6.121; LAMANNA JC, 1992, CAN J PHYSIOL PHARM, V70, pS269, DOI 10.1139/y92-272; Leng TD, 2014, PROG NEUROBIOL, V115, P189, DOI 10.1016/j.pneurobio.2013.12.008; Li MH, 2015, J PHYSIOL-LONDON, V593, P217, DOI 10.1113/jphysiol.2014.275701; Li MH, 2010, J PHYSIOL-LONDON, V588, P3883, DOI 10.1113/jphysiol.2010.192922; MABE H, 1983, J CEREBR BLOOD F MET, V3, P109, DOI 10.1038/jcbfm.1983.13; MacLean DM, 2016, J PHYSIOL-LONDON, V594, P2629, DOI 10.1113/JP271915; MUTCH WAC, 1984, J CEREBR BLOOD F MET, V4, P17, DOI 10.1038/jcbfm.1984.3; NEDERGAARD M, 1991, J NEUROSCI, V11, P2489; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Pfister Y, 2006, J BIOL CHEM, V281, P11787, DOI 10.1074/jbc.M513692200; Pignataro G, 2007, BRAIN, V130, P151, DOI 10.1093/brain/awl325; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; SIESJO BK, 1992, J NEUROSURG, V77, P337, DOI 10.3171/jns.1992.77.3.0337; Svichar N, 2011, J NEUROSCI, V31, P6997, DOI 10.1523/JNEUROSCI.6088-10.2011; TOMBAUGH GC, 1990, J CEREBR BLOOD F MET, V10, P527, DOI 10.1038/jcbfm.1990.94; Ugawa S, 2003, J NEUROSCI, V23, P3616; VONHANWEHR R, 1986, J NEUROCHEM, V46, P331; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2006, TRENDS NEUROSCI, V29, P578, DOI 10.1016/j.tins.2006.06.014; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Xiong ZG, 2007, FRONT BIOSCI-LANDMRK, V12, P1376, DOI 10.2741/2154; Yagi J, 2006, CIRC RES, V99, P501, DOI 10.1161/01.RES.0000238388.79295.4c; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100	69	27	28	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18370	18383		10.1074/jbc.M115.713636	http://dx.doi.org/10.1074/jbc.M115.713636			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402850	hybrid, Green Published			2022-12-26	WOS:000383241800028
J	Ionut, V; Woolcott, OO; Mkrtchyan, HJ; Stefanovski, D; Kabir, M; Iyer, MS; Liu, HW; Castro, AVB; Wu, Q; Broussard, JL; Kolka, CM; Asare-Bediako, I; Bergman, RN				Ionut, Viorica; Woolcott, Orison O.; Mkrtchyan, Hasmik J.; Stefanovski, Darko; Kabir, Morvarid; Iyer, Malini S.; Liu, Huiwen; Castro, Ana V. B.; Wu, Qiang; Broussard, Josiane L.; Kolka, Cathryn M.; Asare-Bediako, Isaac; Bergman, Richard N.			Exenatide Treatment Alone Improves beta-Cell Function in a Canine Model of Pre-Diabetes	PLOS ONE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; INSULIN SENSITIVITY; FASTING GLUCOSE; HUMAN ISLETS; EXENDIN-4; RESISTANCE; METFORMIN; RECEPTOR; HOMEOSTASIS; MECHANISM	Background Exenatide's effects on glucose metabolism have been studied extensively in diabetes but not in pre-diabetes. Objective We examined the chronic effects of exenatide alone on glucose metabolism in pre-diabetic canines. Design and Methods After 10 weeks of high-fat diet (HFD), adult dogs received one injection of streptozotocin (STZ, 18.5 mg/kg). After induction of pre-diabetes, while maintained on HFD, animals were randomized to receive either exenatide (n = 7) or placebo (n = 7) for 12 weeks. beta-Cell function was calculated from the intravenous glucose tolerance test (IVGTT, expressed as the acute insulin response, AIR(G)), the oral glucose tolerance test (OGTT, insulinogenic index) and the graded-hyperglycemic clamp (clamp insulinogenic index). Whole-body insulin sensitivity was assessed by the IVGTT. At the end of the study, pancreatic islets were isolated to assess beta-cell function in vitro. Results OGTT: STZ caused an increase in glycemia at 120 min by 22.0% (interquartile range, IQR, 31.5%) (P = 0.011). IVGTT: This protocol also showed a reduction in glucose tolerance by 48.8% (IQR, 36.9%) (P = 0.002). AIRG decreased by 54.0% (IQR, 40.7%) (P = 0.010), leading to mild fasting hyperglycemia (P = 0.039). Exenatide, compared with placebo, decreased body weight (P<0.001) without altering food intake, fasting glycemia, insulinemia, glycated hemoglobin A1c, or glucose tolerance. Exenatide, compared with placebo, increased both OGTT- (P = 0.040) and clamp-based insulinogenic indexes (P = 0.016), improved insulin secretion in vitro (P = 0.041), but had no noticeable effect on insulin sensitivity (P = 0.405). Conclusions In pre-diabetic canines, 12-week exenatide treatment improved beta-cell function but not glucose tolerance or insulin sensitivity. These findings demonstrate partial beneficial metabolic effects of exenatide alone on an animal model of pre-diabetes.	[Ionut, Viorica; Woolcott, Orison O.; Mkrtchyan, Hasmik J.; Stefanovski, Darko; Kabir, Morvarid; Iyer, Malini S.; Castro, Ana V. B.; Wu, Qiang; Broussard, Josiane L.; Kolka, Cathryn M.; Asare-Bediako, Isaac; Bergman, Richard N.] Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA; [Liu, Huiwen] Univ Southern Calif, Dept Physiol & Biophys, Los Angeles, CA USA	Cedars Sinai Medical Center; University of Southern California	Bergman, RN (corresponding author), Cedars Sinai Med Ctr, Diabet & Obes Res Inst, Los Angeles, CA 90048 USA.	Richard.Bergman@cshs.org	Woolcott, Orison O./AAQ-3440-2020; Kolka, Cathryn/B-1526-2015; Kabir, Morvarid/P-8154-2018	Woolcott, Orison O./0000-0003-2905-972X; Kolka, Cathryn/0000-0002-6636-7062; Kabir, Morvarid/0000-0003-0880-3767; Bergman, Richard/0000-0003-1539-4471; Iyer, Malini S./0000-0001-7776-7216	National Institutes of Health [DK29867, DK27619]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (DK29867 and DK27619 to RNB) (https://report.nih.gov/award/index.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2009, CURR DIABETES REP, V9, P193, DOI 10.1007/s11892-009-0032-7; Ader M, 2014, OBESITY, V22, P1238, DOI 10.1002/oby.20625; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Armato J, 2012, ENDOCR PRACT, V18, P342, DOI 10.4158/EP11194.OR; Bentsi-Barnes K, 2011, ISLETS, V3, P284, DOI 10.4161/isl.3.5.15938; Bergman RN, 2007, DIABETES, V56, P1489, DOI 10.2337/db07-9903; BERGMAN RN, 1981, J CLIN INVEST, V68, P1456, DOI 10.1172/JCI110398; Bradley DP, 2012, APPL PHYSIOL NUTR ME, V37, P893, DOI [10.1139/H2012-068, 10.1139/h2012-068]; Castro AVB, 2015, OBESITY, V23, P105, DOI 10.1002/oby.20906; Cechin SR, 2012, CELL TRANSPLANT, V21, P633, DOI 10.3727/096368911X576027; Colagiuri S, 2011, MED CLIN N AM, V95, P299, DOI 10.1016/j.mcna.2010.11.003; Deeds MC, 2011, LAB ANIM-UK, V45, P131, DOI 10.1258/la.2010.010090; DeFronzo RA, 2010, DIABETES CARE, V33, P951, DOI [10.2337/dc09-1521, 10.2337/dc10-0646]; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Gallwitz B, 2012, LANCET, V379, P2270, DOI 10.1016/S0140-6736(12)60479-6; Garber AJ, 2011, DIABETES CARE, V34, pS258, DOI 10.2337/dc11-s230; Gastaldelli A, 2014, CLIN ENDOCRINOL, V80, P545, DOI 10.1111/cen.12199; Gedulin BR, 2005, ENDOCRINOLOGY, V146, P2069, DOI 10.1210/en.2004-1349; GOKE R, 1993, J BIOL CHEM, V268, P19650; Hamilton LC., 2008, STAT STATA UPDATED V, P387; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Idris I, 2002, BIOCHEM PHARMACOL, V63, P993, DOI 10.1016/S0006-2952(01)00924-8; Ionut V, 2014, AM J PHYSIOL-ENDOC M, V307, pE644, DOI 10.1152/ajpendo.00244.2014; Ionut V, 2010, AM J PHYSIOL-ENDOC M, V298, pE38, DOI 10.1152/ajpendo.00466.2009; Karve A, 2010, DIABETES CARE, V33, P2355, DOI 10.2337/dc09-1957; Kelly AS, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-64; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Lotfy M, 2014, J ENDOCRINOL, V220, P291, DOI 10.1530/JOE-13-0426; Lupi R, 2008, DIABETES OBES METAB, V10, P515, DOI 10.1111/j.1463-1326.2007.00838.x; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Park YJ, 2013, DIABETOLOGIA, V56, P508, DOI 10.1007/s00125-012-2802-z; Parkes DG, 2001, METABOLISM, V50, P583, DOI 10.1053/meta.2001.22519; Richey JM, 2009, AM J PHYSIOL-ENDOC M, V296, pE1311, DOI 10.1152/ajpendo.90972.2008; Rosenstock J, 2010, DIABETES CARE, V33, P1173, DOI 10.2337/dc09-1203; Selph S, 2015, ANN INTERN MED, V162, P765, DOI 10.7326/M14-2221; Stefanovski D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018134; Tella H, 2015, THER ADV ENDOCRINOL, V6, P109, DOI 10.1177/2042018815580257; Vella A, 2002, DIABETOLOGIA, V45, P1410, DOI 10.1007/s00125-002-0924-4; Wang LN, 2011, PEPTIDES, V32, P1313, DOI 10.1016/j.peptides.2011.03.018; Waugh J, 2006, DRUGS, V66, P85, DOI 10.2165/00003495-200666010-00005; Weyer C, 2001, DIABETES CARE, V24, P89, DOI 10.2337/diacare.24.1.89; Woolcott OO, 2006, CELL CALCIUM, V39, P529, DOI 10.1016/j.ceca.2006.02.003; Woolcott OO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123558; Woolcott OO, 2012, PANCREAS, V41, P31, DOI 10.1097/MPA.0b013e318221fd0e; Zheng D, 2009, DIABETES, V58, P352, DOI 10.2337/db08-0875	46	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158703	10.1371/journal.pone.0158703	http://dx.doi.org/10.1371/journal.pone.0158703			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398720	Green Submitted, gold, Green Published			2022-12-26	WOS:000379508100006
J	Alford, JE; Marongiu, M; Watkins, GL; Anderson, EC				Alford, Justine E.; Marongiu, Michela; Watkins, Gemma L.; Anderson, Emma C.			Human Immunodeficiency Virus Type 2 (HIV-2) Gag Is Trafficked in an AP-3 and AP-5 Dependent Manner	PLOS ONE			English	Article							INTRACELLULAR TRAFFICKING; PLASMA-MEMBRANE; SPASTIC PARAPLEGIA; HUMAN MACROPHAGES; PROTEIN; CELLS; ENDOSOMES; PARTICLES; ASSEMBLES; INFECTION	Although human immunodeficiency virus (HIV) types 1 and 2 are closely related lentiviruses with similar replication cycles, HIV-2 infection is associated with slower progression to AIDS, a higher proportion of long term non-progressors, and lower rates of transmission than HIV-1, likely as a consequence of a lower viral load during HIV-2 infection. A mechanistic explanation for the differential viral load remains unclear but knowledge of differences in particle production between HIV-1 and HIV-2 may help to shed light on this issue. In contrast to HIV-1, little is known about the assembly of HIV-2 particles, and the trafficking of HIV-2 Gag, the structural component of the virus, within cells. We have established that HIV-2 Gag accumulates in intracellular CD63 positive compartments, from which it may be delivered or recycled to the cell surface, or degraded. HIV-2 particle release was dependent on the adaptor protein complex AP-3 and the newly identified AP-5 complex, but much less so on AP-1. In contrast, HIV-1 particle release required AP-1 and AP-3, but not AP-5. AP-2, an essential component of clathrin-mediated endocytosis, which was previously shown to be inhibitory to HIV-1 particle release, had no effect on HIV-2. The differential requirement for adaptor protein complexes confirmed that HIV-1 and HIV-2 Gag have distinct cellular trafficking pathways, and that HIV-2 particles may be more susceptible to degradation prior to release.	[Alford, Justine E.; Marongiu, Michela; Watkins, Gemma L.; Anderson, Emma C.] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England	University of Warwick	Anderson, EC (corresponding author), Univ Warwick, Sch Life Sci, Coventry, W Midlands, England.	e.c.anderson@warwick.ac.uk			UK Medical Research Council [G0701220]; Medical Research Council; MRC [G0701220] Funding Source: UKRI; Medical Research Council [G0701220] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (grant number G0701220 to ECA). JEA and GLW were recipients of Medical Research Council PhD studentships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091429; Azevedo C, 2009, P NATL ACAD SCI USA, V106, P21161, DOI 10.1073/pnas.0909176106; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; de Silva TI, 2008, TRENDS MICROBIOL, V16, P588, DOI 10.1016/j.tim.2008.09.003; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Gaudin R, 2012, J CELL BIOL, V199, P467, DOI 10.1083/jcb.201201144; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Griffin SDC, 2001, J VIROL, V75, P12058, DOI 10.1128/JVI.75.24.12058-12069.2001; Hirst J, 2013, MOL BIOL CELL, V24, P2558, DOI 10.1091/mbc.E13-03-0170; Hirst J, 2013, TRAFFIC, V14, P153, DOI 10.1111/tra.12028; Hirst J, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001170; Hogue IB, 2011, J VIROL, V85, P9749, DOI 10.1128/JVI.00743-11; Hunt SD, 2011, BIOCHEM SOC T, V39, P1179, DOI 10.1042/BST0391179; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; KANKI PJ, 1994, LANCET, V343, P943, DOI 10.1016/S0140-6736(94)90065-5; Lee SK, 2012, J BIOL CHEM, V287, P40867, DOI 10.1074/jbc.R112.399444; Liu L, 2012, J VIROL, V86, P11242, DOI 10.1128/JVI.00544-12; LUO LZ, 1990, VIROLOGY, V179, P874, DOI 10.1016/0042-6822(90)90159-O; MacNeil A, 2007, J VIROL, V81, P5325, DOI 10.1128/JVI.02625-06; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; Morikawa Y, 2007, J VIROL, V81, P9911, DOI 10.1128/JVI.00027-07; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Pachulska-Wieczorek K, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0245-1; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Popov S, 2011, J VIROL, V85, P3792, DOI 10.1128/JVI.02329-10; Popper SJ, 1999, J INFECT DIS, V180, P1116, DOI 10.1086/315010; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Saad JS, 2008, J MOL BIOL, V382, P434, DOI 10.1016/j.jmb.2008.07.027; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Zhang FW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002119	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158941	10.1371/journal.pone.0158941	http://dx.doi.org/10.1371/journal.pone.0158941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392064	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400167
J	Monaghan, KA				Monaghan, Kieran A.			Four Reasons to Question the Accuracy of a Biotic Index; the Risk of Metric Bias and the Scope to Improve Accuracy	PLOS ONE			English	Article							WATER-QUALITY; INDICATOR VALUES; ABUNDANCE; TOOL; REAPPRAISAL; ORGANISMS; MODEL	Natural ecological variability and analytical design can bias the derived value of a biotic index through the variable influence of indicator body-size, abundance, richness, and ascribed tolerance scores. Descriptive statistics highlight this risk for 26 aquatic indicator systems; detailed analysis is provided for contrasting weighted-average indices applying the example of the BMWP, which has the best supporting data. Differences in body size between taxa from respective tolerance classes is a common feature of indicator systems; in some it represents a trend ranging from comparatively small pollution tolerant to larger intolerant organisms. Under this scenario, the propensity to collect a greater proportion of smaller organisms is associated with negative bias however, positive bias may occur when equipment (e.g. mesh-size) selectively samples larger organisms. Biotic indices are often derived from systems where indicator taxa are unevenly distributed along the gradient of tolerance classes. Such skews in indicator richness can distort index values in the direction of taxonomically rich indicator classes with the subsequent degree of bias related to the treatment of abundance data. The misclassification of indicator taxa causes bias that varies with the magnitude of the misclassification, the relative abundance of misclassified taxa and the treatment of abundance data. These artifacts of assessment design can compromise the ability to monitor biological quality. The statistical treatment of abundance data and the manipulation of indicator assignment and class richness can be used to improve index accuracy. While advances in methods of data collection (i.e. DNA barcoding) may facilitate improvement, the scope to reduce systematic bias is ultimately limited to a strategy of optimal compromise. The shortfall in accuracy must be addressed by statistical pragmatism. At any particular site, the net bias is a probabilistic function of the sample data, resulting in an error variance around an average deviation. Following standardized protocols and assigning precise reference conditions, the error variance of their comparative ratio (test-site: reference) can be measured and used to estimate the accuracy of the resultant assessment.	[Monaghan, Kieran A.] Univ Aveiro, CESAM Ctr Environm & Marine Studies, Campus Univ Santiago, P-3810193 Aveiro, Portugal; [Monaghan, Kieran A.] Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3810193 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	Monaghan, KA (corresponding author), Univ Aveiro, CESAM Ctr Environm & Marine Studies, Campus Univ Santiago, P-3810193 Aveiro, Portugal.; Monaghan, KA (corresponding author), Univ Aveiro, Dept Biol, Campus Univ Santiago, P-3810193 Aveiro, Portugal.	kamonaghan@ua.pt		monaghan, kieran/0000-0002-3063-7817	CESAM [UID/AMB/50017]; FCT/MEC through national funds; FEDER, within the PT Partnership Agreement and Compete; FCT fellowship [SFRH/BPD98533/2013]	CESAM; FCT/MEC through national funds(Portuguese Foundation for Science and Technology); FEDER, within the PT Partnership Agreement and Compete; FCT fellowship(Portuguese Foundation for Science and Technology)	Thanks are due, for the financial support to CESAM (UID/AMB/50017), to FCT/MEC through national funds, and the co-funding by the FEDER, within the PT2020 Partnership Agreement and Compete 2020. KAM is recipient of FCT fellowship (SFRH/BPD98533/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN MM, 1984, WATER RES, V18, P145, DOI 10.1016/0043-1354(84)90062-9; Andersen T., 2013, INSECT SYST EVOL SUP, V66, P1; [Anonymous], 2000, OFFICIAL J EUROPEAN, V327; Armitage P. D., 1995, CHIRONOMIDAE BIOL EC; ARMITAGE PD, 1983, WATER RES, V17, P333, DOI 10.1016/0043-1354(83)90188-4; Baird DJ, 2012, MOL ECOL, V21, P2039, DOI 10.1111/j.1365-294X.2012.05519.x; Bennett C, 2011, HYDROBIOLOGIA, V667, P31, DOI 10.1007/s10750-011-0635-2; Besse-Lototskaya A, 2011, ECOL INDIC, V11, P456, DOI 10.1016/j.ecolind.2010.06.017; Birk S, 2012, ECOL INDIC, V18, P31, DOI 10.1016/j.ecolind.2011.10.009; Borja A, 2000, MAR POLLUT BULL, V40, P1100, DOI 10.1016/S0025-326X(00)00061-8; Brinkhurst R. O., 1971, AQUATIC OLIGOCHAETA; Cao Y, 2002, ECOL MONOGR, V72, P41, DOI 10.1890/0012-9615(2002)072[0041:COECTP]2.0.CO;2; Carlisle DM, 2007, ECOL INDIC, V7, P22, DOI 10.1016/j.ecolind.2005.09.005; Chilundo M, 2008, PHYS CHEM EARTH, V33, P655, DOI 10.1016/j.pce.2008.06.055; Clarke RT, 2013, HYDROBIOLOGIA, V704, P39, DOI 10.1007/s10750-012-1245-3; Council of the European Communities, 1992, OFFICIAL J EUROPEAN, V35, P7, DOI DOI 10.1017/CB09780511610851.039; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Demars BOL, 2012, FRESHWATER BIOL, V57, P1745, DOI 10.1111/j.1365-2427.2012.02834.x; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; Diekmann M, 2003, BASIC APPL ECOL, V4, P493, DOI 10.1078/1439-1791-00185; Dornelas M, 2014, SCIENCE, V344, P296, DOI 10.1126/science.1248484; ELLENBERG H., 1948, Berichte uber Landtechnik, V4, P130; Feio MJ, 2006, INT REV HYDROBIOL, V91, P509, DOI 10.1002/iroh.200610877; Gray BR, 2005, ECOL MODEL, V185, P1, DOI 10.1016/j.ecolmodel.2004.11.006; Hawkes HA, 1998, WATER RES, V32, P964, DOI 10.1016/S0043-1354(97)00275-3; Hayek LC, 1997, SURVEYING NATURAL PO; Hildrew Alan G., 2007, P326; HILSENHOFF W L, 1988, Journal of the North American Benthological Society, V7, P65, DOI 10.2307/1467832; HILSENHOFF WL, 1987, GREAT LAKES ENTOMOL, V20, P31; Hudson PL, 1998, J KANSAS ENTOMOL SOC, V71, P456; Jaynes ET, 2003, PROBABILITY THEORY L, P753; Kelly M, 2011, ECOL INDIC, V11, P1492, DOI 10.1016/j.ecolind.2011.02.014; Kelly MG, 1998, WATER RES, V32, P236, DOI 10.1016/S0043-1354(97)00157-7; KLERKS PL, 1987, ENVIRON POLLUT, V45, P173, DOI 10.1016/0269-7491(87)90057-1; Kolkwitz R., 1902, MITT PRUFUNGSANST WA, V1, P33; LENAT DR, 1993, J N AM BENTHOL SOC, V12, P279, DOI 10.2307/1467463; Lenoir A, 1996, P INT S INNSBR AUSTR; Magurran A.E, 2004, MEASURING BIOL DIVER; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Monaghan KA, 2015, HYDROBIOLOGIA, V760, P91, DOI 10.1007/s10750-015-2307-0; Niyogi S, 2004, ENVIRON SCI TECHNOL, V38, P6177, DOI 10.1021/es0496524; Norris RH, 1993, FRESHWATER BIOMONITO; PFRENDER ME, 2010, Q REV BIOL, V85, P319, DOI DOI 10.1086/655118; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; R Core Team, 2021, R LANGUAGE ENV STAT; Ranasinghe JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040875; Rimet F, 2012, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2012018; Round FE, 2007, DIATOMS BIOL MORPHOL; Schmidt-Kloiber A, 2015, ECOL INDIC, V53, P271, DOI 10.1016/j.ecolind.2015.02.007; Silveira MP, 2005, ENVIRON MONIT ASSESS, V101, P117; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tachet H., 2000, INVERTEBRES EAU DOUC; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; TAYLOR LR, 1978, J ANIM ECOL, V47, P383, DOI 10.2307/3790; Ter Braak C. J. F., 1995, P91; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tokeshi M, 2002, POPUL ECOL, V44, P189, DOI 10.1007/s101440200022; UK National Biodiversity Network, SEPA MACR DAT SCOTT; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Walley WJ, 2001, WATER RES, V35, P4285, DOI 10.1016/S0043-1354(01)00162-2; Walley WJ, 1996, WATER RES, V30, P2086, DOI 10.1016/0043-1354(96)00013-9; Warwick RM, 2010, MAR POLLUT BULL, V60, P554, DOI 10.1016/j.marpolbul.2009.11.009; WARWICK RM, 1986, MAR BIOL, V92, P557, DOI 10.1007/BF00392515; Whitfield J, 2001, NATURE, V411, P989, DOI 10.1038/35082694; Wright John F., 2000, P1	68	9	9	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158383	10.1371/journal.pone.0158383	http://dx.doi.org/10.1371/journal.pone.0158383			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392036	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400050
J	Mozar, A; Lin, H; Williams, K; Chin, C; Li, R; Kondegowda, NG; Stewart, AF; Garcia-Ocana, A; Vasavada, RC				Mozar, Anais; Lin, Hugo; Williams, Katoura; Chin, Connie; Li, Rosemary; Kondegowda, Nagesha Guthalu; Stewart, Andrew F.; Garcia-Ocana, Adolfo; Vasavada, Rupangi Chhaya			Parathyroid Hormone-Related Peptide (1-36) Enhances Beta Cell Regeneration and Increases Beta Cell Mass in a Mouse Model of Partial Pancreatectomy	PLOS ONE			English	Article							ISLET HYPERPLASIA; IN-VIVO; PROTEIN; PROLIFERATION; ACTIVATION; KINASE; GROWTH; OVEREXPRESSION; MECHANISMS; INDUCTION	Aims/Hypothesis Finding ways to stimulate the regeneration of endogenous pancreatic beta cells is an important goal in the treatment of diabetes. Parathyroid hormone-related protein (PTHrP), the full-length (1-139) and amino-terminal (1-36) peptides, enhance beta cell function, proliferation, and survival. Therefore, we hypothesize that PTHrP(1-36) has the potential to regenerate endogenous beta cells. Methods The partial pancreatectomy (PPx) mouse model of beta cell injury was used to test this hypothesis. Male Balb/c mice underwent either sham-operation or PPx, and were subsequently injected with PTHrP(1-36) (160 mu g/kg) or vehicle (veh), for 7, 30, or 90 days. The four groups of mice, sham-veh, sham-PTHrP, PPx-veh, and PPx-PTHrP were assessed for PTHrP and receptor expression, and glucose and beta cell homeostasis. Results PTHrP-receptor, but not the ligand, was significantly up-regulated in islets from mice that underwent PPx compared to sham-operated mice. This suggests that exogenous PTHrP could further enhance beta cell regeneration after PPx. PTHrP did not significantly affect body weight, blood glucose, plasma insulin, or insulin sensitivity, in either sham or PPx mice. Glucose tolerance improved in the PPx-PTHrP versus PPx-veh mice only in the early stages of treatment. As hypothesized, there was a significant increase in beta cell proliferation in PPx-PTHrP mice at days 7 and 30; however, this was normalized by day 90, compared to PPx-veh mice. Enhanced beta cell proliferation translated to a marked increase in beta cell mass at day 90, in PPx-PTHrP versus PPx-veh mice. Conclusions PTHrP(1-36) significantly enhances beta cell regeneration through increased beta cell proliferation and beta cell mass after PPx. Future studies will determine the potential of PTHrP to enhance functional beta cell mass in the setting of diabetes.	[Mozar, Anais; Li, Rosemary; Kondegowda, Nagesha Guthalu; Stewart, Andrew F.; Garcia-Ocana, Adolfo; Vasavada, Rupangi Chhaya] Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA; [Lin, Hugo; Williams, Katoura; Chin, Connie] Univ Pittsburgh, Div Endocrinol, Pittsburgh, PA USA; [Mozar, Anais] Univ Antilles Guyane, CHU Pointe A Pitre, UMR Inserm U1134, Pointe A Pitre, Guadeloupe, France; [Williams, Katoura] Univ Tennessee, Grad Sch Med, Knoxville, TN USA; [Chin, Connie] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA	Icahn School of Medicine at Mount Sinai; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CHU Guadeloupe; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite des Antilles; University of Tennessee System; University of Tennessee Health Science Center; Case Western Reserve University	Vasavada, RC (corresponding author), Icahn Sch Med Mt Sinai, Diabet Obes & Metab Inst, New York, NY 10029 USA.	rupangi.vasavada@mssm.edu		Li, Rosemary/0000-0002-2605-634X	National Institutes of Health [DK078060]; Juvenile Diabetes Research Foundation [17-2012-46]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105015, P30DK020541, R01DK102893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK078060) and the Juvenile Diabetes Research Foundation (17-2012-46) to RCV.	Alvarez-Perez JC, 2014, DIABETES, V63, P216, DOI 10.2337/db13-0333; ASA SL, 1990, J CLIN ENDOCR METAB, V71, P1112, DOI 10.1210/jcem-71-5-1112; Augustine M, 2013, CURR OSTEOPOROS REP, V11, P400, DOI 10.1007/s11914-013-0171-2; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Boggi U, 2013, CURR OPIN ORGAN TRAN, V18, P102, DOI 10.1097/MOT.0b013e32835c28c5; Bonner-Weir S, 2010, DIABETES, V59, P2340, DOI 10.2337/db10-0084; Cebrian A, 2002, DIABETES, V51, P3003, DOI 10.2337/diabetes.51.10.3003; De Leon DD, 2003, DIABETES, V52, P365, DOI 10.2337/diabetes.52.2.365; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; DRUCKER DJ, 1989, MOL ENDOCRINOL, V3, P1589, DOI 10.1210/mend-3-10-1589; Faucheux C, 2004, DEV DYNAM, V231, P88, DOI 10.1002/dvdy.20117; de Castro LF, 2010, TISSUE ENG PT A, V16, P1157, DOI 10.1089/ten.TEA.2009.0355; Frolik CA, 2003, BONE, V33, P372, DOI 10.1016/S8756-3282(03)00202-3; Fujinaka Y, 2004, DIABETES, V53, P3120, DOI 10.2337/diabetes.53.12.3120; Gremizzi C, 2010, CURR OPIN ORGAN TRAN, V15, P119, DOI 10.1097/MOT.0b013e32833552bc; Guo J, 1997, AM J PHYSIOL-ENDOC M, V273, pE383, DOI 10.1152/ajpendo.1997.273.2.E383; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P569, DOI 10.1210/jc.2002-021122; Kondegowda NG, 2010, DIABETES, V59, P3131, DOI 10.2337/db09-1796; Kudo S, 2011, OSTEOARTHR CARTILAGE, V19, P886, DOI 10.1016/j.joca.2011.04.007; Lee JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008653; Macica CM, 2006, GLIA, V53, P637, DOI 10.1002/glia.20319; McCall M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007823; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; Perl S, 2010, J CLIN ENDOCR METAB, V95, pE234, DOI 10.1210/jc.2010-0932; Philbrick WM, 1996, PHYSIOL REV, V76, P127, DOI 10.1152/physrev.1996.76.1.127; PLAWNER LL, 1995, J BIOL CHEM, V270, P14078, DOI 10.1074/jbc.270.23.14078; Porter SE, 1998, ENDOCRINOLOGY, V139, P3743, DOI 10.1210/en.139.9.3743; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Sachdeva MM, 2009, MOL ENDOCRINOL, V23, P747, DOI 10.1210/me.2008-0400; Sawada Y, 2001, MOL CELL ENDOCRINOL, V182, P265, DOI 10.1016/S0303-7207(01)00482-8; Sawada Y, 2000, ENDOCR PATHOL, V11, P31, DOI 10.1385/EP:11:1:31; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Tschen SI, 2009, DIABETES, V58, P1312, DOI 10.2337/db08-1651; Vasavada RC, 1996, J BIOL CHEM, V271, P1200, DOI 10.1074/jbc.271.2.1200; Vasavada RC, 2007, DIABETES, V56, P2732, DOI 10.2337/db07-0461; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; Villanueva-Penacarrillo ML, 1999, J ENDOCRINOL, V163, P403, DOI 10.1677/joe.0.1630403; Williams K, 2011, DIABETOLOGIA, V54, P2867, DOI 10.1007/s00125-011-2260-z; Wysolmerski JJ, 2012, J CLIN ENDOCR METAB, V97, P2947, DOI 10.1210/jc.2012-2142; Zhang B, 2003, DIABETES, V52, P2720, DOI 10.2337/diabetes.52.11.2720	40	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158414	10.1371/journal.pone.0158414	http://dx.doi.org/10.1371/journal.pone.0158414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391423	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400057
J	Mutyambai, DM; Bruce, TJA; van den Berg, J; Midega, CAO; Pickett, JA; Khan, ZR				Mutyambai, Daniel M.; Bruce, Toby J. A.; van den Berg, Johnnie; Midega, Charles A. O.; Pickett, John A.; Khan, Zeyaur R.			An Indirect Defence Trait Mediated through Egg-Induced Maize Volatiles from Neighbouring Plants	PLOS ONE			English	Article							HERBIVORE-INDUCED VOLATILES; INDUCED RESISTANCE; CHILO-PARTELLUS; SPIDER-MITES; STEM BORERS; CIS-JASMONE; OVIPOSITION; RESPONSES; SIGNALS; APHID	Attack of plants by herbivorous arthropods may result in considerable changes to the plant's chemical phenotype with respect to emission of herbivore-induced plant volatiles (HIPVs). These HIPVs have been shown to act as repellents to the attacking insects as well as attractants for the insects antagonistic to these herbivores. Plants can also respond to HIPV signals from other plants that warn them of impending attack. Recent investigations have shown that certain maize varieties are able to emit volatiles following stemborer egg deposition. These volatiles attract the herbivore's parasitoids and directly deter further oviposition. However, it was not known whether these oviposition-induced maize (Zea mays, L.) volatiles can mediate chemical phenotypic changes in neighbouring unattacked maize plants. Therefore, this study sought to investigate the effect of oviposition-induced maize volatiles on intact neighbouring maize plants in 'Nyamula', a landrace known to respond to oviposition, and a standard commercial hybrid, HB515, that did not. Headspace volatile samples were collected from maize plants exposed to Chilo partellus (Swinhoe) (Lepidoptera: Crambidae) egg deposition and unoviposited neighbouring plants as well as from control plants kept away from the volatile emitting ones. Behavioural bioassays were carried out in a four-arm olfactometer using egg (Trichogramma bournieri Pintureau & Babault (Hymenoptera: Trichogrammatidae)) and larval (Cotesia sesamiae Cameron (Hymenoptera: Braconidae)) parasitoids. Coupled Gas Chromatography-Mass Spectrometry (GC-MS) was used for volatile analysis. For the ` Nyamula' landrace, GC-MS analysis revealed HIPV production not only in the oviposited plants but also in neighbouring plants not exposed to insect eggs. Higher amounts of EAG-active biogenic volatiles such as (E)-4,8-dimethyl-1,3,7-nonatriene were emitted from these plants compared to control plants. Subsequent behavioural assays with female T. bournieri and C. sesamiae parasitic wasps indicated that these parasitoids preferred volatiles from oviposited and neighbouring landrace plants compared to those from the control plants. This effect was absent in the standard commercial hybrid we tested. There was no HIPV induction and no difference in parasitoid attraction in neighbouring and control hybrid maize plants. These results show plant-plant signalling: 'Nyamula' maize plants emitting oviposition-induced volatiles attractive to the herbivore's natural enemies can induce this indirect defence trait in conspecific neighbouring undamaged maize plants. Maize plants growing in a field may thus benefit from this indirect defence through airborne signalling which may enhance the fitness of the volatile-emitting plant by increasing predation pressure on herbivores.	[Mutyambai, Daniel M.; Midega, Charles A. O.; Khan, Zeyaur R.] Int Ctr Insect Physiol & Ecol, Habitat Management Programme, POB 30-40305, Mbita, Kenya; [van den Berg, Johnnie; Khan, Zeyaur R.] North West Univ, Sch Biol Sci, ZA-2520 Potchefstroom, South Africa; [Mutyambai, Daniel M.] South Eastern Kenya Univ, Dept Biol, POB 170-90200, Kitui, Kenya; [Bruce, Toby J. A.; Pickett, John A.] Rothamsted Res, Dept Biol Chem, Harpenden AL5 2JQ, Herts, England	International Centre of Insect Physiology & Ecology (ICIPE); North West University - South Africa; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Mutyambai, DM (corresponding author), Int Ctr Insect Physiol & Ecol, Habitat Management Programme, POB 30-40305, Mbita, Kenya.; Mutyambai, DM (corresponding author), South Eastern Kenya Univ, Dept Biol, POB 170-90200, Kitui, Kenya.	dmutyambai@icipe.org	Van den Berg, Johnnie/M-7256-2013; Bruce, Toby JA/H-3131-2011	Van den Berg, Johnnie/0000-0002-6831-3180; Bruce, Toby JA/0000-0002-9912-0605	German Academic Exchange [A/11/94849]; European Union [DCI-FOOD.2010/230224]; German Academic Exchange (DAAD) fellowship; Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/C/00004945, BBS/E/C/00004944, BB/J011371/1, BBS/E/C/00005194, BB/J020281/1] Funding Source: researchfish; BBSRC [BBS/E/C/00005194, BB/J020281/1, BBS/E/C/00004945, BB/J011371/1, BBS/E/C/00004944] Funding Source: UKRI	German Academic Exchange(Deutscher Akademischer Austausch Dienst (DAAD)); European Union(European Commission); German Academic Exchange (DAAD) fellowship(Deutscher Akademischer Austausch Dienst (DAAD)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by German Academic Exchange, A/11/94849 (https://www.daad.de/en/) and European Union DCI-FOOD.2010/230224 (http://europa.eu/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to local farmers in Homabay County, Kenya, for providing landrace maize seeds. We thank Amos Gadi, Isaac Odera, Silas Ouko, Kennedy Omendo and Daniel Simiyu for insect rearing, technical assistance and screen house operations. Financial support was from German Academic Exchange (DAAD) fellowship to Daniel Mutyambai and European Union funded ADOPT Project DCI-FOOD.2010/230224. Rothamsted Research receives grant-aided support from Biotechnology and Biological Sciences Research Council (BBSRC).	Agelopoulos NG, 1999, J CHEM ECOL, V25, P1411, DOI 10.1023/A:1020939112234; [Anonymous], 2005, NIST MASS SPECTR SEA; [Anonymous], 2013, R3 0 R FDN STAT COMP; Arimura G, 2000, NATURE, V406, P512, DOI 10.1038/35020072; Arimura G, 2002, PLANT J, V29, P87, DOI 10.1046/j.1365-313x.2002.01198.x; Arimura G, 2001, BIOCHEM SYST ECOL, V29, P1049, DOI 10.1016/S0305-1978(01)00049-7; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; BALDWIN IT, 1983, SCIENCE, V221, P277, DOI 10.1126/science.221.4607.277; Bate NJ, 1998, PLANT J, V16, P561, DOI 10.1046/j.1365-313x.1998.00324.x; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Bruce TJA, 2003, PEST MANAG SCI, V59, P1031, DOI 10.1002/ps.730; Bruce TJA, 2010, BIOL LETTERS, V6, P314, DOI 10.1098/rsbl.2009.0953; BRUIN J, 1992, EXPERIENTIA, V48, P525, DOI 10.1007/BF01928181; Chamberlain K, 2001, BIOCHEM SYST ECOL, V29, P1063, DOI 10.1016/S0305-1978(01)00050-3; Chamberlain K, 2014, SKVORTSOVIA, V1, P112; Chamberlain K, 2000, MOL PLANT PATHOL, V1, P67, DOI 10.1046/j.1364-3703.2000.00009.x; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Penaflor MFGV, 2011, PLANTA, V234, P207, DOI 10.1007/s00425-011-1409-9; FOWLER SV, 1985, AM NAT, V126, P181, DOI 10.1086/284408; Gomi K, 2003, J PLANT PHYSIOL, V160, P1219, DOI 10.1078/0176-1617-01177; Gouinguene S, 2001, CHEMOECOLOGY, V11, P9, DOI 10.1007/PL00001832; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Hilker M, 2002, ENTOMOL EXP APPL, V104, P181, DOI 10.1023/A:1021232319226; Hilker M, 2006, J CHEM ECOL, V32, P1379, DOI 10.1007/s10886-006-9057-4; Hoballah ME, 2004, OIKOS, V105, P168, DOI 10.1111/j.0030-1299.2004.12831.x; Hoballah MEF, 2002, J CHEM ECOL, V28, P951, DOI 10.1023/A:1015253600083; Karban R, 2000, OECOLOGIA, V125, P66, DOI 10.1007/PL00008892; Karban R, 2002, ECOLOGY, V83, P1209, DOI 10.1890/0012-9658(2002)083[1209:TFCOIE]2.0.CO;2; Karban R., 1997, INDUCED RESPONSES HE, DOI [DOI 10.7208/CHICAG0/9780226424972.001.0001, 10.7208/chicago/9780226424972.001.0001]; Karban R, 2011, FUNCT ECOL, V25, P339, DOI 10.1111/j.1365-2435.2010.01789.x; Kessler A, 2002, ANNU REV PLANT BIOL, V53, P299, DOI 10.1146/annurev.arplant.53.100301.135207; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kfir R, 2002, ANNU REV ENTOMOL, V47, P701, DOI 10.1146/annurev.ento.47.091201.145254; Khan ZR, 2010, J EXP BOT, V61, P4185, DOI 10.1093/jxb/erq229; Khan ZR, 1997, NATURE, V388, P631, DOI 10.1038/41681; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; Mutyambai DM, 2015, J CHEM ECOL, V41, P323, DOI 10.1007/s10886-015-0570-1; Mutyambai DM, 2014, ENTOMOL EXP APPL, V153, P170, DOI 10.1111/eea.12237; Mutyambai DM, 2015, THESIS; Ninkovic V, 2002, ENTOMOL EXP APPL, V102, P177, DOI 10.1023/A:1015851430481; OCHIENG RS, 1985, INSECT SCI APPL, V6, P425, DOI 10.1017/S1742758400004744; Overholt WA, 1994, INSECT SCI APPL, V15, P253, DOI 10.1017/S1742758400017549; Paschold A, 2006, PLANT J, V45, P275, DOI 10.1111/j.1365-313X.2005.02623.x; Pettersson J, 1999, ACTA AGR SCAND B-S P, V49, P152, DOI 10.1080/09064719909362511; PETTERSSON J, 1970, Entomologica Scandinavica, V1, P63; Pickett JA, 2001, TRENDS PLANT SCI, V6, P137, DOI 10.1016/S1360-1385(01)01899-4; Pickett JA, 2014, CURR OPIN BIOTECH, V26, P125, DOI 10.1016/j.copbio.2013.12.006; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; Roda AL, 2003, BASIC APPL ECOL, V4, P15, DOI 10.1078/1439-1791-00130; Rodriguez-Saona CR, 2009, J CHEM ECOL, V35, P163, DOI 10.1007/s10886-008-9579-z; Ruther J, 2005, J CHEM ECOL, V31, P2217, DOI 10.1007/s10886-005-6413-8; Giron-Calva PS, 2012, J CHEM ECOL, V38, P226, DOI 10.1007/s10886-012-0072-3; Schaller A., 2008, INDUCED PLANT RESIST; SHONLE I, 1995, ECOLOGY, V76, P2660, DOI 10.2307/2265837; Shulaev V, 1997, NATURE, V385, P718, DOI 10.1038/385718a0; Takabayashi J., 1991, Chemoecology, VNo. 2, P1, DOI 10.1007/BF01240659; Tamiru A, 2015, CURR OPIN INSECT SCI, V9, P51, DOI 10.1016/j.cois.2015.02.011; Tamiru A, 2012, J CHEM ECOL, V38, P231, DOI 10.1007/s10886-012-0082-1; Tamiru A, 2011, ECOL LETT, V14, P1075, DOI 10.1111/j.1461-0248.2011.01674.x; Tscharntke T, 2001, BIOCHEM SYST ECOL, V29, P1025, DOI 10.1016/S0305-1978(01)00048-5; Turlings TCJ, 1998, BIOL CONTROL, V11, P122, DOI 10.1006/bcon.1997.0591; van den Berg J., 1998, P333; Van den Berg J., 1998, AFRICAN CEREAL STEMB; War AR, 2011, PLANT SIGNAL BEHAV, V6, P1973, DOI 10.4161/psb.6.12.18053	66	12	13	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158744	10.1371/journal.pone.0158744	http://dx.doi.org/10.1371/journal.pone.0158744			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392034	Green Published, gold, Green Accepted			2022-12-26	WOS:000380005400114
J	Natusch, DJD; Lyons, JA; Mumpuni; Riyanto, A; Shine, R				Natusch, Daniel J. D.; Lyons, Jessica A.; Mumpuni; Riyanto, Awal; Shine, Richard			Jungle Giants: Assessing Sustainable Harvesting in a Difficult-to-Survey Species (Python reticulatus)	PLOS ONE			English	Article							STATISTICAL POWER ANALYSIS; INVASIVE BURMESE PYTHONS; INTERNATIONAL-TRADE; MORELIA-SPILOTA; SNAKE; SIZE; CONSEQUENCES; INDICATORS; SERPENTES; DECLINES	Sustainability of wildlife harvests is critical but difficult to assess. Evaluations of sustainability typically combine modelling with the measurement of underlying abundances. For many taxa harvested in developing countries, however, abundances are near-impossible to survey and a lack of detailed ecological information impedes the reliability of models. In such cases, repeated surveys of the attributes of harvested individuals may provide more robust information on sustainability. If the numbers, sizes and other demographic attributes of animals taken for the commercial trade do not change over biologically significant time intervals (decades), there is a prima facie case that the harvest is indeed sustainable. Here, we report the results of examinations of > 4,200 reticulated pythons (Python reticulatus) taken for the commercial leather industry in northern and southern Sumatra, Indonesia. The numbers, mean body sizes, clutch sizes, sizes at maturity and proportion of giant specimens have not decreased between our first surveys (1995) and repeat surveys (2015). Thus, despite assumptions to the contrary, the harvest appears to be sustainable. We use our data to inform the design of future monitoring programs for this species. Our study underpins the need for robust science to inform wildlife trade policy and decision-making, and urges wildlife managers to assess sustainability of difficult-to-survey terrestrial wildlife by drawing inferences directly from the harvest itself.	[Natusch, Daniel J. D.; Shine, Richard] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Lyons, Jessica A.] Resource Evaluat & Dev, Bamaga, Qld, Australia; [Mumpuni; Riyanto, Awal] Indonesian Inst Sci, Museum Zool Bogoriense, Biol Res Ctr, Bogor, Indonesia	University of Sydney; Bogor Zoology Museum; Indonesian Institute of Sciences	Natusch, DJD (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	d_natusch_14@hotmail.com	Riyanto, Awal/AAE-2791-2020	Lyons, Jessica A./0000-0002-7579-447X; RIYANTO, AWAL/0000-0002-6887-9352	Python Conservation Partnership	Python Conservation Partnership	This study was carried out with funding from the Python Conservation Partnership: http://www.iucn.org/?uNewsID=14068. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abensperg-Traun M, 2011, CITES CBNRM P INT S; Ashley D, 2013, TARCEABILITY SYSTEMS; Balmford A, 2006, CONSERV BIOL, V20, P692, DOI 10.1111/j.1523-1739.2006.00434.x; Caughley GJ, 1994, WILDLIFE ECOLOGY MAN; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cooney R., 2004, IUCN POLICY GLOBAL C, V2; Dorcas ME, 2012, P NATL ACAD SCI USA, V109, P2418, DOI 10.1073/pnas.1115226109; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fearn S, 2001, WILDLIFE RES, V28, P573, DOI 10.1071/WR00106; Fitzgerald LA, 2000, WILDLIFE SOC B, V28, P235; FITZGERALD LA, 1993, J HERPETOL, V27, P70, DOI 10.2307/1564908; GERRODETTE T, 1987, ECOLOGY, V68, P1364, DOI 10.2307/1939220; Groombridge B, 1991, PYTHONS S E ASIA REV; Gunarso P., 2013, OIL PALM LAND USE CH; Harvey RG, 2016, J ENVIRON PLANN MAN, V59, P789, DOI 10.1080/09640568.2015.1040489; Hunter Jr M. L., 2009, FUNDAMENTALS CONSERV; Ingram DJ, 2015, ECOL SOC, V20, DOI 10.5751/ES-07823-200340; Jenkins M., 1994, INT TRADE REPTILE SK; Kasterine A, 2012, TRADE S E ASIAN PYTH; Lyons JA, 2011, BIOL CONSERV, V144, P3073, DOI 10.1016/j.biocon.2011.10.002; Madsen T, 1999, ECOLOGY, V80, P989, DOI 10.1890/0012-9658(1999)080[0989:LHCONS]2.0.CO;2; Margono BA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034010; Natusch DJD, 2015, DEV CITES NONDETRIME; PETERMAN RM, 1990, CAN J FISH AQUAT SCI, V47, P2, DOI 10.1139/f90-001; PHKA, 2015, KUOT PENG TUMB AL PE; Reed RN, 2002, CONSERV BIOL, V16, P451, DOI 10.1046/j.1523-1739.2002.02283.x; Reed RN, 2011, WILDLIFE RES, V38, P114, DOI 10.1071/WR10202; Saputra G, 1998, MERTENSIELLA, V9, P23; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; SHINE R, 1990, HERPETOLOGICA, V46, P283; Shine R, 1998, J ZOOL, V244, P405, DOI 10.1111/j.1469-7998.1998.tb00045.x; Shine R, 1999, BIOL CONSERV, V87, P349, DOI 10.1016/S0006-3207(98)00068-8; Shine R, 1998, FUNCT ECOL, V12, P248, DOI 10.1046/j.1365-2435.1998.00179.x; Siregar J., 2012, UPAYA PELESTARIAN PE; SLIP DJ, 1988, AUST WILDLIFE RES, V15, P515; Smith MJ, 2011, BIOL CONSERV, V144, P82, DOI 10.1016/j.biocon.2010.10.018; Stahlschmidt ZR, 2012, FUNCT ECOL, V26, P812, DOI 10.1111/j.1365-2435.2012.02003.x; Swiss Federal Veterinary Office, 2013, AN HUM KILL METH REP; TRIPPEL EA, 1995, BIOSCIENCE, V45, P759, DOI 10.2307/1312628; Waller Tomas, 2007, P340; Webb JK, 2002, ORYX, V36, P170, DOI 10.1017/S0030605302000248; Weinbaum KZ, 2013, ECOL LETT, V16, P99, DOI 10.1111/ele.12008; World Bank, 2020, WORLD DEV IND; Zhou ZH, 2004, CONSERV BIOL, V18, P1386, DOI 10.1111/j.1523-1739.2004.00251.x	44	20	20	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158397	10.1371/journal.pone.0158397	http://dx.doi.org/10.1371/journal.pone.0158397			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391138	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400054
J	Reichenau, TG; Korres, W; Montzka, C; Fiener, P; Wilken, F; Stadler, A; Waldhoff, G; Schneider, K				Reichenau, Tim G.; Korres, Wolfgang; Montzka, Carsten; Fiener, Peter; Wilken, Florian; Stadler, Anja; Waldhoff, Guido; Schneider, Karl			Spatial Heterogeneity of Leaf Area Index (LAI) and Its Temporal Course on Arable Land: Combining Field Measurements, Remote Sensing and Simulation in a Comprehensive Data Analysis Approach (CDAA)	PLOS ONE			English	Article							FRACTIONAL VEGETATION COVER; SOIL-MOISTURE; CROP GROWTH; CARBON FLUXES; WINTER-WHEAT; PATTERNS; VARIABILITY; SYSTEM; FOREST; ENERGY	The ratio of leaf area to ground area (leaf area index, LAI) is an important state variable in ecosystem studies since it influences fluxes of matter and energy between the land surface and the atmosphere. As a basis for generating temporally continuous and spatially distributed datasets of LAI, the current study contributes an analysis of its spatial variability and spatial structure. Soil-vegetation-atmosphere fluxes of water, carbon and energy are nonlinearly related to LAI. Therefore, its spatial heterogeneity, i.e., the combination of spatial variability and structure, has an effect on simulations of these fluxes. To assess LAI spatial heterogeneity, we apply a Comprehensive Data Analysis Approach that combines data from remote sensing (5 m resolution) and simulation (150 m resolution) with field measurements and a detailed land use map. Test area is the arable land in the fertile loess plain of the Rur catchment on the Germany-Belgium-Netherlands border. LAI from remote sensing and simulation compares well with field measurements. Based on the simulation results, we describe characteristic crop-specific temporal patterns of LAI spatial variability. By means of these patterns, we explain the complex multimodal frequency distributions of LAI in the remote sensing data. In the test area, variability between agricultural fields is higher than within fields. Therefore, spatial resolutions less than the 5 m of the remote sensing scenes are sufficient to infer LAI spatial variability. Frequency distributions from the simulation agree better with the multimodal distributions from remote sensing than normal distributions do. The spatial structure of LAI in the test area is dominated by a short distance referring to field sizes. Longer distances that refer to soil and weather can only be derived from remote sensing data. Therefore, simulations alone are not sufficient to characterize LAI spatial structure. It can be concluded that a comprehensive picture of LAI spatial heterogeneity and its temporal course can contribute to the development of an approach to create spatially distributed and temporally continuous datasets of LAI.	[Reichenau, Tim G.; Korres, Wolfgang; Waldhoff, Guido; Schneider, Karl] Univ Cologne, Inst Geog, Cologne, Germany; [Montzka, Carsten] Res Ctr Julich, Inst Bio & Geosphere Agrosphere IBG 3, Julich, Germany; [Fiener, Peter; Wilken, Florian] Univ Augsburg, Inst Geog, Augsburg, Germany; [Wilken, Florian] Brandenburg Univ Technol Cottbus Senftenberg, Geopedol & Landscape Dev, Cottbus, Germany; [Wilken, Florian] Leibniz Ctr Agr Landscape Res ZALF eV, Inst Soil Landscape Res, Muncheberg, Germany; [Stadler, Anja] Univ Bonn, Inst Crop Sci & Resource Conservat, Bonn, Germany	University of Cologne; Helmholtz Association; Research Center Julich; University of Augsburg; Brandenburg University of Technology Cottbus; Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); University of Bonn	Reichenau, TG; Schneider, K (corresponding author), Univ Cologne, Inst Geog, Cologne, Germany.	tim.reichenau@uni-koeln.de; karl.schneider@uni-koeln.de	Schneider, Karl/B-6303-2016	Schneider, Karl/0000-0002-4381-2151; Fiener, Peter/0000-0001-6244-4705; Reichenau, Tim/0000-0002-5062-6218; Wilken, Florian/0000-0003-0860-4557; Montzka, Carsten/0000-0003-0812-8570	"Patterns in Soil-Vegetation-Atmosphere Systems: Monitoring, Modelling, and Data Assimilation" - German Science Foundation (DFG) [CRC/TR 32, TRR 32/3]; TERENO "Terrestrial Environmental Observatories" - Helmholtz Association; Federal Ministry of Education and Research (BMBF); "Patterns in soil-vegetation-atmosphere-systems" [TR32]	"Patterns in Soil-Vegetation-Atmosphere Systems: Monitoring, Modelling, and Data Assimilation" - German Science Foundation (DFG); TERENO "Terrestrial Environmental Observatories" - Helmholtz Association; Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); "Patterns in soil-vegetation-atmosphere-systems"	Financial support for the study was given by the CRC/TR 32 "Patterns in Soil-Vegetation-Atmosphere Systems: Monitoring, Modelling, and Data Assimilation" funded by the German Science Foundation (DFG, TRR 32/3) and by TERENO "Terrestrial Environmental Observatories" funded by the Helmholtz Association and the Federal Ministry of Education and Research (BMBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors gratefully acknowledge the farmers who allowed the comprehensive scientific observation of their fields. Special thanks go to Ulrike Schwedler for cartography and figure layout of Fig 1, to Karen Schneider for proofreading and to our students for their assistance during fieldwork. RapidEye data were provided by the RapidEye Science Archive (RESA). We also thank all colleagues from the project TR32 "Patterns in soil-vegetation-atmosphere-systems" for lively discussions.	Ali M, 2015, REMOTE SENS-BASEL, V7, P2808, DOI 10.3390/rs70302808; ASRAR G, 1984, AGRON J, V76, P300, DOI 10.2134/agronj1984.00021962007600020029x; Aubin I, 2000, CAN J FOREST RES, V30, P168, DOI 10.1139/cjfr-30-1-168; Bareth, INT ARCH PHOTOGRAMME, VXXXVII, P1059; Barth M, 2004, CYBERNET SYST, V35, P639, DOI 10.1080/01969720490499425; Barthel R, 2012, WATER RESOUR MANAG, V26, P1929, DOI 10.1007/s11269-012-0001-9; Bergamaschi H, 2010, PESQUI AGROPECU BRAS, V45, P1331, DOI 10.1590/S0100-204X2010001200001; Beringer J, 2011, AGR FOREST METEOROL, V151, P1409, DOI 10.1016/j.agrformet.2011.05.003; Boegh E, 2002, REMOTE SENS ENVIRON, V81, P179, DOI 10.1016/S0034-4257(01)00342-X; BONAN GB, 1995, REMOTE SENS ENVIRON, V51, P57, DOI 10.1016/0034-4257(94)00065-U; Breda NJJ, 2003, J EXP BOT, V54, P2403, DOI 10.1093/jxb/erg263; Bsaibes A, 2009, REMOTE SENS ENVIRON, V113, P716, DOI 10.1016/j.rse.2008.11.014; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; Carlson TN, 1997, REMOTE SENS ENVIRON, V62, P241, DOI 10.1016/S0034-4257(97)00104-1; CARLSON TN, 1990, AGR FOREST METEOROL, V52, P45, DOI 10.1016/0168-1923(90)90100-K; Chen M, 2015, J HYDROL, V522, P274, DOI 10.1016/j.jhydrol.2014.12.027; Colombo R, 2003, REMOTE SENS ENVIRON, V86, P120, DOI 10.1016/S0034-4257(03)00094-4; Duan SB, 2014, INT J APPL EARTH OBS, V26, P12, DOI 10.1016/j.jag.2013.05.007; Ehammer A, 2010, REMOTE SENSING SPIE; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Garrigues S, 2006, REMOTE SENS ENVIRON, V103, P81, DOI 10.1016/j.rse.2006.03.013; Garriques S, 2008, AGR FOREST METEOROL, V148, P1193, DOI 10.1016/j.agrformet.2008.02.014; Gates D. M., 1980, BIOPHYSICAL ECOLOGY; Geologischer Dienst Nordrhein-Westfalen, 2009, INF BOD 50 1 50000; Guo X., 2008, INT ARCH PHOTOGRA B7, V37, P31; Haboudane D, 2004, REMOTE SENS ENVIRON, V90, P337, DOI 10.1016/j.rse.2003.12.013; Hasan S, 2014, ISPRS J PHOTOGRAMM, V91, P59, DOI 10.1016/j.isprsjprs.2014.02.005; Hatfield JL, 2007, AGRON J, V99, P285, DOI 10.2134/agronj2005.0116S; Hoffmeister D, 2009, 6 INT S DIG EARTH SP; Jonckheere I, 2004, AGR FOREST METEOROL, V121, P19, DOI 10.1016/j.agrformet.2003.08.027; Jones C., 1986, SIMULATION MODEL MAI; Klar CW, 2008, ECOL MODEL, V217, P181, DOI 10.1016/j.ecolmodel.2008.06.019; Korres W, 2015, J HYDROL, V520, P326, DOI 10.1016/j.jhydrol.2014.11.042; Korres W, 2013, J HYDROL, V498, P89, DOI 10.1016/j.jhydrol.2013.05.050; Kutsch WL, 2005, GLOBAL CHANGE BIOL, V11, P70, DOI 10.1111/j.1365-2486.2004.00884.x; Landsberg JJ., 1986, APPL BOT CROP SCI, V4; Lefsky MA, 2002, BIOSCIENCE, V52, P19, DOI 10.1641/0006-3568(2002)052[0019:LRSFES]2.0.CO;2; Lenz-Wiedemann VIS, 2010, ECOL MODEL, V221, P314, DOI 10.1016/j.ecolmodel.2009.10.014; Lussem U., 2013, ENHANCED LAND USE CL; Mauser W, 2009, J HYDROL, V376, P362, DOI 10.1016/j.jhydrol.2009.07.046; Muerth M, 2012, ENVIRON MODELL SOFTW, V35, P149, DOI 10.1016/j.envsoft.2012.02.017; Nguy-Robertson A, 2012, AGRON J, V104, P1336, DOI 10.2134/agronj2012.0065; NORMAN JM, 1995, AGR FOREST METEOROL, V77, P263, DOI 10.1016/0168-1923(95)02265-Y; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Potithep S, 2013, AGR FOREST METEOROL, V169, P148, DOI 10.1016/j.agrformet.2012.09.003; Propastin P, 2010, INT J APPL EARTH OBS, V12, P47, DOI 10.1016/j.jag.2009.09.013; Rascher U, 2015, GLOBAL CHANGE BIOL; Richter D., 1995, BERICHTE DTSCH WETTE, V194; Rudolph S, 2015, GEODERMA, V241, P262, DOI 10.1016/j.geoderma.2014.11.015; scilands GmbH, 2010, DIG EL MOD 10 ANTHR; Sellers PJ, 1996, J CLIMATE, V9, P706, DOI 10.1175/1520-0442(1996)009<0706:ARLSPF>2.0.CO;2; Simmer C, 2015, B AM METEOROL SOC, V96, P1765, DOI 10.1175/BAMS-D-13-00134.1; Stadler A, 2015, EUR J AGRON, V64, P8, DOI 10.1016/j.eja.2014.12.004; Streck NA, 2003, AGR FOREST METEOROL, V115, P139, DOI 10.1016/S0168-1923(02)00228-9; Streck NA, 2003, AGRON J, V95, P155, DOI 10.2134/agronj2003.0155; Sun YY, 2014, FIELD CROP RES, V167, P1, DOI 10.1016/j.fcr.2014.07.002; Tsialtas JT, 2007, PHOTOSYNTHETICA, V45, P527, DOI 10.1007/s11099-007-0090-5; Vereecken H, 2010, VADOSE ZONE J, V9, P821, DOI 10.2136/vzj2010.0122; Waldhoff G., 2014, THESIS; Waldhoff G., 2012, ISPRS ANN PHOTOGRAMM, V1, DOI [10.5194/isprsannalsI-7-177-2012, DOI 10.5194/ISPRSANNALSI-7-177-2012]; Weiss M, 2004, AGR FOREST METEOROL, V121, P37, DOI 10.1016/j.agrformet.2003.08.001; Woodgate W, 2015, AGR FOREST METEOROL, V205, P83, DOI 10.1016/j.agrformet.2015.02.012; Wulder MA, 2004, BIOSCIENCE, V54, P511, DOI 10.1641/0006-3568(2004)054[0511:HSRRSD]2.0.CO;2; Yin X, 2005, CROP SYSTEMS DYNAMIC; Yin XY, 2000, ANN BOT-LONDON, V85, P579, DOI 10.1006/anbo.1999.1104; Yin XY, 2003, ANN BOT-LONDON, V91, P893, DOI 10.1093/aob/mcg096; Zacharias S, 2011, VADOSE ZONE J, V10, P955, DOI 10.2136/vzj2010.0139; Zeng XB, 2000, J APPL METEOROL, V39, P826, DOI 10.1175/1520-0450(2000)039<0826:DAEOGK>2.0.CO;2; Zeng XB, 2003, J APPL METEOROL, V42, P1525, DOI 10.1175/1520-0450(2003)042<1525:IVADTO>2.0.CO;2; Zhang Y, 2002, ECOL MODEL, V151, P75, DOI 10.1016/S0304-3800(01)00527-0; Zhao B, 2014, AGRON J, V106, P379, DOI 10.2134/agronj2013.0213; Zheng G, 2009, SENSORS-BASEL, V9, P2719, DOI 10.3390/s90402719	72	27	27	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158451	10.1371/journal.pone.0158451	http://dx.doi.org/10.1371/journal.pone.0158451			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391858	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400061
J	Masel, EK; Kitta, A; Huber, P; Rumpold, T; Unseld, M; Schur, S; Porpaczy, E; Watzke, HH				Masel, Eva K.; Kitta, Anna; Huber, Patrick; Rumpold, Tamara; Unseld, Matthias; Schur, Sophie; Porpaczy, Edit; Watzke, Herbert H.			What Makes a Good Palliative Care Physician? A Qualitative Study about the Patient's Expectations and Needs when Being Admitted to a Palliative Care Unit	PLOS ONE			English	Article							OF-LIFE CARE; END; COMMUNICATION; PROGNOSIS; ONCOLOGY; PERSPECTIVES; ISSUES; INFORMATION; DISCUSSIONS; EXPERIENCES	Objective The aims of the study were to examine a) patients' knowledge of palliative care, b) patients' expectations and needs when being admitted to a palliative care unit, and c) patient's concept of a good palliative care physician. Methods The study was based on a qualitative methodology, comprising 32 semistructured interviews with advanced cancer patients admitted to the palliative care unit of the Medical University of Vienna. Interviews were conducted with 20 patients during the first three days after admission to the unit and after one week, recorded digitally, and transcribed verbatim. Data were analyzed using NVivo 10 software, based on thematic analysis enhanced with grounded theory techniques. Results The results revealed four themes: (1) information about palliative care, (2) supportive care needs, (3) being treated in a palliative care unit, and (4) qualities required of palliative care physicians. The data showed that patients lack information about palliative care, that help in social concerns plays a central role in palliative care, and attentiveness as well as symptom management are important to patients. Patients desire a personal patient-physician relationship. The qualities of a good palliative care physician were honesty, the ability to listen, taking time, being experienced in their field, speaking the patient's language, being human, and being gentle. Patients experienced relief when being treated in a palliative care unit, perceived their care as an interdisciplinary activity, and felt that their burdensome symptoms were being attended to with emotional care. Negative perceptions included the overtly intense treatment. Conclusions The results of the present study offer an insight into what patients expect from palliative care teams. Being aware of patient's needs will enable medical teams to improve professional and individualized care.	[Masel, Eva K.; Kitta, Anna; Huber, Patrick; Rumpold, Tamara; Unseld, Matthias; Schur, Sophie; Watzke, Herbert H.] Med Univ Vienna, Div Palliat Care, Dept Internal Med 1, Vienna, Austria; [Porpaczy, Edit] Med Univ Vienna, Div Hematol & Hemostaseol, Dept Internal Med 1, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Masel, EK (corresponding author), Med Univ Vienna, Div Palliat Care, Dept Internal Med 1, Vienna, Austria.	eva.masel@meduniwien.ac.at	Masel, Eva Katharina/AAU-7439-2020; Masel, Eva Katharina/ABH-1594-2020	Masel, Eva Katharina/0000-0001-6415-4488; Kitta, Anna/0000-0001-9102-593X; Unseld, Matthias/0000-0002-1699-9846				Abdul-Razzak A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005653; Aldridge MD, 2015, PALLIATIVE MED, V24; Almack K, 2012, BMC PALLIAT CARE, V11, DOI 10.1186/1472-684X-11-15; Back AL, 2006, J CLIN ONCOL, V24, P4209, DOI 10.1200/JCO.2006.06.007; Back AL, 2014, J PALLIAT MED, V17, P1019, DOI 10.1089/jpm.2013.0651; Bakitas MA, 2015, J CLIN ONCOL, V33, P1438, DOI 10.1200/JCO.2014.58.6362; Beernaert K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137251; Bleidorn J, 2012, DEUT MED WOCHENSCHR, V137, P1343, DOI 10.1055/s-0032-1305045; Bosma H, 2010, PALLIATIVE MED, V24, P510, DOI 10.1177/0269216309351380; Braun V, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.26152; Centeno C, 2015, PALLIATIVE MED, V31; Ciemins EL, 2015, J PALLIAT MED, V18, P282, DOI 10.1089/jpm.2014.0155; Clayton JA, 2005, J PAIN SYMPTOM MANAG, V30, P132, DOI 10.1016/j.jpainsymman.2005.02.014; Dugdale DC, 1999, J GEN INTERN MED, V14, pS34, DOI 10.1046/j.1525-1497.1999.00263.x; Enzinger AC, 2015, J CLIN ONCOL, V33, P3809, DOI 10.1200/JCO.2015.61.9239; Farber Stuart J, 2003, J Palliat Med, V6, P19, DOI 10.1089/10966210360510082; Ferrell B, 2008, J CLIN ONCOL, V26, P3824, DOI 10.1200/JCO.2007.15.7552; Gomes B, 2015, J CLIN ONCOL, V33, P1420, DOI 10.1200/JCO.2014.60.5386; Grande GE, 2000, PALLIATIVE MED, V14, P69, DOI 10.1191/026921600677940614; Gysels M, 2008, BMC MED ETHICS, V9, P1472; Gysels M, 2008, J PAIN SYMPTOM MANAG, V35, P347, DOI 10.1016/j.jpainsymman.2007.05.012; Hoare S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142723; Innes S, 2009, PALLIATIVE MED, V23, P29, DOI 10.1177/0269216308098799; Kapo J, 2007, J PALLIAT MED, V10, P185, DOI 10.1089/jpm.2006.9989; Kogan AC, 2015, J PALLIAT MED, V18, P1019, DOI 10.1089/jpm.2015.0038; Kon AA, 2010, JAMA-J AM MED ASSOC, V304, P903, DOI 10.1001/jama.2010.1208; Mann K, 2015, MED TEACH, V21, P1; Martinsson L, 2016, BMJ SUPPORT PALLIAT, V6, P452, DOI 10.1136/bmjspcare-2014-000688; Masel EK, 2015, SUPPORT CARE CANCER, V23, P2335, DOI 10.1007/s00520-015-2601-4; McAteer R, 2013, AM FAM PHYSICIAN, V88, P807; McIlfatrick S, 2014, PALLIATIVE MED, V28, P273, DOI 10.1177/0269216313502372; Monroe B., 1994, Annals Academy of Medicine Singapore, V23, P252; MOR V, 1984, CANCER-AM CANCER SOC, V53, P2002, DOI 10.1002/1097-0142(19840501)53:9<2002::AID-CNCR2820530933>3.0.CO;2-W; Murray CD, 2015, PALLIAT SUPPORT CARE, V13, P369, DOI 10.1017/S1478951514000455; Parikh RB, 2013, NEW ENGL J MED, V369, P2347, DOI 10.1056/NEJMsb1305469; Parry R, 2014, BMJ SUPPORT PALLIAT, V4, P331, DOI 10.1136/bmjspcare-2014-000649; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Ranganathan A, 2014, ANN PALLIAT MED, V3, P144, DOI 10.3978/j.issn.2224-5820.2014.07.04; Robinson J, 2015, PALLIATIVE MED, V13; Sampson C, 2014, BMJ SUPPORT PALLIAT, V16; Sandsdalen T, 2015, PALLIATIVE MED, V29, P399, DOI 10.1177/0269216314557882; Sapir R, 2000, SUPPORT CARE CANCER, V8, P458, DOI 10.1007/s005200000163; Seccareccia D, 2015, J PALLIAT MED, V18, P758, DOI 10.1089/jpm.2014.0408; Stephen N, 2013, J PALLIAT MED, V16, P555, DOI 10.1089/jpm.2012.0442; Stiel S, 2010, J PALLIAT MED, V13, P997, DOI 10.1089/jpm.2010.0050; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; van der Plas AGM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133197; Virdun C, 2015, PALLIATIVE MED, V29, P774, DOI 10.1177/0269216315583032; Walczak A, 2013, PATIENT EDUC COUNS, V90, P307, DOI 10.1016/j.pec.2011.08.009; Wheatley VJ, 2007, POSTGRAD MED J, V83, P643, DOI 10.1136/pgmj.2007.058487	50	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158830	10.1371/journal.pone.0158830	http://dx.doi.org/10.1371/journal.pone.0158830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389693	Green Published, Green Submitted, gold			2022-12-26	WOS:000379811500052
J	Suzuki, M; Segawa, T; Mori, H; Akiyoshi, A; Ootsuki, R; Kurihara, A; Sakayama, H; Kitayama, T; Abe, T; Kogame, K; Kawai, H; Nozaki, H				Suzuki, Masahiro; Segawa, Takahiro; Mori, Hiroshi; Akiyoshi, Ayumi; Ootsuki, Ryo; Kurihara, Akira; Sakayama, Hidetoshi; Kitayama, Taiju; Abe, Tsuyoshi; Kogame, Kazuhiro; Kawai, Hiroshi; Nozaki, Hisayoshi			Next-Generation Sequencing of an 88-Year-Old Specimen of the Poorly Known Species Liagora japonica (Nemaliales, Rhodophyta) Supports the Recognition of Otohimella gen. nov.	PLOS ONE			English	Article							SENSU-LATO NEMALIALES; CARPOSPOROPHYTE DEVELOPMENT; GANONEMA LIAGORACEAE; SYSTEMATICS; MORPHOLOGY; ALIGNMENT; DATABASE	Liagora japonica is a red algal species distributed in temperate regions of Japan. This species has not been collected from its type locality on the Pacific coast of Japan since 1927 and seems to have become extinct in this area. For molecular characterization of L. japonica, we extracted DNA from the topotype material of L. japonica collected in 1927, analyzed seven genes using Illumina next-generation sequencing, and compared these data with sequences from modern samples of similar red algae collected from the Japan Sea coast of Japan. Both morphological and molecular data from modern samples and historical specimens (including the lectotype and topotype) suggest that the specimens from the Pacific and Japan Sea coasts of Japan should be treated as a single species, and that L. japonica is phylogenetically separated from the genus Liagora. Based on the phylogenetic results and examination of reproductive structures, we propose Otohimella japonica gen. et comb. nov., characterized morphologically by diffuse carposporophytes, undivided carposporangia, and involucral filaments initiated only from the cortical cell on the supporting cell.	[Suzuki, Masahiro; Kawai, Hiroshi] Kobe Univ, Res Ctr Inland Sea, Awaji, Hyogo, Japan; [Segawa, Takahiro] Univ Yamanashi, Ctr Life Sci Res, Yamanashi, Japan; [Segawa, Takahiro; Akiyoshi, Ayumi] Natl Inst Polar Res, Midori Cho, Tachikawa, Tokyo, Japan; [Segawa, Takahiro; Akiyoshi, Ayumi] Transdisciplinary Res Integrat Ctr, Minato Ku, Tokyo, Japan; [Mori, Hiroshi] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Meguro Ku, Tokyo, Japan; [Ootsuki, Ryo] Komazawa Univ, Dept Nat Sci, Fac Arts & Sci, Setagaya Ku, Tokyo, Japan; [Ootsuki, Ryo] Japan Womens Univ, Fac Chem & Biol Sci, Tokyo, Japan; [Kurihara, Akira] Kyushu Univ, Bioresource Sci, Fac Agr, Higashi Ku, Fukuoka, Japan; [Sakayama, Hidetoshi] Kobe Univ, Grad Sch Sci, Dept Biol, Nada Ku, Kobe, Hyogo, Japan; [Kitayama, Taiju] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan; [Abe, Tsuyoshi] Hokkaido Univ, Hokkaido Univ Museum, Sapporo, Hokkaido, Japan; [Kogame, Kazuhiro] Hokkaido Univ, Dept Biol Sci, Fac Sci, Sapporo, Hokkaido, Japan; [Nozaki, Hisayoshi] Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Bunkyo Ku, Tokyo, Japan	Kobe University; University of Yamanashi; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; Tokyo Institute of Technology; Japan Womens University; Kyushu University; Kobe University; National Museum of Nature and Science; Hokkaido University; Hokkaido University; University of Tokyo	Suzuki, M (corresponding author), Kobe Univ, Res Ctr Inland Sea, Awaji, Hyogo, Japan.	dtk-shark2625@goo.jp		Mori, Hiroshi/0000-0003-0806-7704; Nozaki, Hisayoshi/0000-0002-9308-4498; Segawa, Takahiro/0000-0002-3111-708X	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI [26840125, 24247042]; Center for the Promotion of Integrated Science (CPIS) of Sokendai	Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI; Center for the Promotion of Integrated Science (CPIS) of Sokendai	MS and HN were supported by Grants-in-Aid for Scientific Research (grant numbers 26840125 and 24247042) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI (https://www.jsps.go.jp/english/e-grants/).; We are grateful to the late Dr Makoto Yoshizaki (Toho University) for his many suggestions regarding the description of Liagora japonica. We thank Dr Dorothee Huchon, Dr John Huisman, and an anonymous reviewer for their helpful and valuable suggestions. This work was supported by the Center for the Promotion of Integrated Science (CPIS) of Sokendai (to Jun Adachi).	Abbott Isabella A., 1995, Chinese Journal of Oceanology and Limnology, V13, P343, DOI 10.1007/BF02889469; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Boo GH, 2013, TAXON, V62, P1105, DOI 10.12705/626.7; Carlile AL, 2010, PHYCOLOGIA, V49, P336, DOI 10.2216/09-19.1; CHIHARA M, 1972, Bulletin of the National Science Museum (Tokyo), V15, P395; Dabney J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012567; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Guiry GM, 2015, WORLD WIDE ELECT PUB, V10, P28; Hind KR, 2014, J PHYCOL, V50, P760, DOI 10.1111/jpy.12205; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hughey JR, 2014, SCI REP-UK, V4, DOI 10.1038/srep05113; Huisman JM, 2004, EUR J PHYCOL, V39, P257, DOI 10.1080/09670260410001710123; Huisman JM, 2002, AUST SYST BOT, V15, P773, DOI 10.1071/SB01027; Huisman JM, 1999, BOT MAR, V42, P219, DOI 10.1515/BOT.1999.025; Huisman JM, 2006, ALGAE AUSTR NEMALIAL, P116; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le Gall L, 2010, CRYPTOGAMIE ALGOL, V31, P403; Lin SM, 2015, J PHYCOL, V51, P546, DOI 10.1111/jpy.12301; Lin SM, 2014, PHYCOLOGIA, V53, P37, DOI 10.2216/13-201.1; Lin SM, 2013, EUR J PHYCOL, V48, P173, DOI 10.1080/09670262.2013.786791; Lin SM, 2013, PHYCOLOGIA, V52, P161, DOI 10.2216/12-101.1; Lin SM, 2011, EUR J PHYCOL, V46, P249, DOI 10.1080/09670262.2011.592221; Lin SM, 2011, J PHYCOL, V47, P352, DOI 10.1111/j.1529-8817.2011.00965.x; Omori Y, 1988, NAT HIST REP KANAGAW, V19, P105; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Popolizio TR, 2015, J PHYCOL, V51, P637, DOI 10.1111/jpy.12306; Rambaut A., 2007, TRACER V1 4; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Suzuki M, 2012, PHYCOLOGIA, V51, P479, DOI 10.2216/11-78.1; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183; YAMADA Y., 1938, SCI PAPERS INST ALGOL RES HOKKAIDO IMP UNIV, V2, P1; Yokosawa T, 2008, JPN J PHYCOL, V56, P213; YOSHIZAKI M, 1987, PHYCOLOGIA, V26, P47, DOI 10.2216/i0031-8884-26-1-47.1; Yosihda A., 2012, B HOT SPRINGS RES I, V44, P17	38	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158944	10.1371/journal.pone.0158944	http://dx.doi.org/10.1371/journal.pone.0158944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388436	Green Submitted, Green Published, gold			2022-12-26	WOS:000379811500063
J	Tian, XF; Ji, FJ; Zang, HL; Cao, H				Tian, Xiao-Feng; Ji, Fu-Jian; Zang, Hong-Liang; Cao, Hong			Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; CANCER; MICRORNAS; EXPRESSION; RATS; IDENTIFICATION; RESVERATROL; METASTASIS	Liver fibrosis results from a sustained wound healing response to chronic liver injury, and the activation of nonparenchymal hepatic stellate cells (HSCs) is the pivotal process. Micro-RNA-34a (miR-34a) is the direct target gene of p53 and activates p53 through sirtuin 1 (SIRT1) simultaneously. The miR-34a/SIRT1/p53 signaling pathway thus forms a positive feedback loop wherein p53 induces miR-34a and miR-34a activates p53 by inhibiting SIRT1, playing an important role in cell proliferation and apoptosis. miR-34a expression has been found to be increased in animal models or in human patients with different liver diseases, including liver fibrosis. However, the exact role of this classical miR-34a/SIRT1/p53 signaling pathway in liver fibrosis remains unclear. In the present study, using a CCl4-induced rat liver fibrosis model, we found that the miR-34a/SIRT1/p53 signaling pathway was activated and could be inhibited by SIRT1 activator SRT1720. Further studies showed that the miR-34a/SIRT1/p53 signaling pathway was activated in hepatocytes but not in HSCs. The activation of this pathway in hepatocytes resulted in the apoptosis of hepatocytes and thus activated HSCs. Our data indicate that the miR-34a/SIRT1/p53 signaling pathway might be a promising therapeutic target for liver fibrosis.	[Tian, Xiao-Feng; Ji, Fu-Jian; Zang, Hong-Liang; Cao, Hong] Jilin Univ, China Japan Union Hosp, Dept Gen Surg, Changchun 130021, Peoples R China	Jilin University	Cao, H (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Gen Surg, Changchun 130021, Peoples R China.	caohong010829@163.com						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Castro RE, 2013, J HEPATOL, V58, P119, DOI 10.1016/j.jhep.2012.08.008; Chavez E, 2008, J APPL TOXICOL, V28, P35, DOI 10.1002/jat.1249; Chen F, 2012, J BIOCHEM MOL TOXIC, V26, P79, DOI 10.1002/jbt.20412; Duval F, 2014, ADV PHARMACOL SCI, V2014, DOI 10.1155/2014/373295; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Gori M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/741465; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hong SW, 2010, ARCH PHARM RES, V33, P601, DOI 10.1007/s12272-010-0415-y; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Janiszewska J, 2013, CRIT REV ONCOL HEMAT, V88, P716, DOI 10.1016/j.critrevonc.2013.07.012; Ju JF, 2013, FUTURE MED CHEM, V5, P983, DOI 10.4155/fmc.13.74; Katayama Y, 2012, ONCOL LETT, V4, P817, DOI 10.3892/ol.2012.810; Kemper JK, 2013, VITAM HORM, V91, P385, DOI 10.1016/B978-0-12-407766-9.00016-X; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Li WQ, 2011, FEBS J, V278, P1522, DOI 10.1111/j.1742-4658.2011.08075.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallat A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869390; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Murakami Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016081; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; Pang RTK, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-25; Pineau P, 2010, P NATL ACAD SCI USA, V107, P264, DOI 10.1073/pnas.0907904107; Raisch J, 2013, WORLD J GASTROENTERO, V19, P2985, DOI 10.3748/wjg.v19.i20.2985; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Vettori Serena, 2012, Open Rheumatol J, V6, P130, DOI 10.2174/1874312901206010130; Wiggins JF, 2010, CANCER RES, V70, P5923, DOI 10.1158/0008-5472.CAN-10-0655; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033778; Yang S, 2013, ONCOGENE, V32, P4294, DOI 10.1038/onc.2012.432; Zhan SS, 2006, HEPATOLOGY, V43, P435, DOI 10.1002/hep.21093	36	61	69	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158657	10.1371/journal.pone.0158657	http://dx.doi.org/10.1371/journal.pone.0158657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387128	Green Submitted, gold, Green Published			2022-12-26	WOS:000379811500034
J	Baek, SY; Jang, KH; Choi, EH; Ryu, SH; Kim, SK; Lee, JH; Lim, YJ; Lee, J; Jun, J; Kwak, M; Lee, YS; Hwang, JS; Maran, BAV; Chang, CY; Kim, IH; Hwang, UW				Baek, Su Youn; Jang, Kuem Hee; Choi, Eun Hwa; Ryu, Shi Hyun; Kim, Sang Ki; Lee, Jin Hee; Lim, Young Jin; Lee, Jimin; Jun, Jumin; Kwak, Myounghai; Lee, Young-Sup; Hwang, Jae-Sam; Maran, Balu Alagar Venmathi; Chang, Cheon Young; Kim, Il-Hoi; Hwang, Ui Wook			DNA Barcoding of Metazoan Zooplankton Copepods from South Korea	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOME; MOLECULAR PHYLOGENY; CALANOID COPEPODS; COMPARATIVE PHYLOGEOGRAPHY; SPECIES IDENTIFICATION; ESTUARINE COPEPOD; ACARTIA-TONSA; CRUSTACEA; AMPLIFICATION; SEA	Copepods, small aquatic crustaceans, are the most abundant metazoan zooplankton and outnumber every other group of multicellular animals on earth. In spite of ecological and biological importance in aquatic environment, their morphological plasticity, originated from their various lifestyles and their incomparable capacity to adapt to a variety of environments, has made the identification of species challenging, even for expert taxonomists. Molecular approaches to species identification have allowed rapid detection, discrimination, and identification of cryptic or sibling species based on DNA sequence data. We examined sequence variation of a partial mitochondrial cytochrome C oxidase I gene (COI) from 133 copepod individuals collected from the Korean Peninsula, in order to identify and discriminate 94 copepod species covering six copepod orders of Calanoida, Cyclopoida, Harpacticoida, Monstrilloida, Poecilostomatoida and Siphonostomatoida. The results showed that there exists a clear gap with ca. 20 fold difference between the averages of within-specific sequence divergence (2.42%) and that of between-specific sequence divergence (42.79%) in COI, suggesting the plausible utility of this gene in delimitating copepod species. The results showed, with the COI barcoding data among 94 copepod species, that a copepod species could be distinguished from the others very clearly, only with four exceptions as followings: Mesocyclops dissimilis-Mesocyclops pehpeiensis (0.26% K2P distance in percent) and Oithona davisae-Oithona similis (1.1%) in Cyclopoida, Ostrincola japonica-Pseudomyicola spinosus (1.5%) in Poecilostomatoida, and Hatschekia japonica-Caligus quadratus (5.2%) in Siphonostomatoida. Thus, it strongly indicated that COI may be a useful tool in identifying various copepod species and make an initial progress toward the construction of a comprehensive DNA barcode database for copepods inhabiting the Korean Peninsula.	[Baek, Su Youn; Kim, Sang Ki; Lee, Jin Hee; Lee, Young-Sup; Hwang, Ui Wook] Kyungpook Natl Univ, Sch Life Sci, Grad Sch, Daegu, South Korea; [Jang, Kuem Hee; Choi, Eun Hwa; Lim, Young Jin; Maran, Balu Alagar Venmathi; Hwang, Ui Wook] Kyungpook Natl Univ, Dept Biol, Teachers Coll, Daegu, South Korea; [Jang, Kuem Hee; Choi, Eun Hwa; Lim, Young Jin; Maran, Balu Alagar Venmathi; Hwang, Ui Wook] Kyungpook Natl Univ, Inst Phylogen & Evolut, Daegu, South Korea; [Ryu, Shi Hyun] Nakdonggang Natl Inst Biol Resources, Freshwater Biodivers Res Div, Sangju, Gyeongsangbuk D, South Korea; [Lee, Jimin] Korea Inst Ocean Sci & Technol, Marine Ecosyst Res Div, Ansan, South Korea; [Jun, Jumin; Kwak, Myounghai] Natl Inst Biol Resources, Biol Resources Res Dept, Inchon, South Korea; [Hwang, Jae-Sam] Rural Dev Adm, Natl Acad Agr Sci, Dept Agr Biol, Jeonju, South Korea; [Chang, Cheon Young] Daegu Univ, Coll Nat Sci, Dept Biol Sci, Gyongsan, South Korea; [Kim, Il-Hoi] Gangneung Wonju Natl Univ, Dept Biol, Kangnung, Gangwon Do, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Korea Institute of Ocean Science & Technology (KIOST); National Institute of Biological Resources; Rural Development Administration (RDA), Republic of Korea; Daegu University; Kangnung Wonju National University	Hwang, UW (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Grad Sch, Daegu, South Korea.; Hwang, UW (corresponding author), Kyungpook Natl Univ, Dept Biol, Teachers Coll, Daegu, South Korea.; Hwang, UW (corresponding author), Kyungpook Natl Univ, Inst Phylogen & Evolut, Daegu, South Korea.	uwhwang@knu.ac.kr	Venmathi Maran, Balu Alagar/G-5163-2014	Venmathi Maran, Balu Alagar/0000-0003-1090-5295	"Origin of Biological Diversity of Korea: Molecular Phylogenetic Analyses of Major Korean Taxa" - National Institute of Biological Resources (NIBR) [2013-02-013]; "Cooperative Research Program for Agriculture Science Technology Development (National Agricultural Genome Program, Project title: De novo genome annotation for centipede, Scolopendra subspinipes'') Rural Development Administration, Republic of Korea [PJ010338]	"Origin of Biological Diversity of Korea: Molecular Phylogenetic Analyses of Major Korean Taxa" - National Institute of Biological Resources (NIBR); "Cooperative Research Program for Agriculture Science Technology Development (National Agricultural Genome Program, Project title: De novo genome annotation for centipede, Scolopendra subspinipes'') Rural Development Administration, Republic of Korea	This present work was carried out with the support of "Origin of Biological Diversity of Korea: Molecular Phylogenetic Analyses of Major Korean Taxa" funded by the National Institute of Biological Resources (NIBR No. 2013-02-013), and "Cooperative Research Program for Agriculture Science & Technology Development (National Agricultural Genome Program, Project title: De novo genome annotation for centipede, Scolopendra subspinipes, Project No. PJ010338)" Rural Development Administration, Republic of Korea.	Aarbakke ONS, 2014, J EXP MAR BIOL ECOL, V461, P479, DOI 10.1016/j.jembe.2014.10.006; Blanco-Bercial L, 2014, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.cdf8b74881f87e3b01d56b43791626d2; Blanco-Bercial L, 2011, MOL PHYLOGENET EVOL, V59, P103, DOI 10.1016/j.ympev.2011.01.008; Boxshall G. A., 2004, INTRO COPEPOD DIVERS; Boxshall GA, 1997, SYSTEMATICS ASS SPEC, V55, P156; Boxshall GA, 2015, COPEPODA WORLD REGIS; Bradford-Grieve JM, 2010, INVERTEBR SYST, V24, P291, DOI 10.1071/IS10007; Bucklin A, 2010, DEEP-SEA RES PT II, V57, P2234, DOI 10.1016/j.dsr2.2010.09.025; Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046; Burton RS, 2007, GENE, V403, P53, DOI 10.1016/j.gene.2007.07.026; Castellani C, 2012, J MAR BIOL ASSOC UK, V92, P99, DOI 10.1017/S0025315411000932; Caudill CC, 2004, HYDROBIOLOGIA, V511, P91, DOI 10.1023/B:HYDR.0000014032.05680.9d; Cepeda GD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035861; Chang CY, 2005, KEY KOREAN FRESHWATE; Chen G, 2011, MOL ECOL, V20, P2425, DOI 10.1111/j.1365-294X.2011.05079.x; Cheng Fangping, 2013, Advances in Polar Science, V24, P119, DOI 10.3724/SP.J.1085.2013.00119; Cornils A, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-19; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Edmands S, 2001, MOL ECOL, V10, P1743, DOI 10.1046/j.0962-1083.2001.01306.x; Eyun SI, 2007, ZOOL SCI, V24, P265, DOI 10.2108/zsj.24.265; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goetze E, 2005, EVOLUTION, V59, P2378; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ho JS, 2001, HYDROBIOLOGIA, V453, P1, DOI 10.1023/A:1013139212227; HUMES AG, 1994, HYDROBIOLOGIA, V293, P1, DOI 10.1007/BF00229916; Huys R, 2009, ZOOTAXA, P1; Hwang Ui Wook, 2002, Korean Journal of Systematic Zoology, V18, P165; Hwang Ui-Wook, 1999, Korean Journal of Parasitology, V37, P215, DOI 10.3347/kjp.1999.37.4.215; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Hwang UW, 2001, MOL PHYLOGENET EVOL, V19, P345, DOI 10.1006/mpev.2001.0940; Jang KH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-167; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kozol R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045710; Laakmann S, 2013, MOL ECOL RESOUR, V13, P862, DOI 10.1111/1755-0998.12139; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavrov DV, 2013, MOL BIOL EVOL, V30, P865, DOI 10.1093/molbev/mss274; Lee CE, 2000, EVOLUTION, V54, P2014, DOI 10.1111/j.0014-3820.2000.tb01245.x; Lim JT, 2006, MOL CELLS, V22, P314; LOPEZ JV, 1994, J MOL EVOL, V39, P174; Machida RJ, 2006, MAR BIOL, V148, P1071, DOI 10.1007/s00227-005-0140-0; Machida RJ, 2004, GENE, V332, P71, DOI 10.1016/j.gene.2004.01.019; Machida RJ, 2002, MAR BIOTECHNOL, V4, P406, DOI 10.1007/s10126-002-0033-x; Machida RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010278; Matthews B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026700; Mauchline J., 1998, ADV MAR BIOL, V33, P1, DOI DOI 10.1163/156854008784513492; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Park SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-343; Pond DW, 2011, LIMNOL OCEANOGR, V56, P1310, DOI 10.4319/lo.2011.56.4.1310; Saiz E, 2011, HYDROBIOLOGIA, V666, P181, DOI 10.1007/s10750-010-0421-6; Schminke HK, 2007, J PLANKTON RES, V29, pI149, DOI 10.1093/plankt/fbl073; Shao R, 2007, PARASITOLOGY, V134, P153, DOI 10.1017/S0031182006001429; Shearer TL, 2008, MOL ECOL RESOUR, V8, P247, DOI 10.1111/j.1471-8286.2007.01996.x; Soh HY, 2012, ZOOTAXA, P229; Suarez-Morales E., 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V70, P107; Suarez-Morales E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022915; Sukhikh N, 2013, J NAT HIST, V47, P753, DOI 10.1080/00222933.2012.716865; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thum RA, 2009, BIOL J LINN SOC, V96, P150, DOI 10.1111/j.1095-8312.2008.01105.x; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; Vrijenhoek RC, 2009, DEEP-SEA RES PT II, V56, P1713, DOI 10.1016/j.dsr2.2009.05.016; Woo HJ, 2007, MOL CELLS, V23, P182	64	23	27	5	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157307	10.1371/journal.pone.0157307	http://dx.doi.org/10.1371/journal.pone.0157307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383475	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400010
J	EL-Manzalawy, Y; Abbas, M; Malluhi, Q; Honavar, V				EL-Manzalawy, Yasser; Abbas, Mostafa; Malluhi, Qutaibah; Honavar, Vasant			FastRNABindR: Fast and Accurate Prediction of Protein-RNA Interface Residues	PLOS ONE			English	Article							ACCESSIBLE SURFACE-AREA; DNA-BINDING RESIDUES; SECONDARY STRUCTURE; SITES; SERVER; PROPENSITY; GENERATION; BLAST; PLUS	A wide range of biological processes, including regulation of gene expression, protein synthesis, and replication and assembly of many viruses are mediated by RNA-protein interactions. However, experimental determination of the structures of protein-RNA complexes is expensive and technically challenging. Hence, a number of computational tools have been developed for predicting protein-RNA interfaces. Some of the state-of-the-art protein-RNA interface predictors rely on position-specific scoring matrix (PSSM)-based encoding of the protein sequences. The computational efforts needed for generating PSSMs severely limits the practical utility of protein-RNA interface prediction servers. In this work, we experiment with two approaches, random sampling and sequence similarity reduction, for extracting a representative reference database of protein sequences from more than 50 million protein sequences in UniRef100. Our results suggest that random sampled databases produce better PSSM profiles (in terms of the number of hits used to generate the profile and the distance of the generated profile to the corresponding profile generated using the entire UniRef100 data as well as the accuracy of the machine learning classifier trained using these profiles). Based on our results, we developed FastRNABindR, an improved version of RNABindR for predicting protein-RNA interface residues using PSSM profiles generated using 1% of the UniRef100 sequences sampled uniformly at random. To the best of our knowledge, FastRNABindR is the only protein-RNA interface residue prediction online server that requires generation of PSSM profiles for query sequences and accepts hundreds of protein sequences per submission. Our approach for determining the optimal BLAST database for a protein-RNA interface residue classification task has the potential of substantially speeding up, and hence increasing the practical utility of, other amino acid sequence based predictors of protein-protein and protein-DNA interfaces.	[EL-Manzalawy, Yasser; Honavar, Vasant] Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA; [EL-Manzalawy, Yasser] Al Azhar Univ, Syst & Comp Engn, Cairo, Egypt; [Abbas, Mostafa; Malluhi, Qutaibah] Qatar Univ, Coll Engn, KINDI Ctr Comp Res, Duha, Qatar	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Egyptian Knowledge Bank (EKB); Al Azhar University; Qatar University	EL-Manzalawy, Y (corresponding author), Penn State Univ, Coll Informat Sci & Technol, University Pk, PA 16802 USA.; EL-Manzalawy, Y (corresponding author), Al Azhar Univ, Syst & Comp Engn, Cairo, Egypt.	yme2@psu.edu	El-Manzalawy, Yasser/ABE-3489-2020; Honavar, Vasant G/K-9835-2015	Honavar, Vasant G/0000-0001-5399-3489	Edward Frymoyer Endowed Professorship in Information Sciences and Technology; Center for Big Data Analytics and Discovery Informatics - Institute for Cyberscience; Huck Institutes of the Life Sciences; Social Science Research Institute; College of Information Sciences and Technology at the Pennsylvania State University; NPRP grant from the Qatar National Research Fund [4-1454-1-233]	Edward Frymoyer Endowed Professorship in Information Sciences and Technology; Center for Big Data Analytics and Discovery Informatics - Institute for Cyberscience; Huck Institutes of the Life Sciences; Social Science Research Institute; College of Information Sciences and Technology at the Pennsylvania State University; NPRP grant from the Qatar National Research Fund(Qatar National Research Fund (QNRF))	This work was supported in part by the Edward Frymoyer Endowed Professorship in Information Sciences and Technology held by Vasant Honavar and the Center for Big Data Analytics and Discovery Informatics which is co-sponsored by the Institute for Cyberscience, the Huck Institutes of the Life Sciences, the Social Science Research Institute, and the College of Information Sciences and Technology at the Pennsylvania State University. This work was also supported by NPRP grant No. 4-1454-1-233 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak R, 2005, PROTEINS, V59, P467, DOI 10.1002/prot.20441; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bradley AP, 1997, PATTERN RECOGN, V30, P1145, DOI 10.1016/S0031-3203(96)00142-2; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caragea C, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P320; Carson MB, 2010, NUCLEIC ACIDS RES, V38, pW431, DOI 10.1093/nar/gkq361; Chen YC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn008; Darling AE., 2003, 4 INT C LIN CLUST CL; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Faraggi E, 2014, PROTEINS, V82, P3170, DOI 10.1002/prot.24682; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hauser M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-248; Hogan DJ, 2008, PLOS BIOL, V6, P2297, DOI 10.1371/journal.pbio.0060255; Ke A, 2004, METHODS, V34, P408, DOI 10.1016/j.ymeth.2004.03.027; Kim OTP, 2006, NUCLEIC ACIDS RES, V34, P6450, DOI 10.1093/nar/gkl819; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lorkovic ZJ, 2009, TRENDS PLANT SCI, V14, P229, DOI 10.1016/j.tplants.2009.01.007; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Maetschke SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-341; Magnan CN, 2010, BIOINFORMATICS, V26, P2936, DOI 10.1093/bioinformatics/btq551; Marchanka A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8024; Miao ZC, 2015, NUCLEIC ACIDS RES, V43, P5340, DOI 10.1093/nar/gkv446; Murakami Y, 2010, NUCLEIC ACIDS RES, V38, pW412, DOI 10.1093/nar/gkq474; Nagarajan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091140; Nguyen MN, 2006, PROTEINS, V63, P542, DOI 10.1002/prot.20883; Ofran Y, 2007, BIOINFORMATICS, V23, pI347, DOI 10.1093/bioinformatics/btm174; Pape UJ, 2008, BIOINFORMATICS, V24, P350, DOI 10.1093/bioinformatics/btm610; Perez-Cano L, 2010, PROTEINS, V78, P25, DOI 10.1002/prot.22527; Puton T, 2012, J STRUCT BIOL, V179, P261, DOI 10.1016/j.jsb.2011.10.001; Schlessinger A, 2006, BIOINFORMATICS, V22, P891, DOI 10.1093/bioinformatics/btl032; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Terribilini M, 2007, NUCLEIC ACIDS RES, V35, pW578, DOI 10.1093/nar/gkm294; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Towfic F, 2010, INT J DATA MIN BIOIN, V4, P21, DOI 10.1504/IJDMB.2010.030965; Tuszynska I, 2014, METHODS, V65, P310, DOI 10.1016/j.ymeth.2013.09.014; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Walia RR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-89; Walia R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057792; Wang LJ, 2006, NUCLEIC ACIDS RES, V34, pW243, DOI 10.1093/nar/gkl298; Wang LJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S1-S3; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Yuan Z, 2005, PROTEINS, V58, P905, DOI 10.1002/prot.20375	51	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158445	10.1371/journal.pone.0158445	http://dx.doi.org/10.1371/journal.pone.0158445			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383535	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400048
J	Zhang, W; Zhong, L; Wang, J; Han, JY				Zhang, Wei; Zhong, Liang; Wang, Jing; Han, Jianyong			Distinct MicroRNA Expression Signatures of Porcine Induced Pluripotent Stem Cells under Mouse and Human ESC Culture Conditions	PLOS ONE			English	Article							DLK1-DIO3 REGION; SELF-RENEWAL; DIFFERENTIATION; IDENTIFICATION; TARGETS; TRANSITION; CLUSTER; MIR-302; PATHWAY; KINASE	It is well known that microRNAs play a very important role in regulating reprogramming, pluripotency and cell fate decisions. Porcine induced pluripotent stem cells (piPSCs) are now available for studying the pluripotent regulation network in pigs. Two types of piPSCs have been derived from human and mouse embryonic stem cell (ESC) culture conditions: hpiPSCs and mpiPSCs, respectively. The hpiPSCs were morphologically similar to human ESCs, and the mpiPSCs resembled mouse ESCs. However, our current understanding of the role of microRNAs in the development of piPSCs is still very limited. Here, we performed small RNA sequencing to profile the miRNA expression in porcine fibroblasts (pEFs), hpiPSCs and mpiPSCs. There were 22 differential expressed (DE) miRNAs down-regulated in both types of piPSCs compared with pEFs, such as ssc-miR-145-5p and ssc-miR-98. There were 27 DE miRNAs up-regulated in both types of piPSCs compared with pEFs. Among these up-regulated DE miRNAs in piPSCs, ssc-miR-217, ssc-miR-216, ssc-miR-142-5p, ssc-miR-182, ssc-miR-183 and ssc-miR-96-5p have much higher expression levels in mpiPSCs, while ssc-miR-106a, ssc-miR-363, ssc-miR-146b, ssc-miR-195, ssc-miR-497, ssc-miR-935 and ssc-miR-20b highly expressed in hpiPSCs. Quantitative stem-loop RTPCR was performed to confirm selected DE miRNAs expression levels. The results were consistent with small RNA sequencing. Different expression patterns were observed for key miRNA clusters, such as the miR-17-92 cluster, the let-7 family, the miR-106a-363 cluster and the miR-182-183 cluster, in the mpiPSCs and hpiPSCs. Novel miRNAs were also predicted in this study, including a putative porcine miR-302 cluster: ssc_38503, ssc_38503 and ssc_38501 (which resemble human miR-302a and miR-302b) found in both types of piPSCs. The miR-106a-363 cluster and putative miR-302 cluster increased the reprogramming efficiency of pEFs. The study revealed significant differences in the miRNA signatures of hpiPSCs and mpiPSCs under different pluripotent states that were derived from different culture conditions. These differentially expressed miRNAs may play important roles in pluripotent regulation in pigs, and this information will facilitate the understanding of the mechanism of pluripotency in pigs.	[Zhang, Wei; Zhong, Liang; Wang, Jing; Han, Jianyong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China	China Agricultural University	Han, JY (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.	hanjy@cau.edu.cn	Zhong, Liang/AAO-1379-2020; zhang, wei/J-1685-2019	wang, jing/0000-0002-7120-0857	China National Key Research Program [SQ2016ZY05002032-02]; China National Basic Research Program [2011CBB01001]; Program for New Century Excellent Talents in University [NCET-11-0482]; State Key Laboratories for Agrobiotechnology, China Agricultural University [2015SKLAB1-4]; National Thousand Talents Program of China	China National Key Research Program; China National Basic Research Program(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratories for Agrobiotechnology, China Agricultural University; National Thousand Talents Program of China	This study was supported by grants from China National Key Research Program (SQ2016ZY05002032-02), China National Basic Research Program (2011CBB01001), National Thousand Talents Program of China, Program for New Century Excellent Talents in University (NCET-11-0482), and by Research Programs from the State Key Laboratories for Agrobiotechnology, China Agricultural University (2015SKLAB1-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravalli RN, 2012, VET J, V194, P369, DOI 10.1016/j.tvjl.2012.05.013; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen GF, 2014, CELL RES, V24, P1121, DOI 10.1038/cr.2014.112; Cheng D, 2012, CELL REPROGRAM, V14, P312, DOI 10.1089/cell.2012.0025; Dweep H, 2015, NAT METHODS, V12, P697, DOI 10.1038/nmeth.3485; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Furuta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060155; Gao J, 2011, J CELL BIOCHEM, V112, P1844, DOI 10.1002/jcb.23106; Greve TS, 2013, ANNU REV CELL DEV BI, V29, P213, DOI 10.1146/annurev-cellbio-101512-122343; Griffiths-Jones S, 2003, NUCLEIC ACIDS RES, V31, P439, DOI 10.1093/nar/gkg006; Grunhagen J, 2015, J BONE MINER RES, V30, P796, DOI 10.1002/jbmr.2412; Gu MX, 2012, CIRC RES, V111, P882, DOI 10.1161/CIRCRESAHA.112.269001; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Jouneau A, 2012, RNA, V18, P253, DOI 10.1261/rna.028878.111; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li L, 2015, CELL MOL BIOL LETT, V20, P385, DOI 10.1515/cmble-2015-0023; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Li W, 2011, CELL RES, V21, P550, DOI 10.1038/cr.2011.25; Li XR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066688; Li ZH, 2011, EMBO J, V30, P823, DOI 10.1038/emboj.2011.2; Liao BJ, 2011, J BIOL CHEM, V286, P17359, DOI 10.1074/jbc.C111.235960; Lichner Z, 2011, DIFFERENTIATION, V81, P11, DOI 10.1016/j.diff.2010.08.002; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma KY, 2014, MOL CELL BIOCHEM, V389, P209, DOI 10.1007/s11010-013-1942-x; Mackowiak Sebastian D, 2011, Curr Protoc Bioinformatics, VChapter 12, DOI 10.1002/0471250953.bi1210s36; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Ren JQ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-20; Rodriguez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049079; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Sladitschek HL, 2015, CELL SYST BIOL, P11; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tang XL, 2014, NUCLEIC ACIDS RES, V42, P2988, DOI 10.1093/nar/gkt1275; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tsai ZY, 2010, J CELL BIOCHEM, V109, P93, DOI 10.1002/jcb.22385; Wang GY, 2013, P NATL ACAD SCI USA, V110, P2858, DOI 10.1073/pnas.1212769110; Wang YM, 2013, CELL REP, V4, P99, DOI 10.1016/j.celrep.2013.05.027; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Wei Q, 2015, THORAC CANCER, V6, P2, DOI 10.1111/1759-7714.12164; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xia HP, 2013, HEPATOLOGY, V58, P629, DOI 10.1002/hep.26369; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Zhang W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124562; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607; Zhou L, 2011, STEM CELLS, V29, P972, DOI 10.1002/stem.637	64	7	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158655	10.1371/journal.pone.0158655	http://dx.doi.org/10.1371/journal.pone.0158655			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384321	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400073
J	Dai, HY; Wu, GD; Wu, M; Zhi, DG				Dai, Hongying; Wu, Guodong; Wu, Michael; Zhi, Degui			An Optimal Bahadur-Efficient Method in Detection of Sparse Signals with Applications to Pathway Analysis in Sequencing Association Studies	PLOS ONE			English	Article							WEIGHTED Z-TEST; COMBINING PROBABILITIES; ASYMPTOTIC OPTIMALITY; BIOLOGICAL PATHWAYS; INDEPENDENT TESTS; FISHERS METHOD; MODELS	Next-generation sequencing data pose a severe curse of dimensionality, complicating traditional "single marker-single trait" analysis. We propose a two-stage combined p-value method for pathway analysis. The first stage is at the gene level, where we integrate effects within a gene using the Sequence Kernel Association Test (SKAT). The second stage is at the pathway level, where we perform a correlated Lancaster procedure to detect joint effects from multiple genes within a pathway. We show that the Lancaster procedure is optimal in Bahadur efficiency among all combined p-value methods. The Bahadur efficiency, lim(epsilon -> 0) N-(2)/N-(1) = phi(12)(theta), compares sample sizes among different statistical tests when signals become sparse in sequencing data, i.e. epsilon -> 0. The optimal Bahadur efficiency ensures that the Lancaster procedure asymptotically requires a minimal sample size to detect sparse signals (P-N(i) < epsilon -> 0). The Lancaster procedure can also be applied to meta-analysis. Extensive empirical assessments of exome sequencing data show that the proposed method outperforms Gene Set Enrichment Analysis (GSEA). We applied the competitive Lancaster procedure to meta-analysis data generated by the Global Lipids Genetics Consortium to identify pathways significantly associated with high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, triglycerides, and total cholesterol.	[Dai, Hongying] Childrens Mercy Hosp, Hlth Serv & Outcomes Res, Kansas City, MO 64108 USA; [Dai, Hongying] Univ Missouri, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA; [Wu, Guodong] Lovelace Resp Res Inst, Albuquerque, NM USA; [Wu, Michael] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Biostat & Biomath Program, 1124 Columbia St, Seattle, WA 98104 USA; [Zhi, Degui] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Lovelace Respiratory Research Institute; Fred Hutchinson Cancer Center; University of Alabama System; University of Alabama Birmingham	Dai, HY (corresponding author), Childrens Mercy Hosp, Hlth Serv & Outcomes Res, Kansas City, MO 64108 USA.; Dai, HY (corresponding author), Univ Missouri, Dept Biomed & Hlth Informat, Kansas City, MO 64110 USA.	hdai@cmh.edu	Wu, Guodong/U-6549-2018; Wu, Michael/X-5084-2019	Wu, Michael/0000-0002-3357-6570; Dai, Hongying/0000-0003-1395-7904; Wu, Guodong/0000-0003-1550-5952	NHGRI of the National Institutes of Health [R01HG008115]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008115] Funding Source: NIH RePORTER	NHGRI of the National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by NHGRI of the National Institutes of Health under award number R01HG008115 (D.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; There are no competing interests to this work. We thank three reviewers for their constructive comments, which helped us improve the manuscript. This work is supported by NHGRI of the National Institutes of Health under award number R01HG008115 (D.Z.). We also thank David Williams and the Medical Writing Center at Children's Mercy Hospital for their comments, support, and assistance with the manuscript, which significantly enhanced readability of our work.	BAHADUR RR, 1967, ANN MATH STAT, V38, P303, DOI 10.1214/aoms/1177698949; Benjamini Y, 1997, SCAND J STAT, V24, P407, DOI 10.1111/1467-9469.00072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen Z, 2011, J EVOLUTION BIOL, V24, P926, DOI 10.1111/j.1420-9101.2010.02226.x; Dai H, 2014, STAT ITS INTERFACE; DAI H., 2012, J BIOM BIOSTAT, P3, DOI DOI 10.4172/2155-6180.1000E117; Dai HY, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00032; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Genovese CR, 2006, BIOMETRIKA, V93, P509, DOI 10.1093/biomet/93.3.509; GOOD IJ, 1955, J ROY STAT SOC B, V17, P264; He XM, 1996, ANN I STAT MATH, V48, P295, DOI 10.1007/BF00054792; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KILLEEN TJ, 1972, ANN MATH STAT, V43, P181, DOI 10.1214/aoms/1177692712; Lin XH, 1997, BIOMETRIKA, V84, P309, DOI 10.1093/biomet/84.2.309; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; LITTELL RC, 1973, J AM STAT ASSOC, V68, P193, DOI 10.2307/2284167; LITTELL RC, 1971, J AM STAT ASSOC, V66, P802, DOI 10.2307/2284230; Matthews L, 2009, NUCLEIC ACIDS RES, V37, pD619, DOI 10.1093/nar/gkn863; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Peng G, 2010, EUR J HUM GENET, V18, P111, DOI 10.1038/ejhg.2009.115; Rosenbaum PR, 2015, J AM STAT ASS, V110; SAVAGE IR, 1969, SANKHYA SER A, V31, P107; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wu GD, 2013, GENET EPIDEMIOL, V37, P478, DOI 10.1002/gepi.21728; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zaykin DV, 2011, J EVOLUTION BIOL, V24, P1836, DOI 10.1111/j.1420-9101.2011.02297.x; Zhou X, 2014, NAT METHODS, V11, P407, DOI [10.1038/nmeth.2848, 10.1038/NMETH.2848]	31	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0152667	10.1371/journal.pone.0152667	http://dx.doi.org/10.1371/journal.pone.0152667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380176	Green Published, gold, Green Submitted			2022-12-26	WOS:000379798700001
J	Tong, J; Tan, S; Zou, F; Yu, J; Zhang, L				Tong, J.; Tan, S.; Zou, F.; Yu, J.; Zhang, L.			FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation	ONCOGENE			English	Article							UBIQUITIN LIGASE; TUMOR-SUPPRESSOR; MULTIKINASE INHIBITOR; APOPTOTIC RESPONSE; DOWN-REGULATION; REGORAFENIB; SORAFENIB; SURVIVAL; PATHWAY; CELLS	Colorectal cancer (CRC), the second leading cause of cancer-related deaths in the US, has been treated with targeted therapies. However, the mechanisms of differential responses and resistance of CRCs to targeted therapies are not well understood. In this study, we found that genetic alterations of FBW7, an E3 ubiquitin ligase and a tumor suppressor frequently mutated in CRCs, contribute to resistance to targeted therapies. CRC cells containing FBW7-inactivating mutations are insensitive to clinically used multi-kinase inhibitors of RAS/RAF/MEK/ERK signaling, including regorafenib and sorafenib. In contrast, sensitivity to these agents is not affected by oncogenic mutations in KRAS, BRAF, PIK3CA or p53. These cells are defective in apoptosis owing to blocked degradation of Mcl-1, a pro-survival Bcl-2 family protein. Deleting FBW7 in FBW7-wild-type CRC cells abolishes Mcl-1 degradation and recapitulates the in vitro and in vivo drug-resistance phenotypes of FBW7-mutant cells. CRC cells selected for regorafenib resistance have progressive enrichment of pre-existing FBW7 hotspot mutations, and are cross-resistant to other targeted drugs that induce Mcl-1 degradation. Furthermore, a selective Mcl-1 inhibitor restores regorafenib sensitivity in CRC cells with intrinsic or acquired resistance. Together, our results demonstrate FBW7 mutational status as a key genetic determinant of CRC response to targeted therapies, and Mcl-1 as an attractive therapeutic target.	[Tong, J.; Tan, S.; Zhang, L.] Univ Pittsburgh, Sch Med, Inst Canc, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Tan, S.; Zou, F.] Sichuan Univ, Col Life Sci, Chengdu, Peoples R China; [Yu, J.] Univ Pittsburgh, Sch Med, Inst Canc, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Sichuan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Zhang, L (corresponding author), Univ Pittsburgh, Hillman Canc Ctr, Inst Canc, Dept Pharmacol & Chem Biol, UPCI Res Pavil,Room 2-42a,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	zhanglx@upmc.edu	Zhang, Lin/A-7389-2009; Yu, Jian/A-8301-2009	Zhang, Lin/0000-0003-0018-3903; Yu, Jian/0000-0002-4021-1000; Tong, Jingshan/0000-0003-1640-5769; Zou, Fangdong/0000-0002-2133-4320	U.S. National Institute of Health [CA106348, CA172136, CA203028, U01DK085570, AI068021]; American Cancer Society grant [RGS-10-124-01-CCE];  [P30CA047904]; NATIONAL CANCER INSTITUTE [R01CA172136, R01CA106348, R01CA203028, P30CA047904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085570] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society grant(American Cancer Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank our lab members for critical reading. This work is supported by U.S. National Institute of Health grants (CA106348, CA172136 and CA203028 to LZ; U01DK085570 and AI068021 to JY) and American Cancer Society grant (RGS-10-124-01-CCE to JY). This project used the UPCI shared facilities that were supported in part by award P30CA047904.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Balamurugan K, 2010, EMBO J, V29, P4106, DOI 10.1038/emboj.2010.280; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Bhola PD, 2016, MOL CELL, V61, P695, DOI 10.1016/j.molcel.2016.02.019; Chan SL, 2014, EXPERT OPIN DRUG MET, V10, P1607, DOI 10.1517/17425255.2014.970169; Chen DS, 2014, ONCOTARGET, V5, P8107, DOI 10.18632/oncotarget.2440; Chen DS, 2014, CLIN CANCER RES, V20, P3472, DOI 10.1158/1078-0432.CCR-13-2944; Choudhary GS, 2015, ONCOTARGET, V6, P16912, DOI 10.18632/oncotarget.4857; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Davis RJ, 2014, CANCER CELL, V26, P455, DOI 10.1016/j.ccell.2014.09.013; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Dudgeon C, 2012, ONCOGENE, V31, P4848, DOI 10.1038/onc.2011.644; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hata AN, 2015, CANCER DISCOV, V5, P475, DOI 10.1158/2159-8290.CD-15-0011; He L, 2013, CANCER DISCOV, V3, P324, DOI 10.1158/2159-8290.CD-12-0417; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; Lerner M, 2011, CELL CYCLE, V10, P2172, DOI 10.4161/cc.10.13.16248; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Min SH, 2012, MOL CELL, V46, P771, DOI 10.1016/j.molcel.2012.04.012; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Mojsa B, 2014, CELLS-BASEL, V3, P418, DOI 10.3390/cells3020418; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Peng R, 2013, CELL DEATH DIFFER, V20, P744, DOI 10.1038/cdd.2013.4; Qiu W, 2010, P NATL ACAD SCI USA, V107, P20027, DOI 10.1073/pnas.1010430107; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Schulein-Volk C, 2014, CELL REP, V9, P1099, DOI 10.1016/j.celrep.2014.09.057; Schwickart M, 2010, NATURE, V463, P103, DOI 10.1038/nature08646; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Varadarajan S, 2013, CELL DEATH DIFFER, V20, P1475, DOI 10.1038/cdd.2013.79; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Wilhelm S, 2006, NAT REV DRUG DISCOV, V5, P835, DOI 10.1038/nrd2130; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	47	114	116	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 9	2017	36	6					787	796		10.1038/onc.2016.247	http://dx.doi.org/10.1038/onc.2016.247			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IX	27399335	Green Accepted			2022-12-26	WOS:000394168200006
J	Sheng, YH; He, Y; Hasnain, SZ; Wang, R; Tong, H; Clarke, DT; Lourie, R; Oancea, I; Wong, KY; Lumley, JW; Florin, TH; Sutton, P; Hooper, JD; McMillan, NA; McGuckin, MA				Sheng, Y. H.; He, Y.; Hasnain, S. Z.; Wang, R.; Tong, H.; Clarke, D. T.; Lourie, R.; Oancea, I.; Wong, K. Y.; Lumley, J. W.; Florin, T. H.; Sutton, P.; Hooper, J. D.; McMillan, N. A.; McGuckin, M. A.			MUC13 protects colorectal cancer cells from death by activating the NF-kappa B pathway and is a potential therapeutic target	ONCOGENE			English	Article							SURFACE MUCIN; MUCOSAL BARRIER; EXPRESSION; ONCOPROTEIN; INFLAMMATION; RESISTANCE; OVEREXPRESSION; ADENOCARCINOMA; SIRNA	MUC13 is a transmembrane mucin glycoprotein that is over produced by many cancers, although its functions are not fully understood. Nuclear factor-kappa B (NF-kappa B) is a key transcription factor promoting cancer cell survival, but therapeutically targeting this pathway has proved difficult because NF-kappa B has pleiotropic functions. Here, we report that MUC13 prevents colorectal cancer cell death by promoting two distinct pathways of NF-kappa B activation, consequently upregulating BCL-XL. MUC13 promoted tumor necrosis factor (TNF)-induced NF-kappa B activation by interacting with TNFR1 and the E3 ligase, cIAP1, to increase ubiquitination of RIPK1. MUC13 also promoted genotoxin-induced NF-kappa B activation by increasing phosphorylation of ATM and SUMOylation of NF-kappa B essential modulator. Moreover, elevated expression of cytoplasmic MUC13 and NF-kappa B correlated with colorectal cancer progression and metastases. Our demonstration that MUC13 enhances NF-kappa B signaling in response to both TNF and DNA-damaging agents provides a new molecular target for specific inhibition of NFB activation. As proof of principle, silencing MUC13 sensitized colorectal cancer cells to killing by cytotoxic drugs and inflammatory signals and abolished chemotherapy-induced enrichment of CD133(+) CD44(+) cancer stem cells, slowed xenograft growth in mice, and synergized with 5-fluourouracil to induce tumor regression. Therefore, these data indicate that combining chemotherapy and MUC13 antagonism could improve the treatment of metastatic cancers.	[Sheng, Y. H.; Hasnain, S. Z.; Wang, R.; Tong, H.; Lourie, R.; Oancea, I.; Wong, K. Y.; McGuckin, M. A.] Univ Queensland, Translat Res Inst, Mater Res Inst, Inflammatory Dis Biol & Therapeut Grp, 37 Kent St, Brisbane, Qld 4102, Australia; [He, Y.; Hooper, J. D.] Univ Queensland, Translat Res Inst, Mater Res Inst, Canc Biol Grp, Brisbane, Qld, Australia; [Clarke, D. T.; McMillan, N. A.] Griffith Univ, Sch Med Sci, Mol Basis Dis Program, Gold Coast Campus, Southport, Qld, Australia; [Lourie, R.; Oancea, I.; Florin, T. H.] Univ Queensland, Translat Res Inst, Mater Res Inst, Inflammatory Bowel Dis Grp, Brisbane, Qld, Australia; [Lumley, J. W.] Wesley Hosp, Auchenflower, Australia; [Sutton, P.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Mucosal Immunol, Melbourne, Vic, Australia; [Sutton, P.] Univ Melbourne, Sch Vet & Agr Sci, Ctr Anim Biotechnol, Melbourne, Vic, Australia; [Sutton, P.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia	Mater Research; University of Queensland; Mater Research; University of Queensland; Griffith University; Mater Research; University of Queensland; Wesley Hospital; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne	McGuckin, MA (corresponding author), Univ Queensland, Translat Res Inst, Mater Res Inst, Inflammatory Dis Biol & Therapeut Grp, 37 Kent St, Brisbane, Qld 4102, Australia.	michael.mcguckin@mater.uq.edu.au	Hasnain, Sumaira Z/N-3412-2014; Wang, Ran/AAP-1920-2020; McMillan, Nigel/AAQ-5416-2021; McGuckin, Michael/G-2310-2010; sheng, yong H/C-5052-2013; Oancea, Iulia/F-3202-2017; Hooper, John/C-1481-2016	Hasnain, Sumaira Z/0000-0001-8577-8628; Wang, Ran/0000-0002-1741-6446; McGuckin, Michael/0000-0002-8375-2675; sheng, yong H/0000-0002-4623-9098; Oancea, Iulia/0000-0001-5978-5963; Sutton, Philip/0000-0003-3129-1800; Hooper, John/0000-0003-1054-8486; HE, Yaowu/0000-0002-7828-263X; McMillan, Nigel/0000-0002-9471-1406	Australian National Health and Medical Research Council (NHMRC) [1060698]; Mater Foundation; NHMRC Principal Research Fellowship; Australian Government	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Mater Foundation; NHMRC Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Government(Australian GovernmentCGIAR)	This work was supported by the Australian National Health and Medical Research Council (NHMRC) project grant 1060698 and by funding from the Mater Foundation. MAM is supported by an NHMRC Principal Research Fellowship. The Translational Research Institute (TRI) is supported by a grant from the Australian Government. We acknowledge the technical assistance of the TRI core facilities for flow cytometry, microscopy and biological resources. We thank Michael R Tallack for help with Chip analysis and John Silke for providing feedback on our manuscript.	Ahmad R, 2007, NAT CELL BIOL, V9, P1419, DOI 10.1038/ncb1661; Ahmad R, 2009, CANCER RES, V69, P7013, DOI 10.1158/0008-5472.CAN-09-0523; Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Breccia M, 2010, EXPERT OPIN THER TAR, V14, P1157, DOI 10.1517/14728222.2010.522570; Chauhan SC, 2012, MOL CANCER THER, V11, P24, DOI 10.1158/1535-7163.MCT-11-0598; Chauhan SC, 2009, CANCER RES, V69, P765, DOI 10.1158/0008-5472.CAN-08-0587; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Deng M, 2013, ASIAN PAC J CANCER P, V14, P127, DOI 10.7314/APJCP.2013.14.1.127; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Gupta BK, 2014, J GASTROENTEROL, V49, P1378, DOI 10.1007/s00535-013-0885-z; Gupta BK, 2012, J HISTOCHEM CYTOCHEM, V60, P822, DOI 10.1369/0022155412460678; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HOLLINGSWORTH MA, 1994, INT J CANCER, V57, P198, DOI 10.1002/ijc.2910570212; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Iwai K, 2012, TRENDS CELL BIOL, V22, P355, DOI 10.1016/j.tcb.2012.04.001; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Jonckheere N, 2014, BBA-REV CANCER, V1846, P142, DOI 10.1016/j.bbcan.2014.04.008; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Khan S, 2014, ONCOTARGET, V5, P7599, DOI 10.18632/oncotarget.2281; Kufe DW, 2013, ONCOGENE, V32, P1073, DOI 10.1038/onc.2012.158; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; McDermott KM, 2001, INT J CANCER, V94, P783, DOI 10.1002/ijc.1554; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Meier P, 2007, MOL CELL, V28, P746, DOI 10.1016/j.molcel.2007.11.016; Nath S, 2014, TRENDS MOL MED, V20, P332, DOI 10.1016/j.molmed.2014.02.007; Nishii Y, 2015, INT J ONCOL, V46, P1781, DOI 10.3892/ijo.2015.2880; Sheng YH, 2013, MUCOSAL IMMUNOL, V6, P557, DOI 10.1038/mi.2012.98; Sheng YH, 2012, J GASTROEN HEPATOL, V27, P28, DOI 10.1111/j.1440-1746.2011.06909.x; Sheng YH, 2011, GUT, V60, P1661, DOI 10.1136/gut.2011.239194; Shimamura T, 2005, CANCER SCI, V96, P265, DOI 10.1111/j.1349-7006.2005.00043.x; Silke J, 2014, IAPS NECROPTOTIC CEL, P57; Swartz MJ, 2002, AM J CLIN PATHOL, V117, P791; Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x; Walsh MD, 2007, HUM PATHOL, V38, P883, DOI 10.1016/j.humpath.2006.11.020; Williams SJ, 2001, J BIOL CHEM, V276, P18327, DOI 10.1074/jbc.M008850200; Wu SY, 2009, PHARM RES-DORDR, V26, P512, DOI 10.1007/s11095-008-9766-1	44	39	40	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 2	2017	36	5					700	713		10.1038/onc.2016.241	http://dx.doi.org/10.1038/onc.2016.241			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IS	27399336	Green Published, hybrid			2022-12-26	WOS:000394167700011
J	Mi, Y; Coonce, M; Fiete, D; Steirer, L; Dveksler, G; Townsend, RR; Baenziger, JU				Mi, Yiling; Coonce, Marcy; Fiete, Dorothy; Steirer, Lindsay; Dveksler, Gabriela; Townsend, R. Reid; Baenziger, Jacques U.			Functional Consequences of Mannose and Asialoglycoprotein Receptor Ablation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASPARAGINE-LINKED OLIGOSACCHARIDES; PERFORMANCE LIQUID-CHROMATOGRAPHY; GLYCANASE-RELEASED OLIGOSACCHARIDES; PITUITARY GLYCOPROTEIN HORMONES; VON-WILLEBRAND-FACTOR; CYSTEINE-RICH DOMAIN; ACTIVATED PROTEIN-C; BETA 1,4GLCNAC BETA; FACTOR-V-LEIDEN; MICE LACKING	The mannose receptor (ManR, Mrc1) and asialoglycoprotein receptor (ASGR, Asgr1 and Asgr2) are highly abundant endocytic receptors expressed by sinusoidal endothelial cells and parenchymal cells in the liver, respectively. We genetically manipulated either receptor individually or in combination, revealing phenotypic changes in female and male mice associated with changes in circulating levels of many glycoproteins. Both receptors rise and fall in response to progesterone during pregnancy. Thirty percent of Asgr2(-/-) and 65% of Mrc1(-/-) Asgr2(-/-) mice are unable to initiate parturition at the end of pregnancy, whereas Mrcl(-/-) mice initiate normally. Twenty five percent of Mrcl(-/-) Asgr2(-/-) male mice develop priapism when mating due to thrombosis of the penile vein, but neither Mrc1(-/-) nor Asgr2(-/-) mice do so. The half-life for luteinizing hormone (LH) clearance increases in Mrc1(-/-) and Mrc1(-/-) Asgr2(-/-) mice but not in Asgr2(-/-) mice; however, LH and testosterone are elevated in all three knockouts. The ManR clears I,H thus regulating testosterone production, whereas the ASGR appears to mediate clearance of an unidentified glycoprotein that increases LH levels. More than 40 circulating glycoproteins are elevated >3.0-fold in pregnant Mrc1(-/-) Asgr2(-/-) mice. Pregnancy-specific glycoprotein 23, undetectable in WT mice (<50 ng/ml plasma), reaches levels of 1-10 mg/ml in the plasma of Mrc1(-/-) Asgr2(-/-) and Asgr2(-/-) mice, indicating it is cleared by the ASGR. Elevation of multiple coagulation factors in Mrc1(-/-)Asgr2(-/-) mice may account for priapism seen in males. These male and female phenotypic changes underscore the key roles of the ManR and ASGR in controlling circulating levels of numerous glycoproteins critical for regulating reproductive hormones and blood coagulation.	[Mi, Yiling; Coonce, Marcy; Fiete, Dorothy; Steirer, Lindsay; Dveksler, Gabriela; Townsend, R. Reid; Baenziger, Jacques U.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 South Euclid Ave, St Louis, MO 63110 USA	Washington University (WUSTL)	Baenziger, JU (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, 660 South Euclid Ave, St Louis, MO 63110 USA.	Baenziger@wustl.edu	Baenziger, Jacques U/E-9430-2012		National Institutes of Health [R01-CA21923, R01-HD058474]; Washington University Institute of Clinical and Translational Sciences Grant from National Center for Advancing Translational Sciences [UL1 TR000448]; National Institutes of Health from NIGMS [P41 GM103422-35]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058474] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA021923] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Institute of Clinical and Translational Sciences Grant from National Center for Advancing Translational Sciences; National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-CA21923 and R01-HD058474 (to J. U. B), Washington University Institute of Clinical and Translational Sciences Grant UL1 TR000448 from the National Center for Advancing Translational Sciences, and National Institutes of Health Grant P41 GM103422-35 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; BAENZIGER JU, 1992, P NATL ACAD SCI USA, V89, P334, DOI 10.1073/pnas.89.1.334; BAENZIGER JU, 1988, BIOCHIM BIOPHYS ACTA, V947, P287, DOI 10.1016/0304-4157(88)90012-3; BAENZIGER JU, 1980, CELL, V22, P611, DOI 10.1016/0092-8674(80)90371-2; BERTINA RM, 1994, NATURE, V369, P64, DOI 10.1038/369064a0; BERTINA RM, 1995, THROMB HAEMOSTASIS, V74, P449; Braun JR, 1996, J BIOL CHEM, V271, P21160, DOI 10.1074/jbc.271.35.21160; Collier TS, 2011, RAPID COMMUN MASS SP, V25, P2524, DOI 10.1002/rcm.5151; Collier TS, 2010, ANAL CHEM, V82, P8696, DOI 10.1021/ac101978b; Coombs PJ, 2006, GLYCOBIOLOGY, V16, p1C, DOI 10.1093/glycob/cwj126; Dobrkovska A, 1998, HAEMOPHILIA, V4, P33; Fiete D, 1997, J BIOL CHEM, V272, P14629, DOI 10.1074/jbc.272.23.14629; Fiete D, 1997, P NATL ACAD SCI USA, V94, P11256, DOI 10.1073/pnas.94.21.11256; FIETE D, 1991, CELL, V67, P1103, DOI 10.1016/0092-8674(91)90287-9; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Fisher R. A., 1938, STAT TABLES BIOL AGR, P1; GREEN ED, 1985, J BIOL CHEM, V260, P5623; GREEN ED, 1988, J BIOL CHEM, V263, P25; GREEN ED, 1988, J BIOL CHEM, V263, P36; GREEN ED, 1987, ANAL BIOCHEM, V167, P62, DOI 10.1016/0003-2697(87)90134-5; GREEN ED, 1987, J BIOL CHEM, V262, P12030; GREEN ED, 1989, TRENDS BIOCHEM SCI, V14, P168, DOI 10.1016/0968-0004(89)90267-3; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; Ha CT, 2008, AM J REPROD IMMUNOL, V59, P251, DOI 10.1111/j.1600-0897.2007.00573.x; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; HUDGIN RL, 1974, J BIOL CHEM, V249, P5536; ISHIBASHI S, 1994, J BIOL CHEM, V269, P27803; Kang HG, 2001, J BIOL CHEM, V276, P10861, DOI 10.1074/jbc.M011560200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim HJ, 2009, BLOOD, V114, P5206, DOI 10.1182/blood-2009-03-212415; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; Lemmerhirt HL, 2006, BLOOD, V108, P3061, DOI 10.1182/blood-2006-04-014688; Liu Y, 2000, J EXP MED, V191, P1105, DOI 10.1084/jem.191.7.1105; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639; Mandalasi M, 2013, GLYCOBIOLOGY, V23, P877, DOI 10.1093/glycob/cwt025; MAYNARD Y, 1981, J BIOL CHEM, V256, P8063; McLellan AS, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-39; McLellan AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-4; Menache D, 1996, BRIT J HAEMATOL, V94, P740, DOI 10.1046/j.1365-2141.1996.d01-1860.x; MENGELING BJ, 1991, ANAL BIOCHEM, V199, P286, DOI 10.1016/0003-2697(91)90103-Z; MERKLE RK, 1987, METHOD ENZYMOL, V138, P232; Mi YL, 2008, J CLIN INVEST, V118, P1815, DOI 10.1172/JCI32467; Mi YL, 2014, J BIOL CHEM, V289, P12157, DOI 10.1074/jbc.M113.544973; Mohlke KL, 1996, P NATL ACAD SCI USA, V93, P15352, DOI 10.1073/pnas.93.26.15352; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Park EI, 2004, J BIOL CHEM, V279, P40954, DOI 10.1074/jbc.M406647200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piekorz RP, 2005, MOL ENDOCRINOL, V19, P431, DOI 10.1210/me.2004-0302; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; Roseman DS, 2000, P NATL ACAD SCI USA, V97, P9949, DOI 10.1073/pnas.170184597; Roseman DS, 2001, J BIOL CHEM, V276, P17052, DOI 10.1074/jbc.M101027200; Rumjantseva V, 2009, NAT MED, V15, P1273, DOI 10.1038/nm.2030; Shanley DK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057491; Sherwood OD, 2004, ENDOCR REV, V25, P205, DOI 10.1210/er.2003-0013; SMITH PL, 1990, P NATL ACAD SCI USA, V87, P7275, DOI 10.1073/pnas.87.18.7275; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; STAHL P, 1976, P NATL ACAD SCI USA, V73, P4045, DOI 10.1073/pnas.73.11.4045; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; TAYLOR ME, 1993, J BIOL CHEM, V268, P399; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Wu JA, 2008, BIOL REPROD, V79, P1054, DOI 10.1095/biolreprod.108.070268; Xia GQ, 2000, J BIOL CHEM, V275, P38402, DOI 10.1074/jbc.M007821200; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008	71	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18700	18717		10.1074/jbc.M116.738948	http://dx.doi.org/10.1074/jbc.M116.738948			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27405760	Green Published, hybrid			2022-12-26	WOS:000383242300009
J	Follett, J; Bugarcic, A; Yang, Z; Ariotti, N; Norwood, SJ; Collins, BM; Parton, RG; Teasdale, RD				Follett, Jordan; Bugarcic, Andrea; Yang, Zhe; Ariotti, Nicholas; Norwood, Suzanne J.; Collins, Brett M.; Parton, Robert G.; Teasdale, Rohan D.			Parkinson Disease-linked Vps35 R524W Mutation Impairs the Endosomal Association of Retromer and Induces -Synuclein Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; intracellular trafficking; membrane transport; Parkinson disease; protein sorting; retromer	CHAPERONE-MEDIATED AUTOPHAGY; ALPHA-SYNUCLEIN; WASH COMPLEX; MAMMALIAN RETROMER; DROSOPHILA MODEL; CATHEPSIN-D; CARGO; DEGRADATION; RECRUITMENT; CELLS	Endosomal sorting is a highly orchestrated cellular process. Retromer is a heterotrimeric complex that associates with endosomal membranes and facilitates the retrograde sorting of multiple receptors, including the cation-independent mannose 6-phosphate receptor for lysosomal enzymes. The cycling of retromer on and off the endosomal membrane is regulated by a network of retromer-interacting proteins. Here, we find that Parkinson disease-associated Vps35 variant, R524W, but not P316S, is a loss-of-function mutation as marked by a reduced association with this regulatory network and dysregulation of endosomal receptor sorting. Expression of Vps35 R524W-containing retromer results in the accumulation of intracellular -synuclein-positive aggregates, a hallmark of Parkinson disease. Overall, the Vps35 R524W-containing retromer has a decreased endosomal association, which can be partially rescued by R55, a small molecule previously shown to stabilize the retromer complex, supporting the potential for future targeting of the retromer complex in the treatment of Parkinson disease.	[Follett, Jordan; Bugarcic, Andrea; Yang, Zhe; Ariotti, Nicholas; Norwood, Suzanne J.; Collins, Brett M.; Parton, Robert G.; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Teasdale, RD (corresponding author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.	r.teasdale@uq.edu.au	Teasdale, Rohan D/B-2538-2009; Bugarcic, Andrea/AAN-8952-2021; Teasdale, Rohan/AAD-6698-2019; Ariotti, Nicholas/GXH-4833-2022; Yang, Zhe/O-3489-2019; Collins, Brett/J-1563-2014; Parton, Robert/C-5673-2009	Teasdale, Rohan D/0000-0001-7455-5269; Teasdale, Rohan/0000-0001-7455-5269; Yang, Zhe/0000-0002-7987-0855; Collins, Brett/0000-0002-6070-3774; Ariotti, Nicholas/0000-0003-3901-0831; Parton, Robert/0000-0002-7494-5248; Bugarcic, Andrea/0000-0003-2525-2450	National Health and Medical Research Council (NHMRC) of Australia [APP1025538, APP1037320, APP1042082, APP1045092, APP1058734]; Australian Research Council [DP120103930]; Centre of Excellence in Convergent Bio-Nano Science and Technology; ANZ Trustees National Medical Program Grant from Judith Jane Mason and Harold Stannett Williams Memorial Foundation; NHMRC [APP1061574, APP1058565, APP1041929]; ARC Future Fellowship [FT100100027]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Centre of Excellence in Convergent Bio-Nano Science and Technology; ANZ Trustees National Medical Program Grant from Judith Jane Mason and Harold Stannett Williams Memorial Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC Future Fellowship(Australian Research Council)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Grants APP1025538, APP1037320, APP1042082, APP1045092, and APP1058734; Australian Research Council Project Grant DP120103930 and Centre of Excellence in Convergent Bio-Nano Science and Technology; and an ANZ Trustees National Medical Program Grant from the Judith Jane Mason and Harold Stannett Williams Memorial Foundation. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NHMRC Career Development Fellowship APP1061574 and ARC Future Fellowship FT100100027.; Supported by NHMRC Senior Principal Research Fellowship APP1058565.; Supported by NHMRC Senior Research Fellowship APP1041929. To whom correspondence should be addressed. Tel.: 61-3202-9143; E-mail: r.teasdale@uq.edu.au.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Ariotti N, 2015, DEV CELL, V35, P513, DOI 10.1016/j.devcel.2015.10.016; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bugarcic A, 2011, TRAFFIC, V12, P1759, DOI 10.1111/j.1600-0854.2011.01284.x; Chi RJ, 2015, CELL MOL LIFE SCI, V72, P3441, DOI 10.1007/s00018-015-1935-x; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Emmanouilidou E, 2010, NEUROBIOL AGING, V31, P953, DOI 10.1016/j.neurobiolaging.2008.07.008; Follett J, 2017, CURR PROTEIN PEPT SC, V18, P687, DOI 10.2174/1389203717666160311121246; Follett J, 2014, TRAFFIC, V15, P230, DOI 10.1111/tra.12136; Follett J, 2013, NEUROTOX RES, V23, P378, DOI 10.1007/s12640-012-9366-z; Furlong RA, 2000, BIOCHEM J, V346, P577, DOI 10.1042/0264-6021:3460577; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Harbour ME, 2012, BIOCHEM J, V442, P209, DOI 10.1042/BJ20111761; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Harrison MS, 2014, P NATL ACAD SCI USA, V111, P267, DOI 10.1073/pnas.1316482111; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hong Z, 2009, CELL RES, V19, P1334, DOI 10.1038/cr.2009.130; Hossain S, 2001, J ALZHEIMERS DIS, V3, P577, DOI 10.3233/JAD-2001-3608; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jia D, 2012, MOL BIOL CELL, V23, P2352, DOI 10.1091/mbc.E11-12-1059; Kerr MC, 2005, TRAFFIC, V6, P991, DOI 10.1111/j.1600-0854.2005.00328.x; Klein C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a008888; Konno M, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-38; Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200; Lesage S, 2012, NEUROLOGY, V78, P1449, DOI 10.1212/WNL.0b013e318253d5f2; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; McGough IJ, 2014, CURR BIOL, V24, P1670, DOI 10.1016/j.cub.2014.06.024; Mecozzi VJ, 2014, NAT CHEM BIOL, V10, P443, DOI [10.1038/NCHEMBIO.1508, 10.1038/nchembio.1508]; Miura E, 2014, NEUROBIOL DIS, V71, P1, DOI 10.1016/j.nbd.2014.07.014; Munsie LN, 2015, HUM MOL GENET, V24, P1691, DOI 10.1093/hmg/ddu582; Norwood SJ, 2011, TRAFFIC, V12, P56, DOI 10.1111/j.1600-0854.2010.01124.x; Popovic D, 2014, EMBO REP, V15, P392, DOI 10.1002/embr.201337995; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Priya A, 2015, TRAFFIC, V16, P68, DOI 10.1111/tra.12237; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Scotter EL, 2014, J CELL SCI, V127, P1263, DOI 10.1242/jcs.140087; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Sevlever D, 2008, BIOCHEMISTRY-US, V47, P9678, DOI 10.1021/bi800699v; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zavodszky E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4828; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008	54	53	53	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18283	18298		10.1074/jbc.M115.703157	http://dx.doi.org/10.1074/jbc.M115.703157			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27385586	Green Published, hybrid			2022-12-26	WOS:000383241800021
J	Saffert, P; Adamla, F; Schieweck, R; Atkins, JF; Ignatova, Z				Saffert, Paul; Adamla, Frauke; Schieweck, Rico; Atkins, John F.; Ignatova, Zoya			An Expanded CAG Repeat in Huntingtin Causes+1 Frameshifting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aggregation; Huntington disease; translation; translation regulation; trinucleotide repeat disease; frameshifting; seeding	INTRANUCLEAR INCLUSIONS; MOLECULAR ARCHITECTURE; CONTAINING PROTEINS; RAN TRANSLATION; DISORDERS; DISEASE; YEAST; TRANSLOCATION; TRANSCRIPTS; POLYALANINE	Maintenance of triplet decoding is crucial for the expression of functional protein because deviations either into the -1 or +1 reading frames are often non-functional. We report here that expression of huntingtin (Htt) exon 1 with expanded CAG repeats, implicated in Huntington pathology, undergoes a sporadic +1 frameshift to generate from the CAG repeat a trans-frame AGC repeat-encoded product. This +1 recoding is exclusively detected in pathological Htt variants, i.e. those with expanded repeats with more than 35 consecutive CAG codons. An atypical +1 shift site, UUC C at the 5 end of CAG repeats, which has some resemblance to the influenza A virus shift site, triggers the +1 frameshifting and is enhanced by the increased propensity of the expanded CAG repeats to form a stem-loop structure. The +1 trans-frame-encoded product can directly influence the aggregation of the parental Htt exon 1.	[Saffert, Paul; Schieweck, Rico; Ignatova, Zoya] Univ Potsdam, Inst Biochem, D-14467 Potsdam, Germany; [Adamla, Frauke; Ignatova, Zoya] Univ Hamburg, Dept Chem, Biochem & Mol Biol, D-20146 Hamburg, Germany; [Atkins, John F.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Atkins, John F.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	University of Potsdam; University of Hamburg; University College Cork; Utah System of Higher Education; University of Utah	Ignatova, Z (corresponding author), Univ Hamburg, Inst Biochem & Mol Biol, Martin Luther King Pl 6, D-20146 Hamburg, Germany.	zoya.ignatova@uni-hamburg.de		Ignatova, Zoya/0000-0002-9478-8825; Atkins, John/0000-0001-7933-0165	Deutsche Forschungsgemeinschaft [FOR 1805, SFB 740]; Science Foundation Ireland	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants FOR 1805 and SFB 740 (to Z. I.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Science Foundation Ireland.	Albrecht AN, 2004, HUM MOL GENET, V13, P2351, DOI 10.1093/hmg/ddh277; Atkinson J, 1997, MOL MICROBIOL, V26, P747, DOI 10.1046/j.1365-2958.1997.6101959.x; Brierley I, 2008, BIOCHEM SOC T, V36, P684, DOI 10.1042/BST0360684; Caliskan N, 2014, CELL, V157, P1619, DOI 10.1016/j.cell.2014.04.041; Chen J, 2014, NATURE, V512, P328, DOI 10.1038/nature13428; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; Davies JE, 2006, J MED GENET, V43, P893, DOI 10.1136/jmg.2006.044222; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; FARABAUGH PJ, 1993, CELL, V74, P93, DOI 10.1016/0092-8674(93)90297-4; Firth AE, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120109; Gaspar C, 2000, HUM MOL GENET, V9, P1957, DOI 10.1093/hmg/9.13.1957; Girstmair H, 2013, CELL REP, V3, P148, DOI 10.1016/j.celrep.2012.12.019; Griffiths A, 2006, J VIROL, V80, P6568, DOI 10.1128/JVI.00155-06; Gurvich OL, 2005, J BACTERIOL, V187, P4023, DOI 10.1128/JB.187.12.4023-4032.2005; Herr AJ, 2004, J BIOL CHEM, V279, P11081, DOI 10.1074/jbc.M311491200; Hinz J, 2012, J BIOL CHEM, V287, P2068, DOI 10.1074/jbc.M111.318915; Ivanov IP, 2007, NUCLEIC ACIDS RES, V35, P1842, DOI 10.1093/nar/gkm035; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; Kwun HJ, 2014, P NATL ACAD SCI USA, V111, pE4342, DOI 10.1073/pnas.1416122111; Lehmann J, 2008, RNA, V14, P1264, DOI 10.1261/rna.1029808; Liao PY, 2008, NUCLEIC ACIDS RES, V36, P2619, DOI 10.1093/nar/gkn100; Licznar P, 2003, EMBO J, V22, P4770, DOI 10.1093/emboj/cdg465; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; Michlewski G, 2004, J MOL BIOL, V340, P665, DOI 10.1016/j.jmb.2004.05.021; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Oma Y, 2004, J BIOL CHEM, V279, P21217, DOI 10.1074/jbc.M309887200; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Peters MF, 1999, MOL CELL NEUROSCI, V14, P121, DOI 10.1006/mcne.1999.0773; de Pouplana LR, 2014, TRENDS BIOCHEM SCI, V39, P355, DOI 10.1016/j.tibs.2014.06.002; Satpati P, 2014, NUCLEIC ACIDS RES, V42, P12876, DOI 10.1093/nar/gku1044; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Stochmanski SJ, 2012, HUM MOL GENET, V21, P2211, DOI 10.1093/hmg/dds036; Taliaferro D, 2007, RNA, V13, P606, DOI 10.1261/rna.412707; Tamm T, 2009, VIRUS RES, V146, P73, DOI 10.1016/j.virusres.2009.09.002; Temperley R, 2010, SCIENCE, V327, P301, DOI 10.1126/science.1180674; Toulouse A, 2005, HUM MOL GENET, V14, P2649, DOI 10.1093/hmg/ddi299; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; West JP, 2014, SCIENCE, V345, P1118, DOI 10.1126/science.1259461; Wojciechowska M, 2014, NUCLEIC ACIDS RES, V42, P11849, DOI 10.1093/nar/gku794; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yan SN, 2015, CELL, V160, P870, DOI 10.1016/j.cell.2015.02.003; Zhang G, 2010, NUCLEIC ACIDS RES, V38, P4778, DOI 10.1093/nar/gkq196	45	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18505	18513		10.1074/jbc.M116.744326	http://dx.doi.org/10.1074/jbc.M116.744326			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382061	hybrid, Green Published			2022-12-26	WOS:000383241800040
J	Vugmeyster, L; Clark, MA; Falconer, IB; Ostrovsky, D; Gantz, D; Qiang, W; Hoatson, GL				Vugmeyster, Liliya; Clark, Matthew A.; Falconer, Isaac B.; Ostrovsky, Dmitry; Gantz, Donald; Qiang, Wei; Hoatson, Gina L.			Flexibility and Solvation of Amyloid- Hydrophobic Core	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; amyloid; amyloid- (AB); protein dynamic; solid state NMR; solvation	BETA-SHEET; FIBRIL STRUCTURE; A-BETA(1-42) PEPTIDES; HYDROGEN-EXCHANGE; MASS-SPECTROMETRY; HEAT-CAPACITY; FAST DYNAMICS; SIDE-CHAINS; THERMODYNAMICS; ARCHITECTURE	Amyloid fibril deposits found in Alzheimer disease patients are composed of amyloid- (A) protein forming a number of hydrophobic interfaces that are believed to be mostly rigid. We have investigated the s-ms time-scale dynamics of the intra-strand hydrophobic core and interfaces of the fibrils composed of A(1-40) protein. Using solid-state H-2 NMR line shape experiments performed on selectively deuterated methyl groups, we probed the 3-fold symmetric and 2-fold symmetric polymorphs of native A as well as the protofibrils of D23N Iowa mutant, associated with an early onset of Alzheimer disease. The dynamics of the hydrophobic regions probed at Leu-17, Leu-34, Val-36, and Met-35 side chains were found to be very pronounced at all sites and in all polymorphs of A, with methyl axis motions persisting down to 230-200 K for most of the sites. The dominant mode of motions is the rotameric side chain jumps, with the Met-35 displaying the most complex multi-modal behavior. There are distinct differences in the dynamics among the three protein variants, with the Val-36 site displaying the most variability. Solvation of the fibrils does not affect methyl group motions within the hydrophobic core of individual cross- subunits but has a clear effect on the motions at the hydrophobic interface between the cross- subunits, which is defined by Met-35 contacts. In particular, hydration activates transitions between additional rotameric states that are not sampled in the dry protein. Thus, these results support the existence of water-accessible cavity recently predicted by molecular dynamics simulations and suggested by cryo-EM studies.	[Vugmeyster, Liliya; Falconer, Isaac B.; Ostrovsky, Dmitry] Univ Colorado, Denver, CO 80204 USA; [Clark, Matthew A.] Univ Alaska Anchorage, Anchorage, AK 99508 USA; [Gantz, Donald] Boston Univ, Sch Med, Boston, MA 02118 USA; [Qiang, Wei] SUNY Binghamton, Binghamton, NY 13902 USA; [Hoatson, Gina L.] Coll William & Mary, Williamsburg, VA 23187 USA	University of Colorado System; University of Colorado Denver; University of Alaska System; University of Alaska Anchorage; Boston University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; William & Mary	Vugmeyster, L (corresponding author), Univ Colorado, Denver, CO 80204 USA.	liliya.vugmeyster@ucdenver.edu			National Institutes of Health (NIH) [1R15 GM111681-02]; Institutional Development Award (IDeA) under NIH [P20GM103395]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103395, R15GM111681] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Development Award (IDeA) under NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant (NIH) 1R15 GM111681-02 (to L. V.) as well as by an Institutional Development Award (IDeA) under NIH Grant P20GM103395. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adler J, 2014, PHYS CHEM CHEM PHYS, V16, P7461, DOI 10.1039/c3cp54501f; Ahmed AB, 2013, FEBS LETT, V587, P1089, DOI 10.1016/j.febslet.2012.12.006; Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185; BATCHELDER LS, 1982, P NATL ACAD SCI-BIOL, V79, P386, DOI 10.1073/pnas.79.2.386; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; Bertini I, 2011, J AM CHEM SOC, V133, P16013, DOI 10.1021/ja2035859; Cannon MJ, 2004, ANAL BIOCHEM, V328, P67, DOI 10.1016/j.ab.2004.01.014; Chimon S, 2007, BIOPHYS J, p195A; Dubochet J, 1982, ADV OPTICAL ELECT MI, P107; Fawzi NL, 2014, ANGEW CHEM INT EDIT, V53, P10345, DOI 10.1002/anie.201405180; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110; Frauenfelder H, 2009, P NATL ACAD SCI USA, V106, P5129, DOI 10.1073/pnas.0900336106; Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Harris Jonathan Gil, 1994, ELECT MICROSCOPY BIO, P203; Hong L, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.238102; Hou LM, 2013, J ALZHEIMERS DIS, V37, P9, DOI 10.3233/JAD-122389; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Hubin E, 2014, CELL MOL LIFE SCI, V71, P3507, DOI 10.1007/s00018-014-1634-z; Igumenova TI, 2006, CHEM REV, V106, P1672, DOI 10.1021/cr040422h; Jahn TR, 2010, J MOL BIOL, V395, P717, DOI 10.1016/j.jmb.2009.09.039; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; Kheterpal I, 2000, P NATL ACAD SCI USA, V97, P13597, DOI 10.1073/pnas.250288897; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; Kodali R, 2010, J MOL BIOL, V401, P503, DOI 10.1016/j.jmb.2010.06.023; Krushelnitsky A, 2009, J PHYS CHEM B, V113, P10022, DOI 10.1021/jp900337x; Lee AL, 2001, NATURE, V411, P501, DOI 10.1038/35078119; Lewandowski JR, 2011, J AM CHEM SOC, V133, P14686, DOI 10.1021/ja203736z; Linser R, 2014, J BIOMOL NMR, V59, P1, DOI 10.1007/s10858-014-9822-6; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; McDonald M, 2012, J MOL BIOL, V423, P454, DOI 10.1016/j.jmb.2012.08.004; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Miller Y, 2011, J AM CHEM SOC, V133, P2742, DOI 10.1021/ja1100273; O'Nuallain B, 2005, BIOCHEMISTRY-US, V44, P12709, DOI 10.1021/bi050927h; Olofsson A, 2006, J BIOL CHEM, V281, P477, DOI 10.1074/jbc.M508962200; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Pinotsi D, 2013, CHEMBIOCHEM, V14, P846, DOI 10.1002/cbic.201300103; Popova LA, 2010, J AM CHEM SOC, V132, P6324, DOI 10.1021/ja909074j; Prade E, 2016, BIOCHEMISTRY-US, V55, P1839, DOI 10.1021/acs.biochem.5b01272; Prade E, 2015, J BIOL CHEM, V290, P28737, DOI 10.1074/jbc.M115.675215; Qiang W, 2013, J AM CHEM SOC, V135, P6860, DOI 10.1021/ja311963f; Qiang W, 2012, P NATL ACAD SCI USA, V109, P4443, DOI 10.1073/pnas.1111305109; Qiang W, 2011, J AM CHEM SOC, V133, P4018, DOI 10.1021/ja109679q; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Sabo TM, 2012, PROTEIN SCI, V21, P562, DOI 10.1002/pro.2045; Sachse C, 2008, P NATL ACAD SCI USA, V105, P7462, DOI 10.1073/pnas.0712290105; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scheidt HA, 2012, J BIOL CHEM, V287, P2017, DOI 10.1074/jbc.M111.308619; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; Sgourakis NG, 2015, STRUCTURE, V23, P216, DOI 10.1016/j.str.2014.10.022; Song XJ, 2007, BIOPHYS J, V92, pL43, DOI 10.1529/biophysj.106.102160; Tamura A, 1996, PROTEIN SCI, V5, P127; Torok M, 2002, J BIOL CHEM, V277, P40810, DOI 10.1074/jbc.M205659200; Tycko R, 2009, BIOCHEMISTRY-US, V48, P6072, DOI 10.1021/bi9002666; van der Kamp MW, 2010, STRUCTURE, V18, P423, DOI 10.1016/j.str.2010.01.012; Vold R. R., 1991, ADV MAGN OPT RESON, V16, P85; Vugmeyster L, 2011, BIOCHEMISTRY-US, V50, P10637, DOI 10.1021/bi201515b; Vugmeyster L, 2009, J AM CHEM SOC, V131, P13651, DOI 10.1021/ja902977u; Wang SSS, 2003, BIOCHEMISTRY-US, V42, P9507, DOI 10.1021/bi0342766; Weidner T, 2010, P NATL ACAD SCI USA, V107, P13288, DOI 10.1073/pnas.1003832107; Wetzel R, 2006, ACCOUNTS CHEM RES, V39, P567, DOI 10.1021/ar0681934; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Williams AD, 2004, J MOL BIOL, V335, P833, DOI 10.1016/j.jmb.2003.11.008; Zhang R, 2009, P NATL ACAD SCI USA, V106, P4653, DOI 10.1073/pnas.0901085106; Zhang S, 2000, J STRUCT BIOL, V130, P130, DOI 10.1006/jsbi.2000.4288; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700	70	29	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18484	18495		10.1074/jbc.M116.740530	http://dx.doi.org/10.1074/jbc.M116.740530			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402826	Green Published, hybrid			2022-12-26	WOS:000383241800038
J	Wang, SC; Huang, CC; Shen, CH; Lin, LC; Zhao, PW; Chen, SY; Deng, YC; Liu, YW				Wang, Shou-Chieh; Huang, Chin-Chin; Shen, Cheng-Huang; Lin, Lei-Chen; Zhao, Pei-Wen; Chen, Shih-Ying; Deng, Yu-Chiao; Liu, Yi-Wen			Gene Expression and DNA Methylation Status of Glutathione S-Transferase Mu1 and Mu5 in Urothelial Carcinoma	PLOS ONE			English	Article							BLADDER-CANCER; URINARY-BLADDER; POOLED ANALYSIS; P21; SMOKING; NRF2; P53; N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE; DEGRADATION; PROTEIN	Bladder cancer is highly recurrent after therapy, which has an enormous impact on the health and financial condition of the patient. It is worth developing diagnostic tools for bladder cancer. In our previous study, we found that the bladder carcinogen BBN increased urothelial global DNA CpG methylation and decreased GSTM1 protein expression in mice. Here, the correlation of BBN-decreased GSTM1 and GSTM gene CpG methylation status was analyzed in mice bladders. BBN treatment decreased the protein and mRNA expression of GSTM1, and the CpG methylation ratio of GSTM1 gene promoter was slightly increased in mice bladders. Unlike mouse GSTM1, the human GSTM1 gene tends to be deleted in bladder cancers. Among 7 human bladder cancer cell lines, GSTM1 gene is really null in 6 cell lines except one, T24 cells. The CpG methylation level of GSTM1 was 9.9% and 5-aza-dC did not significantly increase GSTM1 protein and mRNA expression in T24 cells; however, the GSTM5 gene was CpG hypermethylated (65.4%) and 5-aza-dC also did not affect the methylation ratio and mRNA expression. However, in other cell lines without GSTM1, 5-aza-dC increased GSTM5 expression and decreased its CpG DNA methylation ratio from 84.6% to 61.5% in 5637, and from 97.4% to 75% in J82 cells. In summary, two biomarkers of bladder tumor were provided. One is the GSTM1 gene which is down-regulated in mice bladder carcinogenesis and is usually deleted in human urothelial carcinoma, while the other is the GSTM5 gene, which is inactivated by DNA CpG methylation.	[Wang, Shou-Chieh] Kuang Tien Gen Hosp, Dept Internal Med, Div Nephrol, Taichung 437, Taiwan; [Huang, Chin-Chin; Zhao, Pei-Wen; Chen, Shih-Ying; Deng, Yu-Chiao; Liu, Yi-Wen] Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Shen, Cheng-Huang] Chiayi Christian Hosp, Dept Urol, Chiayi, Taiwan; [Lin, Lei-Chen] Natl Chiayi Univ, Coll Agr, Dept Forestry & Nat Resources, Chiayi, Taiwan	National Chiayi University; Chia-Yi Christian Hospital; National Chiayi University	Liu, YW (corresponding author), Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	ywlss@mail.ncyu.edu.tw			Ministry of Science and Technology of Republic of China, Taiwan [MOST104-2320-B-415-001-MY3]	Ministry of Science and Technology of Republic of China, Taiwan	This work is supported by grants from the Ministry of Science and Technology MOST104-2320-B-415-001-MY3 of the Republic of China, Taiwan.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Brennan P, 2000, INT J CANCER, V86, P289, DOI 10.1002/(SICI)1097-0215(20000415)86:2<289::AID-IJC21>3.0.CO;2-M; BROCKMOLLER J, 1992, BIOCHEM PHARMACOL, V43, P647, DOI 10.1016/0006-2952(92)90591-6; Chatterjee SJ, 2004, J CLIN ONCOL, V22, P1007, DOI 10.1200/JCO.2004.05.174; Chuang JJ, 2014, TOXICOL APPL PHARM, V279, P322, DOI 10.1016/j.taap.2014.06.018; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Engel LS, 2002, AM J EPIDEMIOL, V156, P95, DOI 10.1093/aje/kwf018; Esteve-Puig R, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004721; Ha YS, 2011, J KOREAN MED SCI, V26, P231, DOI 10.3346/jkms.2011.26.2.231; He ZM, 2012, MUTAT RES-GEN TOX EN, V742, P92, DOI 10.1016/j.mrgentox.2011.11.015; Ibragimova I, 2014, EPIGENETICS-US, V9, P760, DOI 10.4161/epi.28078; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; JANZOWSKI C, 1989, TOXICOLOGY, V59, P195, DOI 10.1016/0300-483X(89)90057-7; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Kim SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026131; Kunze E, 1990, IARC Sci Publ, P345; KUNZE E, 1976, Z KREBSFORSCH KLIN O, V87, P139; Lee JY, 2007, MOL CELL BIOL, V27, P3187, DOI 10.1128/MCB.01461-06; Lin PY, 2012, TOXICOL APPL PHARM, V259, P27, DOI 10.1016/j.taap.2011.11.016; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Matic M, 2013, UROL ONCOL-SEMIN ORI, V31, P1184, DOI 10.1016/j.urolonc.2011.08.005; Michaud DS, 2006, AM J CLIN NUTR, V84, P1177, DOI 10.1093/ajcn/84.5.1177; Mohsen MAA, 1999, INT J CANCER, V82, P789, DOI 10.1002/(SICI)1097-0215(19990909)82:6&lt;789::AID-IJC3&gt;3.0.CO;2-C; Nair J, 1996, CRIT REV TOXICOL, V26, P149, DOI 10.3109/10408449609017928; Nakanishi Y, 2000, AM J RESP CELL MOL, V22, P747, DOI 10.1165/ajrcmb.22.6.3877; OKAJIMA E, 1981, CANCER RES, V41, P1958; Oliveira P. A., 2006, Experimental Oncology, V28, P2; Oliveira PA, 2005, J EXP CLIN CANC RES, V24, P609; Peng DF, 2009, GUT, V58, P5, DOI 10.1136/gut.2007.146290; Poole AJ, 2004, ONCOGENE, V23, P8128, DOI 10.1038/sj.onc.1207994; Riedel K, 2006, J ANAL TOXICOL, V30, P187, DOI 10.1093/jat/30.3.187; Samanic C, 2006, CANCER EPIDEM BIOMAR, V15, P1348, DOI 10.1158/1055-9965.EPI-06-0021; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; STICKLER DJ, 1992, PARAPLEGIA, V30, P855, DOI 10.1038/sc.1992.162; Straif K, 2009, LANCET ONCOL, V10, P453, DOI 10.1016/S1470-2045(09)70134-2; Strange RC, 2001, MUTAT RES-FUND MOL M, V482, P21, DOI 10.1016/S0027-5107(01)00206-8; Tang SC, 2011, CANCER-AM CANCER SOC, V117, P3209, DOI 10.1002/cncr.25875; Williams PD, 2008, NEOPLASIA, V10, P838, DOI 10.1593/neo.08432; Yu MC, 2002, MUTAT RES-FUND MOL M, V506, P21, DOI 10.1016/S0027-5107(02)00148-3	40	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159102	10.1371/journal.pone.0159102	http://dx.doi.org/10.1371/journal.pone.0159102			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404495	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508200034
J	Foley, KR; Taffe, J; Bourke, J; Einfeld, SL; Tonge, BJ; Trollor, J; Leonard, H				Foley, Kitty-Rose; Taffe, John; Bourke, Jenny; Einfeld, Stewart L.; Tonge, Bruce J.; Trollor, Julian; Leonard, Helen			Young People with Intellectual Disability Transitioning to Adulthood: Do Behaviour Trajectories Differ in Those with and without Down Syndrome?	PLOS ONE			English	Article							MENTAL ILL-HEALTH; PSYCHIATRIC-DISORDERS; MALADAPTIVE BEHAVIOR; EMOTIONAL-PROBLEMS; CHILDREN; PSYCHOPATHOLOGY; ADOLESCENTS; DEPRESSION; DEMENTIA; ASSOCIATION	Background Young people with intellectual disability exhibit substantial and persistent problem behaviours compared with their non-disabled peers. The aim of this study was to compare changes in emotional and behavioural problems for young people with intellectual disability with and without Down syndrome as they transition into adulthood in two different Australian cohorts. Methods Emotional and behavioural problems were measured over three time points using the Developmental Behaviour Checklist (DBC) for those with Down syndrome (n = 323 at wave one) and compared to those with intellectual disability of another cause (n = 466 at wave one). Outcome scores were modelled using random effects regression as linear functions of age, Down syndrome status, ability to speak and gender. Results DBC scores of those with Down syndrome were lower than those of people without Down syndrome indicating fewer behavioural problems on all scales except communication disturbance. For both groups disruptive, communication disturbance, anxiety and self-absorbed DBC subscales all declined on average over time. There were two important differences between changes in behaviours for these two cohorts. Depressive symptoms did not significantly decline for those with Down syndrome compared to those without Down syndrome. The trajectory of the social relating behaviours subscale differed between these two cohorts, where those with Down syndrome remained relatively steady and, for those with intellectual disability from another cause, the behaviours increased over time. Conclusions These results have implications for needed supports and opportunities for engagement in society to buffer against these emotional and behavioural challenges.	[Foley, Kitty-Rose; Trollor, Julian] UNSW Australia, Sch Psychiat, Dept Dev Disabil, Neuropsychiat, Sydney, NSW, Australia; [Taffe, John; Tonge, Bruce J.] Monash Univ, Sch Psychol Psychiat & Psychol Med, Ctr Dev Psychiat & Psychol, Melbourne, Vic, Australia; [Bourke, Jenny; Leonard, Helen] Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia; [Einfeld, Stewart L.] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia; [Einfeld, Stewart L.] Univ Sydney, Brain & Mind Res Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Monash University; Telethon Kids Institute; University of Western Australia; University of Sydney; University of Sydney	Bourke, J (corresponding author), Univ Western Australia, Telethon Kids Inst, Perth, WA, Australia.	Jenny.Bourke@telethonkids.org	Tonge, Bruce J/T-8036-2018; Foley, Kitty-Rose/C-8800-2018; Leonard, Helen/A-1010-2013	Tonge, Bruce J/0000-0002-4236-9688; Foley, Kitty-Rose/0000-0002-1956-4995; Leonard, Helen/0000-0001-6405-5834	Australian Research Council [LP0989847]	Australian Research Council(Australian Research Council)	The study was funded by the Australian Research Council (Linkage Grant #LP0989847). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2008, J INTELLECT DISABILI, V12, P267, DOI 10.1177/1744629508100494; Baumer N, 2014, CURR OPIN PEDIATR, V26, P428, DOI 10.1097/MOP.0000000000000122; Berkovits LD, 2014, J INTELL DISABIL RES, V58, P765, DOI 10.1111/jir.12088; Blacher J, 2006, J INTELL DISABIL RES, V50, P184, DOI 10.1111/j.1365-2788.2005.00768.x; Blacher J, 2003, CURR OPIN PSYCHIATR, V16, P495, DOI 10.1097/00001504-200309000-00001; Bourke J, 2008, J PEDIATR-US, V153, P320, DOI 10.1016/j.jpeds.2008.02.047; Bower C, 2012, REPORT W AUSTR REGIS; BURT DB, 1995, AM J MENT RETARD, V100, P262; Clarke AR, 2003, J INTELL DISABIL RES, V47, P210, DOI 10.1046/j.1365-2788.2003.00470.x; COLLACOTT RA, 1992, BRIT J PSYCHIAT, V161, P671, DOI 10.1192/bjp.161.5.671; COOPER SA, 1994, BRIT J PSYCHIAT, V165, P399, DOI 10.1192/bjp.165.3.399; Coppus A, 2006, J INTELL DISABIL RES, V50, P768, DOI 10.1111/j.1365-2788.2006.00842.x; de la Torre R, 2012, PROG BRAIN RES, V197, P1, DOI 10.1016/B978-0-444-54299-1.00001-7; Douma JCH, 2006, J AM ACAD CHILD PSY, V45, P1224, DOI 10.1097/01.chi.0000233158.21925.95; Dyke P., 2007, SYNDROME NEEDS OPINI; Dykens EM, 2007, MENT RETARD DEV D R, V13, P272, DOI 10.1002/mrdd.20159; Dykens EM, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9101-1; Dykens EM, 1997, AM J MENT RETARD, V102, P228, DOI 10.1352/0895-8017(1997)102<0228:MBICWP>2.0.CO;2; Dykens EM, 2002, J INTELL DISABIL RES, V46, P484, DOI 10.1046/j.1365-2788.2002.00431.x; EINFELD SL, 1995, J AUTISM DEV DISORD, V25, P81, DOI 10.1007/BF02178498; Einfeld SL, 1996, J INTELL DISABIL RES, V40, P99, DOI 10.1111/j.1365-2788.1996.tb00611.x; Einfeld SL, 2001, AM J MENT RETARD, V106, P73, DOI 10.1352/0895-8017(2001)106<0073:LCOBAE>2.0.CO;2; Einfeld SL, 2006, JAMA-J AM MED ASSOC, V296, P1981, DOI 10.1001/jama.296.16.1981; Einfeld SL, 2006, INT REV RES MENT RET, V33, P247, DOI 10.1016/S0074-7750(06)33010-8; Esbensen AJ, 2008, AM J MENT RETARD, V113, P263, DOI 10.1352/0895-8017(2008)113[263:SACIHF]2.0.CO;2; Fitzgerald P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070401; Foley KR, 2013, CHILD CARE HLTH DEV, V39, P789, DOI 10.1111/cch.12019; Foley K-R, 2014, SOCIAL PSYCHIAT PSYC; Foley KR, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0266-z; Fonseca LM, 2014, NEUROPSYCH DIS TREAT, V10, P2209, DOI 10.2147/NDT.S68831; Glass TA, 2006, J AGING HEALTH, V18, P604, DOI 10.1177/0898264306291017; Glidden LM, 2014, AJIDD-AM J INTELLECT, V119, P389, DOI 10.1352/1944-7558-119.5.389; Gray KM, 2011, RES DEV DISABIL, V32, P1194, DOI 10.1016/j.ridd.2010.12.044; Griffith GM, 2010, J AUTISM DEV DISORD, V40, P610, DOI 10.1007/s10803-009-0906-1; Guralnick MJ, 2007, CHILD DEV, V78, P459, DOI 10.1111/j.1467-8624.2007.01009.x; Haynes A, 2013, RES DEV DISABIL, V34, P847, DOI 10.1016/j.ridd.2012.11.008; Hughes EK, 2010, J CLIN PSYCHOL, V66, P978, DOI 10.1002/jclp.20695; KHAN S, 2002, MENTAL HLTH ASPECTS, V5, P46; Leonard H, 2005, SOCIAL SCI MED, V60; Leonard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017875; Makary AT, 2014, RES DEV DISABIL, V35, P1868, DOI 10.1016/j.ridd.2014.04.010; Mantry D, 2008, J INTELL DISABIL RES, V52, P141, DOI 10.1111/j.1365-2788.2007.00985.x; McGillivray JA, 2007, RES DEV DISABIL, V28, P59, DOI 10.1016/j.ridd.2005.11.001; Mohr C, 2005, J INTELL DISABIL RES, V49, P469, DOI 10.1111/j.1365-2788.2005.00701.x; Mohr C, 2011, DEV BEHAV CHECKLIST; MYERS BA, 1991, J NERV MENT DIS, V179, P609, DOI 10.1097/00005053-199110000-00004; Partington M, 2000, AM J MED GENET, V92, P57, DOI 10.1002/(SICI)1096-8628(20000501)92:1<57::AID-AJMG10>3.0.CO;2-0; Patti P. J., 2006, INT J DISABIL HUM DE, V5, DOI [DOI 10.155/UDHD.2006.5.4.357, 10.1515/IJDHD.2006.5.4.357]; Pruijssers AC, 2014, J INTELLECTUAL DISAB, V58; Taffe J, 2008, INT J METHODS PSYCHI, V17; Thomas K, 2010, INT REV RES MENTAL R; Thomas K, 2011, J PEDIATR-US, V158, P194, DOI 10.1016/j.jpeds.2010.08.045; Tonge BJ, 2003, INT REV RES MENT RET, V26, P61, DOI 10.1016/S0074-7750(03)01002-4; Walker JC, 2011, RES DEV DISABIL, V32, P1432, DOI 10.1016/j.ridd.2011.02.010; Wark S, 2014, J INTELLECT DISABILI, V18, P305, DOI 10.1177/1744629514552152	55	12	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157667	10.1371/journal.pone.0157667	http://dx.doi.org/10.1371/journal.pone.0157667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391326	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400017
J	Fritze, T; Teipel, S; Ovari, A; Kilimann, I; Witt, G; Doblhammer, G				Fritze, Thomas; Teipel, Stefan; Ovari, Attila; Kilimann, Ingo; Witt, Gabriele; Doblhammer, Gabriele			Hearing Impairment Affects Dementia Incidence. An Analysis Based on Longitudinal Health Claims Data in Germany	PLOS ONE			English	Article							VASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; COGNITIVE DECLINE; FOLLOW-UP; PHYSICAL-ACTIVITY; PREVALENCE; ADULTS; AIDS; EPIDEMIOLOGY; LONELINESS	Recent research has revealed an association between hearing impairment and dementia. The objective of this study is to determine the effect of hearing impairment on dementia incidence in a longitudinal study, and whether ear, nose, and throat (ENT) specialist care, care level, institutionalization, or depression mediates or moderates this pathway. The present study used a longitudinal sample of 154,783 persons aged 65 and older from claims data of the largest German health insurer; containing 14,602 incident dementia diagnoses between 2006 and 2010. Dementia and hearing impairment diagnoses were defined according to International Classification of Diseases, Tenth Revision, codes. We used a Kaplan Meier estimator and performed Cox proportional hazard models to explore the effect of hearing impairment on dementia incidence, controlling for ENT specialist care, care level, institutionalization, and depression. Gender, age, and comorbidities were controlled for as potential confounders. Patients with bilateral (HR = 1.43, p<0.001) and side-unspecified (HR = 1.20, p<0.001) hearing impairment had higher risks of dementia incidence than patients without hearing impairment. We found no significant effect for unilateral hearing impairment and other diseases of the ear. The effect of hearing impairment was only partly mediated through ENT specialist utilization. Significant interaction between hearing impairment and specialist care, care level, and institutionalization, respectively, indicated moderating effects. We discuss possible explanations for these effects. This study underlines the importance of the association between hearing impairment and dementia. Preserving hearing ability may maintain social participation and may reduce the burden associated with dementia. The particular impact of hearing aid use should be the subject of further investigations, as it offers potential intervention on the pathway to dementia.	[Fritze, Thomas; Teipel, Stefan; Kilimann, Ingo] German Ctr Neurodegenerat Dis DZNE, Rostock, Germany; [Fritze, Thomas] Rostock Ctr, Study Demog Change, Rostock, Germany; [Teipel, Stefan; Kilimann, Ingo] Univ Med, Dept Psychosomat Med, Rostock, Germany; [Ovari, Attila; Witt, Gabriele] Univ Med Rostock, Dept Otorhinolaryngol Head & Neck Surg, Rostock, Germany; [Doblhammer, Gabriele] Univ Rostock, Inst Sociol & Demog, Rostock, Germany; [Doblhammer, Gabriele] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Doblhammer, Gabriele] Max Planck Inst Demog Res, Rostock, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Rostock; University of Rostock; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Max Planck Society	Fritze, T (corresponding author), German Ctr Neurodegenerat Dis DZNE, Rostock, Germany.; Fritze, T (corresponding author), Rostock Ctr, Study Demog Change, Rostock, Germany.	thomas.fritze@dzne.de		Fritze, Thomas/0000-0001-7649-6936; Ovari, Attila/0000-0003-4610-6890				Aarsland D, 2010, AGING MENT HEALTH, V14, P386, DOI 10.1080/13607860903586136; Abdollahpour I, 2015, PSYCHOGERIATRICS, V15, P51, DOI 10.1111/psyg.12094; Acar B, 2011, ARCH GERONTOL GERIAT, V52, P250, DOI 10.1016/j.archger.2010.04.013; Aguero-Torres H, 1998, AM J PUBLIC HEALTH, V88, P1452, DOI 10.2105/AJPH.88.10.1452; Aguero-Torres H, 2001, J CLIN EPIDEMIOL, V54, P795, DOI 10.1016/S0895-4356(00)00371-1; Albers Kristi, 2012, Minn Med, V95, P52; Alpar A, 2009, J NEUROSCI RES, V87, P1813, DOI 10.1002/jnr.22008; Amieva H, 2015, J AM GERIATR SOC, V63, P2099, DOI 10.1111/jgs.13649; Bakhos D, 2015, GERIATR PSYCHOL NEUR, V13, P195, DOI 10.1684/pnv.2015.0539; Bennion A, 2013, INT J OLDER PEOPLE N, V8, P270, DOI 10.1111/j.1748-3743.2012.00318.x; Bickel H, 2000, GESUNDHEITSWESEN, V62, P211, DOI 10.1055/s-2000-10858; Bickel H., 2005, DEMENZEN, P1, DOI [10.1055/b-0034-22394, DOI 10.1055/B-0034-22394]; BRAAK H, 1993, EUR NEUROL, V33, P403, DOI 10.1159/000116984; Breteler MMB, 2000, NEUROBIOL AGING, V21, P153, DOI 10.1016/S0197-4580(99)00110-4; Brodaty Henry, 2009, Dialogues Clin Neurosci, V11, P217; Buchman AS, 2007, PSYCHOSOM MED, V69, P483, DOI 10.1097/psy.0b013e318068de1d; Bundesausschuss Gemeinsamer (G-BA), 2004, RICHTL VER HILFSM VE; Cherubini A, 2005, NEUROBIOL AGING, V26, P987, DOI 10.1016/j.neurobiolaging.2004.09.002; Chia EM, 2006, ARCH OPHTHALMOL-CHIC, V124, P1465, DOI 10.1001/archopht.124.10.1465; Ciorba A, 2012, CLIN INTERV AGING, V7, P159, DOI 10.2147/CIA.S26059; Cook G, 2006, INT J OLDER PEOPLE N, V1, P216, DOI 10.1111/j.1748-3743.2006.00034.x; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Dalton DS, 2003, GERONTOLOGIST, V43, P661, DOI 10.1093/geront/43.5.661; DAVIS AC, 1989, INT J EPIDEMIOL, V18, P911, DOI 10.1093/ije/18.4.911; Dawes P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119616; Desmond DW, 2002, STROKE, V33, P2254, DOI 10.1161/01.STR.0000028235.91778.95; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397.abs; Doblhammer G., 2012, DEMOGRAFIE DEMENZ; Doblhammer G, 2013, GERIATRIC MENTAL HLT, V1, P29, DOI DOI 10.1016/J.GMHC.2013.04.002; Doblhammer G, 2015, ALZHEIMERS DEMENT, V11, P291, DOI 10.1016/j.jalz.2014.02.006; Duijvestijn JA, 1999, ACTA OTO-LARYNGOL, V119, P420; Dupuis K, 2015, AGING NEUROPSYCHOL C, V22, P413, DOI 10.1080/13825585.2014.968084; Enache D, 2011, CURR OPIN PSYCHIATR, V24, P461, DOI 10.1097/YCO.0b013e32834bb9d4; Fasano A, 2012, NEUROL SCI, V33, P1215, DOI 10.1007/s10072-012-1126-6; Gorelick PB, 2004, STROKE, V35, P2620, DOI 10.1161/01.STR.0000143318.70292.47; Gray SL, 2013, J GERONTOL A-BIOL, V68, P1083, DOI 10.1093/gerona/glt013; Gruber-Baldini AL, 2003, J AM GERIATR SOC, V51, P1227, DOI 10.1046/j.1532-5415.2003.51406.x; Gurgel RK, 2012, OTOLARYNG HEAD NECK, V147, P803, DOI 10.1177/0194599812458401; Gurgel RK, 2014, OTOL NEUROTOL, V35, P775, DOI 10.1097/MAO.0000000000000313; Hamer M, 2009, PSYCHOL MED, V39, P3, DOI 10.1017/S0033291708003681; Hebert LE, 2013, NEUROLOGY, V80, P1778, DOI 10.1212/WNL.0b013e31828726f5; Holmen K, 2000, ARCH GERONTOL GERIAT, V31, P177, DOI 10.1016/S0167-4943(00)00070-4; Hung SC, 2015, J EPIDEMIOL, V25, P517, DOI 10.2188/jea.JE20140147; Ivan CS, 2004, STROKE, V35, P1264, DOI 10.1161/01.STR.0000127810.92616.78; Jakob A, 2002, Z GERONTOL GERIATR, V35, P474, DOI 10.1007/s00391-002-0066-9; Kiely KM, 2012, J GERONTOL A-BIOL, V67, P997, DOI 10.1093/gerona/gls066; Kilimann I, 2014, Z GERONTOL GERIATR; Kopf D, 2009, J ALZHEIMERS DIS, V16, P677, DOI 10.3233/JAD-2009-1011; Larrieu S, 2004, J Nutr Health Aging, V8, P150; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; Lin FR, 2013, JAMA INTERN MED, V173, P293, DOI 10.1001/jamainternmed.2013.1868; Lin FR, 2011, NEUROPSYCHOLOGY, V25, P763, DOI 10.1037/a0024238; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; Lindsay J, 1997, STROKE, V28, P526, DOI 10.1161/01.STR.28.3.526; Lupsakko TA, 2005, EUR ARCH OTO-RHINO-L, V262, P165, DOI 10.1007/s00405-004-0789-x; McCormack A, 2013, INT J AUDIOL, V52, P360, DOI 10.3109/14992027.2013.769066; MORITZ DJ, 1995, AM J EPIDEMIOL, V141, P41, DOI 10.1093/oxfordjournals.aje.a117344; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P194, DOI 10.1001/archneur.60.2.194; Nondahl DM, 1998, AUDIOLOGY, V37, P295; Nyatsanza S, 2003, J NEUROL NEUROSUR PS, V74, P1398, DOI 10.1136/jnnp.74.10.1398; Okamoto M, 2004, INT J AUDIOL, V43, P54, DOI 10.1080/14992020400050008; Panza F, 2015, NAT REV NEUROL, V11; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; PICHORAFULLER MK, 1995, J ACOUST SOC AM, V97, P593, DOI 10.1121/1.412282; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Quaranta A, 1996, SCAND AUDIOL, V25, P9; Ravaglia G, 2005, NEUROLOGY, V64, P1525, DOI 10.1212/01.WNL.0000160107.02316.BF; Reuben DB, 1999, J AM GERIATR SOC, V47, P930, DOI 10.1111/j.1532-5415.1999.tb01286.x; Richards M, 2004, BMJ-BRIT MED J, V328, P552, DOI 10.1136/bmj.37972.513819.EE; Ries P W, 1994, Vital Health Stat 10, P1; Ronnberg J, 2011, J SPEECH LANG HEAR R, V54, P705, DOI 10.1044/1092-4388(2010/09-0088); Rousseaux M, 2010, NEUROPSYCHOLOGIA, V48, P3884, DOI 10.1016/j.neuropsychologia.2010.09.026; Sauvaget C, 2002, GERONTOLOGY, V48, P226, DOI 10.1159/000058355; SCHOW RL, 1980, J SPEECH HEAR DISORD, V45, P124, DOI 10.1044/jshd.4501.124; Schulz A, 2012, AKTUELLER ZUKUNFTIGE AKTUELLER ZUKUNFTIGE, P161; Sindhusake D, 2001, INT J EPIDEMIOL, V30, P1371, DOI 10.1093/ije/30.6.1371; SINHA UK, 1993, NEUROLOGY, V43, P779, DOI 10.1212/WNL.43.4.779; Solfrizzi V, 2004, NEUROLOGY, V63, P1882, DOI 10.1212/01.WNL.0000144281.38555.E3; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Strawbridge WJ, 2000, GERONTOLOGIST, V40, P320, DOI 10.1093/geront/40.3.320; Teipel S, 2015, J AM GERIATR SOC, V63, P1527, DOI 10.1111/jgs.13561; UHLMANN RF, 1989, JAMA-J AM MED ASSOC, V261, P1916, DOI 10.1001/jama.261.13.1916; Valentijn SAM, 2005, J AM GERIATR SOC, V53, P374, DOI 10.1111/j.1532-5415.2005.53152.x; van der Flier WM, 2005, J NEUROL NEUROSUR PS, V76, pV2, DOI 10.1136/jnnp.2005.082867; Van Eyken E, 2007, AUDIOL NEURO-OTOL, V12, P345, DOI 10.1159/000106478; VandenLangenberg GM, 1998, AM J EPIDEMIOL, V148, P204, DOI 10.1093/oxfordjournals.aje.a009625; von Gablenz P, 2015, HNO, V63, P195, DOI 10.1007/s00106-014-2949-7; Weyerer S., 2005, GESUNDHEITSBERICHTER; Wilson RS, 2007, ARCH GEN PSYCHIAT, V64, P234, DOI 10.1001/archpsyc.64.2.234; Wimo A, 2003, ALZ DIS ASSOC DIS, V17, P63, DOI 10.1097/00002093-200304000-00002; World Health Organization, 2015, GRADES OF HEARING IM	91	45	48	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0156876	10.1371/journal.pone.0156876	http://dx.doi.org/10.1371/journal.pone.0156876			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391486	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400006
J	Murphy, TF; Brauer, AL; Johnson, A; Kirkham, C				Murphy, Timothy F.; Brauer, Aimee L.; Johnson, Antoinette; Kirkham, Charmaine			ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence	PLOS ONE			English	Article							MEMBRANE PROTEIN CD; PULMONARY CLEARANCE; NASOPHARYNGEAL COLONIZATION; STREPTOCOCCUS-PNEUMONIAE; M. CATARRHALIS; PERMEASE; GENOME; OPPA; IDENTIFICATION; ACQUISITION	Moraxella catarrhalis is a human respiratory tract pathogen that causes otitis media (middle ear infections) in children and respiratory tract infections in adults with chronic obstructive pulmonary disease. In view of the huge global burden of disease caused by M. catarrhalis, the development of vaccines to prevent these infections and better approaches to treatment have become priorities. In previous work, we used a genome mining approach that identified three substrate binding proteins (SBPs) of ATP-binding cassette (ABC) transporters as promising candidate vaccine antigens. In the present study, we performed a comprehensive assessment of 19 SBPs of 15 ABC transporter systems in the M. catarrhalis genome by engineering knockout mutants and studying their role in assays that assess mechanisms of infection. The capacity of M. catarrhalis to survive and grow in the nutrient-limited and hostile environment of the human respiratory tract, including intracellular growth, account in part for its virulence. The results show that ABC transporters that mediate uptake of peptides, amino acids, cations and anions play important roles in pathogenesis by enabling M. catarrhalis to 1) grow in nutrient-limited conditions, 2) invade and survive in human respiratory epithelial cells and 3) persist in the lungs in a murine pulmonary clearance model. The knockout mutants of SBPs and ABC transporters showed different patterns of activity in the assay systems, supporting the conclusion that different SBPs and ABC transporters function at different stages in the pathogenesis of infection. These results indicate that ABC transporters are nutritional virulence factors, functioning to enable the survival of M catarrhalis in the diverse microenvironments of the respiratory tract. Based on the role of ABC transporters as virulence factors of M. catarrhalis, these molecules represent potential drug targets to eradicate the organism from the human respiratory tract.	[Murphy, Timothy F.; Brauer, Aimee L.; Johnson, Antoinette; Kirkham, Charmaine] SUNY Buffalo, Clin & Translat Res Ctr, Buffalo, NY 14260 USA; [Murphy, Timothy F.; Brauer, Aimee L.; Johnson, Antoinette; Kirkham, Charmaine] SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14260 USA; [Murphy, Timothy F.] SUNY Buffalo, Dept Microbiol, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Murphy, TF (corresponding author), SUNY Buffalo, Clin & Translat Res Ctr, Buffalo, NY 14260 USA.; Murphy, TF (corresponding author), SUNY Buffalo, Dept Med, Div Infect Dis, Buffalo, NY 14260 USA.; Murphy, TF (corresponding author), SUNY Buffalo, Dept Microbiol, Buffalo, NY 14260 USA.	murphyt@buffalo.edu		Murphy, Timothy/0000-0002-3496-2641	National Institute on Deafness and Other Communication Disorders [R01 DC012200]; National Center for Advancing Translational Sciences [UL1TR001412]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012200] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institute on Deafness and Other Communication Disorders grant R01 DC012200 (TFM) and by the National Center for Advancing Translational Sciences award UL1TR001412 to the University at Buffalo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimana C, 2007, FEMS MICROBIOL LETT, V271, P12, DOI 10.1111/j.1574-6968.2007.00693.x; Balder R, 2009, INFECT IMMUN, V77, P4597, DOI 10.1128/IAI.00212-09; Becker PD, 2007, INFECT IMMUN, V75, P1778, DOI 10.1128/IAI.01081-06; Borezee E, 2000, INFECT IMMUN, V68, P7069, DOI 10.1128/IAI.68.12.7069-7077.2000; CUNDELL DR, 1995, INFECT IMMUN, V63, P2493, DOI 10.1128/IAI.63.7.2493-2498.1995; de Vries SPW, 2010, J BACTERIOL, V192, P3574, DOI 10.1128/JB.00121-10; Faden H, 1997, J INFECT DIS, V175, P1440, DOI 10.1086/516477; FADEN H, 1991, ANN OTO RHINOL LARYN, V100, P612, DOI 10.1177/000348949110000802; FADEN H, 1994, J INFECT DIS, V169, P1312, DOI 10.1093/infdis/169.6.1312; Forsgren A, 2004, J INFECT DIS, V190, P352, DOI 10.1086/422155; Garmory HS, 2004, INFECT IMMUN, V72, P6757, DOI 10.1128/IAI.72.12.6757-6763.2004; Heiniger N, 2007, J INFECT DIS, V196, P1080, DOI 10.1086/521194; HIGGINS CF, 1985, EMBO J, V4, P1033, DOI 10.1002/j.1460-2075.1985.tb03735.x; Hu EG, 2000, INFECT IMMUN, V68, P4980, DOI 10.1128/IAI.68.9.4980-4985.2000; Hu WG, 1999, VACCINE, V18, P799, DOI 10.1016/S0264-410X(99)00335-7; Hung MC, 2015, VACCINE, V33, P4486, DOI 10.1016/j.vaccine.2015.07.032; Jones MM, 2014, INFECT IMMUN, V82, P4758, DOI 10.1128/IAI.02185-14; JUNI E, 1986, APPL ENVIRON MICROB, V52, P546, DOI 10.1128/AEM.52.3.546-551.1986; Kerr AR, 2004, INFECT IMMUN, V72, P3902, DOI 10.1128/IAI.72.7.3902-3906.2004; Lee EM, 2004, FEMS MICROBIOL LETT, V240, P21, DOI 10.1016/j.femsle.2004.09.007; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Linton KJ, 1998, MOL MICROBIOL, V28, P5, DOI 10.1046/j.1365-2958.1998.00764.x; Liu DF, 2007, INFECT IMMUN, V75, P2818, DOI 10.1128/IAI.00074-07; MAO B, 1982, J BIOL CHEM, V257, P1131; Maqbool A, 2015, BIOCHEM SOC T, V43, P1011, DOI 10.1042/BST20150135; MENARD R, 1993, J BACTERIOL, V175, P5899; Murphy TF, 2005, AM J RESP CRIT CARE, V172, P195, DOI 10.1164/rccm.200412-1747OC; Murphy TF, 2016, VACCINE, V34, P3855, DOI 10.1016/j.vaccine.2016.05.045; Murphy TF, 2013, INFECT IMMUN, V81, P3406, DOI 10.1128/IAI.00589-13; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Otsuka T, 2016, INFECT IMMUN, V84, P432, DOI 10.1128/IAI.00799-15; Otsuka T, 2014, INFECT IMMUN, V82, P3503, DOI 10.1128/IAI.01832-14; Pletzer D, 2015, J BACTERIOL, V197, P2217, DOI 10.1128/JB.00234-15; Reddy MS, 1997, OTOLARYNG HEAD NECK, V116, P175, DOI 10.1016/S0194-5998(97)70321-8; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rhodes ER, 2005, INFECT IMMUN, V73, P3758, DOI 10.1128/IAI.73.6.3758-3763.2005; Ruckdeschel EA, 2008, INFECT IMMUN, V76, P1599, DOI 10.1128/IAI.01253-07; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Su YC, 2012, FUTURE MICROBIOL, V7, P1073, DOI [10.2217/fmb.12.80, 10.2217/FMB.12.80]; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Tanabe M, 2006, INFECT IMMUN, V74, P3687, DOI 10.1128/IAI.01837-05; UNHANAND M, 1992, J INFECT DIS, V165, P644, DOI 10.1093/infdis/165.4.644; Vidakovics MLP, 2009, CURR OPIN INFECT DIS, V22, P279, DOI 10.1097/QCO.0b013e3283298e4e; Watson K, 2006, PEDIATR INFECT DIS J, V25, P782, DOI 10.1097/01.inf.0000232705.49634.68; Wilkens Stephan, 2015, F1000Prime Rep, V7, P14, DOI 10.12703/P7-14; Yang M, 2011, INFECT IMMUN, V79, P846, DOI 10.1128/IAI.00314-10; Zomer A, 2012, J BACTERIOL, V194, P6969, DOI 10.1128/JB.01833-12; Zuckert WR, 2014, BBA-MOL CELL RES, V1843, P1509, DOI 10.1016/j.bbamcr.2014.04.022	48	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158689	10.1371/journal.pone.0158689	http://dx.doi.org/10.1371/journal.pone.0158689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391026	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400104
J	Sahoo, BR; Fujiwara, T				Sahoo, Bikash Ranjan; Fujiwara, Toshimichi			Membrane Mediated Antimicrobial and Antitumor Activity of Cathelicidin 6: Structural Insights from Molecular Dynamics Simulation on Multi-Microsecond Scale	PLOS ONE			English	Article							SOLID-STATE NMR; LIPID-BILAYERS; INNATE IMMUNITY; FORCE-FIELD; OLIGOMERIC STRUCTURE; PORE FORMATION; PEPTIDE LL-37; MECHANISM; INSERTION; MELITTIN	The cathelicidin derived bovine antimicrobial peptide BMAP27 exhibits an effective microbicidal activity and moderate cytotoxicity towards erythrocytes. Irrespective of its therapeutic and multidimensional potentiality, the structural studies are still elusive. Moreover, the mechanism of BMAP27 mediated pore formation in heterogeneous lipid membrane systems is poorly explored. Here, we studied the effect of BMAP27 in model cell-membrane systems such as zwitterionic, anionic, thymocytes-like (TLM) and leukemia-like membranes (LLM) by performing molecular dynamics (MD) simulation longer than 100 mu s. All-atom MD studies revealed a stable helical conformation in the presence of anionic lipids, however, significant loss of helicity was identified in TLM and zwitterionic systems. A peptide tilt (similar to 45 degrees) and central kink (at residue F10) was found in anionic and LLM models, respectively, with an average membrane penetration of < 0.5 nm. Coarse-grained (CG) MD analysis on a multi-mu s scale shed light on the membrane-dependent peptide and lipid organization. Stable micelle and end-to-end like oligomers were formed in zwitterionic and TLM models, respectively. In contrast, unstable oligomer formation and monomeric BMAP27 penetration were observed in anionic and LLM systems with selective anionic lipid aggregation (in LLM). Peptide penetration up to similar to 1.5 nm was observed in CG-MD systems with the BMAP27 C-terminal oriented towards the bilayer core. Structural inspection suggested membrane penetration by micelle/end-to-end like peptide oligomers (carpet-model like) in the zwitterionic/TLM systems, and transmembrane-mode (toroidal-pore like) in the anionic/LLM systems, respectively. Structural insights and energetic interpretation in BMAP27 mutant highlighted the role of F10 and hydrophobic residues in mediating a membrane-specific peptide interaction. Free energy profiling showed a favorable (-4.58 kcal mol(-1) for LLM) and unfavorable (+0.17 kcal mol(-1) for TLM) peptide insertion in anionic and neutral systems, respectively. This determination can be exploited to regulate cell-specific BMAP27 cytotoxicity for the development of potential drugs and antibiotics.	[Sahoo, Bikash Ranjan; Fujiwara, Toshimichi] Osaka Univ, Inst Prot Res, Lab Mol Biophys, Suita, Osaka, Japan	Osaka University	Fujiwara, T (corresponding author), Osaka Univ, Inst Prot Res, Lab Mol Biophys, Suita, Osaka, Japan.	tfjwr@protein.osaka-u.ac.jp	Sahoo, Bikash Ranjan/H-7399-2012	Sahoo, Bikash Ranjan/0000-0002-3683-1178	Japan Society for the Promotion of Science (JSPS) [26291029]; Grants-in-Aid for Scientific Research [26291029] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS), Grant-in-Aid for Scientific Research (https://www.jsps.go.jp/english/e-grants/), Grant Number 26291029. TF has received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2009, BIOCHEMISTRY-US, V48, P10905, DOI 10.1021/bi9009874; Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Andoh Y, 2013, BBA-BIOMEMBRANES, V1828, P1259, DOI 10.1016/j.bbamem.2013.01.005; Arnusch CJ, 2007, BIOCHEMISTRY-US, V46, P13437, DOI 10.1021/bi7015553; Berglund NA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004180; Boman HG, 2000, IMMUNOL REV, V173, P5, DOI 10.1034/j.1600-065X.2000.917301.x; Bond PJ, 2008, BIOCHEMISTRY-US, V47, P11321, DOI 10.1021/bi800642m; Bond PJ, 2008, BIOPHYS J, V95, P3802, DOI 10.1529/biophysj.108.128686; Bonucci A, 2015, BIOCHEMISTRY-US, V54, P6760, DOI 10.1021/acs.biochem.5b00813; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chen W, 2015, J PHYS CHEM B, V119, P7902, DOI 10.1021/acs.jpcb.5b02290; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Dennison SR, 2008, CHEM PHYS LIPIDS, V151, P92, DOI 10.1016/j.chemphyslip.2007.10.007; Ding B, 2013, SCI REP-UK, V3, DOI 10.1038/srep01854; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Ghahremanpour MM, 2014, BIOINFORMATICS, V30, P439, DOI 10.1093/bioinformatics/btt680; Gkeka P, 2010, J PHYS CHEM B, V114, P826, DOI 10.1021/jp908320b; He Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066440; Hong M, 2011, PROTEIN SCI, V20, P641, DOI 10.1002/pro.600; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johansson J, 1998, J BIOL CHEM, V273, P3718, DOI 10.1074/jbc.273.6.3718; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krauson AJ, 2012, J AM CHEM SOC, V134, P12732, DOI 10.1021/ja3042004; Kreder R, 2015, ACS CHEM BIOL, V10, P1435, DOI 10.1021/cb500922m; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0; Langham A, 2010, METHODS MOL BIOL, V618, P267, DOI 10.1007/978-1-60761-594-1_17; Li YL, 2005, J VIROL, V79, P12065, DOI 10.1128/JVI.79.18.12065-12076.2005; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mani R, 2006, P NATL ACAD SCI USA, V103, P16242, DOI 10.1073/pnas.0605079103; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Nawae W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03933; Nielsen SL, 2007, PROTEIN SCI, V16, P1969, DOI 10.1110/ps.072966007; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Oren Z, 1998, BIOPOLYMERS, V47, P451; Orioni B, 2009, BBA-BIOMEMBRANES, V1788, P1523, DOI 10.1016/j.bbamem.2009.04.013; Park TJ, 2011, BIOPHYS J, V101, P1193, DOI 10.1016/j.bpj.2011.06.067; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Ramamoorthy A, 2013, J PHYS CHEM B, V117, P6693, DOI 10.1021/jp4034003; Risso A, 2002, MOL CELL BIOL, V22, P1926, DOI 10.1128/MCB.22.6.1926-1935.2002; Risso A, 1998, CELL IMMUNOL, V189, P107, DOI 10.1006/cimm.1998.1358; Santo KP, 2013, J PHYS CHEM B, V117, P5031, DOI 10.1021/jp312328n; Saravanan R, 2011, BBA-BIOMEMBRANES, V1808, P369, DOI 10.1016/j.bbamem.2010.10.001; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375; Splith K, 2011, EUR BIOPHYS J BIOPHY, V40, P387, DOI 10.1007/s00249-011-0682-7; Stafford JH, NEOPLASIA, V13, P299; Suh JY, 1996, FEBS LETT, V392, P309, DOI 10.1016/0014-5793(96)00840-X; Tieleman DP, 2001, INT J QUANTUM CHEM, V83, P166, DOI 10.1002/qua.1208; Ulmschneider JP, 2012, BIOPHYS J, V103, P472, DOI 10.1016/j.bpj.2012.06.040; Upadhyay SK, 2015, J MEMBRANE BIOL, V248, P497, DOI 10.1007/s00232-015-9807-8; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANBLITTERSWIJK WJ, 1982, BIOCHIM BIOPHYS ACTA, V688, P495, DOI 10.1016/0005-2736(82)90361-3; Wang Y, 2012, BBA-BIOMEMBRANES, V1818, P1402, DOI 10.1016/j.bbamem.2012.02.017; Wang YK, 2014, BBA-BIOMEMBRANES, V1838, P2280, DOI 10.1016/j.bbamem.2014.04.009; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yu LL, 2009, BBA-BIOMEMBRANES, V1788, P333, DOI 10.1016/j.bbamem.2008.10.005; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	61	7	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158702	10.1371/journal.pone.0158702	http://dx.doi.org/10.1371/journal.pone.0158702			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391304	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400107
J	Valm, AM; Oldenbourg, R; Borisy, GG				Valm, Alex M.; Oldenbourg, Rudolf; Borisy, Gary G.			Multiplexed Spectral Imaging of 120 Different Fluorescent Labels	PLOS ONE			English	Article							ARCHITECTURE; MICROSCOPY; PROTEINS	The number of fluorescent labels that can unambiguously be distinguished in a single image when acquired through band pass filters is severely limited by the spectral overlap of available fluorophores. The recent development of spectral microscopy and the application of linear unmixing algorithms to spectrally recorded image data have allowed simultaneous imaging of fluorophores with highly overlapping spectra. However, the number of distinguishable fluorophores is still limited by the unavoidable decrease in signal to noise ratio when fluorescence signals are fractionated over multiple wavelength bins. Here we present a spectral image analysis algorithm to greatly expand the number of distinguishable objects labeled with binary combinations of fluorophores. Our algorithm utilizes a priori knowledge about labeled specimens and imposes a binary label constraint on the unmixing solution. We have applied our labeling and analysis strategy to identify microbes labeled by fluorescence in situ hybridization and here demonstrate the ability to distinguish 120 differently labeled microbes in a single image.	[Valm, Alex M.; Oldenbourg, Rudolf] Marine Biol Lab, Woods Hole, MA 02543 USA; [Valm, Alex M.; Oldenbourg, Rudolf] Brown Univ, Providence, RI 02912 USA; [Borisy, Gary G.] Forsyth Inst, Cambridge, MA USA; [Valm, Alex M.] NICHHD, NIH, NIH NICHD, Bethesda, MD 20892 USA	Marine Biological Laboratory - Woods Hole; Brown University; Harvard University; Forsyth Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Valm, AM (corresponding author), Marine Biol Lab, Woods Hole, MA 02543 USA.; Valm, AM (corresponding author), Brown Univ, Providence, RI 02912 USA.; Valm, AM (corresponding author), NICHHD, NIH, NIH NICHD, Bethesda, MD 20892 USA.	Alex.Valm@nih.gov			Alfred P. Sloan Foundation [2007-3-13]; National Institutes of Health from the National Institute of Dental and Craniofacial Research (NIDCR) [1RC1-DE020630]; National Institutes of Health from NIDCR [1F31-DE019576]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114274] Funding Source: NIH RePORTER	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); National Institutes of Health from the National Institute of Dental and Craniofacial Research (NIDCR); National Institutes of Health from NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant 2007-3-13 from the Alfred P. Sloan Foundation (to GGB), National Institutes of Health Grant 1RC1-DE020630 from the National Institute of Dental and Craniofacial Research (NIDCR) (to GGB) and by National Institutes of Health Fellowship 1F31-DE019576 from NIDCR (to AMV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Collman F, 2015, J NEUROSCI, V35, P5792, DOI 10.1523/JNEUROSCI.4274-14.2015; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Garini Y, 2006, CYTOM PART A, V69A, P735, DOI 10.1002/cyto.a.20311; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lubeck E, 2012, NAT METHODS, V9, P743, DOI [10.1038/NMETH.2069, 10.1038/nmeth.2069]; Mansfield James R, 2008, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1419s84; Neher R, 2004, J MICROSC-OXFORD, V213, P46, DOI 10.1111/j.1365-2818.2004.01262.x; Subach FV, 2011, NAT METHODS, V8, P1019, DOI [10.1038/nmeth.1776, 10.1038/NMETH.1776]; Tsuriel S, 2015, NAT METHODS, V12, P547, DOI 10.1038/nmeth.3367; Valm AM, 2011, P NATL ACAD SCI USA, V108, P4152, DOI 10.1073/pnas.1101134108; Wan XH, 2009, CELL, V137, P672, DOI 10.1016/j.cell.2009.03.035; Waters JC, 2009, J CELL BIOL, V185, P1135, DOI 10.1083/jcb.200903097; Zimmermann T, 2014, METHODS MOL BIOL, V1075, P129, DOI 10.1007/978-1-60761-847-8_5	17	44	46	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158495	10.1371/journal.pone.0158495	http://dx.doi.org/10.1371/journal.pone.0158495			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391327	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400069
J	Zakharchenko, M; Los, F; Brodska, H; Balik, M				Zakharchenko, Mychajlo; Los, Ferdinand; Brodska, Helena; Balik, Martin			The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill	PLOS ONE			English	Article							CONTINUOUS VENOVENOUS HEMODIAFILTRATION; RENAL-REPLACEMENT THERAPY; ACID-BASE; SERUM MAGNESIUM; HEPARIN; HEMODIALYSIS; RISK; HEMOFILTRATION; HYPOMAGNESEMIA; METABOLISM	Background The requirements for magnesium (Mg) supplementation increase under regional citrate anticoagulation (RCA) because citrate acts by chelation of bivalent cations within the blood circuit. The level of magnesium in commercially available fluids for continuous renal replacement therapy (CRRT) may not be sufficient to prevent hypomagnesemia. Methods Patients (n = 45) on CRRT (2,000 ml/h, blood flow (Qb) 100 ml/min) with RCA modality (4% trisodium citrate) using calcium free fluid with 0.75 mmol/l of Mg with additional magnesium substitution were observed after switch to the calcium-free fluid with magnesium concentration of 1.50 mmol/l (n = 42) and no extra magnesium replenishment. All patients had renal indications for CRRT, were treated with the same devices, filters and the same postfilter ionized calcium endpoint (< 0.4 mmol/l) of prefilter citrate dosage. Under the high level Mg fluid the Qb, dosages of citrate and CRRT were consequently escalated in 9h steps to test various settings. Results Median balance of Mg was -0.91 (-1.18 to -0.53) mmol/h with Mg 0.75 mmol/l and 0.2 (0.06-0.35) mmol/h when fluid with Mg 1.50 mmol/l was used. It was close to zero (0.02 (-0.12-0.18) mmol/h) with higher blood flow and dosage of citrate, increased again to 0.15 (-0.11-0.25) mmol/h with 3,000 ml/h of high magnesium containing fluid (p< 0.001). The arterial levels of Mg were mildly increased after the change for high level magnesium containing fluid (p< 0.01). Conclusions Compared to ordinary dialysis fluid the mildly hypermagnesemic fluid provided even balances and adequate levels within ordinary configurations of CRRT with RCA and without a need for extra magnesium replenishment.	[Zakharchenko, Mychajlo; Balik, Martin] Charles Univ Prague, Fac Med 1, Dept Anesthesiol & Intens Care, Prague, Czech Republic; [Zakharchenko, Mychajlo; Los, Ferdinand; Brodska, Helena; Balik, Martin] Gen Univ Hosp Prague, Prague, Czech Republic; [Los, Ferdinand; Brodska, Helena] Charles Univ Prague, Fac Med 1, Dept Clin Biochem, Prague, Czech Republic	Charles University Prague; General University Hospital Prague; Charles University Prague	Balik, M (corresponding author), Charles Univ Prague, Fac Med 1, Dept Anesthesiol & Intens Care, Prague, Czech Republic.; Balik, M (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.	martin.balik@vfn.cz	Lahoda Brodska, Helena/I-6694-2017	Lahoda Brodska, Helena/0000-0001-7962-8287	ESICM Stoutenbeek Award	ESICM Stoutenbeek Award	The study (ClinicalTrials.gov Identifier: NCT01361581) was supported in part from ESICM Stoutenbeek Award 2012.	Alves SC, 2013, NEPHROL DIAL TRANSPL, V28, P910, DOI 10.1093/ndt/gfs268; Balik M, 2005, BLOOD PURIFICAT, V23, P325, DOI 10.1159/000087770; Balik M, 2014, BLOOD PURIFICAT, V38, P263, DOI 10.1159/000369956; Balik M, 2013, J CRIT CARE, V28, P87, DOI 10.1016/j.jcrc.2012.06.003; Balik M, 2012, BLOOD PURIFICAT, V33, P80, DOI 10.1159/000334641; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Bollmann MD, 2004, INTENS CARE MED, V30, P1103, DOI 10.1007/s00134-004-2251-3; Brain M, 2012, CRIT CARE RESUSC, V14, P274; Brain M, 2011, CRIT CARE RESUSC, V13, P72; Cole L, 2003, INTENS CARE MED, V29, P1113, DOI 10.1007/s00134-003-1812-1; Dorval M, 2003, INTENS CARE MED, V29, P1186, DOI 10.1007/s00134-003-1801-4; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Escuela MP, 2005, INTENS CARE MED, V31, P151, DOI 10.1007/s00134-004-2508-x; Fairley J, 2015, J CRIT CARE, V30, P1349, DOI 10.1016/j.jcrc.2015.07.029; Hebert P, 1997, CRIT CARE MED, V25, P749, DOI 10.1097/00003246-199705000-00007; Hetzel GR, 2011, NEPHROL DIAL TRANSPL, V26, P232, DOI 10.1093/ndt/gfq575; Huijgen HJ, 2000, AM J CLIN PATHOL, V114, P688, DOI 10.1309/JR9Y-PPTX-AJTC-QDRD; Karvellas CJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10061; Matias PJ, 2014, BLOOD PURIFICAT, V38, P244, DOI 10.1159/000366124; Morgera S, 2005, NEPHRON CLIN PRACT, V101, pC211, DOI 10.1159/000088177; Morgera S, 2004, NEPHRON CLIN PRACT, V97, pC131, DOI 10.1159/000079171; Morgera S, 2009, CRIT CARE MED, V37, P2018, DOI 10.1097/CCM.0b013e3181a00a92; Oudemans-van Straaten HM, 2009, CRIT CARE MED, V37, P545, DOI 10.1097/CCM.0b013e3181953c5e; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; Relton S, 1992, ASAIO J, V38, pM691, DOI 10.1097/00002480-199207000-00127; Seabra VF BE, 2008, AM J KIDNEY DIS, V52; Soliman HM, 2003, CRIT CARE MED, V31, P1082, DOI 10.1097/01.CCM.0000060867.17556.A0; Tong Garrison M, 2005, J Intensive Care Med, V20, P3, DOI 10.1177/0885066604271539; Uchino S, 2003, INTENS CARE MED, V29, P575, DOI 10.1007/s00134-003-1672-8; Wu MY, 2012, AM J KIDNEY DIS, V59, P810, DOI 10.1053/j.ajkd.2011.11.030; Zakharchenko M, 2016, BLOOD PURIFICAT, V41, P41, DOI 10.1159/000440972; Zhang ZH, 2012, INTENS CARE MED, V38, P20, DOI 10.1007/s00134-011-2438-3	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158179	10.1371/journal.pone.0158179	http://dx.doi.org/10.1371/journal.pone.0158179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391902	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400035
J	Guang-Han, O; Leang-Chung, C; Vellasamy, KM; Mariappan, V; Li-Yen, C; Vadivelu, J				Guang-Han, Ong; Leang-Chung, Choh; Vellasamy, Kumutha Malar; Mariappan, Vanitha; Li-Yen, Chang; Vadivelu, Jamuna			Experimental Phage Therapy for Burkholderia pseudomallei Infection	PLOS ONE			English	Article							MYCOBACTERIUM-AVIUM; IN-VIVO; BACTERIOPHAGE; MELIOIDOSIS; RESISTANCE; SUSCEPTIBILITY; EFFICACY; MODEL; MICE	Burkholderia pseudomallei is an intracellular Gram-negative bacterial pathogen intrinsically resistant to a variety of antibiotics. Phages have been developed for use as an alternative treatment therapy, particularly for bacterial infections that do not respond to conventional antibiotics. In this study, we investigated the use of phages to treat cells infected with B. pseudomallei. Phage C34 isolated from seawater was purified and characterised on the basis of its host range and morphology using transmission electron microscopy (TEM). Phage C34 was able to lyse 39.5% of B. pseudomallei clinical strains. Due to the presence of contractile tail, phage C34 is classified as a member of the family Myoviridae, a tailed double-stranded DNA virus. When 2 x 10(5) A549 cells were exposed to 2 x 10(7) PFU of phage C34, 24 hours prior to infection with 2 x 10(6) CFU of B. pseudomallei, it was found that the survivability of the cells increased to 41.6 +/- 6.8% as compared to 22.8 +/- 6.0% in untreated control. Additionally, application of phage successfully rescued 33.3% of mice infected with B. pseudomallei and significantly reduced the bacterial load in the spleen of the phage-treated mice. These findings indicate that phage can be a potential antimicrobial agent for B. pseudomallei infections.	[Guang-Han, Ong; Leang-Chung, Choh; Vellasamy, Kumutha Malar; Mariappan, Vanitha; Li-Yen, Chang; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [Li-Yen, Chang] Univ Malaya, TIDREC, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Vadivelu, J (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia.	jamuna@ummc.edu.my	Mariappan, Vanitha/ABD-4066-2020; Mariappan, Vanitha/I-4769-2013; Vellasamy, Kumutha Malar/CAF-0007-2022; VADIVELU, JAMUNARANI S/B-8696-2010; Vellasamy, Kumutha Malar/A-6592-2017; CHANG, LI-YEN/B-8353-2010	Mariappan, Vanitha/0000-0002-2351-1597; Mariappan, Vanitha/0000-0002-2351-1597; Vellasamy, Kumutha Malar/0000-0001-7661-3928; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Vellasamy, Kumutha Malar/0000-0001-7661-3928; Ong, Guang Han/0000-0003-3286-3823; Chang, Li-Yen/0000-0001-6850-2435	Ministry of Education (MOE), Malaysia under the High Impact Research (HIR)-MOE [UM.C/625/1/HIR/MoE/CHAN/02 H-50001-A000013, UM.C/625/1/HIR/MoE/CHAN/13/5 (H-50001-00-A000033)]; Postgraduate Research Fund under University of Malaya [PV066/2011A]; University of Malaya Research Grant (UMRG) [RP013C-13HTM]; University of Malaya Postgraduate Research Fund [PV066/2011A]	Ministry of Education (MOE), Malaysia under the High Impact Research (HIR)-MOE; Postgraduate Research Fund under University of Malaya; University of Malaya Research Grant (UMRG); University of Malaya Postgraduate Research Fund(Universiti Malaya)	Research in the authors' laboratory was supported by Ministry of Education (MOE), Malaysia under the High Impact Research (HIR)-MOE, project UM.C/625/1/HIR/MoE/CHAN/13/5 (H-50001-00-A000033), University of Malaya Research Grant (UMRG) (RP013C-13HTM) and University of Malaya Postgraduate Research Fund (PV066/2011A). Funding was awarded to JV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Research in the authors' laboratory was supported by Ministry of Education (MOE), Malaysia under the High Impact Research (HIR)-MOE, project UM.C/625/1/HIR/MoE/CHAN/02 H-50001-A000013 and the Postgraduate Research Fund (PV066/2011A) under University of Malaya.	Ackermann Hans-W., 2009, V501, P127, DOI 10.1007/978-1-60327-164-6_13; Alegado RA, 2011, CELL MICROBIOL, V13, P1618, DOI 10.1111/j.1462-5822.2011.01645.x; Brockhurst MA, 2007, INFECT GENET EVOL, V7, P547, DOI 10.1016/j.meegid.2007.01.005; Broxmeyer L, 2002, J INFECT DIS, V186, P1155, DOI 10.1086/343812; Brussow H, 2005, MICROBIOL-SGM, V151, P2133, DOI 10.1099/mic.0.27849-0; Bruynoghe R, 1921, C R SOC BIOL, V85, P1; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Capra ML, 2004, LETT APPL MICROBIOL, V38, P499, DOI 10.1111/j.1472-765X.2004.01525.x; Carmody LA, 2010, J INFECT DIS, V201, P264, DOI 10.1086/649227; Chan BK, 2013, FUTURE MICROBIOL, V8, P769, DOI [10.2217/FMB.13.47, 10.2217/fmb.13.47]; CHAOWAGUL W, 1993, J INFECT DIS, V168, P1181, DOI 10.1093/infdis/168.5.1181; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Choh LC, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00005; Conejero L, 2011, AM J PATHOL, V179, P270, DOI 10.1016/j.ajpath.2011.03.031; D'Herelle F., 1926, BACTERIOPHAGE SON CO; d'Herelle F., 1917, ACAD SCI PARIS, V165, P3; DANCE DAB, 1989, J ANTIMICROB CHEMOTH, V24, P295, DOI 10.1093/jac/24.3.295; Danelishvili L, 2006, MICROB DRUG RESIST, V12, P1, DOI 10.1089/mdr.2006.12.1; Dubos RJ, 1943, J EXP MED, V78, P161, DOI 10.1084/jem.78.3.161; Filippov AA, 2012, ADV EXP MED BIOL, V954, P337, DOI 10.1007/978-1-4614-3561-7_41; Gatedee J, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-366; Hall AR, 2012, APPL ENVIRON MICROB, V78, P5646, DOI 10.1128/AEM.00757-12; Hanlon GW, 2007, INT J ANTIMICROB AG, V30, P118, DOI 10.1016/j.ijantimicag.2007.04.006; Hyman Paul, 2009, V501, P175, DOI 10.1007/978-1-60327-164-6_18; Jenney AWJ, 2001, INT J ANTIMICROB AG, V17, P109, DOI 10.1016/S0924-8579(00)00334-4; Kvitko BH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-289; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Limmathurotsakul D, 2006, CLIN INFECT DIS, V43, P979, DOI 10.1086/507632; Lipsitz Rebecca, 2012, Emerg Infect Dis, V18, pe2, DOI 10.3201/eid1812.120638; Markoishvili K, 2002, INT J DERMATOL, V41, P453, DOI 10.1046/j.1365-4362.2002.01451.x; Merril CR, 1996, P NATL ACAD SCI USA, V93, P3188, DOI 10.1073/pnas.93.8.3188; Nasner-Posso KM, 2015, INT J INFECT DIS, V35, P103, DOI 10.1016/j.ijid.2015.05.009; Nobrega FL, 2015, TRENDS MICROBIOL, V23, P185, DOI 10.1016/j.tim.2015.01.006; O'Flynn G, 2004, APPL ENVIRON MICROB, V70, P3417, DOI 10.1128/AEM.70.6.3417-3424.2004; OHSHIMA Y, 1988, MED MICROBIOL IMMUN, V177, P229; Puthucheary S D, 2009, Med J Malaysia, V64, P266; Sambrook J., 2001, MOL CLONING LAB MANU; Sariya L, 2006, SCI ASIA, V32, P9; Scanlan PD, 2011, MOL ECOL, V20, P981, DOI 10.1111/j.1365-294X.2010.04903.x; Semler DD, 2014, ANTIMICROB AGENTS CH, V58, P4005, DOI 10.1128/AAC.02388-13; SMITH HW, 1982, J GEN MICROBIOL, V128, P307; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; SOOKPRANEE M, 1992, ANTIMICROB AGENTS CH, V36, P158, DOI 10.1128/AAC.36.1.158; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Suppiah J, 2010, FEMS MICROBIOL LETT, V306, P9, DOI 10.1111/j.1574-6968.2010.01923.x; Takemura-Uchiyama I, 2014, MICROBES INFECT, V16, P512, DOI 10.1016/j.micinf.2014.02.011; Van Twest Rohan, 2009, V501, P15, DOI 10.1007/978-1-60327-164-6_2; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; YAMAMOTO KR, 1970, VIROLOGY, V40, P734, DOI 10.1016/0042-6822(70)90218-7; Yordpratum U, 2011, FEMS MICROBIOL LETT, V314, P81, DOI 10.1111/j.1574-6968.2010.02150.x	51	24	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158213	10.1371/journal.pone.0158213	http://dx.doi.org/10.1371/journal.pone.0158213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387381	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500016
J	Zea, AH; Stewart, T; Ascani, J; Tate, DJ; Finkel-Jimenez, B; Wilk, A; Reiss, K; Smoyer, WE; Aviles, DH				Zea, Arnold H.; Stewart, Tyrus; Ascani, Jeannine; Tate, David J.; Finkel-Jimenez, Beatriz; Wilk, Anna; Reiss, Krzysztof; Smoyer, William E.; Aviles, Diego H.			Activation of the IL-2 Receptor in Podocytes: A Potential Mechanism for Podocyte Injury in Idiopathic Nephrotic Syndrome?	PLOS ONE			English	Article							SOLUBLE UROKINASE RECEPTOR; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; VASCULAR LEAK SYNDROME; GROWTH-FACTOR-BETA; DIABETIC-NEPHROPATHY; GLOMERULAR PROTEIN; LIPOID NEPHROSIS; STAT5 REGULATION; EXPRESSION; DISEASE	The renal podocyte plays an important role in maintaining the structural integrity of the glomerular basement membrane. We have previously reported that patients with idiopathic nephrotic syndrome (INS) have increased IL-2 production. We hypothesized that podocytes express an IL-2 receptor (IL-2R) and signaling through this receptor can result in podocyte injury. To confirm the presence of the IL-2R, we tested a conditionally immortalized murine podocyte cell line by flow cytometry, qPCR, and Western blot. To test for the presence of the IL-2R in vivo, immunohistochemical staining was performed on human renal biopsies in children with FSGS and control. Podocytes were stimulated with IL-2 in vitro, to study signaling events via the JAK/STAT pathway. The results showed that stimulation with IL-2 resulted in increased mRNA and protein expression of STAT 5a, phosphorylated STAT 5, JAK 3, and phosphorylated JAK 3. We then investigated for signs of cellular injury and the data showed that pro-apoptotic markers Bax and cFLIP were significantly increased following IL-2 exposure, whereas LC3 II was decreased. Furthermore, mitochondrial depolarization and apoptosis were both significantly increased following activation of the IL-2R. We used a paracellular permeability assay to monitor the structural integrity of a podocyte monolayer following IL-2 exposure. The results showed that podocytes exposed to IL-2 have increased albumin leakage across the monolayer. We conclude that murine podocytes express the IL-2R, and that activation through the IL-2R results in podocyte injury.	[Zea, Arnold H.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA USA; [Stewart, Tyrus; Aviles, Diego H.] Louisiana State Univ, Hlth Sci Ctr, Dept Pediat Nephrol, New Orleans, LA 70112 USA; [Ascani, Jeannine] Ochsner Hlth Syst, Dept Res Ochsner Biobank, New Orleans, LA USA; [Tate, David J.] Eurofins Cent Analyt Labs, New Orleans, LA USA; [Finkel-Jimenez, Beatriz] Amer Univ, Caribbean Sch Med, Dept Med Microbiol & Immunol, Coral Gables, FL USA; [Wilk, Anna; Reiss, Krzysztof] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Smoyer, William E.] Nationwide Childrens Hosp, Dept Nephrol, Columbus, OH USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Ochsner Health System; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Aviles, DH (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pediat Nephrol, New Orleans, LA 70112 USA.	davile@lsuhsc.edu						Aviles DH, 2004, KIDNEY INT, V66, P60, DOI 10.1111/j.1523-1755.2004.00706.x; Baqi N, 1997, J NEPHROL, V10, P85; Bianchi M, 2000, P NATL ACAD SCI USA, V97, P9573, DOI 10.1073/pnas.160099797; Bitzer M, 1998, KIDNEY BLOOD PRESS R, V21, P1, DOI 10.1159/000025837; Bock ME, 2013, CLIN J AM SOC NEPHRO, V8, P1304, DOI 10.2215/CJN.07680712; Bonilla-Felix M, 1999, KIDNEY INT, V55, P1885, DOI 10.1046/j.1523-1755.1999.00408.x; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Buckler JL, 2006, J IMMUNOL, V177, P4262, DOI 10.4049/jimmunol.177.7.4262; Cho BS, 1999, PEDIATR NEPHROL, V13, P199, DOI 10.1007/s004670050592; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060546; Hicks C, 1991, Growth Factors, V5, P201, DOI 10.3109/08977199109000284; HISANAGA S, 1990, NEPHRON, V54, P277, DOI 10.1159/000185875; Huber TB, 2002, J IMMUNOL, V168, P6244, DOI 10.4049/jimmunol.168.12.6244; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; KOYAMA A, 1991, KIDNEY INT, V40, P453, DOI 10.1038/ki.1991.232; KRAMS SM, 1992, TRANSPLANTATION, V53, P151, DOI 10.1097/00007890-199201000-00031; Kumar PA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00151; Laflam PF, 2002, NEPHRON, V91, P620, DOI 10.1159/000065022; LAGRUE G, 1975, BIOMED EXPRESS, V23, P37; Lennon R, 2008, J AM SOC NEPHROL, V19, P2140, DOI 10.1681/ASN.2007080940; Leonard W.J., 1999, FUNDAMENTAL IMMUNOLO, Vfourth, P741; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; LIN WC, 1995, J IMMUNOL, V155, P4805; Maas RJH, 2012, KIDNEY INT, V81, P1043, DOI 10.1038/ki.2012.32; Marrero MB, 2006, AM J PHYSIOL-RENAL, V290, pF762, DOI 10.1152/ajprenal.00181.2005; Meijers B, 2014, KIDNEY INT, V85, P636, DOI 10.1038/ki.2013.505; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; Nagy ZS, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-67; PLAISANCE S, 1992, INT IMMUNOL, V4, P739, DOI 10.1093/intimm/4.7.739; Pollak MR, 2008, CURR OPIN NEPHROL HY, V17, P138, DOI 10.1097/MNH.0b013e3282f5dbe4; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Rafi-Janajreh AQ, 1999, J IMMUNOL, V163, P1619; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735; SAVIN M, 1993, RENAL FAILURE, V15, P551, DOI 10.3109/08860229309054973; Schiffer M, 2001, J CLIN INVEST, V108, P807, DOI 10.1172/JCI12367; Schonenberger E, 2011, NEPHROL DIAL TRANSPL, V26, P18, DOI 10.1093/ndt/gfq617; SHALHOUB RJ, 1974, LANCET, V2, P556; Shimoyama H, 2004, PEDIATR NEPHROL, V19, P1115, DOI 10.1007/s00467-004-1569-y; Sinha A, 2014, KIDNEY INT, V85, P649, DOI 10.1038/ki.2013.546; Sivakumar PV, 2013, COMPARATIVE MED, V63, P13; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Wada T, 2014, KIDNEY INT, V85, P641, DOI 10.1038/ki.2013.544; Waldman M, 2007, CLIN J AM SOC NEPHRO, V2, P445, DOI 10.2215/CJN.03531006; Wei C, 2008, J AM SOC NEPHROL, V19, p103A; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; WHITE RHR, 1970, LANCET, V1, P1353; WHITESIDE TL, 1995, CURR OPIN IMMUNOL, V7, P704, DOI 10.1016/0952-7915(95)80080-8; YOSHIMURA N, 1985, TRANSPLANTATION, V40, P661, DOI 10.1097/00007890-198512000-00018; Yu CL, 2000, J BIOL CHEM, V275, P599, DOI 10.1074/jbc.275.1.599; Zeng CH, 2014, J PATHOL, V234, P203, DOI 10.1002/path.4382	56	12	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157907	10.1371/journal.pone.0157907	http://dx.doi.org/10.1371/journal.pone.0157907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389192	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500009
J	Fuwa, M; Ueda, K; Akaishi, T; Yamashita, N; Kirihara, T; Shimazaki, A; Mano, H; Kawazu, K				Fuwa, Masahiro; Ueda, Kenji; Akaishi, Takahiro; Yamashita, Naoko; Kirihara, Tomoko; Shimazaki, Atsushi; Mano, Hidetoshi; Kawazu, Kouichi			Advantages of Efficacy and Safety of Fixed-Dose Tafluprost/Timolol Combination Over Fixed-Dose Latanoprost/Timolol Combination	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OCULAR HYPERTENSION; INDIVIDUAL COMPONENTS; INTRAOCULAR-PRESSURE; OPHTHALMIC SOLUTION; TIMOLOL; ADHERENCE; MULTICENTER; MEDICATION; BIOAVAILABILITY	Purpose To compare the safety and efficacy of fixed-dose tafluprost/timolol combination (Taf/T-FDC) with those of fixed-dose latanoprost/timolol combination (Lat/T-FDC) by measuring the intraocular pressure (IOP)-lowering effect, ocular pharmacokinetics, and ocular surface toxicity. Methods The IOP-lowering effect of Taf/T-FDC and Lat/T-FDC in ocular normotensive monkeys was evaluated at 4 and 8 h after instillation in study A, at 12, 14, 16, and 18 h after instillation in study B, and at 24, 26, 28, and 30 h after instillation in study C. Drug penetration into the eye was evaluated by measuring the concentrations of timolol, tafluprost acid (active metabolic form of tafluprost), and latanoprost acid (active metabolic form of latanoprost) using liquid chromatography coupled with tandem mass spectrometry after single instillation of Taf/T-FDC or Lat/T-FDC to Sprague Dawley rats. Cytotoxicity following 1-30 min exposure of SV40-transformed human corneal epithelial cells to Taf/T-FDC or Lat/T-FDC was analyzed using 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetra-zolium assays. Undiluted and 10-fold diluted solutions of each FDC were evaluated. Results The IOP-lowering effect of Taf/T-FDC was almost equivalent to that of Lat/T-FDC at 4-8 h after instillation. The peak IOP reduction of Taf/T-FDC and Lat/T-FDC was observed at 8 h after instillation, and there is no difference between the two. The difference between them was observed at 24-30 h after instillation, and Taf/T-FDC demonstrated a significantly greater IOP-lowering effect than Lat/T-FDC at 24-30 h after instillation. The IOP-lowering effect of Taf/T-FDC was sustained up to 30 h after instillation, while that of Lat/T-FDC had almost disappeared at 28 h after instillation. Timolol concentrations in aqueous humor after Taf/T-FDC instillation were higher than those after Lat/T-FDC instillation (C-max, 3870 ng/mL vs 1330 ng/mL; AUC(inf), 3970 ng.h/mL vs 1250 ng.h/mL). The concentrations of tafluprost acid and latanoprost acid in aqueous humor after instillation of Taf/T-FDC and Lat/T-FDC, respectively, were similar to those after instillation of mono-preparations of tafluprost and latanoprost, respectively. The cytotoxic effect of Taf/T-FDC to the human corneal epithelial cells was significantly lower than that of Lat/T-FDC at all evaluated time points in both undiluted and 10-fold diluted FDCs. Conclusion Taf/T-FDC provides increased IOP-lowering effect duration and lower potential ocular surface toxicity than Lat/T-FDC.x	[Fuwa, Masahiro; Ueda, Kenji; Akaishi, Takahiro; Yamashita, Naoko; Kirihara, Tomoko; Shimazaki, Atsushi; Mano, Hidetoshi; Kawazu, Kouichi] Santen Pharmaceut Co Ltd, Global Res & Dev, Ikoma, Nara, Japan	Santen Pharmaceutical Co Ltd	Fuwa, M (corresponding author), Santen Pharmaceut Co Ltd, Global Res & Dev, Ikoma, Nara, Japan.	Masahiro.Fuwa@santen.co.jp			Santen Pharmaceutical Co., Ltd.	Santen Pharmaceutical Co., Ltd.	The funder provided support in the form of salaries for authors [MF, KU, TA, NY, TK, AS, HM, KK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The authors received no specific funding for this work. Santen Pharmaceutical Co., Ltd. provided support in the form of salaries for authors [MF, KU, TA, NY, TK, AS, HM, KK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDERSON DR, 1989, AM J OPHTHALMOL, V108, P485, DOI 10.1016/0002-9394(89)90423-6; [Anonymous], 1989, INT J PHARM, V57, P163; Asada H, 2010, YAKUGAKU ZASSHI, V130, P867, DOI 10.1248/yakushi.130.867; Asrani S, 2000, J GLAUCOMA, V9, P134; Baudouin C, 2005, CURR OPIN ALLERGY CL, V5, P459, DOI 10.1097/01.all.0000183112.86181.9e; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; BROADWAY DC, 1994, ARCH OPHTHALMOL-CHIC, V112, P1446, DOI 10.1001/archopht.1994.01090230060021; Diestelhorst M, 2006, OPHTHALMOLOGY, V113, P70, DOI 10.1016/j.ophtha.2005.06.027; Diestelhorst M, 2004, BRIT J OPHTHALMOL, V88, P199, DOI 10.1136/bjo.2003.018234; Dietlein TS, 2006, GRAEF ARCH CLIN EXP, V244, P859, DOI 10.1007/s00417-005-0142-0; Djafari F, 2009, J GLAUCOMA, V18, P238, DOI 10.1097/IJG.0b013e3181815421; Erb C, 2008, GRAEF ARCH CLIN EXP, V246, P1593, DOI 10.1007/s00417-008-0881-9; Fechtner Robert D, 2004, Curr Opin Ophthalmol, V15, P132, DOI 10.1097/00055735-200404000-00013; Francis BA, 2004, J CLIN PHARM THER, V29, P375, DOI 10.1111/j.1365-2710.2004.00574.x; Garcia-Feijoo J, 2012, CLIN OPHTHALMOL, V6, P441, DOI 10.2147/OPTH.S29158; Higashiyama M, 2004, INT J PHARM, V272, P91, DOI 10.1016/j.ijpharm.2003.11.035; Kuwayama Y, 2013, J EYE, V30, P1185; KYYRONEN K, 1990, J PHARM SCI, V79, P688, DOI 10.1002/jps.2600790808; Laurence J, 1993, J Glaucoma, V2, P177; Leung EW, 2008, J GLAUCOMA, V17, P350, DOI 10.1097/IJG.0b013e31815c5f4f; Mundorf TK, 2004, CLIN THER, V26, P541, DOI 10.1016/S0149-2918(04)90056-2; Nelson J D, 1995, Trans Am Ophthalmol Soc, V93, P709; Noecker RJ, 2004, CORNEA, V23, P490, DOI 10.1097/01.ico.0000116526.57227.82; Offord EA, 1999, INVEST OPHTH VIS SCI, V40, P1091; Olthoff CMG, 2005, OPHTHALMOLOGY, V112, P953, DOI 10.1016/j.ophtha.2004.12.035; Pauly A, 2012, INVEST OPHTH VIS SCI, V53, P8172, DOI 10.1167/iovs.12-10766; Robin AL, 2005, OPHTHALMOLOGY, V112, P863, DOI 10.1016/j.ophtha.2004.12.026; Robin AL, 2007, AM J OPHTHALMOL, V144, P533, DOI 10.1016/j.ajo.2007.06.012; Shedden A, 2001, CLIN THER, V23, P440, DOI 10.1016/S0149-2918(01)80048-5; Singh K, 2011, INDIAN J OPHTHALMOL, V59, pS88, DOI 10.4103/0301-4738.73691; Takagi Y, 2004, EXP EYE RES, V78, P767, DOI 10.1016/j.exer.2003.12.007; Ueda K., 2013, J EYE, V30, P1761; Ung C, 2013, OPHTHALMOLOGY, V120, P1150, DOI 10.1016/j.ophtha.2012.11.026; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Xing Y, 2014, INT J OPHTHALMOL-CHI, V7, P879, DOI 10.3980/j.issn.2222-3959.2014.05.26; Zhao JL, 2011, BMC OPHTHALMOL, V11, DOI 10.1186/1471-2415-11-23; Zimmerman T J, 1983, Surv Ophthalmol, V28 Suppl, P252, DOI 10.1016/0039-6257(83)90142-X; 1998, AM J OPHTHALMOLOGY, V126, P498	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158797	10.1371/journal.pone.0158797	http://dx.doi.org/10.1371/journal.pone.0158797			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383260	gold, Green Published, Green Submitted			2022-12-26	WOS:000379809400085
J	Roberts, P; Henshilwood, CS; van Niekerk, KL; Keene, P; Gledhill, A; Reynard, J; Badenhorst, S; Lee-Thorp, J				Roberts, Patrick; Henshilwood, Christopher S.; van Niekerk, Karen L.; Keene, Petro; Gledhill, Andrew; Reynard, Jerome; Badenhorst, Shaw; Lee-Thorp, Julia			Climate, Environment and Early Human Innovation: Stable Isotope and Faunal Proxy Evidence from Archaeological Sites (98-59ka) in the Southern Cape, South Africa	PLOS ONE			English	Article							MIDDLE STONE-AGE; MODERN HUMAN-BEHAVIOR; BLOMBOS CAVE; HOWIESONS POORT; STILL BAY; ADDITIONAL EVIDENCE; KLIPDRIFT SHELTER; FOOD SELECTION; OSTRICH; KA	The Middle Stone Age (MSA) of southern Africa, and in particular its Still Bay and Howiesons Poort lithic traditions, represents a period of dramatic subsistence, cultural, and technological innovation by our species, Homo sapiens. Climate change has frequently been postulated as a primary driver of the appearance of these innovative behaviours, with researchers invoking either climate instability as a reason for the development of buffering mechanisms, or environmentally stable refugia as providing a stable setting for experimentation. Testing these alternative models has proved intractable, however, as existing regional palaeoclimatic and palaeoenvironmental records remain spatially, stratigraphically, and chronologically disconnected from the archaeological record. Here we report high-resolution records of environmental shifts based on stable carbon and oxygen isotopes in ostrich eggshell (OES) fragments, faunal remains, and shellfish assemblages excavated from two key MSA archaeological sequences, Blombos Cave and Klipdrift Shelter. We compare these records with archaeological material remains in the same strata. The results from both sites, spanning the periods 98-73 ka and 72-59 ka, respectively, show significant changes in vegetation, aridity, rainfall seasonality, and sea temperature in the vicinity of the sites during periods of human occupation. While these changes clearly influenced human subsistence strategies, we find that the remarkable cultural and technological innovations seen in the sites cannot be linked directly to climate shifts. Our results demonstrate the need for scale-appropriate, on-site testing of behavioural-environmental links, rather than broader, regional comparisons.	[Roberts, Patrick; Lee-Thorp, Julia] Univ Oxford, Sch Archaeol, Res Lab Archaeol & Hist Art, Dyson Perrins Bldg,South Parks Rd, Oxford, England; [Henshilwood, Christopher S.; van Niekerk, Karen L.; Keene, Petro; Reynard, Jerome] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Henshilwood, Christopher S.; van Niekerk, Karen L.] Univ Bergen, Dept Archaeol Hist Cultural Studies & Relig, Bergen, Norway; [Gledhill, Andrew] Univ Bradford, Div Geog Archaeol & Environm Sci, Bradford, W Yorkshire, England; [Reynard, Jerome] Univ Witwatersrand, Sch Geog Archaeol & Environm Studies, Johannesburg, South Africa; [Badenhorst, Shaw] Ditsong Natl Museum Nat Hist, Archaeozool & Large Mammal Sect, Paul Kruger St, Pretoria, South Africa; [Badenhorst, Shaw] Univ South Africa, Dept Anthropol & Archaeol, Durban, South Africa	University of Oxford; University of Witwatersrand; University of Bergen; University of Bradford; University of Witwatersrand; University of South Africa	Roberts, P (corresponding author), Univ Oxford, Sch Archaeol, Res Lab Archaeol & Hist Art, Dyson Perrins Bldg,South Parks Rd, Oxford, England.	patrick.roberts@rlaha.ox.ac.uk	Henshilwood, Christopher S/K-3806-2014; van Niekerk, Karen/J-3511-2015; Badenhorst, Shaw/HGC-7123-2022; Reynard, Jerome/AGV-6706-2022	Henshilwood, Christopher S/0000-0002-2818-293X; van Niekerk, Karen/0000-0003-2261-6861; Badenhorst, Shaw/0000-0002-6651-9660; Reynard, Jerome/0000-0002-7092-2188; Roberts, Patrick/0000-0002-4403-7548	Clarendon Fund; Natural Environmental Research Council; National Research Foundation/Department of Science and Technology at the University of the Witwatersrand, South Africa; University of Bergen, Norway; University of Oxford; NERC [NE/G005338/1] Funding Source: UKRI; Natural Environment Research Council [NE/G005338/1] Funding Source: researchfish	Clarendon Fund; Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Research Foundation/Department of Science and Technology at the University of the Witwatersrand, South Africa; University of Bergen, Norway; University of Oxford; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research would not have been possible without financial support from the Clarendon Fund, University of Oxford, and a Natural Environmental Research Council studentship to PR. Financial support for the KDS and BBC projects was provided to CSH by a National Research Foundation/Department of Science and Technology funded Chair at the University of the Witwatersrand, South Africa, and by the University of Bergen, Norway.	Ambrose SH., 2022, SOCIAL ECOLOGICAL MO, P3, DOI [DOI 10.1515/9781474470957-003, 10.1515/9781474470957-003]; Bar-Matthews M, 2010, QUATERNARY SCI REV, V29, P2131, DOI 10.1016/j.quascirev.2010.05.009; Barbour MM, 2007, FUNCT PLANT BIOL, V34, P83, DOI 10.1071/FP06228; Blinkhom J, 2015, PALAEOGEOGR PALAEOCL, V417, P80, DOI 10.1016/j.palaeo.2014.10.026; BROOKS AS, 1990, SCIENCE, V248, P60, DOI 10.1126/science.248.4951.60; BUYS D, 1990, S AFR J WILDL RES, V20, P16; Chase BM, 2007, EARTH-SCI REV, V84, P103, DOI 10.1016/j.earscirev.2007.06.002; Chase BM, 2010, J ARCHAEOL SCI, V37, P1359, DOI 10.1016/j.jas.2009.12.040; COHEN AL, 1995, HOLOCENE, V5, P304, DOI 10.1177/095968369500500305; Compton JS, 2011, QUATERNARY SCI REV, V30, P506, DOI 10.1016/j.quascirev.2010.12.012; Cooper RG, 2010, TROP ANIM HEALTH PRO, V42, P363, DOI 10.1007/s11250-009-9428-2; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; D'Errico F, 2001, ANTIQUITY, V75, P309, DOI 10.1017/S0003598X00060968; d'Errico F, 2007, J HUM EVOL, V52, P142, DOI 10.1016/j.jhevol.2006.08.003; DEACON HJ, 2001, HUMAN ROOTS AFRICA A, P55; Driver J. C., 2005, CROW CANYON ARCHAEOL; Ecker M, 2015, CHANCING CLIMATES EC, V33; Faith JT, 2011, PALAEOGEOGR PALAEOCL, V306, P219, DOI 10.1016/j.palaeo.2011.04.025; Fisher EC, 2010, QUATERNARY SCI REV, V29, P1382, DOI 10.1016/j.quascirev.2010.01.015; FLANAGAN LB, 1991, PLANT PHYSIOL, V96, P588, DOI 10.1104/pp.96.2.588; Gonfiantini R., 1965, ISOTOPES RAD SOIL PL, P405; Henshilwood C.S., 2005, TOOLS SYMBOLS EARLY, P441; Henshilwood C. S., 2008, S AFRICAN ARCHAEOLOG, V10, P35; Henshilwood C. S., 2011, HOMOSYMBOLICUS DAWN, P75; Henshilwood CS, 2014, J ARCHAEOL SCI, V45, P284, DOI 10.1016/j.jas.2014.01.033; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2009, J HUM EVOL, V57, P27, DOI 10.1016/j.jhevol.2009.01.005; Henshilwood CS, 2011, CURR ANTHROPOL, V52, P361, DOI 10.1086/660022; Henshilwood CS, 2003, CURR ANTHROPOL, V44, P627, DOI 10.1086/377665; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Henshilwood CS, 2013, ENCY GLOBAL ARCHAEOL, P240; Henshilwood CS, 2012, J WORLD PREHIST, V52, P361; Hillestad-Nel TH, 2007, SO CAPE S AFRICA NYA, V68, P52; Hoffmann V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137847; Inskeep R.R., 1987, BAR INT SERIES, V357; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2006, J HUM EVOL, V51, P255, DOI 10.1016/j.jhevol.2006.03.007; Jacobs Z, 2013, J ARCHAEOL SCI, V40, P579, DOI 10.1016/j.jas.2012.06.037; Johnson BJ, 1998, GEOCHIM COSMOCHIM AC, V62, P2451, DOI 10.1016/S0016-7037(98)00175-6; Johnson BJ, 1997, PALAEOGEOGR PALAEOCL, V136, P121, DOI 10.1016/S0031-0182(97)00043-6; Jones H. L., 2001, THESIS; Klein R.G., 1984, ANAL ANIMAL BONES AR; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Klein RG, 1974, ANN S AFR MUS, V65, P99; Lee-Thorp JA, 2015, AFR ARCHAEOL REV, V32, P793, DOI 10.1007/s10437-015-9202-y; Lombard M, 2007, S AFR ARCHAEOL BULL, V62, P62, DOI 10.2307/20474947; Lombard M, 2011, J ARCHAEOL SCI, V38, P1918, DOI 10.1016/j.jas.2011.04.001; MILTON SJ, 1994, J WILDLIFE MANAGE, V58, P234, DOI 10.2307/3809386; Mitchell PJ., 1996, AFR ARCHAEOL REV, V13, P35, DOI DOI 10.1007/BF01956132; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Reynard JP, 2016, PALAEOGEOGR PALAEOCL, V449, P349, DOI 10.1016/j.palaeo.2016.02.035; Rundel PW, 1999, PLANT ECOL, V142, P133, DOI 10.1023/A:1009878429455; SAUER E.G.F., 1966, OSTRICH J AFRICAN OR, P183; Sealy J, 1996, S AFR J SCI, V92, P441; Segalen L, 2006, EARTH PLANET SC LETT, V244, P725, DOI 10.1016/j.epsl.2005.12.012; Segalen L, 2009, PALAEOGEOGR PALAEOCL, V277, P191, DOI 10.1016/j.palaeo.2009.03.018; Sharp Z., 2007, PRINCIPLES STABLE IS; SINCLAIR ARE, 1978, IBIS, V120, P480, DOI 10.1111/j.1474-919X.1978.tb06813.x; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; SMITH BN, 1971, PLANT PHYSIOL, V47, P380, DOI 10.1104/pp.47.3.380; Stiner MC, 1999, SCIENCE, V283, P190, DOI 10.1126/science.283.5399.190; Stiner MC, 2001, P NATL ACAD SCI USA, V98, P6993, DOI 10.1073/pnas.121176198; Stynder DD, 2009, QUATERNARY RES, V71, P62, DOI 10.1016/j.yqres.2008.06.003; Thompson JC, 2014, J ARCHAEOL SCI, V41, P214, DOI 10.1016/j.jas.2013.08.017; Thompson JC, 2011, J HUM EVOL, V60, P746, DOI 10.1016/j.jhevol.2011.01.013; Tribolo C, 2006, ARCHAEOMETRY, V48, P341, DOI 10.1111/j.1475-4754.2006.00260.x; Vaesen K, 2016, P NATL ACAD SCI USA, V113, pE2241, DOI 10.1073/pnas.1520288113; Van Niekerk K. L., 2011, THESIS; Vanhaeren M, 2013, J HUM EVOL, V64, P500, DOI 10.1016/j.jhevol.2013.02.001; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; VOGEL JC, 1978, S AFR J SCI, V74, P209; VONSCHIRNDING Y, 1982, ARCHAEOMETRY, V24, P3, DOI 10.1111/j.1475-4754.1982.tb00643.x; West AG, 2014, J GEOCHEM EXPLOR, V145, P213, DOI 10.1016/j.gexplo.2014.06.009; WILLIAMS JB, 1993, ECOLOGY, V74, P390, DOI 10.2307/1939301; Zeder MA, 2012, J ANTHROPOL ARCHAEOL, V31, P241, DOI 10.1016/j.jaa.2012.03.003; Ziegler M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2897	78	45	45	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157408	10.1371/journal.pone.0157408	http://dx.doi.org/10.1371/journal.pone.0157408			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27383620	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400011
J	Sada, K; Nishikawa, T; Kukidome, D; Yoshinaga, T; Kajihara, N; Sonoda, K; Senokuchi, T; Motoshima, H; Matsumura, T; Araki, E				Sada, Kiminori; Nishikawa, Takeshi; Kukidome, Daisuke; Yoshinaga, Tomoaki; Kajihara, Nobuhiro; Sonoda, Kazuhiro; Senokuchi, Takafumi; Motoshima, Hiroyuki; Matsumura, Takeshi; Araki, Eiichi			Hyperglycemia Induces Cellular Hypoxia through Production of Mitochondrial ROS Followed by Suppression of Aquaporin-1	PLOS ONE			English	Article							DIABETIC COMPLICATIONS; ENDOTHELIAL-CELLS; EXPRESSION; PIMONIDAZOLE; ACTIVATION; MELLITUS; DAMAGE; MICE	We previously proposed that hyperglycemia-induced mitochondrial reactive oxygen species (mtROS) generation is a key event in the development of diabetic complications. Interestingly, some common aspects exist between hyperglycemia and hypoxia-induced phenomena. Thus, hyperglycemia may induce cellular hypoxia, and this phenomenon may also be involved in the pathogenesis of diabetic complications. In endothelial cells (ECs), cellular hypoxia increased after incubation with high glucose (HG). A similar phenomenon was observed in glomeruli of diabetic mice. HG-induced cellular hypoxia was suppressed by mitochondria blockades or manganese superoxide dismutase (MnSOD) overexpression, which is a specific SOD for mtROS. Overexpression of MnSOD also increased the expression of aquaporin-1 (AQP1), a water and oxygen channel. AQP1 overexpression in ECs suppressed hyperglycemia-induced cellular hypoxia, endothelin-1 and fibronectin overproduction, and apoptosis. Therefore, hyperglycemia-induced cellular hypoxia and mtROS generation may promote hyperglycemic damage in a coordinated manner.	[Sada, Kiminori; Nishikawa, Takeshi; Kukidome, Daisuke; Yoshinaga, Tomoaki; Kajihara, Nobuhiro; Sonoda, Kazuhiro; Senokuchi, Takafumi; Motoshima, Hiroyuki; Matsumura, Takeshi; Araki, Eiichi] Kumamoto Univ, Fac Life Sci, Dept Metab Med, Kumamoto, Japan; [Nishikawa, Takeshi; Senokuchi, Takafumi] Kumamoto Univ, Fac Life Sci, Dept Mol Diabetol, Kumamoto, Japan	Kumamoto University; Kumamoto University	Nishikawa, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Metab Med, Kumamoto, Japan.; Nishikawa, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Mol Diabetol, Kumamoto, Japan.	t-nishikawa@kumamed.jp; t-nishikawa@kumamed.jp		sada, kiminori/0000-0001-9663-6035	Japan Society for the Promotion of Science, Japan [26461340, 15K09393]	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, Japan (no. 26461340 to TN and no. 15K09393 to DK). The URL of the funder is https://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteel GE, 1998, EUR J BIOCHEM, V253, P743, DOI 10.1046/j.1432-1327.1998.2530743.x; ARTEEL GE, 1995, BRIT J CANCER, V72, P889, DOI 10.1038/bjc.1995.429; Bae EH, 2008, AM J PHYSIOL-RENAL, V294, pF272, DOI 10.1152/ajprenal.00352.2007; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Dandona P, 1996, LANCET, V347, P444, DOI 10.1016/S0140-6736(96)90013-6; Echevarria M, 2007, J BIOL CHEM, V282, P30207, DOI 10.1074/jbc.M702639200; Esposti MD, 1999, J BIOL CHEM, V274, P29831, DOI 10.1074/jbc.274.42.29831; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; Goto H, 2008, BIOCHEM BIOPH RES CO, V366, P814, DOI 10.1016/j.bbrc.2007.12.041; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Ivanov II, 2004, BIOCHEM BIOPH RES CO, V322, P746, DOI 10.1016/j.bbrc.2004.07.187; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lai EY, 2012, AM J PHYSIOL-RENAL, V303, pF64, DOI 10.1152/ajprenal.00005.2012; Madonna R, 2010, INT J IMMUNOPATH PH, V23, P755, DOI 10.1177/039463201002300309; Madonna R, 2015, CURR DRUG TARGETS, V16, P361, DOI 10.2174/1389450116666141219115720; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Nishikawa T, 2003, DIABETES CARE, V26, P1507, DOI 10.2337/diacare.26.5.1507; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Su X, 2004, RESP PHYSIOL NEUROBI, V142, P1, DOI 10.1016/j.resp.2004.05.001; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Zhang SJ, 2010, CANCER RES, V70, P4490, DOI 10.1158/0008-5472.CAN-09-3948	22	66	70	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158619	10.1371/journal.pone.0158619	http://dx.doi.org/10.1371/journal.pone.0158619			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383386	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400066
J	Zhang, X; Zhang, L; Du, Y; Zheng, H; Zhang, P; Sun, Y; Wang, Y; Chen, J; Ding, P; Wang, N; Yang, C; Huang, T; Yao, X; Qiao, Q; Gu, H; Cai, G; Cai, S; Zhou, X; Hu, W				Zhang, X.; Zhang, L.; Du, Y.; Zheng, H.; Zhang, P.; Sun, Y.; Wang, Y.; Chen, J.; Ding, P.; Wang, N.; Yang, C.; Huang, T.; Yao, X.; Qiao, Q.; Gu, H.; Cai, G.; Cai, S.; Zhou, X.; Hu, W.			A novel FOXM1 isoform, FOXM1D, promotes epithelial-mesenchymal transition and metastasis through ROCKs activation in colorectal cancer	ONCOGENE			English	Article							FORKHEAD BOX M1; RHO-ASSOCIATED KINASE; COILED-COILS; TARGET; TUMORIGENESIS; TRANSCRIPTION; PROGRESSION; INHIBITION; EXPRESSION; INVASION	Epithelial-mesenchymal transition (EMT) is a critical event in metastasis of colorectal cancer (CRC). Rho/ROCKs signaling has a pivotal role in orchestrating actin cytoskeleton, leading to EMT and cancer invasion. However, the underlying mechanisms for ROCKs activation are not fully understood. Here, we identified FOXM1D, a novel isoform of Forkhead box M1 (FOXM1) that has a pivotal role in ROCKs activation by directly interacting with coiled-coil region of ROCK2. FOXM1D overexpression significantly polymerizes actin assembly and impairs E-cadherin expression, resulting in EMT and metastasis in xenograft mouse model and knockdown of FOXM1D has the opposite effect. Moreover, a high FOXM1D level correlates closely with clinical CRC metastasis. FOXM1D-induced ROCKs activation could be abrogated by the ROCKs inhibitors Y-27632 and fasudil. These observations indicate that the FOXM1D-ROCK2 interaction is crucial for Rho/ROCKs signaling and provide novel insight into actin cytoskeleton regulation and therapeutic potential for CRC metastasis.	[Zhang, X.; Zhang, L.; Du, Y.; Zhang, P.; Sun, Y.; Chen, J.; Ding, P.; Wang, N.; Qiao, Q.; Gu, H.; Hu, W.] Fudan Univ, Shanghai Canc Ctr, Collaborat Innovat Ctr Canc Med, Shanghai Med Coll, Shanghai, Peoples R China; [Zhang, X.; Zhang, L.; Du, Y.; Zhang, P.; Sun, Y.; Chen, J.; Ding, P.; Wang, N.; Qiao, Q.; Gu, H.; Hu, W.] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Zheng, H.; Wang, Y.; Cai, G.; Cai, S.] Fudan Univ, Shanghai Med Coll, Dept Colorectal Surg, Shanghai, Peoples R China; [Yang, C.; Zhou, X.] Second Mil Med Univ, Changzheng Hosp, Shanghai, Peoples R China; [Huang, T.; Yao, X.] Shanghai Tenth Peoples Hosp, Dept Urol, Shanghai, Peoples R China; [Hu, W.] Fudan Univ, Shanghai Med Coll, Dept Immunol, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Naval Medical University; Fudan University	Hu, W (corresponding author), Fudan Univ, Shanghai Canc Ctr, Inst Canc, 270 Dongan Rd, Shanghai 200032, Peoples R China.	weiguohu@fudan.edu.cn	Zhang, Long/HCI-5197-2022; Hu, Weiguo/AAP-2239-2021	Hu, Weiguo/0000-0002-7397-6800; Chen, Jianfeng/0000-0002-4182-145X	Major State Basic Research Development Program of China [2013CB910802]; National Natural Science Foundation of China [81171910, 81372258]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning	Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning	This research was supported by the Major State Basic Research Development Program of China (2013CB910802), the National Natural Science Foundation of China (81171910, 81372258) and the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning to WH. We thank Professor Thomas M Roberts (DFCI, Harvard Medical School) and Professor Hua Lu (Department of Biochemistry and Molecular Biology, Tulane University) for scientific suggestions and critical reading of this manuscript. We are also grateful to Dr Yuhu Xin for assistance with confocal microscopy; to Mrs Ping Zhang for assistance with flow cytometry; to Dr Yi Qin, who provided the pCMV-C-FLAG and pCMV-C-HA plasmids; to Professor Yanhui Xu, who kindly provided the modified pGEX-6P-1 plasmid; and to Professor Shenglin Huang, who provided the p-pLVX-IRES-Neo and pwpxl-eGFP-2A-CBGr99 lentiviral vectors; to Dr Fangning Wan for advices on statistics and revision of manuscript.	Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Halasi M, 2013, MOL CANCER THER, V12, P245, DOI 10.1158/1535-7163.MCT-12-0712; Halasi M, 2009, CELL CYCLE, V8, P1966, DOI 10.4161/cc.8.12.8708; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kalin TV, 2011, CELL CYCLE, V10, P396, DOI 10.4161/cc.10.3.14709; Kim YH, 2014, J FOOD SAFETY, V34, P1, DOI 10.1111/jfs.12088; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liu J, 2008, EURASIP J ADV SIG PR, DOI 10.1155/2008/162587; Liu MG, 2006, CANCER RES, V66, P3593, DOI 10.1158/0008-5472.CAN-05-2912; Liu PY, 2008, METHOD ENZYMOL, V439, P181, DOI 10.1016/S0076-6879(07)00414-4; Liu X, 2015, FUTURE ONCOL, V11, P2911, DOI 10.2217/fon.15.235; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Morgan-Fisher M, 2013, J HISTOCHEM CYTOCHEM, V61, P185, DOI 10.1369/0022155412470834; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Park H, 2011, J HIGH ENERGY PHYS, DOI [10.1007/JHEP10(2011)092, 10.1155/2011/485173]; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Rajput A, 2008, J SURG RES, V147, P276, DOI 10.1016/j.jss.2007.04.021; Rath N, 2012, EMBO REP, V13, P900, DOI 10.1038/embor.2012.127; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rohaly G, 2005, CELL, V122, P21, DOI 10.1016/j.cell.2005.04.032; Sebbagh M, 2005, J EXP MED, V201, P465, DOI 10.1084/jem.20031877; Shi JW, 2013, CELL CYCLE, V12, P1119, DOI 10.4161/cc.24164; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sun LC, 2011, AM J PATHOL, V179, P380, DOI 10.1016/j.ajpath.2011.03.046; Teh MT, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00146; Tseng William, 2007, J Vis Exp, P484, DOI 10.3791/484; Wang IC, 2005, MOL CELL BIOL, V25, P10875, DOI 10.1128/MCB.25.24.10875-10894.2005; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wierstra I, 2013, ADV CANCER RES, V119, P191, DOI 10.1016/B978-0-12-407190-2.00016-2; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yang C, 2013, CANCER LETT, V340, P104, DOI 10.1016/j.canlet.2013.07.004; Ye HG, 1997, MOL CELL BIOL, V17, P1626, DOI 10.1128/MCB.17.3.1626; Ying H, 2006, MOL CANCER THER, V5, P2158, DOI 10.1158/1535-7163.MCT-05-0440; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016	42	31	35	4	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 9	2017	36	6					807	819		10.1038/onc.2016.249	http://dx.doi.org/10.1038/onc.2016.249			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IX	27399334	Green Published, hybrid			2022-12-26	WOS:000394168200008
J	Babbitt, SE; Hsu, J; Kranz, RG				Babbitt, Shalon E.; Hsu, Jennifer; Kranz, Robert G.			Molecular Basis Behind Inability of Mitochondrial Holocytochrome c Synthase to Mature Bacterial Cytochromes: DEFINING A CRITICAL ROLE FOR CYTOCHROME c alpha HELIX-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c; heme; post-translational modification (PTM); protein structure; substrate specificity; system III; thioether	BIOGENESIS SYSTEM-I; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; HEME LYASE; SUBSTRATE SPECIFICITIES; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; PEP-FOLD; MECHANISMS; RESOLUTION	Mitochondrial holocytochrome c synthase (HCCS) is required for cytochrome c (cyt c) maturation and therefore respiration. HCCS efficiently attaches heme via two thioethers to CXXCH of mitochondrial but not bacterial cyt c even though they are functionally conserved. This inability is due to residues in the bacterial cyt c N terminus, but the molecular basis is unknown. Human cyts c with deletions of single residues in helix-1, which mimic bacterial cyt c, are poorly matured by human HCCS. Focusing on M13 cyt c, we co-purified this variant with HCCS, demonstrating that HCCS recognizes the bacterial-like cytochrome. Although an HCCS-WT cyt c complex contains two covalent links, HCCS-M13 cyt c contains only one thioether attachment. Using multiple approaches, we show that the single attachment is to the second thiol of C(15)SQC(18)H, indicating that helix-1 is required for positioning the first cysteine for covalent attachment, whereas the histidine of CXXCH positions the second cysteine. Modeling of the N-terminal structure suggested that the serine residue (of CSQCH) would be anchored where the first cysteine should be in M13 cyt c. An engineered cyt c with a CQCH motif in the M13 background is matured at higher levels (2-3-fold), providing further evidence for helix-1 positioning the first cysteine. Bacterial cyt c biogenesis pathways (Systems I and II) appear to recognize simply the CXXCH motif, not requiring helix-1. Results here explain mechanistically how HCCS (System III) requires an extended region adjacent to CXXCH for maturation.	[Babbitt, Shalon E.; Hsu, Jennifer; Kranz, Robert G.] Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA	Washington University (WUSTL)	Kranz, RG (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr,Campus Box 1137, St Louis, MO 63130 USA.	kranz@biology.wustl.edu			National Institutes of Health [R01 GM47909, F32 GM108278]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM108278, R01GM047909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01 GM47909 (to R. G. K.) and F32 GM108278 (to S. E. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen JWA, 2011, FEBS J, V278, P4198, DOI 10.1111/j.1742-4658.2011.08231.x; Allen JWA, 2009, BIOCHEM J, V419, P177, DOI 10.1042/BJ20081999; AXELROD HL, 1994, ACTA CRYSTALLOGR D, V50, P596, DOI 10.1107/S0907444994001319; Babbitt SE, 2015, TRENDS BIOCHEM SCI, V40, P446, DOI 10.1016/j.tibs.2015.05.006; Babbitt SE, 2014, J BIOL CHEM, V289, P28795, DOI 10.1074/jbc.M114.593509; Babbitt SE, 2014, BIOCHEMISTRY-US, V53, P5261, DOI 10.1021/bi500704p; BANCI L, 2001, HDB METALLOPROTEINS, V1, P33; Beckett CS, 2000, MOL MICROBIOL, V38, P465, DOI 10.1046/j.1365-2958.2000.02174.x; Bernard DG, 2003, J BIOL CHEM, V278, P49732, DOI 10.1074/jbc.M308881200; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; Braun M, 2004, P NATL ACAD SCI USA, V101, P12830, DOI 10.1073/pnas.0402435101; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Clarke TA, 2011, P NATL ACAD SCI USA, V108, P9384, DOI 10.1073/pnas.1017200108; Corvest V, 2010, GENETICS, V186, P561, DOI 10.1534/genetics.110.120022; DUMONT ME, 1987, EMBO J, V6, P235, DOI 10.1002/j.1460-2075.1987.tb04744.x; Elias DA, 2005, PROTEOMICS, V5, P3120, DOI 10.1002/pmic.200401140; Feissner R, 2003, ANAL BIOCHEM, V315, P90, DOI 10.1016/S0003-2697(02)00658-9; Feissner RE, 2006, MOL MICROBIOL, V60, P563, DOI 10.1111/j.1365-2958.2006.05132.x; Giege P, 2008, MITOCHONDRION, V8, P61, DOI 10.1016/j.mito.2007.10.001; Goddard AD, 2010, FEBS J, V277, P726, DOI 10.1111/j.1742-4658.2009.07517.x; Hamel P, 2009, BBA-MOL CELL RES, V1793, P125, DOI 10.1016/j.bbamcr.2008.06.017; Herbaud ML, 2000, BBA-PROTEIN STRUCT M, V1481, P18, DOI 10.1016/S0167-4838(00)00117-5; Kadziola A, 1997, STRUCTURE, V5, P203, DOI 10.1016/S0969-2126(97)00179-2; Kleingardner JG, 2011, METALLOMICS, V3, P396, DOI 10.1039/c0mt00086h; Kranz R, 1998, MOL MICROBIOL, V29, P383, DOI 10.1046/j.1365-2958.1998.00869.x; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; LOUIE GV, 1990, J MOL BIOL, V214, P527, DOI 10.1016/0022-2836(90)90197-T; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moore G. R., 1990, CYTOCHROMES C EVOLUT, P115; Pattarkine MV, 2006, J MOL BIOL, V358, P1314, DOI 10.1016/j.jmb.2006.03.010; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; PETTIGREW GW, 1975, BIOCHEM J, V147, P291, DOI 10.1042/bj1470291; PRIEST JW, 1992, J BIOL CHEM, V267, P20188; Rajagopal BS, 2013, BIOCHEM J, V456, P441, DOI 10.1042/BJ20130758; Richard-Fogal CL, 2012, BBA-BIOENERGETICS, V1817, P911, DOI 10.1016/j.bbabio.2011.09.008; Romine MF, 2004, OMICS, V8, P239, DOI 10.1089/omi.2004.8.239; Rosell FI, 2002, BIOCHEMISTRY-US, V41, P7811, DOI 10.1021/bi016060e; San Francisco B, 2013, P NATL ACAD SCI USA, V110, P3221, DOI 10.1073/pnas.1213897109; Sanders C, 2000, BBA-BIOENERGETICS, V1459, P131, DOI 10.1016/S0005-2728(00)00122-5; Sanders C, 2010, TRENDS MICROBIOL, V18, P266, DOI 10.1016/j.tim.2010.03.006; Santos-Silva T, 2007, J MOL BIOL, V370, P659, DOI 10.1016/j.jmb.2007.04.055; Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m; Simon J, 2011, FEBS J, V278, P4179, DOI 10.1111/j.1742-4658.2011.08374.x; Stevens JM, 2011, FEBS J, V278, P4170, DOI 10.1111/j.1742-4658.2011.08376.x; Stevens JM, 2011, FEBS LETT, V585, P1891, DOI 10.1016/j.febslet.2011.04.058; Thevenet P, 2012, NUCLEIC ACIDS RES, V40, pW288, DOI 10.1093/nar/gks419; VELOSO D, 1984, J BIOL CHEM, V259, P6067; Verissimo AF, 2012, BIOCHEM BIOPH RES CO, V424, P130, DOI 10.1016/j.bbrc.2012.06.088; Xie ZY, 1998, BBA-BIOENERGETICS, V1365, P309, DOI 10.1016/S0005-2728(98)00085-1; Xie ZY, 1996, J BIOL CHEM, V271, P4632; Zaidi S, 2014, CELL MOL LIFE SCI, V71, P229, DOI 10.1007/s00018-013-1341-1; Zhang YL, 2014, FEBS LETT, V588, P3367, DOI 10.1016/j.febslet.2014.07.026; ZOLLNER A, 1992, EUR J BIOCHEM, V207, P1093, DOI 10.1111/j.1432-1033.1992.tb17146.x	53	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17523	17534		10.1074/jbc.M116.741231	http://dx.doi.org/10.1074/jbc.M116.741231			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27387500	hybrid, Green Published			2022-12-26	WOS:000383241300004
J	Schrem, H; Schneider, V; Kurok, M; Goldis, A; Dreier, M; Kaltenborn, A; Gwinner, W; Barthold, M; Liebeneiner, J; Winny, M; Klempnauer, J; Kleine, M				Schrem, Harald; Schneider, Valentin; Kurok, Marlene; Goldis, Alon; Dreier, Maren; Kaltenborn, Alexander; Gwinner, Wilfried; Barthold, Marc; Liebeneiner, Jan; Winny, Markus; Klempnauer, Juergen; Kleine, Moritz			Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control	PLOS ONE			English	Article							DE-NOVO MALIGNANCIES; RENAL-TRANSPLANTATION; CENTER EXPERIENCE; ORGAN; TUMORS; PAPILLOMAVIRUS; SPECTRUM; DISEASE; COHORT	Background The aim of this study is to identify independent pre-transplant cancer risk factors after kidney transplantation and to assess the utility of G-chart analysis for clinical process control. This may contribute to the improvement of cancer surveillance processes in individual transplant centers. Patients and Methods 1655 patients after kidney transplantation at our institution with a total of 9,425 person-years of follow-up were compared retrospectively to the general German population using site-specific standardized-incidence-ratios (SIRs) of observed malignancies. Risk-adjusted multivariable Cox regression was used to identify independent pre-transplant cancer risk factors. G-chart analysis was applied to determine relevant differences in the frequency of cancer occurrences. Results Cancer incidence rates were almost three times higher as compared to the matched general population (SIR = 2.75; 95%-CI: 2.33-3.21). Significantly increased SIRs were observed for renal cell carcinoma (SIR = 22.46), post-transplant lymphoproliferative disorder (SIR = 8.36), prostate cancer (SIR = 2.22), bladder cancer (SIR = 3.24), thyroid cancer (SIR = 10.13) and melanoma (SIR = 3.08). Independent pre-transplant risk factors for cancer-free survival were age <52.3 years (p = 0.007, Hazard ratio (HR): 0.82), age >62.6 years (p = 0.001, HR: 1.29), polycystic kidney disease other than autosomal dominant polycystic kidney disease (ADPKD) (p = 0.001, HR: 0.68), high body mass index in kg/m(2) (p<0.001, HR: 1.04), ADPKD (p = 0.008, HR: 1.26) and diabetic nephropathy (p = 0.004, HR = 1.51). G-chart analysis identified relevant changes in the detection rates of cancer during aftercare with no significant relation to identified risk factors for cancer-free survival (p<0.05). Conclusions Risk-adapted cancer surveillance combined with prospective G-chart analysis likely improves cancer surveillance schemes by adapting processes to identified risk factors and by using G-chart alarm signals to trigger Kaizen events and audits for root-cause analysis of relevant detection rate changes. Further, comparative G-chart analysis would enable benchmarking of cancer surveillance processes between centers.	[Schrem, Harald; Winny, Markus; Klempnauer, Juergen; Kleine, Moritz] Hannover Med Sch, Gen Visceral & Transplant Surg, Hannover, Germany; [Schrem, Harald; Schneider, Valentin; Kurok, Marlene; Goldis, Alon; Kaltenborn, Alexander; Barthold, Marc; Liebeneiner, Jan; Kleine, Moritz] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Core Facil Qual Management & Hlth Technol Assessm, Hannover, Germany; [Kurok, Marlene] KRH Klinikum Nordstadt, Gynecol & Obstet, Hannover, Germany; [Goldis, Alon] Lean Six Sigma Black Belt, Amstelveen, Netherlands; [Dreier, Maren] Hannover Med Sch, Inst Epidemiol Social Med & Hlth Syst Res, Hannover, Germany; [Kaltenborn, Alexander] Fed Armed Forces Hosp Westerstede, Med Serv Fed Armed Forces, Trauma & Orthoped Surg, Westerstede, Germany; [Gwinner, Wilfried] Hannover Med Sch, Nephrol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Schrem, H (corresponding author), Hannover Med Sch, Gen Visceral & Transplant Surg, Hannover, Germany.; Schrem, H (corresponding author), Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Core Facil Qual Management & Hlth Technol Assessm, Hannover, Germany.	schrem.harald@mh-hannover.de			German Federal Ministry of Education and Research [01EO1302]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO1302) to authors HS and MB. The contributions provided by author AG who is also professionally affiliated with a commercial company have been funded within the framework of the same grant agreement with the German Federal Ministry of Education and Research in the context of a consultancy agreement on quality management methodology. The commercial affiliation of author AG and the funder of the grant support for this study did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Altaee IK, 2006, SAUDI J KIDNEY DIS T, V17, P408; Apel H, 2013, CLIN TRANSPLANT, V27, pE30, DOI 10.1111/ctr.12050; Baccarani U, 2006, TRANSPLANT P, V38, P1135, DOI 10.1016/j.transproceed.2006.02.016; Benneyan J C, 2001, Health Care Manag Sci, V4, P305, DOI 10.1023/A:1011846412909; Benneyan J C, 2001, Health Care Manag Sci, V4, P319, DOI 10.1023/A:1011806727354; Berger NA, 2014, ANN NY ACAD SCI, V1311, P57, DOI 10.1111/nyas.12416; Bichari W, 2009, TRANSPL P, V41, P672, DOI 10.1016/j.transproceed.2008.12.013; Birkeland S A, 1997, Ann Transplant, V2, P22; BIRKELAND SA, 1983, CANCER, V51, P1571, DOI 10.1002/1097-0142(19830501)51:9<1571::AID-CNCR2820510903>3.0.CO;2-S; Bosmans JL, 2007, KIDNEY INT, V71, P1197, DOI 10.1038/sj.ki.5002306; Brady PW, 2014, BMJ QUAL SAF, V23, P499, DOI 10.1136/bmjqs-2013-002179; Bretagnol A, 2010, TRANSPL INT, V23, P878, DOI 10.1111/j.1432-2277.2010.01070.x; Buysschaert M, 2013, DIABETES METAB SYND, V7, P247, DOI 10.1016/j.dsx.2013.08.001; Chiang YJ, 2004, TRANSPL P, V36, P2150, DOI 10.1016/j.transproceed.2004.08.013; Collett D, 2010, AM J TRANSPLANT, V10, P1889, DOI 10.1111/j.1600-6143.2010.03181.x; Debray D, 2009, TRANSPL P, V41, P674, DOI 10.1016/j.transproceed.2008.12.020; Engels EA, 2011, JAMA-J AM MED ASSOC, V306, P1891, DOI 10.1001/jama.2011.1592; GAYA SBM, 1995, TRANSPLANTATION, V59, P1705, DOI 10.1097/00007890-199506270-00011; Haberal AN, 2007, TRANSPL P, V39, P1057, DOI 10.1016/j.transproceed.2007.02.036; HARRISON J H, 1956, Surg Forum, V6, P432; Hosmer DW, 2008, APPL SURVIVAL ANAL R, P154; Hung YM, 2007, UROLOGY, V69, P1041, DOI 10.1016/j.urology.2007.02.046; Imao T, 2007, CANCER-AM CANCER SOC, V109, P2109, DOI 10.1002/cncr.22636; Knechtges P, 2014, J AM COLL RADIOL, V11, P1126, DOI 10.1016/j.jacr.2014.08.027; Langer RM, 2003, TRANSPL P, V35, P1396, DOI 10.1016/S0041-1345(03)00472-X; Lanza LL, 2009, CLIN TRANSPLANT, V23, P582, DOI 10.1111/j.1399-0012.2009.01061.x; Maglennon GA, 2014, J VIROL, V88, P710, DOI 10.1128/JVI.02589-13; Montagnino G, 1996, CLIN TRANSPLANT, V10, P461; Nocera A, 2000, EUR J CANCER, V36, P80, DOI 10.1016/S0959-8049(99)00234-8; Piselli P, 2013, EUR J CANCER, V49, P336, DOI 10.1016/j.ejca.2012.09.013; Popov Z, 2007, TRANSPL P, V39, P2589, DOI 10.1016/j.transproceed.2007.08.022; Rodriguez RM, 2010, FUTURE ONCOL, V6, P905, DOI [10.2217/fon.10.57, 10.2217/FON.10.57]; Rubin P, 2010, SEMIN RADIAT ONCOL, V20, P3, DOI 10.1016/j.semradonc.2009.08.001; Sampaio MS, 2012, TRANSPLANTATION, V94, P990, DOI 10.1097/TP.0b013e318270bc7b; Schrem H, 2013, LIVER TRANSPLANT, V19, P1252, DOI 10.1002/lt.23722; Shaaban A A, 1998, Saudi J Kidney Dis Transpl, V9, P116; Stallone G, 2003, G Ital Nefrol, V20, P611; SUZUKI S, 1994, TRANSPLANT P, V26, P938; Talbot D, 1999, INT SURG, V84, P291; Tillou X, 2012, AM J TRANSPLANT, V12, P3308, DOI 10.1111/j.1600-6143.2012.04248.x; Tjon ASW, 2010, LIVER TRANSPLANT, V16, P837, DOI 10.1002/lt.22064; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Veroux M, 2004, TRANSPL P, V36, P718, DOI 10.1016/j.transproceed.2004.03.021; Viart L, 2013, AM J NEPHROL, V37, P91, DOI 10.1159/000346624; Wetmore JB, 2014, J AM SOC NEPHROL, V25, P2335, DOI 10.1681/ASN.2013101122; Wieland U, 2014, CURR PROBL DERMATOL, V45, P154, DOI 10.1159/000357907; Winkelhorst JT, 2001, EUR J SURG ONCOL, V27, P409, DOI 10.1053/ejso.2001.1119; Xie M, 2002, RELIAB ENG SYST SAFE, V77, P143, DOI 10.1016/S0951-8320(02)00041-8; Zavos G, 2003, TRANSPLANT P, V35, P1399, DOI 10.1016/S0041-1345(03)00518-9; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158732	10.1371/journal.pone.0158732	http://dx.doi.org/10.1371/journal.pone.0158732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398803	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508100007
J	Ziegler, AS; Mcllroy, SJ; Larsen, P; Albertsen, M; Hansen, AA; Heinen, N; Nielsen, PH				Ziegler, Anja S.; Mcllroy, Simon J.; Larsen, Poul; Albertsen, Mads; Hansen, Aviaja A.; Heinen, Nicolas; Nielsen, Per Halkjaer			Dynamics of the Fouling Layer Microbial Community in a Membrane Bioreactor	PLOS ONE			English	Article							BIOLOGICAL PHOSPHORUS REMOVAL; MUNICIPAL WASTE-WATER; ACTIVATED-SLUDGE; FILAMENTOUS BACTERIA; NITRIFYING BACTERIA; CHLOROFLEXI; SEQUENCES; PLANTS; MBRS	Membrane fouling presents the greatest challenge to the application of membrane bioreactor (MBR) technology. Formation of biofilms on the membrane surface is the suggested cause, yet little is known of the composition or dynamics of the microbial community responsible. To gain an insight into this important question, we applied 16S rRNA gene amplicon sequencing with a curated taxonomy and fluorescent in situ hybridization to monitor the community of a pilot-scale MBR carrying out enhanced biological nitrogen and phosphorus removal with municipal wastewater. In order to track the dynamics of the fouling process, we concurrently investigated the communities of the biofilm, MBR bulk sludge, and the conventional activated sludge system used to seed the MBR system over several weeks from start-up. As the biofilm matured the initially abundant betaproteobacterial genera Limnohabitans, Hydrogenophaga and Malikia were succeeded by filamentous Chloroflexi and Gordonia as the abundant species. This study indicates that, although putative pioneer species appear, the biofilm became increasingly similar to the bulk community with time. This suggests that the microbial population in bulk water will largely determine the community structure of the mature biofilm.	[Ziegler, Anja S.; Mcllroy, Simon J.; Larsen, Poul; Albertsen, Mads; Hansen, Aviaja A.; Nielsen, Per Halkjaer] Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, Aalborg, Denmark; [Heinen, Nicolas] Alfa Laval Nakskov AS, Nakskov, Denmark	Aalborg University	Nielsen, PH (corresponding author), Aalborg Univ, Dept Chem & Biosci, Ctr Microbial Communities, Aalborg, Denmark.	phn@bio.aau.dk	Nielsen, Per Halkjær/T-6796-2018; McIlroy, Simon/P-4785-2017; Albertsen, Mads/T-7358-2018	Nielsen, Per Halkjær/0000-0002-6402-1877; McIlroy, Simon/0000-0003-3749-8730; Albertsen, Mads/0000-0002-6151-190X	Danish Research Council for Strategic Research	Danish Research Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	Alfa Laval Nakskov A/S provided the MBR system but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by Danish Research Council for Strategic Research (Receiver: PHN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2007, APPL ENVIRON MICROB, V73, P2257, DOI 10.1128/AEM.02080-06; Albertsen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132783; Bjornsson L, 2002, MICROBIOL-SGM, V148, P2309, DOI 10.1099/00221287-148-8-2309; Bugge TV, 2013, WATER RES, V47, P6719, DOI 10.1016/j.watres.2013.09.009; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Eikelboom D.H., 2000, PROCESS CONTROL ACTI; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Gao DW, 2013, WATER RES, V47, P6680, DOI 10.1016/j.watres.2013.09.007; Gao WJ, 2011, J MEMBRANE SCI, V374, P110, DOI 10.1016/j.memsci.2011.03.019; Gich F, 2001, ARCH MICROBIOL, V177, P1, DOI 10.1007/s00203-001-0354-6; Guo F, 2012, WATER RES, V46, P2772, DOI 10.1016/j.watres.2012.02.039; Jinhua P, 2006, SEP SCI TECHNOL, V41, P1527, DOI 10.1080/01496390600683571; Judd S, 2011, MBR BOOK: PRINCIPLES AND APPLICATIONS OF MEMBRANE BIOREACTORS FOR WATER AND WASTEWATER TREATMENT, 2ND EDITION, P1; Kindaichi T, 2004, APPL ENVIRON MICROB, V70, P1641, DOI 10.1128/AEM.70.3.1641-1650.2004; Kong YH, 2007, MICROBIOL-SGM, V153, P4061, DOI 10.1099/mic.0.2007/007245-0; Kragelund C, 2007, FEMS MICROBIOL ECOL, V59, P671, DOI 10.1111/j.1574-6941.2006.00251.x; Kragelund C, 2011, FEMS MICROBIOL ECOL, V76, P451, DOI 10.1111/j.1574-6941.2011.01065.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larsen P, 2008, WATER RES, V42, P2814, DOI 10.1016/j.watres.2008.02.015; Le-Clech P, 2010, APPL MICROBIOL BIOT, V88, P1253, DOI 10.1007/s00253-010-2885-8; Ma JX, 2013, PROCESS BIOCHEM, V48, P510, DOI 10.1016/j.procbio.2013.02.003; McIlroy SJ, 2009, ANTON LEEUW INT J G, V96, P593, DOI 10.1007/s10482-009-9374-z; McIlroy SJ, 2016, ISME J, V10, P2223, DOI 10.1038/ismej.2016.14; McIlroy SJ, 2016, ENVIRON MICROBIOL, V18, P50, DOI 10.1111/1462-2920.12614; McIlroy SJ, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav062; Meng FG, 2006, J MEMBRANE SCI, V272, P161, DOI 10.1016/j.memsci.2005.07.041; Mielczarek AT, 2013, WATER RES, V47, P1529, DOI 10.1016/j.watres.2012.12.003; Miura Y, 2007, ENVIRON SCI TECHNOL, V41, P7787, DOI 10.1021/es071263x; Miura Y, 2007, ENVIRON SCI TECHNOL, V41, P632, DOI 10.1021/es0615371; Nielsen P.H., 2009, FISH HDB BIOL WASTEW; Nielsen PH, 2010, WATER RES, V44, P5070, DOI 10.1016/j.watres.2010.07.036; Okasanen J., 2013, VEGAN COMMUNITY ECOL; Poorasgari E, 2014, CHEMOSPHERE, V117, P144, DOI 10.1016/j.chemosphere.2014.06.006; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2013, R LANG ENV STAT COMP; Sanguin H, 2006, ENVIRON MICROBIOL, V8, P289, DOI 10.1111/j.1462-2920.2005.00895.x; Saunders AM, 2013, WATER SCI TECHNOL, V68, P366, DOI 10.2166/wst.2013.183; Saunders AM, 2016, ISME J, V10, P11, DOI 10.1038/ismej.2015.117; Speirs L, 2009, APPL ENVIRON MICROB, V75, P2446, DOI 10.1128/AEM.02310-08; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang ZW, 2010, CHEM ENG J, V158, P608, DOI 10.1016/j.cej.2010.02.019; Wilen BM, 2008, WATER RES, V42, P2300, DOI 10.1016/j.watres.2007.12.013; Zhang K, 2006, ENVIRON MICROBIOL, V8, P433, DOI 10.1111/j.1462-2920.2005.00909.x	47	33	34	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158811	10.1371/journal.pone.0158811	http://dx.doi.org/10.1371/journal.pone.0158811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27399199	Green Submitted, gold, Green Published			2022-12-26	WOS:000379508100010
J	Ayenew, HY				Ayenew, Habtamu Yesigat			Production Efficiency and Market Orientation in Food Crops in North West Ethiopia: Application of Matching Technique for Impact Assessment	PLOS ONE			English	Article							AGRICULTURAL EXTENSION	Introduction Agricultural technologies developed by national and international research institutions were not benefiting the rural population of Ethiopia to the extent desired. As a response, integrated agricultural extension approaches are proposed as a key strategy to transform the smallholder farming sector. Improving Productivity and Market Success (IPMS) of Ethiopian Farmers project is one of the development projects initiated by integrating productivity enhancement technological schemes with market development model. This paper explores the impact of the project intervention in the smallholder farmers' wellbeing. Methods To test the research hypothesis of whether the project brought a significant change in the input use, marketed surplus, efficiency and income of farm households, we use a cross-section data from 200 smallholder farmers in Northwest Ethiopia, collected through multi-stage sampling procedure. To control for self-selection from observable characteristics of the farm households, we employ Propensity Score Matching (PSM). We finally use Data Envelopment Analysis (DEA) techniques to estimate technical efficiency of farm households. Results The outcome of the research is in line with the premises that the participation of the household in the IPMS project improves purchased input use, marketed surplus, efficiency of farms and the overall gain from farming. The participant households on average employ more purchased agricultural inputs and gain higher gross margin from the production activities as compared to the non-participant households. The non-participant households on average supply less output (measured both in monetary terms and proportion of total produce) to the market as compared to their participant counterparts. Except for the technical efficiency of production in potato, project participant households are better-off in production efficiency compared with the non-participant counterparts. Conclusion We verified the idea that Improving Productivity and Market Success (IPMS) of Ethiopian farmers' project has contributed for the input and out market integration and/or market oriented agricultural production. Overall, we argue that these can be seen as an experimental model with a promising potential to improve the livelihood of the poor. Furthermore, we suggest that it is worthwhile to employ integrated agricultural extension programs with further targeting in the developing world.	[Ayenew, Habtamu Yesigat] Tech Univ Munich, Prod & Resource Econ, Freising Weihenstephan, Germany	Technical University of Munich	Ayenew, HY (corresponding author), Tech Univ Munich, Prod & Resource Econ, Freising Weihenstephan, Germany.	zebabilon@gmail.com			Improving Productivity and Market Success Project (IPMS_ILRI Ethiopia); Improving Productivity and Market Success (IPMS)-ILRI-Ethiopia project	Improving Productivity and Market Success Project (IPMS_ILRI Ethiopia); Improving Productivity and Market Success (IPMS)-ILRI-Ethiopia project	The study was funded by the Improving Productivity and Market Success Project (IPMS_ILRI Ethiopia).; The author acknowledges the financial support from Improving Productivity and Market Success (IPMS)-ILRI-Ethiopia project for the financial support for the study. The paper benefits from the critical comments and suggestions of the anonymous reviewers and editor of this journal.	Abebaw D, 2013, FOOD POLICY, V38, P82, DOI 10.1016/j.foodpol.2012.10.003; [Anonymous], 2000, MOFED ACC SUST DEV E, P15; Aynsau A, 2007, ECOL ECON, V61, P294, DOI 10.1016/j.ecolecon.2006.01.014; Benin S., 2003, 25 INT C AGR EC DURB; Berhanu G., 2006, COMMERCIALIZATION ET, P36; Botes L., 2000, Community Development Journal, V35, P41, DOI 10.1093/cdj/35.1.41; Bryson A., 2002, LSE RES ONLINE DOCUM; Caeyers B, 2012, ECON DEV CULT CHANGE, V60, P639, DOI 10.1086/665602; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Coelli T., 2002, DEAP V 2 1 DATA ENVE, V2; Coelli T. J., 2005, MEDICINE; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Demese C., 2006, 8 ANN C AGR EC SOC E, P9; Dercon S, 2009, AM J AGR ECON, V91, P1007, DOI 10.1111/j.1467-8276.2009.01325.x; EPRDF, 2001, RUR DEV STRAT ETH, P15; Faltermeier L, 2009, AGR ECON-BLACKWELL, V40, P365, DOI 10.1111/j.1574-0862.2009.00383.x; Gezahegn A., 2006, PRODUCTIVITY EFFICIE; Gibson MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048708; Haji J, 2007, J AFR ECON, V16, P1, DOI 10.1093/jae/ejl044; Hasan M.F., 2013, IMPACTS AGR EXTENSIO, P33; IPMS Bure Woreda Diagnosis and Design Program, 2007, IPMS IMPR PROD MARK; IPMS IPMS-Ethiopia Information Resources Portal, 2006, ETH INF RES PORT; Jalan J., 1999, POLICY RES WORKING P; Jennifer L., 2007, FUTURE AGR PRINTING; Kebede Y., 1990, Agricultural Economics, V4, P27, DOI 10.1016/0169-5150(90)90018-V; Kidanemariam G., 2013, BIOECONOMICS WORKING, P33; King G, 2016, WHY PROPENSITY SCORE; Kydd J., 2003, DEV STUD ASS ANN C S; Lokshin M, 2004, STATA J, V4, P282, DOI 10.1177/1536867X0400400306; Mengistu H, 2000, FOOD CHAIN SUBSAHARA; Moti J., 2009, SMALLHOLDER COMMERCI, P55; Nannicini T., 2006, SENSATT SIMULATION B; Owens T, 2003, ECON DEV CULT CHANGE, V51, P337, DOI 10.1086/346113; Pedro C., 2008, IMPACT AGR EXTENSION, P54; ROSENBAUM PR, 1983, J ROY STAT SOC B MET, V45, P212; Smith HL, 1997, SOCIOL METHODOL, V27, P325, DOI 10.1111/1467-9531.271030; Smith JA, 2005, J ECONOMETRICS, V125, P305, DOI 10.1016/j.jeconom.2004.04.011; Takemura K., 2014, PLOS ONE, V9; Teklewold H, 2013, J AGR ECON, V64, P597, DOI 10.1111/1477-9552.12011	40	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158454	10.1371/journal.pone.0158454	http://dx.doi.org/10.1371/journal.pone.0158454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391961	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400062
J	De Silva, JR; Lau, YL; Fong, MY				De Silva, Jeremy Ryan; Lau, Yee-Ling; Fong, Mun-Yik			Expression and Evaluation of Recombinant Plasmodium knowlesi Merozoite Surface Protein-3 (MSP-3) for Detection of Human Malaria	PLOS ONE			English	Article							VIVAX; FALCIPARUM; IMMUNOGENICITY; INFECTIONS; REACTIVITY; FEATURES; PEPTIDE; VACCINE; SAFETY; ELISA	Malaria remains a major health threat in many parts of the globe and causes high mortality and morbidity with 214 million cases of malaria occurring globally in 2015. Recent studies have outlined potential diagnostic markers and vaccine candidates one of which is the merozoite surface protein (MSP)-3. In this study, novel recombinant Plasmodium knowlesi MSP-3 was cloned, expressed and purified in an Escherichia coli system. Subsequently, the recombinant protein was evaluated for its sensitivity and specificity. The recombinant pkMSP-3 protein reacted with sera from patients with P. knowlesi infection in both Western blot (61%) and ELISA (100%). Specificity-wise, pkMSP-3 did not react with healthy donor sera in either assay and only reacted with a few non-malarial parasitic patient sera in the ELISA assay (3 of 49). In conclusion, sensitivity and specificity of pkMSP-3 was found to be high in the ELISA and Western Blot assay and thus utilising both assays in tandem would provide the best sero-diagnostic result for P. knowlesi infection.	[De Silva, Jeremy Ryan; Lau, Yee-Ling; Fong, Mun-Yik] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia; [Lau, Yee-Ling; Fong, Mun-Yik] Univ Malaya, Fac Med, Trop Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Lau, YL (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia.; Lau, YL (corresponding author), Univ Malaya, Fac Med, Trop Dis Res & Educ Ctr, Kuala Lumpur 50603, Malaysia.	lauyeeling@um.edu.my	FONG, MUN YIK/B-5443-2010; de Silva, Jeremy Ryan/P-5565-2017; Lau, Yee Ling/C-6996-2009; Singh, Balbir/A-3610-2009	de Silva, Jeremy Ryan/0000-0001-9378-3830; Lau, Yee Ling/0000-0002-2037-2165; 	University of Malaya High Impact Research Fund, UMMOHE [E000050: UM.C/HIR/MOHE/MED/16]	University of Malaya High Impact Research Fund, UMMOHE	This study was funded by the University of Malaya High Impact Research Fund, UMMOHE (E000050: UM.C/HIR/MOHE/MED/16). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz C, 1990, J Vet Diagn Invest, V2, P191; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chao CC, 2008, CLIN VACCINE IMMUNOL, V15, P684, DOI 10.1128/CVI.00281-07; Cheong FW, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-454; Cheong FW, 2013, AM J TROP MED HYG, V88, P835, DOI 10.4269/ajtmh.12-0250; Cox-Singh J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-269; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; DIGGS CL, 1965, EXP PARASITOL, V16, P217, DOI 10.1016/0014-4894(65)90046-9; Galinski MR, 1999, MOL BIOCHEM PARASIT, V101, P131, DOI 10.1016/S0166-6851(99)00063-8; GONNET GH, 1994, BIOCHEM BIOPH RES CO, V199, P489, DOI 10.1006/bbrc.1994.1255; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Jiang N, 2010, EMERG INFECT DIS, V16, P1476, DOI 10.3201/eid1609.100339; Jimenez MCS, 2008, BBA-GEN SUBJECTS, V1780, P983, DOI 10.1016/j.bbagen.2008.03.016; Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293; KAMBOJ KK, 1988, J PARASITOL, V74, P403, DOI 10.2307/3282046; Lajmi AR, 2000, PROTEIN EXPRES PURIF, V18, P394, DOI 10.1006/prep.2000.1209; Lau YL, 2014, TROP BIOMED, V31, P749; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Lee WC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-88; LOPEZLONGO FJ, 1994, J RHEUMATOL, V21, P1450; Luchavez J, 2008, EMERG INFECT DIS, V14, P811, DOI 10.3201/eid1405.071407; Marchand RP, 2011, EMERG INFECT DIS, V17, P1232, DOI 10.3201/eid1707.101551; MCCOLL DJ, 1994, MOL BIOCHEM PARASIT, V68, P53, DOI 10.1016/0166-6851(94)00149-9; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863; OEUVRAY C, 1994, MEM I OSWALDO CRUZ, V89, P77, DOI 10.1590/S0074-02761994000600018; Palaeya V, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-182; Parodi A, 1998, BRIT J DERMATOL, V138, P114; Rayner JC, 2004, INFECT GENET EVOL, V4, P309, DOI 10.1016/j.meegid.2004.03.003; Rice BL, 2014, MOL PHYLOGENET EVOL, V78, P172, DOI 10.1016/j.ympev.2014.05.013; Rogl H, 1998, FEBS LETT, V432, P21, DOI 10.1016/S0014-5793(98)00825-4; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Sirima SB, 2007, VACCINE, V25, P2723, DOI 10.1016/j.vaccine.2006.05.090; Sirima SB, 2011, NEW ENGL J MED, V365, P1062, DOI 10.1056/NEJMc1100670; Sirima SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007549; Son Eui-Sun, 2001, Korean Journal of Parasitology, V39, P171, DOI 10.3347/kjp.2001.39.2.171; Sonaimuthu P, 2015, EXP PARASITOL, V153, P118, DOI 10.1016/j.exppara.2015.03.010; SUCHANKOVA A, 1991, J GEN VIROL, V72, P2577, DOI 10.1099/0022-1317-72-10-2577; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; YANG CF, 1994, AM J TROP MED HYG, V51, P365, DOI 10.4269/ajtmh.1994.51.365	41	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158998	10.1371/journal.pone.0158998	http://dx.doi.org/10.1371/journal.pone.0158998			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391270	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400185
J	Fuchs, A; Zimmermann, L; Graz, MB; Cherpillod, J; Tolsa, JF; Buclin, T; Giannoni, E				Fuchs, Aline; Zimmermann, Lara; Graz, Myriam Bickle; Cherpillod, Jacques; Tolsa, Jean-Francois; Buclin, Thierry; Giannoni, Eric			Gentamicin Exposure and Sensorineural Hearing Loss in Preterm Infants	PLOS ONE			English	Article							PERINATAL RISK-FACTORS; SWISS NATIONAL COHORT; BIRTH-WEIGHT INFANTS; OTOTOXICITY; IMPAIRMENT; PREVALENCE; AGE; AMINOGLYCOSIDES; MUTATIONS; PREMATURE	Objective To evaluate the impact of gentamicin exposure on sensorineural hearing loss (SNHL) in very low birth weight (VLBW) infants. Methods Exposure to gentamicin was determined in infants born between 1993 and 2010 at a gestational age < 32 weeks and/or with a birthweight < 1500 g, who presented with SNHL during the first 5 years of life. For each case, we selected two controls matched for gender, gestational age, birthweight, and year of birth. Results We identified 25 infants affected by SNHL, leading to an incidence of SNHL of 1.58% in our population of VLBW infants. The proportion of infants treated with gentamicin was 76% in the study group and 70% in controls (p = 0.78). The total cumulated dose of gentamicin administered did not differ between the study group (median 10.2 mg/kg, Q1-Q3 1.6-13.2) and the control group (median 7.9 mg/kg, Q1-Q3 0-12.8, p = 0.47). The median duration of gentamicin treatment was 3 days both in the study group and the control group (p = 0.58). Maximum predicted trough serum levels of gentamicin, cumulative area under the curve and gentamicin clearance were not different between cases and controls. Conclusion The impact of gentamicin on SNHL can be minimized with treatments of short duration, monitoring of blood levels and dose adjustment.	[Fuchs, Aline; Buclin, Thierry] Univ Lausanne Hosp, Dept Labs, Serv Biomed, Div Clin Pharmacol, Lausanne, Switzerland; [Zimmermann, Lara; Graz, Myriam Bickle; Tolsa, Jean-Francois; Giannoni, Eric] Univ Lausanne Hosp, Clin Neonatol, Lausanne, Switzerland; [Cherpillod, Jacques] Univ Lausanne Hosp, Clin Otorhinolaryngol & Head & Neck Surg, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Giannoni, E (corresponding author), Univ Lausanne Hosp, Clin Neonatol, Lausanne, Switzerland.	Eric.Giannoni@chuv.ch	Graz, Myriam Bickle/AAI-8796-2020; Buclin, Thierry/P-1640-2014	Graz, Myriam Bickle/0000-0003-2733-3588; Buclin, Thierry/0000-0003-0639-5536; Giannoni, Eric/0000-0003-0897-6529				Aust G, 2001, Int Tinnitus J, V7, P27; BERNARD PA, 1981, LARYNGOSCOPE, V91, P1985; Bitner-Glindzicz M, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-66; Boghossian NS, 2013, J PEDIATR-US, V162, P1120, DOI 10.1016/j.jpeds.2012.11.089; Borradori C, 1997, BIOL NEONATE, V71, P1; BROWN DR, 1991, DEV MED CHILD NEUROL, V33, P816; Busa J, 2007, PEDIATRICS, V120, P898, DOI 10.1542/peds.2007-2333; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Cristobal R, 2008, ARCH DIS CHILD-FETAL, V93, P1462, DOI 10.1136/adc.2007.124214; Davis NM, 2001, DEV MED CHILD NEUROL, V43, P191, DOI 10.1017/S0012162201000366; DEVRIES LS, 1985, PEDIATRICS, V76, P351; Ealy M, 2011, LARYNGOSCOPE, V121, P1184, DOI 10.1002/lary.21778; El-barbary MN, 2015, INT J PEDIATR OTORHI, V79, P1294, DOI 10.1016/j.ijporl.2015.05.036; Ertl T, 2001, BIOL NEONATE, V79, P109, DOI 10.1159/000047076; Fjalstad JW, 2014, EUR J PEDIATR, V173, P489, DOI 10.1007/s00431-013-2194-1; Fligor BJ, 2005, PEDIATRICS, V115, P1519, DOI 10.1542/peds.2004-0247; Fuchs A, 2014, BRIT J CLIN PHARMACO, V78, P1090, DOI 10.1111/bcp.12444; Gopel W, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-210; HALPERN J, 1987, EAR HEARING, V8, P21, DOI 10.1097/00003446-198702000-00004; Hess M, 1998, INT J PEDIATR OTORHI, V46, P81, DOI 10.1016/S0165-5876(98)00151-7; Hille ETM, 2007, ACTA PAEDIATR, V96, P1155, DOI 10.1111/j.1651-2227.2007.00398.x; Huth M E, 2011, Int J Otolaryngol, V2011, P937861, DOI 10.1155/2011/937861; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; Loughnan PM, 2006, ARCH DIS CHILD-FETAL, V91, pF156, DOI 10.1136/adc.2005.084699; Marlow ES, 2000, ARCH DIS CHILD-FETAL, V82, pF141, DOI 10.1136/fn.82.2.F141; Martin S, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13873; Metzger D, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13905; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Musiime GM, 2015, TROP MED INT HEALTH, V20, P1593, DOI 10.1111/tmi.12608; Norton SJ, 2000, EAR HEARING, V21, P529, DOI 10.1097/00003446-200010000-00014; PETTIGREW AG, 1988, MED J AUSTRALIA, V148, P174; Pirozzo S, 2003, BRIT MED J, V327, P967, DOI 10.1136/bmj.327.7421.967; Polin RA, 2012, PEDIATRICS, V129, P1006, DOI 10.1542/peds.2012-0541; Rao SC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005091.pub3; Robertson CMT, 2009, PEDIATRICS, V123, pE797, DOI 10.1542/peds.2008-2531; Robertson CMT, 2006, ACTA PAEDIATR, V95, P214, DOI 10.1080/08035250500294098; Roth DAE, 2006, ARCH DIS CHILD-FETAL, V91, pF257, DOI 10.1136/adc.2005.074476; SAWCHUK RJ, 1977, CLIN PHARMACOL THER, V21, P362; Schlapbach LJ, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-198; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Schmidt B, 2012, JAMA-J AM MED ASSOC, V307, P275, DOI 10.1001/jama.2011.2024; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Setiabudy R, 2013, INT J CLIN PHARM TH, V51, P401, DOI 10.5414/CP201833; THIRINGER K, 1984, DEV MED CHILD NEUROL, V26, P799; Usami SI, 1998, J COMMUN DISORD, V31, P423, DOI 10.1016/S0021-9924(98)00014-8; Vella-Brincat JWA, 2011, NEONATOLOGY, V100, P186, DOI 10.1159/000324857; Vellanki H, 2012, PEDIATRICS, V130, pE1352, DOI 10.1542/peds.2011-2611; WALTON JP, 1991, J SPEECH HEAR RES, V34, P1362, DOI 10.1044/jshr.3406.1362; Williams AL, 2007, J ACOUST SOC AM, V121, P2681, DOI 10.1121/1.2717500; Wu J, 2015, J MED GENET, V52, P95, DOI 10.1136/jmedgenet-2014-102753	50	20	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158806	10.1371/journal.pone.0158806	http://dx.doi.org/10.1371/journal.pone.0158806			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390846	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400129
J	Gibbs, J; Elle, E; Bobiwash, K; Haapalainen, T; Isaacs, R				Gibbs, Jason; Elle, Elizabeth; Bobiwash, Kyle; Haapalainen, Tiia; Isaacs, Rufus			Contrasting Pollinators and Pollination in Native and Non-Native Regions of Highbush Blueberry Production	PLOS ONE			English	Article							BOMBUS-IMPATIENS HYMENOPTERA; APIS-MELLIFERA HYMENOPTERA; LOWBUSH BLUEBERRY; BEES HYMENOPTERA; BUMBLE BEES; HONEY-BEES; NORTH-AMERICA; WILD; VACCINIUM; APIDAE	Highbush blueberry yields are dependent on pollination by bees, and introduction of managed honey bees is the primary strategy used for pollination of this crop. Complementary pollination services are also provided by wild bees, yet highbush blueberry is increasingly grown in regions outside its native range where wild bee communities may be less adapted to the crop and growers may still be testing appropriate honey bee stocking densities. To contrast crop pollination in native and non-native production regions, we sampled commercial 'Bluecrop' blueberry fields in British Columbia and Michigan with grower-selected honey bee stocking rates (0-39.5 hives per ha) to compare bee visitors to blueberry flowers, pollination and yield deficits, and how those vary with local-and landscape-scale factors. Observed and Chao-1 estimated species richness, as well as Shannon diversity of wild bees visiting blueberries were significantly higher in Michigan where the crop is within its native range. The regional bee communities were also significantly different, with Michigan farms having greater dissimilarity than British Columbia. Blueberry fields in British Columbia had fewer visits by honey bees than those in Michigan, irrespective of stocking rate, and they also had lower berry weights and a significant pollination deficit. In British Columbia, pollination service increased with abundance of wild bumble bees, whereas in Michigan the abundance of honey bees was the primary predictor of pollination. The proportion of seminatural habitat at local and landscape scales was positively correlated with wild bee abundance in both regions. Wild bee abundance declined significantly with distance from natural borders in Michigan, but not in British Columbia where large-bodied bumble bees dominated the wild bee community. Our results highlight the varying dependence of crop production on different types of bees and reveal that strategies for pollination improvement in the same crop can vary greatly across production regions.	[Gibbs, Jason; Isaacs, Rufus] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Elle, Elizabeth; Bobiwash, Kyle; Haapalainen, Tiia] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC, Canada	Michigan State University; Simon Fraser University	Gibbs, J (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	jgibbs@msu.edu	Isaacs, Rufus/AAF-4646-2019; Gibbs, Jason/H-6963-2012	Isaacs, Rufus/0000-0001-7523-4643; Gibbs, Jason/0000-0002-4945-5423	United States Department of Agriculture -National Institute for Food and Agriculture Specialty Crop Research Initiative [2012-01534]	United States Department of Agriculture -National Institute for Food and Agriculture Specialty Crop Research Initiative	The authors acknowledge funding provided by the United States Department of Agriculture -National Institute for Food and Agriculture Specialty Crop Research Initiative (http://nifa.usda.gov), from project 2012-01534: Developing Sustainable Pollination Strategies for U.S Specialty Crops awarded to RI (principal investigator) and EE (co-prinicipal investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003128; Artz DR, 2011, J ECON ENTOMOL, V104, P1153, DOI 10.1603/EC10431; Barton K, 2014, MUMIN MULTIMODEL INF; BC Ministry of Agriculture, 2012, BERR PROD GUID BEN M; Benjamin FE, 2014, ENVIRON ENTOMOL, V43, P1574, DOI 10.1603/EN13314; Benjamin FE, 2014, J APPL ECOL, V51, P440, DOI 10.1111/1365-2664.12198; Blaauw BR, 2015, BIOL CONTROL, V91, P94, DOI 10.1016/j.biocontrol.2015.08.003; Blaauw BR, 2014, J APPL ECOL, V51, P890, DOI 10.1111/1365-2664.12257; Bouseman J. K., 1979, Transactions of the American Entomological Society, V104, P275; BREWER JW, 1969, J ECON ENTOMOL, V62, P815, DOI 10.1093/jee/62.4.815; Buchmann S.L., 1983, P73; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Button L, 2014, AGR ECOSYST ENVIRON, V197, P255, DOI 10.1016/j.agee.2014.08.004; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; CANE JH, 1985, AM J BOT, V72, P135, DOI 10.2307/2443575; CHAO A, 1984, SCAND J STAT, V11, P265; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Courcelles DMM, 2013, J APPL ENTOMOL, V137, P693, DOI 10.1111/jen.12059; Delaplane K. S., 2000, Crop pollination by bees., DOI 10.1079/9780851994482.0000; Desjardins EC, 2006, J ECON ENTOMOL, V99, P443, DOI 10.1603/0022-0493-99.2.443; Dogterom MH, 2000, AM J BOT, V87, P1584, DOI 10.2307/2656734; Dogterom MH, 1999, CAN ENTOMOL, V131, P757, DOI 10.4039/Ent131757-6; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Garibaldi LA, 2014, FRONT ECOL ENVIRON, V12, P439, DOI 10.1890/130330; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Gibbs J, 2011, ZOOTAXA, P1; Gibbs J, 2010, ZOOTAXA, P1; Gibbs J, 2013, ZOOTAXA, V3672, P1, DOI 10.11646/zootaxa.3672.1.1; Girard M, 2012, BOTANY, V90, P545, DOI [10.1139/B2012-049, 10.1139/b2012-049]; Gotelli Nicholas J., 2011, P39; Greenleaf SS, 2007, OECOLOGIA, V153, P589, DOI 10.1007/s00442-007-0752-9; Greenleaf SS, 2006, P NATL ACAD SCI USA, V103, P13890, DOI 10.1073/pnas.0600929103; Hurd P. D. Jr., 1979, Catalog of Hymenoptera in America north of Mexico. Volume 2. Apocrita (Aculeata)., P1741; Isaacs R, 2010, J APPL ECOL, V47, P841, DOI 10.1111/j.1365-2664.2010.01823.x; Javorek SK, 2002, ANN ENTOMOL SOC AM, V95, P345, DOI 10.1603/0013-8746(2002)095[0345:CPEABH]2.0.CO;2; Kearns C. A., 1993, TECHNIQUES POLLINATI; Kennedy CM, 2013, ECOL LETT, V16, P584, DOI 10.1111/ele.12082; Kephart S., 2005, PRACTICAL POLLINATIO, P364; Kevan Peter G., 2001, P7; Kleijn D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8414; La Berge W.E., 1973, Transactions American Ent Soc, V99, P235; LABERGE W E, 1980, Transactions of the American Entomological Society (Philadelphia), V106, P395; LABERGE W E, 1970, Transactions of the American Entomological Society (Philadelphia), V96, P543; LABERGE W E, 1971, Transactions of the American Entomological Society (Philadelphia), V97, P441; LABERGE W E, 1986, Transactions of the American Entomological Society (Philadelphia), V112, P191; LAVERTY TM, 1988, CAN ENTOMOL, V120, P965, DOI 10.4039/Ent120965-11; MacKenzie KE, 1996, J KANSAS ENTOMOL SOC, V69, P185; MacKenzie KE, 1997, J AM SOC HORTIC SCI, V122, P891, DOI 10.21273/JASHS.122.6.891; Maurer Brian A., 2011, P55; MCGINLEY RJ, 1986, SMITHSONIAN CONTRIBU, V429, P1, DOI DOI 10.5479/SI.00810282.429; Miranda G.F.G., 2013, Canadian Journal of Arthropod Identification, V23, P1; Mitchell T. B., 1962, Technical Bulletin North Carolina Agricultural Experiment Station, Vno. 152, P1; MITCHELL THEODORE B., 1960, N CAROLINA AGRIC EXPT STA TECH BULL, V141, P1; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pritts MP, 1992, HIGHBUSH BLUEBERRY P, P156; Pritts MP, 1992, HIGHBUSH BLUEBERRY P, P37; R Core Team, 2016, R FDN STAT COMP; Ratti CM, 2008, CAN ENTOMOL, V140, P348, DOI 10.4039/N07-065; Rehan SM, 2011, ZOOTAXA, P35; RIBBLE D. W., 1967, BULL UNIV NEBR STATE MUS, V6, P27; Richards Kenneth W., 1996, Linnean Society Symposium Series, V18, P81; Richards KW, 2003, J APICULT RES, V42, P21, DOI 10.1080/00218839.2003.11101082; Rightmyer MG, 2010, ZOOKEYS, P37, DOI 10.3897/zookeys.60.484; Skaug H, 2014, GLMMADMB GEN LINEAR; Strange JP, 2015, J ECON ENTOMOL, V108, P873, DOI 10.1093/jee/tov078; Strik BC, 2005, HORTTECHNOLOGY, V15, P391, DOI 10.21273/HORTTECH.15.2.0391; Stubbs CS, 2001, J ECON ENTOMOL, V94, P609, DOI 10.1603/0022-0493-94.3.609; Stubbs CS, 1997, ACTA HORTIC, P341, DOI 10.17660/ActaHortic.1997.437.42; TORCHIO PF, 1985, J KANSAS ENTOMOL SOC, V58, P448; Tuell JK, 2010, J ECON ENTOMOL, V103, P557, DOI 10.1603/EC09387; Tuell JK, 2009, ANN ENTOMOL SOC AM, V102, P275, DOI 10.1603/008.102.0209; Vander Kloet S.P., 1988, GENUS VACCINIUM N AM; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Vicens N, 2000, ENVIRON ENTOMOL, V29, P235, DOI 10.1603/0046-225X(2000)029[0235:PEOOCA]2.0.CO;2; Vockeroth JR, 1992, FLOWER FLIES SUBFAMI; Whidden TL, 1996, CAN ENTOMOL, V128, P957, DOI 10.4039/Ent128957-5; Williams NM, 2010, BIOL CONSERV, V143, P2280, DOI 10.1016/j.biocon.2010.03.024; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Winfree R, 2015, ECOL LETT, V18, P626, DOI 10.1111/ele.12424; Winfree R, 2010, ANN NY ACAD SCI, V1195, P169, DOI 10.1111/j.1749-6632.2010.05449.x; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Zhang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121143; Zurbuchen A, 2010, BIOL CONSERV, V143, P669, DOI 10.1016/j.biocon.2009.12.003	85	33	34	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158937	10.1371/journal.pone.0158937	http://dx.doi.org/10.1371/journal.pone.0158937			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391969	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400166
J	Mohee, AR; Gascoyne-Binzi, D; West, R; Bhattarai, S; Eardley, I; Sandoe, JAT				Mohee, Amar Raj; Gascoyne-Binzi, Deborah; West, Robert; Bhattarai, Selina; Eardley, Ian; Sandoe, Jonathan A. T.			Bacteraemia during Transurethral Resection of the Prostate: What Are the Risk Factors and Is It More Common than We Think?	PLOS ONE			English	Article							ANTIBIOTIC-PROPHYLAXIS; COMPLICATIONS; SURGERY; TURP	The aim of this work was to investigate the microbial causes, incidence, duration, risk factors and clinical implications of bacteraemia occurring during transurethral resection of the prostate (TURP) surgery to better inform prophylaxis strategies. An ethically approved, prospective, cohort study of patients undergoing TURP was conducted. Clinical information and follow-up details were collected using standardized data collection sheets. Blood was obtained for culture at 6 different time points peri-procedure. Standard of care antibiotic prophylaxis was given prior to surgery. Bacteriuria was assessed in a pre-procedure urine sample. Histopathology from all prostate chips was assessed for inflammation and malignancy. 73 patients were consented and 276 blood samples obtained. No patients developed symptomatic bacteraemia during the procedure, 17 patients developed asymptomatic bacteraemia (23.2%). Enterococcus faecalis and Pseudomonas aeruginosa were the most common organisms cultured. 10 minutes after the start of the TURP, the odds ratio (OR) of developing bacteraemia was 5.38 (CI 0.97-29.87 p = 0.05), and 20 minutes after the start of the procedure, the OR was 6.46 (CI 1.12-37.24, p = 0.03), compared to before the procedure. We also found an association between the development of intra-operative bacteraemia and recent antibiotic use (OR 4.34, CI 1.14-16.62, p = 0.032), the presence of a urinary catheter (OR 4.92, CI 1.13-21.51, p = 0.034) and a malignant histology (OR 4.90, CI 1.30-18.46, p = 0.019). There was no statistical relationship between pre-operative urine culture results and blood culture results. This study shows that asymptomatic bacteraemia is commonly caused by TURP and occurs in spite of antibiotic prophylaxis. Our findings challenge the commonly held view that urine is the primary source of bacteraemia in TURP-associated sepsis and raise the possibility of occult prostatic infection as a cause of bacteraemia. More work will be needed to determine the significance of transient bacteraemia in relation to more serious complications like infective endocarditis and malignancy.	[Mohee, Amar Raj] Christie NHS Fdn Trust, Dept Urol, 550 Wilmslow Rd, Manchester, Lancs, England; [Gascoyne-Binzi, Deborah] Leeds Teaching Hosp NHS Trust, Dept Microbiol, Beckett St, Leeds, W Yorkshire, England; [West, Robert] Univ Leeds, Dept Biostat, Woodhouse Lane, Leeds, W Yorkshire, England; [Bhattarai, Selina] Leeds Teaching Hosp NHS Trust, Dept Pathol, Beckett St, Leeds, W Yorkshire, England; [Eardley, Ian] Leeds Teaching Hosp NHS Trust, Dept Urol, Beckett St, Leeds, W Yorkshire, England; [Sandoe, Jonathan A. T.] Univ Leeds, Beckett St, Leeds, W Yorkshire, England; [Sandoe, Jonathan A. T.] Leeds Teaching Hosp NHS Trust, Beckett St, Leeds, W Yorkshire, England	Christie NHS Foundation Trust; University of Leeds; University of Leeds; University of Leeds; University of Leeds; University of Leeds; University of Leeds	Mohee, AR (corresponding author), Christie NHS Fdn Trust, Dept Urol, 550 Wilmslow Rd, Manchester, Lancs, England.	amar.mohee@gmail.com	Sandoe, Jonathan/AAL-2117-2020	Sandoe, Jonathan/0000-0003-0193-8677; Mohee, Amar/0000-0002-2672-618X	Leeds Charitable Trust, at Leeds Teaching Hospitals NHS Trust; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: researchfish	Leeds Charitable Trust, at Leeds Teaching Hospitals NHS Trust; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was supported by the Leeds Charitable Trust, a charity supporting medical research at the Leeds Teaching Hospitals NHS Trust. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Epstein JI, 2014, AM J SURG PATHOL, V38, pE6, DOI 10.1097/PAS.0000000000000238; GRABE M, 1987, EUR J CLIN MICROBIOL, V6, P11, DOI 10.1007/BF02097183; Grabe M, 2015, EUROPEAN ASS UROLOGY; Hall JC, 1996, UROLOGY, V47, P852, DOI 10.1016/S0090-4295(96)00066-0; Harris KA, 2003, J MED MICROBIOL, V52, P685, DOI 10.1099/jmm.0.05213-0; Ibrahim AIA, 2002, EUR UROL, V41, P250, DOI 10.1016/S0302-2838(02)00013-1; Mohee A, 2013, BJU INT, V114, P118; National Institute for Health and Care Excellence (NICE), 2008, SURG SIT INF PREV TR; National Institute for Health and Clinical Excellence, 2008, PROPH INF END; NIELSEN PB, 1987, INFECTION, V15, P245, DOI 10.1007/BF01644123; OHKAWA M, 1993, CHEMOTHERAPY, V39, P140, DOI 10.1159/000239117; Omabe M, 2011, INFECT GENET EVOL, V11, P1195, DOI 10.1016/j.meegid.2011.03.002; PRESCOTT S, 1990, BRIT J UROL, V66, P509, DOI 10.1111/j.1464-410X.1990.tb14999.x; Qiang W, 2005, J UROLOGY, V173, P1175, DOI 10.1097/01.ju.0000149676.15561.cb; Rassweiler J, 2006, EUR UROL, V50, P969, DOI 10.1016/j.eururo.2005.12.042; Richter SS, 2002, J CLIN MICROBIOL, V40, P2437, DOI 10.1128/JCM.40.7.2437-2444.2002; ROBINSON MRG, 1982, BRIT J UROL, V54, P542, DOI 10.1111/j.1464-410X.1982.tb13586.x; Rodrigues Paulo, 2004, Sao Paulo Med. J., V122, P4, DOI 10.1590/S1516-31802004000100002; SHEARMAN CP, 1988, BRIT J UROL, V62, P434, DOI 10.1111/j.1464-410X.1988.tb04391.x; SPRAYCAR M, 1995, STEDMANS MED DICT; SULLIVAN NM, 1972, APPL MICROBIOL, V23, P1101, DOI 10.1128/AEM.23.6.1101-1106.1972; TAYLOR EW, 1988, J HOSP INFECT, V12, P75, DOI 10.1016/0195-6701(88)90129-6; Turk S, 2014, MICROB ECOL HEALTH D, V25, DOI 10.3402/mehd.v25.22701; Wagenlehner FME, 2005, EUR UROL, V47, P549, DOI 10.1016/j.eururo.2005.01.004; Yamamoto Hiroki, 2002, J Anesth, V16, P242, DOI 10.1007/s005400200032	25	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157864	10.1371/journal.pone.0157864	http://dx.doi.org/10.1371/journal.pone.0157864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391962	gold, Green Published			2022-12-26	WOS:000380005400023
J	Paolicelli, D; Iannazzo, S; Santoni, L; Iaffaldano, A; Di Lecce, V; Manni, A; Lavolpe, V; Tortorella, C; D'Onghia, M; Direnzo, V; Puma, E; Trojano, M				Paolicelli, Damiano; Iannazzo, Sergio; Santoni, Laura; Iaffaldano, Antonio; Di Lecce, Valentina; Manni, Alessia; Lavolpe, Vito; Tortorella, Carla; D'Onghia, Mariangela; Direnzo, Vita; Puma, Elisa; Trojano, Maria			The Cost of Relapsing-Remitting Multiple Sclerosis Patients Who Develop Neutralizing Antibodies during Interferon Beta Therapy	PLOS ONE			English	Article							IFN-BETA; IMPACT	Background Relapsing Remitting Multiple Sclerosis (RRMS) patients treated with interferon beta (IFN beta) can develop neutralizing antibodies (NAbs) that reduce treatment efficacy. Several clinical studies explored the association of NAb+ status with increased disease activity. Objective The aim of this study was to estimate the cost of RRMS patients who develop NAbs while treated with IFN beta by the Italian National Healthcare Service (NHS) and the Italian Society perspectives. Methods The clinical data derived from a published observational study on 567 RRMS Italian patients treated with IFN beta. The management cost data derived from the published literature. Cost data were inflated to Euro 2014. Results The annual direct cost to treat a patient was estimated in (sic)15,428 in the NAb+ cohort and (sic)14,317 in the NAb-cohort. The annual societal cost was estimated in (sic)33,890 and (sic)30,790 in NAb+ and NAb-patients, respectively. The cost increase related to the NAb+ status was (sic)3,100 in the Italian societal perspective and (sic)1,111 in the Italian NHS perspective. Conclusion The results of this economic evaluation suggest the presence of an association between NAb+ status and increased costs for the management of RRMS in Italy. Further pharmacoeconomic research will be needed to confirm this first result.	[Paolicelli, Damiano; Iaffaldano, Antonio; Di Lecce, Valentina; Manni, Alessia; Lavolpe, Vito; Tortorella, Carla; D'Onghia, Mariangela; Direnzo, Vita; Trojano, Maria] Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Iannazzo, Sergio] SIHS Hlth Econ Consulting, Turin, Italy; [Santoni, Laura; Puma, Elisa] Biogen Italia, Milan, Italy	Universita degli Studi di Bari Aldo Moro	Paolicelli, D (corresponding author), Univ Bari Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy.	damiano.paolicelli@uniba.it	Manni, Alessia/AHE-8058-2022; tortorella, carla/J-2557-2012	Manni, Alessia/0000-0001-6740-5844; tortorella, carla/0000-0001-9037-7300; Trojano, Maria/0000-0002-6329-8946	Biogen, Milan, Italy	Biogen, Milan, Italy(Biogen)	S. Iannazzo is owner and General Manager of SIHS Health Economics Consulting. Biogen, Milan, Italy, supported the development of the study through a service contract with SIHS. L. Santoni and E. Puma are Biogen's employees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2004, STATA J, V4, P290, DOI 10.1177/1536867X0400400307; Abadie A, 2011, J BUS ECON STAT, V29, P1, DOI 10.1198/jbes.2009.07333; Agenzia Italiana del Farmaco (AIFA) (The Italian Drug Agency), REG RIMB PREZZ VEND; Amato MP, 2002, J NEUROL, V249, P152, DOI 10.1007/PL00007858; Associazione Italiana Sclerosi Multipla (AISM) (The Italian Association of Multiple Sclerosis), BIL SOC AISM 2013; Berto P, 2011, NEUROL SCI, V32, P1035, DOI 10.1007/s10072-011-0578-4; Bertolotto A, 2014, NEUROL SCI, V35, P307, DOI 10.1007/s10072-013-1616-1; Chiao E, 2009, CURR MED RES OPIN, V25, P1445, DOI 10.1185/03007990902876040; Istituto Italiano di Statistica (ISTAT) (The Italian Institute of Statistics), CONS PRIC IND; Karampampa K, 2012, MULT SCLER J, V18, P29, DOI 10.1177/1352458512441566c; Kobelt Gisela, 2006, Eur J Health Econ, V7 Suppl 2, pS45; Paolicelli D, 2013, J NEUROL, V260, P1562, DOI 10.1007/s00415-012-6829-3; Patti F, 2011, NEUROL SCI, V32, P787, DOI 10.1007/s10072-011-0499-2; Petkau AJ, 2004, MULT SCLER J, V10, P126, DOI 10.1191/1352458504ms1004oa; Ponzio M, 2015, NEUROL SCI, V36, P227, DOI 10.1007/s10072-014-1925-z; Rudick RA, 1998, NEUROLOGY, V50, P1266, DOI 10.1212/WNL.50.5.1266; Runkel L, 2001, J INTERF CYTOK RES, V21, P931, DOI 10.1089/107999001753289541; Russo P, 2004, CLIN DRUG INVEST, V24, P409, DOI 10.2165/00044011-200424070-00004; Sorensen PS, 2005, NEUROLOGY, V65, P33, DOI 10.1212/01.WNL.0000166049.51502.6A; Trojano M, 2011, NEUROL CLIN, V29, P309, DOI 10.1016/j.ncl.2010.12.008; Walter E, 2014, MULT SCLER RELAT DIS, V3, P670, DOI 10.1016/j.msard.2014.09.003	21	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159214	10.1371/journal.pone.0159214	http://dx.doi.org/10.1371/journal.pone.0159214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390865	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400220
J	Sperling, E; Gorecki, K; Drakenberg, T; Hagerhall, C				Sperling, Eva; Gorecki, Kamil; Drakenberg, Torbjorn; Hagerhall, Cecilia			Functional Differentiation of Antiporter-Like Polypeptides in Complex I; a Site-Directed Mutagenesis Study of Residues Conserved in MrpA and NuoL but Not in MrpD, NuoM, and NuoN	PLOS ONE			English	Article							NADH-QUINONE OXIDOREDUCTASE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; NA+/H+ ANTIPORTER; PROTON TRANSLOCATION; STRUCTURAL BASIS; ACIDIC RESIDUES; SUBUNIT; MECHANISM; DOMAIN	It has long been known that the three largest subunits in the membrane domain (NuoL, NuoM and NuoN) of complex I are homologous to each other, as well as to two subunits (MrpA and MrpD) from a Na+/H+ antiporter, Mrp. MrpA and NuoL are more similar to each other and the same is true for MrpD and NuoN. This suggests a functional differentiation which was proven experimentally in a deletion strain model system, where NuoL could restore the loss of MrpA, but not that of MrpD and vice versa. The simplest explanation for these observations was that the MrpA and MrpD proteins are not antiporters, but rather single subunit ion channels that together form an antiporter. In this work our focus was on a set of amino acid residues in helix VIII, which are only conserved in NuoL and MrpA (but not in any of the other antiporter-like subunits.) and to compare their effect on the function of these two proteins. By combining complementation studies in B. subtilis and Na-23-NMR, response of mutants to high sodium levels were tested. All of the mutants were able to cope with high salt levels; however, all but one mutation (M258I/M225I) showed differences in the efficiency of cell growth and sodium efflux. Our findings showed that, although very similar in sequence, NuoL and MrpA seem to differ on the functional level. Nonetheless the studied mutations gave rise to interesting phenotypes which are of interest in complex I research.	[Sperling, Eva; Gorecki, Kamil; Hagerhall, Cecilia] Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden; [Drakenberg, Torbjorn] Lund Univ, Dept Biophys Chem, Ctr Mol Prot Sci, Lund, Sweden	Lund University; Lund University	Sperling, E (corresponding author), Lund Univ, Dept Biochem & Struct Biol, Ctr Mol Prot Sci, Lund, Sweden.	eva.sperling@biochemistry.lu.se		Gorecki, Kamil/0000-0002-9672-2408	Swedish Research Council [2010-5058]; Crafoord Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation	This work was supported by the Swedish Research Council, www.vr.se,2010-5058 to CH and the Crafoord Foundation, www.crafoord.se to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; ARWERT F, 1973, MOL GEN GENET, V123, P185, DOI 10.1007/BF00267334; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; FORTNAGEL P, 1968, J BACTERIOL, V95, P1431, DOI 10.1128/JB.95.4.1431-1438.1968; Friedrich T, 1998, BBA-BIOENERGETICS, V1364, P134, DOI 10.1016/S0005-2728(98)00024-3; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Gorecki K, 2014, ANAL BIOCHEM, V445, P80, DOI 10.1016/j.ab.2013.10.003; Gustavsson T, 2010, PROTEIN SCI, V19, P1445, DOI 10.1002/pro.424; HAMAMOTO T, 1994, MOL MICROBIOL, V14, P939, DOI 10.1111/j.1365-2958.1994.tb01329.x; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kajiyama Y, 2009, MICROBIOL-SGM, V155, P2137, DOI 10.1099/mic.0.025205-0; Kosono S, 2006, BBA-BIOMEMBRANES, V1758, P627, DOI 10.1016/j.bbamem.2006.04.012; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Michel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017420; Moparthi VK, 2014, BBA-BIOENERGETICS, V1837, P178, DOI 10.1016/j.bbabio.2013.09.012; Moparthi VK, 2011, BBA-BIOENERGETICS, V1807, P427, DOI 10.1016/j.bbabio.2011.01.005; Moparthi VK, 2011, STRUCTURAL PERSPECTI; Morino M, 2010, J BIOL CHEM, V285, P30942, DOI 10.1074/jbc.M110.118661; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Ripple MO, 2013, J BIOL CHEM, V288, P5374, DOI 10.1074/jbc.M112.438945; Sambrook S, 1989, MOL CLONING LAB MANU; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2014, J BIOENERG BIOMEMBR, V46, P247, DOI 10.1007/s10863-014-9554-z; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Tseng WC, 2008, ANAL BIOCHEM, V375, P376, DOI 10.1016/j.ab.2007.12.013; Verkhovskaya M, 2013, INT J BIOCHEM CELL B, V45, P491, DOI 10.1016/j.biocel.2012.08.024; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1	38	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158972	10.1371/journal.pone.0158972	http://dx.doi.org/10.1371/journal.pone.0158972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391676	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400176
J	Venturas, MD; MacKinnon, ED; Dario, HL; Jacobsen, AL; Pratt, RB; Davis, SD				Venturas, Martin D.; MacKinnon, Evan D.; Dario, Hannah L.; Jacobsen, Anna L.; Pratt, R. Brandon; Davis, Stephen D.			Chaparral Shrub Hydraulic Traits, Size, and Life History Types Relate to Species Mortality during California's Historic Drought of 2014	PLOS ONE			English	Article							WATER-STRESS TOLERANCE; INDUCED TREE MORTALITY; CAVITATION RESISTANCE; VULNERABILITY CURVES; CHLOROPHYLL FLUORESCENCE; PHYSIOLOGICAL-MECHANISMS; CEANOTHUS-MEGACARPUS; CLIMATE-CHANGE; DIE-OFF; SEEDLINGS	Chaparral is the most abundant vegetation type in California and current climate change models predict more frequent and severe droughts that could impact plant community structure. Understanding the factors related to species-specific drought mortality is essential to predict such changes. We predicted that life history type, hydraulic traits, and plant size would be related to the ability of species to survive drought. We evaluated the impact of these factors in a mature chaparral stand during the drought of 2014, which has been reported as the most severe in California in the last 1,200 years. We measured tissue water potential, native xylem specific conductivity, leaf specific conductivity, percentage loss in conductivity, and chlorophyll fluorescence for 11 species in February 2014, which was exceptionally dry following protracted drought. Mortality among the 11 dominant species ranged from 0 to 93%. Total stand density was reduced 63.4% and relative dominance of species shifted after the drought. Mortality was negatively correlated with water potential, native xylem specific conductivity, and chlorophyll fluorescence, but not with percent loss in hydraulic conductivity and leaf specific conductivity. The model that best explained mortality included species and plant size as main factors and indicated that larger plants had greater survival for 2 of the species. In general, species with greater resistance to water-stress induced cavitation showed greater mortality levels. Despite adult resprouters typically being more vulnerable to cavitation, results suggest that their more extensive root systems enable them to better access soil moisture and avoid harmful levels of dehydration. These results are consistent with the hypothesis that short-term high intensity droughts have the strongest effect on mature plants of shallow-rooted dehydration tolerant species, whereas deep-rooted dehydration avoiding species fare better in the short-term. Severe droughts can drive changes in chaparral structure as a result of the differential mortality among species.	[Venturas, Martin D.; MacKinnon, Evan D.; Jacobsen, Anna L.; Pratt, R. Brandon] Calif State Univ, Dept Biol, 9001 Stockdale Hwy, Bakersfield, CA 93311 USA; [Venturas, Martin D.] Univ Politecn Madrid, Grp Invest Genet Fisiol & Hist Forestal, Avda Moreras S-N, E-28040 Madrid, Spain; [Dario, Hannah L.; Davis, Stephen D.] Pepperdine Univ, Div Nat Sci, 24255 Pacific Coast Highway, Malibu, CA 90263 USA	California State University System; California State University Bakersfield; Universidad Politecnica de Madrid; Pepperdine University	Venturas, MD (corresponding author), Calif State Univ, Dept Biol, 9001 Stockdale Hwy, Bakersfield, CA 93311 USA.; Venturas, MD (corresponding author), Univ Politecn Madrid, Grp Invest Genet Fisiol & Hist Forestal, Avda Moreras S-N, E-28040 Madrid, Spain.	martin.venturas@gmail.com	Venturas, Martin D./J-2423-2014	Venturas, Martin D./0000-0001-5972-9064; Jacobsen, Anna/0000-0001-7830-5590	Technical University of Madrid (Legado Gonzalez Esparcia Grant); National Science Foundation [IOS-0845125, IOS-1252232]; William M. Keck Foundation; Natural Science Division of Pepperdine University; National Parks Service	Technical University of Madrid (Legado Gonzalez Esparcia Grant); National Science Foundation(National Science Foundation (NSF)); William M. Keck Foundation(W.M. Keck Foundation); Natural Science Division of Pepperdine University; National Parks Service	MDV acknowledges support from the Technical University of Madrid (Legado Gonzalez Esparcia Grant; www.upm.es). MDV, EDM, and RBP were supported by National Science Foundation (IOS-0845125; www.nsf.gov). ALJ was supported by National Science Foundation (IOS-1252232; www.nsf.gov). SDD and HLD were supported by the William M. Keck Foundation (www.wmkeck.org) and the Natural Science Division of Pepperdine University (www.pepperdine.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Jo Kitz and Debbie Sharpton of the Mountains Restoration Trust for access to the study site from 1993 to present, and Marti Witter from the National Parks Service for her support. Authors would like to thank Kevin B. Doak, Allison L. Hubbard, and Alawna R. Jamison for their assistance in collecting PQS data.	Ackerly D, 2004, ECOL MONOGR, V74, P25, DOI 10.1890/03-4022; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2013, GLOBAL CHANGE BIOL, V19, P1188, DOI 10.1111/gcb.12100; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; Barton K., 1995, THESIS; BJORKMAN O, 1987, PLANTA, V170, P489, DOI 10.1007/BF00402983; Board M.E.A., 2005, EC HUM WELL BEING SY; Bond WJ, 2001, TRENDS ECOL EVOL, V16, P45, DOI 10.1016/S0169-5347(00)02033-4; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Coates AR, 2015, REMOTE SENS-BASEL, V7, P14276, DOI 10.3390/rs71114276; Cook BI, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400082; COTTAM G, 1953, ECOLOGY, V34, P741, DOI 10.2307/1931337; Cox G. W., 1985, LAB MANUAL GEN ECOLO; DAMESIN C, 1995, NEW PHYTOL, V131, P159, DOI 10.1111/j.1469-8137.1995.tb05717.x; Davis SD, 1999, ECOSCIENCE, V6, P180, DOI 10.1080/11956860.1999.11682519; Davis SD, 2002, AM J BOT, V89, P820, DOI 10.3732/ajb.89.5.820; Miranda JD, 2010, FUNCT PLANT BIOL, V37, P828, DOI 10.1071/FP09296; EPRON D, 1992, PLANT CELL ENVIRON, V15, P809, DOI 10.1111/j.1365-3040.1992.tb02148.x; Franco G, 2012, OUR CHANGING CLIMATE; FRAZER JM, 1988, OECOLOGIA, V76, P215, DOI 10.1007/BF00379955; Griffin D, 2014, GEOPHYS RES LETT, V41, P9017, DOI 10.1002/2014GL062433; Guanter L, 2014, P NATL ACAD SCI USA, V111, pE1327, DOI 10.1073/pnas.1320008111; Hacke UG, 2009, PLANT CELL ENVIRON, V32, P1324, DOI 10.1111/j.1365-3040.2009.02000.x; Hacke UG, 2000, BASIC APPL ECOL, V1, P31, DOI 10.1078/1439-1791-00006; Hacke UG, 2015, NEW PHYTOL, V205, P116, DOI 10.1111/nph.13017; HELLMERS H, 1955, ECOLOGY, V36, P667, DOI 10.2307/1931305; HORTON JS, 1955, ECOLOGY, V36, P244, DOI 10.2307/1933230; Jacobsen AL, 2007, PLANT CELL ENVIRON, V30, P1599, DOI 10.1111/j.1365-3040.2007.01729.x; Jacobsen AL, 2007, ECOL MONOGR, V77, P99, DOI 10.1890/05-1879; Jacobsen AL, 2012, NEW PHYTOL, V194, P982, DOI 10.1111/j.1469-8137.2012.04118.x; Keeley JE, 2001, CONSERV BIOL, V15, P1536, DOI 10.1046/j.1523-1739.2001.00097.x; Korner C, 2015, CURR OPIN PLANT BIOL, V25, P107, DOI 10.1016/j.pbi.2015.05.003; Mann ME, 2015, P NATL ACAD SCI USA, V112, P3858, DOI 10.1073/pnas.1503667112; Maseda PH, 2006, J EXP BOT, V57, P3963, DOI 10.1093/jxb/erl127; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; McDowell NG, 2016, NAT CLIM CHANGE, V6, P295, DOI [10.1038/nclimate2873, 10.1038/NCLIMATE2873]; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; McDowell NG, 2011, TRENDS ECOL EVOL, V26, P523, DOI 10.1016/j.tree.2011.06.003; Meddens AJH, 2015, NEW PHYTOL, V206, P91, DOI 10.1111/nph.13193; Meentemeyer RK, 2001, PLANT ECOL, V156, P19, DOI 10.1023/A:1011944805738; Mencuccini M, 2015, NEW PHYTOL, V208, P396, DOI 10.1111/nph.13461; Mueller RC, 2005, J ECOL, V93, P1085, DOI 10.1111/j.1365-2745.2005.01042.x; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Oliva J, 2014, NEW PHYTOL, V203, P1028, DOI 10.1111/nph.12857; Ovalle JF, 2015, FORESTS, V6, P3733, DOI 10.3390/f6103733; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Paddock William A. S. III, 2013, Aliso, V31, P49; Padilla FM, 2007, FUNCT ECOL, V21, P489, DOI 10.1111/j.1365-2435.2007.01267.x; Parker VT, 2016, ECOSYSTEMS OF CALIFORNIA, P479; Pausas JG, 2016, NEW PHYTOL, V209, P945, DOI 10.1111/nph.13644; Plaut JA, 2012, PLANT CELL ENVIRON, V35, P1601, DOI 10.1111/j.1365-3040.2012.02512.x; Porcar-Castell A, 2014, J EXP BOT, V65, P4065, DOI 10.1093/jxb/eru191; Pratt RB, 2008, J ECOL, V96, P1252, DOI 10.1111/j.1365-2745.2008.01428.x; Pratt RB, 2007, ECOL MONOGR, V77, P239, DOI 10.1890/06-0780; Pratt RB, 2014, GLOBAL CHANGE BIOL, V20, P893, DOI 10.1111/gcb.12477; Pratt RB, 2012, AM J BOT, V99, P1464, DOI 10.3732/ajb.1200193; R Core Team, 2021, R LANGUAGE ENV STAT; Redtfeldt RA, 1996, ECOSCIENCE, V3, P290, DOI 10.1080/11956860.1996.11682345; Rice KJ, 2004, OECOLOGIA, V139, P190, DOI 10.1007/s00442-004-1503-9; Rodriguez-Calcerrada J, 2007, NEW FOREST, V33, P67, DOI 10.1007/s11056-006-9014-7; Rowland L, 2015, NATURE, V528, P119, DOI 10.1038/nature15539; Sala A, 2010, NEW PHYTOL, V186, P274, DOI 10.1111/j.1469-8137.2009.03167.x; Salmon Y, 2015, PLANT CELL ENVIRON, V38, P2575, DOI 10.1111/pce.12572; SCHLESINGER WH, 1982, BOT REV, V48, P71, DOI 10.1007/BF02860536; SCHLESINGER WH, 1980, ECOLOGY, V61, P781, DOI 10.2307/1936748; Sevanto S, 2014, PLANT CELL ENVIRON, V37, P153, DOI 10.1111/pce.12141; Skelton RP, 2015, P NATL ACAD SCI USA, V112, P5744, DOI 10.1073/pnas.1503376112; Sperry JS, 2012, PLANT CELL ENVIRON, V35, P601, DOI 10.1111/j.1365-3040.2011.02439.x; SPERRY JS, 1988, PLANT CELL ENVIRON, V11, P35, DOI 10.1111/j.1365-3040.1988.tb01774.x; Swain DL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501344; THOMAS CM, 1989, OECOLOGIA, V80, P309, DOI 10.1007/BF00379032; Urli M, 2013, TREE PHYSIOL, V33, P672, DOI 10.1093/treephys/tpt030; Valladares F, 2006, PLANT BIOLOGY, V8, P688, DOI 10.1055/s-2006-924107; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; Venturas MD, 2015, PLANT CELL ENVIRON, V38, P1060, DOI 10.1111/pce.12461; Vilagrosa A, 2010, ENVIRON EXP BOT, V69, P233, DOI 10.1016/j.envexpbot.2010.04.013; Wiens D, 2012, BIOL J LINN SOC, V105, P269, DOI 10.1111/j.1095-8312.2011.01820.x; Witter M, 2007, FLORA ECOLOGY SANTA, P173	79	70	72	3	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159145	10.1371/journal.pone.0159145	http://dx.doi.org/10.1371/journal.pone.0159145			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391489	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400214
J	Vieira, WF; Kenzo-Kagawa, B; Cogo, JC; Baranauskas, V; da Cruz-Hofling, MA				Vieira, Willians Fernando; Kenzo-Kagawa, Bruno; Cogo, Jose Carlos; Baranauskas, Vitor; da Cruz-Hofling, Maria Alice			Low-Level Laser Therapy (904 nm) Counteracts Motor Deficit of Mice Hind Limb following Skeletal Muscle Injury Caused by Snakebite-Mimicking Intramuscular Venom Injection	PLOS ONE			English	Article							RAT SCIATIC-NERVE; CELL-PROLIFERATION; BOTHROPS-JARARACA; CATWALK METHOD; GAIT ANALYSIS; SAO-PAULO; IRRADIATION; PAIN; REGENERATION; LOCOMOTION	Myotoxins present in Bothrops venom disrupt the sarcolemma of muscle fibers leading to the release of sarcoplasmic proteins and loss of muscle homeostasis. Myonecrosis and tissue anoxia induced by vascularization impairment can lead to amputation or motor functional deficit. The objective of this study was to investigate the dynamic behavior of motor function in mice subjected to injection of Bothrops jararacussu venom (Bjssu) and exposed to low-level laser therapy (LLLT). Male Swiss mice received Bjssu injection (830 mu g/kg) into the medial portion of the right gastrocnemius muscle. Three hours later the injected region was irradiated with diode semiconductor Gallium Arsenide (GaAs-904 nm, 4 J/cm(2)) laser following by irradiation at 24, 48 and 72 hours. Saline injection (0.9% NaCl) was used as control. Gait analysis was performed 24 hours before Bjssu injection and at every period post-Bjssu using CatWalk method. Data from spatiotemporal parameters Stand, Maximum Intensity, Swing, Swing Speed, Stride Length and Step Cycle were considered. The period of 3 hours post venom-induced injury was considered critical for all parameters evaluated in the right hindlimb. Differences (p<0.05) were concentrated in venom and venom + placebo laser groups during the 3 hours post-injury period, in which the values of stand of most animals were null. After this period, the gait characteristics were re-established for all parameters. The venom + laser group kept the values at 3 hours post-Bjssu equal to that at 24 hours before Bjssu injection indicating that the GaAs laser therapy improved spatially and temporally gait parameters at the critical injury period caused by Bjssu. This is the first study to analyze with cutting edge technology the gait functional deficits caused by snake envenoming and gait gains produced by GaAs laser irradiation. In this sense, the study fills a gap on the field of motor function after laser treatment following snake envenoming.	[Vieira, Willians Fernando; Baranauskas, Vitor] Univ Estadual Campinas, UNICAMP, Fac Elect Engn & Computat, Dept Semicond Instruments & Photon DSIF, Campinas, SP, Brazil; [Cogo, Jose Carlos] Univ Vale Paraiba UNIVAP, Inst Res & Dev IP&D, Sao Jose Dos Campos, SP, Brazil; [Vieira, Willians Fernando; Kenzo-Kagawa, Bruno; da Cruz-Hofling, Maria Alice] Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biochem & Tissue Biol DBBT, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade do Vale do Paraiba; Universidade de Sao Paulo; Universidade Estadual de Campinas	da Cruz-Hofling, MA (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Biol, Dept Biochem & Tissue Biol DBBT, Campinas, SP, Brazil.	hofling@unicamp.br	Vieira, Willians F/A-8235-2018	Vieira, Willians F/0000-0003-3022-7997	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [05/53625-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [488792/2011, 486142/2012-4]; CNPq [305099/2011-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) at the Departamento de Semicondutores, Instrumentos e Fotonica (FEEC-UNICAMP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) at Departamento de Bioquimica e Biologia Tecidual (IB-UNICAMP)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) at the Departamento de Semicondutores, Instrumentos e Fotonica (FEEC-UNICAMP)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) at Departamento de Bioquimica e Biologia Tecidual (IB-UNICAMP)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Proc. 05/53625-1) (http://www.fapesp.br/) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grants #488792/2011 and #486142/2012-4) (http://www.cnpq.br/). MACH is a IA research fellow from CNPq (grant #305099/2011-6); WFV was a Master Sci. student granted with a scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (http://www.capes.gov.br/) at the Departamento de Semicondutores, Instrumentos e Fotonica (FEEC-UNICAMP) and Departamento de Bioquimica e Biologia Tecidual (IB-UNICAMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves AN, 2014, AM J PHYS MED REHAB, V93, P1073, DOI 10.1097/PHM.0000000000000158; Amaral AC, 2001, LASER MED SCI, V16, P44, DOI 10.1007/PL00011336; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Barbosa AM, 2008, TOXICON, V51, P1236, DOI 10.1016/j.toxicon.2008.02.007; Ben-Dov N, 1999, BBA-MOL CELL RES, V1448, P372, DOI 10.1016/S0167-4889(98)00147-5; Bervar M, 2000, J NEUROSCI METH, V102, P109, DOI 10.1016/S0165-0270(00)00281-8; Borato E, 2008, REV BRAS MED ESPORTE, V14, P446, DOI 10.1590/S1517-86922008000500009; Bozkurt A, 2011, BEHAV BRAIN RES, V219, P55, DOI 10.1016/j.bbr.2010.12.018; Bozkurt A, 2008, J NEUROSCI METH, V170, P117, DOI 10.1016/j.jneumeth.2008.01.006; Brazilian Health Ministry, 1999, MAN DIAGN TREATM ENV, P131; CARDOSO JLC, 1993, Q J MED, V86, P315; Andraus RAC, 2010, ACTA ORTOP BRAS, V18, P152, DOI 10.1590/S1413-78522010000300007; Conlan MJ, 1996, J CLIN PERIODONTOL, V23, P492, DOI 10.1111/j.1600-051X.1996.tb00580.x; CRISCO JJ, 1994, AM J SPORT MED, V22, P702, DOI 10.1177/036354659402200521; DEMEDINACELI L, 1982, EXP NEUROL, V77, P634, DOI 10.1016/0014-4886(82)90234-5; Desmet KD, 2006, PHOTOMED LASER SURG, V24, P121, DOI 10.1089/pho.2006.24.121; Deumens R, 2007, J NEUROSCI METH, V164, P120, DOI 10.1016/j.jneumeth.2007.04.009; Doin-Silva R, 2009, PHOTOCHEM PHOTOBIOL, V85, P63, DOI 10.1111/j.1751-1097.2008.00397.x; Dourado DM, 2003, LASER SURG MED, V33, P352, DOI 10.1002/lsm.10237; Dourado DM, 2011, PHOTOCHEM PHOTOBIOL, V87, P418, DOI 10.1111/j.1751-1097.2010.00878.x; Ferreira-Gomes J, 2008, J PAIN, V9, P945, DOI 10.1016/j.jpain.2008.05.012; Filipe VM, 2006, J NEUROSCI METH, V153, P55, DOI 10.1016/j.jneumeth.2005.10.006; Gabriel AF, 2007, J NEUROSCI METH, V163, P9, DOI 10.1016/j.jneumeth.2007.02.003; Gabriel AF, 2009, BEHAV BRAIN RES, V198, P477, DOI 10.1016/j.bbr.2008.12.018; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; GRILLNER S, 1975, PHYSIOL REV, V55, P247, DOI 10.1104/pp.55.2.247; GUTIERREZ J M, 1989, Memorias do Instituto Butantan (Sao Paulo), V51, P211; Gutierrez Jose Maria, 1995, P645; Gutierrez JM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002162; Hui Wen Fan, 1995, P667; Iwata A, 2010, MUSCLE NERVE, V41, P694, DOI 10.1002/mus.21567; Milani R, 1997, QJM-MON J ASSOC PHYS, V90, P323, DOI 10.1093/qjmed/90.5.323; Moller KA, 2008, J NEUROSCI METH, V174, P1, DOI 10.1016/j.jneumeth.2008.06.017; Picolo G, 2002, BRAZ J MED BIOL RES, V35, P1221, DOI 10.1590/S0100-879X2002001000016; Posten W, 2005, DERMATOL SURG, V31, P334, DOI 10.1097/00042728-200503000-00016; PUBLICOVER SJ, 1978, J NEUROPATH EXP NEUR, V37, P544, DOI 10.1097/00005072-197809000-00009; Pugliese Livia Souza, 2003, Pesqui Odontol Bras, V17, P307; Queiroz LD, 2002, TOXICON, V40, P1483, DOI 10.1016/S0041-0101(02)00166-6; QUEIROZ LS, 1984, TOXICON, V22, P339, DOI 10.1016/0041-0101(84)90077-1; SANTOS PM, 1995, J NEUROSCI METH, V61, P79, DOI 10.1016/0165-0270(95)00026-Q; Shefer G, 2002, J CELL SCI, V115, P1461; Shefer G, 2003, BBA-MOL CELL RES, V1593, P131, DOI 10.1016/S0167-4889(02)00350-6; Smith KC, 2005, PHOTOMED LASER SURG, V23, P78, DOI 10.1089/pho.2005.23.78; Song H, 2004, AM J SPORT MED, V32, P1263, DOI 10.1177/0363546503262199; TONUSSI CR, 1992, PAIN, V48, P421, DOI 10.1016/0304-3959(92)90095-S; Varejao ASP, 2003, EXP NEUROL, V183, P695, DOI 10.1016/S0014-4886(03)00208-5; Varejao ASP, 2002, MUSCLE NERVE, V26, P630, DOI 10.1002/mus.10242; Vladimirov YA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P81, DOI 10.1023/B:BIRY.0000016356.93968.7e; WALKER JL, 1994, J NEUROSCI METH, V52, P47, DOI 10.1016/0165-0270(94)90054-X; WALT. World Association for Laser Therapy, 1994, DOS REC; WROGEMANN K, 1976, LANCET, V1, P672; Yu W, 1997, PHOTOCHEM PHOTOBIOL, V66, P866, DOI 10.1111/j.1751-1097.1997.tb03239.x	52	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158980	10.1371/journal.pone.0158980	http://dx.doi.org/10.1371/journal.pone.0158980			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392016	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400179
J	Kondo, T; Kondo, Y; Orita, Y; Mitarai, F; Ishitsuka, Y; Irikura, M; Shimodozono, Y; Douchi, T; Takeda, Y; Irie, T				Kondo, Tomoko; Kondo, Yuki; Orita, Yuji; Mitarai, Fumi; Ishitsuka, Yoichi; Irikura, Mitsuru; Shimodozono, Yoshihiro; Douchi, Tsutomu; Takeda, Yasuo; Irie, Tetsumi			Predictive Factors for Efficacy and Safety of Prophylactic Theophylline for Extubation in Infants with Apnea of Prematurity	PLOS ONE			English	Article							CONTROLLED-TRIAL; WEIGHING LESS; MANAGEMENT; CAFFEINE; GRAMS	Purpose This study aimed to evaluate predictive factors involved in efficacy and safety in Japanese infants who received theophylline therapy to prevent apnea of prematurity (AOP) after weaning from mechanical ventilation. Methods We retrospectively reviewed the medical records of infants who were administered intravenous aminophylline (theophylline ethylenediamine) for AOP at the neonatal intensive care unit, Kagoshima University Hospital, Japan, between January 2009 and June 2013. Results A total of 100 infants were evaluated as two separate groups in terms of efficacy and safety of theophylline. Sixty-seven (67.0%) infants had effective theophylline therapy. Multivariate logistic regression analysis showed that gestational age at birth was significant, with an odds ratio of 0.59 (p < 0.001). Receiver operating characteristic analysis showed that the cut-off value was 31.1 weeks old for predicting the efficacy of theophylline (specificity, 66.7%; sensitivity, 86.6%; p < 0.001; area under the curve, 0.750; 95% confidence interval, 0.45-0.74). Adverse reactions were identified in 21 (21.0%) infants. Multivariate logistic regression analysis showed that the number of days of theophylline administration from birth was associated with an increased risk of adverse reactions after theophylline administration (p = 0.01). Conclusions Physicians need to be aware of the possibility that theophylline fails to produce therapeutic effects for extubation in infants aged less than 31.1 weeks old, and adverse reactions can easily develop when theophylline is administered soon after birth.	[Kondo, Tomoko; Kondo, Yuki; Mitarai, Fumi; Ishitsuka, Yoichi; Irie, Tetsumi] Kumamoto Univ, Dept Clin Chem & Informat, Grad Sch Pharmaceut Sci, Kumamoto, Japan; [Kondo, Tomoko; Takeda, Yasuo] Kagoshima Univ Hosp, Dept Clin Pharm & Pharmacol, Kagoshima, Japan; [Orita, Yuji; Douchi, Tsutomu] Kagoshima Univ, Dept Obstet & Gynecol, Fac Med, Kagoshima, Japan; [Irikura, Mitsuru] Daiichi Univ, Lab Evidence Based Pharmacotherapy, Coll Pharmaceut Sci, Fukuoka, Japan; [Shimodozono, Yoshihiro] Kyusyu Univ Hlth & Welf, Lab Drug Informat, Dept Pharmaceut Sci, Nobeoka, Japan; [Irie, Tetsumi] Kumamoto Univ, Ctr Clin Pharmaceut Sci, Fac Pharmaceut Sci, Kumamoto, Japan	Kumamoto University; Kagoshima University; Kagoshima University; Kyushu University; Kumamoto University	Kondo, Y (corresponding author), Kumamoto Univ, Dept Clin Chem & Informat, Grad Sch Pharmaceut Sci, Kumamoto, Japan.	ykondo@kumamoto-u.ac.jp	KONDO, Yuki/ABB-9085-2020; Ishitsuka, Yoichi/H-5743-2019	KONDO, Yuki/0000-0003-1456-7721; Irie, Tetsumi/0000-0001-8664-7048; Ishitsuka, Yoichi/0000-0001-9442-4469				ALDEN ER, 1972, PEDIATRICS, V50, P40; ARANDA JV, 1979, CLIN PERINATOL, V6, P87, DOI 10.1016/S0095-5108(18)31165-5; BANAGALE RC, 1984, RESUSCITATION, V11, P9, DOI 10.1016/0300-9572(84)90030-3; Bhatia J, 2000, CLIN PEDIATR, V39, P327, DOI 10.1177/000992280003900602; Bhatt-Mehta Varsha, 2003, Paediatr Drugs, V5, P195, DOI 10.2165/00128072-200305030-00006; Blackmon LR, 2003, PEDIATRICS, V111, P914; BOUTROY MJ, 1979, J PEDIATR-US, V94, P996, DOI 10.1016/S0022-3476(79)80248-6; DURAND DJ, 1987, PEDIATRICS, V80, P684; Eichenwald EC, 1997, PEDIATRICS, V100, P354, DOI 10.1542/peds.100.3.354; Fukuda T, 2005, J CLIN PHARM THER, V30, P591, DOI 10.1111/j.1365-2710.2005.00689.x; HARGREAVES DB, 1983, J CLIN HOSP PHARM, V8, P133, DOI 10.1111/j.1365-2710.1983.tb01042.x; Henderson-Smart DJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000432.pub2; Henderson-Smart DJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000273.pub2; HENDERSONSMART DJ, 1981, AUST PAEDIATR J, V17, P273; KATTWINKEL J, 1977, J PEDIATR-US, V90, P342, DOI 10.1016/S0022-3476(77)80691-4; KAUFFMAN RE, 1992, PEDIATRICS, V89, P781; REESE J, 1994, ARCH DIS CHILD-FETAL, V71, pF51, DOI 10.1136/fn.71.1.F51; Rigatto H, 1984, PEDIATR CLIN N AM, V29, P1105; Skouroliakou M, 2009, J PAEDIATR CHILD H, V45, P587, DOI 10.1111/j.1440-1754.2009.01570.x	19	2	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157198	10.1371/journal.pone.0157198	http://dx.doi.org/10.1371/journal.pone.0157198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388444	Green Submitted, gold, Green Published			2022-12-26	WOS:000379811500003
J	Nguyen, DG; Funk, J; Robbins, JB; Crogan-Grundy, C; Presnell, SC; Singer, T; Roth, AB				Nguyen, Deborah G.; Funk, Juergen; Robbins, Justin B.; Crogan-Grundy, Candace; Presnell, Sharon C.; Singer, Thomas; Roth, Adrian B.			Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; TROVAFLOXACIN HEPATOTOXICITY; INJURY; HEPATOCYTES; CULTURE; LIPOPOLYSACCHARIDE; IDIOSYNCRASY; RELEVANT; SYSTEM	Modeling clinically relevant tissue responses using cell models poses a significant challenge for drug development, in particular for drug induced liver injury (DILI). This is mainly because existing liver models lack longevity and tissue-level complexity which limits their utility in predictive toxicology. In this study, we established and characterized novel bioprinted human liver tissue mimetics comprised of patient-derived hepatocytes and non-parenchymal cells in a defined architecture. Scaffold-free assembly of different cell types in an in vivo-relevant architecture allowed for histologic analysis that revealed distinct intercellular hepatocyte junctions, CD31+ endothelial networks, and desmin positive, smooth muscle actin negative quiescent stellates. Unlike what was seen in 2D hepatocyte cultures, the tissues maintained levels of ATP, Albumin as well as expression and drug-induced enzyme activity of Cytochrome P450s over 4 weeks in culture. To assess the ability of the 3D liver cultures to model tissue-level DILI, dose responses of Trovafloxacin, a drug whose hepatotoxic potential could not be assessed by standard pre-clinical models, were compared to the structurally related non-toxic drug Levofloxacin. Trovafloxacin induced significant, dose-dependent toxicity at clinically relevant doses (<= 4uM). Interestingly, Trovafloxacin toxicity was observed without lipopolysaccharide stimulation and in the absence of resident macrophages in contrast to earlier reports. Together, these results demonstrate that 3D bioprinted liver tissues can both effectively model DILI and distinguish between highly related compounds with differential profile. Thus, the combination of patient-derived primary cells with bioprinting technology here for the first time demonstrates superior performance in terms of mimicking human drug response in a known target organ at the tissue level.	[Nguyen, Deborah G.; Robbins, Justin B.; Crogan-Grundy, Candace; Presnell, Sharon C.] Organovo Holdings Inc, San Diego, CA USA; [Funk, Juergen; Singer, Thomas; Roth, Adrian B.] Roche Innovat Ctr, Roche Pharmaceut Res & Early Dev, Basel, Switzerland	Roche Holding	Nguyen, DG (corresponding author), Organovo Holdings Inc, San Diego, CA USA.	dnguyen@organovo.com	Funk, Juergen/AGD-6896-2022	Nguyen, Deborah/0000-0002-1694-0617	Roche Pharmaceuticals; Organovo Holdings Inc.	Roche Pharmaceuticals(Roche Holding); Organovo Holdings Inc.	All studies were funded internally by Roche Pharmaceuticals and Organovo Holdings Inc. No specific awards or grants funded this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoine DJ, 2013, BIOMARK MED, V7, P383, DOI [10.2217/BMM.13.42, 10.2217/bmm.13.42]; Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M; Boelsterli UA, 2007, TOXICOL APPL PHARM, V220, P92, DOI 10.1016/j.taap.2006.12.013; Cho CH, 2010, BIOTECHNIQUES, V48, P47, DOI 10.2144/000113317; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; De Minicis S, 2007, GASTROENTEROLOGY, V132, P1937, DOI 10.1053/j.gastro.2007.02.033; Forgacs G., 2012, US patent, Patent No. [US 8,241,905 B2, 8241905]; Forgacs G., 2014, US Pat, Patent No. [US 8,852,932 B2, 8852932]; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Godoy P, 2013, ARCH TOXICOL, V87, P1315, DOI 10.1007/s00204-013-1078-5; Jakab K, 2008, TISSUE ENG PT A, V14, P413, DOI 10.1089/tea.2007.0173; KAPLOWITZ N, 1986, ANN INTERN MED, V104, P826, DOI 10.7326/0003-4819-104-6-826; Kegel V, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/640631; Kostadinova R, 2013, TOXICOL APPL PHARM, V268, P1, DOI 10.1016/j.taap.2013.01.012; Lazarczyk DA, 2001, DIGEST DIS SCI, V46, P925, DOI 10.1023/A:1010741510046; Messner S, 2013, ARCH TOXICOL, V87, P209, DOI 10.1007/s00204-012-0968-2; Murphy K, 2015, United States of America patent, Patent No. [US 9,149,952 B2, 9149952]; Murphy SV, 2014, NAT BIOTECHNOL, V32, P773, DOI 10.1038/nbt.2958; Naisbitt DJ, 2000, DRUG SAFETY, V23, P483, DOI 10.2165/00002018-200023060-00002; Nguyen DG, 2016, ENG RENAL TISSUES AR; Nicholson SC, 2002, PHARMACOTHERAPY, V22, P794, DOI 10.1592/phco.22.9.794.34066; Oh MK, 2008, ALIMENT PHARM THER, V28, P503, DOI 10.1111/j.1365-2036.2008.03752.x; Olsen AL, 2011, AM J PHYSIOL-GASTR L, V301, pG110, DOI 10.1152/ajpgi.00412.2010; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Olson MJ, 1989, CELL INTERCOMMUNICAT; Otu HH, 2007, J BIOL CHEM, V282, P11197, DOI 10.1074/jbc.M608441200; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Robbins J. B., 2013, BIOPRINTED 3 DIMENSI; Robbins JB, 2013, STEM CELL M MES JOLL; Roth RA, 2003, J PHARMACOL EXP THER, V307, P1, DOI 10.1124/jpet.102.041624; Shaw PJ, 2007, TOXICOL SCI, V100, P259, DOI 10.1093/toxsci/kfm218; Shaw PJ, 2010, TOXICOL SCI, V118, P7, DOI 10.1093/toxsci/kfq168; Shepherd B. R., 2015, US Patent, Patent No. [US9222932, 9222932]; Soldatow VY, 2013, TOXICOL RES-UK, V2, P23, DOI 10.1039/c2tx20051a; Tostoes RM, 2012, HEPATOLOGY, V55, P1227, DOI 10.1002/hep.24760; Uetrecht J, 2003, DRUG DISCOV TODAY, V8, P832, DOI 10.1016/S1359-6446(03)02816-2; Uetrecht JP, 1999, CHEM RES TOXICOL, V12, P387, DOI 10.1021/tx980249i; Waring JF, 2006, J PHARMACOL EXP THER, V316, P1080, DOI 10.1124/jpet.105.096347; Watkins PB, 2005, HEPATOLOGY, V41, P229, DOI 10.1002/hep.20598; Watkins PB, 2005, TOXICOL PATHOL, V33, P1, DOI 10.1080/01926230590888306; Williams DP, 2003, DRUG DISCOV TODAY, V8, P1044, DOI 10.1016/S1359-6446(03)02888-5; Williamson B, 2013, ANTIMICROB AGENTS CH, V57, P6366, DOI 10.1128/AAC.01124-13; Zimmerman HJ., 1999, HEPATOTOXICITY ADVER, V2nd ed	43	214	228	6	114	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158674	10.1371/journal.pone.0158674	http://dx.doi.org/10.1371/journal.pone.0158674			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387377	gold, Green Published, Green Submitted			2022-12-26	WOS:000379811500036
J	Noar, RD; Daub, ME				Noar, Roslyn D.; Daub, Margaret E.			Bioinformatics Prediction of Polyketide Synthase Gene Clusters from Mycosphaerella fijiensis	PLOS ONE			English	Article							COLLO-CYGNI SUTTON; BLACK SIGATOKA; FUMONISIN B-1; PENTAKETIDE METABOLITES; MELANIN BIOSYNTHESIS; VERTICILLIUM-DAHLIAE; ASCOCHYTA-RABIEI; CAUSATIVE AGENT; CARRIER PROTEIN; DIELS-ALDERASE	Mycosphaerella fijiensis, causal agent of black Sigatoka disease of banana, is a Dothideo-mycete fungus closely related to fungi that produce polyketides important for plant pathogenicity. We utilized the M. fijiensis genome sequence to predict PKS genes and their gene clusters and make bioinformatics predictions about the types of compounds produced by these clusters. Eight PKS gene clusters were identified in the M. fijiensis genome, placing M. fijiensis into the 23rd percentile for the number of PKS genes compared to other Dothi-deomycetes. Analysis of the PKS domains identified three of the PKS enzymes as non-reducing and two as highly reducing. Gene clusters contained types of genes frequently found in PKS clusters including genes encoding transporters, oxidoreductases, methyl-transferases, and non-ribosomal peptide synthases. Phylogenetic analysis identified a putative PKS cluster encoding melanin biosynthesis. None of the other clusters were closely aligned with genes encoding known polyketides, however three of the PKS genes fell into clades with clusters encoding alternapyrone, fumonisin, and solanapyrone produced by Alternaria and Fusarium species. A search for homologs among available genomic sequences from 103 Dothideomycetes identified close homologs (>80% similarity) for six of the PKS sequences. One of the PKS sequences was not similar (<60% similarity) to sequences in any of the 103 genomes, suggesting that it encodes a unique compound. Comparison of the M. fijiensis PKS sequences with those of two other banana pathogens, M. musicola and M. eumusae, showed that these two species have close homologs to five of the M. fijiensis PKS sequences, but three others were not found in either species. RTPCR and RNA-Seq analysis showed that the melanin PKS cluster was down-regulated in infected banana as compared to growth in culture. Three other clusters, however were strongly upregulated during disease development in banana, suggesting that they may encode polyketides important in pathogenicity.	[Noar, Roslyn D.] North Carolina State Univ, Dept Plant Pathol, Raleigh, NC 27695 USA; [Daub, Margaret E.] North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Daub, ME (corresponding author), North Carolina State Univ, Dept Plant & Microbial Biol, Raleigh, NC 27695 USA.	margaret_daub@ncsu.edu		Noar, Roslyn/0000-0003-1645-7147	Dole Food Company; National Science Foundation; National Institutes of Health	Dole Food Company; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by a gift from Dole Food Company to MED and by graduate fellowships from the National Science Foundation and National Institutes of Health to RDN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie C, 2009, ACTA HORTIC, V828, P171; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Balint-Kurti P, 2004, BANANA IMPROVEMENT: CELLULAR, MOLECULAR BIOLOGY, AND INDUCED MUTATIONS, P147; BELL AA, 1976, TETRAHEDRON, V32, P1353, DOI 10.1016/0040-4020(76)85009-0; BELL AA, 1976, CAN J MICROBIOL, V22, P787, DOI 10.1139/m76-115; Beltran-Garcia MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091616; Blackwell BA, 1996, ADV EXP MED BIOL, V392, P75; Bradshaw RE, 2013, NEW PHYTOL, V198, P525, DOI 10.1111/nph.12161; BRANHAM BE, 1993, MYCOPATHOLOGIA, V124, P99, DOI 10.1007/BF01103109; Brush L, 1999, FUNGAL GENET BIOL, V28, P190, DOI 10.1006/fgbi.1999.1176; Caldas ED, 1998, J AGR FOOD CHEM, V46, P4734, DOI 10.1021/jf980210j; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chen HQ, 2007, MOL MICROBIOL, V64, P755, DOI 10.1111/j.1365-2958.2007.05689.x; Chen M, 2009, ADV PHOTOSYNTH RESP, V30, P77; Cho Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002974; Choquer M, 2005, MOL PLANT MICROBE IN, V18, P468, DOI 10.1094/MPMI-18-0468; CHUMLEY FG, 1990, MOL PLANT MICROBE IN, V3, P135, DOI 10.1094/MPMI-3-135; Churchill ACL, 2011, MOL PLANT PATHOL, V12, P307, DOI 10.1111/j.1364-3703.2010.00672.x; Cox RJ, 2007, ORG BIOMOL CHEM, V5, P2010, DOI 10.1039/b704420h; D.O.E. Joint Genome Institute, 2016, MYC FIJ V2 0; Droc G, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat035; Du L, 2008, J IND MICROBIOL BIOT, V35, P455, DOI 10.1007/s10295-008-0316-y; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finking R, 2004, BIOCHEMISTRY-US, V43, P8946, DOI 10.1021/bi0496891; Fujii I, 2005, CHEM BIOL, V12, P1301, DOI 10.1016/j.chembiol.2005.09.015; Gerber R, 2009, J AM CHEM SOC, V131, P3148, DOI 10.1021/ja8091054; Gilchrist DG, 1997, CELL DEATH DIFFER, V4, P689, DOI 10.1038/sj.cdd.4400312; Glenn AE, 2008, MOL PLANT MICROBE IN, V21, P87, DOI 10.1094/MPMI-21-1-0087; Goodwin S.B., 2014, GENOMICS PLANT ASS F, P123; Grigoriev I. V., 2011, Mycology - An International Journal on Fungal Biology, V2, P192; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Heiser I, 2004, PHYSIOL MOL PLANT P, V64, P135, DOI 10.1016/j.pmpp.2004.08.002; Heiser I, 2003, PHYSIOL MOL PLANT P, V62, P29, DOI 10.1016/S0885-5765(03)00007-9; Holler U, 2002, J NAT PROD, V65, P876, DOI 10.1021/np020097y; HOWARD RJ, 1989, EXP MYCOL, V13, P403, DOI 10.1016/0147-5975(89)90036-4; Huang WJ, 1998, EMBO J, V17, P1183, DOI 10.1093/emboj/17.5.1183; Jacobson ES, 2005, MED MYCOL, V43, P327, DOI 10.1080/13693780412331271081; Jenke-Kodama H, 2005, MOL BIOL EVOL, V22, P2027, DOI 10.1093/molbev/msi193; Kabir MS, 2015, PLANT PATHOL, V64, P225, DOI 10.1111/ppa.12229; Kasahara K, 2010, CHEMBIOCHEM, V11, P1245, DOI 10.1002/cbic.201000173; KAUR S, 1995, PLANT SCI, V109, P23, DOI 10.1016/0168-9452(95)04144-J; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keatinge-Clay AT, 2006, STRUCTURE, V14, P737, DOI 10.1016/j.str.2006.01.009; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kim W, 2015, MOL PLANT MICROBE IN, V28, P482, DOI 10.1094/MPMI-08-14-0234-R; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maddison WP., 2021, MESQUITE MODULAR SYS; Marasas WFO, 2004, J NUTR, V134, P711, DOI 10.1093/jn/134.4.711; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marin DH, 2003, PLANT DIS, V87, P208, DOI 10.1094/PDIS.2003.87.3.208; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mizushina Y, 2002, J BIOL CHEM, V277, P630, DOI 10.1074/jbc.M105144200; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nicoletti R, 2009, INT J MOL SCI, V10, P1430, DOI 10.3390/ijms10041430; Pata MO, 2010, NEW PHYTOL, V185, P611, DOI 10.1111/j.1469-8137.2009.03123.x; Peraza-Echeverria L, 2008, AUSTRALAS PLANT PATH, V37, P460, DOI 10.1071/AP08042; Perpetua NS, 1996, MOL PLANT MICROBE IN, V9, P323, DOI 10.1094/MPMI-9-0323; Ploetz R. C., 2001, PLANT HLTH INSTR, DOI [10.1094/PHI-I-2001-0126-02, DOI 10.1094/PHI-I-2001-0126-02]; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Sanchez-Rangel D, 2010, TOXIN REV, V29, P73, DOI 10.3109/15569543.2010.515370; Saparrat MCN, 2009, MYCOPATHOLOGIA, V168, P41, DOI 10.1007/s11046-009-9194-8; Seo JA, 2001, FUNGAL GENET BIOL, V34, P155, DOI 10.1006/fgbi.2001.1299; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Steiner U, 2007, PHYTOPATHOLOGY, V97, P1222, DOI 10.1094/PHYTO-97-10-1222; STIERLE AA, 1991, EXPERIENTIA, V47, P853, DOI 10.1007/BF01922472; STIPANOVIC RD, 1977, MYCOLOGIA, V69, P164, DOI 10.2307/3758627; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; UPADHYAY RK, 1990, EXPERIENTIA, V46, P982, DOI 10.1007/BF01939396; WANG YL, 1994, INFECT IMMUN, V62, P3004, DOI 10.1128/IAI.62.7.3004-3007.1994; Weissman KJ, 2015, NAT CHEM BIOL, V11, P660, DOI [10.1038/NCHEMBIO.1883, 10.1038/nchembio.1883]; WHEELER MH, 1985, ARCH MICROBIOL, V142, P234, DOI 10.1007/BF00693396; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Wight WD, 2009, MOL PLANT MICROBE IN, V22, P1258, DOI 10.1094/MPMI-22-10-1258; Yadav G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000351; Yoder OC, 1998, DEV PLANT PATHOL, V13, P3; Yu JJ, 2004, FEBS LETT, V564, P126, DOI 10.1016/S0014-5793(04)00327-8; Zhang Y, 2005, HDB IND MYCOLOGY, P410	81	17	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158471	10.1371/journal.pone.0158471	http://dx.doi.org/10.1371/journal.pone.0158471			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388157	gold, Green Published, Green Submitted			2022-12-26	WOS:000379811500021
J	Campbell, NG; Kaneko, M; Shintani, Y; Narita, T; Sawhney, V; Coppen, SR; Yashiro, K; Mathur, A; Suzuki, K				Campbell, Niall G.; Kaneko, Masahiro; Shintani, Yasunori; Narita, Takuya; Sawhney, Vinit; Coppen, Steven R.; Yashiro, Kenta; Mathur, Anthony; Suzuki, Ken			Cell Size Critically Determines Initial Retention of Bone Marrow Mononuclear Cells in the Heart after Intracoronary Injection: Evidence from a Rat Model	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; ISCHEMIC CARDIOMYOPATHY; THERAPY; DELIVERY; MICROVASCULATURE; TRANSPLANTATION; ENGRAFTMENT; INFUSION; DISEASE	Intracoronary injection of bone marrow mononuclear cells (BMMNC) is an emerging treatment for heart failure. Initial donor cell retention in the heart is the key to the success of this approach, but this process remains insufficiently characterized. Although it is assumed that cell size of injected cells may influence their initial retention, no scientific evidence has been reported. We developed a unique model utilizing an ex-vivo rat heart perfusion system, enabling quantitative assessment of retention of donor cells after intracoronary injection. The initial (5 minutes after intracoronary injection) retention rate of BMMNC was as low as approximately 20% irrespective of donor cell doses injected (1x10(6), 8x10(6), 4x10(7)). Quantitative cell-size assessment revealed a positive relationship between the size of BMMNC and retention ratio; larger subpopulations of BMMNC were more preferentially retained compared to smaller ones. Furthermore, a larger cell type-bone marrow-derived mesenchymal stromal cells (median size = 11.5 mu m versus 7.0 mu m for BMMNC)-had a markedly increased retention rate (77.5 +/- 1.8%). A positive relationship between the cell size and retention ratio was also seen in mesenchymal stromal cells. Flow-cytometric studies showed expression of cell-surface proteins, including integrins and selectin-ligands, was unchanged between pre-injection BMMNC and those exited from the heart, suggesting that biochemical interaction between donor cells and host coronary endothelium is not critical for BMMNC retention. Histological analyses showed that retained BMMNC and mesenchymal stromal cells were entrapped in the coronary vasculature and did not extravasate by 60 minutes after transplantation. Whilst BMMNC did not change coronary flow after intracoronary injection, mesenchymal stromal cells reduced it, suggesting coronary embolism, which was supported by the histological finding of intravascular cell-clump formation. These data indicate that cell-size dependent, passive (mechanical), intravascular entrapment is responsible for the initial donor cell retention after intracoronary injection of BMMNC in the heart having normal vasculatures (at least).	[Campbell, Niall G.; Kaneko, Masahiro; Shintani, Yasunori; Narita, Takuya; Sawhney, Vinit; Coppen, Steven R.; Yashiro, Kenta; Mathur, Anthony; Suzuki, Ken] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London	Suzuki, K (corresponding author), Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England.	ken.suzuki@qmul.ac.uk		MAthur, Anthony/0000-0001-7941-9653; Campbell, Niall/0000-0003-4269-3848; Shintani, Yasunori/0000-0001-9579-0727	British Heart Foundation Clinical Research Fellowship [FS/08/072]; National Institute for Health Research; British Heart Foundation [PG/12/10/29389, RG/15/3/31236] Funding Source: researchfish	British Heart Foundation Clinical Research Fellowship; National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This project was funded by British Heart Foundation Clinical Research Fellowship (FS/08/072 awarded to NGC), and also supported by the National Institute for Health Research-funded Barts Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal MR, 2015, CIRC RES, V117, P558, DOI 10.1161/CIRCRESAHA.114.304792; Assmus B, 2015, EUR HEART J; Bartolucci J, 2015, REV MED CHILE, V143, P415, DOI 10.4067/S0034-98872015000400001; BASSINGT.JB, 1974, MICROVASC RES, V7, P229, DOI 10.1016/0026-2862(74)90008-9; Campbell NG, 2012, J CARDIOVASC TRANSL, V5, P713, DOI 10.1007/s12265-012-9378-3; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; Choudry F, 2016, EUR HEART J, V37, P256, DOI 10.1093/eurheartj/ehv493; Delewi R, 2014, EUR HEART J, V35, P989, DOI 10.1093/eurheartj/eht372; Doyle B, 2007, J NUCL MED, V48, P1708, DOI 10.2967/jnumed.107.042838; Fisher SA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007888.pub2; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Fukushima S, 2011, J HEART LUNG TRANSPL, V30, P227, DOI 10.1016/j.healun.2010.09.002; Goebel S, 2003, J VASC RES, V40, P442, DOI 10.1159/000073909; Hedrich O, 2004, CORONARY ARTERY DIS, V15, P291, DOI 10.1097/01.mca.0000136186.85058.b8; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Kaneko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076908; Kim H, 2010, CIRC RES, V107, P602, DOI 10.1161/CIRCRESAHA.110.218396; Makela J, 2009, SCAND CARDIOVASC J, V43, P366, DOI 10.3109/14017430903045350; Martino H, 2015, EUR HEART J, V36, P2898, DOI 10.1093/eurheartj/ehv477; Mathiasen AB, 2015, EUR HEART J, V36, P1744, DOI 10.1093/eurheartj/ehv136; Nowbar AN, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2688; ONO T, 1986, SCAN ELECTRON MICROS, V1986, P263; Penicka M, 2007, HEART, V93, P837, DOI 10.1136/hrt.2006.091934; Shintani Y, 2013, P NATL ACAD SCI USA, V110, P5109, DOI 10.1073/pnas.1219243110; Shiraishi M, 2016, J CLIN INVEST; Surder D, 2013, CIRCULATION, V127, P1968, DOI 10.1161/CIRCULATIONAHA.112.001035; Tanol N, 2014, MOL THER, V22, P1864, DOI 10.1038/mt.2014.110; Taylor DA, 2015, CELL TRANSPLANT; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Toma C, 2009, CIRC RES, V104, P398, DOI 10.1161/CIRCRESAHA.108.187724; Traverse JH, 2012, JAMA-J AM MED ASSOC, V308, P2380, DOI 10.1001/jama.2012.28726; van der Spoel TIG, 2012, J CELL MOL MED, V16, P2768, DOI 10.1111/j.1582-4934.2012.01594.x	33	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158232	10.1371/journal.pone.0158232	http://dx.doi.org/10.1371/journal.pone.0158232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380410	gold, Green Submitted, Green Published			2022-12-26	WOS:000379798700023
J	Yugami, M; Odagiri, H; Endo, M; Tsutsuki, H; Fujii, S; Kadomatsu, T; Masuda, T; Miyata, K; Terada, K; Tanoue, H; Ito, H; Morinaga, J; Horiguchi, H; Sugizaki, T; Akaike, T; Gotoh, T; Takai, T; Sawa, T; Mizuta, H; Oike, Y				Yugami, Masaki; Odagiri, Haruki; Endo, Motoyoshi; Tsutsuki, Hiroyasu; Fujii, Shigemoto; Kadomatsu, Tsuyoshi; Masuda, Tetsuro; Miyata, Keishi; Terada, Kazutoyo; Tanoue, Hironori; Ito, Hitoshi; Morinaga, Jun; Horiguchi, Haruki; Sugizaki, Taichi; Akaike, Takaaki; Gotoh, Tomomi; Takai, Toshiyuki; Sawa, Tomohiro; Mizuta, Hiroshi; Oike, Yuichi			Mice Deficient in Angiopoietin-like Protein 2 (Angptl2) Gene Show Increased Susceptibility to Bacterial Infection Due to Attenuated Macrophage Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHESIS; IFN-GAMMA; MYCOBACTERIUM-TUBERCULOSIS; INTERFERON-GAMMA; HOST-DEFENSE; IN-VITRO; GM-CSF; INFLAMMATION; SALMONELLA; EXPRESSION	Macrophages play crucial roles in combatting infectious disease by promoting inflammation and phagocytosis. Angiopoiefin-like protein 2 (ANGPTL2) is a secreted factor that induces tissue inflammation by attracting and activating macrophages to produce inflammatory cytokines in chronic inflammation associated diseases such as obesity-associated metabolic syndrome, atherosclerosis, and rheumatoid arthritis. Here, we asked whether and how ANGPTL2 activates macrophages in the innate immune response. ANGPTL2 was predominantly expressed in proinflammatory mouse bone marrow-derived differentiated macrophages (GM-BMMs) following GM-CSF treatment relative to anti-inflammatory cells (M-BMMs) established by M-CSF treatment. Expression of the proinflammatory markers IL-1 beta, IL-12p35, and IL-12p10 significantly decreased in GM-BMMs from Angpt12-deficient compared with wild-type (WT) mice, suggestive of attenuated proinflammatory activity. We also report that ANGPTL2 inflammatory signaling is transduced through integrin alpha 5 beta 1 rather than through paired immunoglobulin-like receptor B. Interestingly, Angpt12-deficient mice were more susceptible to infection with Salmonella enterica serovar Typhimurium than were WT mice, Moreover, nitric oxide (NO) production by Angpt/2-deficient GM-BMMs was significantly lower than in WT GM-BMMs. Collectively, our findings suggest that macrophage-derived ANGPTL2 promotes an innate immune response in those cells by enhancing proinflammatory activity and NO production required to fight infection.	[Yugami, Masaki; Odagiri, Haruki; Endo, Motoyoshi; Kadomatsu, Tsuyoshi; Masuda, Tetsuro; Miyata, Keishi; Terada, Kazutoyo; Tanoue, Hironori; Ito, Hitoshi; Morinaga, Jun; Horiguchi, Haruki; Sugizaki, Taichi; Gotoh, Tomomi; Oike, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Kumamoto 8608556, Japan; [Yugami, Masaki; Odagiri, Haruki; Masuda, Tetsuro; Tanoue, Hironori; Ito, Hitoshi; Mizuta, Hiroshi] Kumamoto Univ, Grad Sch Med Sci, Dept Orthoped Surg, Kumamoto 8608556, Japan; [Tsutsuki, Hiroyasu; Sawa, Tomohiro] Kumamoto Univ, Grad Sch Med Sci, Dept Microbiol, Kumamoto 8608556, Japan; [Fujii, Shigemoto; Akaike, Takaaki] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci & Mol Toxicol, Sendai, Miyagi 9808575, Japan; [Takai, Toshiyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Expt Immunol, Sendai, Miyagi 9808575, Japan; [Oike, Yuichi] Japan Agcy Med Res & Dev AMED, CREST, Tokyo 1020076, Japan	Kumamoto University; Kumamoto University; Kumamoto University; Tohoku University; Tohoku University; Japan Science & Technology Agency (JST)	Endo, M; Oike, Y (corresponding author), Kumamoto Univ, Dept Mol Genet, 1-1-1 Honjo, Kumamoto 8608556, Japan.	enmoto@gpo.kurnamoto-u.ac.jp; oike@gpo.kumamoto-u.ac.jp	Miyata, Keishi/HGF-1876-2022; Endo, Motoyoshi/T-5840-2019	Miyata, Keishi/0000-0003-0336-1859; 	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan [15K20008, 25461192, 15H01159]; Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency [13417915]; CREST program of the Japan Agency for Medical Research and Development [15gm0610007h0003]; Grants-in-Aid for Scientific Research [15H06508] Funding Source: KAKEN	Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); CREST program of the Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Scientific Research Fund of the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants 15K20008, 25461192, and 15H01159), the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (Grant 13417915), and the CREST program of the Japan Agency for Medical Research and Development (Grant 15gm0610007h0003). The authors declare that they have no conflicts of interest with the contents of this article.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; Beletskii A, 2005, BIOTECHNIQUES, V39, P894, DOI 10.2144/000112001; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Chacon-Salinas R, 2005, CLIN EXP IMMUNOL, V140, P443, DOI 10.1111/j.1365-2249.2005.02797.x; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Cunnick J, 2006, J IMMUNOL METHODS, V311, P96, DOI 10.1016/j.jim.2006.01.017; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Haverslag RT, 2013, CURR VASC PHARMACOL, V11, P21; Henard CA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00084; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Igietseme JU, 1998, INFECT IMMUN, V66, P1282, DOI 10.1128/IAI.66.4.1282-1286.1998; JAMES SL, 1995, MICROBIOL REV, V59, P533, DOI 10.1128/MMBR.59.4.533-547.1995; Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Kubota Y, 2005, GENE EXPR PATTERNS, V5, P679, DOI 10.1016/j.modgep.2005.02.006; Lacey DC, 2012, J IMMUNOL, V188, P5752, DOI 10.4049/jimmunol.1103426; Lari R, 2007, BONE, V40, P323, DOI 10.1016/j.bone.2006.09.003; Lima DS, 2013, NAT MED, V19, P909, DOI 10.1038/nm.3221; Mantovani A, 2008, EUR J IMMUNOL, V38, P3269, DOI 10.1002/eji.200838918; Martin AM, 2002, TRENDS IMMUNOL, V23, P81, DOI 10.1016/S1471-4906(01)02155-X; MELNICOFF MJ, 1988, J LEUKOCYTE BIOL, V44, P367, DOI 10.1002/jlb.44.5.367; Murphy JT, 2006, PHYSIOL GENOMICS, V28, P67, DOI 10.1152/physiolgenomics.00098.2006; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; NATHAN CF, 1991, CURR OPIN IMMUNOL, V3, P65, DOI 10.1016/0952-7915(91)90079-G; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; Shimizu T, 2012, MOL MICROBIOL, V85, P492, DOI 10.1111/j.1365-2958.2012.08122.x; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Terzyan SS, 1999, J MOL BIOL, V285, P205, DOI 10.1006/jmbi.1998.2288; Thale C, 2005, IMMUNOBIOLOGY, V210, P673, DOI 10.1016/j.imbio.2005.07.003; Torii I, 2008, J IMMUNOL, V181, P4229, DOI 10.4049/jimmunol.181.6.4229; Tsutsuki H, 2012, INFECT IMMUN, V80, P3939, DOI 10.1128/IAI.00581-12; Ujike A, 2002, NAT IMMUNOL, V3, P542, DOI 10.1038/ni801; Umezawa K, 1997, INFECT IMMUN, V65, P2932, DOI 10.1128/IAI.65.7.2932-2940.1997; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342	46	10	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18843	18852		10.1074/jbc.M116.720870	http://dx.doi.org/10.1074/jbc.M116.720870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402837	hybrid, Green Published			2022-12-26	WOS:000383242300020
J	Smith, TH; Coronel, LJ; Li, JG; Dores, MR; Nieman, MT; Trejo, J				Smith, Thomas H.; Coronel, Luisa J.; Li, Julia G.; Dores, Michael R.; Nieman, Marvin T.; Trejo, JoAnn			Protease-activated Receptor-4 Signaling and Trafficking Is Regulated by the Clathrin Adaptor Protein Complex-2 Independent of -Arrestins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						arrestin; clathrin; extracellular-signal-regulated kinase (ERK); G protein-coupled receptor (GPCR); lysosome; thrombin; Akt; adaptor protein complex-2; megakaryocyte	INTRACELLULAR TRAFFICKING; INTERNALIZATION; ENDOCYTOSIS; PAR4; REQUIREMENTS; MECHANISMS; MOTIF; AP-2; PHOSPHORYLATION; HEMOSTASIS	Protease-activated receptor-4 (PAR4) is a G protein-coupled receptor (GPCR) for thrombin and is proteolytically activated, similar to the prototypical PAR1. Due to the irreversible activation of PAR1, receptor trafficking is intimately linked to signal regulation. However, unlike PAR1, the mechanisms that control PAR4 trafficking are not known. Here, we sought to define the mechanisms that control PAR4 trafficking and signaling. In HeLa cells depleted of clathrin by siRNA, activated PAR4 failed to internalize. Consistent with clathrin-mediated endocytosis, expression of a dynamin dominant-negative K44A mutant also blocked activated PAR4 internalization. However, unlike most GPCRs, PAR4 internalization occurred independently of -arrestins and the receptor's C-tail domain. Rather, we discovered a highly conserved tyrosine-based motif in the third intracellular loop of PAR4 and found that the clathrin adaptor protein complex-2 (AP-2) is important for internalization. Depletion of AP-2 inhibited PAR4 internalization induced by agonist. In addition, mutation of the critical residues of the tyrosine-based motif disrupted agonist-induced PAR4 internalization. Using Dami megakaryocytic cells, we confirmed that AP-2 is required for agonist-induced internalization of endogenous PAR4. Moreover, inhibition of activated PAR4 internalization enhanced ERK1/2 signaling, whereas Akt signaling was markedly diminished. These findings indicate that activated PAR4 internalization requires AP-2 and a tyrosine-based motif and occurs independent of -arrestins, unlike most classical GPCRs. Moreover, these findings are the first to show that internalization of activated PAR4 is linked to proper ERK1/2 and Akt activation.	[Smith, Thomas H.] Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Smith, Thomas H.; Coronel, Luisa J.; Li, Julia G.; Dores, Michael R.; Trejo, JoAnn] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Dores, Michael R.] Hofstra Univ, Dept Biol, Hempstead, NY 11549 USA; [Nieman, Marvin T.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44016 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Hofstra University; Case Western Reserve University	Trejo, J (corresponding author), Univ Calif San Diego, Dept Pharmacol, Biomed Sci Bldg 3044A,9500 Gilman Dr, La Jolla, CA 92093 USA.	joanntrejo@ucsd.edu		Smith, Thomas/0000-0002-8798-7228; Orlando, Luisa/0000-0002-3177-5242	National Institutes of Health (NIGMS) [R01 GM090689]; NHLBI, National Institutes of Health [F31 HL116187]; Initiative for Maximizing Student Development at UCSD; San Diego IRACDA (Institutional Research and Academic Career Development Award) Program NIH [K12 GM06852]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, K12GM068524, R01GM090689] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Initiative for Maximizing Student Development at UCSD; San Diego IRACDA (Institutional Research and Academic Career Development Award) Program NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM090689 (NIGMS; to J. T.). The authors declare that they have no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by an NHLBI, National Institutes of Health Predoctoral Fellowship F31 HL116187.; Supported by the Initiative for Maximizing Student Development at UCSD.; Supported by the San Diego IRACDA (Institutional Research and Academic Career Development Award) Program NIH K12 GM06852.	Brass LF, 2003, CHEST, V124, p18S, DOI 10.1378/chest.124.3_suppl.18S; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Dores MR, 2012, MOL BIOL CELL, V23, P3612, DOI 10.1091/mbc.E12-03-0251; Dores MR, 2012, J CELL BIOL, V197, P407, DOI 10.1083/jcb.201110031; Edelstein LC, 2014, BLOOD, V124, P3450, DOI 10.1182/blood-2014-04-572479; Edelstein LC, 2013, NAT MED, V19, P1609, DOI 10.1038/nm.3385; French SL, 2015, BLOOD REV, V29, P179, DOI 10.1016/j.blre.2014.10.006; Gasnereau I, 2011, J BIOL CHEM, V286, P43324, DOI 10.1074/jbc.M111.307231; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Grimsey N, 2014, METHOD ENZYMOL, V535, P389, DOI 10.1016/B978-0-12-397925-4.00022-5; Grimsey NJ, 2015, J CELL BIOL, V210, P1117, DOI 10.1083/jcb.201504007; Holinstat M, 2006, J BIOL CHEM, V281, P26665, DOI 10.1074/jbc.M602174200; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Khan A, 2014, MOL PHARMACOL, V86, P1, DOI 10.1124/mol.114.091595; Khandoga AL, 2011, CARDIOVASC RES, V90, P157, DOI 10.1093/cvr/cvq369; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Li DJ, 2011, J BIOL CHEM, V286, P3805, DOI 10.1074/jbc.M110.118018; Magnone M, 2008, J BIOL CHEM, V283, P24460, DOI 10.1074/jbc.M710568200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mumaw MM, 2015, THROMB RES, V135, P1165, DOI 10.1016/j.thromres.2015.03.027; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Ricks TK, 2009, J BIOL CHEM, V284, P34444, DOI 10.1074/jbc.M109.048942; Rosciglione S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5556; SCARBOROUGH RM, 1992, J BIOL CHEM, V267, P13146; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Shapiro MJ, 2000, J BIOL CHEM, V275, P25216, DOI 10.1074/jbc.M004589200; Shapiro MJ, 1996, J BIOL CHEM, V271, P32874, DOI 10.1074/jbc.271.51.32874; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Tian XF, 2016, J BIOL CHEM, V291, P14510, DOI 10.1074/jbc.M116.716589; Tourdot BE, 2014, ARTERIOSCL THROM VAS, V34, P2644, DOI 10.1161/ATVBAHA.114.304249; Trejo J, 2000, J BIOL CHEM, V275, P31255, DOI 10.1074/jbc.M003770200; Trejo J, 1999, J BIOL CHEM, V274, P2216, DOI 10.1074/jbc.274.4.2216; Trejo J, 1998, P NATL ACAD SCI USA, V95, P13698, DOI 10.1073/pnas.95.23.13698; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; Withey JME, 2005, BRIT J HAEMATOL, V129, P377, DOI 10.1111/j.1365-2141.2005.05468.x; Wolfe BL, 2007, J CELL BIOL, V177, P905, DOI 10.1083/jcb.200610154; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Woulfe DS, 2005, J THROMB HAEMOST, V3, P2193, DOI 10.1111/j.1538-7836.2005.01338.x; Zhang J, 1996, J BIOL CHEM, V271, P18302, DOI 10.1074/jbc.271.31.18302	53	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18453	18464		10.1074/jbc.M116.729285	http://dx.doi.org/10.1074/jbc.M116.729285			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402844	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000383241800035
J	Adu-Gyamfi, R; Wetten, A; Lopez, CMR				Adu-Gyamfi, Raphael; Wetten, Andy; Lopez, Carlos Marcelino Rodriguez			Effect of Cryopreservation and Post-Cryopreservation Somatic Embryogenesis on the Epigenetic Fidelity of Cocoa (Theobroma cacao L.)	PLOS ONE			English	Article							ELAEIS-GUINEENSIS JACQ.; DNA METHYLATION CHANGES; IN-VITRO; SOMACLONAL VARIATION; TISSUE-CULTURE; GENETIC FIDELITY; EMBRYOS; QUANTIFICATION; STABILITY; SEQUENCE	While cocoa plants regenerated from cryopreserved somatic embryos can demonstrate high levels of phenotypic variability, little is known about the sources of the observed variability. Previous studies have shown that the encapsulation-dehydration cryopreservation methodology imposes no significant extra mutational load since embryos carrying high levels of genetic variability are selected against during protracted culture. Also, the use of secondary rather than primary somatic embryos has been shown to further reduce the incidence of genetic somaclonal variation. Here, the effect of in vitro conservation, cryopreservation and post-cryopreservation generation of somatic embryos on the appearance of epigenetic somaclonal variation were comparatively assessed. To achieve this we compared the epigenetic profiles, generated using Methylation Sensitive Amplified Polymorphisms, of leaves collected from the ortet tree and from cocoa somatic embryos derived from three in vitro conditions: somatic embryos, somatic embryos cryopreserved in liquid nitrogen and somatic embryos generated from cryoproserved somatic embryos. Somatic embryos accumulated epigenetic changes but these were less extensive than in those regenerated after storage in LN. Furthermore, the passage of cryopreserved embryos through another embryogenic stage led to further increase in variation. Interestingly, this detected variability appears to be in some measure reversible. The outcome of this study indicates that the cryopreservation induced phenotypic variability could be, at least partially, due to DNA methylation changes. Key message: Phenotypic variability observed in cryostored cocoa somatic-embryos is epigenetic in nature. This variability is partially reversible, not stochastic in nature but a directed response to the in-vitro culture and cryopreservation.	[Adu-Gyamfi, Raphael] Univ Dev Studies, Fac Agr, POB TL 1882, Tamale, Ghana; [Wetten, Andy] Univ Reading, Sch Agr Policy & Dev, Reading RG6 6AS, Berks, England; [Lopez, Carlos Marcelino Rodriguez] Univ Adelaide, Fac Sci, Sch Agr Food & Wine, Environm Epigenet & Genet Grp,Plant Res Ctr, Waite Campus,PMB1, Glen Osmond, SA 5064, Australia	University for Development Studies; University of Reading; University of Adelaide	Lopez, CMR (corresponding author), Univ Adelaide, Fac Sci, Sch Agr Food & Wine, Environm Epigenet & Genet Grp,Plant Res Ctr, Waite Campus,PMB1, Glen Osmond, SA 5064, Australia.	carlos.rodriguezlopez@adelaide.edu.au		Rodriguez Lopez, Carlos Marcelino/0000-0002-9704-9788	Ghana government through Ghana Education Trust Fund (GETFund)	Ghana government through Ghana Education Trust Fund (GETFund)	This project was funded by Ghana government through Ghana Education Trust Fund (GETFund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu-Gyamfi R, 2012, CRYOLETTERS, V33, P494; Alemanno L, 1997, IN VITRO CELL DEV-PL, V33, P163, DOI 10.1007/s11627-997-0016-8; Alemanno L, 1996, PLANT CELL TISS ORG, V46, P187, DOI 10.1007/BF02307094; Alonso C, 2016, MOL ECOL RESOUR, V16, P80, DOI 10.1111/1755-0998.12426; Amoah S, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-193; Aronen TS, 1999, PLANT SCI, V142, P163, DOI 10.1016/S0168-9452(98)00244-1; Baranek M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126638; Bardini M, 2003, PLANT CELL TISS ORG, V72, P157, DOI 10.1023/A:1022208302819; Bednarek PT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-10; Burg K, 2007, J EXP BOT, V58, P687, DOI 10.1093/jxb/erl241; Chakrabarty D, 2003, PLANT SCI, V165, P61, DOI 10.1016/S0168-9452(03)00127-4; Cote FX, 2001, IN VITRO CELL DEV-PL, V37, P539; Dann AL, 2011, PLANT CELL REP, V30, P631, DOI 10.1007/s00299-010-0983-9; Davey C, 1997, J MOL BIOL, V267, P276, DOI 10.1006/jmbi.1997.0899; Gimenez MD, 2016, PLANT CELL REP, V35, P129, DOI 10.1007/s00299-015-1874-x; Fang JY, 2009, AGR FOOD SCI, V18, P152, DOI 10.2137/145960609789267579; Fang JY, 2004, PLANT SCI, V166, P669, DOI 10.1016/j.plantsci.2003.11.002; Guiltinan M. J., 2007, Transgenic Crops V, P497; HARDING K, 1994, PLANT CELL TISS ORG, V37, P31, DOI 10.1007/BF00048114; INAMDAR NM, 1991, PLANT MOL BIOL, V17, P111, DOI 10.1007/BF00036811; Jaligot E, 2000, PLANT CELL REP, V19, P684, DOI 10.1007/s002999900177; Joyce SM, 2002, PLANT CELL TISS ORG, V70, P125, DOI 10.1023/A:1016312303320; Kaity A, 2008, PLANT CELL REP, V27, P1529, DOI 10.1007/s00299-008-0558-1; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Kitimu SR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00590; Li ZJ, 1998, IN VITRO CELL DEV-PL, V34, P293, DOI 10.1007/BF02822737; Lopez CMR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00397; Lopez CMR, 2010, NEW PHYTOL, V186, P856, DOI 10.1111/j.1469-8137.2010.03242.x; Lopez CMR, 2010, MOL BREEDING, V25, P501, DOI 10.1007/s11032-009-9348-x; Lopez CMR, 2004, THEOR APPL GENET, V110, P157, DOI 10.1007/s00122-004-1823-5; Martin C, 2011, J PLANT PHYSIOL, V168, P158, DOI 10.1016/j.jplph.2010.06.025; Matthes M, 2001, THEOR APPL GENET, V102, P971, DOI 10.1007/s001220000491; Maximova SN, 2002, IN VITRO CELL DEV-PL, V38, P252, DOI 10.1079/IVP2001257; Miguel C, 2011, J EXP BOT, V62, P3713, DOI 10.1093/jxb/err155; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peredo EL, 2009, J PLANT PHYSIOL, V166, P1101, DOI 10.1016/j.jplph.2008.12.015; PHILLIPS RL, 1994, P NATL ACAD SCI USA, V91, P5222, DOI 10.1073/pnas.91.12.5222; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Lopez CMR, 2012, FOOD CHEM, V131, P1493, DOI 10.1016/j.foodchem.2011.09.120; Schmitt F, 1997, J BIOL CHEM, V272, P1534, DOI 10.1074/jbc.272.3.1534; Smykal P, 2007, PLANT CELL REP, V26, P1985, DOI 10.1007/s00299-007-0413-9; Soen Y, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0097-y; Tan CL, 2003, PLANT SCI, V164, P407, DOI 10.1016/S0168-9452(02)00428-4; Tuttle JR, 2008, PLANT PHYSIOL, V148, P41, DOI 10.1104/pp.108.123869; Vogt G, 2015, J BIOSCIENCES, V40, P159, DOI 10.1007/s12038-015-9506-8; Wetten A, 2009, CRYOLETTERS, V30, P84; Wilkinson T, 2003, ANN BOT-LONDON, V91, P65, DOI 10.1093/aob/mcg009; Xiong LZ, 1999, MOL GEN GENET, V261, P439, DOI 10.1007/s004380050986	48	16	16	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158857	10.1371/journal.pone.0158857	http://dx.doi.org/10.1371/journal.pone.0158857			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403857	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000379508200018
J	Bonazza, C; Andrade, SS; Sumikawa, JT; Batista, FP; Paredes-Gamero, EJ; Girao, MJBC; Oliva, MLV; Castro, RA				Bonazza, Camila; Andrade, Sheila Siqueira; Sumikawa, Joana Tomomi; Batista, Fabricio Pereira; Paredes-Gamero, Edgar J.; Girao, Manoel J. B. C.; Oliva, Maria Luiza V.; Castro, Rodrigo Aquino			Primary Human Uterine Leiomyoma Cell Culture Quality Control: Some Properties of Myometrial Cells Cultured under Serum Deprivation Conditions in the Presence of Ovarian Steroids	PLOS ONE			English	Article							SMOOTH-MUSCLE; STEM-CELLS; EXPRESSION; GROWTH; CYCLE; PREGNANCY; PROTEINS; ACTIVATE; ESTROGEN; UTERUS	Cell culture is considered the standard media used in research to emulate the in vivo cell environment. Crucial in vivo experiments cannot be conducted in humans and depend on in vitro methodologies such as cell culture systems. However, some procedures involving the quality control of cells in culture have been gradually neglected by failing to acknowledge that primary cells and cell lines change over time in culture. Thus, we report methods based on our experience for monitoring primary cell culture of human myometrial cells derived from uterine leiomyoma. We standardized the best procedure of tissue dissociation required for the study of multiple genetic marker systems that include species-specific antigens, expression of myofibroblast or myoblast markers, growth curve, serum deprivation, starvation by cell cycle synchronization, culture on collagen coated plates, and 17 beta-estradiol (E-2) and progesterone (P-4) effects. The results showed that primary myometrial cells from patients with uterine leiomyoma displayed myoblast phenotypes before and after in vitro cultivation, and leiomyoma cells differentiated into mature myocyte cells under the appropriate differentiation-inducing conditions (serum deprivation). These cells grew well on collagen coated plates and responded to E2 and P4, which may drive myometrial and leiomyoma cells to proliferate and adhere into a focal adhesion complex involvement in a paracrine manner. The establishment of these techniques as routine procedures will improve the understanding of the myometrial physiology and pathogenesis of myometrium-derived diseases such as leiomyoma. Mimicking the in vivo environment of fibrotic conditions can prevent false results and enhance results that are based on cell culture integrity.	[Bonazza, Camila; Andrade, Sheila Siqueira; Sumikawa, Joana Tomomi; Girao, Manoel J. B. C.; Castro, Rodrigo Aquino] Univ Fed Sao Paulo, Dept Gynecol, Sao Paulo, SP, Brazil; [Batista, Fabricio Pereira; Paredes-Gamero, Edgar J.; Oliva, Maria Luiza V.] Univ Fed Sao Paulo, Dept Biochem, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Castro, RA (corresponding author), Univ Fed Sao Paulo, Dept Gynecol, Sao Paulo, SP, Brazil.	rodrigo.castro@uol.com.br	Oliva, Maria Luiza V/B-9537-2012; Girao, Manoel Batista Castello/ABA-6558-2021; Bonazza, Camila/ABG-1495-2020; Castro, Rodrigo A/F-3195-2012; Paredes-Gamero, Edgar J/C-4791-2012; Vilela Oliva, Maria Luiza/AGI-6283-2022; Pereira Batista, Fabricio/H-6089-2016; Andrade, Sheila/E-1215-2012	Castro, Rodrigo A/0000-0002-0959-7363; Paredes-Gamero, Edgar J/0000-0003-3686-8402; Pereira Batista, Fabricio/0000-0001-5386-9584; Bonazza, Camila/0000-0002-7346-2746; Oliva, Maria Luiza/0000-0002-5822-0060; Andrade, Sheila/0000-0001-5524-1360	Associacao Beneficente de Coleta de Sangue (Colsan); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/19780-3, 2012/19851-8, 2009/53766-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Associacao Beneficente de Coleta de Sangue (Colsan); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Associacao Beneficente de Coleta de Sangue (Colsan), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - Process 2012/19780-3, 2012/19851-8 and 2009/53766-5), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).; This study was supported by the Associacao Beneficente de Coleta de Sangue (Colsan), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-Process 2012/19780-3, 2012/19851-8 and 2009/53766-5), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). We are thankful to Magda Theodoro for the technical assistance. The authors have no conflicts of interests to disclose.	de Paula CAA, 2012, J BIOL CHEM, V287, P170, DOI 10.1074/jbc.M111.263996; Basu A, 1998, MOL HUM REPROD, V4, P1099, DOI 10.1093/molehr/4.12.1099; Belt AR, 1999, AM J OBSTET GYNECOL, V181, P359, DOI 10.1016/S0002-9378(99)70562-4; BORNSTEIN MB, 1958, LAB INVEST, V7, P134; Bulun SE, 2013, NEW ENGL J MED, V369, P1344, DOI 10.1056/NEJMra1209993; Capes-Davis A, 2010, INT J CANCER, V127, P1, DOI 10.1002/ijc.25242; Chen MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028203; Condon J, 2002, BIOL REPROD, V67, P506, DOI 10.1095/biolreprod67.2.506; Davis PK, 2001, BIOTECHNIQUES, V30, P1322, DOI 10.2144/01306rv01; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Dimco G, 2010, CELL CYCLE, V9, P4638, DOI 10.4161/cc.9.23.13955; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; Fitzgibbon J, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-2; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoekstra AV, 2009, J CLIN ENDOCR METAB, V94, P1768, DOI 10.1210/jc.2008-2093; Holdsworth-Carson SJ, 2014, MOL HUM REPROD, V20, P250, DOI 10.1093/molehr/gat083; Karginov AV, 2014, NAT CHEM BIOL, V10, P286, DOI [10.1038/NCHEMBIO.1477, 10.1038/nchembio.1477]; KIRKLAND JL, 1979, BIOL REPROD, V21, P269, DOI 10.1095/biolreprod21.2.269; Moore AB, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-10; Moravek MB, 2015, HUM REPROD UPDATE, V21, P1, DOI 10.1093/humupd/dmu048; Mosher AA, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S7; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Riley M, 2005, J CELL MOL MED, V9, P122, DOI 10.1111/j.1582-4934.2005.tb00342.x; Rohr S, 2011, J CARDIOVASC PHARM, V57, P389, DOI 10.1097/FJC.0b013e3182137e17; Ruiz-Cortes Z.T., 2012, STEROIDS PHYSL CLIN, P3, DOI [10.5772/52994, DOI 10.5772/52994]; Sakaguchi H, 2003, STEROIDS, V68, P11, DOI 10.1016/S0039-128X(02)00111-3; Shaw JE, 1998, IN VITRO CELL DEV-AN, V34, P604, DOI 10.1007/s11626-996-0002-1; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; Sparey C, 1999, J CLIN ENDOCR METAB, V84, P1705, DOI 10.1210/jc.84.5.1705; Tanaka A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061540; Weinberg RA, 2014, BIOLOGY OF CANCER, SECOND EDITION, P1; WORD RA, 1993, J CLIN INVEST, V92, P29, DOI 10.1172/JCI116564; Wu XX, 2002, J STEROID BIOCHEM, V80, P77, DOI 10.1016/S0960-0760(01)00177-7; YANG NS, 1981, CANCER RES, V41, P4093; Yin P, 2007, J CLIN ENDOCR METAB, V92, P4459, DOI 10.1210/jc.2007-0725; Young L, 2010, NAT PROTOC, V5, P929, DOI 10.1038/nprot.2010.43; Zaitseva M, 2008, HUM REPROD, V23, P1076, DOI 10.1093/humrep/den083; Zhao D, 2013, REPROD BIOMED ONLINE, V27, P64, DOI 10.1016/j.rbmo.2013.04.001	38	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158578	10.1371/journal.pone.0158578	http://dx.doi.org/10.1371/journal.pone.0158578			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391384	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400082
J	Brzuzan, P; Florczyk, M; Lakomiak, A; Wozny, M				Brzuzan, Pawel; Florczyk, Maciej; Lakomiak, Alicja; Wozny, Maciej			Illumina Sequencing Reveals Aberrant Expression of MicroRNAs and Their Variants in Whitefish (Coregonus lavaretus) Liver after Exposure to Microcystin-LR	PLOS ONE			English	Article							GENE-EXPRESSION; RAINBOW-TROUT; MATURE MICRORNAS; DRINKING-WATER; 3' ADENYLATION; IN-VIVO; C-MYC; CANCER; INSIGHTS; PATHWAYS	Molecular analyses show that challenging fish with microcystin-LR (MC-LR) causes perturbations of microRNA (miRNA) signaling. However, the significance and scope of these alterations is currently unknown. To address this issue, we studied miRNA gene expression in the liver of juvenile whitefish, C. lavaretus, during 28 days of exposure to a subacute dose of MC-LR (100 mu g.kg(-1) body mass). Using genomic resources of Atlantic salmon (AGKD03), the mature miRNA library of Atlantic salmon (miRBase-21) and bioinformatics tools (sRNAbench), we discovered and annotated a total of 377 distinct mature miRNAs belonging to 93 families of evolutionary conserved miRNAs, as well as 24 novel mature miRNA candidates that were mapped to 14 distinct S. salar miRNA precursors. miRNA-Seq transcriptome profiling of liver tissues revealed differential miRNA expression in control and treated fish at 14 days (73 miRNAs were modulated) and at 28 days (83 miRNAs) of the treatment, subsequently validated by qPCR for nine selected differentially expressed miRNAs. Additional qPCR study confirmed the miRNA-Seq data and revealed consistent, aberrant miRNAs expression profile in the later phase of MC-LR hepatotoxicity (7-28 d). Functional annotation analysis revealed that the aberrantly expressed miRNAs have target genes involved in cytoskeletal remodeling, cell metabolism, cell cycle regulation and apoptosis; dysregulation of these processes in liver cells leads to cirrhosis and hepatocellular carcinoma in humans. To enable deeper insight into the molecular responses of liver cells in fish exposed to MC-LR, we expanded the miRNAome analysis by inclusion of miRNA variants (isomiRs) profiles, and we showed that the isomiR profiles of liver specific MiR122, and a few other miRNAs, correlated with MC-LR treatment. Given the importance of isomiRs for disease biology in mammals, we believe that further research focused on the miRNA isoforms will bring us closer to better understanding the molecular mechanisms of MC-LR hepatotoxicity.	[Brzuzan, Pawel; Florczyk, Maciej; Lakomiak, Alicja; Wozny, Maciej] Univ Warmia & Mazury, Fac Environm Sci, Dept Environm Biotechnol, Olsztyn, Poland	University of Warmia & Mazury	Brzuzan, P (corresponding author), Univ Warmia & Mazury, Fac Environm Sci, Dept Environm Biotechnol, Olsztyn, Poland.	brzuzan@uwm.edu.pl	Brzuzan, Pawel/AAI-9291-2021	Brzuzan, Pawel/0000-0001-9701-5716; Wozny, Maciej/0000-0001-5201-2925; Florczyk, Maciej/0000-0003-2277-312X	National Science Centre, Poland [DEC-2012/07/B/NZ9/01320]	National Science Centre, Poland(National Science Centre, Poland)	The study was supported by research grant from National Science Centre, Poland (https://www.ncn.gov.pl/) No. DEC-2012/07/B/NZ9/01320. Grant recipient: PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovsky O, 2015, ENVIRON SCI TECHNOL, V49, P12457, DOI 10.1021/acs.est.5b02049; Agostini M, 2014, ONCOTARGET, V5, P872, DOI 10.18632/oncotarget.1825; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Andreassen R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-482; Asensio PE, 2016, CURR DRUG TARGETS, V17, P1083, DOI 10.2174/1389450116666150213114103; Bailey KA, 2014, MICRORNAS TOXICOLOGY, P5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Barturen G., 2014, METHODS NEXT GENERAT, V1, P21, DOI [DOI 10.2478/MNGS-2014-0001, 10.2478/mngs-2014-0001]; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Biggar KK, 2014, ANAL BIOCHEM, V462, P32, DOI 10.1016/j.ab.2014.05.032; Bizuayehu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-11; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Brzuzan P, 2015, FISH PHYSIOL BIOCHEM, V41, P1155, DOI 10.1007/s10695-015-0077-2; Brzuzan P, 2012, AQUAT TOXICOL, V122, P188, DOI 10.1016/j.aquatox.2012.07.001; Brzuzan P, 2009, TOXICON, V54, P170, DOI 10.1016/j.toxicon.2009.03.032; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chao A, 2012, ONCOGENE, V31, P764, DOI 10.1038/onc.2011.269; Chen Y, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-43; Clark SP, 2008, TOXICOL PATHOL, V36, P190, DOI 10.1177/0192623307311406; Davidson WS, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-403; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Desvignes T, 2015, TRENDS GENET, V31, P613, DOI 10.1016/j.tig.2015.09.002; Dillies MA, 2013, BRIEF BIOINFORM, V14, P671, DOI 10.1093/bib/bbs046; Djediat C, 2010, TOXICON, V55, P531, DOI 10.1016/j.toxicon.2009.10.005; Dobosz Stefan, 1997, Polskie Archiwum Hydrobiologii, V44, P287; Erhard F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r79; Ernst B, 2001, ENVIRON TOXICOL, V16, P483, DOI 10.1002/tox.10006.abs; Ernst B, 2007, AQUAT TOXICOL, V82, P15, DOI 10.1016/j.aquatox.2007.01.007; Florczyk M, 2016, J FISH DIS, V39, P741, DOI 10.1111/jfd.12406; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Hata A, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005825; Heimberg AM, 2008, P NATL ACAD SCI USA, V105, P2946, DOI 10.1073/pnas.0712259105; Hudder A, 2008, TOXICOL SCI, V103, P228, DOI 10.1093/toxsci/kfn033; Juanchich A, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2505-9; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kazun K., 2012, Archives of Polish Fisheries, V20, P173; Kazun Krzysztof, 2001, Archiwum Rybactwa Polskiego, V9, P183; Komatsu M, 2007, TOXICOL SCI, V97, P407, DOI 10.1093/toxsci/kfm054; Koop Ben F., 2008, P77; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lakomiak A, 2016, COMP BIOCHEM PHYS B, V193, P47, DOI 10.1016/j.cbpb.2015.12.005; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Li HY, 2009, TOXICON, V53, P169, DOI 10.1016/j.toxicon.2008.10.027; Lillycrop KA, 2012, BEST PRACT RES CL EN, V26, P667, DOI 10.1016/j.beem.2012.03.009; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055532; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-104; Loher P, 2014, ONCOTARGET, V5, P8790, DOI 10.18632/oncotarget.2405; Malbrouck C, 2006, ENVIRON TOXICOL CHEM, V25, P72, DOI 10.1897/05-029R.1; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Maza Elie, 2013, Commun Integr Biol, V6, pe25849, DOI 10.4161/cib.25849; Meng FX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034394; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mennigen JA, 2014, COMP BIOCHEM PHYS B, V169, P16, DOI 10.1016/j.cbpb.2013.12.002; Miller MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012576; Nakano H, 2013, INT J ONCOL, V42, P1875, DOI 10.3892/ijo.2013.1896; NISHIWAKIMATSUSHIMA R, 1992, J CANCER RES CLIN, V118, P420, DOI 10.1007/BF01629424; Paskerova H, 2012, ENVIRON SCI POLLUT R, V19, P2024, DOI 10.1007/s11356-012-0960-7; Peckova L, 2009, NEUROENDOCRINOL LETT, V30, P199; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rueda A, 2015, NUCLEIC ACIDS RES, V43, pW467, DOI 10.1093/nar/gkv555; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Shin C, 2010, MOL CELL, V38, P789, DOI 10.1016/j.molcel.2010.06.005; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Takumi S, 2010, ENVIRON HEALTH PERSP, V118, P1292, DOI 10.1289/ehp.1001899; Telonis AG, 2015, NUCLEIC ACIDS RES, V43, P9158, DOI 10.1093/nar/gkv922; Thakral S, 2015, CURR GENE THER, V15, P142, DOI 10.2174/1566523214666141224095610; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; U.S. EPA, 2015, EPA820R15100; Ueno Y, 1996, CARCINOGENESIS, V17, P1317, DOI 10.1093/carcin/17.6.1317; van Apeldoorn ME, 2007, MOL NUTR FOOD RES, V51, P7, DOI 10.1002/mnfr.200600185; Wang MH, 2010, TOXICOL SCI, V113, P60, DOI 10.1093/toxsci/kfp248; Wang R, 2013, CURR DRUG TARGETS, V14, P1185, DOI 10.2174/13894501113149990191; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wojcicka A, 2014, INT J BIOCHEM CELL B, V53, P208, DOI 10.1016/j.biocel.2014.05.020; Wozny M, 2015, TOXICOL LETT, V238, pS259, DOI 10.1016/j.toxlet.2015.08.750; Xu LZ, 2012, MUTAT RES-GEN TOX EN, V743, P75, DOI 10.1016/j.mrgentox.2011.12.024; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035331; Zhang DW, 2009, CHEMOSPHERE, V76, P974, DOI 10.1016/j.chemosphere.2009.04.034; Zhao YY, 2012, ENVIRON SCI TECHNOL, V46, P34, DOI 10.1021/es201514h; Zhou L, 2002, BIOMED ENVIRON SCI, V15, P166	86	15	16	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158899	10.1371/journal.pone.0158899	http://dx.doi.org/10.1371/journal.pone.0158899			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391076	gold, Green Submitted, Green Published			2022-12-26	WOS:000380005400157
J	Fernandes, SA; Ruiz, FS; Antonietti, LS; Tufik, S; de Mello, MT				Fernandes-Junior, Silvio Araujo; Ruiz, Francieli Silva; Antonietti, Leandro Stetner; Tufik, Sergio; de Mello, Marco Tulio			Sleep, Fatigue and Quality of Life: A Comparative Analysis among Night Shift Workers with and without Children	PLOS ONE			English	Article							VALIDATION; DURATION; HEALTH	Introduction The reversal of the natural cycle of wakefulness and sleep may cause damage to the health of workers. However, there are few studies evaluating sleep, fatigue and quality of life of night shift workers considering the influence of small children on these variables. Aims Evaluate the sleep time, fatigue and quality of life of night shift workers and verify the relationship between these variables with the presence or absence of children in different age groups. Methods Were evaluated 78 mens shiftworkers, with or without children. Group 1, workers without children (G1-NC), group 2, workers with children pre-school age (G2-PS) and group 3, workers with children school age (G3-S). The sleep time (ST), sleep efficiency (SE), sleep latency (SL) and maximum time awake (MTA) were recorded by actigraphy. The risk of being fatigued at work was estimated by risk index for fatigue (RIF). Results The G1-NC showed a longer ST on working days and when evaluated only the first nights shift, after day off (p<0,005). This sample, the age of the children did not influence the sleep time these workers. The MTA on day off was lower in the workers from G2-PS. The RIF was lower on G1-NC in the first nights shift compared to the other groups. Conclusion In this research, workers without children had higher sleep time during the working days. These workers also were less likely to feel fatigued during night work than workers with children, regardless of age these children.	[Fernandes-Junior, Silvio Araujo; Ruiz, Francieli Silva; Tufik, Sergio; de Mello, Marco Tulio] Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Antonietti, Leandro Stetner; de Mello, Marco Tulio] Ctr Multidisciplinary Studies Sleepiness & Accide, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Fernandes, SA (corresponding author), Univ Fed Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil.	silviocelula@gmail.com	RUIZ, Francieli Silva/L-3160-2015; fernandes-junior, silvio f/C-8395-2019; de Mello, Marco Tulio/G-3237-2010	RUIZ, Francieli Silva/0000-0001-9975-0298; fernandes-junior, silvio f/0000-0001-7231-623X; Ruiz, Francieli S/0000-0002-9675-4063; de Mello, Marco Tulio/0000-0003-3896-2208	Universidade Federal de Sao Paulo; Associacao Fundo de Incentivo a Pesquisa; Fundacao de Amparo a pesquisa do Estado de Sao Paulo- FAPESP (CEPID) [98/14303-3]; Centro Multidisciplinar em Sonolencia e Acidentes (CEMSA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [133659/2013-5]	Universidade Federal de Sao Paulo; Associacao Fundo de Incentivo a Pesquisa; Fundacao de Amparo a pesquisa do Estado de Sao Paulo- FAPESP (CEPID)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centro Multidisciplinar em Sonolencia e Acidentes (CEMSA); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Universidade Federal de Sao Paulo, the Associacao Fundo de Incentivo a Pesquisa, Fundacao de Amparo a pesquisa do Estado de Sao Paulo- FAPESP (CEPID No. 98/14303-3 to ST), the Centro Multidisciplinar em Sonolencia e Acidentes (CEMSA), and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), number 133659/2013-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEDT T, 1995, SLEEP, V18, P1; Akerstedt T, 2009, SLEEP MED CLIN, V4, P257, DOI 10.1016/j.jsmc.2009.03.001; Alvarenga TA, 2013, FERTIL STERIL, V100, P1752, DOI 10.1016/j.fertnstert.2013.08.014; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; ANDERSON RM, 1987, HUM FACTORS, V29, P477, DOI 10.1177/001872088702900411; BENEDITOSILVA AA, 1990, PROG CLIN BIOL RES, V341, P89; Bertolazi AN, 2009, J BRAS PNEUMOL, V35, P877, DOI 10.1590/S1806-37132009000900009; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Borbely A A, 1982, Hum Neurobiol, V1, P195; Brown D, 1982, J Hum Ergol (Tokyo), V11 Suppl, P475; Crispim CA, 2011, METABOLISM, V60, P1726, DOI 10.1016/j.metabol.2011.04.014; CZEISLER CA, 1981, PHOTOCHEM PHOTOBIOL, V34, P239; Dawson D, 1997, FATIGUE ALCOHOL PERF, V388; Dawson D, 2012, SLEEP MED REV, V16, P167, DOI 10.1016/j.smrv.2011.05.004; Falcao DD, 2003, J RHEUMATOL, V30, P379; Folkard S, 2003, OCCUP MED-OXFORD, V53, P95, DOI 10.1093/occmed/kqg047; Gander P., 2008, TRANSPORT RES, P49; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Iber C., 2007, AASM MANUAL SCORING; ICAO, 2011, UN VERS FRMS FAT RIS; Jansen NWH, 2003, OCCUP ENVIRON MED, V60, P47; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; Kryger M, 2012, J CLIN SLEEP MED, V8, P117, DOI 10.5664/jcsm.1754; Mongrain V, 2006, J SLEEP RES, V15, P162, DOI 10.1111/j.1365-2869.2006.00532.x; Pandi-Perumal SR, 2002, AGEING RES REV, V1, P559, DOI 10.1016/S1568-1637(02)00014-4; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Rotenberg L, 2000, BIOL RHYTHM RES, V31, P515, DOI 10.1076/0929-1016(200010)31:4;1-2;FT515; Ruiz FS, 2012, INNATE IMMUN-LONDON, V18, P44, DOI 10.1177/1753425910385962; Santos EHR, 2004, CHRONOBIOL INT, V21, P881, DOI 10.1081/CBI-200035952; Smith PM, 2013, J OCCUP ENVIRON MED, V55, P932, DOI 10.1097/JOM.0b013e31829178e1; SORENSEN G, 1987, ANNU REV PUBL HEALTH, V8, P235, DOI 10.1146/annurev.publhealth.8.1.235; Taillard J, 2001, J BIOL RHYTHM, V16, P183, DOI 10.1177/074873001129001764; Taillard J, 1999, J SLEEP RES, V8, P291, DOI 10.1046/j.1365-2869.1999.00176.x; Tuchsen F, 2008, OCCUP MED-OXFORD, V58, P302, DOI 10.1093/occmed/kqn019; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Yeung J, 2011, SCAND J WORK ENV HEA, V37, P62, DOI 10.5271/sjweh.3122; Zimberg IZ, 2012, WORK, V41, P4376, DOI 10.3233/WOR-2012-0733-4376	38	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158580	10.1371/journal.pone.0158580	http://dx.doi.org/10.1371/journal.pone.0158580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391478	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400083
J	Kakehashi, A; Ishii, N; Fujioka, M; Doi, K; Gi, M; Wanibuchi, H				Kakehashi, Anna; Ishii, Naomi; Fujioka, Masaki; Doi, Kenichiro; Gi, Min; Wanibuchi, Hideki			Ethanol-Extracted Brazilian Propolis Exerts Protective Effects on Tumorigenesis in Wistar Hannover Rats	PLOS ONE			English	Article							ACID PHENETHYL ESTER; PROSTATE-CANCER CELLS; ABERRANT CRYPT FOCI; CAFFEIC ACID; RED PROPOLIS; BREAST-CANCER; ARTEPILLIN-C; IN-VIVO; GROWTH; CARCINOGENESIS	The present study was conducted over a course of 104 weeks to estimate the carcinogenicity of ethanol-extracted Brazilian green propolis (EEP). Groups of 50 male and 50 female Wistar Hannover rats, 6-week-old at commencement were exposed to EEP at doses of 0, 0.5 or 2.5% in the diet. Survival rates of 0.5% and 2.5% EEP-treated male and female rats, respectively, were significantly higher than those of respective control groups. Overall histopathological evaluation of neoplasms in rat tissues after 2 years showed no significant increase of tumors or preneoplastic lesions in any organ of animals administered EEP. Significantly lower incidences of pituitary tumors in 0.5% EEP male and 2.5% EEP female groups, malignant lymphoma/ leukemia in both 2.5% EEP-treated males and females and total thyroid tumors in 0.5% EEP male group were found. Administration of EEP caused significant decreases of lymphoid hyperplasia of the thymus and lymph nodes in 2.5% EEP-treated rats, tubular cell hyperplasia of kidneys in all EEP groups, and cortical hyperplasia of adrenals in EEP-treated females. In the blood, significant reduction of neutrophils in all EEP-treated males and band neutrophils in 2.5% EEP-treated females was found indicating lower levels of inflammation. Total cholesterol and triglicerides levels were significantly lower in the blood of 2.5% EEP-treated female rats. In conclusion, under the conditions of the 2-year feeding experiment, EEP was not carcinogenic, did not induce significant histopathological changes in any organ, and further exerted anti-inflammatory and antitumorigenic effects resulting in increase of survival of Wistar Hannover rats.	[Kakehashi, Anna; Ishii, Naomi; Fujioka, Masaki; Doi, Kenichiro; Gi, Min; Wanibuchi, Hideki] Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan	Osaka Metropolitan University	Wanibuchi, H (corresponding author), Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	wani@med.osaka-cu.ac.jp	Kakehashi, Anna/ABF-2986-2020; Fujioka, Masaki/C-7817-2019	Kakehashi, Anna/0000-0003-1149-1450; Fujioka, Masaki/0000-0003-0048-2874	Ministry of Health, Labor and Welfare of Japan	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported by a grant from the Ministry of Health, Labor and Welfare of Japan (grant title: Research on genotoxicity and carcinogenicity of food additives and health foods). No number existed.	Ahn MR, 2007, CANCER LETT, V252, P235, DOI 10.1016/j.canlet.2006.12.039; Alizadeh AM, 2015, ARCH IRAN MED, V18, P18, DOI 0151801/AIM.006; Almeida E. C. de, 2002, J. Venom. Anim. Toxins, V8, P191, DOI 10.1590/S0104-79302002000200002; Basini G, 2012, INVEST NEW DRUG, V30, P186, DOI 10.1007/s10637-010-9550-z; Baykara M, 2015, DIAGN INTERV RADIOL, V21, P317, DOI 10.5152/dir.2015.14075; Borrelli F, 2002, FITOTERAPIA, V73, pS38, DOI 10.1016/S0367-326X(02)00189-2; Bufalo MC, 2015, J PHARM PHARMACOL, V67, P740, DOI 10.1111/jphp.12364; Campos JF, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/296186; Cavendish RL, 2015, J ETHNOPHARMACOL, V173, P127, DOI 10.1016/j.jep.2015.07.022; CHIAO C, 1995, CANCER RES, V55, P3576; Chirumbolo S, 2015, J CLIN BIOCHEM NUTR, V56, P163, DOI 10.3164/jcbn.14-110; Conti BJ, 2015, J PHARM PHARMACOL, V67, P1431, DOI 10.1111/jphp.12431; da Silva RO, 2015, J ETHNOPHARMACOL, V170, P66, DOI 10.1016/j.jep.2015.05.009; Fu JY, 2004, BIOMED ENVIRON SCI, V17, P469; GHISALBERTI EL, 1979, BEE WORLD, V60, P59, DOI 10.1080/0005772X.1979.11097738; Jung BI, 2010, PHYTOTHER RES, V24, P295, DOI 10.1002/ptr.2966; Khalil Mahmoud Lotfy, 2006, Asian Pac J Cancer Prev, V7, P22; Kimoto N, 1999, CANCER LETT, V147, P221, DOI 10.1016/S0304-3835(99)00305-5; Kimoto T, 1996, Gan To Kagaku Ryoho, V23, P1855; Kimoto T, 2001, VIRCHOWS ARCH, V438, P259, DOI 10.1007/s004280000350; Kubina R, 2015, ADV CLIN EXP MED, V24, P203, DOI 10.17219/acem/31792; Li HZ, 2007, INT J ONCOL, V31, P601; Li X, 2011, TOXICOL IN VITRO, V25, P630, DOI 10.1016/j.tiv.2010.12.013; Lopez BG, 2015, J APPL MICROBIOL, DOI 10.11110m.12874; Luo JQ, 2001, ANTICANCER RES, V21, P1665; Mani F, 2006, J ETHNOPHARMACOL, V105, P95, DOI 10.1016/j.jep.2005.10.011; Mishima S, 2005, BIOL PHARM BULL, V28, P1025, DOI 10.1248/bpb.28.1025; Missima F, 2010, PHYTOTHER RES, V24, P1501, DOI 10.1002/ptr.3142; Moreno MIN, 2005, J AGR FOOD CHEM, V53, P8957, DOI 10.1021/jf0513359; Nouhi A., 2008, ARAK MED U J, V11, P102; OECD, 2009, TEST 451 CARC STUD; OECD, 2009, GOOD LAB PRACT; Okamoto Y, 2015, J TOXICOL SCI, V40, P235, DOI 10.2131/jts.40.235; Orsolic N, 2005, BIOMED PHARMACOTHER, V59, P561, DOI 10.1016/j.biopha.2005.03.013; Padmavathi R, 2006, COMP BIOCHEM PHYS C, V143, P349, DOI 10.1016/j.cbpc.2006.03.009; Patel Seema, 2016, Journal of Dietary Supplements, V13, P245, DOI 10.3109/19390211.2015.1008614; Ribeiro DR, 2015, BASIC CLIN PHARMACOL, V117, P85, DOI 10.1111/bcpt.12374; Schmidt JO, 1992, OTHER PRODUCTS HIVE, P927; Selamoglu ZS, 2015, ADV CLIN EXP MED, V24, P227, DOI 10.17219/acem/40461; Senedese JM, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen049; Shimizu K, 2004, ARCH BIOCHEM BIOPHYS, V424, P181, DOI 10.1016/j.abb.2004.02.021; Szliszka E, 2009, MOLECULES, V14, P738, DOI [10.3390/molecules14020738, 10.3390/molecules]; Szliszka E, 2011, INT J ONCOL, V38, P941, DOI 10.3892/ijo.2011.930; Valente MJ, 2011, FOOD CHEM TOXICOL, V49, P86, DOI 10.1016/j.fct.2010.10.001; Wagh VD, 2013, ADV PHARMACOL SCI, V2013, DOI 10.1155/2013/308249; Xie XL, 2015, FOOD CHEM TOXICOL, V83, P193, DOI 10.1016/j.fct.2015.06.007; Yasui Y, 2008, ONCOL REP, V20, P493, DOI 10.3892/or_00000033; Zhang JL, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/307594; Zhao JQ, 2009, INDIAN J EXP BIOL, V47, P264	49	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158654	10.1371/journal.pone.0158654	http://dx.doi.org/10.1371/journal.pone.0158654			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391589	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400097
J	Koo, HY; Seo, YG; Cho, MH; Kim, MJ; Choi, HC				Koo, Hye-Yeon; Seo, Young-Gyun; Cho, Mi-Hee; Kim, Min-Jung; Choi, Ho-Chun			Weight Change and Associated Factors in Long-Term Breast Cancer Survivors	PLOS ONE			English	Article							BODY-MASS INDEX; ADJUVANT CHEMOTHERAPY; LIFE-STYLE; KOREAN WOMEN; GAIN; DIAGNOSIS; PREMENOPAUSAL; POPULATION; PROGNOSIS; MENOPAUSE	Purpose Weight gain often occurs after breast cancer diagnosis and significantly impacts the general health of cancer survivors. While the number of breast cancer survivors is increasing, few studies have reported data on weight change beyond 5 years post-diagnosis. We investigated weight change and associated factors in long-term survivors of breast cancer. Patients and Methods Medical records were reviewed on 1363 breast cancer patients and a total of 822 women who had survived beyond 5 years since diagnosis were included in the final analysis. The association between demographic, anthropometric, lifestyle, cancer related factors (including time since diagnosis, treatment modality, pathologic stage, and hormone receptor status), and weight-change over 5 years were examined. Results During an average 8.2 years of follow-up time, mean weight gain was 0.32kg (p = 0.017). 175 (21.3%) patients had gained more than 5% of their weight at diagnosis and their average gain was 5.55kg. Body mass index (BMI) at diagnosis, age at diagnosis, aromatase inhibitor (AI) use, heavy drinking, and type of surgery were associated with relative weight gain (>= 5%) in univariate analysis (all p-values< 0.05). Patients who were non-obese at diagnosis showed weight gain, while those who were obese at diagnosis lost weight (0.78kg, -1.11kg, respectively, p< 0.001). In multivariate analysis, the non-obese group showed odds ratio of 2.7 (p = 0.001) relative to the obese group. Younger age group (age 18-54 years) showed odds ratio of 1.9 (p = 0.021) relative to the older age group (age 55-75 years), and patients who did not use AI showed odds ratio of 2.2 (p = 0.006) relative to women who did. Conclusion Long-term breast cancer survivors who were non-obese at diagnosis are more likely to gain weight than obese survivors. Younger survivors and survivors who have never used AI are also likely to gain weight.	[Koo, Hye-Yeon; Seo, Young-Gyun; Cho, Mi-Hee; Kim, Min-Jung] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Choi, Ho-Chun] Seoul Natl Univ Hosp, Dept Family Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Choi, HC (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Healthcare Syst Gangnam Ctr, Seoul, South Korea.	skyho331@gmail.com	Seo, Young-Gyun/AAV-3487-2020	Koo, Hye Yeon/0000-0002-0387-4278; Seo, Young-Gyun/0000-0001-8294-1741				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; BROWN BW, 1993, J NATL CANCER I, V85, P979, DOI 10.1093/jnci/85.12.979; Caan BJ, 2008, CANCER CAUSE CONTROL, V19, P1319, DOI 10.1007/s10552-008-9203-0; Caan BJ, 2006, BREAST CANCER RES TR, V99, P47, DOI 10.1007/s10549-006-9179-y; CAMORIANO JK, 1990, J CLIN ONCOL, V8, P1327, DOI 10.1200/JCO.1990.8.8.1327; CHLEBOWSKI RT, 1986, BREAST CANCER RES TR, V7, P23, DOI 10.1007/BF01886732; Chlebowski RT, 2002, J CLIN ONCOL, V20, P1128, DOI 10.1200/JCO.20.4.1128; Demark-Wahnefried W, 2001, J CLIN ONCOL, V19, P2381, DOI 10.1200/JCO.2001.19.9.2381; Demark-Wahnefried W, 2012, CANCER-AM CANCER SOC, V118, P2277, DOI 10.1002/cncr.27466; DemarkWahnefried W, 1997, J AM DIET ASSOC, V97, P519, DOI 10.1016/S0002-8223(97)00133-8; Erickson KD, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-P2-11-09; Freedman RJ, 2004, J CLIN ENDOCR METAB, V89, P2248, DOI 10.1210/jc.2003-031874; Goodwin PJ, 1999, J CLIN ONCOL, V17, P120, DOI 10.1200/JCO.1999.17.1.120; Goodwin PJ, 2001, J CLIN ONCOL, V19, P2367, DOI 10.1200/JCO.2001.19.9.2367; Han HS, 2009, BREAST CANCER RES TR, V114, P147, DOI 10.1007/s10549-008-9984-6; HEASMAN KZ, 1985, BREAST CANCER RES TR, V5, P195, DOI 10.1007/BF01805994; Heideman WH, 2009, EUR J CANCER, V45, P119, DOI 10.1016/j.ejca.2008.09.003; Herman DR, 2005, BREAST CANCER RES TR, V93, P13, DOI 10.1007/s10549-005-2418-9; Irwin ML, 2005, J CLIN ONCOL, V23, P774, DOI 10.1200/JCO.2005.04.036; Jeon YW, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0849-z; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kawachi I, 1999, J CLIN PSYCHIAT, V60, P5; Kim SH, 2013, ASIAN NURS RES, V7, P161, DOI 10.1016/j.anr.2013.09.002; Korean Statistical Information Service, 2014, KOR STAT INF SERV 5; Kroenke CH, 2005, J CLIN ONCOL, V23, P1370, DOI 10.1200/JCO.2005.01.079; Lewis CE, 1997, AM J PUBLIC HEALTH, V87, P635, DOI 10.2105/AJPH.87.4.635; Loi S, 2005, CANCER EPIDEM BIOMAR, V14, P1686, DOI 10.1158/1055-9965.EPI-05-0042; Makari-Judson G, 2007, BREAST J, V13, P258, DOI 10.1111/j.1524-4741.2007.00419.x; Makari-Judson G, 2014, WORLD J CLIN ONCOL, V5, P272, DOI 10.5306/wjco.v5.i3.272; Morrow M, 2010, DIS BREAST, P823; Nichols HB, 2009, CANCER EPIDEM BIOMAR, V18, P1403, DOI 10.1158/1055-9965.EPI-08-1094; Nissen MJ, 2011, CLIN BREAST CANCER, V11, P52, DOI 10.3816/CBC.2011.n.009; Rock CL, 2002, J NUTR, V132, p3504S, DOI 10.1093/jn/132.11.3504S; Rock CL, 1999, J AM DIET ASSOC, V99, P1212, DOI 10.1016/S0002-8223(99)00298-9; Saquib N, 2007, BREAST CANCER RES TR, V105, P177, DOI 10.1007/s10549-006-9442-2; SHAH M, 1991, INT J OBESITY, V15, P499; Vagenas D, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1026-2; Vance V, 2011, OBES REV, V12, P282, DOI 10.1111/j.1467-789X.2010.00805.x; Wang JS, 2014, MOL CLIN ONCOL, V2, P105, DOI 10.3892/mco.2013.209; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; WILLIAMSON DF, 1990, ARCH INTERN MED, V150, P665, DOI 10.1001/archinte.150.3.665; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P646, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00004; World Health Organization Pacific Region International Association for the Study of Obesity International Obesity Task Force, 2000, AS PAC PERSP RED OB	43	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159098	10.1371/journal.pone.0159098	http://dx.doi.org/10.1371/journal.pone.0159098			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391162	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400210
J	Kouyoumdzian, NM; Mikusic, NLR; Kravetz, MC; Lee, BM; Carranza, A; Del Mauro, JS; Pandolfo, M; Gironacci, MM; Gorzalczany, S; Toblli, JE; Fernandez, BE; Choi, MR				Kouyoumdzian, Nicolas M.; Rukavina Mikusic, Natalia L.; Kravetz, Maria C.; Lee, Brenda M.; Carranza, Andrea; Del Mauro, Julieta S.; Pandolfo, Marcela; Gironacci, Mariela M.; Gorzalczany, Susana; Toblli, Jorge E.; Fernandez, Belisario E.; Choi, Marcelo R.			Atrial Natriuretic Peptide Stimulates Dopamine Tubular Transport by Organic Cation Transporters: A Novel Mechanism to Enhance Renal Sodium Excretion	PLOS ONE			English	Article							LOW-DOSE DOPAMINE; INTRARENAL DOPAMINE; DYSFUNCTION; FAILURE; SYSTEM; ROCT1	The aim of this study was to demonstrate the effects of atrial natriuretic peptide (ANP) on organic cation transporters (OCTs) expression and activity, and its consequences on dopamine urinary levels, Na+, K+-ATPase activity and renal function. Male Sprague Dawley rats were infused with isotonic saline solution during 120 minutes and randomized in nine different groups: control, pargyline plus tolcapone (P+T), ANP, dopamine (DA), D-22, DA+D-22, ANP+D-22, ANP+DA and ANP+DA+D-22. Renal functional parameters were determined and urinary dopamine concentration was quantified by HPLC. Expression of OCTs and D1-receptor in membrane preparations from renal cortex tissues were determined by western blot and Na+, K+-ATPase activity was determined using in vitro enzyme assay. H-3-DA renal uptake was determined in vitro. Compared to P+T group, ANP and dopamine infusion increased diuresis, urinary sodium and dopamine excretion significantly. These effects were more pronounced in ANP+DA group and reversed by OCTs blockade by D-22, demonstrating that OCTs are implied in ANP stimulated-DA uptake and transport in renal tissues. The activity of Na+, K+-ATPase exhibited a similar fashion when it was measured in the same experimental groups. Although OCTs and D1-receptor protein expression were not modified by ANP, OCTs-dependent-dopamine tubular uptake was increased by ANP through activation of NPR-A receptor and protein kinase G as signaling pathway. This effect was reflected by an increase in urinary dopamine excretion, natriuresis, diuresis and decreased Na+, K+-ATPase activity. OCTs represent a novel target that links the activity of ANP and dopamine together in a common mechanism to enhance their natriuretic and diuretic effects.	[Kouyoumdzian, Nicolas M.; Rukavina Mikusic, Natalia L.; Toblli, Jorge E.; Fernandez, Belisario E.; Choi, Marcelo R.] Natl Sci & Tech Res Council, Cardiol Res Inst, Buenos Aires, DF, Argentina; [Kouyoumdzian, Nicolas M.; Rukavina Mikusic, Natalia L.; Pandolfo, Marcela; Fernandez, Belisario E.; Choi, Marcelo R.] Pathophysiol & Clin Biochem Inst, Buenos Aires, DF, Argentina; [Kravetz, Maria C.; Carranza, Andrea; Del Mauro, Julieta S.; Gorzalczany, Susana] Univ Buenos Aires, Sch Pharm & Biochem, Dept Pharmacol, Buenos Aires, DF, Argentina; [Lee, Brenda M.] Johns Hopkins Univ Hosp, Dept Gen Surg, Baltimore, MD 21287 USA; [Gironacci, Mariela M.] Univ Buenos Aires, Sch Pharm & Biochem, Dept Biol Chem, Buenos Aires, DF, Argentina; [Toblli, Jorge E.] Deutsch Hosp, Buenos Aires, DF, Argentina; [Choi, Marcelo R.] Univ Buenos Aires, Sch Pharm & Biochem, Dept Anat & Histol, Buenos Aires, DF, Argentina; [Choi, Marcelo R.] Univ Buenos Aires, Sch Pharm & Biochem, Dept Pathophysiol, Buenos Aires, DF, Argentina	University of Buenos Aires; Johns Hopkins University; Johns Hopkins Medicine; University of Buenos Aires; University of Buenos Aires; University of Buenos Aires	Choi, MR (corresponding author), Natl Sci & Tech Res Council, Cardiol Res Inst, Buenos Aires, DF, Argentina.; Choi, MR (corresponding author), Pathophysiol & Clin Biochem Inst, Buenos Aires, DF, Argentina.; Choi, MR (corresponding author), Univ Buenos Aires, Sch Pharm & Biochem, Dept Anat & Histol, Buenos Aires, DF, Argentina.; Choi, MR (corresponding author), Univ Buenos Aires, Sch Pharm & Biochem, Dept Pathophysiol, Buenos Aires, DF, Argentina.	marcelinkchoi@yahoo.com.ar	Choi, Marcelo Roberto/I-4082-2019	Gironacci, Mariela/0000-0002-8189-0388; Carranza, Andrea/0000-0001-8352-5504	PICT (Proyectos de Investigacion Cientifica y Tecnologica) [2012-01775]; UBACyT (Universidad de Buenos Aires Ciencia y Tecnica) [20020130200105BA]; SAHA; Hansang Latinoamerica (Confederacion Latinoamericana de Empresarios Coreanos)	PICT (Proyectos de Investigacion Cientifica y Tecnologica)(ANPCyT); UBACyT (Universidad de Buenos Aires Ciencia y Tecnica); SAHA; Hansang Latinoamerica (Confederacion Latinoamericana de Empresarios Coreanos)	The work was supported by the following: PICT (Proyectos de Investigacion Cientifica y Tecnologica), 2012-01775 MRC; UBACyT (Universidad de Buenos Aires Ciencia y Tecnica), 20020130200105BA MRC; SAHA 2014-2015 MRC; Hansang Latinoamerica (Confederacion Latinoamericana de Empresarios Coreanos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aperia AC, 2000, ANNU REV PHYSIOL, V62, P621, DOI 10.1146/annurev.physiol.62.1.621; Bellomo R, 2000, LANCET, V356, P2139; Breidert T, 1998, BRIT J PHARMACOL, V125, P218, DOI 10.1038/sj.bjp.0702065; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Carey RM, 2001, HYPERTENSION, V38, P297, DOI 10.1161/hy0901.096422; Carranza A, 2004, PFLUG ARCH EUR J PHY, V448, P85, DOI 10.1007/s00424-003-1220-y; Carranza A, 2001, HORM RES, V55, P282, DOI 10.1159/000050014; Carranza A, 2008, AM J PHYSIOL-CELL PH, V295, pC1602, DOI 10.1152/ajpcell.00090.2008; Chamorro C, 2001, LANCET, V357, P1707, DOI 10.1016/S0140-6736(00)04838-8; Chen HH, 2013, JAMA-J AM MED ASSOC, V310, P2533, DOI 10.1001/jama.2013.282190; Choi MR, 2006, NEPHRON PHYSIOL, V104, P136, DOI 10.1159/000095856; Ciarimboli G, 2005, J AM SOC NEPHROL, V16, P1562, DOI 10.1681/ASN.2004040256; Ciarimboli G, 2005, PFLUG ARCH EUR J PHY, V449, P423, DOI 10.1007/s00424-004-1355-5; Citarella MR, 2009, REGUL PEPTIDES, V153, P19, DOI 10.1016/j.regpep.2008.11.009; Correa AH, 2007, REGUL PEPTIDES, V138, P26, DOI 10.1016/j.regpep.2006.08.001; Costa MD, 2004, REGUL PEPTIDES, V118, P151, DOI 10.1016/j.regpep.2003.12.009; Cuevas S, 2013, INT J MOL SCI, V14, P17553, DOI 10.3390/ijms140917553; DEBOLD AJ, 1985, SCIENCE, V230, P767, DOI 10.1126/science.2932797; del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; Eisenhofer G, 2001, PHARMACOL THERAPEUT, V91, P35, DOI 10.1016/S0163-7258(01)00144-9; Eklof AC, 2001, CLIN EXP HYPERTENS, V23, P449, DOI 10.1081/CEH-100104236; Fernandes-Cerqueira C, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/397391; Fernandez BE, 2005, REGUL PEPTIDES, V124, P137, DOI 10.1016/j.regpep.2004.07.006; Graefe KH, 1997, N-S ARCH PHARMACOL, V356, P115, DOI 10.1007/PL00005018; Grundemann D, 1998, J BIOL CHEM, V273, P30915, DOI 10.1074/jbc.273.47.30915; Holtback U, 1999, P NATL ACAD SCI USA, V96, P7271, DOI 10.1073/pnas.96.13.7271; Ibarra FR, 2006, MEDICINA-BUENOS AIRE, V66, P81; Jonker JW, 2004, J PHARMACOL EXP THER, V308, P2, DOI 10.1124/jpet.103.053298; Jose PA, 2003, NEPHRON PHYSIOL, V95, P19, DOI DOI 10.1159/000073676; Kellum JA, 2001, CRIT CARE MED, V29, P1526, DOI 10.1097/00003246-200108000-00005; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; LOWRY OH, 1946, J BIOL CHEM, V162, P421; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marik PE, 2002, INTENS CARE MED, V28, P877, DOI 10.1007/s00134-002-1346-y; Marinosci GZ, 2012, TRANSL MED UNISA, V4, P90; Mehrens T, 2000, J AM SOC NEPHROL, V11, P1216, DOI 10.1681/ASN.V1171216; Schlatter E, 2002, J MEMBRANE BIOL, V189, P237, DOI 10.1007/s00232-002-1023-7; Thomas MC, 2003, KIDNEY INT, V63, P2152, DOI 10.1046/j.1523-1755.2003.00006.x; VandeStolpe A, 1988, AM J PHYSIOL, V54, P477; Wright SH, 2004, PHYSIOL REV, V84, P987, DOI 10.1152/physrev.00040.2003; Zhang MZ, 2011, J CLIN INVEST, V121, P2845, DOI 10.1172/JCI57324	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157487	10.1371/journal.pone.0157487	http://dx.doi.org/10.1371/journal.pone.0157487			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392042	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400011
J	Qian, JH; Liu, SX; Lei, Q				Qian, Jiehui; Liu, Shengxi; Lei, Quan			Illusory Distance Modulates Perceived Size of Afterimage despite the Disappearance of Depth Cues	PLOS ONE			English	Article							PONZO ILLUSION; PERCEPTION; INVARIANCE; ATTENTION; REPRESENTATION; CONSCIOUSNESS; CONSTANCY; AREA; LAW	It is known that the perceived size of an afterimage is modulated by the perceived distance between the observer and the depth plane on which the afterimage is projected (Emmert's law). Illusions like Ponzo demonstrate that illusory distance induced by depth cues can also affect the perceived size of an object. In this study, we report that the illusory distance not only modulates the perceived size of object's afterimage during the presence of the depth cues, but the modulation persists after the disappearance of the depth cues. We used an adapted version of the classic Ponzo illusion. Illusory depth perception was induced by linear perspective cues with two tilted lines converging at the upper boundary of the display. Two horizontal bars were placed between the two lines, resulting in a percept of the upper bar to be farther away than the lower bar. Observers were instructed to make judgment about the relative size of the afterimage of the lower and the upper bars after adaptation. When the perspective cues and the bars were static, the illusory effect of the Ponzo afterimage is consistent with that of the traditional size-distance illusion. When the perspective cues were flickering and the bars were static, only the afterimage of the latter was perceived, yet still a considerable amount of the illusory effect was perceived. The results could not be explained by memory of a prejudgment of the bar length during the adaptation phase. The findings suggest that cooccurrences of depth cues and object may link a depth marker for the object, so that the perceived size of the object or its afterimage is modulated by feedback of depth information from higher-level visual cortex even when there is no depth cues directly available on the retinal level.	[Qian, Jiehui; Liu, Shengxi] Sun Yat Sen Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China; [Lei, Quan] Univ Minnesota Twin Cities, Dept Psychol, Minneapolis, MN USA	Sun Yat Sen University; University of Minnesota System; University of Minnesota Twin Cities	Qian, JH (corresponding author), Sun Yat Sen Univ, Dept Psychol, Guangzhou, Guangdong, Peoples R China.	qianjh3@mail.sysu.edu.cn		Lei, Quan/0000-0001-8277-9473	National Natural Science Foundation of China [31500919]; Fundamental Research Funds for the Central Universities [14wkpy20]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work has been supported by the National Natural Science Foundation of China, No. 31500919 (http://www.nsfc.gov.cn) and Fundamental Research Funds for the Central Universities, No. 14wkpy20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work has been supported in part by the National Natural Science Foundation of China (31500919) and Fundamental Research Funds for the Central Universities (14wkpy20).	Boring EG, 1941, AM J PSYCHOL, V53, P293; BOWER T, 1964, PERCEPT MOTOR SKILL, V19, P510, DOI 10.2466/pms.1964.19.2.510; BRINDLEY GS, 1962, J PHYSIOL-LONDON, V164, P168, DOI 10.1113/jphysiol.1962.sp007011; BROERSE J, 1992, PERCEPTION, V21, P261, DOI 10.1068/p210261; Bross M, 2000, PERCEPTION, V29, P1385, DOI 10.1068/p3038; BURBECK CA, 1986, J OPT SOC AM A, V3, P1159, DOI 10.1364/JOSAA.3.001159; Campbell F. W., 1957, OPT ACTA, V4, P157, DOI DOI 10.1080/713826091; Chan D, 2001, J NEUROL NEUROSUR PS, V71, P515, DOI 10.1136/jnnp.71.4.515; Conway BR, 2002, CEREB CORTEX, V12, P915, DOI 10.1093/cercor/12.9.915; CORMACK RH, 1984, PERCEPT PSYCHOPHYS, V35, P423, DOI 10.3758/BF03203918; DEES JW, 1966, PERCEPT MOTOR SKILL, V23, P629, DOI 10.2466/pms.1966.23.2.629; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; DWYER J, 1990, PERCEPTION, V19, P35, DOI 10.1068/p190035; Emmert E., 1881, KLIN MONATSBL AUGENH, P443; EPSTEIN W, 1963, J EXP PSYCHOL, V66, P78, DOI 10.1037/h0047819; EPSTEIN W, 1961, PSYCHOL BULL, V58, P491, DOI 10.1037/h0042260; Ernst M. O., 2006, HUMAN BODY PERCEPTIO, P105; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; Fujita K, 1997, PERCEPT PSYCHOPHYS, V59, P284, DOI 10.3758/BF03211896; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Gregory RichardL., 2009, SEEING ILLUSIONS; GREGORY RL, 1963, NATURE, V199, P678, DOI 10.1038/199678a0; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Kim J, 2011, J VISION, V11, DOI 10.1167/11.3.23; Kirschfeld K, 1999, CONSCIOUS COGN, V8, P462, DOI 10.1006/ccog.1999.0388; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; LEIBOWIT.H, 1966, J OPT SOC AM, V56, P1120, DOI 10.1364/JOSA.56.001120; MACLEOD DIA, 1974, SCIENCE, V185, P1171, DOI 10.1126/science.185.4157.1171; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Nakamizo Sachio, 2004, J Physiol Anthropol Appl Human Sci, V23, P325, DOI 10.2114/jpa.23.325; OGLE KN, 1962, VISION RES, V2, P439, DOI 10.1016/0042-6989(62)90008-1; PRESSEY AW, 1992, PERCEPT PSYCHOPHYS, V52, P211, DOI 10.3758/BF03206774; Prinzmetal W, 2001, PERCEPT PSYCHOPHYS, V63, P99, DOI 10.3758/BF03200506; Qian JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129377; Qian JH, 2013, J VISION, V13, DOI 10.1167/13.11.7; Qian JH, 2012, J VISION, V12, DOI 10.1167/12.2.15; Ross HE, 2000, PERCEPTION, V29, P863, DOI 10.1068/p2937; ROSS HE, 1967, BRIT J PSYCHOL, V58, P301, DOI 10.1111/j.2044-8295.1967.tb01087.x; Schwarzkopf DS, 2011, NAT NEUROSCI, V14, P28, DOI 10.1038/nn.2706; Shen MW, 2015, COGNITION, V141, P26, DOI 10.1016/j.cognition.2015.04.010; Sperandio I, 2012, NAT NEUROSCI, V15, P540, DOI 10.1038/nn.3069; Sperandio I, 2012, J VISION, V12, DOI 10.1167/12.2.18; van Boxtel JJA, 2010, P NATL ACAD SCI USA, V107, P8883, DOI 10.1073/pnas.0913292107; van Lier R, 2009, CURR BIOL, V19, pR323, DOI 10.1016/j.cub.2009.03.010; WALLACH H, 1963, AM J PSYCHOL, V76, P404, DOI 10.2307/1419781; Wheatstone C, 1853, PHILOS TR R SOC, V142, P1; WILLIAMS DR, 1979, VISION RES, V19, P867, DOI 10.1016/0042-6989(79)90020-8	47	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159228	10.1371/journal.pone.0159228	http://dx.doi.org/10.1371/journal.pone.0159228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391335	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400225
J	Wu, WS; Hsieh, YC; Lai, FJ				Wu, Wei-Sheng; Hsieh, Yen-Chen; Lai, Fu-Jou			YCRD: Yeast Combinatorial Regulation Database	PLOS ONE			English	Article							COOPERATIVE TRANSCRIPTION FACTORS; CELL-CYCLE; SYSTEMATIC IDENTIFICATION; STATISTICAL-METHODS; FACTOR PAIRS; FACTORS GLN3; GENE; EXPRESSION; PREDICTION; NETWORK	In eukaryotes, the precise transcriptional control of gene expression is typically achieved through combinatorial regulation using cooperative transcription factors (TFs). Therefore, a database which provides regulatory associations between cooperative TFs and their target genes is helpful for biologists to study the molecular mechanisms of transcriptional regulation of gene expression. Because there is no such kind of databases in the public domain, this prompts us to construct a database, called Yeast Combinatorial Regulation Database (YCRD), which deposits 434,197 regulatory associations between 2535 cooperative TF pairs and 6243 genes. The comprehensive collection of more than 2500 cooperative TF pairs was retrieved from 17 existing algorithms in the literature. The target genes of a cooperative TF pair (e.g. TF1-TF2) are defined as the common target genes of TF1 and TF2, where a TF's experimentally validated target genes were downloaded from YEASTRACT database. In YCRD, users can (i) search the target genes of a cooperative TF pair of interest, (ii) search the cooperative TF pairs which regulate a gene of interest and (iii) identify important cooperative TF pairs which regulate a given set of genes. We believe that YCRD will be a valuable resource for yeast biologists to study combinatorial regulation of gene expression. YCRD is available at http://cosbi.ee.ncku.edu.tw/YCRD/ or http://cosbi2.ee.ncku.edu.tw/YCRD/.	[Wu, Wei-Sheng; Hsieh, Yen-Chen; Lai, Fu-Jou] Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan	National Cheng Kung University	Wu, WS (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, Tainan, Taiwan.	wessonwu@gmail.com	Wu, Wei-Sheng/P-5367-2019		National Cheng Kung University; Ministry of Science and Technology of Taiwan [MOST-103-2221-E-006-174-MY2]	National Cheng Kung University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Cheng Kung University and Ministry of Science and Technology of Taiwan [MOST-103-2221-E-006-174-MY2]. Funding for open access charge: National Cheng Kung University and Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The physical/genetic interaction data and a TF's experimentally validated target genes were retrieved from BioGRID and YEASTRACT in March 2016, respectively. We greatly appreciate the effort of both research teams in collecting and curating such valuable data from the literature. This work was supported by National Cheng Kung University and Ministry of Science and Technology of Taiwan [MOST-103-2221-E-006-174-MY2]. Funding for open access charge: National Cheng Kung University and Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Banerjee N, 2003, NUCLEIC ACIDS RES, V31, P7024, DOI 10.1093/nar/gkg894; Chang YH, 2006, BIOINFORMATICS, V22, P2276, DOI 10.1093/bioinformatics/btl380; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chen MJM, 2012, BIOINFORMATICS, V28, P701, DOI 10.1093/bioinformatics/bts002; Cheng C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-116; Chuang CL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-400; Costanzo MC, 2014, NUCLEIC ACIDS RES, V42, pD717, DOI 10.1093/nar/gkt1158; Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200; Dabas N, 2007, EUKARYOT CELL, V6, P875, DOI 10.1128/EC.00307-06; Datta D, 2008, BIOINFORMATICS, V24, P545, DOI 10.1093/bioinformatics/btm523; Elati M, 2007, BIOINFORMATICS, V23, P2407, DOI 10.1093/bioinformatics/btm352; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; He D, 2006, GCC 2006: FIFTH INTERNATIONAL CONFERENCE ON GRID AND COOPERATIVE COMPUTING WORKSHOPS, PROCEEDINGS, P357; Hernandez H, 2011, BIOCHEM BIOPH RES CO, V404, P859, DOI 10.1016/j.bbrc.2010.12.075; Hofman-Bang J, 1999, MOL BIOTECHNOL, V12, P35, DOI 10.1385/MB:12:1:35; Lai FJ, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S18-S2; Lai FJ, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S5-S2; Lai FJ, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S9; Lelli KM, 2012, ANNU REV GENET, V46, P43, DOI 10.1146/annurev-genet-110711-155437; Nagamine N, 2005, NUCLEIC ACIDS RES, V33, P4828, DOI 10.1093/nar/gki793; Nemer G, 2001, ANN MED, V33, P604, DOI 10.3109/07853890109002106; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tanguay RM., 1998, BIOCH CELL BIOL, V66, P584; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; Tsai HK, 2005, P NATL ACAD SCI USA, V102, P13532, DOI 10.1073/pnas.0505874102; Wang JB, 2007, J BIOMED INFORM, V40, P707, DOI 10.1016/j.jbi.2007.02.003; Wang Y, 2009, NUCLEIC ACIDS RES, V37, P5943, DOI 10.1093/nar/gkp625; Wu WS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-421; Wu WS, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S12-S10; Wu WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-522; Wu WS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-439; Yang Y, 2010, CELL RES, V20, P1276, DOI 10.1038/cr.2010.146; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P917, DOI 10.1093/nar/gkj487	35	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159213	10.1371/journal.pone.0159213	http://dx.doi.org/10.1371/journal.pone.0159213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392072	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400219
J	Yu, L; Gong, XJ; Sun, L; Zhou, QY; Lu, BL; Zhu, LY				Yu, Lei; Gong, Xuejun; Sun, Lei; Zhou, Qiying; Lu, Baoling; Zhu, Liying			The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression	PLOS ONE			English	Article							DOWN-REGULATION; IDENTIFICATION; PROLIFERATION; TRANSCRIPTION; BIOGENESIS; INSIGHTS	CircRNAs are a class of endogenous RNA that regulates gene expression at the post-transcriptional or transcriptionallevel through interacting with other molecules or microRNAs. Increasing studies have demonstrated that circRNAs play a crucial role in biology processes. CircRNAs are proved as potentialbiomarkers in many diseases including cancers. However, the role of Cdr1as in Hepatocellular carcinoma (HCC) remains to be elucidated. We demonstrated that Cdr1as expression was upregulated in HCC tissues compared with the adjacent non-tumor tissues. In addtion, miR-7 expression was downregulated in HCC tissues compared with the adjacent non-tumor tissues. Moreover, the expression level of miR-7 was inversely correlated with that in HCC tissues. Knockdown of Cdr1as suppressed the HCC cell proliferation and invasion. Overexpression of miR-7 inhibited the HCC cell proliferation and invasion. Overexpression of miR-7 could suppress the direct target gene CCNE1 and PIK3CD expression. Knockdown of Cdr1as suppressed the expression of miR-7 and also inhibited the CCNE1 and PIK3CD expression. Furthermore, knockdown of Cdr1as suppressed the HCC cell proliferation and invasion through targeting miR-7. These data suggested that Cdr1as acted as an oncogene partly through targeting miR-7 in HCC.	[Yu, Lei; Lu, Baoling; Zhu, Liying] Harbin Med Univ, Hosp 4, Dept Infect Dis, Harbin 150001, Heilongjiang, Peoples R China; [Gong, Xuejun] Cent S Univ, Xiangya Hosp, Dept Biliary & Pancreat Surg, Changsha 410008, Hunan, Peoples R China; [Sun, Lei] Harbin Med Univ, Hosp 4, Dept Ophthalmol, Harbin 150001, Heilongjiang, Peoples R China; [Zhou, Qiying] Jilin Univ, Coll Comp Sci & Technol Network & Informat Securi, Changchun 130001, Jilin, Peoples R China	Harbin Medical University; Central South University; Harbin Medical University; Jilin University	Yu, L; Zhu, LY (corresponding author), Harbin Med Univ, Hosp 4, Dept Infect Dis, Harbin 150001, Heilongjiang, Peoples R China.	widedoor@sina.com; zlyhmu@126.com		YU, LEI/0000-0002-8837-2022	Postdoctoral scientific research developmental fund of Heilongjiang Province [LBH-Q14115]; National Science and Technology Major Project [2014ZX10002002]; Natural Science Foundation of Heilongjiang Province [ZD2015019]	Postdoctoral scientific research developmental fund of Heilongjiang Province; National Science and Technology Major Project; Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province)	This work was supported by the Postdoctoral scientific research developmental fund of Heilongjiang Province (No. LBH-Q14115), and sponsored by National Science and Technology Major Project (2014ZX10002002) and Natural Science Foundation of Heilongjiang Province (ZD2015019), URL: http://jj.hljkj.cn/zr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae HJ, 2014, ONCOGENE, V33, P2557, DOI 10.1038/onc.2013.216; Boeckel JN, 2015, CIRC RES, V117, P884, DOI 10.1161/CIRCRESAHA.115.306319; Chen I, 2015, WIRES RNA, V6, P563, DOI 10.1002/wrna.1294; Chen YJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/682380; Ebbesen KK, 2016, BBA-GENE REGUL MECH, V1859, P163, DOI 10.1016/j.bbagrm.2015.07.007; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Furuta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060155; Giray BG, 2014, MOL BIOL REP, V41, P4513, DOI 10.1007/s11033-014-3322-3; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Huang C, 2015, TRANSCR-AUSTIN, V6, P61, DOI 10.1080/21541264.2015.1071301; Lasda E, 2014, RNA, V20, P1829, DOI 10.1261/rna.047126.114; Li JQ, 2015, AM J CANCER RES, V5, P472; Li PF, 2015, CLIN CHIM ACTA, V444, P132, DOI 10.1016/j.cca.2015.02.018; Li QJ, 2012, TUMOR BIOL, V33, P1455, DOI 10.1007/s13277-012-0396-1; Liao CG, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0234-x; Liu JB, 2015, TUMOR BIOL, V36, P219, DOI 10.1007/s13277-014-2622-5; Lu TT, 2015, RNA, V21, P2076, DOI 10.1261/rna.052282.115; Lukiw Walter J., 2013, Frontiers in Genetics, V4, P307, DOI [10.3389/fgene.2013.00307, 10.3389/fgene.2013.00077]; Ma CQ, 2013, IUBMB LIFE, V65, P1026, DOI 10.1002/iub.1231; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Veno MT, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0801-3; Xu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12453; Xu LB, 2014, J HEPATOL, V60, P590, DOI 10.1016/j.jhep.2013.10.028; Yang XY, 2012, PHARMAZIE, V67, P645, DOI 10.1691/ph.2012.1704; Yu L, 2015, ONCOTARGET, V6, P39225, DOI 10.18632/oncotarget.4407; Yu L, 2014, AM J CANCER RES, V4, P897; Yu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091661; Zhang HY, 2014, INT J ONCOL, V45, P2143, DOI 10.3892/ijo.2014.2596; Zhang X, 2014, BIOCHEM BIOPH RES CO, V443, P1078, DOI 10.1016/j.bbrc.2013.12.095; Zhao ZJ, 2017, RNA BIOL, V14, P514, DOI 10.1080/15476286.2015.1122162; Zheng QL, 2014, MOL CELL BIOCHEM, V389, P187, DOI 10.1007/s11010-013-1940-z; Zhou X, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-19	34	242	259	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158347	10.1371/journal.pone.0158347	http://dx.doi.org/10.1371/journal.pone.0158347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391479	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400045
J	van Schooten, KS; Pijnappels, M; Rispens, SM; Elders, PJM; Lips, P; Daffertshofer, A; Beek, PJ; van Dieen, JH				van Schooten, Kimberley S.; Pijnappels, Mirjam; Rispens, Sietse M.; Elders, Petra J. M.; Lips, Paul; Daffertshofer, Andreas; Beek, Peter J.; van Dieen, Jaap H.			Daily-Life Gait Quality as Predictor of Falls in Older People: A 1-Year Prospective Cohort Study	PLOS ONE			English	Article							DYNAMIC STABILITY; RISK; COMMUNITY; VALIDATION; ACCURACY; PROVIDE; SCALE	Falls can have devastating consequences for older people. We determined the relationship between the likelihood of fall incidents and daily-life behavior. We used wearable sensors to assess habitual physical activity and daily-life gait quality (in terms of e.g. stability, variability, smoothness and symmetry), and determined their predictive ability for time-to-first-and-second-falls. 319 older people wore a trunk accelerometer (Dynaport MoveMonitor, McRoberts) during one week. Participants further completed questionnaires and performed grip strength and trail making tests to identify risk factors for falls. Their prospective fall incidence was followed up for six to twelve months. We determined interrelations between commonly used gait characteristics to gain insight in their interpretation and determined their association with time-to-falls. For all data-including questionnaires and tests-we determined the corresponding principal components and studied their predictive ability for falls. We showed that gait characteristics of walking speed, stride length, stride frequency, intensity, variability, smoothness, symmetry and complexity were often moderately to highly correlated (r > 0.4). We further showed that these characteristics were predictive of falls. Principal components dominated by history of falls, alcohol consumption, gait quality and muscle strength proved predictive for time-to-fall. The cross-validated prediction models had adequate to high accuracy (time dependent AUC of 0.66-0.72 for time-to-first-fall and 0.69-0.76 for -second-fall). Daily-life gait quality obtained from a single accelerometer on the trunk is predictive for falls. These findings confirm that ambulant measurements of daily behavior contribute substantially to the identification of elderly at (high) risk of falling.	[van Schooten, Kimberley S.; Pijnappels, Mirjam; Rispens, Sietse M.; Daffertshofer, Andreas; Beek, Peter J.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Elders, Petra J. M.] Vrije Univ Amsterdam Med Ctr, Dept Gen Practice & Elderly Care, EMGO Inst, Amsterdam, Netherlands; [Lips, Paul] Vrije Univ Amsterdam Med Ctr, Dept Internal Med, MOVE Res Inst Amsterdam, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	van Dieen, JH (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	j.van.dieen@vu.nl	van Schooten, Kim/ABE-3702-2020; van Dieen, Jaap/B-3937-2013; van Schooten, Kimberley/A-5844-2012	van Dieen, Jaap/0000-0002-7719-5585; Rispens, Sietse/0000-0002-9400-6125; Daffertshofer, Andreas/0000-0001-9107-3552; Elders, Petra/0000-0002-5907-7219; Pijnappels, Mirjam/0000-0001-8416-2602; Beek, Peter/0000-0002-0917-8548; van Schooten, Kimberley/0000-0003-0902-8440	Netherlands Organisation for Scientific Research (NWO TOP NIG grant) [91209021]; NWO grant [400-08-127]; commercial grant of McRoberts (the Hague, the Netherlands)	Netherlands Organisation for Scientific Research (NWO TOP NIG grant)(Netherlands Organization for Scientific Research (NWO)); NWO grant; commercial grant of McRoberts (the Hague, the Netherlands)	This work was supported by the Netherlands Organisation for Scientific Research (NWO TOP NIG grant 91209021 to MP (http://www.zonmw.nl/nl/projecten/project-detail/a-novel-instrument-to-support-fall-prevention-in-extramural-care/samenvatting/) and NWO grant 400-08-127 to AD (http://www.nwo.nl/onderzoek-en-resultaten/onderzoeksprojecten/i/80/4780.html)). KS was partially supported by a commercial grant of McRoberts (the Hague, the Netherlands; http://www.mcroberts.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellanca JL, 2013, J BIOMECH, V46, P828, DOI 10.1016/j.jbiomech.2012.12.008; Brodie MA, 2015, MED HYPOTHESES, V84, P356, DOI 10.1016/j.mehy.2015.01.017; Bruijn SM, 2009, J NEUROSCI METH, V178, P327, DOI 10.1016/j.jneumeth.2008.12.015; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; Dijkstra B, 2010, AGE AGEING, V39, P259, DOI 10.1093/ageing/afp249; Doi T, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-7; Dumith SC, 2011, PREV MED, V53, P24, DOI 10.1016/j.ypmed.2011.02.017; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gates S, 2008, J REHABIL RES DEV, V45, P1105, DOI 10.1682/JRRD.2008.04.0057; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Graafmans WC, 1996, AM J EPIDEMIOL, V143, P1129; Holtzer R, 2007, NEUROPSYCHOLOGY, V21, P540, DOI 10.1037/0894-4105.21.5.540; Klenk J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129098; Lamoth CJC, 2002, GAIT POSTURE, V16, P101, DOI 10.1016/S0966-6362(01)00146-1; Lee J, 2013, PM&R, V5, P609, DOI 10.1016/j.pmrj.2013.04.001; Marschollek M, 2011, METHOD INFORM MED, V50, P420, DOI 10.3414/ME10-01-0040; Milat Andrew J, 2011, N S W Public Health Bull, V22, P43, DOI 10.1071/NB10065; Moe-Nilssen R, 2004, J BIOMECH, V37, P121, DOI 10.1016/S0021-9290(03)00233-1; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P320, DOI 10.1016/S0268-0033(98)00089-8; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rispens SM, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.3931; Rispens SM, 2015, NEUROREHAB NEURAL RE, V29, P54, DOI 10.1177/1545968314532031; Rispens SM, 2014, GAIT POSTURE, V40, P187, DOI 10.1016/j.gaitpost.2014.03.182; Salva A, 2004, MED CLIN-BARCELONA, V122, P172, DOI 10.1157/13057813; Schwenk M, 2014, GERONTOL; Scott V, 2007, AGE AGEING, V36, P130, DOI 10.1093/ageing/afl165; Shany T, 2015, HEALTHC TECHNOL LETT, V2, P79, DOI 10.1049/htl.2015.0019; Tromp AM, 2001, J CLIN EPIDEMIOL, V54, P837, DOI 10.1016/S0895-4356(01)00349-3; van Schooten KS, 2015, J GERONTOL A-BIOL, V70, P608, DOI 10.1093/gerona/glu225; van Schooten KS, 2014, GAIT POSTURE, V39, P695, DOI 10.1016/j.gaitpost.2013.09.020; van Schooten KS, 2014, JAPA; Weiss A, 2013, NEUROREHAB NEURAL RE, V27, P742, DOI 10.1177/1545968313491004; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; YACK HJ, 1993, J GERONTOL, V48, pM225, DOI 10.1093/geronj/48.5.M225; Yardley L, 2005, AGE AGEING, V34, P614, DOI 10.1093/ageing/afi196; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zijlstra W, 2003, GAIT POSTURE, V18, P1, DOI 10.1016/S0966-6362(02)00190-X	39	83	83	5	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158623	10.1371/journal.pone.0158623	http://dx.doi.org/10.1371/journal.pone.0158623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389583	Green Published, Green Submitted, gold			2022-12-26	WOS:000379811500031
J	Gheerbrant, E; Filippo, A; Schmitt, A				Gheerbrant, Emmanuel; Filippo, Andrea; Schmitt, Arnaud			Convergence of Afrotherian and Laurasiatherian Ungulate-Like Mammals: First Morphological Evidence from the Paleocene of Morocco	PLOS ONE			English	Article							OULED-ABDOUN BASIN; LOWER EOCENE; EARLY TERTIARY; ORIGINS; PROBOSCIDEA; ORDER	Molecular-based analyses showed that extant "ungulate" mammals are polyphyletic and belong to the two main clades Afrotheria (Paenungulata) and Laurasiatheria (Euungulata: Cetartiodactyla-Perissodactyla). However, paleontological and neontological studies hitherto failed to demonstrate the morphological convergence of African and Laurasian "ungulate" orders. They support an "Altungulata" group including the Laurasian order Perissodactyla and the African superorder Paenungulata and characterized especially by quadritubercular and bilophodont molars adapted for a folivorous diet. We report new critical fossils of one of the few known African condylarth-like mammal, the enigmatic Abdounodus from the middle Paleocene of Morocco. They show that Abdounodus and Ocepeia display key intermediate morphologies refuting the homology of the fourth main cusp of upper molars in Paenungulata and Perissodactyla: Paenungulates unexpectedly have a metaconule-derived pseudohypocone, instead of a cingular hypocone. Comparative and functional dental anatomy of Abdounodus demonstrates indeed the convergence of the quadritubercular and bilophodont pattern in "ungulates". Consistently with our reconstruction of the structural evolution of paenungulate bilophodonty, the phylogenetic analysis relates Abdounodus and Ocepeia to Paenungulata as stem taxa of the more inclusive new clade Paenungulatomorpha which is distinct from the Perissodactyla and Anthracobunidae. Abdounodus and Ocepeia help to identify the first convincing synapomorphy within the Afrotheria-i.e., the pseudohypocone-that demonstrates the morphological convergence of African and Laurasian ungulate-like placentals, in agreement with molecular phylogeny. Abdounodus and Ocepeia are the only known representatives of the early African ungulate radiation predating the divergence of extant paenungulate orders. Paenungulatomorpha evolved in Africa since the early Tertiary independently from laurasiatherian euungulates and "condylarths" such as apheliscids. The rapid early Tertiary radiation of the Afrotheria and Paenungulatomorpha, as illustrated by the Paleocene Moroccan mammals, is concurrent with that of the Laurasiatheria in a general, explosive mammal evolution in both the South and North Tethyan continents following the K/Pg event.	[Gheerbrant, Emmanuel; Filippo, Andrea; Schmitt, Arnaud] Univ Paris 04, CR2P Ctr Rech Paleobiodiversite & Paleoenvironnem, Museum Natl Hist Nat, CNRS,UPMC,MNHN,UMR 7207,CP38, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Gheerbrant, E (corresponding author), Univ Paris 04, CR2P Ctr Rech Paleobiodiversite & Paleoenvironnem, Museum Natl Hist Nat, CNRS,UPMC,MNHN,UMR 7207,CP38, Paris, France.	gheerbra@mnhn.fr	Gheerbrant, Emmanuel/F-6943-2010	Gheerbrant, Emmanuel/0000-0003-3355-458X				Arambourg C., 1952, NOTES ME MOIRES SERV, V92, P1; Benoit J, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2015.1034358; BUTLER PM, 1952, P ZOOL SOC LOND, V121, P777, DOI 10.1111/j.1096-3642.1952.tb00784.x; Cooper LN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109232; Cote S, 2007, P NATL ACAD SCI USA, V104, P5510, DOI 10.1073/pnas.0700441104; COURT N, 1993, J PALEONTOL, V67, P889, DOI 10.1017/S002233600003715X; Court N., 1992, Historical Biology, V6, P91; Crompton AW, 1971, ZOOLOGICAL J LINN S1, P65; Gheerbrant E, 2003, B SOC GEOL FR, V174, P279, DOI 10.2113/174.3.279; Gheerbrant E, 2005, GEODIVERSITAS, V27, P239; Gheerbrant E, 1996, NATURE, V383, P68, DOI 10.1038/383068a0; Gheerbrant E, 2001, J VERTEBR PALEONTOL, V21, P107, DOI 10.1671/0272-4634(2001)021[0107:FAACMP]2.0.CO;2; Gheerbrant E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089739; Gheerbrant E, 2012, PALAEONTOGR ABT A, V297, P151; Gheerbrant Emmanuel, 2010, P563; Gheerbrant E, 2009, P NATL ACAD SCI USA, V106, P10717, DOI 10.1073/pnas.0900251106; Ginsburg L, 1999, CR ACAD SCI II A, V328, P209, DOI 10.1016/S1251-8050(99)80098-6; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gunnell GF, 2010, CENOZOIC MAMMALS AFR, P123; Halliday TJD, 2017, BIOL REV, V92, P521, DOI 10.1111/brv.12242; Halliday TJD, 2016, BIOL J LINN SOC, V118, P152, DOI 10.1111/bij.12731; Hooker Jeremy J., 2005, P199; Hooker JJ, 2012, ZOOL J LINN SOC-LOND, V164, P856, DOI 10.1111/j.1096-3642.2011.00787.x; HOOKER JJ, 1984, ZOOL J LINN SOC-LOND, V82, P229, DOI 10.1111/j.1096-3642.1984.tb00545.x; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Kocsis L, 2014, PALAEOGEOGR PALAEOCL, V394, P74, DOI 10.1016/j.palaeo.2013.11.002; Kullmer O, 2009, AM J PHYS ANTHROPOL, V139, P600, DOI 10.1002/ajpa.21086; Linnaeus C, 1766, SYSTEMAE NATURAE; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; MAHBOUBI M, 1986, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V192, P15; Mao FY, 2016, HIST BIOL, V28, P787, DOI 10.1080/08912963.2015.1034120; McKenna M.C., 1977, GEOBIOS MEM SPEC, V1, P61; McKenna MC, 1997, CLASSIFICATION MAMMA; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Nixon KC, 1999, WINCLADA BETA VERSIO; Noubhani Abdelmajid, 1997, Palaeo Ichthyologica, V8, P1; Pardini AT, 2007, P ROY SOC B-BIOL SCI, V274, P1333, DOI 10.1098/rspb.2007.0088; Polly PD, 2007, NATURE, V229, P413; Prothero D. R., 1993, MAMMAL PHYLOGENY, V2, P173; Prothero D. R., 1989, EVOLUTION PERISSODAC, P504; Robinson TJ, 2008, P NATL ACAD SCI USA, V105, P14477, DOI 10.1073/pnas.0807433105; Robinson TJ, 2004, CURR TOP DEV BIOL, V63, P37, DOI 10.1016/S0070-2153(04)63002-X; ROSE KD, 2006, BEGINNING AGE MAMMAL; Rose KD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6570; Seiffert ER, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-224; SIMPSON GG, 1945, B AM MUS NAT HIST, V85, P1; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Tabuce R, 2007, P ROY SOC B-BIOL SCI, V274, P1159, DOI 10.1098/rspb.2006.0229; Thewissen J.G.M., 1992, Journal of Vertebrate Paleontology, V12, P494; von Koenigswald W, 2013, PALAEONTOL Z, V87, P141, DOI 10.1007/s12542-012-0142-4; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Welker F, 2015, NATURE, V522, P81, DOI 10.1038/nature14249; Wilson LAB, 2012, PALEOBIOLOGY, V38, P308, DOI 10.1666/11001.1; Yans J, 2014, GONDWANA RES, V25, P257, DOI 10.1016/j.gr.2013.04.004	56	20	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157556	10.1371/journal.pone.0157556	http://dx.doi.org/10.1371/journal.pone.0157556			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384169	gold, Green Submitted, Green Published			2022-12-26	WOS:000379809400015
J	Iwasaki, Y; Sugita, S; Mandai, M; Yonemura, S; Onishi, A; Ito, S; Mochizuki, M; Ohno-Matsui, K; Takahashi, M				Iwasaki, Yuko; Sugita, Sunao; Mandai, Michiko; Yonemura, Shigenobu; Onishi, Akishi; Ito, Shin-ichiro; Mochizuki, Manabu; Ohno-Matsui, Kyoko; Takahashi, Masayo			Differentiation/Purification Protocol for Retinal Pigment Epithelium from Mouse Induced Pluripotent Stem Cells as a Research Tool	PLOS ONE			English	Article							VISUAL CYCLE; IN-VITRO; CADHERIN EXPRESSION; EYE DEVELOPMENT; DOWN-REGULATION; 1B PROTEIN; RPE CELLS; ACTIVATION; CULTURE; PROMOTER	Purpose To establish a novel protocol for differentiation of retinal pigment epithelium (RPE) with high purity from mouse induced pluripotent stem cells (iPSC). Methods Retinal progenitor cells were differentiated from mouse iPSC, and RPE differentiation was then enhanced by activation of the Wnt signaling pathway, inhibition of the fibroblast growth factor signaling pathway, and inhibition of the Rho-associated, coiled-coil containing protein kinase signaling pathway. Expanded pigmented cells were purified by plate adhesion after Accutase (R) treatment. Enriched cells were cultured until they developed a cobblestone appearance with cuboidal shape. The characteristics of iPS-RPE were confirmed by gene expression, immunocytochemistry, and electron microscopy. Functions and immunologic features of the iPS-RPE were also evaluated. Results We obtained iPS-RPE at high purity (approximately 98%). The iPS-RPE showed apicalbasal polarity and cellular structure characteristic of RPE. Expression levels of several RPE markers were lower than those of freshly isolated mouse RPE but comparable to those of primary cultured RPE. The iPS-RPE could form tight junctions, phagocytose photoreceptor outer segments, express immune antigens, and suppress lymphocyte proliferation. Conclusion We successfully developed a differentiation/purification protocol to obtain mouse iPS-RPE. The mouse iPS-RPE can serve as an attractive tool for functional and morphological studies of RPE.	[Iwasaki, Yuko; Sugita, Sunao; Mandai, Michiko; Onishi, Akishi; Ito, Shin-ichiro; Takahashi, Masayo] RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Iwasaki, Yuko; Mochizuki, Manabu; Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Yonemura, Shigenobu] RIKEN Ctr Life Sci Technol, Ultrastruct Res Team, Kobe, Hyogo, Japan; [Yonemura, Shigenobu] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Cell Biol, Tokushima, Japan	RIKEN; Tokyo Medical & Dental University (TMDU); RIKEN; Tokushima University	Takahashi, M (corresponding author), RIKEN Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan.	retinalab@cdb.riken.jp		Shida, Yuko/0000-0003-0584-0407	Junior Research Associate Program of RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan [25293357]	Junior Research Associate Program of RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	YI was supported by Junior Research Associate Program of RIKEN (http://www.riken.jp/en/careers/programs/jra/). SS was supported by Scientific Research Grant (B, 25293357) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisenbrey S, 2006, INVEST OPHTH VIS SCI, V47, P5537, DOI 10.1167/iovs.05-1590; Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Aoki H, 2006, EXP EYE RES, V82, P265, DOI 10.1016/j.exer.2005.06.021; Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011; Baas D, 2000, MOL BRAIN RES, V78, P26, DOI 10.1016/S0169-328X(00)00060-7; Benny O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012515; Bharti K, 2008, DEVELOPMENT, V135, P1169, DOI 10.1242/dev.014142; Bora N, 1998, DEV DYNAM, V213, P283, DOI 10.1002/(SICI)1097-0177(199811)213:3<283::AID-AJA5>3.0.CO;2-H; Chen Y, 2003, MOL VIS, V9, P345; Chucair-Elliott AJ, 2012, J BIOL CHEM, V287, P24092, DOI 10.1074/jbc.M112.378240; Croze RH, 2014, STEM CELL TRANSL MED, V3, P1066, DOI 10.5966/sctm.2014-0079; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Furukawa T, 1997, P NATL ACAD SCI USA, V94, P3088, DOI 10.1073/pnas.94.7.3088; Geisen P, 2006, CURR EYE RES, V31, P739, DOI 10.1080/02713680600837408; Gibbs D, 2003, P NATL ACAD SCI USA, V100, P6481, DOI 10.1073/pnas.1130432100; Gong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143272; Gonzalez-Cordero A, 2013, NAT BIOTECHNOL, V31, P741, DOI 10.1038/nbt.2643; GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; Homma K, 2013, STEM CELLS, V31, P1149, DOI 10.1002/stem.1372; Jo YJ, 2011, INVEST OPHTH VIS SCI, V52, P6089, DOI 10.1167/iovs.10-5189; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; Kanemura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085336; KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kuwahara A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7286; Leung T, 1996, MOL CELL BIOL, V16, P5313; Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X; Liu W, 2010, J CLIN INVEST, V120, P3568, DOI 10.1172/JCI43219; Lopes VS, 2011, HUM MOL GENET, V20, P2560, DOI 10.1093/hmg/ddr155; Maeda T, 2013, J BIOL CHEM, V288, P34484, DOI 10.1074/jbc.M113.518571; Maekawa Y., 2015, CURR EYE RES, V41, P558, DOI [10.3109/02713683.2015.1038359, DOI 10.3109/02713683.2015.1038359]; Manes G, 1998, FEBS LETT, V423, P133, DOI 10.1016/S0014-5793(98)00081-7; Maruotti J, 2015, P NATL ACAD SCI USA, V112, P10950, DOI 10.1073/pnas.1422818112; Masuda T, 2014, J BIOL CHEM, V289, P12908, DOI 10.1074/jbc.M114.556738; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; Muniz A, 2014, INVEST OPHTH VIS SCI, V55, P198, DOI 10.1167/iovs.13-11740; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; NOSE A, 1986, J CELL BIOL, V103, P2649, DOI 10.1083/jcb.103.6.2649; Okada T, 2003, IUL BIOTECH, P253; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; Street CA, 2011, ANTICANCER RES, V31, P3645; Sugita S, 2003, J EXP MED, V198, P161, DOI 10.1084/jem.20030097; Sugita S, 2006, EXP EYE RES, V83, P1459, DOI 10.1016/j.exer.2006.08.005; Sugita S, 2015, INVEST OPHTH VIS SCI, V56, P1051, DOI 10.1167/iovs.14-15619; Sugita S, 2009, INVEST OPHTH VIS SCI, V50, P2862, DOI 10.1167/iovs.08-2846; Toyofuku T, 2012, GENE DEV, V26, P816, DOI 10.1101/gad.184481.111; Usui Y, 2008, EXP EYE RES, V86, P52, DOI 10.1016/j.exer.2007.09.007; Wang CXZ, 2012, EXP EYE RES, V102, P1, DOI 10.1016/j.exer.2012.06.003; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu L, 2002, EXP EYE RES, V74, P753, DOI 10.1006/exer.2002.1175	57	12	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158282	10.1371/journal.pone.0158282	http://dx.doi.org/10.1371/journal.pone.0158282			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27385038	Green Published, gold			2022-12-26	WOS:000379809400041
J	Liu, R; Huang, Q; Shan, JJ; Duan, JA; Zhu, ZH; Liu, P; Bian, Y; Shang, EX; Qian, DW				Liu, Rui; Huang, Qiong; Shan, Jinjun; Duan, Jin-ao; Zhu, Zhenhua; Liu, Pei; Bian, Yong; Shang, Er-xin; Qian, Dawei			Metabolomics of the Antipyretic Effects of Bubali Cornu (Water Buffalo Horn) in Rats	PLOS ONE			English	Article							PATTERN-RECOGNITION APPROACH; MASS-SPECTROMETRY; ANIMAL HORNS; INDUCED INFLAMMATION; BIOCHEMICAL-CHANGES; FEBRILE RESPONSE; RHINOCEROS HORN; BAKERS-YEAST; FEVER; LYSOPHOSPHATIDYLCHOLINE	Bubali Cornu (water buffalo horn, WBH) has been used for thousands of years in traditional Chinese medicine (TCM) as an effective treatment for heat. In the present study, we have carried out a metabolomics profiling study on plasma and urine samples to explore potential biomarkers and determine how WBH exerts its antipyretic effects in yeast-induced pyrexia at a metabolomic level. Ultra-high performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS), together with multivariate statistical analysis, was used to detect and identify potential biomarkers associated with pyrexia and with WBH treatment. In total, sixteen endogenous metabolites were identified in plasma samples and twenty-one metabolites were detected in urine samples. The biomarkers identified in this study, using metabolic pathway analysis (MetPA), are involved in glycerophospholipid, arachidonic acid, amino acid, sphingolipid, and purine metabolism, all of which are disturbed in rats with pyrexia. As a result, WBH affect arachidonic acid metabolism and oxidative stress in yeast-induced pyrexia rats chiefly. The present study determines the important substances underlying the antipyretic efficacy of WBH at a metabolic level. It might pave the way for further investigations into the mechanisms of action of other animal horn-derived traditional Chinese medicines (TCMs).	[Liu, Rui; Duan, Jin-ao; Zhu, Zhenhua; Liu, Pei; Bian, Yong; Shang, Er-xin; Qian, Dawei] Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Nanjing, Jiangsu, Peoples R China; [Liu, Rui; Duan, Jin-ao; Zhu, Zhenhua; Liu, Pei; Bian, Yong; Shang, Er-xin; Qian, Dawei] Nanjing Univ Chinese Med, Natl & Local Collaborat Engn Ctr Chinese Med Reso, Nanjing, Jiangsu, Peoples R China; [Liu, Rui] Nanjing Univ Chinese Med, Jiangsu Key Lab Res & Dev Marine Bioresource Phar, Nanjing, Jiangsu, Peoples R China; [Liu, Rui; Duan, Jin-ao; Zhu, Zhenhua; Liu, Pei; Shang, Er-xin; Qian, Dawei] Nanjing Univ Chinese Med, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing, Jiangsu, Peoples R China; [Huang, Qiong] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Shan, Jinjun] Nanjing Univ Chinese Med, Inst Pediat, Jiangsu Key Lab Pediat Resp Dis, Nanjing, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing University of Chinese Medicine; Nanjing Medical University; Nanjing University of Chinese Medicine	Liu, R; Duan, JA (corresponding author), Nanjing Univ Chinese Med, Jiangsu Collaborat Innovat Ctr Chinese Med Resour, Nanjing, Jiangsu, Peoples R China.; Liu, R; Duan, JA (corresponding author), Nanjing Univ Chinese Med, Natl & Local Collaborat Engn Ctr Chinese Med Reso, Nanjing, Jiangsu, Peoples R China.; Liu, R (corresponding author), Nanjing Univ Chinese Med, Jiangsu Key Lab Res & Dev Marine Bioresource Phar, Nanjing, Jiangsu, Peoples R China.; Liu, R; Duan, JA (corresponding author), Nanjing Univ Chinese Med, Jiangsu Key Lab High Technol Res TCM Formulae, Nanjing, Jiangsu, Peoples R China.	cpulr@126.com; dja@njutcm.edu.cn			Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Technology Research Funds of State Administration of Traditional Chinese Medicine [201407002]; National Science Foundation of China [81202861, 81274017]; Doctoral Fund of Ministry of Education of China [20113237120011]; Flagship Major Development of Jiangsu Higher Education Institutions; Qin Lan Project	Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Technology Research Funds of State Administration of Traditional Chinese Medicine; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Flagship Major Development of Jiangsu Higher Education Institutions; Qin Lan Project	This study was funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Technology Research Funds of State Administration of Traditional Chinese Medicine (201407002), National Science Foundation of China (81202861 and 81274017), Doctoral Fund of Ministry of Education of China (20113237120011), and the Flagship Major Development of Jiangsu Higher Education Institutions, and Qin Lan Project.	Adham KG, 2012, NEUROENDOCRINOL LETT, V33, P713; Bayle MS, 2000, ACTA PAEDIATR, V89, P367, DOI 10.1080/080352500750028573; Brkic L, 2012, ATHEROSCLEROSIS, V224, P348, DOI 10.1016/j.atherosclerosis.2012.07.038; BUT PP, 1990, J ETHNOPHARMACOL, V30, P157; BUT PPH, 1991, J ETHNOPHARMACOL, V33, P45; Feleder C, 2007, AM J PHYSIOL-REG I, V293, pR1135, DOI 10.1152/ajpregu.00067.2007; Fraunberger P, 2002, CLIN CHEM LAB MED, V40, P304, DOI 10.1515/CCLM.2002.048; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gao XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100017; Gao XY, 2013, CHEM-BIOL INTERACT, V204, P39, DOI 10.1016/j.cbi.2013.04.001; Guan NZ, 2015, METABOLOMICS, V11, P1106, DOI 10.1007/s11306-014-0766-3; Kaneko K, 2011, J INVEST DERMATOL, V131, P1262, DOI 10.1038/jid.2011.37; Kondeti V, 2016, J ALLERGY CLIN IMMUN, V137, P289, DOI 10.1016/j.jaci.2015.06.030; Liu R, 2015, J LIQ CHROMATOGR R T, V38, P1185, DOI 10.1080/10826076.2015.1025142; Liu R, 2012, J LIQ CHROMATOGR R T, V35, P205, DOI 10.1080/10826076.2011.597070; Liu R, 2011, J SEP SCI, V34, P354, DOI 10.1002/jssc.201000617; Liu R, 2010, PEPTIDES, V31, P786, DOI 10.1016/j.peptides.2010.02.016; Liu R, 2010, AM J CHINESE MED, V38, P293, DOI 10.1142/S0192415X10007853; Liu SM, 2011, AM J CHINESE MED, V39, P95, DOI 10.1142/S0192415X11008671; Luo JY, 2011, J ETHNOPHARMACOL, V136, P210, DOI 10.1016/j.jep.2011.04.053; Hung ND, 2012, INFLAMM RES, V61, P473, DOI 10.1007/s00011-012-0434-x; Ferreira APO, 2012, INFLAMM RES, V61, P103, DOI 10.1007/s00011-011-0392-8; Panasenko OM, 2003, FREE RADICAL BIO MED, V34, P553, DOI 10.1016/S0891-5849(02)01358-8; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; Schober C, 2009, BIOORG CHEM, V37, P202, DOI 10.1016/j.bioorg.2009.09.002; Strobel G, 2002, LIFE SCI, V71, P55, DOI 10.1016/S0024-3205(02)01620-X; Su SL, 2013, J PROTEOME RES, V12, P852, DOI 10.1021/pr300935x; [王斐 Wang Fei], 2005, [南京中医药大学学报, Journal of Nanjing University of Traditional Chinese Medicine], V21, P163; [王斐 WANG Fei], 2007, [南京中医药大学学报, Journal of Nanjing University of Traditional Chinese Medicine], V23, P36; Wang PC, 2015, AM J CHINESE MED, V43, P1281, DOI 10.1142/S0192415X15500731; Wang XJ, 2012, J PROTEOME RES, V11, P1284, DOI 10.1021/pr200963e; Zhang FS, 2013, J PHARMACEUT BIOMED, V81-82, P168, DOI 10.1016/j.jpba.2013.04.005; Zou LJ, 2013, SCI REP-UK, V3, DOI [10.1038/srep02243, 10.1038/srep03108]	33	12	18	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158478	10.1371/journal.pone.0158478	http://dx.doi.org/10.1371/journal.pone.0158478			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384078	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400052
J	Xu, L; Zhang, G; Cui, HY				Xu, Li; Zhang, Guang; Cui, Haoyue			Dependence of Initial Value on Pattern Formation for a Logistic Coupled Map Lattice	PLOS ONE			English	Article							TURING PATTERNS; TIME-DELAY; SYSTEMS	The logistic coupled map lattices (LCML) have been widely investigated as well as their pattern dynamics. The patterns formation may depend on not only fluctuations of system parameters, but variation of the initial conditions. However, the mathematical discussion is quite few for the effect of initial values so far. The present paper is concerned with the pattern formation for a two-dimensional Logistic coupled map lattice, where any initial value can be linear expressed by corresponding eigenvectors, and patterns formation can be determined by selecting the corresponding eigenvectors. A set of simulations are conducted whose results demonstrate the fact. The method utilized in the present paper could be applied to other discrete systems as well.	[Xu, Li; Zhang, Guang; Cui, Haoyue] Tianjin Univ Commerce, Sch Sci, Tianjin, Peoples R China	Tianjin University of Commerce	Xu, L (corresponding author), Tianjin Univ Commerce, Sch Sci, Tianjin, Peoples R China.	beifang_xl@163.com		Zhang, Guang/0000-0001-9064-9345	national natural science foundation of China [11371277]; cultivation program for excellent youth teacher in university, Tianjin [507-125RCPY0314]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); cultivation program for excellent youth teacher in university, Tianjin	This work was financially supported by the national natural science foundation of China under grant No. 11371277 and cultivation program for excellent youth teacher in university with the grant number 507-125RCPY0314, Tianjin.	Almirantis Y, 2000, COMPUT CHEM, V24, P159, DOI 10.1016/S0097-8485(99)00057-1; Brovelli A, 2009, ENVIRON MODELL SOFTW, V24, P611, DOI 10.1016/j.envsoft.2008.10.001; DELCOURT F, 1995, APPL MICROBIOL BIOT, V43, P321, DOI [10.1007/BF00172832, 10.1007/s002530050410]; dos Santos AM, 2008, PHYSICA A, V387, P1655, DOI 10.1016/j.physa.2007.09.051; Enderlein J, 1996, J PHYS CHEM-US, V100, P19642, DOI 10.1021/jp9615870; FIELD RJ, 1985, OSCILLATIONS TRAVELL; Ide Y, 2016, PHYSICA A, V457, P331, DOI 10.1016/j.physa.2016.03.055; Kytta K, 2007, PHYSICA A, V385, P105, DOI 10.1016/j.physa.2007.06.034; Lagzi I, 2004, CHEM PHYS, V303, P151, DOI 10.1016/j.chemphys.2004.05.016; Li L, 2016, APPL MATH MODEL, V40, P4765, DOI 10.1016/j.apm.2015.12.003; Murray JD., 1989, MATH BIOL BIOMATHEMA, DOI [10.1007/978-3-662-08539-4, DOI 10.1007/978-3-662-08539-4]; Navickas Z, 2011, DISCRETE CONT DYN-B, V16, P927, DOI 10.3934/dcdsb.2011.16.927; Nomura A, 1997, J PHYS SOC JPN, V66, P598, DOI 10.1143/JPSJ.66.598; Rangarajan G, 2003, PHYS LETT A, V310, P415, DOI 10.1016/S0375-9601(03)00447-X; Skudarnov PV, 2002, INT J HEAT MASS TRAN, V45, P5191, DOI 10.1016/S0017-9310(02)00224-7; Sun GQ, 2016, NONLINEAR DYNAM, V83, P811, DOI 10.1007/s11071-015-2369-6; Sun GQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11246; Sun GQ, 2014, COMMUN NONLINEAR SCI, V19, P1507, DOI 10.1016/j.cnsns.2013.09.016; Sun GQ, 2012, APPL MATH COMPUT, V218, P11151, DOI 10.1016/j.amc.2012.04.071; Voroney JP, 1996, PHYSICA D, V99, P303, DOI 10.1016/S0167-2789(96)00132-7; White A, 1996, P ROY SOC B-BIOL SCI, V263, P325, DOI 10.1098/rspb.1996.0050; Xu L, 2010, PHYS LETT A, V374, P3447, DOI 10.1016/j.physleta.2010.06.065; Zhang YQ, 2014, PHYSICA A, V402, P104, DOI 10.1016/j.physa.2014.01.051	23	2	2	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158591	10.1371/journal.pone.0158591	http://dx.doi.org/10.1371/journal.pone.0158591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27382964	gold, Green Published, Green Submitted			2022-12-26	WOS:000379809400062
J	Droit-Volet, S				Droit-Volet, Sylvie			Emotion and Implicit Timing	PLOS ONE			English	Article							SIMPLE REACTION-TIME; PERCEPTION; STIMULI; FEAR; RESPONSES; EXPLICIT	This study examined the effects of emotion on implicit timing. In the implicit timing task used, the participants did not receive any temporal instructions. Instead they were simply asked and trained to press a key as quickly as possible after a stimulus (response stimulus) that was separated from a preceding stimulus by a given temporal interval (reference interval duration). However, in the testing phase, the interval duration was the reference interval duration or a shorter or longer interval duration. In addition, the participants attended two sessions: a first baseline session in which no stimulus was presented during the inter-stimulus intervals, and a second emotional session in which emotional facial expressions (angry, neutral and sad facial expressions) were presented during these intervals. Results showed faster RTs for interval durations close to the reference duration in both the baseline and the emotional conditions and yielded a U-shaped curve. This suggests that implicit processing of time persists in emotional contexts. In addition, the RT was faster for the facial expressions of anger than for those of neutrality and sadness. However, the U-shaped RT curve did not peak clearly at a shorter interval duration for the angry than for the other facial expressions. This lack of time distortion in an implicit timing task in response to arousing emotional stimuli questions the idea of an automatic speeding-up of the interval clock system involved in the representation of time.	[Droit-Volet, Sylvie] Univ Clermont Auvergne, Lab Psychol Sociale & Cognit, CNRS, UMR 6024, Clermont Ferrand, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Clermont Auvergne (UCA)	Droit-Volet, S (corresponding author), Univ Clermont Auvergne, Lab Psychol Sociale & Cognit, CNRS, UMR 6024, Clermont Ferrand, France.	Sylvie.DROIT-VOLET@univ-bpclermont.fr			European Commission, Horizon research and innovation action (H-FETPROACT)	European Commission, Horizon research and innovation action (H-FETPROACT)	This work was supported by a grant (TIMESTORM) from European Commission, Horizon 2020 research and innovation action (H2020-FETPROACT-2014).	Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; Cheng R.-K., 2016, TIMING TIME PERCEPT, V4, P99, DOI [10.1163/22134468-00002064, DOI 10.1163/22134468-00002064]; Coull J, 2009, PLOS ONE, V8; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Dimberg U, 2002, COGNITION EMOTION, V16, P449, DOI 10.1080/02699930143000356; Droit-Volet S, 2015, CONSCIOUS COGN, V38, P155, DOI 10.1016/j.concog.2015.02.021; Droit-Volet S, 2004, COGNITION EMOTION, V18, P849, DOI 10.1080/02699930341000194; Droit-Volet S., 2013, TIMING TIME PERCEPTI, V1, P1; Droit-Volet S, 2016, J EXPT CHILD PSYCHOL; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Droit-Volet S, 2019, TIME SOC, V28, P60, DOI 10.1177/0961463X16656852; Ekman P., 1976, PICTURES FACIAL AFFE; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Fayolle S, 2015, BEHAV PROCESS, V120, P135, DOI 10.1016/j.beproc.2015.09.014; Frijda N. H., 2007, LAWS EMOTION; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gil S, 2012, COGNITION EMOTION, V26, P847, DOI 10.1080/02699931.2011.625401; Greba Q, 2001, BRAIN RES, V899, P218, DOI 10.1016/S0006-8993(01)02243-0; Izard C. E., 1991, PSYCHOL EMOTIONS; Johnson KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123625; Judd C. M., 2011, DATA ANAL MODEL COMP; Laflamme V, 2015, ATTEN PERCEPT PSYCHO, V77, P1507, DOI 10.3758/s13414-015-0937-y; Los SA, 2001, J EXP PSYCHOL HUMAN, V27, P370, DOI 10.1037/0096-1523.27.2.370; Los SA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01058; Merchant H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003169; Mogg K, 1999, COGNITION EMOTION, V13, P713, DOI 10.1080/026999399379050; Naugle KM, 2011, EMOTION, V11, P267, DOI 10.1037/a0022577; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Noulhiane M, 2007, EMOTION, V7, P697, DOI 10.1037/1528-3542.7.4.697; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Ohman A, 2002, CURR DIR PSYCHOL SCI, V11, P62, DOI 10.1111/1467-8721.00169; Piras F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018203; Schirmer A., 2015, EMOTION; Tipples J, 2008, EMOTION, V8, P127, DOI 10.1037/1528-3542.8.1.127; Vallesi A, 2014, COGNITION, V130, P141, DOI 10.1016/j.cognition.2013.10.006; Vangkilde S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0054; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131; Zelaznik HN, 2002, J EXP PSYCHOL HUMAN, V28, P575, DOI 10.1037//0096-1523.28.3.575	41	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158474	10.1371/journal.pone.0158474	http://dx.doi.org/10.1371/journal.pone.0158474			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3JE	27380409	Green Published, gold, Green Submitted			2022-12-26	WOS:000379798700033
J	Watters, SA; Mlcochova, P; Maldarelli, F; Goonetilleke, N; Pillay, D; Gupta, RK				Watters, Sarah A.; Mlcochova, Petra; Maldarelli, Frank; Goonetilleke, Nilu; Pillay, Deenan; Gupta, Ravindra K.			Sequential CCR5-Tropic HIV-1 Reactivation from Distinct Cellular Reservoirs following Perturbation of Elite Control	PLOS ONE			English	Article							T-CELLS; DISCONTINUATION; IDENTIFICATION; MACROPHAGES; PREDICTION	Background HIV Elite Controllers may reveal insights into virus persistence given they harbour small reservoir sizes, akin to HIV non-controllers treated early with combination antiretroviral therapy. Both groups of patients represent the most promising candidates for interventions aimed at sustained remission or 'cure'. Analytic treatment interruption (ATI) in the latter group leads to stochastic rebound of virus, though it is unclear whether loss of elite control is also associated with similar rebound characteristics. Methods We studied three discrete periods of virus rebound during myeloma related immune disruption over 2.5 years in an elite controller who previously underwent autologous stem cell transplantation (ASCT) in the absence of any antiretroviral therapy. Single genome sequencing of the V1-V4 region of env in PBMC and plasma was performed and phylogenies reconstructed. Average pairwise distance (APD) was calculated and non-parametric methods used to assess compartmentalisation. Coreceptor usage was predicted based on genotypic algorithms. Results 122 single genome sequences were obtained (median 26 sequences per rebound). The initial rebounding plasma env sequences following ASCT represented two distinct lineages, and clustered with proviral DNA sequences isolated prior to ASCT. One of the lineages was monophyletic, possibly indicating reactivation from clonally expanded cells. The second rebound occurred 470 days after spontaneous control of the first rebound and was phylogenetically distinct from the first, confirmed by compartmentalisation analysis, with a different cellular origin rather than ongoing replication. By contrast, third rebound viruses clustered with second rebound viruses, with evidence for ongoing evolution that was associated with lymphopenia and myeloma progression. Following ASCT a shift in tropism from CXCR4-tropic viruses to a CCR5-tropic population was observed to persist through to the third rebound. Conclusions Our data highlight similarities in the viral reservoir between elite and non-controllers undergoing ATI following allogeneic transplantation. The lack of propagation of CXCR4 using viruses following transplantation warrants further study.	[Watters, Sarah A.; Mlcochova, Petra; Pillay, Deenan; Gupta, Ravindra K.] UCL, Div Infect & Immun, London, England; [Watters, Sarah A.; Maldarelli, Frank] NCI, HIV Dynam & Replicat Program, Frederick, MD USA; [Goonetilleke, Nilu] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC USA; [Pillay, Deenan] Africa Ctr Hlth & Populat Studies, Durban, Kwazulu Natal, South Africa	University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill	Gupta, RK (corresponding author), UCL, Div Infect & Immun, London, England.	Ravindra.gupta@ucl.ac.uk	Maldarelli, Frank/O-2428-2016; Gupta, Ravindra/G-5529-2015	Gupta, Ravindra/0000-0001-9751-1808; Watters, Sarah A./0000-0001-6628-1261	Wellcome Trust [WT098251AIA]; National Institutes for Health Research University College London Hospitals Biomedical Research Centre; NATIONAL CANCER INSTITUTE [ZIABC011464] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes for Health Research University College London Hospitals Biomedical Research Centre; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Wellcome Trust (SAW) WT098251AIA; National Institutes for Health Research University College London Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achaz G, 2004, MOL BIOL EVOL, V21, P1902, DOI 10.1093/molbev/msh196; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Apolonia L, 2007, MOL THER, V15, P1947, DOI 10.1038/sj.mt.6300281; Cashin K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08543; Cashin K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-24; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; De Keersmaecker B, 2012, J VIROL, V86, P9351, DOI 10.1128/JVI.00472-12; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Graf EH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001300; Haaland RE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000274; Haslett PAJ, 1998, J EXP MED, V187, P1885, DOI 10.1084/jem.187.11.1885; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Imamichi H, 2001, J INFECT DIS, V183, P36, DOI 10.1086/317641; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Jordan MR, 2010, J VIROL METHODS, V168, P114, DOI 10.1016/j.jviromet.2010.04.030; Kearney MF, 2016, J VIROL, V90, P1369, DOI 10.1128/JVI.02139-15; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Ndung'u T, 2001, J VIROL, V75, P4964, DOI 10.1128/JVI.75.11.4964-4972.2001; Olson AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086719; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rambaut A, 2007, PHYLOGENETICS AND EP; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; SLATKIN M, 1989, GENETICS, V123, P603; Smith NMG, 2015, CLIN INFECT DIS, V61, P120, DOI 10.1093/cid/civ219; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wang TH, 2001, J VIROL, V75, P11686, DOI 10.1128/JVI.75.23.11686-11699.2001	31	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158854	10.1371/journal.pone.0158854	http://dx.doi.org/10.1371/journal.pone.0158854			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403738	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508200017
J	Wong, NS; Wong, KH; Lee, MP; Tsang, OTY; Chan, DPC; Lee, SS				Wong, Ngai Sze; Wong, Ka Hing; Lee, Man Po; Tsang, Owen T. Y.; Chan, Denise P. C.; Lee, Shui Shan			Estimation of the Undiagnosed Intervals of HIV-Infected Individuals by a Modified Back-Calculation Method for Reconstructing the Epidemic Curves	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS HIV; LYMPHOCYTE SUBSETS; REFERENCE RANGES; HONG-KONG; POPULATION; ADULTS; PREVENTION; DIAGNOSIS; SEX; MEN	Background Undiagnosed infections accounted for the hidden proportion of HIV cases that have escaped from public health surveillance. To assess the population risk of HIV transmission, we estimated the undiagnosed interval of each known infection for constructing the HIV incidence curves. Methods We used modified back-calculation methods to estimate the seroconversion year for each diagnosed patient attending any one of the 3 HIV specialist clinics in Hong Kong. Three approaches were used, depending on the adequacy of CD4 data: (A) estimating one's pretreatment CD4 depletion rate in multilevel model;(B) projecting one's seroconversion year by referencing seroconverters' CD4 depletion rate; or (C) projecting from the distribution of estimated undiagnosed intervals in (B). Factors associated with long undiagnosed interval (>2 years) were examined in univariate analyses. Epidemic curves constructed from estimated seroconversion data were evaluated by modes of transmission. Results Between 1991 and 2010, a total of 3695 adult HIV patients were diagnosed. The undiagnosed intervals were derived from method (A) (28%), (B) (61%) and (C) (11%) respectively. The intervals ranged from 0 to 10 years, and were shortened from 2001. Heterosexual infection, female, Chinese and age >64 at diagnosis were associated with long undiagnosed interval. Overall, the peaks of the new incidence curves were reached 4-6 years ahead of reported diagnoses, while their contours varied by mode of transmission. Characteristically, the epidemic growth of heterosexual male and female declined after 1998 with slight rebound in 2004-2006, but that of MSM continued to rise after 1998. Conclusions By determining the time of seroconversion, HIV epidemic curves could be reconstructed from clinical data to better illustrate the trends of new infections. With the increasing coverage of antiretroviral therapy, the undiagnosed interval can add to the measures for assessing HIV transmission risk in the population.	[Wong, Ngai Sze; Chan, Denise P. C.; Lee, Shui Shan] Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Wong, Ngai Sze] Univ North Carolina Chapel Hill, Inst Global Hlth & Infect Dis, Chapel Hill, NC USA; [Wong, Ngai Sze] Univ North Carolina Project China, Guangzhou, Guangdong, Peoples R China; [Wong, Ka Hing] Hong Kong Special Adm Reg Govt, Dept Hlth, Special Prevent Programme, Hong Kong, Hong Kong, Peoples R China; [Lee, Man Po] Queen Elizabeth Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Tsang, Owen T. Y.] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lee, SS (corresponding author), Chinese Univ Hong Kong, Stanley Ho Ctr Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	sslee@cuhk.edu.hk	Lee, Shui Shan/B-9374-2008; Wong, Ngai Sze/A-3145-2012	Lee, Shui Shan/0000-0003-1448-765X; Wong, Ngai Sze/0000-0003-3788-8114	Council for the AIDS Trust Fund, Hong Kong Special Administrative Region Government [MSS229R]; Guangdong Provincial Centers for Skin Diseases and STI Control; UNC-South China STD Research Training Center [FIC1D43TW009532-01, FIC1D43TW009532]; Fogarty International Center; NIH Fogarty International Center; FOGARTY INTERNATIONAL CENTER [D43TW009532] Funding Source: NIH RePORTER	Council for the AIDS Trust Fund, Hong Kong Special Administrative Region Government; Guangdong Provincial Centers for Skin Diseases and STI Control; UNC-South China STD Research Training Center; Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by a grant approved by the Council for the AIDS Trust Fund, Hong Kong Special Administrative Region Government (project code: MSS229R). First author NSW is supported by Guangdong Provincial Centers for Skin Diseases and STI Control, the UNC-South China STD Research Training Center (FIC1D43TW009532-01) and the Fogarty International Center.; The authors thank all patients and staff of the Integrated Treatment Centre, Queen Elizabeth Hospital and Princess Margaret Hospital for their assistance in the maintenance of clinical data used in this study. Li Ka Shing Institute of Health Sciences and Stanley Ho Centre for Emerging Infectious Diseases of The Chinese University of Hong Kong are acknowledged for providing technical support in conducting the research. NSW is supported by Guangdong Provincial Center for Skin Diseases and STI Control and the UNC-South China STD Research Training Center (FIC1D43TW009532) and NIH Fogarty International Center.	Adolescents. PoAGfAa, GUIDELINES FOR THE U; Armstrong G, 2015, AIDS CARE, V27, P288, DOI 10.1080/09540121.2014.972322; BROOKMEYER R, 1986, LANCET, V2, P1320; Chang H, 2013, SHU TE ONLINE STUDIE, V9; Chau PH, 2003, J ROY STAT SOC C-APP, V52, P237, DOI 10.1111/1467-9876.00401; Chen JHK, 2009, JAIDS-J ACQ IMM DEF, V51, P530, DOI 10.1097/QAI.0b013e3181aac516; Cleveland R, J OFFICIAL STATISTIC, V6, P3; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cohen M, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.5.20482; Department of Health HKSAR, 2010, REPORT; Department of Health HKSAR, 2015, HIV SURVEILLANCE REP; Department of Health HKSAR, 2007, REPORT; Ellman TM, 2014, AIDS PATIENT CARE ST, V28, P530, DOI 10.1089/apc.2014.0152; Ferrer L, 2015, EUR J PUBLIC HEALTH, V25, P494, DOI 10.1093/eurpub/cku139; Forbi JC, 2010, J INFECT DEV COUNTR, V4, P662, DOI 10.3855/jidc.1015; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Infections HPACf, LONGITUDINAL ANALYSI; Jentsch-Ullrich K, 2005, CLIN IMMUNOL, V116, P192, DOI 10.1016/j.clim.2005.03.020; Jia ZW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11205; Kassu A, 2001, CLIN DIAGN LAB IMMUN, V8, P1171, DOI 10.1128/CDLI.8.6.1171-1176.2001; Lee SS, 2007, PUBLIC HEALTH, V121, P884, DOI 10.1016/j.puhe.2007.02.017; Maartens G, 2014, LANCET, V384, P258, DOI 10.1016/S0140-6736(14)60164-1; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Mastro Timothy D, 2010, J HIV AIDS Surveill Epidemiol, V2, P1; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Ndawinz JDA, 2011, AIDS, V25, P1905, DOI 10.1097/QAD.0b013e32834af619; Rana Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0120580, 10.1371/journal.pone.0125187, 10.1371/journal.pone.0121992]; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Taffe P, 2008, STAT MED, V27, P4837, DOI 10.1002/sim.3294; Vanhems P, 1999, J INFECT DIS, V180, P1803, DOI 10.1086/315110; Wolbers M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000239; Wong H., 2013, J SEXUALLY TRANSMITT, DOI [10.1155/2013/958967, DOI 10.1155/2013/958967]; Wong NS, 2015, ASIA-PAC J PUBLIC HE, V27, P756, DOI 10.1177/1010539515589340; Wong NS, 2015, J INFECTION, V70, P676, DOI 10.1016/j.jinf.2014.10.012; Wong WS, 2013, CLIN VACCINE IMMUNOL, V20, P602, DOI 10.1128/CVI.00476-12; World Health Organization, 2015, GUIDELINE ON WHEN TO	36	6	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159021	10.1371/journal.pone.0159021	http://dx.doi.org/10.1371/journal.pone.0159021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27403882	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508200029
J	Burgi, J; Xue, B; Uversky, VN; van der Goot, FG				Burgi, Jerome; Xue, Bin; Uversky, Vladimir N.; van der Goot, F. Gisou			Intrinsic Disorder in Transmembrane Proteins: Roles in Signaling and Topology Prediction	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; BINDING; SEQUENCE; REGIONS; PHOSPHORYLATION; RECOGNITION; MECHANISM; DOMAIN; ORDER; TOOL	Intrinsically disordered regions (IDRs) are peculiar stretches of amino acids that lack stable conformations in solution. Intrinsic Disorder containing Proteins (IDP) are defined by the presence of at least one large IDR and have been linked to multiple cellular processes including cell signaling, DNA binding and cancer. Here we used computational analyses and publicly available databases to deepen insight into the prevalence and function of IDRs specifically in transmembrane proteins, which are somewhat neglected in most studies. We found that 50% of transmembrane proteins have at least one IDR of 30 amino acids or more. Interestingly, these domains preferentially localize to the cytoplasmic side especially of multi-pass transmembrane proteins, suggesting that disorder prediction could increase the confidence of topology prediction algorithms. This was supported by the successful prediction of the topology of the uncharacterized multi-pass transmembrane protein TMEM117, as confirmed experimentally. Pathway analysis indicated that IDPs are enriched in cell projection and axons and appear to play an important role in cell adhesion, signaling and ion binding. In addition, we found that IDP are enriched in phosphorylation sites, a crucial post translational modification in signal transduction, when compared to fully ordered proteins and to be implicated in more protein-protein interaction events. Accordingly, IDPs were highly enriched in short protein binding regions called Molecular Recognition Features (MoRFs). Altogether our analyses strongly support the notion that the transmembrane IDPs act as hubs in cellular signal events.	[Burgi, Jerome; van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Global Hlth Inst, Fac Life Sci, Lausanne, Switzerland; [Xue, Bin] Univ S Florida, Coll Arts & Sci, Sch Nat Sci & Math, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33647 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, USF Hlth Byrd Alzheimers Res Inst, Tampa, FL 33647 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino, Moscow Region, Russia; [Uversky, Vladimir N.] King Abdulaziz Univ, Fac Sci, Dept Biol, POB 80203, Jeddah 21589, Saudi Arabia	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Russian Academy of Sciences; King Abdulaziz University	van der Goot, FG (corresponding author), Ecole Polytech Fed Lausanne, Global Hlth Inst, Fac Life Sci, Lausanne, Switzerland.	gisou.vandergoot@epfl.ch	Uversky, Vladimir N./F-4515-2011; van der Goot, Gisou/B-2279-2012	Uversky, Vladimir N./0000-0002-4037-5857; van der Goot, Gisou/0000-0002-8522-274X; Burgi, Jerome/0000-0003-1171-3455	Swiss National Science Foundation; EPFL	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL	This work was funded by the Swiss National Science Foundation and core funding of the EPFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoutzias GD, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009555; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Blaskovic S, 2014, CHEM PHYS LIPIDS, V180, P44, DOI 10.1016/j.chemphyslip.2014.02.001; Bozoky Z, 2013, P NATL ACAD SCI USA, V110, pE4427, DOI 10.1073/pnas.1315104110; Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Disfani FM, 2012, BIOINFORMATICS, V28, pI75, DOI 10.1093/bioinformatics/bts209; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2006, J PROTEOME RES, V5, P2985, DOI 10.1021/pr060171o; Ferreon ACM, 2013, NATURE, V498, P390, DOI 10.1038/nature12294; Fischer E, 1895, BERICHTE DTSCH CHEM, V28, P1429, DOI [10.1002/CBER.18950280243, DOI 10.1002/CBER.18950280243]; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; Haynes C, 2006, PLOS COMPUT BIOL, V2, P890, DOI 10.1371/journal.pcbi.0020100; Hegedus T, 2008, J MOL BIOL, V378, P1052, DOI 10.1016/j.jmb.2008.03.033; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hsu WL, 2013, PROTEIN SCI, V22, P258, DOI 10.1002/pro.2207; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Huber AH, 2001, J BIOL CHEM, V276, P12301, DOI 10.1074/jbc.M010377200; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Kotta-Loizou I, 2013, BBA-PROTEINS PROTEOM, V1834, P798, DOI 10.1016/j.bbapap.2013.01.006; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Minezaki Y, 2007, J MOL BIOL, V368, P902, DOI 10.1016/j.jmb.2007.02.033; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Noutsou M, 2011, J MOL BIOL, V405, P773, DOI 10.1016/j.jmb.2010.11.013; Orchard S, 2012, NAT METHODS, V9, P345, DOI [10.1038/NMETH.1931, 10.1038/nmeth.1931]; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Pryor EE, 2014, BIOPHYS J, V106, P1638, DOI 10.1016/j.bpj.2014.02.025; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schaefer MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031826; Shammas SL, 2016, J BIOL CHEM, V291, P6689, DOI 10.1074/jbc.R115.692715; Singh GP, 2015, PEERJ, V3, DOI 10.7717/peerj.724; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tusnady GE, 2015, BBA-BIOMEMBRANES, V1848, P2839, DOI 10.1016/j.bbamem.2015.08.002; Uversky VN, 2013, PROTEIN SCI, V22, P693, DOI 10.1002/pro.2261; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Vuzman D, 2010, P NATL ACAD SCI USA, V107, P21004, DOI 10.1073/pnas.1011775107; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Xue B, 2009, MOL BIOSYST, V5, P1688, DOI [10.1039/b905913j, 10.1039/B905913J]; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0	51	34	35	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158594	10.1371/journal.pone.0158594	http://dx.doi.org/10.1371/journal.pone.0158594			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391701	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400085
J	Fernando, DR; Marshall, AT; Lynch, JP				Fernando, Denise R.; Marshall, Alan T.; Lynch, Jonathan P.			Foliar Nutrient Distribution Patterns in Sympatric Maple Species Reflect Contrasting Sensitivity to Excess Manganese	PLOS ONE			English	Article							X-RAY-MICROANALYSIS; UNGUICULATA L WALP; COMMON BEAN GENOTYPES; SUGAR MAPLE; FREEZE-SUBSTITUTION; ACIDIC DEPOSITION; OXIDATIVE STRESS; CALCIUM-OXALATE; TOXICITY; SOILS	Sugar maple and red maple are closely-related co-occurring tree species significant to the North American forest biome. Plant abiotic stress effects including nutritional imbalance and manganese (Mn) toxicity are well documented within this system, and are implicated in enhanced susceptibility to biotic stresses such as insect attack. Both tree species are known to overaccumulate foliar manganese (Mn) when growing on unbuffered acidified soils, however, sugar maple is Mn-sensitive, while red maple is not. Currently there is no knowledge about the cellular sequestration of Mn and other nutrients in these two species. Here, electron-probe x-ray microanalysis was employed to examine cellular and sub-cellular deposition of excessively accumulated foliar Mn and other mineral nutrients in vivo. For both species, excess foliar Mn was deposited in symplastic cellular compartments. There were striking between-species differences in Mn, magnesium (Mg), sulphur (S) and calcium (Ca) distribution patterns. Unusually, Mn was highly co-localised with Mg in mesophyll cells of red maple only. The known sensitivity of sugar maple to excess Mn is likely linked to Mg deficiency in the leaf mesophyll. There was strong evidence that Mn toxicity in sugar maple is primarily a symplastic process. For each species, leaf-surface damage due to biotic stress including insect herbivory was compared between sites with acidified and non-acidified soils. Although it was greatest overall in red maple, there was no difference in biotic stress damage to red maple leaves between acidified and non-acidified soils. Sugar maple trees on buffered non-acidified soil were less damaged by biotic stress compared to those on unbuffered acidified soil, where they are also affected by Mn toxicity abiotic stress. This study concluded that foliar nutrient distribution in symplastic compartments is a determinant of Mn sensitivity, and that Mn stress hinders plant resistance to biotic stress.	[Fernando, Denise R.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia; [Marshall, Alan T.] La Trobe Univ, Analyt Electron Microscopy Lab, Bundoora, Vic, Australia; [Lynch, Jonathan P.] Penn State Univ, Dept Plant Sci, University Pk, PA 16802 USA	La Trobe University; La Trobe University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Fernando, DR (corresponding author), La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia.	d.fernando@latrobe.edu.au			Australian Research Council (ARC); Australian Research Council	Australian Research Council (ARC)(Australian Research Council); Australian Research Council(Australian Research Council)	This research was funded by an Australian Research Council (ARC) 'Discovery Early Career Research Award' to DRF [http://www.arc.gov.au/]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank R. Snyder (PSU), J. Gomola and E. Wiltsie (US Forest Service), and A. Fernando for fieldwork support; A. Traverse for herbarium expertise; G. Ning, M. Hazens and J. Cantolina (PSU microscopy laboratory) for sample preparation and microscopy support. DF acknowledges funding from the Australian Research Council.	Asemaneh T, 2006, PLANTA, V225, P193, DOI 10.1007/s00425-006-0340-y; Baker AJM, 2000, PHYTOREMEDIATION OF CONTAMINATED SOIL AND WATER, P85; BERNIER B, 1988, CAN J FOREST RES, V18, P1265, DOI 10.1139/x88-195; Bidwell SD, 2002, FUNCT PLANT BIOL, V29, P899, DOI 10.1071/PP01192; Bidwell SD, 2004, PLANT CELL ENVIRON, V27, P705, DOI 10.1111/j.0016-8025.2003.01170.x; Boyd R. S., 1992, P279; Brooks R. R., 1998, PLANTS HYPERACCUMULA; CHRISTELLER JT, 1979, BIOCHEM J, V183, P747, DOI 10.1042/bj1830747; Clode PL, 2004, TISSUE CELL, V36, P379, DOI 10.1016/j.tice.2004.06.005; Dean JM, 2007, CHEM ECOLOGY PLANT M; Driscoll CT, 2001, BIOSCIENCE, V51, P180, DOI 10.1641/0006-3568(2001)051[0180:ADITNU]2.0.CO;2; Drohan JR, 1997, WATER AIR SOIL POLL, V95, P299, DOI 10.1023/A:1026469814427; Edenhofer O., 2014, IPCC 2014 SUMM POL; Fecht-Christoffers MM, 2006, PLANT PHYSIOL, V140, P1451, DOI 10.1104/pp.105.070474; Fernando DR, 2008, NEW PHYTOL, V177, P178, DOI 10.1111/j.1469-8137.2007.02253.x; Fernando DR, 2006, NEW PHYTOL, V171, P751, DOI 10.1111/j.1469-8137.2006.01783.x; Fernando DR, 2010, NEW PHYTOL, V188, P1014, DOI 10.1111/j.1469-8137.2010.03431.x; Fernando DR, 2009, AUST J BOT, V57, P406, DOI 10.1071/BT09077; Fernando DR, 2008, FUNCT PLANT BIOL, V35, P193, DOI 10.1071/FP07272; Fernando DR, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00319; Fernando DR, 2013, AM J BOT, V100, P690, DOI 10.3732/ajb.1200545; Fernando DR, 2012, PLANTA, V236, P1459, DOI 10.1007/s00425-012-1699-6; Fernando DR, 2006, PLANT CELL ENVIRON, V29, P1012, DOI 10.1111/j.1365-3040.2006.01498.x; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; FRANCESCHI VR, 1989, PROTOPLASMA, V148, P130, DOI 10.1007/BF02079332; Gonzalez A, 1997, PHYSIOL PLANTARUM, V101, P872, DOI 10.1111/j.1399-3054.1997.tb01076.x; Gonzalez A, 1999, J PLANT NUTR, V22, P511, DOI 10.1080/01904169909365648; Gonzalez A, 1998, PLANT PHYSIOL, V118, P493, DOI 10.1104/pp.118.2.493; Gonzalez A, 1999, AUST J PLANT PHYSIOL, V26, P811, DOI 10.1071/PP99030; Graham R. D., 1988, INT S MANG SOILS PLA; Harvey DMR, 1980, SCANNING ELECTRON MI, VII, P409; Hayes RC, 2012, CROP PASTURE SCI, V63, P875, DOI 10.1071/CP12138; HEENAN DP, 1990, AUST J AGR RES, V41, P835, DOI 10.1071/AR9900835; HEENAN DP, 1977, PLANT SOIL, V47, P219, DOI 10.1007/BF00010381; HEISEY RM, 1995, WATER AIR SOIL POLL, V82, P675, DOI 10.1007/BF00479419; Horsley SB, 2000, CAN J FOREST RES, V30, P1365, DOI 10.1139/cjfr-30-9-1365; Horsley SB, 1998, SUG MAPL EC HLTH P I; HORST WJ, 1978, Z PFLANZ BODENKUNDE, V141, P129, DOI 10.1002/jpln.19781410202; KOLB TE, 1993, CAN J FOREST RES, V23, P2395, DOI 10.1139/x93-296; Lynch JP, 2004, FIELD CROP RES, V90, P101, DOI 10.1016/j.fcr.2004.07.008; Marshall A T, 1980, Scan Electron Microsc, P395; Marshall AT, 2007, J EXP BIOL, V210, P2453, DOI 10.1242/jeb.003343; MCCAIN DC, 1989, PLANT PHYSIOL, V90, P1417, DOI 10.1104/pp.90.4.1417; MORAGHAN JT, 1985, SOIL SCI SOC AM J, V49, P1584, DOI 10.2136/sssaj1985.03615995004900060051x; ORLOVICH DA, 1995, J MICROSC-OXFORD, V180, P117, DOI 10.1111/j.1365-2818.1995.tb03666.x; PALLAGHY CK, 1973, AUST J BIOL SCI, V26, P1015, DOI 10.1071/BI9731015; PALSGARD E, 1994, MICROSC RES TECHNIQ, V28, P254; POUCHOU JL, 1991, ELECTRON PROBE QUANTITATION, P31; Pouchou JL, 1992, ADV QUANTITATIVE PRO; RUFTY TW, 1979, AGRON J, V71, P638, DOI 10.2134/agronj1979.00021962007100040029x; Scott B. J., 1987, GENETIC ASPECTS PLAN; SIMAN A, 1974, PLANT SOIL, V41, P129, DOI 10.1007/BF00017950; SPARROW LA, 1987, AUST J EXP AGR, V27, P303, DOI 10.1071/EA9870303; St Clair SB, 2008, CAN J FOREST RES, V38, P401, DOI 10.1139/X07-161; St Clair SB, 2010, PLANT SOIL, V335, P101, DOI 10.1007/s11104-010-0328-z; St Clair SB, 2005, OECOLOGIA, V145, P258, DOI 10.1007/s00442-005-0121-5; St Clair SB, 2005, PLANT CELL ENVIRON, V28, P874, DOI 10.1111/j.1365-3040.2005.01337.x; St Clair SB, 2005, NEW PHYTOL, V165, P581, DOI 10.1111/j.1469-8137.2004.01249.x; St Clair SB, 2005, TREE PHYSIOL, V25, P85, DOI 10.1093/treephys/25.1.85; St Clair SB, 2004, FUNCT PLANT BIOL, V31, P1005, DOI 10.1071/FP04049; Tomlinson GH, 2003, BIOGEOCHEMISTRY, V65, P51, DOI 10.1023/A:1026069927380; WISSEMEIER AH, 1987, PLANT SOIL, V102, P283, DOI 10.1007/BF02370718; WISSEMEIER AH, 1990, J PLANT PHYSIOL, V136, P103, DOI 10.1016/S0176-1617(11)81622-6; WISSEMEIER AH, 1992, PLANT SOIL, V143, P299, DOI 10.1007/BF00007886	64	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157702	10.1371/journal.pone.0157702	http://dx.doi.org/10.1371/journal.pone.0157702			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391424	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400018
J	Remis, RS; Liu, J; Loutfy, MR; Tharao, W; Rebbapragada, A; Huibner, S; Kesler, M; Halpenny, R; Grennan, T; Brunetta, J; Smith, G; Reko, T; Kaul, R				Remis, Robert S.; Liu, Juan; Loutfy, Mona R.; Tharao, Wangari; Rebbapragada, Anuradha; Huibner, Sanja; Kesler, Maya; Halpenny, Roberta; Grennan, Troy; Brunetta, Jason; Smith, Graham; Reko, Tatjana; Kaul, Rupert			Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-PAPILLOMAVIRUS INFECTION; RISK-FACTORS; B-VIRUS; ANTIRETROVIRAL THERAPY; COHORT; MORTALITY; WOMEN; SEMEN; EPIDEMIOLOGY	Background Hepatitis B (HBV), hepatitis C (HCV) and other sexually transmitted infections (STIs) have been associated with HIV transmission risk and disease progression among gay men and other men who have sex with men (MSM), but the frequency and distribution of STIs in this community in Canada has not been extensively studied. Methods We recruited MSM living with and without HIV from a large primary care clinic in Toronto. Participants completed a detailed socio-behavioural questionnaire using ACASI and provided blood for syphilis, HIV, HBV and HCV, herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), and human cytomegalovirus (CMV) serology, urine for chlamydia and gonorrhea, and a self-collected anal swab for human papillomavirus (HPV) molecular diagnostics. Prevalences were expressed as a proportion and compared using chi-square. Results 442 MSM were recruited, 294 living with HIV and 148 without. Active syphilis (11.0% vs. 3.4%), ever HBV (49.4% vs. 19.1%), HCV (10.4% vs. 3.4%), HSV-2 (55.9% vs. 38.2%), CMV (98.3% vs. 80.3%) and high-risk (HR) anal HPV (67.6% vs. 51.7%) infections were significantly more common in men living with HIV. Chlamydia and gonorrhea were infrequent in both groups. Regardless of HIV infection status, age and number of lifetime male sexual partners were associated with HBV infection and lifetime injection drug use with HCV infection. Conclusions Syphilis and viral infections, including HBV, HCV, HSV-2, CMV, and HR-HPV, were common in this clinic-based population of MSM in Toronto and more frequent among MSM living with HIV. This argues for the implementation of routine screening, vaccine-based prevention, and education programs in this high-risk population.	[Remis, Robert S.; Liu, Juan; Loutfy, Mona R.; Kesler, Maya] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Loutfy, Mona R.] Univ Toronto, Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Loutfy, Mona R.; Halpenny, Roberta; Grennan, Troy; Brunetta, Jason; Smith, Graham; Reko, Tatjana] Maple Leaf Med Clin, Toronto, ON, Canada; [Tharao, Wangari] Womens Hlth Womens Hands Community Hlth Ctr, Toronto, ON, Canada; [Rebbapragada, Anuradha] Toronto Publ Hlth Ontario, Publ Hlth Lab, Toronto, ON, Canada; [Rebbapragada, Anuradha] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Huibner, Sanja; Kaul, Rupert] Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Grennan, Troy] McMaster Univ, Dept Med, Hamilton, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University	Kaul, R (corresponding author), Univ Toronto, Univ Hlth Network, Dept Med, Toronto, ON, Canada.	rupert.kaul@utoronto.ca	Grennan, Troy/AAH-5588-2020	Kaul, Rupert/0000-0002-1586-4093	Canadian Institutes of Health Research [HET-85518]; Emerging Team Grant from the Canadian Institutes of Health Research, Canada [HET-85518]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Emerging Team Grant from the Canadian Institutes of Health Research, Canada(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (HET-85518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the study participants, Jennifer Robinette and physicians at Maple Leaf Medical Clinic, staff at laboratories for diagnostic testing (Rupert Kaul laboratory; Department of Pathology, UHN; Toronto Medical Laboratories, Mt. Sinai Hospital; Toronto Public Health Laboratory; and Public Health Ontario). The study was funded by an Emerging Team Grant from the Canadian Institutes of Health Research, Canada (Grant number HET-85518). Dr. Robert Remis passed away before the submission of the final version of this manuscript; Dr. Rupert Kaul accepts responsibility for the integrity and validity of the data collected and analyzed.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Andonov A, 2013, PRIMARY CARE MANAGEM; [Anonymous], 2011, ESTIMATES HIV PREVAL; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bohl DD, 2011, SEX TRANSM DIS, V38, P617, DOI 10.1097/OLQ.0b013e31820a8c10; Boily MC, 2009, LANCET INFECT DIS, V9, P118, DOI 10.1016/S1473-3099(09)70021-0; Briat A, 2005, AIDS, V19, P1827, DOI 10.1097/01.aids.0000189847.98569.2d; Burchell AN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-246; Butler DA, 2008, AIDS, V22, P1667, DOI 10.1097/QAD.0b013e32830bfed8; Centers for Disease C Prevention, 2011, MMWR-MORBID MORTAL W, V60, P945; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P966; Chesson HW, 2013, SEX TRANSM DIS, V40, P366, DOI 10.1097/OLQ.0b013e318284e544; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Chun Helen M, 2013, J Sex Transm Dis, V2013, P176459, DOI 10.1155/2013/176459; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; DREW WL, 1981, J INFECT DIS, V143, P188, DOI 10.1093/infdis/143.2.188; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Geibel S, 2010, PUBLIC HEALTH REP, V125, P316, DOI 10.1177/003335491012500222; Gilbert M, 2011, SEX TRANSM DIS, V38, P964, DOI 10.1097/OLQ.0b013e318222899d; Giraudon I, 2008, SEX TRANSM INFECT, V84, P111, DOI 10.1136/sti.2007.027334; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hill C, 2009, EUROSURVEILLANCE; Houlihan CF, 2012, AIDS, V26, P2211, DOI 10.1097/QAD.0b013e328358d908; Howard M, 2003, J CLIN MICROBIOL, V41, P84, DOI 10.1128/JCM.41.1.84-89.2003; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182; Leruez-Ville M, 2000, LANCET, V356, P42, DOI 10.1016/S0140-6736(00)02435-1; Marcus JL, 2011, SEX TRANSM DIS, V38, P922, DOI 10.1097/OLQ.0b013e31822a2b2e; McKinnon LR, 2015, AIDS BEHAV; Nikolopoulos GK, 2009, CLIN INFECT DIS, V48, P1763, DOI 10.1086/599110; Nyitray AG, 2011, J INFECT DIS, V203, P49, DOI 10.1093/infdis/jiq021; Pathela P, 2011, JAIDS-J ACQ IMM DEF, V58, P408, DOI 10.1097/QAI.0b013e318230e1ca; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rauch A, 2005, CLIN INFECT DIS, V41, P395, DOI 10.1086/431486; Rebbapragada A., 2007, DRUG DISCOV TODAY DI, V4, P237, DOI [10.1016/j.ddmec.2007.12.003, DOI 10.1016/J.DDMEC.2007.12.003]; Remis RS, 2012, REPORT HIV AIDS ONTA; Rockstroh JK, 2006, J HEPATOL, V44, pS25, DOI 10.1016/j.jhep.2005.11.007; Schmidt AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017781; Singh AE, 2005, SEX TRANSM DIS, V32, P95, DOI 10.1097/01.olq.0000151415.78210.85; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; Urbanus AT, 2009, AIDS, V23, pF1, DOI 10.1097/QAD.0b013e32832e5631; van de Laar TJW, 2007, J INFECT DIS, V196, P230, DOI 10.1086/518796; van de Laar TJW, 2010, AIDS, V24, P1799, DOI 10.1097/QAD.0b013e32833c11a5; van der Helm J, 2013, GASTROENTEROLOGY, V144, P751, DOI 10.1053/j.gastro.2012.12.026; Wang HL, 2012, AIDS, V26, P1755, DOI 10.1097/QAD.0b013e328355ced2; Wiley DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079492; Witt MD, 2013, CLIN INFECT DIS, V57, P77, DOI 10.1093/cid/cit197; Wolitski RJ, 2011, AIDS BEHAV, V15, pS9, DOI 10.1007/s10461-011-9901-6; Xu FJ, 2010, SEX TRANSM DIS, V37, P399, DOI 10.1097/OLQ.0b013e3181ce122b; Zubach V, 2012, J CLIN MICROBIOL, V50, P460, DOI 10.1128/JCM.06090-11	52	41	42	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158090	10.1371/journal.pone.0158090	http://dx.doi.org/10.1371/journal.pone.0158090			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391265	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400029
J	Schroder, S; Leydolt, C; Menapace, R; Eppig, T; Langenbucher, A				Schroeder, Simon; Leydolt, Christina; Menapace, Rupert; Eppig, Timo; Langenbucher, Achim			Determination of Personalized IOL-Constants for the Haigis Formula under Consideration of Measurement Precision	PLOS ONE			English	Article							INTRAOCULAR-LENS POWER; PARTIAL COHERENCE INTERFEROMETRY; HOFFER-Q; REPEATABILITY; BIOMETRY; SRK/T; ERROR	The capabilities of a weighted least squares approach for the optimization of the intraocular lens (IOL) constants for the Haigis formula are studied in comparison to an ordinary least squares approach. The weights are set to the inverse variances of the effective optical anterior chamber depth. The effect of random measurement noise is simulated 100000 times using data from N = 69 cataract patients and the measurement uncertainty of two different biometers. A second, independent data set (N = 33) is used to show the differences that can be expected between both methods. The weighted least squares formalism reduces the effect of measurement error on the final constants. In more than 64% it will result in a better approximation, if the measurement errors are estimated correctly. The IOL constants can be calculated with higher precision using the weighted least squares method.	[Schroeder, Simon; Eppig, Timo; Langenbucher, Achim] Univ Saarland, Inst Expt Ophthalmol, Homburg, Germany; [Leydolt, Christina; Menapace, Rupert] Univ Eye Clin, Vienna, Austria	Saarland University	Schroder, S (corresponding author), Univ Saarland, Inst Expt Ophthalmol, Homburg, Germany.	Simon.Schroeder@uks.eu	Eppig, Timo/H-7413-2019	Eppig, Timo/0000-0003-0661-6239				Drexler W, 1998, AM J OPHTHALMOL, V126, P524, DOI 10.1016/S0002-9394(98)00113-5; Haigis W, 2004, INTRAOCULAR LENS POW, P41; Haigis W, 2007, Z MED PHYS, V17, P45, DOI 10.1016/j.zemedi.2006.11.001; HOFFER KJ, 1993, J CATARACT REFR SURG, V19, P700, DOI 10.1016/S0886-3350(13)80338-0; HOLLADAY JT, 1988, J CATARACT REFR SURG, V14, P17, DOI 10.1016/S0886-3350(88)80059-2; Huang JH, 2015, J CATARACT REFR SURG, V41, P2233, DOI 10.1016/j.jcrs.2015.10.062; International Organization for Standardization, 2000, OPHTH IMPL INTR LE 2, P11979; Kunert KS, 2016, J CATARACT REFR SURG, V42, P76, DOI 10.1016/j.jcrs.2015.07.039; Langenbucher A, 2012, OPHTHALMOLOGE, V109, P468, DOI 10.1007/s00347-012-2535-x; Leinonen J, 2006, ACTA OPHTHALMOL SCAN, V84, P532, DOI 10.1111/j.1600-0420.2006.00695.x; Liou HL, 1997, J OPT SOC AM A, V14, P1684, DOI 10.1364/JOSAA.14.001684; Norrby NES, 1996, J CATARACT REFR SURG, V22, P983; Norrby S, 2003, J CATARACT REFR SURG, V29, P100, DOI 10.1016/S0886-3350(02)01817-5; Norrby S, 2008, J CATARACT REFR SURG, V34, P368, DOI 10.1016/j.jcrs.2007.10.031; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P472, DOI 10.1111/j.1600-0420.2007.00879.x; Olsen T, 2014, J CATARACT REFR SURG, V40, P764, DOI 10.1016/j.jcrs.2013.10.037; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; RETZLAFF JA, 1990, J CATARACT REFR SURG, V16, P333, DOI 10.1016/S0886-3350(13)80705-5; Schmidt I, 2015, OPHTHALMOLOGE, V112, P261, DOI 10.1007/s00347-014-3121-1; Srivannaboon S, 2015, J CATARACT REFR SURG, V41, P2224, DOI 10.1016/j.jcrs.2015.03.019	20	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158988	10.1371/journal.pone.0158988	http://dx.doi.org/10.1371/journal.pone.0158988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391100	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400183
J	Ventrella, D; Laghi, L; Barone, F; Elmi, A; Romagnoli, N; Bacci, ML				Ventrella, Domenico; Laghi, Luca; Barone, Francesca; Elmi, Alberto; Romagnoli, Noemi; Bacci, Maria Laura			Age-Related H-1 NMR Characterization of Cerebrospinal Fluid in Newborn and Young Healthy Piglets	PLOS ONE			English	Article							PIG; METABOLOME; GLUTAMINE; MODEL; MICROBIOTA; DIAGNOSIS; PATHWAYS; LACTATE; BARRIER; PLASMA	When it comes to neuroscience, pigs represent an important animal model due to their resemblance with humans' brains for several patterns including anatomy and developmental stages. Cerebrospinal fluid (CSF) is a relatively easy-to-collect specimen that can provide important information about neurological health and function, proving its importance as both a diagnostic and biomedical monitoring tool. Consequently, it would be of high scientific interest and value to obtain more standard physiological information regarding its composition and dynamics for both swine pathology and the refinement of experimental protocols. Recently, proton nuclear magnetic resonance (H-1 NMR) spectroscopy has been applied in order to analyze the metabolomic profile of this biological fluid, and results showed the technique to be highly reproducible and reliable. The aim of the present study was to investigate in both qualitative and quantitative manner the composition of Cerebrospinal Fluid harvested form healthy newborn (5 days old-P5) and young (30-P30 and 50-P50 days old) piglets using H-1 NMR Spectroscopy, and to analyze any possible difference in metabolites concentration between age groups, related to age and Blood-Brain-Barrier maturation. On each of the analyzed samples, 30 molecules could be observed above their limit of quantification, accounting for 95-98% of the total area of the spectra. The concentrations of adenine, tyrosine, leucine, valine, 3-hydroxyvalerate, 3-methyl-2-oxovalerate were found to decrease between P05 and P50, while the concentrations of glutamine, creatinine, methanol, trimethylamine and myo-inositol were found to increase. The P05-P30 comparison was also significant for glutamine, creatinine, adenine, tyrosine, leucine, valine, 3-hydroxyisovalerate, 3-methyl-2-oxovalerate, while for the P30-P50 comparison we found significant differences for glutamine, myo-inositol, leucine and trimethylamine. None of these molecules showed at P30 concentrations outside the P05 -P50 range.	[Ventrella, Domenico; Barone, Francesca; Elmi, Alberto; Romagnoli, Noemi; Bacci, Maria Laura] Univ Bologna, Dept Vet Med Sci, Bologna, Italy; [Laghi, Luca] Univ Bologna, Dept Agrofood Sci & Technol, Ctr Food, Bologna, Italy	University of Bologna; University of Bologna	Ventrella, D (corresponding author), Univ Bologna, Dept Vet Med Sci, Bologna, Italy.	domenico.ventrella2@unibo.it	Laghi, Luca/R-5278-2016; Elmi, Alberto/U-2252-2019	Laghi, Luca/0000-0003-1593-7376; Elmi, Alberto/0000-0002-7827-5034; Bacci, Maria Laura/0000-0001-6702-5868; Ventrella, Domenico/0000-0002-9330-979X	RFO 60%, Ateneo di Bologna	RFO 60%, Ateneo di Bologna	This study was supported by RFO 60%, Ateneo di Bologna.	Aasly J, 1997, ACTA NEUROL SCAND, V95, P9, DOI 10.1111/j.1600-0404.1997.tb00060.x; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Amaral AI, 2016, GLIA, V64, P21, DOI 10.1002/glia.22900; Andrews FM, 1998, COMP CONT EDUC PRACT, V20, P376; BAILEY CS, 1985, AM J VET RES, V46, P1162; Bandeira F, 2009, P NATL ACAD SCI USA, V106, P14108, DOI 10.1073/pnas.0804650106; Bassols A, 2014, PROTEOM CLIN APPL, V8, P715, DOI 10.1002/prca.201300099; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Bourgoin-Voillard S, 2016, PROTEOMICS, V16, P831, DOI 10.1002/pmic.201500347; Brekke E, 2015, NEUROCHEM INT, V82, P33, DOI 10.1016/j.neuint.2015.02.002; Cao KAL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-253; Cobas JC, 2006, J MAGN RESON, V183, P145, DOI 10.1016/j.jmr.2006.07.013; Carnevali A, 2014, FOOD RES INT, V63, P218, DOI 10.1016/j.foodres.2014.01.065; Chen KF, 2007, INT J BIOL SCI, V3, P153; Crews B, 2009, ANAL CHEM, V81, P8538, DOI 10.1021/ac9014947; De Filippis F., 2015, GUT; Desnoyers M, 2008, DIAGNOSTIC CYTOLOGY, P215; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Di Terlizzi R, 2006, VET J, V172, P422, DOI 10.1016/j.tvjl.2005.07.021; Di Terlizzi R, 2009, VET J, V180, P15, DOI 10.1016/j.tvjl.2007.11.024; Dickens Alex M, 2015, AIDS, V29, P559, DOI 10.1097/QAD.0000000000000580; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Dorokhov YL, 2015, PHYSIOL REV, V95, P603, DOI 10.1152/physrev.00034.2014; Eid T, 2013, NEUROCHEM INT, V63, P670, DOI 10.1016/j.neuint.2013.06.008; Eriksson L., 2001, MULTI MEGAVARIATE DA; Francavilla R, 2012, PEDIAT ALLERG IMM-UK, V23, P420, DOI 10.1111/j.1399-3038.2012.01286.x; Giulieri S, 2015, EUR J CLIN MICROBIOL, V34, P2049, DOI 10.1007/s10096-015-2450-6; Jeon JP, 2014, NEUROSURGERY, V75, pN12, DOI 10.1227/NEU.0000000000000517; Jones CM, 2006, ANN CLIN BIOCHEM, V43, P63, DOI 10.1258/000456306775141759; Laghi L, 2014, ANTIMICROB AGENTS CH, V58, P3411, DOI 10.1128/AAC.02469-14; Lambertini C, 2015, J NEUROSCI METH, V255, P17, DOI 10.1016/j.jneumeth.2015.07.021; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Levine J, 2000, BIOL PSYCHIAT, V47, P586, DOI 10.1016/S0006-3223(99)00284-X; Lohren H, 2015, METALLOMICS, V7, P1420, DOI 10.1039/c5mt00171d; Merrifield CA, 2011, MOL BIOSYST, V7, P2577, DOI 10.1039/c1mb05023k; Musteata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081192; Nakamizo S, 2013, J NEURO-ONCOL, V113, P65, DOI 10.1007/s11060-013-1090-x; Niblock MM, 2005, BRAIN RES REV, V50, P169, DOI 10.1016/j.brainresrev.2005.05.006; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; Ohman A, 2015, NEUROSCI LETT, V594, P36, DOI 10.1016/j.neulet.2015.03.051; OuYang D, 2011, APPL BIOCHEM BIOTECH, V165, P148, DOI 10.1007/s12010-011-9240-0; Romagnoli N, 2014, LAB ANIM-UK, V48, P345, DOI 10.1177/0023677214540881; Rubtsov DV, 2007, METABOLOMICS, V3, P223, DOI 10.1007/s11306-006-0040-4; Saunders NR, 2016, F1000RES, V5; Schicho R, 2012, J PROTEOME RES, V11, P3344, DOI 10.1021/pr300139q; Simmler C, 2014, CURR OPIN BIOTECH, V25, P51, DOI 10.1016/j.copbio.2013.08.004; Sorrentino NC, 2016, MOL THER, V24, P276, DOI 10.1038/mt.2015.212; Trimigno A, 2015, CURR OPIN FOOD SCI, V4, P99, DOI 10.1016/j.cofs.2015.06.008; van der Sar SA, 2015, ANAL BIOANAL CHEM, V407, P4835, DOI 10.1007/s00216-015-8663-9; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wiczkowski W, 2015, MOL NUTR FOOD RES, V59, P1088, DOI 10.1002/mnfr.201400567; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Zheng XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24125	53	24	25	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157623	10.1371/journal.pone.0157623	http://dx.doi.org/10.1371/journal.pone.0157623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391145	Green Published, gold			2022-12-26	WOS:000380005400015
J	Wang, H; Zhao, BJ; Liu, CK; Wang, C; Tan, XY; Hu, M				Wang, Hong; Zhao, Bingjing; Liu, Changkui; Wang, Chao; Tan, Xinying; Hu, Min			A Comparison of Biocompatibility of a Titanium Alloy Fabricated by Electron Beam Melting and Selective Laser Melting	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; BONE; TI-6AL-4V; IMPLANTS; EXPRESSION; CELLS; DIFFERENTIATION; MICROSTRUCTURES; RECONSTRUCTION; PHENOTYPE	Electron beam melting (EBM) and selective laser melting (SLM) are two advanced rapid prototyping manufacturing technologies capable of fabricating complex structures and geometric shapes from metallic materials using computer tomography (CT) and Computeraided Design (CAD) data. Compared to traditional technologies used for metallic products, EBM and SLM alter the mechanical, physical and chemical properties, which are closely related to the biocompatibility of metallic products. In this study, we evaluate and compare the biocompatibility, including cytocompatibility, haemocompatibility, skin irritation and skin sensitivity of Ti6Al4V fabricated by EBM and SLM. The results were analysed using one-way ANOVA and Tukey's multiple comparison test. Both the EBM and SLM Ti6Al4V exhibited good cytobiocompatibility. The haemolytic ratios of the SLM and EBM were 2.24% and 2.46%, respectively, which demonstrated good haemocompatibility. The EBM and SLM Ti6Al4V samples showed no dermal irritation when exposed to rabbits. In a delayed hyper-sensitivity test, no skin allergic reaction from the EBM or the SLM Ti6Al4V was observed in guinea pigs. Based on these results, Ti6Al4V fabricated by EBM and SLM were good cyto-biocompatible, haemocompatible, non-irritant and non-sensitizing materials. Although the data for cell adhesion, proliferation, ALP activity and the haemolytic ratio was higher for the SLM group, there were no significant differences between the different manufacturing methods.	[Wang, Hong; Zhao, Bingjing; Hu, Min] Gen Hosp Peoples Librat Army, Dept Stomatol, Beijing, Peoples R China; [Wang, Hong; Zhao, Bingjing] Liaoning Med Univ, Affiliated Stomatol Hosp 2, Dept Stomatol, Jinzhou, Peoples R China; [Liu, Changkui] 451th Hosp Peoples Librat Army, Dept Stomatol, Xian, Peoples R China; [Wang, Chao] Nankai Univ, Sch Med, Tianjin, Peoples R China; [Tan, Xinying] 304th Hosp Peoples Librat Army, Dept Stomatol, Beijing, Peoples R China	Jinzhou Medical University; Nankai University	Hu, M (corresponding author), Gen Hosp Peoples Librat Army, Dept Stomatol, Beijing, Peoples R China.	humin48@vip.163.com						[Anonymous], 1099342002 ISO; [Anonymous], 10993122002 ISO; [Anonymous], 2002, 10993102002 ISO; Bertollo N, 2012, J ARTHROPLASTY, V27, P1429, DOI 10.1016/j.arth.2012.02.025; Cadosch D, 2009, J BIOMED MATER RES A, V91A, P29, DOI 10.1002/jbm.a.32183; Carbonare LD, 2012, STEM CELL REV REP, V8, P891, DOI 10.1007/s12015-011-9337-4; Ciocca L, 2011, MED BIOL ENG COMPUT, V49, P1347, DOI 10.1007/s11517-011-0813-4; de Peppo GM, 2012, SCI WORLD J, DOI 10.1100/2012/646417; de Wild M, 2013, TISSUE ENG PT A, V19, P2645, DOI [10.1089/ten.TEA.2012.0753, 10.1089/ten.tea.2012.0753]; FANTI P, 1992, AM J PHYSIOL, V263, pE1113; Ferrigno N, 2002, CLIN ORAL IMPLAN RES, V13, P260, DOI 10.1034/j.1600-0501.2002.130305.x; GERSTENFELD LC, 1987, DEV BIOL, V122, P49, DOI 10.1016/0012-1606(87)90331-9; Haslauer CM, 2010, MED ENG PHYS, V32, P645, DOI 10.1016/j.medengphy.2010.04.003; Hosoki M, 2009, BIO-MED MATER ENG, V19, P53, DOI 10.3233/BME-2009-0563; Hrabe NW, 2013, CONNECT TISSUE RES, V54, P351, DOI 10.3109/03008207.2013.822864; Hsieh JY, 2010, STEM CELLS DEV, V19, P1895, DOI 10.1089/scd.2009.0485; Kawase M., 2014, MAT SCI APPL, V05, P475, DOI DOI 10.4236/MSA.2014.57051; Khan SN, 2000, ORTHOP CLIN N AM, V31, P389, DOI 10.1016/S0030-5898(05)70158-9; Koike M, 2011, MATERIALS, V4, P1776, DOI 10.3390/ma4101776; LALOR PA, 1991, J BONE JOINT SURG BR, V73, P25, DOI 10.1302/0301-620X.73B1.1991768; Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4; Leopold SS, 2000, J ARTHROPLASTY, V15, P938, DOI 10.1054/arth.2000.6632; Li SJ, 2014, ACTA BIOMATER, V10, P4537, DOI 10.1016/j.actbio.2014.06.010; Li WZ, 2009, INT J MED ROBOT COMP, V5, P158, DOI 10.1002/rcs.242; Li X, 2009, P I MECH ENG H, V223, P173, DOI 10.1243/09544119JEIM466; Lian J. B., 2003, Current Pharmaceutical Design, V9, P2677, DOI 10.2174/1381612033453659; Liu CK, 2014, J MED HYPOTHESES IDE, V8, P69, DOI 10.1016/j.jmhi.2013.11.003; LUNDSTROM IMC, 1984, INT J ORAL MAXILLOF, V13, P16, DOI 10.1016/S0300-9785(84)80051-4; Merritt K, 1996, CLIN ORTHOP RELAT R, P71; Moin DA, 2013, CLIN ORAL IMPLAN RES, V24, P25, DOI 10.1111/j.1600-0501.2011.02359.x; Murdoch B, 2014, INT J ORAL MAX SURG, V43, P595, DOI 10.1016/j.ijom.2013.11.004; Murr LE, 2009, MATER CHARACT, V60, P96, DOI 10.1016/j.matchar.2008.07.006; Murr LE, 2009, J MECH BEHAV BIOMED, V2, P20, DOI 10.1016/j.jmbbm.2008.05.004; Mustafa SF, 2011, INT J ORAL MAX SURG, V40, P1357, DOI 10.1016/j.ijom.2011.04.020; Otto F, 2003, J CELL BIOCHEM, V89, P9, DOI 10.1002/jcb.10491; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Peng Q, 2015, ANN MED, V47, P186, DOI 10.3109/07853890.2015.1007520; Ponader S, 2008, J BIOMED MATER RES A, V84A, P1111, DOI 10.1002/jbm.a.31540; Rafi HK, 2013, J MATER ENG PERFORM, V22, P3872, DOI 10.1007/s11665-013-0658-0; Rogers SD, 1997, J BONE JOINT SURG BR, V79B, P311, DOI 10.1302/0301-620X.79B2.7192; Ryan GE, 2008, BIOMATERIALS, V29, P3625, DOI 10.1016/j.biomaterials.2008.05.032; Sallica-Leva E, 2013, J MECH BEHAV BIOMED, V26, P98, DOI 10.1016/j.jmbbm.2013.05.011; Sicilia A, 2008, CLIN ORAL IMPLAN RES, V19, P823, DOI 10.1111/j.1600-0501.2008.01544.x; SOLOMON E, 1980, NATURE, V286, P656, DOI 10.1038/286656a0; Stejskal V, 2013, NEUROENDOCRINOL LETT, V34, P559; Takahashi Tomihisa, 2005, J Oral Sci, V47, P199, DOI 10.2334/josnusd.47.199; Thijs L, 2010, ACTA MATER, V58, P3303, DOI 10.1016/j.actamat.2010.02.004; Thomas P, 2006, CONTACT DERMATITIS, V55, P199, DOI 10.1111/j.1600-0536.2006.00931.x; Vaithilingam J, 2015, MAT SCI ENG C-MATER, V46, P52, DOI 10.1016/j.msec.2014.10.015; Wang GS, 2012, OR SURG OR MED OR PA, V113, P356, DOI 10.1016/j.tripleo.2011.03.034; Warnke PH, 2009, TISSUE ENG PART C-ME, V15, P115, DOI 10.1089/ten.tec.2008.0288; ZHOU H, 1994, J BONE MINER RES, V9, P1489	52	45	48	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158513	10.1371/journal.pone.0158513	http://dx.doi.org/10.1371/journal.pone.0158513			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391895	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400074
J	Halluin, C; Madelaine, R; Naye, F; Peers, B; Roussigne, M; Blader, P				Halluin, Caroline; Madelaine, Romain; Naye, Francois; Peers, Bernard; Roussigne, Myriam; Blader, Patrick			Habenular Neurogenesis in Zebrafish Is Regulated by a Hedgehog, Pax6 Proneural Gene Cascade	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; SONIC-HEDGEHOG; FOREBRAIN DEVELOPMENT; LATERAL HABENULA; SIGNAL-TRANSDUCTION; MIDBRAIN TARGET; DIENCEPHALON; EXPRESSION; IDENTITY; NEURONS	The habenulae are highly conserved nuclei in the dorsal diencephalon that connect the forebrain to the midbrain and hindbrain. These nuclei have been implicated in a broad variety of behaviours in humans, primates, rodents and zebrafish. Despite this, the molecular mechanisms that control the genesis and differentiation of neural progenitors in the habenulae remain relatively unknown. We have previously shown that, in zebrafish, the timing of habenular neurogenesis is left-right asymmetric and that in the absence of Nodal signalling this asymmetry is lost. Here, we show that habenular neurogenesis requires the homeobox transcription factor Pax6a and the redundant action of two proneural bHLH factors, Neurog1 and Neurod4. We present evidence that Hedgehog signalling is required for the expression of pax6a, which is in turn necessary for the expression of neurog1 and neurod4. Finally, we demonstrate by pharmacological inhibition that Hedgehog signalling is required continuously during habenular neurogenesis and by cell transplantation experiments that pathway activation is required cell autonomously. Our data sheds light on the mechanism underlying habenular development that may provide insights into how Nodal signalling imposes asymmetry on the timing of habenular neurogenesis.	[Halluin, Caroline; Madelaine, Romain; Roussigne, Myriam; Blader, Patrick] Univ Toulouse 3, CBD, CBI, 118 Route Narbonne, F-31062 Toulouse, France; [Halluin, Caroline; Madelaine, Romain; Roussigne, Myriam; Blader, Patrick] CNRS, CBD UMR 5547, F-31062 Toulouse, France; [Halluin, Caroline; Madelaine, Romain] Stanford Univ, Sch Med, 269-279 Campus Dr, Stanford, CA 94305 USA; [Naye, Francois; Peers, Bernard] Univ Liege, GIGA R, Unit Mol Biol & Genet Engn, B34,Ave Hop 1, B-4000 Liege, Belgium	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Stanford University; University of Liege	Roussigne, M; Blader, P (corresponding author), Univ Toulouse 3, CBD, CBI, 118 Route Narbonne, F-31062 Toulouse, France.; Roussigne, M; Blader, P (corresponding author), CNRS, CBD UMR 5547, F-31062 Toulouse, France.	myriam.roussigne@univ-tlse3.fr; patrick.blader@univ-tlse3.fr		Blader, Patrick/0000-0003-3299-6108; Roussigne, Myriam/0000-0002-4240-4105	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (INSERM); Universite de Toulouse III (UPS); Ministere de la Recherche; ARC; CNRS; INSERM; FEBS; FRM; Fondation pour la Recherche Medicale (FRM) [DEQ20131029166]; Federation pour la Recherche sur le Cerveau (FRC); Association pour la Recherche sur le Cancer (ARC) [SFI20101201699, PJA 20131200173]; Federation of European Biochemical Societies (FEBS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Toulouse III (UPS); Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); ARC(Australian Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); FEBS; FRM(Fondation pour la Recherche Medicale); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Federation pour la Recherche sur le Cerveau (FRC); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Federation of European Biochemical Societies (FEBS)	The present work was supported (Staff Salary, Equipment or functioning expenses) by the following agencies or associations: The Centre National de la Recherche Scientifique (CNRS); The Institut National de la Sante et de la Recherche Medicale (INSERM); The Universite de Toulouse III (UPS); The Ministere de la Recherche. The Fondation pour la Recherche Medicale (FRM; DEQ20131029166; http://www.frm.org); The Federation pour la Recherche sur le Cerveau (FRC; http://www.frc.asso.fr); The Association pour la Recherche sur le Cancer (ARC; http://www.fondation-arc.org) [SFI20101201699 and PJA 20131200173 to P.B.]; The Federation of European Biochemical Societies (FEBS; //www.febs.org). R.M. was financed by the Ministere de la Recherche and ARC, C.H. by the CNRS, P.B. by INSERM and M.R. by FEBS, FRM and CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Aizawa H, 2007, DEV CELL, V12, P87, DOI 10.1016/j.devcel.2006.10.004; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Beretta CA, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-19; Beretta CA, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00051; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Bianco IH, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-9; Blader P, 2004, DEVELOPMENT, V131, P5627, DOI 10.1242/dev.01455; Blader P, 2003, MECH DEVELOP, V120, P211, DOI 10.1016/S0925-4773(02)00413-6; Blader P, 1997, DEVELOPMENT, V124, P4557; Caballero IM, 2014, CELL REP, V8, P1405, DOI 10.1016/j.celrep.2014.07.051; Carl M, 2007, NEURON, V55, P393, DOI 10.1016/j.neuron.2007.07.007; Cau E, 2008, DEVELOPMENT, V135, P2391, DOI 10.1242/dev.013482; Chatterjee M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-13; Chatterjee M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00066; Cohen M, 2013, CURR OPIN GENET DEV, V23, P423, DOI 10.1016/j.gde.2013.04.003; Concha ML, 2012, NAT REV NEUROSCI, V13, P832, DOI 10.1038/nrn3371; Concha ML, 2003, NEURON, V39, P423, DOI 10.1016/S0896-6273(03)00437-9; Concha ML, 2001, J ANAT, V199, P63, DOI 10.1046/j.1469-7580.2001.19910063.x; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; David NB, 2002, P NATL ACAD SCI USA, V99, P16297, DOI 10.1073/pnas.252339399; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Gamse JT, 2005, DEVELOPMENT, V132, P4869, DOI 10.1242/dev.02046; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; Golling G, 2002, NAT GENET, V31, P135, DOI 10.1038/ng896; Grindley JC, 1997, MECH DEVELOP, V64, P111, DOI 10.1016/S0925-4773(97)00055-5; Hagemann AIH, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00076; Halpern ME, 2003, TRENDS NEUROSCI, V26, P308, DOI 10.1016/S0166-2236(03)00129-2; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Huang P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002762; Husken U, 2014, CURR BIOL, V24, P2217, DOI 10.1016/j.cub.2014.08.006; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Kiecker C, 2004, NAT NEUROSCI, V7, P1242, DOI 10.1038/nn1338; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleinjan DA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040029; Kong JH, 2015, DEV CELL, V33, P373, DOI 10.1016/j.devcel.2015.03.005; Kuan YS, 2015, DEV BIOL, V406, P117, DOI 10.1016/j.ydbio.2015.06.006; Lagadec R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7686; Lawson RP, 2014, P NATL ACAD SCI USA, V111, P11858, DOI 10.1073/pnas.1323586111; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Lee A, 2010, CURR BIOL, V20, P2211, DOI 10.1016/j.cub.2010.11.025; Li B, 2011, NATURE, V470, P535, DOI 10.1038/nature09742; Liang JO, 2000, DEVELOPMENT, V127, P5101; MACDONALD R, 1994, NEURON, V13, P1039, DOI 10.1016/0896-6273(94)90044-2; Madelaine R, 2011, DEVELOPMENT, V138, P4753, DOI 10.1242/dev.066563; Martinez-Ferre A, 2009, J NEUROSCI, V29, P13389, DOI 10.1523/JNEUROSCI.2625-09.2009; Masai I, 1997, NEURON, V18, P43, DOI 10.1016/S0896-6273(01)80045-3; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Nornes S, 1998, MECH DEVELOP, V77, P185, DOI 10.1016/S0925-4773(98)00156-7; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Park SH, 2003, BIOCHEM BIOPH RES CO, V308, P184, DOI 10.1016/S0006-291X(03)01353-6; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; Regan JC, 2009, NEURON, V61, P27, DOI 10.1016/j.neuron.2008.11.030; Roussigne M, 2012, DEV NEUROBIOL, V72, P269, DOI 10.1002/dneu.20885; Roussigne M, 2009, DEVELOPMENT, V136, P1549, DOI 10.1242/dev.034793; Sartorius A, 2007, MED HYPOTHESES, V69, P1305, DOI 10.1016/j.mehy.2007.03.021; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Scholpp S, 2006, DEVELOPMENT, V133, P855, DOI 10.1242/dev.02248; Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324; Stoykova A, 2000, J NEUROSCI, V20, P8042; Szabo NE, 2009, J NEUROSCI, V29, P2453, DOI 10.1523/JNEUROSCI.4524-08.2009; Varga ZM, 2001, DEVELOPMENT, V128, P3497; Vue TY, 2009, J NEUROSCI, V29, P4484, DOI 10.1523/JNEUROSCI.0656-09.2009; Walshe J, 2003, DEVELOPMENT, V130, P4337, DOI 10.1242/dev.00660; Warren N, 1997, DEVELOPMENT, V124, P1573; Yamaguchi T, 2013, NEURON, V78, P537, DOI 10.1016/j.neuron.2013.02.035	75	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158210	10.1371/journal.pone.0158210	http://dx.doi.org/10.1371/journal.pone.0158210			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387288	Green Published, Green Submitted, gold			2022-12-26	WOS:000379811500015
J	Fukunaga, A; Kosaki, RK; Wagner, D; Kane, C				Fukunaga, Atsuko; Kosaki, Randall K.; Wagner, Daniel; Kane, Corinne			Structure of Mesophotic Reef Fish Assemblages in the Northwestern Hawaiian Islands	PLOS ONE			English	Article							CORALS CNIDARIA ANTIPATHARIA; BLACK CORALS; SCLERACTINIAN CORALS; QUANTILE REGRESSION; CANONICAL-ANALYSIS; AUAU CHANNEL; DEEP; DIVERSITY; ECOLOGY; HABITAT	Mesophotic coral ecosystems (MCEs) support diverse communities of marine organisms with changes in community structure occurring along a depth gradient. In recent years, MCEs have gained attention due to their depths that provide protection from natural and anthropogenic stressors and their relative stability over evolutionary time periods, yet ecological structures of fish assemblages in MCEs remain largely un-documented. Here, we investigated composition and trophic structure of reef fish assemblages in the Northwestern Hawaiian Islands (NWHI) along a depth gradient from 1 to 67 m. The structure of reef fish assemblages as a whole showed a clear gradient from shallow to mesophotic depths. Fish assemblages at mesophotic depths had higher total densities than those in shallower waters, and were characterized by relatively high densities of planktivores and invertivores and relatively low densities of herbivores. Fishes that typified assemblages at mesophotic depths included six species that are endemic to the Hawaiian Islands. The present study showed that mesophotic reefs in the NWHI support unique assemblages of fish that are characterized by high endemism and relatively high densities of planktivores. Our findings underscore the ecological importance of these undersurveyed ecosystems and warrant further studies of MCEs.	[Fukunaga, Atsuko; Kosaki, Randall K.; Wagner, Daniel] NOAA, Papahanaumokuakea Marine Natl Monument, Honolulu, HI USA; [Kane, Corinne] Washington State Univ, Vancouver, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; Washington State University	Fukunaga, A (corresponding author), NOAA, Papahanaumokuakea Marine Natl Monument, Honolulu, HI USA.	atsuko.fukunaga@noaa.gov		Kosaki, Randall/0000-0003-1363-5702; Fukunaga, Atsuko/0000-0003-2175-6635	National Oceanic and Atmospheric Administration's (NOAA's) Office of National Marine Sanctuaries, through the Papahanaumokuakea Marine National Monument	National Oceanic and Atmospheric Administration's (NOAA's) Office of National Marine Sanctuaries, through the Papahanaumokuakea Marine National Monument	This work was funded in part by National Oceanic and Atmospheric Administration's (NOAA's) Office of National Marine Sanctuaries, through the Papahanaumokuakea Marine National Monument. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank the officers and crew of the NOAA ship Hi'ialakai, and J. Leonard, B. Hauk, K. Keogh, G. McFall, R. Boland, A. Montgomery, Y. Papastamatiou, K. Lopes, C. Clark, J. Bostick, E. Kehn, R. Pyle and S. Harris for field support. We also thank M. J. Anderson for initial R codes for quantile regression and three anonymous reviewers for their comments that improved this manuscript. This work was funded in part by NOAA's Office of National Marine Sanctuaries, through the Papahanaumokuakea Marine National Monument. The scientific results and conclusions, as well as any views or opinions expressed herein, are those of the authors and do not necessarily reflect the views of NOAA or the Department of Commerce.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2008, J EXP MAR BIOL ECOL, V366, P16, DOI 10.1016/j.jembe.2008.07.006; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Arreola-Robles JL, 2002, B MAR SCI, V70, P1; Bak RP, 2005, CORAL REEFS, V24, P475, DOI 10.1007/s00338-005-0009-1; Behrens MD, 2007, CAN J FISH AQUAT SCI, V64, P867, DOI 10.1139/F07-063; Behrens MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045901; Bongaerts P, 2010, CORAL REEFS, V29, P309, DOI 10.1007/s00338-009-0581-x; Bongaerts P, 2015, SCI REP-UK, V5, DOI 10.1038/srep07652; Bongaerts P, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-205; Brazeau DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065845; Bridge TCL, 2011, MAR ECOL PROG SER, V428, P63, DOI 10.3354/meps09046; BROCK VE, 1968, PAC SCI, V22, P373; Brokovich E, 2006, ECOL INDIC, V6, P494, DOI 10.1016/j.ecolind.2005.07.002; Brokovich E, 2010, MAR ECOL PROG SER, V399, P69, DOI 10.3354/meps08354; Brokovich E, 2008, MAR ECOL PROG SER, V371, P253, DOI 10.3354/meps07591; Bryan DR, 2013, J APPL ICHTHYOL, V29, P108, DOI 10.1111/j.1439-0426.2012.02055.x; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; Carassou L, 2008, AQUAT LIVING RESOUR, V21, P1, DOI 10.1051/alr:2008017; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Colvocoresses J, 2007, FISH RES, V85, P130, DOI 10.1016/j.fishres.2007.01.012; Costantini F, 2011, CORAL REEFS, V30, P991, DOI 10.1007/s00338-011-0771-1; Feitoza BM, 2005, B MAR SCI, V76, P725; FRICKE H, 1985, MAR BIOL, V88, P175, DOI 10.1007/BF00397165; Friedlander AM, 1998, J EXP MAR BIOL ECOL, V224, P1, DOI 10.1016/S0022-0981(97)00164-0; Gorley C.K., 2006, GETTING STARTED PRIM; Greenwood NDW, 2010, CORAL REEFS, V29, P785, DOI 10.1007/s00338-010-0626-1; Grigg Richard W., 2008, V1, P573, DOI 10.1007/978-1-4020-6847-8_14; Grigg RW, 2006, CORAL REEFS, V25, P77, DOI 10.1007/s00338-005-0073-6; HIATT RW, 1960, ECOL MONOGR, V30, P66; Hilting AK, 2013, MAR BIOL, V160, P1681, DOI 10.1007/s00227-013-2220-x; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; HOBSON ES, 1974, FISH B-NOAA, V72, P915; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoover J.P., 1993, HAWAIIS FISH; Hurley KKC, 2016, CORAL REEFS, V35, P103, DOI 10.1007/s00338-015-1382-z; Kahng S., 2012, P 12 INT COR REEF S; Kahng SE, 2007, CORAL REEFS, V26, P679, DOI 10.1007/s00338-007-0253-7; Kahng SE, 2014, CURR OPIN ENV SUST, V7, P72, DOI 10.1016/j.cosust.2013.11.019; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kahng SE, 2006, CORAL REEFS, V25, P254, DOI 10.1007/s00338-006-0098-5; Kane C, 2014, B MAR SCI, V90, P693, DOI 10.5343/bms.2013.1053; KOSAKI R K, 1991, Pacific Science, V45, P186; Kosaki RK, 2017, MAR BIODIVERS, V47, P783, DOI 10.1007/s12526-016-0510-5; Lesser MP, 2009, J EXP MAR BIOL ECOL, V375, P1, DOI 10.1016/j.jembe.2009.05.009; LIDDELL W D, 1988, Palaios, V3, P413, DOI 10.2307/3514787; Lindfield SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092628; Locker SD, 2010, CORAL REEFS, V29, P329, DOI 10.1007/s00338-010-0613-6; MCGEHEE MA, 1994, MAR ECOL PROG SER, V105, P243, DOI 10.3354/meps105243; Menza C, 2008, REV BIOL TROP, V56, P11; Nanami A, 2002, ENVIRON BIOL FISH, V63, P353, DOI 10.1023/A:1014952932694; Parrish FA, 2004, MAR BIOL, V144, P1065, DOI 10.1007/s00227-003-1288-0; Pearson R, 2015, MAR ECOL PROG SER, V532, P184, DOI 10.3354/meps11351; Pereira GH, 2011, BRAZ J OCEANOGR, V59, P201, DOI 10.1590/S1679-87592011000300001; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Pyle Richard L., 1996, Global Biodiversity, V6, P3; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Rooney J, 2010, CORAL REEFS, V29, P361, DOI 10.1007/s00338-010-0596-3; Russ GR, 2003, CORAL REEFS, V22, P63, DOI 10.1007/s00338-003-0286-5; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Tenggardjaja KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115493; THRESHER RE, 1986, B MAR SCI, V38, P253; van Oppen MJH, 2011, MOL ECOL, V20, P1647, DOI 10.1111/j.1365-294X.2011.05050.x; Wagner D, 2012, CORAL REEFS, V31, P795, DOI 10.1007/s00338-012-0882-3; Wagner D, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00024; Wagner Daniel, 2015, Marine Biodiversity Records, V8, pe54, DOI 10.1017/S1755267215000202; Wagner Daniel, 2014, Marine Biodiversity Records, V7, pe68, DOI 10.1017/S1755267214000785; Wagner D, 2011, INVERTEBR BIOL, V130, P211, DOI 10.1111/j.1744-7410.2011.00233.x; Wagner D, 2011, PAC SCI, V65, P249, DOI 10.2984/65.2.249; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516	73	37	37	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157861	10.1371/journal.pone.0157861	http://dx.doi.org/10.1371/journal.pone.0157861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383614	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400029
J	Gan, N; Xiong, YY; Jiao, T				Gan, Ning; Xiong, Yaoyang; Jiao, Ting			Accuracy of Intraoral Digital Impressions for Whole Upper Jaws, Including Full Dentitions and Palatal Soft Tissues	PLOS ONE			English	Article							DENTAL IMPRESSIONS	Intraoral digital impressions have been stated to meet the clinical requirements for some teeth-supported restorations, though fewer evidences were proposed for larger scanning range. The aim of this study was to compare the accuracy (trueness and precision) of intraoral digital impressions for whole upper jaws, including the full dentitions and palatal soft tissues, as well as to determine the effect of different palatal vault height or arch width on accuracy of intraoral digital impressions. Thirty-two volunteers were divided into three groups according to the palatal vault height or arch width. Each volunteer received three scans with TRIOS intraoral scanner and one conventional impression of whole upper jaw. Three-dimensional (3D) images digitized from conventional gypsum casts by a laboratory scanner were chose as the reference models. All datasets were imported to a specific software program for 3D analysis by "best fit alignment" and "3D compare" process. Color-coded deviation maps showed qualitative visualization of the deviations. For the digital impressions for palatal soft tissues, trueness was (130.54 +/- 33.95) mu m and precision was (55.26 +/- 11.21) mu m. For the digital impressions for upper full dentitions, trueness was (80.01 +/- 17.78) mu m and precision was (59.52 +/- 11.29) mu m. Larger deviations were found between intraoral digital impressions and conventional impressions in the areas of palatal soft tissues than that in the areas of full dentitions (p<0.001). Precision of digital impressions for palatal soft tissues was slightly better than that for full dentitions (p = 0.049). There was no significant effect of palatal vault height on accuracy of digital impressions for palatal soft tissues (p>0.05), but arch width was found to have a significant effect on precision of intraoral digital impressions for full dentitions (p = 0.016). A linear correlation was found between arch width and precision of digital impressions for whole upper jaws (r = 0.326, p = 0.034 for palatal soft tissues and r = 0.485, p = 0.002 for full dentitions). It was feasible to use the intraoral scanner to obtain digital impressions for whole upper jaws. Wider dental arch contributed to lower precision of an intraoral digital impression. It should be confirmed in further studies that whether accuracy of digital impressions for whole upper jaws is clinically acceptable.	[Gan, Ning; Xiong, Yaoyang; Jiao, Ting] Shanghai Jiao Tong Univ, Sch Med, Dept Prosthodont, Peoples Hosp 9,Shanghai Key Lab Stomatol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xiong, YY; Jiao, T (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Prosthodont, Peoples Hosp 9,Shanghai Key Lab Stomatol, Shanghai, Peoples R China.	jiao_ting@126.com; yaoyang_x@163.com			National Natural Science Foundation of China [81100774]; Shanghai Science and Technology Commission [114119a3900, 14411964200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission(Shanghai Science & Technology CommitteeScience & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by the National Natural Science Foundation of China (Project Number: 81100774; URL: http://www.nsfc.gov.cn/), and Shanghai Science and Technology Commission Funded Projects (Project Number: 114119a3900, 14411964200; URL: http://www.stcsm.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Silva JSAE, 2014, CLIN ORAL INVEST, V18, P515, DOI 10.1007/s00784-013-0987-2; [Anonymous], 572531994 DIN ISO; Berrendero S, 2016, CLIN ORAL INVESTIG; Brawek PK, 2013, CLIN ORAL INVEST, V17, P2119, DOI 10.1007/s00784-013-0923-5; Ender A, 2013, J PROSTHET DENT, V109, P121, DOI 10.1016/S0022-3913(13)60028-1; Flugge TV, 2013, AM J ORTHOD DENTOFAC, V144, P471, DOI 10.1016/j.ajodo.2013.04.017; Gjelvold B, 2015, J PROSTHODONT; Goodacre CJ, 2012, J PROSTHET DENT, V107, P34, DOI 10.1016/S0022-3913(12)60015-8; Jiao T, 2014, INT J PROSTHODONT, V27, P480, DOI 10.11607/ijp.3733; Kattadiyil MT, 2014, J PROSTHET DENT, V112, P444, DOI 10.1016/j.prosdent.2014.03.022; Lee SJ, 2015, CLIN ORAL IMPLAN RES, V26, P715, DOI 10.1111/clr.12375; Mehl A, 2009, Int J Comput Dent, V12, P11; Michalakis KX, 2012, J PROSTHET DENT, V108, P189, DOI 10.1016/S0022-3913(12)60146-2; Moreno A, 2013, IMPLANT DENT, V22, P320, DOI 10.1097/ID.0b013e3182980fe9; Patzelt SBM, 2013, J AM DENT ASSOC, V144, P914, DOI 10.14219/jada.archive.2013.0209; Quaas S, 2007, J DENT, V35, P903, DOI 10.1016/j.jdent.2007.08.008; Rudolph H, 2007, COMPUT BIOL MED, V37, P579, DOI 10.1016/j.compbiomed.2006.05.006; Seelbach P, 2013, CLIN ORAL INVEST, V17, P1759, DOI 10.1007/s00784-012-0864-4; Su TS, 2015, J PROSTHODONTIC RES; Svanborg P, 2014, INT J DENT, V2014, DOI 10.1155/2014/534382; Syrek A, 2010, J DENT, V38, P553, DOI 10.1016/j.jdent.2010.03.015; Takanashi T, 2009, J PROSTHODONT RES, V53, P95, DOI 10.1016/j.jpor.2008.10.002; Yan H, 2005, MED STAT, P258	23	79	84	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158800	10.1371/journal.pone.0158800	http://dx.doi.org/10.1371/journal.pone.0158800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383409	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400086
J	Iwai, Y; Shibuya, K; Misawa, S; Sekiguchi, Y; Watanabe, K; Amino, H; Kuwabara, S				Iwai, Yuta; Shibuya, Kazumoto; Misawa, Sonoko; Sekiguchi, Yukari; Watanabe, Keisuke; Amino, Hiroshi; Kuwabara, Satoshi			Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							EXCITABILITY PROPERTIES; MODEL	Wide-spread fasciculations are a characteristic feature in amyotrophic lateral sclerosis (ALS), suggesting motor axonal hyperexcitability. Previous excitability studies have shown increased nodal persistent sodium conductances and decreased potassium currents in motor axons of ALS patients, both of the changes inducing hyperexcitability. Altered axonal excitability potentially contributes to motor neuron death in ALS, but the relationship of the extent of motor neuronal death and abnormal excitability has not been fully elucidated. We performed multiple nerve excitability measurements in the median nerve at the wrist of 140 ALS patients and analyzed the relationship of compound muscle action potential (CMAP) amplitude (index of motor neuronal loss) and excitability indices, such as strength-duration time constant, threshold electrotonus, recovery cycle and current-threshold relationships. Compared to age-matched normal controls (n = 44), ALS patients (n = 140) had longer strength-duration time constant (SDTC: a measure of nodal persistent sodium current; p < 0.05), greater threshold changes in depolarizing threshold electrotonus (p < 0.05) and depolarizing current threshold relationship (i.e. less accommodation; (p < 0.05), greater superexcitability (a measure of fast potassium current; p < 0.05) and reduced late subexcitability (a measure of slow potassium current; p < 0.05), suggesting increased persistent sodium currents and decreased potassium currents. The reduced potassium currents were found even in the patient subgroups with normal CMAP (> 5mV). Regression analyses showed that SDTC (R = -0.22) and depolarizing threshold electrotonus (R = -0.22) increased with CMAP decline. These findings suggest that motor nerve hyperexcitability occurs in the early stage of the disease, and precedes motor neuronal loss in ALS. Modulation of altered ion channel function could be a treatment option for ALS.	[Iwai, Yuta; Shibuya, Kazumoto; Misawa, Sonoko; Sekiguchi, Yukari; Watanabe, Keisuke; Amino, Hiroshi; Kuwabara, Satoshi] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan	Chiba University	Shibuya, K (corresponding author), Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan.	kazumoto@net.email.ne.jp		Kuwabara, Satoshi/0000-0002-4716-8578	Ministry of Education, Culture, Sports, Science, and Technology of Japan [30375753, 70282481]; International Federation of Clinical Neurophysiology Research Scholarship	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Federation of Clinical Neurophysiology Research Scholarship	SM and SK receive research support from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (SM, 30375753, SK, 70282481). KS is a recipient of International Federation of Clinical Neurophysiology Research Scholarship.	[Anonymous], 1901, ARCH ITAL BIOL; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; Charcot J-M, 1869, ARCH PHYSL NORM PATH, V2, P744; Cheah BC, 2010, CURR MED CHEM, V17, P1942, DOI 10.2174/092986710791163939; Cheah BC, 2012, CLIN NEUROPHYSIOL, V123, P2460, DOI 10.1016/j.clinph.2012.06.020; Cheah BC, 2011, AMYOTROPH LATERAL SC, V12, P33, DOI 10.3109/17482968.2010.531742; de Carvalho M, 2000, MUSCLE NERVE, V23, P344, DOI 10.1002/(SICI)1097-4598(200003)23:3<344::AID-MUS5>3.0.CO;2-N; de Carvalho M, 2016, CLIN NEUROPHYSIOL, V127, P2257, DOI 10.1016/j.clinph.2016.02.011; de Carvalho M, 2013, JAMA NEUROL, V70, P1562, DOI 10.1001/jamaneurol.2013.4437; Devlin AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6999; Dong H, 2014, NEUROSCIENCE, V272, P141, DOI 10.1016/j.neuroscience.2014.04.032; Kanai K, 2006, BRAIN, V129, P953, DOI 10.1093/brain/awl024; Kanai Kazuaki, 2011, Rinsho Shinkeigaku, V51, P1118; Kanouchi T, 2012, J NEUROL NEUROSUR PS, V83, P739, DOI 10.1136/jnnp-2011-301826; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Krishnan AV, 2009, PROG NEUROBIOL, V89, P288, DOI 10.1016/j.pneurobio.2009.08.002; Kuo JJ, 2005, J PHYSIOL-LONDON, V563, P843, DOI 10.1113/jphysiol.2004.074138; Kuwabara S, 2014, CLIN NEUROPHYSIOL, V125, P872, DOI 10.1016/j.clinph.2013.11.014; Kuwabara S, 2011, J NEUROL NEUROSUR PS, V82, P1181, DOI 10.1136/jnnp-2011-300691; MELDRUM B, 1990, TRENDS PHARMACOL SCI, V11, P379, DOI 10.1016/0165-6147(90)90184-A; Nwosu VK, 2010, AMYOTROPH LATERAL SC, V11, P392, DOI 10.3109/17482960903452283; Regan RF, 1995, BRAIN RES, V705, P188, DOI 10.1016/0006-8993(95)01170-6; Salkind NJ., 2013, STAT PEOPLE WHO THIN; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Sekiguchi T, 2014, J NEUROL NEUROSUR PS, V85, P85, DOI 10.1136/jnnp-2013-305617; Shibuya K, 2015, AMYOTROPH LATERAL SC, V16, P1; Shibuya K, 2013, J NEUROL NEUROSUR PS, V84, P969, DOI 10.1136/jnnp-2012-304109; Shibuya K, 2011, EXP NEUROL, V232, P149, DOI 10.1016/j.expneurol.2011.08.015; Tomlinson SE, 2010, BRAIN, V133, P3530, DOI 10.1093/brain/awq318; Van Damme P, 2005, J NEUROPATH EXP NEUR, V64, P605, DOI 10.1097/01.jnen.0000171647.09589.07; Vucic S, 2006, CLIN NEUROPHYSIOL, V117, P1458, DOI 10.1016/j.clinph.2006.04.016; Wainger BJ, 2014, CELL REP, V7, P1, DOI 10.1016/j.celrep.2014.03.019	33	28	29	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158596	10.1371/journal.pone.0158596	http://dx.doi.org/10.1371/journal.pone.0158596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383069	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400063
J	Bennani-Baiti, B; Dietzel, M; Baltzer, PA				Bennani-Baiti, Barbara; Dietzel, Matthias; Baltzer, Pascal Andreas			MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer	PLOS ONE			English	Article							REDUCING SALPINGO-OOPHORECTOMY; CONTRAST-MEDIUM ENHANCEMENT; MAMMOGRAPHIC DENSITY; FIBROGLANDULAR TISSUE; REPLACEMENT THERAPY; MUTATION CARRIERS; RISK; BRCA1; WOMEN; IMPACT	Background Previously, a strong positive association between background parenchymal enhancement (BPE) at magnetic resonance imaging (MRI) and breast cancer was reported in high-risk populations. We sought to determine, whether this was also true for non-high-risk patients. Methods 540 consecutive patients underwent breast MRI for assessment of breast findings (BI-RADS 0-5, non-high-risk screening (no familial history of breast cancer, no known genetic mutation, no prior chest irradiation, or previous breast cancer diagnosis)) and subsequent histological work-up. For this IRB-approved study, BPE and fibroglandular tissue FGT were retrospectively assessed by two experienced radiologists according to the BI-RADS lexicon. Pearson correlation coefficients were calculated to explore associations between BPE, FGT, age and final diagnosis of breast cancer. Subsequently, multivariate logistic regression analysis, considering covariate colinearities, was performed, using final diagnosis as the target variable and BPE, FGT and age as covariates. Results Age showed a moderate negative correlation with FGT (r = -0.43, p<0.001) and a weak negative correlation with BPE (r = -0.28, p<0.001). FGT and BPE correlated moderately (r = 0.35, p<0.001). Final diagnosis of breast cancer displayed very weak negative correlations with FGT (r = -0.09, p = 0.046) and BPE (r = -0.156, p<0.001) and weak positive correlation with age (r = 0.353, p<0.001). On multivariate logistic regression analysis, the only independent covariate for prediction of breast cancer was age (OR 1.032, p<0.001). Conclusions Based on our data, neither BPE nor FGT independently correlate with breast cancer risk in non-high-risk patients at MRI. Our model retained only age as an independent risk factor for breast cancer in this setting.	[Bennani-Baiti, Barbara; Baltzer, Pascal Andreas] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria; [Bennani-Baiti, Barbara] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna Gen Hosp AKH, Vienna, Austria; [Dietzel, Matthias] Univ Erlangen Nurnberg, Dept Radiol, Nurnberg, Germany	University of Vienna; Medical University of Vienna; University of Erlangen Nuremberg	Bennani-Baiti, B; Baltzer, PA (corresponding author), Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria.; Bennani-Baiti, B (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna Gen Hosp AKH, Vienna, Austria.	barbara.bennani-baiti@meduniwien.ac.at; pascal.baltzer@meduniwien.ac.at		Baltzer, Pascal/0000-0002-3755-5398	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna. The authors received no other specific funding for this work.	Baltzer PA, 2011, ROFO-FORTSCHR RONTG, V183, P441, DOI 10.1055/s-0029-1246072; Bhatia S, 2015, CANCER-AM CANCER SOC, V121, P648, DOI 10.1002/cncr.29096; BOYD NF, 1995, J NATL CANCER I, V87, P670, DOI 10.1093/jnci/87.9.670; Boyd NF, 2007, NEW ENGL J MED, V356, P227, DOI 10.1056/NEJMoa062790; Byrne C, 2001, CANCER CAUSE CONTROL, V12, P103, DOI 10.1023/A:1008935821885; Cubuk R, 2010, RADIOL MED, V115, P434, DOI 10.1007/s11547-010-0513-4; Deleo MJ, 2015, AM J ROENTGENOL, V204, P669, DOI 10.2214/AJR.13.12146; Delille JP, 2005, RADIOLOGY, V235, P36, DOI 10.1148/radiol.2351040012; DeMartini WB, 2012, AM J ROENTGENOL, V198, pW373, DOI 10.2214/AJR.10.6272; Dolan NC, 2015, ANN INTERN MED, V162, P729, DOI 10.7326/M15-0821; Dontchos BN, 2015, RADIOLOGY, V276, P371, DOI 10.1148/radiol.2015142304; Faresjo T, 2010, INT J ENV RES PUB HE, V7, P325, DOI 10.3390/ijerph7010325; Fridlich R, 2015, DNA REPAIR, V30, P11, DOI 10.1016/j.dnarep.2015.03.002; Gorrini C, 2014, P NATL ACAD SCI USA, V111, P4472, DOI 10.1073/pnas.1324136111; Hansen NL, 2014, J MAGN RESON IMAGING, V40, P483, DOI 10.1002/jmri.24495; King V, 2011, RADIOLOGY, V260, P50, DOI 10.1148/radiol.11102156; Ko ES, 2011, EUR J RADIOL, V80, P719, DOI 10.1016/j.ejrad.2010.07.019; Kuhl CK, 1997, RADIOLOGY, V203, P137, DOI 10.1148/radiology.203.1.9122382; Lee EYHP, 2014, P NATL ACAD SCI USA, V111, P4353, DOI 10.1073/pnas.1403033111; Lehman CD, 2014, ACR PRACTICE PARAMET; Morris C, 2013, ACR BI RADS1 MAGNETI; MullerSchimpfle M, 1997, RADIOLOGY, V203, P145; Price ER, 2014, EUR RADIOL, V24, P162, DOI 10.1007/s00330-013-2993-9; Ramadan S, 2015, RADIOLOGY, V275, P675, DOI 10.1148/radiol.15140967; Reichenbach JR, 1999, J COMPUT ASSIST TOMO, V23, P407, DOI 10.1097/00004728-199905000-00015; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Singer CF, 2015, WIEN KLIN WOCHENSCHR, V127, P981, DOI 10.1007/s00508-015-0880-x; Talele Anjali C, 2003, Breast J, V9, P237, DOI 10.1046/j.1524-4741.2003.09322.x; Ursin G, 2003, CANCER EPIDEM BIOMAR, V12, P332; Vachon CM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1829; van der Velden BHM, 2015, RADIOLOGY, V276, P675, DOI 10.1148/radiol.15142192; Wei J, 2004, MED PHYS, V31, P933, DOI 10.1118/1.1668512; Wu S, 2013, INT SOC MAGN RES MED; WU SD, 2013, MED PHYS, V40, DOI DOI 10.1118/1; Wu SD, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0577-0; Wu SD, 2013, MED PHYS, V40, DOI 10.1118/1.4829496; Wu SD, 2012, LECT NOTES COMPUT SC, V7511, P437, DOI 10.1007/978-3-642-33418-4_54	37	34	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158573	10.1371/journal.pone.0158573	http://dx.doi.org/10.1371/journal.pone.0158573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379395	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700035
J	Piepenbrink, MS; Samuel, M; Zheng, B; Carter, B; Fucile, C; Bunce, C; Kiebala, M; Khan, AA; Thakar, J; Maggirwar, SB; Morse, D; Rosenberg, AF; Haughey, NJ; Valenti, W; Keefer, MC; Kobie, JJ				Piepenbrink, Michael S.; Samuel, Memorie; Zheng, Bo; Carter, Brittany; Fucile, Christopher; Bunce, Catherine; Kiebala, Michelle; Khan, Atif A.; Thakar, Juilee; Maggirwar, Sanjay B.; Morse, Diane; Rosenberg, Alexander F.; Haughey, Norman J.; Valenti, William; Keefer, Michael C.; Kobie, James J.			Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users	PLOS ONE			English	Article							BLOOD B-CELLS; DRUG-USERS; IMMUNE ACTIVATION; MICROBIAL TRANSLOCATION; OPIOID RECEPTORS; HIGH-RISK; RHEUMATOID-ARTHRITIS; HIV-1 INFECTION; EFFICACY TRIAL; VACCINE	Background Injection drug use is a growing major public health concern. Injection drug users (IDUs) have a higher incidence of co-morbidities including HIV, Hepatitis, and other infections. An effective humoral response is critical for optimal homeostasis and protection from infection; however, the impact of injection heroin use on humoral immunity is poorly understood. We hypothesized that IDUs have altered B cell and antibody profiles. Methods and Findings A comprehensive systems biology-based cross-sectional assessment of 130 peripheral blood B cell flow cytometry- and plasma-based features was performed on HIV-/Hepatitis C-, active heroin IDUs who participated in a syringe exchange program (n = 19) and healthy control subjects (n = 19). The IDU group had substantial polydrug use, with 89% reporting cocaine injection within the preceding month. IDUs exhibited a significant, 2-fold increase in total B cells compared to healthy subjects, which was associated with increased activated B cell subsets. Although plasma total IgG titers were similar between groups, IDUs had significantly higher IgG3 and IgG4, suggestive of chronic B cell activation. Total IgM was also increased in IDUs, as well as HIV Envelope-specific IgM, suggestive of increased HIV exposure. IDUs exhibited numerous features suggestive of systemic inflammation, including significantly increased plasma sCD40L, TNF-alpha, TGF-alpha, IL-8, and ceramide metabolites. Machine learning multivariate analysis distilled a set of 10 features that classified samples based on group with absolute accuracy. Conclusions These results demonstrate broad alterations in the steady-state humoral profile of IDUs that are associated with increased systemic inflammation. Such dysregulation may impact the ability of IDUs to generate optimal responses to vaccination and infection, or lead to increased risk for inflammation-related co-morbidities, and should be considered when developing immune-based interventions for this growing population.	[Piepenbrink, Michael S.; Zheng, Bo; Bunce, Catherine; Valenti, William; Keefer, Michael C.; Kobie, James J.] Univ Rochester, Dept Med, Div Infect Dis, Rochester, NY 14627 USA; [Samuel, Memorie] Howard Univ, Sch Med, Washington, DC 20059 USA; [Carter, Brittany] Texas A&M Univ, Sch Med, Bryan, TX USA; [Fucile, Christopher; Rosenberg, Alexander F.] Univ Rochester, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY USA; [Kiebala, Michelle; Khan, Atif A.; Thakar, Juilee; Maggirwar, Sanjay B.] Univ Rochester, Dept Microbiol & Immunol, Rochester, NY USA; [Morse, Diane] Univ Rochester, Dept Psychiat, Rochester, NY USA; [Morse, Diane] Univ Rochester, Dept Med, Rochester, NY USA; [Haughey, Norman J.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA; [Valenti, William] Trillium Hlth, Rochester, NY USA	University of Rochester; Howard University; Texas A&M University System; Texas A&M University College Station; University of Rochester; University of Rochester; University of Rochester; University of Rochester; Johns Hopkins University	Kobie, JJ (corresponding author), Univ Rochester, Dept Med, Div Infect Dis, Rochester, NY 14627 USA.	james_kobie@urmc.rochester.edu	Khan, Atif/I-4947-2019; Piepenbrink, Michael/GPK-5944-2022	Khan, Atif/0000-0002-6006-2620; Morse, Diane/0000-0001-9603-0324	National Institutes of Health (NIH) grants [1R01AI117787, 1R21AI116285]; HIV Vaccines Trials Network Research and Mentorship Program (RAMP) [5UM1AI068614]; University of Rochester Center for AIDS Research [5P30AI078498]; University of Rochester HIV/AIDS Clinical Trials Unit; Units for HIV/AIDS Clinical Trials Networks [5UM1AI069511]; PhRMA informatics research starter award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117787, P30AI078498, R21AI116285, UM1AI069511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096636] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066801] Funding Source: NIH RePORTER	National Institutes of Health (NIH) grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HIV Vaccines Trials Network Research and Mentorship Program (RAMP); University of Rochester Center for AIDS Research; University of Rochester HIV/AIDS Clinical Trials Unit; Units for HIV/AIDS Clinical Trials Networks; PhRMA informatics research starter award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health (NIH) grants (1R01AI117787 and 1R21AI116285 to JK); the HIV Vaccines Trials Network Research and Mentorship Program (RAMP) (5UM1AI068614 to MS and BC); and funding through the University of Rochester Center for AIDS Research (5P30AI078498 to JK and JT); PhRMA informatics research starter award (to JT) and the University of Rochester HIV/AIDS Clinical Trials Unit; Units for HIV/AIDS Clinical Trials Networks (5UM1AI069511 to JK and MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Anthony IC, 2010, BRAIN, V133, P3685, DOI 10.1093/brain/awq263; BAGASRA O, 1989, CLIN EXP IMMUNOL, V77, P289; Bandaru VVR, 2013, NEUROLOGY, V81, P1492, DOI 10.1212/WNL.0b013e3182a9565e; Bandaru VVR, 2013, NEUROLOGY IN PRESS; Baral S, 2007, LANCET INFECT DIS, V7, P667, DOI 10.1016/S1473-3099(07)70237-2; Bergman BC, 2015, AM J PHYSIOL-ENDOC M, V309, pE398, DOI 10.1152/ajpendo.00134.2015; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buettner M, 2014, AM J KIDNEY DIS, V63, P945, DOI 10.1053/j.ajkd.2014.01.428; Chan YY, 2015, PSYCHIAT RES, V226, P230, DOI 10.1016/j.psychres.2014.12.053; Chen SL, 2012, J NEUROIMMUNE PHARM, V7, P1025, DOI 10.1007/s11481-012-9400-1; Cheng GLF, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.36; Cheng JM, 2015, ATHEROSCLEROSIS, V243, P560, DOI 10.1016/j.atherosclerosis.2015.10.022; Cognasse F, 2007, EXP HEMATOL, V35, P1376, DOI 10.1016/j.exphem.2007.05.021; Corey L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7732; Dart RC, 2015, NEW ENGL J MED, V372, P241, DOI [10.1056/NEJMsa1406143, 10.1056/NEJMc1501822]; Davidson DC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-144; Dettmeyer R, 2009, FORENSIC SCI INT, V187, P42, DOI 10.1016/j.forsciint.2009.02.014; Dwyer R, 2009, DRUG ALCOHOL DEPEN, V100, P9, DOI 10.1016/j.drugalcdep.2008.08.016; Fink K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00078; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Fugelstad A, 2014, SCAND J PUBLIC HEALT, V42, P364, DOI 10.1177/1403494814525006; Goldkorn Tzipora, 2013, Handb Exp Pharmacol, P93, DOI 10.1007/978-3-7091-1511-4_5; Tucker RDGY, 2014, ANAEROBE, V30, P108, DOI 10.1016/j.anaerobe.2014.09.005; Gracia-Garcia P, 2011, J NEUROPSYCH CLIN N, V23, P215, DOI 10.1176/appi.neuropsych.23.2.215; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hammad SM, 2010, J LIPID RES, V51, P3074, DOI 10.1194/jlr.D008532; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Henneken M, 2005, ARTHRITIS RES THER, V7, pR1001, DOI 10.1186/ar1776; Hernandez-Corbacho MJ, 2015, J BIOL CHEM, V290, P25356, DOI 10.1074/jbc.M115.658658; Hidalgo-Munoz AR, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00020; Jamali A, 2007, COMP IMMUNOL MICROB, V30, P71, DOI 10.1016/j.cimid.2006.10.002; Jego G, 2001, BLOOD, V97, P1817, DOI 10.1182/blood.V97.6.1817; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Jourdan M, 2011, J IMMUNOL, V187, P3931, DOI 10.4049/jimmunol.1101230; Kakazu E, 2016, J LIPID RES, V57, P233, DOI 10.1194/jlr.M063412; Kamath GR, 2014, VACCINE, V32, P2265, DOI 10.1016/j.vaccine.2014.02.072; Kaminski DA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00302; Kassambara A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004077; Kaushik KS, 2011, J MED MICROBIOL, V60, P408, DOI 10.1099/jmm.0.027540-0; Kiebala M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130061; Kobie JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035356; Kobie JJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3542; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kovacs GG, 2015, NEUROBIOL AGING, V36, P3100, DOI 10.1016/j.neurobiolaging.2015.07.018; Kuramoto SJ, 2011, DRUG ALCOHOL DEPEN, V118, P237, DOI 10.1016/j.drugalcdep.2011.03.030; Larsen PJ, 2014, MOL METAB, V3, P252, DOI 10.1016/j.molmet.2014.01.011; Lavender TW, 2013, CLIN MED, V13, P511, DOI 10.7861/clinmedicine.13-5-511; Leng SX, 2015, AIDS RES HUM RETROV, V31, P1257, DOI [10.1089/aid.2015.0134, 10.1089/AID.2015.0134]; Leung-Hagesteijn C, 2013, CANCER CELL, V24, P289, DOI 10.1016/j.ccr.2013.08.009; Liu RX, 2015, HEPATOLOGY, V62, P1779, DOI 10.1002/hep.28020; Machowska A, 2016, TRANSL RES, V167, P204, DOI 10.1016/j.trsl.2015.06.012; McCarthy L, 2001, DRUG ALCOHOL DEPEN, V62, P111, DOI 10.1016/S0376-8716(00)00181-2; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Meacham MC, 2015, SUBST USE MISUSE, V50, P1351, DOI 10.3109/10826084.2015.1013132; Mielke MM, 2015, AGING CELL, V14, P1014, DOI 10.1111/acel.12369; Mielke MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073094; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Murphy EL, 2001, CLIN INFECT DIS, V33, P35, DOI 10.1086/320879; Narvaez JCM, 2013, NEUROSCI LETT, V544, P80, DOI 10.1016/j.neulet.2013.03.045; Neri M, 2013, INT J MOL SCI, V14, P19831, DOI 10.3390/ijms141019831; Palmer CD, 2014, AIDS, V28, P2162, DOI 10.1097/QAD.0000000000000386; Pereira J, 2011, PLATELETS, V22, P596, DOI 10.3109/09537104.2011.578181; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Reece AS, 2014, J CLIN PHARM THER, V39, P158, DOI 10.1111/jcpt.12121; Regan PM, 2012, J CELL PHYSIOL, V227, P2832, DOI 10.1002/jcp.24004; Reichel M, 2015, BBA-MOL CELL BIOL L, V1851, P1501, DOI 10.1016/j.bbalip.2015.08.005; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rivera IG, 2015, TOXINS, V7, P1457, DOI 10.3390/toxins7051457; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rudd RA, 2014, MMWR-MORBID MORTAL W, V63, P849; Sacerdote P, 2008, BRAIN BEHAV IMMUN, V22, P606, DOI 10.1016/j.bbi.2007.12.013; Schneider-Schaulies J, 2015, BIOL CHEM, V396, P585, DOI 10.1515/hsz-2014-0273; Serre K, 2012, BLOOD, V120, P4552, DOI 10.1182/blood-2012-03-417733; TAUB DD, 1991, P NATL ACAD SCI USA, V88, P360, DOI 10.1073/pnas.88.2.360; Todd DJ, 2011, ARTHRITIS RHEUM-US, V63, P894, DOI 10.1002/art.30213; Tomescu C, 2015, JAIDS-J ACQ IMM DEF, V68, P264, DOI 10.1097/QAI.0000000000000470; Tomescu C, 2010, AIDS, V24, P2151, DOI 10.1097/QAD.0b013e32833dfc20; Toskulkao T, 2010, NEUROCHEM INT, V56, P285, DOI 10.1016/j.neuint.2009.10.013; van Holst Ruth Janke, 2011, Curr Drug Abuse Rev, V4, P42; Vassallo M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-174; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228; Warshow UM, 2012, J VIRAL HEPATITIS, V19, P501, DOI 10.1111/j.1365-2893.2011.01574.x; Yao ZQ, 2013, ARCH IMMUNOL THER EX, V61, P193, DOI 10.1007/s00005-013-0219-0; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730	89	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158641	10.1371/journal.pone.0158641	http://dx.doi.org/10.1371/journal.pone.0158641			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379802	Green Published, gold, Green Submitted			2022-12-26	WOS:000379798700038
J	Ma, F; Deng, LW; Secrest, P; Shi, LD; Zhao, JE; Gagneux, P				Ma, Fang; Deng, Liwen; Secrest, Patrick; Shi, Linda; Zhao, June; Gagneux, Pascal			A Mouse Model for Dietary Xenosialitis ANTIBODIES TO XENOGLYCAN CAN REDUCE FERTILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; autoimmunity; diet; sialic acid; spermatozoa; N-Glycolylneuraminic acid; anti-carbohydrate antibodies; infertility; xenoglycan	N-GLYCOLYLNEURAMINIC ACID; NONHUMAN SIALIC-ACID; HUMAN XENO-AUTOANTIBODIES; VERTEBRATE AMINO-SUGARS; ANTISPERM ANTIBODIES; MAMMALIAN SPERM; LEUKOCYTIC REACTION; MEAT CONSUMPTION; INFERTILITY; MECHANISM	Humans can incorporate the xenoglycan N-glycolylneuraminic acid (Neu5Gc) from the diet into reproductive tissues and secretions. Most humans also have circulating antibodies specific for this dietary xenoglycan. The potential for inflammation induced by incorporated Neu5Gc and circulating anti-Neu5Gc antibodies, termed xenosialitis, has been discussed as a factor influencing several human diseases. Potential effects of xenosialitis on human fertility remain unknown. Here, we investigate possible adverse effects of the presence of Neu5Gc on sperm or endometrium combined with anti-Neu5Gc antibodies in semen or uterine secretions in a mouse model. We use Cmah(-/-) mice, humanized for Neu5Gc deficiency. We find that the viability, migration, and capacitation of sperm with incorporated Neu5Gc are negatively affected when these are exposed to anti-Neu5Gc antibodies. In addition, we find that after copulation, activated uterine neutrophils and macrophages show increased phagocytosis of sperm in the presence of anti-Neu5Gc antibodies via the complement receptor 3 (C3R) and Fc I/II/III (Fc receptor). Furthermore, Neu5Gc in endometrial cells combined with the presence of anti-Neu5Gc antibodies alters the receptivity and decidualization of endometrial explants. These studies provide mechanistic insights on how Neu5Gc on sperm and/or endometrium combined with anti-Neu5Gc antibodies in semen and uterine fluid might contribute to unexplained human infertility.	[Ma, Fang] Sichuan Univ, West China Univ Hosp 2, Sichuan Univ Chinese Univ Hong Kong Joint Lab Rep, Minist Educ,Key Lab Obstet Gynecol & Pediat Dis &, Chengdu 610041, Peoples R China; [Ma, Fang] Sichuan Univ, West China Univ Hosp 2, Dept Obstet & Gynecol, Chengdu 610041, Peoples R China; [Deng, Liwen; Secrest, Patrick; Gagneux, Pascal] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Deng, Liwen; Secrest, Patrick; Gagneux, Pascal] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Shi, Linda] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Zhao, June] Univ Calif San Diego, Transgen Mouse Core, La Jolla, CA 92093 USA	Chinese University of Hong Kong; Sichuan University; Sichuan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Gagneux, P (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pgagneux@ucsd.edu		Ma, Fang/0000-0002-7781-821X; Deng, Liwen/0000-0002-7984-8471	National Institutes of Health [P30 NS047101]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Ajit Varki for the Cmah<SUP>-/-</SUP> mice, Nissi Varki for precious advice on histology, and Noritaka for help setting up the sperm migration assay. We gratefully acknowledge the UCSD Neuroscience Microscopy Facility (National Institutes of Health Grant P30 NS047101).	Aghajanova L, 2004, ANN NY ACAD SCI, V1034, P176, DOI 10.1196/annals.1335.020; Balasuriya A, 2011, REPROD BIOMED ONLINE, V22, P428, DOI 10.1016/j.rbmo.2011.01.012; Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bergfeld AK, 2012, J BIOL CHEM, V287, P28898, DOI 10.1074/jbc.M112.363499; Buttke DE, 2006, BIOL REPROD, V74, P889, DOI 10.1095/biolreprod.105.046219; Chamley LW, 2007, SEMIN IMMUNOPATHOL, V29, P169, DOI 10.1007/s00281-007-0075-2; Chou HH, 2002, P NATL ACAD SCI USA, V99, P11736, DOI 10.1073/pnas.182257399; Cisneros-Mejorado A, 2014, ANDROLOGY-US, V2, P145, DOI 10.1111/j.2047-2927.2013.00169.x; Colette S, 2011, HUM REPROD, V26, P1362, DOI 10.1093/humrep/der079; Daniel CR, 2011, PUBLIC HEALTH NUTR, V14, P575, DOI 10.1017/S1368980010002077; DCRUZ OJ, 1995, J ANDROL, V16, P432; Deng LQ, 2014, CELL, V159, P1290, DOI 10.1016/j.cell.2014.10.057; DEVINE PL, 1991, CANCER RES, V51, P5826; Diekman AB, 2000, AM J REPROD IMMUNOL, V43, P134, DOI 10.1111/j.8755-8920.2000.430302.x; Foote RH, 2003, ANIM REPROD SCI, V75, P119, DOI 10.1016/S0378-4320(02)00233-6; Francavilla F, 2007, FRONT BIOSCI-LANDMRK, V12, P2890, DOI 10.2741/2280; Ghaderi D, 2011, P NATL ACAD SCI USA, V108, P17743, DOI 10.1073/pnas.1102302108; Godbole G, 2011, FERTIL STERIL, V95, P1278, DOI 10.1016/j.fertnstert.2010.09.045; Hahn S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00362; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; HENDRY WF, 1989, REPROD FERT DEVELOP, V1, P205, DOI 10.1071/RD9890205; HIGASHI H, 1985, CANCER RES, V45, P3796; Jha KN, 2006, MOL HUM REPROD, V12, P781, DOI 10.1093/molehr/gal085; Kirchhoff C, 2001, CELLS TISSUES ORGANS, V168, P93, DOI 10.1159/000016810; Kombe A, 2003, STEROIDS, V68, P651, DOI 10.1016/S0039-128X(03)00094-1; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; KREMER J, 1992, HUM REPROD, V7, P781, DOI 10.1093/oxfordjournals.humrep.a137737; KUTTEH WH, 1994, AM J REPROD IMMUNOL, V31, P77, DOI 10.1111/j.1600-0897.1994.tb00850.x; Ma X, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137810; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; Mantovani A, 2006, ANN NY ACAD SCI, V1076, P239, DOI 10.1196/annals.1371.063; Marquez B, 2007, BIOL REPROD, V76, P660, DOI 10.1095/biolreprod.106.055038; Minelli A, 2003, REPRODUCTION, V125, P827, DOI 10.1530/reprod/125.6.827; Mitchell LA, 2007, MOL HUM REPROD, V13, P605, DOI 10.1093/molehr/gam043; MIYOSHI I, 1986, MOL IMMUNOL, V23, P631, DOI 10.1016/0161-5890(86)90100-8; Naz RK, 2004, AM J REPROD IMMUNOL, V51, P390, DOI 10.1111/j.1600-0897.2004.00174.x; Nguyen DH, 2005, J IMMUNOL, V175, P228, DOI 10.4049/jimmunol.175.1.228; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Norat T, 2002, INT J CANCER, V98, P241, DOI 10.1002/ijc.10126; Padler-Karavani V, 2008, GLYCOBIOLOGY, V18, P818, DOI 10.1093/glycob/cwn072; Padler-Karavani V, 2011, CANCER RES, V71, P3352, DOI 10.1158/0008-5472.CAN-10-4102; PANDYA IJ, 1985, FERTIL STERIL, V43, P417; PETERS AJ, 1992, AM J REPROD IMMUNOL, V27, P156, DOI 10.1111/j.1600-0897.1992.tb00743.x; Pham T, 2009, BLOOD, V114, P5225, DOI 10.1182/blood-2009-05-220400; Ray A, 2012, REPROD BIOMED ONLINE, V24, P591, DOI 10.1016/j.rbmo.2012.02.021; Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112; Smith C, 2012, J AM PHARM ASSOC, V52, pE27, DOI 10.1331/JAPhA.2012.12044; Sroga J. L., 2015, CLIN OBSTET GYNECOL, V1, P72, DOI DOI 10.15761/C0GRM.1000120; Sutovsky P, 2012, CELL TISSUE RES, V349, P631, DOI 10.1007/s00441-012-1480-y; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Taylor RE, 2010, J EXP MED, V207, P1637, DOI 10.1084/jem.20100575; Tecle E, 2015, MOL REPROD DEV, V82, P635, DOI 10.1002/mrd.22500; THOMPSON LA, 1992, AM J REPROD IMMUNOL, V28, P85, DOI 10.1111/j.1600-0897.1992.tb00765.x; Varki A, 2001, YEARB PHYS ANTHROPOL, V44, P54, DOI 10.1002/ajpa.10018; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Varki A, 2011, GLYCOBIOLOGY, V21, P1121, DOI 10.1093/glycob/cwr087; Varki NM, 2011, ANNU REV PATHOL-MECH, V6, P365, DOI 10.1146/annurev-pathol-011110-130315; Willett WC, 1999, CA-CANCER J CLIN, V49, P331, DOI 10.3322/canjclin.49.6.331; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; Zhang JJ, 2005, NUTR CANCER, V53, P65, DOI 10.1207/s15327914nc5301_8	63	12	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18222	18231		10.1074/jbc.M116.739169	http://dx.doi.org/10.1074/jbc.M116.739169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382056	Green Published, hybrid			2022-12-26	WOS:000383241800015
J	McCullough, CE; Song, SF; Shin, MH; Johnson, FB; Marmorstein, R				McCullough, Cheryl E.; Song, Shufei; Shin, Michael H.; Johnson, F. Brad; Marmorstein, Ronen			Structural and Functional Role of Acetyltransferase hMOF K274 Autoacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); acetylation; chemical modification; histone acetylase; post-translational modification (PTM)	HISTONE ACETYLTRANSFERASE; PROTEIN ACETYLATION; CATALYTIC MECHANISM; RECRUITMENT; GCN5	Many histone acetyltransferases undergo autoacetylation, either through chemical or enzymatic means, to potentiate enzymatic cognate substrate lysine acetylation, although the mode and molecular role of such autoacetylation is poorly understood. The MYST family of histone acetyltransferases is autoacetylated at an active site lysine residue to facilitate cognate substrate lysine binding and acetylation. Here, we report on a detailed molecular investigation of Lys-274 autoacetylation of the human MYST protein Males Absent on the First (hMOF). A mutational scan of hMOF Lys-274 reveals that all amino acid substitutions of this residue are able to bind cofactor but are significantly destabilized, both in vitro and in cells, and are catalytically inactive for cognate histone H4 peptide lysine acetylation. The x-ray crystal structure of a hMOF K274P mutant suggests that the reduced stability and catalytic activity stems from a disordering of the residue 274-harboring a 2-7 loop. We also provide structural evidence that a C316S/E350Q mutant, which is defective for cognate substrate lysine acetylation; and biochemical evidence that a K268M mutant, which is defective for Lys-274 chemical acetylation in the context of a K274-peptide, can still undergo quantitative K274 autoacetylation. Together, these studies point to the critical and specific role of hMOF Lys-274 autoacetylation in hMOF stability and cognate substrate acetylation and argues that binding of Ac-CoA to hMOF likely drives Lys-274 autoacetylation for subsequent cognate substrate acetylation.	[McCullough, Cheryl E.; Shin, Michael H.; Marmorstein, Ronen] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Dept Biochem & Biophys, 421 Curie Blvd, Philadelphia, PA 19104 USA; [McCullough, Cheryl E.; Shin, Michael H.; Marmorstein, Ronen] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA; [Song, Shufei; Johnson, F. Brad] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Song, Shufei; Johnson, F. Brad; Marmorstein, Ronen] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Marmorstein, R (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Dept Biochem & Biophys, 421 Curie Blvd, Philadelphia, PA 19104 USA.	marmor@mail.med.upenn.edu			National Institutes of Health [P30 CA010815, P30 CA016520]; NATIONAL CANCER INSTITUTE [P30CA016520, P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060293, T32GM008275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank John Domsic and Adam Olia for helpful discussions regarding the crystal structure determination and refinement and programming for analysis of melting temperatures. We acknowledge support of the proteomics facility at the Wistar Institute (National Institutes of Health Grant P30 CA010815) and the DNA Sequencing Facility at the Perelman School of Medicine, University of Pennsylvania (National Institutes of Health Grant P30 CA016520).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albaugh BN, 2011, J BIOL CHEM, V286, P24694, DOI 10.1074/jbc.M111.251579; Albaugh BN, 2010, BIOCHEMISTRY-US, V49, P6375, DOI 10.1021/bi100381y; Baeza J, 2015, ACS CHEM BIOL, V10, P122, DOI 10.1021/cb500848p; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Blanco-Garcia N, 2009, J BIOL CHEM, V284, P1343, DOI 10.1074/jbc.M806075200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Herrera JE, 1997, J BIOL CHEM, V272, P27253, DOI 10.1074/jbc.272.43.27253; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kadlec J, 2011, NAT STRUCT MOL BIOL, V18, P142, DOI 10.1038/nsmb.1960; Li Y, 2014, GENE DEV, V28, P1217, DOI 10.1101/gad.240531.114; Liu X, 2008, NATURE, V451, P846, DOI 10.1038/nature06546; Lu L, 2011, CELL RES, V21, P1182, DOI 10.1038/cr.2011.71; Marmorstein R, 2009, BBA-GENE REGUL MECH, V1789, P58, DOI 10.1016/j.bbagrm.2008.07.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCullough CE, 2016, ACS CHEM BIOL, V11, P632, DOI 10.1021/acschembio.5b00841; Olia AS, 2015, ACS CHEM BIOL, V10, P2034, DOI 10.1021/acschembio.5b00342; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Smith KT, 2009, NAT BIOTECHNOL, V27, P917, DOI 10.1038/nbt1009-917; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Sun BF, 2011, CELL RES, V21, P1262, DOI 10.1038/cr.2011.105; Thompson PR, 2004, NAT STRUCT MOL BIOL, V11, P308, DOI 10.1038/nsmb740; Wu H, 2012, P NATL ACAD SCI USA, V109, P8925, DOI 10.1073/pnas.1114117109; Yan Y, 2002, NAT STRUCT BIOL, V9, P862, DOI 10.1038/nsb849; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032886; Yuan H, 2012, EMBO J, V31, P58, DOI 10.1038/emboj.2011.382; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	30	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18190	18198		10.1074/jbc.M116.736264	http://dx.doi.org/10.1074/jbc.M116.736264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382063	Green Published, hybrid			2022-12-26	WOS:000383241800012
J	Huang, LJ; Minematsu, T; Kitamura, A; Quinetti, PC; Nakagami, G; Mugita, Y; Oe, M; Noguchi, H; Mori, T; Sanada, H				Huang, Lijuan; Minematsu, Takeo; Kitamura, Aya; Quinetti, Paes C.; Nakagami, Gojiro; Mugita, Yuko; Oe, Makoto; Noguchi, Hiroshi; Mori, Taketoshi; Sanada, Hiromi			Topical Administration of Acylated Homoserine Lactone Improves Epithelialization of Cutaneous Wounds in Hyperglycaemic Rats	PLOS ONE			English	Article							KERATINOCYTE MIGRATION; GENE-EXPRESSION; IV COLLAGEN; MATRIX; LAMININ-5; ULCERS; DIFFERENTIATION; FIBRONECTIN; RESPONSES; RECEPTOR	Clinicians often experience delayed epithelialization in diabetic patients, for which a high glucose condition is one of the causes. However, the mechanisms underlying delayed wound closure have not been fully elucidated, and effective treatments to enhance epithelialization in patients with hyperglycaemia have not been established. Here we propose a new reagent, acylated homoserine lactone (AHL), to improve the delayed epithelialization due to the disordered formation of a basement membrane of epidermis in hyperglycaemic rats. Acute hyperglycaemia was induced by streptozotocin injection in this experiment. Full thickness wounds were created on the flanks of hyperglycaemic or control rats. Histochemical and immunohistochemical analyses were performed to identify hyperglycaemia-specific abnormalities in epidermal regeneration by comparison between groups. We then examined the effects of AHL on delayed epithelialization in hyperglycaemic rats. Histological analysis showed the significantly shorter epithelializing tissue (P < 0.05), abnormal structure of basement membrane (fragmentation and immaturity), and hypo-and hyperproliferation of basal keratinocytes in hyperglycaemic rats. Treating the wound with AHL resulted in the decreased abnormalities of basement membrane, normal distribution of proliferating epidermal keratinocytes, and significantly promoted epithelialization (P < 0.05) in hyperglycemic rats, suggesting the improving effects of AHL on abnormal epithelialization due to hyperglycemia.	[Huang, Lijuan; Minematsu, Takeo; Kitamura, Aya; Quinetti, Paes C.; Nakagami, Gojiro; Mugita, Yuko; Sanada, Hiromi] Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Hongo, Tokyo, Japan; [Oe, Makoto] Univ Tokyo, Grad Sch Med, Dept Adv Nursing Technol, Hongo, Tokyo, Japan; [Noguchi, Hiroshi; Mori, Taketoshi] Univ Tokyo, Grad Sch Med, Dept Life Support Technol Molten, Hongo, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Minematsu, T; Sanada, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gerontol Nursing Wound Care Management, Hongo, Tokyo, Japan.	tminematsu-tky@umin.ac.jp; hsanada-tky@umin.ac.jp	Noguchi, Hiroshi/GQI-0676-2022; Minematsu, Takeo/AAH-7406-2020; Nakagami, Gojiro/V-9093-2019; Mori, Taketoshi/E-3849-2016	Noguchi, Hiroshi/0000-0002-5303-5210; Minematsu, Takeo/0000-0001-5859-7290; Nakagami, Gojiro/0000-0002-9650-2464; Mori, Taketoshi/0000-0002-7208-6435; Mugita, Yuko/0000-0003-4964-7107				Antunes LCM, 2010, MICROBIOL-SGM, V156, P2271, DOI 10.1099/mic.0.038794-0; Berlowitz DR, 2007, J AM MED DIR ASSOC, V8, pS37, DOI 10.1016/j.jamda.2006.12.029; CARTER WG, 1991, CELL, V65, P599, DOI 10.1016/0092-8674(91)90092-D; Cooley MA, 2010, MICROBES INFECT, V12, P231, DOI 10.1016/j.micinf.2009.12.009; Demerjian M, 2006, EXP DERMATOL, V15, P154, DOI 10.1111/j.1600-0625.2006.00402.x; Gorecki C, 2009, J AM GERIATR SOC, V57, P1175, DOI 10.1111/j.1532-5415.2009.02307.x; Hamill KJ, 2005, CLIN EXP DERMATOL, V30, P398, DOI 10.1111/j.1365-2230.2005.01842.x; Han H, 2002, PLAST RECONSTR SURG, V110, P118, DOI 10.1097/00006534-200207000-00021; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Ibuki A, 2012, EXP DERMATOL, V21, P178, DOI 10.1111/j.1600-0625.2011.01409.x; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Kessler L, 2003, DIABETES CARE, V26, P2378, DOI 10.2337/diacare.26.8.2378; KIM JP, 1994, LAB INVEST, V71, P401; KOLBE M, 1990, CONNECT TISSUE RES, V25, P77, DOI 10.3109/03008209009009814; Lan CCE, 2008, BRIT J DERMATOL, V159, P1103, DOI 10.1111/j.1365-2133.2008.08789.x; Lerman OZ, 2003, AM J PATHOL, V162, P303, DOI 10.1016/S0002-9440(10)63821-7; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Maruyama K, 2007, AM J PATHOL, V170, P1178, DOI 10.2353/ajpath.2007.060018; Minematsu T, 2012, BIOL RES NURS, V14, P242, DOI 10.1177/1099800411410870; Motzkau M, 2011, EXP CLIN ENDOCR DIAB, V119, P286, DOI 10.1055/s-0030-1267235; Nakagami G, 2011, FEMS IMMUNOL MED MIC, V62, P157, DOI 10.1111/j.1574-695X.2011.00796.x; Natarajan E, 2006, AM J PATHOL, V168, P1821, DOI 10.2353/ajpath.2006.051027; Orgill DP, 2011, PLAST RECONSTR SURG, V127, p105S, DOI 10.1097/PRS.0b013e318200a427; Paes C, 2012, BIOCHEM BIOPH RES CO, V427, P273, DOI 10.1016/j.bbrc.2012.09.037; Paolisso Giuseppe, 2010, Acta Biomed, V81 Suppl 1, P47; Qiu ZY, 2007, J SURG RES, V138, P64, DOI 10.1016/j.jss.2006.06.034; ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567; Sakaguchi K., 1996, J KYUSHU DENT SOC, V50, P332; Santoro MM, 2005, EXP CELL RES, V304, P274, DOI 10.1016/j.yexcr.2004.10.033; Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145; Sullivan SR, 2007, J DERMATOL SCI, V48, P177, DOI 10.1016/j.jdermsci.2007.07.002; TINOIS E, 1987, ARCH DERMATOL RES, V279, P241, DOI 10.1007/BF00417322; Ueda K, 2010, J WOUND CARE, V19, P295; Usui ML, 2008, J HISTOCHEM CYTOCHEM, V56, P687, DOI 10.1369/jhc.2008.951194; van Westerloo DJ, 2005, AM J PATHOL, V166, P721, DOI 10.1016/S0002-9440(10)62293-6; Yasuoka R., 1990, J OSAKA ODONTOL SOC, V53, P361; Zboralski D, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-215; Zins SR, 2010, ANGIOGENESIS, V13, P293, DOI 10.1007/s10456-010-9186-9	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158647	10.1371/journal.pone.0158647	http://dx.doi.org/10.1371/journal.pone.0158647			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404587	gold, Green Submitted, Green Published			2022-12-26	WOS:000379508200013
J	Wheeler, GM; Sweeting, MJ; Mander, AP				Wheeler, Graham M.; Sweeting, Michael J.; Mander, Adrian P.			AplusB: A Web Application for Investigating A plus B Designs for Phase I Cancer Clinical Trials	PLOS ONE			English	Article							CONTINUAL REASSESSMENT METHOD; ONCOLOGY	In phase I cancer clinical trials, the maximum tolerated dose of a new drug is often found by a dose-escalation method known as the A + B design. We have developed an interactive web application, AplusB, which computes and returns exact operating characteristics of A + B trial designs. The application has a graphical user interface (GUI), requires no programming knowledge and is free to access and use on any device that can open an internet browser. A customised report is available for download for each design that contains tabulated operating characteristics and informative plots, which can then be compared with other dose-escalation methods. We present a step-by-step guide on how to use this application and provide several illustrative examples of its capabilities.	[Wheeler, Graham M.; Mander, Adrian P.] Cambridge Inst Publ Hlth, MRC Biostat Unit Hub Trials Methodol Res, Cambridge, England; [Wheeler, Graham M.] UCL, Canc Res UK & UCL Canc Trials Ctr, London, England; [Sweeting, Michael J.] Univ Cambridge, Strangeways Res Lab, Cardiovasc Epidemiol Unit, Cambridge, England	MRC Biostatistics Unit; University of Cambridge; Cancer Research UK; University of London; University College London; University of Cambridge	Wheeler, GM (corresponding author), Cambridge Inst Publ Hlth, MRC Biostat Unit Hub Trials Methodol Res, Cambridge, England.; Wheeler, GM (corresponding author), UCL, Canc Res UK & UCL Canc Trials Ctr, London, England.	graham.wheeler@ucl.ac.uk	Sweeting, Michael John/U-3917-2019	Sweeting, Michael John/0000-0003-0980-8965	UK Medical Research Council [G0800860, MR/L003120/1]; European Research Council Advanced Investigator Award: EPIC-Heart [268834]; British Heart Foundation; Cambridge National Institute for Health Research Biomedical Research Centre; MRC [MC_UP_1302/2, MR/L003120/1, MC_UU_00002/3] Funding Source: UKRI; Medical Research Council [MR/L003120/1, MC_UU_00002/3, MC_UP_1302/2] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council Advanced Investigator Award: EPIC-Heart; British Heart Foundation(British Heart Foundation); Cambridge National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GMW and APM are supported by the UK Medical Research Council (www.mrc.ac.uk; grant number G0800860). MJS is supported by a European Research Council Advanced Investigator Award: EPIC-Heart (https://erc.europa.eu; grant number 268834), the UK Medical Research Council (grant number MR/L003120/1), the British Heart Foundation (www.bhf.org.uk), and the Cambridge National Institute for Health Research Biomedical Research Centre (http://www.cambridge-brc.org.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Babb JS, 2004, ADV CLIN TRIAL BIOST, P1; Carter SK, 1973, DESIGN CLIN TRIALS C, P242; Chang W, 2015, WEB APPLICATION FRAM; Chen ZJ, 2009, CONTEMP CLIN TRIALS, V30, P123, DOI 10.1016/j.cct.2008.10.006; Chiuzan C, 2015, CLIN TRIALS, V12, P24, DOI 10.1177/1740774514555585; Dignam J, 2006, ONCOLOGY EVIDENCE BA, P112; Gonen M, 2009, CLIN TRIALS, V6, P203, DOI 10.1177/1740774509105374; He W, 2014, METHODS AND APPLICAT, V1, P40; Iasonos A, 2008, CLIN TRIALS, V5, P465, DOI 10.1177/1740774508096474; Iasonos A, 2012, CLIN CANCER RES, V18, P5179, DOI 10.1158/1078-0432.CCR-12-0726; Jaki T, 2013, CLIN TRIALS, V10, P344, DOI 10.1177/1740774512474375; Ji Y, 2013, J CLIN ONCOL, V31, P1785, DOI 10.1200/JCO.2012.45.7903; Kang SH, 2001, DRUG INF J, V35, P1189, DOI 10.1177/009286150103500416; Le Tourneau C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051039; Le Tourneau C, 2009, JNCI-J NATL CANCER I, V101, P708, DOI 10.1093/jnci/djp079; Lin Y, 2001, Biostatistics, V2, P203, DOI 10.1093/biostatistics/2.2.203; National Cancer Institute, 2016, DICTIONARY OF CANCER; NCI, 2009, COMMON TOXICITY CRIT; O'Quigley J, 2006, BRIT J CANCER, V94, P609, DOI 10.1038/sj.bjc.6602969; Onar A, 2009, J BIOPHARM STAT, V19, P437, DOI 10.1080/10543400902800486; Onar-Thomas A, 2010, CONTEMP CLIN TRIALS, V31, P259, DOI 10.1016/j.cct.2010.03.006; Penel Nicolas, 2009, Invest New Drugs, V27, P552, DOI 10.1007/s10637-008-9213-5; Reiner E, 1999, COMPUT STAT DATA AN, V30, P303, DOI 10.1016/S0167-9473(98)00095-4; Rogatko A, 2007, J CLIN ONCOL, V25, P4982, DOI 10.1200/JCO.2007.12.1012; Skolnik JM, 2008, J CLIN ONCOL, V26, P190, DOI 10.1200/JCO.2007.12.7712; STORER BE, 1989, BIOMETRICS, V45, P925, DOI 10.2307/2531693; Sweeting M, 2013, J STAT SOFTW, V54, DOI 10.18637/jss.v054.i13; Yuan Y, 2011, STAT MED, V30, P2098, DOI 10.1002/sim.4164	29	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159026	10.1371/journal.pone.0159026	http://dx.doi.org/10.1371/journal.pone.0159026			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403961	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508200030
J	Giallongo, C; Romano, A; Parrinello, NL; La Cava, P; Brundo, MV; Bramanti, V; Stagno, F; Vigneri, P; Chiarenza, A; Palumbo, GA; Tibullo, D; Di Raimondo, F				Giallongo, Cesarina; Romano, Alessandra; Parrinello, Nunziatina Laura; La Cava, Piera; Brundo, Maria Violetta; Bramanti, Vincenzo; Stagno, Fabio; Vigneri, Paolo; Chiarenza, Annalisa; Palumbo, Giuseppe Alberto; Tibullo, Daniele; Di Raimondo, Francesco			Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; IMMUNE-SYSTEM; T-CELLS; TUMOR-GROWTH; EXPRESSION; IMATINIB; INDUCE; CML; MICROENVIRONMENT	It is well known that mesenchymal stem cells (MSC) have a role in promotion of tumor growth, survival and drug-resistance in chronic myeloid leukemia (CML). Recent reports indicated that a subpopulation of myeloid cells, defined as granulocyte-like myeloid-derived suppressor cells (G-MDSC) is increased in these patients. So far, the role of MSC in MDSC expansion and activation into the BM microenvironment remains unexplored. To address this question, here we use a specific experimental model in vitro, co-culturing MSC with peripheral blood mononucleated cells (PBMC) from normal individuals, in order to generate MSC-educated G-MDSC. Although MSC of healthy donors (HD) and CML patients were able to generate the same amount of MDSC, only CML-MSC-educated G-MDSC exhibited suppressive ability on autologous T lymphocytes. In addition, compared with HD-MSC, CML-MSC over-expressed some immunomodulatory factors including TGF beta, IL6 and IL10, that could be involved in MDSC activation. CML-MSC-educated G-MDSC expressed higher levels of ARG1, TNF alpha, IL1 beta, COX2 and IL6 than G-MDSC isolated from co-culture with HD-MSC. Our data provide evidence that CML-MSC may play a critical role in tumor microenvironment by orchestrating G-MDSC activation and regulating T lymphocytes-mediated leukemia surveillance, thus contributing to CML immune escape.	[Giallongo, Cesarina; Romano, Alessandra; Parrinello, Nunziatina Laura; La Cava, Piera; Stagno, Fabio; Chiarenza, Annalisa; Palumbo, Giuseppe Alberto; Tibullo, Daniele; Di Raimondo, Francesco] Univ Catania, AOU Policlin OVE, Div Hematol, Catania, Italy; [Giallongo, Cesarina; Bramanti, Vincenzo] Univ Catania, Dept Biomed & Biotechnol Sci, Catania, Italy; [Brundo, Maria Violetta; Tibullo, Daniele] Univ Catania, Dept Biol Geol & Environm Sci, Catania, Italy; [Vigneri, Paolo] Univ Catania, Dept Clin & Expt Med, Oncol, Catania, Italy	University of Catania; University of Catania; University of Catania; University of Catania	Tibullo, D (corresponding author), Univ Catania, AOU Policlin OVE, Div Hematol, Catania, Italy.; Tibullo, D (corresponding author), Univ Catania, Dept Biol Geol & Environm Sci, Catania, Italy.	d.tibullo@unict.it	Giallongo, Cesarina/J-7225-2016; Romano, Alessandra/I-9201-2012; Stagno, Fabio/AAH-2033-2020; Palumbo, Giuseppe/W-7072-2019; Chiarenza, Annalisa/AAC-2013-2019; TIBULLO, Daniele/AAC-1276-2019; Bramanti, Vincenzo/L-8828-2019; Di Raimondo, Francesco/K-7965-2016; Brundo, Maria Violetta/Q-4354-2016; VIGNERI, Paolo/K-8504-2016	Giallongo, Cesarina/0000-0002-7667-6088; Romano, Alessandra/0000-0002-6333-4433; Stagno, Fabio/0000-0002-7947-158X; Palumbo, Giuseppe/0000-0003-1859-6319; Chiarenza, Annalisa/0000-0002-8759-4854; TIBULLO, Daniele/0000-0002-4416-8556; Di Raimondo, Francesco/0000-0002-7749-0293; Brundo, Maria Violetta/0000-0001-5146-3564; Bramanti, Vincenzo/0000-0002-9380-8062; VIGNERI, Paolo/0000-0002-5943-6066	A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania; FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue)	A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania; FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue)	This study has been supported in part by A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania and by FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study has been supported in part by A.I.L. (Associazione Italiana contro le Leucemie) sezione di Catania and by FON.CA.NE.SA. (Fondazione Catanese per lo Studio delle Malattie Neoplastiche del Sangue).	Botta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00348; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Carrara RCV, 2007, BRAZ J MED BIOL RES, V40, P57, DOI 10.1590/S0100-879X2006005000055; Chen MF, 2014, ONCOTARGET, V5, P8716, DOI 10.18632/oncotarget.2368; Christiansson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055818; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gallina G, 2006, J CLIN INVEST, V116, P2777, DOI 10.1172/JCI28828; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Giallongo C, 2011, ACTA HAEMATOL-BASEL, V126, P205, DOI 10.1159/000329911; Giallongo C., 2016, ONCOTARGET; Giallongo C, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00107; Giallongo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101848; Giallongo C, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-60; Giallongo C, 2011, EUR J HAEMATOL, V86, P216, DOI 10.1111/j.1600-0609.2010.01570.x; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Han ZP, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-8; Hass R, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-26; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Lechner MG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-90; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Mougiakakos D, 2011, BLOOD, V117, P4826, DOI 10.1182/blood-2010-12-324038; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2012, SEMIN CANCER BIOL, V22, P282, DOI 10.1016/j.semcancer.2012.01.010; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Poggi A, 2014, IMMUNOL LETT, V159, P55, DOI 10.1016/j.imlet.2014.03.001; Rodriguez PC, 2005, J EXP MED, V202, P931, DOI 10.1084/jem.20050715; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Sanchez N, 2014, CELL IMMUNOL, V289, P174, DOI 10.1016/j.cellimm.2014.04.007; Serafini P, 2008, CANCER RES, V68, P5439, DOI 10.1158/0008-5472.CAN-07-6621; Soleymaninejadian E, 2012, AM J REPROD IMMUNOL, V67, P1, DOI 10.1111/j.1600-0897.2011.01069.x; Tibullo D, 2012, HEMATOL ONCOL, V30, P27, DOI 10.1002/hon.988; Vanella L, 2011, PROSTAG OTH LIPID M, V96, P54, DOI 10.1016/j.prostaglandins.2011.07.005; Wang GY, 2013, CELL BIOL INT, V37, P137, DOI 10.1002/cbin.10024; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Yu JP, 2014, J IMMUNOL, V193, P2574, DOI 10.4049/jimmunol.1400833; Zhang B, 2012, CANCER CELL, V21, P577, DOI 10.1016/j.ccr.2012.02.018; Zhu XS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-47	44	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158392	10.1371/journal.pone.0158392	http://dx.doi.org/10.1371/journal.pone.0158392			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391078	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400053
J	Ryzak, M; Bieganowski, A; Korbiel, T				Ryzak, Magdalena; Bieganowski, Andrzej; Korbiel, Tomasz			Sound Wave Energy Resulting from the Impact of Water Drops on the Soil Surface	PLOS ONE			English	Article							RAINDROP IMPACT; SIZE DISTRIBUTIONS; LASER DIFFRACTION; SINGLE WATERDROP; SPLASH EROSION; KINETIC-ENERGY; DETACHMENT; EROSIVITY; QUANTIFICATION; MOMENTUM	The splashing of water drops on a soil surface is the first step of water erosion. There have been many investigations into splashing-most are based on recording and analysing images taken with high-speed cameras, or measuring the mass of the soil moved by splashing. Here, we present a new aspect of the splash phenomenon's characterization the measurement of the sound pressure level and the sound energy of the wave that propagates in the air. The measurements were carried out for 10 consecutive water drop impacts on the soil surface. Three soils were tested (Endogleyic Umbrisol, Fluvic Endogleyic Cambisol and Haplic Chernozem) with four initial moisture levels (pressure heads: 0.1 kPa, 1 kPa, 3.16 kPa and 16 kPa). We found that the values of the sound pressure and sound wave energy were dependent on the particle size distribution of the soil, less dependent on the initial pressure head, and practically the same for subsequent water drops (from the first to the tenth drop). The highest sound pressure level (and the greatest variability) was for Endogleyic Umbrisol, which had the highest sand fraction content. The sound pressure for this soil increased from 29 dB to 42 dB with the next incidence of drops falling on the sample The smallest (and the lowest variability) was for Fluvic Endogleyic Cambisol which had the highest clay fraction. For all experiments the sound pressure level ranged from similar to 27 to similar to 42 dB and the energy emitted in the form of sound waves was within the range of 0.14 mu J to 5.26 mu J. This was from 0.03 to 1.07% of the energy of the incident drops.	[Ryzak, Magdalena; Bieganowski, Andrzej] Polish Acad Sci, Inst Agrophys, Doswiadczalna 4, PL-20290 Lublin, Poland; [Korbiel, Tomasz] AGH Univ Sci & Technol, Dept Mech & Vibroacoust, Krakow, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences; AGH University of Science & Technology	Bieganowski, A (corresponding author), Polish Acad Sci, Inst Agrophys, Doswiadczalna 4, PL-20290 Lublin, Poland.	a.bieganowski@ipan.lublin.pl		Bieganowski, Andrzej/0000-0002-3571-3241; Korbiel, Tomasz/0000-0003-0783-6348; Ryzak, Magdalena/0000-0002-6400-5375	National Science Centre, Poland in the frame of project [2014/14/E/ST10/00851]; Statutory Research of Institute of Agrophysics Polish Academy of Sciences; Statutory Research of Department of Mechanics and Vibroacoustics University of Science and Technology Krakow [11.11.130.955]	National Science Centre, Poland in the frame of project; Statutory Research of Institute of Agrophysics Polish Academy of Sciences; Statutory Research of Department of Mechanics and Vibroacoustics University of Science and Technology Krakow	This work was partly financed from: 1) National Science Centre, Poland in the frame of project no. 2014/14/E/ST10/00851; 2) Statutory Research of Institute of Agrophysics Polish Academy of Sciences; and 3) Statutory Research of Department of Mechanics and Vibroacoustics University of Science and Technology Krakow No. 11.11.130.955. The authors declare that all the funding or sources of support (whether external or internal) were listed and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2013, EARTH SURF PROC LAND, V38, P1225, DOI 10.1002/esp.3364; ALDURRAH M, 1981, SOIL SCI SOC AM J, V45, P949, DOI 10.2136/sssaj1981.03615995004500050026x; ALDURRAH MM, 1982, SOIL SCI SOC AM J, V46, P1086, DOI 10.2136/sssaj1982.03615995004600050040x; Angulo-Martinez M, 2012, GEOMORPHOLOGY, V175, P38, DOI 10.1016/j.geomorph.2012.06.016; [Anonymous], 1972, J APPL METEOROL; Assouline S, 1997, COLLOID SURFACE A, V127, P201, DOI 10.1016/S0927-7757(97)00144-1; Bieganowski A, 2013, INT AGROPHYS, V27, P335, DOI 10.2478/intag-2013-0003; Bochet E, 2002, Z GEOMORPHOL, V46, P223; BRADFORD JM, 1986, SOIL SCI SOC AM J, V50, P1547, DOI 10.2136/sssaj1986.03615995005000060033x; EPEMA GF, 1983, CATENA, P1; Furbish DJ, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000498; Ghadiri H, 2004, EARTH SURF PROC LAND, V29, P77, DOI 10.1002/esp.1014; GHADIRI H, 1988, J SOIL SCI, V39, P563, DOI 10.1111/j.1365-2389.1988.tb01240.x; Glab T, 2009, GEODERMA, V149, P298, DOI 10.1016/j.geoderma.2008.12.007; Goebes P, 2014, J HYDROL, V517, P310, DOI 10.1016/j.jhydrol.2014.05.031; Jager H, 2015, CATENA, V128, P63, DOI 10.1016/j.catena.2015.01.018; Legout C, 2005, GEODERMA, V124, P279, DOI 10.1016/j.geoderma.2004.05.006; Lipiec J, 2003, GEODERMA, V116, P107, DOI 10.1016/S0016-7061(03)00097-1; Long EJ, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032201; Mouzai L, 2011, EARTH SURF PROC LAND, V36, P87, DOI 10.1002/esp.2021; Mouzai L, 2003, J HYDRAUL RES, V41, P61, DOI 10.1080/00221680309499929; NEARING MA, 1985, SOIL SCI SOC AM J, V49, P547, DOI 10.2136/sssaj1985.03615995004900030003x; Poesen J., 1988, Catena Supplement, P113; Polakowski C, 2015, SOIL SCI SOC AM J, V79, P30, DOI 10.2136/sssaj2013.07.0286n; Polakowski C, 2014, INT AGROPHYS, V28, P195, DOI 10.2478/intag-20014-0008; PROSPERETTI A, 1993, ANNU REV FLUID MECH, V25, P577, DOI 10.1146/annurev.fl.25.010193.003045; Pumphrey H. C., 1988, European Journal of Physics, V9, P225, DOI 10.1088/0143-0807/9/3/011; Rejman J, 2014, SOIL TILL RES, V143, P77, DOI 10.1016/j.still.2014.05.011; Ryzak M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119269; Ryzak M, 2012, SENSORS-BASEL, V12, P11527, DOI 10.3390/s120911527; Salles C, 2000, WATER RESOUR RES, V36, P2721, DOI 10.1029/2000WR900024; SHARMA PP, 1989, SOIL SCI SOC AM J, V53, P1005, DOI 10.2136/sssaj1989.03615995005300040003x; Torri D., 1988, CATENA, V12, P127; Wysocka-Czubaszek Agnieszka, 2014, Polish Journal of Soil Science, V47, P1	34	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158472	10.1371/journal.pone.0158472	http://dx.doi.org/10.1371/journal.pone.0158472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388276	gold, Green Published, Green Submitted			2022-12-26	WOS:000379811500022
J	Choi, AYJ; Nivison-Smith, L; Khuu, SK; Kalloniatis, M				Choi, Agnes Yiu Jeung; Nivison-Smith, Lisa; Khuu, Sieu K.; Kalloniatis, Michael			Determining Spatial Summation and Its Effect on Contrast Sensitivity across the Central 20 Degrees of Visual Field	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; PROBABILITY SUMMATION; MACULAR DEGENERATION; PROJECTION PERIMETRY; LAYER THICKNESS; HUMAN-VISION; TEST OBJECT; LUMINANCE; DAMAGE; AREA	Purpose Recent studies propose that the use of target stimuli within or close to complete spatial summation reveal larger threshold elevation in ocular disease. The Humphrey Visual Field Analyzer (HFA) is used to assess visual function yet the spatial summation characteristics are unexplored for the central macular region. We therefore wanted to establish the relationship between contrast sensitivity and stimulus size (spatial summation) within the central 20 degrees visual field using the high sampling density of the 10-2 test grid. Methods Thresholds were measured for one eye from 37 normal subjects using the HFA 10-2 test grid with all five Goldmann (G) targets (GI to GV). Subject data were converted to 50-year-old equivalent using published and calculated location-specific decade correction factors. Spatial summation curves were fitted for all data at all locations. The size of Ricco's critical area (Ac) within which complete spatial summation operates (k = 1), and the slope of partial summation (k < 1: to characterize partial summation), was established. Results The 50-year-old age normative data were determined for all Goldmann stimulus sizes for the 10-2 HFA test grid and showed a marked change in contrast sensitivity for small test stimuli (e.g. GI) and little change in larger test stimuli (e.g. GV). Both the Ac and k values did not vary with age allowing for the application of the age correction factors. Ac and k values increased with eccentricity with GI remaining within complete spatial summation and GII was close or within complete spatial summation. GIII or larger test sizes were always outside complete spatial summation operating within various levels of partial summation. Conclusions The developed normative data now allows comparisons of data sets with high sampling density using the 10-2 grid irrespective of subject age. Test size is important when assessing ocular disease yet only GI or GII stimuli operate close to or within complete spatial summation in the macula. Current visual field testing protocols employ GIII which is always outside complete spatial summation and operates under various values of partial summation: GIII may not be the most suitable test size to assess ocular disease affecting the macula.	[Choi, Agnes Yiu Jeung; Nivison-Smith, Lisa; Kalloniatis, Michael] Univ New South Wales, Ctr Eye Hlth, Kensington, NSW, Australia; [Choi, Agnes Yiu Jeung; Nivison-Smith, Lisa; Khuu, Sieu K.; Kalloniatis, Michael] Univ New South Wales, Sch Optometry & Vis Sci, Kensington, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Kalloniatis, M (corresponding author), Univ New South Wales, Ctr Eye Hlth, Kensington, NSW, Australia.; Kalloniatis, M (corresponding author), Univ New South Wales, Sch Optometry & Vis Sci, Kensington, NSW, Australia.	m.kalloniatis@unsw.edu.au	Choi, Agnes Yiu Jeung/AAZ-3484-2020; Khuu, Sieu/N-7957-2019; Nivison-Smith, Lisa/H-3297-2019	Khuu, Sieu/0000-0003-1850-0225; Nivison-Smith, Lisa/0000-0001-6677-1949; Kalloniatis, Michael/0000-0002-5264-4639	University of New South Wales (Early Career Research Grant) [P535430]; University of New South Wales (Australian Postgraduate Award); National Health and Medical Research Council (NHMRC) [1033224]	University of New South Wales (Early Career Research Grant); University of New South Wales (Australian Postgraduate Award); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported, in part, by grants and awards from the University of New South Wales (Early Career Research Grant 2015 #P535430, an Australian Postgraduate Award) and a National Health and Medical Research Council (NHMRC) grant (#1033224). The Centre for Eye Health is an initiative between UNSW Australia and Guide Dogs NSW/ACT. Guide Dogs NSW/ACT is also a partner on the NHMRC grant and provides a supplementary PhD scholarship for AC and support for LN-S. The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton JH, 2012, INVEST OPHTH VIS SCI, V53, P7618, DOI 10.1167/iovs.12-10361; Acton JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039944; Anderson RS, 2006, PROG RETIN EYE RES, V25, P79, DOI 10.1016/j.preteyeres.2005.06.001; BARLOW HB, 1958, J PHYSIOL-LONDON, V141, P337, DOI 10.1113/jphysiol.1958.sp005978; Bosworth C F, 2000, Semin Ophthalmol, V15, P172, DOI 10.3109/08820530009037869; Centofanti M, 2005, OPHTHALMOLOGY, V112, P366, DOI 10.1016/j.ophtha.2004.11.030; Cubbidge RP, 2005, VISUAL FIELDS; Cukras C, 2015, OPHTHALMOLOGY, V122, P356, DOI 10.1016/j.ophtha.2014.07.056; Davson H., 1990, PHYSL EYE; Garway-Heath DF, 2000, INVEST OPHTH VIS SCI, V41, P1774; GLEZER V. D., 1965, VISION RES, V5, P497, DOI 10.1016/0042-6989(65)90084-2; GOLDMANN H, 1945, OPHTHALMOLOGICA, V109, P57, DOI 10.1159/000300224; HEIJL A, 1987, ARCH OPHTHALMOL-CHIC, V105, P1544; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Heijl A, 2012, FIELD ANAL PRIMER EF; Hood DC, 2014, INVEST OPHTH VIS SCI, V55, P632, DOI 10.1167/iovs.13-13130; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; JAFFE GJ, 1986, ARCH OPHTHALMOL-CHIC, V104, P1021; Jampel HD, 2011, OPHTHALMOLOGY, V118, P986, DOI 10.1016/j.ophtha.2011.03.019; Jivrajka RV, 2013, EYE, V27, P1044, DOI 10.1038/eye.2013.112; Kalloniatis M, 2016, ASS RES VISION OPHTH; Kalloniatis M, 2016, OPHTHAL PHYSL OPT, V36, P439, DOI 10.1111/opo.12295; Kaplan E., 1990, Progress in Retinal Research, V9, P273, DOI 10.1016/0278-4327(90)90009-7; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Khuu SK, 2015, INVEST OPHTH VIS SCI, V56, P3565, DOI 10.1167/iovs.14-15606; Khuu SK, 2015, J VISION, V15, DOI 10.1167/15.1.6; LEGGE GE, 1978, VISION RES, V18, P959, DOI 10.1016/0042-6989(78)90024-X; Malik R, 2012, CLIN EXP OPHTHALMOL, V40, P369, DOI 10.1111/j.1442-9071.2012.02770.x; Meese TS, 2000, VISION RES, V40, P2101, DOI 10.1016/S0042-6989(00)00074-2; Ohkubo S, 2014, INVEST OPHTHALMOL, V55, P5269; Omodaka K, 2013, JPN J OPHTHALMOL, V57, P457, DOI 10.1007/s10384-013-0258-4; Pan F, 2006, J VISION, V6, P1159, DOI 10.1167/6.11.2; Park SC, 2013, OPHTHALMOLOGY, V120, P1546, DOI 10.1016/j.ophtha.2013.01.045; PERRY VH, 1984, NEUROSCIENCE, V12, P1125, DOI 10.1016/0306-4522(84)90007-1; Rao HL, 2015, INVEST OPHTH VIS SCI, V56, P3883, DOI 10.1167/iovs.15-16943; Raza AS, 2015, INVEST OPHTH VIS SCI, V56, P2254, DOI 10.1167/iovs.14-15952; Redmond T., 2011, OPTOM PRACT, V12, P11; Redmond T, 2013, OPTOMETRY VISION SCI, V90, P66, DOI 10.1097/OPX.0b013e318278fc2b; Redmond T, 2010, INVEST OPHTH VIS SCI, V51, P6540, DOI 10.1167/iovs.10-5718; Ricco A., 1877, ANNALI OTTALMOLOGIA, V6, P373; ROBSON JG, 1981, VISION RES, V21, P409, DOI 10.1016/0042-6989(81)90169-3; Schiefer U, 2010, INVEST OPHTH VIS SCI, V51, P5685, DOI 10.1167/iovs.09-5067; SLOAN LL, 1961, VISION RES, V1, P121, DOI 10.1016/0042-6989(61)90024-4; SLOAN LL, 1962, VISION RES, V2, P527, DOI 10.1016/0042-6989(62)90053-6; Swanson WH, 2004, INVEST OPHTH VIS SCI, V45, P466, DOI 10.1167/iovs.03-0374; Swanson WH, 2013, INVESTIGATIVE OPHTHA, V54; TOLENTINO MJ, 1994, VISION RES, V34, P409, DOI 10.1016/0042-6989(94)90099-X; Traynis I, 2014, JAMA OPHTHALMOL, V132, P291, DOI 10.1001/jamaophthalmol.2013.7656; Wall M, 1997, INVEST OPHTH VIS SCI, V38, P426; Weinreb RN, 2009, INVEST OPHTH VIS SCI, V50, P1497, DOI 10.1167/iovs.08-2843; WILSON ME, 1970, J PHYSIOL-LONDON, V207, P611, DOI 10.1113/jphysiol.1970.sp009083	51	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158263	10.1371/journal.pone.0158263	http://dx.doi.org/10.1371/journal.pone.0158263			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384954	Green Published, gold			2022-12-26	WOS:000379809400040
J	Choi, HY; Ko, ES; Han, BK; Kim, EJ; Kim, SM; Lim, Y; Kim, RB				Choi, Hye Young; Ko, Eun Sook; Han, Boo-Kyung; Kim, Eun Ju; Kim, Sun Mi; Lim, Yaeji; Kim, Rock Bum			Prognostic Significance of Transverse Relaxation Rate (R2*) in Blood Oxygenation Level-Dependent Magnetic Resonance Imaging in Patients with Invasive Breast Cancer	PLOS ONE			English	Article							DUCTAL CARCINOMA; HUMAN TUMORS; PREDICTIVE-VALUE; BOLD CONTRAST; HYPOXIA; MRI; EXPRESSION; CHEMOTHERAPY; PARAMETERS; THERAPY	Objective To examine the relationship between magnetic resonance transverse relaxation rate (R2*) and prognostic factors. Materials and Methods A total of 159 women with invasive ductal carcinomas (IDCs) underwent breast magnetic resonance imaging (MRI) including blood oxygenation level-dependent (BOLD) sequence at 3 T. The distribution of the measured R2* values were analyzed, and the correlation between R2* and various prognostic factors (age, tumor size, histologic grade, lymphovascular invasion, and axillary lymph node status, as well as expression of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, p53, and Ki-67) were retrospectively assessed using patient medical records. Results The baseline R2* values of the IDCs were very heterogeneous with wide range among the patients. The mean R2* value was (32.8 +/- 14.0) Hz with a median of 29.3 Hz (range 13.5-109.4 Hz). In multivariate analysis, older age was associated with decreased R2* value (P = 0.011) and IDCs with p53-overexpression showed higher R2* values than those without p53-overexpression group (P = 0.031). Other prognostic factors were not significantly correlated with R2* value. Conclusion In this study, R2* values were significantly correlated with age and expression of p53. Further studies are necessary to determine the prognostic value of BOLD-MRI.	[Choi, Hye Young] Gyeongsang Natl Univ Hosp, Dept Radiol, Jinju, South Korea; [Choi, Hye Young] Grad Sch Med, Jinju, South Korea; [Ko, Eun Sook; Han, Boo-Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea; [Kim, Eun Ju] Philips Healthcare Korea, Dept Clin Sci, MR, Seoul, South Korea; [Kim, Sun Mi] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea; [Lim, Yaeji] Samsung Med Ctr, Biostat & Clin Epidemiol Ctr, Seoul, South Korea; [Kim, Rock Bum] Gyeongsang Natl Univ Hosp, Reg Cardiocerebrovasc Ctr, Jinju, South Korea	Gyeongsang National University; Gyeongsang National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Philips; Philips Healthcare; Seoul National University (SNU); Sungkyunkwan University (SKKU); Samsung Medical Center; Gyeongsang National University; Gyeongsang National University Hospital	Ko, ES (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea.	mathilda0330@gmail.com			Philips Healthcare Korea	Philips Healthcare Korea	Philips Healthcare Korea provided support by way of salary to EJK. The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussink J, 2003, RADIOTHER ONCOL, V67, P3, DOI 10.1016/S0167-8140(03)00011-2; El Khouli RH, 2010, RADIOLOGY, V256, P64, DOI 10.1148/radiol.10091367; Fischer DR, 2005, EUR RADIOL, V15, P829, DOI 10.1007/s00330-004-2484-0; Gennari R, 2004, CANCER-AM CANCER SOC, V101, P1302, DOI 10.1002/cncr.20535; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Jatoi I, 1999, J CLIN ONCOL, V17, P2334, DOI 10.1200/JCO.1999.17.8.2334; Jiang L, 2013, J MAGN RESON IMAGING, V37, P1083, DOI 10.1002/jmri.23891; Kim HS, 2010, BREAST CANCER RES TR, V121, P777, DOI 10.1007/s10549-009-0560-5; Kim JY, 2015, MAGN RESON IMAGING, V33, P72, DOI 10.1016/j.mri.2014.08.034; Krause BJ, 2006, Q J NUCL MED MOL IM, V50, P28; Kumar R, 2001, SEMIN ONCOL, V28, P27, DOI 10.1016/S0093-7754(01)90279-9; Lee DS, 2011, JPN J CLIN ONCOL, V41, P854, DOI 10.1093/jjco/hyr066; Li SP, 2010, RADIOLOGY, V257, P643, DOI 10.1148/radiol.10100421; Liu M, 2013, EUR RADIOL, V23, P3221, DOI 10.1007/s00330-013-2937-4; McPhail LD, 2010, RADIOLOGY, V254, P110, DOI 10.1148/radiol.2541090395; Ovrebo KM, 2012, RADIOTHER ONCOL, V102, P429, DOI 10.1016/j.radonc.2011.11.013; Padhani A, 2010, RADIOLOGY, V254, P1, DOI 10.1148/radiol.091669; Padhani AR, 2007, EUR RADIOL, V17, P861, DOI 10.1007/s00330-006-0431-y; Padhani AR, 2005, P 13 M ISMRM BERK; Perini R, 2008, CANCER METAST REV, V27, P615, DOI 10.1007/s10555-008-9147-6; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rakow-Penner R, 2010, J MAGN RESON IMAGING, V32, P120, DOI 10.1002/jmri.22227; Robinson SP, 2006, NEW TECHNIQUES ONCOL, P257; Schnitt S J, 2001, J Natl Cancer Inst Monogr, P22; Shin S, 2015, BREAST CANCER RES TR, V149, P751, DOI 10.1007/s10549-015-3278-6; STONE HB, 1993, RADIAT RES, V136, P422, DOI 10.2307/3578556; Taylor NJ, 2001, J MAGN RESON IMAGING, V14, P156, DOI 10.1002/jmri.1166; VAUPEL P, 1991, CANCER RES, V51, P3316; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Xiang L, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-32; Zhang XN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4295; Zhao DW, 2009, MAGN RESON MED, V62, P357, DOI 10.1002/mrm.22020; Zheng LF, 2015, AM J TRANSL RES, V7, P535	33	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158500	10.1371/journal.pone.0158500	http://dx.doi.org/10.1371/journal.pone.0158500			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384310	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400054
J	Huang, LL; Liu, CX; Deng, Y; Liu, YQ; Zhao, JY; Huang, XL; Tang, WJ; Sun, YF; Qin, X; Li, S				Huang, Liling; Liu, Cunxu; Deng, Yan; Liu, Yanqiong; Zhao, Jiangyang; Huang, Xiuli; Tang, Wenjun; Sun, Yifan; Qin, Xue; Li, Shan			Association of Hypoxia-Inducible Factor-2 Alpha Gene Polymorphisms with the Risk of Hepatitis B Virus-Related Liver Disease in Guangxi Chinese: A Case-Control Study	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; HEPATOCELLULAR-CARCINOMA; FACTOR 1-ALPHA; HUMAN CANCER; POPULATION; FACTOR-1-ALPHA; HIF-1-ALPHA; ACTIVATION; EXPRESSION; GROWTH	Objective Hypoxia-inducible factor-2 alpha (HIF-2a) plays a major role in the progression of disease, although the role of HIF-2a gene polymorphisms in hepatitis B virus (HBV)-related diseases remains elusive. The aim of this study is to determine whether HIF-2a rs13419896 and rs6715787 single-nucleotide polymorphisms (SNPs) are associated with susceptibility to chronic hepatitis B (CHB), liver cirrhosis (LC), or hepatocellular carcinoma (HCC). Method A case-control study of 107 patients with CHB, 83 patients with LC, 234 patients with HCC, and 224 healthy control subjects was carried out, and the HIF-2a rs13419896 and rs6715787 SNPs were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results No significant differences were observed in the genotype or allele frequency of two HIF-2a SNPs between the cases and controls (all p>0.05). However, in subgroup analysis by gender, the HIF-2a rs13419896 GA and AA genotypes were significantly associated with a risk of CHB (odds ratio [OR] = 3.565, 95% confidence interval [CI] = 1.123-11.314, p = 0.031 and OR = 12.506, 95% CI = 1.329-117.716, p = 0.027) in females, and the A allele of rs13419896 was associated with a risk of CHB (OR = 2.624, 95% CI = 1.244-5.537, p = 0.011) and LC (OR = 2.351, 95% CI = 1.002-5.518, p = 0.050) in females. The rs6715787 CG genotype polymorphism may contribute to a reduced risk of LC in the Guangxi Zhuang Chinese population (OR = 0.152, 95% CI = 0.028-0.807, p = 0.027), as determined via subgroup analysis by ethnicity. Moreover, binary logistic regression analyses that were adjusted by drinking status indicated that the AA genotype of rs13419896 may contribute to an increased risk of LC in the non-alcohol-drinking population (OR = 3.124, 95% CI = 1.091-8.947, p = 0.034). In haplotype analysis, GG haplotype was significantly associated with a reduced risk of LC (OR = 0.601, 95% CI = 0.419-0.862, p = 0.005). Conclusions The HIF-2a rs13419896 polymorphism is associated with an increased risk of CHB and LC in the Guangxi Chinese population, especially in females and in the non-alcohol-drinking population, while the HIF-2a gene rs6715787 polymorphism is associated with a decreased risk of LC in the Guangxi Zhuang population.	[Huang, Liling; Deng, Yan; Liu, Yanqiong; Zhao, Jiangyang; Huang, Xiuli; Tang, Wenjun; Qin, Xue; Li, Shan] Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China; [Huang, Liling] Longtan Hosp Guangxi Zhuang Autonomous Reg, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China; [Liu, Cunxu] Longtan Hosp Guangxi Zhuang Autonomous Reg, Dept Infect Dis, Liuzhou, Guangxi, Peoples R China; [Sun, Yifan] Guangxi Univ Chinese Med, Affiliated Hosp 3, Dept Clin Lab, Liuzhou, Guangxi, Peoples R China	Guangxi Medical University; Guangxi University of Chinese Medicine	Qin, X; Li, S (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Clin Lab, Nanning, Guangxi, Peoples R China.	qinxue919@126.com; lis8858@126.com			Natural Science Foundation of Guangxi [2012GXNSFAA053088]	Natural Science Foundation of Guangxi(National Natural Science Foundation of Guangxi Province)	This study was supported by grants from the Natural Science Foundation of Guangxi (NO. 2012GXNSFAA053088). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonacopoulou AG, 2011, CELL ONCOL, V34, P381, DOI 10.1007/s13402-011-0038-4; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bhandari T, 2014, INFECT DIS THER, V3, P159, DOI 10.1007/s40121-014-0030-1; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chen ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080337; Ciampa J, 2011, CANCER RES, V71, P3287, DOI 10.1158/0008-5472.CAN-10-2646; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Frede S, 2006, BIOCHEM J, V396, P517, DOI 10.1042/BJ20051839; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Gong J, 2012, HUM MUTAT, V33, P254, DOI 10.1002/humu.21641; Gong L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075094; Guo L, 2015, EXP THER MED, V10, P907, DOI 10.3892/etm.2015.2611; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Harkisoen S, 2012, ANN HEPATOL, V11, P164, DOI 10.1016/S1665-2681(19)31020-8; Henderson J, 2005, HUM GENET, V118, P416, DOI 10.1007/s00439-005-0066-0; Holmquist L, 2006, ADV EXP MED BIOL, V587, P179; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu JL, 2016, ONCOL REP, V35, P1443, DOI 10.3892/or.2015.4480; Huang XM, 2015, GENE, V569, P218, DOI 10.1016/j.gene.2015.05.054; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Iwamoto S, 2014, J THORAC ONCOL, V9, P1709, DOI 10.1097/JTO.0000000000000309; Jia Zhong-zhi, 2011, Chinese Medical Sciences Journal, V26, P158; Karapetsas A, 2011, INT J BIOCHEM CELL B, V43, P1582, DOI 10.1016/j.biocel.2011.07.007; Kondo K, 2001, EXP CELL RES, V264, P117, DOI 10.1006/excr.2000.5139; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Li SS, 2011, HEPAT MON, V11, P821, DOI 10.5812/kowsar.1735143X.771; Liu YQ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0200-8; Loboda A, 2010, MOL CELLS, V29, P435, DOI 10.1007/s10059-010-0067-2; Lofstedt T, 2007, CELL CYCLE, V6, P919, DOI 10.4161/cc.6.8.4133; Lu Y, 2015, GENE, V564, P96, DOI 10.1016/j.gene.2015.03.053; Lu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110061; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; Mo CJ, 2014, ASIAN PAC J CANCER P, V15, P4697, DOI 10.7314/APJCP.2014.15.11.4697; Morgan TR, 2004, GASTROENTEROLOGY, V127, pS87, DOI 10.1053/j.gastro.2004.09.020; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Peng QL, 2013, MOL MED REP, V8, P613, DOI 10.3892/mmr.2013.1558; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Putra AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134496; Qing GL, 2009, CURR OPIN GENET DEV, V19, P60, DOI 10.1016/j.gde.2008.12.001; Rannala B, 2001, Am J Pharmacogenomics, V1, P203, DOI 10.2165/00129785-200101030-00005; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Reddy KR, 2011, PROSTATE, V71, P1796, DOI 10.1002/pros.21397; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2002, INTERNAL MED, V41, P79, DOI 10.2169/internalmedicine.41.79; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Sumbayev VV, 2008, IMMUNOL LETT, V115, P126, DOI 10.1016/j.imlet.2007.10.013; Sun YF, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0184-2; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Te HS, 2010, CLIN LIVER DIS, V14, pvii, DOI DOI 10.1016/J.CLD.2009.11.009]; Arias-Loste MT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/319745; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Xi XE, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0355-3; Zhong H, 1999, CANCER RES, V59, P5830	61	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158241	10.1371/journal.pone.0158241	http://dx.doi.org/10.1371/journal.pone.0158241			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384772	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400039
J	Beck, B; Ham, DJ; Best, SA; Carstairs, GL; Savage, RJ; Straney, L; Caldwell, JN				Beck, Ben; Ham, Daniel J.; Best, Stuart A.; Carstairs, Greg L.; Savage, Robert J.; Straney, Lahn; Caldwell, Joanne N.			Predicting Endurance Time in a Repetitive Lift and Carry Task Using Linear Mixed Models	PLOS ONE			English	Article							HANDLING TASKS; WORK; FREQUENCY; FATIGUE; BACK; PERFORMANCE; STRENGTH; DURATION; MUSCLES; SPINE	Objectives Repetitive manual handling tasks account for a substantial portion of work-related injuries. However, few studies report endurance time in repetitive manual handling tasks. Consequently, there is little guidance to inform expected work time for repetitive manual handling tasks. We aimed to investigate endurance time and oxygen consumption of a repetitive lift and carry task using linear mixed models. Methods Fourteen male soldiers (age 22.4 +/- 4.5 yrs, height 1.78 +/- 0.04 m, body mass 76.3 +/- 10.1 kg) conducted four assessment sessions that consisted of one maximal box lifting session and three lift and carry sessions. The relationships between carry mass (range 17.5-37.5 kg) and the duration of carry, and carry mass and oxygen consumption, were assessed using linear mixed models with random effects to account for between-subject variation. Results Results demonstrated that endurance time was inversely associated with carry mass (R-2 = 0.24), with significant individual-level variation (R-2 = 0.85). Normalising carry mass to performance in a maximal box lifting test improved the prediction of endurance time (R-2 = 0.40). Oxygen consumption presented relative to total mass (body mass, external load and carried mass) was not significantly related to lift and carry mass (beta(1) = 0.16, SE = 0.10, 95% CI: -0.04, 0.36, p = 0.12), indicating that there was no change in oxygen consumption relative to total mass with increasing lift and carry mass. Conclusion Practically, these data can be used to guide work-rest schedules and provide insight into methods assessing the physical capacity of workers conducting repetitive manual handling tasks.	[Beck, Ben; Ham, Daniel J.; Best, Stuart A.; Carstairs, Greg L.; Savage, Robert J.] Def Sci & Technol Grp, Land Div, Fishermans Bend, Australia; [Beck, Ben; Straney, Lahn] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Caldwell, Joanne N.] Univ Wollongong, Fac Hlth & Behav Sci, Ctr Human & Appl Physiol, Wollongong, NSW, Australia	Defence Science & Technology; Monash University; University of Wollongong	Beck, B (corresponding author), Def Sci & Technol Grp, Land Div, Fishermans Bend, Australia.; Beck, B (corresponding author), Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	ben.beck@monash.edu	Beck, Ben/ABD-5556-2020	Beck, Ben/0000-0003-3262-5956; Ham, Daniel/0000-0002-4552-8373; Caldwell Odgers, Joanne Nellie/0000-0002-5359-2455				Beck B., 2015, ERGONOMICS IN PRESS; Beck B, 2016, APPL ERGON, V55, P124, DOI 10.1016/j.apergo.2016.02.002; Bernard B., 1997, MUSCULOSKELETAL DISO; Best SA, 2011, 2 INT C SOLD PHYS PE; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bonato P, 2002, IEEE T NEUR SYS REH, V10, P38, DOI 10.1109/TNSRE.2002.1021585; Choobineh A, 2007, J OCCUP HEALTH, V49, P418, DOI 10.1539/joh.49.418; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Dempsey PG, 1998, ERGONOMICS, V41, P73, DOI 10.1080/001401398187332; Dolan P, 1998, J BIOMECH, V31, P713, DOI 10.1016/S0021-9290(98)00086-4; GENAIDY AM, 1993, ERGONOMICS, V36, P509, DOI 10.1080/00140139308967909; GENAIDY AM, 1989, ERGONOMICS, V32, P51, DOI 10.1080/00140138908966067; Kemp PA, 2010, AM J PREV MED, V38, pS148, DOI 10.1016/j.amepre.2009.10.011; KRUEGER GP, 1989, WORK STRESS, V3, P129, DOI 10.1080/02678378908256939; LEGG SJ, 1985, ERGONOMICS, V28, P309, DOI 10.1080/00140138508963138; LEGG SJ, 1981, ERGONOMICS, V24, P907, DOI 10.1080/00140138108924913; Lotters F, 2003, SCAND J WORK ENV HEA, V29, P431; Mamansari DU, 1996, APPL ERGON, V27, P53, DOI 10.1016/0003-6870(95)00055-0; Marras WS, 2006, CLIN BIOMECH, V21, P345, DOI 10.1016/j.clinbiomech.2005.10.004; PANDOLF KB, 1977, J APPL PHYSIOL, V43, P577, DOI 10.1152/jappl.1977.43.4.577; Savage RJ, 2014, J STRENGTH COND RES, V28, P767, DOI 10.1519/JSC.0b013e3182a364a6; Sawka M, 2003, 507AFPAM48152ITBMED5; SNOOK SH, 1991, ERGONOMICS, V34, P1197, DOI 10.1080/00140139108964855; Sparto PJ, 1997, J ORTHOP SPORT PHYS, V25, P3, DOI 10.2519/jospt.1997.25.1.3; YATES JW, 1980, ERGONOMICS, V23, P37, DOI 10.1080/00140138008924716; ZHU ZX, 1990, ERGONOMICS, V33, P875, DOI 10.1080/00140139008925295	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158418	10.1371/journal.pone.0158418	http://dx.doi.org/10.1371/journal.pone.0158418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3JE	27379902	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700029
J	Oliveira, MP; Soares, JBRC; Oliveira, MF				Oliveira, Matheus P.; Correa Soares, Juliana B. R.; Oliveira, Marcus F.			Sexual Preferences in Nutrient Utilization Regulate Oxygen Consumption and Reactive Oxygen Species Generation in Schistosoma mansoni: Potential Implications for Parasite Redox Biology	PLOS ONE			English	Article							EXTENDS LIFE-SPAN; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; CAENORHABDITIS-ELEGANS; ENERGY-METABOLISM; ENZYMATIC CHARACTERIZATION; CARBOHYDRATE-METABOLISM; INTERMEDIATE PRODUCTION; PARAGONIMUS-WESTERMANI; SUPEROXIDE-PRODUCTION	Schistosoma mansoni, one of the causative agents of human schistosomiasis, has a unique antioxidant network that is key to parasite survival and a valuable chemotherapeutic target. The ability to detoxify and tolerate reactive oxygen species increases along S. mansoni development in the vertebrate host, suggesting that adult parasites are more exposed to redox challenges than young stages. Indeed, adult parasites are exposed to multiple redox insults generated from blood digestion, activated immune cells, and, potentially, from their own parasitic aerobic metabolism. However, it remains unknown how reactive oxygen species are produced by S. mansoni metabolism, as well as their biological effects on adult worms. Here, we assessed the contribution of nutrients and parasite gender to oxygen utilization pathways, and reactive oxygen species generation in whole unpaired adult S. mansoni worms. We also determined the susceptibilities of both parasite sexes to a pro-oxidant challenge. We observed that glutamine and serum importantly contribute to both respiratory and non-respiratory oxygen utilization in adult worms, but with different proportions among parasite sexes. Analyses of oxygen utilization pathways revealed that respiratory rates were high in male worms, which contrast with high non-respiratory rates in females, regardless nutritional sources. Interestingly, mitochondrial complex I-III activity was higher than complex IV specifically in females. We also observed sexual preferences in substrate utilization to sustain hydrogen peroxide production towards glucose in females, and glutamine in male worms. Despite strikingly high oxidant levels and hydrogen peroxide production rates, female worms were more resistant to a pro-oxidant challenge than male parasites. The data presented here indicate that sexual preferences in nutrient metabolism in adult S. mansoni worms regulate oxygen utilization and reactive oxygen species production, which may differently contribute to redox biology among parasite sexes.	[Oliveira, Matheus P.; Correa Soares, Juliana B. R.; Oliveira, Marcus F.] Univ Fed Rio de Janeiro, Lab Bioquim Resposta Estresse, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Oliveira, MF (corresponding author), Univ Fed Rio de Janeiro, Lab Bioquim Resposta Estresse, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.	maroli@bioqmed.ufrj.br	Oliveira, Marcus/G-3158-2011	Oliveira, Marcus/0000-0002-9890-8425; Pinto De Oliveira, Matheus/0000-0002-2124-8799	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [402409/2012-4]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/102.333/2013, E-26/111.169/2011]; CNPq [307636/2012-7, 160357/2012-8]; PAPD-FAPERJ [E26/102.752/11]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PAPD-FAPERJ	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/) grant 402409/2012-4 and the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, http://www.faperj.br/) grants E-26/102.333/2013 and E-26/111.169/2011. MFO was a research scholar from CNPq (grant 307636/2012-7), JBRCS was a PAPD-FAPERJ fellow (grant E26/102.752/11), and MPO is a CNPq fellow (grant 160357/2012-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger HM, 2002, INT J PARASITOL, V32, P1285, DOI 10.1016/S0020-7519(02)00108-X; Alger HM, 2002, MOL BIOCHEM PARASIT, V121, P129, DOI 10.1016/S0166-6851(02)00031-2; Anderson L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004334; Angelucci F, 2009, J BIOL CHEM, V284, P28977, DOI 10.1074/jbc.M109.020701; Aragon AD, 2008, MOL BIOCHEM PARASIT, V162, P134, DOI 10.1016/j.molbiopara.2008.08.004; AW TY, 1994, J CLIN INVEST, V94, P2426, DOI 10.1172/JCI117610; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; BOROS DL, 1989, CLIN MICROBIOL REV, V2, P250, DOI 10.1128/CMR.2.3.250-269.1989; BOUT DT, 1981, J IMMUNOL, V127, P1; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Braschi S, 2006, MOL CELL PROTEOMICS, V5, P347, DOI 10.1074/mcp.M500287-MCP200; Bruce J.I., 1972, International J Parasit, V2, P425, DOI 10.1016/0020-7519(72)90086-0; BRUCE JI, 1974, COMP BIOCHEM PHYSIOL, V49, P157, DOI 10.1016/0305-0491(74)90235-1; BUEDING E, 1968, COMP BIOCHEM PHYSIOL, V24, P511, DOI 10.1016/0010-406X(68)91003-7; BUEDING E, 1953, BRIT J PHARM CHEMOTH, V8, P15, DOI 10.1111/j.1476-5381.1953.tb00741.x; BUEDING E, 1952, J BIOL CHEM, V196, P615; BUEDING E, 1950, J GEN PHYSIOL, V33, P475, DOI 10.1085/jgp.33.5.475; Cioli D, 2014, MOL BIOCHEM PARASIT, V195, P23, DOI 10.1016/j.molbiopara.2014.06.002; CLEGG JA, 1965, EXP PARASITOL, V16, P133, DOI 10.1016/0014-4894(65)90037-8; COLES G C, 1973, International Journal for Parasitology, V3, P505, DOI 10.1016/0020-7519(73)90047-7; COLES GC, 1972, NATURE, V240, P488, DOI 10.1038/240488a0; Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A; CORNFORD EM, 1974, EXP PARASITOL, V36, P210, DOI 10.1016/0014-4894(74)90060-5; CORNFORD EM, 1974, GEN COMP ENDOCR, V23, P286, DOI 10.1016/0016-6480(74)90072-0; CORNFORD EM, 1988, J PARASITOL, V74, P116, DOI 10.2307/3282487; CORNFORD EM, 1979, J PARASITOL, V65, P357, DOI 10.2307/3280273; CORNFORD EM, 1987, EXP PARASITOL, V64, P448, DOI 10.1016/0014-4894(87)90059-2; CORNFORD EM, 1985, COMP BIOCHEM PHYS B, V82, P25, DOI 10.1016/0305-0491(85)90122-1; CORNFORD EM, 1981, SCIENCE, V213, P1269, DOI 10.1126/science.7268436; CORNFORD EM, 1985, MOL BIOCHEM PARASIT, V17, P131, DOI 10.1016/0166-6851(85)90012-X; Soares JBRC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120600; Soares JBRC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000477; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P334, DOI 10.1016/0003-9861(84)90206-6; DIMONTE D, 1984, ARCH BIOCHEM BIOPHYS, V235, P343, DOI 10.1016/0003-9861(84)90207-8; el-Din SHS, 2011, EXP PARASITOL, V128, P230, DOI 10.1016/j.exppara.2011.03.006; ESPARZA I, 1988, IMMUNOBIOLOGY, V177, P105, DOI 10.1016/S0171-2985(88)80032-9; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Figueira TR, 2013, ANTIOXID REDOX SIGN, V18, P2029, DOI 10.1089/ars.2012.4729; Fitzpatrick JM, 2007, FASEB J, V21, P823, DOI 10.1096/fj.06-7314com; Fitzpatrick JM, 2004, MOL BIOCHEM PARASIT, V136, P191, DOI 10.1016/j.molbiopara.2004.03.014; Forbes RA, 2001, CIRC RES, V88, P802, DOI 10.1161/hh0801.089342; FOSTER LA, 1989, EXP PARASITOL, V69, P44, DOI 10.1016/0014-4894(89)90170-7; FRAPPIER F, 1988, BIOCHEM PHARMACOL, V37, P2864, DOI 10.1016/0006-2952(88)90053-6; FUJIMOTO D, 1969, J BIOL CHEM, V244, P205; Furukawa S, 2000, NUTRITION, V16, P323, DOI 10.1016/S0899-9007(00)00228-8; Furukawa S, 2000, SHOCK, V13, P274, DOI 10.1097/00024382-200004000-00004; GAZZINELLI G, 1985, J IMMUNOL, V135, P2121; GIBIAN MJ, 1976, BIOCHEMISTRY-US, V15, P4209, DOI 10.1021/bi00664a012; Girardini JE, 2005, EXP PARASITOL, V110, P157, DOI 10.1016/j.exppara.2005.02.011; Girardini JE, 2002, MOL BIOCHEM PARASIT, V124, P37, DOI 10.1016/S0166-6851(02)00158-5; GOLDRING OL, 1976, CLIN EXP IMMUNOL, V26, P181; Goncalves RLS, 2011, J BIOENERG BIOMEMBR, V43, P651, DOI 10.1007/s10863-011-9398-8; Goossens V, 1996, J BIOL CHEM, V271, P192, DOI 10.1074/jbc.271.1.192; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; HALANGK W, 1985, BIOMED BIOCHIM ACTA, V44, P411; Hamdan FF, 1999, J BIOL CHEM, V274, P21746, DOI 10.1074/jbc.274.31.21746; Hermes-Lima M, 2002, COMP BIOCHEM PHYS C, V133, P537, DOI 10.1016/S1532-0456(02)00080-7; Hey-Mogensen M, 2014, FREE RADICAL BIO MED, V72, P149, DOI 10.1016/j.freeradbiomed.2014.04.007; Hoffmann KF, 2004, PARASITOLOGY, V128, pS11, DOI 10.1017/S0031182004006213; HOSONO R, 1982, EXP GERONTOL, V17, P163, DOI 10.1016/0531-5565(82)90052-3; Huang SCC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002996; HUANG TY, 1980, INT J BIOCHEM, V12, P457, DOI 10.1016/0020-711X(80)90128-7; Ismail M, 1999, AM J TROP MED HYG, V60, P932, DOI 10.4269/ajtmh.1999.60.932; KATZ IR, 1980, J NEUROCHEM, V35, P760, DOI 10.1111/j.1471-4159.1980.tb03721.x; Kuntz AN, 2007, PLOS MED, V4, P1071, DOI 10.1371/journal.pmed.0040206; KUNTZ RE, 1980, J PARASITOL, V66, P364, DOI 10.2307/3280844; Kwatia MA, 2000, J PARASITOL, V86, P908, DOI 10.1645/0022-3395(2000)086[0908:MAECOS]2.0.CO;2; LANE CA, 1987, PARASITOLOGY, V94, P233, DOI 10.1017/S0031182000053919; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; LOPASCHUK GD, 1988, CIRC RES, V63, P1036, DOI 10.1161/01.RES.63.6.1036; Maglioni S, 2014, EXP GERONTOL, V56, P89, DOI 10.1016/j.exger.2014.03.026; Mair GR, 2004, FASEB J, V18, P114, DOI 10.1096/fj.03-0429com; Martins D, 2014, ANTIOXID REDOX SIGN, V21, P1490, DOI 10.1089/ars.2013.5575; Mei HP, 1996, INFECT IMMUN, V64, P4299, DOI 10.1128/IAI.64.10.4299-4306.1996; Mei HP, 1997, EXP PARASITOL, V86, P69, DOI 10.1006/expr.1997.4150; Messerli SM, 2006, MOL BIOCHEM PARASIT, V150, P367, DOI 10.1016/j.molbiopara.2006.08.003; MEYER F, 1970, BIOCHIM BIOPHYS ACTA, V210, P257, DOI 10.1016/0005-2760(70)90170-0; MKOJI GM, 1988, INT J PARASITOL, V18, P661, DOI 10.1016/0020-7519(88)90101-4; MKOJI GM, 1988, INT J PARASITOL, V18, P667, DOI 10.1016/0020-7519(88)90102-6; MKOJI GM, 1989, BIOCHEM PHARMACOL, V38, P4307, DOI 10.1016/0006-2952(89)90530-3; NARE B, 1990, EXP PARASITOL, V70, P389, DOI 10.1016/0014-4894(90)90122-S; NEWPORT GR, 1982, AM J TROP MED HYG, V31, P349, DOI 10.4269/ajtmh.1982.31.349; Okumura-Noji K, 2013, FASEB J, V27, P1236, DOI 10.1096/fj.12-219816; Oliveira MF, 2004, J INFECT DIS, V190, P843, DOI 10.1086/422759; Oliveira MF, 2002, FEBS LETT, V512, P139, DOI 10.1016/S0014-5793(02)02243-3; Oliveira MF, 2000, MOL BIOCHEM PARASIT, V111, P217, DOI 10.1016/S0166-6851(00)00299-1; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; Pearce EJ, 2015, CELL MICROBIOL, V17, P796, DOI 10.1111/cmi.12444; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Pelletier M, 2012, SEMIN IMMUNOL, V24, P384, DOI 10.1016/j.smim.2013.01.002; Perevoshchikova IV, 2013, FREE RADICAL BIO MED, V61, P298, DOI 10.1016/j.freeradbiomed.2013.04.006; Piacenza L, 2013, ANTIOXID REDOX SIGN, V19, P723, DOI 10.1089/ars.2012.4618; PINO ECD, 1966, EXP PARASITOL, V18, P320, DOI 10.1016/0014-4894(66)90033-6; Pon LA, 2007, METHOD CELL BIOL, V80, P1; Ponsot E, 2005, J CELL PHYSIOL, V203, P479, DOI 10.1002/jcp.20245; PRICHARD RK, 1971, EXP PARASITOL, V29, P215, DOI 10.1016/0014-4894(71)90027-0; Quinlan CL, 2014, J BIOL CHEM, V289, P8312, DOI 10.1074/jbc.M113.545301; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; Ramirez B, 2007, EXPERT OPIN DRUG DIS, V2, pS53, DOI 10.1517/17460441.2.S1.S53; Rasmussen UF, 2004, COMP BIOCHEM PHYS A, V137, P435, DOI 10.1016/j.cbpb.2003.11.002; Ristow M, 2011, FREE RADICAL BIO MED, V51, P327, DOI 10.1016/j.freeradbiomed.2011.05.010; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; RUMJANEK FD, 1980, MOL BIOCHEM PARASIT, V1, P31, DOI 10.1016/0166-6851(80)90039-0; Saeed HM, 2002, FEBS LETT, V519, P205, DOI 10.1016/S0014-5793(02)02755-2; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Sayed AA, 2008, NAT MED, V14, P407, DOI 10.1038/nm1737; Sayed AA, 2006, J BIOL CHEM, V281, P17001, DOI 10.1074/jbc.M512601200; SAZ HJ, 1966, PHARMACOL REV, V18, P871; SCHILLER EL, 1975, J PARASITOL, V61, P385, DOI 10.2307/3279308; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmeisser S, 2013, AGING CELL, V12, P508, DOI 10.1111/acel.12076; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; SEED JL, 1978, J PARASITOL, V64, P283, DOI 10.2307/3279674; Simeonov A, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000127; Skelly PJ, 2006, ADV PARASIT, V63, P185, DOI 10.1016/S0065-308X(06)63003-0; SKELLY PJ, 1993, MOL BIOCHEM PARASIT, V60, P93, DOI 10.1016/0166-6851(93)90032-S; SMITH JM, 1989, AM J TROP MED HYG, V40, P186, DOI 10.4269/ajtmh.1989.40.186; SMITHERS SR, 1965, PARASITOLOGY, V55, P695, DOI 10.1017/S0031182000086248; SRERE PA, 1963, ACTA CHEM SCAND, V17, P129, DOI 10.3891/acta.chem.scand.17s-0129; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Steinmann P, 2006, LANCET INFECT DIS, V6, P411, DOI 10.1016/S1473-3099(06)70521-7; SUN JC, 2015, PLOS COMPUT BIOL, V11, DOI DOI 10.1371/JOURNAL.PONE.0129626; Sun J, 2014, PARASITOL RES, V113, P881, DOI 10.1007/s00436-013-3719-2; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; TAKAMIYA S, 1994, ARCH BIOCHEM BIOPHYS, V312, P142, DOI 10.1006/abbi.1994.1292; Takamiya S, 2010, INT J PARASITOL, V40, P1651, DOI 10.1016/j.ijpara.2010.07.009; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; THOMPSON DP, 1984, MOL BIOCHEM PARASIT, V13, P39, DOI 10.1016/0166-6851(84)90100-2; THOR H, 1982, J BIOL CHEM, V257, P2419; TIELENS AGM, 1984, MOL BIOCHEM PARASIT, V13, P301, DOI 10.1016/0166-6851(84)90121-X; TIELENS AGM, 1981, MOL BIOCHEM PARASIT, V3, P205, DOI 10.1016/0166-6851(81)90052-9; TIELENS AGM, 1989, INT J PARASITOL, V19, P447, DOI 10.1016/0020-7519(89)90102-1; Treberg JR, 2011, J BIOL CHEM, V286, P27103, DOI 10.1074/jbc.M111.252502; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; TZENG WF, 1994, J MOL CELL CARDIOL, V26, P889, DOI 10.1006/jmcc.1994.1106; UGLEM GL, 1975, J PARASITOL, V61, P390, DOI 10.2307/3279309; Vanden Hoek TL, 1998, J BIOL CHEM, V273, P18092, DOI 10.1074/jbc.273.29.18092; VANOORDT BEP, 1985, MOL BIOCHEM PARASIT, V16, P117, DOI 10.1016/0166-6851(85)90080-5; WARREN KS, 1978, NATURE, V273, P609, DOI 10.1038/273609a0; Yanase S, 1999, MUTAT RES-FUND MOL M, V426, P31, DOI 10.1016/S0027-5107(99)00079-2; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; YAZDANBAKHSH M, 1987, J IMMUNOL, V138, P3443; Zarse K, 2012, CELL METAB, V15, P451, DOI 10.1016/j.cmet.2012.02.013; Zelck UE, 2004, PARASITOLOGY, V128, P493, DOI 10.1017/S0031182004004895; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	151	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158429	10.1371/journal.pone.0158429	http://dx.doi.org/10.1371/journal.pone.0158429			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380021	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700030
J	Zhang, XB; Tang, QL; Wang, XJ; Wang, ZX				Zhang, Xiaobing; Tang, Qiaoling; Wang, Xujing; Wang, Zhixing			Structure of Exogenous Gene Integration and Event-Specific Detection in the Glyphosate-Tolerant Transgenic Cotton Line BG2-7	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; T-DNA INTEGRATION; REAL-TIME PCR; QUANTITATIVE PCR; MAIZE; SEQUENCES; BT11; CANOLA; POLLEN; GENOME	In this study, the flanking sequence of an inserted fragment conferring glyphosate tolerance on transgenic cotton line BG2-7 was analyzed by thermal asymmetric interlaced polymerase chain reaction (TAIL-PCR) and standard PCR. The results showed apparent insertion of the exogenous gene into chromosome D10 of the Gossypium hirsutum L. genome, as the left and right borders of the inserted fragment are nucleotides 61,962,952 and 61,962,921 of chromosome D10, respectively. In addition, a 31-bp cotton microsatellite sequence was noted between the genome sequence and the 5' end of the exogenous gene. In total, 84 and 298 bp were deleted from the left and right borders of the exogenous gene, respectively, with 30 bp deleted from the cotton chromosome at the insertion site. According to the flanking sequence obtained, several pairs of event-specific detection primers were designed to amplify sequence between the 5' end of the exogenous gene and the cotton genome junction region as well as between the 3' end and the cotton genome junction region. Based on screening tests, the 5'-end primers GTCATAACGTGACTCCCTTAA TTCTCC/CCTATTACACGGCTATGC and 3'-end primers TCCTTTCGCTTTCTTCCCTT/ACACTTACATGGCGTCTTCT were used to detect the respective BG2-7 event-specific primers. The limit of detection of the former primers reached 44 copies, and that of the latter primers reached 88 copies. The results of this study provide useful data for assessment of BG2-7 safety and for accelerating its industrialization.	[Zhang, Xiaobing; Tang, Qiaoling; Wang, Xujing; Wang, Zhixing] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China; [Zhang, Xiaobing] Hebei Acad Sci, Inst Biol, Shijiazhuan, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Wang, XJ; Wang, ZX (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China.	xujingwang0514@126.com; wangcotton@126.com		Zhang, Xiao Bing/0000-0001-7517-613X	Genetically Modified Major Projects [2012ZX08011-003, 2014ZX08011-004B]	Genetically Modified Major Projects	This work was supported by the Genetically Modified Major Projects (No. 2012ZX08011-003 and No. 2014ZX08011-004B).	Andow DA, 2006, ECOL LETT, V9, P196, DOI 10.1111/j.1461-0248.2005.00846.x; [Anonymous], 2015, THESIS; Christou P., 2002, TRANSGENIC RES, V11, P3, DOI [DOI 10.1023/A:1013903300469, 10.1023/A:1013903300469]; De Buck S, 1999, PLANT J, V20, P295, DOI 10.1046/j.1365-313X.1999.t01-1-00602.x; Kyndt T, 2015, P NATL ACAD SCI USA, V112, P5844, DOI 10.1073/pnas.1419685112; Lee SH, 2006, J AGR FOOD CHEM, V54, P1124, DOI 10.1021/jf052199a; Li Yi, 2012, [Frontiers in Biology, 生物学前沿], V7, P557; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Marmiroli N, 2008, ANAL BIOANAL CHEM, V392, P369, DOI 10.1007/s00216-008-2303-6; PARKER JD, 1991, NUCLEIC ACIDS RES, V19, P3055, DOI 10.1093/nar/19.11.3055; Quist D, 2001, NATURE, V414, P541, DOI 10.1038/35107068; Sears MK, 2001, P NATL ACAD SCI USA, V98, P11937, DOI 10.1073/pnas.211329998; Singh RJ, 2013, ENVIRON MONIT ASSESS, V185, P485, DOI 10.1007/s10661-012-2569-1; Taverniers I, 2005, J AGR FOOD CHEM, V53, P3041, DOI 10.1021/jf0483467; Wang XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099651; Windels P, 2003, PLANT PHYSIOL, V133, P2061, DOI 10.1104/pp.103.027532; Wu G, 2010, FOOD CHEM, V119, P417, DOI 10.1016/j.foodchem.2009.08.031; Xu WT, 2009, J AGR FOOD CHEM, V57, P395, DOI 10.1021/jf802323m; Yang LT, 2006, J AGR FOOD CHEM, V54, P9735, DOI 10.1021/jf061918y; Yang LT, 2005, TRANSGENIC RES, V14, P817, DOI 10.1007/s11248-005-0010-z; Yang LT, 2005, J AGR FOOD CHEM, V53, P6222, DOI 10.1021/jf050095u; Yang LT, 2005, PLANT CELL REP, V24, P237, DOI 10.1007/s00299-005-0929-9; Zhang Baohong, 2013, Methods Mol Biol, V958, P3, DOI 10.1007/978-1-62703-212-4_1; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang XB, 2015, CROP J, V3, P163, DOI 10.1016/j.cj.2014.11.001; [赵建华 Zhao Jianhua], 2013, [分子植物育种, Molecular Plant Breeding], V11, P701; Zhu CF, 2010, J GENET GENOMICS, V37, P189, DOI 10.1016/S1673-8527(09)60037-0; Zimmermann A, 2000, LEBENSM-WISS TECHNOL, V33, P210, DOI 10.1006/fstl.2000.0637	29	5	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158384	10.1371/journal.pone.0158384	http://dx.doi.org/10.1371/journal.pone.0158384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27379683	Green Published, gold, Green Submitted			2022-12-26	WOS:000379798700027
J	de Queiroz, RM; Madan, R; Chien, J; Dias, WB; Slawson, C				de Queiroz, Rafaela Muniz; Madan, Rashna; Chien, Jeremy; Dias, Wagner Barbosa; Slawson, Chad			Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN MODIFICATION; HEXOSAMINE BIOSYNTHESIS; TUMOR SUPPRESSION; X-CHROMOSOME; GLCNACYLATION; PHOSPHORYLATION; GLYCOSYLATION; TRANSCRIPTION; TRANSFERASE; RESISTANCE	O-GlcNAcylation is a dynamic post-translational modification consisting of the addition of a single N-acetylglucosamine sugar to serine and threonine residues in proteins by the enzyme O-linked beta-N-acetylglucosamine transferase (OGT), whereas the enzyme O-GlcNAcase (OGA) removes the modification. In cancer, tumor samples present with altered O-GlcNAcylation; however, changes in O-GlcNAcylation are not consistent between tumor types. Interestingly, the tumor suppressor p53 is modified by O-GlcNAc, and most solid tumors contain mutations in p53 leading to the loss of p53 function. Because ovarian cancer has a high frequency of p53 mutation rates, we decided to investigate the relationship between O-GlcNAcylation and p53 function in ovarian cancer. We measured a significant decrease in O-GlcNAcylation of tumor tissue in an ovarian tumor microarray. Furthermore, O-GlcNAcylation was increased, and OGA protein and mRNA levels were decreased in ovarian tumor cell lines not expressing the protein p53. Treatment with the OGA inhibitor Thiamet-G (TMG), silencing of OGA, or overexpression of OGA and OGT led to p53 stabilization, increased nuclear localization, and increased protein and mRNA levels of p53 target genes. These data suggest that changes in O-GlcNAc homeostasis activate the p53 pathway. Combination treatment of the chemotherapeutic cisplatin with TMG decreased tumor cell growth and enhanced cell cycle arrest without impairing cytotoxicity. The effects of TMG on tumor cell growth were partially dependent on wild type p53 activation. In conclusion, changes in O-GlcNAc homeostasis activate the wild type p53 pathway in ovarian cancer cells, and OGA inhibition has the potential as an adjuvant treatment for ovarian carcinoma.	[de Queiroz, Rafaela Muniz; Dias, Wagner Barbosa] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Glicobiol Estrutural & Func, BR-21941902 Rio De Janeiro, RJ, Brazil; [Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA; [Chien, Jeremy] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66160 USA; [Madan, Rashna] Univ Kansas, Med Ctr, Dept Pathol, Div Hematol Oncol, Kansas City, KS 66160 USA	Universidade Federal do Rio de Janeiro; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Dias, WB (corresponding author), Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Biofis Carlos Chagas Filho, Lab Glicobiol Estrutural & Func, BR-21941902 Rio De Janeiro, RJ, Brazil.; Slawson, C (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	diaswb@biof.ufrj.br; cslawson@kumc.edu	Dias, Wagner/B-1401-2016; Chien, Jeremy/AID-8939-2022	Dias, Wagner/0000-0002-8378-8846; Chien, Jeremy/0000-0003-4744-8374; Muniz de Queiroz, Rafaela/0000-0001-5962-9071	NCI Cancer Center Support Grant from National Institutes of Health [P30 CA168524]; NATIONAL CANCER INSTITUTE [P30CA168524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103326] Funding Source: NIH RePORTER	NCI Cancer Center Support Grant from National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Biospecimen Core Resources was recipient of NCI Cancer Center Support Grant P30 CA168524 from the National Institutes of Health.	Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Bond MR, 2015, J CELL BIOL, V208, P869, DOI 10.1083/jcb.201501101; Dai C, 2010, TRENDS MOL MED, V16, P528, DOI 10.1016/j.molmed.2010.09.002; Dashzeveg N, 2015, CANCER LETT, V367, P108, DOI 10.1016/j.canlet.2015.07.019; de Queiroz RM, 2014, CANCER INVEST, V32, P226, DOI 10.3109/07357907.2014.905587; de Queirozl RM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00132; Dias WB, 2012, BIOCHEM BIOPH RES CO, V422, P224, DOI 10.1016/j.bbrc.2012.04.124; Dias WB, 2009, J BIOL CHEM, V284, P21327, DOI 10.1074/jbc.M109.007310; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Gewinner C, 2004, J BIOL CHEM, V279, P3563, DOI 10.1074/jbc.M306449200; Groves JA, 2013, CELL STRESS CHAPERON, V18, P535, DOI 10.1007/s12192-013-0426-y; Gu B, 2012, INT J BIOL SCI, V8, P672, DOI 10.7150/ijbs.4283; Gurel Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095561; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hart GW, 1997, ANNU REV BIOCHEM, V66, P315, DOI 10.1146/annurev.biochem.66.1.315; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Krzeslak A, 2010, INT J MOL MED, V25, P643, DOI 10.3892/ijmm_00000387; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; Macauley MS, 2010, CHEM BIOL, V17, P949, DOI 10.1016/j.chembiol.2010.07.005; Malaguarnera R, 2007, ENDOCR-RELAT CANCER, V14, P43, DOI 10.1677/erc.1.01223; Malmlof M, 2007, J BIOL CHEM, V282, P2288, DOI 10.1074/jbc.M604953200; Marsh SA, 2011, AMINO ACIDS, V40, P819, DOI 10.1007/s00726-010-0699-8; Marshall S, 2004, J BIOL CHEM, V279, P35313, DOI 10.1074/jbc.M404133200; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Peternelj TT, 2015, BIOCHEM CELL BIOL, V93, P63, DOI 10.1139/bcb-2014-0106; Peternelj TT, 2015, MOL CELL BIOCHEM, V400, P265, DOI 10.1007/s11010-014-2283-0; Schuijer M, 2003, HUM MUTAT, V21, P285, DOI 10.1002/humu.10181; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi Dingding, 2012, Genes Cancer, V3, P240, DOI 10.1177/1947601912455199; Shi Y, 2010, LEUKEMIA, V24, P1588, DOI 10.1038/leu.2010.152; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Van Maerken T, 2014, CANCER LETT, V344, P157, DOI 10.1016/j.canlet.2013.11.002; Vasconcelos-dos-Santos A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00138; Venkatachalam S, 2001, TOXICOL PATHOL, V29, P147, DOI 10.1080/019262301753178555; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Wang XY, 2015, CANCER RES, V75, P5001, DOI 10.1158/0008-5472.CAN-15-0563; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WATTEL E, 1994, BLOOD, V84, P3148, DOI 10.1182/blood.V84.9.3148.3148; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Zhang Cen, 2015, RNA Dis, V2, pe502; Zhang EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143814; Zhang X, 2014, ONCOTARGET, V5, P11365, DOI 10.18632/oncotarget.2497; Zhang XM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00094; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zhong J, 2015, PROTEOMICS, V15, P591, DOI 10.1002/pmic.201400339	52	52	53	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18897	18914		10.1074/jbc.M116.734533	http://dx.doi.org/10.1074/jbc.M116.734533			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402830	Green Published, hybrid			2022-12-26	WOS:000383242300027
J	Gao, XF; Pham, TH; Feuerbacher, LA; Chen, KM; Hays, MP; Singh, G; Rueter, C; Hurtado-Guerrero, R; Hardwidge, PR				Gao, Xiaofei; Pham, Thanh H.; Feuerbacher, Leigh Ann; Chen, Kangming; Hays, Michael P.; Singh, Gyanendra; Rueter, Christian; Hurtado-Guerrero, Ramon; Hardwidge, Philip R.			Citrobacter rodentium NleB Protein Inhibits Tumor Necrosis Factor (TNF) Receptor-associated Factor 3 (TRAF3) Ubiquitination to Reduce Host Type I Interferon Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial pathogenesis; infection; innate immunity; interferon; signal transduction	NF-KAPPA-B; ENTEROPATHOGENIC ESCHERICHIA-COLI; ANTIVIRAL RESPONSE; GENE-EXPRESSION; IKK-EPSILON; CELL-DEATH; ACTIVATION; EFFECTOR; LIPOPOLYSACCHARIDE; DEFENSE	Interferon signaling plays important roles in both intestinal homeostasis and in the host response to pathogen infection. The extent to which bacterial pathogens inhibit this host pathway is an understudied area of investigation. We characterized Citrobacter rodentium strains bearing deletions in individual type III secretion system effector genes to determine whether this pathogen inhibits the host type I IFN response and which effector is responsible. The NleB effector limited host IFN- production by inhibiting Lys(63)-linked ubiquitination of TNF receptor-associated factor 3 (TRAF3). Inhibition was dependent on the glycosyltransferase activity of NleB. GAPDH, a target of NleB during infection, bound to TRAF3 and was required for maximal TRAF3 ubiquitination. NleB glycosyltransferase activity inhibited GAPDH-TRAF3 binding, resulting in reduced TRAF3 ubiquitination. Collectively, our data reveal important interplay between GAPDH and TRAF3 and suggest a mechanism by which the NleB effector inhibits type I IFN signaling.	[Gao, Xiaofei] Whitehead Inst, Cambridge, MA 02142 USA; [Pham, Thanh H.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Feuerbacher, Leigh Ann; Chen, Kangming; Hays, Michael P.; Hardwidge, Philip R.] Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA; [Singh, Gyanendra] Natl Inst Occupat Hlth, Ahmadabad 380016, Gujarat, India; [Rueter, Christian] Univ Munster, Inst Infectiol, D-48149 Munster, Germany; [Hurtado-Guerrero, Ramon] Fdn ARAID, Edificio CEEI ARAGON, Zaragoza 50018, Spain; [Hurtado-Guerrero, Ramon] Univ Zaragoza, BIFI IQFR CSIC Joint Unit, Inst Biocomputat & Phys Complex Syst BIFI, Mariano Esquillor S-N,Campus Rio Ebro,Edificio I, Zaragoza 50018, Spain	Massachusetts Institute of Technology (MIT); Whitehead Institute; Case Western Reserve University; Kansas State University; Indian Council of Medical Research (ICMR); ICMR - National Institute of Occupational Health (NIOH); University of Munster; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza	Hardwidge, PR (corresponding author), Kansas State Univ, Coll Vet Med, Manhattan, KS 66506 USA.	hardwidg@vet.k-state.edu	Rüter, Christian/B-5127-2017	Rüter, Christian/0000-0003-1982-4811; Hurtado-Guerrero, Ramon/0000-0002-3122-9401; PHAM, THANH/0000-0001-8959-7947	NIAID, National Institutes of Health [AI093913]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI127973, R21AI093913] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health Grant AI093913. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BELARDELLI F, 1995, APMIS, V103, P161, DOI 10.1111/j.1699-0463.1995.tb01092.x; Caillaud A, 2005, J BIOL CHEM, V280, P17671, DOI 10.1074/jbc.M411389200; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Cornelis GR, 2010, BIOL CHEM, V391, P745, DOI 10.1515/BC.2010.079; Dang O, 2004, J IMMUNOL, V172, P747, DOI 10.4049/jimmunol.172.2.747; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Gold JA, 2004, INFECT IMMUN, V72, P1291, DOI 10.1128/IAI.72.3.1291-1297.2004; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hiscott J, 1999, J INTERF CYTOK RES, V19, P1, DOI 10.1089/107999099314360; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; Li S, 2013, NATURE, V501, P242, DOI 10.1038/nature12436; Long TM, 2014, INFECT IMMUN, V82, P2802, DOI 10.1128/IAI.00105-14; Lung TWF, 2016, INFECT IMMUN, V84, P1346, DOI 10.1128/IAI.01523-15; Mogensen KE, 1999, J INTERF CYTOK RES, V19, P1069, DOI 10.1089/107999099313019; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Pearson JS, 2013, NATURE, V501, P247, DOI 10.1038/nature12524; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; Rahman MM, 2011, NAT REV MICROBIOL, V9, P291, DOI 10.1038/nrmicro2539; Rani MRS, 2010, J INTERF CYTOK RES, V30, P163, DOI 10.1089/jir.2009.0032; Sanchez-Villamil J, 2015, FUTURE MICROBIOL, V10, P1009, DOI [10.2217/FMB.15.17, 10.2217/fmb.15.17]; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Tao MF, 2009, CURR BIOL, V19, P1255, DOI 10.1016/j.cub.2009.06.038; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Wang XG, 2012, CELL MICROBIOL, V14, P1231, DOI 10.1111/j.1462-5822.2012.01793.x	35	14	15	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18232	18238		10.1074/jbc.M116.738278	http://dx.doi.org/10.1074/jbc.M116.738278			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27387501	hybrid, Green Published			2022-12-26	WOS:000383241800016
J	Jain, K; Warmack, RA; Debler, EW; Hadjikyriacou, A; Stavropoulos, P; Clarke, SG				Jain, Kanishk; Warmack, Rebeccah A.; Debler, Erik W.; Hadjikyriacou, Andrea; Stavropoulos, Peter; Clarke, Steven G.			Protein Arginine Methyltransferase Product Specificity Is Mediated by Distinct Active-site Architectures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						enzyme catalysis; epigenetics; histone methylation; post-translational modification (PTM); protein methylation; PRMT; PRMT product specificity; methyltransferase; protein arginine methylation	SYMMETRIC DIMETHYLATION; POSTTRANSLATIONAL MODIFICATIONS; EPIGENETIC REGULATION; TRYPANOSOMA-BRUCEI; BREAST-CANCER; HISTONE H4; 7 PRMT7; METHYLATION; EXPRESSION; BIOLOGY	In the family of protein arginine methyltransferases (PRMTs) that predominantly generate either asymmetric or symmetric dimethylarginine (SDMA), PRMT7 is unique in producing solely monomethylarginine (MMA) products. The type of methylation on histones and other proteins dictates changes in gene expression, and numerous studies have linked altered profiles of methyl marks with disease phenotypes. Given the importance of specific inhibitor development, it is crucial to understand the mechanisms by which PRMT product specificity is conferred. We have focused our attention on active-site residues of PRMT7 from the protozoan Trypanosoma brucei. We have designed 26 single and double mutations in the active site, including residues in the Glu-Xaa(8)-Glu (double E) loop and the Met-Gln-Trp sequence of the canonical Thr-His-Trp (THW) loop known to interact with the methyl-accepting substrate arginine. Analysis of the reaction products by high resolution cation exchange chromatography combined with the knowledge of PRMT crystal structures suggests a model where the size of two distinct subregions in the active site determines PRMT7 product specificity. A dual mutation of Glu-181 to Asp in the double E loop and Gln-329 to Ala in the canonical THW loop enables the enzyme to produce SDMA. Consistent with our model, the mutation of Cys-431 to His in the THW loop of human PRMT9 shifts its product specificity from SDMA toward MMA. Together with previous results, these findings provide a structural basis and a general model for product specificity in PRMTs, which will be useful for the rational design of specific PRMT inhibitors.	[Jain, Kanishk; Warmack, Rebeccah A.; Hadjikyriacou, Andrea; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA; [Jain, Kanishk; Warmack, Rebeccah A.; Hadjikyriacou, Andrea; Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA; [Debler, Erik W.; Stavropoulos, Peter] Rockefeller Univ, Cell Biol Lab, New York, NY 10065 USA; [Stavropoulos, Peter] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10065 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Rockefeller University; Rockefeller University	Clarke, SG (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.; Clarke, SG (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, 607 Charles E Young Dr East, Los Angeles, CA 90095 USA.	clarke@mbi.ucla.edu		Jain, Kanishk/0000-0001-8039-0464; Debler, Erik/0000-0002-2587-2150; Clarke, Steven/0000-0002-7303-6632	National Institutes of Health [GM026020]; Ruth L. Kirschstein National Service Award [GM007185];  [DRG-1977-08]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM026020 (to S. G. C.) and Ruth L. Kirschstein National Service Award GM007185 (to K. J., R. A. W., and A. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Frey Fellow of the Damon Runyon Cancer Research Foundation supported by Grant DRG-1977-08.	Baldwin RM, 2015, ONCOTARGET, V6, P3013, DOI 10.18632/oncotarget.3072; Bao XX, 2013, J HISTOCHEM CYTOCHEM, V61, P206, DOI 10.1369/0022155413475452; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Cura V, 2014, ACTA CRYSTALLOGR D, V70, P2401, DOI 10.1107/S1399004714014278; Debler EW, 2016, P NATL ACAD SCI USA, V113, P2068, DOI 10.1073/pnas.1525783113; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Feng Y, 2011, BIOCHEMISTRY-US, V50, P7033, DOI 10.1021/bi200456u; Ferreira TR, 2014, MOL MICROBIOL, V94, P1085, DOI 10.1111/mmi.12819; Fisk JC, 2009, J BIOL CHEM, V284, P11590, DOI 10.1074/jbc.M807279200; Fuhrmann J, 2016, ACS CHEM BIOL, V11, P654, DOI 10.1021/acschembio.5b00942; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; GOTTSCHLING H, 1962, NATURE, V196, P829, DOI 10.1038/196829a0; Gui SY, 2014, J BIOL CHEM, V289, P9320, DOI 10.1074/jbc.M113.535278; Hadjikyriacou A, 2015, J BIOL CHEM, V290, P16723, DOI 10.1074/jbc.M115.659433; Hasegawa M, 2014, FEBS LETT, V588, P1942, DOI 10.1016/j.febslet.2014.03.053; Hu H, 2016, EXPERT OPIN INV DRUG, V25, P335, DOI 10.1517/13543784.2016.1144747; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Lott K, 2014, MICROBIOLOGYOPEN, V3, P595, DOI 10.1002/mbo3.191; Martens-Lobenhoffer J, 2016, ANAL BIOCHEM, V493, P14, DOI 10.1016/j.ab.2015.10.001; Migliori V, 2012, NAT STRUCT MOL BIOL, V19, P136, DOI 10.1038/nsmb.2209; Morales Y, 2016, ARCH BIOCHEM BIOPHYS, V590, P138, DOI 10.1016/j.abb.2015.11.030; Schapira M, 2016, CURR OPIN CHEM BIOL, V33, P81, DOI 10.1016/j.cbpa.2016.05.030; Schapira M, 2014, MEDCHEMCOMM, V5, P1779, DOI 10.1039/c4md00269e; Suarez-Calvet M, 2016, ACTA NEUROPATHOL, V131, P587, DOI 10.1007/s00401-016-1544-2; Sun LT, 2011, P NATL ACAD SCI USA, V108, P20538, DOI 10.1073/pnas.1106946108; Tarighat SS, 2016, LEUKEMIA, V30, P789, DOI 10.1038/leu.2015.308; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang CY, 2014, STRUCTURE, V22, P756, DOI 10.1016/j.str.2014.03.003; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wang YC, 2014, CELL RES, V24, P143, DOI 10.1038/cr.2013.151; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	40	28	29	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18299	18308		10.1074/jbc.M116.740399	http://dx.doi.org/10.1074/jbc.M116.740399			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27387499	Green Published, hybrid			2022-12-26	WOS:000383241800022
J	Kountz, TS; Lee, KS; Aggarwal-Howarth, S; Curran, E; Park, JM; Harris, DA; Stewart, A; Hendrickson, J; Camp, ND; Wolf-Yadlin, A; Wang, EH; Scott, JD; Hague, C				Kountz, Timothy S.; Lee, Kyung-Soon; Aggarwal-Howarth, Stacey; Curran, Elizabeth; Park, Ji-Min; Harris, Dorathy-Ann; Stewart, Aaron; Hendrickson, Joseph; Camp, Nathan D.; Wolf-Yadlin, Alejandro; Wang, Edith H.; Scott, John D.; Hague, Chris			Endogenous N-terminal Domain Cleavage Modulates alpha(1D)-Adrenergic Receptor Pharmacodynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adrenergic receptor; catecholamine; cell signaling; cell surface receptor; G protein-coupled receptor (GPCR); molecular pharmacology; PDZ domain; N-terminus; alpha1D adre; label-free signaling	PROTEIN-COUPLED RECEPTORS; BLADDER OUTLET OBSTRUCTION; CELL-SURFACE EXPRESSION; VASCULAR SMOOTH-MUSCLE; ALPHA(1)-ADRENOCEPTOR SUBTYPES; BETA(1)-ADRENERGIC RECEPTOR; ALPHA-1D ADRENOCEPTOR; ANTAGONIST TAMSULOSIN; BINDING; LOCALIZATION	The (1D)-adrenergic receptor (ADRA1D) is a key regulator of cardiovascular, prostate, and central nervous system functions. This clinically relevant G protein-coupled receptor has proven difficult to study, as it must form an obligate modular homodimer containing the PDZ proteins scribble and syntrophin or become retained in the endoplasmic reticulum as non-functional protein. We previously determined that targeted removal of the N-terminal (NT) 79 amino acids facilitates ADRA1D plasma membrane expression and agonist-stimulated functional responses. However, whether such an event occurs in physiological contexts was unknown. Herein, we report the ADRA1D is subjected to innate NT processing in cultured human cells. SNAP near-infrared imaging and tandem-affinity purification revealed the ADRA1D is expressed as both full-length and NT truncated forms in multiple human cell lines. Serial truncation mapping identified the cleavage site as Leu(90)/Val(91) in the 95-amino acid ADRA1D NT domain, suggesting human cells express a 1-91 ADRA1D species. Tandem-affinity purification MS/MS and co-immunoprecipitation analysis indicate NT processing of ADRA1D is not required to form scribble-syntrophin macromolecular complexes. Yet, label-free dynamic mass redistribution signaling assays demonstrate that 1-91 ADRA1D agonist responses were greater than WT ADRA1D. Mutagenesis of the cleavage site nullified the processing event, resulting in ADRA1D agonist responses less than the WT receptor. Thus, we propose that processing of the ADRA1D NT domain is a physiological mechanism employed by cells to generate a functional ADRA1D isoform with optimal pharmacodynamic properties.	[Aggarwal-Howarth, Stacey; Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Kountz, Timothy S.; Lee, Kyung-Soon; Aggarwal-Howarth, Stacey; Curran, Elizabeth; Park, Ji-Min; Harris, Dorathy-Ann; Stewart, Aaron; Hendrickson, Joseph; Wang, Edith H.; Scott, John D.; Hague, Chris] Univ Washington, Sch Med, Dept Pharmacol, 1959 Pacific Ave,Box 357280, Seattle, WA 98195 USA; [Camp, Nathan D.; Wolf-Yadlin, Alejandro] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hague, C (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, 1959 Pacific Ave,Box 357280, Seattle, WA 98195 USA.	chague@uw.edu	Wolf-Yadlin, Alejandro/E-6574-2011	Wolf-Yadlin, Alejandro/0000-0003-2909-3880	National Institutes of Health [RO1 GM100893, DK054441, DK105542]; National Institutes of Health, USPHS, National Research Service Award [T32GM007270]; National Institutes of Health Human Genome Research Institute [T32 HG00035]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441, R01DK105542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100893, T32GM007750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, USPHS, National Research Service Award; National Institutes of Health Human Genome Research Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants RO1 GM100893 (to C. H.) and DK054441 and DK105542 (to J. D. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Institutes of Health, USPHS, National Research Service Award, T32GM007270.; Supported by National Institutes of Health Human Genome Research Institute Grant T32 HG00035.	Andersson H, 2003, MOL PHARMACOL, V64, P570, DOI 10.1124/mol.64.3.570; Aono Y, 2015, BEHAV PHARMACOL, V26, P73, DOI 10.1097/FBP.0000000000000113; Belmer A, 2014, MOL PHARMACOL, V85, P127, DOI 10.1124/mol.113.089086; Bouchelouche K, 2005, J UROLOGY, V173, P657, DOI 10.1097/01.ju.0000143198.16610.84; Camp ND, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.11; Chalothorn D, 2002, MOL PHARMACOL, V61, P1008, DOI 10.1124/mol.61.5.1008; Chen Q, 2005, J UROLOGY, V174, P370, DOI 10.1097/01.ju.0000161210.17365.cc; Chen ZJ, 2006, J BIOL CHEM, V281, P12414, DOI 10.1074/jbc.M508651200; Dunham JH, 2009, BIOCHEMISTRY-US, V48, P10286, DOI 10.1021/bi9013775; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Fan LL, 2009, ACTA PHARMACOL SIN, V30, P1585, DOI 10.1038/aps.2009.160; Fang Ye, 2007, Journal of Pharmacological and Toxicological Methods, V55, P314, DOI 10.1016/j.vascn.2006.11.001; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; Garcia-Cazarin Mary L, 2008, J Mol Signal, V3, P6, DOI 10.1186/1750-2187-3-6; Garcia-Sainz JA, 2004, EUR J PHARMACOL, V500, P113, DOI 10.1016/j.ejphar.2004.07.016; Gong HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034003; GREEN SA, 1994, BIOCHEMISTRY-US, V33, P9414, DOI 10.1021/bi00198a006; Hague C, 2006, MOL PHARMACOL, V69, P45, DOI 10.1124/mol.105.014985; Hague C, 2004, J BIOL CHEM, V279, P15541, DOI 10.1074/jbc.M314014200; Hague C, 2004, J PHARMACOL EXP THER, V309, P388, DOI 10.1124/jpet.103.060509; Hakalahti AE, 2013, MOL PHARMACOL, V83, P129, DOI 10.1124/mol.112.080440; Hakalahti AE, 2010, J BIOL CHEM, V285, P28850, DOI 10.1074/jbc.M110.149989; Hampel C, 2002, J UROLOGY, V167, P1513, DOI 10.1016/S0022-5347(05)65355-4; Jensen BC, 2009, J AM COLL CARDIOL, V54, P1137, DOI 10.1016/j.jacc.2009.05.056; Jensen BC, 2009, N-S ARCH PHARMACOL, V379, P409, DOI 10.1007/s00210-008-0368-6; Kojima Y, 2011, J UROLOGY, V186, P1530, DOI 10.1016/j.juro.2011.05.048; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Levin MC, 2002, J BIOL CHEM, V277, P30429, DOI 10.1074/jbc.M200681200; Lin ZC, 2004, PHARMACOGENETICS, V14, P805, DOI 10.1097/00008571-200412000-00003; Lyssand JS, 2008, J BIOL CHEM, V283, P18792, DOI 10.1074/jbc.M801860200; Lyssand JS, 2010, P NATL ACAD SCI USA, V107, P21854, DOI 10.1073/pnas.1010819107; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; McCune DF, 2000, MOL PHARMACOL, V57, P659, DOI 10.1124/mol.57.4.659; Minneman KP, 2000, J NEUROCHEM, V74, P2392, DOI 10.1046/j.1471-4159.2000.0742392.x; Mishima K, 2004, BEHAV BRAIN RES, V152, P365, DOI 10.1016/j.bbr.2003.10.038; Morelli MB, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-921; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Overton MC, 2002, J BIOL CHEM, V277, P41463, DOI 10.1074/jbc.M205368200; Paavola KJ, 2012, MOL PHARMACOL, V82, P777, DOI 10.1124/mol.112.080309; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Pace AJ, 1999, J BIOL CHEM, V274, P11629, DOI 10.1074/jbc.274.17.11629; PEREZ DM, 1991, MOL PHARMACOL, V40, P876; Petrovska R, 2005, BRIT J PHARMACOL, V144, P651, DOI 10.1038/sj.bjp.0706087; PIASCIK MT, 1994, MOL PHARMACOL, V46, P30; Piascik MT, 1995, J PHARMACOL EXP THER, V275, P1583; Pupo AS, 2003, EUR J PHARMACOL, V462, P1, DOI 10.1016/S0014-2999(03)01292-5; Ramachandran R, 2008, BRIT J PHARMACOL, V153, pS263, DOI 10.1038/sj.bjp.0707507; Sadalge A, 2003, MOL PSYCHIATR, V8, P664, DOI 10.1038/sj.mp.4001351; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Strasser A, 2008, J PHARMACOL EXP THER, V326, P783, DOI 10.1124/jpet.108.140913; Tanoue A, 2002, HYPERTENSION, V40, P101, DOI 10.1161/01.HYP.0000022062.70639.1C; Uberti MA, 2005, J PHARMACOL EXP THER, V313, P16, DOI 10.1124/jpet.104.079541; Walden PD, 1999, J UROLOGY, V161, P635, DOI 10.1016/S0022-5347(01)61986-4; Wang SY, 2007, ACTA PHARMACOL SIN, V28, P359, DOI 10.1111/j.1745-7254.2007.00509.x; Yang M, 1998, J PHARMACOL EXP THER, V286, P841	55	20	20	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18210	18221		10.1074/jbc.M116.729517	http://dx.doi.org/10.1074/jbc.M116.729517			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382054	Green Published, hybrid			2022-12-26	WOS:000383241800014
J	Mei, ZZ; Chen, XY; Hu, SW; Wang, N; Ou, XL; Wang, J; Luo, HH; Liu, JH; Jiang, Y				Mei, Zhu-Zhong; Chen, Xin-Yu; Hu, Shui-Wang; Wang, Ni; Ou, Xiao-Li; Wang, Jing; Luo, Hai-Hua; Liu, Jinghua; Jiang, Yong			Kelch-like Protein 21 (KLHL21) Targets IB Kinase- to Regulate Nuclear Factor -Light Chain Enhancer of Activated B Cells (NF-kappa B) Signaling Negatively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; E3 ubiquitin ligase; NF-kappaB; protein-protein interaction; tumor necrosis factor (TNF); IKKbeta; KLHL21	IKK-BETA; ALPHA; EXPRESSION; TNF; PHOSPHORYLATION; DEGRADATION; DEFICIENCY; COMPLEX; INNATE; ROLES	Activation of IKK is the key step in canonical activation of NF-B signaling. Extensive work has provided insight into the mechanisms underlying IKK activation through the identification of context-specific regulators. However, the molecular processes responsible for its negative regulation are not completely understood. Here, we identified KLHL21, a member of the Kelch-like gene family, as a novel negative regulator of IKK. The expression of KLHL21 was rapidly down-regulated in macrophages upon treatment with proinflammatory stimuli. Overexpression of KLHL21 inhibited the activation of IKK and degradation of IB, whereas KLHL21 depletion via siRNA showed the opposite results. Coimmunoprecipitation assays revealed that KLHL21 specifically bound to the kinase domain of IKK via its Kelch domains and that this interaction was gradually attenuated upon TNF treatment. Furthermore, KLHL21 did not disrupt the interaction between IKK and TAK1, TRAF2, or IB. Also, KLHL21 did not require its E3 ubiquitin ligase activity for IKK inhibition. Our findings suggest that KLHL21 may exert its inhibitory function by binding to the kinase domain and sequestering the region from potential IKK inducers. Taken together, our data clearly demonstrate that KLHL21 negatively regulates TNF-activated NF-B signaling via targeting IKK, providing new insight into the mechanisms underlying NF-B regulation in cells.	[Mei, Zhu-Zhong; Chen, Xin-Yu; Hu, Shui-Wang; Wang, Ni; Ou, Xiao-Li; Wang, Jing; Luo, Hai-Hua; Liu, Jinghua; Jiang, Yong] Southern Med Univ, Dept Pathophysiol, Key Lab Transcript & Prote, Minist Educ China, Guangzhou 510515, Guangdong, Peoples R China	Ministry of Education, China; Southern Medical University - China	Mei, ZZ; Liu, JH; Jiang, Y (corresponding author), Southern Med Univ, Dept Pathophysiol, Key Lab Transcript & Prote, Minist Educ China, Guangzhou 510515, Guangdong, Peoples R China.	mzhuong@126.com; liujhua@163.com; jiang48231@163.com			National Natural Science Foundation of China [81272149, 81030055, 81372030]; Science and Technology Innovation Projects of the Department of Education of Guangdong Province [2013KJCX0040]; Guangdong Natural Science Foundation Grant [2015A030313294]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Projects of the Department of Education of Guangdong Province; Guangdong Natural Science Foundation Grant	This work was supported by National Natural Science Foundation of China Grants 81272149 (to J. L.) and 81030055 and 81372030 (to Y. J.); Science and Technology Innovation Projects of the Department of Education of Guangdong Province Grant 2013KJCX0040 (to Z. Z. M.); and Project Supported by Guangdong Natural Science Foundation Grant 2015A030313294 (to Z. Z. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Baltimore D, 2011, NAT IMMUNOL, V12, P683, DOI 10.1038/ni.2072; Bradford JW, 2014, ADV CANCER RES, V121, P125, DOI 10.1016/B978-0-12-800249-0.00003-2; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Djiane A, 2011, J CELL BIOL, V192, P189, DOI 10.1083/jcb.201007023; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hong YK, 2004, NAT GENET, V36, P683, DOI 10.1038/ng1383; Hu GQ, 2010, J BIOL CHEM, V285, P11800, DOI 10.1074/jbc.M109.079384; Kane CM, 2004, J IMMUNOL, V173, P7454, DOI 10.4049/jimmunol.173.12.7454; Kim JE, 2010, CELL SIGNAL, V22, P1645, DOI 10.1016/j.cellsig.2010.06.004; Kim YL, 2008, CELL SIGNAL, V20, P2127, DOI 10.1016/j.cellsig.2008.08.001; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Kroll J, 2005, MOL CELL BIOL, V25, P8531, DOI 10.1128/MCB.25.19.8531-8540.2005; Lee DF, 2009, MOL CELL, V36, P131, DOI 10.1016/j.molcel.2009.07.025; Li HY, 2008, NAT IMMUNOL, V9, P533, DOI 10.1038/ni.1600; Li SZ, 2014, BBA-MOL CELL RES, V1843, P1365, DOI 10.1016/j.bbamcr.2014.03.028; Liu F, 2012, IMMUNOL REV, V246, P239, DOI 10.1111/j.1600-065X.2012.01107.x; Liu JH, 2010, J IMMUNOL, V184, P5802, DOI 10.4049/jimmunol.0904127; Macagno A, 2006, J EXP MED, V203, P1481, DOI 10.1084/jem.20060136; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Murray RZ, 2005, J BIOL CHEM, V280, P10478, DOI 10.1074/jbc.M414420200; Pannicke U, 2013, NEW ENGL J MED, V369, P2504, DOI 10.1056/NEJMoa1309199; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Siebert S, 2015, PHARMACOL REV, V67, P280, DOI 10.1124/pr.114.009639; Smale ST, 2011, NAT IMMUNOL, V12, P689, DOI 10.1038/ni.2070; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Stolovitzky GA, 2005, P NATL ACAD SCI USA, V102, P1402, DOI 10.1073/pnas.0406555102; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yao F, 2014, CELL RES, V24, P359, DOI 10.1038/cr.2013.162; Yarilina A, 2008, NAT IMMUNOL, V9, P378, DOI 10.1038/ni1576	36	10	10	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18176	18189		10.1074/jbc.M116.715854	http://dx.doi.org/10.1074/jbc.M116.715854			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27387502	hybrid, Green Published			2022-12-26	WOS:000383241800011
J	Raltschev, C; Hetsch, F; Winkelmann, A; Meier, JC; Semtner, M				Raltschev, Constanze; Hetsch, Florian; Winkelmann, Aline; Meier, Jochen C.; Semtner, Marcus			Electrophysiological Signature of Homomeric and Heteromeric Glycine Receptor Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alternative splicing; glycine receptor; patch clamp; receptor desensitization; recombinant protein expression; current-voltage relationship; desensitization; homomeric	RECTIFIER K+ CHANNELS; GATED ION CHANNELS; VOLTAGE-DEPENDENCE; FUNCTIONAL-CHARACTERIZATION; DESENSITIZATION BEHAVIOR; CHLORIDE CONDUCTANCE; HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; ANION PERMEATION; LIGAND-BINDING	Glycine receptors are chloride-permeable, ligand-gated ion channels and contribute to the inhibition of neuronal firing in the central nervous system or to facilitation of neurotransmitter release if expressed at presynaptic sites. Recent structure-function studies have provided detailed insights into the mechanisms of channel gating, desensitization, and ion permeation. However, most of the work has focused only on comparing a few isoforms, and among studies, different cellular expression systems were used. Here, we performed a series of experiments using recombinantly expressed homomeric and heteromeric glycine receptor channels, including their splice variants, in the same cellular expression system to investigate and compare their electrophysiological properties. Our data show that the current-voltage relationships of homomeric channels formed by the 2 or 3 subunits change upon receptor desensitization from a linear to an inwardly rectifying shape, in contrast to their heteromeric counterparts. The results demonstrate that inward rectification depends on a single amino acid (Ala(254)) at the inner pore mouth of the channels and is closely linked to chloride permeation. We also show that the current-voltage relationships of glycine-evoked currents in primary hippocampal neurons are inwardly rectifying upon desensitization. Thus, the alanine residue Ala(254) determines voltage-dependent rectification upon receptor desensitization and reveals a physio-molecular signature of homomeric glycine receptor channels, which provides unprecedented opportunities for the identification of these channels at the single cell level.	[Raltschev, Constanze] Univ Basel, Dept Biomed, Cellular Neurophysiol, Pestalozzistr 20, CH-4056 Basel, Switzerland; [Hetsch, Florian; Winkelmann, Aline; Meier, Jochen C.] Tech Univ Carolo Wilhelmina Braunschweig, Div Cell Physiol, Spielmannstr 7, D-38106 Braunschweig, Germany; [Semtner, Marcus] Max Delbruck Ctr Mol Med MDC, Cellular Neurosci, Robert Rossle Str 10, D-13092 Berlin, Germany; [Raltschev, Constanze] Univ Zurich, Dept Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland	University of Basel; Braunschweig University of Technology; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Zurich	Meier, JC (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Div Cell Physiol, Spielmannstr 7, D-38106 Braunschweig, Germany.; Semtner, M (corresponding author), Max Delbruck Ctr Mol Med MDC, Cellular Neurosci, Robert Rossle Str 10, D-13092 Berlin, Germany.	jochen.meier@tu-braunschweig.de; marcus.semtner@mdc-berlin.de		Meier, Jochen/0000-0001-5574-3336; , Florian/0000-0001-8743-3818	Bundesministerium fur Bildung und Forschung (BMBF); Helmholtz Association [VH-NG-246]; Deutsche Forschungsgemeinschaft (DFG) [SPP 1784 ME2075/7-1]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Helmholtz Association(Helmholtz Association); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Bundesministerium fur Bildung und Forschung (BMBF) Grant Era-Net NEURON II CIPRESS (to J. C. M.), Helmholtz Association Grant VH-NG-246 (to J. C. M.), and Deutsche Forschungsgemeinschaft (DFG) Priority Programme SPP 1784 ME2075/7-1 (to J. C. M.). The authors declare that they have no conflicts of interest with the contents of the article.	AKAIKE N, 1989, J NEUROPHYSIOL, V62, P1400, DOI 10.1152/jn.1989.62.6.1400; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; BORMANN J, 1993, EMBO J, V12, P3729, DOI 10.1002/j.1460-2075.1993.tb06050.x; BORMANN J, 1987, J PHYSIOL-LONDON, V385, P243, DOI 10.1113/jphysiol.1987.sp016493; Breitinger HG, 2009, J BIOL CHEM, V284, P28624, DOI 10.1074/jbc.M109.043174; Breitinger HG, 2002, J NEUROCHEM, V83, P30, DOI 10.1046/j.1471-4159.2002.01109.x; Breitinger HG, 2001, J BIOL CHEM, V276, P29657, DOI 10.1074/jbc.M100446200; Breitinger U, 2004, J BIOL CHEM, V279, P1627, DOI 10.1074/jbc.M303811200; BREWER GJ, 1989, BRAIN RES, V494, P65, DOI 10.1016/0006-8993(89)90144-3; Caliskan G, 2016, CEREB CORTEX, V26, P2325, DOI 10.1093/cercor/bhw001; Chen XB, 2009, NEUROPHARMACOLOGY, V56, P318, DOI 10.1016/j.neuropharm.2008.07.001; Chen Z, 2007, NEUROPHARMACOLOGY, V52, P1606, DOI 10.1016/j.neuropharm.2007.03.005; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cubelos B, 2005, CEREB CORTEX, V15, P448, DOI 10.1093/cercor/bhh147; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Eichler SA, 2009, EUR J NEUROSCI, V30, P1077, DOI 10.1111/j.1460-9568.2009.06903.x; FABER DS, 1987, J NEUROSCI, V7, P807; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; FATIMASHAD K, 1993, P ROY SOC B-BIOL SCI, V253, P69, DOI 10.1098/rspb.1993.0083; Forstera B, 2014, J CELL SCI, V127, P3687, DOI 10.1242/jcs.146662; Forstera B, 2010, BRAIN, V133, P3778, DOI 10.1093/brain/awq298; Fucile S, 2000, NEURON, V28, P571, DOI 10.1016/S0896-6273(00)00134-3; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; GUNDERSEN CB, 1984, PROC R SOC SER B-BIO, V221, P235, DOI 10.1098/rspb.1984.0032; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Harvey RJ, 2004, SCIENCE, V304, P884, DOI 10.1126/science.1094925; Heindl C, 2007, NEUROSCI LETT, V429, P59, DOI 10.1016/j.neulet.2007.10.001; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Karlsson U, 2011, J GEN PHYSIOL, V138, P609, DOI 10.1085/jgp.201110674; Keramidas A, 2000, BIOPHYS J, V79, P247, DOI 10.1016/S0006-3495(00)76287-4; Keramidas A, 2004, PROG BIOPHYS MOL BIO, V86, P161, DOI 10.1016/j.pbiomolbio.2003.09.002; Keramidas A, 2002, J GEN PHYSIOL, V119, P393, DOI 10.1085/jgp.20028552; Kubota H, 2010, BIOCHEM BIOPH RES CO, V393, P587, DOI 10.1016/j.bbrc.2010.02.019; KUHSE J, 1991, FEBS LETT, V283, P73, DOI 10.1016/0014-5793(91)80557-J; Langlhofer G, 2015, NEUROSCI LETT, V600, P176, DOI 10.1016/j.neulet.2015.06.017; Legendre P, 2002, MOL PHARMACOL, V62, P817, DOI 10.1124/mol.62.4.817; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Legendre P, 1999, J NEUROPHYSIOL, V82, P2120, DOI 10.1152/jn.1999.82.5.2120; Legendre P, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.023.2009; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; MALOSIO ML, 1991, J BIOL CHEM, V266, P2048; Meiselbach H, 2014, J BIOL CHEM, V289, P29135, DOI 10.1074/jbc.M114.559138; Miller PS, 2004, BRIT J PHARMACOL, V143, P19, DOI 10.1038/sj.bjp.0705875; Moorhouse AJ, 2002, J GEN PHYSIOL, V119, P411, DOI 10.1085/jgp.20028553; Moroni M, 2011, J NEUROSCI, V31, P14095, DOI 10.1523/JNEUROSCI.1985-11.2011; Nikolic Z, 1998, J BIOL CHEM, V273, P19708, DOI 10.1074/jbc.273.31.19708; Papke D, 2014, J NEUROSCI, V34, P7238, DOI 10.1523/JNEUROSCI.5105-13.2014; Pilorge M, 2016, MOL PSYCHIATR, V21, P936, DOI 10.1038/mp.2015.139; Plant TD, 2005, N-S ARCH PHARMACOL, V371, P266, DOI 10.1007/s00210-005-1055-5; Saul B, 1999, J NEUROSCI, V19, P869; Schenck S, 2009, NAT NEUROSCI, V12, P156, DOI 10.1038/nn.2248; Shan Q, 2012, J BIOL CHEM, V287, P21244, DOI 10.1074/jbc.M111.337741; Song YP, 2010, EUR J PHARMACOL, V636, P59, DOI 10.1016/j.ejphar.2010.03.020; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sugiharto S, 2008, BIOPHYS J, V95, P4698, DOI 10.1529/biophysj.107.125690; TABB JS, 1992, J BIOL CHEM, V267, P15412; Webb TI, 2007, CURR PHARM DESIGN, V13, P2350; Weltzien F, 2012, J COMP NEUROL, V520, P3962, DOI 10.1002/cne.23139; Winkelmann A, 2014, J CLIN INVEST, V124, P696, DOI 10.1172/JCI71472; Yang Z, 2007, J NEUROCHEM, V103, P580, DOI 10.1111/j.1471-4159.2007.04850.x; Yevenes GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023886; ZHANG ZW, 1995, J PHYSIOL-LONDON, V487, P395, DOI 10.1113/jphysiol.1995.sp020888; Zhorov BS, 2000, BIOPHYS J, V78, P1786, DOI 10.1016/S0006-3495(00)76729-4	66	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					18030	18040		10.1074/jbc.M116.735084	http://dx.doi.org/10.1074/jbc.M116.735084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27382060	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000383241300044
J	Zhao, CH; Zeng, HW; Wu, RTY; Cheng, WH				Zhao, Changhui; Zeng, Huawei; Wu, Ryan T. Y.; Cheng, Wen-Hsing			Loss of Selenium-Binding Protein 1 Decreases Sensitivity to Clastogens and Intracellular Selenium Content in HeLa Cells	PLOS ONE			English	Article							CELLULAR GLUTATHIONE-PEROXIDASE; COLORECTAL-CANCER; DNA-DAMAGE; OVARIAN-CANCER; IN-VITRO; EXPRESSION; MICE; SURVIVAL; OVEREXPRESSION; CARCINOGENESIS	Selenium-binding protein 1 (SBP1) is not a selenoprotein but structurally binds selenium. Loss of SBP1 during carcinogenesis usually predicts poor prognosis. Because genome instability is a hallmark of cancer, we hypothesize that SBP1 sequesters cellular selenium and sensitizes cancer cells to DNA-damaging agents. To test this hypothesis, we knocked down SBP1 expression in HeLa cervical cancer cells by employing a short hairpin RNA (shRNA) approach. Reduced sensitivity to hydrogen peroxide, paraquat and camptothecin, reactive oxygen species content, and intracellular retention of selenium after selenomethionine treatment were observed in SBP1 shRNA HeLa cells. Results from Western analyses showed that treatment of HeLa cells with selenomethionine resulted in increased SBP1 protein expression in a dose-dependent manner. Knockdown of SBP1 rendered HeLa cells increased expression of glutathione peroxidase-1 but not glutathione peroxidase-4 protein levels and accelerated migration from a wound. Altogether, SBP1 retains supplemental selenium and sensitizes HeLa cancer cells to clastogens, suggesting a new cancer treatment strategy by sequestering selenium through SBP1.	[Zhao, Changhui] Jilin Univ, Coll Food Sci & Engn, Dept Food Qual & Safety, Changchun 130062, Jilin Province, Peoples R China; [Zhao, Changhui; Wu, Ryan T. Y.] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Zeng, Huawei] USDA ARS, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58202 USA; [Cheng, Wen-Hsing] Mississippi State Univ, Dept Food Sci Nutr & Hlth Promot, Mississippi State, MS 39762 USA	Jilin University; University System of Maryland; University of Maryland College Park; United States Department of Agriculture (USDA); Mississippi State University	Zhao, CH (corresponding author), Jilin Univ, Coll Food Sci & Engn, Dept Food Qual & Safety, Changchun 130062, Jilin Province, Peoples R China.; Zhao, CH (corresponding author), Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA.; Cheng, WH (corresponding author), Mississippi State Univ, Dept Food Sci Nutr & Hlth Promot, Mississippi State, MS 39762 USA.	czhao@jlu.edu.cn; wc523@msstate.edu	Zhao, Changhui/N-2378-2019	Zhao, Changhui/0000-0002-1882-7490	USDA intramural program; Chinese Top University Graduate Student Studying Abroad Program; China Scholarship Council; ARS [ARS-0426336] Funding Source: Federal RePORTER	USDA intramural program; Chinese Top University Graduate Student Studying Abroad Program; China Scholarship Council(China Scholarship Council); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	H.W. Zeng is supported by the USDA intramural program. C.Z. was partially supported by the Chinese Top University Graduate Student Studying Abroad Program, China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baliga MS, 2007, BIOL TRACE ELEM RES, V115, P227, DOI 10.1007/BF02685998; BANSAL MP, 1989, CARCINOGENESIS, V10, P541, DOI 10.1093/carcin/10.3.541; Chen GA, 2004, J PATHOL, V202, P321, DOI 10.1002/path.1524; Cheng WH, 1997, J NUTR, V127, P675, DOI 10.1093/jn/127.5.675; Cheung-Ong K, 2013, CHEM BIOL, V20, P648, DOI 10.1016/j.chembiol.2013.04.007; Fang WF, 2010, CARCINOGENESIS, V31, P1360, DOI 10.1093/carcin/bgq114; Fukushima Tetsuhito, 2002, Environ Health Prev Med, V7, P89, DOI 10.1265/ehpm.2002.89; Glatt SJ, 2005, P NATL ACAD SCI USA, V102, P15533, DOI 10.1073/pnas.0507666102; He QY, 2004, PROTEOMICS, V4, P3276, DOI 10.1002/pmic.200300916; Huang C, 2012, CLIN CANCER RES, V18, P3042, DOI 10.1158/1078-0432.CCR-12-0183; Huang KC, 2006, INT J CANCER, V118, P2433, DOI 10.1002/ijc.21671; Jeong JY, 2009, BIOCHEM BIOPH RES CO, V379, P583, DOI 10.1016/j.bbrc.2008.12.110; Jerome-Morais A, 2012, PROSTATE, V72, P1006, DOI 10.1002/pros.21506; Kalivendi SV, 2005, BIOCHEM J, V389, P527, DOI 10.1042/BJ20050285; Kim H, 2006, PROTEOMICS, V6, P3466, DOI 10.1002/pmic.200500629; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; LI YB, 1994, CARCINOGENESIS, V15, P1421, DOI 10.1093/carcin/15.7.1421; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Lu YP, 1997, CANCER RES, V57, P1468; McClung JP, 2004, P NATL ACAD SCI USA, V101, P8852, DOI 10.1073/pnas.0308096101; Pass HI, 2004, CLIN CANCER RES, V10, P849, DOI 10.1158/1078-0432.CCR-0607-3; Pohl NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007774; PUMFORD NR, 1992, BIOCHEM BIOPH RES CO, V182, P1348, DOI 10.1016/0006-291X(92)91881-P; Qi YM, 2010, J BIOL CHEM, V285, P33010, DOI 10.1074/jbc.M110.137406; Raucci R, 2011, BBA-PROTEINS PROTEOM, V1814, P513, DOI 10.1016/j.bbapap.2011.02.006; Roman M, 2014, METALLOMICS, V6, P25, DOI 10.1039/c3mt00185g; Safaralizadeh R, 2005, NUTR J, V4, DOI 10.1186/1475-2891-4-32; Sawiris GP, 2002, CANCER RES, V62, P2923; Silvers AL, 2010, CLIN CANCER RES, V16, P2009, DOI 10.1158/1078-0432.CCR-09-2801; Singh K, 2015, HUM EXP TOXICOL, V34, P380, DOI 10.1177/0960327114533577; Slimen IB, 2014, INT J HYPERTHER, V30, P513, DOI 10.3109/02656736.2014.971446; Stewart MS, 1999, FREE RADICAL BIO MED, V26, P42, DOI 10.1016/S0891-5849(98)00147-6; Stone JR, 2004, ARCH BIOCHEM BIOPHYS, V422, P119, DOI 10.1016/j.abb.2003.12.029; Thiry C, 2013, BRIT J NUTR, V109, P2126, DOI 10.1017/S0007114512004412; Torrealba JR, 2005, AM J TRANSPLANT, V5, P58, DOI 10.1111/j.1600-6143.2004.00651.x; Van Cauwenbergh R, 2010, TRACE ELEM ELECTROLY, V27, P47; Wu RTY, 2014, J BIOL CHEM, V289, P34378, DOI 10.1074/jbc.M114.611970; Yang MH, 1998, CANCER RES, V58, P3150; Yang Y, 2009, ONCOL RES, V18, P1; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005; Zeng HW, 2011, BIOL TRACE ELEM RES, V143, P1209, DOI 10.1007/s12011-010-8935-3	42	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158650	10.1371/journal.pone.0158650	http://dx.doi.org/10.1371/journal.pone.0158650			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404728	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508200014
J	Darzi, S; Tiong, SK; Islam, MT; Soleymanpour, HR; Kibria, S				Darzi, Soodabeh; Tiong, Sieh Kiong; Islam, Mohammad Tariqul; Soleymanpour, Hassan Rezai; Kibria, Salehin			An Experience Oriented-Convergence Improved Gravitational Search Algorithm for Minimum Variance Distortionless Response Beamforming Optimum	PLOS ONE			English	Article							LINEAR ANTENNA-ARRAYS; BEAM PATTERN SYNTHESIS; PARAMETERS IDENTIFICATION; DIFFERENTIAL EVOLUTION; OPTIMIZATION; AMPLITUDE; DESIGN; SYSTEM	An experience oriented-convergence improved gravitational search algorithm (ECGSA) based on two new modifications, searching through the best experiments and using of a dynamic gravitational damping coefficient (a), is introduced in this paper. ECGSA saves its best fitness function evaluations and uses those as the agents' positions in searching process. In this way, the optimal found trajectories are retained and the search starts from these trajectories, which allow the algorithm to avoid the local optimums. Also, the agents can move faster in search space to obtain better exploration during the first stage of the searching process and they can converge rapidly to the optimal solution at the final stage of the search process by means of the proposed dynamic gravitational damping coefficient. The performance of ECGSA has been evaluated by applying it to eight standard benchmark functions along with six complicated composite test functions. It is also applied to adaptive beamforming problem as a practical issue to improve the weight vectors computed by minimum variance distortionless response (MVDR) beamforming technique. The results of implementation of the proposed algorithm are compared with some well-known heuristic methods and verified the proposed method in both reaching to optimal solutions and robustness.	[Darzi, Soodabeh] Univ Tenaga Nas, Coll Engn, Ctr Syst & Machine Intelligence, Selangor, Malaysia; [Tiong, Sieh Kiong] Univ Tenaga Nas, Power Engn Ctr, Selangor, Malaysia; [Islam, Mohammad Tariqul; Kibria, Salehin] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Bangi, Malaysia; [Soleymanpour, Hassan Rezai] Semnan Univ, Dept Elect Engn, Semnan, Iran	Universiti Tenaga Nasional; Universiti Tenaga Nasional; Universiti Kebangsaan Malaysia; Semnan University	Darzi, S (corresponding author), Univ Tenaga Nas, Coll Engn, Ctr Syst & Machine Intelligence, Selangor, Malaysia.	sdtutn@yahoo.com	Islam, Mohammad Tariqul/M-7377-2016; Tiong, Sieh Kiong/GLR-1734-2022	Islam, Mohammad Tariqul/0000-0002-4929-3209; 	Universiti Tenaga Nasional	Universiti Tenaga Nasional	This study is supported by Universiti Tenaga Nasional. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdagli A, 2003, MICROW OPT TECHN LET, V36, P16, DOI 10.1002/mop.10657; Akdagli A, 2006, ELECTROMAGNETICS, V26, P615, DOI 10.1080/02726340600978349; Ashouri M, 2013, J ADV COMPUT RES Q, V4, P41; Babayigit B, 2006, J ELECTROMAGNET WAVE, V20, P1007, DOI 10.1163/156939306776930222; BARRETT M, 1994, ELECTRON COMMUN ENG, V6, P203, DOI 10.1049/ecej:19940404; CAPON J, 1969, P IEEE, V57, P1408, DOI 10.1109/PROC.1969.7278; Dahrouj H, 2010, IEEE T WIREL COMMUN, V9, P1748, DOI 10.1109/TWC.2010.05.090936; Darzi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140526; Darzi S, 2014, SCI WORLD J, DOI 10.1155/2014/724639; Derrac J, 2011, SWARM EVOL COMPUT, V1, P3, DOI 10.1016/j.swevo.2011.02.002; Gu BJ, 2013, INT J INNOV COMPUT I, V9, P4531; Guney K, 2007, PROG ELECTROMAGN RES, V70, P21, DOI 10.2528/PIER07011204; Guney K., 2001, PROGR ELECTROMAGNETI, V33, P167; Guney K, 2006, NEURAL NETW WORLD, V16, P489; Han XH, 2012, INFORM SCIENCES, V208, P14, DOI 10.1016/j.ins.2012.04.039; Holland J. H., 1973, SIAM Journal on Computing, V2, P88, DOI 10.1137/0202009; Karaboga D, 2004, INT J ELECTRON, V91, P241, DOI 10.1080/00207210410001690638; Karaboga N, 2002, INT J RF MICROW C E, V12, P375, DOI 10.1002/mmce.10034; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/icnn.1995.488968; Khajehzadeh M, 2013, STRUCT ENG MECH, V45, P111, DOI 10.12989/sem.2013.45.1.111; Khajehzadeh M, 2012, ENG APPL ARTIF INTEL, V25, P1589, DOI 10.1016/j.engappai.2012.01.011; Khatibinia M, 2014, APPL SOFT COMPUT, V16, P223, DOI 10.1016/j.asoc.2013.12.008; Khodier MM, 2005, IEEE T ANTENN PROPAG, V53, P2674, DOI 10.1109/TAP.2005.851762; Kiong TS, 2006, J APPL SCI, V6, P1766; Li CS, 2012, CHAOS SOLITON FRACT, V45, P539, DOI 10.1016/j.chaos.2012.02.005; Li CS, 2011, ENERG CONVERS MANAGE, V52, P374, DOI 10.1016/j.enconman.2010.07.012; Liang JJ, 2005, 2005 IEEE SWARM INTELLIGENCE SYMPOSIUM, P68; Liu F. L., 2011, Progress In Electromagnetics Research C, V20, P239; Lorenz RG, 2005, IEEE T SIGNAL PROCES, V53, P1684, DOI 10.1109/TSP.2005.845436; Mirjalili S, 2012, APPL MATH COMPUT, V218, P11125, DOI 10.1016/j.amc.2012.04.069; Nourani Y, 1998, J PHYS A-MATH GEN, V31, P8373, DOI 10.1088/0305-4470/31/41/011; Omar O. Kaid, 2012, Progress In Electromagnetics Research C, V32, P65; Rashedi E, 2009, INFORM SCIENCES, V179, P2232, DOI 10.1016/j.ins.2009.03.004; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tiong S. K., 2014, SCI WORLD J; van den Bergh F, 2001, ANAL PARTICLE SWARM, P315; Xu Z, 2008, PROG ELECTROMAGN RES, V79, P75, DOI 10.2528/PIER07091901; Xue B, 2013, IEEE T CYBERNETICS, V43, P1656, DOI 10.1109/TSMCB.2012.2227469; Yang SW, 2004, INT J RF MICROW C E, V14, P57, DOI 10.1002/mmce.10118; Zaharis ZD, 2011, PROG ELECTROMAGN RES, V117, P165, DOI 10.2528/PIER11041904	42	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0156749	10.1371/journal.pone.0156749	http://dx.doi.org/10.1371/journal.pone.0156749			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27399904	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508100001
J	Hayashi, H; Wu, Q; Horie, M				Hayashi, Hideki; Wu, Qi; Horie, Minoru			Association between Progressive Intraventricular Conduction Disturbance and Cardiovascular Events	PLOS ONE			English	Article							BUNDLE-BRANCH-BLOCK; CARDIAC-RESYNCHRONIZATION THERAPY; CONGESTIVE-HEART-FAILURE; QRS DURATION; GENERAL-POPULATION; MORTALITY; DEATH; PREVENTION; PREDICTOR; RISK	Background Prolonged QRS duration on electrocardiogram (ECG) has been known as a poor prognostic marker. However, little is known about association between progressive intraventricular conduction disturbance and cardiovascular prognosis. Methods From among a database containing 359,737 12-lead ECG recordings, patients whose QRS duration progressively increased from <120 msec to >= 120 msec were selected using software. The prognosis of patients was searched by medical record. The primary endpoint was defined as heart failure hospitalization. The secondary endpoint was heart failure hospitalization, device implantation, or cardiovascular death. Results A total of 143 patients (100 males; age, 58.9 +/- 11.1 years) were enrolled in this study. QRS duration increased by 46.4 +/- 13.8 msec, manifesting right bundle branch block (RBBB) in 99 (69.2%) patients and non-RBBB (i.e., left bundle branch block, RBBB with left anterior hemiblock, or nonspecific intraventricular conduction disturbance) in 44 (30.8%). During the follow-up (mean, 16.6 +/- 5.3 years), 44 (30.3%), 15 (10.3%), and 6 (4.1%) patients resulted in heart failure hospitalization, device implantation, and cardiovascular death, respectively. Multivariate Cox proportional hazards models revealed that 1) the temporal increase in QRS duration was associated with the primary endpoint (hazard ratio [HR] 1.98; 95% confidence interval [CI] 1.05-3.80; p = 0.04) and the secondary endpoint (HR 2.79; 95% CI 1.55-5.00; p = 0.0001) and 2) the development of non-RBBB was associated with the primary endpoint (HR 3.02; 95% CI 1.59-5.73; p = 0.0001) and the secondary endpoint (HR 2.82; 95% CI 1.57-5.09; p = 0.001). Conclusion The temporal increase in QRS duration and the development of non-RBBB patterns were independently associated with adverse cardiovascular prognosis.	[Hayashi, Hideki; Wu, Qi; Horie, Minoru] Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga, Japan	Shiga University of Medical Science	Hayashi, H (corresponding author), Shiga Univ Med Sci, Dept Cardiovasc & Resp Med, Otsu, Shiga, Japan.	hayashih@belle.shiga-med.ac.jp	Horie, Minoru/ABG-7128-2020					Adesanya CO, 2008, ANN NONINVAS ELECTRO, V13, P165, DOI 10.1111/j.1542-474X.2008.00216.x; Aro AL, 2011, CIRC-ARRHYTHMIA ELEC, V4, P704, DOI 10.1161/CIRCEP.111.963561; Auricchio A, 2004, CIRCULATION, V109, P1133, DOI 10.1161/01.CIR.0000118502.91105.F6; Bleeker GB, 2004, J CARDIOVASC ELECTR, V15, P544, DOI 10.1046/j.1540-8167.2004.03604.x; Bongioanni S, 2007, AM J CARDIOL, V100, P503, DOI 10.1016/j.amjcard.2007.03.049; Desai AD, 2006, AM J MED, V119, P600, DOI 10.1016/j.amjmed.2005.08.028; Eriksson P, 2005, EUR HEART J, V26, P2300, DOI 10.1093/eurheartj/ehi580; Fahy GJ, 1996, AM J CARDIOL, V77, P1185, DOI 10.1016/S0002-9149(96)00160-9; Grigioni F, 2002, J HEART LUNG TRANSPL, V21, P899, DOI 10.1016/S1053-2498(02)00431-X; Haataja P, 2015, ANN MED, V47, P74, DOI 10.3109/07853890.2014.985704; Kashani A, 2005, J AM COLL CARDIOL, V46, P2183, DOI 10.1016/j.jacc.2005.01.071; Kawaguchi T, 2013, CIRC J, V77, P60, DOI 10.1253/circj.CJ-12-0849; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; SCHNEIDER JF, 1980, ANN INTERN MED, V92, P37, DOI 10.7326/0003-4819-92-1-37; SCHNEIDER JF, 1985, AM J CARDIOL, V55, P1332, DOI 10.1016/0002-9149(85)90499-0; Shamim W, 2002, HEART, V88, P47, DOI 10.1136/heart.88.1.47; Shenkman HJ, 2002, CHEST, V122, P528, DOI 10.1378/chest.122.2.528; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Wang NC, 2008, JAMA-J AM MED ASSOC, V299, P2656, DOI 10.1001/jama.299.22.2656; Zareba W, 2011, CIRCULATION, V123, P1061, DOI 10.1161/CIRCULATIONAHA.110.960898; Zimetbaum PJ, 2004, CIRCULATION, V110, P766, DOI 10.1161/01.CIR.0000139311.32278.32	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157412	10.1371/journal.pone.0157412	http://dx.doi.org/10.1371/journal.pone.0157412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391877	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400009
J	Hollander, MR; de Waard, GA; Konijnenberg, LSF; Meijer-van Putten, RME; van den Brom, CE; Paauw, N; de Vries, HE; van de Ven, PM; Aman, J; Van Nieuw-Amerongen, GP; Hordijk, PL; Niessen, HWM; Horrevoets, AJG; Van Royen, N				Hollander, Maurits R.; de Waard, Guus A.; Konijnenberg, Lara S. F.; Meijer-van Putten, Rosalie M. E.; van den Brom, Charissa E.; Paauw, Nanne; de Vries, Helga E.; van de Ven, Peter M.; Aman, Jurjan; Van Nieuw-Amerongen, Geerten P.; Hordijk, Peter L.; Niessen, Hans W. M.; Horrevoets, Anton J. G.; Van Royen, Niels			Dissecting the Effects of Ischemia and Reperfusion on the Coronary Microcirculation in a Rat Model of Acute Myocardial Infarction	PLOS ONE			English	Article							NO-REFLOW PHENOMENON; MICROVASCULAR OBSTRUCTION; ISCHEMIA/REPERFUSION INJURY; INTRAMYOCARDIAL HEMORRHAGE; VASCULAR-PERMEABILITY; THROMBUS ASPIRATION; ARTERY OCCLUSION; RANDOMIZED-TRIAL; CELL INJURY; BLOOD-FLOW	Background Microvascular injury (MVI) after coronary ischemia-reperfusion is associated with high morbidity and mortality. Both ischemia and reperfusion are involved in MVI, but to what degree these phases contribute is unknown. Understanding the etiology is essential for the development of new potential therapies. Methods and Findings Rats were divided into 3 groups receiving either 30 minutes ischemia, 90 minutes ischemia or 30 minutes ischemia followed by 60 minutes reperfusion. Subsequently hearts were ex-vivo perfused in a Langendorff-model. Fluorescence and electron microscopy was used for analysis of capillary density, vascular permeability and ultrastructure. Most MVI was observed after 30 minutes ischemia followed by 60 minutes reperfusion. In comparison to the 30' and 90' ischemia group, wall thickness decreased (207.0 +/- 74 vs 407.8 +/- 75 and 407.5 +/- 71, p = 0.02). Endothelial nuclei in the 30'-60' group showed irreversible damage and decreased chromatin density variation (50.5 +/- 9.4, 35.4 +/- 7.1 and 23.7 +/- 3.8, p = 0.03). Cell junction density was lowest in the 30'-60' group (0.15 +/- 0.02 vs 2.5 +/- 0.6 and 1.8 +/- 0.7, p<0.01). Microsphere extravasation was increased in both the 90' ischemia and 30'-60' group. Conclusions Ischemia alone for 90 minutes induces mild morphological changes to the coronary micro-circulation, with increased vascular permeability. Ischemia for 30 minutes, followed by 60 minutes of reperfusion, induces massive MVI. This shows the direct consequences of reperfusion on the coronary microcirculation. These data imply that a therapeutic window exists to protect the microcirculation directly upon coronary revascularization.	[Hollander, Maurits R.; de Waard, Guus A.; Konijnenberg, Lara S. F.; Meijer-van Putten, Rosalie M. E.; Van Royen, Niels] Vrije Univ Amsterdam Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [Hollander, Maurits R.; de Waard, Guus A.; Konijnenberg, Lara S. F.; Meijer-van Putten, Rosalie M. E.; van den Brom, Charissa E.; Aman, Jurjan; Van Nieuw-Amerongen, Geerten P.; Hordijk, Peter L.; Niessen, Hans W. M.; Horrevoets, Anton J. G.; Van Royen, Niels] Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Amsterdam, Netherlands; [van den Brom, Charissa E.] Vrije Univ Amsterdam Med Ctr, Dept Anesthesiol, Amsterdam, Netherlands; [Paauw, Nanne; de Vries, Helga E.; Horrevoets, Anton J. G.] Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [van de Ven, Peter M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Aman, Jurjan; Van Nieuw-Amerongen, Geerten P.; Hordijk, Peter L.] Vrije Univ Amsterdam Med Ctr, Dept Physiol, Amsterdam, Netherlands; [Niessen, Hans W. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol & Cardiac Surg, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Van Royen, N (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Cardiol, Amsterdam, Netherlands.; Van Royen, N (corresponding author), Vrije Univ Amsterdam Med Ctr, Inst Cardiovasc Res, Amsterdam, Netherlands.	n.vanroyen@vumc.nl	van den Brom, Charissa/AAG-7246-2019; Konijnenberg, Lara S.F./Q-4002-2018; van Royen, Niels/Q-1097-2017; de+Waard, Guus/K-5639-2019	Konijnenberg, Lara S.F./0000-0002-2634-2864; Hordijk, Peter/0000-0002-3348-078X; de Vries, Helga/0000-0001-7904-7124; van den Brom, Charissa/0000-0002-0886-1388; Niessen, Hans/0000-0001-9404-9822	Institute for Cardiovascular Research of the VU University of Amsterdam (ICaR-VU); Netherlands Heart Foundation (NHF) (The Hague) [2011T072]	Institute for Cardiovascular Research of the VU University of Amsterdam (ICaR-VU); Netherlands Heart Foundation (NHF) (The Hague)	This study was supported by the Institute for Cardiovascular Research of the VU University of Amsterdam (ICaR-VU). GPvNA was supported by the Netherlands Heart Foundation (NHF) (The Hague, grant 2011T072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2014, ONCOTARGET, V5, P2761, DOI 10.18632/oncotarget.1942; Amado LC, 2004, J AM COLL CARDIOL, V43, P1291, DOI 10.1016/j.jacc.2003.11.034; Aman J, 2012, CIRCULATION, V126, P2728, DOI 10.1161/CIRCULATIONAHA.112.134304; AMBROSIO G, 1989, CIRCULATION, V80, P1846, DOI 10.1161/01.CIR.80.6.1846; BACHE RJ, 1974, J CLIN INVEST, V54, P1462, DOI 10.1172/JCI107894; Betgem RP, 2015, NAT REV CARDIOL, V12, P156, DOI 10.1038/nrcardio.2014.188; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; Bruder O, 2008, HERZ, V33, P136, DOI 10.1007/s00059-008-3102-8; CAMILLERI JP, 1983, EXP MOL PATHOL, V39, P89, DOI 10.1016/0014-4800(83)90043-6; Carrick D, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004148; Carrick D, 2014, J AM COLL CARDIOL, V63, P2088, DOI 10.1016/j.jacc.2014.02.530; Chen M, 2013, J CARDIOVASC PHARM, V62, P320, DOI 10.1097/FJC.0b013e31829be05b; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Clarke M, 2007, HEART, V93, P659, DOI 10.1136/hrt.2006.088203; Das M, 2012, ANN MED, V44, P530, DOI 10.3109/07853890.2011.577445; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Fernandez-Jimenez R, 2015, J AM COLL CARDIOL, V66, P816, DOI 10.1016/j.jacc.2015.06.023; Ge L, 2015, AM J PHYSIOL-HEART C, V308, pH500, DOI 10.1152/ajpheart.00381.2014; Gerber BL, 2000, CIRCULATION, V101, P2734, DOI 10.1161/01.CIR.101.23.2734; Hamirani YS, 2014, JACC-CARDIOVASC IMAG, V7, P940, DOI 10.1016/j.jcmg.2014.06.012; Handoko ML, 2009, AM J PHYSIOL-HEART C, V297, pH1752, DOI 10.1152/ajpheart.00555.2009; Harrison RW, 2013, AM J CARDIOL, V111, P178, DOI 10.1016/j.amjcard.2012.09.015; Huang XJ, 2016, CIRCULATION, V133, P1093, DOI 10.1161/CIRCULATIONAHA.115.020918; Jiang FY, 2014, CLIN CARDIOL, V37, P530, DOI 10.1002/clc.22292; Johnson HL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-678; KLONER RA, 1974, AM J PATHOL, V74, P399; KLONER RA, 1984, CIRCULATION, V70, P513, DOI 10.1161/01.CIR.70.3.513; KLONER RA, 1980, CIRCULATION, V62, P945, DOI 10.1161/01.CIR.62.5.945; KLONER RA, 1979, EXP MOL PATHOL, V30, P129, DOI 10.1016/0014-4800(79)90050-9; Limalanathan S, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000679; Liu DX, 2005, BLOOD, V105, P2350, DOI 10.1182/blood-2004-05-1963; Lleres D, 2009, J CELL BIOL, V187, P481, DOI 10.1083/jcb.200907029; Marzilli M, 2000, J AM COLL CARDIOL, V35, P327, DOI 10.1016/S0735-1097(99)00554-9; Milovanova T, 2008, BBA-MOL CELL RES, V1783, P1866, DOI 10.1016/j.bbamcr.2008.05.010; Morishima I, 2000, J AM COLL CARDIOL, V36, P1202, DOI 10.1016/S0735-1097(00)00865-2; Naaijkens BA, 2015, CELL TISSUE RES, V362, P623, DOI 10.1007/s00441-015-2239-z; Nagy JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006544; Nanobasvili J, 2003, EUR SURG RES, V35, P417, DOI 10.1159/000072226; Ndrepepa G, 2010, J AM COLL CARDIOL, V55, P2383, DOI 10.1016/j.jacc.2009.12.054; Neil DAH, 2002, AM J TRANSPLANT, V2, P400, DOI 10.1034/j.1600-6143.2002.20502.x; Nilsen DWT, 2013, CATHETER CARDIO INTE, V82, P594, DOI 10.1002/ccd.24705; Panneerselvam M, 2012, ADV EXP MED BIOL, V729, P145, DOI 10.1007/978-1-4614-1222-9_10; Phinikaridou A, 2012, CIRCULATION, V126, P707, DOI 10.1161/CIRCULATIONAHA.112.092098; Pomfy M, 1992, Funct Dev Morphol, V2, P253; Reffelmann T, 2002, AM J PHYSIOL-HEART C, V282, pH766, DOI 10.1152/ajpheart.00767.2001; Regenfus M, 2015, AM J CARDIOL, V116, P1022, DOI 10.1016/j.amjcard.2015.06.034; Robbers LFHJ, 2013, EUR HEART J, V34, P2346, DOI 10.1093/eurheartj/eht100; Sardella G, 2009, J AM COLL CARDIOL, V53, P309, DOI 10.1016/j.jacc.2008.10.017; Scarabelli T, 2001, CIRCULATION, V104, P253, DOI 10.1161/01.CIR.104.3.253; Skovsted GF, 2014, BRIT J PHARMACOL, V171, P2726, DOI 10.1111/bph.12606; Teunissen PFA, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001786; Tramontano AF, 2003, BIOCHEM BIOPH RES CO, V308, P990, DOI 10.1016/S0006-291X(03)01503-1; Waldow T, 2009, J SURG RES, V157, P30, DOI 10.1016/j.jss.2008.07.042; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Yang ZQ, 2008, AM J PHYSIOL-HEART C, V295, pH2328, DOI 10.1152/ajpheart.00091.2008	55	35	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157233	10.1371/journal.pone.0157233	http://dx.doi.org/10.1371/journal.pone.0157233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391645	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400007
J	Saikia, N; Moradhvaj; Bora, JK				Saikia, Nandita; Moradhvaj; Bora, Jayanta Kumar			Gender Difference in Health-Care Expenditure: Evidence from India Human Development Survey	PLOS ONE			English	Article							SEEKING BEHAVIOR; IMMUNIZATION; DISADVANTAGE; SERVICES; CHILDREN; CHINA; LIFE	Background While the gender disparity in health and mortality in various stages of life in India is well documented, there is limited evidence on female disadvantage in health-care expenditure (HCE). Aims Examine the gender difference in HCE in short-term and major morbidity in India, and understand the role of factors underlying the difference. Data and Methods Using two rounds of nationally representative panel data-the India Human Development Survey (IHDS) 2004-2005 and 2011-2012 (IHDS I & II)-we calculate morbidity prevalence rate and mean HCE by gender, and examine the adjusted effect of gender on major morbidity-related HCE by using a two-part regression model. Further, we performed Oaxaca-Blinder decomposition of the gender gap in HCE in major morbidity to understand the contribution of demographic and socio-economic factors. Results Health-care expenditure on females was systematically lower than on males across all demographic and socio-economic groups. Multivariate analysis confirms that female HCE is significantly lower than male HCE even after controlling demographic and socio-economic factors (beta = -0.148, p = 0.000, CI:-0.206-0.091). For both short-term and major morbidity, a female disadvantage on HCE increased from IHDS I to IHDS II. For instance, the male-female gap in major morbidity related expenditure increased from INR 1298 to INR 4172. A decomposition analysis of gender gap in HCE demonstrates that about 48% of the gap is attributable to differences in demographic and socio-economic factors (endowment effect), whereas 50% of the gap is due to the differential effect of the determinants (coefficient effect). Interpretation Indians spend less on female health care than on male health care. Most of the gender gap in HCE is not due to differential distribution of factors affecting HCE.	[Saikia, Nandita; Moradhvaj] Jawaharlal Nehru Univ, Ctr Study Reg Dev, New Delhi, India; [Bora, Jayanta Kumar] Publ Hlth Fdn India, Gurgaon, India	Jawaharlal Nehru University, New Delhi; Public Health Foundation of India	Saikia, N (corresponding author), Jawaharlal Nehru Univ, Ctr Study Reg Dev, New Delhi, India.	nanditasts@gmail.com	Bora, Jayanta/AAK-9419-2020	Bora, Jayanta/0000-0002-9735-3042; , Moradhvaj/0000-0002-8798-385X				Agarwal B, 1997, FEM EC, V3, P1, DOI [https://doi.org/10.1080/135457097338799, DOI 10.1080/135457097338799]; Ahmed SM, 2000, SOC SCI MED, V51, P361, DOI 10.1016/S0277-9536(99)00461-X; Alemayehu B, 2004, HEALTH SERV RES, V39, P627, DOI 10.1111/j.1475-6773.2004.00248.x; Anderson S., 2012, ECON POLIT WEEKLY, P87; [Anonymous], 1997, ENDANGERED SEX NEGLE; [Anonymous], 2008, ANAL HLTH EQUITY USI; Asfaw A, 2007, INTRAHOSEHOLD GENDED; Asfaw A, 2010, HEALTH ECON, V19, P265, DOI 10.1002/hec.1468; Batra A., 2014, 1403 IND STAT I; BEHRMAN JR, 1988, OXFORD ECON PAP, V40, P32, DOI 10.1093/oxfordjournals.oep.a041845; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Bora JK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141953; Borooah VK, 2004, SOC SCI MED, V58, P1719, DOI 10.1016/S0277-9536(03)00342-3; Cameron C., 2005, MICROECONOMETRICS US, P1056; Canudas-Romo V., 2015, ASIA PACIFIC POPULAT, V30; EPWRF India time series, 2016, EPWRF INDIA TIMES SE; Fikree FF, 2004, BMJ-BRIT MED J, V328, P823, DOI 10.1136/bmj.328.7443.823; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gao MT, 2006, ECON DEV CULT CHANGE, V55, P87, DOI 10.1086/505720; Guilmoto Christophe Z., 2015, POPUL DEV REV, V41, P241, DOI DOI 10.1111/J.1728-4457.2015.00046.X; Gupta M. D., 1987, POPUL DEV REV, V1, P77; HILL K, 1995, POPUL DEV REV, V21, P127, DOI 10.2307/2137416; Humphreys B R, 2010, DEALING ZEROS EC DAT; Iyer A, 2008, Glob Public Health, V3 Suppl 1, P13, DOI 10.1080/17441690801892174; Jayachandran S, 2015, Q J ECON, V126, P1485, DOI [10.2307/23015706, DOI 10.2307/23015706]; Kurz K M, 1997, GEBDER DIFFERENCES; Maharana B, 2014, GENDER DISPARITY HLT; Mckinsey Global Institute, 2015, POW PART ADV WOM EQ; Mishra V, 2004, POPUL DEV REV, V30, P269, DOI 10.1111/j.1728-4457.2004.013_1.x; NATHANSON CA, 1975, SOC SCI MED, V9, P57, DOI 10.1016/0037-7856(75)90094-3; NSSO, 2013, NSSO 68 ROUND JUL 20; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Owens GM, 2008, J MANAGE CARE PHARM, V14, pS2; Pande RP, 2003, DEMOGRAPHY, V40, P395, DOI 10.1353/dem.2003.0029; Pandey A, 2002, J HEALTH POPUL NUTR, V20, P306; Roy K, 2008, SOC SCI MED, V66, P1951, DOI 10.1016/j.socscimed.2008.01.015; Saikia N, 2011, POP STUD-J DEMOG, V65, P73, DOI 10.1080/00324728.2010.534642; SANTOW G, 1995, SOC SCI MED, V40, P147, DOI 10.1016/0277-9536(94)E0069-5; Sen G, 2002, ENGENDER INT HLTH CH, V4, P281; Shugarman LR, 2008, WOMEN HEALTH ISS, V18, P199, DOI 10.1016/j.whi.2008.02.008; Song Y, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-8; Sudha S, 1999, DEV CHANGE, V30, P585, DOI 10.1111/1467-7660.00130; Sustainable development knowledge platform, 2015, SUST DEV GOAL; Vaidya V, 2012, J WOMENS HEALTH, V21, P140, DOI 10.1089/jwh.2011.2876; Willis JR, 2009, J HEALTH POPUL NUTR, V27, P62	46	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158332	10.1371/journal.pone.0158332	http://dx.doi.org/10.1371/journal.pone.0158332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391322	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400043
J	Zhang, WZ; Xiong, XM; Zhang, XJ; Wan, SM; Guan, NN; Nie, CH; Zhao, BW; Hsiao, CD; Wang, WM; Gao, ZX				Zhang, Wei-Zhuo; Xiong, Xue-Mei; Zhang, Xiu-Jie; Wan, Shi-Ming; Guan, Ning-Nan; Nie, Chun-Hong; Zhao, Bo-Wen; Hsiao, Chung-Der; Wang, Wei-Min; Gao, Ze-Xia			Mitochondrial Genome Variation after Hybridization and Differences in the First and Second Generation Hybrids of Bream Fishes	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DNA CONTROL REGION; GENE ORGANIZATION; DARWINS COROLLARY; EVOLUTION; POLYMORPHISMS; PERCIFORMES; TELEOSTEI; TRAITS	Hybridization plays an important role in fish breeding. Bream fishes contribute a lot to aquaculture in China due to their economically valuable characteristics and the present study included five bream species, Megalobrama amblycephala, Megalobrama skolkovii, Megalobrama pellegrini, Megalobrama terminalis and Parabramis pekinensis. As maternal inheritance of mitochondrial genome (mitogenome) involves species specific regulation, we aimed to investigate in which way the inheritance of mitogenome is affected by hybridization in these fish species. With complete mitogenomes of 7 hybrid groups of bream species being firstly reported in the present study, a comparative analysis of 17 mitogenomes was conducted, including representatives of these 5 bream species, 6 first generation hybrids and 6 second generation hybrids. The results showed that these 17 mitogenomes shared the same gene arrangement, and had similar gene size and base composition. According to the phylogenetic analyses, all mitogenomes of the hybrids were consistent with a maternal inheritance. However, a certain number of variable sites were detected in all F-1 hybrid groups compared to their female parents, especially in the group of M. terminalis (female) xM. amblycephala (male) (MTxMA), with a total of 86 variable sites between MTxMA and its female parent. Among the mitogenomes genes, the protein-coding gene nd5 displayed the highest variability. The number of variation sites was found to be related to phylogenetic relationship of the parents: the closer they are, the lower amount of variation sites their hybrids have. The second generation hybrids showed less mitogenome variation than that of first generation hybrids. The non-synonymous and synonymous substitution rates (dN/dS) were calculated between all the hybrids with their own female parents and the results indicated that most PCGs were under negative selection.	[Zhang, Wei-Zhuo; Xiong, Xue-Mei; Zhang, Xiu-Jie; Wan, Shi-Ming; Guan, Ning-Nan; Nie, Chun-Hong; Zhao, Bo-Wen; Wang, Wei-Min; Gao, Ze-Xia] Huazhong Agr Univ, Minist Agr, Key Lab Freshwater Anim Breeding, Coll Fisheries, Wuhan, Hubei, Peoples R China; [Zhang, Wei-Zhuo; Xiong, Xue-Mei; Zhang, Xiu-Jie; Wan, Shi-Ming; Guan, Ning-Nan; Nie, Chun-Hong; Zhao, Bo-Wen; Gao, Ze-Xia] Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Peoples R China; [Hsiao, Chung-Der] Chung Yuan Christian Univ, Dept Biosci Technol, Chungli, Taiwan	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Chung Yuan Christian University	Gao, ZX (corresponding author), Huazhong Agr Univ, Minist Agr, Key Lab Freshwater Anim Breeding, Coll Fisheries, Wuhan, Hubei, Peoples R China.; Gao, ZX (corresponding author), Freshwater Aquaculture Collaborat Innovat Ctr Hub, Wuhan, Peoples R China.	gaozexia@hotmail.com	Hsiao, Chung-Der/W-4535-2019	Hsiao, Chung-Der/0000-0002-6398-8672	National Natural Science Foundation of China [31472271]; Modern Agriculture Industry Technology System Construction Projects of China titled as-Staple Freshwater Fishes Industry Technology System [CARS-46-05]; Fundamental Research Funds for the Central Universities [2662015PY088]; Fundamental Research Funds for Innovation Center of Hubei Province [2016ZXPY04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern Agriculture Industry Technology System Construction Projects of China titled as-Staple Freshwater Fishes Industry Technology System; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fundamental Research Funds for Innovation Center of Hubei Province	This work was financially supported by National Natural Science Foundation of China (No. 31472271), Modern Agriculture Industry Technology System Construction Projects of China titled as-Staple Freshwater Fishes Industry Technology System (No. CARS-46-05), Fundamental Research Funds for the Central Universities (2662015PY088) and Fundamental Research Funds for Innovation Center of Hubei Province (2016ZXPY04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquatic Products Bureau of Foushan in Guangdong Province, 1975, FISHERIES SCI TECHNO, V8, P18; AVISE JC, 1984, GENETICS, V108, P237; Bai YD, 2000, MOL CELL BIOL, V20, P805, DOI 10.1128/MCB.20.3.805-815.2000; Biase FH, 2007, GENET MOL BIOL, V30, P1058, DOI 10.1590/S1415-47572007000600005; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Bolnick DI, 2008, GENETICS, V178, P1037, DOI 10.1534/genetics.107.081364; Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; Broughton RE, 2001, GENOME RES, V11, P1958, DOI 10.1101/gr.156801; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; Chen DX, 2012, MITOCHONDR DNA, V23, P70, DOI 10.3109/19401736.2011.653799; Chen Jie, 2014, Journal of Shanghai Ocean University, V23, P388; Chomyn A, 2001, J BIOENERG BIOMEMBR, V33, P251, DOI 10.1023/A:1010791204961; Fernandez AI, 2008, J ANIM SCI, V86, P1283, DOI 10.2527/jas.2007-0568; Guo XH, 2006, GENETICS, V172, P1745, DOI 10.1534/genetics.105.049841; Guo XH, 2003, AQUACULTURE, V224, P25, DOI 10.1016/S0044-8486(03)00168-6; Guo XH, 2004, ACTA ZOOL SINICA, V50, P408; Guo Xin-hong, 2004, Acta Genetica Sinica, V31, P983; GYLLENSTEN U, 1991, NATURE, V352, P255, DOI 10.1038/352255a0; Henderson-Arzapalo Anne, 1994, Journal of the World Aquaculture Society, V25, P289, DOI 10.1111/j.1749-7345.1994.tb00193.x; HIXSON JE, 1986, J BIOL CHEM, V261, P2384; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Ke H W, 1965, ACTA HYDROBIOL SIN, V5, P282; Kim KK, 1996, FISHERIES SCI, V62, P490, DOI 10.2331/fishsci.62.490; Lai RuiFang, 2014, Journal of Fisheries of China, V38, P1; LEE WJ, 1995, J MOL EVOL, V41, P54; Li P, 2009, J GUANGDONG OCEAN U, V29, P12; Li Si-Fa, 2002, Acta Zoologica Sinica, V48, P339; Li T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055381; Li X, 2016, MITOCHONDRIAL DNA B; Liu Y, 2009, MAR GENOM, V2, P133, DOI 10.1016/j.margen.2009.07.003; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Nei M., 2000, MOL EVOLUTION PHYLOG; Nicholls JA, 2000, J AVIAN BIOL, V31, P165, DOI 10.1034/j.1600-048X.2000.310208.x; Oh DJ, 2007, GENE, V392, P174, DOI 10.1016/j.gene.2006.12.007; Qin YH, 2012, ANIM BIOTECHNOL, V23, P204, DOI 10.1080/10495398.2012.686468; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Shirai K, 2014, GENE, V552, P239, DOI 10.1016/j.gene.2014.09.039; SPRINZL M, 1991, NUCLEIC ACIDS RES, V19, P2127, DOI 10.1093/nar/19.suppl.2127; SUOMALAINEN A, 1995, NAT GENET, V9, P146, DOI 10.1038/ng0295-146; Sutarno, 2002, THERIOGENOLOGY, V57, P1603, DOI 10.1016/S0093-691X(02)00664-7; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turelli M, 2007, GENETICS, V176, P1059, DOI 10.1534/genetics.106.065979; Wang CH, 2008, GENE, V424, P96, DOI 10.1016/j.gene.2008.07.011; Wang CH, 2012, MOL BIOL REP, V39, P6337, DOI 10.1007/s11033-012-1455-9; Wang XY, 2013, MITOCHONDR DNA, V24, P1, DOI 10.3109/19401736.2012.710222; Xie G, 2002, J HUBEI AGR COLL, V22, P330; Xu Hui, 2007, JOURNAL OF TROPICAL OCEANOGRAPHY, V26, P60; Xu W, 2008, J HYDROECOL, V1, P7; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zardoya R, 1995, J MOL EVOL, V41, P942, DOI 10.1007/BF00173174; Zhang B, 2008, BIOCHEM GENET, V46, P362, DOI 10.1007/s10528-008-9152-z; Zhang DaLong, 2014, Journal of Dalian Ocean University, V29, P121; Zhao Jin-Liang, 2006, Acta Genetica Sinica, V33, P793, DOI 10.1016/S0379-4172(06)60112-1; Zheng LeYun, 2014, Journal of Shanghai Ocean University, V23, P351; Zhou HL, 2012, J TROPICAL ORGANISMS, V3, P2; Zhou XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092033; Zhu F, 2015, MITOCHONDRIAL DNA; 刘焕章, 2002, [自然科学进展, Progress in Natural Science], V12, P266	60	6	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158915	10.1371/journal.pone.0158915	http://dx.doi.org/10.1371/journal.pone.0158915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391325	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400160
J	Horthongkham, N; Athipanyasilp, N; Pattama, A; Kaewnapan, B; Sornprasert, S; Srisurapanont, S; Kantakamalakul, W; Amaranond, P; Sutthent, R				Horthongkham, Navin; Athipanyasilp, Niracha; Pattama, Archiraya; Kaewnapan, Bualan; Sornprasert, Suthatta; Srisurapanont, Surangrat; Kantakamalakul, Wannee; Amaranond, Palanee; Sutthent, Ruengpung			Epidemiological, Clinical and Virological Characteristics of Influenza B Virus from Patients at the Hospital Tertiary Care Units in Bangkok during 2011-2014	PLOS ONE			English	Article							ANTIGENIC STRUCTURE; COCIRCULATING LINEAGES; EVOLUTIONARY PATTERN; SEQUENCE-ANALYSIS; HONG-KONG; HEMAGGLUTININ; SURVEILLANCE; VARIANTS; REASSORTMENT; DELETION	Influenza B virus, which causes acute respiratory infections, has increased in prevalence in recent years. Based on the nucleotide sequence of the hemagglutinin (HA) gene, influenza B virus can be divided into two lineages, Victoria and Yamagata, that co-circulate during the influenza season. However, analysis of the potential association between the clinical and virological characteristic and the lineage of influenza B viruses isolated in Thailand was lacking. To investigate influenza B virus genetically and determine its neuraminidase (NA) inhibitor susceptibility phenotype, a total of 6920 nasopharyngeal-wash samples were collected from patients with influenza-like illness between the years 2011 and 2014 and were screened for influenza B virus by real-time PCR. Of these samples, 3.1% (216/6920) were confirmed to contain influenza B viruses, and 110 of these influenza viruses were randomly selected for nucleotide sequence analysis of the HA and NA genes. Phylogenetic analysis of the HA sequences showed clustering into various clades: Yamagata clade 3 (11/110, 10%), Yamagata clade 2 (71/110, 64.5%), and Victoria clade 1 (28/110, 25.5%). The analysis of clinical characteristic demonstrated that the Victoria lineage was significantly associated with the duration of hospitalization, number of deceased cases, pneumonia, secondary bacterial infection and underlying disease. When combined with phylogenetic analysis of the NA sequences, four samples showed viruses with reassortant sequences between the Victoria and Yamagata lineages. Statistical analysis of the clinical outcomes and demographic data for the reassortant strains did not differ from those of the other strains in circulation. Oseltamivir-resistant influenza B viruses were not detected. Our findings indicated the co-circulation of the Victoria and Yamagata lineages over the past four cold seasons in Bangkok. We also demonstrated differences in the clinical symptoms between these lineages.	[Horthongkham, Navin; Athipanyasilp, Niracha; Pattama, Archiraya; Kaewnapan, Bualan; Sornprasert, Suthatta; Kantakamalakul, Wannee; Sutthent, Ruengpung] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand; [Srisurapanont, Surangrat] Srinakharinwirot Univ, Fac Med, Dept Pathol, Bangkok, Thailand; [Amaranond, Palanee] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Blood Transfus, Bangkok, Thailand	Mahidol University; Srinakharinwirot University; Chulalongkorn University	Sutthent, R (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok, Thailand.	ruengpung.sut@mahidol.ac.th	Horthongkham, Navin/AAZ-7963-2021		Faculty of Medicine, Srinakharinwirot University	Faculty of Medicine, Srinakharinwirot University	This work was funded by Faculty of Medicine, Srinakharinwirot University (to S. Srisurapanont).	BERTON MT, 1984, J VIROL, V52, P919, DOI 10.1128/JVI.52.3.919-927.1984; BERTON MT, 1985, VIROLOGY, V143, P583, DOI 10.1016/0042-6822(85)90396-4; Byarugaba DK, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-11; Chi XS, 2003, J CLIN MICROBIOL, V41, P5770, DOI 10.1128/JCM.41.12.5770-5773.2003; Chittaganpitch M., 2011, Regional Health Forum, V15, P57; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; Chiu SC, 2014, INT J INFECT DIS, V23, P94, DOI 10.1016/j.ijid.2014.02.017; Chiu SS, 2016, VACCINE, V34, P2164, DOI 10.1016/j.vaccine.2016.03.032; Escuret V, 2008, J CLIN VIROL, V41, P25, DOI 10.1016/j.jcv.2007.10.019; Gutierrez-Pizarraya A, 2012, J INFECTION, V65, P423, DOI 10.1016/j.jinf.2012.07.004; HOVANEC DL, 1984, VIROLOGY, V139, P384, DOI 10.1016/0042-6822(84)90384-2; KANEGAE Y, 1990, J VIROL, V64, P2860, DOI 10.1128/JVI.64.6.2860-2865.1990; KINNUNEN L, 1992, J GEN VIROL, V73, P733, DOI 10.1099/0022-1317-73-3-733; Kittikraisak W, 2015, INFLUENZA OTHER RESP, V9, P85, DOI 10.1111/irv.12302; Lindstrom SE, 1999, J VIROL, V73, P4413, DOI 10.1128/JVI.73.5.4413-4426.1999; McCullers JA, 1999, J VIROL, V73, P7343, DOI 10.1128/JVI.73.9.7343-7348.1999; Nerome R, 1998, ARCH VIROL, V143, P1569, DOI 10.1007/s007050050399; Ni FY, 2013, VIROLOGY, V446, P112, DOI 10.1016/j.virol.2013.07.035; Okomo-Adhiambo M, 2010, VIRUSES-BASEL, V2, P2269, DOI 10.3390/v2102269; Oong XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136254; Payungporn S, 2011, J VIROL METHODS, V177, P133, DOI 10.1016/j.jviromet.2011.07.008; RIVERA K, 1995, VIROLOGY, V206, P787, DOI 10.1006/viro.1995.1001; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Shaw MW, 2002, VIROLOGY, V303, P1, DOI 10.1006/viro.2002.1719; Sheu TG, 2008, ANTIMICROB AGENTS CH, V52, P3284, DOI 10.1128/AAC.00555-08; Sleeman K, 2011, EMERG INFECT DIS, V17, P2043, DOI 10.3201/eid1711.110787; Socan M, 2014, J CLIN VIROL, V61, P156, DOI 10.1016/j.jcv.2014.06.018; Tan Y, 2013, J VIROL, V87, P12447, DOI 10.1128/JVI.01039-13; Tewawong N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116302; Thailand Ministry of Public Health, 2011, CLIN PRACT GUID INFL; Wang QH, 2008, J VIROL, V82, P3011, DOI 10.1128/JVI.02477-07; WEBSTER RG, 1981, J GEN VIROL, V54, P243, DOI 10.1099/0022-1317-54-2-243; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P57; World Health Organization, 2003, WKLY EPIDEMIOL REC, V77, P341; YAMASHITA M, 1988, VIROLOGY, V163, P112, DOI 10.1016/0042-6822(88)90238-3; Yang JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047179	36	20	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158244	10.1371/journal.pone.0158244	http://dx.doi.org/10.1371/journal.pone.0158244			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387488	gold, Green Submitted, Green Published			2022-12-26	WOS:000379811500017
J	Burblies, N; Schulze, J; Schwarz, HC; Kranz, K; Motz, D; Vogt, C; Lenarz, T; Warnecke, A; Behrens, P				Burblies, Niklas; Schulze, Jennifer; Schwarz, Hans-Christoph; Kranz, Katharina; Motz, Damian; Vogt, Carla; Lenarz, Thomas; Warnecke, Athanasia; Behrens, Peter			Coatings of Different Carbon Nanotubes on Platinum Electrodes for Neuronal Devices: Preparation, Cytocompatibility and Interaction with Spiral Ganglion Cells	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; STIMULATION; NANOMATERIALS; PURIFICATION; COMPOSITES; GRAPHITE; DISORDER; RELEASE; SYSTEMS	Cochlear and deep brain implants are prominent examples for neuronal prostheses with clinical relevance. Current research focuses on the improvement of the long-term functionality and the size reduction of neural interface electrodes. A promising approach is the application of carbon nanotubes (CNTs), either as pure electrodes but especially as coating material for electrodes. The interaction of CNTs with neuronal cells has shown promising results in various studies, but these appear to depend on the specific type of neurons as well as on the kind of nanotubes. To evaluate a potential application of carbon nanotube coatings for cochlear electrodes, it is necessary to investigate the cytocompatibility of carbon nanotube coatings on platinum for the specific type of neuron in the inner ear, namely spiral ganglion neurons. In this study we have combined the chemical processing of as delivered CNTs, the fabrication of coatings on platinum, and the characterization of the electrical properties of the coatings as well as a general cytocompatibility testing and the first cell culture investigations of CNTs with spiral ganglion neurons. By applying a modification process to three different as-received CNTs via a reflux treatment with nitric acid, long-term stable aqueous CNT dispersions free of dispersing agents were obtained. These were used to coat platinum substrates by an automated spray-coating process. These coatings enhance the electrical properties of platinum electrodes, decreasing the impedance values and raising the capacitances. Cell culture investigations of the different CNT coatings on platinum with NIH3T3 fibroblasts attest an overall good cytocompatibility of these coatings. For spiral ganglion neurons, this can also be observed but a desired positive effect of the CNTs on the neurons is absent. Furthermore, we found that the well-established DAPI staining assay does not function on the coatings prepared from single-wall nanotubes.	[Burblies, Niklas; Schwarz, Hans-Christoph; Motz, Damian; Vogt, Carla; Behrens, Peter] Leibniz Univ Hannover, Inst Inorgan Chem, Hannover, Germany; [Schulze, Jennifer; Kranz, Katharina; Lenarz, Thomas; Warnecke, Athanasia] Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany; [Burblies, Niklas; Schulze, Jennifer; Schwarz, Hans-Christoph; Kranz, Katharina; Lenarz, Thomas; Warnecke, Athanasia; Behrens, Peter] Cluster Excellence Hearing4all, Hannover, Germany	Leibniz University Hannover; Hannover Medical School	Behrens, P (corresponding author), Leibniz Univ Hannover, Inst Inorgan Chem, Hannover, Germany.; Behrens, P (corresponding author), Cluster Excellence Hearing4all, Hannover, Germany.	Peter.Behrens@acb.uni-hannover.de	Warnecke, Athanasia/HHC-6174-2022	Motz, Damian Alexander/0000-0003-2013-9117	DFG Cluster of Excellence "Hearing4all" [EXC 1077/1]	DFG Cluster of Excellence "Hearing4all"	This work was supported by DFG Cluster of Excellence EXC 1077/1 "Hearing4all", http://hearing4all.eu/, NB JS KK.; This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4all".	Anto BT, 2016, PHYS STATUS SOLIDI A, V213, P1447, DOI 10.1002/pssa.201532798; Baranauskas G, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066013; Bareket-Keren L, 2012, FRONT NEURAL CIRCUIT, V6, P1; Belyanskaya L, 2009, NEUROTOXICOLOGY, V30, P702, DOI 10.1016/j.neuro.2009.05.005; Bostrom M, 2007, OTOL NEUROTOL, V28, P1109, DOI 10.1097/MAO.0b013e318159e710; Bruggemann D, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/26/265104; Cancado LG, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2196057; Castagnola E, 2010, PHYS STATUS SOLIDI B, V247, P2703, DOI 10.1002/pssb.201000217; Chen CH, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/48/485501; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Endo M, 2001, APPL PHYS LETT, V79, P1531, DOI 10.1063/1.1400774; Ferrari AC, 2007, SOLID STATE COMMUN, V143, P47, DOI 10.1016/j.ssc.2007.03.052; Ferrari AC, 2013, NAT NANOTECHNOL, V8, P235, DOI 10.1038/nnano.2013.46; Gillespie LN, 2001, NEUROREPORT, V12, P275, DOI 10.1097/00001756-200102120-00019; Grobert N, 2007, MATER TODAY, V10, P28, DOI 10.1016/S1369-7021(06)71789-8; Hou PX, 2008, CARBON, V46, P2003, DOI 10.1016/j.carbon.2008.09.009; Hu H, 2003, J PHYS CHEM B, V107, P13838, DOI 10.1021/jp035719i; Hu LB, 2010, CHEM REV, V110, P5790, DOI 10.1021/cr9002962; Hussain S., 2011, J MODERN PHYS, V2, P538, DOI DOI 10.4236/JMP.2011.26063; Keefer EW, 2008, NAT NANOTECHNOL, V3, P434, DOI 10.1038/nnano.2008.174; Kim YG, 2014, J BIOMATER APPL, V28, P790, DOI 10.1177/0885328213481637; Kotov NA, 2009, ADV MATER, V21, P3970, DOI 10.1002/adma.200801984; Krug HF, 2014, ANGEW CHEM INT EDIT, V53, P12304, DOI 10.1002/anie.201403367; Liu W, 2014, CELL TISSUE RES, V355, P267, DOI 10.1007/s00441-013-1735-2; Luo XL, 2011, BIOMATERIALS, V32, P6316, DOI 10.1016/j.biomaterials.2011.05.020; Marchesan S., 2014, MATER TODAY, V18, P12; Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175; Pimenta MA, 2007, PHYS CHEM CHEM PHYS, V9, P1276, DOI 10.1039/b613962k; Schroper F, 2008, ELECTROCHIM ACTA, V53, P6265, DOI 10.1016/j.electacta.2008.03.068; SLUYTERSREHBACH M, 1994, PURE APPL CHEM, V66, P1831, DOI 10.1351/pac199466091831; Stover T., 2009, HEAD NECK SURG, V8, P1, DOI DOI 10.3205/CTO000062; Thostenson ET, 2001, COMPOS SCI TECHNOL, V61, P1899, DOI 10.1016/S0266-3538(01)00094-X; Vaisman L, 2006, ADV COLLOID INTERFAC, V128, P37, DOI 10.1016/j.cis.2006.11.007; von Ilberg CA, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000327765; Wang K, 2006, NANO LETT, V6, P2043, DOI 10.1021/nl061241t; Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c; Xie JN, 2006, SMART MATER STRUCT, V15, pN85, DOI 10.1088/0964-1726/15/4/N02; Yang KX, 2010, J ANAL ATOM SPECTROM, V25, P1290, DOI 10.1039/c0ja00012d; Yoon I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065715; Zhang Q, 2013, SMALL, V9, P1237, DOI 10.1002/smll.201203252	42	11	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158571	10.1371/journal.pone.0158571	http://dx.doi.org/10.1371/journal.pone.0158571			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27385031	Green Published, gold			2022-12-26	WOS:000379809400060
J	Gefter, L; Morioka-Douglas, N; Srivastava, A; Rodriguez, E				Gefter, Liana; Morioka-Douglas, Nancy; Srivastava, Ashini; Rodriguez, Eunice			Supporting At-Risk Youth and Their Families to Manage and Prevent Diabetes: Developing a National Partnership of Medical Residency Programs and High Schools	PLOS ONE			English	Article							HEALTH BEHAVIORS; ADOLESCENTS; SERVICES; DISEASE; TEXT; RACE	Background The Stanford Youth Diabetes Coaches Program (SYDCP) is a school based health program in which Family Medicine residents train healthy at-risk adolescents to become diabetes self-management coaches for family members with diabetes. This study evaluates the impact of the SYDCP when disseminated to remote sites. Additionally, this study aims to assess perceived benefit of enhanced curriculum. Methods From 2012-2015, 10 high schools and one summer camp in the US and Canada and five residency programs were selected to participate. Physicians and other health providers implemented the SYDCP with racial/ethnic-minority students from low-income communities. Student coaches completed pre- and posttest surveys which included knowledge, health behavior, and psychosocial asset questions (i.e., worth and resilience), as well as open-ended feedback questions. T-test pre-post comparisons were used to determine differences in knowledge and psychosocial assets, and open and axial coding methods were used to analyze qualitative data. Results A total of 216 participating high school students completed both pre-and posttests, and 96 nonparticipating students also completed pre- and posttests. Student coaches improved from pre- to posttest significantly on knowledge (p<0.005 in 2012-13, 2014 camp, and 2014-15); worth (p<0.1 in 2014-15); problem solving (p<0.005 in 2014 camp and p<0.1 in 2014-15); and self-efficacy (p<0.05 in 2014 camp). Eighty-two percent of student coaches reported that they considered making a behavior change to improve their own health as a result of program participation. Qualitative feedback themes included acknowledgment of usefulness and relevance of the program, appreciation for physician instructors, knowledge gain, pride in helping family members, improved relationships and connectedness with family members, and lifestyle improvements. Conclusion Overall, when disseminated, this program can increase health knowledge and some psychosocial assets of at-risk youth and holds promise to empower these youth with health literacy and encourage them to adopt healthy behaviors.	[Gefter, Liana; Morioka-Douglas, Nancy] Stanford Univ, Sch Med, Dept Med, Ctr Primary Care Res,Div Gen Med Disciplines, Stanford, CA USA; [Srivastava, Ashini; Rodriguez, Eunice] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA USA	Stanford University; Stanford University	Gefter, L (corresponding author), Stanford Univ, Sch Med, Dept Med, Ctr Primary Care Res,Div Gen Med Disciplines, Stanford, CA USA.	lianagefter@gmail.com			California HealthCare Foundation [08-1783]; Goldman Sachs Philanthropy Fund	California HealthCare Foundation; Goldman Sachs Philanthropy Fund	This project was funded by the California HealthCare Foundation (grant 08-1783) (http://www.chcf.org/), Goldman Sachs Philanthropy Fund (private donation) (http://www.goldmansachs.com/citizenship/goldman-sachs-gives/index.html), and anonymous private funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 1997, HEALTH EDUC RES, V12, P363, DOI 10.1093/her/12.3.363; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bodenheimer T, 2009, HEALTH AFFAIR, V28, P64, DOI 10.1377/hlthaff.28.1.64; Boulware LE, 2003, PUBLIC HEALTH REP, V118, P358, DOI 10.1016/S0033-3549(04)50262-5; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Brown BD, 2010, DIABETES EDUCATOR, V36, P924, DOI 10.1177/0145721710382582; Burnet DL, 2011, J NATL MED ASSOC, V103, P269, DOI 10.1016/S0027-9684(15)30290-X; California Healthy Kids Survey California State of Education, 2011, AB THE CHKS; Corbie-Smith G, 2002, ARCH INTERN MED, V162, P2458, DOI 10.1001/archinte.162.21.2458; Corbin J, 2014, BASICS QUALITATIVE R; DeBar LL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-711; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Fassnacht DB, 2015, J NUTR EDUC BEHAV, V47, P75, DOI 10.1016/j.jneb.2014.08.006; Gefter L, 2015, FAM MED, V47, P803; Gefter L, 2014, DIABETES EDUCATOR, V40, P786, DOI 10.1177/0145721714549676; Greenberg MT, 2003, AM PSYCHOL, V58, P466, DOI 10.1037/0003-066X.58.6-7.466; Hoyt LT, 2012, J ADOLESCENT HEALTH, V50, P66, DOI 10.1016/j.jadohealth.2011.05.002; Irons M, 2015, J URBAN HEALTH, P1; Leffert N, 1998, APPL DEV SCI, V2; Lim MSC, 2012, J EPIDEMIOL COMMUN H, V66, P69, DOI 10.1136/jech.2009.100396; May AL, 2012, PEDIATRICS, V129, P1035, DOI 10.1542/peds.2011-1082; Paradis AD, 2011, CHILD ADOL MENT H-UK, V16, P30, DOI 10.1111/j.1475-3588.2010.00577.x; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Rothman RL, 2005, DIABETES EDUCATOR, V31, P215, DOI 10.1177/0145721705275002; Scales P.C., 2003, SEARCH I INSIGHTS EV, V1, P1; Shaw M, 2009, DIABETES CARE, V32, P45, DOI 10.2337/dc08-0808; Shaw-Perry M, 2007, J NATL MED ASSOC, V99, P368; Summerbell CD, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001871.pub4, 10.1002/14651858.CD001871.pub2]; Wild LG, 2004, J CHILD PSYCHOL PSYC, V45, P1454, DOI 10.1111/j.1469-7610.2004.00330.x	29	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158477	10.1371/journal.pone.0158477	http://dx.doi.org/10.1371/journal.pone.0158477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27383902	gold, Green Submitted, Green Published			2022-12-26	WOS:000379809400051
J	Grams, L; Garrido, G; Villacieros, J; Ferro, A				Grams, Lena; Garrido, Guadalupe; Villacieros, Jorge; Ferro, Amelia			Marginal Micronutrient Intake in High-Performance Male Wheelchair Basketball Players: A Dietary Evaluation and the Effects of Nutritional Advice	PLOS ONE			English	Article							SPINAL-CORD-INJURY; ATHLETIC PERFORMANCE; ENERGY-EXPENDITURE; SPORTS; GAMES; EXERCISE; DENSITY; HEALTH; RISK	Wheelchair basketball has evolved into a high-performance sport over several years, and small variations in player performance can determine the difference between winning and losing. Therefore, adequate micronutrient intake may influence this difference if performance-promoting macronutrient intake and physical fitness are equal between teams. Seventeen elite male wheelchair basketball players belonging to the Spanish National Team participated in this study. Macro-and micronutrient intake were determined using a food-weighing diary over three consecutive days during three training camps in two consecutive years. Current Dietary Reference Intake levels were used to determine the adequacy of intake of seventeen micronutrients of particular interest for athletes. After categorizing the consumed foods into fourteen food groups according to the National Nutrient Database for Standard References (USDA) these groups were used to identify the best predictors of the adequacy of intake for each micronutrient. Total energy intake correlated positively with the adequacy of all micronutrient intake levels, except for vitamins A and E. Five B vitamins and phosphorus, selenium, and iron showed 100% adequacy. All other micronutrient intake levels were found to be inadequate, e.g., vitamin E (51% adequacy) and calcium (73%). The fruit, fish and cereal food groups were found to be predictors of adequate intake of most micronutrients. Together with energy intake (p = .009,eta(2) = 0.49), the intake of the fruit (p = .032,eta(2) = 0.39) and egg (p = .036, Kendall's W = 0.42) food groups increased significantly over time, along with improved iodine (p = .008, W = 0.61) and magnesium (p = .030, W = 0.44) adequacy levels. Because the adequacy of micronutrient intake correlates positively with energy intake (R = 0.64, p<.001), a varied diet that includes cereals, fish and fruits is especially important for players with low levels of energy intake. Supplements may be a possible solution if adequate micronutrient intake cannot be achieved through regular dietary intake alone. However, dietary analyses should be conducted on a regular basis throughout the year to improve the nutritional knowledge of the athletes and assure adequate micronutrient intake.	[Grams, Lena; Garrido, Guadalupe] Tech Univ Madrid, Dept Hlth & Human Performance, Fac Phys Act & Sport Sci, Madrid, Spain; [Villacieros, Jorge; Ferro, Amelia] Tech Univ Madrid, Dept Sports, Fac Phys Act & Sport Sci, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid	Ferro, A (corresponding author), Tech Univ Madrid, Dept Sports, Fac Phys Act & Sport Sci, Madrid, Spain.	amelia.ferro@upm.es	Ferro, Amelia/K-7746-2012	Ferro, Amelia/0000-0002-9585-8725; GARRIDO PASTOR, M. GUADALUPE/0000-0002-2695-9741; VILLACIEROS RODRIGUEZ, JORGE/0000-0002-5904-0774	Ministry of Economy and Competitiveness' (MINECO) National Plan RDI [DEP2012-38785]; Higher Sport Council (CSD)	Ministry of Economy and Competitiveness' (MINECO) National Plan RDI; Higher Sport Council (CSD)	This study was supported by the Ministry of Economy and Competitiveness' (MINECO) National Plan R&D&I 2012-2016 (DEP2012-38785). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Higher Sport Council (CSD) for their support and the Spanish Sports Federation for People with Physical Disabilities (FEDDF) and their wheelchair basketball players for participating in the study.	Abel T, 2008, SPINAL CORD, V46, P785, DOI 10.1038/sc.2008.54; Bernardi M, 2010, MED SCI SPORT EXER, V42, P1200, DOI 10.1249/MSS.0b013e3181c67d82; Garcia RB, 2011, NUTR HOSP, V26, P945, DOI [10.3305/nh.2011.26.5.5056, 10.1590/S0212-16112011000500004]; Broad E, 2014, SPORTS NUTR PARALYMP, P23, DOI DOI 10.1201/BL6375-4; Calvo MS, 2013, ANN NY ACAD SCI, V1301, P29, DOI 10.1111/nyas.12300; Canda Alicia, 2009, Journal of Physiological Anthropology, V28, P71, DOI 10.2114/jpa2.28.71; Collins EG, 2010, MED SCI SPORT EXER, V42, P691, DOI 10.1249/MSS.0b013e3181bb902f; Croft L, 2010, INT J SPORT PHYSIOL, V5, P301, DOI 10.1123/ijspp.5.3.301; Deakin V., 2011, Sport and exercise nutrition, P66; Derman W, 2014, PM&R, V6, pS23, DOI 10.1016/j.pmrj.2014.05.016; Flueck JL, 2016, SPINAL IN PRESS 0315; Glaser R M, 1985, Exerc Sport Sci Rev, V13, P263; Gleeson M, 2013, NESTLE NUTR WORKS SE, V75, P85, DOI 10.1159/000345822; Goktepe AS, 2004, AM J PHYS MED REHAB, V83, P279, DOI 10.1097/01.PHM.0000118036.20170.6C; Goosey-Tolfrey V, 2010, DISABIL REHABIL, V32, P2237, DOI 10.3109/09638288.2010.491577; Goosey-Tolfrey VL, 2010, ADAPT PHYS ACT Q, V27, P47, DOI 10.1123/apaq.27.1.47; Halliday TM, 2011, MED SCI SPORT EXER, V43, P335, DOI 10.1249/MSS.0b013e3181eb9d4d; Hemila H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000980.pub4; Institute of Medicine, 2001, DIETARY REFERENCE IN; Institute of Medicine, 2011, DIETARY REFERENCE IN; Institute of Medicine, 2000, DRI DIET REF INT APP; Kreider RB, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-7; Krempien JL, 2011, INT J SPORT NUTR EXE, V21, P417, DOI 10.1123/ijsnem.21.5.417; Krempien JL, 2012, EAT BEHAV, V13, P36, DOI 10.1016/j.eatbeh.2011.11.005; Leicht CA, 2012, SCAND J MED SCI SPOR, V22, P729, DOI 10.1111/j.1600-0838.2011.01328.x; Lin VWH, 2002, ARCH PHYS MED REHAB, V83, P806, DOI 10.1053/apmr.2002.32644; Miyahara K, 2008, J BONE MINER METAB, V26, P101, DOI 10.1007/s00774-007-0789-1; Molina-Lopez J, 2013, NUTR HOSP, V28, P1065, DOI 10.3305/nh.2013.28.4.6600; Murphy SP, 2011, J AM DIET ASSOC, V111, P1065, DOI 10.1016/j.jada.2011.04.004; National Research Council, 2006, DIETARY REFERENCE IN; Perret C., 2015, DISABIL REHABIL, P1; Perret C, 2011, J SPINAL CORD MED, V34, P569, DOI 10.1179/2045772311Y.0000000026; Price M, 2010, SPORTS MED, V40, P681, DOI 10.2165/11531960-000000000-00000; Rodriguez NR, 2009, MED SCI SPORT EXER, V41, P709, DOI 10.1249/MSS.0b013e31890eb86; Ruohola JP, 2006, J BONE MINER RES, V21, P1483, DOI 10.1359/JBMR.060607; Thomas DT, 2016, J ACAD NUTR DIET, V116, P501, DOI 10.1016/j.jand.2015.12.006; Williams JR, 2008, B WORLD HEALTH ORGAN, V86, P650, DOI 10.2471/BLT.08.050955	37	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157931	10.1371/journal.pone.0157931	http://dx.doi.org/10.1371/journal.pone.0157931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383836	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400031
J	Kopiez, R; Wolf, A; Platz, F; Mons, J				Kopiez, Reinhard; Wolf, Anna; Platz, Friedrich; Mons, Jan			Replacing the Orchestra? - The Discernibility of Sample Library and Live Orchestra Sounds	PLOS ONE			English	Article							DISCRIMINATION	Recently, musical sounds from pre-recorded orchestra sample libraries (OSL) have become indispensable in music production for the stage or popular charts. Surprisingly, it is unknown whether human listeners can identify sounds as stemming from real orchestras or OSLs. Thus, an internet-based experiment was conducted to investigate whether a classic orchestral work, produced with sounds from a state-of-the-art OSL, could be reliably discerned from a live orchestra recording of the piece. It could be shown that the entire sample of listeners (N = 602) on average identified the correct sound source at 72.5%. This rate slightly exceeded Alan Turing's well-known upper threshold of 70% for a convincing, simulated performance. However, while sound experts tended to correctly identify the sound source, participants with lower listening expertise, who resembled the majority of music consumers, only achieved 68.6%. As non-expert listeners in the experiment were virtually unable to tell the real-life and OSL sounds apart, it is assumed that OSLs will become more common in music production for economic reasons.	[Kopiez, Reinhard; Wolf, Anna; Mons, Jan] Univ Mus Drama & Media, Hannover, Germany; [Platz, Friedrich] State Univ Mus & Performing Arts, Stuttgart, Germany		Kopiez, R (corresponding author), Univ Mus Drama & Media, Hannover, Germany.	reinhard.kopiez@hmtm-hannover.de	Wolf, Anna/AAX-5289-2021; Platz, Friedrich/N-9224-2015	Wolf, Anna/0000-0002-6196-6488; Platz, Friedrich/0000-0002-9758-9434; Kopiez, Reinhard/0000-0003-3356-3478				[Anonymous], 2012, DBSONIC V 4 501 COMP; Bacal J, 2002, VIENNA INSTRUMENTS; Batzdorf N, 2003, FIELD TEXT VIENNA SY; Bi J, 2006, SENSORY DISCRIMINATION TESTS AND MEASUREMENTS: STATISTICAL PRINCIPLES, PROCEDURES AND TABLES, P1; Bigand E, 2006, COGNITION, V100, P100, DOI 10.1016/j.cognition.2005.11.007; COOPER M., 2014, NY TIMES; d'Escrivan Julio, 2012, MUSIC TECHNOLOGY; DIVENYI PL, 1974, J ACOUST SOC AM, V56, P144, DOI 10.1121/1.1903245; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Ennis JM, 2011, J SENS STUD, V26, P371, DOI 10.1111/j.1745-459X.2011.00353.x; Gatys L.A., 2015, PREPRINT; Hahnel T, 2013, MUSIC SCI, V17, P410, DOI 10.1177/1029864913492531; Irish D, 2005, GAME PRODUCERS HDB; Kendall RA, 1999, MUSIC PERCEPT, V16, P327; Lebrecht N., 2014, 1 RING WORDS NOW RIN; Macmillan NA, 2005, DETECTION THEORY USE; Massey H., 2009, BEHIND THE GLASS, VII; Massey Howard, 2000, GLASS TOP RECORD PRO; Maxwell S. E., 2004, DESIGNING EXPT ANAL; McGuire S, 2007, AUDIO SAMPLING PRACT; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; Munte TF, 2001, NATURE, V409, P580, DOI 10.1038/35054668; Nager W, 2003, COGNITIVE BRAIN RES, V17, P83, DOI 10.1016/S0926-6410(03)00083-1; Oehler M, 2007, P 123 CONV AUD ENV S; Oehler M, 2008, P 10 INT C MUS PERC; Reips U.-D., 2012, APA HDB RES METHODS, V2, P291, DOI [DOI 10.1037/13620-017, 10.1037/13620-017]; Reips UD, 2002, SOC SCI COMPUT REV, V20, P241, DOI 10.1177/08939302020003002; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Russell JH, 2007, WALL STREET J; Smith P., 2003, HANSEL GRETEL ORCHES; Sorkin RD, 1999, BEHAV RES METH INS C, V31, P46, DOI 10.3758/BF03207691; Stewart D, 2003, VIENNA SYMPHONIC LIB; Stravinsky I, 2013, SACRE PRINTEMPS; SUEN CY, 1972, PERCEPT PSYCHOPHYS, V11, P417, DOI 10.3758/BF03206282; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; Wright BA, 2003, P INT C AUD DISPL JU	36	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158324	10.1371/journal.pone.0158324	http://dx.doi.org/10.1371/journal.pone.0158324			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27382932	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400042
J	Lu, YC; Lee, YR; Liao, JD; Lin, CY; Chen, YY; Chen, PT; Tseng, YS				Lu, Yin-Che; Lee, Ying-Ray; Liao, Ji-Der; Lin, Ching-Yen; Chen, Yih-Yuan; Chen, Ping-Tzu; Tseng, Ya-Shih			Reversine Induced Multinucleated Cells, Cell Apoptosis and Autophagy in Human Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							AURORA KINASE; ANTITUMOR-ACTIVITY; MITOTIC KINASE; OVEREXPRESSION; RESISTANCE; EXPRESSION; CARCINOMA; AMPLIFICATION; INHIBITOR; ERLOTINIB	Reversine, an A3 adenosine receptor antagonist, has been shown to induce differentiated myogenic-lineage committed cells to become multipotent mesenchymal progenitor cells. We and others have reported that reversine has an effect on human tumor suppression. This study revealed anti-tumor effects of reversine on proliferation, apoptosis and autophagy induction in human non-small cell lung cancer cells. Treatment of these cells with reversine suppressed cell growth in a time- and dosage-dependent manner. Moreover, polyploidy occurred after reversine treatment. In addition, caspase-dependent apoptosis and activation of autophagy by reversine in a dosage-dependent manner were also observed. We demonstrated in this study that reversine contributes to growth inhibition, apoptosis and autophagy induction in human lung cancer cells. Therefore, reversine used as a potential therapeutic agent for human lung cancer is worthy of further investigation.	[Lu, Yin-Che] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Lu, Yin-Che] Chia Yi Christian Hosp, Ditmanson Med Fdn, Div Hematol Oncol, Chiayi, Taiwan; [Lee, Ying-Ray; Lin, Ching-Yen; Chen, Ping-Tzu] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan; [Liao, Ji-Der; Tseng, Ya-Shih] Chung Hwa Univ Med Technol, Coll Med & Life Sci, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Chen, Yih-Yuan] Natl Chiayi Univ, Dept Biochem Sci & Technol, Chiayi, Taiwan; [Chen, Yih-Yuan] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan	Chia Nan University of Pharmacy & Science; Chung Hua University; National Chiayi University	Tseng, YS (corresponding author), Chung Hwa Univ Med Technol, Coll Med & Life Sci, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan.	shih415@mail.hwai.edu.tw		Lee, Ying-Ray/0000-0002-0349-0960	Chiayi Christian Hospital [R99-20]; Ministry of Science and Technology, ROC [MOST 104-2314-B-705-003]; Chung Hwa University of Medical Technology [1011001]	Chiayi Christian Hospital; Ministry of Science and Technology, ROC; Chung Hwa University of Medical Technology	This study was supported by research grants from Chiayi Christian Hospital (Grant R99-20), the Ministry of Science and Technology, ROC (MOST 104-2314-B-705-003), and Chung Hwa University of Medical Technology (Grant 1011001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese V, 2007, ANN ONCOL, V18, P47, DOI 10.1093/annonc/mdm224; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chieffi P, 2006, PROSTATE, V66, P326, DOI 10.1002/pros.20345; Chung BM, 2009, ONCOGENE, V28, P1821, DOI 10.1038/onc.2009.31; Clark P A, 1998, J Ky Med Assoc, V96, P440; D'Alise AM, 2008, MOL CANCER THER, V7, P1140, DOI 10.1158/1535-7163.MCT-07-2051; Filosto S, 2013, MOL CANCER THER, V12, P1579, DOI 10.1158/1535-7163.MCT-12-1029; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Guo YA, 2013, MOL CANCER RES, V11, P282, DOI 10.1158/1541-7786.MCR-12-0558; Hamidi T, 2012, CLIN CANCER RES, V18, P5234, DOI 10.1158/1078-0432.CCR-12-0026; Hardwicke MA, 2009, MOL CANCER THER, V8, P1808, DOI 10.1158/1535-7163.MCT-09-0041; Hsieh TC, 2007, INT J ONCOL, V31, P1293; Hua SC, 2012, PHARM RES-DORDR, V29, P1990, DOI 10.1007/s11095-012-0727-3; Jani JP, 2010, MOL CANCER THER, V9, P883, DOI 10.1158/1535-7163.MCT-09-0915; Jemaa M, 2012, CELL CYCLE, V11, P2149, DOI 10.4161/cc.20621; Jeng YM, 2004, CLIN CANCER RES, V10, P2065, DOI 10.1158/1078-0432.CCR-1057-03; Kanda R, 2013, CANCER RES, V73, P6243, DOI 10.1158/0008-5472.CAN-12-4502; Kim YK, 2007, BIOCHEM BIOPH RES CO, V358, P553, DOI 10.1016/j.bbrc.2007.04.165; Kuo CH, 2014, BREAST CANCER-TOKYO, V21, P358, DOI 10.1007/s12282-012-0400-z; Lee YR, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-9; Li R, 2013, MOL CANCER THER, V12, P2200, DOI 10.1158/1535-7163.MCT-13-0095; Looyenga BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030820; Lu CH, 2012, BIOMED PHARMACOTHER, V66, P642, DOI 10.1016/j.biopha.2012.08.001; McMillin DW, 2010, NAT MED, V16, P483, DOI 10.1038/nm.2112; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ogawa E, 2008, ANN SURG ONCOL, V15, P547, DOI 10.1245/s10434-007-9653-8; Perreira M, 2005, J MED CHEM, V48, P4910, DOI 10.1021/jm050221l; Pihan GA, 2001, CANCER RES, V61, P2212; Qin HX, 2013, CYTOTECHNOLOGY, V65, P643, DOI 10.1007/s10616-012-9520-8; Sato M, 2002, AM J RESP CELL MOL, V26, P127, DOI 10.1165/ajrcmb.26.1.4319; Scrima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030427; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Shepherd FA, 2013, AM SOC CLIN ONCOL ED, V2013, P339, DOI DOI 10.1200/EDBOOK_AM.2013.33.339; Sorrentino R, 2005, J CLIN ENDOCR METAB, V90, P928, DOI 10.1210/jc.2004-1518; Sun YG, 2011, J THORAC ONCOL, V6, P699, DOI 10.1097/JTO.0b013e31820d9d11; Tatsuka M, 1998, CANCER RES, V58, P4811; Vischioni B, 2006, MOL CANCER THER, V5, P2905, DOI 10.1158/1535-7163.MCT-06-0301; Xu ZH, 2013, INT J CLIN EXP PATHO, V6, P1493; Xu ZH, 2014, MOL CARCINOGEN, V53, P917, DOI 10.1002/mc.22059; Yeh CT, 2013, CARCINOGENESIS, V34, P2918, DOI 10.1093/carcin/bgt255; Zeng WFF, 2007, J CLIN PATHOL, V60, P218, DOI 10.1136/jcp.2006.036806; Zhang XY, 2009, ANTICANCER RES, V29, P4497; Zhao M, 2011, LUNG CANCER, V73, P366, DOI 10.1016/j.lungcan.2011.01.002; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zhu JJ, 2005, CANCER GENET CYTOGEN, V159, P10, DOI 10.1016/j.cancergencyto.2004.09.008; Zou ZZ, 2012, AUTOPHAGY, V8, P1798, DOI 10.4161/auto.22110	47	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158587	10.1371/journal.pone.0158587	http://dx.doi.org/10.1371/journal.pone.0158587			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27385117	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400061
J	Zhao, YP; Zhang, T; Huo, HH; Ye, YH; Liu, YF				Zhao, Yupeng; Zhang, Ting; Huo, Huanhuan; Ye, Yihong; Liu, Yanfen			Lunapark Is a Component of a Ubiquitin Ligase Complex Localized to the Endoplasmic Reticulum Three-way Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic-reticulum-associated protein degradation (ERAD); protein misfolding; ubiquitin; ubiquitin ligase; ubiquitin-conjugating enzyme (E2 enzyme); Atlastin; ER three-way junction; Lunapark; Lnp; gp78; misfolded	ER-ASSOCIATED DEGRADATION; MEMBRANE-PROTEINS; POLYUBIQUITIN CHAINS; GP78; REQUIRES; CYTOSOL; GENERATION; MORPHOLOGY; NETWORK; ENZYMES	The endoplasmic reticulum (ER) network comprises sheets and tubules that are connected by dynamic three-way junctions. Lunapark (Lnp) localizes to and stabilizes ER three-way junctions by antagonizing the small GTPase Atlastin, but how Lnp shapes the ER network is unclear. Here, we used an affinity purification approach and mass spectrometry to identify Lnp as an interacting partner of the ER protein quality control ubiquitin ligase gp78. Accordingly, Lnp purified from mammalian cells has a ubiquitin ligase activity in vitro. Intriguingly, biochemical analyses show that this activity can be attributed not only to associated ubiquitin ligase, but also to an intrinsic ubiquitin ligase activity borne by Lnp itself. This activity is contained in the N-terminal 45 amino acids of Lnp although this segment does not share homology to any known ubiquitin ligase motifs. Despite its interaction with gp78, Lnp does not seem to have a broad function in degradation of misfolded ER proteins. On the other hand, the N-terminal ubiquitin ligase-bearing motif is required for the ER three-way junction localization of Lnp. Our study identifies a new type of ubiquitin ligase and reveals a potential link between ubiquitin and ER morphology regulation.	[Zhao, Yupeng; Huo, Huanhuan; Liu, Yanfen] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China; [Zhang, Ting; Ye, Yihong] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	ShanghaiTech University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Liu, YF (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China.; Ye, YH (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov; liuyf@shanghaitech.edu.cn			National Institutes of Health Intramural Research Program NIDDK Grant [1ZIADK033008-06]; National Natural Science Foundation of China [31570781]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK033008] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program NIDDK Grant; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program NIDDK Grant 1ZIADK033008-06 and National Natural Science Foundation of China Grant 31570781. The authors declare no conflict of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ballar P, 2010, INT J BIOCHEM CELL B, V42, P167, DOI 10.1016/j.biocel.2009.10.005; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Casey AK, 2015, MOL BIOL CELL, V26, P2833, DOI 10.1091/mbc.E15-01-0053; Chen S, 2015, P NATL ACAD SCI USA, V112, P418, DOI 10.1073/pnas.1423026112; Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; Chen SL, 2012, NAT CELL BIOL, V14, P707, DOI 10.1038/ncb2523; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; English AR, 2013, NAT CELL BIOL, V15, P169, DOI 10.1038/ncb2647; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Lee JN, 2006, J BIOL CHEM, V281, P39308, DOI 10.1074/jbc.M608999200; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Liu YF, 2014, ELIFE, V3, DOI 10.7554/eLife.01369; Maculins T, 2016, CELL RES, V26, P499, DOI 10.1038/cr.2016.30; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Moriya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078235; Neutzner A, 2011, J BIOL CHEM, V286, P8633, DOI 10.1074/jbc.M110.197459; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; SCHEFFNER M, 1995, NATURE, V373, P81, DOI 10.1038/373081a0; Shemesh T, 2014, P NATL ACAD SCI USA, V111, pE5243, DOI 10.1073/pnas.1419997111; Shen YX, 2006, BIOCHEM BIOPH RES CO, V349, P1285, DOI 10.1016/j.bbrc.2006.08.173; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang QY, 2011, MOL CELL, V42, P758, DOI 10.1016/j.molcel.2011.05.010; Wang Y, 2014, ONCOTARGET, V5, P2044, DOI 10.18632/oncotarget.1478; Wiener R, 2013, NAT STRUCT MOL BIOL, V20, P1033, DOI 10.1038/nsmb.2655; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang T, 2015, MOL BIOL CELL, V26, P4438, DOI 10.1091/mbc.E15-06-0354	48	14	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18252	18262		10.1074/jbc.M116.737783	http://dx.doi.org/10.1074/jbc.M116.737783			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27387505	Green Published, hybrid			2022-12-26	WOS:000383241800018
J	Alencar, J; de Mello, CF; Serra-Freire, NM; Guimaraes, AE; Gil-Santana, HR; Gleiser, RM				Alencar, Jeronimo; de Mello, Cecilia Ferreira; Serra-Freire, Nicolau Maues; Guimaraes, Anthony Erico; Gil-Santana, Helcio R.; Gleiser, Raquel M.			Biodiversity and Temporal Distribution of Immature Culicidae in the Atlantic Forest, Rio de Janeiro State, Brazil	PLOS ONE			English	Article							MOSQUITOS DIPTERA-CULICIDAE; ARTHROPODS; DIVERSITY; SAMPLE; PARK	To increase the knowledge of biodiversity and identify larval habitats used by immature mosquitoes in the Atlantic Forest, we conducted a study in areas with various stages of preservation within the Guapiacu Ecological Reserve in Cachoeiras de Macacu, Rio de Janeiro state. The Culicidae fauna were sampled during February, April, June, August, October, and December 2012; February, March, April, May, June, August, October, and December 2013; and January and March 2014. Immature mosquitoes were collected with dippers and suction tubes (mouth aspirators). Over the sampling period, 2697 larvae of 56 species were collected, some of which are recognized vectors of human diseases. The larval mosquito community found in artificial habitats, temporary ground water, and phytotel-mata differed between sites, except for the mosquito fauna in bromeliads, which were almost 80% similar. Species segregation was more evident between larval habitats than between sites. Culex usquatus was the dominant species and colonized the highest number of larval habitats. The artificial larval habitats found in REGUA were colonized by a great diversity of species and high abundance as well, thus human artifacts left by the public in the area that collect water may promote an increase in mosquito populations. Among the species collected, some are known or suspected vectors of pathogens to humans and/or veterinary relevance, and their medical relevance is discussed.	[Alencar, Jeronimo; de Mello, Cecilia Ferreira; Guimaraes, Anthony Erico; Gil-Santana, Helcio R.] Fiocruz MS, Inst Oswaldo Cruz, Diptera Lab, Rio De Janeiro, Brazil; [de Mello, Cecilia Ferreira] Univ Fed Rural Rio de Janeiro, Postgrad Program Anim Biol, Inst Biol, Seropedica, RJ, Brazil; [Serra-Freire, Nicolau Maues] Fiocruz MS, Inst Oswaldo Cruz, Natl Reference Lab Rickettsioses Vectors, Rio De Janeiro, Brazil; [Gleiser, Raquel M.] Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, CONICET, Ctr Relevamiento & Evaluac Recursos Agr & Nat,Ins, Cordoba, Argentina	Fundacao Oswaldo Cruz; Universidade Federal Rural do Rio de Janeiro (UFRRJ); Fundacao Oswaldo Cruz; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Alencar, J (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Diptera Lab, Rio De Janeiro, Brazil.; Gleiser, RM (corresponding author), Univ Nacl Cordoba, Fac Ciencias Exactas Fis & Nat, CONICET, Ctr Relevamiento & Evaluac Recursos Agr & Nat,Ins, Cordoba, Argentina.	jalencar@ioc.fiocruz.br; raquel.gleiser@unc.edu.ar	Gil-Santana, Hélcio Reinaldo/AAG-2534-2021	Gil-Santana, Hélcio Reinaldo/0000-0002-0544-348X; Gleiser, Raquel/0000-0003-0726-2639; Guimaraes, Anthony/0000-0002-9982-2471; Alencar, Jeronimo/0000-0001-7863-2698	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ [112.076/2012]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [301345/2013-9]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ (contract 112.076/2012) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (301345/2013-9) for their financial support. Raquel M. Gleiser is a Career Member of CONICET, Argentina.; We thank the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ (contract 112.076/2012) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq (301345/2013-9) for their financial support. Raquel M. Gleiser is a Career Member of CONICET, Argentina. The authors thank Nicholas and Rachel Locke, president and vice president, and Jorge Bizarro, research coordinator, of REGUA, for the facilities granted for conducting the present study.	Alencar J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122268; Alencar J, 2013, REV SOC BRAS MED TRO, V46, P769, DOI 10.1590/0037-8682-1670-2013; Alencar J, 2011, J MED ENTOMOL, V48, P223, DOI 10.1603/ME09214; Alencar J, 2010, J AM MOSQUITO CONTR, V26, P249, DOI 10.2987/09-5896.1; ARAGAO MARIO B., 1956, REV BRASIL MALARIOL AND DOENCAS TROP, V8, P621; Nelson M. J., 1971, Contr Am ent Inst, V7, P1; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chao A, 2010, PROGRAM USERS GUIDE; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Colwell RK, 2013, ESTIMATES STAT ESTIM; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Couto AVS, 2010, MONOGRAPH U FEDERAL; DEANE L M, 1986, Memorias do Instituto Oswaldo Cruz, V81, P5, DOI 10.1590/S0074-02761986000600002; FARAN M E, 1981, Mosquito Systematics, V13, P1; Forattini OP, 2000, REV SAUDE PUBL, V34, P543, DOI 10.1590/S0034-89102000000500016; Forattini OP, 1965, ENTOMOLOGIA MED; Forattini OP, 2002, CULICIDOLOGIA MED; Foss KA, 2007, J AM MOSQUITO CONTR, V23, P476, DOI 10.2987/5582.1; Godfray HCJ, 1999, PHILOS T R SOC B, V354, P1811, DOI 10.1098/rstb.1999.0523; Gotelli N, 2013, ENCY BIODIVERSITY, V5; GUIMARAES A E, 1985, Memorias do Instituto Oswaldo Cruz, V80, P171, DOI 10.1590/S0074-02761985000200008; Guimaraes A. E., 1984, Memorias do Instituto Oswaldo Cruz, V79, P309, DOI 10.1590/S0074-02761984000300004; GUIMARAES AE, 1989, MEM I OSWALDO CRUZ, V84, P243, DOI 10.1590/S0074-02761989000800044; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Harbach R, 2008, FAMILY CULICIDAE MEI; Hutchings RSG, 2005, MED VET ENTOMOL, V19, P428, DOI 10.1111/j.1365-2915.2005.00587.x; Koppen W., 1936, HDB KLIMATOLOGIE, P7; Lamarre GPA, 2012, ZOOKEYS, P43, DOI 10.3897/zookeys.216.3332; Lane J., 1953, NEOTROPICAL CULICIDA, VI; Lane J., 1953, NEOTROPICAL CULICIDA, V2; Lopes J., 2002, BACIA RIO TIBAGI, V19, P327; Lopes Jose, 1997, Revista Brasileira de Zoologia, V14, P571, DOI 10.1590/S0101-81751997000300007; LOURENCO-DE-OLIVEIRA R, 1986, Memorias do Instituto Oswaldo Cruz, V81, P265; Lozovei A.L., 1976, Arquivos de Biologia e Tecnologia (Curitiba), V19, P25; Neves DP, 1977, BRAZ J BIOL, V37, P803; Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468; Rapini A, 2006, GREATER KNOWLEDGE BR, P27; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; SERRAFREIRE NM, 2002, PLANEJAMENTO ANALISE; Shen TJ, 2003, ECOLOGY, V84, P798, DOI 10.1890/0012-9658(2003)084[0798:PTNONS]2.0.CO;2; Silva MB, 2007, SITIENTIBUS CB, V7, P125; THOMAS CD, 1990, NATURE, V347, P237, DOI 10.1038/347237a0; Veloso H.P., 1991, CLASSIFICACAO VEGETA; Ward R.A., 1982, P417; Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602	46	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159240	10.1371/journal.pone.0159240	http://dx.doi.org/10.1371/journal.pone.0159240			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404496	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508200045
J	Hermes, R; Schwarzenberger, F; Goritz, F; Oh, S; Fernandes, T; Bernardino, R; Leclerc, A; Greunz, E; Mathew, A; Forsyth, S; Saragusty, J; Hildebrandt, TB				Hermes, Robert; Schwarzenberger, Franz; Goeritz, Frank; Oh, Serena; Fernandes, Teresa; Bernardino, Rui; Leclerc, Antoine; Greunz, Eva; Mathew, Abraham; Forsyth, Sarah; Saragusty, Joseph; Hildebrandt, Thomas Bernd			Ovarian down Regulation by GnRF Vaccination Decreases Reproductive Tract Tumour Size in Female White and Greater One-Horned Rhinoceroses	PLOS ONE			English	Article							CERATOTHERIUM-SIMUM-SIMUM; HORMONE VACCINE; BREEDING MANAGEMENT; FECAL PROGESTERONE; INDIAN RHINOCEROS; ESTROUS BEHAVIOR; BOAR TAINT; PHYTOESTROGENS; CONTRACEPTION; IMMUNIZATION	Reproductive tract tumours, specifically leiomyoma, are commonly found in female rhinoceroses. Similar to humans, tumour growth in rhinoceroses is thought to be sex hormone dependent. Tumours can form and expand from the onset of ovarian activity at puberty until the cessation of sex-steroid influences at senescence. Extensive tumour growth results in infertility. The aim of this study was to down regulate reproductive function of tumour-diseased and infertile females to stop further tumour growth using a Gonadotropin releasing factor (GnRF) vaccine. Four infertile southern white (Ceratotherium simum simum) and three Greater one-horned rhinoceroses (rhinoceros unicorns) with active ovaries and 2.7 +/- 0.9 and 14.0 +/- 1.5 reproductive tract tumours respectively were vaccinated against GnRF (Improvac (R), Zoetis, Germany) at 0, 4 and 16 weeks and re-boostered every 6-8 months thereafter. After GnRF vaccination ovarian and luteal activity was suppressed in all treated females. Three months after vaccination the size of the ovaries, the number of follicles and the size of the largest follicle were significantly reduced (P<0.03). Reproductive tract tumours decreased significantly in diameter (Greater-one horned rhino: P<0.0001; white rhino: P<0.01), presumably as a result of reduced sex-steroid influence. The calculated tumour volumes were reduced by 50.8 +/- 10.9% in Greater one-horned and 48.6 +/- 12.9% in white rhinoceroses. In conclusion, GnRF vaccine effectively down regulated reproductive function and decreased the size of reproductive tract tumours in female rhinoceros. Our work is the first to use down regulation of reproductive function as a symptomatic treatment against benign reproductive tumour disease in a wildlife species. Nonetheless, full reversibility and rhinoceros fertility following GnRF vaccination warrants further evaluation.	[Hermes, Robert; Goeritz, Frank; Saragusty, Joseph; Hildebrandt, Thomas Bernd] Leibniz Inst Zoo & Wildlife Res, PF 700430, D-10342 Berlin, Germany; [Schwarzenberger, Franz] Univ Vet Med, Biomed Sci, Vet Pl 1, A-1210 Vienna, Austria; [Oh, Serena; Mathew, Abraham] Singapore Zool Gardens, 80 Mandai Lakerd, Singapore 729826, Singapore; [Fernandes, Teresa; Bernardino, Rui] Lisbon Zoo, Vet Hosp, Estr Benf 158-160, Lisbon, Portugal; [Leclerc, Antoine] ZooParc Beauval, F-41110 St Aignan, France; [Greunz, Eva] Thoiry Zoo, F-78770 Thoiry, France; [Forsyth, Sarah] Colchester Zoo, Maldon Rd, Stanway CO3 0SL, Essex, England	Leibniz Institut fur Zoo und Wildtierforschung; University of Veterinary Medicine Vienna	Hermes, R (corresponding author), Leibniz Inst Zoo & Wildlife Res, PF 700430, D-10342 Berlin, Germany.	hermes@izw-berlin.de	Schwarzenberger, Franz/A-9236-2013; Leclerc, Antoine/F-4395-2014; Saragusty, Joseph/M-5030-2016	Schwarzenberger, Franz/0000-0002-2961-0545; Saragusty, Joseph/0000-0002-9274-7800				Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Boedeker NC, 2012, J ZOO WILDLIFE MED, V43, P603, DOI 10.1638/2011-0270.1; Brunius C, 2011, VACCINE, V29, P9514, DOI 10.1016/j.vaccine.2011.10.014; Cook H, 2010, Minerva Ginecol, V62, P225; Cooper NP, 2005, OBSTET GYNECOL SURV, V60, P132, DOI 10.1097/01.ogx.0000154688.02423.68; CRAMER SF, 1990, AM J CLIN PATHOL, V94, P435, DOI 10.1093/ajcp/94.4.435; Davis SR, 1999, RECENT PROG HORM RES, V54, P185; De Nys HM, 2010, J S AFR VET ASSOC, V81, P8; Donovan CE, 2013, ANIM REPROD SCI, V142, P42, DOI 10.1016/j.anireprosci.2013.09.002; FRIEDMAN AJ, 1991, OBSTET GYNECOL, V77, P720; Guldenschuh G, 2002, HUSBANDRY MANUAL GRE; Hermes R, 2009, THERIOGENOLOGY, V71, P393, DOI 10.1016/j.theriogenology.2008.10.008; Hermes R, 2006, THERIOGENOLOGY, V65, P1492, DOI 10.1016/j.theriogenology.2005.09.002; Hermes R, 2004, ANIM REPROD SCI, V82-3, P49, DOI 10.1016/j.anireprosci.2004.05.015; Hermes R, 2012, THERIOGENOLOGY, V78, P1217, DOI 10.1016/j.theriogenology.2012.05.015; Hermes R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092595; Higham JP, 2007, HORM BEHAV, V52, P384, DOI 10.1016/j.yhbeh.2007.06.003; Huggins C, 1941, CANCER RES, V1, P293; Imboden I, 2006, THERIOGENOLOGY, V66, P1866, DOI 10.1016/j.theriogenology.2006.04.038; Klein LV, 1997, ANN C AM ASS ZOO VET, P127; Lu A, 2011, HORM BEHAV, V59, P28, DOI 10.1016/j.yhbeh.2010.09.012; Lueders I, 2014, J ZOO WILDLIFE MED, V45, P611, DOI 10.1638/2013-0233R.1; Miller LA, 2004, J WILDLIFE DIS, V40, P725, DOI 10.7589/0090-3558-40.4.725; Miller LA, 2008, AM J REPROD IMMUNOL, V60, P214, DOI 10.1111/j.1600-0897.2008.00616.x; Munson L, 2006, THERIOGENOLOGY, V66, P126, DOI 10.1016/j.theriogenology.2006.03.016; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Patton ML, 2006, THERIOGENOLOGY, V66, P431, DOI 10.1016/j.theriogenology.2005.10.025; Penfold LM, 2014, ZOO BIOL, V33, P20, DOI 10.1002/zoo.21104; Powers JG, 2011, BIOL REPROD, V85, P1152, DOI 10.1095/biolreprod.110.088237; Radcliffe RM, 2000, J ZOO WILDLIFE MED, V31, P201, DOI 10.1638/1042-7260(2000)031[0201:SLGUBI]2.0.CO;2; Radcliffe Robin W., 2007, P543, DOI 10.1002/9780470376478.ch48; Sabry M, 2012, REPROD SCI, V19, P339, DOI 10.1177/1933719111432867; Schaffer N.E. M., 2001, INT EL RHIN RES S 7; Schulman ML, 2013, EQUINE VET J, V45, P111, DOI 10.1111/j.2042-3306.2012.00577.x; Schwarz C, 2014, TIERAERZTL PRAX G N, V42, P150; Schwarzenberger F, 2000, GEN COMP ENDOCR, V119, P300, DOI 10.1006/gcen.2000.7523; Schwarzenberger F, 2013, WIEN TIERARZTL MONAT, V100, P209; Schwarzenberger F, 1998, ANIM REPROD SCI, V53, P173, DOI 10.1016/S0378-4320(98)00112-2; Simms MS, 2000, BRIT J CANCER, V83, P443, DOI 10.1054/bjoc.2000.1315; Steck B, 2012, EUR ASS ZOOS AQ ANN; Stoops MA, 2004, REPRODUCTION, V128, P843, DOI 10.1530/rep.1.00328; Toh MF, 2012, STEROIDS, V77, P765, DOI 10.1016/j.steroids.2012.03.013; Tsigkou A, 2015, FERTIL STERIL, V104, P170, DOI 10.1016/j.fertnstert.2015.04.024; Tubbs C, 2012, ENDOCRINOLOGY, V153, P1444, DOI 10.1210/en.2011-1962; Valades GB, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-63; Versteege L, 2012, EAZA HUSBANDRY GUIDE, P75; Viswanathan M, 2007, EVID REP TECHNOL ASS, V154, P100; Walker WJ, 2002, BJOG-INT J OBSTET GY, V109, P1262, DOI 10.1046/j.1471-0528.2002.01449.x; Wilson M, 2010, J ZOO WILDLIFE MED, V41, P111, DOI 10.1638/2009-0128.1; Zamaratskaia G, 2008, REPROD DOMEST ANIM, V43, P351, DOI 10.1111/j.1439-0531.2007.00914.x; Zava DT, 1998, P SOC EXP BIOL MED, V217, P369	51	4	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0157963	10.1371/journal.pone.0157963	http://dx.doi.org/10.1371/journal.pone.0157963			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403662	Green Published, gold			2022-12-26	WOS:000379508200005
J	Gamage, SMKW; McGrath, DJ; Persley, DM; Dietzgen, RG				Gamage, Shirani M. K. Widana; McGrath, Desmond J.; Persley, Denis M.; Dietzgen, Ralf G.			Transcriptome Analysis of Capsicum Chlorosis Virus-Induced Hypersensitive Resistance Response in Bell Capsicum	PLOS ONE			English	Article							PATHOGENESIS-RELATED PROTEINS; GLUTATHIONE S-TRANSFERASES; CELL-DEATH; MOLECULAR CHARACTERIZATION; DISEASE RESISTANCE; GENE-EXPRESSION; PROTEASE INHIBITORS; FUSARIUM-OXYSPORUM; DEFENSE RESPONSES; PROVIDES INSIGHTS	Background Capsicum chlorosis virus (CaCV) is an emerging pathogen of capsicum, tomato and peanut crops in Australia and South-East Asia. Commercial capsicum cultivars with CaCV resistance are not yet available, but CaCV resistance identified in Capsicum chinense is being introgressed into commercial Bell capsicum. However, our knowledge of the molecular mechanisms leading to the resistance response to CaCV infection is limited. Therefore, transcriptome and expression profiling data provide an important resource to better understand CaCV resistance mechanisms. Methodology/Principal Findings We assembled capsicum transcriptomes and analysed gene expression using Illumina HiSeq platform combined with a tag-based digital gene expression system. Total RNA extracted from CaCV/mock inoculated CaCV resistant (R) and susceptible (S) capsicum at the time point when R line showed a strong hypersensitive response to CaCV infection was used in transcriptome assembly. Gene expression profiles of R and S capsicum in CaCV-and buffer-inoculated conditions were compared. None of the genes were differentially expressed (DE) between R and S cultivars when mock-inoculated, while 2484 genes were DE when inoculated with CaCV. Functional classification revealed that the most highly up-regulated DE genes in R capsicum included pathogenesis-related genes, cell death-associated genes, genes associated with hormone-mediated signalling pathways and genes encoding enzymes involved in synthesis of defense-related secondary metabolites. We selected 15 genes to confirm DE expression levels by real-time quantitative PCR. Conclusion/Significance DE transcript profiling data provided comprehensive gene expression information to gain an understanding of the underlying CaCV resistance mechanisms. Further, we identified candidate CaCV resistance genes in the CaCV-resistant C. annuum x C. chinense breeding line. This knowledge will be useful in future for fine mapping of the CaCV resistance locus and potential genetic engineering of resistance into CaCV-susceptible crops.	[Gamage, Shirani M. K. Widana; Dietzgen, Ralf G.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia; [McGrath, Desmond J.] AgriSci Queensland, Queensland Dept Agr & Fisheries, Gatton, Qld, Australia; [Persley, Denis M.] EcoSci Precinct, AgriSci Queensland, Queensland Dept Agr & Fisheries, Dutton Pk, Qld, Australia	University of Queensland	Dietzgen, RG (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld, Australia.	r.dietzgen@uq.edu.au	Kumari, Widana Gamage Shirani Manel/O-5603-2018; Dietzgen, Ralf Georg/A-5565-2010	Kumari, Widana Gamage Shirani Manel/0000-0003-4361-5622; Dietzgen, Ralf Georg/0000-0002-7772-2250	Queensland Department of Agriculture and Fisheries; University of Queensland through the Queensland Alliance for Agriculture and Food Innovation institute for RGD; Illumina through Miseq Pilot the Possibilities Grant Programme; "Faculty for the Future" PhD Fellowship from the Schlumberger Foundation, The Netherlands	Queensland Department of Agriculture and Fisheries; University of Queensland through the Queensland Alliance for Agriculture and Food Innovation institute for RGD; Illumina through Miseq Pilot the Possibilities Grant Programme; "Faculty for the Future" PhD Fellowship from the Schlumberger Foundation, The Netherlands	This research was jointly supported by the Queensland Department of Agriculture and Fisheries and the University of Queensland through internal support by the Queensland Alliance for Agriculture and Food Innovation institute for RGD. We thank Illumina for financial support through its Miseq Pilot the Possibilities Grant Programme. SMKWG was supported by a "Faculty for the Future" PhD Fellowship from the Schlumberger Foundation, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex D, 2000, PLANT J, V22, P415, DOI 10.1046/j.1365-313X.2000.00751.x; Antcheva N, 2001, PROTEIN SCI, V10, P2280, DOI 10.1110/ps.21701; ARANDA FJ, 1995, BBA-BIOMEMBRANES, V1234, P225, DOI 10.1016/0005-2736(94)00293-X; Ayliffe MA, 1999, PLANT J, V17, P287, DOI 10.1046/j.1365-313X.1999.00377.x; Aza-Gonzalez C, 2011, PLANT CELL REP, V30, P695, DOI 10.1007/s00299-010-0968-8; Back K, 2001, PLANT CELL PHYSIOL, V42, P475, DOI 10.1093/pcp/pce060; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bernier F, 2001, PLANT PHYSIOL BIOCH, V39, P545, DOI 10.1016/S0981-9428(01)01285-2; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Black L, 1991, PLANT DIS, V75; BOHLMANN H, 1994, CRIT REV PLANT SCI, V13, P1, DOI 10.1080/713608052; Chen H, 2016, MOL PLANT PATHOLOGY; Chen K, 2007, J PHYTOPATHOL, V155, P178, DOI 10.1111/j.1439-0434.2007.01217.x; Chen TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080816; CHOI D, 1994, P NATL ACAD SCI USA, V91, P2329, DOI 10.1073/pnas.91.6.2329; Choi H, 2015, PLANT MOL BIOL, V88, P233, DOI 10.1007/s11103-015-0317-y; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; David P, 2010, THEOR APPL GENET, V121, P87, DOI 10.1007/s00122-010-1293-x; de Leon IP, 2002, PLANT J, V29, P61, DOI 10.1046/j.1365-313x.2002.01195.x; Diaz Jose, 2004, Phytochemistry Reviews, V3, P141, DOI 10.1023/B:PHYT.0000047801.41574.6e; Dinesh-Kumar SP, 2000, P NATL ACAD SCI USA, V97, P1908, DOI 10.1073/pnas.020367497; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Epple P, 1997, PLANT CELL, V9, P509, DOI 10.1105/tpc.9.4.509; Finkemeier I, 2013, PLANT PHYSIOL, V162, P239, DOI 10.1104/pp.113.214114; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Goyer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1666-2; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Guo YL, 2011, PLANT PHYSIOL, V157, P757, DOI 10.1104/pp.111.181990; HammondKosack KE, 1997, ANNU REV PLANT PHYS, V48, P575, DOI 10.1146/annurev.arplant.48.1.575; Hermosa MR, 2006, PHYSIOL MOL PLANT P, V68, P138, DOI 10.1016/j.pmpp.2006.09.004; Hwang IS, 2010, PLANT PHYSIOL, V152, P948, DOI 10.1104/pp.109.147827; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim DS, 2014, PLANT MOL BIOL, V84, P329, DOI 10.1007/s11103-013-0137-x; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kim YC, 2006, BIOCHEM BIOPH RES CO, V345, P638, DOI 10.1016/j.bbrc.2006.04.124; Kirsch C, 1997, PLANT PHYSIOL, V115, P283, DOI 10.1104/pp.115.1.283; Knierim D, 2006, ARCH VIROL, V151, P1761, DOI 10.1007/s00705-006-0749-4; Ko MK, 2005, PLANT MOL BIOL, V58, P529, DOI 10.1007/s11103-005-7088-9; Kong HY, 2002, PHYSIOL PLANTARUM, V115, P550, DOI 10.1034/j.1399-3054.2002.1150409.x; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kraikruan W, 2008, EFFECT CAPSAICIN GER; Krishnareddy M, 2008, PLANT DIS, V92, P1469, DOI 10.1094/PDIS-92-10-1469B; Kunkalikar SR, 2010, ARCH VIROL, V155, P1047, DOI 10.1007/s00705-010-0681-5; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lee BJ, 2009, FEBS LETT, V583, P2315, DOI 10.1016/j.febslet.2009.06.028; Lee H, 1999, J BIOL CHEM, V274, P36637, DOI 10.1074/jbc.274.51.36637; Lee SC, 2005, PLANTA, V221, P790, DOI 10.1007/s00425-005-1488-6; Li J, 2008, MOL PLANT, V1, P482, DOI 10.1093/mp/ssn013; LINTHORST HJM, 1993, PLANT MOL BIOL, V21, P985, DOI 10.1007/BF00023597; Liu HY, 2010, J INTEGR PLANT BIOL, V52, P315, DOI 10.1111/j.1744-7909.2010.00912.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopukhina A, 2001, PLANT PHYSIOL, V126, P1678, DOI 10.1104/pp.126.4.1678; Lu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043447; Mandal B, 2012, PLANT DIS, V96, P468, DOI 10.1094/PDIS-06-11-0520; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Maruthi MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096642; McHale L, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-212; McMichael LA, 2002, AUSTRALAS PLANT PATH, V31, P231, DOI 10.1071/AP02016; Morgan PW, 1997, PHYSIOL PLANTARUM, V100, P620, DOI 10.1034/j.1399-3054.1997.1000325.x; Morimoto S, 2007, J BIOL CHEM, V282, P20739, DOI 10.1074/jbc.M700133200; Moscone EA, 2006, 6 INT SOL C GEN MEET, V745; Mun JH, 2009, MOL GENET GENOMICS, V282, P617, DOI 10.1007/s00438-009-0492-0; Nie XZ, 2002, GENOME, V45, P905, DOI [10.1139/g02-062, 10.1139/G02-062]; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Oh BJ, 1999, PLANT MOL BIOL, V41, P313, DOI 10.1023/A:1006336203621; Park CJ, 2004, PLANTA, V219, P797, DOI 10.1007/s00425-004-1290-x; Persley D., 2010, DIS VEGETABLE CROPS; Persley DM, 2006, AUSTRALAS PLANT PATH, V35, P161, DOI 10.1071/AP06015; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Premachandra WTSD, 2005, PHYTOPATHOLOGY, V95, P659, DOI 10.1094/PHYTO-95-0659; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Qu ZL, 2006, PLANT CELL PHYSIOL, V47, P1058, DOI 10.1093/pcp/pcj076; Reddy M. K., 2014, SABRAO Journal of Breeding and Genetics, V46, P160; Roberts JA, 2000, ANN BOT-LONDON, V86, P223, DOI 10.1006/anbo.2000.1203; Roitsch T, 2003, J EXP BOT, V54, P513, DOI 10.1093/jxb/erg050; Rubio M, 2015, MOL PLANT PATHOL, V16, P164, DOI 10.1111/mpp.12169; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schornack S, 2004, PLANT J, V37, P46, DOI 10.1046/j.1365-313X.2003.01937.x; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Stall RE, 2009, ANNU REV PHYTOPATHOL, V47, P265, DOI 10.1146/annurev-phyto-080508-081752; Stukkens Y, 2005, PLANT PHYSIOL, V139, P341, DOI 10.1104/pp.105.062372; Tang F, 2013, PLANT MOL BIOL, V82, P367, DOI 10.1007/s11103-013-0068-6; Thomma BPHJ, 2001, CURR OPIN IMMUNOL, V13, P63, DOI 10.1016/S0952-7915(00)00183-7; Tomita R, 2011, MOL PLANT MICROBE IN, V24, P108, DOI 10.1094/MPMI-06-10-0127; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; van der Biezen EA, 1998, CURR BIOL, V8, pR226, DOI 10.1016/S0960-9822(98)70145-9; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; van Ooijen G, 2007, ANNU REV PHYTOPATHOL, V45, P43, DOI 10.1146/annurev.phyto.45.062806.094430; Veloso J, 2014, PLANT BIOLOGY, V16, P177, DOI 10.1111/j.1438-8677.2012.00717.x; VICK BA, 1983, BIOCHEM BIOPH RES CO, V111, P470, DOI 10.1016/0006-291X(83)90330-3; Walters D, 2003, NEW PHYTOL, V159, P109, DOI 10.1046/j.1469-8137.2003.00802.x; WHITEHEAD IM, 1989, PHYTOCHEMISTRY, V28, P775, DOI 10.1016/0031-9422(89)80114-1; Widana Gamage S, 2015, ARCH VIROL, P1; Yang SM, 2014, INT J MOL SCI, V15, P10424, DOI 10.3390/ijms150610424; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zavala-Paramo G, 2000, PHYSIOL PLANTARUM, V110, P410, DOI 10.1034/j.1399-3054.2000.1100316.x; Zhang XC, 2003, PLANT CELL, V15, P2333, DOI 10.1105/tpc.013474	104	17	17	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0159085	10.1371/journal.pone.0159085	http://dx.doi.org/10.1371/journal.pone.0159085			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27398596	Green Submitted, gold, Green Published			2022-12-26	WOS:000379508100017
J	Kim, HY; Jang, EJ; Park, B; Kim, TY; Shin, SA; Ha, YC; Jang, S				Kim, Ha Young; Jang, Eun Jin; Park, ByeongJu; Kim, Tae-Young; Shin, Soon-Ae; Ha, Yong-Chan; Jang, Sunmee			Development of a Korean Fracture Risk Score (KFRS) for Predicting Osteoporotic Fracture Risk: Analysis of Data from the Korean National Health Insurance Service	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; HIP-FRACTURES; OLDER WOMEN; METAANALYSIS; BMD; MEN; QFRACTURESCORES; PERFORMANCE; COHORT; FRAX	Background Asian-specific prediction models for estimating individual risk of osteoporotic fractures are rare. We developed a Korean fracture risk prediction model using clinical risk factors and assessed validity of the final model. Methods A total of 718,306 Korean men and women aged 50-90 years were followed for 7 years in a national system-based cohort study. In total, 50% of the subjects were assigned randomly to the development dataset and 50% were assigned to the validation dataset. Clinical risk factors for osteoporotic fracture were assessed at the biennial health check. Data on osteoporotic fractures during the follow-up period were identified by ICD-10 codes and the nationwide database of the National Health Insurance Service (NHIS). Results During the follow-up period, 19,840 osteoporotic fractures were reported (4,889 in men and 14,951 in women) in the development dataset. The assessment tool called the Korean Fracture Risk Score (KFRS) is comprised of a set of nine variables, including age, body mass index, recent fragility fracture, current smoking, high alcohol intake, lack of regular exercise, recent use of oral glucocorticoid, rheumatoid arthritis, and other causes of secondary osteoporosis. The KFRS predicted osteoporotic fractures over the 7 years. This score was validated using an independent dataset. A close relationship with overall fracture rate was observed when we compared the mean predicted scores after applying the KFRS with the observed risks after 7 years within each 10th of predicted risk. Conclusion We developed a Korean specific prediction model for osteoporotic fractures. The KFRS was able to predict risk of fracture in the primary population without bone mineral density testing and is therefore suitable for use in both clinical setting and self-assessment. The website is available at http://www.nhis.or.kr.	[Kim, Ha Young] Wonkwang Univ, Sanbon Hosp, Dept Internal Med, Gunpo, South Korea; [Jang, Eun Jin] Andong Natl Univ, Dept Informat Stat, Andong, South Korea; [Park, ByeongJu] Kyungpook Natl Univ, Dept Stat, Daegu, South Korea; [Kim, Tae-Young] Hallym Univ, Dept Orthopaed Surg, Sch Med, Anyang, South Korea; [Shin, Soon-Ae] Natl Hlth Insurance Serv, Big Data Steering Dept, Seoul, South Korea; [Ha, Yong-Chan] Chung Ang Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea; [Jang, Sunmee] Gachon Univ, Coll Pharm, Inchon, South Korea	Wonkwang University; Andong National University; Kyungpook National University; Hallym University; National Health Insurance Service; Chung Ang University; Chung Ang University Hospital; Gachon University	Ha, YC (corresponding author), Chung Ang Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea.; Jang, S (corresponding author), Gachon Univ, Coll Pharm, Inchon, South Korea.	hayongch@naver.com; smjang@gachon.ac.kr	Kim, Hayoung/GQP-0924-2022	Ha, Yong-Chan/0000-0002-6249-0581	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare, Korea [HI13C1522]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health Welfare, Korea	This study was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Korea (grant number: HI13C1522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barrett-Connor E, 2005, J BONE MINER RES, V20, P185, DOI 10.1359/JBMR.041007; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Bolland MJ, 2011, J BONE MINER RES, V26, P420, DOI 10.1002/jbmr.215; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Cummins NM, 2011, CALCIFIED TISSUE INT, V89, P172, DOI 10.1007/s00223-011-9504-2; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Gregg EW, 1998, ANN INTERN MED, V129, P81, DOI 10.7326/0003-4819-129-2-199807150-00002; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P399, DOI 10.1007/s00198-008-0560-z; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2004, BONE, V35, P1029, DOI 10.1016/j.bone.2004.06.017; Kanis JA, 2004, J BONE MINER RES, V19, P893, DOI 10.1359/JBMR.040134; Kanis JA, 2004, BONE, V35, P375, DOI 10.1016/j.bone.2004.03.024; Kanis JA, 2002, OSTEOPOROSIS INT, V13, P527, DOI 10.1007/s001980200069; Klotzbuecher CM, 2000, J BONE MINER RES, V15, P721, DOI 10.1359/jbmr.2000.15.4.721; Kung AWC, 2007, J BONE MINER RES, V22, P1080, DOI [10.1359/jbmr.070320, 10.1359/JBMR.070320]; Lee SH, 2010, J BONE MINER RES, V25, P369, DOI 10.1359/jbmr.090722; Lim S, 2008, J BONE MINER METAB, V26, P400, DOI 10.1007/s00774-007-0835-z; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Lippuner K, 2009, Rev Med Suisse, V5, P1304; Nayak S, 2014, OSTEOPOROSIS INT, V25, P23, DOI 10.1007/s00198-013-2504-5; Nguyen ND, 2008, OSTEOPOROSIS INT, V19, P1431, DOI 10.1007/s00198-008-0588-0; Nguyen ND, 2007, OSTEOPOROSIS INT, V18, P1109, DOI 10.1007/s00198-007-0362-8; Park C, 2011, J BONE MINER METAB, V29, P744, DOI 10.1007/s00774-011-0279-3; PECK WA, 1993, AM J MED, V94, P646; Sambrook PN, 2011, J BONE MINER RES, V26, P2770, DOI 10.1002/jbmr.503; Wolbers M, 2014, BIOSTATISTICS, V15, P526, DOI 10.1093/biostatistics/kxt059; Wolbers M, 2009, EPIDEMIOLOGY, V20, P555, DOI 10.1097/EDE.0b013e3181a39056; Yoo Je-Hyun, 2015, J Bone Metab, V22, P175, DOI 10.11005/jbm.2015.22.4.175; Yoon HK, 2011, J KOREAN MED SCI, V26, P1087, DOI 10.3346/jkms.2011.26.8.1087	33	21	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2016	11	7							e0158918	10.1371/journal.pone.0158918	http://dx.doi.org/10.1371/journal.pone.0158918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CN	27399597	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508100012
J	Kim, IS; Kim, YS; Kim, YH; Park, AK; Kim, HW; Lee, JH; Yoon, HS				Kim, Il-Sup; Kim, Young-Saeng; Kim, Yul-Ho; Park, Ae-Kyung; Kim, Han-Woo; Lee, Jun-Hyuk; Yoon, Ho-Sung			Potential Application of the Oryza sativa Monodehydroascorbate Reductase Gene (OsMDHAR) to Improve the Stress Tolerance and Fermentative Capacity of Saccharomyces cerevisiae	PLOS ONE			English	Article							OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; ASCORBIC-ACID; ERYTHROASCORBIC ACID; ENHANCED TOLERANCE; ETHANOL-PRODUCTION; MESSENGER-RNA; YEAST STRAINS; CDNA CLONING; WINE YEAST	Monodehydroascorbate reductase (MDHAR; EC 1.6.5.4) is an important enzyme for ascorbate recycling. To examine whether heterologous expression of MDHAR from Oryza sativa (OsMDHAR) can prevent the deleterious effects of unfavorable growth conditions, we constructed a transgenic yeast strain harboring a recombinant plasmid carrying OsMDHAR (p426GPD::OsMDHAR). OsMDHAR-expressing yeast cells displayed enhanced tolerance to hydrogen peroxide by maintaining redox homoeostasis, proteostasis, and the ascorbate (AsA)-like pool following the accumulation of antioxidant enzymes and molecules, metabolic enzymes, and molecular chaperones and their cofactors, compared to wild-type (WT) cells carrying vector alone. The addition of exogenous AsA or its analogue isoascorbic acid increased the viability of WT and ara2 Delta cells under oxidative stress. Furthermore, the survival of OsMDHAR-expressing cells was greater than that of WT cells when cells at mid-log growth phase were exposed to high concentrations of ethanol. High OsMDHAR expression also improved the fermentative capacity of the yeast during glucose-based batch fermentation at a standard cultivation temperature (30 degrees C). The alcohol yield of OsMDHAR-expressing transgenic yeast during fermentation was approximately 25% (0.18 g.g(-1)) higher than that of WT yeast. Accordingly, OsMDHAR-expressing transgenic yeast showed prolonged survival during the environmental stresses produced during fermentation. These results suggest that heterologous OsMDHAR expression increases tolerance to reactive oxygen species-induced oxidative stress by improving cellular redox homeostasis and improves survival during fermentation, which enhances fermentative capacity.	[Kim, Il-Sup; Yoon, Ho-Sung] Kyungpook Natl Univ, Sch Life Sci, Plus KNU Creat BioRes Grp BK21, Daegu, South Korea; [Kim, Young-Saeng] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Kim, Yul-Ho] Rural Dev Adm, Highland Agr Res Inst, Natl Inst Crop Sci, Pyeongchang, South Korea; [Park, Ae-Kyung; Kim, Han-Woo; Lee, Jun-Hyuk] Korea Polar Res Inst, Div Polar Life Sci, Inchon, South Korea	Kyungpook National University; University of California System; University of California San Diego; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Korea Institute of Ocean Science & Technology (KIOST); Korea Polar Research Institute (KOPRI)	Kim, IS; Yoon, HS (corresponding author), Kyungpook Natl Univ, Sch Life Sci, Plus KNU Creat BioRes Grp BK21, Daegu, South Korea.	92kis@hanmail.net; hsy@knu.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Korea [PJ011122022016]	Next-Generation BioGreen 21 Program, Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ011122022016), Rural Development Administration, Korea.	Abbott DA, 2009, APPL ENVIRON MICROB, V75, P2320, DOI 10.1128/AEM.00009-09; Abreu-Cavalheiro A, 2013, BRAZ J MICROBIOL, V44, P665, DOI 10.1590/S1517-83822013000300001; Aguado A, 2015, ARCH BIOCHEM BIOPHYS, V580, P121, DOI 10.1016/j.abb.2015.07.006; Belloch C, 2008, INT J FOOD MICROBIOL, V122, P188, DOI 10.1016/j.ijfoodmicro.2007.11.083; Ben Rejeb I, 2004, CR BIOL, V327, P679, DOI 10.1016/j.crvi.2004.06.002; Breiman A, 2014, CURR PROTEIN PEPT SC, V15, P232, DOI 10.2174/1389203715666140331115603; Campagno C, 2001, YEAST, V18, P663, DOI 10.1002/yea.715; Chum HL, 2014, BIOFUEL BIOPROD BIOR, V8, P205, DOI 10.1002/bbb.1448; Ding JM, 2009, APPL MICROBIOL BIOT, V85, P253, DOI 10.1007/s00253-009-2223-1; Do H, 2014, ACTA CRYSTALLOGR F, V70, P1244, DOI 10.1107/S2053230X14015908; Drew DP, 2007, PLANTA, V225, P945, DOI 10.1007/s00425-006-0394-x; Du X, 2007, APPL MICROBIOL BIOT, V75, P1343, DOI 10.1007/s00253-007-0940-x; Eastmond PJ, 2007, PLANT CELL, V19, P1376, DOI 10.1105/tpc.106.043992; Eltayeb AE, 2007, PLANTA, V225, P1255, DOI 10.1007/s00425-006-0417-7; Fernandes PN, 2007, REDOX REP, V12, P236, DOI 10.1179/135100007X200344; Fierro-Risco J, 2013, APPL MICROBIOL BIOT, V97, P6867, DOI 10.1007/s00253-013-4850-9; Gallie DR, 2013, J EXP BOT, V64, P433, DOI 10.1093/jxb/ers330; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Gietz RD, 2001, BIOTECHNIQUES, V30, P816, DOI 10.2144/01304rv02; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gillespie KM, 2007, NAT PROTOC, V2, P871, DOI 10.1038/nprot.2007.101; Gomez-Pastor R, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-4; Gomez-Pastor R, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-9; Gorsich SW, 2006, APPL MICROBIOL BIOT, V71, P339, DOI 10.1007/s00253-005-0142-3; Grabowska D, 2003, J BIOL CHEM, V278, P13984, DOI 10.1074/jbc.M210076200; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Herrero E, 2008, BBA-GEN SUBJECTS, V1780, P1217, DOI 10.1016/j.bbagen.2007.12.004; Husnik JI, 2006, METAB ENG, V8, P315, DOI 10.1016/j.ymben.2006.02.003; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Kiani-Esfahani A, 2013, SYST BIOL REPROD MED, V59, P352, DOI 10.3109/19396368.2013.829536; Kim IS, 2013, APPL MICROBIOL BIOT, V97, P8997, DOI 10.1007/s00253-013-4729-9; Kim IS, 2013, APPL MICROBIOL BIOT, V97, P3519, DOI 10.1007/s00253-012-4410-8; Kim IS, 2013, MOL CELLS, V35, P210, DOI 10.1007/s10059-013-2258-0; Kwak MK, 2015, FEBS LETT, V589, P1863, DOI 10.1016/j.febslet.2015.04.050; Larsson S, 2001, APPL MICROBIOL BIOT, V57, P167, DOI 10.1007/s002530100742; Lee JS, 2001, BBA-GEN SUBJECTS, V1527, P31, DOI 10.1016/S0304-4165(01)00134-9; Li F, 2010, PHYSIOL PLANTARUM, V139, P421, DOI 10.1111/j.1399-3054.2010.01369.x; Lopez-Mirabal HR, 2008, BBA-MOL CELL RES, V1783, P629, DOI 10.1016/j.bbamcr.2007.10.013; Luo N, 2012, PLANT SCI, V197, P122, DOI 10.1016/j.plantsci.2012.09.010; MEHLHORN H, 1986, PLANT PHYSIOL, V82, P336, DOI 10.1104/pp.82.1.336; MISHRA NP, 1993, PLANT PHYSIOL, V102, P903, DOI 10.1104/pp.102.3.903; Morano KA, 2012, GENETICS, V190, P1157, DOI 10.1534/genetics.111.128033; Munhoz DC, 2004, J BIOL CHEM, V279, P35219, DOI 10.1074/jbc.M313773200; Noctor G, 2016, PLANT CELL ENVIRON, V39, P1140, DOI 10.1111/pce.12726; Omoto E, 2013, PHYSIOL PLANTARUM, V149, P1, DOI 10.1111/ppl.12017; Ostergaard J, 1997, J BIOL CHEM, V272, P30009, DOI 10.1074/jbc.272.48.30009; Priya S, 2013, FEBS LETT, V587, P1981, DOI 10.1016/j.febslet.2013.05.014; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Ribeiro TP, 2015, FREE RADICAL BIO MED, V80, P67, DOI 10.1016/j.freeradbiomed.2014.12.005; Saini JK, 2015, 3 BIOTECH, V5, P337, DOI 10.1007/s13205-014-0246-5; Sakihama Y, 2000, BIOCHEM BIOPH RES CO, V279, P949, DOI 10.1006/bbrc.2000.4053; SANO S, 1994, PLANT CELL PHYSIOL, V35, P425; Shigeoka S, 2014, BIOSCI BIOTECH BIOCH, V78, P1457, DOI 10.1080/09168451.2014.942254; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Steensels J, 2014, FEMS MICROBIOL REV, V38, P947, DOI 10.1111/1574-6976.12073; Sudhakar D, 1998, TRANSGENIC RES, V7, P371, DOI 10.1023/A:1008856703464; Sultana S, 2012, J PLANT PHYSIOL, V169, P311, DOI 10.1016/j.jplph.2011.09.004; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Tang HMV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000697; Tanghe A, 2006, BIODIVERSITY AND ECOPHYSIOLOGY OF YEASTS, P175, DOI 10.1007/3-540-30985-3_9; Verghese J, 2012, MICROBIOL MOL BIOL R, V76, P115, DOI 10.1128/MMBR.05018-11; Wang LY, 2009, BIOCHEM BIOPH RES CO, V384, P210, DOI 10.1016/j.bbrc.2009.04.101; WENZEL TJ, 1995, NUCLEIC ACIDS RES, V23, P883, DOI 10.1093/nar/23.5.883; Yoon HS, 2004, BBA-BIOENERGETICS, V1658, P181, DOI 10.1016/j.bbabio.2004.05.013; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhao XQ, 2009, J BIOTECHNOL, V144, P23, DOI 10.1016/j.jbiotec.2009.05.001	68	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158841	10.1371/journal.pone.0158841	http://dx.doi.org/10.1371/journal.pone.0158841			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392090	gold, Green Submitted, Green Published			2022-12-26	WOS:000380005400141
J	Nguyen, THP; Pham, VTH; Nguyen, SH; Baulin, V; Croft, RJ; Phillips, B; Crawford, RJ; Ivanova, EP				The Hong Phong Nguyen; Pham, Vy T. H.; Song Ha Nguyen; Baulin, Vladimir; Croft, Rodney J.; Phillips, Brian; Crawford, Russell J.; Ivanova, Elena P.			The Bioeffects Resulting from Prokaryotic Cells and Yeast Being Exposed to an 18 GHz Electromagnetic Field	PLOS ONE			English	Article							MICROWAVE-RADIATION; BIOLOGICAL TISSUES; METABOLIC-ACTIVITY; MEMBRANE-FLUIDITY; IRRADIATION; FREQUENCIES; PERMEABILITY; CATARRHALIS; MODULATION; PROTEINS	The mechanisms by which various biological effects are triggered by exposure to an electromagnetic field are not fully understood and have been the subject of debate. Here, the effects of exposing typical representatives of the major microbial taxa to an 18 GHz microwave electromagnetic field (EMF) were studied. It appeared that the EMF exposure induced cell permeabilisation in all of the bacteria and yeast studied, while the cells remained viable (94% throughout the exposure), independent of the differences in cell membrane fatty acid and phospholipid composition. The resulting cell permeabilisation was confirmed by detection of the uptake of propidium iodine and 23 nm fluorescent silica nanospheres using transmission electron microscopy (TEM) and confocal laser scanning microscopy (CLSM). Upon EMF exposure, the bacterial cell membranes are believed to become permeable through quasi-endocytosis processes. The dosimetry analysis revealed that the EMF threshold level required to induce the uptake of the large (46 nm) nanopsheres was between three and six EMF doses, with a specific absorption rate (SAR) of 3 kW/kg and 5 kW/kg per exposure, respectively, depending on the bacterial taxa being studied. It is suggested that the taxonomic affiliation and lipid composition (e.g. the presence of phosphatidyl-glycerol and/or pentadecanoic fatty acid) may affect the extent of uptake of the large nanospheres (46 nm). Multiple 18 GHz EMF exposures over a one-hour period induced periodic anomalous increases in the cell growth behavior of two Staphylococcus aureus strains, namely ATCC 25923 and CIP 65.8(T).	[The Hong Phong Nguyen; Pham, Vy T. H.; Song Ha Nguyen; Phillips, Brian; Crawford, Russell J.; Ivanova, Elena P.] Swinburne Univ Technol, Fac Sci Engn & Technol, POB 218, Hawthorn, Vic 3122, Australia; [Baulin, Vladimir] Univ Rovira & Virgili, Dept Engn Quim, 26 Av Dels Paisos Catalans, Tarragona 43007, Spain; [Croft, Rodney J.] Univ Wollongong, Sch Psychol, Wollongong, NSW 2522, Australia	Swinburne University of Technology; Universitat Rovira i Virgili; University of Wollongong	Ivanova, EP (corresponding author), Swinburne Univ Technol, Fac Sci Engn & Technol, POB 218, Hawthorn, Vic 3122, Australia.	eivanova@swin.edu.au	Baulin, Vladimir/AAB-8593-2019; Baulin, Vladimir A/B-9718-2012; Nguyen, The Hong Phong/ABE-4841-2020; Ivanova, Elena P/B-1255-2019; Nguyen, The Hong Phong/U-2301-2018	Baulin, Vladimir/0000-0003-2086-4271; Baulin, Vladimir A/0000-0003-2086-4271; Nguyen, The Hong Phong/0000-0003-3847-6963; Ivanova, Elena P/0000-0002-5509-8071; Nguyen, The Hong Phong/0000-0003-3847-6963; Crawford, Russell/0000-0003-1054-5285; Croft, Rodney/0000-0002-5986-9136; Nguyen, Song Ha/0000-0002-7450-8814	Australian Centre for Electromagnetic Bioeffects Research (ACEBR); National Health & Medical Research Council Centre of Research Excellence (NHMRC); Marie Curie Actions under EU FP7 Initial Training Network [SNAL 608184]; National Health & Medical Research Council Centre of Research Excellence	Australian Centre for Electromagnetic Bioeffects Research (ACEBR); National Health & Medical Research Council Centre of Research Excellence (NHMRC); Marie Curie Actions under EU FP7 Initial Training Network; National Health & Medical Research Council Centre of Research Excellence	This work was partly supported by the Australian Centre for Electromagnetic Bioeffects Research (ACEBR, http://acebr.uow.edu.au/index.html T.H.P.N., Ro.J.C., E.P.I.), a National Health & Medical Research Council Centre of Research Excellence (NHMRC). VB and EI acknowledge funding from Marie Curie Actions under EU FP7 Initial Training Network SNAL 608184 (http://cordis.europa.eu/project/rcn/110943_en.html T.H.P.N., V.B.E.P.I.). This work was also supported by the National Health & Medical Research Council Centre of Research Excellence. The authors have no financial or personal relationship with other people or organisations that could inappropriately influence this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Nicolle Marshall for technical assistance. This work was partly supported by the Australian Centre for Electromagnetic Bioeffects Research (ACEBR, http://acebr.uow.edu.au/index.html T.H.P.N Ro.J.C E.P.I), a National Health & Medical Research Council Centre of Research Excellence (NHMRC). VB and EI acknowledge funding from Marie Curie Actions under EU FP7 Initial Training Network SNAL 608184 (http://cordis.europa.eu/project/rcn/110943_en.html T.H.P.N V.B E.P.I). The authors have no financial or personal relationship with other people or organisations that could inappropriately influence this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair RK, 2002, BIOPHYS J, V82, P1147, DOI 10.1016/S0006-3495(02)75473-8; Aitken RJ, 2005, INT J ANDROL, V28, P171, DOI 10.1111/j.1365-2605.2005.00531.x; Annous BA, 1997, APPL ENV MICROBIOL, V63; [Anonymous], [No title captured]; Apodaca G, 2002, AM J PHYSIOL-RENAL, V282, pF179, DOI 10.1152/ajprenal.2002.282.2.F179; Banik S, 2003, BIORESOURCE TECHNOL, V87, P155, DOI 10.1016/S0960-8524(02)00169-4; Beneduci A, 2012, BIOELECTROCHEMISTRY, V84, P18, DOI 10.1016/j.bioelechem.2011.10.003; Bohr H, 2000, PHYS REV E, V61, P4310, DOI 10.1103/PhysRevE.61.4310; Bohr H, 2000, BIOELECTROMAGNETICS, V21, P68, DOI 10.1002/(SICI)1521-186X(200001)21:1<68::AID-BEM10>3.0.CO;2-9; Celandroni F, 2004, J APPL MICROBIOL, V97, P1220, DOI 10.1111/j.1365-2672.2004.02406.x; Clark DE, 1996, ANNU REV MATER SCI, V26, P299, DOI 10.1146/annurev.ms.26.080196.001503; Cohen I, 2010, INT J RADIAT BIOL, V86, P390, DOI 10.3109/09553000903567912; Copty AB, 2006, BIOPHYS J, V91, P1413, DOI 10.1529/biophysj.106.084111; Dekiwadia CD, 2012, J PEPT SCI, V18, P527, DOI 10.1002/psc.2430; DREYFUSS MS, 1980, APPL ENVIRON MICROB, V39, P13, DOI 10.1128/AEM.39.1.13-16.1980; English NJ, 2003, J CHEM PHYS, V118, P1589, DOI 10.1063/1.1538595; Feldmann H, 2012, YEAST GROWTH YEAST C, P175; Gabriel S, 1996, PHYS MED BIOL, V41, P2251, DOI 10.1088/0031-9155/41/11/002; George DF, 2008, BIOELECTROMAGNETICS, V29, P324, DOI 10.1002/bem.20382; Gunstone FD, 1994, LIPID HDB; Gurisik E, 2006, CELL BIOL INT, V30, P793, DOI 10.1016/j.cellbi.2006.06.001; Haemmerich D, 2005, PHYSIOL MEAS, V26, P59, DOI 10.1088/0967-3334/26/1/006; Hasted JB., 1972, WATER COMPREHENSIVE, V1, P255; Inhan-Garip A, 2011, INT J RADIAT BIOL, V87, P1155, DOI 10.3109/09553002.2011.560992; LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67; Laurence JA, 2000, J THEOR BIOL, V206, P291, DOI 10.1006/jtbi.2000.2123; Le Quement C, 2012, BIOELECTROMAGNETICS, V33, P147, DOI 10.1002/bem.20693; LECHEVALIER MP, 1977, CRC CR REV MICROBIOL, V5, P109, DOI 10.3109/10408417709102311; Lentacker I, 2014, ADV DRUG DELIVER REV, V72, P49, DOI 10.1016/j.addr.2013.11.008; Li G, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2938692; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; LUFT JH, 1961, J BIOPHYS BIOCHEM CY, V9, P409, DOI 10.1083/jcb.9.2.409; McCormick JR, 2012, FEMS MICROBIOL REV, V36, P206, DOI 10.1111/j.1574-6976.2011.00317.x; MCLANUGH.SG, 1970, P NATL ACAD SCI USA, V67, P1268, DOI 10.1073/pnas.67.3.1268; Mortimer RK, 2000, GENOME RES, V10, P403, DOI 10.1101/gr.10.4.403; Mu QS, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-29; Murphy TF, 1996, MICROBIOL REV, V60, P267, DOI 10.1128/MMBR.60.2.267-279.1996; Nesin OM, 2011, BBA-BIOMEMBRANES, V1808, P792, DOI 10.1016/j.bbamem.2010.12.012; Panagopoulos DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062663; Pogodin S, 2012, ACS NANO, V6, P10555, DOI 10.1021/nn3028858; Purty S, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.71; Rai S, 1999, ELECTRO MAGNETOBIOL, V18, P221, DOI 10.3109/15368379909022578; Ruediger Hugo W, 2009, Pathophysiology, V16, P89, DOI 10.1016/j.pathophys.2008.11.004; Ruiz-Gomez MJ, 2009, ELECTROMAGN BIOL MED, V28, P201, DOI 10.1080/15368370802608696; Sato S, 1996, BIOTECHNOL TECH, V10, P145, DOI 10.1007/BF00158936; Shamis Y., 2012, J PHYS SCI APPL, V2, P143; Shamis Y, 2011, APPL ENVIRON MICROB, V77, P3017, DOI 10.1128/AEM.01899-10; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Shimanouchi T, 2009, COLLOID SURFACE B, V73, P156, DOI 10.1016/j.colsurfb.2009.05.014; Soghomonyan D, 2013, CELL BIOCHEM BIOPHYS, V67, P829, DOI 10.1007/s12013-013-9571-2; STACKEBRANDT E, 1995, INT J SYST BACTERIOL, V45, P682, DOI 10.1099/00207713-45-4-682; Nguyen THP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10980; Torgomyan H, 2012, CELL BIOCHEM BIOPHYS, V62, P451, DOI 10.1007/s12013-011-9327-9; Torgomyan H, 2012, FEMS MICROBIOL LETT, V329, P131, DOI 10.1111/j.1574-6968.2012.02512.x; Torgomyan H, 2011, CURR MICROBIOL, V62, P962, DOI 10.1007/s00284-010-9811-2; Verduin CM, 2002, CLIN MICROBIOL REV, V15, P125, DOI 10.1128/CMR.15.1.125-144.2002; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; WAKSMAN SA, 1948, J BACTERIOL, V56, P259, DOI 10.1128/JB.56.3.259-269.1948; Wan HD, 2012, APPL BIOCHEM BIOTECH, V166, P1454, DOI 10.1007/s12010-012-9539-5; Zhao YN, 2011, ACS NANO, V5, P1366, DOI 10.1021/nn103077k	60	32	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158135	10.1371/journal.pone.0158135	http://dx.doi.org/10.1371/journal.pone.0158135			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391488	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400032
J	Peto, TJ; Tripura, R; Lee, SJ; Althaus, T; Dunachie, S; Nguon, C; Dhorda, M; Promnarate, C; Chalk, J; Imwong, M; von Seidlein, L; Day, NP; Dondorp, AM; White, NJ; Lubell, Y				Peto, Thomas J.; Tripura, Rupam; Lee, Sue J.; Althaus, Thomas; Dunachie, Susanna; Nguon, Chea; Dhorda, Mehul; Promnarate, Cholrawee; Chalk, Jeremy; Imwong, Mallika; von Seidlein, Lorenz; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.; Lubell, Yoel			Association between Subclinical Malaria Infection and Inflammatory Host Response in a Pre-Elimination Setting	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; FALCIPARUM-MALARIA; CAMBODIA; EPIDEMIOLOGY; PREVALENCE; RESISTANCE; MORTALITY; KNOWLEDGE; CHILDREN	Background Subclinical infections in endemic areas of Southeast Asia sustain malaria transmission. These asymptomatic infections might sustain immunity against clinical malaria and have been considered benign for the host, but if they are associated with chronic low-grade inflammation this could be harmful. We conducted a case-control study to explore the association between subclinical malaria and C-reactive protein (CRP), an established biomarker of inflammation. Methods Blood samples from asymptomatic villagers in Pailin, Western Cambodia were tested for malaria by high-volume ultra-sensitive polymerase chain reaction (uPCR) to determine the Plasmodium species. Plasma CRP concentration was measured in 328 individuals with parasitaemia (cases) and compared with: i) the same individual's value at the first time point when they had no detectable parasites (n = 282); and ii) age-sex-and village-matched controls (n = 328) free of Plasmodium infection. Plasma CRP concentrations were compared against thresholds of 3mg/L and 10mg/L. Subgroup analysis was carried out for cases with P vivax and P falciparum mono-infections. Results Median plasma CRP level for all samples was 0.59mg/L (interquartile range: 0.24-1.64mg/L). CRP concentrations were higher in parasitaemic individuals compared with same-person-controls (p = 0.050); and matched-controls (p = 0.025). 4.9% of samples had CRP concentrations above 10mg/L and 14.6% were above 3mg/L. Cases were more likely to have plasma CRP concentrations above these thresholds than age/sex matched controls, odds ratio 3.5 (95% CI 1.5-9.8) and 1.8 (95% CI 1.1-2.9), respectively. Amongst cases, parasite density and CRP were positively correlated (p<0.001), an association that remained significant when controlling for age and fever. Individuals with P. vivax mono-infections had the highest plasma CRP concentrations with the greatest association with parasitaemia. Discussion In this setting persistent malaria infections in asymptomatic individuals were associated with moderately elevated plasma CRP concentrations; chiefly evident in cases with P. vivax mono-infections. As well as interrupting malaria transmission within the community, treatment of asymptomatic malaria infections, in particular radical cure of vivax malaria, may benefit the health of infected individuals.	[Peto, Thomas J.; Tripura, Rupam; Lee, Sue J.; Althaus, Thomas; Dunachie, Susanna; Chalk, Jeremy; Imwong, Mallika; von Seidlein, Lorenz; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.; Lubell, Yoel] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Peto, Thomas J.; Lee, Sue J.; Dunachie, Susanna; Dhorda, Mehul; Chalk, Jeremy; von Seidlein, Lorenz; Day, Nicholas P.; Dondorp, Arjen M.; White, Nicholas J.; Lubell, Yoel] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Nguon, Chea] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Dhorda, Mehul; Promnarate, Cholrawee] Mahidol Univ, Fac Trop Med, Worldwide Antimalarial Resistance Network, Bangkok, Thailand; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; National Center Parasitology, Entomology & Malaria Control; Mahidol University; Worldwide Antimalarial Resistance Network (WWARN); Mahidol University	Peto, TJ (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand.; Peto, TJ (corresponding author), Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England.	tom@tropmedres.ac	White, Nick/AAC-6527-2019; Althaus, Thomas/J-3759-2019; Imwong, Mallika/ABE-6493-2020	White, Nick/0000-0002-1897-1978; Althaus, Thomas/0000-0002-6997-3877; Lubell, Yoel/0000-0002-0237-1070; Dunachie, Susanna/0000-0001-5665-6293; Peto, Thomas/0000-0003-3197-9891	Bill and Melinda Gates Foundation [BMGF OPP1081420]; Wellcome Trust of Great Britain [101148/Z/13/Z]; Grand Challenges Canada Stars in Global Health award [S5 0443-01]; National Institute for Health Research [CL-2008-13-010] Funding Source: researchfish	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust of Great Britain(Wellcome Trust); Grand Challenges Canada Stars in Global Health award; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Bill and Melinda Gates Foundation (gatesfoundation.org/) BMGF OPP1081420 and was part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme funded by the Wellcome Trust of Great Britain (wellcome.ac.uk/) reference 101148/Z/13/Z. Yoel Lubell received a Grand Challenges Canada Stars in Global Health (grandchallenges.ca/) award to work on biomarkers of infection and their use as diagnostic tools in the rural tropics (Round 5, Grant number S5 0443-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; CNM, 2014, NAT TREATM GUID MAL; Cox J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-371; de Mast Q, 2015, J INFECTION, V71, P587, DOI 10.1016/j.jinf.2015.08.005; Diez-Padrisa N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013226; Eriksson UK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070076; Imrie H, 2007, AM J TROP MED HYG, V76, P280, DOI 10.4269/ajtmh.2007.76.280; Imwong M, 2015, J INFECT DIS; Imwong M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0906-x; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Koenig W, 2008, CLIN CHEM, V54, P335, DOI 10.1373/clinchem.2007.100271; Kuper H, 2000, J INTERN MED, V248, P171, DOI 10.1046/j.1365-2796.2000.00742.x; Lim Sachiko, 2012, BMC Res Notes, V5, P405, DOI 10.1186/1756-0500-5-405; Lubell Y, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1272-6; Macy EM, 1997, CLIN CHEM, V43, P52; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; Mugittu K, 2006, TROP MED INT HEALTH, V11, P1350, DOI 10.1111/j.1365-3156.2006.01688.x; Narayanasamy K, 2012, ACTA TROP, V121, P256, DOI 10.1016/j.actatropica.2012.01.008; Pelkonen T, 2015, T ROY SOC TROP MED H, V109, P535, DOI 10.1093/trstmh/trv046; Ridker PM, 2007, NUTR REV, V65, pS253, DOI [10.1111/j.1753-4887.2007.tb00372.x, 10.1301/nr.2007.dec.S253-S259]; Ridker PM, 2003, CIRCULATION, V107, P363, DOI 10.1161/01.CIR.0000053730.47739.3C; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; von Seidlein L, 2015, EXPERT REV ANTI-INFE, V13, P715, DOI 10.1586/14787210.2015.1031744; Wu A.H.B., 2006, TIETZ CLIN GUIDE LAB; Yeo TW, 2010, J INFECT DIS, V202, P109, DOI 10.1086/653211; Yeung S, 2015, AM J TROP MED HYG, V92, P39, DOI 10.4269/ajtmh.14-0391; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016	30	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158656	10.1371/journal.pone.0158656	http://dx.doi.org/10.1371/journal.pone.0158656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27386859	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500033
J	Rostagno, C; Buzzi, R; Campanacci, D; Boccacini, A; Cartei, A; Virgili, G; Belardinelli, A; Matarrese, D; Ungar, A; Rafanelli, M; Gusinu, R; Marchionni, N				Rostagno, Carlo; Buzzi, Roberto; Campanacci, Domenico; Boccacini, Alberto; Cartei, Alessandro; Virgili, Gianni; Belardinelli, Andrea; Matarrese, Daniela; Ungar, Andrea; Rafanelli, Martina; Gusinu, Roberto; Marchionni, Niccolo			In Hospital and 3-Month Mortality and Functional Recovery Rate in Patients Treated for Hip Fracture by a Multidisciplinary Team	PLOS ONE			English	Article							PREOPERATIVE ECHOCARDIOGRAPHY; META-REGRESSION; SURGERY; DELAY; OUTCOMES; METAANALYSIS; DEMENTIA; TIME	Objectives Medical comorbidities affect outcome in elderly patients with hip fracture. This study was designed to preliminarily evaluate the usefulness of a hip-fracture unit led by an internal medicine specialist. Methods In-hospital and 3-month outcomes in patients with hip fracture were prospectively evaluated in 121 consecutive patients assessed before and followed after surgery by a multidisciplinary team led by internal medicine specialist; 337 consecutive patients were recalled from ICD-9 discharge records and considered for comparison regarding in-hospital mortality. Results In the intervention period, patients treated within 48 hours were 54% vs. 26% in the historical cohort (P< 0.0001). In-hospital mortality remained stable at about 2.3 per 1000 persondays. At 3 months, 10.3% of discharged patients had died, though less than 8% of patients developed postoperative complications (mainly pneumonia and respiratory failure). The presence of more than 2 major comorbidities and the loss of 3 or more BADL were independent predictors of death. 50/105 patients recovered previous functional capacity, but no independent predictor of functional recovery could be identified. Mean length of hospital stay significantly decreased in comparison to the historical cohort (13.6 +/- 4.7 vs 17 +/- 5 days, p = 0.0001). Combined end-point of mortality and length of hospitalization < 12 days was significantly lower in study period (27 vs 34%, p < 0.0132). Conclusions Identification and stabilization of concomitant clinical problems by internal medicine specialists may safely decrease time to surgery in frail subjects with hip fracture. Moreover, integrated perioperative clinical management may shorten hospital stay with no apparent increase in in-hospital mortality and ultimately improve the outcome. These results are to be confirmed by a larger study presently ongoing at our institution.	[Rostagno, Carlo] Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy; [Rostagno, Carlo; Cartei, Alessandro] AOU Careggi, SOD Med Interna & Postchirurg, Florence, Italy; [Buzzi, Roberto; Campanacci, Domenico] AOU Careggi, SOD Ortopedia & Traumatol, Florence, Italy; [Boccacini, Alberto] AOU Careggi, SOD Anestesia, Florence, Italy; [Virgili, Gianni; Belardinelli, Andrea; Matarrese, Daniela; Rafanelli, Martina; Gusinu, Roberto] AOU Careggi, Direz Sanit, Florence, Italy; [Ungar, Andrea; Marchionni, Niccolo] AOU Careggi, SOD Geriatria, Florence, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; Azienda Ospedaliero Universitaria Careggi	Rostagno, C (corresponding author), Univ Florence, Dipartimento Med Sperimentale & Clin, Florence, Italy.; Rostagno, C (corresponding author), AOU Careggi, SOD Med Interna & Postchirurg, Florence, Italy.	carlo.rostagno@unifi.it	Rafanelli, Martina/AAB-3444-2019; rostagno, carlo/K-3658-2018; CAMPANACCI, DOMENICO ANDREA/Q-3862-2019; Rostagno, Carlo/N-6215-2019; , aungar/AAB-3720-2019; Marchionni, Niccolò/ABE-3977-2020; Virgili, Gianni/P-6607-2014	CAMPANACCI, DOMENICO ANDREA/0000-0002-3912-3943; Rostagno, Carlo/0000-0002-7764-8919; Marchionni, Niccolò/0000-0002-8101-4695; Ungar, Andrea/0000-0002-8965-4523; Virgili, Gianni/0000-0002-9960-2989	Italian Health Ministry and Regione Toscana	Italian Health Ministry and Regione Toscana	This work was supported by a Grant from the Italian Health Ministry and Regione Toscana.	Adunsky A, 2012, AGING CLIN EXP RES, V24, P233; Alibhai M, 2013, INDIAN J ANAESTH, V57, P408, DOI 10.4103/0019-5049.118538; Bielza Galindo Rafael, 2013, Rev Esp Geriatr Gerontol, V48, P26, DOI 10.1016/j.regg.2012.03.002; Cullen MW, 2011, J HOSP MED, V6, P507, DOI 10.1002/jhm.918; Doleman B, 2015, INJURY, V46, P954, DOI 10.1016/j.injury.2015.03.024; Grimes JP, 2002, AM J MED, V112, P702, DOI 10.1016/S0002-9343(02)01119-1; Harris I, 2012, ANZ J SURG, V82, P871, DOI 10.1111/j.1445-2197.2012.06319.x; Hebert-Davies J, 2012, INJURY, V43, P1978, DOI 10.1016/j.injury.2012.08.061; Heyburn G, 2012, ANAESTHESIA, V67, P1189, DOI 10.1111/j.1365-2044.2012.07330.x; Huang YF, 2012, REJUV RES, V15, P476, DOI 10.1089/rej.2011.1308; Huusko TM, 2000, BRIT MED J, V321, P1107, DOI 10.1136/bmj.321.7269.1107; Kammerlander C, 2010, OSTEOPOROSIS INT, V21, pS637, DOI 10.1007/s00198-010-1396-x; Kristoffersen DT, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-364; Manaqibwala MI, 2014, ARCH ORTHOP TRAUM SU, V134, P747, DOI 10.1007/s00402-014-1981-0; Marsh JL, 2007, J ORTHOP TRAUMA, V21, pS1, DOI 10.1097/00005131-200711101-00001; Orosz GM, 2002, J AM GERIATR SOC, V50, P1336, DOI 10.1046/j.1532-5415.2002.50353.x; Piscitellil P, 2011, CLIN CASES MINER BON, V8, P29; Rostagno C., 2013, OPEN ACCESS EMERG M, V03, P148, DOI [10.4172/2165-7548.1000148, DOI 10.4172/2165-7548.1000148]; Sanders KM, 1999, MED J AUSTRALIA, V170, P467, DOI 10.5694/j.1326-5377.1999.tb127845.x; Shiga T, 2008, CAN J ANAESTH, V55, P146, DOI 10.1007/BF03016088; Stoddart J, 2002, ANZ J SURG, V72, P405, DOI 10.1046/j.1445-2197.2002.02425.x	21	21	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158607	10.1371/journal.pone.0158607	http://dx.doi.org/10.1371/journal.pone.0158607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389193	Green Published, Green Submitted, gold			2022-12-26	WOS:000379811500029
J	Magallon, S; Narbona, J; Crespo-Eguilaz, N				Magallon, Sara; Narbona, Juan; Crespo-Eguilaz, Nerea			Acquisition of Motor and Cognitive Skills through Repetition in Typically Developing Children	PLOS ONE			English	Article							MIRROR-DRAWING TEST; PURDUE PEGBOARD; PROCEDURAL MEMORY; BRAIN-DEVELOPMENT; NORMS; AGE; ADOLESCENTS; CEREBELLUM; MODULARITY; CHILDHOOD	Background Procedural memory allows acquisition, consolidation and use of motor skills and cognitive routines. Automation of procedures is achieved through repeated practice. In children, improvement in procedural skills is a consequence of natural neurobiological development and experience. Methods The aim of the present research was to make a preliminary evaluation and description of repetition-based improvement of procedures in typically developing children (TDC). Ninety TDC children aged 6-12 years were asked to perform two procedural learning tasks. In an assembly learning task, which requires predominantly motor skills, we measured the number of assembled pieces in 60 seconds. In a mirror drawing learning task, which requires more cognitive functions, we measured time spent and efficiency. Participants were tested four times for each task: three trials were consecutive and the fourth trial was performed after a 10-minute nonverbal interference task. The influence of repeated practice on performance was evaluated by means of the analysis of variance with repeated measures and the paired-sample test. Correlation coefficients and simple linear regression test were used to examine the relationship between age and performance. Results TDC achieved higher scores in both tasks through repetition. Older children fitted more pieces than younger ones in assembling learning and they were faster and more efficient at the mirror drawing learning task. Conclusions These findings indicate that three consecutive trials at a procedural task increased speed and efficiency, and that age affected basal performance in motor-cognitive procedures.	[Magallon, Sara] Univ Leeds, Fac Med & Hlth, Sch Psychol, Lifton Pl, Leeds LS2 9JZ, W Yorkshire, England; [Magallon, Sara; Narbona, Juan; Crespo-Eguilaz, Nerea] Univ Navarra, Fac Educ & Psychol, Campus Univ, Navarra 31080, Spain; [Narbona, Juan; Crespo-Eguilaz, Nerea] Univ Navarra, Fac Med, Unit Paediat Neurol, Av Pio 12,36, Navarra 31008, Spain	University of Leeds; University of Navarra; University of Navarra	Magallon, S (corresponding author), Univ Leeds, Fac Med & Hlth, Sch Psychol, Lifton Pl, Leeds LS2 9JZ, W Yorkshire, England.; Magallon, S (corresponding author), Univ Navarra, Fac Educ & Psychol, Campus Univ, Navarra 31080, Spain.	S.Magallon@leeds.ac.uk	Crespo-Eguilaz, Nerea/L-1752-2017; MAGALLON, SARA/K-8287-2017	Crespo-Eguilaz, Nerea/0000-0003-3778-7655; MAGALLON, SARA/0000-0001-9269-1336	Marie Curie - Intra-European Fellowships for career development (IEF); Navarra Government Predoctoral Grant; School of Psychology of the University of Leeds; "Pre-doctoral grant from the Government of Navarra"; Marie-Curie Actions (European Commission)	Marie Curie - Intra-European Fellowships for career development (IEF); Navarra Government Predoctoral Grant; School of Psychology of the University of Leeds; "Pre-doctoral grant from the Government of Navarra"; Marie-Curie Actions (European Commission)	This study was supported by Marie Curie - Intra-European Fellowships for career development (IEF), Navarra Government Predoctoral Grant, School of Psychology of the University of Leeds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the "Pre-doctoral grant from the Government of Navarra". We are very grateful to the children, parents and teachers who participated in this project for their generous cooperation. Finally, we are immensely grateful to the School of Psychology of the University of Leeds, and the Marie-Curie Actions (European Commission) for funding the publication of the paper.	Balinsky B, 1940, PEDAGOG SEMIN J GEN, V56, P207; Barakat M, 2011, BEHAV BRAIN RES, V217, P117, DOI 10.1016/j.bbr.2010.10.019; Bo J, 2012, J SPORT EXERCISE PSY; Capio CM, 2012, BMC SPORTS SCI MED R, V4, DOI 10.1186/1758-2555-4-1; Carlson Neil R., 2006, FISIOLOGIA CONDUCTA; Cavaco S, 2004, BRAIN, V127, P1853, DOI 10.1093/brain/awh208; Chan JSY, 2015, HUM MOVEMENT SCI, V42, P261, DOI 10.1016/j.humov.2015.06.002; Chang SH, 2010, DEV MED CHILD NEUROL, V52, P244, DOI 10.1111/j.1469-8749.2009.03478.x; Clark JE, 2012, J SPORT EXERCISE PSY; Clinton RJ, 1930, J EDUC PSYCHOL, V21, P221, DOI 10.1037/h0072249; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; COSTA LD, 1963, J CONSULT PSYCHOL, V27, P133, DOI 10.1037/h0040737; Crespo-Eguilaz N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00449; De Guise E, 2001, DEV NEUROPSYCHOL, V19, P253, DOI 10.1207/S15326942DN1903_2; Desmond JE, 1998, TRENDS COGN SCI, V2, P355, DOI 10.1016/S1364-6613(98)01211-X; Doyon J, 2003, NEUROPSYCHOLOGIA, V41, P252, DOI 10.1016/S0028-3932(02)00158-6; Dunn LlM, 2006, TEST VOCABULARIO IMA; Dunn R, 1845, LANCET, V2, P588; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; Ericsson KA, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P1, DOI 10.2277/ 0521600812; EWERT J, 1989, ARCH NEUROL-CHICAGO, V46, P911, DOI 10.1001/archneur.1989.00520440105027; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gofer-Levi M, 2014, RES DEV DISABIL, V35, P1952, DOI 10.1016/j.ridd.2014.04.017; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; HEINDEL WC, 1988, BEHAV NEUROSCI, V102, P141, DOI 10.1037/0735-7044.102.1.141; Hollingshead AB, 1957, 2 FACTORS INDEX SOCI; Homma Shinji, 2006, Journal of Smooth Muscle Research, V42, P9, DOI 10.1540/jsmr.42.9; Julius MS, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00225; Karatekin C, 2007, J EXP CHILD PSYCHOL, V96, P107, DOI 10.1016/j.jecp.2006.05.005; Kaufman A. S., 1993, KAUFMAN ADOLESCENT A; Kaufman AS, 1990, MANUAL KAUFMAN BRIEF; Kharraz-Tavakol OD, 2000, NEUROSCI LETT, V282, P33, DOI 10.1016/S0304-3940(00)00851-X; KNIGHTS RM, 1968, PERCEPT MOTOR SKILL, V26, P643, DOI 10.2466/pms.1968.26.2.643; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Louis ED, 2015, PEDIATR NEUROL, V52, P187, DOI 10.1016/j.pediatrneurol.2014.10.017; Lum J, 2010, AUST J PSYCHOL, V62, P139, DOI 10.1080/00049530903150547; Magallon S, 2015, J CHILD NEUROLOGY; Magallon S, 2009, REV NEUROLOGIA S2, V48, P71; Marks R, 1996, PERCEPT MOTOR SKILL, V83, P715, DOI 10.2466/pms.1996.83.3.715; Mayor-Dubois C, 2016, CHILD NEUROPSYCHOL, V22, P718, DOI 10.1080/09297049.2015.1058347; Mergl R, 1999, J NEUROSCI METH, V90, P157, DOI 10.1016/S0165-0270(99)00080-1; Meulemans T, 1998, J EXP CHILD PSYCHOL, V69, P199, DOI 10.1006/jecp.1998.2442; Milner B., 1965, COGNITIVE PROCESSES; Mizuno K, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-17; Molinari M, 1997, BRAIN, V120, P1753, DOI 10.1093/brain/120.10.1753; MOSCOVITCH M, 1995, J CLIN EXP NEUROPSYC, V17, P276, DOI 10.1080/01688639508405123; Murphy KL, 2002, RES Q EXERCISE SPORT, V73, pA51; NELSON CA, 1995, DEV PSYCHOL, V31, P723, DOI 10.1037/0012-1649.31.5.723; O'Donnell KJ, 2002, DEV MED CHILD NEUROL, V44, P76, DOI 10.1017/S0012162201001712; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Prehn-Kristensen A, 2009, J EXP CHILD PSYCHOL, V104, P132, DOI 10.1016/j.jecp.2009.01.005; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; RAPIN I, 1966, DEV MED CHILD NEUROL, V8, P45; REDDON JR, 1988, PERCEPT MOTOR SKILL, V66, P503, DOI 10.2466/pms.1988.66.2.503; Rourke B. P., 1995, SYNDROME NONVERBAL L; Rourke B.P., 1989, NONVERBAL LEARNING D; Rourke BP, 1996, TOP LANG DISORD, V16, P30, DOI 10.1097/00011363-199602000-00005; Rourke BP., 1987, CLIN NEUROPSYCHOL, V1, P209, DOI [DOI 10.1080/13854048708520056, 10.1080/13854048708520056]; Schacter D.L., 1995, MEMORY WARS; Schacter DL, 1984, INFANT MEMORY, P173; Sidaway B, 2012, J SPORT EXERCISE PSY; Smith PJ, 2009, J SPORT EXERCISE PSY; Soprano A., 2007, MEMORIA NINO DESARRO, P1; SQUIRE LR, 1986, SCIENCE, V232, P1612, DOI 10.1126/science.3086978; Starch D, 1910, PSYCHOL BULL, V7, P20, DOI 10.1037/h0063796; Sullivan KI, 2008, PHYS THER, V88, P720, DOI 10.2522/ptj.20070196; Tallet J, 2015, SOCIOAFFECTIVE NEURO, V5, DOI 10.3402/snp.v5.28004; Thomas KM, 2004, J COGNITIVE NEUROSCI, V16, P1339, DOI 10.1162/0898929042304688; Tiffin J, 1968, PURDUE PEGBOARD EXAM; Tiffin J, 1948, J APPL PSYCHOL, V32, P234, DOI 10.1037/h0061266; TULVING E, 1987, HUM NEUROBIOL, V6, P67; Vakil E, 1997, J GERONTOL B-PSYCHOL, V52, pP229, DOI 10.1093/geronb/52B.5.P229; Vicari S, 2005, J NEUROL NEUROSUR PS, V76, P1392, DOI 10.1136/jnnp.2004.061093; Vicari S, 2003, NEUROPSYCHOLOGIA, V41, P108, DOI 10.1016/S0028-3932(02)00082-9; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Ward H, 2002, J CLIN EXP NEUROPSYC, V24, P458, DOI 10.1076/jcen.24.4.458.1032; Wechsler D., 1991, WISC 3 WECHSLER INTE; Whipple G. E, 1921, MANUAL MENTAL PHYS T; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; WILLINGHAM DB, 1993, PSYCHOBIOLOGY, V21, P173; Yoakum C, 1913, J EDUC PSYCHOL, V4, P283; Yoshiuchi K, 1997, AM J HYPERTENS, V10, P243, DOI 10.1016/S0895-7061(96)00382-2	82	10	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158684	10.1371/journal.pone.0158684	http://dx.doi.org/10.1371/journal.pone.0158684			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3NH	27384671	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400076
J	Metzgar, D; Frinder, MW; Rothman, RE; Peterson, S; Carroll, KC; Zhang, SX; Avornu, GD; Rounds, MA; Carolan, HE; Toleno, DM; Moore, D; Hall, TA; Massire, C; Richmond, GS; Gutierrez, JR; Sampath, R; Ecker, DJ; Blyn, LB				Metzgar, David; Frinder, Mark W.; Rothman, Richard E.; Peterson, Stephen; Carroll, Karen C.; Zhang, Sean X.; Avornu, Gideon D.; Rounds, Megan A.; Carolan, Heather E.; Toleno, Donna M.; Moore, David; Hall, Thomas A.; Massire, Christian; Richmond, Gregory S.; Gutierrez, Jose R.; Sampath, Rangarajan; Ecker, David J.; Blyn, Lawrence B.			The IRIDICA BAC BSI Assay: Rapid, Sensitive and Culture-Independent Identification of Bacteria and Candida in Blood	PLOS ONE			English	Article							REAL-TIME PCR; CRITICALLY-ILL; MOLECULAR DIAGNOSIS; MASS-SPECTROMETRY; STREAM INFECTIONS; SEPSIS; PATHOGENS; THERAPY; IMPACT	Bloodstream infection (BSI) and sepsis are rising in incidence throughout the developed world. The spread of multi-drug resistant organisms presents increasing challenges to treatment. Surviving BSI is dependent on rapid and accurate identification of causal organisms, and timely application of appropriate antibiotics. Current culture-based methods used to detect and identify agents of BSI are often too slow to impact early therapy and may fail to detect relevant organisms in many positive cases. Existing methods for direct molecular detection of microbial DNA in blood are limited in either sensitivity (likely the result of small sample volumes) or in breadth of coverage, often because the PCR primers and probes used target only a few specific pathogens. There is a clear unmet need for a sensitive molecular assay capable of identifying the diverse bacteria and yeast associated with BSI directly from uncultured whole blood samples. We have developed a method of extracting DNA from larger volumes of whole blood (5 ml per sample), amplifying multiple widely conserved bacterial and fungal genes using a mismatch-and background-tolerant PCR chemistry, and identifying hundreds of diverse organisms from the amplified fragments on the basis of species-specific genetic signatures using electrospray ionization mass spectrometry (PCR/ESI-MS). We describe the analytical characteristics of the IRIDICA BAC BSI Assay and compare its preclinical performance to current standard-of-care methods in a collection of prospectively collected blood specimens from patients with symptoms of sepsis. The assay generated matching results in 80% of culture-positive cases (86% when common contaminants were excluded from the analysis), and twice the total number of positive detections. The described method is capable of providing organism identifications directly from uncultured blood in less than 8 hours. Disclaimer: The IRIDICA BAC BSI Assay is not available in the United States.	[Metzgar, David; Frinder, Mark W.; Rounds, Megan A.; Carolan, Heather E.; Toleno, Donna M.; Moore, David; Hall, Thomas A.; Massire, Christian; Richmond, Gregory S.; Gutierrez, Jose R.; Sampath, Rangarajan; Ecker, David J.; Blyn, Lawrence B.] Ibis Biosci, Carlsbad, CA USA; [Rothman, Richard E.; Peterson, Stephen; Avornu, Gideon D.] Johns Hopkins Univ, Sch Med, Dept Emergency Med, Baltimore, MD USA; [Carroll, Karen C.; Zhang, Sean X.] Johns Hopkins Univ Hosp, Clin Microbiol Lab, Baltimore, MD 21287 USA; [Rounds, Megan A.] Illumina, San Diego, CA USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Illumina	Metzgar, D (corresponding author), Ibis Biosci, Carlsbad, CA USA.	david.l.metzgar@abbott.com		Ecker, David/0000-0003-4350-9037	Middle Atlantic RCE Program; NIAID/NIH [2 U54 AI057168]; Ibis Biosciences, a division of Abbott Laboratories; IRIDICA BAC BSI Assay	Middle Atlantic RCE Program; NIAID/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Ibis Biosciences, a division of Abbott Laboratories; IRIDICA BAC BSI Assay	This work was funded in part by the Middle Atlantic RCE Program, NIAID/NIH 2 U54 AI057168, and in part by Ibis Biosciences, a division of Abbott Laboratories, which manufactures and markets the IRIDICA System and the IRIDICA BAC BSI Assay. Abbott employees, as detailed in the Competing Interests Statement, were partly or entirely responsible for study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bacconi A, 2014, J CLIN MICROBIOL, V52, P3164, DOI 10.1128/JCM.00801-14; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brun-Buisson C, 2004, INTENS CARE MED, V30, P580, DOI 10.1007/s00134-003-2121-4; Crowder CD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010650; Cruz AT, 2007, J CLIN MICROBIOL, V45, P2745, DOI 10.1128/JCM.00359-07; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Ecker DJ, 2009, METHODS MOL BIOL, V551, P71, DOI 10.1007/978-1-60327-999-4_7; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Eshoo MW, 2010, J CLIN MICROBIOL, V48, P472, DOI 10.1128/JCM.01669-09; Fenollar F, 2007, INT J ANTIMICROB AG, V30, pS7, DOI 10.1016/j.ijantimicag.2007.06.024; Fitting C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038916; Fraser A, 2006, AM J MED, V119, P970, DOI 10.1016/j.amjmed.2006.03.034; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Jordana-Lluch E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140865; Josefson P, 2011, EUR J CLIN MICROBIOL, V30, P1127, DOI 10.1007/s10096-011-1201-6; Kane TD, 1998, ANN SURG, V227, P1, DOI 10.1097/00000658-199801000-00001; Kumar A, 2009, CHEST, V136, P1237, DOI 10.1378/chest.09-0087; Lamy B, 2002, CLIN INFECT DIS, V35, P842, DOI 10.1086/342383; Lehmann LE, 2010, INTENS CARE MED, V36, P49, DOI 10.1007/s00134-009-1608-z; Liesenfeld O, 2014, EUR J MICROBIOL IMMU, V4, P1, DOI 10.1556/EuJMI.4.2014.1.1; Lodes U, 2012, LANGENBECK ARCH SURG, V397, P447, DOI 10.1007/s00423-011-0870-z; Lyle N, 2013, CURR INFECT DIS REP, V15, P372, DOI 10.1007/s11908-013-0350-4; McEnroe RJ, 2005, EP7A2 CLSI; Metzgar D, 2012, ADV TECHNIQUES DIAGN, P441; Metzgar D, 2013, VIRULENCE, V4, P752, DOI 10.4161/viru.26652; Metzgar D, 2013, J CLIN MICROBIOL, V51, P2670, DOI 10.1128/JCM.00966-13; Morrell M, 2005, ANTIMICROB AGENTS CH, V49, P3640, DOI 10.1128/AAC.49.9.3640-3645.2005; Pien BC, 2010, AM J MED, V123, P819, DOI 10.1016/j.amjmed.2010.03.021; Rantakokko-Jalava K, 2000, J CLIN MICROBIOL, V38, P32; Reinhart K, 2012, CLIN MICROBIOL REV, V25, P609, DOI 10.1128/CMR.00016-12; Rhodes J, 2010, AM J TROP MED HYG, V83, P301, DOI 10.4269/ajtmh.2010.09-0584; Riedel S, 2013, CLIN LAB MED, V33, P413, DOI 10.1016/j.cll.2013.03.006; Riedel S, 2010, J INFECT CHEMOTHER, V16, P301, DOI 10.1007/s10156-010-0069-1; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sampath R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036528; Schmid A, 2002, Eur J Health Econ, V3, P77; Schreiber J, 2013, MED KLIN-INTENSIVMED, V108, P311, DOI 10.1007/s00063-013-0227-1; SMARON MF, 1985, J CLIN MICROBIOL, V21, P298, DOI 10.1128/JCM.21.3.298-301.1985; Valles J, 2003, CHEST, V123, P1615, DOI 10.1378/chest.123.5.1615; Vincent JL, 2015, CRIT CARE MED, V43, P2283, DOI 10.1097/CCM.0000000000001249; Weinstein M. P., 2011, Journal of Clinical Microbiology, V49, pS26, DOI 10.1128/JCM.00765-11; Weinstein MP, 2003, J CLIN MICROBIOL, V41, P2275, DOI 10.1128/JCM.41.6.2275-2278.2003; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Wolk DM, 2012, J MOL DIAGN, V14, P295, DOI 10.1016/j.jmoldx.2012.02.005; Woo PCY, 2008, CLIN MICROBIOL INFEC, V14, P908, DOI 10.1111/j.1469-0691.2008.02070.x	49	50	51	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158186	10.1371/journal.pone.0158186	http://dx.doi.org/10.1371/journal.pone.0158186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384540	gold, Green Submitted, Green Published			2022-12-26	WOS:000379809400037
J	Sone, D; Matsuda, H; Ota, M; Maikusa, N; Kimura, Y; Sumida, K; Yokoyama, K; Imabayashi, E; Watanabe, M; Watanabe, Y; Okazaki, M; Sato, N				Sone, Daichi; Matsuda, Hiroshi; Ota, Miho; Maikusa, Norihide; Kimura, Yukio; Sumida, Kaoru; Yokoyama, Kota; Imabayashi, Etsuko; Watanabe, Masako; Watanabe, Yutaka; Okazaki, Mitsutoshi; Sato, Noriko			Graph Theoretical Analysis of Structural Neuroimaging in Temporal Lobe Epilepsy with and without Psychosis	PLOS ONE			English	Article							POSTICTAL PSYCHOSIS; BRAIN NETWORKS; FUNCTIONAL CONNECTIVITY; CORTICAL THICKNESS; SMALL-WORLD; SCHIZOPHRENIA; ORGANIZATION; ABNORMALITIES; MRI	Purpose Psychosis is one of the most important psychiatric comorbidities in temporal lobe epilepsy (TLE), and its pathophysiology still remains unsolved. We aimed to explore the connectivity differences of structural neuroimaging between TLE with and without psychosis using a graph theoretical analysis, which is an emerging mathematical method to investigate network connections in the brain as a small-world system. Materials and Methods We recruited 11 TLE patients with unilateral hippocampal sclerosis (HS) presenting psychosis or having a history of psychosis (TLE-P group). As controls, 15 TLE patients with unilateral HS without any history of psychotic episodes were also recruited (TLE-N group). For graph theoretical analysis, the normalized gray matter images of both groups were subjected to Graph Analysis Toolbox (GAT). As secondary analyses, each group was compared to 14 age-and gender-matched healthy subjects. Results The hub node locations were found predominantly in the ipsilateral hemisphere in the TLE-N group, and mainly on the contralateral side in the TLE-P group. The TLE-P group showed significantly higher characteristic path length, transitivity, lower global efficiency, and resilience to random or targeted attack than those of the TLE-N group. The regional comparison in betweenness centrality revealed significantly decreased connectivity in the contralateral temporal lobe, ipsilateral middle frontal gyrus, and bilateral postcentral gyri in the TLE-P group. The healthy subjects showed well-balanced nodes/edges distributions, similar metrics to TLE-N group except for higher small-worldness/modularity/assortativity, and various differences of regional betweenness/clustering. Conclusion In TLE with psychosis, graph theoretical analysis of structural imaging revealed disrupted connectivity in the contralateral hemisphere. The network metrics suggested that the existence of psychosis can bring vulnerability and decreased efficiency of the whole-brain network. The sharp differences in structural networks between morphologically homogeneous groups are remarkable and may contribute to a better understanding of psychosis in TLE.	[Sone, Daichi; Kimura, Yukio; Sumida, Kaoru; Yokoyama, Kota; Sato, Noriko] Natl Ctr Neurol & Psychiat, Dept Radiol, Tokyo, Japan; [Sone, Daichi] Univ Tokyo, Grad Sch Med, Dept Neuropsychiat, Tokyo, Japan; [Matsuda, Hiroshi; Maikusa, Norihide; Imabayashi, Etsuko] Natl Ctr Neurol & Psychiat, Integrat Brain Imaging Ctr, Tokyo, Japan; [Ota, Miho] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan; [Watanabe, Masako; Watanabe, Yutaka; Okazaki, Mitsutoshi] Natl Ctr Neurol & Psychiat, Dept Psychiat, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; University of Tokyo; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Sato, N (corresponding author), Natl Ctr Neurol & Psychiat, Dept Radiol, Tokyo, Japan.	snoriko@ncnp.go.jp	Sone, Daichi/J-7634-2019; Imabayashi, Etsuko/GLR-4602-2022	Sone, Daichi/0000-0001-9617-706X; Imabayashi, Etsuko/0000-0003-1708-3618; Yokoyama, Kota/0000-0001-5151-3146				Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; *APA, 1994, DSM 4 DIAGN STAT MAN; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; Bernhardt BC, 2008, NEUROIMAGE, V42, P515, DOI 10.1016/j.neuroimage.2008.04.261; Bernhardt BC, 2015, EPILEPSY BEHAV, V50, P162, DOI 10.1016/j.yebeh.2015.06.005; Bernhardt BC, 2011, CEREB CORTEX, V21, P2147, DOI 10.1093/cercor/bhq291; Bettus G, 2009, HUM BRAIN MAPP, V30, P1580, DOI 10.1002/hbm.20625; Bonilha L, 2012, J NEUROL NEUROSUR PS, V83, P903, DOI 10.1136/jnnp-2012-302476; Clancy MJ, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-75; Collin G, 2013, EUR NEUROPSYCHOPHARM, V23, P46, DOI 10.1016/j.euroneuro.2012.09.001; DuBois JM, 2011, EPILEPSY BEHAV, V21, P132, DOI 10.1016/j.yebeh.2011.03.024; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Evans AC, 2013, NEUROIMAGE, V80, P489, DOI 10.1016/j.neuroimage.2013.05.054; Falip M, 2009, SEIZURE-EUR J EPILEP, V18, P145, DOI 10.1016/j.seizure.2008.08.009; Fluegel D, 2006, EPILEPSIA, V47, P941, DOI 10.1111/j.1528-1167.2006.00527.x; Gaitatzis A, 2004, ACTA NEUROL SCAND, V110, P207, DOI 10.1111/j.1600-0404.2004.00324.x; Guarnieri R, 2005, PSYCHIAT RES-NEUROIM, V138, P75, DOI 10.1016/j.pscychresns.2004.10.003; Gutierrez-Galve L, 2012, EPILEPSIA, V53, P1077, DOI 10.1111/j.1528-1167.2012.03504.x; Guye M, 2010, MAGN RESON MATER PHY, V23, P409, DOI 10.1007/s10334-010-0205-z; Hilger E, 2013, EUR J NEUROL, V20, P955, DOI 10.1111/ene.12125; Hosseini SMH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040709; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Mega MS, 1997, J NEUROPSYCH CLIN N, V9, P315; Rusch N, 2004, J NEUROPSYCH CLIN N, V16, P148, DOI 10.1176/appi.neuropsych.16.2.148; Sundram F, 2010, BRIT J PSYCHIAT, V197, P482, DOI 10.1192/bjp.bp.110.080218; Tijms BM, 2013, NEUROBIOL AGING, V34, P2023, DOI 10.1016/j.neurobiolaging.2013.02.020; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; UMBRICHT D, 1995, AM J PSYCHIAT, V152, P224; van den Heuvel MP, 2014, NEUROPSYCHOL REV, V24, P32, DOI 10.1007/s11065-014-9248-7; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Yasuda CL, 2015, EPILEPSIA, V56, P1992, DOI 10.1111/epi.13225; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zhang YC, 2012, SCHIZOPHR RES, V141, P109, DOI 10.1016/j.schres.2012.08.021	36	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158728	10.1371/journal.pone.0158728	http://dx.doi.org/10.1371/journal.pone.0158728			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27385130	gold, Green Published, Green Submitted			2022-12-26	WOS:000379809400080
J	Arsenijevic, J; Pavlova, M; Rechel, B; Groot, W				Arsenijevic, Jelena; Pavlova, Milena; Rechel, Bernd; Groot, Wim			Catastrophic Health Care Expenditure among Older People with Chronic Diseases in 15 European Countries	PLOS ONE			English	Article							PREVENTING CHRONIC DISEASES; NONCOMMUNICABLE DISEASES; ECONOMIC BURDEN; HOUSEHOLDS; IMPOVERISHMENT; PROTECTION; PRIORITY; EXPENSES; ILLNESS; POLICY	Introduction It is well-known that the prevalence of chronic diseases is high among older people, especially those who are poor. Moreover, chronic diseases can result in catastrophic health expenditure. The relationship between chronic diseases and their financial burden on households is thus double-sided, as financial difficulties can give rise to, and result from, chronic diseases. Our aim was to examine the levels of catastrophic health expenditure imposed by private out-of-pocket payments among older people diagnosed with diabetes mellitus, cardiovascular diseases and cancer in 15 European countries. Methods The SHARE dataset for individuals aged 50+ and their households, collected in 2010-2012 was used. The total number of participants included in this study was N = 51,661. The sample consisted of 43.8% male and 56.2% female participants. The average age was 67 years. We applied an instrumental variable approach for binary instrumented variables known as a treatment-effect model. Results We found that being diagnosed with diabetes mellitus and cardiovascular diseases was associated with catastrophic health expenditure among older people even in comparatively wealthy countries with developed risk-pooling mechanisms. When compared to the Netherlands (the country with the lowest share of out-of-pocket payments as a percentage of total health expenditure in our study), older people diagnosed with diabetes mellitus in Portugal, Poland, Denmark, Italy, Switzerland, Belgium, the Czech Republic and Hungary were more likely to experience catastrophic health expenditure. Similar results were observed for diagnosed cardiovascular diseases. In contrast, cancer was not associated with catastrophic health expenditure. Discussion Our study shows that older people with diagnosed chronic diseases face catastrophic health expenditure even in some of the wealthiest countries in Europe. The effect differs across chronic diseases and countries. This may be due to different socio-economic contexts, but also due to the specific characteristics of the different health systems. In view of the ageing of European populations, it will be crucial to strengthen the mechanisms for financial protection for older people with chronic diseases.	[Arsenijevic, Jelena; Pavlova, Milena; Groot, Wim] Maastricht Univ, Fac Hlth Med & Life Sci, Med Ctr, Dept Hlth Serv Res,CAPHRI, Maastricht, Netherlands; [Rechel, Bernd] London Sch Hyg & Trop Med, European Observ Hlth Syst & Policies, London, England; [Groot, Wim] Maastricht Univ, Top Inst Evidence Based Educ Res TIER, Maastricht, Netherlands	Maastricht University; European Observatory on Health Systems & Policies; University of London; London School of Hygiene & Tropical Medicine; Maastricht University	Arsenijevic, J (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Med Ctr, Dept Hlth Serv Res,CAPHRI, Maastricht, Netherlands.	j.arsenijevic@maastrichtuniversity.nl	Pavlova, Milena/B-4778-2011	Pavlova, Milena/0000-0002-6082-8446; Arsenijevic, Jelena/0000-0003-3405-849X; Rechel, Bernd/0000-0001-8020-3956	Theme 8 Socio-economic Sciences and Humanities, Project ASSPRO CEE [217431]; School for Public Health and Primary Care (CAPHRI), Maastricht University [CAP12.5326]; European Commission under the 7th Framework Programme	Theme 8 Socio-economic Sciences and Humanities, Project ASSPRO CEE; School for Public Health and Primary Care (CAPHRI), Maastricht University; European Commission under the 7th Framework Programme	The study is financed by the European Commission under the 7th Framework Programme, Theme 8 Socio-economic Sciences and Humanities, Project ASSPRO CEE 2007 (Grant Agreement no. 217431). The views expressed in this publication are the sole responsibility of the authors and do not necessarily reflect the views of the European Commission or its services. Also, the study is supported by the School for Public Health and Primary Care (CAPHRI), Maastricht University under the travel grant, reference CAP12.5326.	Abegunde DO, 2008, SOC SCI MED, V66, P2296, DOI 10.1016/j.socscimed.2008.01.041; Abma TA, 2013, CROSSING CULTURES HL; Adeyi O, 2007, DIR DEV, P1, DOI 10.1596/978-0-8213-7044-5; Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6; [Anonymous], 2010, WORLD HLTH REP; Barnieh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090434; Basu S, 2013, PUBLIC HEALTH NUTR, V16, P179, DOI [10.1017/S1368980012002881, 10.1017/S1368980012003758]; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bihan H, 2005, DIABETES CARE, V28, P2680, DOI 10.2337/diacare.28.11.2680; Boutayeb A, 2006, T ROY SOC TROP MED H, V100, P191, DOI 10.1016/j.trstmh.2005.07.021; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Busse R., 2010, TACKLING CHRONIC DIS; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Combes JB, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-10; Essue B, 2011, J HEALTH SERV RES PO, V16, P226, DOI 10.1258/jhsrp.2011.010159; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Geneau R, 2010, LANCET, V376, P1689, DOI 10.1016/S0140-6736(10)61414-6; Gotsadze G, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-69; Habicht J, 2006, HEALTH POLICY PLANN, V21, P421, DOI 10.1093/heapol/czl026; Harbers M.M., 2012, INFORM INDICATORS DA; Haughton J., 2009, HDB POVERTY INEQUALI; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Karami M, 2009, J RES HEALTH SCI, V9, P36; Kawabata K, 2002, B WORLD HEALTH ORGAN, V80, P612; Kenkel DS, 2014, J HUM RESOUR, V49, P1094; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Li Y, 2012, B WORLD HEALTH ORGAN, V90, P664, DOI 10.2471/BLT.12.102178; Luczak J, 2012, HEALTH POLICY, V105, P256, DOI 10.1016/j.healthpol.2012.01.004; Ludwig J., 2013, LONG TERM NEIGHBORHO; Malter F., 2013, SHARE WAVE 4 INNOVAT; Mayer-Foulkes DA, 2012, GLOB ECON J, V12, DOI 10.1515/1524-5861.1889; Morabia A, 2006, SOZ PRAVENTIV MED, V51, P74, DOI 10.1007/s00038-005-0015-7; Murphy A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-38; Olejaz M., 2012, DENMARK HLTH SYSTEM; Organization WH, 2005, DES HLTH FIN SYST RE; Osborn R, 2014, HEALTH AFFAIR, V33, P2247, DOI 10.1377/hlthaff.2014.0947; Rechel B, 2013, LANCET, V381, P1312, DOI 10.1016/S0140-6736(12)62087-X; Russell S, 2005, HEALTH POLICY PLANN, V20, P277, DOI 10.1093/heapol/czi035; Saksena P, 2010, DRIVERS CATASTROPHIC; Sargent-Cox K, 2011, SOC SCI MED, V73, P1105, DOI 10.1016/j.socscimed.2011.06.063; Schoenberg NE, 2007, GERONTOLOGIST, V47, P423, DOI 10.1093/geront/47.4.423; Smith O, 2013, EUROPE CENT ASIA REP, P1, DOI 10.1596/978-0-8213-9883-8; Stuck S., 2012, SHARE RELEASE GUIDE; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Suhrcke M, 2005, CONTRIBUTION HLTH EC; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; Tambor M, 2013, HEALTH POLICY, V113, P284, DOI 10.1016/j.healthpol.2013.09.011; Tambor M, 2011, EUR J PUBLIC HEALTH, V21, P585, DOI 10.1093/eurpub/ckq139; Van Kippersluis H, 2013, WHY RICH DRINK MORE; Verhagen I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-227; Wagstaff A, 2014, WORLD BANK POLICY RE; Wong YN, 2010, ONCOLOGIST, V15, P566, DOI 10.1634/theoncologist.2009-0307; Wooldridge J. M., 2016, INTRO ECONOMETRICS M; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yardim MS, 2010, HEALTH POLICY, V94, P26, DOI 10.1016/j.healthpol.2009.08.006	57	47	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157765	10.1371/journal.pone.0157765	http://dx.doi.org/10.1371/journal.pone.0157765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR3JE	27379926	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000379798700009
J	Garcia-Concejo, A; Jimenez-Gonzalez, A; Rodriguez, RE				Garcia-Concejo, Adrian; Jimenez-Gonzalez, Ada; Rodriguez, Raquel E.			mu Opioid Receptor Expression after Morphine Administration Is Regulated by miR-212/132 Cluster	PLOS ONE			English	Article							MICRORNAS	Since their discovery, miRNAs have emerged as a promising therapeutical approach in the treatment of several diseases, as demonstrated by miR-212 and its relation to addiction. Here we prove that the miR-212/132 cluster can be regulated by morphine, through the activation of mu opioid receptor (Oprm1). The molecular pathways triggered after morphine administration also induce changes in the levels of expression of oprm1. In addition, miR-212/132 cluster is actively repressing the expression of mu opioid receptor by targeting a sequence in the 3' UTR of its mRNA. These findings suggest that this cluster is closely related to opioid signaling, and function as a post-transcriptional regulator, modulating morphine response in a dose dependent manner. The regulation of miR-212/132 cluster expression is mediated by MAP kinase pathway, CaMKII-CaMKIV and PKA, through the phosphorylation of CREB. Moreover, the regulation of both oprm1 and of the cluster promoter is mediated by MeCP2, acting as a transcriptional repressor on methylated DNA after prolonged morphine administration. This mechanism explains the molecular signaling triggered by morphine as well as the regulation of the expression of the mu opioid receptor mediated by morphine and the implication of miR-212/132 in these processes.	[Garcia-Concejo, Adrian; Jimenez-Gonzalez, Ada; Rodriguez, Raquel E.] INCyL, C Pintor Fernando Gallego,1, Salamanca 37007, Spain; [Rodriguez, Raquel E.] Univ Salamanca, Fac Med, Dept Biochem & Mol Biol, C Alfonso X El Sabio,0 S-N Campus Miguel Unamun, Salamanca 37007, Spain; [Garcia-Concejo, Adrian; Jimenez-Gonzalez, Ada; Rodriguez, Raquel E.] Hosp Univ Salamanca, Inst Biomed Res Salamanca IBSAL, Edificio Virgen Vega Decima Planta, Salamanca 37007, Spain	University of Salamanca; University of Salamanca	Rodriguez, RE (corresponding author), INCyL, C Pintor Fernando Gallego,1, Salamanca 37007, Spain.; Rodriguez, RE (corresponding author), Univ Salamanca, Fac Med, Dept Biochem & Mol Biol, C Alfonso X El Sabio,0 S-N Campus Miguel Unamun, Salamanca 37007, Spain.; Rodriguez, RE (corresponding author), Hosp Univ Salamanca, Inst Biomed Res Salamanca IBSAL, Edificio Virgen Vega Decima Planta, Salamanca 37007, Spain.	requelmi@usal.es		Rodriguez Rodriguez, Raquel/0000-0003-1805-3066; Garcia-Concejo, Adrian/0000-0002-7269-5783; Jimenez-Gonzalez, Ada/0000-0001-7702-6135	Ministerio Espanol de Economia y Competitividad [SAF 2013-48776-P]; Junta de Castilla y Leon [SA106UIH]	Ministerio Espanol de Economia y Competitividad(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by the grant from Ministerio Espanol de Economia y Competitividad (SAF 2013-48776-P) and Junta de Castilla y Leon (SA106UIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bijkerk R, 2016, KIDNEY INT, V89, P1268, DOI 10.1016/j.kint.2016.01.029; Bourinet E, 1996, P NATL ACAD SCI USA, V93, P1486, DOI 10.1073/pnas.93.4.1486; Buchthal B, 2012, J BIOL CHEM, V287, P30967, DOI 10.1074/jbc.M112.382507; Chang YY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0301-9; Chen Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082288; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; de Chevigny A, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00006; Doench JG, 2004, GENES DEV, V18; Formisano L, 2007, P NATL ACAD SCI USA, V104, P4170, DOI 10.1073/pnas.0611704104; Garcia-Perez D, 2015, ADDICT BIOL, V20, P104, DOI 10.1111/adb.12083; Gonzalez-Nunez V, 2013, MOL MED, V19, P7, DOI 10.2119/molmed.2012.00318; Greco SJ, 2007, P NATL ACAD SCI USA, V104, P15484, DOI 10.1073/pnas.0703037104; He XJ, 2011, ZEBRAFISH, V8, P1, DOI 10.1089/zeb.2010.0680; Hollander JA, 2010, NAT NEUROSCIENCE, V466; Hwang CK, 2004, J BIOL CHEM, V279; Im HI, 2010, NAT NEUROSCIENCE, V13; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Jimenez-Gonzalez A, 2016, BBA-GEN SUBJECTS, V1860, P1308, DOI 10.1016/j.bbagen.2016.03.001; Kawamata T, 2010, TRENDS BIOCH SCI, V35; Kuhn DE, 2008, METHODS, V44, P47, DOI 10.1016/j.ymeth.2007.09.005; Kumarswamy R, 2014, EUR HEART J, V35, P3224, DOI 10.1093/eurheartj/ehu344; Lopez-Bellido R, 2012, PLOS ONE, V7; Luo J, 2014, INT J CLIN EXP MED, V7; Ma W, 2001, EUR J NEUROSCI, V14; Sanchez-Simon FM, 2010, EUR J NEUROSCI, V32, P550, DOI 10.1111/j.1460-9568.2010.07317.x; Marron Fdez de Velasco E, 2011, ZEBRAFISH; Mohammed J, 2014, RNA, V20; Muller M, 2011, P NATL ACAD SCI USA, V108, P13293, DOI 10.1073/pnas.1109297108; Murthy KS, 1996, MOL PHARM, V50; Nasevicius A, 2000, NAT GENETICS, V26; Nestler EJ, 1996, MOL PSYCHIATR, V1, P190; Numakawa T, 2011, NEUROCHEM INT, V59, P551, DOI 10.1016/j.neuint.2011.06.009; Park IK, 1995, J BIOL CHEM, V270; PERT CB, 1973, SCIENCE, V182, P1359, DOI 10.1126/science.182.4119.1359; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Ryazansky SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-371; Sanchez-Simon FM, 2010, MOL PHARM, V78; Sidhu K, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00068; Song RH, 2015, J THEOR BIOL, V380, P271, DOI 10.1016/j.jtbi.2015.05.025; Tebar F, 2002, FEBS LETT, V517, P206, DOI 10.1016/S0014-5793(02)02624-8; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Westerfield M., 2000, GUIDE LAB USE ZEBRAF; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; Zhang XM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/732397; Zhou Z, 2006, NEURON, V52	50	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157806	10.1371/journal.pone.0157806	http://dx.doi.org/10.1371/journal.pone.0157806			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380026	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700010
J	Hirohashi, N; Tamura-Nakano, M; Nakaya, F; Iida, T; Iwata, Y				Hirohashi, Noritaka; Tamura-Nakano, Miwa; Nakaya, Fumio; Iida, Tomohiro; Iwata, Yoko			Sneaker Male Squid Produce Long-lived Spermatozoa by Modulating Their Energy Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell motility; glucose metabolism; glycogen; reproduction; spermatozoa; alternative reproductive tactics; cephalopods; male dimorphism; postcopulatory sexual selection	SPERM SWIMMING SPEED; REPRODUCTIVE-TRACT; STORAGE; COMPETITION; MOTILITY; LACTATE; DEHYDROGENASE; GLYCOLYSIS; EVOLUTION; OXYGEN	Spermatozoa released by males should remain viable until fertilization. Hence, sperm longevity is governed by intrinsic and environmental factors in accordance with the male mating strategy. However, whether intraspecific variation of insemination modes can impact sperm longevity remains to be elucidated. In the squid Heterololigo bleekeri, male dimorphism (consort and sneaker) is linked to two discontinuous insemination modes that differ in place and time. Notably, only sneaker male spermatozoa inseminated long before egg spawning can be stored in the seminal receptacle. We found that sneaker spermatozoa exhibited greater persistence in fertilization competence and flagellar motility than consort ones because of a larger amount of flagellar glycogen. Sneaker spermatozoa also showed higher capacities in glucose uptake and lactate efflux. Lactic acidosis was considered to stabilize CO2-triggered self-clustering of sneaker spermatozoa, thus establishing hypoxia-induced metabolic changes and sperm survival. These results, together with comparative omics analyses, suggest that postcopulatory reproductive contexts define sperm longevity by modulating the inherent energy levels and metabolic pathways.	[Hirohashi, Noritaka; Iida, Tomohiro] Shimane Univ, Oki Marine Biol Stn, Educ & Res Ctr Biol Resources, Oki 6850024, Japan; [Tamura-Nakano, Miwa] Natl Ctr Global Hlth & Med, Res Inst, Tokyo 1628655, Japan; [Nakaya, Fumio] Osaka Kyoiku Univ, Ctr Sci Educ, Osaka 582858, Japan; [Iwata, Yoko] Univ Tokyo, Atmosphere & Ocean Res Inst, Chiba 2778564, Japan	Shimane University; National Center for Global Health & Medicine - Japan; Osaka University of Education; University of Tokyo	Hirohashi, N (corresponding author), Shimane Univ, Oki Marine Biol Stn, Educ & Res Ctr Biol Resources, Oki 6850024, Japan.	hiro@life.shimane-u.ac.jp		Tamura-Nakano, Miwa/0000-0002-8502-6474				Amaral A, 2013, MOL CELL PROTEOMICS, V12, P330, DOI 10.1074/mcp.M112.020552; AUSTIN CR, 1964, PROC R SOC SER B-BIO, V161, P143, DOI 10.1098/rspb.1964.0085; Bennison C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1897; Binet MT, 2014, J EXP MAR BIOL ECOL, V452, P91, DOI 10.1016/j.jembe.2013.12.008; Boussouar F, 2004, TRENDS ENDOCRIN MET, V15, P345, DOI 10.1016/j.tem.2004.07.003; Burness G, 2004, BEHAV ECOL SOCIOBIOL, V56, P65, DOI 10.1007/s00265-003-0752-7; CHRISTEN R, 1983, J BIOL CHEM, V258, P5392; Drew GA, 1911, J MORPHOL, V22, P327, DOI 10.1002/jmor.1050220207; Fitzpatrick JL, 2009, P NATL ACAD SCI USA, V106, P1128, DOI 10.1073/pnas.0809990106; Gasparini C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012146; Montoto LG, 2011, REPRODUCTION, V142, P819, DOI 10.1530/REP-11-0232; Hanlon RT, 2002, B MAR SCI, V71, P331; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirohashi Noritaka, 2013, Communicative & Integrative Biology, V6, pe26729, DOI 10.4161/cib.26729; Hirohashi N, 2013, CURR BIOL, V23, P775, DOI 10.1016/j.cub.2013.03.040; Hirschhaeuser F, 2011, CANCER RES, V71, P6921, DOI 10.1158/0008-5472.CAN-11-1457; Iwata Y, 2005, MAR ECOL PROG SER, V298, P219, DOI 10.3354/meps298219; Iwata Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-236; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Konno A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126005; LEVITAN DR, 1991, BIOL BULL, V181, P371, DOI 10.2307/1542357; Lindemann CB, 1996, CELL MOTIL CYTOSKEL, V34, P258, DOI 10.1002/(SICI)1097-0169(1996)34:4<258::AID-CM1>3.0.CO;2-4; MANN T, 1946, BIOCHEM J, V40, P481, DOI 10.1042/bj0400481; MANN T, 1974, SCIENCE, V185, P453, DOI 10.1126/science.185.4149.453; Matsuzaki M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17643; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miller GT, 2002, SCIENCE, V298, P1230, DOI 10.1126/science.1076968; MITA M, 1982, BIOL REPROD, V26, P445, DOI 10.1095/biolreprod26.3.445; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Nascimento JM, 2008, J CELL PHYSIOL, V217, P745, DOI 10.1002/jcp.21549; Orr TJ, 2015, TRENDS ECOL EVOL, V30, P261, DOI 10.1016/j.tree.2015.03.006; PARKER GA, 1993, P ROY SOC B-BIOL SCI, V253, P245, DOI 10.1098/rspb.1993.0110; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Ribou AC, 2012, P ROY SOC B-BIOL SCI, V279, P2196, DOI 10.1098/rspb.2011.2422; Sasanami T, 2013, J REPROD DEVELOP, V59, P334, DOI 10.1262/jrd.2013-038; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; THORNHILL R, 1983, AM NAT, V122, P765, DOI 10.1086/284170; Tourmente M, 2013, EVOLUTION, V67, P1838, DOI 10.1111/evo.12079; Yoshida MA, 2014, BIOCHEM BIOPH RES CO, V450, P1218, DOI 10.1016/j.bbrc.2014.04.076; Zhang LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16096	41	19	21	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2016	291	37					19324	19334		10.1074/jbc.M116.737494	http://dx.doi.org/10.1074/jbc.M116.737494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EL	27385589	Green Published, hybrid			2022-12-26	WOS:000383242800013
J	Ibarra, R; Sandoval, D; Fredrickson, EK; Gardner, RG; Kleiger, G				Ibarra, Rebeca; Sandoval, Daniella; Fredrickson, Eric K.; Gardner, Richard G.; Kleiger, Gary			The San1 Ubiquitin Ligase Functions Preferentially with Ubiquitin-conjugating Enzyme Ubc1 during Protein Quality Control	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC MISFOLDED PROTEINS; CONTROL DEGRADATION; ENDOPLASMIC-RETICULUM; EXPOSED HYDROPHOBICITY; PROTEASOME SYSTEM; E3 LIGASE; MECHANISM; SUBSTRATE; E2; CHAINS	Protein quality control (PQC) is a critical process wherein misfolded or damaged proteins are cleared from the cell to maintain protein homeostasis. In eukaryotic cells, the removal of misfolded proteins is primarily accomplished by the ubiquitin-proteasome system. In the ubiquitin-proteasome system, ubiquitin-conjugating enzymes and ubiquitin ligases append polyubiquitin chains onto misfolded protein substrates signaling for their degradation. The kinetics of protein ubiquitylation are paramount as a balance must be achieved between the rapid removal of misfolded proteins versus providing sufficient time for protein chaperones to attempt refolding. To uncover the molecular basis for how PQC substrate ubiquitylation rates are controlled, the reaction catalyzed by nuclear ubiquitin ligase San1 was reconstituted in vitro. Our results demonstrate that San1. can function with two ubiquitin-conjugating enzymes, Cdc34 and Ubc1. Although Cdc34 and Ubc1 are both sufficient for promoting Sanl activity, Sanl functions preferentially with Ubc1, including when both Ubc1 and Cdc34 are present. Notably, a homogeneous peptide that mimics a misfolded PQC substrate was developed and enabled quantification of the kinetics of Sanl-catalyzed ubiquitylation reactions. We discuss how these results may have broad implications for the regulation of PQC-mediated protein degradation.	[Ibarra, Rebeca; Sandoval, Daniella; Kleiger, Gary] Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA; [Fredrickson, Eric K.; Gardner, Richard G.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Washington; University of Washington Seattle	Kleiger, G (corresponding author), Univ Nevada, Dept Chem & Biochem, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA.	gary.kleiger@unlv.edu		Gardner, Richard/0000-0003-2162-6275	National Institutes of Health (NIGMS) [P20 GM103440, R15 GM117555-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750, P20GM103440, R15GM117555] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 GM103440 and R15 GM117555-01 (NIGMS; to G. K. and R. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; Baker MJ, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a007559; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Benyair R, 2011, INT REV CEL MOL BIO, V292, P197, DOI 10.1016/B978-0-12-386033-0.00005-0; Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Fang NN, 2014, NAT CELL BIOL, V16, P1227, DOI 10.1038/ncb3054; Fang NN, 2011, NAT CELL BIOL, V13, P1344, DOI 10.1038/ncb2343; Fredrickson EK, 2013, MOL BIOL CELL, V24, P1041, DOI 10.1091/mbc.E12-11-0811; Fredrickson EK, 2013, J BIOL CHEM, V288, P6130, DOI 10.1074/jbc.M112.406710; Fredrickson EK, 2011, MOL BIOL CELL, V22, P2384, DOI 10.1091/mbc.E11-03-0256; Gallagher PS, 2014, J CELL SCI, V127, P1980, DOI 10.1242/jcs.141838; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Kim HG, 2015, ALTERNAT MED, P1, DOI DOI 10.3171/2014.11.JNS141382; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kleiger G, 2014, TRENDS CELL BIOL, V24, P352, DOI 10.1016/j.tcb.2013.12.003; Kleiger G, 2009, J BIOL CHEM, V284, P36012, DOI 10.1074/jbc.M109.058529; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pierce NW, 2009, NATURE, V462, P615, DOI 10.1038/nature08595; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Rodrigo-Brenni MC, 2007, CELL, V130, P127, DOI 10.1016/j.cell.2007.05.027; Rosenbaum JC, 2011, NUCLEUS-PHILA, V2, P264, DOI 10.4161/nucl.2.4.16118; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tramutola A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2756068; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; Wang F, 2013, MOL CELL, V50, P368, DOI 10.1016/j.molcel.2013.03.009; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Woulfe J, 2008, BBA-MOL CELL RES, V1783, P2195, DOI 10.1016/j.bbamcr.2008.05.005; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	58	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18778	18790		10.1074/jbc.M116.737619	http://dx.doi.org/10.1074/jbc.M116.737619			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27405755	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000383242300015
J	Ramirez, VT; Ramos-Fernandez, E; Henriquez, JP; Lorenzo, A; Inestrosa, NC				Ramirez, Valerie T.; Ramos-Fernandez, Eva; Pablo Henriquez, Juan; Lorenzo, Alfredo; Inestrosa, Nibaldo C.			Wnt-5a/Frizzled9 Receptor Signaling through the G alpha(o)-G beta gamma Complex Regulates Dendritic Spine Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; WNT RECEPTOR; SYNAPTIC-TRANSMISSION; WNT/BETA-CATENIN; PERTUSSIS-TOXIN; NMDA-RECEPTOR; GROWTH CONES; HIPPOCAMPAL; ACTIVATION; FRIZZLED-9	Wnt ligands play crucial roles in the development and regulation of synapse structure and function. Specifically, Wnt-5a acts as a secreted growth factor that regulates dendritic spine formation in rodent hippocampal neurons, resulting in postsynaptic development that promotes the clustering of the PSD-95 (postsynaptic density protein 95). Here, we focused on the early events occurring after the interaction between Wnt-5a and its Frizzled receptor at the neuronal cell surface. Additionally, we studied the role of heterotrimeric G proteins in Wnt-5a-dependent synaptic development. We report that FZD9 (Frizzled9), a Wnt receptor related to Williams syndrome, is localized in the postsynaptic region, where it interacts with Wnt-5a. Functionally, FZD9 is required for the Wnt-5a-mediated increase in dendritic spine density. FZD9 forms a precoupled complex with G alpha(o) under basal conditions that dissociates after Wnt-5a stimulation. Accordingly, we found that G protein inhibition abrogates the Wnt-5a-dependent pathway in hippocampal neurons. In particular, the activation of G alpha(o) appears to be a key factor controlling the Wnt-5a-induced dendritic spine density. In addition, we found that G beta gamma is required for the Wnt-5a-mediated increase in cytosolic calcium levels and spinogenesis. Our findings reveal that FZD9 and heterotrimeric G proteins regulate Wnt-5a signaling and dendritic spines in cultured hippocampal neurons.	[Ramirez, Valerie T.; Ramos-Fernandez, Eva; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac, Alameda 340,POB 114-D, Santiago 8331150, Chile; [Pablo Henriquez, Juan] Univ Concepcion, Ctr Microscop Avanzada, Nucleo Milenio Biol Regenerat, Fac Ciencias Biol,Lab Neurobiol Desarrollo,Dept B, Concepcion 4089100, Chile; [Lorenzo, Alfredo] Univ Nacl Cordoba, INIMEC CONICET, Inst Invest Med Mercedes & Martin Ferreyra, Lab Neuropatol Expt, RA-5016 Cordoba, Argentina; [Inestrosa, Nibaldo C.] Univ New South Wales, Fac Med, Ctr Hlth Brain Ageing, Sch Psychiat, Sydney, NSW 2031, Australia; [Inestrosa, Nibaldo C.] Univ Magallanes, Ctr Excelencia Biomed Magallanes, Punta Arenas 6200000, Chile	Pontificia Universidad Catolica de Chile; Universidad de Concepcion; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; University of New South Wales Sydney; Universidad de Magallanes	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Envejecimiento & Regenerac, Alameda 340,POB 114-D, Santiago 8331150, Chile.	ninestrosa@bio.puc.cl			FONDECYT [1120156, 1160724]; Basal Center of Excellence in Science and Technology [CONICYT-PFB12/2007]; CONICYT [3140355]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Basal Center of Excellence in Science and Technology(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by FONDECYT Grant 1120156, FONDECYT Grant 1160724 and Basal Center of Excellence in Science and Technology Grant CONICYT-PFB12/2007 (to N. C. I.), a predoctoral grant (to V. T. R.), and CONICYT Postdoctoral Fellowship 3140355 (to E. R.-F.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Alfaro IE, 2015, MOL CELL NEUROSCI, V67, P22, DOI 10.1016/j.mcn.2015.05.002; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; Aviles EC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00110; Beaumont V, 2007, MOL CELL NEUROSCI, V35, P513, DOI 10.1016/j.mcn.2007.03.004; Belkouch M, 2011, J NEUROSCI, V31, P18381, DOI 10.1523/JNEUROSCI.3386-11.2011; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; CACERES A, 1984, J NEUROSCI, V4, P394; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Cerpa W, 2015, P NATL ACAD SCI USA, V112, P4797, DOI 10.1073/pnas.1417053112; Cerpa W, 2011, J NEUROSCI, V31, P9466, DOI 10.1523/JNEUROSCI.6311-10.2011; Cerpa W, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-3; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Dijksterhuis JP, 2014, BRIT J PHARMACOL, V171, P1195, DOI 10.1111/bph.12364; Egger-Adam D, 2010, DEV DYNAM, V239, P168, DOI 10.1002/dvdy.22060; Exner T, 1999, P NATL ACAD SCI USA, V96, P1327, DOI 10.1073/pnas.96.4.1327; Farias GG, 2009, J BIOL CHEM, V284, P15857, DOI 10.1074/jbc.M808986200; Feigin ME, 2007, J CELL SCI, V120, P3404, DOI 10.1242/jcs.011254; Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Halleskog C, 2013, CELL SIGNAL, V25, P822, DOI 10.1016/j.cellsig.2012.12.006; Halleskog C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-111; Hiester BG, 2013, MOL CELL NEUROSCI, V56, P115, DOI 10.1016/j.mcn.2013.04.006; Hohenegger M, 1998, P NATL ACAD SCI USA, V95, P346, DOI 10.1073/pnas.95.1.346; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; Karasawa T, 2002, J BIOL CHEM, V277, P37479, DOI 10.1074/jbc.M205658200; Katanaev VL, 2005, CELL, V120, P111, DOI 10.1016/j.cell.2004.11.014; Kilander MBC, 2011, ACTA PHYSIOL, V203, P363, DOI 10.1111/j.1748-1716.2011.02324.x; Kilander MBC, 2014, FASEB J, V28, P2293, DOI 10.1096/fj.13-246363; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Koval A, 2011, BIOCHEM J, V433, P435, DOI 10.1042/BJ20101878; Li YP, 2011, GENESIS, V49, P919, DOI 10.1002/dvg.20765; Ma L, 2006, J BIOL CHEM, V281, P30990, DOI 10.1074/jbc.M603603200; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Momoi A, 2003, MECH DEVELOP, V120, P477, DOI 10.1016/S0925-4773(03)00003-0; Munoz FJ, 2014, BIOCHEM BIOPH RES CO, V444, P189, DOI 10.1016/j.bbrc.2014.01.031; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nialbon C. C., 2005, SCI STKE, V2005, ppe35; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nishita M, 2010, MOL CELL BIOL, V30, P3610, DOI 10.1128/MCB.00177-10; Nusse O, 1996, J CELL SCI, V109, P221; Oliva CA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00224; Oliva CA, 2013, AGEING RES REV, V12, P786, DOI 10.1016/j.arr.2013.03.006; Onishi K, 2013, J NEUROSCI, V33, P19071, DOI 10.1523/JNEUROSCI.2800-13.2013; Park M, 2012, EMBO J, V31, P2697, DOI 10.1038/emboj.2012.145; PITCHER JA, 1995, J BIOL CHEM, V270, P11707, DOI 10.1074/jbc.270.20.11707; Plaut RD, 2008, CELL MICROBIOL, V10, P1130, DOI 10.1111/j.1462-5822.2007.01115.x; Purro SA, 2014, J MOL CELL BIOL, V6, P75, DOI 10.1093/jmcb/mjt049; Ramirez VT, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4258171; Runnenburger K, 2002, EUR J CELL BIOL, V81, P539, DOI 10.1078/0171-9335-00277; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Shah SM, 2009, NEUROSCIENCE, V164, P478, DOI 10.1016/j.neuroscience.2009.08.049; Silva-Alvarez C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00097; Vigo FS, 2009, NEUROBIOL AGING, V30, P1379, DOI 10.1016/j.neurobiolaging.2007.11.017; Spalloni A, 2011, CEREB CORTEX, V21, P796, DOI 10.1093/cercor/bhq152; STEIN PE, 1994, STRUCTURE, V2, P45, DOI 10.1016/S0969-2126(00)00007-1; Varela-Nallar L, 2012, CYTOSKELETON, V69, P528, DOI 10.1002/cm.21022; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Varela-Nallar L, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-41; Vargas JY, 2014, J NEUROSCI, V34, P2191, DOI 10.1523/JNEUROSCI.0862-13.2014; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; Willert K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007864; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Zhao CJ, 2005, DEVELOPMENT, V132, P2917, DOI 10.1242/dev.01871; Zhao CJ, 2004, GENESIS, V40, P32, DOI 10.1002/gene.20058; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	75	36	37	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					19092	19107		10.1074/jbc.M116.722132	http://dx.doi.org/10.1074/jbc.M116.722132			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402827	hybrid, Green Published			2022-12-26	WOS:000383242300042
J	Ababou, A; Koronakis, V				Ababou, Abdessamad; Koronakis, Vassilis			Structures of Gate Loop Variants of the AcrB Drug Efflux Pump Bound by Erythromycin Substrate	PLOS ONE			English	Article							MULTIDRUG EFFLUX; TRANSPORTER; RESISTANCE; REVEAL; PHENIX	Gram-negative bacteria such as E. coli use tripartite efflux pumps such as AcrAB-TolC to expel antibiotics and noxious compounds. A key feature of the inner membrane transporter component, AcrB, is a short stretch of residues known as the gate/switch loop that divides the proximal and distal substrate binding pockets. Amino acid substitutions of the gate loop are known to decrease antibiotic resistance conferred by AcrB. Here we present two new AcrB gate loop variants, the first stripped of its bulky side chains, and a second in which the gate loop is removed entirely. By determining the crystal structures of the variant AcrB proteins in the presence and absence of erythromycin and assessing their ability to confer erythromycin tolerance, we demonstrate that the gate loop is important for AcrB export activity but is not required for erythromycin binding.	[Ababou, Abdessamad; Koronakis, Vassilis] Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge, England	University of Cambridge	Ababou, A; Koronakis, V (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge, England.	aa673@cam.ac.uk; vk103@cam.ac.uk		Koronakis, Vassilis/0000-0002-1353-1092	UK Medical Research Council; Wellcome Trust; MRC [G1001104, MR/N000994/1] Funding Source: UKRI; Medical Research Council [G1001104, MR/N000994/1] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the UK Medical Research Council and Wellcome Trust.; We thank the beam line staff at the Diamond Light Source (UK), Swiss Light Source (Switzerland), and the European Synchrotron Radiation Facility (Grenoble, France) for their help. We thank Dr D. Chirgadze for use of the Cambridge Biochemistry X-ray crystallography facility. This work was supported by grants from the UK Medical Research Council and Wellcome Trust.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bohnert JA, 2008, J BACTERIOL, V190, P8225, DOI 10.1128/JB.00912-08; Cha HJ, 2014, ANTIMICROB AGENTS CH, V58, P4767, DOI 10.1128/AAC.02733-13; DiMaio F, 2013, NAT METHODS, V10, P1102, DOI [10.1038/nmeth.2648, 10.1038/NMETH.2648]; Eicher T, 2012, P NATL ACAD SCI USA, V109, P5687, DOI 10.1073/pnas.1114944109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hinchliffe P, 2013, ANNU REV MICROBIOL, V67, P221, DOI 10.1146/annurev-micro-092412-155718; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089143; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nakashima R, 2011, NATURE, V480, P565, DOI 10.1038/nature10641; Nikaido H, 1998, CLIN INFECT DIS, V27, pS32, DOI 10.1086/514920; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Pos KM, 2009, BBA-PROTEINS PROTEOM, V1794, P782, DOI 10.1016/j.bbapap.2008.12.015; Seeger MA, 2006, SCIENCE, V313, P1295, DOI 10.1126/science.1131542; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wehmeier C, 2009, ANTIMICROB AGENTS CH, V53, P329, DOI 10.1128/AAC.00921-08; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	23	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159154	10.1371/journal.pone.0159154	http://dx.doi.org/10.1371/journal.pone.0159154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403665	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508200038
J	Kantomaa, MT; Tikanmaki, M; Kankaanpaa, A; Vaarasmaki, M; Sipola-Leppanen, M; Ekelund, U; Hakonen, H; Jarvelin, MR; Kajantie, E; Tammelin, TH				Kantomaa, Marko T.; Tikanmaki, Marjaana; Kankaanpaa, Anna; Vaarasmaki, Marja; Sipola-Leppanen, Marika; Ekelund, Ulf; Hakonen, Harto; Jarvelin, Marjo-Riitta; Kajantie, Eero; Tammelin, Tuija H.			Accelerometer-Measured Physical Activity and Sedentary Time Differ According to Education Level in Young Adults	PLOS ONE			English	Article							SITTING TIME; SOCIOECONOMIC DIFFERENCES; ENERGY-EXPENDITURE; METABOLIC SYNDROME; VIEWING TIME; RISK-FACTORS; HEALTH; ASSOCIATIONS; PARTICIPATION; OVERWEIGHT	This study examined the association of education level with objectively measured physical activity and sedentary time in young adults. Data from the Finnish ESTER study (20092011) (n = 538) was used to examine the association between educational attainment and different subcomponents of physical activity and sedentary time measured using hip-worn accelerometers (ActiGraph GT1M) for seven consecutive days. Overall physical activity, moderate-to-vigorous physical activity (MVPA), light-intensity physical activity and sedentary time were calculated separately for weekdays and weekend days. A latent profile analysis was conducted to identify the different profiles of sedentary time and the subcomponents of physical activity. The educational differences in accelerometer-measured physical activity and sedentary time varied according to the subcomponents of physical activity, and between weekdays and weekend days. A high education level was associated with high MVPA during weekdays and weekend days in both sexes, high sedentary time during weekdays in both sexes, and a low amount of light-intensity physical activity during weekdays in males and during weekdays and weekend days in females. The results indicate different challenges related to unhealthy behaviours in young adults with low and high education: low education is associated with a lack of MVPA, whereas high education is associated with a lack of light-intensity physical activity and high sedentary time especially during weekdays.	[Kantomaa, Marko T.; Kankaanpaa, Anna; Hakonen, Harto; Tammelin, Tuija H.] LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland; [Kantomaa, Marko T.; Jarvelin, Marjo-Riitta] Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC Hlth Protect Agcy HPE,Ctr Environm & Hlth, London, England; [Tikanmaki, Marjaana; Sipola-Leppanen, Marika] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Helsinki, Finland; [Tikanmaki, Marjaana; Sipola-Leppanen, Marika] Natl Inst Hlth & Welf, Chron Dis Prevent Unit, Oulu, Finland; [Tikanmaki, Marjaana; Sipola-Leppanen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Vaarasmaki, Marja; Kajantie, Eero] Oulu Univ Hosp, Med Res Ctr Oulu, PEDEGO Res Unit, Oulu, Finland; [Vaarasmaki, Marja; Kajantie, Eero] Univ Oulu, Oulu, Finland; [Vaarasmaki, Marja; Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf Oulu, Dept Children & Young People & Families, Oulu, Finland; [Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway; [Ekelund, Ulf] Univ Cambridge, Med Res Council Epidemiol Unit, Cambridge, England; [Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Oulu, Finland; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Childrens Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland	Imperial College London; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; University of Oulu; Norwegian School of Sport Sciences; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Oulu; University of Oulu; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Kantomaa, MT (corresponding author), LIKES Res Ctr Sport & Hlth Sci, Jyvaskyla, Finland.; Kantomaa, MT (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC Hlth Protect Agcy HPE,Ctr Environm & Hlth, London, England.	m.kantomaa@imperial.ac.uk	Paalanne, Marika/ABE-5008-2020; Ekelund, Ulf/AAE-8471-2019	Paalanne, Marika/0000-0003-1626-9410; Ekelund, Ulf/0000-0003-2115-9267; Vaarasmaki, Marja/0000-0002-8234-4434; Kankaanpaa, Anna/0000-0002-6973-5385; Kantomaa, Marko/0000-0002-5937-3456; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Finnish Ministry of Education and Culture [OKM/123/626/2012]; Academy of Finland [273971, 127437, 129306, 130326, 134791, 263924]; Doctoral Programme in Public Health (DPPH); Emil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; National Graduate School of Clinical Investigation; Novo Nordisk Foundation; Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation; Yrjo Jahnsson Foundation; Novo Nordisk Fonden [NNF12OC1016374, NNF15OC0016362] Funding Source: researchfish	Finnish Ministry of Education and Culture; Academy of Finland(Academy of Finland); Doctoral Programme in Public Health (DPPH); Emil Aaltonen Foundation; Finnish Foundation for Pediatric Research; Jalmari and Rauha Ahokas Foundation; Juho Vainio Foundation; National Graduate School of Clinical Investigation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Signe and Ane Gyllenberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Yrjo Jahnsson Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was funded by the Finnish Ministry of Education and Culture (OKM/123/626/2012) and the Academy of Finland (grant 273971). The Ester study was supported by grants from the Academy of Finland (grants 127437, 129306, 130326, 134791, and 263924), Doctoral Programme in Public Health (DPPH), Emil Aaltonen Foundation, Finnish Foundation for Pediatric Research, Jalmari and Rauha Ahokas Foundation, Juho Vainio Foundation, National Graduate School of Clinical Investigation, Novo Nordisk Foundation, Signe and Ane Gyllenberg Foundation, Sigrid Juselius Foundation, and Yrjo Jahnsson Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Bischoff AL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056700, 10.1371/journal.pone.0071417]; Boyle T, 2011, AM J EPIDEMIOL, V173, P1183, DOI 10.1093/aje/kwq513; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Burton NW, 2012, AM J PREV MED, V42, P363, DOI 10.1016/j.amepre.2011.11.012; Camhi SM, 2011, PREV MED, V52, P358, DOI 10.1016/j.ypmed.2011.01.030; Chandola T, 2006, J R STAT SOC A STAT, V169, P337, DOI 10.1111/j.1467-985X.2006.00411.x; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Chen IJ, 2008, NURS ECON, V26, P263; Clark BK, 2010, J PHYS ACT HEALTH, V7, P595, DOI 10.1123/jpah.7.5.595; Expert Committee on the Sport Services Offered by Higher Education, 2011, REC SPORT SERV PROV; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hansen BH, 2014, INT J PUBLIC HEALTH, V59, P221, DOI 10.1007/s00038-013-0472-3; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Kirk MA, 2011, AM J PREV MED, V40, P476, DOI 10.1016/j.amepre.2010.12.015; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Miettola S, 2013, EUR J EPIDEMIOL, V28, P87, DOI 10.1007/s10654-013-9763-5; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Proper KI, 2007, INT J OBESITY, V31, P169, DOI 10.1038/sj.ijo.0803357; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Salmon J, 2000, INT J OBESITY, V24, P600, DOI 10.1038/sj.ijo.0801203; Santos R, 2010, INT J ENV RES PUB HE, V7, P1500, DOI 10.3390/ijerph7041500; Sipola-Leppanen M, 2015, AM J EPIDEMIOL, V181, P861, DOI 10.1093/aje/kwu443; Smith L, 2015, SPORTS MED, V45, P449, DOI 10.1007/s40279-015-0310-2; Smith L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004103; SPSS, 2010, IBM SPSS STAT 19 COR; Stamatakis E, 2012, INT J EPIDEMIOL, V41, P1328, DOI 10.1093/ije/dys077; Statistics Finland, 2001, UNESCOS INTERNATIONA, P169; Sugiyama T, 2007, AM J PREV MED, V33, P444, DOI 10.1016/j.amepre.2007.07.035; Thorp AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-128; Tigbe WW, 2011, PREV MED, V53, P48, DOI 10.1016/j.ypmed.2011.04.018; Trost SG, 2002, MED SCI SPORT EXER, V34, P1996, DOI 10.1097/00005768-200212000-00020; Vaarasmaki M, 2009, AM J EPIDEMIOL, V169, P1209, DOI 10.1093/aje/kwp020; van Sluijs EMF, 2010, BRIT J SPORT MED, V44, P747, DOI 10.1136/bjsm.2008.049783; Wapllmann-Sperlich B, 2013, BMC PUBLIC HEALTH, V13, P196, DOI [10.1186/1471-2458-13-196, DOI 10.1186/1471-2458-13-196]; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440	43	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158902	10.1371/journal.pone.0158902	http://dx.doi.org/10.1371/journal.pone.0158902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27403958	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000379508200019
J	Thakur, S; Grover, RK; Gupta, S; Yadav, AK; Das, BC				Thakur, Seema; Grover, Rajesh K.; Gupta, Sanjay; Yadav, Ajay K.; Das, Bhudev C.			Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer	PLOS ONE			English	Article							LYMPH-NODE METASTASES; CIRCULATING MICRORNAS; TAMOXIFEN RESISTANCE; RISK-FACTORS; EXPRESSION; BIOMARKER; MIR-155; MARKERS; MIR-21; TUMORS	Of several subtypes of breast cancer, triple negative breast cancer (TNBC) is a highly aggressive tumor that lacks expression of hormone receptors for estrogen, progesterone and human epidermal growth factor receptor 2 and shows a worst prognosis. The small noncoding RNAs (miRNAs) considered as master regulator of gene expression play a key role in cancer initiation, progression and drug resistance and have emerged as attractive molecular biomarkers for diagnosis, prognosis and treatment targets in cancer. We have done expression profiling of selected miRNAs in paired serum and tissue samples of TNBC patients and corresponding cell lines and compared with that of other subtypes, in order to identify novel serum miRNA biomarkers for early detection and progression of TNBC. A total of 85 paired tumor tissues and sera with an equal number of adjacent normal tissue margins and normal sera from age matched healthy women including tissue and sera samples from 15 benign fibroadenomas were employed for the study. We report for the first time an extremely high prevalence (73.9%) of TNBC in premenopausal women below 35 years of age and a significant altered expression of a panel of three specific oncogenic miRNAs-miR- 21, miR-221, miR-210, and three tumor suppressor miRNAs-miR-195, miR-145 and Let-7a in both tissues and corresponding sera of TNBC patients when compared with triple positive breast cancer (TPBC) patients. While miR-21, miR-221 and miR-210 showed significant over-expression, miR-195 and miR-145 were downregulated and well correlated with various clinicopathological and demographic risk factors, tumor grade, clinical stage and hormone receptor status. Interestingly, despite being a known tumor suppressor, Let-7a showed a significant overexpression in TNBCs. It is suggested that this panel of six miRNA signature may serve as a minimally invasive biomarker for an early detection of TNBC patients.	[Thakur, Seema; Yadav, Ajay K.; Das, Bhudev C.] Univ Delhi, Dr BR Ambedker Ctr Biomed Res, New Delhi, India; [Grover, Rajesh K.] Delhi State Canc Inst, Delhi, India; [Gupta, Sanjay] Guru Teg Bahadur Hosp, Delhi, India; [Das, Bhudev C.] Amity Univ, AIMMSCR, Stem Cell & Canc Res Lab, Sect 125, Noida 201313, Uttar Pradesh, India	University of Delhi; University of Delhi; University College of Medical Sciences; Amity University Noida	Das, BC (corresponding author), Univ Delhi, Dr BR Ambedker Ctr Biomed Res, New Delhi, India.; Das, BC (corresponding author), Amity Univ, AIMMSCR, Stem Cell & Canc Res Lab, Sect 125, Noida 201313, Uttar Pradesh, India.	bcdas@amity.edu			Department of Science & Technology (DST), Govt. of India, New Delhi, India under Women Scientist Scheme A (WOS-A) [SR/WOS-A/LS-177/2011]; Department of Science & Technology (DST), Govt. of India, New Delhi under J. C. Bose National Fellowship	Department of Science & Technology (DST), Govt. of India, New Delhi, India under Women Scientist Scheme A (WOS-A); Department of Science & Technology (DST), Govt. of India, New Delhi under J. C. Bose National Fellowship	Authors acknowledge the Department of Science & Technology (DST), Govt. of India, New Delhi, India, for the award of Women Scientist fellowship under Women Scientist Scheme A (WOS-A), Grand No. SR/WOS-A/LS-177/2011 to Seema Thakur for her doctoral research. Authors are also thankful to the Department of Science & Technology (DST), Govt. of India, New Delhi for partial funding under J. C. Bose National Fellowship to B. C. Das. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asaga S, 2011, CLIN CHEM, V57, P84, DOI 10.1373/clinchem.2010.151845; Avery-Kiejda KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-253; Avery-Kiejda KA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-51; Bockmeyer CL, 2011, BREAST CANCER RES TR, V130, P735, DOI 10.1007/s10549-010-1303-3; Chan M, 2013, CLIN CANCER RES, V19, P4477, DOI 10.1158/1078-0432.CCR-12-3401; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; Chen LQ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-52; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Dietze EC, 2015, NAT REV CANCER, V15, P248, DOI 10.1038/nrc3896; Dolle JM, 2009, CANCER EPIDEM BIOMAR, V18, P1157, DOI 10.1158/1055-9965.EPI-08-1005; Eichelser C, 2014, ONCOTARGET, V5, P9650, DOI 10.18632/oncotarget.2520; Eichelser C, 2013, CLIN CHEM, V59, P1489, DOI 10.1373/clinchem.2013.205161; Erbes T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1190-4; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gasparini P, 2014, ONCOTARGET, V5, P1174, DOI 10.18632/oncotarget.1682; Gezer U, 2014, ONCOL LETT, V8, P845, DOI 10.3892/ol.2014.2188; Gyparaki MT, 2014, CANCER LETT, V354, P1, DOI 10.1016/j.canlet.2014.07.036; Heneghan HM, 2010, ONCOLOGIST, V15, P673, DOI 10.1634/theoncologist.2010-0103; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu JH, 2015, TUMOR BIOL, V36, P251, DOI 10.1007/s13277-014-2611-8; Igglezou M, 2014, ANTICANCER RES, V34, P7443; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jack RH, 2013, EUR J CANCER, V49, P696, DOI 10.1016/j.ejca.2012.09.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiao QL, 2014, J THORAC DIS, V6, P1329, DOI 10.3978/j.issn.2072-1439.2014.08.13; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kawai M, 2014, CANCER-AM CANCER SOC, V120, P1548, DOI 10.1002/cncr.28601; Dang K, 2015, INT J MOL SCI, V16, P6353, DOI 10.3390/ijms16036353; Le Quesne J, 2010, MOL ONCOL, V4, P230, DOI 10.1016/j.molonc.2010.04.009; Li B, 2014, ASIAN PAC J CANCER P, V15, P3555, DOI 10.7314/APJCP.2014.15.8.3555; Li D, 2011, CLIN CANCER RES, V17, P1722, DOI 10.1158/1078-0432.CCR-10-1800; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mar-Aguilar F, 2013, DIS MARKERS, V34, P163, DOI [10.1155/2013/259454, 10.3233/DMA-120957]; Medimegh I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111877; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mishra S, 2015, CANCER LETT, V369, P67, DOI 10.1016/j.canlet.2015.07.045; Qi LQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-163; Radojicic J, 2011, CELL CYCLE, V10, P507, DOI 10.4161/cc.10.3.14754; Rais G, 2012, EUR J CANCER, V48, pS57; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Serguienko A, 2015, ONCOTARGET, V6, P2451, DOI 10.18632/oncotarget.3235; Shah S, 2012, BREAST CANC INDIA; Sisic L, 2015, ONCOL LETT, V10, P869, DOI 10.3892/ol.2015.3341; Svoboda M, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-31; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vyas Dinesh, 2016, J Clin Med Res, V8, P162, DOI 10.14740/jocmr2365w; Wang FJ, 2010, GYNECOL ONCOL, V119, P586, DOI 10.1016/j.ygyno.2010.07.021; Wu JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133643; Yang Q, 2014, ASIAN PAC J CANCER P, V16, P3229; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zheng H, 2013, PLASMA MIRNAS DIAGNO; Zhu J, 2014, FRONT GENET, P5; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	56	49	49	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158946	10.1371/journal.pone.0158946	http://dx.doi.org/10.1371/journal.pone.0158946			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404381	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508200022
J	Chang, YK; Choi, H; Jeong, JY; Na, KR; Lee, KW; Lim, BJ; Choi, DE				Chang, Yoon-Kyung; Choi, Hyunsu; Jeong, Jin Young; Na, Ki-Ryang; Lee, Kang Wook; Lim, Beom Jin; Choi, Dae Eun			Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; GENE-EXPRESSION; ERK ACTIVATION; TUBULAR CELLS; HIF; HIF-1-ALPHA; APOPTOSIS; FAILURE; GLUCOSE; LIVER	Dapagliflozin, a new type of drug used to treat diabetes mellitus (DM), is a sodium/glucose cotransporter 2 (SGLT2) inhibitor. Although some studies showed that SGLT2 inhibition attenuated reactive oxygen generation in diabetic kidney the role of SGLT2 inhibition is unknown. We evaluated whether SLT2 inhibition has renoprotective effects in ischemia-reperfusion (IR) models. We evaluated whether dapagliflozin reduces renal damage in IR mice model. In addition, hypoxic HK2 cells were treated with or without SGLT2 inhibitor to investigate cell survival, the apoptosis signal pathway, and the induction of hypoxia-inducible factor 1 (HIF1) and associated proteins. Dapagliflozin improved renal function. Dapagliflozin reduced renal expression of Bax, renal tubule injury and TUNEL-positive cells and increased renal expression of HIF1 in IR-injured mice. HIF1 inhibition by albendazole negated the renoprotective effects of dapagliflozin treatment in IR-injured mice. In vitro, dapagliflozin increased the expression of HIF1, AMP-activated protein kinase (AMPK), and ERK and increased cell survival of hypoxic HK2 cells in a dose-dependent manner. In conclusion, dapagliflozin attenuates renal IR injury. HIF1 induction by dapagliflozin may play a role in renoprotection against renal IR injury.	[Chang, Yoon-Kyung] Daejeon St Mary Hosp, Dept Nephrol, Daejeon, South Korea; [Chang, Yoon-Kyung] Catholic Univ Korea, Dept Nephrol, Seoul, South Korea; [Choi, Hyunsu] Daejeon St Mary Hosp, Clin Res Inst, Daejeon, South Korea; [Jeong, Jin Young; Na, Ki-Ryang; Lee, Kang Wook; Choi, Dae Eun] Chungnam Natl Univ, Sch Med, Dept Nephrol, Daejeon, South Korea; [Jeong, Jin Young] Chungnam Natl Univ, Sch Med, Dept Med Sci, Daejeon, South Korea; [Lim, Beom Jin] Yeonse Univ, Coll Med, Dept Pathol, Seoul, South Korea	Catholic University of Korea; Chungnam National University; Chungnam National University; Yonsei University; Yonsei University Health System	Choi, DE (corresponding author), Chungnam Natl Univ, Sch Med, Dept Nephrol, Daejeon, South Korea.; Lim, BJ (corresponding author), Yeonse Univ, Coll Med, Dept Pathol, Seoul, South Korea.	bjlim@yuhs.ac; daenii@cnu.ac.kr	Choi, Dae Eun/B-5996-2014	Choi, Dae Eun/0000-0003-2870-3958; Lim, Beom Jin/0000-0003-2856-0133; Na, Ki Ryang/0000-0002-0136-176X	Clinical Research Institute grant - Catholic University of Korea Daejeon St. Mary's Hospital [CMCDJ-A-2015-020]; faculty research grant of Yonsei University College of Medicine [6-2009-0103]	Clinical Research Institute grant - Catholic University of Korea Daejeon St. Mary's Hospital; faculty research grant of Yonsei University College of Medicine	This work was supported by a Clinical Research Institute grant (CMCDJ-A-2015-020) funded by The Catholic University of Korea Daejeon St. Mary's Hospital. This study was supported by a faculty research grant of Yonsei University College of Medicine for 2009 (6-2009-0103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adluri RS, 2011, ANTIOXID REDOX SIGN, V15, P1789, DOI 10.1089/ars.2010.3769; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Chang YK, 2009, J UROLOGY, V181, P1434, DOI 10.1016/j.juro.2008.10.105; Choi DE, 2009, AM J PHYSIOL-RENAL, V297, pF362, DOI 10.1152/ajprenal.90609.2008; Conde E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033258; Cursio R, 2008, TRANSPL P, V40, P2042, DOI 10.1016/j.transproceed.2008.05.037; Fernando M, 2014, BIOMARK MED, V8, P1247, DOI [10.2217/bmm.14.86, 10.2217/BMM.14.86]; Gunaratnam L, 2009, J AM SOC NEPHROL, V20, P1877, DOI 10.1681/ASN.2008070804; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Haase VH, 2006, KIDNEY INT, V69, P1302, DOI 10.1038/sj.ki.5000221; Haase VH, 2006, AM J PHYSIOL-RENAL, V291, pF271, DOI 10.1152/ajprenal.00071.2006; Hill P, 2008, J AM SOC NEPHROL, V19, P39, DOI 10.1681/ASN.2006090998; Knudsen AR, 2012, AM J PHYSIOL-GASTR L, V303, pG482, DOI 10.1152/ajpgi.00337.2011; Layton AT, 2016, AM J PHYSIOL-RENAL, V310, pF1269, DOI 10.1152/ajprenal.00543.2015; Lee KW, 2009, TOXICOLOGY, V257, P137, DOI 10.1016/j.tox.2008.12.017; Lee M, 2003, J BIOL CHEM, V278, P39653, DOI 10.1074/jbc.M306104200; Minet E, 2000, FEBS LETT, V468, P53, DOI 10.1016/S0014-5793(00)01181-9; Morrisey K, 1999, KIDNEY INT, V55, P2548, DOI 10.1046/j.1523-1755.1999.00454.x; Nakamura N, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0044-1; Nangaku M, 2008, NEPHRON EXP NEPHROL, V110, pE1, DOI 10.1159/000148256; O'Neill J, 2015, AM J PHYSIOL-RENAL, V309, pF227, DOI 10.1152/ajprenal.00689.2014; Panchapakesan U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054442; Schley G, 2012, AM J PATHOL, V181, P1595, DOI 10.1016/j.ajpath.2012.07.010; Song H, 2015, LIFE SCI, V126, P69, DOI 10.1016/j.lfs.2015.02.004; Vercauteren SR, 2003, AM J TRANSPLANT, V3, P570, DOI 10.1034/j.1600-6143.2003.00117.x; Veroux M, 2009, TRANSPL INFECT DIS, V11, P266, DOI 10.1111/j.1399-3062.2009.00388.x; Versteilen AMG, 2004, INT J ARTIF ORGANS, V27, P1019, DOI 10.1177/039139880402701203; Weidemann A, 2008, J AM SOC NEPHROL, V19, P486, DOI 10.1681/ASN.2007040419; Yang CC, 2009, TRANSPLANTATION, V88, P1251, DOI 10.1097/TP.0b013e3181bb4a07; Yeh CH, 2010, LIFE SCI, V86, P115, DOI 10.1016/j.lfs.2009.11.022; Zapata-Morales JR, 2014, J BIOL CHEM, V289, P346, DOI 10.1074/jbc.M113.526814; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	32	79	88	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158810	10.1371/journal.pone.0158810	http://dx.doi.org/10.1371/journal.pone.0158810			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391020	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400130
J	Cheng, XJ; Tian, XY; Wu, XJ; Xing, XF; Du, H; Zhou, CL; Zhang, QY; Hao, CY; Wen, XZ; Ji, JF				Cheng, Xiaojing; Tian, Xiuyun; Wu, Xiaojiang; Xing, Xiaofang; Du, Hong; Zhou, Chunlian; Zhang, Qingyun; Hao, Chunyi; Wen, Xianzi; Ji, Jiafu			Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers	PLOS ONE			English	Article							POOR-PROGNOSIS; SUSCEPTIBILITY; PROMOTES; PROTEIN; ANGIOGENESIS; ASSOCIATION	Background Lysosome-associated transmembrane-4 beta (LAPTM4B) is an oncogene that participates tumorgenesis in a variety of human solid tumors, and it has two alleles named as LAPTM4B *1 and *2. The present study aimed to identify the association of LAPTM4B genotype with clinicopathological features and prognosis in colorectal and esophageal cancer patients. Method Genotypes of LAPTM4B were determined by PCR in 167 colon cancer cases (72 patients in a discovery cohort and 95 patients in a testing cohort), 160 rectal cancer cases and 164 esophageal cancer cases. Association between the LAPTM4B gene polymorphism and clinicopathological variables was calculated by Chi-square test or Fisher's exact test. Patient survival differences were calculated by the Kaplan-Meier method. Prognostic factors were determined with Log-rank test and Cox regression model. Results LAPTM4B *1/1 was more frequently detected in colon cancer patients with lymph node metastasis and TNM III+IV stages in total colon cancer (discovery + testing cohorts). LAPTM4B *2/2 decreased in recurrent patients in total colon cancer patients (P = 0.045). Kaplan-Meier survival curves and Log-rank test showed that LAPTM4B *1 was correlated with shorter overall survival (OS) in discovery and testing cohorts of colon cancer (P = 0.0254 and 0.0292, respectively), but not in rectal and esophageal cancer cases (P = 0.7669 and 0.9356, respectively). Multivariate analysis showed that LAPTM4B genotype was an independent prognostic factor for OS in total colon cancer [P = 0.004, hazard ratio (HR) = 0.432; 95% confidence interval (CI) = 0.243-0.768], but not in rectal and esophageal cancers (P = 0.791, HR = 1.073, 95% CI = 0.638-1.804 and 0.998, HR = 1.000, 95% CI = 0.663-1.530, respectively). Conclusion These findings suggested that LAPTM4B allele *1 was a risk factor associated with poor prognosis in patients with colon cancer, but not in patients with rectal or esophageal cancers. LAPTM4B genotype status might be a useful prognostic indicator for patients that need surgical operation in colon cancer.	[Cheng, Xiaojing; Xing, Xiaofang; Du, Hong; Wen, Xianzi; Ji, Jiafu] Peking Univ Canc Hosp & Inst, Div Gastrointestinal Canc, Translat Res Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China; [Tian, Xiuyun; Hao, Chunyi] Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Dept Hepatopancreatobiliary Surg, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China; [Wu, Xiaojiang; Ji, Jiafu] Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Surg, Beijing, Peoples R China; [Zhou, Chunlian] Capital Med Univ, Beijing Friendship Hosp, Dept Nosocomial Infect Prevent & Control, Beijing, Peoples R China; [Zhang, Qingyun] Peking Univ Canc Hosp & Inst, Dept Clin Lab, Beijing, Peoples R China	Peking University; Peking University; Peking University; Capital Medical University; Peking University	Wen, XZ; Ji, JF (corresponding author), Peking Univ Canc Hosp & Inst, Div Gastrointestinal Canc, Translat Res Lab, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing, Peoples R China.; Hao, CY (corresponding author), Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Dept Hepatopancreatobiliary Surg, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China.; Ji, JF (corresponding author), Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Surg, Beijing, Peoples R China.	haochunyi@bjmu.edu.cn; wenxz@bjmu.edu.cn; jiafuji@outlook.com		JI, JIAFU/0000-0001-6878-5543; Hao, Chunyi/0000-0002-1233-1689	National Nature Science Foundation of China [81402308]; National High Technology Research and Development Program of China (863 Program) [2014AA020603]; capital health research and development of special [2016-2-2151]; Beijing municipal natural science foundation [7153161]; International science and technology cooperation program of China [2013DFG32720]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); capital health research and development of special; Beijing municipal natural science foundation(Beijing Natural Science Foundation); International science and technology cooperation program of China	The National Nature Science Foundation of China (No. 81402308), the National High Technology Research and Development Program of China (863 Program, No. 2014AA020603), the capital health research and development of special (No. 2016-2-2151), Beijing municipal natural science foundation, (No. 7153161), International science and technology cooperation program of China (No. 2013DFG32720).	Chen WQ, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0042-6; Cheng XJ, 2008, ANN ONCOL, V19, P527, DOI 10.1093/annonc/mdm469; Cheng XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121559; Deng Li-juan, 2005, Beijing Da Xue Xue Bao Yi Xue Ban, V37, P302; Fan MR, 2012, CANCER EPIDEMIOL, V36, P364, DOI 10.1016/j.canep.2011.12.004; Hashemi M, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0111-8; He Jing, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P348; Kasper G, 2005, CANCER LETT, V224, P93, DOI 10.1016/j.canlet.2004.10.004; Li Changlin, 2006, Zhongguo Fei Ai Za Zhi, V9, P109, DOI 10.3779/j.issn.1009-3419.2006.02.02; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li L, 2011, ANAT REC, V294, P1135, DOI 10.1002/ar.21421; Li X, 2012, ORG MED CHEM LETT, V2, P2, DOI DOI 10.1371/J0URNAL.P0NE.0044916; Liu LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118026; Liu XR, 2004, WORLD J GASTROENTERO, V10, P1555, DOI 10.3748/wjg.v10.i11.1555; Liu Y, 2007, ANN ONCOL, V18, P311, DOI 10.1093/annonc/mdl394; Maki Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep13846; Meng FL, 2015, CELL PHYSIOL BIOCHEM, V37, P890, DOI 10.1159/000430216; Meng FL, 2013, BIOMARKERS, V18, P136, DOI 10.3109/1354750X.2012.752526; Milkereit R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8250; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng C, 2005, WORLD J GASTROENTERO, V11, P2704, DOI 10.3748/wjg.v11.i18.2704; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Shao GZ, 2003, THESIS; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Tan XJ, 2015, CELL, V160, P145, DOI 10.1016/j.cell.2014.12.006; Tang H, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0974-8; Tang H, 2014, ONCOL REP, V31, P2454, DOI 10.3892/or.2014.3116; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Xu Y, 2012, JPN J CLIN ONCOL, V42, P413, DOI 10.1093/jjco/hys026; Yang H, 2012, MED ONCOL, V29, P2809, DOI 10.1007/s12032-012-0173-4; Yang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034984; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yin MZ, 2011, J SURG ONCOL, V104, P29, DOI 10.1002/jso.21912; Zhang HY, 2014, TUMOR BIOL, V35, P12737, DOI 10.1007/s13277-014-2599-0	35	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158715	10.1371/journal.pone.0158715	http://dx.doi.org/10.1371/journal.pone.0158715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391361	gold, Green Submitted, Green Published			2022-12-26	WOS:000380005400108
J	Hadler, C; Aliuos, P; Brandes, G; Warnecke, A; Bohlmann, J; Dempwolf, W; Menzel, H; Lenarz, T; Reuter, G; Wissel, K				Hadler, C.; Aliuos, P.; Brandes, G.; Warnecke, A.; Bohlmann, J.; Dempwolf, W.; Menzel, H.; Lenarz, T.; Reuter, G.; Wissel, K.			Polymer Coatings of Cochlear Implant Electrode Surface - An Option for Improving Electrode-Nerve-Interface by Blocking Fibroblast Overgrowth	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; SATELLITE GLIAL-CELLS; EXTRACELLULAR-MATRIX; ADHESION; HYDROGELS; FILMS; BONE; DEXAMETHASONE; TOPOGRAPHY; ATTACHMENT	Overgrowth of connective tissue and scar formation induced by the electrode array insertion increase the impedance and, thus, diminish the interactions between neural probes as like cochlear implants (CI) and the target tissue. Therefore, it is of great clinical interest to modify the carrier material of the electrodes to improve the electrode nerve interface for selective cell adhesion. On one side connective tissue growth needs to be reduced to avoid electrode array encapsulation, on the other side the carrier material should not compromise the interaction with neuronal cells. The present in vitro-study qualitatively and quantitatively characterises the interaction of fibroblasts, glial cells and spiral ganglion neurons (SGN) with ultrathin poly(N,N-dimethylacrylamide) (PDMAA), poly(2-ethyloxazoline) (PEtOx) and poly ([2-methacryloyloxy)ethyl]trimethylammoniumchlorid) (PMTA) films immobilised onto glass surfaces using a photoreactive anchor layer. The layer thickness and hydrophilicity of the polymer films were characterised by ellipsometric and water contact angle measurement. Moreover the topography of the surfaces was investigated using atomic force microscopy (AFM). The neuronal and non-neuronal cells were dissociated from spiral ganglions of postnatal rats and cultivated for 48 h on top of the polymer coatings. Immunocytochemical staining of neuronal and intermediary filaments revealed that glial cells predominantly attached on PMTA films, but not on PDMAA and PEtOx monolayers. Hereby, strong survival rates and neurite outgrowth were only found on PMTA, whereas PDMAA and PEtOx coatings significantly reduced the SG neuron survival and neuritogenesis. As also shown by scanning electron microscopy (SEM) SGN strongly survived and retained their differentiated phenotype only on PMTA. In conclusion, survival and neuritogenesis of SGN may be associated with the extent of the glial cell growth. Since PMTA was the only of the polar polymers used in this study bearing a cationic charge, it can be assumed that this charge favours adhesion of both glial cells and SG neurons glial cells and SGN.	[Aliuos, P.; Warnecke, A.; Bohlmann, J.; Lenarz, T.; Reuter, G.; Wissel, K.] Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany; [Hadler, C.; Dempwolf, W.; Menzel, H.] Univ Technol Braunschweig, Inst Tech Chem, Braunschweig, Germany; [Aliuos, P.; Warnecke, A.; Lenarz, T.] Cluster Excellence Hearing 4 All, Hannover, Germany; [Brandes, G.] Hannover Med Sch, Inst Cell Biol, Ctr Anat, Hannover, Germany	Hannover Medical School; Braunschweig University of Technology; Hannover Medical School	Wissel, K (corresponding author), Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany.	Wissel.Kirsten@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022; Menzel, Henning/AAZ-6446-2020		Deutsche Forschungsgemeinschaft [Sonderforschungsbereich (SFB) 599, SFB 599]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding by "Deutsche Forschungsgemeinschaft" as "Sonderforschungsbereich (SFB) 599", subproject D2, Speaker: TL, Reciever of funding: TL and HM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank S. Zwittian and G. Preiss, Institute of Cell Biology, Hannover Medical School for their helpful support. This study was funded by the Deutsche Forschungsgemeinschaft (SFB 599, subproject D2).	Adden N, 2007, J BIOMAT SCI-POLYM E, V18, P303, DOI 10.1163/156856207779996896; Aliuos P, 2014, J BIOMED MATER RES A, V102, P117, DOI 10.1002/jbm.a.34686; Aliuos P, 2013, J BIOMED MATER RES A, V101, P981, DOI 10.1002/jbm.a.34401; Bacakova L, 2011, BIOTECHNOL ADV, V29, P739, DOI 10.1016/j.biotechadv.2011.06.004; Bauer M, 2012, MACROMOL BIOSCI, V12, P986, DOI 10.1002/mabi.201200017; Berkingali N, 2008, HEARING RES, V243, P121, DOI 10.1016/j.heares.2008.07.003; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bettinger CJ, 2009, ANGEW CHEM INT EDIT, V48, P5406, DOI 10.1002/anie.200805179; Bohl A, 2012, J MATER SCI-MATER M, V23, P2151, DOI 10.1007/s10856-012-4698-z; Brammer KS, 2012, TRENDS BIOTECHNOL, V30, P315, DOI 10.1016/j.tibtech.2012.02.005; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; Burridge K, 2001, CURR OPIN CELL BIOL, V13, P525, DOI 10.1016/S0955-0674(00)00246-5; Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644; Cai L, 2012, BIOMACROMOLECULES, V13, P342, DOI 10.1021/bm201763n; Chang BJ, 2002, COLLOID SURFACE A, V198, P519, DOI 10.1016/S0927-7757(01)00952-9; Chen YM, 2014, J BIOMED MATER RES A, V102, P2258, DOI 10.1002/jbm.a.34904; Clark G M, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P40; Clark GM, 2014, COCHLEAR IMPLANTS IN, V15, P1; COLEMAN DL, 1974, J BIOMED MATER RES, V8, P199, DOI 10.1002/jbm.820080503; Dadsetan M, 2009, BIOMATERIALS, V30, P3874, DOI 10.1016/j.biomaterials.2009.04.018; Dahm M, 2001, ANN THORAC SURG, V71, pS437, DOI 10.1016/S0003-4975(01)02513-9; Dalby Matthew J, 2007, Curr Stem Cell Res Ther, V2, P129, DOI 10.2174/157488807780599220; Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7; DUCKERT LG, 1983, LARYNGOSCOPE, V93, P841; Eshraghi AA, 2006, ANAT REC PART A, V288A, P473, DOI 10.1002/ar.a.20305; FAYAD J, 1991, ANN OTO RHINOL LARYN, V100, P807, DOI 10.1177/000348949110001004; Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Furze A, 2008, ACTA OTO-LARYNGOL, V128, P122, DOI 10.1080/00016480701390128; Gebert A, 1998, J MICROSC-OXFORD, V191, P297, DOI 10.1046/j.1365-2818.1998.00380.x; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Harvey AG, 2013, EXPERT REV MED DEVIC, V10, P257, DOI [10.1586/erd.12.82, 10.1586/ERD.12.82]; Hickok NJ, 2012, ADV DRUG DELIVER REV, V64, P1165, DOI 10.1016/j.addr.2012.03.015; Hirose M, 2000, BIOMACROMOLECULES, V1, P377, DOI 10.1021/bm0002961; Hu YF, 2014, INT J PHARMACEUT, V476, P31, DOI 10.1016/j.ijpharm.2014.09.029; Huang Christie Qi, 2007, Cochlear Implants Int, V8, P123, DOI 10.1002/cii.336; Hutten M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104564; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Kim S, 2009, ACTA BIOMATER, V5, P144, DOI 10.1016/j.actbio.2008.07.033; Kronek J, 2011, J MATER SCI-MATER M, V22, P1725, DOI 10.1007/s10856-011-4346-z; LEE JH, 1993, J BIOMAT SCI-POLYM E, V4, P467; Lefebvre PP, 2002, AUDIOL NEURO-OTOL, V7, P165, DOI 10.1159/000058304; Lenarz Thomas, 2006, Audiol Neurootol, V11 Suppl 1, P34, DOI 10.1159/000095612; Liu W, 2014, CELL TISSUE RES, V355, P267, DOI 10.1007/s00441-013-1735-2; Liu YL, 2010, J R SOC INTERFACE, V7, pS631, DOI 10.1098/rsif.2010.0115.focus; Loizou PC, 2003, J ACOUST SOC AM, V114, P475, DOI 10.1121/1.1582861; Loschonsky S, 2008, BIOMACROMOLECULES, V9, P543, DOI 10.1021/bm7010714; Nadol JB, 2004, OTOL NEUROTOL, V25, P257, DOI 10.1097/00129492-200405000-00010; Paasche G, 2006, OTOL NEUROTOL, V27, P639, DOI 10.1097/01.mao.0000227662.88840.61; Pandiyarajan CK, 2013, MACROMOL BIOSCI, V13, P873, DOI 10.1002/mabi.201200445; Prucker O, 1999, J AM CHEM SOC, V121, P8766, DOI 10.1021/ja990962+; Reich U, 2008, J BIOMED MATER RES B, V87B, P146, DOI 10.1002/jbm.b.31084; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Ruhe J, 1999, J BIOMAT SCI-POLYM E, V10, P859, DOI 10.1163/156856299X00928; Samuel JDJS, 2004, LANGMUIR, V20, P10080, DOI 10.1021/la049428s; Schlie S, 2010, J BIOMATER APPL, V25, P217, DOI 10.1177/0885328209345553; Schmidt W, 2013, CURR PHARM BIOTECHNO, V14, P98; Somdas MA, 2007, AUDIOL NEURO-OTOL, V12, P277, DOI 10.1159/000103208; Sosnik A, 2005, J BIOMED MATER RES A, V75A, P295, DOI 10.1002/jbm.a.30419; TAMADA Y, 1994, J BIOMED MATER RES, V28, P783, DOI 10.1002/jbm.820280705; Tan F, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/5/055009; Tauhardt L, 2013, CHEM SOC REV, V42, P7998, DOI 10.1039/c3cs60161g; Tong J, 2011, BIOMATERIALS, V32, P3654, DOI 10.1016/j.biomaterials.2011.01.068; Treharne AJ, 2012, J BIOMED MATER RES A, V100A, P2358, DOI 10.1002/jbm.a.34178; Tykocinski M, 2001, OTOL NEUROTOL, V22, P33, DOI 10.1097/00129492-200101000-00007; Wang H, 2011, ACS APPL MATER INTER, V3, P3463, DOI 10.1021/am200690s; Wang X, 2011, ACTA BIOMATER, V7, P4149, DOI 10.1016/j.actbio.2011.07.011; Wardrop P, 2005, HEARING RES, V203, P54, DOI 10.1016/j.heares.2004.11.006; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Whitilon DS, 2009, NEUROSCIENCE, V161, P227, DOI 10.1016/j.neuroscience.2009.03.044; Wilkinson CDW, 2002, MAT SCI ENG C-BIO S, V19, P263, DOI 10.1016/S0928-4931(01)00396-4; Wise SG, 2009, INT J BIOCHEM CELL B, V41, P494, DOI 10.1016/j.biocel.2008.03.017; Wrzeszcz A, 2014, J BIOMED MATER RES A, V102, P442, DOI 10.1002/jbm.a.34719; Xu J, 1997, HEARING RES, V105, P1, DOI 10.1016/S0378-5955(96)00193-1; Zasonska BA, 2013, J BIOMED NANOTECHNOL, V9, P479, DOI 10.1166/jbn.2013.1552; Zhang QY, 2014, ACTA BIOMATER, V10, P1167, DOI 10.1016/j.actbio.2013.12.017	79	11	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0157710	10.1371/journal.pone.0157710	http://dx.doi.org/10.1371/journal.pone.0157710			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391483	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400019
J	Liu, LY; Mao, Z; Zhang, JH; Liu, N; Liu, QH				Liu, Linying; Mao, Zheng; Zhang, Jianhua; Liu, Na; Liu, Qing Huo			The Influence of Vesicle Shape and Medium Conductivity on Possible Electrofusion under a Pulsed Electric Field	PLOS ONE			English	Article							HIGH TEMPORAL RESOLUTION; CELL ELECTROFUSION; SPHEROIDAL CELLS; MEMBRANE-FUSION; GIANT VESICLES; MODEL; ELECTROPORATION; DEFORMATION; ORIENTATION; VACCINES	The effects of electric field on lipid membrane and cells have been extensively studied in the last decades. The phenomena of electroporation and electrofusion are of particular interest due to their wide use in cell biology and biotechnology. However, numerical studies on the electrofusion of cells (or vesicles) with different deformed shapes are still rare. Vesicle, being of cell size, can be treated as a simple model of cell to investigate the behaviors of cell in electric field. Based on the finite element method, we investigate the effect of vesicle shape on electrofusion of contact vesicles in various medium conditions. The transmembrane voltage (TMV) and pore density induced by a pulsed field are examined to analyze the possibility of vesicle fusion. In two different medium conditions, the prolate shape is observed to have selective electroporation at the contact area of vesicles when the exterior conductivity is smaller than the interior one; selective electroporation is more inclined to be found at the poles of the oblate vesicles when the exterior conductivity is larger than the interior one. Furthermore, we find that when the exterior conductivity is lower than the internal conductivity, the pulse can induce a selective electroporation at the contact area between two vesicles regardless of the vesicle shape. Both of these two findings have important practical applications in guiding electrofusion experiments.	[Liu, Linying; Mao, Zheng; Zhang, Jianhua; Liu, Na; Liu, Qing Huo] Xiamen Univ, Inst Electromagnet & Acoust, Xiamen 361005, Peoples R China; [Liu, Linying; Mao, Zheng; Zhang, Jianhua; Liu, Na; Liu, Qing Huo] Xiamen Univ, Dept Elect Sci, Xiamen 361005, Peoples R China; [Liu, Qing Huo] Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA	Xiamen University; Xiamen University; Duke University	Zhang, JH; Liu, QH (corresponding author), Xiamen Univ, Inst Electromagnet & Acoust, Xiamen 361005, Peoples R China.; Zhang, JH; Liu, QH (corresponding author), Xiamen Univ, Dept Elect Sci, Xiamen 361005, Peoples R China.; Liu, QH (corresponding author), Duke Univ, Dept Elect & Comp Engn, Durham, NC 27708 USA.	jhzh@xmu.edu.cn; qhliu@duke.edu	Liu, Qing/GWC-9222-2022; Liu, Qing Huo/AFO-6814-2022; Liu, Qing Huo/AFR-9899-2022	Liu, Qing Huo/0000-0001-5286-4423; Liu, Qing Huo/0000-0001-5286-4423	China Postdoctoral Science Foundation [2012M511447]; National Natural Science Foundation of China [11204257]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by China Postdoctoral Science Foundation (No. 2012M511447) and National Natural Science Foundation of China (No. 11204257). The funder (JZ) designed the experiments and analyzed the data and modified the paper.	ASENCOR FJ, 1993, BIOPHYS J, V64, P1626, DOI 10.1016/S0006-3495(93)81509-1; Batzing BL, 2002, MICROBIOLOGY AN INTR; Chang D.C., 1992, GUIDE ELECTROPORATIO; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; DeBruin KA, 1999, BIOPHYS J, V77, P1213, DOI 10.1016/S0006-3495(99)76973-0; Dimitrov V, 2013, PHYS CHEM CHEM PHYS, V15, P6303, DOI 10.1039/c3cp42873g; Dimova R, 2007, SOFT MATTER, V3, P817, DOI 10.1039/b703580b; Dimova R, 2009, SOFT MATTER, V5, P3201, DOI 10.1039/b901963d; Gantz DL, 1999, BIOPHYS J, V76, P1436, DOI 10.1016/S0006-3495(99)77304-2; Gimsa J, 2001, BIOPHYS J, V81, P1888, DOI 10.1016/S0006-3495(01)75840-7; Haluska CK, 2006, P NATL ACAD SCI USA, V103, P15841, DOI 10.1073/pnas.0602766103; HELFRICH W, 1974, Z NATURFORSCH C, VC 29, P510; Hu Q, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.011901; Hu Q, 2009, IEEE T BIO-MED ENG, V56, P1617, DOI 10.1109/TBME.2009.2015459; Kanduser M, 2014, EXPERT OPIN DRUG DEL, V11, P1885, DOI 10.1517/17425247.2014.938632; Kotnik T, 2000, BIOPHYS J, V79, P670, DOI 10.1016/S0006-3495(00)76325-9; Kotnik T, 2013, PHYS LIFE REV, V10, P351, DOI 10.1016/j.plrev.2013.05.001; Li JB, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3324847; Maswiwat K, 2007, J PHYS D APPL PHYS, V40, P914, DOI 10.1088/0022-3727/40/3/033; MM S, 2011, PHYSICAL REVIEW E ST, V83, P557; NEEDHAM D, 1989, BIOPHYS J, V55, P1001, DOI 10.1016/S0006-3495(89)82898-X; Nesin OM, 2011, BBA-BIOMEMBRANES, V1808, P792, DOI 10.1016/j.bbamem.2010.12.012; Nganguia H, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052718; Pucihar G, 2006, ANN BIOMED ENG, V34, P642, DOI 10.1007/s10439-005-9076-2; Pucihar G, 2012, IFMBE PROC, V37, P1326; Pucihar G, 2009, IEEE T BIO-MED ENG, V56, P1491, DOI 10.1109/TBME.2009.2014244; Radu M, 2005, BIOPHYS J, V89, P3548, DOI 10.1529/biophysj.104.057463; Rems L., 2014, 13 MED C MED BIOL EN, V41, P896; Rems L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03382; Riske KA, 2005, BIOPHYS J, V88, P1143, DOI 10.1529/biophysj.104.050310; Riske Karin. A., 2006, Biophysical Reviews and Letters, V1, P387, DOI 10.1142/S179304800600032X; Salipante PF, 2014, SOFT MATTER, V10, P3386, DOI 10.1039/c3sm52870g; Smith KC, 2008, BIOPHYS J, V95, P1547, DOI 10.1529/biophysj.107.121921; Strioga MM, 2013, CRIT REV IMMUNOL, V33, P489; SUGAR IP, 1987, BIOPHYS CHEM, V26, P321, DOI 10.1016/0301-4622(87)80033-9; Techaumnat B, 2013, IEEE T DIELECT EL IN, V20, P1567, DOI 10.1109/TDEI.2013.6633685; TEISSIE J, 1986, BIOCHEM BIOPH RES CO, V140, P258, DOI 10.1016/0006-291X(86)91084-3; Trontelj K, 2008, BIOELECTROCHEMISTRY, V74, P124, DOI 10.1016/j.bioelechem.2008.06.003; Vacchelli E, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.25595; Vlahovska PM, 2009, BIOPHYS J, V96, P4789, DOI 10.1016/j.bpj.2009.03.054; vor dem Esche U, 2011, IMMUNOBIOLOGY, V216, P847, DOI 10.1016/j.imbio.2010.12.001; Xiao M, 1996, BIOELECTROCH BIOENER, V41, P161, DOI 10.1016/S0302-4598(96)05100-8; Zimmermann U, 1986, REV PHYSL BIOCH PHAR, V105, P175; Zimmermann U., 1996, ELECTROMANIPULATION	44	15	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158739	10.1371/journal.pone.0158739	http://dx.doi.org/10.1371/journal.pone.0158739			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391692	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400111
J	Weber, SN; Bohner, A; Dapito, DH; Schwabe, RF; Lammert, F				Weber, Susanne Nicole; Bohner, Annika; Dapito, Dianne H.; Schwabe, Robert F.; Lammert, Frank			TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; P-GLYCOPROTEIN GENE; HOMOZYGOUS DISRUPTION; LIPOPOLYSACCHARIDE; ACTIVATION; MICE; POLYMORPHISMS; CHOLANGITIS; MOLECULES; DISEASE	Background The development of hepatocellular carcinoma (HCC) is a common consequence of advanced liver fibrosis but the interactions between fibrogenesis and carcinogenesis are still poorly understood. Recently it has been shown that HCC promotion depends on Tolllike receptor (TLR) 4. Pre-cancerogenous events can be modelled in mice by the administration of a single dose of diethylnitrosamine (DEN), with HCC formation depending amongst others on interleukin (IL) 6 production. Mice lacking the hepatocanalicular phosphatidylcholine transporter ABCB4 develop liver fibrosis spontaneously, resemble patients with sclerosing cholangitis due to mutations of the orthologous human gene, and represent a valid model to study tumour formation in pre-injured cholestatic liver. The aim of this study was to investigate DEN-induced liver injury in TLR4-deficient mice with biliary fibrosis. Methods ABCB4-deficient mice on the FVB/NJ genetic background were crossed to two distinct genetic backgrounds (TLR4-sufficient C3H/HeN and TLR4-deficient C3H/HeJ) for more than 10 generations. The two congenic knockout and the two corresponding wild-type mouse lines were treated with a single dose of DEN for 48 hours. Phenotypic differences were assessed by measuring hepatic collagen contents, inflammatory markers (ALT, CRP, IL6) as well as hepatic apoptosis (TUNEL) and proliferation (Ki67) rates. Results Hepatic collagen accumulation is significantly reduced in ABCB4(-/-): TLR4(-/-)double-deficient mice. After DEN challenge, apoptosis, proliferation and inflammatory markers are decreased in TLR4-deficient in comparison to TLR4-sufficient mice. When combining ABCB4 and TLR4 deficiency with DEN treatment, hepatic IL6 expression and proliferation rates are lowest in fibrotic livers from the double-deficient line. Consistent with these effects, selective digestive tract decontamination in ABCB4(-/-) mice also led to reduced tumor size and number after DEN. Conclusion This study demonstrates that liver injury upon DEN challenge depends on pre-existing fibrosis and genetic background. The generation of ABCB4(-/): TLR4(-/-) double-deficient mice illustrates that TLR4-deficiency protects against hepatic injury in a preclinical mouse model of chronic liver disease.	[Weber, Susanne Nicole; Bohner, Annika; Lammert, Frank] Univ Saarland, Med Ctr, Dept Med 2, Homburg, Germany; [Dapito, Dianne H.; Schwabe, Robert F.] Columbia Univ, Dept Med, New York, NY USA	Saarland University; Columbia University	Lammert, F (corresponding author), Univ Saarland, Med Ctr, Dept Med 2, Homburg, Germany.	frank.lammert@uks.eu	Schwabe, Robert/AAY-6506-2021		local HOMFOR programme	local HOMFOR programme	The study was funded by the local HOMFOR programme (http://www.uniklinikum-saarland.de/forschung/homfor) to SNW.	Agundez JA, 2012, ONCOLOGY-BASEL, V82, P35, DOI 10.1159/000335606; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Fox JG, 2010, GUT, V59, P88, DOI 10.1136/gut.2009.183749; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada K, 2003, LAB INVEST, V83, P1657, DOI 10.1097/01.LAB.0000097190.56734.FE; Hillebrandt S, 2002, GASTROENTEROLOGY, V123, P2041, DOI 10.1053/gast.2002.37069; Hochrath K, 2012, FASEB J, V26, P5081, DOI 10.1096/fj.12-209379; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; Katzenellenbogen M, 2007, MOL CANCER RES, V5, P1159, DOI 10.1158/1541-7786.MCR-07-0172; Kitamoto T, 2013, HUM GENET, V132, P783, DOI 10.1007/s00439-013-1294-3; Kluwe J, 2009, J MOL MED, V87, P125, DOI 10.1007/s00109-008-0426-z; Liu SB, 2002, INFECT IMMUN, V70, P3433, DOI 10.1128/IAI.70.7.3433-3442.2002; MAUAD TH, 1994, AM J PATHOL, V145, P1237; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Patin E, 2012, GASTROENTEROLOGY, V143, P1244, DOI 10.1053/j.gastro.2012.07.097; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Potikha T, 2013, HEPATOLOGY, V58, P192, DOI 10.1002/hep.26335; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Roderfeld M, 2010, WORLD J HEPATOL, V2, P175, DOI 10.4254/wjh.v2.i5.175; Rogers AB, 2011, GUT MICROBES, V2, P52, DOI 10.4161/gmic.2.1.14761; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Su GL, 2000, HEPATOLOGY, V31, P932, DOI 10.1053/he.2000.5634; Szabo G, 2006, HEPATOLOGY, V44, P287, DOI 10.1002/hep.21308; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332; Weber S, 2008, CLIN LIVER DIS, V12, P747, DOI 10.1016/j.cld.2008.07.012; Yu LX, 2010, HEPATOLOGY, V52, P1322, DOI 10.1002/hep.23845	38	17	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158819	10.1371/journal.pone.0158819	http://dx.doi.org/10.1371/journal.pone.0158819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391331	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400134
J	Facciuolo, A; Gonzalez-Cano, P; Napper, S; Griebel, PJ; Mutharia, LM				Facciuolo, Antonio; Gonzalez-Cano, Patricia; Napper, Scott; Griebel, Philip J.; Mutharia, Lucy M.			Marked Differences in Mucosal Immune Responses Induced in Ileal versus Jejunal Peyer's Patches to Mycobacterium avium subsp paratuberculosis Secreted Proteins following Targeted Enteric Infection in Young Calves	PLOS ONE			English	Article							ANTIBODY-RESPONSE; LYMPHOID-TISSUE; JOHNES-DISEASE; T-CELLS; SHEEP; ANTIGENS; CATTLE; MACROPHAGES; MECHANISMS; GUT	In cattle, Mycobacterium avium subsp. paratuberculosis infection is primarily mediated through M cells overlying Peyer's patches (PP) in the ileum. The capacity of M. avium subsp. paratuberculosis to invade ileal PP (IPP) versus discrete PP in the jejunum (JPP) and subsequent differences in mucosal immune responses were investigated. Intestinal segments were surgically prepared in both mid-jejunum, containing two JPPs, and in terminal small intestine containing continuous IPP. M. avium subsp. paratuberculosis (10(9) CFU) was injected into the lumen of half of each intestinal segment when calves were 10-14 days-old and infection confirmed 1-2 months later by PCR and immunohistochemistry. Thirteen recombinant M. avium subsp. paratuberculosis proteins, previously identified as immunogenic, were used to analyze pathogen-specific B-and T-cell responses in PP and mesenteric lymph nodes. IgA plasma cell responses to 9 of 13 recombinant proteins were detected in JPP but not in IPP. Secretory IgA reacting in ELISA with 9 of the 13 recombinant proteins was detected in luminal contents from both jejunal and ileal segments. These observations support the conclusion that pathogen-specific IgA B cells were induced in JPP but not IPP early after a primary infection. The presence of secretory IgA in intestinal contents is consistent with dissemination of IgA plasma cells from the identified mucosa-associated immune induction sites. This is the first direct evidence for M. avium subsp. paratuberculosis uptake by bovine JPP and for local induction of pathogen-specific IgA plasma cell responses after enteric infection. We also provide evidence that bacterial invasion of IPP, a primary B lymphoid tissue, provides a novel strategy to evade induction of mucosal immune responses. Over 60% of PPs in the newborn calf small intestine is primary lymphoid tissue, which has significant implications when designing oral vaccines or diagnostic tests to detect early M. avium subsp. paratuberculosis infections.	[Facciuolo, Antonio; Mutharia, Lucy M.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Gonzalez-Cano, Patricia; Napper, Scott; Griebel, Philip J.] Univ Saskatchewan, VIDO InterVac, Saskatoon, SK, Canada; [Napper, Scott] Univ Saskatchewan, Dept Biochem, Saskatoon, SK, Canada; [Griebel, Philip J.] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada	University of Guelph; University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Mutharia, LM (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON, Canada.	lmuthari@uoguelph.ca		Facciuolo, Antonio/0000-0003-4551-9386	AAFC Growing Forward 2 Cluster - Beef Cattle Research Council [ANH.01.13]; Tier I CRC in Neonatal Mucosal Immunology [950-231111]	AAFC Growing Forward 2 Cluster - Beef Cattle Research Council; Tier I CRC in Neonatal Mucosal Immunology	This work was supported by the AAFC Growing Forward 2 Cluster - Beef Cattle Research Council (http://www.beefresearch.ca/) Grant # ANH.01.13 to LMM and PJG. PJG is funded by a Tier I CRC in Neonatal Mucosal Immunology provided by Canada Institutes for Health Research (CIHR) (www.cihr-irsc.gc.ca/e/193.html) Grant # 950-231111. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitorabi MA, 1996, J IMMUNOL, V156, P3111; Allen AJ, 2009, CLIN VACCINE IMMUNOL, V16, P453, DOI 10.1128/CVI.00347-08; Arsenault RJ, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-54; Bannantine JP, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-5; Begg DJ, 2015, VET IMMUNOL IMMUNOP, V166, P125, DOI 10.1016/j.vetimm.2015.06.011; Benedictus A, 2008, PREV VET MED, V83, P215, DOI 10.1016/j.prevetmed.2007.07.008; Charavaryamath C, 2013, CLIN VACCINE IMMUNOL, V20, P156, DOI 10.1128/CVI.00496-12; Charavaryamath C, 2011, GUT MICROBES, V2, P134, DOI 10.4161/gmic.2.3.16483; Clarke CJ, 1996, J COMP PATHOL, V114, P419, DOI 10.1016/S0021-9975(96)80017-X; Everman JL, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00058; Facciuolo A, 2013, CLIN VACCINE IMMUNOL, V20, P1783, DOI 10.1128/CVI.00380-13; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fries P, 2011, DEV COMP IMMUNOL, V35, P1038, DOI 10.1016/j.dci.2011.04.003; Gonzalez J, 2005, J COMP PATHOL, V133, P184, DOI 10.1016/j.jcpa.2005.04.007; Griebel PJ, 1996, IMMUNOL TODAY, V17, P30, DOI 10.1016/0167-5699(96)80566-4; Harris NB, 2001, CLIN MICROBIOL REV, V14, P489, DOI 10.1128/CMR.14.3.489-512.2001; Hostetter J, 2005, CLIN DIAGN LAB IMMUN, V12, P793, DOI 10.1128/CDLI.12.6.793-796.2005; Khare S, 2009, VET PATHOL, V46, P717, DOI 10.1354/vp.08-VP-0187-G-FL; Koets A, 2002, INFECT IMMUN, V70, P3856, DOI 10.1128/IAI.70.7.3856-3864.2002; Liljavirta J, 2013, MUCOSAL IMMUNOL, V6, P942, DOI 10.1038/mi.2012.132; Lindhout E, 1997, IMMUNOL TODAY, V18, P573, DOI 10.1016/S0167-5699(97)01160-2; LOWDEN S, 1992, J ANAT, V181, P209; MOMOTANI E, 1988, VET PATHOL, V25, P131, DOI 10.1177/030098588802500205; Mortier RAR, 2014, J DAIRY SCI, V97, P5558, DOI 10.3168/jds.2014-8139; MOTYKA B, 1991, EUR J IMMUNOL, V21, P1951, DOI 10.1002/eji.1830210825; Mutwiri G, 1999, IMMUNOLOGY, V97, P455, DOI 10.1046/j.1365-2567.1999.00791.x; PARSONS KR, 1989, VET PATHOL, V26, P396, DOI 10.1177/030098588902600505; Ponnusamy D, 2013, RES VET SCI, V94, P306, DOI 10.1016/j.rvsc.2012.09.023; REYNAUD CA, 1995, CELL, V80, P115, DOI 10.1016/0092-8674(95)90456-5; Secott TE, 2004, INFECT IMMUN, V72, P3724, DOI 10.1128/IAI.72.7.3724-3732.2004; Sigurdardottir OG, 2001, VET PATHOL, V38, P184, DOI 10.1354/vp.38-2-184; Waters WR, 2003, INFECT IMMUN, V71, P5130, DOI 10.1128/IAI.71.9.5130-5138.2003; Wu CW, 2007, INFECT IMMUN, V75, P2110, DOI 10.1128/IAI.01739-06; Yasuda M, 2006, VET RES, V37, P401, DOI 10.1051/vetres:2006008; Yasuda M, 2004, DEV COMP IMMUNOL, V28, P357, DOI 10.1016/j.dci.2003.09.013	35	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158747	10.1371/journal.pone.0158747	http://dx.doi.org/10.1371/journal.pone.0158747			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387969	gold, Green Published, Green Submitted			2022-12-26	WOS:000379811500040
J	Gigante, ED; Benaliouad, F; Zamora-Olivencia, V; Wise, RA				Gigante, Eduardo D.; Benaliouad, Faiza; Zamora-Olivencia, Veronica; Wise, Roy A.			Optogenetic Activation of a Lateral Hypothalamic-Ventral Tegmental Drive-Reward Pathway	PLOS ONE			English	Article							MEDIAL FOREBRAIN-BUNDLE; BRAIN-STIMULATION REWARD; SELF-STIMULATION; ELECTRICAL-STIMULATION; REFRACTORY PERIODS; PREOPTIC AREA; RAT; DOPAMINE; SEEKING; FIBERS	Electrical stimulation of the lateral hypothalamus can motivate feeding or can serve as a reward in its own right. It remains unclear whether the same or independent but anatomically overlapping circuitries mediate the two effects. Electrical stimulation findings implicate medial forebrain bundle (MFB) fibers of passage in both effects, and optogenetic studies confirm a contribution from fibers originating in the lateral hypothalamic area and projecting to or through the ventral tegmental area. Here we report that optogenetic activation of ventral tegmental fibers from cells of origin in more anterior or posterior portions of the MFB failed to induce either reward or feeding. The feeding and reward induced by optogenetic activation of fibers from the lateral hypothalamic cells of origin were influenced similarly by variations in stimulation pulse width and pulse frequency, consistent with the hypothesis of a common substrate for the two effects. There were, however, several cases where feeding but not self-stimulation or self-stimulation but not feeding were induced, consistent with the hypothesis that distinct but anatomically overlapping systems mediate the two effects. Thus while optogenetic stimulation provides a more selective tool for characterizing the mechanisms of stimulation-induced feeding and reward, it does not yet resolve the question of common or independent substrates.	[Gigante, Eduardo D.; Benaliouad, Faiza; Zamora-Olivencia, Veronica; Wise, Roy A.] NIDA, Intramural Res Program, NIH, Dept Hlth & Human Serv, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Wise, RA (corresponding author), NIDA, Intramural Res Program, NIH, Dept Hlth & Human Serv, Baltimore, MD 21224 USA.	rwise@intra.nida.nih.gov	Gigante, Eduardo/AAK-8556-2020; Core, Vector/CAF-4832-2022	Gigante, Eduardo/0000-0002-1486-5377; 	Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000471] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by the Intramural Research Program of the National Institute on Drug Abuse, National Institutes of Health.	ANAND BK, 1951, P SOC EXP BIOL MED, V77, P323, DOI 10.3181/00379727-77-18766; BALL GG, 1970, PHYSIOL BEHAV, V5, P1343, DOI 10.1016/0031-9384(70)90118-6; Barbano MF, 2016, J NEUROSCIE IN PRESS; BIELAJEW C, 1982, PHYSIOL BEHAV, V28, P125, DOI 10.1016/0031-9384(82)90113-5; Bielajew C, 2001, BEHAV NEUROSCI, V115, P900, DOI 10.1037/0735-7044.115.4.900; BIELAJEW C, 1986, J NEUROSCI, V6, P919; BISHOP MP, 1963, SCIENCE, V140, P394, DOI 10.1126/science.140.3565.394; BOWER GH, 1958, J COMP PHYSIOL PSYCH, V51, P669, DOI 10.1037/h0038925; Bushnik T, 2000, BRAIN RES, V881, P103, DOI 10.1016/S0006-8993(00)02564-6; CROW TJ, 1971, EXPERIENTIA, V27, P662, DOI 10.1007/BF02136947; Geisler S, 2007, J NEUROSCI, V27, P5730, DOI 10.1523/JNEUROSCI.0012-07.2007; Geisler S, 2006, EUR J NEUROSCI, V24, P116, DOI 10.1111/j.1460-9568.2006.04928.x; Geisler S, 2008, REV NEUROSCIENCE, V19, P227; GLICKMAN SE, 1967, PSYCHOL REV, V74, P81, DOI 10.1037/h0024290; GRATTON A, 1988, BRAIN RES, V438, P264, DOI 10.1016/0006-8993(88)91345-5; GRATTON A, 1988, BRAIN RES, V438, P256, DOI 10.1016/0006-8993(88)91344-3; GRATTON A, 1983, BRAIN RES, V274, P25, DOI 10.1016/0006-8993(83)90518-8; HOEBEL BG, 1962, SCIENCE, V135, P375, DOI 10.1126/science.135.3501.375; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jennings JH, 2015, CELL, V160, P516, DOI 10.1016/j.cell.2014.12.026; Jennings JH, 2013, SCIENCE, V341, P1517, DOI 10.1126/science.1241812; Kempadoo KA, 2013, J NEUROSCI, V33, P7618, DOI 10.1523/JNEUROSCI.2588-12.2013; MARGULES DL, 1962, SCIENCE, V135, P374, DOI 10.1126/science.135.3501.374; MENDELSON J, 1973, BEHAV BIOL, V8, P619, DOI 10.1016/S0091-6773(73)80147-6; MICCO DJ, 1974, BRAIN RES, V75, P172, DOI 10.1016/0006-8993(74)90780-X; MORGANE PJ, 1961, NATURE, V191, P672, DOI 10.1038/191672a0; Nieh EH, 2015, CELL, V160, P528, DOI 10.1016/j.cell.2015.01.003; NIEUWENHUYS R, 1982, J COMP NEUROL, V206, P49, DOI 10.1002/cne.902060106; OLDS J, 1956, SCI AM, V195, P105, DOI 10.1038/scientificamerican1056-105; OLDS ME, 1963, J COMP NEUROL, V120, P259, DOI 10.1002/cne.901200206; Paxinos G., 2013, RAT BRAIN STEREOTAXI; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; ROBERTS WW, 1958, J COMP PHYSIOL PSYCH, V51, P391, DOI 10.1037/h0042900; ROUTTENB.A, 1969, J COMP PHYSIOL PSYCH, V68, P22, DOI 10.1037/h0027655; SHIZGAL P, 1980, J COMP PHYSIOL PSYCH, V94, P227, DOI 10.1037/h0077668; SOPER W Y, 1971, T.-I.-T. (Tower International Technomedical) Journal of Life Sciences, V1, P79; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; VALENSTEIN ES, 1970, PSYCHOL REV, V77, P16, DOI 10.1037/h0028581; VEENING JG, 1982, J COMP NEUROL, V206, P82, DOI 10.1002/cne.902060107; Wang H, 2007, P NATL ACAD SCI USA, V104, P8143, DOI 10.1073/pnas.0700384104; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1971, PHYSIOL BEHAV, V6, P569, DOI 10.1016/0031-9384(71)90207-1; WISE RA, 1974, BRAIN RES, V67, P187, DOI 10.1016/0006-8993(74)90272-8; Wise RA, 2013, BIOL PSYCHIAT, V73, P819, DOI 10.1016/j.biopsych.2012.09.001; YEOMANS JS, 1988, BRAIN RES, V450, P86, DOI 10.1016/0006-8993(88)91547-8; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; ZIGMOND MJ, 1972, SCIENCE, V177, P1211	48	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158885	10.1371/journal.pone.0158885	http://dx.doi.org/10.1371/journal.pone.0158885			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387668	gold, Green Published, Green Submitted			2022-12-26	WOS:000379811500058
J	Lee, JJ; Ho, CY; Chen, HJ; Huang, N; Yeh, JC; deFerranti, S				Lee, Jason Jiunshiou; Ho, ChinYu; Chen, Hsin-Jen; Huang, Nicole; Yeh, Jade Chienyu; deFerranti, Sarah			Is the 90th Percentile Adequate? The Optimal Waist Circumference Cutoff Points for Predicting Cardiovascular Risks in 124,643 15-Year-Old Taiwanese Adolescents	PLOS ONE			English	Article							3RD NATIONAL-HEALTH; BODY-MASS INDEX; METABOLIC SYNDROME; CHILDREN; OBESITY; CHILDHOOD; ADULTHOOD; AMERICAN; DISEASE; BMI	Adolescent obesity has increased to alarming proportions globally. However, few studies have investigated the optimal waist circumference (WC) of Asian adolescents. This study sought to establish the optimal WC cutoff points that identify a cluster of cardiovascular risk factors (CVRFs) among 15-year-old ethnically Chinese adolescents. This study was a regional population-based study on the CVRFs among adolescents who enrolled in all the senior high schools in Taipei City, Taiwan, between 2011 and 2014. Four cross-sectional health examinations of first-year senior high school (grade 10) students were conducted from September to December of each year. A total of 124,643 adolescents aged 15 (boys: 63,654; girls: 60,989) were recruited. Participants who had at least three of five CVRFs were classified as the high-risk group. We used receiver-operating characteristic curves and the area under the curve (AUC) to determine the optimal WC cutoff points and the accuracy of WC in predicting high cardiovascular risk. WC was a good predictor for high cardiovascular risk for both boys (AUC: 0.845, 95% confidence interval [CI]: 0.833-0.857) and girls (AUC: 0.763, 95% CI: 0.731-0.795). The optimal WC cutoff points were >= 78.9 cm for boys (77th percentile) and >= 70.7 cm for girls (77th percentile). Adolescents with normal weight and an abnormal WC were more likely to be in the high cardiovascular risk group (odds ratio: 3.70, 95% CI: 2.65-5.17) compared to their peers with normal weight and normal WC. The optimal WC cutoff point of 15-year-old Taiwanese adolescents for identifying CVRFs should be the 77th percentile; the 90th percentile of the WC might be inadequate. The high WC criteria can help health professionals identify higher proportion of the adolescents with cardiovascular risks and refer them for further evaluations and interventions. Adolescents' height, weight and WC should be measured as a standard practice in routine health checkups.	[Lee, Jason Jiunshiou; Ho, ChinYu] Taipei City Hosp, Yangming Branch, Dept Family Med, Taipei, Taiwan; [Lee, Jason Jiunshiou; Chen, Hsin-Jen] Natl Yang Ming Univ, Sch Med, Dept Publ Hlth, Taipei, Taiwan; [Lee, Jason Jiunshiou; Ho, ChinYu] Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan; [Ho, ChinYu] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Ho, ChinYu] Natl Taipei Univ Nursing & Hlth Sci, Dept Leisure Ind & Hlth Promot, Taipei, Taiwan; [Huang, Nicole] Natl Yang Ming Univ, Inst Hosp & Hlth Care Adm, Taipei, Taiwan; [Yeh, Jade Chienyu] Minist Hlth & Welf, Lo Sheng Sanat & Hosp, Dept Family Med, New Taipei, Taiwan; [deFerranti, Sarah] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA	Taipei City Hospital; National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); National Yang Ming Chiao Tung University; National Taipei University of Nursing & Health Science (NTUNHS); National Yang Ming Chiao Tung University; Harvard University; Boston Children's Hospital	Ho, CY (corresponding author), Taipei City Hosp, Yangming Branch, Dept Family Med, Taipei, Taiwan.; Ho, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Hlth Care Management, Taipei, Taiwan.; Ho, CY (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan.; Ho, CY (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Leisure Ind & Hlth Promot, Taipei, Taiwan.	dag21@tpech.gov.tw	Chen, Hsin-Jen/H-8393-2014	Chen, Hsin-Jen/0000-0003-4876-634X; Lee, Jason Jiunshiou/0000-0003-3638-8492	Department of Health of Taipei City Government, Taiwan [10003-4-005, 10102-62-082, 10301-62-079]	Department of Health of Taipei City Government, Taiwan	This study was funded by grants (10003-4-005, 10102-62-082, 10301-62-079) from the Department of Health of Taipei City Government, Taiwan (http://www.health.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Anderson PJ, 2001, INT J OBESITY, V25, P1782, DOI 10.1038/sj.ijo.0801837; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bauer KW, 2015, PEDIATR OBES, V10, P329, DOI 10.1111/ijpo.267; Chen W, 2010, PEDIATR NEONATOL, V51, P69, DOI 10.1016/S1875-9572(10)60014-9; Clasey JL, 1999, OBES RES, V7, P256, DOI 10.1002/j.1550-8528.1999.tb00404.x; de Ferranti SD, 2004, CIRCULATION, V110, P2494, DOI 10.1161/01.CIR.0000145117.40114.C7; Despres J P, 2006, J Endocrinol Invest, V29, P77; Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2; Falkner B, 2004, HYPERTENSION, V43, P203, DOI 10.1161/01.HYP.0000109322.72948.24; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; Hirschler V, 2005, ARCH PEDIAT ADOL MED, V159, P740, DOI 10.1001/archpedi.159.8.740; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Katzmarzyk PT, 2011, OBESITY, V19, P1272, DOI 10.1038/oby.2010.319; Lakshman R, 2012, CIRCULATION, V126, P1770, DOI 10.1161/CIRCULATIONAHA.111.047738; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Lee SJ, 2006, J PEDIATR-US, V149, P809, DOI 10.1016/j.jpeds.2006.08.075; Leibowitz KL, 2009, INT J PEDIATR OBES, V4, P150, DOI 10.1080/17477160802596130; Maffeis C, 2001, OBES RES, V9, P179, DOI 10.1038/oby.2001.19; Ng VWS, 2007, OBESITY, V15, P494, DOI 10.1038/oby.2007.588; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Taylor SA, 2011, INT J PEDIATR OBES, V6, pE307, DOI 10.3109/17477166.2011.575149; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wofford Linda G, 2008, J Pediatr Nurs, V23, P5, DOI 10.1016/j.pedn.2007.07.006; World Health Organization, 2008, WAIST CIRCUMFERENCE; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743; Zimmet P, 2007, PEDIATR DIABETES, V8, P299, DOI 10.1111/j.1399-5448.2007.00271.x	37	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158818	10.1371/journal.pone.0158818	http://dx.doi.org/10.1371/journal.pone.0158818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389572	Green Submitted, Green Published, gold			2022-12-26	WOS:000379811500051
J	Derbre, F; Droguet, M; Leon, K; Troadec, S; Pennec, JP; Giroux-Metges, MA; Rannou, F				Derbre, Frederic; Droguet, Mickael; Leon, Karelle; Troadec, Samuel; Pennec, Jean-Pierre; Giroux-Metges, Marie-Agnes; Rannou, Fabrice			Single Muscle Immobilization Decreases Single-Fibre Myosin Heavy Chain Polymorphism: Possible Involvement of p38 and JNK MAP Kinases	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE; SOLEUS MUSCLE; GENE-EXPRESSION; SHORTENING VELOCITY; THYROID-HORMONE; SKINNED FIBERS; MESSENGER-RNA; MOTOR UNITS; BED-REST	Purpose Muscle contractile phenotype is affected during immobilization. Myosin heavy chain (MHC) isoforms are the major determinant of the muscle contractile phenotype. We therefore sought to evaluate the effects of muscle immobilization on both the MHC composition at single-fibre level and the mitogen-activated protein kinases (MAPK), a family of intracellular signaling pathways involved in the stress-induced muscle plasticity. Methods The distal tendon of female Wistar rat Peroneus Longus (PL) was cut and fixed to the adjacent bone at neutral muscle length. Four weeks after the surgery, immobilized and contralateral PL were dissociated and the isolated fibres were sampled to determine MHC composition. Protein kinase 38 (p38), extracellular signal-regulated kinases (ERK1/2), and c-Jun-NH2-terminal kinase (JNK) phosphorylations were measured in 6-and 15-day immobilized and contralateral PL. Results MHC distribution in immobilized PL was as follows: I = 0%, IIa = 11.8 +/- 2.8%, IIx = 53.0 +/- 6.1%, IIb = 35.3 +/- 7.3% and I = 6.1 +/- 3.9%, IIa = 22.1 +/- 3.4%, IIx = 46.6 +/- 4.5%, IIb = 25.2 +/- 6.6% in contralateral muscle. The MHC composition in immobilized muscle is consistent with a faster contractile phenotype according to the Hill's model of the force-velocity relationship. Immobilized and contralateral muscles displayed a polymorphism index of 31.1% (95% CI 26.1-36.0) and 39.3% (95% CI 37.0-41.5), respectively. Significant increases in p38 and JNK phosphorylation were observed following 6 and 15 days of immobilization. Conclusions Single muscle immobilization at neutral length induces a shift of MHC composition toward a faster contractile phenotype and decreases the polymorphic profile of single fibres. Activation of p38 and JNK could be a potential mechanism involved in these contractile phenotype modifications during muscle immobilization.	[Derbre, Frederic] Univ Rennes 2, Lab Movement Sport & Hlth Sci M2S, ENS Rennes, EA1274, Rennes, France; [Droguet, Mickael; Leon, Karelle; Troadec, Samuel; Pennec, Jean-Pierre; Giroux-Metges, Marie-Agnes; Rannou, Fabrice] Sch Med, Dept Physiol, EA1274 M2S, Brest, France	Ecole Normale Superieure de Rennes (ENS Rennes); Universite Rennes 2; CHU Brest; Universite de Franche-Comte	Rannou, F (corresponding author), Sch Med, Dept Physiol, EA1274 M2S, Brest, France.	fabrice.rannou@chu-brest.fr	Rannou, Fabrice/AAI-1924-2021; Derbre, Frederic/R-8776-2017	Droguet, Mickael/0000-0002-5408-8859; Derbre, Frederic/0000-0002-1531-6425				Andersen JL, 1999, J APPL PHYSIOL, V86, P455, DOI 10.1152/jappl.1999.86.2.455; Baldwin KM, 2001, J APPL PHYSIOL, V90, P345, DOI 10.1152/jappl.2001.90.1.345; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boppart MD, 2001, AM J PHYSIOL-CELL PH, V280, pC352, DOI 10.1152/ajpcell.2001.280.2.C352; Borina E, 2010, SCAND J MED SCI SPOR, V20, P65, DOI 10.1111/j.1600-0838.2009.01029.x; BOTTINELLI R, 1991, J PHYSIOL-LONDON, V437, P655, DOI 10.1113/jphysiol.1991.sp018617; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Caiozzo VJ, 2003, AM J PHYSIOL-REG I, V285, pR570, DOI 10.1152/ajpregu.00646.2002; Caiozzo VJ, 1997, AM J PHYSIOL-CELL PH, V273, pC944, DOI 10.1152/ajpcell.1997.273.3.C944; Caiozzo VJ, 1998, J APPL PHYSIOL, V85, P2237, DOI 10.1152/jappl.1998.85.6.2237; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Canepari M, 2010, SCAND J MED SCI SPOR, V20, P10, DOI 10.1111/j.1600-0838.2009.00965.x; Caron AZ, 2009, J APPL PHYSIOL, V106, P2049, DOI 10.1152/japplphysiol.91505.2008; Childs TE, 2003, AM J PHYSIOL-CELL PH, V285, pC391, DOI 10.1152/ajpcell.00478.2002; Clark BC, 2009, MED SCI SPORT EXER, V41, P1869, DOI 10.1249/MSS.0b013e3181a645a6; D'Antona G, 2003, J PHYSIOL-LONDON, V552, P499, DOI 10.1113/jphysiol.2003.046276; Derbre F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046668; Dupont E, 2011, AM J PHYSIOL-REG I, V300, pR408, DOI 10.1152/ajpregu.00793.2009; FILIPPI GM, 1994, EXP BRAIN RES, V101, P406; FISCHBACH GD, 1969, J PHYSIOL-LONDON, V201, P305, DOI 10.1113/jphysiol.1969.sp008757; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; FURBY A, 1993, MUSCLE NERVE, V16, P720, DOI 10.1002/mus.880160706; GALLER S, 1994, J PHYSIOL-LONDON, V478, P513, DOI 10.1113/jphysiol.1994.sp020270; Giroux-Metges MA, 2005, EXP NEUROL, V194, P495, DOI 10.1016/j.expneurol.2005.03.008; Glaser BW, 2010, EXP PHYSIOL, V95, P211, DOI 10.1113/expphysiol.2009.049023; Higginson J, 2002, PFLUG ARCH EUR J PHY, V445, P437, DOI 10.1007/s00424-002-0939-1; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hokari F, 2010, J APPL PHYSIOL, V109, P332, DOI 10.1152/japplphysiol.00335.2009; Jakubiec-Puka A, 1999, ACTA BIOCHIM POL, V46, P823, DOI 10.18388/abp.1999_4154; Jankala H, 1997, J APPL PHYSIOL, V82, P977, DOI 10.1152/jappl.1997.82.3.977; Kim J, 2009, KOREAN J PHYSIOL PHA, V13, P491, DOI 10.4196/kjpp.2009.13.6.491; Koh TJ, 1998, J PHYSIOL-LONDON, V508, P267, DOI 10.1111/j.1469-7793.1998.267br.x; Kostovski E, 2013, AM J PHYSIOL-ENDOC M, V305, pE1071, DOI 10.1152/ajpendo.00132.2013; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; LETERME D, 1994, PFLUG ARCH EUR J PHY, V429, P274, DOI 10.1007/BF00374323; Maffei M, 2014, ACTA PHYSIOL, V212, P316, DOI 10.1111/apha.12320; Meissner JD, 2011, NUCLEIC ACIDS RES, V39, P5907, DOI 10.1093/nar/gkr162; Murgia M, 2000, NAT CELL BIOL, V2, P142, DOI 10.1038/35004013; Narici MV, 2011, EUR J APPL PHYSIOL, V111, P403, DOI 10.1007/s00421-010-1556-x; NICKS DK, 1989, J ANAT, V163, P1; Oishi Y, 1998, ACTA PHYSIOL SCAND, V162, P127; PATTULLO MC, 1992, EXP PHYSIOL, V77, P433, DOI 10.1113/expphysiol.1992.sp003604; PETIT J, 1993, J APPL PHYSIOL, V74, P1131, DOI 10.1152/jappl.1993.74.3.1131; Porter CM, 2000, J BIOL CHEM, V275, P3543, DOI 10.1074/jbc.275.5.3543; RANATUNGA KW, 1990, J MUSCLE RES CELL M, V11, P240, DOI 10.1007/BF01843577; Rannou F, 2012, J APPL PHYSIOL, V112, P1454, DOI 10.1152/japplphysiol.00944.2011; Rannou F, 2009, J PHYSIOL-LONDON, V587, P5249, DOI 10.1113/jphysiol.2009.176446; Rannou F, 2011, J APPL PHYSIOL, V111, P495, DOI 10.1152/japplphysiol.01136.2010; Scharf M, 2013, MOL CELL BIOL, V33, P2586, DOI 10.1128/MCB.01692-12; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shi H, 2008, FASEB J, V22, P2990, DOI 10.1096/fj.07-097600; STARON RS, 1993, HISTOCHEMISTRY, V100, P149, DOI 10.1007/BF00572901; Stevens L, 1999, AM J PHYSIOL-CELL PH, V277, pC1044, DOI 10.1152/ajpcell.1999.277.6.C1044; TABARY JC, 1972, J PHYSIOL-LONDON, V224, P231, DOI 10.1113/jphysiol.1972.sp009891; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; TALMADGE RJ, 1995, J APPL PHYSIOL, V78, P1256, DOI 10.1152/jappl.1995.78.4.1256; Trappe S, 2004, J PHYSIOL-LONDON, V557, P501, DOI 10.1113/jphysiol.2004.062166; Wall BT, 2014, ACTA PHYSIOL, V210, P600, DOI 10.1111/apha.12190; Wretman C, 2000, ACTA PHYSIOL SCAND, V170, P45	60	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158630	10.1371/journal.pone.0158630	http://dx.doi.org/10.1371/journal.pone.0158630			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383612	gold, Green Submitted, Green Published			2022-12-26	WOS:000379809400068
J	Kim, KH; Yoon, HS; Yoon, H; Chung, WS; Sim, BS; Ryu, DR; Lee, DH				Kim, Kwang Hyun; Yoon, Hyun Suk; Yoon, Hana; Chung, Woo Sik; Sim, Bong Suk; Ryu, Dong-Ryeol; Lee, Dong Hyeon			Risk Factors for Developing Metabolic Acidosis after Radical Cystectomy and Ileal Neobladder	PLOS ONE			English	Article							CONTINENT URINARY-DIVERSION; RENAL-FUNCTION; ORTHOTOPIC NEOBLADDER; DIABETES-MELLITUS; LONG-TERM; BASE; COMPLICATIONS; ELECTROLYTE; BICARBONATE; PROGRESSION	Purpose To investigate the serial changes of metabolic acidosis and identify associated risk factors in patients who underwent radical cystectomy and ileal neobladder. Material and Methods From January 2010 to August 2014, 123 patients who underwent radical cystectomy and ileal neobladder reconstruction for bladder cancer were included in this study. Metabolic acidosis was defined as a serum bicarbonate level less than 22 mEq/L and impaired renal function was defined as a GFR <50ml/min. The presence of metabolic acidosis was evaluated at 1 month, 1 year, and 2 years after surgery. Multivariate logistic regression analysis was conducted to identify risk factors associated with development of metabolic acidosis. Results Metabolic acidosis was observed in 52%, 19.5%, and 7.3% of patients at 1 month, 1 year, and 2 years after surgery, respectively. At 1 month after surgery, impaired renal function was the only independent risk factor associated with metabolic acidosis (OR 3.87, P = 0.046). At 1 year after surgery, diabetes was the only independent risk factor associated with metabolic acidosis (OR 5.68, P = 0.002). At 2 years post-surgery, both age and diabetes were significant risk factors associated with metabolic acidosis. Conclusion Approximately, half of patients experienced metabolic acidosis one month after ileal neobladder reconstruction. Preoperative impaired renal function was the most significant risk factor for developing metabolic acidosis in the early postoperative period. However, the incidence of metabolic acidosis decreased to less than 20% 1 year after surgery, and diabetes was an independent risk factor during this period.	[Kim, Kwang Hyun; Yoon, Hyun Suk; Yoon, Hana; Chung, Woo Sik; Sim, Bong Suk; Lee, Dong Hyeon] Ewha Womans Univ, Sch Med, Dept Urol, Seoul, South Korea; [Ryu, Dong-Ryeol] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea	Ewha Womans University; Ewha Womans University	Lee, DH (corresponding author), Ewha Womans Univ, Sch Med, Dept Urol, Seoul, South Korea.	leedohn@ewha.ac.kr		Ryu, Dong-Ryeol/0000-0002-5309-7606; Yoon, Hyun Suk/0000-0003-1806-3539; Kim, Kwang Hyun/0000-0002-6264-5109				Ahmadi H, 2013, J UROLOGY, V189, P1782, DOI 10.1016/j.juro.2012.11.078; BARADA K, 1994, J CLIN INVEST, V93, P2725, DOI 10.1172/JCI117287; Caravaca F, 1999, AM J KIDNEY DIS, V33, P892, DOI 10.1016/S0272-6386(99)70422-1; Chen W, 2015, AM J KIDNEY DIS, V65, P240, DOI 10.1053/j.ajkd.2014.07.007; Dash RP, 2015, EUR J PHARMACOL, V767, P67, DOI 10.1016/j.ejphar.2015.10.009; Davidsson T, 1996, BRIT J UROL, V78, P64, DOI 10.1046/j.1464-410X.1996.05212.x; DEFRONZO RA, 1980, KIDNEY INT, V17, P118, DOI 10.1038/ki.1980.14; Grocela JA, 1999, UROLOGY, V54, P373, DOI 10.1016/S0090-4295(99)00095-3; Gupta A, 2014, J CLIN ONCOL, V32, P3291, DOI 10.1200/JCO.2013.54.3173; Hautmann RE, 2003, J UROLOGY, V169, P834, DOI 10.1097/01.ju.0000029010.97686.eb; Hautmann RE, 2007, UROLOGY, V69, P17, DOI 10.1016/j.urology.2006.05.058; Hautmann RE, 2013, EUR UROL, V63, P67, DOI 10.1016/j.eururo.2012.08.050; Hautmann RE, 2011, J UROLOGY, V185, P2207, DOI 10.1016/j.juro.2011.02.006; Inker LA, 2014, AM J KIDNEY DIS, V63, P713, DOI 10.1053/j.ajkd.2014.01.416; Jin XD, 2012, EUR UROL, V61, P491, DOI 10.1016/j.eururo.2011.09.004; Karet FE, 2009, J AM SOC NEPHROL, V20, P251, DOI 10.1681/ASN.2008020166; Kovesdy CP, 2012, NEPHROL DIAL TRANSPL, V27, P3056, DOI 10.1093/ndt/gfs291; Kristjansson A, 1997, J UROLOGY, V157, P2099, DOI 10.1016/S0022-5347(01)64684-6; Marangella M, 2008, BJU INT, V101, P1571, DOI 10.1111/j.1464-410X.2007.07403.x; Mills RD, 1999, J UROLOGY, V161, P1057, DOI 10.1016/S0022-5347(01)61590-8; Miyake H, 2004, INT J UROL, V11, P83, DOI 10.1111/j.1442-2042.2004.00749.x; Nam JK, 2013, YONSEI MED J, V54, P690, DOI 10.3349/ymj.2013.54.3.690; Nieuwenhuijzen JA, 2008, EUR UROL, V53, P834, DOI 10.1016/j.eururo.2007.09.008; Nyman U, 2011, SCAND J CLIN LAB INV, V71, P129, DOI 10.3109/00365513.2010.543143; Palmer BF, 2015, NEW ENGL J MED, V373, P548, DOI 10.1056/NEJMra1503102; Racioppi M, 1999, UROLOGY, V54, P629, DOI 10.1016/S0090-4295(99)00317-9; Studer UE, 2004, BJU INT, V93, P183, DOI 10.1111/j.1464-410X.2004.04641.x; Studer UE, 2006, J UROLOGY, V176, P161, DOI 10.1016/S0022-5347(06)00573-8; Thurairaja R, 2008, BJU INT, V102, P1307, DOI 10.1111/j.1464-410X.2008.07975.x; Wild GE, 1999, DIGEST DIS SCI, V44, P407, DOI 10.1023/A:1026631207219	30	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158220	10.1371/journal.pone.0158220	http://dx.doi.org/10.1371/journal.pone.0158220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384686	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400038
J	Petersen, AM; Earp, NC; Redmond, ME; Postlethwait, JH; von Hippel, FA; Buck, CL; Cresko, WA				Petersen, Ann M.; Earp, Nathanial C.; Redmond, Mandy E.; Postlethwait, John H.; von Hippel, Frank A.; Buck, C. Loren; Cresko, William A.			Perchlorate Exposure Reduces Primordial Germ Cell Number in Female Threespine Stickleback	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; GASTEROSTEUS-ACULEATUS L.; SEX-DETERMINATION; AMMONIUM-PERCHLORATE; THYROID-FUNCTION; KIDNEY HYPERTROPHY; MODEL ORGANISM; RAINBOW-TROUT; ZEBRAFISH; MECHANISMS	Perchlorate is a common aquatic contaminant that has long been known to affect thyroid function in vertebrates, including humans. More recently perchlorate has been shown to affect primordial sexual differentiation in the aquatic model fishes zebrafish and threespine stickleback, but the mechanism has been unclear. Stickleback exposed to perchlorate from fertilization have increased androgen levels in the embryo and disrupted reproductive morphologies as adults, suggesting that perchlorate could disrupt the earliest stages of primordial sexual differentiation when primordial germ cells (PGCs) begin to form the gonad. Female stickleback have three to four times the number of PGCs as males during the first weeks of development. We hypothesized that perchlorate exposure affects primordial sexual differentiation by reducing the number of germ cells in the gonad during an important window of stickleback sex determination at 14-18 days post fertilization (dpf). We tested this hypothesis by quantifying the number of PGCs at 16 dpf in control and 100 mg/L perchlorate-treated male and female stickleback. Perchlorate exposure from the time of fertilization resulted in significantly reduced PGC number only in genotypic females, suggesting that the masculinizing effects of perchlorate observed in adult stickleback may result from early changes to the number of PGCs at a time critical for sex determination. To our knowledge, this is the first evidence of a connection between an endocrine disruptor and reduction in PGC number prior to the first meiosis during sex determination. These findings suggest that a mode of action of perchlorate on adult reproductive phenotypes in vertebrates, including humans, such as altered fecundity and sex reversal or intersex gonads, may stem from early changes to germ cell development.	[Petersen, Ann M.; Earp, Nathanial C.; Redmond, Mandy E.; Cresko, William A.] Univ Oregon, Dept Biol, Inst Ecol & Evolut, Eugene, OR 97403 USA; [Postlethwait, John H.] Univ Oregon, Dept Biol, Inst Neurosci, Eugene, OR 97403 USA; [von Hippel, Frank A.; Buck, C. Loren] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86001 USA; [Buck, C. Loren] No Arizona Univ, Ctr Bioengn Innovat, Flagstaff, AZ 86001 USA; [Petersen, Ann M.] Oregon State Univ Cascades, Dept Integrat Biol, Bend, OR 97703 USA	University of Oregon; University of Oregon; Northern Arizona University; Northern Arizona University; Oregon State University; Oregon State University Cascades	Cresko, WA (corresponding author), Univ Oregon, Dept Biol, Inst Ecol & Evolut, Eugene, OR 97403 USA.	wcresko@uoregon.edu	Cresko, William/H-4010-2014	Cresko, William/0000-0002-3496-8074; Buck, Charles Loren/0000-0001-6008-7257	NIH [1RO1ES017039]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085318] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the NIH, grant number 1RO1ES017039. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Poh Kheng Loi for expertise in histology preparations, and Ruth Bremiller, Yi-Lin Yan, and Catherine Wilson for helpful discussion and technical expertise. Funding was provided by NIH grant number 1RO1ES017039. All research protocols were approved by the University of Oregon Animal Care and Use Committee (protocol #10-16R). All authors on this manuscript declare that we have no actual or potential competing financial interests.	Albertson RC, 2009, TRENDS GENET, V25, P74, DOI 10.1016/j.tig.2008.11.006; Anderson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040701; Anway MD, 2006, J ANDROL, V27, P868, DOI 10.2164/jandrol.106.000349; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Ben Hamida F, 2001, ANN ENDOCRINOL-PARIS, V62, P446; Bernhardt R, 2008, BEHAVIOUR; Bernhardt RR, 2006, ENVIRON TOXICOL CHEM, V25, P2087, DOI 10.1897/05-454R.1; Bernhardt RR, 2011, ENVIRON TOXICOL CHEM, V30, P1468, DOI 10.1002/etc.521; Birnbaum LS, 2003, ENVIRON HEALTH PERSP, V111, P389, DOI 10.1289/ehp.5686; Blount BC, 2007, J EXPO SCI ENV EPID, V17, P400, DOI 10.1038/sj.jes.7500535; Blount BC, 2006, ENVIRON HEALTH PERSP, V114, P1865, DOI 10.1289/ehp.9466; BORG B, 1993, CAN J ZOOL, V71, P2327, DOI 10.1139/z93-326; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Brent GA, 2010, J CLIN ENDOCR METAB, V95, P3154, DOI 10.1210/jc.2010-0979; Capps T, 2004, J AQUAT ANIM HEALTH, V16, P145, DOI 10.1577/H04-019.1; Carr JA, 2011, GEN COMP ENDOCR, V170, P299, DOI 10.1016/j.ygcen.2010.06.001; Cheng GJ, 2002, BIOL REPROD, V66, P77, DOI 10.1095/biolreprod66.1.77; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Crane HM, 2005, ENVIRON HEALTH PERSP, V113, P396, DOI 10.1289/ehp.7333; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dranow DB, 2013, DEV BIOL, V376, P43, DOI 10.1016/j.ydbio.2013.01.016; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Fenton SE, 2002, TOXICOL SCI, V67, P63, DOI 10.1093/toxsci/67.1.63; Furin CG, 2015, GEN COMP ENDOCR, V219, P24, DOI 10.1016/j.ygcen.2015.04.002; Furin CG, 2015, GEN COMP ENDOCR, V219, P36, DOI 10.1016/j.ygcen.2015.02.016; Gimeno S, 1996, NATURE, V384, P221, DOI 10.1038/384221a0; Goleman WL, 2002, ENVIRON TOXICOL CHEM, V21, P590, DOI 10.1897/1551-5028(2002)021<0590:ERCOAP>2.0.CO;2; Goto R, 2012, DEV BIOL, V370, P98, DOI 10.1016/j.ydbio.2012.07.010; Grandjean P, 2008, NEW ENGL J MED, V359, P1523, DOI 10.1056/NEJMc081629; Griffiths R, 2000, J FISH BIOL, V57, P1331, DOI 10.1111/j.1095-8649.2000.tb00490.x; Hahlbeck E, 2004, AQUAT TOXICOL, V70, P311, DOI 10.1016/j.aquatox.2004.10.004; Hahlbeck E, 2004, AQUAT TOXICOL, V70, P287, DOI 10.1016/j.aquatox.2004.10.003; HAMAGUCHI S, 1982, CELL TISSUE RES, V227, P139; HERPIN A, 2007, BMC DEV BIOL, V7; Herpin A, 2009, MOL CELL ENDOCRINOL, V306, P51, DOI 10.1016/j.mce.2009.02.004; Iguchi T, 2001, HORM BEHAV, V40, P248, DOI 10.1006/hbeh.2001.1675; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Kirk AB, 2006, ANAL CHIM ACTA, V567, P4, DOI 10.1016/j.aca.2006.03.047; Kobayashi T, 2004, MOL REPROD DEV, V67, P91, DOI 10.1002/mrd.20003; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; Lewis ZR, 2008, J MORPHOL, V269, P909, DOI 10.1002/jmor.10608; Lokman PM, 2007, REPRODUCTION, V133, P955, DOI 10.1530/REP-06-0229; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Merlet J, 2007, P NATL ACAD SCI USA, V104, P3615, DOI 10.1073/pnas.0611421104; Milnes MR, 2006, ENVIRON RES, V100, P3, DOI 10.1016/j.envres.2005.04.002; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Morrish BC, 2002, REPRODUCTION, V124, P447, DOI 10.1530/rep.0.1240447; Mukhi S, 2007, TOXICOL SCI, V96, P246, DOI 10.1093/toxsci/kfm001; NAKAMURA M, 1985, DEV GROWTH DIFFER, V27, P701; Patino R, 2003, ENVIRON TOXICOL CHEM, V22, P1115, DOI [10.1897/1551-5028(2003)022&lt;1115:EOAPOT&gt;2.0.CO;2, 10.1002/etc.5620220520]; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Petersen AM, 2015, GEN COMP ENDOCR, V210, P130, DOI 10.1016/j.ygcen.2014.10.015; Power DM, 2001, COMP BIOCHEM PHYS C, V130, P447, DOI 10.1016/S1532-0456(01)00271-X; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Schug TT, 2015, ENDOCRINOLOGY, V156, P1941, DOI 10.1210/en.2014-1734; Sharma P, 2013, GEN COMP ENDOCR, V184, P111, DOI 10.1016/j.ygcen.2012.12.018; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Silveira PP, 2007, J PEDIAT, V83, P494, DOI [10.2223/JPED.1728, 10.1590/S0021-75572007000800004]; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Smith PN, 2001, ECOTOXICOLOGY, V10, P305, DOI 10.1023/A:1016715502717; Takeuchi Y, 2002, BIOL REPROD, V67, P1087, DOI 10.1095/biolreprod67.4.1087; Trumpolt CW, 2005, REMEDIATION, V16, P65, DOI 10.1002/rem.20071; Tzung KW, 2015, STEM CELL REP, V5, P156, DOI 10.1016/j.stemcr.2015.07.001; Urbansky ET, 2002, ENVIRON SCI POLLUT R, V9, P187, DOI 10.1007/BF02987487; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494; Wester PW, 2003, IDENTIFICATION ENDOC; Wilson CA, 2014, GENETICS, V198, P1291, DOI 10.1534/genetics.114.169284; Woodling JD, 2006, COMP BIOCHEM PHYS C, V144, P10, DOI 10.1016/j.cbpc.2006.04.019	75	11	11	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0157792	10.1371/journal.pone.0157792	http://dx.doi.org/10.1371/journal.pone.0157792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383240	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400026
J	Wakura, D; Kotani, T; Takeuchi, T; Komori, T; Yoshida, S; Makino, S; Hanafusa, T				Wakura, Daisuke; Kotani, Takuya; Takeuchi, Tohru; Komori, Tsuyoshi; Yoshida, Shuzo; Makino, Shigeki; Hanafusa, Toshiaki			Differentiation between Polymyalgia Rheumatica (PMR) and Elderly-Onset Rheumatoid Arthritis Using 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography: Is Enthesitis a New Pathological Lesion in PMR?	PLOS ONE			English	Article							CRITERIA; CLASSIFICATION; SYNOVITIS	Background It is difficult to differentiate polymyalgia rheumatica (PMR) from elderly-onset rheumatoid arthritis (EORA) in clinical practice. We compared FDG-PET/CT findings between patients with PMR and those with EORA and extracted factors useful for differentiating the two disorders. Methods We compared abnormal FDG accumulation sites and maximum standardized uptake value (SUVmax) between 15 patients with PMR and 7 with EORA in whom FDG-PET/CT was performed. Results The proportion of patients in the PMR group with abnormal FDG accumulation at the following 9 sites on FDG-PET/CT was significantly higher than that in the EORA group: periarticular region of the scapulohumeral joint, enthesis of the pectineus muscle, vicinity of the enthesis of the rectus femoris muscle, lateral side of the greater trochanter, ischial tuberosity, hip joint, spinous process of the lower cervical vertebra, intervertebral joint of the lumbar vertebra, and spinous process of the lumbar vertebra. The PET/CT score was evaluated at 9 sites consisting of the abovementioned sites. The median score in the PMR group was 8, which was significantly higher than that of 0 in the EORA group (P = 0.0003). ROC curve analysis was performed with the PET/CT scores, and a score of 5 was shown to maximize the area under the ROC curve (sensitivity: 86.7%, specificity: 86.7%). Conclusions FDG-PET/CT is useful for differentiating PMR from EORA. In patients with PMR, abnormal FDG accumulation was observed at the entheses, suggesting the presence of enthesitis in addition to bursitis and synovitis.	[Wakura, Daisuke; Kotani, Takuya; Takeuchi, Tohru; Yoshida, Shuzo; Makino, Shigeki; Hanafusa, Toshiaki] Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka, Japan; [Komori, Tsuyoshi] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka, Japan	Osaka Medical College; Osaka Medical College	Kotani, T (corresponding author), Osaka Med Coll, Dept Internal Med 1, Takatsuki, Osaka, Japan.	in1242@poh.osaka-med.ac.jp						Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BIRD HA, 1979, ANN RHEUM DIS, V38, P434, DOI 10.1136/ard.38.5.434; Blockmans D, 2007, RHEUMATOLOGY, V46, P672, DOI 10.1093/rheumatology/kel376; Blockmans D, 1999, RHEUMATOLOGY, V38, P444, DOI 10.1093/rheumatology/38.5.444; Camellino D, 2012, RHEUMATOLOGY, V51, P77, DOI 10.1093/rheumatology/keq450; HEALEY LA, 1984, SEMIN ARTHRITIS RHEU, V13, P322, DOI 10.1016/0049-0172(84)90012-X; Hochberg M.C., 2011, RHEUMATOLOGY; INOUE K, 1987, ANN RHEUM DIS, V46, P908, DOI 10.1136/ard.46.12.908; KOSKI JM, 1992, BRIT J RHEUMATOL, V31, P201; Mavragani CP, 1999, EXP GERONTOL, V34, P463, DOI 10.1016/S0531-5565(98)00072-2; Mori Shunsuke, 2007, Mod Rheumatol, V17, P369, DOI 10.1007/s10165-007-0595-6; Takahashi H, 2015, MOD RHEUMATOL, V25, P546, DOI 10.3109/14397595.2014.978936; Taniguchi Y, 2011, CLIN NUCL MED, V36, P121, DOI 10.1097/RLU.0b013e318203bb97; Turkcapar N, 2006, ARCH GERONTOL GERIAT, V42, P225, DOI 10.1016/j.archger.2005.07.003; Yamashita H, 2013, JOINT BONE SPINE, V80, P171, DOI 10.1016/j.jbspin.2012.04.006	16	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158509	10.1371/journal.pone.0158509	http://dx.doi.org/10.1371/journal.pone.0158509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384410	Green Submitted, gold, Green Published			2022-12-26	WOS:000379809400055
J	Kim, S; Park, J; Na, J; Jung, GY; Hwang, J				Kim, Sobin; Park, Jungyun; Na, Jeongkyeong; Jung, Gyoo Yeol; Hwang, Jungwook			Simultaneous Determination of Multiple microRNA Levels Utilizing Biotinylated Dideoxynucleotides and Mass Spectrometry	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; DISEASE; PCR; MS	MicroRNAs (miRNAs) are important regulators of gene translation and have been suggested as potent biomarkers in various disease states. In this study, we established an efficient method for simultaneous determination of multiple miRNA levels, employing the previously developed SPC-SBE (solid phase capture-single base extension) approach and MALDI-TOF mass spectrometry (MS). In this approach, we first perform reverse transcription of miRNAs extracted using stem-loop primers. Then the cDNA is co-amplified with competitors, synthetic oligonucleotides whose sequences precisely match cDNA except for one base, and the amplicons serve as templates for a multiplexed SBE reaction. Extension products are isolated using SPC and quantitatively analyzed with MALDI-TOF MS to determine multiple miRNA levels. Here we demonstrated concurrent analysis of four miRNA levels utilizing the approach. Furthermore, we showed the presented method significantly facilitated MS analysis of peak area ratio owing to SPC. The SPC process allowed effective removal of irrelevant reaction components prior to MS and promoted MS sample purification. Data obtained in this study was verified with RT-qPCR and agreement was shown on one order of magnitude scale, suggesting the SPC-SBE and MS approach has strong potential as a viable tool for high throughput miRNA analysis.	[Kim, Sobin; Park, Jungyun; Hwang, Jungwook] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul, South Korea; [Hwang, Jungwook] Hanyang Univ, Coll Med, Dept Med Genet, Seoul, South Korea; [Na, Jeongkyeong; Jung, Gyoo Yeol] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeongbuk, South Korea; [Jung, Gyoo Yeol] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang, Gyeongbuk, South Korea	Hanyang University; Hanyang University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Kim, S; Hwang, J (corresponding author), Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul, South Korea.; Hwang, J (corresponding author), Hanyang Univ, Coll Med, Dept Med Genet, Seoul, South Korea.	kimsobin@gmail.com; jwhwang@hanyang.ac.kr	Jung, Gyoo Yeol/R-7194-2019; Hwang, Jungwook/P-1614-2015	Hwang, Jungwook/0000-0002-2290-1649	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01058878]; Medical Research Center - National Research Foundation of the Korea (NRF) of the Ministry of Science, ICT and Future Planning, Republic of Korea [2008-0062287]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education; Medical Research Center - National Research Foundation of the Korea (NRF) of the Ministry of Science, ICT and Future Planning, Republic of Korea	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A01058878 to J.H.) and by a grant from the Medical Research Center (2008-0062287 to J.H.) funded by the National Research Foundation of the Korea (NRF) of the Ministry of Science, ICT and Future Planning, Republic of Korea.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; de Planell-Saguer M, 2013, CLIN BIOCHEM, V46, P869, DOI 10.1016/j.clinbiochem.2013.02.017; Ding CM, 2003, P NATL ACAD SCI USA, V100, P3059, DOI 10.1073/pnas.0630494100; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Duffield DS, 2010, RNA, V16, P1285, DOI 10.1261/rna.1859810; Duncan Mark W., 2008, Briefings in Functional Genomics & Proteomics, V7, P355, DOI 10.1093/bfgp/eln041; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Iorio MV, 2012, EMBO MOL MED, V4, P143, DOI 10.1002/emmm.201100209; Kim S, 2003, NAT REV GENET, V4, P1001, DOI 10.1038/nrg1230; Kim S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf084; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Meyer K, 2004, CLIN CHEM, V50, P391, DOI 10.1373/clinchem.2003.026799; Misra A, 2007, CLIN CHEM, V53, P933, DOI 10.1373/clinchem.2006.080739; Omahen DA, 2011, NEUROSURGERY, V69, P440, DOI 10.1227/NEU.0b013e318215a3b3; Pager CT, 2009, PROG MOL BIOL TRANSL, V90, P187, DOI 10.1016/S1877-1173(09)90005-9; Sauer S, 2006, CLIN CHIM ACTA, V363, P95, DOI 10.1016/j.cccn.2005.05.040; Szajli E, 2008, MOL CELL PROTEOMICS, V7, P2410, DOI 10.1074/mcp.M800108-MCP200; Tian T, 2015, ORG BIOMOL CHEM, V13, P2226, DOI 10.1039/c4ob02104e; Waldman SA, 2008, CLIN CHEM, V54, P943, DOI 10.1373/clinchem.2008.105353; Wang Gang, 2013, Methods Mol Biol, V1024, P211, DOI 10.1007/978-1-62703-453-1_17; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341	24	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0153201	10.1371/journal.pone.0153201	http://dx.doi.org/10.1371/journal.pone.0153201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380276	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700002
J	San Martin, L; Cerda, F; Jin, CY; Jimenez, V; Yevenes, GE; Hernandez, T; Nova, D; Fuentealba, J; Aguayo, LG; Guzman, L				San Martin, Loreto; Cerda, Fabian; Jin, Chunyang; Jimenez, Veronica; Yevenes, Gonzalo E.; Hernandez, Tania; Nova, Daniela; Fuentealba, Jorge; Aguayo, Luis G.; Guzman, Leonardo			Reversal of Ethanol-induced Intoxication by a Novel Modulator of G beta gamma Protein Potentiation of the Glycine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE DISRUPTION; ACTIVATED CL-CURRENT; ALPHA-1 SUBUNIT; ION-CHANNEL; NEURONS; MICE; ALCOHOL; SENSITIVITY; EXPRESSION; CURRENTS	The acute intoxicating effects of ethanol in the central nervous system result from the modulation of several molecular targets. It is widely accepted that ethanol enhances the activity of the glycine receptor (GIyR), thus enhancing inhibitory neurotransmission, leading to motor effects, sedation, and respiratory depression. We previously reported that small peptides interfered with the binding of G beta gamma to the GlyR and consequently inhibited the ethanol-induced potentiation of the receptor. Now, using virtual screening, we identified a subset of small molecules capable of interacting with the binding site of G beta gamma. One of these compounds, M554, inhibited the ethanol potentiation of the GIyR in both evoked currents and synaptic transmission in vitro. When this compound was tested in vivo in mice treated with ethanol (1-3.5 g/kg), it was found to induce a faster recovery of motor incoordination in rotarod experiments and a shorter sedative effect in loss of righting reflex assays. This study describes a novel molecule that might be relevant for the design of useful therapeutic compounds in the treatment of acute alcohol intoxication.	[San Martin, Loreto; Cerda, Fabian; Yevenes, Gonzalo E.; Hernandez, Tania; Nova, Daniela; Fuentealba, Jorge; Guzman, Leonardo] Univ Concepcion, Dept Physiol, Lab Mol Neurobiol, Concepcion 403901, Chile; [Aguayo, Luis G.] Univ Concepcion, Dept Physiol, Labs Neurophysiol, Concepcion 403901, Chile; [Jin, Chunyang] Res Triangle Inst, Ctr Drug Discovery, POB 12194, Res Triangle Pk, NC 27709 USA; [Jimenez, Veronica] Univ Andres Bello, Fac Ciencias Exactas, Dept Ciencias Quim, Concepcion 403901, Chile	Universidad de Concepcion; Universidad de Concepcion; Research Triangle Institute; Universidad Andres Bello	Guzman, L (corresponding author), Univ Concepcion, Dept Fisiol, Casilla 160-C, Concepcion, Chile.	joleguzman@gmail.com	Jiménez, Verónica A/B-8789-2017; Guzman, Jose/AAM-7649-2020	Guzman, Jose/0000-0001-9596-5494; Jin, Chunyang/0000-0001-6733-3094	CONICYT FONDECYT [1131004]; FONDEF IDeA Grant [CA12i10280]; National Institutes of Health [R01-AA15150]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA015150] Funding Source: NIH RePORTER	CONICYT FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDEF IDeA Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by CONICYT FONDECYT Grant 1131004, FONDEF IDeA Grant CA12i10280 (to L. G.), and National Institutes of Health Grant R01-AA15150 (to L. G. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguayo LG, 1996, J PHARMACOL EXP THER, V279, P1116; AGUAYO LG, 1994, J PHARMACOL EXP THER, V270, P61; Aguayo LG, 2014, NEUROPSYCHOPHARMACOL, V39, P2538, DOI 10.1038/npp.2014.100; Blednov YA, 2015, J PHARMACOL EXP THER, V353, P181, DOI 10.1124/jpet.114.221895; Blednov YA, 2012, J PHARMACOL EXP THER, V340, P317, DOI 10.1124/jpet.111.185124; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Casey LM, 2010, CIRC RES, V107, P532, DOI 10.1161/CIRCRESAHA.110.217075; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Findlay GS, 2002, J PHARMACOL EXP THER, V300, P526, DOI 10.1124/jpet.300.2.526; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Guzman L, 2009, J PHARMACOL EXP THER, V331, P933, DOI 10.1124/jpet.109.160440; Harris RA, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.128re7; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lovinger DM, 2013, CURR TOP BEHAV NEURO, V13, P31, DOI 10.1007/7854_2011_143; Mariqueo TA, 2014, J NEUROPHYSIOL, V111, P1940, DOI 10.1152/jn.00789.2013; Mathews JL, 2008, J NEUROSCI, V28, P12183, DOI 10.1523/JNEUROSCI.2326-08.2008; McCracken LM, 2013, J PHARMACOL EXP THER, V344, P489, DOI 10.1124/jpet.112.197707; San Martin L, 2012, J BIOL CHEM, V287, P40713, DOI DOI 10.1074/JBC.M112.393603; Wells CA, 2012, ACS CHEM NEUROSCI, V3, P69, DOI 10.1021/cn200102d; Welsh BT, 2009, J PHARMACOL EXP THER, V330, P198, DOI 10.1124/jpet.109.154344; WILLIAMS KL, 1995, PHARMACOL BIOCHEM BE, V50, P199, DOI 10.1016/0091-3057(94)00288-T; Xie W, 1999, P NATL ACAD SCI USA, V96, P10385, DOI 10.1073/pnas.96.18.10385; Ye JH, 2009, ALCOHOL CLIN EXP RES, V33, P1069, DOI 10.1111/j.1530-0277.2009.00928.x; Yevenes GE, 2003, NAT NEUROSCI, V6, P819, DOI 10.1038/nn1095; Yevenes GE, 2008, P NATL ACAD SCI USA, V105, P20523, DOI 10.1073/pnas.0806257105; Yevenes GE, 2006, J BIOL CHEM, V281, P39300, DOI 10.1074/jbc.M608272200; Zhu L, 2005, BRAIN RES, V1033, P102, DOI 10.1016/j.brainres.2004.11.027	29	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18791	18798		10.1074/jbc.M116.740555	http://dx.doi.org/10.1074/jbc.M116.740555			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402845	Green Published, hybrid			2022-12-26	WOS:000383242300016
J	Wongsamitkul, N; Baur, R; Sigel, E				Wongsamitkul, Nisa; Baur, Roland; Sigel, Erwin			Toward Understanding Functional Properties and Subunit Arrangement of alpha(4)beta(2)delta gamma-Aminobutyric Acid, Type A (GABA(A)) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; GABA; ion channel; neurotransmitter receptor; Xenopus; -aminobutyric acid type A; subunit; GABA(A) receptor	DELTA-SUBUNIT; STOICHIOMETRY; PHARMACOLOGY; RECOMBINANT; MODULATION; ALPHA-4; SENSITIVITY; ACTIVATION; EXPRESSION; CHANNELS	GABA(A) receptors are pentameric ligand-gated channels mediating inhibitory neurotransmission in the CNS. (4x) GABA(A) receptors are extrasynaptic receptors important for tonic inhibition. The functional properties and subunit arrangement of these receptors are controversial. We predefined subunit arrangement by using subunit concatenation. (4), (2), and subunits were concatenated to dimeric, trimeric, and, in some cases, pentameric subunits. We constructed in total nine different receptor pentamers in at least two different ways and expressed them in Xenopus oocytes. The subunit was substituted in any of the five positions in the (12) receptor. In addition, we investigated all receptors with the 2:2:1 subunit stoichiometry for (4), (2), and . Several functional receptors were obtained. Interestingly, all of these receptors had very similar EC50 values for GABA in the presence of the neurosteroid 3, 21-dihydroxy-5-pregnan-20-one (THDOC). All functional receptors containing subunits were sensitive to 4-chloro-N-[2-(2-thienyl)imidazo[1,2-a]pyridin-3-yl]benzamide (DS2). Moreover, none of the receptors was affected by ethanol up to 30 mm. These properties recapitulate those of non-concatenated receptors expressed from a cRNA ratio of 1:1:5 coding for (4), (2), and subunits. We conclude that the subunit arrangement of (42) GABA(A) receptors is not strongly predefined but is mostly satisfying the 2:2:1 subunit stoichiometry for (4), (2), and subunits and that several subunit arrangements result in receptors with similar functional properties tuned to physiological conditions.	[Wongsamitkul, Nisa; Baur, Roland; Sigel, Erwin] Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland	University of Bern	Sigel, E (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.	erwin.sigel@ibmm.unibe.ch			Swiss National Science Foundation Grant [315230_156929/1]	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF))	This work was supported by Swiss National Science Foundation Grant 315230_156929/1. The authors declare that they have no conflicts of interest with the contents of this article.	ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Baumann SW, 2003, J NEUROSCI, V23, P11158; Baumann SW, 2002, J BIOL CHEM, V277, P46020, DOI 10.1074/jbc.M207663200; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; Baur R, 2006, FEBS LETT, V580, P1616, DOI 10.1016/j.febslet.2006.02.002; Baur R, 2010, J BIOL CHEM, V285, P17398, DOI 10.1074/jbc.M110.108670; Baur R, 2009, J NEUROCHEM, V111, P1172, DOI 10.1111/j.1471-4159.2009.06387.x; Belelli D, 2009, J NEUROSCI, V29, P12757, DOI 10.1523/JNEUROSCI.3340-09.2009; Bianchi MT, 2003, J NEUROSCI, V23, P10934; Bollan KA, 2008, MOL CELL NEUROSCI, V37, P610, DOI 10.1016/j.mcn.2007.12.011; Chang YC, 1996, J NEUROSCI, V16, P5415; Eaton MM, 2014, MOL PHARMACOL, V86, P647, DOI 10.1124/mol.114.094813; Farrant M, 2005, NAT REV NEUROSCI, V6, P215, DOI 10.1038/nrn1625; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Glykys J, 2007, NAT NEUROSCI, V10, P40, DOI 10.1038/nn1813; Hartiadi LY, 2016, BIOCHEM PHARMACOL, V103, P98, DOI 10.1016/j.bcp.2015.12.021; Jensen ML, 2013, BRIT J PHARMACOL, V168, P1118, DOI 10.1111/bph.12001; Jones A, 1997, J NEUROSCI, V17, P1350; Karim N, 2012, BIOCHEM PHARMACOL, V84, P549, DOI 10.1016/j.bcp.2012.05.017; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Minier F, 2004, TRENDS PHARMACOL SCI, V25, P499, DOI 10.1016/j.tips.2004.07.005; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Patel B, 2014, BRIT J PHARMACOL, V171, P985, DOI 10.1111/bph.12514; Patel B, 2016, J NEUROSCI, V36, P607, DOI 10.1523/JNEUROSCI.2047-15.2016; Peng Z, 2002, J COMP NEUROL, V446, P179, DOI 10.1002/cne.10210; Richerson GB, 2003, J NEUROPHYSIOL, V90, P1363, DOI 10.1152/jn.00317.2003; Shu HJ, 2012, BRIT J PHARMACOL, V165, P2228, DOI 10.1111/j.1476-5381.2011.01690.x; Sigel E, 2005, MOL NUTR FOOD RES, V49, P228, DOI 10.1002/mnfr.200400104; SIGEL E, 1987, J PHYSIOL-LONDON, V386, P73, DOI 10.1113/jphysiol.1987.sp016523; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sigel E, 2009, BIOCHEM SOC T, V37, P1338, DOI 10.1042/BST0371338; Sundstrom-Poromaa I, 2002, NAT NEUROSCI, V5, P721, DOI 10.1038/nn888; Sur C, 1999, MOL PHARMACOL, V56, P110, DOI 10.1124/mol.56.1.110; Tretter V, 1997, J NEUROSCI, V17, P2728; Ueno S, 1996, MOL PHARMACOL, V50, P931; Wafford KA, 2009, NEUROPHARMACOLOGY, V56, P182, DOI 10.1016/j.neuropharm.2008.08.004; Wagoner KR, 2010, J BIOL CHEM, V285, P14187, DOI 10.1074/jbc.M110.104257; Wallner M, 2003, P NATL ACAD SCI USA, V100, P15218, DOI 10.1073/pnas.2435171100; Wohlfarth KM, 2002, J NEUROSCI, V22, P1541, DOI 10.1523/JNEUROSCI.22-05-01541.2002; Wu YM, 2007, NEURON, V56, P851, DOI 10.1016/j.neuron.2007.10.021; You H, 2007, J NEUROCHEM, V103, P1092, DOI 10.1111/j.1471-4159.2007.04817.x; Zheleznova N, 2008, BRIT J PHARMACOL, V153, P1062, DOI 10.1038/sj.bjp.0707665	45	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18474	18483		10.1074/jbc.M116.738906	http://dx.doi.org/10.1074/jbc.M116.738906			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382064	Green Published, hybrid			2022-12-26	WOS:000383241800037
J	La Venuta, G; Wegehingel, S; Sehr, P; Muller, HM; Dimou, E; Steringer, JP; Grotwinkel, M; Hentze, N; Mayer, MP; Will, DW; Uhrig, U; Lewis, JD; Nickel, W				La Venuta, Giuseppe; Wegehingel, Sabine; Sehr, Peter; Mueller, Hans-Michael; Dimou, Eleni; Steringer, Julia P.; Grotwinkel, Mareike; Hentze, Nikolai; Mayer, Matthias P.; Will, David W.; Uhrig, Ulrike; Lewis, Joe D.; Nickel, Walter			Small Molecule Inhibitors Targeting Tec Kinase Block Unconventional Secretion of Fibroblast Growth Factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fibroblast growth factor (FGF); phosphoinositide; protein phosphorylation; protein secretion; protein translocation; FGF2; protein translocation across membranes; Tec kinase; unconventional protein secretion	PROTEIN SECRETION; CELL-SURFACE; MAMMALIAN-CELLS; PLASMA-MEMBRANE; HIV-1 TAT; ESSENTIAL COMPONENTS; SIGNALING PATHWAYS; TYROSINE KINASES; EXPORT MACHINERY; FGF-2	Fibroblast growth factor 2 (FGF2) is a potent mitogen promoting both tumor cell survival and tumor-induced angiogenesis. It is secreted by an unconventional secretory mechanism that is based upon direct translocation across the plasma membrane. Key steps of this process are (i) phosphoinositide-dependent membrane recruitment, (ii) FGF2 oligomerization and membrane pore formation, and (iii) extracellular trapping mediated by membrane-proximal heparan sulfate proteoglycans. Efficient secretion of FGF2 is supported by Tec kinase that stimulates membrane pore formation based upon tyrosine phosphorylation of FGF2. Here, we report the biochemical characterization of the direct interaction between FGF2 and Tec kinase as well as the identification of small molecules that inhibit (i) the interaction of FGF2 with Tec, (ii) tyrosine phosphorylation of FGF2 mediated by Tec in vitro and in a cellular context, and (iii) unconventional secretion of FGF2 from cells. We further demonstrate the specificity of these inhibitors for FGF2 because tyrosine phosphorylation of a different substrate of Tec is unaffected in their presence. Building on previous evidence using RNA interference, the identified compounds corroborate the role of Tec kinase in unconventional secretion of FGF2. In addition, they are valuable lead compounds with great potential for drug development aiming at the inhibition of FGF2-dependent tumor growth and metastasis.	[La Venuta, Giuseppe; Wegehingel, Sabine; Mueller, Hans-Michael; Dimou, Eleni; Steringer, Julia P.; Grotwinkel, Mareike; Nickel, Walter] Heidelberg Univ Biochem Ctr BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany; [Sehr, Peter; Will, David W.; Uhrig, Ulrike; Lewis, Joe D.] European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Hentze, Nikolai; Mayer, Matthias P.] Zentrum Mol Biol Univ Heidelberg ZMBH, DKFZ ZMBH Allianz, Neuenheimer Feld 282, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Nickel, W (corresponding author), Heidelberg Univ Biochem Ctr BZH, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	walter.nickel@bzh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Lewis, Joe/0000-0002-9926-1328; Sehr, Peter/0000-0002-4348-5066; Dimou, Eleni/0000-0003-4885-135X; Muller, Hans-Michael/0000-0002-2384-7285	Baden-Wurttemberg Stiftung (Stuttgart, Germany); German Research Council [DFG-SFB 638, DFG-SFB/TRR 186, DFG-SFB/TRR 83, DFG Ni 423/6-1, DFG Ni 423/7-1]; AID-NET program of the Federal Ministry for Education and Research of Germany; DFG Cluster of Excellence, Cell-Networks	Baden-Wurttemberg Stiftung (Stuttgart, Germany); German Research Council(German Research Foundation (DFG)); AID-NET program of the Federal Ministry for Education and Research of Germany; DFG Cluster of Excellence, Cell-Networks(German Research Foundation (DFG))	This work was supported by the Baden-Wurttemberg Stiftung (Stuttgart, Germany). In addition, funds were received from the German Research Council (DFG-SFB 638, DFG-SFB/TRR 186, DFG-SFB/TRR 83, DFG Ni 423/6-1, and DFG Ni 423/7-1), the AID-NET program of the Federal Ministry for Education and Research of Germany, and the DFG Cluster of Excellence, Cell-Networks. The authors declare that they have no conflicts of interest with the contents of this article.	Backhaus R, 2004, J CELL SCI, V117, P1727, DOI 10.1242/jcs.01027; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Bikfalvi A, 1997, ENDOCR REV, V18, P26, DOI 10.1210/er.18.1.26; Bradshaw JM, 2010, CELL SIGNAL, V22, P1175, DOI 10.1016/j.cellsig.2010.03.001; Contreras-Gomez A, 2014, BIOTECHNOL PROGR, V30, P1, DOI 10.1002/btpr.1842; Dahl JP, 2000, BIOCHEMISTRY-US, V39, P14877, DOI 10.1021/bi001073y; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Deretic V, 2012, TRENDS CELL BIOL, V22, P397, DOI 10.1016/j.tcb.2012.04.008; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Ebert AD, 2010, TRAFFIC, V11, P813, DOI 10.1111/j.1600-0854.2010.01059.x; Engling A, 2002, J CELL SCI, V115, P3619, DOI 10.1242/jcs.00036; FISCHERFANTUZZI L, 1988, MOL CELL BIOL, V8, P5495, DOI 10.1128/MCB.8.12.5495; FLORKIEWICZ RZ, 1995, J CELL PHYSIOL, V162, P388, DOI 10.1002/jcp.1041620311; Florkiewicz RZ, 1998, J BIOL CHEM, V273, P544, DOI 10.1074/jbc.273.1.544; Jameson DM, 1999, METHODS, V19, P222, DOI 10.1006/meth.1999.0853; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; La Venuta G, 2015, J BIOL CHEM, V290, P27015, DOI 10.1074/jbc.R115.689257; Lewis CM, 2001, CURR OPIN IMMUNOL, V13, P317, DOI 10.1016/S0952-7915(00)00221-1; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Malhotra V, 2013, EMBO J, V32, P1660, DOI 10.1038/emboj.2013.104; Mano H, 1999, CYTOKINE GROWTH F R, V10, P267, DOI 10.1016/S1359-6101(99)00019-2; Martin-Sanchez F, 2016, CELL DEATH DIFFER, V23, P1219, DOI 10.1038/cdd.2015.176; Muller HM, 2015, J BIOL CHEM, V290, P8925, DOI 10.1074/jbc.M114.622456; NGUYEN M, 1994, J NATL CANCER I, V86, P356, DOI 10.1093/jnci/86.5.356; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W., 2016, [No title captured], Patent No. [GB1605173, 16051732]; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nickel W, 2007, J CELL SCI, V120, P2295, DOI 10.1242/jcs.011080; Nickel W, 2011, TRAFFIC, V12, P799, DOI 10.1111/j.1600-0854.2011.01187.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Ohya K, 1999, P NATL ACAD SCI USA, V96, P11976, DOI 10.1073/pnas.96.21.11976; Pardo OE, 2006, EMBO J, V25, P3078, DOI 10.1038/sj.emboj.7601198; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Piccioli P, 2013, SEMIN IMMUNOL, V25, P425, DOI 10.1016/j.smim.2013.10.007; Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004; Rabouille C, 2012, J CELL SCI, V125, P5251, DOI 10.1242/jcs.103630; Rayne F, 2010, CELL BIOL INT, V34, P409, DOI 10.1042/CBI20090376; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; RUBARTELLI A, 1990, EMBO J, V9, P1503, DOI 10.1002/j.1460-2075.1990.tb08268.x; Schafer T, 2004, J BIOL CHEM, V279, P6244, DOI 10.1074/jbc.M310500200; Scharenberg AM, 1998, CELL, V94, P5, DOI 10.1016/S0092-8674(00)81214-3; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; Steringer JP, 2015, J MOL BIOL, V427, P1202, DOI 10.1016/j.jmb.2014.07.012; Steringer JP, 2012, J BIOL CHEM, V287, P27659, DOI 10.1074/jbc.M112.381939; Takesono A, 2002, J CELL SCI, V115, P3039; Taouji S, 2009, CURR GENOMICS, V10, P93, DOI 10.2174/138920209787847041; Temmerman K, 2008, TRAFFIC, V9, P1204, DOI 10.1111/j.1600-0854.2008.00749.x; Temmerman K, 2009, J LIPID RES, V50, P1245, DOI 10.1194/jlr.D800043-JLR200; Thrall SH, 1996, BIOCHEMISTRY-US, V35, P4609, DOI 10.1021/bi9526387; Torrado LC, 2009, J CELL SCI, V122, P3322, DOI 10.1242/jcs.049791; Trudel C, 2000, J CELL PHYSIOL, V185, P260, DOI 10.1002/1097-4652(200011)185:2<260::AID-JCP11>3.0.CO;2-X; Yokohari K, 2001, BIOCHEM BIOPH RES CO, V289, P414, DOI 10.1006/bbrc.2001.6008; Zacherl S, 2015, J BIOL CHEM, V290, P3654, DOI 10.1074/jbc.M114.590067; Zehe C, 2006, P NATL ACAD SCI USA, V103, P15479, DOI 10.1073/pnas.0605997103; Zeitler M, 2015, J BIOL CHEM, V290, P21976, DOI 10.1074/jbc.M115.667097; Zhang M, 2015, ELIFE, V4, DOI 10.7554/eLife.11205; Zhang M, 2013, SCIENCE, V340, P559, DOI 10.1126/science.1234740	58	23	24	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17787	17803		10.1074/jbc.M116.729384	http://dx.doi.org/10.1074/jbc.M116.729384			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27382052	Green Published, hybrid			2022-12-26	WOS:000383241300026
J	Cooper, I; Fridkin, M; Shechter, Y				Cooper, Itzik; Fridkin, Mati; Shechter, Yoram			Conjugation of Methotrexate-Amino Derivatives to Macromolecules through Carboxylate Moieties Is Superior Over Conventional Linkage to Amino Residues: Chemical, Cell-Free and In Vitro Characterizations	PLOS ONE			English	Article							TARGETED DRUG-DELIVERY; LONG-ACTING INSULIN; ALBUMIN-BINDING PRODRUG; PEPTIDE; VIVO; DESIGN; CIRCULATION; PROTEIN	In this study, we examined the possibility of introducing methotrexate (MTX) to the carboxyl ate rather than to the epsilon-amino side chains of proteins. We found that MIX amino compounds covalently linked to the carboxylate moieties of macromolecules, undergo unusual peptide-bond cleavage, with the release of the MTX amino derivatives from the conjugates. This event takes place at an accelerated rate under acidic conditions, and at a slower rate at physiological pH values. The glutamate portion of MTX is responsible for this behavior, with little or no contribution of the p-aminobenzoate-pteridine ring that is linked to the a amino side chain of the glutamate. Carboxylate-linked Fmoc-Glu-gamma-CONH-(CH2)(6)-NH2 undergoes hydrolysis in a nearly indistinguishable fashion. A free a carboxylate moiety is essential for this effect. Carboxylate linked Fmoc-glutamic-amide-gamma-CONH-(CH2)(6)-NH2 undergoes no hydrolysis under acidic conditions. Based on these findings, we engineered a cysteine specific MTX containing reagent. Its linkage to bovine serum albumin (BSA) yielded a conjugate with profound antiproliferative efficacy in a MTX-sensitive glioma cell line. In conclusion, carboxylate linked MTX-amino derivatives in particular, and carboxylate linked R-alpha-GLU-gamma amino compounds in general are equipped with'built-in chemical machinery' that releases them under mild acidic conditions.	[Cooper, Itzik] Sheba Med Ctr, BBB Grp, Joseph Sagol Neurosci Ctr, IL-52621 Ramat Gan, Israel; [Fridkin, Mati] Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; [Shechter, Yoram] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel	Chaim Sheba Medical Center; Weizmann Institute of Science; Weizmann Institute of Science	Cooper, I (corresponding author), Sheba Med Ctr, BBB Grp, Joseph Sagol Neurosci Ctr, IL-52621 Ramat Gan, Israel.	Itzik.cooper@sheba.health.gov.il		cooper, itzik/0000-0003-0723-5542	Kimmelman grant from the Weizmann Institute	Kimmelman grant from the Weizmann Institute	This work was supported by a Kimmelman grant from the Weizmann Institute.	ALBERT A, 1958, NATURE, V182, P421, DOI 10.1038/182421a0; Cooper I, 2011, J NEUROCHEM, V116, P467, DOI 10.1111/j.1471-4159.2010.06934.x; Ettmayer P, 2004, J MED CHEM, V47, P2393, DOI 10.1021/jm0303812; Fiehn C, 2008, ANN RHEUM DIS, V67, P1188, DOI 10.1136/ard.2007.086843; Gershonov E, 1999, DIABETES, V48, P1437, DOI 10.2337/diabetes.48.7.1437; Gershonov E, 2000, J MED CHEM, V43, P2530, DOI 10.1021/jm990533m; HAZUM E, 1992, J BIOCHEM BIOPH METH, V24, P95, DOI 10.1016/0165-022X(92)90050-K; Huang X, 1999, J PEPT RES, V53, P126, DOI 10.1034/j.1399-3011.1999.00005.x; Huttunen KM, 2011, PHARMACOL REV, V63, P750, DOI 10.1124/pr.110.003459; KAUFMAN BT, 1976, ARCH BIOCHEM BIOPHYS, V172, P289, DOI 10.1016/0003-9861(76)90078-3; KULKARNI PN, 1985, CANCER IMMUNOL IMMUN, V19, P211; Lin CR, 2012, AM J THER, V19, P33, DOI 10.1097/MJT.0b013e3181f47f3f; Neumann E, 2010, EXPERT OPIN DRUG DEL, V7, P915, DOI 10.1517/17425247.2010.498474; Pasquetto MV, 2011, J IMMUNOTHER, V34, P611, DOI 10.1097/CJI.0b013e318234ecf5; Shechter Y, 2007, INT J PEPT RES THER, V13, P105, DOI 10.1007/s10989-006-9052-1; Shechter Y, 2005, BIOCONJUGATE CHEM, V16, P913, DOI 10.1021/bc050055w; Shechter Y, 2005, FEBS LETT, V579, P2439, DOI 10.1016/j.febslet.2005.03.044; Shechter Y, 2001, P NATL ACAD SCI USA, V98, P1212, DOI 10.1073/pnas.98.3.1212; Testa B, 2004, BIOCHEM PHARMACOL, V68, P2097, DOI 10.1016/j.bcp.2004.07.005; Tsubery H, 2004, J BIOL CHEM, V279, P38118, DOI 10.1074/jbc.M405155200; Warnecke A, 2007, ARCH PHARM, V340, P389, DOI 10.1002/ardp.200700025; Wosikowski K, 2003, CLIN CANCER RES, V9, P1917	22	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158352	10.1371/journal.pone.0158352	http://dx.doi.org/10.1371/journal.pone.0158352			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403959	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508200008
J	Dauleh, S; Santeramo, I; Fielding, C; Ward, K; Herrmann, A; Murray, P; Wilm, B				Dauleh, Sumaya; Santeramo, Ilaria; Fielding, Claire; Ward, Kelly; Herrmann, Anne; Murray, Patricia; Wilm, Bettina			Characterisation of Cultured Mesothelial Cells Derived from the Murine Adult Omentum	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; MESENCHYMAL STEM-CELLS; MYOCARDIAL-INFARCTION; PERITONEAL ADHESIONS; SEROSAL MESOTHELIUM; TRANSITION; INJURY; HEART; FIBROBLASTS; MECHANISM	The human omentum has been long regarded as a healing patch, used by surgeons for its ability to immunomodulate, repair and vascularise injured tissues. A major component of the omentum are mesothelial cells, which display some of the characteristics of mesenchymal stem/stromal cells. For instance, lineage tracing studies have shown that mesothelial cells give rise to adipocytes and vascular smooth muscle cells, and human and rat mesothelial cells have been shown to differentiate into osteoblast-and adipocyte-like cells in vitro, indicating that they have considerable plasticity. However, so far, long-term cultures of mesothelial cells have not been successfully established due to early senescence. Here, we demonstrate that mesothelial cells isolated from the mouse omentum could be cultured for more than 30 passages. While epithelial markers were downregulated over passages in the mesothelial cells, their mesenchymal profile remained unchanged. Early passage mesothelial cells displayed clonogenicitiy, expressed several stem cell markers, and up to passage 5 and 13, respectively, could differentiate along the adipogenic and osteogenic lineages, demonstrating stem/progenitor characteristics and differentiation potential.	[Dauleh, Sumaya; Santeramo, Ilaria; Fielding, Claire; Ward, Kelly; Murray, Patricia; Wilm, Bettina] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England; [Herrmann, Anne] Univ Liverpool, Inst Integrat Biol, Dept Biochem, Liverpool, Merseyside, England; [Fielding, Claire] Univ Cambridge, Dept Haematol, Cambridge, England	University of Liverpool; University of Liverpool; University of Cambridge	Wilm, B (corresponding author), Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Liverpool, Merseyside, England.	b.wilm@liv.ac.uk	Wilm, Bettina/V-8621-2018	Wilm, Bettina/0000-0002-9245-993X; Herrmann, Anne/0000-0002-0858-419X	Biotechnology and Biological Sciences Research Council [BB/F016905/1]; Wellcome Trust [WT096566MA]; Nephrotools FP7 Marie Curie training grant; Alder Hey Children's Kidney fund; Neuroblastoma UK; Biotechnology and Biological Sciences Research Council [1091794] Funding Source: researchfish; Medical Research Council [MR/M012751/1] Funding Source: researchfish; MRC [MR/M012751/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Nephrotools FP7 Marie Curie training grant; Alder Hey Children's Kidney fund; Neuroblastoma UK; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Nicole Cash, Daniel Turnham, Jonathan Hanmer, Aleksandra Rak-Raszeswka and Emma Smith for technical help, and Sokratis Theocharatos for the GFP-lentivirus vector. The work was supported by a PhD training grant, number BB/F016905/1, for SD, from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/), and a Wellcome Trust (www.wellcome.ac.uk) 4 year PhD training grant, number WT096566MA, for KW. IS was funded by the Nephrotools FP7 Marie Curie training grant, and Alder Hey Children's Kidney fund. AH received funding from Neuroblastoma UK (neuroblastoma.org.uk). CF was self-funded for this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahina K, 2011, HEPATOLOGY, V53, P983, DOI 10.1002/hep.24119; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Chau YY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002404; Chen YT, 2014, J AM SOC NEPHROL, V25, P2847, DOI 10.1681/ASN.2013101079; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; CONNELL ND, 1983, CELL, V34, P245, DOI 10.1016/0092-8674(83)90155-1; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Davies Jamie A, 2012, Methods Mol Biol, V886, P135, DOI 10.1007/978-1-61779-851-1_12; Delany AM, 2003, ENDOCRINOLOGY, V144, P2588, DOI 10.1210/en.2002-221044; Dettman RW, 1998, DEV BIOL, V193, P169, DOI 10.1006/dbio.1997.8801; Essafi A, 2011, DEV CELL, V21, P559, DOI 10.1016/j.devcel.2011.07.014; Foley-Comer AJ, 2002, J CELL SCI, V115, P1383; Herrick SE, 2007, INT J ARTIF ORGANS, V30, P527, DOI 10.1177/039139880703000611; Herrick SE, 2004, INT J BIOCHEM CELL B, V36, P621, DOI 10.1016/j.biocel.2003.11.002; Herrick SE, 2000, J PATHOL, V192, P67; Holmdahl Lena E., 1994, Wound Repair and Regeneration, V2, P171, DOI 10.1046/j.1524-475X.1994.20306.x; Hsu YC, 2012, NAT REV MOL CELL BIO, V13, P103, DOI 10.1038/nrm3272; Karki S, 2014, FASEB J, V28, P1122, DOI 10.1096/fj.13-236828; Kawaguchi M, 2007, DEV DYNAM, V236, P2973, DOI 10.1002/dvdy.21334; Ksiazek K, 2006, J APPL PHYSIOL, V100, P988, DOI 10.1152/japplphysiol.01086.2005; Ksiazek K, 2013, AGEING RES REV, V12, P595, DOI 10.1016/j.arr.2013.01.008; Kuzma-Kuzniarska M, 2012, DIFFERENTIATION, V83, P128, DOI 10.1016/j.diff.2011.11.004; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li YC, 2013, P NATL ACAD SCI USA, V110, P2324, DOI 10.1073/pnas.1214136110; Loureiro J, 2013, INT J NEPHROL, V2013, DOI 10.1155/2013/263285; Merrell AJ, 2016, NAT REV MOL CELL BIO; Minot C. S., 1890, American Naturalist, Vxxiv, P877; Mora CF, 2012, STEM CELLS DEV, V21, P296, DOI 10.1089/scd.2010.0470; PIFARRE R, 1968, AM J SURG, V115, P589, DOI 10.1016/0002-9610(68)90082-2; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rak-Raszewska A, 2012, ORGANOGENESIS, V8, P125, DOI 10.4161/org.22597; Ranghini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062953; Rinkevich Y, 2012, NAT CELL BIOL, V14, P1251, DOI 10.1038/ncb2610; Sally ML, 2011, J CELL MOL MED, V15, P2095, DOI 10.1111/j.1582-4934.2010.01212.x; Shudo Y, 2011, J THORAC CARDIOV SUR, V142, P1188, DOI 10.1016/j.jtcvs.2011.07.002; Siegel N, 2010, HUM MOL GENET, V19, P3320, DOI 10.1093/hmg/ddq236; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Sulaiman H, 2000, J PATHOL, V192, P396, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH710>3.0.CO;2-4; Unbekandt M, 2010, KIDNEY INT, V77, P407, DOI 10.1038/ki.2009.482; Verardo R, 2014, STEM CELLS, V32, P2998, DOI 10.1002/stem.1791; von Gise A, 2011, DEV BIOL, V356, P421, DOI 10.1016/j.ydbio.2011.05.668; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Winters NI, 2014, DEV BIOL, V391, P125, DOI 10.1016/j.ydbio.2014.04.003; Winters NI, 2012, DEVELOPMENT, V139, P2926, DOI 10.1242/dev.082396; Yanez-Mo M, 2003, NEW ENGL J MED, V348, P403, DOI 10.1056/NEJMoa020809; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	48	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158997	10.1371/journal.pone.0158997	http://dx.doi.org/10.1371/journal.pone.0158997			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403660	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508200027
J	Gopalani, M; Dhiman, A; Rahi, A; Kandari, D; Bhatnagar, R				Gopalani, Monisha; Dhiman, Alisha; Rahi, Amit; Kandari, Divya; Bhatnagar, Rakesh			Identification, Functional Characterization and Regulon Prediction of a Novel Two Component System Comprising BAS0540-BAS0541 of Bacillus anthracis	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEMS; RESPONSE-REGULATOR; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; VANCOMYCIN RESISTANCE; STAPHYLOCOCCUS-AUREUS; VIRULENCE FACTOR; STRESS-RESPONSE; CELL-DIVISION; SUBTILIS	Two component systems (TCSs) can be envisaged as complex molecular devices that help the bacteria to sense its environment and respond aptly. 41 TCSs are predicted in Bacillus anthracis, a potential bioterrorism agent, of which only four have been studied so far. Thus, the intricate signaling network contributed by TCSs remains largely unmapped in B. anthracis and needs comprehensive exploration. In this study, we functionally characterized one such system composed of BAS0540 (Response regulator) and BAS0541 (Histidine kinase). BAS0540-BAS0541, the closest homolog of CiaRH of Streptococcus in B. anthracis, forms a functional TCS with BAS0541 displaying autophosphorylation and subsequent phosphotransfer to BAS0540. BAS0540 was also found to accept phosphate from physiologically relevant small molecule phosphodonors like acetyl phosphate and carbamoyl phosphate. Results of qRT-PCR and immunoblotting demonstrated that BAS0540 exhibits a constitutive expression throughout the growth of B. anthracis. Regulon prediction for BAS0540 in B. anthracis was done in silico using the consensus DNA binding sequence of CiaR of Streptococcus. The predicted regulon of BAS0540 comprised of 23 genes, which could be classified into 8 functionally diverse categories. None of the proven virulence factors were a part of the predicted regulon, an observation contrasting with the regulon of CiaRH in Streptococci. Electrophoretic mobility shift assay was used to show direct binding of purified BAS0540 to the upstream regions of 5 putative regulon candidates-BAS0540 gene itself; a gene predicted to encode cell division protein FtsA; a self-immunity gene; a RND family transporter gene and a gene encoding stress (heat) responsive protein. A significant enhancement in the DNA binding ability of BAS0540 was observed upon phosphorylation. Overexpression of response regulator BAS0540 in B. anthracis led to a prodigious increase of similar to 6 folds in the cell length, thereby conferring it a filamentous phenotype. Furthermore, the sporulation titer of the pathogen also decreased markedly by similar to 16 folds. Thus, this study characterizes a novel TCS of B. anthracis and elucidates its role in two of the most important physiological processes of the pathogen: cell division and sporulation.	[Gopalani, Monisha; Dhiman, Alisha; Rahi, Amit; Kandari, Divya; Bhatnagar, Rakesh] Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Bhatnagar, R (corresponding author), Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, India.	rakeshbhatnagar@jnu.ac.in	Dhiman, Alisha/ABY-2171-2022	Dhiman, Alisha/0000-0002-4395-9292; Kandari, Divya/0000-0002-9575-0263	Department of Science and Technology, Govt. of India; Council of Scientific and Industrial Research-India; CSIR, Government of India; DST, Government of India; DBT, Government of India	Department of Science and Technology, Govt. of India(Department of Science & Technology (India)); Council of Scientific and Industrial Research-India(Council of Scientific & Industrial Research (CSIR) - India); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); DST, Government of India(Department of Science & Technology (India)); DBT, Government of India(Department of Biotechnology (DBT) India)	This study was funded in part by Department of Science and Technology, Govt. of India. MG and AD acknowledge fellowships by Council of Scientific and Industrial Research-India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the financial support from CSIR, DST and DBT, Government of India. While Monisha Gopalani and Alisha Dhiman are recipients of a Senior Research Fellowship from CSIR, Government of India, Divya Kandari is a recipient of Junior Research Fellowship from DBT, Government of India. The funding agency has no role in study design or data analysis and interpretation. Mr. Ashok Kumar Sahu at AIRF, JNU is acknowledged for his technical help in Confocal microscopy experiments. We thank Shashwat Deepali Nagar for his inputs in the bioinformatics study.	Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143; Barakat M, 2011, NUCLEIC ACIDS RES, V39, pD771, DOI 10.1093/nar/gkq1023; Barbieri CM, 2010, J BIOL CHEM, V285, P32325, DOI 10.1074/jbc.M110.157164; BEALL B, 1992, J BACTERIOL, V174, P2398, DOI 10.1128/JB.174.7.2398-2403.1992; BEALL B, 1991, GENE DEV, V5, P447, DOI 10.1101/gad.5.3.447; Belcheva A, 2008, J BIOL CHEM, V283, P12354, DOI 10.1074/jbc.M710010200; Bhate MP, 2015, STRUCTURE, V23, P981, DOI 10.1016/j.str.2015.04.002; Biasini M, 2014, NUCLEIC ACIDS RES; Bourret RB, 2002, J BIOL CHEM, V277, P9625, DOI 10.1074/jbc.R100066200; Brocker M, 2011, J BACTERIOL, V193, P1237, DOI 10.1128/JB.01032-10; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Comolli JC, 2002, J BACTERIOL, V184, P390, DOI 10.1128/JB.184.2.390-399.2002; de Been M, 2006, MICROBIOL-SGM, V152, P3035, DOI 10.1099/mic.0.29137-0; Dhiman A, 2014, FEBS OPEN BIO, V4, P65, DOI 10.1016/j.fob.2013.12.005; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Feng XH, 2004, MOL MICROBIOL, V54, P823, DOI 10.1111/j.1365-2958.2004.04317.x; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Fisher SL, 1996, BIOCHEMISTRY-US, V35, P4732, DOI 10.1021/bi9525435; Fukuchi K, 2000, MICROBIOL-UK, V146, P1573, DOI 10.1099/00221287-146-7-1573; Galperin MY, 2010, MOL BIOSYST, V6, P721, DOI 10.1039/b908047c; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Grimshaw CE, 1998, BIOCHEMISTRY-US, V37, P1365, DOI 10.1021/bi971917m; Halfmann A, 2011, J MOL MICROB BIOTECH, V20, P96, DOI 10.1159/000324893; Helmann JD, 2001, J BACTERIOL, V183, P7318, DOI 10.1128/JB.183.24.7318-7328.2001; Hoch JA, 2001, J BACTERIOL, V183, P4941, DOI 10.1128/JB.183.17.4941-4949.2001; Hoch JA, 1995, 2 COMPONENT SIGNAL T; HOLMAN TR, 1994, BIOCHEMISTRY-US, V33, P4625, DOI 10.1021/bi00181a024; Hudson MJ, 2008, INT J MED MICROBIOL, V298, P345, DOI 10.1016/j.ijmm.2007.09.007; Ibrahim YM, 2004, J BACTERIOL, V186, P5258, DOI 10.1128/JB.186.16.5258-5266.2004; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kjos M, 2010, J BACTERIOL, V192, P2068, DOI 10.1128/JB.01553-09; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Liu W, 1997, J BACTERIOL, V179, P6302, DOI 10.1128/jb.179.20.6302-6310.1997; Mao XZ, 2014, NUCLEIC ACIDS RES, V42, pD654, DOI 10.1093/nar/gkt1048; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marx P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-661; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Ng WL, 2005, J BACTERIOL, V187, P7444, DOI 10.1128/JB.187.21.7444-7459.2005; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Periago PM, 2002, APPL ENVIRON MICROB, V68, P3486, DOI 10.1128/AEM.68.7.3486-3495.2002; Price CW, 2001, MOL MICROBIOL, V41, P757, DOI 10.1046/j.1365-2958.2001.02534.x; Puppe W, 1996, J BIOL CHEM, V271, P25027, DOI 10.1074/jbc.271.40.25027; Rangannan Vetriselvi, 2011, BMC Res Notes, V4, P257, DOI 10.1186/1756-0500-4-257; Ray JCJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000676; Ruiz D, 2008, MICROBIOL-SGM, V154, P3002, DOI 10.1099/mic.0.2008/020677-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHRODER I, 1994, J BACTERIOL, V176, P4985, DOI 10.1128/jb.176.16.4985-4992.1994; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334; Stephenson K, 2002, PHARMACOL THERAPEUT, V93, P293, DOI 10.1016/S0163-7258(02)00198-5; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Thomas-Chollier M, 2011, NUCLEIC ACIDS RES, V39, pW86, DOI 10.1093/nar/gkr377; Throup JP, 2000, MOL MICROBIOL, V35, P566, DOI 10.1046/j.1365-2958.2000.01725.x; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200; Zapf JW, 1996, BIOCHEMISTRY-US, V35, P2926, DOI 10.1021/bi9519361	59	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158895	10.1371/journal.pone.0158895	http://dx.doi.org/10.1371/journal.pone.0158895			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392063	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400154
J	Jeong, SY; Lee, JH; Shin, Y; Chung, S; Kuh, HJ				Jeong, Su-Yeong; Lee, Ji-Hyun; Shin, Yoojin; Chung, Seok; Kuh, Hyo-Jeong			Co-Culture of Tumor Spheroids and Fibroblasts in a Collagen Matrix-Incorporated Microfluidic Chip Mimics Reciprocal Activation in Solid Tumor Microenvironment	PLOS ONE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; STROMAL INTERACTIONS; COLON-CANCER; CELLS; RESISTANCE; CULTURE; MODEL; EXPRESSION; SYSTEM; POLYDIMETHYLSILOXANE	Multicellular 3D culture and interaction with stromal components are considered essential elements in establishing a 'more clinically relevant' tumor model. Matrix-embedded 3D cultures using a microfluidic chip platform can recapitulate the microscale interaction within tumor microenvironments. As a major component of tumor microenvironment, cancer-associated fibroblasts (CAFs) play a role in cancer progression and drug resistance. Here, we present a microfluidic chip-based tumor tissue culture model that integrates 3D tumor spheroids (TSs) with CAF in proximity within a hydrogel scaffold. HT-29 human colorectal carcinoma cells grew into 3D TSs and the growth was stimulated when co-cultured with fibroblasts as shown by 1.5-folds increase of % changes in diameter over 5 days. TS cultured for 6 days showed a reduced expression of Ki-67 along with increased expression of fibronectin when co-cultured with fibroblasts compared to mono-cultured TSs. Fibroblasts were activated under co-culture conditions, as demonstrated by increases in alpha-SMA expression and migratory activity. When exposed to paclitaxel, a survival advantage was observed in TSs co-cultured with activated fibroblasts. Overall, we demonstrated the reciprocal interaction between TSs and fibroblasts in our 7-channel microfluidic chip. The co-culture of 3D TS-CAF in a collagen matrix-incorporated microfluidic chip may be useful to study the tumor microenvironment and for evaluation of drug screening and evaluation.	[Jeong, Su-Yeong; Lee, Ji-Hyun; Kuh, Hyo-Jeong] Catholic Univ Korea, Grad Sch, Dept Biomed & Hlth Sci, Seoul, South Korea; [Shin, Yoojin] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Chung, Seok] Korea Univ, Sch Mech Engn, Seoul, South Korea; [Kuh, Hyo-Jeong] Catholic Univ Korea, Coll Med, Canc Evolut Res Ctr, Seoul, South Korea; [Kuh, Hyo-Jeong] Catholic Univ Korea, Coll Med, Dept Med Life Sci, Seoul, South Korea	Catholic University of Korea; Massachusetts Institute of Technology (MIT); Korea University; Catholic University of Korea; Catholic University of Korea	Kuh, HJ (corresponding author), Catholic Univ Korea, Grad Sch, Dept Biomed & Hlth Sci, Seoul, South Korea.; Kuh, HJ (corresponding author), Catholic Univ Korea, Coll Med, Canc Evolut Res Ctr, Seoul, South Korea.; Kuh, HJ (corresponding author), Catholic Univ Korea, Coll Med, Dept Med Life Sci, Seoul, South Korea.	hkuh@catholic.ac.kr			National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning) [2012R1A2A2A01003361, 2012R1A5A2047939]	National Research Foundation of Korea (NRF) - Korea government (Ministry of Science, ICT and Future Planning)	This work was supported by the National Research Foundation of Korea (NRF, http://www.nrf.re.kr) grant funded by the Korea government (Ministry of Science, ICT and Future Planning) (Nos. 2012R1A2A2A01003361 and 2012R1A5A2047939) to H-JK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Amornsupak K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-955; An D, 2014, BIOMOL THER, V22, P355, DOI 10.4062/biomolther.2014.078; Aref AR, 2013, INTEGR BIOL-UK, V5, P381, DOI 10.1039/c2ib20209c; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Burguera EF, 2010, EUR CELLS MATER, V19, P166, DOI 10.22203/eCM.v019a17; Cao Y, 2015, CANCER LETT, V360, P141, DOI 10.1016/j.canlet.2015.01.041; Celgene Corporation, 2000, PHAS 2 STUD ABR NAB; Choe C, 2013, ANTICANCER RES, V33, P3715; Chuah YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18162; Cirri P, 2011, AM J CANCER RES, V1, P482; Cohen A, 2014, AUSTIN J GASTROENTER, V1, P1003; Davies S, 2015, BIOMED PHARMACOTHER, V71, P135, DOI 10.1016/j.biopha.2015.02.031; Denayer T, 2014, NEW HORIZ TRANSL MED, V2, P5, DOI 10.1016/j.nhtm.2014.08.001; Doillon CJ, 2004, ANTICANCER RES, V24, P2169; Elliott NT, 2012, BIOTECHNOL BIOENG, V109, P1326, DOI 10.1002/bit.24397; Fang Wei Bin, 2014, Front Biol (Beijing), V9, P114; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Fuchs S, 2007, TISSUE ENG, V13, P2577, DOI 10.1089/ten.2007.0022; Fujita H, 2009, CANCER SCI, V100, P2309, DOI 10.1111/j.1349-7006.2009.01317.x; Fujiwara M, 2016, ONCOL LETT, V11, P2773, DOI 10.3892/ol.2016.4289; Halldorsson S, 2015, BIOSENS BIOELECTRON, V63, P218, DOI 10.1016/j.bios.2014.07.029; Han S, 2012, LAB CHIP, V12, P2305, DOI 10.1039/c2lc21285d; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Herrera M, 2013, CLIN CANCER RES, V19, P5914, DOI 10.1158/1078-0432.CCR-13-0694; Horman SR, 2013, J BIOMOL SCREEN, V18, P1298, DOI 10.1177/1087057113499405; Hu J, 2015, ONCOL LETT, V10, P2378, DOI 10.3892/ol.2015.3499; Huang SM, 2014, ENDOCR-RELAT CANCER, V21, P73, DOI 10.1530/ERC-13-0351; Jensen SA, 2010, EUR J CANCER, V46, P3233, DOI 10.1016/j.ejca.2010.07.046; Jia DS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-364; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Khawar IA, 2015, J CONTROL RELEASE, V201, P78, DOI 10.1016/j.jconrel.2014.12.018; Kim SY, 2012, ARCH PHARM RES, V35, P531, DOI 10.1007/s12272-012-0317-2; Kim S, 2013, LAB CHIP, V13, P1489, DOI 10.1039/c3lc41320a; Kim SA, 2015, EXP CELL RES, V335, P187, DOI 10.1016/j.yexcr.2015.05.016; Larrinaga G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119436; Lee DW, 2013, SENSOR ACTUAT B-CHEM, V177, P78, DOI 10.1016/j.snb.2012.10.129; Lee H, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4894595; Liu TJ, 2010, LAB CHIP, V10, P1671, DOI 10.1039/c000022a; Majety M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127948; Mazzoccoli G, 2012, J CANCER RES CLIN, V138, P501, DOI 10.1007/s00432-011-1126-6; Mellor LF, 2014, AVIAT SPACE ENVIR MD, V85, P798, DOI 10.3357/ASEM.3905.2014; Mesker WE, 2007, CELL ONCOL, V29, P387; Miyanaga K, 2002, ANTICANCER RES, V22, P3941; Nebiker CA, 2014, CLIN CANCER RES, V20, P3094, DOI 10.1158/1078-0432.CCR-13-2774; Ongusaha PP, 2004, CANCER RES, V64, P5283, DOI 10.1158/0008-5472.CAN-04-0925; Paraiso KHT, 2013, BIOCHEM PHARMACOL, V85, P1033, DOI 10.1016/j.bcp.2013.01.018; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Ryu J, 2010, ADV FUNCT MATER, V20, P2132, DOI 10.1002/adfm.200902347; Schyschka L, 2013, ARCH TOXICOL, V87, P1581, DOI 10.1007/s00204-013-1080-y; Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Unger C, 2014, ADV DRUG DELIVER REV, V79-80, P50, DOI 10.1016/j.addr.2014.10.015; van Duinen V, 2015, CURR OPIN BIOTECH, V35, P118, DOI 10.1016/j.copbio.2015.05.002; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Zeng Fan, 2014, Journal of Pharmaceutical Investigation, V44, P493, DOI 10.1007/s40005-014-0154-z; Zheng LH, 2014, ONCOL LETT, V8, P479, DOI 10.3892/ol.2014.2225	61	160	164	3	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159013	10.1371/journal.pone.0159013	http://dx.doi.org/10.1371/journal.pone.0159013			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391808	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400190
J	Knappova, J; Pankova, H; Munzbergov, Z				Knappova, Jana; Pankova, Hana; Munzbergov, Zuzana			Roles of Arbuscular Mycorrhizal Fungi and Soil Abiotic Conditions in the Establishment of a Dry Grassland Community	PLOS ONE			English	Article							INFLUENCE PLANT DIVERSITY; ZEA-MAYS L.; AGRICULTURAL PRACTICES; VERTICAL-DISTRIBUTION; SPECIES RICHNESS; FIELD; COLONIZATION; DYNAMICS; BIOMASS; BENOMYL	Background The importance of soil biota in the composition of mature plant communities is commonly acknowledged. In contrast, the role of soil biota in the early establishment of new plant communities and their relative importance for soil abiotic conditions are still poorly understood. Aims and Methods The aim of this study was to understand the effects of soil origin and soil fungal communities on the composition of a newly established dry grassland plant community. We used soil from two different origins (dry grassland and abandoned field) with different pH and nutrient and mineral content. Grassland microcosms were established by sowing seeds of 54 species of dry grassland plants into the studied soils. To suppress soil fungi, half of the pots were regularly treated with fungicide. In this way, we studied the independent and combined effects of soil origin and soil community on the establishment of dry grassland communities. Key Results The effect of suppressing the soil fungal community on the richness and composition of the plant communities was much stronger than the effect of soil origin. Contrary to our expectations, the effects of these two factors were largely additive, indicating the same degree of importance of soil fungal communities in the establishment of species-rich plant communities in the soils from both origins. The negative effect of suppressing soil fungi on species richness, however, occurred later in the soil from the abandoned field than in the soil from the grassland. This result likely occurred because the negative effects of the suppression of fungi in the field soil were caused mainly by changes in plant community composition and increased competition. In contrast, in the grassland soil, the absence of soil fungi was limiting for plants already at the early stages of their establishment, i.e., in the phases of germination and early recruitment. While fungicide affects not only arbuscular mycorrhizal fungi but also other biota, our data indicate that changes in the AMF communities are the most likely drivers of the observed changes. The effects of other soil biota, however, cannot be fully excluded. Conclusions These results suggest that the availability of soil fungi may not be the most important limiting factor for the establishment of grassland species in abandoned fields if we manage to reduce the intensity of competition at these sites e.g., by mowing or grazing.	[Knappova, Jana; Pankova, Hana; Munzbergov, Zuzana] Acad Sci, Inst Bot, Zamek 1, Pruhonice 25243, Czech Republic; [Knappova, Jana; Munzbergov, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Benatska 2, Prague 12801, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague	Munzbergov, Z (corresponding author), Acad Sci, Inst Bot, Zamek 1, Pruhonice 25243, Czech Republic.; Munzbergov, Z (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Benatska 2, Prague 12801, Czech Republic.	zuzmun@natur.cuni.cz	Pánková, Hana/H-1617-2014; Münzbergová, Zuzana/F-6321-2013; Knappová, Jana/I-7197-2016	Pánková, Hana/0000-0001-6012-541X; Münzbergová, Zuzana/0000-0002-4026-6220; Knappová, Jana/0000-0002-8095-2583	Grant agency of the Czech Republic [GACR 15-11635S]; Czech Academy of Sciences [RVO 67985939]	Grant agency of the Czech Republic(Grant Agency of the Czech Republic); Czech Academy of Sciences(Czech Academy of Sciences)	The study was support by Grant agency of the Czech Republic (www.gacr.cz, grant no. GACR 15-11635S) and institutional projects of Ministry of education (www.msmt.cz) and Czech Academy of Sciences (www.cas.cz, project no. RVO 67985939).; We thank Lenka Cosentino for help with maintenance and for evaluating the experiment, David Cmiral, Vaclav Rimal and Michal Knapp for help with soil collection, Helena Kebrtova, Vera Rydlova, Marketa Sequencova, Ondrej Minovsky and student helpers for harvesting and preparing root samples and the POPEKOL discussion group and two anonymous reviewers for useful comments on the previous version of the manuscript. The study was support by Grant agency of the Czech Republic (www.gacr.cz, grant no. GACR 15-11635S) and institutional projects of Ministry of education (www.msmt.cz) and Czech Academy of Sciences (www.cas.cz, project no. RVO 67985939).	AERTS R, 1991, OECOLOGIA, V87, P551, DOI 10.1007/BF00320419; AN ZQ, 1990, SOIL BIOL BIOCHEM, V22, P715, DOI 10.1016/0038-0717(90)90020-Z; Anderson RC, 2008, RESTOR ECOL, V16, P650, DOI 10.1111/j.1526-100X.2008.00488.x; Barni E, 2000, MYCORRHIZA, V10, P63, DOI 10.1007/s005720000059; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Boddington CL, 2000, PLANT SOIL, V218, P137, DOI 10.1023/A:1014966801446; Boddington CL, 2000, PLANT SOIL, V218, P145, DOI 10.1023/A:1014911318284; Boerner REJ, 1996, MYCORRHIZA, V6, P79, DOI 10.1007/s005720050111; Boyer LR, 2015, MYCORRHIZA, V25, P215, DOI 10.1007/s00572-014-0603-6; Braak Ter C., 1998, CANOCO REFERENCE MAN; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Cerna L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116992; Chen SK, 2001, SOIL BIOL BIOCHEM, V33, P1971, DOI 10.1016/S0038-0717(01)00131-6; Chylova T, 2008, PRESLIA, V80, P183; Dhillion SS, 2004, CAN J BOT, V82, P104, DOI [10.1139/b03-139, 10.1139/B03-139]; Dostalek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080535; Doubkova P, 2013, PLANT SOIL, V370, P149, DOI 10.1007/s11104-013-1610-7; Drouin P, 2010, J ENVIRON SCI HEAL B, V45, P757, DOI 10.1080/03601234.2010.515168; Duchicela J, 2013, J APPL ECOL, V50, P1266, DOI 10.1111/1365-2664.12130; Ejrnaes R, 2006, ECOLOGY, V87, P1225, DOI 10.1890/0012-9658(2006)87[1225:CAIEGS]2.0.CO;2; Environmental Protection Agency, 2001, BEN; Eriksson O, 1998, ECOL RES, V13, P229, DOI 10.1046/j.1440-1703.1998.00260.x; FITTER AH, 1986, NEW PHYTOL, V103, P767, DOI 10.1111/j.1469-8137.1986.tb00851.x; FITTER AH, 1988, NEW PHYTOL, V110, P201, DOI 10.1111/j.1469-8137.1988.tb00253.x; Foster BL, 2009, ECOL APPL, V19, P1884, DOI 10.1890/08-0849.1; FRIESE CF, 1991, MYCOLOGIA, V83, P409, DOI 10.2307/3760351; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Fukami T, 2011, ECOL LETT, V14, P973, DOI 10.1111/j.1461-0248.2011.01663.x; Gange AC, 1999, OIKOS, V87, P615, DOI 10.2307/3546829; GANGE AC, 1993, FUNCT ECOL, V7, P616, DOI 10.2307/2390139; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; GRYNDLER M, 1995, ROST VYROBA, V41, P533; HARLEY JL, 1987, NEW PHYTOL, V107, P741, DOI 10.1111/j.1469-8137.1987.tb00912.x; Hart MM, 2003, TRENDS ECOL EVOL, V18, P418, DOI 10.1016/S0169-5347(03)00127-7; Hart MM, 2002, NEW PHYTOL, V153, P335, DOI 10.1046/j.0028-646X.2001.00312.x; Hartnett DC, 1999, ECOLOGY, V80, P1187, DOI 10.1890/0012-9658(1999)080[1187:MIPCSA]2.0.CO;2; Helgason T, 2007, J ECOL, V95, P623, DOI 10.1111/j.1365-2745.2007.01239.x; Hemrova L, 2015, OIKOS, V124, P437, DOI 10.1111/oik.01130; Heneghan L, 2008, RESTOR ECOL, V16, P608, DOI 10.1111/j.1526-100X.2008.00477.x; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Hoechst Schering AgrEvo, TECHN INF CARB; JAKOBSEN I, 1983, NEW PHYTOL, V93, P401, DOI 10.1111/j.1469-8137.1983.tb03440.x; JANOS DP, 1980, BIOTROPICA, V12, P56, DOI 10.2307/2388157; Jansa J, 2002, MYCORRHIZA, V12, P225, DOI [10.1007/s005572-002-0163-z, 10.1007/s00572-002-0163-z]; Janssens F, 1998, PLANT SOIL, V202, P69, DOI 10.1023/A:1004389614865; Johnson Nancy Collins, 1992, V54, P71; JOHNSON NC, 1991, OECOLOGIA, V86, P349, DOI 10.1007/BF00317600; JOHNSON NC, 1993, ECOL APPL, V3, P749, DOI 10.2307/1942106; JOHNSON NC, 1991, NEW PHYTOL, V117, P657, DOI 10.1111/j.1469-8137.1991.tb00970.x; Kabir Z, 1998, MYCORRHIZA, V8, P53, DOI 10.1007/s005720050211; Karanika ED, 2008, PLANT ECOL, V199, P225, DOI 10.1007/s11258-008-9427-9; Kardol P, 2014, J ECOL, V102, P622, DOI 10.1111/1365-2745.12234; Kardol P, 2013, OIKOS, V122, P84, DOI 10.1111/j.1600-0706.2012.20546.x; Knappova J, 2015, AGR ECOSYST ENVIRON, V200, P200, DOI 10.1016/j.agee.2014.11.008; Knappova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065879; Knappova J, 2012, LANDSCAPE ECOL, V27, P97, DOI 10.1007/s10980-011-9680-5; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Lepa J., 2003, MULTIVARIATE ANAL EC; Lindborg R, 2006, BIODIVERS CONSERV, V15, P957, DOI 10.1007/s10531-004-3508-4; Lopez-Garcia A, 2014, OECOLOGIA, V176, P1075, DOI 10.1007/s00442-014-3091-7; Mader P, 2000, BIOL FERT SOILS, V31, P150, DOI 10.1007/s003740050638; MARTENSSON AM, 1992, SOIL BIOL BIOCHEM, V24, P435, DOI 10.1016/0038-0717(92)90206-D; Massenssini AM, 2014, PLANTA DANINHA, V32, P873, DOI 10.1590/S0100-83582014000400022; MCGONIGLE TP, 1990, NEW PHYTOL, V116, P629, DOI 10.1111/j.1469-8137.1990.tb00548.x; Merryweather J, 1996, NEW PHYTOL, V132, P307, DOI 10.1111/j.1469-8137.1996.tb01850.x; Middleton EL, 2012, RESTOR ECOL, V20, P218, DOI 10.1111/j.1526-100X.2010.00752.x; Mouillot D, 2006, OIKOS, V115, P349, DOI 10.1111/j.2006.0030-1299.14894.x; Mouquet N, 2004, OIKOS, V104, P77, DOI 10.1111/j.0030-1299.2004.12644.x; Munzbergova Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046704; Munzbergova Z, 2004, OIKOS, V105, P408, DOI 10.1111/j.0030-1299.2004.13017.x; Muthukumar T, 2004, MYCORRHIZA, V14, P65, DOI 10.1007/s00572-004-0296-3; NEWSHAM KK, 1994, J ECOL, V82, P805, DOI 10.2307/2261445; O'Connor PJ, 2002, NEW PHYTOL, V154, P209, DOI 10.1046/j.1469-8137.2002.00364.x; Oehl F, 2005, NEW PHYTOL, V165, P273, DOI 10.1111/j.1469-8137.2004.01235.x; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Olsen R., 1954, US DEP AGR CIRCULAR, V939, P1; Osbornova J., 1990, SUCCESSION ABANDONED, VVolume 15; Pankova H, 2008, OECOLOGIA, V157, P211, DOI 10.1007/s00442-008-1064-4; Pankova H, 2011, AM J BOT, V98, P850, DOI 10.3732/ajb.0900350; Poggio SL, 2011, WEED RES, V51, P241, DOI 10.1111/j.1365-3180.2011.00845.x; Puschel D, 2007, BASIC APPL ECOL, V8, P510, DOI 10.1016/j.baae.2006.09.002; Pywell RF, 2002, J APPL ECOL, V39, P294, DOI 10.1046/j.1365-2664.2002.00718.x; Raabova J, 2011, BASIC APPL ECOL, V12, P152, DOI 10.1016/j.baae.2011.01.001; READ DJ, 1988, P ROY SOC EDINB B, V94, P13, DOI 10.1017/S0269727000007065; REEVES FB, 1979, AM J BOT, V66, P6, DOI 10.2307/2442618; Richter BS, 2002, APPL SOIL ECOL, V20, P227, DOI 10.1016/S0929-1393(02)00038-0; Sakai S, 2004, J THEOR BIOL, V226, P253, DOI 10.1016/S0022-5193(03)00281-9; Schweiger PF, 2001, SOIL BIOL BIOCHEM, V33, P1231, DOI 10.1016/S0038-0717(01)00028-1; Skalova H, 1999, PLANT ECOL, V143, P129, DOI 10.1023/A:1009899803229; Smith MD, 1999, OECOLOGIA, V121, P574, DOI 10.1007/s004420050964; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Standish RJ, 2007, J APPL ECOL, V44, P435, DOI 10.1111/j.1365-2664.2006.01262.x; Stover HJ, 2012, APPL SOIL ECOL, V60, P61, DOI 10.1016/j.apsoil.2012.02.016; Tognetti PM, 2012, BIOL INVASIONS, V14, P2531, DOI 10.1007/s10530-012-0249-2; van Breugel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082433; van der Heijden MGA, 2004, ECOL LETT, V7, P293, DOI 10.1111/j.1461-0248.2004.00577.x; van der Heijden MGA, 2003, NEW PHYTOL, V157, P569, DOI 10.1046/j.1469-8137.2003.00688.x; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; van der Wal A, 2009, RESTOR ECOL, V17, P308, DOI 10.1111/j.1526-100X.2007.00349.x; Verbruggen E, 2010, EVOL APPL, V3, P547, DOI 10.1111/j.1752-4571.2010.00145.x; Voriskova A, 2016, AGR ECOSYST ENVIRON, V221, P28, DOI 10.1016/j.agee.2016.01.012; Walker KJ, 2004, BIOL CONSERV, V119, P1, DOI 10.1016/j.biocon.2003.10.020; Wilson GWT, 1998, AM J BOT, V85, P1732, DOI 10.2307/2446507; WILSON JM, 1983, AUST J SOIL RES, V21, P73, DOI 10.1071/SR9830073; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; Zhao RX, 2015, APPL SOIL ECOL, V88, P41, DOI 10.1016/j.apsoil.2014.11.016	107	9	10	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158925	10.1371/journal.pone.0158925	http://dx.doi.org/10.1371/journal.pone.0158925			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391899	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400165
J	Simon, N; Vasseur, M; Pinturaud, M; Soichot, M; Richeval, C; Humbert, L; Lebecque, M; Sidikou, O; Barthelemy, C; Bonnabry, P; Allorge, D; Decaudin, B; Odou, P				Simon, Nicolas; Vasseur, Michele; Pinturaud, Marine; Soichot, Marion; Richeval, Camille; Humbert, Luc; Lebecque, Michele; Sidikou, Ousseini; Barthelemy, Christine; Bonnabry, Pascal; Allorge, Delphine; Decaudin, Bertrand; Odou, Pascal			Effectiveness of a Closed-System Transfer Device in Reducing Surface Contamination in a New Antineoplastic Drug-Compounding Unit: A Prospective, Controlled, Parallel Study	PLOS ONE			English	Article							HOSPITAL PHARMACIES; WORKPLACE CONTAMINATION; ENVIRONMENTAL CONTAMINATION; CLEANING SOLUTIONS; ANTICANCER DRUGS; HAZARDOUS DRUGS; CYCLOPHOSPHAMIDE; AGENTS; EXPOSURE; EFFICACY	Background The objective of this randomized, prospective and controlled study was to investigate the ability of a closed-system transfer device (CSTD; BD-Phaseal) to reduce the occupational exposure of two isolators to 10 cytotoxic drugs and compare to standard compounding devices. Methods and Findings The 6-month study started with the opening of a new compounding unit. Two isolators were set up with 2 workstations each, one to compound with standard devices (needles and spikes) and the other using the Phaseal system. Drugs were alternatively compounded in each isolator. Sampling involved wiping three surfaces (gloves, window, worktop), before and after a cleaning process. Exposure to ten antineoplastic drugs (cyclophosphamide, ifosfamide, dacarbazine, 5-FU, methotrexate, gemcitabine, cytarabine, irinotecan, doxorubicine and ganciclovir) was assessed on wipes by LC-MS/MS analysis. Contamination rates were compared using a Chi(2) test and drug amounts by a Mann-Whitney test. Significance was defined for p<0.05. Overall contamination was lower in the "Phaseal" isolator than in the "Standard" isolator (12.24% vs. 26.39%; p < 0.0001) although it differed according to drug. Indeed, the contamination rates of gemcitabine were 49.3 and 43.4%(NS) for the Standard and Phaseal isolators, respectively, whereas for ganciclovir, they were 54.2 and 2.8% (p < 0.0001). Gemcitabine amounts were 220.6 and 283.6 ng for the Standard and Phaseal isolators (NS), and ganciclovir amounts were 179.9 and 2.4 ng (p < 0.0001). Conclusion This study confirms that using a CSTD may significantly decrease the chemical contamination of barrier isolators compared to standard devices for some drugs, although it does not eliminate contamination totally.	[Simon, Nicolas; Vasseur, Michele; Barthelemy, Christine; Decaudin, Bertrand; Odou, Pascal] GRITA Grp Rech Formes Injectables & Technol Assoc, EA 7365, F-59000 Lille, France; [Simon, Nicolas; Vasseur, Michele; Pinturaud, Marine; Lebecque, Michele; Sidikou, Ousseini; Decaudin, Bertrand; Odou, Pascal] CHU Lille, Inst Pharmacie, F-59000 Lille, France; [Soichot, Marion] Hop Lariboisiere, AP HP, Lab Toxicol, Paris, France; [Richeval, Camille; Humbert, Luc; Allorge, Delphine] CHRU Lille, Unite Fonct Toxicol, Pole Biol Pathol Genet, F-59037 Lille, France; [Bonnabry, Pascal] Univ Hosp Geneva, Pharm, Geneva, Switzerland; [Bonnabry, Pascal] Univ Geneva, Univ Lausanne, Sch Pharmaceut Sci, Geneva, Switzerland	Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; University of Geneva; University of Geneva; University of Lausanne	Simon, N (corresponding author), GRITA Grp Rech Formes Injectables & Technol Assoc, EA 7365, F-59000 Lille, France.; Simon, N (corresponding author), CHU Lille, Inst Pharmacie, F-59000 Lille, France.	nicolas.simon@univ-lille2.fr	BARTHELEMY, Christine/A-8968-2017; SIMON, Nicolas/G-4328-2016	BARTHELEMY, Christine/0000-0001-9774-1857; allorge, delphine/0000-0003-2356-3319; SIMON, Nicolas/0000-0001-5257-440X	Becton-Dickinson laboratories, manufacturer of the tested device	Becton-Dickinson laboratories, manufacturer of the tested device	The study was funded by Becton-Dickinson laboratories, manufacturer of the tested device. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Society of Health-System Pharmacists, 2006, AM J HEALTH-SYST PH, V63, P1172, DOI DOI 10.2146/AJHP050529; Anastasi M, 2015, ANN OCCUP HYG, V59, P895, DOI 10.1093/annhyg/mev031; [Anonymous], 1996, AM J HEALTH-SYST PH, V53, P1669; Bobin-Dubigeon C, 2013, J ANAL TOXICOL, V37, P433, DOI 10.1093/jat/bkt045; Clark Bernadette A, 2013, J Oncol Pharm Pract, V19, P99, DOI 10.1177/1078155212468367; Comite Francais d'Accreditation, SH GTA 04 GUIDE TECH; Connor TH, 2002, AM J HEALTH-SYST PH, V59, P68, DOI 10.1093/ajhp/59.1.68; Connor TH, 2014, J OCCUP ENVIRON MED, V56, P901, DOI 10.1097/JOM.0000000000000249; Connor TH, 2010, J OCCUP ENVIRON MED, V52, P1019, DOI 10.1097/JOM.0b013e3181f72b63; De Ausen L, 2013, AM J HEALTH-SYST PH, V70, P619, DOI 10.2146/ajhp110678; Dekyndt B, 2015, J ONCOL PHARM PRACT, V21, P102, DOI 10.1177/1078155214520820; Edwards Michael S, 2013, J Oncol Pharm Pract, V19, P338, DOI 10.1177/1078155213499387; FALCK K, 1979, LANCET, V1, P1250; Favier B, 2012, J Oncol Pharm Pract, V18, P37, DOI 10.1177/1078155211401454; Fleury-Souverain S, 2015, EUR J HOSP PHARM, V22, P333, DOI 10.1136/ejhpharm-2014-000549; Forges Fabien, 2011, J Oncol Pharm Pract, V17, P61, DOI 10.1177/1078155210380291; GERPAC-Europharmat Workgroup, 2007, PREP ADM DRUGS RISK; Guillemette A, 2014, J ONCOL PHARM PRACT, V20, P426, DOI 10.1177/1078155213517127; Hama Koji, 2011, J Oncol Pharm Pract, V17, P55, DOI 10.1177/1078155210373671; HARRISON BR, 1981, AM J HOSP PHARM, V38, P1686, DOI 10.1093/ajhp/38.11.1686; Harrison BR, 2006, AM J HEALTH-SYST PH, V63, P1736, DOI 10.2146/ajhp050258; Hombourger B, 2004, EUR J HOSP PHARM, V5, P71; Hon CY, 2014, ANN OCCUP HYG, V58, P761, DOI 10.1093/annhyg/meu019; Ikeno Yohei, 2014, Gan To Kagaku Ryoho, V41, P611; International Society of Oncology Pharmacy Practicioners Standards Committee, 2007, J Oncol Pharm Pract, V13 Suppl, P1; Janes Alexia, 2015, Can J Hosp Pharm, V68, P279; Jorgenson J.A., 2007, HOSP PHARM, V42, P219, DOI 10.1310/hpj4203-219; Jorgenson JA., 2008, HOSP PHARM, V43, P718; Kopp B, 2013, ANN OCCUP HYG, V57, P374, DOI 10.1093/annhyg/mes073; Lamerie TQ, 2013, ANN OCCUP HYG, V57, P456, DOI 10.1093/annhyg/mes087; Le Garlantezec P., 2011, Annales Pharmaceutiques Francaises, V69, P182, DOI 10.1016/j.pharma.2011.03.001; Martin Susan, 2003, Oncol Nurs Forum, V30, P575, DOI 10.1188/03.ONF.575-581; Mason HJ, 2003, ANN OCCUP HYG, V47, P681, DOI 10.1093/annhyg/meg078; McDiarmid MA, 2010, J OCCUP ENVIRON MED, V52, P1028, DOI 10.1097/JOM.0b013e3181f73ae6; Miyake T, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-273; National Institute for Occupational Safety and Health, 2004, PREV OCC EXP ANT OTH, V2004-165; Nishigaki R, 2010, J JAPAN SOC HOSP PHA, V46, P113; Nussbaumer S, 2012, ANAL BIOANAL CHEM, V402, P2499, DOI 10.1007/s00216-011-5157-2; Nygren O, 2002, J ENVIRON MONITOR, V4, P739, DOI 10.1039/b205132j; Nygren O, 2008, ANN OCCUP HYG, V52, P95, DOI 10.1093/annhyg/mem067; Odraska P, 2013, ANN OCCUP HYG, V57, P240, DOI 10.1093/annhyg/mes057; Sanchez-Rubio Ferrandez J, 2012, Int J Pharm Compd, V16, P431; Sato Junya, 2010, Gan To Kagaku Ryoho, V37, P1753; Sessink P. J. M., 1999, HOSP PHARM, V34, P1311; Sessink Paul J M, 2013, Hosp Pharm, V48, P204, DOI 10.1310/hpj4803-204; Sessink Paul J M, 2011, J Oncol Pharm Pract, V17, P39, DOI 10.1177/1078155210361431; Siderov Jim, 2010, J Oncol Pharm Pract, V16, P19, DOI 10.1177/1078155209352543; Smith ST, 2014, J ONCOL PHARM PRACT, V20, P381, DOI 10.1177/1078155214526428; SPIVEY S, 2003, HOSP PHARM, V38, P135; Vyas N, 2014, J ONCOL PHARM PRACT; Wick C, 2003, AM J HEALTH-SYST PH, V60, P2314, DOI 10.1093/ajhp/60.22.2314; Yodaiken R E, 1986, Am J Hosp Pharm, V43, P1193; Yoshida J, 2009, ANN OCCUP HYG, V53, P153, DOI 10.1093/annhyg/men081; ZELLMER WA, 1981, AM J HOSP PHARM, V38, P1679, DOI 10.1093/ajhp/38.11.1679; ZIMMERMAN PF, 1981, AM J HOSP PHARM, V38, P1693, DOI 10.1093/ajhp/38.11.1693; Zock Matthew D, 2011, J Oncol Pharm Pract, V17, P49, DOI 10.1177/1078155210374673	56	35	35	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159052	10.1371/journal.pone.0159052	http://dx.doi.org/10.1371/journal.pone.0159052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391697	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400202
J	Wu, GL; Kuo, TH; Tsay, TT; Tsai, IJ; Chen, PJ				Wu, Guan-Long; Kuo, Tzu-Hao; Tsay, Tung-Tsuan; Tsai, Isheng J.; Chen, Peichen J.			Glycoside Hydrolase (GH) 45 and 5 Candidate Cellulases in Aphelenchoides besseyi Isolated from Bird's-Nest Fern	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; FOLIAR NEMATODE; ROOT-KNOT; CD-HIT; EVOLUTION; PROTEINS; SEQUENCE; GENOME; FAMILY; BETA-1,4-ENDOGLUCANASE	Five Aphelenchoides besseyi isolates collected from bird's-nest ferns or rice possess different parasitic capacities in bird's-nest fern. Two different glycoside hydrolase (GH) 45 genes were identified in the fern isolates, and only one was found in the rice isolates. A Abe GH5-1 gene containing an SCP-like family domain was found only in the fern isolates. Abe GH5-1 gene has five introns suggesting a eukaryotic origin. A maximum likelihood phylogeny revealed that Abe GH5-1 is part of the nematode monophyletic group that can be clearly distinguished from those of other eukaryotic and bacterial GH5 sequences with high bootstrap support values. The fern A. besseyi isolates were the first parasitic plant nematode found to possess both GH5 and GH45 genes. Surveying the genome of the five A. besseyi isolates by Southern blotting using an 834 bp probe targeting the GH5 domain suggests the presence of at least two copies in the fern-origin isolates but none in the rice-origin isolates. The in situ hybridization shows that the Abe GH5-1 gene is expressed in the nematode ovary and testis. Our study provides insights into the diversity of GH in isolates of plant parasitic nematodes of different host origins.	[Wu, Guan-Long; Tsay, Tung-Tsuan; Chen, Peichen J.] Natl Chung Hsing Univ, Dept Plant Pathol, Taichung, Taiwan; [Kuo, Tzu-Hao; Tsai, Isheng J.] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan	National Chung Hsing University; Academia Sinica - Taiwan	Chen, PJ (corresponding author), Natl Chung Hsing Univ, Dept Plant Pathol, Taichung, Taiwan.	janetchen@nchu.edu.tw	Tsai, Isheng Jason/ABB-8273-2021	Tsai, Isheng Jason/0000-0002-2123-5058	Ministry of Science and Technology, Taiwan [MOST 103-2313-B-005-022-MY3]; National Chung Hsing University [104 S0516]; Academia Sinica [104-2313-B-001-001]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Chung Hsing University; Academia Sinica(Academia Sinica - Taiwan)	GW, PJC were funded by Ministry of Science and Technology, Taiwan, project #MOST 103-2313-B-005-022-MY3 and research grant 104 S0516 from National Chung Hsing University. IJT and THK were funded by Academia Sinica grant 104-2313-B-001-001.; We would like to thank Dr. Minn-Huey Lee for her kind advice and for her technical support with the Southern blot experiment, and Dr. Kuang Ren Chung and Dr. Wen Hsiung Ko for their suggestions and discussions about the manuscript. This research was partly funded by the Ministry of Science and Technology, Taiwan, project # MOST 103-2313-B-005-022-MY3, and research grant 104 S0516 from National Chung Hsing University. IJT and THK were funded by Academia Sinica 104-2313-B-001-001.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Alenda C, 2013, PHYSIOL MOL PLANT P, V84, P107, DOI 10.1016/j.pmpp.2013.08.004; [Anonymous], 2004, B OEPP, V34, P303; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Bird D. M., 2014, PARASITOLOGY, P1, DOI [10.1017/S0031182013002163, DOI 10.1017/S0031182013002163]; Buljan M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r74; Cantacessi C, 2012, MOL CELL PROBE, V26, P54, DOI 10.1016/j.mcp.2011.10.001; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chalmers IW, 2012, PARASITOLOGY, V139, P1231, DOI 10.1017/S0031182012000704; Cotton JA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r43; Danchin EG, 2016, MOL BIOL EVOL; Danchin Etienne G J, 2011, Mob Genet Elements, V1, P269; de Boer JM, 1998, J NEMATOL, V30, P309; Dieterich C, 2009, TRENDS GENET, V25, P203, DOI 10.1016/j.tig.2009.03.006; Franklin M.T., 1972, CIH DESCRIPTIONS PLA, VVolume 1; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Fu Z, 2012, PHYTOPATHOLOGY, V102, P804, DOI 10.1094/PHYTO-12-11-0336; Haegeman A, 2012, GENE, V492, P19, DOI 10.1016/j.gene.2011.10.040; Haegeman A, 2011, MOL PLANT MICROBE IN, V24, P879, DOI 10.1094/MPMI-03-11-0055; Holterman M, 2006, MOL BIOL EVOL, V23, P1792, DOI 10.1093/molbev/msl044; Howe KL, 2016, NUCLEIC ACIDS RES, V44, pD774, DOI 10.1093/nar/gkv1217; Hsieh SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040886; Jamali S, 2006, J AGR TECHNOL, V2, P337; Jen FY, 2012, PLANT DIS, V96, P1763, DOI 10.1094/PDIS-03-12-0229-RE; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kersting AR, 2012, GENOME BIOL EVOL, V4, P316, DOI 10.1093/gbe/evs004; Khan MR, 2012, J NEMATOL, V44, P391; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kikuchi T, 2014, NEMATOLOGY, V16, P99, DOI 10.1163/15685411-00002748; Kovalick GE, 2005, INSECT BIOCHEM MOLEC, V35, P825, DOI 10.1016/j.ibmb.2005.03.003; Li BW, 2005, MOL BIOCHEM PARASIT, V143, P49, DOI 10.1016/j.molbiopara.2005.05.005; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Manosalva P, 2015, NAT COMMUN, P6; Mayer WE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-13; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Osman A, 2012, BIOTECHNOL ADV, V30, P652, DOI 10.1016/j.biotechadv.2011.11.002; Palomares-Rius JE, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-69; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rosso MN, 1999, MOL PLANT MICROBE IN, V12, P585, DOI 10.1094/MPMI.1999.12.7.585; Rybarczyk-Mydlowska K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-221; Tang YT, 2014, NAT GENET, V46, P261, DOI 10.1038/ng.2875; Tsay T. T., 1998, Plant Protection Bulletin (Taichung), V40, P277; Tzeng C. Y., 2005, Plant Pathology Bulletin, V14, P67; Visser A, 2008, INT J PARASITOL, V38, P455, DOI 10.1016/j.ijpara.2007.08.008; Wang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091591; Wu HC, 2010, ENVIRON POLLUT, V158, P1741, DOI 10.1016/j.envpol.2009.11.015	50	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158663	10.1371/journal.pone.0158663	http://dx.doi.org/10.1371/journal.pone.0158663			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391812	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400099
J	Yang, Q; Rui, YY				Yang, Qiu; Rui, Yongyu			Two Multiplex Real-Time PCR Assays to Detect and Differentiate Acinetobacter baumannii and Non-baumannii Acinetobacter spp. Carrying bla(NDM), bla(OXA-23-Like), bla(OXA-40-Like), bla(OXA-51-Like), and bla(OXA-58-Like) Genes	PLOS ONE			English	Article							MELTING CURVE ANALYSIS; RAPID DETECTION; MOLECULAR EPIDEMIOLOGY; ESCHERICHIA-COLI; SYBR GREEN; IDENTIFICATION; ENTEROBACTERIACEAE; SURVEILLANCE; EMERGENCE; SPACER	Nosocomial infections caused by Acinetobacter spp. resistant to carbapenems are increasingly reported worldwide. Carbapenem-resistant Acinetobacter (CRA) is becoming a serious concern with increasing patient morbidity, mortality, and lengths of hospital stay. Therefore, the rapid detection of CRA is essential for epidemiological surveillance. Polymerase chain reaction (PCR) has been extensively used for the rapid identification of most pathogens. In this study, we have developed two multiplex real-time PCR assays to detect and differentiate A. baumannii and non-A. baumannii Acinetobacter spp, and common carbapenemase genes, including bla(NDM), bla(OXA-23-like), bla(OXA-40-like), bla(OXA-51-like), and bla(OXA-58-like). We demonstrate the potential utility of these assays for the direct detection of bla(NDM)-, bla(OXA-23-like)-, bla(OXA-40-like)-, bla(OXA-51-like)-, and bla(OXA-58-like)-positive CRA in clinical specimens. Primers were specifically designed, and two multiplex real-time PCR assays were developed: multiplex real-time PCR assay1 for the detection of Acinetobacter baumannii 16S-23S rRNA internal transcribed spacer sequence, the Acinetobacter recA gene, and class-B-metalloenzyme-encoding gene bla(NDM); and multiplex real-time PCR assay2 to detect class-D-oxacillinase-encoding genes (bla(OXA-23-like), bla(OXA-40-like), bla(OXA-51-like), and bla(OXA-58-like)). The assays were performed on an ABI Prism 7500 FAST Real-Time PCR System. CRA isolates were used to compare the assays with conventional PCR and sequencing. Known amounts of CRA cells were added to sputum and fecal specimens and used to test the multiplex real-time PCR assays. The results for target and nontarget amplification showed that the multiplex real-time PCR assays were specific, the limit of detection for each target was 10 copies per 20 mu L reaction volume, the assays were linear over six log dilutions of the target genes (r(2) > 0.99), and the Ct values of the coefficients of variation for intra- and interassay reproducibility were less than 5%. The multiplex real-time PCR assays showed 100% concordance with conventional PCR when tested against 400 CRA isolates and their sensitivity for the target DNA in sputum and fecal specimens was 10(2) CFU/mL. Therefore, these novel multiplex real-time PCR assays allow the sensitive and specific characterization and differentiation of bla(NDM)-, bla(OXA-23-like)-, bla(OXA-40-like)-, bla(OXA-51-like)-, and bla(OXA-58-like)-positive CRA, making them potential tools for the direct detection of CRA in clinical specimens and the surveillance of nosocomial infections.	[Yang, Qiu; Rui, Yongyu] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Rui, YY (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou, Guangdong, Peoples R China.	yongyuruigroup@sina.cm			 [2013B010404021];  [2014A010107011];  [2015A020211011];  [2015100101671]	; ; ; 	This work was supported by no. 2013B010404021 (http://pro.gdstc.gov.cn/egrantweb/), no. 2014A010107011 (http://pro.gdstc.gov.cn/egrantweb/), no. 2015A020211011 (http://pro.gdstc.gov.cn/egrantweb/), and no. 2015100101671 (http://pro.gdstc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biedenbach D, 2015, ANTIMICROB AGENTS CH, V59, P826, DOI 10.1128/AAC.03938-14; Castanheira M, 2014, CLIN INFECT DIS, V59, pS367, DOI 10.1093/cid/ciu706; Chai Z, 2013, ARCH VIROL, V158, P407, DOI 10.1007/s00705-012-1504-7; Chang HC, 2005, J CLIN MICROBIOL, V43, P1632, DOI 10.1128/JCM.43.4.1632-1639.2005; Chassagne L, 2009, DIAGN MICR INFEC DIS, V64, P98, DOI 10.1016/j.diagmicrobio.2009.01.031; Chen TL, 2007, CLIN MICROBIOL INFEC, V13, P801, DOI 10.1111/j.1469-0691.2007.01744.x; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Chui L, 2005, DIAGN MICR INFEC DIS, V53, P47, DOI 10.1016/j.diagmicrobio.2005.03.007; Diene SM, 2014, CLIN MICROBIOL INFEC, V20, P831, DOI 10.1111/1469-0691.12655; Espinal P, 2012, CLIN MICROBIOL INFEC, V18, P1097, DOI 10.1111/j.1469-0691.2011.03696.x; Espinal P, 2012, J HOSP INFECT, V80, P56, DOI 10.1016/j.jhin.2011.08.013; Evans BA, 2014, CLIN MICROBIOL REV, V27, P241, DOI 10.1128/CMR.00117-13; Fu Y, 2012, J ANTIMICROB CHEMOTH, V67, P2114, DOI 10.1093/jac/dks192; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Karah N, 2011, J ANTIMICROB CHEMOTH, V66, P738, DOI 10.1093/jac/dkq521; Kuo SC, 2012, CLIN MICROBIOL INFEC, V18, P870, DOI 10.1111/j.1469-0691.2011.03682.x; Lefterova MI, 2013, J CLIN MICROBIOL, V51, P3000, DOI 10.1128/JCM.00991-13; Mendes RE, 2007, J CLIN MICROBIOL, V45, P544, DOI 10.1128/JCM.01728-06; Nakano R, 2015, J INFECT CHEMOTHER, V21, P202, DOI 10.1016/j.jiac.2014.11.010; Pan SY, 2013, J THORAC DIS, V5, P251, DOI 10.3978/j.issn.2072-1439.2013.05.08; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Rafei R, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0441-5; Schleicher X, 2013, CLIN MICROBIOL INFEC, V19, P737, DOI 10.1111/1469-0691.12026; Shorr AF, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0572-6; Souza TB, 2013, J CLIN MICROBIOL, V51, P1031, DOI 10.1128/JCM.02478-12; Turton JF, 2010, J CLIN MICROBIOL, V48, P1445, DOI 10.1128/JCM.02467-09; Uddin Mohammad Khaja Mafij, 2013, BMC Res Notes, V6, P291, DOI 10.1186/1756-0500-6-291; Vasoo S, 2013, J CLIN MICROBIOL, V51, P3609, DOI 10.1128/JCM.01731-13; Wang HY, 2014, J CLIN MICROBIOL, V52, P1911, DOI 10.1128/JCM.00389-14; Wang QQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066406; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Yamamoto N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133204; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zheng F, 2015, MICROB DRUG RESIST, V21, P178, DOI 10.1089/mdr.2014.0085; Zheng LL, 2013, J VIROL METHODS, V187, P15, DOI 10.1016/j.jviromet.2012.06.024	35	14	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158958	10.1371/journal.pone.0158958	http://dx.doi.org/10.1371/journal.pone.0158958			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391234	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400172
J	Wang, Q; Guo, YZ; Zhang, YT; Xue, JJ; Chen, ZC; Cheng, SY; Ou, MD; Cheng, KL; Zeng, WJ				Wang, Qing; Guo, Yi-Zhan; Zhang, Yi-Tao; Xue, Jiao-Jie; Chen, Zhi-Chong; Cheng, Shi-Yao; Ou, Mao-De; Cheng, Kang-Lin; Zeng, Wei-Jie			The Effects and Mechanism of Atorvastatin on Pulmonary Hypertension Due to Left Heart Disease	PLOS ONE			English	Article							RHO-KINASE INHIBITOR; SILDENAFIL IMPROVES; FAILURE PATIENTS; SECONDARY; DYSFUNCTION; 1-YEAR; RAT	Background Pulmonary hypertension due to left heart disease (PH-LHD) is one of the most common forms of PH, termed group 2 PH. Atorvastatin exerts beneficial effects on the structural remodeling of the lung in ischemic heart failure. However, few studies have investigated the effects of atorvastatin on PH due to left heart failure induced by overload. Methods Group 2 PH was induced in animals by aortic banding. Rats (n = 20) were randomly divided into four groups: a control group (C), an aortic banding group (AOB(63)), an atorvastatin prevention group (AOB(63)/ATOR(63)) and an atorvastatin reversal group (AOB(63)/ATOR(50-63)). Atorvastatin was administered for 63 days after banding to the rats in the AOB(63)/ATOR(63) group and from days 50 to 63 to the rats in the AOB(63)/ATOR(50-63) group. Results Compared with the controls, significant increases in the mean pulmonary arterial pressure, pulmonary arteriolar medial thickening, biventricular cardiac hypertrophy, wet and dry weights of the right middle lung, percentage of PCNA-positive vascular smooth muscle cells, inflammatory infiltration and expression of RhoA and Rho-kinase II were observed in the AOB(63) group, and these changes concomitant with significant decreases in the percentage of TUNEL-positive vascular smooth muscle cells. Treatment of the rats in the AOB(63)/ATOR(63) group with atorvastatin at a dose of 10 mg/kg/day significantly decreased the mean pulmonary arterial pressure, right ventricular hypertrophy, pulmonary arteriolar medial thickness, inflammatory infiltration, percentage of PCNA-positive cells and pulmonary expression of RhoA and Rho-kinase II and significantly augmented the percentage of TUNEL-positive cells compared with the AOB(63) group. However, only a trend of improvement in pulmonary vascular remodeling was detected in the AOB(63)/ATOR(50-63) group. Conclusions Atorvastatin prevents pulmonary vascular remodeling in the PH-LHD model by down-regulating the expression of RhoA/Rho kinase, by inhibiting the proliferation and increasing the apoptosis of pulmonary arterial smooth muscle cells, and by attenuating the inflammation of pulmonary arteries.	[Wang, Qing; Zhang, Yi-Tao; Xue, Jiao-Jie; Chen, Zhi-Chong; Cheng, Shi-Yao; Ou, Mao-De; Cheng, Kang-Lin; Zeng, Wei-Jie] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Guo, Yi-Zhan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Hepat Surg, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Cheng, KL; Zeng, WJ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	chengkangling@126.com; zengwj2011@126.com	Guo, Yizhan/ABG-3539-2020	Wang, Qing/0000-0002-3882-6540	National Natural Science Foundation of China [81400301]; Fundamental Research Funds for the Central Universities [21612312]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (81400301) and the Fundamental Research Funds for the Central Universities (21612312). The funders had no role in study design, decision to publish and preparation of manuscript.	Bussotti M, 2008, INT J CARDIOL, V126, P68, DOI 10.1016/j.ijcard.2007.03.118; Dai ZK, 2011, PEDIATR PULM, V46, P45, DOI 10.1002/ppul.21323; Duan S, 2010, EXP LUNG RES, V36, P573, DOI 10.3109/01902141003739715; Guazzi M, 2011, CIRCULATION, V124, P164, DOI 10.1161/CIRCULATIONAHA.110.983866; Guazzi M, 2011, CIRC-HEART FAIL, V4, P8, DOI 10.1161/CIRCHEARTFAILURE.110.944694; Jiang BH, 2010, J CARD FAIL, V16, P679, DOI 10.1016/j.cardfail.2010.03.003; Kaluski E, 2008, CARDIOLOGY, V109, P273, DOI 10.1159/000107791; Lewis GD, 2007, CIRCULATION, V116, P1555, DOI 10.1161/CIRCULATIONAHA.107.716373; Montalescot G, 1998, AM J CARDIOL, V82, P749, DOI 10.1016/S0002-9149(98)00439-1; Oka M, 2008, BRIT J PHARMACOL, V155, P444, DOI 10.1038/bjp.2008.239; Phrommintikul A, 2008, AM J PHYSIOL-HEART C, V294, pH1804, DOI 10.1152/ajpheart.01078.2007; Rakotoniaina Z, 2006, N-S ARCH PHARMACOL, V374, P195, DOI 10.1007/s00210-006-0112-z; Rhodes CJ, 2009, PHARMACOL THERAPEUT, V121, P69, DOI 10.1016/j.pharmthera.2008.10.002; Sola S, 2006, J AM COLL CARDIOL, V47, P332, DOI 10.1016/j.jacc.2005.06.088; Yin J, 2011, CIRC-HEART FAIL, V4, P198, DOI 10.1161/CIRCHEARTFAILURE.110.957050; Zhang Man, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P73	16	15	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157171	10.1371/journal.pone.0157171	http://dx.doi.org/10.1371/journal.pone.0157171			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388289	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500002
J	Gerke, O; Wings, O				Gerke, Oliver; Wings, Oliver			Multivariate and Cladistic Analyses of Isolated Teeth Reveal Sympatry of Theropod Dinosaurs in the Late Jurassic of Northern Germany	PLOS ONE			English	Article							MEGALOSAURUS-BUCKLANDII; JUVENILE SPECIMEN; CRANIAL OSTEOLOGY; EVOLUTION; IDENTIFICATION; MESOEUCROCODYLIA; TYRANNOSAURIDAE; THALATTOSUCHIA; PHYLOGENY; ANATOMY	Remains of theropod dinosaurs are very rare in Northern Germany because the area was repeatedly submerged by a shallow epicontinental sea during the Mesozoic. Here, 80 Late Jurassic theropod teeth are described of which the majority were collected over decades from marine carbonates in nowadays abandoned and backfilled quarries of the 19th century. Eighteen different morphotypes (A-R) could be distinguished and 3D models based on micro-CT scans of the best examples of all morphotypes are included as supplements. The teeth were identified with the assistance of discriminant function analysis and cladistic analysis based on updated datamatrices. The results show that a large variety of theropod groups were present in the Late Jurassic of northern Germany. Identified specimens comprise basal Tyrannosauroidea, as well as Allosauroidea, Megalosauroidea cf. Marshosaurus, Megalosauridae cf. Torvosaurus and probably Ceratosauria. The formerly reported presence of Dromaeosauridae in the Late Jurassic of northern Germany could not be confirmed. Some teeth of this study resemble specimens described as pertaining to Carcharo-dontosauria (morphotype A) and Abelisauridae (morphotype K). This interpretation is however, not supported by discriminant function analysis and cladistic analysis. Two smaller morphotypes (N and Q) differ only in some probably size-related characteristics from larger morphotypes (B and C) and could well represent juveniles of adult specimens. The similarity of the northern German theropods with groups from contemporaneous localities suggests faunal exchange via land-connections in the Late Jurassic between Germany, Portugal and North America.	[Gerke, Oliver; Wings, Oliver] Landesmuseum Hannover, Dept Nat Hist, Willy Brandt Allee 5, Hannover, Germany		Gerke, O (corresponding author), Landesmuseum Hannover, Dept Nat Hist, Willy Brandt Allee 5, Hannover, Germany.	oliver.gerke@t-online.de	Wings, Oliver/ABC-9644-2021		Volkswagen Foundation	Volkswagen Foundation(Volkswagen)	The Volkswagen Foundation provided funding for our research in the "Europasaurus-Project" in the initiative "Research in Museums". The Volkswagen Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2012, UEXKULL PSYCHOSOMATI, V2nd; Allain R, 2005, LIFE O PAST, P72; ANTUNES MT, 1991, CR ACAD SCI II, V313, P113; Araujo R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01924; Baszio Sven, 1997, Courier Forschungsinstitut Senckenberg, V196, P33; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Benson RBJ, 2010, NATURWISSENSCHAFTEN, V97, P71, DOI 10.1007/s00114-009-0614-x; Benson RBJ, 2009, PALAEONTOLOGY, V52, P857, DOI 10.1111/j.1475-4983.2009.00884.x; Boslaugh S., 2008, STAT NUTSHELL; Brauns D, 1874, OBERE JURA NORDWESTL; Britt B.B., 1991, Brigham Young University Geology Studies, V37, P1; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P1052, DOI 10.1671/0272-4634(2007)27[1052:TSUOTE]2.0.CO;2; Brusatte SL, 2013, ACTA PALAEONTOL POL, V58, P47, DOI 10.4202/app.2011.0141; Buckley LG, 2010, CAN J EARTH SCI, V47, P1227, DOI 10.1139/E10-029; Buffetaut E, 2012, ORYCTOS, V10, P1; Carballido JL, 2013, J SYSTEMATIC PALAEON, P1, DOI DOI 10.1080/14772019.2013.764935; Carrano MT, 2012, J SYST PALAEONTOL, V10, P211, DOI 10.1080/14772019.2011.630927; Chiappe LM, 2010, NEUES JAHRB GEOL P-A, V258, P257, DOI 10.1127/0077-7749/2010/0125; Chure DJ, 2001, NEUES JAHRB GEOL P-M, P565; Credner H, 1863, UEBER GLIEDERUNG OBE; Credner H, 1864, Z DTSCH GEOL GES, V16, P196; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; De Andrade MB, 2010, J VERTEBR PALEONTOL, V30, P1451, DOI 10.1080/02724634.2010.501442; Dubbers H., 1888, OBERE JURA NORDOSTFL; Everitt B.S., 2005, R S PLUS COMPANION M; Ezcurra MD, 2012, P GEOLOGIST ASSOC, V123, P500, DOI 10.1016/j.pgeola.2011.12.003; Fanti F, 2007, ACTA PALAEONTOL POL, V52, P155; Farlow J.O., 1991, Modern Geology, V16, P161; Farlow James O., 2002, Historical Biology, V16, P21; Fastnacht M, 2005, ACTA PALAEONTOL POL, V50, P273; Fellows I, 2012, J STAT SOFTW, V49, P1; Fischer R., 1991, ARBEITSKREIS PAL ONT, V19, P21; Forster JR., 2007, DINOSAURS MORRISON F; Galton P.M., 1979, Brigham Young University Geology Studies, V26, P1; GERKE O, 2014, J VERTEBR PALEONTOL, V2014, P137; Gohlich UB, 2006, NATURE, V440, P329, DOI 10.1038/nature04579; Gohlich UB, 2006, ARCHAEOPTERYX, V24, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gramann F., 1997, Z DT GEOL GES, V148, P165, DOI 10.1127/zdgg/148/1997/165; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer O, 2015, REFERENCE MANUAL VER; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Helbig M, 2013, JGR JGR JAVA GUI R R; Hendrickx C, 2014, DRYAD DIGITAL REPOSI; Hendrickx C, 2015, ACTA PALAEONTOL POL, V60, P627, DOI 10.4202/app.00056.2013; Hendrickx C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088905; Hendrickx C, 2014, ZOOTAXA, V 3759, P1, DOI 10.11646/zootaxa.3759.1.1; Herrmann A, 1971, BEIHEFTE GEOL JB, V95, P1; Hocking T, 2014, DIRECTLABELS DIRECT; Hwang SH., 2007, THESIS; Hwang SH, 2011, BIOL REV, V86, P183, DOI 10.1111/j.1469-185X.2010.00142.x; IBM Support Portal, QUADR DISCR AN SPSS; Janensch W., 1925, PALAEONTOGRAPHICA S7, V1, P1; Janensch W., 1920, SITZUNGSBERICHTE GES, V1920, P225; Jansen M, 2014, PALAEONTOLOGY, V57, P743, DOI 10.1111/pala.12085; JENSEN JA, 1985, GREAT BASIN NAT, V45, P710; Karl H-V, 2006, CLAUSTHALER GEOWISSE, V5, P59; Kear BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084041; la Grange A, 2009, J STAT SOFTW, V30, P1; Lallensack J.N., 2015, PALAEONTOL ELECTRON, V18, P1, DOI DOI 10.26879/529; Larson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054329; Larson DW, 2008, CAN J EARTH SCI, V45, P1455, DOI 10.1139/E08-070; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Longrich NR, 2009, P NATL ACAD SCI USA, V106, P5002, DOI 10.1073/pnas.0811664106; Lotze F, 1968, NEUES JB GEOLOGIE PA, V1968, P730; Luppold FW, 2015, GEOLOGISCHE OBJEKTE, P1; Madsen J H, 1976, UTAH GEOLOGY, V3, P51; Madsen JH., 2000, UTAH GEOLOGICAL SURV, V2, P1; Madzia D, 2014, ACTA PALAEONTOL POL, V59, P855, DOI 10.4202/app.2012.0111; Marpmann JS, 2015, J SYST PALAEONTOL, V13, P221, DOI 10.1080/14772019.2013.875074; Martin T, ACTA PALAEO IN PRESS; Mateus O., 2006, PALEONTOLOGY GEOLOGY, V36, P123; Mirisola A, 2012, DEDUCERPLUGINSCALING; Mudroch A, 2001, FISCHZAHNE OBERJURA; Mudroch Alexander, 1996, Geologica et Palaeontologica, V30, P239; Munster G Gz, 1846, BEITRAGE PETREFACTEN, P36; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Osi A, 2010, CRETACEOUS RES, V31, P304, DOI 10.1016/j.cretres.2010.01.001; Pape H, 1970, MITTEILUNGEN GEOLOGI, V9, P41; Pienkowski G., 2008, GEOL SOC LONDON, V2, P823; Porfiri JD, 2014, CRETACEOUS RES, V51, P35, DOI 10.1016/j.cretres.2014.04.007; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rauhut OWM, 2011, SPEC PAP PALAEONTOL, P195, DOI 10.1111/j.1475-4983.2011.01084.x; Rauhut OWM, 2012, P GEOLOGIST ASSOC, V123, P779, DOI 10.1016/j.pgeola.2012.05.008; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut Oliver W.M., 2000, P75; Rauhut OWM, 2004, J VERTEBR PALEONTOL, V24, P894, DOI 10.1671/0272-4634(2004)024[0894:PAAOGS]2.0.CO;2; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Rauhut OWM, 2002, CRETACEOUS RES, V23, P255, DOI 10.1006/cres.2002.1003; RICHTER A, 2013, J VERTEBR PALEONTOL, V2013, P198; Roemer FA, 1838, VERSTEINERUNGEN NORD; Sander PM, 2006, NATURE, V441, P739, DOI 10.1038/nature04633; Sankey JT, 2002, J PALEONTOL, V76, P751, DOI 10.1666/0022-3360(2002)076<0751:STABTF>2.0.CO;2; SAS Institute Inc, 2014, JMP 11 MULT METH; Schweigert G., 1999, OSNABRUCKER NATURWIS, V25, P25; Serrano-Martinez A, 2015, P GEOLOGIST ASSOC, V126, P107, DOI 10.1016/j.pgeola.2014.10.005; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Smith JB, 2003, J VERTEBR PALEONTOL, V23, P1, DOI 10.1671/0272-4634(2003)23[1:APFAST]2.0.CO;2; Smith JB, 2006, NATURWISSENSCHAFTEN, V93, P242, DOI 10.1007/s00114-006-0092-3; Smith JP, 1893, THESIS; *SPSS INC, 2006, SPSS WIND VERS 15 0; Strombeck Av, 1832, ARCH MINERALOGIE GEO, V4, P395; Struckmann C., 1878, OBERE JURA UMGEBUNG; Thies D, 1995, J VERTEBR PALEONTOL, V15, P463, DOI 10.1080/02724634.1995.10011242; Thies Detlev, 1997, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V205, P393; Torices A, 2015, ACTA PALAEONTOL POL, V60, P611, DOI 10.4202/app.2012.0121; Torices A, 2014, CAN J EARTH SCI, V51, DOI 10.1139/cjes-2014-0072; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Turner AH, 2012, B AM MUS NAT HIST, P5; van der Lubbe T, 2009, ACTA PALAEONTOL POL, V54, P401, DOI 10.4202/app.2008.0007; Venables WN., 2002, MODERN APPL STAT S 4; von Huene F, 1923, BULL GEOL SOC AM, V34, P449; von Koenen A, 1906, GEOLOGISCHE KARTE PR, DOI Berlin; von Koenen A, 1911, GEOLOGISCHE KARTE PR; WALKER AD, 1964, PHILOS T ROY SOC B, V248, P53, DOI 10.1098/rstb.1964.0009; Williamson TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093190; Windolf R., 1997, 1 TREFF DEUTSCHSPR P, P33; Wings O., 2015, 12 S MES TERR EC SHE, P99; Wings O, 2012, IFUNDAMENTAL, V20, P281; Xu X, 2010, CHINESE SCI BULL, V55, P3971, DOI 10.1007/s11434-010-4150-z; Young MT, 2010, ZOOL J LINN SOC-LOND, V158, P801, DOI 10.1111/j.1096-3642.2009.00571.x; Ziegler P. A., 1990, GEOLOGICAL ATLAS W C; Zinke Jens, 1998, Palaeontologische Zeitschrift, V72, P179; Zinke Jens, 1994, Berliner Geowissenschaftliche Abhandlungen Reihe E Palaeobiologie, V13, P163; [No title captured]	127	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158334	10.1371/journal.pone.0158334	http://dx.doi.org/10.1371/journal.pone.0158334			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383054	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400043
J	von Wulffen, J; Sawodny, O; Feuer, R				von Wulffen, Joachim; Sawodny, Oliver; Feuer, Ronny		RecogNice-Team	Transition of an Anaerobic Escherichia coli Culture to Aerobiosis: Balancing mRNA and Protein Levels in a Demand-Directed Dynamic Flux Balance Analysis	PLOS ONE			English	Article							SCALE METABOLIC MODELS; GENE-EXPRESSION DATA; OXIDATIVE STRESS; GROWTH; TRANSCRIPTION; FERMENTATION; OPTIMIZATION; CONSTRAINTS; BIOREACTORS; OCCUPANCY	The facultative anaerobic bacterium Escherichia coli is frequently forced to adapt to changing environmental conditions. One important determinant for metabolism is the availability of oxygen allowing a more efficient metabolism. Especially in large scale bioreactors, the distribution of oxygen is inhomogeneous and individual cells encounter frequent changes. This might contribute to observed yield losses during process upscaling. Short-term gene expression data exist of an anaerobic E. coli batch culture shifting to aerobic conditions. The data reveal temporary upregulation of genes that are less efficient in terms of energy conservation than the genes predicted by conventional flux balance analyses. In this study, we provide evidence for a positive correlation between metabolic fluxes and gene expression. We then hypothesize that the more efficient enzymes are limited by their low expression, restricting flux through their reactions. We define a demand that triggers expression of the demanded enzymes that we explicitly include in our model. With these features we propose a method, demand-directed dynamic flux balance analysis, dddFBA, bringing together elements of several previously published methods. The introduction of additional flux constraints proportional to gene expression provoke a temporary demand for less efficient enzymes, which is in agreement with the transient upregulation of these genes observed in the data. In the proposed approach, the applied objective function of growth rate maximization together with the introduced constraints triggers expression of metabolically less efficient genes. This finding is one possible explanation for the yield losses observed in large scale bacterial cultivations where steady oxygen supply cannot be warranted.	[von Wulffen, Joachim; Sawodny, Oliver; Feuer, Ronny; RecogNice-Team] Univ Stuttgart, Inst Syst Dynam, Stuttgart, Germany	University of Stuttgart	von Wulffen, J (corresponding author), Univ Stuttgart, Inst Syst Dynam, Stuttgart, Germany.	vonwulffen@isys.uni-stuttgart.de		Feuer, Ronny/0000-0002-5653-7670	Federal Ministry of Education and Research of Germany (BMBF) [0316178A]	Federal Ministry of Education and Research of Germany (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was funded by the Federal Ministry of Education and Research of Germany (BMBF, support code 0316178A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adadi R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002575; Akesson M, 2004, METAB ENG, V6, P285, DOI 10.1016/j.ymben.2003.12.002; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Beg QK, 2007, P NATL ACAD SCI USA, V104, P12663, DOI 10.1073/pnas.0609845104; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; BOLGIANO B, 1993, BIOCHIM BIOPHYS ACTA, V1141, P95, DOI 10.1016/0005-2728(93)90194-K; Brandt F, 2009, CELL, V136, P261, DOI 10.1016/j.cell.2008.11.016; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Covert MW, 2008, BIOINFORMATICS, V24, P2044, DOI 10.1093/bioinformatics/btn352; Covert MW, 2003, J THEOR BIOL, V221, P309, DOI 10.1006/jtbi.2003.3071; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; De Vos D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028494; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards JS, 2000, BMC BIOINFORMATICS, V1, DOI 10.1186/1471-2105-1-1; Edwards JS, 2001, NAT BIOTECHNOL, V19, P125, DOI 10.1038/84379; Enfors SO, 2001, J BIOTECHNOL, V85, P175, DOI 10.1016/S0168-1656(00)00365-5; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Imlay JA, 2013, NAT REV MICROBIOL, V11, P443, DOI 10.1038/nrmicro3032; Iuchi S, 1996, J BIOCHEM-TOKYO, V120, P1055; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; Junker BH, 2004, J BIOSCI BIOENG, V97, P347, DOI 10.1263/jbb.97.347; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kosuri S, 2013, P NATL ACAD SCI USA, V110, P14024, DOI 10.1073/pnas.1301301110; Lara AR, 2006, MOL BIOTECHNOL, V34, P355, DOI 10.1385/MB:34:3:355; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; Lindqvist A, 2000, ANTON LEEUW INT J G, V78, P23, DOI 10.1023/A:1002779201379; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; Molenaar D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.82; O'Brien EJ, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.52; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Oyarzun DA, 2009, B MATH BIOL, V71, P1851, DOI 10.1007/s11538-009-9427-5; Rapisarda VA, 1999, ARCH BIOCHEM BIOPHYS, V370, P143, DOI 10.1006/abbi.1999.1398; RICE CW, 1978, J BACTERIOL, V134, P115, DOI 10.1128/JB.134.1.115-124.1978; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; SCHULZE E, 1991, EUR J BIOCHEM, V201, P561, DOI 10.1111/j.1432-1033.1991.tb16315.x; Takors R, 2012, J BIOTECHNOL, V160, P3, DOI 10.1016/j.jbiotec.2011.12.010; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; van Berlo RJP, 2011, IEEE ACM T COMPUT BI, V8, P206, DOI 10.1109/TCBB.2009.55; VARMA A, 1994, APPL ENVIRON MICROB, V60, P3724, DOI 10.1128/AEM.60.10.3724-3731.1994; von Wulffen J, RNA SEQUENCING OF E; Waldherr S, 2015, J THEOR BIOL, V365, P469, DOI 10.1016/j.jtbi.2014.10.035; WASKIEWICZ DE, 1984, BIOCHEMISTRY-US, V23, P3136, DOI 10.1021/bi00309a005; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348; Zelezniak A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003572; Zhuang K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.34	54	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158711	10.1371/journal.pone.0158711	http://dx.doi.org/10.1371/journal.pone.0158711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384956	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400078
J	Liu, HD; Li, P; Zhu, MY; Wang, XF; Lu, JW; Yu, TW				Liu, Haodong; Li, Peng; Zhu, Mengyao; Wang, Xiaofei; Lu, Jianwei; Yu, Tianwei			Nonlinear Network Reconstruction from Gene Expression Data Using Marginal Dependencies Measured by DCOL	PLOS ONE			English	Article							REGULATORY NETWORKS; R-PACKAGE; COEXPRESSION; PATTERNS; ADAMS; FGF10	Reconstruction of networks from high-throughput expression data is an important tool to identify new regulatory relations. Given that nonlinear and complex relations exist between biological units, methods that can utilize nonlinear dependencies may yield insights that are not provided by methods using linear associations alone. We have previously developed a distance to measure predictive nonlinear relations, the Distance based on Conditional Ordered List (DCOL), which is sensitive and computationally efficient on large matrices. In this study, we explore the utility of DCOL in the reconstruction of networks, by combining it with local false discovery rate (lfdr)-based inference. We demonstrate in simulations that the new method named nlnet is effective in recovering hidden nonlinear modules. We also demonstrate its utility using a single cell RNA seq dataset.	[Liu, Haodong; Zhu, Mengyao; Lu, Jianwei] Tongji Univ, Sch Software Engn, Shanghai, Peoples R China; [Li, Peng] Tongji Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Wang, Xiaofei] Shandong Univ Sci & Technol, Coll Informat Sci & Engn, Qingdao, Shandong, Peoples R China; [Lu, Jianwei] Tongji Univ, Inst Translat Med, Shanghai, Peoples R China; [Yu, Tianwei] Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Tongji University; Tongji University; Shandong University of Science & Technology; Tongji University; Emory University; Rollins School Public Health	Lu, JW (corresponding author), Tongji Univ, Sch Software Engn, Shanghai, Peoples R China.; Lu, JW (corresponding author), Tongji Univ, Inst Translat Med, Shanghai, Peoples R China.; Yu, TW (corresponding author), Emory Univ, Dept Biostat & Bioinformat, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA.	jwlu33@gmail.com; tianwei.yu@emory.edu		Yu, Tianwei/0000-0003-2502-1628	NIH [P30AI50409]; 973 Program of the Ministry of Science and Technology of China [2013CB967101]; Natural Science Foundation of China [41476120, 61572362, 81571347, 21477087]; Shanghai Eastern Scholar program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 Program of the Ministry of Science and Technology of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Eastern Scholar program	This work was partially supported by NIH grant P30AI50409, 973 Program (No. 2013CB967101) of the Ministry of Science and Technology of China, Natural Science Foundation of China No. 41476120, No. 61572362, No. 81571347 and No. 21477087, and the Shanghai Eastern Scholar program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030790; Allen JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029348; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boscolo R, 2008, IEEE ACM T COMPUT BI, V5, P15, DOI 10.1109/TCBB.2007.1056; Burns JC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9557; Ceci M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144031; Chen J, 2011, BIOMETRICS, V67, P299, DOI 10.1111/j.1541-0420.2010.01413.x; Chen XH, 2006, BIOINFORMATICS, V22, P2952, DOI 10.1093/bioinformatics/btl491; Cho DY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002820; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Hase T, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003361; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li KC, 2002, P NATL ACAD SCI USA, V99, P16875, DOI 10.1073/pnas.252466999; Li YP, 2015, G3-GENES GENOM GENET, V5, P1075, DOI 10.1534/g3.115.018127; Liang KC, 2008, EURASIP J BIOINFORM, DOI 10.1155/2008/253894; Lin JT, 2013, DEV GROWTH DIFFER, V55, P368, DOI 10.1111/dgd.12051; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Moayedi Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004055; Okano T, 2011, J NEUROSCI, V31, P18104, DOI 10.1523/JNEUROSCI.3619-11.2011; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Pauley S, 2003, DEV DYNAM, V227, P203, DOI 10.1002/dvdy.10297; Peng J, 2009, J AM STAT ASSOC, V104, P735, DOI 10.1198/jasa.2009.0126; Qin S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3633; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Raghavan UN, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036106; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Sahoo D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r157; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Shpargel KB, 2004, ACTA OTO-LARYNGOL, V124, P242, DOI 10.1080/00016480410016162; Siegenthaler C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090481; Slowik Amber D, 2013, Trends Dev Biol, V7, P73; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Thompson D, 2015, ANNU REV CELL DEV BI, V31, P399, DOI 10.1146/annurev-cellbio-100913-012908; Urness LD, 2015, DEV BIOL, V400, P59, DOI 10.1016/j.ydbio.2015.01.015; Vignes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029165; Villaverde AF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096732; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Wang JX, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt147; Wang K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/918954; Yamamoto N, 2011, DEV BIOL, V353, P367, DOI 10.1016/j.ydbio.2011.03.016; Yan X, 2010, DEV DYNAM, V239, P2256, DOI 10.1002/dvdy.22360; Yu TW, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S13-S6; Yu TW, 2013, IEEE ACM T COMPUT BI, V10, P1080, DOI 10.1109/TCBB.2013.99; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhao J, 2016, P NATL ACAD SCI USA, V113, P5130, DOI 10.1073/pnas.1522586113	49	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158247	10.1371/journal.pone.0158247	http://dx.doi.org/10.1371/journal.pone.0158247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380516	gold, Green Published, Green Submitted			2022-12-26	WOS:000379798700024
J	Liu, YZ; Han, YW; Chen, RS; Zhang, HJ; Liu, SM; Liang, F				Liu, Yingzhu; Han, Yanwei; Chen, Rongsheng; Zhang, Haijun; Liu, Simin; Liang, Feng			In situ Immobilization of Copper Nanoparticles on Polydopamine Coated Graphene Oxide for H2O2 Determination	PLOS ONE			English	Article							HYDROGEN-PEROXIDE SENSOR; GLASSY-CARBON ELECTRODE; CU NANOPARTICLES; GREEN SYNTHESIS; NANOCOMPOSITE; GLUCOSE; EFFICIENT; COMPOSITE; COATINGS	Nanostructured electrochemical sensors often suffer from irreversible aggregation and poor adhesion to the supporting materials, resulting in reduced sensitivity and selectivity over time. We describe a versatile method for fabrication of a H2O2 sensor by immobilizing copper nanoparticles (Cu NPs; 20 nm) on graphene oxide ( GO) sheets via in-situ reduction of copper(II) on a polydopamine (PDA) coating on a glassy carbon electrode. The PDA film with its amino groups and catechol groups acts as both a reductant and an adhesive that warrants tight bonding between the Cu NPs and the support. The modified electrode, best operated at a working voltage of -0.4 V ( vs. Ag/AgCl), has a linear response to H2O2 in the 5 mu M to 12 mM concentration range, a sensitivity of 141.54 mu A.mM(-1).cm(-2), a response time of 4 s, and a 1.4 mu M detection limit ( at an S/N ratio of 3). The sensor is highly reproducible and selective ( with minimal interference to ascorbic acid and uric acid). The method was applied to the determination of H2O2 in sterilant by the standard addition method and gave recoveries between 97% and 99%.	[Liu, Yingzhu; Han, Yanwei; Chen, Rongsheng; Zhang, Haijun; Liu, Simin; Liang, Feng] Wuhan Univ Sci & Technol, Sch Chem Engn & Technol, State Key Lab Refractories & Met, Wuhan 430081, Peoples R China; [Chen, Rongsheng; Liang, Feng] Wuhan Univ, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China; [Chen, Rongsheng] Chinese Acad Sci, Key Lab Inorgan Coating Mat, Shanghai 200050, Peoples R China	Wuhan University of Science & Technology; Wuhan University; Chinese Academy of Sciences	Chen, RS; Liang, F (corresponding author), Wuhan Univ Sci & Technol, Sch Chem Engn & Technol, State Key Lab Refractories & Met, Wuhan 430081, Peoples R China.; Chen, RS; Liang, F (corresponding author), Wuhan Univ, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China.; Chen, RS (corresponding author), Chinese Acad Sci, Key Lab Inorgan Coating Mat, Shanghai 200050, Peoples R China.	chenrs@wust.edu.cn; feng_liang@whu.edu.cn	Liang, Feng/GZK-4305-2022; Liu, Simin/I-3391-2012; Zhang, Haijun/C-2168-2016; Liang, Feng/A-4823-2011	Liu, Simin/0000-0002-8696-4833; Liang, Feng/0000-0002-3974-2621	National Natural Science Foundation of China [21105077, 21372183]; Open Funds of Key Laboratory of Analytical Chemistry for Biology and Medicine of Ministry of Education [ACBM2014001]; Open Funds of Key Laboratory of Inorganic Coating Materials of Chinese Academy of Sciences [KLICM-2013-05]; Hubei Provincial Natural Science Foundation of China [2013CFB328]; Wuhan Applied Basic Research Programs of China [2015060101010069]; Open Funds of the State Key Laboratory of Electroanalytical Chemistry [SKLEAC201609]; Thousand Youth Talents Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Funds of Key Laboratory of Analytical Chemistry for Biology and Medicine of Ministry of Education; Open Funds of Key Laboratory of Inorganic Coating Materials of Chinese Academy of Sciences; Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Applied Basic Research Programs of China; Open Funds of the State Key Laboratory of Electroanalytical Chemistry; Thousand Youth Talents Program	R.S.C. acknowledges support by the National Natural Science Foundation of China under award number 21105077, the Open Funds of Key Laboratory of Analytical Chemistry for Biology and Medicine of Ministry of Education under contract number ACBM2014001, and the Open Funds of Key Laboratory of Inorganic Coating Materials of Chinese Academy of Sciences KLICM-2013-05. F.L. thanks the National Natural Science Foundation of China under award number 21372183, Hubei Provincial Natural Science Foundation of China 2013CFB328, Wuhan Applied Basic Research Programs of China 2015060101010069, and the Open Funds of the State Key Laboratory of Electroanalytical Chemistry SKLEAC201609. S.M.L. acknowledges support by the Thousand Youth Talents Program.	Alegret S, 2007, COMP ANAL C, V49, P1; Butwong N, 2014, J ELECTROANAL CHEM, V717, P41, DOI 10.1016/j.jelechem.2013.12.028; Chuah YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18162; Ensafi AA, 2014, SENSOR ACTUAT B-CHEM, V196, P398, DOI 10.1016/j.snb.2014.02.028; Freire RLH, 2014, J PHYS CHEM C, V118, P19051, DOI 10.1021/jp5033228; Harris D.C., 2002, QUANTITATIVE CHEM AN, V6th ed.; Heli H, 2014, ELECTROCHIM ACTA, V123, P518, DOI 10.1016/j.electacta.2014.01.032; Karuppiah C, 2014, SENSOR ACTUAT B-CHEM, V196, P450, DOI 10.1016/j.snb.2014.02.034; Kivrak H, 2015, ELECTROCHIM ACTA, V176, P497, DOI 10.1016/j.electacta.2015.06.151; Kumar GG, 2014, RSC ADV, V4, P7944, DOI 10.1039/c3ra45596c; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lin YQ, 2014, SENSOR ACTUAT B-CHEM, V202, P527, DOI 10.1016/j.snb.2014.05.113; Liu HY, 2013, ANAL CHEM, V85, P3385, DOI 10.1021/ac303789x; Liu MM, 2013, BIOSENS BIOELECTRON, V45, P206, DOI 10.1016/j.bios.2013.02.010; Lorestani F, 2015, SENSOR ACTUAT B-CHEM, V208, P389, DOI 10.1016/j.snb.2014.11.074; Mahmoudian MR, 2014, SENSOR ACTUAT B-CHEM, V201, P526, DOI 10.1016/j.snb.2014.05.030; Mane GP, 2012, ADV FUNCT MATER, V22, P3596, DOI 10.1002/adfm.201200207; Murali S, 2015, RSC ADV, V5, P4286, DOI 10.1039/c4ra12989j; Qiu HW, 2015, CHEMPHYSCHEM, V16, P2953, DOI 10.1002/cphc.201500502; Rong JP, 2014, NANO LETT, V14, P473, DOI 10.1021/nl403404v; Su L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24420; Tahir D, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/17/175002; Tahirovic A, 2007, TALANTA, V72, P1378, DOI 10.1016/j.talanta.2007.01.072; Wang Y., 2007, SCI STKE, V2007, P1, DOI DOI 10.4018/JCINI.2007100101; Wu MY, 2013, J AM CHEM SOC, V135, P12048, DOI 10.1021/ja4054465; Xu HL, 2011, CHEM MATER, V23, P5105, DOI 10.1021/cm2028417; Yan YH, 2013, ANAL CHEM, V85, P8483, DOI 10.1021/ac401668e; Yang J, 2015, ANAL LETT, V48, P2031, DOI 10.1080/00032719.2015.1010120; Yang W, 2016, CARBON, V96, P947, DOI 10.1016/j.carbon.2015.10.059; Yang Y, 2015, MICROCHIM ACTA, V182, P2241, DOI 10.1007/s00604-015-1558-9; Yin ZJ, 2011, BIOSENS BIOELECTRON, V26, P1970, DOI 10.1016/j.bios.2010.08.049; Zaino LP, 2014, CHEMELECTROCHEM, V1, P1570, DOI 10.1002/celc.201402111; Zeng T, 2013, APPL CATAL B-ENVIRON, V134, P26, DOI 10.1016/j.apcatb.2012.12.037; Zhang C, 2015, MICROCHIM ACTA, V182, P1811, DOI 10.1007/s00604-015-1511-y; Zhang MY, 2014, J ELECTROANAL CHEM, V730, P10, DOI 10.1016/j.jelechem.2014.07.020; Zhang TT, 2008, SENSORS-BASEL, V8, P5141, DOI 10.3390/s8085141	36	19	19	2	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0157926	10.1371/journal.pone.0157926	http://dx.doi.org/10.1371/journal.pone.0157926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380524	Green Published, gold, Green Submitted			2022-12-26	WOS:000379798700014
J	Wang, Y; Hong, X; Wang, J; Yin, Y; Zhang, Y; Zhou, Y; Piao, HI; Liang, Z; Zhang, L; Li, G; Xu, G; Kwiatkowski, DJ; Liu, Y				Wang, Y.; Hong, X.; Wang, J.; Yin, Y.; Zhang, Y.; Zhou, Y.; Piao, H-I; Liang, Z.; Zhang, L.; Li, G.; Xu, G.; Kwiatkowski, D. J.; Liu, Y.			Inhibition of MAPK pathway is essential for suppressing Rheb-Y35N driven tumor growth	ONCOGENE			English	Article							TSC2 GAP ACTIVITY; RHEB GTPASE; CELL-PROLIFERATION; MAMMALIAN TARGET; MTOR; ACTIVATION; KINASE; MUTATIONS; AMPK; IDENTIFICATION	Rheb is a Ras family GTPase, which binds to and activates mammalian target of rapamycin complex 1 (mTORC1) when GTP loaded. Recently, cancer genome sequencing efforts have identified recurrent Rheb Tyr35Asn mutations in kidney and endometrial carcinoma. Here we show that Rheb-Y35N causes not only constitutive mTORC1 activation, but sustained activation of the MEK-ERK pathway in a TSC1/TSC2/TBC1D7 protein complex and mTORC1-independent manner, contributing to intrinsic resistance to rapamycin. Rheb-Y35N transforms NIH3T3 cells, resulting in aggressive tumor formation in xenograft nude mice, which could be suppressed by combined treatment with rapamycin and an extracellular signal-regulated kinase (ERK) inhibitor. Furthermore, Rheb-Y35N inhibits AMPKa activation in response to nutrient depletion or 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), leading to attenuated phosphorylation of BRAF-S729 and retained mitogen-activated protein kinase (MAPK) activation. Finally, we demonstrate that Rheb-WT can bind AMPK to facilitate AMPK activation, whereas Rheb-Y35N competitively binds AMPK, impairing AMPK phosphorylation. In summary, our findings indicate that Rheb-Y35N is a dominantly active tumor driver that activates both mTORC1 and MAPK to promote tumor growth, suggesting a combination of mTORC1 and MAPK inhibitors may be of therapeutic value in patients whose cancers sustain this mutation.	[Wang, Y.; Yin, Y.; Piao, H-I; Liu, Y.] Chinese Acad Sci, Sci Res Ctr Translat Med, Dalian Inst Chem Phys, Dept Biotechnol, 457 Zhongshan Rd,Rm 114, Dalian 116023, Liaoning, Peoples R China; [Wang, Y.; Wang, J.] Dalian Univ, Sch Life Sci, Dalian, Peoples R China; [Hong, X.] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing, Peoples R China; [Hong, X.] Peking Union Med Coll, Beijing, Peoples R China; [Zhang, Y.; Li, G.] Chinese Acad Sci, Dalian Inst Chem Phys, Dept Biotechnol, State Key Lab Mol React Dynam,Lab Mol Modelling &, Dalian, Peoples R China; [Zhou, Y.; Piao, H-I; Liang, Z.; Zhang, L.; Xu, G.; Liu, Y.] Chinese Acad Sci, Dalian Inst Chem Phys, Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Kwiatkowski, D. J.; Liu, Y.] Harvard Med Sch, Brigham & Women Hosp, Div Pulm & Crit Care Med, Boston, MA USA	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Dalian University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Liu, Y (corresponding author), Chinese Acad Sci, Sci Res Ctr Translat Med, Dalian Inst Chem Phys, Dept Biotechnol, 457 Zhongshan Rd,Rm 114, Dalian 116023, Liaoning, Peoples R China.; Kwiatkowski, DJ (corresponding author), Harvard Med Sch Thorn Bldg, Brigham & Womens Hosp, Div Pulm & Crit Care, RM 826c,20 Shattuck St, Boston, MA 02115 USA.	dk@rics.bwh.harvard.edu; yliuqq@dicp.ac.cn	Xu, Guowang/L-6910-2014	Xu, Guowang/0000-0003-4298-3554	NIH [NCI 1P01CA120964]; NATIONAL CANCER INSTITUTE [P01CA120964] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH NCI 1P01CA120964. We thank Nathanael Gray, Heidi Greulich and John Blenis for the gift of reagents.	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Choudhary S, 2007, MOL CANCER THER, V6, P1099, DOI 10.1158/1535-7163.MCT-06-0586; Eom M, 2008, PATHOL INT, V58, P226, DOI 10.1111/j.1440-1827.2008.02215.x; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; Ghosh AP, 2015, ONCOTARGET, V6, P17895, DOI 10.18632/oncotarget.4963; Goorden SMI, 2011, MOL CELL BIOL, V31, P1672, DOI 10.1128/MCB.00985-10; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hodges AK, 2001, HUM MOL GENET, V10, P2899, DOI 10.1093/hmg/10.25.2899; Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200; Im E, 2002, ONCOGENE, V21, P6356, DOI 10.1038/sj.onc.1205792; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jeon MT, 2015, BIOMED REP, V3, P137, DOI 10.3892/br.2014.397; Jiang H, 2008, ONCOGENE, V27, P5729, DOI 10.1038/onc.2008.180; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Lacher MD, 2010, ONCOGENE, V29, P6543, DOI 10.1038/onc.2010.393; Lafourcade CA, 2013, J NEUROSCI, V33, P2419, DOI 10.1523/JNEUROSCI.1840-12.2013; Langendorf CG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10912; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Li Y, 2004, MOL CELL BIOL, V24, P7965, DOI 10.1128/MCB.24.18.7965-7975.2004; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Lu ZH, 2010, CANCER RES, V70, P3287, DOI 10.1158/0008-5472.CAN-09-3467; Martin TD, 2014, MOL CELL, V53, P209, DOI 10.1016/j.molcel.2013.12.004; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mazhab-Jafari MT, 2012, STRUCTURE, V20, P1528, DOI 10.1016/j.str.2012.06.013; Morris EJ, 2013, CANCER DISCOV, V3, P742, DOI 10.1158/2159-8290.CD-13-0070; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996; Shen CH, 2013, MOL CELL, V52, P161, DOI 10.1016/j.molcel.2013.08.044; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Wang YN, 2008, J MOL CELL CARDIOL, V45, P812, DOI 10.1016/j.yjmcc.2008.07.016; Yan LJ, 2006, J BIOL CHEM, V281, P19793, DOI 10.1074/jbc.C600028200; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026; Zhou XM, 2009, P NATL ACAD SCI USA, V106, P8923, DOI 10.1073/pnas.0903621106	37	11	12	2	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 9	2017	36	6					756	765		10.1038/onc.2016.246	http://dx.doi.org/10.1038/onc.2016.246			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK8IX	27399332				2022-12-26	WOS:000394168200003
J	Chen, GY; Mickolajczyk, KJ; Hancock, WO				Chen, Geng-Yuan; Mickolajczyk, Keith J.; Hancock, William O.			The Kinesin-5 Chemomechanical Cycle Is Dominated by a Two-heads-bound State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytoskeleton; kinesin; microtubule; mitotic spindle; molecular motor; single-molecule biophysics	STIMULATED ATP HYDROLYSIS; MITOTIC KINESIN; CHROMOSOME CONGRESSION; MOLECULAR MOTORS; DIMERIC EG5; FRONT HEAD; IN-VIVO; PROCESSIVITY; KINETICS; MICROTUBULES	Single-molecule microscopy and stopped-flow kinetics assays were carried out to understand the microtubule polymerase activity of kinesin-5 (Eg5). Four lines of evidence argue that the motor primarily resides in a two-heads-bound (2HB) state. First, upon microtubule binding, dimeric Eg5 releases both bound ADPs. Second, microtubule dissociation in saturating ADP is 20-fold slower for the dimer than for the monomer. Third, ATP-triggered mant-ADP release is 5-fold faster than the stepping rate. Fourth, ATP binding is relatively fast when the motor is locked in a 2HB state. Shortening the neck-linker does not facilitate rear-head detachment, suggesting a minimal role for rear-head-gating. This 2HB state may enable Eg5 to stabilize incoming tubulin at the growing microtubule plus-end. The finding that slowly hydrolyzable ATP analogs trigger slower nucleotide release than ATP suggests that ATP hydrolysis in the bound head precedes stepping by the tethered head, leading to a mechanochemical cycle in which processivity is determined by the race between unbinding of the bound head and attachment of the tethered head.	[Chen, Geng-Yuan; Mickolajczyk, Keith J.; Hancock, William O.] Penn State Univ, Dept Biomed Engn, 205 Hallowell Bldg, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hancock, WO (corresponding author), Penn State Univ, Dept Biomed Engn, 205 Hallowell Bldg, University Pk, PA 16802 USA.	wohbio@engr.psu.edu	; Hancock, William/E-7653-2016	Mickolajczyk, Keith/0000-0001-9445-0325; Hancock, William/0000-0001-5547-8755; Chen, Geng-Yuan/0000-0002-0103-4494	National Institutes of Health [R01 GM076476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076476 (to W. O. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arpag G, 2014, BIOPHYS J, V107, P1896, DOI 10.1016/j.bpj.2014.09.009; Avunie-Masala R, 2011, J CELL SCI, V124, P873, DOI 10.1242/jcs.077396; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Chen GY, 2015, J BIOL CHEM, V290, P10274, DOI 10.1074/jbc.M114.628032; Chen YL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9160; Chen Y, 2014, MOL BIOL CELL, V25, P3630, DOI 10.1091/mbc.E14-06-1146; Cochran JC, 2006, BIOCHEMISTRY-US, V45, P12334, DOI 10.1021/bi0608562; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Fridman V, 2013, J CELL SCI, V126, P4147, DOI 10.1242/jcs.125153; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; Gerson-Gurwitz A, 2011, EMBO J, V30, P4942, DOI 10.1038/emboj.2011.403; Goulet A, 2014, P NATL ACAD SCI USA, V111, P1837, DOI 10.1073/pnas.1319848111; Goulet A, 2013, INT REV CEL MOL BIO, V304, P419, DOI 10.1016/B978-0-12-407696-9.00008-7; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; HACKNEY DD, 1989, J BIOL CHEM, V264, P15943; Hariharan V, 2009, CELL MOL BIOENG, V2, P177, DOI 10.1007/s12195-009-0059-5; Jiang W, 1997, J BIOL CHEM, V272, P7626, DOI 10.1074/jbc.272.12.7626; Kaan HYK, 2011, SCIENCE, V333, P883, DOI 10.1126/science.1204824; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapoor TM, 2000, J CELL BIOL, V150, P975, DOI 10.1083/jcb.150.5.975; Kaseda K, 2008, EMBO REP, V9, P761, DOI 10.1038/embor.2008.96; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Larson J, 2014, NAT PROTOC, V9, P2317, DOI 10.1038/nprot.2014.155; Lebel P, 2014, NAT METHODS, V11, P456, DOI 10.1038/nmeth.2854; Ma YZ, 1997, J BIOL CHEM, V272, P724, DOI 10.1074/jbc.272.2.724; Mccoy KM, 2015, MOL BIOL CELL, V26, P3999, DOI 10.1091/mbc.E14-10-1454; Mickolajczyk KJ, 2015, P NATL ACAD SCI USA, V112, pE7186, DOI 10.1073/pnas.1517638112; Milic B, 2014, P NATL ACAD SCI USA, V111, P14136, DOI 10.1073/pnas.1410943111; Murata JM, 2013, J BIOL CHEM, V288, P34839, DOI 10.1074/jbc.M113.518845; Muretta JM, 2015, P NATL ACAD SCI USA, V112, pE6606, DOI 10.1073/pnas.1512305112; Myers KA, 2007, J CELL BIOL, V178, P1081, DOI 10.1083/jcb.200702074; Nadar VC, 2008, CURR BIOL, V18, P1972, DOI 10.1016/j.cub.2008.11.021; Roostalu J, 2011, SCIENCE, V332, P94, DOI 10.1126/science.1199945; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Scholey JE, 2014, ELIFE, V3, DOI 10.7554/eLife.02217; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; Shastry S, 2010, CURR BIOL, V20, P939, DOI 10.1016/j.cub.2010.03.065; Shimamoto Y, 2015, DEV CELL, V34, P669, DOI 10.1016/j.devcel.2015.08.017; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Skoufias DA, 2006, J BIOL CHEM, V281, P17559, DOI 10.1074/jbc.M511735200; SVOBODA K, 1994, P NATL ACAD SCI USA, V91, P11782, DOI 10.1073/pnas.91.25.11782; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Talapatra SK, 2012, ACTA CRYSTALLOGR D, V68, P1311, DOI 10.1107/S0907444912027965; Valentine MT, 2009, BIOPHYS J, V97, P1671, DOI 10.1016/j.bpj.2009.07.013; Valentine MT, 2006, NAT CELL BIOL, V8, P470, DOI 10.1038/ncb1394; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Verbrugge S, 2009, BIOPHYS J, V97, P2287, DOI 10.1016/j.bpj.2009.08.001	58	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 23	2016	291	39					20283	20294		10.1074/jbc.M116.730697	http://dx.doi.org/10.1074/jbc.M116.730697			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DX7NN	27402829	Green Published, hybrid			2022-12-26	WOS:000384574800001
J	Baumann, S; Hennet, T				Baumann, Stephan; Hennet, Thierry			Collagen Accumulation in Osteosarcoma Cells lacking GLT25D1 Collagen Galactosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; CRISPR; Cas; endoplasmic reticulum (ER); glycosylation; osteosarcoma; protein trafficking (Golgi)	LYSYL HYDROXYLASE 3; GLYCOSYLATION; MUTATIONS; IDENTIFICATION; DEFICIENCY; SECRETION; GLUCOSYLTRANSFERASE; ENZYMES; GENES; CHAIN	Collagen is post-translationally modified by prolyl and lysyl hydroxylation and subsequently by glycosylation of hydroxylysine. Despite the widespread occurrence of the glycan structure Glc(1-2)Gal linked to hydroxylysine in animals, the functional significance of collagen glycosylation remains elusive. To address the role of glycosylation in collagen expression, folding, and secretion, we used the CRISPR/Cas9 system to inactivate the collagen galactosyltransferase GLT25D1 and GLT25D2 genes in osteosarcoma cells. Loss of GLT25D1 led to increased expression and intracellular accumulation of collagen type I, whereas loss of GLT25D2 had no effect on collagen secretion. Inactivation of the GLT25D1 gene resulted in a compensatory induction of GLT25D2 expression. Loss of GLT25D1 decreased collagen glycosylation by up to 60% but did not alter collagen folding and thermal stability. Whereas cells harboring individually inactivated GLT25D1 and GLT25D2 genes could be recovered and maintained in culture, cell clones with simultaneously inactive GLT25D1 and GLT25D2 genes could be not grown and studied, suggesting that a complete loss of collagen glycosylation impairs osteosarcoma cell proliferation and viability.	[Baumann, Stephan; Hennet, Thierry] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland	University of Zurich	Hennet, T (corresponding author), Univ Zurich, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	thierry.hennet@uzh.ch		Hennet, Thierry/0000-0002-7276-737X	Research Credit of the University of Zurich; Swiss National Foundation [310030_149949]	Research Credit of the University of Zurich; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Research Credit of the University of Zurich (to S. B.) and by Swiss National Foundation Grant 310030_149949 (to T. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Bank RA, 1996, ANAL BIOCHEM, V240, P167, DOI 10.1006/abio.1996.0346; Brinckmann J, 1998, ARCH DERMATOL RES, V290, P181, DOI 10.1007/s004030050287; Burger W., 2008, DIGITAL IMAGE PROCES, P469; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; COLLEY KJ, 1987, J BIOL CHEM, V262, P10290; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Gardner H, 1999, J CELL SCI, V112, P263; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hakansson K, 2000, PROTEIN SCI, V9, P1607, DOI 10.1110/ps.9.9.1607; HARWOOD R, 1975, BIOCHEM J, V152, P291, DOI 10.1042/bj1520291; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Heise CT, 2000, J IMMUNOL, V165, P1403, DOI 10.4049/jimmunol.165.3.1403; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; JUNQUA S, 1974, CONNECT TISSUE RES, V2, P193, DOI 10.3109/03008207409152244; Jurgensen HJ, 2011, J BIOL CHEM, V286, P32736, DOI 10.1074/jbc.M111.266692; Kukkola L, 2003, J BIOL CHEM, V278, P47685, DOI 10.1074/jbc.M306806200; Lauer-Fields JL, 2003, J BIOL CHEM, V278, P14321, DOI 10.1074/jbc.M212246200; Liefhebber JMP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-33; Malhotra V, 2011, EMBO J, V30, P3475, DOI 10.1038/emboj.2011.255; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; MCQUILLAN DJ, 1995, BONE, V16, P415; Mizuno K, 2001, MICRON, V32, P317, DOI 10.1016/S0968-4328(00)00036-6; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Myllyharju J, 2008, ANN MED, V40, P402, DOI 10.1080/07853890801986594; Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Pace JM, 2001, J MED GENET, V38, P443, DOI 10.1136/jmg.38.7.443; Pautke C, 2004, ANTICANCER RES, V24, P3743; Peake PW, 2007, J MOL ENDOCRINOL, V39, P45, DOI 10.1677/JME-07-0030; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rauch F, 2015, AM J HUM GENET, V96, P425, DOI 10.1016/j.ajhg.2014.12.027; Rossert J, 2000, NEPHROL DIAL TRANSPL, V15, P66, DOI 10.1093/ndt/15.suppl_6.66; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; ROWE DW, 1985, J CLIN INVEST, V76, P604, DOI 10.1172/JCI112012; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; SHINKAI H, 1979, BIOCHEM J, V177, P847, DOI 10.1042/bj1770847; SPIRO RG, 1967, J BIOL CHEM, V242, P4813; Sricholpech M, 2011, J BIOL CHEM, V286, P8846, DOI 10.1074/jbc.M110.178509; Stawikowski MJ, 2014, J BIOL CHEM, V289, P21591, DOI 10.1074/jbc.M114.572073; Terajima M, 2014, J BIOL CHEM, V289, P22636, DOI 10.1074/jbc.M113.528513; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; van Dijk FS, 2011, MOL SYNDROMOL, V2, P1, DOI 10.1159/000332228; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wang CG, 2009, J CELL MOL MED, V13, P508, DOI 10.1111/j.1582-4934.2008.00286.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yoshikawa K, 2001, J BIOCHEM-TOKYO, V129, P929, DOI 10.1093/oxfordjournals.jbchem.a002939	51	37	37	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18514	18524		10.1074/jbc.M116.723379	http://dx.doi.org/10.1074/jbc.M116.723379			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402836	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000383241800041
J	Wang, JB; Galvao, J; Beach, KM; Luo, WJ; Urrutia, RA; Goldberg, JL; Otteson, DC				Wang, Jianbo; Galvao, Joana; Beach, Krista M.; Luo, Weijia; Urrutia, Raul A.; Goldberg, Jeffrey L.; Otteson, Deborah C.			Novel Roles and Mechanism for Kruppel-like Factor 16 (KLF16) Regulation of Neurite Outgrowth and Ephrin Receptor A5 (EphA5) Expression in Retinal Ganglion Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin immunoprecipitation (ChIP); DNA methylation; gene regulation; Kruppel-like factor (KLF); mouse; neurite outgrowth; neurodevelopment; promoter; protein expression; retina	FINGER TRANSCRIPTION FACTOR; MOUSE RETINA; FUNCTIONAL-ANALYSIS; GROWTH CONES; OPTIC-NERVE; CYCLIC-AMP; AXON REGENERATION; ADENOVIRUS TYPE-5; TYROSINE KINASES; GENE-EXPRESSION	Regenerative medicine holds great promise for the treatment of degenerative retinal disorders. Kruppel-like factors (KLFs) are transcription factors that have recently emerged as key tools in regenerative medicine because some of them can function as epigenetic reprogrammers in stem cell biology. Here, we show that KLF16, one of the least understood members of this family, is a POU4F2 independent transcription factor in retinal ganglion cells (RGCs) as early as embryonic day 15. When overexpressed, KLF16 inhibits RGC neurite outgrowth and enhances RGC growth cone collapse in response to exogenous ephrinA5 ligands. Ephrin/EPH signaling regulates RGC connectivity. The EphA5 promoter contains multiple GC- and GT-rich KLF-binding sites, which, as shown by ChIP-assays, bind KLF16 in vivo. In electrophoretic mobility shift assays, KLF16 binds specifically to a single KLF site near the EphA5 transcription start site that is required for KLF16 transactivation. Interestingly, methylation of only six of 98 CpG dinucleotides within the EphA5 promoter blocks its transactivation by KLF16 but enables transactivation by KLF2 and KLF15. These data demonstrate a role for KLF16 in regulation of RGC neurite outgrowth and as a methylation-sensitive transcriptional regulator of EphA5 expression. Together, these data identify differential low level methylation as a novel mechanism for regulating KLF16-mediated EphA5 expression across the retina. Because of the critical role of ephrin/EPH signaling in patterning RGC connectivity, understanding the role of KLFs in regulating neurite outgrowth and Eph receptor expression will be vital for successful restoration of functional vision through optic nerve regenerative therapies.	[Wang, Jianbo; Beach, Krista M.; Otteson, Deborah C.] Univ Houston, Dept Physiol Opt & Vis Sci, Houston, TX 77204 USA; [Luo, Weijia; Otteson, Deborah C.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Galvao, Joana; Goldberg, Jeffrey L.] Stanford Univ, Sch Med, Byers Eye Inst, Palo Alto, CA 94303 USA; [Galvao, Joana; Goldberg, Jeffrey L.] Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA; [Urrutia, Raul A.] Mayo Clin, Lab Epigenet & Chromatin Dynam, Gastroenterol Res Unit, Dept Med,Epigen Translat Program,Ctr Individualiz, Rochester, MN 55905 USA; [Urrutia, Raul A.] Mayo Clin, Lab Epigenet & Chromatin Dynam, Ctr Individualized Med, Dept Biochem,Gastroenterol Res Unit,Epigen Transl, Rochester, MN 55905 USA; [Urrutia, Raul A.] Mayo Clin, Lab Epigenet & Chromatin Dynam, Ctr Individualized Med, Dept Mol Biol,Gastroenterol Res Unit,Epigen Trans, Rochester, MN 55905 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Stanford University; University of California System; University of California San Diego; Mayo Clinic; Mayo Clinic; Mayo Clinic	Otteson, DC (corresponding author), Univ Houston, Coll Optometry, JD Armistead Bldg,Rm 2195,4901 Calhoun Rd, Houston, TX 77204 USA.	dotteson@central.uh.edu	Wang, Jianbo/D-9991-2011; Wang, Jianbo/AAQ-3235-2020	Wang, Jianbo/0000-0002-3315-3105; Wang, Jianbo/0000-0002-3315-3105; Luo, Weijia/0000-0002-4261-5084; Otteson, Deborah/0000-0001-6093-6837; Goldberg, Jeffrey/0000-0002-1390-7360	Cancer Center Support Grant (National Institutes of Health NCI) [P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA102701] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020913, P30EY022589, P30EY007551, R01EY021792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913, P30DK084567] Funding Source: NIH RePORTER	Cancer Center Support Grant (National Institutes of Health NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	STR DNA fingerprinting was done by the Cancer Center Support Grant-funded Characterized Cell Line Core (National Institutes of Health NCI Grant P30 CA016672). We thank Dr. William Klein (M. D. Anderson Cancer Center, Houston TX) for the Pou4f2 knock-out mice, Dr. Robert Schwartz (University of Houston, Houston TX) for use of the imaging system, and Micah Mesko-Smith for expert technical assistance.	Alewijnse AE, 1997, FEBS LETT, V419, P171, DOI 10.1016/S0014-5793(97)01440-3; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Buensuceso AV, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.100123; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Chen J, 2015, CYTOKINE GROWTH F R, V26, P1, DOI 10.1016/j.cytogfr.2014.05.001; Chierzi S, 2005, EUR J NEUROSCI, V21, P2051, DOI 10.1111/j.1460-9568.2005.04066.x; Clancy JP, 1999, AM J PHYSIOL-CELL PH, V276, pC361, DOI 10.1152/ajpcell.1999.276.2.C361; Cooper MA, 2009, J COMP NEUROL, V514, P310, DOI 10.1002/cne.22030; Corredor RG, 2012, J NEUROSCI, V32, P7734, DOI 10.1523/JNEUROSCI.5288-11.2012; D'Souza UM, 2002, MECH DEVELOP, V110, P197, DOI 10.1016/S0925-4773(01)00564-0; Daftary GS, 2012, J BIOL CHEM, V287, P7010, DOI 10.1074/jbc.M111.266007; de Melo J, 2003, J COMP NEUROL, V461, P187, DOI 10.1002/cne.10674; Dhande OS, 2012, J COMP NEUROL, V520, P1562, DOI 10.1002/cne.23000; DRESCHER U, 1995, CELL, V82, P359, DOI 10.1016/0092-8674(95)90425-5; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Feldheim DA, 2004, J NEUROSCI, V24, P2542, DOI 10.1523/JNEUROSCI.0239-03.2004; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Fu DY, 2010, HUM PATHOL, V41, P48, DOI 10.1016/j.humpath.2009.06.007; Fu XY, 2009, DEV DYNAM, V238, P2309, DOI 10.1002/dvdy.21974; Funk SD, 2013, PHARMACOL RES, V67, P42, DOI 10.1016/j.phrs.2012.10.008; Gamble JA, 2005, J NEUROSCI, V25, P3142, DOI 10.1523/JNEUROSCI.4759-04.2005; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Gao PP, 2000, J NEUROSCI RES, V60, P427, DOI 10.1002/(SICI)1097-4547(20000515)60:4<427::AID-JNR1>3.3.CO;2-4; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grassot J, 2003, NUCLEIC ACIDS RES, V31, P353, DOI 10.1093/nar/gkg036; HARRISON T, 1977, VIROLOGY, V77, P319, DOI 10.1016/0042-6822(77)90428-7; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hu Y, 2007, MOL CELL NEUROSCI, V34, P88, DOI 10.1016/j.mcn.2006.10.005; Hwang CK, 2001, P NATL ACAD SCI USA, V98, P7558, DOI 10.1073/pnas.121635798; Jassen AK, 2006, MOL PHARMACOL, V70, P71, DOI 10.1124/mol.105.021998; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kober P, 2011, MOL CARCINOGEN, V50, P846, DOI 10.1002/mc.20763; Li SB, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1025-3; Marcus RC, 1996, DEV BIOL, V180, P786, DOI 10.1006/dbio.1996.0347; Meng F, 2013, NEUROSCIENCE, V250, P381, DOI 10.1016/j.neuroscience.2013.07.001; Meyer JS, 2011, STEM CELLS, V29, P1206, DOI 10.1002/stem.674; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mojumder DK, 2008, MOL VIS, V14, P1600; Monsul NT, 2004, EXP NEUROL, V186, P124, DOI 10.1016/S0014-4886(03)00311-X; Moore DL, 2009, SCIENCE, V326, P298, DOI 10.1126/science.1175737; Moshiri A, 2008, DEV BIOL, V316, P214, DOI 10.1016/j.ydbio.2008.01.015; Mu XQ, 2004, DEVELOPMENT, V131, P1197, DOI 10.1242/dev.01010; Nicol X, 2007, NAT NEUROSCI, V10, P340, DOI 10.1038/nn1842; Otteson D. C., 2014, GANGLION CELLS MORPH, P1; Park I, 2015, MOL CELLS, V38, P14, DOI 10.14348/molcells.2015.2116; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Petkova TD, 2011, VISION RES, V51, P260, DOI 10.1016/j.visres.2010.09.022; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Philipsen S, 1999, NUCLEIC ACIDS RES, V27, P2991, DOI 10.1093/nar/27.15.2991; Polozov RV, 2015, J BIOMOL STRUCT DYN, V33, P253, DOI 10.1080/07391102.2013.879074; Qiu F, 2008, J NEUROSCI, V28, P3392, DOI 10.1523/JNEUROSCI.0043-08.2008; Rodger J, 2001, EUR J NEUROSCI, V14, P1929, DOI 10.1046/j.0953-816x.2001.01822.x; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Schuetz A, 2011, CELL MOL LIFE SCI, V68, P3121, DOI 10.1007/s00018-010-0618-x; SIMON DK, 1992, J NEUROSCI, V12, P1212; Simpson D, 2000, MOL VIS, V6, P178; Singleton BK, 2011, BLOOD, V118, P3137, DOI 10.1182/blood-2011-04-349985; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; Steketee MB, 2014, INVEST OPHTH VIS SCI, V55, P4369, DOI 10.1167/iovs.14-13882; Steketee MB, 2011, P NATL ACAD SCI USA, V108, P19042, DOI 10.1073/pnas.1019624108; Thakar S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1445; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Tiwari S, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-30; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Triplett JW, 2012, SEMIN CELL DEV BIOL, V23, P7, DOI 10.1016/j.semcdb.2011.10.026; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang SW, 2002, DEVELOPMENT, V129, P467; Washburn Christopher P, 2007, Neurosci Bull, V23, P249, DOI 10.1007/s12264-007-0037-7; White BEP, 2014, CELL ADHES MIGR, V8, P327, DOI 10.4161/19336918.2014.970012; Wilson DM, 1999, J HISTOCHEM CYTOCHEM, V47, P1095, DOI 10.1177/002215549904700814; Xie BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112175; Zhu Kuichun, 2003, Curr Opin Investig Drugs, V4, P1428	77	15	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18084	18095		10.1074/jbc.M116.732339	http://dx.doi.org/10.1074/jbc.M116.732339			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402841	hybrid, Green Published			2022-12-26	WOS:000383241800003
J	Harapan, H; Anwar, S; Bustaman, A; Radiansyah, A; Angraini, P; Fasli, R; Salwiyadi, S; Bastian, RA; Oktiviyari, A; Akmal, I; Iqbalamin, M; Adil, J; Henrizal, F; Darmayanti, D; Pratama, R; Fajar, JK; Setiawan, AM; Imrie, A; Kuch, U; Groneberg, DA; Sasmono, T; Dhimal, M; Muller, R				Harapan, Harapan; Anwar, Samsul; Bustaman, Aslam; Radiansyah, Arsil; Angraini, Pradiba; Fasli, Riny; Salwiyadi, Salwiyadi; Bastian, Reza Akbar; Oktiviyari, Ade; Akmal, Imaduddin; Iqbalamin, Muhammad; Adil, Jamalul; Henrizal, Fenni; Darmayanti, Darmayanti; Pratama, Rovy; Fajar, Jonny Karunia; Setiawan, Abdul Malik; Imrie, Allison; Kuch, Ulrich; Groneberg, David Alexander; Sasmono, Tedjo; Dhimal, Meghnath; Mueller, Ruth			Community Willingness to Participate in a Dengue Study in Aceh Province, Indonesia	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; AFRICAN-AMERICAN WOMEN; GENETIC RESEARCH; CLINICAL-TRIALS; HEALTH RESEARCH; MYOCARDIAL-INFARCTION; PATIENT WILLINGNESS; GENERAL-POPULATION; PREVENTION TRIALS; PUBLIC-ATTITUDES	Background Dengue virus infection is the most rapidly spreading vector-borne disease in the world. Essential research on dengue virus transmission and its prevention requires community participation. Therefore, it is crucial to understand the factors that are associated with the willingness of communities in high prevalence areas to participate in dengue research. The aim of this study was to explore factors associated with the willingness of healthy community members in Aceh province, Indonesia, to participate in dengue research that would require phlebotomy. Methodology/Principal Findings A community-based cross-sectional study was carried out in nine regencies and municipalities of Aceh from November 2014 to March 2015. Interviews using a set of validated questionnaires were conducted to collect data on demography, history of dengue infection, socioeconomic status, and knowledge, attitude and practice regarding dengue fever. Two-step logistic regression and Spearman's rank correlation (r(s)) analysis were used to assess the influence of independent variables on dependent variables. Among 535 participants, less than 20% had a good willingness to participate in the dengue study. The factors associated with good willingness to participate were being female, working as a civil servant, private employee or entrepreneur, having a high socioeconomic status and good knowledge, attitude and practice regarding dengue. Good knowledge and attitude regarding dengue were positive independent predictors of willingness to participate (OR: 2.30 [95% CI: 1.36-3.90] and 3.73 [95% CI: 2.24-6.21], respectively). Conclusion/Significance The willingness to participate in dengue research is very low among community members in Aceh, and the two most important associated factors are knowledge and attitude regarding dengue. To increase participation rate, efforts to improve the knowledge and attitude of community members regarding dengue fever and dengue-related research is required before such studies are launched.	[Harapan, Harapan; Radiansyah, Arsil; Angraini, Pradiba; Fasli, Riny; Salwiyadi, Salwiyadi; Bastian, Reza Akbar; Oktiviyari, Ade; Akmal, Imaduddin; Iqbalamin, Muhammad; Adil, Jamalul; Henrizal, Fenni; Darmayanti, Darmayanti; Pratama, Rovy; Fajar, Jonny Karunia] Syiah Kuala Univ, Sch Med, Med Res Unit, Banda Aceh, Indonesia; [Harapan, Harapan] Syiah Kuala Univ, Sch Med, Trop Dis Ctr, Banda Aceh, Indonesia; [Harapan, Harapan] Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh, Indonesia; [Harapan, Harapan; Imrie, Allison] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA, Australia; [Anwar, Samsul] Syiah Kuala Univ, Fac Math & Nat Sci, Dept Stat, Banda Aceh, Indonesia; [Bustaman, Aslam] Syiah Kuala Univ, Fac Teacher Training & Educ, Dept Biol, Banda Aceh, Indonesia; [Setiawan, Abdul Malik] State Islamic Univ Maulana Malik Ibrahim, Fac Med & Hlth Sci, Dept Microbiol, Malang, Indonesia; [Kuch, Ulrich; Groneberg, David Alexander; Mueller, Ruth] Goethe Univ Frankfurt, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany; [Sasmono, Tedjo] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Dhimal, Meghnath] NHRC, Minist Hlth Complex, Kathmandu, Nepal	Universitas Syiah Kuala; Universitas Syiah Kuala; Universitas Syiah Kuala; University of Western Australia; Universitas Syiah Kuala; Universitas Syiah Kuala; Goethe University Frankfurt; Eijkman Institute	Harapan, H (corresponding author), Syiah Kuala Univ, Sch Med, Med Res Unit, Banda Aceh, Indonesia.; Harapan, H (corresponding author), Syiah Kuala Univ, Sch Med, Trop Dis Ctr, Banda Aceh, Indonesia.; Harapan, H (corresponding author), Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh, Indonesia.; Harapan, H (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA, Australia.	harapan@unsyiah.ac.id	Setiawan, Abdul Malik/AAB-7458-2021; Dhimal, Meghnath/AAD-7261-2021; Sasmono, Tedjo/H-5680-2016; Groneberg, David/A-5132-2018; Oktiviyari, Ade/GPG-3649-2022; Imrie, Allison/AAH-2421-2019; Fajar, Jonny Karunia/N-8039-2018; Muller, Ruth/GXA-1300-2022; Harapan, Harapan/I-8741-2016; Muller, Ruth/D-2551-2009	Setiawan, Abdul Malik/0000-0002-6913-2007; Dhimal, Meghnath/0000-0001-7176-7821; Sasmono, Tedjo/0000-0003-0986-2590; Groneberg, David/0000-0001-8551-6556; Oktiviyari, Ade/0000-0002-1392-200X; Fajar, Jonny Karunia/0000-0002-0309-5813; Harapan, Harapan/0000-0001-7630-8413; Bastian, Reza Akbar/0000-0002-4062-0461; Muller, Ruth/0000-0003-3909-3876				Abdullah M.N., 2013, AM INT J CONT RES, V3, P69; Afshar R, 2012, SAUDI J KIDNEY DIS T, V23, P929, DOI 10.4103/1319-2442.100863; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bhatti P, 2005, CANCER EPIDEM BIOMAR, V14, P2449, DOI 10.1158/1055-9965.EPI-05-0463; Bonett DG, 2000, PSYCHOMETRIKA, V65, P23, DOI 10.1007/BF02294183; Bower P, 2007, FAM PRACT, V24, P601, DOI 10.1093/fampra/cmm051; Bower P, 2009, FAM PRACT, V26, P391, DOI 10.1093/fampra/cmp037; BPS, 2015, AC DAL ANGK 2015; Braunstein JB, 2008, MEDICINE, V87, P1, DOI 10.1097/MD.0b013e3181625d78; Brown DR, 2003, GERONTOLOGIST, V43, P62, DOI 10.1093/geront/43.1.62; Buchwald D, 2006, J GEN INTERN MED, V21, P648, DOI 10.1111/j.1525-1497.2006.00449.x; Bussey-Jones J, 2010, GENET MED, V12, P116, DOI 10.1097/GIM.0b013e3181cd6689; Caldwell PHY, 2003, J PEDIATR-US, V142, P554, DOI 10.1067/mpd.2003.192; Caprara A, 2015, T ROY SOC TROP MED H, V109, P99, DOI 10.1093/trstmh/tru187; Chu SH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-014-1339-0; Clark MA, 2007, CANCER EPIDEM BIOMAR, V16, P2605, DOI 10.1158/1055-9965.EPI-07-0157; Comis RL, 2003, J CLIN ONCOL, V21, P830, DOI 10.1200/JCO.2003.02.105; Costenbader KH, 2007, ARTHRIT RHEUM-ARTHR, V57, P49, DOI 10.1002/art.22480; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028; Dias L, 2005, CLIN TRIALS, V2, P443, DOI 10.1191/1740774505cn113oa; Dong Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111321; Du W, 2008, J THORAC ONCOL, V3, P23, DOI 10.1097/JTO.0b013e31815e8bb2; Dunlop AL, 2011, J CLIN EPIDEMIOL, V64, P872, DOI 10.1016/j.jclinepi.2010.11.008; Effler PV, 2005, EMERG INFECT DIS, V11, P742; Filmer D, 1999, POPUL DEV REV, V25, P85, DOI 10.1111/j.1728-4457.1999.00085.x; Ford BM, 2006, CANCER EPIDEM BIOMAR, V15, P1355, DOI 10.1158/1055-9965.EPI-05-0816; Godskesen T, 2015, EUR J CANCER CARE, V24, P133, DOI 10.1111/ecc.12184; Green D, 2006, AM J EPIDEMIOL, V164, P845, DOI 10.1093/aje/kwj286; Hadisoemarto PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002427; Harapan H, 2016, KNOWLEDGE ATTI UNPUB; Harapan H, 2016, VACCINE, V34, P3670, DOI 10.1016/j.vaccine.2016.05.026; Hemachandra A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-S3-P202; Hendren E, 2015, TRANSPLANTATION, V99, P1894, DOI 10.1097/TP.0000000000000533; Iacobucci D, 2003, J CONSUM PSYCHOL, V13, P478, DOI 10.1207/S15327663JCP1304_14; James DCS, 2016, TELEMED E-HEALTH, V22, P191, DOI 10.1089/tmj.2015.0071; Johnsson L, 2010, EUR J HUM GENET, V18, P1261, DOI 10.1038/ejhg.2010.106; Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412; Kemenkes RI, 2015, PROFIL KESEHATAN IND; Kettis-Lindblad A, 2006, EUR J PUBLIC HEALTH, V16, P433, DOI 10.1093/eurpub/cki198; Koenraadt CJ, 2005, AM J TROP MED HYG, V73, P156; Krousel-Wood MA, 2001, J TELEMED TELECARE, V7, P281, DOI 10.1258/1357633011936543; Lanfear DE, 2011, GENOME MED, V3, DOI 10.1186/gm255; Lanfear DE, 2008, CIRCULATION, V118, pS624; Limkakeng A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051328; Lin JS, 2005, J COMMUN HEALTH, V30, P451, DOI 10.1007/s10900-005-7280-5; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Mbunda T, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.22853; McCann SK, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-31; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; McQuillan GM, 2006, GENET MED, V8, P354, DOI 10.1097/01.gim.0000223552.70393.08; McQuillan GM, 2003, GENET MED, V5, P35, DOI 10.1097/00125817-200301000-00006; Newman PA, 2014, VACCINE, V32, P5854, DOI 10.1016/j.vaccine.2014.08.043; Noordzij M, 2010, NEPHROL DIAL TRANSPL, V25, P1388, DOI 10.1093/ndt/gfp732; Perez-Guerra CL, 2012, HUM VACC IMMUNOTHER, V8, P905, DOI 10.4161/hv.20056; Prayitno A, 2016, INT J INFECT DIS, V45, P242, DOI 10.1016/j.ijid.2016.02.543; Pulley JM, 2008, CELL TISSUE BANK, V9, P55, DOI 10.1007/s10561-007-9051-2; Rocha C, 2009, AM J TROP MED HYG, V80, P656, DOI 10.4269/ajtmh.2009.80.656; Rodriguez H, 2015, J ALLERGY CLIN IMMUN, V135, pAB245, DOI 10.1016/j.jaci.2014.12.1737; Russell KM, 2008, APPL NURS RES, V21, P90, DOI 10.1016/j.apnr.2006.05.001; Shavers VL, 2002, ANN EPIDEMIOL, V12, P248, DOI 10.1016/S1047-2797(01)00265-4; Shavers-Hornaday V L, 1997, Ethn Health, V2, P31; Smit J, 2006, INT J STD AIDS, V17, P176, DOI 10.1258/095646206775809259; Suhud U., 2014, J ECO SUSTAIN DEV, V5, P91; Sygna K, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0948-y; Tapia-Conyer R, 2012, PAEDIATR INT CHILD H, V32, P10, DOI 10.1179/2046904712Z.00000000047; Treweek S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002360; Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959; Wang S, 1999, AM J HUM GENET, V65, pA411; Wang S, 2011, COMMUNITY GENET, V4, P18; Wendler D, 2006, PLOS MED, V3, P201, DOI 10.1371/journal.pmed.0030019; WHO, 2019, DENG SEV DENG; Wong ML, 2004, CLIN GENET, V65, P45, DOI 10.1111/j..2004.00192.x; World Health Organization, 2009, DENGUE GUIDELINES DI; Yap BW, 2011, J STAT COMPUT SIM, V81, P2141, DOI 10.1080/00949655.2010.520163; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	76	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159139	10.1371/journal.pone.0159139	http://dx.doi.org/10.1371/journal.pone.0159139			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27404663	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000379508200036
J	Ye, YJ; Cai, M; Ju, YQ; Jiao, Y; Feng, L; Pan, HT; Cheng, TR; Zhang, QX				Ye, Yuanjun; Cai, Ming; Ju, Yiqian; Jiao, Yao; Feng, Lu; Pan, Huitang; Cheng, Tangren; Zhang, Qixiang			Identification and Validation of SNP Markers Linked to Dwarf Traits Using SLAF-Seq Technology in Lagerstroemia	PLOS ONE			English	Article							BULKED SEGREGANT ANALYSIS; SEQUENCE REPEAT MARKERS; DENSITY GENETIC-MAP; PLANT ARCHITECTURE; CRAPE MYRTLE; QTL ANALYSIS; LINKAGE MAP; APPLE-TREES; MICROSATELLITE MARKERS; INTERNODE LENGTH	The genetic control of plant architecture is a promising approach to breed desirable cultivars, particularly in ornamental flowers. In this study, the F-1 population (142 seedlings) derived from Lagerstroemia fauriei (non-dwarf) x L. indica 'Pocomoke' (dwarf) was pheno-typed for six traits (plant height (PH), internode length (IL), internode number, primary lateral branch height (PLBH), secondary lateral branch height and primary branch number), and the IL and PLBH traits were positively correlated with the PH trait and considered representative indexes of PH. Fifty non-dwarf and dwarf seedlings were pooled and subjected to a specific-locus amplified fragment sequencing (SLAF-seq) method, which screened 1221 polymorphic markers. A total of 3 markers segregating between bulks were validated in the F-1 population, with the M16337 and M38412 markers highly correlated with the IL trait and the M25207 marker highly correlated with the PLBH trait. These markers provide a predictability of approximately 80% using a single marker (M25207) and a predictability of 90% using marker combinations (M16337 + M25207) in the F-1 population, which revealed that the IL and the PLBH traits, especially the PLBH, were the decisive elements for PH in terms of molecular regulation. Further validation was performed in the BC1 population and a set of 28 Lagerstroemia stocks using allele-specific PCR (AS-PCR) technology, and the results showed the stability and reliability of the SNP markers and the co-determination of PH by multiple genes. Our findings provide an important theoretical and practical basis for the early prediction and indirect selection of PH using the IL and the PLBH, and the detected SNPs may be useful for marker-assisted selection (MAS) in crape myrtle.	[Pan, Huitang] Beijing Forestry Univ, Beijing Key Lab Ornamental Plants Germplasm Innov, Natl Engn Res Ctr Floriculture, Beijing Lab Urban & Rural Ecol Environm, Beijing 100083, Peoples R China; Beijing Forestry Univ, Coll Landscape Architecture, Beijing 100083, Peoples R China	Beijing Forestry University; Beijing Forestry University	Pan, HT (corresponding author), Beijing Forestry Univ, Beijing Key Lab Ornamental Plants Germplasm Innov, Natl Engn Res Ctr Floriculture, Beijing Lab Urban & Rural Ecol Environm, Beijing 100083, Peoples R China.	htpan@bjfu.edu.cn	Cheng, Tangren/HDM-6455-2022		12th Five Years Key Programs for Science and Technology Development of China [2013BAD01B07]; National Science Foundation of China [31470695]; Fundamental Research Funds for the Central Universities [BLYJ201612]; Special Fund for Beijing Common Construction Project (HTP)	12th Five Years Key Programs for Science and Technology Development of China(Chinese Academy of Sciences); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Special Fund for Beijing Common Construction Project (HTP)	This work was supported by 1) The 12th Five Years Key Programs for Science and Technology Development of China (#2013BAD01B07, http://program.most.gov.cn/, HTP); 2) National Science Foundation of China (No. 31470695, http://www.nsfc.gov.cn, HTP); 3) The Fundamental Research Funds for the Central Universities (No. BLYJ201612, http://graduate.bjfu.edu.cn/article-18-10121.aspx, YJY); and 4) Special Fund for Beijing Common Construction Project (HTP). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bello MH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-903; Brickell C., 1996, ENCY GARDEN PLANTS, P250; Bundock PC, 2006, THEOR APPL GENET, V112, P358, DOI 10.1007/s00122-005-0137-6; Cai M, 2010, CONSERV GENET RESOUR, V2, P89, DOI 10.1007/s12686-010-9197-2; Celton JM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-155; Chen SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065122; Chutimanitsakun Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-4; Cregan PB, 1999, THEOR APPL GENET, V99, P811, DOI 10.1007/s001220051300; Dardick C, 2013, PLANT J, V75, P618, DOI 10.1111/tpj.12234; Dhanasekar P, 2007, PLANT BREEDING, V126, P551, DOI 10.1111/j.1439-0523.2007.01427.x; EGOLF DR, 1981, HORTSCIENCE, V16, P576; EGOLF DR, 1990, HORTSCIENCE, V25, P992, DOI 10.21273/HORTSCI.25.8.992; EGOLF DR, 1986, HORTSCIENCE, V21, P1250; Gargul JM, 2015, PLANT BIOTECHNOL J, V13, P51, DOI 10.1111/pbi.12234; Guidry R. K., 1975, FLORISTS REV, V157, P30; Han YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127065; He D, 2012, GENET MOL RES, V11, P3522, DOI 10.4238/2012.September.26.9; He D, 2014, PLANT BREEDING, V133, P138, DOI 10.1111/pbr.12100; Hwang J, 2014, MOL BREEDING, V34, P949, DOI 10.1007/s11032-014-0088-1; Jiao YQ, 2010, NAT GENET, V42, P541, DOI 10.1038/ng.591; Kalinina EY, 2011, CYTOL GENET+, V45, P101, DOI 10.3103/S0095452711020058; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Knox GW, 1992, CRAPEMYRTLE IN FLORI; Ku LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020621; Kuraparthy V, 2008, FUNCT INTEGR GENOMIC, V8, P33, DOI 10.1007/s10142-007-0057-4; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li F, 2016, PLANT SCI, V242, P169, DOI 10.1016/j.plantsci.2015.05.012; Li YH, 2011, THEOR APPL GENET, V123, P973, DOI 10.1007/s00122-011-1640-6; Liu RZ, 2014, EUPHYTICA, V196, P51, DOI 10.1007/s10681-013-1013-0; Liu YS, 2008, GRANA, V47, P262, DOI 10.1080/00173130802457255; Liu Z, 2015, RICE, V8, DOI 10.1186/s12284-015-0042-9; Mencuccini M, 2015, PLANT CELL ENVIRON, V38, P1, DOI 10.1111/pce.12442; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; One KT, 2014, J AM SOC HORTIC SCI, V139, P582, DOI 10.21273/JASHS.139.5.582; Peng H, 2015, EUPHYTICA, V202, P385, DOI 10.1007/s10681-014-1259-1; Petersen R, 2013, PLANTA, V238, P1, DOI 10.1007/s00425-013-1898-9; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Pilcher RLR, 2008, J AM SOC HORTIC SCI, V133, P100, DOI 10.21273/JASHS.133.1.100; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Pounders C, 2007, HORTSCIENCE, V42, P1496, DOI 10.21273/HORTSCI.42.6.1496; Pounders C, 2007, HORTSCIENCE, V42, P1317, DOI 10.21273/HORTSCI.42.6.1317; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Ripetti V, 2008, J EXP BOT, V59, P1399, DOI 10.1093/jxb/ern049; Segura V, 2008, NEW PHYTOL, V178, P302, DOI 10.1111/j.1469-8137.2007.02374.x; Seleznyova AN, 2007, ACTA HORTIC, P79, DOI 10.17660/ActaHortic.2007.732.6; Socquet-Juglard D, 2013, PLANT MOL BIOL REP, V31, P387, DOI 10.1007/s11105-012-0511-x; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Teng F, 2013, PLANT J, V73, P405, DOI 10.1111/tpj.12038; Tong HN, 2014, PLANT CELL, V26, P4376, DOI 10.1105/tpc.114.132092; Wang N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-148; Wang XW, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/528395; Wang X, 2011, J AM SOC HORTIC SCI, V136, P116, DOI 10.21273/JASHS.136.2.116; Wang XW, 2010, HORTSCIENCE, V45, P842, DOI 10.21273/HORTSCI.45.5.842; Wang YH, 2008, ANNU REV PLANT BIOL, V59, P253, DOI 10.1146/annurev.arplant.59.032607.092902; Wei QZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1158; Xia C, 2015, EUPHYTICA, V202, P35, DOI 10.1007/s10681-014-1202-5; Xin M, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-014-1703-9; Xu FF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122206; Xu XW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00768; Yang XM, 2014, PLANT BREEDING, V133, P335, DOI 10.1111/pbr.12154; Ye YJ, 2015, GENET MOL RES, V14, P4369, DOI 10.4238/2015.April.30.10; Zeng XH, 2011, THEOR APPL GENET, V122, P421, DOI 10.1007/s00122-010-1457-8; Zhang F, 2012, MOL BREEDING, V30, P1027, DOI 10.1007/s11032-011-9686-3; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141; Zhang ZY, 2014, DNA CELL BIOL, V33, P680, DOI 10.1089/dna.2014.2469; Zhu YM, 2011, MOL BREEDING, V27, P525, DOI 10.1007/s11032-010-9449-6	69	19	24	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158970	10.1371/journal.pone.0158970	http://dx.doi.org/10.1371/journal.pone.0158970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404662	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508200025
J	Dong, Y; Sun, Q; Liu, T; Wang, HY; Jiao, K; Xu, JH; Liu, X; Liu, HR; Wang, W				Dong, Yu; Sun, Qi; Liu, Teng; Wang, Huanyuan; Jiao, Kun; Xu, Jiahui; Liu, Xin; Liu, Huirong; Wang, Wen			Nitrative Stress Participates in Endothelial Progenitor Cell Injury in Hyperhomocysteinemia	PLOS ONE			English	Article							SYNTHASE-DEFICIENT MICE; NITRIC-OXIDE; METHYLENETETRAHYDROFOLATE REDUCTASE; CARDIOVASCULAR RISK; SUPEROXIDE-DISMUTASE; VASCULAR DYSFUNCTION; PLASMA HOMOCYSTEINE; PERIPHERAL-BLOOD; C677T MUTATION; PEROXYNITRITE	In order to investigate the role of nitrative stress in vascular endothelial injury in hyperhomocysteinemia (HHcy), thirty healthy adult female Wistar rats were randomly divided into three groups: control, hyperhomocysteinemia model, and hyperhomocysteinemia with FeTMPyP (peroxynitrite scavenger) treatment. The endothelium-dependent dilatation of thoracic aorta in vitro was determined by response to acetylcholine (ACh). The histological changes in endothelium were assessed by HE staining and scanning electron microscopy (SEM). The expression of 3-nitrotyrosine (NT) in thoracic aorta was demonstrated by immunohistochemistry and immunofluorescence, and the number of circulating endothelial progenitor cells (EPCs) was quantified by flow cytometry. Hyperhomocysteinemia caused significant endothelial injury and dysfunction including vasodilative and histologic changes, associated with higher expression of NT in thoracic aorta. FeTMPyP treatment reversed these injuries significantly. Further, the effect of nitrative stress on cultured EPCs in vitro was investigated by administering peroxynitrite donor (3-morpholino-sydnonimine, SIN-1) and peroxynitrite scavenger (FeTMPyP). The roles of nitrative stress on cell viability, necrosis and apoptosis were evaluated with 3-(4,5-dimethylthiazol)-2,5-diphenyl tetrazolium (MTT) assay, lactate dehydrogenase (LDH) release assay and terminal deoxynucleotidyl transferase dUTP nickend labeling (TUNEL) assay, respectively. Also, the phospho-eNOS expression and tube formation in Matrigel of cultured EPCs was detected. Our data showed that the survival of EPCs was much lower in SIN-1 group than in vehicle group, both the apoptosis and necrosis of EPCs were much more severe, and the p-eNOS expression and tube formation in Matrigel were obviously declined. Subsequent pretreatment with FeTMPyP reversed these changes. Further, pretreatment with FeTMPyP reversed homocysteine-induced EPC injury. In conclusion, this study indicates that nitrative stress plays a role in vascular endothelial injury in hyperhomocysteinemia, as well as induces endothelial progenitor cell injury directly.	[Dong, Yu; Sun, Qi; Liu, Teng; Wang, Huanyuan; Jiao, Kun; Xu, Jiahui; Liu, Xin; Liu, Huirong; Wang, Wen] Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China; [Dong, Yu; Sun, Qi; Liu, Teng; Wang, Huanyuan; Jiao, Kun; Xu, Jiahui; Liu, Xin; Liu, Huirong; Wang, Wen] Capital Med Univ, Beijing Key Lab Metab Disorders Related Cardiovas, Beijing, Peoples R China	Capital Medical University; Capital Medical University	Wang, W (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Beijing, Peoples R China.; Wang, W (corresponding author), Capital Med Univ, Beijing Key Lab Metab Disorders Related Cardiovas, Beijing, Peoples R China.	wangwen@ccmu.edu.cn	xu, jia/GSD-6347-2022; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454	National Natural Science Foundation of China [448 81370450, 81370450]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China (No. 448 81370450) to Wen Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the assistance of the Flow Cytometry Facility in the central laboratory in the Capital Medical University. We also thank Dr. Xiangjun Zeng, Yanan Gu and Ru Yuan from School of Basic Medical Sciences, Capital Medical University, for their selfless support with Matrigel and suggestions in capillary-like structures formation experiment. Funding was provided by the National Natural Science Foundation of China (No. 81370450) to Wen Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2004, FREE RADICAL BIO MED, V37, P813, DOI 10.1016/j.freeradbiomed.2004.06.006; Becchi C, 2008, INT J IMMUNOPATH PH, V21, P697, DOI 10.1177/039463200802100324; Bogoslovsky T, 2015, BIOMARK MED, V9, P625, DOI [10.2217/BMM.15.34, 10.2217/bmm.15.34]; Boos Christopher J., 2007, V139, P211; Brandes RP, 2005, CARDIOVASC RES, V66, P286, DOI 10.1016/j.cardiores.2004.12.027; Brown RM, 2016, METHODS MOL BIOL, V1430, P149, DOI 10.1007/978-1-4939-3628-1_9; Brunt Keith R., 2007, V139, P197; Calcerrada P, 2011, CURR PHARM DESIGN, V17, P3905, DOI 10.2174/138161211798357719; Cheng ZJ, 2011, BLOOD, V118, P1998, DOI 10.1182/blood-2011-01-333310; Cignarella Andrea, 2010, Cardiovascular & Hematological Agents in Medicinal Chemistry, V8, P147; Crabtree B, 2007, IN VITRO CELL DEV-AN, V43, P87, DOI 10.1007/s11626-007-9012-x; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; Davel AP, 2011, BRAZ J MED BIOL RES, V44, P920, DOI [10.1590/S0100-879X2011007500104, 10.1590/S0100-879X2011000900014]; Deloughery TG, 1996, CIRCULATION, V94, P3074, DOI 10.1161/01.CIR.94.12.3074; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Forstermann U, 2006, CIRCULATION, V113, P1708, DOI 10.1161/CIRCULATIONAHA.105.602532; Girelli D, 1998, BLOOD, V91, P4158, DOI 10.1182/blood.V91.11.4158.411k23_4158_4163; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Kar S, 2003, FREE RADIC BIOL MED, V63, P161; Kavdia Mahendra, 2011, Critical Reviews in Biomedical Engineering, V39, P461, DOI 10.1615/CritRevBiomedEng.v39.i5.60; Kumar KH, 2013, NEUROTOXICOLOGY, V34, P150, DOI 10.1016/j.neuro.2012.11.002; Lentz SR, 2000, AM J PHYSIOL-HEART C, V279, pH970, DOI 10.1152/ajpheart.2000.279.3.H970; Lentz SR, 1996, J CLIN INVEST, V98, P24, DOI 10.1172/JCI118771; Maas R, 2003, ATHEROSCLEROSIS SUPP, V4, P15; MacMillan-Crow LA, 1998, BIOCHEMISTRY-US, V37, P1613, DOI 10.1021/bi971894b; Mayo JN, 2012, J CEREBR BLOOD F MET, V32, P825, DOI 10.1038/jcbfm.2011.185; Menegazzo L, 2012, BIOFACTORS, V38, P194, DOI 10.1002/biof.1016; Miller-Kasprzak E, 2007, ARCH IMMUNOL THER EX, V55, P247, DOI 10.1007/s00005-007-0027-5; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Refsum H, 2001, AM J CLIN NUTR, V74, P233; Sen S, 2011, CLIN SCI, V120, P263, DOI 10.1042/CS20100429; Smadja DM, 2009, CIRCULATION, V119, P374, DOI 10.1161/CIRCULATIONAHA.108.808246; Soriente L, 1998, STROKE, V29, P869, DOI 10.1161/01.STR.29.4.869; STAMLER JS, 1993, J CLIN INVEST, V91, P308, DOI 10.1172/JCI116187; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; Szabo C, 2002, MOL MED, V8, P571, DOI 10.1007/BF03402167; Tofler GH, 2002, THROMB HAEMOSTASIS, V88, P799; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Tyagi N, 2005, AM J PHYSIOL-HEART C, V289, pH2649, DOI 10.1152/ajpheart.00548.2005; Ungvari Z, 1999, ARTERIOSCL THROM VAS, V19, P1899, DOI 10.1161/01.ATV.19.8.1899; van der Loo B, 2000, J EXP MED, V192, P1731, DOI 10.1084/jem.192.12.1731; Vizzardi E, 2007, CARDIOLOGY, V107, P354, DOI 10.1159/000099050; Widner B, 2002, CURR DRUG METAB, V3, P225, DOI 10.2174/1389200024605091; Zhang XH, 2000, AM J PHYSIOL-RENAL, V279, pF671, DOI 10.1152/ajprenal.2000.279.4.F671	44	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158672	10.1371/journal.pone.0158672	http://dx.doi.org/10.1371/journal.pone.0158672			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391949	Green Submitted, gold, Green Published			2022-12-26	WOS:000380005400100
J	Gan, MY; Liu, QY; Yang, CG; Gao, Q; Luo, T				Gan, Mingyu; Liu, Qingyun; Yang, Chongguang; Gao, Qian; Luo, Tao			Deep Whole-Genome Sequencing to Detect Mixed Infection of Mycobacterium tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT STRAIN; DRUG-RESISTANCE; REINFECTION; POPULATION; TRANSMISSION; PREVALENCE; PATTERNS; AFRICA; CHINA	Mixed infection by multiple Mycobacterium tuberculosis (MTB) strains is associated with poor treatment outcome of tuberculosis (TB). Traditional genotyping methods have been used to detect mixed infections of MTB, however, their sensitivity and resolution are limited. Deep whole-genome sequencing (WGS) has been proved highly sensitive and discriminative for studying population heterogeneity of MTB. Here, we developed a phylogenetic-based method to detect MTB mixed infections using WGS data. We collected published WGS data of 782 global MTB strains from public database. We called homogeneous and heterogeneous single nucleotide variations (SNVs) of individual strains by mapping short reads to the ancestral MTB reference genome. We constructed a phylogenomic database based on 68,639 homogeneous SNVs of 652 MTB strains. Mixed infections were determined if multiple evolutionary paths were identified by mapping the SNVs of individual samples to the phylogenomic database. By simulation, our method could specifically detect mixed infections when the sequencing depth of minor strains was as low as 1x coverage, and when the genomic distance of two mixed strains was as small as 16 SNVs. By applying our methods to all 782 samples, we detected 47 mixed infections and 45 of them were caused by locally endemic strains. The results indicate that our method is highly sensitive and discriminative for identifying mixed infections from deep WGS data of MTB isolates.	[Gan, Mingyu; Liu, Qingyun; Yang, Chongguang; Gao, Qian] Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Key Lab Med Mol Virol,Minist Educ, Shanghai, Peoples R China; [Gan, Mingyu; Liu, Qingyun; Yang, Chongguang; Gao, Qian] Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Minist Hlth, Shanghai, Peoples R China; [Gan, Mingyu; Liu, Qingyun; Yang, Chongguang; Gao, Qian] Fudan Univ, Inst Med Microbiol, Sch Basic Med Sci, Shanghai, Peoples R China; [Luo, Tao] Sichuan Univ, Sch Basic Med Sci, West China Ctr Med Sci, Lab Infect & Immun, Chengdu, Sichuan, Peoples R China	Fudan University; Fudan University; Fudan University; Sichuan University	Gao, Q (corresponding author), Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Key Lab Med Mol Virol,Minist Educ, Shanghai, Peoples R China.; Gao, Q (corresponding author), Fudan Univ, Sch Basic Med Sci, Inst Biomed Sci, Minist Hlth, Shanghai, Peoples R China.; Gao, Q (corresponding author), Fudan Univ, Inst Med Microbiol, Sch Basic Med Sci, Shanghai, Peoples R China.; Luo, T (corresponding author), Sichuan Univ, Sch Basic Med Sci, West China Ctr Med Sci, Lab Infect & Immun, Chengdu, Sichuan, Peoples R China.	qgao99@yahoo.com; taoluo@scu.edu.cn	Yang, Chongguang/N-3298-2016; Yang, Chongguang/S-9117-2019; , 罗涛/AHA-1191-2022	Yang, Chongguang/0000-0001-8109-4974; Yang, Chongguang/0000-0001-8109-4974; Liu, Qingyun/0000-0002-2284-5050	National Natural Science Foundation of China (CN) [31301033]; Ministry of Science and Technology of the People's Republic of China [2014DFA30340]; National Science and Technology Major Project [2013ZX10004903-006]	National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science and Technology Major Project	This study was supported by National Natural Science Foundation of China (CN) (31301033) (website: http://www.nsfc.gov.cn/) (PI: Tao Luo), Ministry of Science and Technology of the People's Republic of China (2014DFA30340) (website:http://www.most.gov.cn/index.htm) (PI: Qian Gao) and the National Science and Technology Major Project [2013ZX10004903-006] (website: http://www.most.gov.cn/index.htm) (PI: Qian Gao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PF, 2003, NEW ENGL J MED, V349, P1149, DOI 10.1056/NEJMra021964; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Chan JZM, 2013, NEW ENGL J MED, V369, P289, DOI 10.1056/NEJMc1302295; Chaves F, 1999, AIDS, V13, P615, DOI 10.1097/00002030-199904010-00011; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; Cohen T, 2011, J CLIN MICROBIOL, V49, P385, DOI 10.1128/JCM.01378-10; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; de Boer AS, 2000, J CLIN MICROBIOL, V38, P4478, DOI 10.1128/JCM.38.12.4478-4484.2000; Eyre DW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003059; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Guerra-Assuncao JA, 2015, J INFECT DIS, V211, P1154, DOI 10.1093/infdis/jiu574; Hanekom M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070178; Ismail F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114832; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Luo T, 2015, P NATL ACAD SCI USA, V112, P8136, DOI 10.1073/pnas.1424063112; Luo T, 2014, TUBERCULOSIS, V94, P434, DOI 10.1016/j.tube.2014.04.005; Niemann S, 2000, EMERG INFECT DIS, V6, P548, DOI 10.3201/eid0605.000518; Pang Y, 2015, J INFECTION, V71, P231, DOI 10.1016/j.jinf.2015.03.012; Plazzotta G, 2015, J THEOR BIOL, V368, P67, DOI 10.1016/j.jtbi.2014.12.009; Pulido-Tamayo S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv478; Sandgren A, 2009, PLOS MED, V6, P132, DOI 10.1371/journal.pmed.1000002; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; THEISEN A, 1995, LANCET, V345, P1512, DOI 10.1016/S0140-6736(95)91073-5; Tukey JW, 1977, EXPLORATORY DATA ANA; van Rie A, 2005, AM J RESP CRIT CARE, V172, P636, DOI 10.1164/rccm.200503-449OC; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Wlodarska M, 2015, CLIN MICROBIOL REV, V28, P523, DOI 10.1128/CMR.00124-14; World Health Organization, 2015, WHOHTMTB201522; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735	35	28	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159029	10.1371/journal.pone.0159029	http://dx.doi.org/10.1371/journal.pone.0159029			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391214	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400197
J	Kawano, S; Grassian, AR; Tsuda, M; Knutson, SK; Warholic, NM; Kuznetsov, G; Xu, SQ; Xiao, YH; Pollock, RM; Smith, JS; Kuntz, KK; Ribich, S; Minoshima, Y; Matsui, J; Copeland, RA; Tanaka, S; Keilhack, H				Kawano, Satoshi; Grassian, Alexandra R.; Tsuda, Masumi; Knutson, Sarah K.; Warholic, Natalie M.; Kuznetsov, Galina; Xu, Shanqin; Xiao, Yonghong; Pollock, Roy M.; Smith, Jesse S.; Kuntz, Kevin K.; Ribich, Scott; Minoshima, Yukinori; Matsui, Junji; Copeland, Robert A.; Tanaka, Shinya; Keilhack, Heike			Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial Sarcoma	PLOS ONE			English	Article							SOFT-TISSUE TUMORS; SWI/SNF COMPLEXES; FUSION; CANCER; GENES; H3K27; SYT; IDENTIFICATION; PROLIFERATION; CYTOGENETICS	The catalytic activities of covalent and ATP-dependent chromatin remodeling are central to regulating the conformational state of chromatin and the resultant transcriptional output. The enzymes that catalyze these activities are often contained within multiprotein complexes in nature. Two such multiprotein complexes, the polycomb repressive complex 2 (PRC2) methyltransferase and the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeler have been reported to act in opposition to each other during development and homeostasis. An imbalance in their activities induced by mutations/deletions in complex members (e.g. SMARCB1) has been suggested to be a pathogenic mechanism in certain human cancers. Here we show that preclinical models of synovial sarcoma-a cancer characterized by functional SMARCB1 loss via its displacement from the SWI/SNF complex through the pathognomonic SS18-SSX fusion protein-display sensitivity to pharmacologic inhibition of EZH2, the catalytic subunit of PRC2. Treatment with tazemetostat, a clinicalstage, selective and orally bioavailable small-molecule inhibitor of EZH2 enzymatic activity reverses a subset of synovial sarcoma gene expression and results in concentration-dependent cell growth inhibition and cell death specifically in SS18-SSX fusion-positive cells in vitro. Treatment of mice bearing either a cell line or two patient-derived xenograft models of synovial sarcoma leads to dose-dependent tumor growth inhibition with correlative inhibition of trimethylation levels of the EZH2-specific substrate, lysine 27 on histone H3. These data demonstrate a dependency of SS18-SSX-positive, SMARCB1-deficient synovial sarcomas on EZH2 enzymatic activity and suggests the potential utility of EZH2-targeted drugs in these genetically defined cancers.	[Grassian, Alexandra R.; Knutson, Sarah K.; Warholic, Natalie M.; Xiao, Yonghong; Pollock, Roy M.; Smith, Jesse S.; Kuntz, Kevin K.; Ribich, Scott; Tanaka, Shinya; Keilhack, Heike] Epizyme Inc, Cambridge, MA 02139 USA; [Kawano, Satoshi; Minoshima, Yukinori; Matsui, Junji] Eisai & Co Ltd, Tsukuba, Ibaraki, Japan; [Kuznetsov, Galina; Xu, Shanqin] Eisai Inc, Andover, MA USA; [Tsuda, Masumi; Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido, Japan	Eisai Co Ltd; Eisai Co Ltd; Hokkaido University	Grassian, AR; Ribich, S (corresponding author), Epizyme Inc, Cambridge, MA 02139 USA.	agrassian@epizyme.com; sribich@epizyme.com	Tanaka, Shinya/D-3586-2011		Epizyme, Inc.; Eisai Co; Eisai, Inc.	Epizyme, Inc.; Eisai Co(Eisai Co Ltd); Eisai, Inc.(Eisai Co Ltd)	This work was funded by Epizyme, Inc., Eisai Co, and Eisai, Inc. The funding entities had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaimy A, 2014, ADV ANAT PATHOL, V21, P394, DOI 10.1097/PAP.0000000000000038; Arnold MA, 2013, HUM PATHOL, V44, P881, DOI 10.1016/j.humpath.2012.08.014; Campbell JE, 2015, ACS MED CHEM LETT, V6, P491, DOI 10.1021/acsmedchemlett.5b00037; CLARK J, 1994, NAT GENET, V7, P502, DOI 10.1038/ng0894-502; Copeland RA, 2013, CLIN CANCER RES, V19, P6344, DOI 10.1158/1078-0432.CCR-13-0223; CREW AJ, 1995, EMBO J, V14, P2333, DOI 10.1002/j.1460-2075.1995.tb07228.x; Dabbs DJ., 2010, DIAGNOSTIC IMMUNOHIS; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; DELEEUW B, 1995, HUM MOL GENET, V4, P1097, DOI 10.1093/hmg/4.6.1097; Folpe AL, 1998, AM J SURG PATHOL, V22, P673, DOI 10.1097/00000478-199806000-00004; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Hartel PH, 2007, MODERN PATHOL, V20, P760, DOI 10.1038/modpathol.3800795; Hiraga H, 1998, DIAGN MOL PATHOL, V7, P102, DOI 10.1097/00019606-199804000-00007; Hoglund M, 2005, INT J CANCER, V116, P401, DOI 10.1002/ijc.21021; Italiano A, 2015, EUROPEAN SOC MED ONC; Kadoch C, 2013, NAT GENET, V45, P592, DOI 10.1038/ng.2628; Kadoch C, 2013, CELL, V153, P71, DOI 10.1016/j.cell.2013.02.036; Kato H, 2002, J BIOL CHEM, V277, P5498, DOI 10.1074/jbc.M108702200; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; Knutson SK, 2013, P NATL ACAD SCI USA, V110, P7922, DOI 10.1073/pnas.1303800110; Knutson SK, 2012, NAT CHEM BIOL, V8, P890, DOI [10.1038/NCHEMBIO.1084, 10.1038/nchembio.1084]; Kohashi K, 2010, MODERN PATHOL, V23, P981, DOI 10.1038/modpathol.2010.71; Lagarde P, 2013, J CLIN ONCOL, V31, P608, DOI 10.1200/JCO.2012.46.0147; LIMON J, 1991, GENE CHROMOSOME CANC, V3, P338, DOI 10.1002/gcc.2870030504; Lopes JM, 1998, ANAL CELL PATHOL, V16, P45; Lubieniecka JM, 2008, CANCER RES, V68, P4303, DOI 10.1158/0008-5472.CAN-08-0092; Middeljans E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033834; MIETTINEN M, 1993, HUM PATHOL, V24, P62, DOI 10.1016/0046-8177(93)90064-N; Nielsen TO, 2015, CANCER DISCOV, V5, P124, DOI 10.1158/2159-8290.CD-14-1246; NOJIMA T, 1990, ACTA PATHOL JAPON, V40, P486; Przybyl J, 2014, INT J BIOCHEM CELL B, V53, P505, DOI 10.1016/j.biocel.2014.05.006; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Sandberg AA, 2002, CANCER GENET CYTOGEN, V133, P1, DOI 10.1016/S0165-4608(01)00626-4; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shen JK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25239; Skytting B, 1999, J NATL CANCER I, V91, P974, DOI 10.1093/jnci/91.11.974; Sneeringer CJ, 2010, P NATL ACAD SCI USA, V107, P20980, DOI 10.1073/pnas.1012525107; Soni EEC, 2014, CLIN ORTHOP RELAT R, V472, P874, DOI 10.1007/s11999-013-3065-9; SONOBE H, 1992, LAB INVEST, V67, P498; Su L, 2012, CANCER CELL, V21, P333, DOI 10.1016/j.ccr.2012.01.010; Tsuda M, 2005, ONCOGENE, V24, P7984, DOI 10.1038/sj.onc.1208942; Turc-Carel C, 1995, Curr Top Pathol, V89, P73; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068; Wilson BG, 2010, CANCER CELL, V18, P316, DOI 10.1016/j.ccr.2010.09.006	44	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158888	10.1371/journal.pone.0158888	http://dx.doi.org/10.1371/journal.pone.0158888			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391784	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400151
J	Malhotra, S; Vashist, P; Gupta, N; Kalaivani, M; Satpathy, G; Shah, A; Krishnan, S; Azad, R				Malhotra, Sumit; Vashist, Praveen; Gupta, Noopur; Kalaivani, Mani; Satpathy, Gita; Shah, Anita; Krishnan, Sujaya; Azad, Rajvardhan			Prevalence of Trachoma in Car-Nicobar Island, India after Three Annual Rounds of Mass Drug Administration with Azithromycin	PLOS ONE			English	Article							RISK-FACTORS; GLOBAL ELIMINATION; CHLAMYDIA; SENSITIVITY; SMEARS	Background A high proportion of active trachoma infection in children of Car-Nicobar Island was reported through the Trachoma Rapid Assessment survey conducted in year 2010 by the same researchers. Annual mass drug treatment with azithromycin was administered from years 2010-12 to all individuals residing in this island for reducing the burden of active trachoma infection. A cross-sectional prevalence survey was conducted in the year 2013 to assess the post-treatment burden of trachoma in this population. Methods In the 15 randomly selected compact segments from each village of the island, children aged 1-9 years were examined for evidence of active trachoma infection and participants aged ten years and above were examined for trachomatous trichiasis and corneal opacity. Results A total of 809 children (1-9 years) and 2735 adults were examined. Coverage with azithromycin for all the three rounds was more than 80%. The prevalence of active trachoma infection in children aged 1-9 years old was 6.8% (95% CI 5.1, 8.5) and Trachomatous Trichiasis (TT) was 3.9% (95% CI 3.2, 4.6). The risk factors associated with active trachoma infection were older age and unclean faces. The risk factors associated with TT were older age and lower literacy level. Conclusion Trachoma has not been eliminated from Car-Nicobar Island in accordance to 'Global Elimination of Trachoma, 2020' guidelines. Sustained efforts and continuous surveillance admixed with adequate programmatic response is imperative for elimination of trachoma in the island.	[Malhotra, Sumit; Vashist, Praveen; Gupta, Noopur] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Community Ophthalmol, New Delhi, India; [Kalaivani, Mani] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Satpathy, Gita] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Ocular Microbiol, New Delhi, India; [Shah, Anita] Gobind Ballabh Pant Hosp, Port Blair, Andaman & Nicob, India; [Krishnan, Sujaya] Govt India, Minist Hlth & Family Welf, New Delhi, India; [Azad, Rajvardhan] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; Govind Ballabh Pant Institute of Postgraduate Medical Education & Research; All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences	Vashist, P (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, Dept Community Ophthalmol, New Delhi, India.	praveenvashist@yahoo.com	Satpathy, Gita/GSI-9330-2022; GUPTA, NOOPUR/AAX-5043-2021	GUPTA, NOOPUR/0000-0001-8022-6656	National Programme for Control of Blindness, Andaman and Nicobar Islands; Ministry of Health and Family Welfare, Government of India	National Programme for Control of Blindness, Andaman and Nicobar Islands; Ministry of Health and Family Welfare, Government of India	This work was supported by the National Programme for Control of Blindness, Andaman and Nicobar Islands and Ministry of Health and Family Welfare, Government of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, RAP ASS TRACH IND; Blake K, 2007, MEASURING OVERCROWDI; Silva JC, 2015, OPHTHAL EPIDEMIOL, V22, P231, DOI 10.3109/09286586.2015.1037846; Edwards T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001585; Ejere HOD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002219.pub2; Emerson PM, 2001, MED VET ENTOMOL, V15, P314, DOI 10.1046/j.0269-283x.2001.00318.x; Frick KD, 2003, AM J TROP MED HYG, V69, P1; Government of India, 2013, NAT PROGR CONTR BLIN; Jip NF, 2008, OPHTHAL EPIDEMIOL, V15, P294, DOI 10.1080/09286580802256542; Kalua K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009067; Katz J, 1996, BRIT J OPHTHALMOL, V80, P1037, DOI 10.1136/bjo.80.12.1037; LINDNER LE, 1986, AM J CLIN PATHOL, V85, P180, DOI 10.1093/ajcp/85.2.180; Mariotti SP, 2003, AM J TROP MED HYG, V69, P33; Mohan M., 1989, NATL SURVEY BLINDNES; Mohile Mukula, 2002, Indian Journal of Ophthalmology, V50, P295; Mpyet C, 2015, OPHTHAL EPIDEMIOL, V22, P148, DOI 10.3109/09286586.2015.1045987; Mpyet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040421; Negrel A., 2001, GUIDELINES RAPID ASS; Nicobar District, 2013, NICOBAR DISTRICT; Osama MB, 1995, BAHARAIN MED BULL, V17, P11; PREOBRAGENSKI V V, 1964, J All India Ophthalmol Soc, V12, P68; Roba AA, 2013, INT OPHTHALMOL, V33, P53, DOI 10.1007/s10792-012-9632-3; Salpietro CD, 1999, ARCH PEDIATRIE, V6, P317, DOI 10.1016/S0929-693X(99)80273-5; Schemann JF, 2002, INT J EPIDEMIOL, V31, P194, DOI 10.1093/ije/31.1.194; Solomon AW, 2015, OPHTHAL EPIDEMIOL, V22, P214, DOI 10.3109/09286586.2015.1037401; THOMAS BJ, 1984, J CLIN PATHOL, V37, P812, DOI 10.1136/jcp.37.7.812; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; Vashist P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065918; WHO Global Health Observatory, 2010, TRACHOMA; World Health Organization, 2013, WKLY EPIDEMIOL REC, V88, P241; World Health Organization, 2015, OVERCROWDING; Wright HR, 2005, BRIT J OPHTHALMOL, V89, P526, DOI 10.1136/bjo.2005.066183	32	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158625	10.1371/journal.pone.0158625	http://dx.doi.org/10.1371/journal.pone.0158625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391274	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400094
J	Abe, M; Pelus, LM; Singh, P; Hirade, T; Onishi, C; Purevsuren, J; Taketani, T; Yamaguchi, S; Fukuda, S				Abe, Mariko; Pelus, Louis M.; Singh, Pratibha; Hirade, Tomohiro; Onishi, Chie; Purevsuren, Jamiyan; Taketani, Takeshi; Yamaguchi, Seiji; Fukuda, Seiji			Internal Tandem Duplication in FLT3 Attenuates Proliferation and Regulates Resistance to the FLT3 Inhibitor AC220 by Modulating p21(Cdkn1a) and Pbx1 in Hematopoietic Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; PROGENITOR CELLS; STEM-CELLS; DEPENDENT KINASES; GROWTH ARREST; BCR-ABL; P21; P21(CIP1/WAF1); P21(WAF1/CIP1)	Internal tandem duplication (ITD) mutations in the Fms-related tyrosine kinase 3 (FLT3) gene (FLT3-ITD) are associated with poor prognosis in patients with acute myeloid leukemia (AML). Due to the development of drug resistance, few FLT3-ITD inhibitors are effective against FLT3-ITD+ AML. In this study, we show that FLT3-ITD activates a novel pathway involving p21(Cdkn1a) (p21) and pre-B cell leukemia transcription factor 1 (Pbx1) that attenuates FLT3-ITD cell proliferation and is involved in the development of drug resistance. FLT3-ITD up-regulated p21 expression in both mouse bone marrow c-kit(+)-Sca-1(+)-Lin(-)( KSL) cells and Ba/F3 cells. The loss of p21 expression enhanced growth factor-independent proliferation and sensitivity to cytarabine as a consequence of concomitantly enriching the S+G(2)/M phase population and significantly increasing the expression of Pbx1, but not Evi-1, in FLT3-ITD+ cells. This enhanced cell proliferation following the loss of p21 was partially abrogated when Pbx1 expression was silenced in FLT3-ITD+ primary bone marrow colony-forming cells and Ba/F3 cells. When FLT3-ITD was antagonized with AC220, a selective inhibitor of FLT3-ITD, p21 expression was decreased coincident with Pbx1 mRNA up-regulation and a rapid decline in the number of viable FLT3-ITD+Ba/F3 cells; however, the cells eventually became refractory to AC220. Overexpressing p21 in FLT3-ITD+Ba/F3 cells delayed the emergence of cells that were refractory to AC220, whereas p21 silencing accelerated their development. These data indicate that FLT3-ITD is capable of inhibiting FLT3-ITD+ cell proliferation through the p21/Pbx1 axis and that treatments that antagonize FLT3-ITD contribute to the subsequent development of cells that are refractory to a FLT3-ITD inhibitor by disrupting p21 expression.	[Abe, Mariko; Hirade, Tomohiro; Purevsuren, Jamiyan; Taketani, Takeshi; Yamaguchi, Seiji; Fukuda, Seiji] Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane, Japan; [Pelus, Louis M.; Singh, Pratibha] Indiana Univ, Sch Med, Dept Microbiol Immunol, Indianapolis, IN 46202 USA; [Onishi, Chie] Shimane Univ, Sch Med, Dept Hematol Oncol, Izumo, Shimane, Japan; [Taketani, Takeshi] Shimane Univ Hosp, Div Blood Transfus, Izumo, Shimane, Japan	Shimane University; Indiana University System; Indiana University-Purdue University Indianapolis; Shimane University; Shimane University	Abe, M; Fukuda, S (corresponding author), Shimane Univ, Sch Med, Dept Pediat, Izumo, Shimane, Japan.	itomari@med.shimane-u.ac.jp; sfukuda@med.shimane-u.ac.jp	Singh, Pratibha/AAI-9796-2020		Japan Society for the Promotion of Science [24791063, 20390298, 25461593]; National Heart Lung and Blood Institute [HL079654]; Japan Leukemia Research Fund; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sankyo Biomedical Research Foundation; Mitsubishi Pharma Research Foundation; AstraZeneca Research Grant; Naito Foundation; Grants-in-Aid for Scientific Research [25461593] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Sankyo Biomedical Research Foundation; Mitsubishi Pharma Research Foundation; AstraZeneca Research Grant(AstraZeneca); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Support was provided by: Japan Society for the Promotion of Science [https://www.jsps.go.jp/] grant number 24791063 to MA; National Heart Lung and Blood Institute [http://www.nih.gov/] grant number HL079654 to LP; Japan Society for the Promotion of Science [https://www.jsps.go.jp/] grant number 20390298 to SF; Japan Society for the Promotion of Science [https://www.jsps.go.jp/] grant number 25461593 to SF; Japan Leukemia Research Fund [http://flrf.gr.jp/] to SF; Research Support Funds from the Mochida Memorial Foundation for Medical and Pharmaceutical Research [http://www.mochida.co.jp/zaidan/] to SF; Sankyo Biomedical Research Foundation and the Mitsubishi Pharma Research Foundation [http://www.ds-fdn.or.jp/] to SF; AstraZeneca Research Grant [http://www. astrazeneca.co.jp/] to SF; Naito Foundation [https://www.naito-f.or.jp/jp/index.php] to SF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braun SE, 1998, BLOOD CELL MOL DIS, V24, P138, DOI 10.1006/bcmd.1998.0181; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Coqueret O, 2000, J BIOL CHEM, V275, P18794, DOI 10.1074/jbc.M001601200; Daver N, 2015, BLOOD, V125, P3236, DOI 10.1182/blood-2014-10-605808; de Jonge HJM, 2011, LEUKEMIA, V25, P1825, DOI 10.1038/leu.2011.172; DiMartino JF, 2001, BLOOD, V98, P618, DOI 10.1182/blood.V98.3.618; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Forster K, 2008, ANN HEMATOL, V87, P183, DOI 10.1007/s00277-007-0400-9; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; FRITSCHE M, 1993, ONCOGENE, V8, P307; Fukuda S, 2005, BLOOD, V105, P3117, DOI 10.1182/blood-2004-04-1440; Fukuda S, 2004, BLOOD, V103, P120, DOI 10.1182/blood-2003-05-1756; Fukuda S, 2009, BLOOD, V114, P394, DOI 10.1182/blood-2008-11-188714; Garcia-Wilson E, 2005, CELL CYCLE, V4, P1113; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grunwald MR, 2015, SEMIN HEMATOL, V52, P193, DOI 10.1053/j.seminhematol.2015.03.004; Grunwald MR, 2013, INT J HEMATOL, V97, P683, DOI 10.1007/s12185-013-1334-8; HARPER JW, 1993, CELL, V75, P805; Harris TE, 2001, J BIOL CHEM, V276, P29200, DOI 10.1074/jbc.M011587200; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kitaura H, 2000, J BIOL CHEM, V275, P10477, DOI 10.1074/jbc.275.14.10477; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lee YH, 2001, BIOCHEM BIOPH RES CO, V280, P675, DOI 10.1006/bbrc.2000.4215; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mantel C, 1996, BLOOD, V88, P3710, DOI 10.1182/blood.V88.10.3710.bloodjournal88103710; Mishra A, 2000, AM J RESP CELL MOL, V22, P543, DOI 10.1165/ajrcmb.22.5.3851; Overton KW, 2014, P NATL ACAD SCI USA, V111, pE4386, DOI 10.1073/pnas.1409797111; Ozeki K, 2004, BLOOD, V103, P1901, DOI 10.1182/blood-2003-06-1845; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Peterson LF, 2007, BLOOD, V109, P4392, DOI 10.1182/blood-2006-03-012575; Rego MA, 2012, ONCOGENE, V31, P366, DOI 10.1038/onc.2011.237; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Santos MA, 2014, NATURE, V514, P107, DOI 10.1038/nature13483; Shimabe M, 2009, ONCOGENE, V28, P4364, DOI 10.1038/onc.2009.288; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Spiekermann K, 2003, BLOOD, V101, P1494, DOI 10.1182/blood-2002-04-1045; Suzuki D, 2015, DEVELOPMENT, V142, P282, DOI 10.1242/dev.118307; Takahashi S, 2004, BIOCHEM BIOPH RES CO, V316, P85, DOI 10.1016/j.bbrc.2004.02.018; Tokunaga M, 2010, J BIOL CHEM, V285, P31774, DOI 10.1074/jbc.M110.118653; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; WALDMAN T, 1995, CANCER RES, V55, P5187; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034	48	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158290	10.1371/journal.pone.0158290	http://dx.doi.org/10.1371/journal.pone.0158290			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387666	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500018
J	Zhang, Y; Li, FY; Song, YL; Sheng, XL; Ren, FZ; Xiong, K; Chen, L; Zhang, HQ; Liu, DQ; Lengner, CJ; Xue, LX; Yu, ZQ				Zhang, Yue; Li, Fengyin; Song, Yongli; Sheng, Xiaole; Ren, Fazheng; Xiong, Kai; Chen, Lei; Zhang, Hongquan; Liu, Dequan; Lengner, Christopher J.; Xue, Lixiang; Yu, Zhengquan			Numb and Numbl act to determine mammary myoepithelial cell fate, maintain epithelial identity, and support lactogenesis	FASEB JOURNAL			English	Article						mammary gland development; EMT; Notch signaling pathway; p53	GLAND DEVELOPMENT; BRANCHING MORPHOGENESIS; MESENCHYMAL TRANSITION; MYELOID-LEUKEMIA; STEM-CELL; NOTCH; P63; DIFFERENTIATION; COMMITMENT; ACTIVATION	Mammary epithelium is comprised of an inner layer of luminal epithelial cells and an outer layer of contractile myoepithelial cells with mesenchymal properties. These two compartments interact throughout mammary morphogenesis to form branching ducts during puberty and terminate in secretory alveoli during lactation. It is not known how the myoepithelial cell lineage is specified, nor how signals in myoepithelial cells contribute to lactogenesis. Here, we show that Numb and Numbl are enriched in mammary myoepithelial cells, with their expression peaking during pregnancy. We use conditional Numb- and Numbl-knockout mouse models to demonstrate that loss of Numb/Numbl compromised the myoepithelial layer and expanded the luminal layer, led epithelial cells to undergo epithelial-to-mesenchymal transition, and resulted in lactation failure as a result of abnormal alveolar formation during pregnancy. Numb and Numbl function via repression of the Notch signaling pathway and of the p53-p21 axis during mammary gland development. These findings highlight the importance of Numb and Numbl in the control of myoepithelial cell fate determination, epithelial identity, and lactogenesis.	[Zhang, Yue; Song, Yongli; Sheng, Xiaole; Ren, Fazheng; Yu, Zhengquan] China Agr Univ, Coll Biol Sci, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Zhang, Yue; Li, Fengyin; Song, Yongli; Sheng, Xiaole; Yu, Zhengquan] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing, Peoples R China; [Xiong, Kai; Xue, Lixiang] Peking Univ, Hosp 3, Med Res Ctr, Dept Radiat Oncol, Beijing, Peoples R China; [Chen, Lei] Southwest Univ, Dept Anim Sci, Chongqing, Peoples R China; [Zhang, Hongquan] Peking Univ, Hlth Sci Ctr, Lab Mol Cell Biol & Tumor Biol, Beijing, Peoples R China; [Zhang, Hongquan] Peking Univ, Hlth Sci Ctr, Dept Anat Histol & Embryol, Beijing, Peoples R China; [Liu, Dequan] Kunming Med Univ, Affiliated Hosp 3, Dept Breast Surg, Kunming, Yunnan, Peoples R China; [Lengner, Christopher J.] Univ Penn, Med Res Ctr, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Lengner, Christopher J.] Univ Penn, Med Res Ctr, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Lengner, Christopher J.] Univ Penn, Med Res Ctr, Inst Regenerat Med, Philadelphia, PA 19104 USA	China Agricultural University; China Agricultural University; Peking University; Southwest University - China; Peking University; Peking University; Kunming Medical University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Xue, LX (corresponding author), Peking Univ, Hosp 3, 49 Huayuan North Rd, Beijing 100191, Peoples R China.; Yu, ZQ (corresponding author), China Agr Univ, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	lixiangxue@bjmu.eu.cn; zyu@cau.edu.cn	tian, yuhua/AAK-1312-2020; Li, Fengyin/AAG-9476-2019	Lengner, Christopher/0000-0002-0574-5189	National Natural Science Foundation [81572614, 31271584, 81541142]; Modern Agro-industry Technology Research Program Grant [CARAS-37]; Beijing Nature Foundation [5162018]; Basic Research Program [2015QC104, 2015TC041, 2016SY001]; State Key Laboratory Open Project [2015SKLB6-16]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Modern Agro-industry Technology Research Program Grant; Beijing Nature Foundation; Basic Research Program; State Key Laboratory Open Project	The authors thank Cong Lv, Xiang Li, and Feifei Li (Peking University) for kindly sharing the reagents and methods. The authors also thank the Core Facilities at School of Life Sciences (Peking University), for assistance with the MoFlo XDP cell sorter and are grateful to Liying Du (Peking University) for the sorting of mammary epithelia. This work was supported by National Natural Science Foundation Grants 81572614, 31271584 (to Z.Y.), and 81541142 (to L.X.); Modern Agro-industry Technology Research Program Grant CARAS-37 (to Z.Y.); Beijing Nature Foundation Grant 5162018 (to Z.Y.); Basic Research Program Grants 2015QC104, 2015TC041, and 2016SY001; and State Key Laboratory Open Project Grant 2015SKLB6-16. The authors declare no conflicts of interest.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Baxter FO, 2007, J MAMMARY GLAND BIOL, V12, P3, DOI 10.1007/s10911-007-9033-9; Benetka W, 2008, CELL CYCLE, V7, P3709, DOI 10.4161/cc.7.23.7176; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Brisken C, 1999, DEV BIOL, V210, P96, DOI 10.1006/dbio.1999.9271; Casimiro MC, 2013, MOL ENDOCRINOL, V27, P1415, DOI 10.1210/me.2013-1065; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Ewald AJ, 2012, J CELL SCI, V125, P2638, DOI 10.1242/jcs.096875; Forster N, 2014, DEV CELL, V28, P147, DOI 10.1016/j.devcel.2013.11.019; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961; Godde NJ, 2010, J MAMMARY GLAND BIOL, V15, P149, DOI 10.1007/s10911-010-9180-2; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Katz Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03915; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Muraoka-Cook RS, 2008, J MAMMARY GLAND BIOL, V13, P235, DOI 10.1007/s10911-008-9080-x; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; TAVERNA D, 1991, CELL GROWTH DIFFER, V2, P145; Tosoni D, 2015, J CELL BIOL, V211, P845, DOI 10.1083/jcb.201505037; Watanabe K, 2014, DEV CELL, V29, P59, DOI 10.1016/j.devcel.2014.03.006; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yalcin-Ozuysal O, 2010, CELL DEATH DIFFER, V17, P1600, DOI 10.1038/cdd.2010.37; Yallowitz AR, 2014, CELL DEATH DIFFER, V21, P645, DOI 10.1038/cdd.2013.199; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	42	20	22	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3474	3488		10.1096/fj.201600387R	http://dx.doi.org/10.1096/fj.201600387R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27383182				2022-12-26	WOS:000384329800018
J	Trashin, S; de Jong, M; Luyckx, E; Dewilde, S; De Wael, K				Trashin, Stanislav; de Jong, Mats; Luyckx, Evi; Dewilde, Sylvia; De Wael, Karolien			Electrochemical Evidence for Neuroglobin Activity on NO at Physiological Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE-PLASMON RESONANCE; HORSE HEART MYOGLOBIN; NITRIC-OXIDE; ELECTRON-TRANSFER; CYTOCHROME-C; TEMPERATURE-DEPENDENCE; BINDING-PROPERTIES; MOUSE NEUROGLOBIN; OXYGEN-BINDING; MESSENGER-RNA	The true function of neuroglobin (Ngb) and, particularly, human Ngb (NGB) has been under debate since its discovery 15 years ago. It has been expected to play a role in oxygen binding/supply, but a variety of other functions have been put forward, including NO dioxygenase activity. However, in vitro studies that could unravel these potential roles have been hampered by the lack of an Ngb-specific reductase. In this work, we used electrochemical measurements to investigate the role of an intermittent internal disulfide bridge in determining NO oxidation kinetics at physiological NO concentrations. The use of a polarized electrode to efficiently interconvert the ferric (Fe3+) and ferrous (Fe2+) forms of an immobilized NGB showed that the disulfide bridge both defines the kinetics of NO dioxygenase activity and regulates appearance of the free ferrous deoxy-NGB, which is the redox active form of the protein in contrast to oxy-NGB. Our studies further identified a role for the distal histidine, interacting with the hexacoordinated iron atom of the heme, in oxidation kinetics. These findings may be relevant in vivo, for example, in blocking apoptosis by reduction of ferric cytochrome c, and gentle tuning of NO concentration in the tissues.	[Trashin, Stanislav; de Jong, Mats; De Wael, Karolien] Univ Antwerp, Dept Chem, B-2010 Antwerp, Belgium; [Luyckx, Evi; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2010 Antwerp, Belgium	University of Antwerp; University of Antwerp	De Wael, K (corresponding author), Univ Antwerp, Dept Chem, AXES Res Grp, Groenenborgerlaan 171, B-2010 Antwerp, Belgium.	karolien.dewael@uantwerpen.be	De Wael, Karolien/U-5545-2018; Trashin, Stanislav A./C-9824-2013; Trashin, Stanislav A./S-3506-2019; de Jong, Mats/N-8095-2015	Trashin, Stanislav A./0000-0002-4089-4251; de Jong, Mats/0000-0001-8930-7962; De Wael, Karolien/0000-0003-4495-0748	Fonds Wetenschappelijk Onderzoek (FWO) [G.0687.13]; Universiteit Antwerpen GOA BOF [28312]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Universiteit Antwerpen GOA BOF	This work was supported by Fonds Wetenschappelijk Onderzoek (FWO) Grant G.0687.13 and Universiteit Antwerpen GOA BOF 28312. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 1981, SOLUBILITY DATA SERI; Armstrong FA, 1997, CHEM SOC REV, V26, P169, DOI 10.1039/cs9972600169; Ascenzi P, 2014, IUBMB LIFE, V66, P268, DOI 10.1002/iub.1267; Balland V, 2009, LANGMUIR, V25, P6532, DOI 10.1021/la900062y; Bonding SH, 2008, INT J BIOL MACROMOL, V43, P295, DOI 10.1016/j.ijbiomac.2008.07.003; Brunori M, 2005, P NATL ACAD SCI USA, V102, P8483, DOI 10.1073/pnas.0408766102; Burmester T, 2000, NATURE, V407, P520, DOI 10.1038/35035093; Burmester T, 2014, ACTA PHYSIOL, V211, P501, DOI 10.1111/apha.12312; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Chen H, 2008, J AM CHEM SOC, V130, P14778, DOI 10.1021/ja805434m; Chen LM, 2012, J NEUROCHEM, V120, P157, DOI 10.1111/j.1471-4159.2011.07275.x; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Dewilde S, 2008, METHOD ENZYMOL, V436, P341, DOI 10.1016/S0076-6879(08)36019-4; Emara M, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-33; Fago A, 2004, J BIOL CHEM, V279, P44417, DOI 10.1074/jbc.M407126200; Fago A, 2006, FEBS LETT, V580, P4884, DOI 10.1016/j.febslet.2006.08.003; Fan CH, 2000, PHYS CHEM CHEM PHYS, V2, P4409, DOI 10.1039/b005527l; Ferrer I, 2011, J ALZHEIMERS DIS, V23, P537, DOI 10.3233/JAD-2010-101485; Fiocchetti M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.418; Fiocchetti M, 2013, BBA-PROTEINS PROTEOM, V1834, P1744, DOI 10.1016/j.bbapap.2013.01.015; Fordel E, 2007, FEBS J, V274, P1312, DOI 10.1111/j.1742-4658.2007.05679.x; Gardner PR, 2005, J INORG BIOCHEM, V99, P247, DOI 10.1016/j.jinorgbio.2004.10.003; Gulaboski R, 2005, ELECTROCHEM COMMUN, V7, P515, DOI 10.1016/j.elecom.2005.03.009; Gulaboski R, 2012, J SOLID STATE ELECTR, V16, P2315, DOI 10.1007/s10008-011-1397-5; Haines B, 2012, NEUROSCI LETT, V514, P137, DOI 10.1016/j.neulet.2012.01.080; Hall CN, 2009, NITRIC OXIDE-BIOL CH, V21, P92, DOI 10.1016/j.niox.2009.07.002; Hamdane D, 2003, J BIOL CHEM, V278, P51713, DOI 10.1074/jbc.M309396200; Hankeln T, 2005, J INORG BIOCHEM, V99, P110, DOI 10.1016/j.jinorgbio.2004.11.009; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hundahl CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034462; Hundahl CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028160; Hundahl CA, 2010, BRAIN RES, V1331, P58, DOI 10.1016/j.brainres.2010.03.056; Jain K. K., 2013, APPL BIOTECHNOLOGY N, P249; Juodkazis K, 1999, ELECTROCHEM COMMUN, V1, P315, DOI 10.1016/S1388-2481(99)00062-4; Khan AA, 2008, FASEB J, V22, P1737, DOI 10.1096/fj.07-100784; Khan AA, 2007, P NATL ACAD SCI USA, V104, P19114, DOI 10.1073/pnas.0706167104; Kiger L, 2004, IUBMB LIFE, V56, P709, DOI 10.1080/15216540500037711; Kiger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020478; KING BC, 1992, J AM CHEM SOC, V114, P10603, DOI 10.1021/ja00052a066; Kroning S, 2004, ELECTROANAL, V16, P253, DOI 10.1002/elan.200402780; Lim MD, 2005, METHOD ENZYMOL, V396, P3, DOI 10.1016/S0076-6879(05)96001-1; Mao X. O, 2008, NEUROSCI LETT, V430, P135, DOI DOI 10.1016/j.neulet.2007.10.031; PIELA B, 1995, J ELECTROANAL CHEM, V388, P69, DOI 10.1016/0022-0728(94)03848-W; Raida Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076565; Raida Zindy, 2012, Exp Transl Stroke Med, V4, P15, DOI 10.1186/2040-7378-4-15; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Schaming D, 2012, LANGMUIR, V28, P14065, DOI 10.1021/la302913j; Scheller FW, 2005, ADV COLLOID INTERFAC, V116, P111, DOI 10.1016/j.cis.2005.05.006; Schmidt-Kastner R, 2006, BRAIN RES, V1103, P173, DOI 10.1016/j.brainres.2006.05.047; Smagghe BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002039; TANIGUCHI I, 1992, J ELECTROANAL CHEM, V333, P331, DOI 10.1016/0022-0728(92)80402-P; Tejero J, 2015, BIOCHEMISTRY-US, V54, P722, DOI 10.1021/bi501196k; Tejero J, 2014, BIOL CHEM, V395, P631, DOI 10.1515/hsz-2013-0289; Tiso M, 2011, J BIOL CHEM, V286, P18277, DOI 10.1074/jbc.M110.159541; Tiwari PB, 2015, INORG CHEM COMMUN, V62, P37, DOI 10.1016/j.inoche.2015.10.010; Trashin S, 2016, CHEMELECTROCHEM, V3, P1035, DOI 10.1002/celc.201600021; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Van Doorslaer S, 2003, J BIOL CHEM, V278, P4919, DOI 10.1074/jbc.M210617200; Van Doorslaer S, 2014, BIOPHYS CHEM, V190, P8, DOI 10.1016/j.bpc.2014.03.007; Vinck E, 2006, J BIOL INORG CHEM, V11, P467, DOI 10.1007/s00775-006-0100-2; Wakasugi K, 2004, BIOCHEM BIOPH RES CO, V318, P453, DOI 10.1016/j.bbrc.2004.04.045; Wakasugi K, 2003, J BIOL CHEM, V278, P36505, DOI 10.1074/jbc.M305519200; Walker FA, 2006, J BIOL INORG CHEM, V11, P391, DOI 10.1007/s00775-006-0095-8; Wang YZ, 2006, BIOSENS BIOELECTRON, V22, P10, DOI 10.1016/j.bios.2005.11.012; Weiland TR, 2004, J AM CHEM SOC, V126, P11930, DOI 10.1021/ja046990w; Yu ZY, 2016, MOL NEUROBIOL, V53, P3249, DOI 10.1007/s12035-015-9273-4; Yu ZY, 2013, NEUROBIOL DIS, V56, P95, DOI 10.1016/j.nbd.2013.04.015	67	15	16	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18959	18966		10.1074/jbc.M116.730176	http://dx.doi.org/10.1074/jbc.M116.730176			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402851	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000383242300031
J	Sun, L; Zhang, Y; Zhang, ZQ; Zheng, Y; Du, LL; Zhu, B				Sun, Lue; Zhang, Yan; Zhang, Zhuqiang; Zheng, Yong; Du, Lilin; Zhu, Bing			Preferential Protection of Genetic Fidelity within Open Chromatin by the Mismatch Repair Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin regulation; DNA repair; heterochromatin; mutagenesis mechanism	YEAST SCHIZOSACCHAROMYCES-POMBE; MUTATION-RATE VARIATION; FISSION YEAST; HUMAN GENOME; DNA-REPLICATION; SEQUENCING DATA; TUMOR-CELLS; HETEROCHROMATIN; CANCER; RATES	Epigenetic systems are well known for the roles they play in regulating the differential expression of the same genome in different cell types. However, epigenetic systems can also directly impact genomic integrity by protecting genetic sequences. Using an experimental evolutionary approach, we studied rates of mutation in the fission yeast Schizosaccharomyces pombe strains that lacked genes encoding several epigenetic regulators or mismatch repair components. We report that loss of a functional mismatch repair pathway in S. pombe resulted in the preferential enrichment of mutations in euchromatin, indicating that the mismatch repair machinery preferentially protected genetic fidelity in euchromatin. This preference is probably determined by differences in the accessibility of chromatin at distinct chromatin regions, which is supported by our observations that chromatin accessibility positively correlated with mutation rates in S. pombe or human cancer samples with deficiencies in mismatch repair. Importantly, such positive correlation was not observed in S. pombe strains or human cancer samples with functional mismatch repair machinery.	[Sun, Lue] Tsinghua Univ, Tsinghua Univ Peking Univ Natl Inst Biol Sci Join, Sch Life Sci, Beijing 100084, Peoples R China; [Sun, Lue; Zhang, Yan; Zhang, Zhuqiang; Zheng, Yong; Zhu, Bing] Chinese Acad Sci, Natl Lab Biomacromol, CAS Ctr Excellence Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Sun, Lue; Du, Lilin] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhu, Bing] Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, B (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, CAS Ctr Excellence Biomacromol, Inst Biophys, Beijing 100101, Peoples R China.; Zhu, B (corresponding author), Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.	zhubing@ibp.ac.cn	Zhang, Zhuqiang/P-7329-2019	Zhang, Zhuqiang/0000-0001-6513-2854; Zhang, Yan/0000-0002-5644-4765; Du, Li-Lin/0000-0002-1028-7397	Chinese Ministry of Science and Technology [2015CB856200]; China National Science Foundation [31401114, 31501059, 31425013, 31530037, 31521002]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08010103]; Howard Hughes Medical Institute International Early Career Scientist Program	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); China National Science Foundation(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Howard Hughes Medical Institute International Early Career Scientist Program	This work was supported by Chinese Ministry of Science and Technology Grant 2015CB856200. This work was also supported by China National Science Foundation Grant 31401114 (to Z.Z.), Grant 31501059 (to Y. Zhang), and Grants 31425013, 31530037, and 31521002 (to B.Z.); Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDB08010103; and the Howard Hughes Medical Institute International Early Career Scientist Program. The authors declare that they have no conflicts of interest with the contents of this article.	Allis C. D., 2007, EPIGENETICS, P16; ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; ALMER A, 1986, EMBO J, V5, P2681, DOI 10.1002/j.1460-2075.1986.tb04551.x; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; BLUMENTH.AB, 1973, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/SQB.1974.038.01.024; BRANCH P, 1993, NATURE, V362, P652, DOI 10.1038/362652a0; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Chen XS, 2012, SCIENCE, V335, P1235, DOI 10.1126/science.1217580; CLARKE L, 1990, MOL CELL BIOL, V10, P1863, DOI 10.1128/MCB.10.5.1863; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drake JW, 1998, GENETICS, V148, P1667; DRAKE JW, 1991, ANNU REV GENET, V25, P125, DOI 10.1146/annurev.ge.25.120191.001013; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egel R., 2013, MOL BIOL SCHIZOSACCH, P149; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Farlow A, 2015, GENETICS, V201, P737, DOI 10.1534/genetics.115.177329; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Fukui K, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/260512; Gaffney DJ, 2005, GENOME RES, V15, P1086, DOI 10.1101/gr.3895005; Garcia JF, 2010, GENE DEV, V24, P1758, DOI 10.1101/gad.1946410; Gasser R, 1996, J MOL BIOL, V258, P224, DOI 10.1006/jmbi.1996.0245; Goodfellow PJ, 2003, P NATL ACAD SCI USA, V100, P5908, DOI 10.1073/pnas.1030231100; Hodgkinson A, 2011, NAT REV GENET, V12, P756, DOI 10.1038/nrg3098; Hombauer H, 2011, SCIENCE, V334, P1713, DOI 10.1126/science.1210770; Hombauer H, 2011, CELL, V147, P1040, DOI 10.1016/j.cell.2011.10.025; Hormozdiari F, 2011, GENOME RES, V21, P840, DOI 10.1101/gr.115956.110; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; KAT A, 1993, P NATL ACAD SCI USA, V90, P6424, DOI 10.1073/pnas.90.14.6424; KOI M, 1994, CANCER RES, V54, P4308; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lang GI, 2011, GENOME BIOL EVOL, V3, P799, DOI 10.1093/gbe/evr054; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LOVELESS A, 1969, NATURE, V223, P206, DOI 10.1038/223206a0; Makova KD, 2015, NAT REV GENET, V16, P213, DOI 10.1038/nrg3890; Martin M, 2011, EMBNET J; MCKNIGHT SL, 1977, CELL, V12, P795, DOI 10.1016/0092-8674(77)90278-1; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ngan VK, 1997, MOL CELL BIOL, V17, P3305, DOI 10.1128/MCB.17.6.3305; Peltomaki P, 2001, HUM MOL GENET, V10, P735, DOI 10.1093/hmg/10.7.735; Peltomaki P, 2001, MUTAT RES-REV MUTAT, V488, P77, DOI 10.1016/S1383-5742(00)00058-2; Peng JC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000435; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Polak P, 2015, NATURE, V518, P360, DOI 10.1038/nature14221; Prendergast JGD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-72; Price AL, 2004, GENOME RES, V14, P2245, DOI 10.1101/gr.2693004; Ramachandran S, 2016, CELL, V165, P580, DOI 10.1016/j.cell.2016.02.062; Romanova NV, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003920; Sasaki S, 2009, SCIENCE, V323, P401, DOI 10.1126/science.1163183; Schuster-Bockler B, 2012, NATURE, V488, P504, DOI 10.1038/nature11273; SEGA GA, 1984, MUTAT RES, V134, P113, DOI 10.1016/0165-1110(84)90007-1; Serero A, 2014, P NATL ACAD SCI USA, V111, P1897, DOI 10.1073/pnas.1314423111; Shevelev IV, 2002, NAT REV MOL CELL BIO, V3, P364, DOI 10.1038/nrm804; Smith NGC, 2002, GENOME RES, V12, P1350, DOI 10.1101/gr.220502; Stamatoyannopoulos JA, 2009, NAT GENET, V41, P393, DOI 10.1038/ng.363; STEINER NC, 1993, MOL CELL BIOL, V13, P4578, DOI 10.1128/MCB.13.8.4578; Su M, 2014, CELL REP, V7, P376, DOI 10.1016/j.celrep.2014.03.011; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; TAKAHASHI K, 1991, J MOL BIOL, V218, P13, DOI 10.1016/0022-2836(91)90867-6; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Tian L, 2009, J BIOL CHEM, V284, P11557, DOI 10.1074/jbc.M900908200; Tornier C, 2001, GENETICS, V158, P65; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; WOLFE KH, 1989, NATURE, V337, P283, DOI 10.1038/337283a0; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Yu R, 2014, MOL CELL, V53, P262, DOI 10.1016/j.molcel.2013.11.014; Zanders S, 2010, GENETICS, V186, P493, DOI 10.1534/genetics.110.120105	88	16	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2016	291	34					17692	17705		10.1074/jbc.M116.719971	http://dx.doi.org/10.1074/jbc.M116.719971			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9DX	27382058	hybrid, Green Published			2022-12-26	WOS:000383241300019
J	Park, SB; Seronello, S; Mayer, W; Ojcius, DM				Park, Seung Bum; Seronello, Scott; Mayer, Wasima; Ojcius, David M.			Hepatitis C Virus Frameshift/Alternate Reading Frame Protein Suppresses Interferon Responses Mediated by Pattern Recognition Receptor Retinoic-Acid-Inducible Gene-I	PLOS ONE			English	Article							F-PROTEIN; CORE PROTEIN; RNA; EXPRESSION; TRANSLATION; REGION; MECHANISMS; INHIBITION; PREDICTION; CLEAVAGE	Hepatitis C virus (HCV) actively evades host interferon (IFN) responses but the mechanisms of how it does so are not completely understood. In this study, we present evidence for an HCV factor that contributes to the suppression of retinoic-acid-inducible gene-1 (RIG-1)-mediated IFN induction. Expression of frameshift/alternate reading frame protein (F/ARFP) from HCV-2/+1 frame in Huh7 hepatoma cells suppressed type I IFN responses stimulated by HCV RNA pathogen -associated molecular pattern (PAMP) and poly(IC). The suppression occurred independently of other HCV factors; and activation of interferon stimulated genes, TNF alpha, IFN-lambda 1, and IFN-lambda 2/3 was likewise suppressed by HCV F/ARFP. Point mutations in the full-length HCV sequence (JFH1 genotype 2a strain) were made to introduce premature termination codons in the-2+1 reading frame coding for F/ARFP while preserving the original reading frame, which enhanced IFN alpha and IFN beta induction by HCV. The potentiation of IFN response by the F/ARFP mutations was diminished in Huh7.5 cells, which already have a defective RIG-I, and by decreasing RIG-I expression in Huh7 cells. Furthermore, adding F/ARFP back via trans-complementation suppressed IFN induction in the F/ARFP mutant. The F/ARFP mutants, on the other hand, were not resistant to exogenous IFN alpha. Finally, HCV-infected human liver samples showed significant F/ARFP antibody reactivity, compared to HCV-uninfected control livers. Therefore, HCV F/ARFP likely cooperates with other viral factors to suppress type I and III IFN induction occurring through the RIG-I signaling pathway. This study identifies a novel mechanism of pattern recognition receptor modulation by HCV and suggests a biological function of the HCV alternate reading frame in the modulation of host innate immunity.	[Park, Seung Bum; Seronello, Scott; Mayer, Wasima; Ojcius, David M.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Ojcius, David M.] Univ Pacific, Arthur A Dugoni Sch Dent, San Francisco, CA 94103 USA	University of California System; University of California Merced; University of the Pacific	Ojcius, DM (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA.; Ojcius, DM (corresponding author), Univ Pacific, Arthur A Dugoni Sch Dent, San Francisco, CA 94103 USA.	dojcius@pacific.edu	Ojcius, David/ABE-6557-2020	Ojcius, David/0000-0003-1461-4495; Park, Seung Bum/0000-0003-2834-9071	National Institutes of Health [R56AI083353]; University of California, Merced	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Merced(University of California System)	This work was supported by the National Institutes of Health: R56AI083353 (JC), and University of California, Merced. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain C, 2004, J VIROL, V78, P10460, DOI 10.1128/JVI.78.19.10460-10469.2004; Baril M, 2005, NUCLEIC ACIDS RES, V33, P1474, DOI 10.1093/nar/gki292; Basu A, 2004, J GEN VIROL, V85, P2299, DOI 10.1099/vir.0.80028-0; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boulant S, 2003, J BIOL CHEM, V278, P45785, DOI 10.1074/jbc.M307174200; Breiman A, 2005, J VIROL, V79, P3969, DOI 10.1128/JVI.79.7.3969-3978.2005; Choi JA, 2003, MOL CELL BIOL, V23, P1489, DOI 10.1128/MCB.23.5.1489-1497.2003; Chuang WCM, 2008, J GEN VIROL, V89, P1890, DOI 10.1099/vir.0.83677-0; Cohen M, 2007, DIGEST DIS SCI, V52, P2427, DOI 10.1007/s10620-006-9630-2; Dalagiorgou G, 2011, J GEN VIROL, V92, P1343, DOI 10.1099/vir.0.023010-0; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Eng FJ, 2009, J VIROL, V83, P3104, DOI 10.1128/JVI.01679-08; Fiorucci M, 2007, J GEN VIROL, V88, P1149, DOI 10.1099/vir.0.82575-0; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Hou J, 2014, CANCER CELL, V25, P49, DOI 10.1016/j.ccr.2013.11.011; Inoue K, 2012, BIOCHEM BIOPH RES CO, V428, P494, DOI 10.1016/j.bbrc.2012.10.079; Iversen MB, 2010, J INTERF CYTOK RES, V30, P573, DOI 10.1089/jir.2010.0063; Kaukinen P, 2013, J MED VIROL, V85, P71, DOI 10.1002/jmv.23442; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Komurian-Pradel F, 2004, HEPATOLOGY, V40, P900, DOI 10.1002/hep.20406; Kotta-Loizou I, 2013, J GEN VIROL, V94, P1528, DOI 10.1099/vir.0.050328-0; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McMullan LK, 2007, P NATL ACAD SCI USA, V104, P2879, DOI 10.1073/pnas.0611267104; Morice Y, 2009, HEPATOLOGY, V49, P1449, DOI 10.1002/hep.22821; Nitta S, 2013, HEPATOLOGY, V57, P46, DOI 10.1002/hep.26017; Otsuka M, 2005, HEPATOLOGY, V41, P1004, DOI 10.1002/hep.20666; PARKIN NT, 1992, J VIROL, V66, P5147, DOI 10.1128/JVI.66.8.5147-5151.1992; Pickett BE, 2011, J VIRAL HEPATITIS, V18, P608, DOI 10.1111/j.1365-2893.2010.01342.x; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Seronello S, 2010, J BIOL CHEM, V285, P845, DOI 10.1074/jbc.M109.045740; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Sundararajan A, 1999, MOL CELL, V4, P1005, DOI 10.1016/S1097-2765(00)80229-4; Tsao ML, 2006, BIOCHEM BIOPH RES CO, V348, P271, DOI 10.1016/j.bbrc.2006.07.062; Tuplin A, 2004, J GEN VIROL, V85, P3037, DOI 10.1099/vir.0.80141-0; Vassilaki N, 2003, J BIOL CHEM, V278, P40503, DOI 10.1074/jbc.M305504200; Vassilaki N, 2008, J VIROL, V82, P11503, DOI 10.1128/JVI.01640-08; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walewski JL, 2002, RNA, V8, P557, DOI 10.1017/S1355838202029023; Walewski JL, 2001, RNA, V7, P710, DOI 10.1017/S1355838201010111; Xu XD, 2014, MOL MED REP, V9, P730, DOI 10.3892/mmr.2013.1816; Xu ZM, 2003, J VIROL, V77, P1578, DOI 10.1128/JVI.77.2.1578-1583.2003; Xu ZM, 2001, EMBO J, V20, P3840, DOI 10.1093/emboj/20.14.3840; Yuksek K, 2009, J VIROL, V83, P612, DOI 10.1128/JVI.00832-08	46	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158419	10.1371/journal.pone.0158419	http://dx.doi.org/10.1371/journal.pone.0158419			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404108	Green Submitted, Green Published, gold			2022-12-26	WOS:000379508200009
J	Rahnert, JA; Zheng, B; Hudson, MB; Woodworth-Hobbs, ME; Price, SR				Rahnert, Jill A.; Zheng, Bin; Hudson, Matthew B.; Woodworth-Hobbs, Myra E.; Price, S. Russ			Glucocorticoids Alter CRTC-CREB Signaling in Muscle Cells: Impact on PGC-1 alpha Expression and Atrophy Markers	PLOS ONE			English	Article							SKELETAL-MUSCLE; UBIQUITIN LIGASES; GENE-EXPRESSION; IDENTIFICATION; COACTIVATORS; MICRORNAS; PROTEIN; TRANSCRIPTION; PROTEOLYSIS; BIOGENESIS	Muscle wasting associated with chronic diseases has been linked to decreased expression of PGC-1 alpha and overexpression of PGC-1 alpha counters muscle loss. CREB, in conjunction with the CREB-regulated transcription coactivator (CRTC2), is a positive modulator of PGC-1 alpha transcription. We previously reported that PGC-1 alpha expression is decreased in skeletal muscle of diabetic rats despite a high level of CREB phosphorylation (i.e., activation), suggesting that CRTC2-CREB signaling may be dysregulated. In this study, the relationship between CREB/CRTC signaling and PGC-1 alpha expression was examined in L6 myotubes treated with dexamethasone (Dex, 48h) to induce atrophy. Dex decreased PGC-1 alpha mRNA and protein as well as the levels of CRTC1 and CRTC2 in the nucleus. Dex also altered the nuclear levels of two known regulators of CRTC2 localization; the amount of calcinuerin catalytic A subunit (CnA) was decreased whereas SIK was increased. To assess PGC-1 alpha transcription, muscle cells were transfected with a PGC-1 alpha luciferase reporter plasmid (PGC-1 alpha-Luc). Dex suppressed PGC-1 alpha luciferase activity while both isobutylmethylxanthine (IBMX) and over-expression of CRTC1 or CRTC2 increased PGC-1 alpha-Luc activity. Mutation of the CRE binding site from PGC-1 alpha-Luc reporter attenuated the responses to both IBMX and the CRTC proteins. Consistent with the reporter gene results, overexpression of CRTC2 produced an increase in CRTC2 in the nucleus and in PGC-1 alpha mRNA and PGC-1 alpha protein. Overexpression of CRTC2 was not sufficient to prevent the decrease in PGC-1 alpha mRNA or protein by Dex. In summary, these data suggest that attenuated CREB/CRTC signaling contributes to the decrease in PGC-1 alpha expression during atrophy.	[Rahnert, Jill A.; Zheng, Bin; Hudson, Matthew B.; Woodworth-Hobbs, Myra E.; Price, S. Russ] Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA; [Zheng, Bin; Hudson, Matthew B.; Price, S. Russ] Atlanta Vet Affairs Med Ctr, Decatur, GA USA	Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Price, SR (corresponding author), Emory Univ, Dept Med, Div Renal, Atlanta, GA 30322 USA.; Price, SR (corresponding author), Atlanta Vet Affairs Med Ctr, Decatur, GA USA.	russ.price@emory.edu			National Institutes of Health [RO1DK95610, T32DK007656]; US Department of Veterans Affairs Biomedical Development Laboratory Research and Development Service [I01BX001456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095610] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs Biomedical Development Laboratory Research and Development Service; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health grants to SRP (RO1DK95610) and to JAR and MBH (T32DK007656), and a Merit Review Award from the US Department of Veterans Affairs Biomedical Development Laboratory Research and Development Service to SRP (I01BX001456).	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brault JJ, 2010, J BIOL CHEM, V285, P19460, DOI 10.1074/jbc.M110.113092; Braun TP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00012; Bruno NE, 2014, EMBO J, V33, P1027, DOI 10.1002/embj.201386145; Chan MC, 2014, METABOLISM, V63, P441, DOI 10.1016/j.metabol.2014.01.006; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Du J, 2004, J CLIN INVEST, V113, P115, DOI 10.1172/JCI200418330; Gao YM, 2008, J APPL PHYSIOL, V105, P1772, DOI 10.1152/japplphysiol.90636.2008; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hindi SM, 2014, FASEB J, V28, P1398, DOI 10.1096/fj.13-242123; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V307, pC314, DOI 10.1152/ajpcell.00395.2013; Hudson MB, 2014, AM J PHYSIOL-CELL PH, V306, pC551, DOI 10.1152/ajpcell.00266.2013; Ibrahim NM, 2000, BIOTECHNIQUES, V29, P782, DOI 10.2144/00294st04; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Menconi M, 2007, CRIT CARE MED, V35, pS602, DOI 10.1097/01.CCM.0000279194.11328.77; Mitch WE, 1999, AM J PHYSIOL-CELL PH, V276, pC1132, DOI 10.1152/ajpcell.1999.276.5.C1132; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Qin WP, 2010, BIOCHEM BIOPH RES CO, V403, P473, DOI 10.1016/j.bbrc.2010.11.061; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Roberts-Wilson TK, 2010, BBA-MOL CELL RES, V1803, P960, DOI 10.1016/j.bbamcr.2010.03.019; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sharma M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00239; Shen H, 2013, MOL CELL BIOCHEM, V381, P105, DOI 10.1007/s11010-013-1692-9; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Zhang YG, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-17; Zheng B, 2010, FASEB J, V24, P2660, DOI 10.1096/fj.09-151480	38	27	28	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159181	10.1371/journal.pone.0159181	http://dx.doi.org/10.1371/journal.pone.0159181			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404111	gold, Green Published, Green Submitted			2022-12-26	WOS:000379508200042
J	Cano, I; Verner-Jeffreys, DW; van Aerle, R; Paley, RK; Peeler, EJ; Green, M; Rimmer, GSE; Savage, J; Joiner, CL; Bayley, AE; Mewett, J; Hulland, J; Feist, SW				Cano, Irene; Verner-Jeffreys, David W.; van Aerle, Ronny; Paley, Richard K.; Peeler, Edmund J.; Green, Matthew; Rimmer, Georgina S. E.; Savage, Jacqueline; Joiner, Claire L.; Bayley, Amanda E.; Mewett, Jason; Hulland, Jonathan; Feist, Stephen W.			Puffy Skin Disease Is an Emerging Transmissible Condition in Rainbow Trout Oncorhynchus mykiss Walbaum	PLOS ONE			English	Article							RICKETTSIA-LIKE ORGANISM; STRAWBERRY DISEASE; RIBOSOMAL-RNA; FISH; CELL; COMPLEX; LESIONS; VIRUS; TOOL	The transmission of puffy skin disease (PSD) to rainbow trout Oncorhynchus mykiss Walbaum was tested in the laboratory by conducting co-habitation challenges with puffy skin (PS)-affected fish (Trojans) collected from the field. Two separate challenges were conducted using Trojans sourced from two different sites and diploid (first trial) or triploid (second trial) naive fish. PSD-specific clinical signs were observed in both groups of naive fish, with 66% of the fish sampled during the challenges showing signs of varying severity. The first clinical features of PSD were presented as white oval skin patches on one or both flanks 15-21 days post-challenge (dpc). The extent of the lesions ranged from 10 to 90% of the body surface, depending on the severity of the lesion. Both the severity and number of affected fish increased during the challenge. Macroscopically, oedema of the skin and multi-focal petechial haemorrhaging were observed towards the end of the trials. Abnormal fish behaviour consisting of "flashing" and excessive mucous production was noted from 15 dpc onwards. Fish with severe PSD lesions also displayed inappetence and associated emaciation. Rodlet cells were observed in 41% of the fresh skin scrapes analysed from the second trial. Histologically epidermal oedema was observed in 31% of the naive fish showing gross pathology, with additional 12% displaying epidermal hyperplasia, mostly observed at the end of the challenge. Other concomitant features of the PSD lesions in challenged fish were epithelial erosion and sloughing, and occasionally mild or focal inflammation. No consistent pathology of internal organs was observed. The parasites Ichthyophthirius multifiliis and Ichthyobodo necator were observed in skin samples of a proportion of naive challenged fish and in Trojans but not in control fish. The presence of these and other known fish pathogens in the skin of PSD-fish was confirmed by high-throughput sequencing analysis. In summary, we have demonstrated that PSD is a transmissible condition. However, even though a number of known fish pathogens were identified in the skin tissues of PSD-fish, the actual causative infectious agent(s) remain(s) unknown.	[Cano, Irene; Verner-Jeffreys, David W.; van Aerle, Ronny; Paley, Richard K.; Peeler, Edmund J.; Green, Matthew; Rimmer, Georgina S. E.; Savage, Jacqueline; Joiner, Claire L.; Bayley, Amanda E.; Mewett, Jason; Hulland, Jonathan; Feist, Stephen W.] Ctr Environm Fisheries & Aquaculture Sci, Aquat Anim Dis, Barrack Rd, Weymouth DT4 8UB, Dorset, England	Centre for Environment Fisheries & Aquaculture Science	Verner-Jeffreys, DW (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Aquat Anim Dis, Barrack Rd, Weymouth DT4 8UB, Dorset, England.	david.verner-jeffreys@cefas.co.uk	Joiner, Claire/Q-5042-2019	van Aerle, Ronny/0000-0002-2605-6518	UK Department for Environment Food and Rural Affairs [FB002]	UK Department for Environment Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	The work was supported by UK Department for Environment Food and Rural Affairs. Contract FB002 awarded to Dr Stephen W. Feist and their Strategic Evidence Partnership Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams IP, 2009, MOL PLANT PATHOL, V10, P537, DOI [10.1111/J.1364-3703.2009.00545.X, 10.1111/j.1364-3703.2009.00545.x]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANACKER RL, 1955, J BACTERIOL, V70, P738, DOI 10.1128/JB.70.6.738-741.1955; Atlas RM., 2004, HDB MICROBIOLOGICAL; Bengtsson-Palme J, 2015, MOL ECOL RESOUR, V15, P1403, DOI 10.1111/1755-0998.12399; Bernoth Eva-Maria, 1997, P1, DOI 10.1016/B978-012093040-1/50003-8; Bielek E, 2005, ANAT REC PART A, V283A, P239, DOI 10.1002/ar.a.20162; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buller NB, 2004, BACTERIA FISH OTHER; Cafiso A, 2016, J FISH DIS, V39, P497, DOI 10.1111/jfd.12371; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lloyd SJ, 2011, J FISH DIS, V34, P701, DOI 10.1111/j.1365-2761.2011.01285.x; Lloyd SJ, 2008, DIS AQUAT ORGAN, V82, P111, DOI 10.3354/dao01969; MacFaddin J.F., 1985, MEDIA ISOLATION CULT, V1; Maddocks CE, 2015, J FISH DIS, V38, P653, DOI 10.1111/jfd.12306; Madetoja J, 2002, DIS AQUAT ORGAN, V52, P109, DOI 10.3354/dao052109; Marston DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-444; Matthews RA, 2005, ADV PARASIT, V59, P159, DOI 10.1016/S0065-308X(05)59003-1; Metselaar M, 2010, J FISH DIS, V33, P849, DOI 10.1111/j.1365-2761.2010.01187.x; Miller RR, 2013, GENOME MED, V5, DOI 10.1186/gm485; Montagna M, 2013, APPL ENVIRON MICROB, V79, P3241, DOI 10.1128/AEM.03971-12; Mueller JH, 1941, P SOC EXP BIOL MED, V48, P330, DOI 10.3181/00379727-48-13311; Oidtmann B, 2013, J FISH DIS, V36, P921, DOI 10.1111/jfd.12086; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Peeler EJ, 2014, J FISH DIS, V37, P1021, DOI 10.1111/jfd.12241; Reite OB, 2005, FISH SHELLFISH IMMUN, V19, P253, DOI 10.1016/j.fsi.2005.01.002; ROBERTSON DA, 1981, J FISH DIS, V4, P113, DOI 10.1111/j.1365-2761.1981.tb01116.x; Suau A, 1999, APPL ENVIRON MICROB, V65, P4799; Todal JA, 2004, DIS AQUAT ORGAN, V58, P9, DOI 10.3354/dao058009; Touchon M, 2011, APPL ENVIRON MICROB, V77, P7656, DOI 10.1128/AEM.05625-11; Verner-Jeffreys DW, 2008, DIS AQUAT ORGAN, V79, P207, DOI 10.3354/dao01916; Wergeland HI, 2001, DIS AQUAT ORGAN, V44, P183, DOI 10.3354/dao044183; WOLF K, 1966, SCIENCE, V151, P1004, DOI 10.1126/science.151.3713.1004; Zobell CE, 1941, J MAR RES, V4, P42	37	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158151	10.1371/journal.pone.0158151	http://dx.doi.org/10.1371/journal.pone.0158151			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391648	gold, Green Submitted, Green Published			2022-12-26	WOS:000380005400033
J	Dopstadt, J; Neubauer, L; Tudzynski, P; Humpf, HU				Dopstadt, Julian; Neubauer, Lisa; Tudzynski, Paul; Humpf, Hans-Ulrich			The Epipolythiodiketopiperazine Gene Cluster in Claviceps purpurea: Dysfunctional Cytochrome P450 Enzyme Prevents Formation of the Previously Unknown Clapurines	PLOS ONE			English	Article							GLIOTOXIN BIOSYNTHESIS; ASPERGILLUS-FUMIGATUS; NATURAL-PRODUCTS; EPIPOLYTHIODIOXOPIPERAZINE TOXINS; EMERICELLA-HETEROTHALLICA; LEPTOSPHAERIA-MACULANS; HISTAMINE-RELEASE; MASS-SPECTROMETRY; FILAMENTOUS FUNGI; HYALODENDRON SP	Claviceps purpurea is an important food contaminant and well known for the production of the toxic ergot alkaloids. Apart from that, little is known about its secondary metabolism and not all toxic substances going along with the food contamination with Claviceps are known yet. We explored the metabolite profile of a gene cluster in C. purpurea with a high homology to gene clusters, which are responsible for the formation of epipolythiodiketopiperazine (ETP) toxins in other fungi. By overexpressing the transcription factor, we were able to activate the cluster in the standard C. purpurea strain 20.1. Although all necessary genes for the formation of the characteristic disulfide bridge were expressed in the overexpression mutants, the fungus did not produce any ETPs. Isolation of pathway intermediates showed that the common biosynthetic pathway stops after the first steps. Our results demonstrate that hydroxylation of the diketopiperazine backbone is the critical step during the ETP biosynthesis. Due to a dysfunctional enzyme, the fungus is not able to produce toxic ETPs. Instead, the pathway end-products are new unusual metabolites with a unique nitrogen-sulfur bond. By heterologous expression of the Leptosphaeria maculans cytochrome P450 encoding gene sirC, we were able to identify the end-products of the ETP cluster in C. purpurea. The thioclapurines are so far unknown ETPs, which might contribute to the toxicity of other C. purpurea strains with a potentially intact ETP cluster.	[Dopstadt, Julian; Humpf, Hans-Ulrich] Univ Munster, Inst Food Chem, Corrensstr 45, D-48149 Munster, Germany; [Neubauer, Lisa; Tudzynski, Paul] Univ Munster, Inst Plant Biol & Biotechnol, Schlosspl 8, D-48143 Munster, Germany	University of Munster; University of Munster	Humpf, HU (corresponding author), Univ Munster, Inst Food Chem, Corrensstr 45, D-48149 Munster, Germany.	humpf@uni-muenster.de	Humpf, Hans-Ulrich/AAV-4845-2020	Humpf, Hans-Ulrich/0000-0003-3296-3058	Deutsche Forschungsgemeinschaft [50/18 1, 730/11-1, 50/18-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by Deutsche Forschungsgemeinschaft grants 50/18 1 (to PT) and 730/11-1 (to HUH).; This research was funded by Deutsche Forschungsgemeinschaft grants 50/18-1 (to P.T.) and 730/11-1 (to H.-U.H.). We thank Jens Kohler for NMR measurements and Thierry Rouxel for providing a L. maculans DNA sample.	Bhatnagar I, 2015, INT J MED MICROBIOL, V305, P11, DOI 10.1016/j.ijmm.2014.09.005; Bok JW, 2006, INFECT IMMUN, V74, P6761, DOI 10.1128/IAI.00780-06; Borthwick AD, 2012, CHEM REV, V112, P3641, DOI 10.1021/cr200398y; Bove JF, 1970, THE STORY OF ERGOT; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Chang SL, 2013, BIOORG MED CHEM LETT, V23, P2155, DOI 10.1016/j.bmcl.2013.01.099; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cryle MJ, 2010, BIOCHEMISTRY-US, V49, P7282, DOI 10.1021/bi100910y; CURTIS PJ, 1977, J CHEM SOC P1, V1, P180; Davis C, 2011, CHEM BIOL, V18, P542, DOI 10.1016/j.chembiol.2010.12.022; Demarque DP, 2016, NAT PROD REP, V33, P432, DOI 10.1039/c5np00073d; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DEVAULT RL, 1973, J ANTIBIOT, V26, P532, DOI 10.7164/antibiotics.26.532; Dolan SK, 2014, CHEM BIOL, V21, P999, DOI 10.1016/j.chembiol.2014.07.006; Duell ER, 2016, ACS CHEM BIOL, V11, P1082, DOI 10.1021/acschembio.5b00905; Eadie MJ, 2003, LANCET NEUROL, V2, P429, DOI 10.1016/S1474-4422(03)00439-3; Elliott CE, 2007, MOL PLANT PATHOL, V8, P791, DOI [10.1111/j.1364-3703.2007.00433.x, 10.1111/J.1364-3703.2007.00433.X]; ESSER K, 1978, THEOR APPL GENET, V53, P145, DOI 10.1007/BF00273574; Forseth RR, 2011, J AM CHEM SOC, V133, P9678, DOI 10.1021/ja2029987; Fox EM, 2008, MYCOL RES, V112, P162, DOI 10.1016/j.mycres.2007.08.017; Furtado NAJC, 2007, J MASS SPECTROM, V42, P1279, DOI 10.1002/jms.1166; Gardiner DM, 2005, FEMS MICROBIOL LETT, V248, P241, DOI 10.1016/j.femsle.2005.05.046; Gardiner DM, 2004, MOL MICROBIOL, V53, P1307, DOI 10.1111/j.1365-2958.2004.04215.x; Gerhards N, 2014, TOXINS, V6, P3281, DOI 10.3390/toxins6123281; Giesbert S, 2008, MOL PLANT PATHOL, V9, P317, DOI [10.1111/j.1364-3703.2008.00466.x, 10.1111/J.1364-3703.2008.00466.X]; Guo CJ, 2013, J AM CHEM SOC, V135, P7205, DOI 10.1021/ja3123653; Haarmann T, 2008, FUNGAL GENET BIOL, V45, P35, DOI 10.1016/j.fgb.2007.04.008; Hurne AM, 2002, J BIOL CHEM, V277, P31631, DOI 10.1074/jbc.M201699200; Hurne AM, 2000, J BIOL CHEM, V275, P25202, DOI 10.1074/jbc.M002278200; Husgen U, 1999, J PHYTOPATHOL, V147, P591, DOI 10.1046/j.1439-0434.1999.00432.x; JORDAN TW, 1987, TRENDS PHARMACOL SCI, V8, P144, DOI 10.1016/0165-6147(87)90184-2; JUNGEHULSING U, 1994, CURR GENET, V25, P101, DOI 10.1007/BF00309533; Kajula M, 2016, J NAT PROD; KAWAHARA N, 1990, CHEM PHARM BULL, V38, P73; KAWAHARA N, 1989, CHEM PHARM BULL, V37, P2592; KAWAHARA N, 1986, J CHEM SOC CHEM COMM, P1495, DOI 10.1039/c39860001495; KAWAHARA N, 1987, J CHEM SOC PERK T 1, P2099, DOI 10.1039/p19870002099; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kimura M, 2014, PATHWAYS GENES EVOLU, V71, P2105; Klaric MK, 2008, ARCH TOXICOL, V82, P247, DOI 10.1007/s00204-007-0245-y; Kremer A, 2010, MICROBIOL-SGM, V156, P278, DOI 10.1099/mic.0.033886-0; MANTLE PG, 1976, J GEN MICROBIOL, V93, P321, DOI 10.1099/00221287-93-2-321; Marroquin-Cardona AG, 2014, FOOD CHEM TOXICOL, V69, P220, DOI 10.1016/j.fct.2014.04.025; Mukherjee PK, 2012, MICROBIOL-SGM, V158, P35, DOI 10.1099/mic.0.053629-0; MULLBACHER A, 1986, MOL IMMUNOL, V23, P231, DOI 10.1016/0161-5890(86)90047-7; MUNDAY R, 1987, J APPL TOXICOL, V7, P17, DOI 10.1002/jat.2550070105; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nielsen KF, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00071; Park HB, 2011, J NAT PROD, V74, P2309, DOI 10.1021/np200563x; Patron NJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-174; Pfohl-Leszkowicz A, FOOD CONTAMINANTS MY; Pretsch E., 2009, STRUCTURE DETERMINAT; Reece KM, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-91; Sambrook J, 1989, MOL CLONING; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Scharf DH, 2014, J AM CHEM SOC, V136, P11674, DOI 10.1021/ja5033106; Scharf DH, 2013, ANGEW CHEM INT EDIT, V52, P11092, DOI 10.1002/anie.201305059; Scharf DH, 2013, J BIOTECHNOL, V163, P179, DOI 10.1016/j.jbiotec.2012.06.027; Scharf DH, 2012, ANGEW CHEM INT EDIT, V51, P10064, DOI 10.1002/anie.201205041; Scharf DH, 2011, J AM CHEM SOC, V133, P12322, DOI 10.1021/ja201311d; Scharf DH, 2010, J AM CHEM SOC, V132, P10136, DOI 10.1021/ja103262m; Scharf DH, 2015, GLIOTOXIN BANE BOON; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; SMIT R, 1992, MOL GEN GENET, V234, P297, DOI 10.1007/BF00283850; STILLWELL MA, 1974, CAN J MICROBIOL, V20, P759, DOI 10.1139/m74-116; Stoev SD, 2012, EXP TOXICOL PATHOL, V64, P733, DOI 10.1016/j.etp.2011.01.008; STRUNZ GM, 1974, CAN J CHEM, V52, P325, DOI 10.1139/v74-052; STRUNZ GM, 1975, CAN J CHEM, V53, P295, DOI 10.1139/v75-040; Sun Y, 2012, J NAT PROD, V75, P111, DOI 10.1021/np200740e; SUTTON P, 1994, INFECT IMMUN, V62, P1192, DOI 10.1128/IAI.62.4.1192-1198.1994; Tenberge KB, 1996, PHYTOPATHOLOGY, V86, P1084, DOI 10.1094/Phyto-86-1084; Vargas WA, 2014, MICROBIOL-SGM, V160, P2319, DOI 10.1099/mic.0.079210-0; WARING P, 1988, J BIOL CHEM, V263, P18493; Waring P, 1996, GEN PHARMACOL, V27, P1311, DOI 10.1016/S0306-3623(96)00083-3; WARING P, 1995, BIOCHEM PHARMACOL, V49, P1195, DOI 10.1016/0006-2952(95)00039-3; Weindling R, 1934, PHYTOPATHOLOGY, V24, P1153; Welch TR, 2014, NAT PROD REP, V31, P1376, DOI 10.1039/c3np70097f; Wiemann P, 2014, J IND MICROBIOL BIOT, V41, P301, DOI 10.1007/s10295-013-1366-3; Williams DE, 1998, TETRAHEDRON LETT, V39, P9579, DOI 10.1016/S0040-4039(98)02277-1; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107	82	6	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158945	10.1371/journal.pone.0158945	http://dx.doi.org/10.1371/journal.pone.0158945			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27390873	Green Submitted, Green Published, gold			2022-12-26	WOS:000380005400168
J	Gomes, C; Sousa, R; Mendes, T; Borges, R; Vilares, P; Vasconcelos, V; Guilhermino, L; Antunes, A				Gomes, Cidalia; Sousa, Ronaldo; Mendes, Tito; Borges, Rui; Vilares, Pedro; Vasconcelos, Vitor; Guilhermino, Lucia; Antunes, Agostinho			Low Genetic Diversity and High Invasion Success of Corbicula fluminea (Bivalvia, Corbiculidae) (Muller, 1774) in Portugal	PLOS ONE			English	Article							FRESH-WATER CLAM; NON-REDUCTIONAL SPERMATOZOA; MOLECULAR PHYLOGENY; DNA; ANDROGENESIS; MORPHOLOGY; MORTALITY; LINEAGES; MOLLUSCA; AMPLIFICATION	The Asian clam, Corbicula fluminea, is an invasive alien species (IAS) originally from Asia that has spread worldwide causing major ecological and economic impacts in aquatic ecosystems. Here, we evaluated C. fluminea genetic (using COI mtDNA, CYTb mtDNA and 18S rDNA gene markers), morphometric and sperm morphology variation in Portuguese freshwater ecosystems. The COI marker revealed a single haplotype, which belongs to the Asian FW5 invasive lineage, suggesting a common origin for all the 13 Portuguese C. fluminea populations analysed. Morphometric analyses showed differences between the populations colonizing the North (with the exception of the Lima River) and the Centre/South ecosystems. The sperm morphology examination revealed the presence of biflagellate sperm, a distinctive character of the invasive androgenetic lineages. The low genetic variability of the Portuguese C. fluminea populations and the pattern of sperm morphology have been illuminating for understanding the demographic history of this invasive species. We hypothesize that these populations were derived from a unique introductory event of a Corbicula fluminea FW5 invasive androgenic lineage in the Tejo River, which subsequently dispersed to other Portuguese freshwater ecosystems. The C. fluminea asexual reproductive mode may have assisted these populations to become highly invasive despite the low genetic diversity.	[Gomes, Cidalia; Sousa, Ronaldo; Mendes, Tito; Borges, Rui; Vilares, Pedro; Vasconcelos, Vitor; Guilhermino, Lucia; Antunes, Agostinho] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, Terminal Cruzeiros Porto Leixoes, Av Gen Norton de Matos S-N, P-4450208 Oporto, Portugal; [Gomes, Cidalia; Vilares, Pedro; Guilhermino, Lucia] Univ Porto, Lab Ecotoxicol, Dept Populat Study, Inst Biomed Sci Abel Salazar,ICBAS, Rua Jorge Viterbo Ferreira 228, P-4050313 Oporto, Portugal; [Sousa, Ronaldo] Univ Minho, Dept Biol, Ctr Mol & Environm Biol, CBMA, Campus Gualtar, P-4710057 Braga, Portugal; [Mendes, Tito; Borges, Rui; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Fac Sci, Dept Biol, FCUP, Rua Campo Alegre S-N Edificio FC5, P-4169007 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Minho; Universidade do Porto	Antunes, A (corresponding author), Univ Porto, Interdisciplinary Ctr Marine & Environm Res, CIIMAR CIMAR, Terminal Cruzeiros Porto Leixoes, Av Gen Norton de Matos S-N, P-4450208 Oporto, Portugal.; Antunes, A (corresponding author), Univ Porto, Fac Sci, Dept Biol, FCUP, Rua Campo Alegre S-N Edificio FC5, P-4169007 Oporto, Portugal.	aantunes@ciimar.up.pt	Vasconcelos, Vitor/A-8933-2008; Borges, Rui/H-5873-2016; Sousa, Ronaldo/C-4887-2008	Vasconcelos, Vitor/0000-0003-3585-2417; Borges, Rui/0000-0002-5905-3778; Sousa, Ronaldo/0000-0002-5961-5515; Guilhermino, Lucia/0000-0002-1009-8967; Mendes, Tito/0000-0001-7590-5523; Antunes, Agostinho/0000-0002-1328-1732; Gomes, Cidalia/0000-0001-5119-7964; Borges, Rui/0000-0003-3931-9476	Portuguese Foundation for Science and Technology (FCT) [SFRH/BD/71041/2010]; FCT [UID/Multi/04423/2013, PTDC/AAG-GLO/6887/2014]; European Regional Development Fund (ERDF) by the Northern Regional Operational Program [NORTE-01-0145-FEDER-000035]; ERDF	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); European Regional Development Fund (ERDF) by the Northern Regional Operational Program; ERDF(European Commission)	Cidalia Gomes was supported by a PhD grant from the Portuguese Foundation for Science and Technology (FCT) (SFRH/BD/71041/2010). This research was partially supported by the Strategic Funding UID/Multi/04423/2013 through national funds provided by FCT and European Regional Development Fund (ERDF) in the framework of the program PT2020, the Structured Program of R&D&I INNOVMAR - Innovation and Sustainability in the Management and Exploitation of Marine Resources (NORTE-01-0145-FEDER-000035; Research Line ECOSERVICES) by the Northern Regional Operational Program (NORTE2020) and ERDF, and the FCT project PTDC/AAG-GLO/6887/2014.	Adamkewicz SL, 1997, MOL BIOL EVOL, V14, P619, DOI 10.1093/oxfordjournals.molbev.a025801; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, TRACER V1 6; ARAUJO R, 1993, AM MALACOL BULL, V10, P39; Baker AM, 2003, MOL ECOL, V12, P2707, DOI 10.1046/j.1365-294X.2003.01941.x; Belz CE, 2012, J SHELLFISH RES, V31, P777, DOI 10.2983/035.031.0322; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Britton J.C., 1979, P249; Britton J. C., 1982, MALACOL REV S, P1; Byrne M, 2000, HYDROBIOLOGIA, V418, P185, DOI 10.1023/A:1003986512832; Chicharo L, 2000, VALORIZACAO RECURSOS; Clavero M, 2012, AQUAT CONSERV, V22, P277, DOI 10.1002/aqc.2231; Corbicula Morton B., 1986, AM MALAC B, V2, P113; COUNTS CL, 1981, NAUTILUS, V95, P12; Crespo D, 2015, BIOL INVASIONS, V17, P2087, DOI 10.1007/s10530-015-0862-y; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darrigran Gustavo, 2002, Biological Invasions, V4, P145, DOI 10.1023/A:1020521811416; Dill WA, 1993, INLAND FISHERIES EUR; Douda K, 2012, BIOL INVASIONS, V14, P127, DOI 10.1007/s10530-011-9989-7; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Espineira M, 2009, J AGR FOOD CHEM, V57, P495, DOI 10.1021/jf802787d; Ferreira Veronica, 2004, Limnetica, V23, P295; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frischer ME, 2002, HYDROBIOLOGIA, V487, P33, DOI 10.1023/A:1022971918673; GARDNER JPA, 1991, MAR ECOL PROG SER, V71, P235, DOI 10.3354/meps071235; Giribet G, 2002, INVERTEBR BIOL, V121, P271; Glaubrecht M, 2003, MALACOLOGIA, V45, P1; Golani D, 2007, BIOLOGY LETT, V3, P541, DOI 10.1098/rsbl.2007.0308; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hatsumi Machiko, 1995, Venus the Japanese Journal of Malacology, V54, P185; Hedtke SM, 2008, EVOLUTION, V62, P1119, DOI 10.1111/j.1558-5646.2008.00344.x; Hedtke SM, 2011, P NATL ACAD SCI USA, V108, P9520, DOI 10.1073/pnas.1106742108; Hedtke SM, 2011, SYST BIOL, V60, P87, DOI 10.1093/sysbio/syq070; Higgins SN, 2010, ECOL MONOGR, V80, P179, DOI 10.1890/09-1249.1; HILLIS DM, 1982, AM MIDL NAT, V108, P74, DOI 10.2307/2425294; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ilarri MI, 2015, MAR FRESHWATER RES, V66, P549, DOI 10.1071/MF14004; Ilarri MI, 2012, J SEA RES, V72, P113, DOI 10.1016/j.seares.2011.10.002; Ilarri MI, 2011, BIOL INVASIONS, V13, P277, DOI 10.1007/s10530-010-9833-5; Ishibashi R, 2003, ZOOL SCI, V20, P727, DOI 10.2108/zsj.20.727; ITUARTE CF, 1994, NAUTILUS, V107, P129; Karatayev AY, 2007, BIOL INVASIONS, V9, P161, DOI 10.1007/s10530-006-9013-9; KIJVIRIYA V, 1991, AM MALACOL BULL, V8, P97; Kinzelbach Ragnar, 1991, Mainzer Naturwissenschaftliches Archiv, V29, P215; Komaru A, 1999, ZOOL SCI, V16, P105, DOI 10.2108/zsj.16.105; Komaru A, 1997, BIOL BULL, V193, P320, DOI 10.2307/1542934; Komaru A, 1998, DEV GENES EVOL, V208, P46, DOI 10.1007/s004270050152; Komaru A, 2001, DEV BIOL, V18, P87; Komaru A, 2006, ZOOL SCI, V23, P529, DOI 10.2108/zsj.23.529; Konishi K, 1998, J SHELLFISH RES, V17, P185; Korniushin AV, 2004, HYDROBIOLOGIA, V529, P251; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee Jun-Sang, 1997, Korean Journal of Systematic Zoology, V13, P233; Lee T, 2005, AM MALACOL BULL, V20, P113; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu J, 2006, BIOL INVASIONS, V8, P1461, DOI 10.1007/s10530-005-5838-x; McMahon RF, 2000, NONINDIGENOUS FRESHWATER ORGANISMS, P315; MCMAHON RF, 1982, NAUTILUS, V96, P134; McMahon RF, 2002, CAN J FISH AQUAT SCI, V59, P1235, DOI 10.1139/F02-105; Mergeay J, 2006, P R SOC B, V273, P2839, DOI 10.1098/rspb.2006.3661; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOUTHON J, 1981, Basteria, V45, P109; Nagel K. O., 1989, MITT DTSCH MALAKOZOO, V17, P44; Nei M., 1987, MOL EVOLUTIONARY GEN; NORBERG J, 1995, J EXP MAR BIOL ECOL, V186, P207, DOI 10.1016/0022-0981(94)00158-A; Novais A, 2015, SCI TOTAL ENVIRON, V538, P664, DOI 10.1016/j.scitotenv.2015.08.106; Novais A, 2015, MAR ECOL PROG SER, V522, P157, DOI 10.3354/meps11168; OKAMOTO A, 1986, Venus the Japanese Journal of Malacology, V45, P194; Park JK, 2003, MOL PHYLOGENET EVOL, V29, P529, DOI 10.1016/S1055-7903(03)00138-6; Park JK, 2002, MOL CELLS, V14, P318; Pigneur LM, 2012, HEREDITY, V108, P581, DOI 10.1038/hdy.2012.3; Pigneur LM, 2014, MOL ECOL, V23, P5102, DOI 10.1111/mec.12912; Pigneur LM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-147; PREZANT RS, 1984, SCIENCE, V225, P1491, DOI 10.1126/science.225.4669.1491; Qiu AD, 2001, J SHELLFISH RES, V20, P323; Ren MX, 2005, WEED RES, V45, P236, DOI 10.1111/j.1365-3180.2005.00445.x; Renard E, 2000, MOL ECOL, V9, P2009, DOI 10.1046/j.1365-294X.2000.01104.x; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Siripattrawan S, 2000, J MOLLUS STUD, V66, P423, DOI 10.1093/mollus/66.3.423; Sousa R, 2008, ANN LIMNOL-INT J LIM, V44, P85, DOI 10.1051/limn:2008017; Sousa R, 2006, ANN LIMNOL-INT J LIM, V42, P165, DOI 10.1051/limn/2006017; Sousa R, 2007, ESTUAR COAST SHELF S, V74, P166, DOI 10.1016/j.ecss.2007.04.011; Sousa R, 2014, HYDROBIOLOGIA, V735, P233, DOI 10.1007/s10750-012-1409-1; Sousa R, 2012, ANN LIMNOL-INT J LIM, V48, P105, DOI 10.1051/limn/2012003; Sousa R, 2009, BIOL INVASIONS, V11, P2367, DOI 10.1007/s10530-009-9422-7; Stanley SM, 1983, THE MOLLUSCA; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor JD, 2007, ZOOL SCR, V36, P587, DOI 10.1111/j.1463-6409.2007.00299.x; Teles M, 2007, SCI TOTAL ENVIRON, V372, P562, DOI 10.1016/j.scitotenv.2006.10.033; TSOI S C M, 1991, Malacological Review, V24, P25; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Vrijenhoek RC, 1998, BIOSCIENCE, V48, P617, DOI 10.2307/1313421; WILLIS GL, 1992, MAR BIOL, V112, P403, DOI 10.1007/BF00356285; Yamada M, 2010, NIPPON SUISAN GAKK, V76, P926, DOI 10.2331/suisan.76.926	96	17	21	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158108	10.1371/journal.pone.0158108	http://dx.doi.org/10.1371/journal.pone.0158108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391333	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400030
J	Reynard, LN; Ratnayake, M; Santibanez-Koref, M; Loughlin, J				Reynard, Louise N.; Ratnayake, Madhushika; Santibanez-Koref, Mauro; Loughlin, John			Functional Characterization of the Osteoarthritis Susceptibility Mapping to CHST11-A Bioinformatics and Molecular Study	PLOS ONE			English	Article							GENOME-WIDE; EXPRESSION ANALYSIS; ALLELIC EXPRESSION; CELL-TYPES; CARTILAGE; SOX9; GENE; IDENTIFICATION; INSIGHTS; REVEALS	The single nucleotide polymorphism (SNP) rs835487 is associated with hip osteoarthritis (OA) at the genome-wide significance level and is located within CHST11, which codes for carbohydrate sulfotransferase 11. This enzyme post-translationally modifies proteoglycan prior to its deposition in the cartilage extracellular matrix. Using bioinformatics and experimental analyses, our aims were to characterise the rs835487 association signal and to identify the causal functional variant/s. Database searches revealed that rs835487 resides within a linkage disequilibrium (LD) block of only 2.7 kb and is in LD (r(2) >= 0.8) with six other SNPs. These are all located within intron 2 of CHST11, in a region that has predicted enhancer activity and which shows a high degree of conservation in primates. Luciferase reporter assays revealed that of the seven SNPs, rs835487 and rs835488, which have a pairwise r(2) of 0.962, are the top functional candidates; the haplotype composed of the OA-risk conferring G allele of rs835487 and the corresponding T allele of rs835488 (the G-T haplotype) demonstrated significantly different enhancer activity relative to the haplotype composed of the non-risk A allele of rs835487 and the corresponding C allele of rs835488 (the A-C haplotype) (p < 0.001). Electrophoretic mobility shift assays and supershifts identified several transcription factors that bind more strongly to the risk-conferring G and T alleles of the two SNPs, including SP1, SP3, YY1 and SUB1. CHST11 was found to be upregulated in OA versus non-OA cartilage (p < 0.001) and was expressed dynamically during chondrogenesis. Its expression in adult cartilage did not however correlate with rs835487 genotype. Our data demonstrate that the OA susceptibility is mediated by differential protein binding to the alleles of rs835487 and rs835488, which are located within an enhancer whose target may be CHST11 during chondrogenesis or an alternative gene.	[Reynard, Louise N.; Ratnayake, Madhushika; Loughlin, John] Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Santibanez-Koref, Mauro] Newcastle Univ, Inst Med Genet, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Reynard, LN (corresponding author), Newcastle Univ, Inst Cellular Med, Musculoskeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.	louise.reynard@newcastle.ac.uk		Reynard, Louise/0000-0002-6613-1797; Loughlin, John/0000-0003-2018-3361	Arthritis Research UK [19824, 20231]; Medical Research Council; Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA); European Union's Seventh Framework Program for research, technological development and demonstration [305815]; NIHR Newcastle Biomedical Research Centre; MRC [MR/K006312/1] Funding Source: UKRI; Medical Research Council [MR/K006312/1] Funding Source: researchfish; Versus Arthritis [20231, 19824, 20771] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA)(Versus Arthritis); European Union's Seventh Framework Program for research, technological development and demonstration; NIHR Newcastle Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	This research was funded by Arthritis Research UK (http://www.arthritisresearchuk.org/; grant codes 19824 and 20231), by the Medical Research Council and Arthritis Research UK as part of the MRC-Arthritis Research UK Centre for Integrated Research into Musculoskeletal Ageing (CIMA; http://www.cimauk.org/), and by the European Union's Seventh Framework Program for research, technological development and demonstration under grant agreement number No. 305815 (D-BOARD; http://www.d-board.eu/dboard/index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Patient tissue was provided by the Newcastle Bone and Joint Biobank supported by the NIHR Newcastle Biomedical Research Centre awarded to the Newcastle upon Tyne NHS Foundation Trust and Newcastle University. We thank the surgeons and research nurses at the Trust for providing us with access to these samples.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Barter MJ, 2015, STEM CELLS, V33, P3266, DOI 10.1002/stem.2093; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bos SD, 2012, ANN RHEUM DIS, V71, P1254, DOI 10.1136/annrheumdis-2011-200981; Bos SD, 2008, CURR OPIN RHEUMATOL, V20, P553, DOI 10.1097/BOR.0b013e32830aba48; Cortes M, 2009, DEVELOPMENT, V136, P1697, DOI 10.1242/dev.030742; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Egli RJ, 2009, ARTHRITIS RHEUM-US, V60, P2055, DOI 10.1002/art.24616; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gee F, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-53; Gualeni B, 2010, MATRIX BIOL, V29, P453, DOI 10.1016/j.matbio.2010.05.001; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hawker GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091286; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kluppel M, 2010, PROG MOL BIOL TRANSL, V93, P113, DOI 10.1016/S1877-1173(10)93006-8; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Liu CF, 2015, NUCLEIC ACIDS RES, V43, P8183, DOI 10.1093/nar/gkv688; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Panoutsopoulou K, 2011, ANN RHEUM DIS, V70, P864, DOI 10.1136/ard.2010.141473; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Raine EVA, 2012, ANN RHEUM DIS, V71, P2020, DOI 10.1136/annrheumdis-2012-201304; Reynard LN, 2014, HUM GENET, V133, P1059, DOI 10.1007/s00439-014-1447-z; Reynard LN, 2013, NAT REV RHEUMATOL, V9, P573, DOI 10.1038/nrrheum.2013.121; Rushton MD, 2014, ARTHRITIS RHEUMATOL, V66, P2450, DOI 10.1002/art.38713; Sandell LJ, 2012, NAT REV RHEUMATOL, V8, P77, DOI 10.1038/nrrheum.2011.199; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Styrkarsdottir U, 2014, NAT GENET, V46, P498, DOI 10.1038/ng.2957; Syddall CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003557; Thiele H, 2004, P NATL ACAD SCI USA, V101, P10155, DOI 10.1073/pnas.0400334101; Ward LD, 2016, NUCLEIC ACIDS RES, V44, pD877, DOI 10.1093/nar/gkv1340; Xu Y, 2012, OSTEOARTHR CARTILAGE, V20, P1029, DOI 10.1016/j.joca.2012.05.006; YANT SR, 1995, NUCLEIC ACIDS RES, V23, P4353, DOI 10.1093/nar/23.21.4353; Yao BJ, 2015, NUCLEIC ACIDS RES, V43, P5394, DOI 10.1093/nar/gkv426; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	45	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159024	10.1371/journal.pone.0159024	http://dx.doi.org/10.1371/journal.pone.0159024			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391021	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400195
J	Yang, WJ; Cai, XL; Han, XY; Ji, LN				Yang, Wenjia; Cai, Xiaoling; Han, Xueyao; Ji, Linong			Clinical Characteristics of Young Type 2 Diabetes Patients with Atherosclerosis	PLOS ONE			English	Article							COMPLICATIONS; MELLITUS; CORONARY; STENOSIS; COHORT	Objective The prevalence of type 2 diabetes is increasing rapidly in the young population. The clinical characteristics and risk factors for young type 2 diabetes patients with atherosclerosis are not fully explicated. The aim of the present study was to investigate various clinical and biochemical characteristics of young type 2 diabetic patients with atherosclerosis. Design and Methods This was a cross-sectional study. The study involved 2199 hospitalized patients with type 2 diabetes. The young patients were classified into the atherosclerotic group or the non-atherosclerotic group, and we also enrolled an older group with peripheral atherosclerosis disease and an age of at least 45 years. Comparisons were made between the different groups to investigate the cardiovascular and metabolic risk profiles of young type 2 diabetes patients with atherosclerosis. We also used logistic regression models to assess the atherosclerosis risk factors for young patients. Results Compared to older type 2 diabetes patients with atherosclerosis, young patients with atherosclerosis had more deleterious profiles of weight and hyperlipidemia. Only age and diabetes duration were found to be significant independent risk factors for atherosclerosis in young patients. The ratio of the presence of atherosclerosis in the lower extremity arteries alone was significantly higher in young patients than older patients (26.4% vs. 14.0%, P = 0.000). Conclusion Young type 2 diabetes patients with atherosclerosis have more adverse cardiovascular risk profiles and inadequate control of these risk factors. Lower extremity examination is of high importance in young patients.	[Yang, Wenjia; Cai, Xiaoling; Han, Xueyao; Ji, Linong] Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China	Peking University	Ji, LN (corresponding author), Peking Univ, Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020	Yang, Wenjia/0000-0003-0610-5121; Cai, Xiaoling/0000-0002-7881-0543	National High Technology Research and Development Program of China [2012AA02A509]; National Key Basic Research Program of China [2011CB504000]; Beijing Science and Technology Committee Funding [D131100005313008]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); Beijing Science and Technology Committee Funding	This study is supported by National High Technology Research and Development Program of China (2012AA02A509); National Key Basic Research Program of China (2011CB504000) and Beijing Science and Technology Committee Funding (D131100005313008).	Adraktas DD, 2010, STROKE, V41, P1604, DOI 10.1161/STROKEAHA.109.577437; Benhalima K, 2011, PRIM CARE DIABETES, V5, P245, DOI 10.1016/j.pcd.2011.06.003; BOTS ML, 1994, ARTERIOSCLER THROMB, V14, P1885, DOI 10.1161/01.ATV.14.12.1885; CRAVEN TE, 1990, CIRCULATION, V82, P1230, DOI 10.1161/01.CIR.82.4.1230; Feltbower RG, 2003, ARCH DIS CHILD, V88, P676, DOI 10.1136/adc.88.8.676; Gunathilake W, 2010, QJM-INT J MED, V103, P881, DOI 10.1093/qjmed/hcq135; Harron KL, 2011, DIABETES CARE, V34, P652, DOI 10.2337/dc10-1512; Pasterkamp G, 1998, ATHEROSCLEROSIS, V137, P205, DOI 10.1016/S0021-9150(97)00255-4; Song SH, 2009, QJM-INT J MED, V102, P799, DOI 10.1093/qjmed/hcp121; Sosnowski C, 2007, KARDIOL POL, V65, P760; Waernbaum I, 2006, DIABETOLOGIA, V49, P653, DOI 10.1007/s00125-005-0135-x; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yu Li-bo, 2013, Zhonghua Yi Xue Za Zhi, V93, P2143	13	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159055	10.1371/journal.pone.0159055	http://dx.doi.org/10.1371/journal.pone.0159055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391819	Green Published, gold, Green Submitted			2022-12-26	WOS:000380005400203
J	Liang, CN; Wang, LZ; Wu, XY; Wang, K; Ding, XZ; Wang, MC; Chu, M; Xie, XY; Qiu, Q; Yan, P				Liang, Chunnian; Wang, Lizhong; Wu, Xiaoyun; Wang, Kun; Ding, Xuezhi; Wang, Mingcheng; Chu, Min; Xie, Xiuyue; Qiu, Qiang; Yan, Ping			Genome-wide Association Study Identifies Loci for the Polled Phenotype in Yak	PLOS ONE			English	Article							CATTLE; GENE; SELECTION; INSIGHTS; FORMAT; HORN	The absence of horns, known as the polled phenotype, is an economically important trait in modern yak husbandry, but the genomic structure and genetic basis of this phenotype have yet to be discovered. Here, we conducted a genome-wide association study with a panel of 10 horned and 10 polled yaks using whole genome sequencing. We mapped the POLLED locus to a 200-kb interval, which comprises three protein-coding genes. Further characterization of the candidate region showed recent artificial selection signals resulting from the breeding process. We suggest that expressional variations rather than structural variations in protein probably contribute to the polled phenotype. Our results not only represent the first and important step in establishing the genomic structure of the polled region in yak, but also add to our understanding of the polled trait in bovid species.	[Liang, Chunnian; Wu, Xiaoyun; Chu, Min; Yan, Ping] Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Key Lab Yak Breeding Engn Gansu Prov, Lanzhou, Peoples R China; [Wang, Lizhong; Wang, Kun; Ding, Xuezhi; Wang, Mingcheng; Xie, Xiuyue; Qiu, Qiang] Lanzhou Univ, Coll Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS; Lanzhou University	Yan, P (corresponding author), Chinese Acad Agr Sci, Lanzhou Inst Husb & Pharmaceut Sci, Key Lab Yak Breeding Engn Gansu Prov, Lanzhou, Peoples R China.; Qiu, Q (corresponding author), Lanzhou Univ, Coll Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Peoples R China.	qiuqiang@lzu.edu.cn; pingyanlz@163.com		wang, lizhong/0000-0002-3571-8771	Agricultural Science and Technology Innovation Program [CAAS-ASTIP-2014-LIHPS-01]; National Beef Cattle Industry Technology System [CARS-38]; National High Technology Research and Development Program of China [2013AA102505 3-2]; National Natural Science Foundation of China [31322052]; Fok Ying Tung Education Foundation [151105]; Fundamental Research Funds for the Central Universities [lzujbky-2016-k04]	Agricultural Science and Technology Innovation Program; National Beef Cattle Industry Technology System; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by grants from the Agricultural Science and Technology Innovation Program (www.caas.cn/en/research/research_program/index.shtml; CAAS-ASTIP-2014-LIHPS-01; P.Y.), National Beef Cattle Industry Technology & System (www.beefsys.com/; CARS-38; Q.Q.), the National High Technology Research and Development Program of China (www.most.gov.cn/eng/programmes1/; 2013AA102505 3-2; Q.Q.), the National Natural Science Foundation of China (www.nsfc.gov.cn/; 31322052; Q.Q.), the Fok Ying Tung Education Foundation (www.hydef.edu.cn; 151105; Q.Q.) and the Fundamental Research Funds for the Central Universities (www.moe.edu.cn; lzujbky-2016-k04; Q.Q.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allais-Bonnet A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063512; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Brenneman RA, 1996, J HERED, V87, P156, DOI 10.1093/oxfordjournals.jhered.a022975; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Capitan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049084; Capitan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022242; Carlson DF, 2016, NAT BIOTECHNOL, V34, P479, DOI 10.1038/nbt.3560; Chen H, 2010, GENOME RES, V20, P393, DOI 10.1101/gr.100545.109; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Drouet V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/289728; GEORGES M, 1993, NAT GENET, V4, P206, DOI 10.1038/ng0693-206; Glatzer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067992; Gotz KU, 2015, LIVEST SCI, V179, P80, DOI 10.1016/j.livsci.2015.05.019; Graf B, 1999, APPL ANIM BEHAV SCI, V62, P153, DOI 10.1016/S0168-1591(98)00218-4; Guo XS, 2014, CRIT REV FOOD SCI, V54, P292, DOI 10.1080/10408398.2011.584134; Han Jianlin R.C., 2000, P 3 INT C YAK HELD L; Harlizius B, 1997, MAMM GENOME, V8, P255, DOI 10.1007/s003359900404; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Lan X, 2012, NUCLEIC ACIDS RES, V40, P7690, DOI 10.1093/nar/gks501; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu WB, 2014, ANIM GENET, V45, P138, DOI 10.1111/age.12081; Mariasegaram M, 2012, ANIM GENET, V43, P683, DOI 10.1111/j.1365-2052.2012.02336.x; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Ohadi M, 2015, AM J PRIMATOL, V77, P34, DOI 10.1002/ajp.22308; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Prayaga KC, 2007, AUST J AGR RES, V58, P1, DOI 10.1071/AR06044; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10283; Qiu Q, 2012, NAT GENET, V44, P946, DOI 10.1038/ng.2343; Rothammer S, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-44; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Schaller GB, 1996, BIOL CONSERV, V76, P1, DOI 10.1016/0006-3207(96)85972-6; SCHMUTZ SM, 1995, MAMM GENOME, V6, P710, DOI 10.1007/BF00354293; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Trapani JG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000480; Wang K, 2016, ANIM GENET, V47, P28, DOI 10.1111/age.12377; Wiedemar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093435; Wiener DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127691; Wiener G, 2003, FAO REGIONAL OFFICE; Windig JJ, 2015, LIVEST SCI, V179, P96, DOI 10.1016/j.livsci.2015.05.021; Wunderlich KR, 2006, ANIM GENET, V37, P592, DOI 10.1111/j.1365-2052.2006.01538.x; Xu X, 2013, CURR BIOL, V23, P1031, DOI 10.1016/j.cub.2013.04.054; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	47	12	19	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158642	10.1371/journal.pone.0158642	http://dx.doi.org/10.1371/journal.pone.0158642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389700	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500032
J	Makadzange, AT; Bogezi, C; Boyd, K; Gumbo, A; Mukura, D; Matubu, A; Ndhlovu, CE				Makadzange, Azure Tariro; Bogezi, Carola; Boyd, Kathryn; Gumbo, Anesu; Mukura, Dorinda; Matubu, Allen; Ndhlovu, Chiratidzo Ellen			Evaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+T Cell Counts in HIV Infection	PLOS ONE			English	Article							STARTING ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; PERFORMANCE; AFRICA; INITIATION; MORTALITY; SYSTEMS; ADULTS; TESTS; RATES	Introduction Enumeration of CD4+ T lymphocytes is important for pre-ART disease staging and screening for opportunistic infections, however access to CD4 testing in resource limited settings is poor. Point of care (POC) technologies can facilitate improved access to CD4 testing. We evaluated the analytical performance of a novel POC device the FACSPresto compared to the FACSCalibur as a reference standard and to the PIMA, a POC device in widespread use in sub-Saharan Africa. Method Specimens were obtained from 253 HIV infected adults. Venous blood samples were analyzed on the FACSPresto and the FACSCalibur, in a subset of 41 samples additional analysis was done on the PIMA. Results The absolute CD4 count results obtained on the FACSPresto were comparable to those on the FACSCalibur with low absolute (9.5cells/mu l) and relative bias (3.2%). Bias in CD4% values was also low (1.06%) with a relative bias of 4.9%. The sensitivity was lower at a CD4 count threshold of <= 350cells/mu l compared with <= 500cells/mu l (84.9% vs. 92.8%) resulting in a high upward misclassification rate at low CD4 counts. Specificity at thresholds of <= 350cells/mu l and <= 500cells/mu l were 96.6% and 96.8% respectively. The PIMA had a high absolute (-68.6cells/mu l) and relative bias (-10.5%) when compared with the FACSCalibur. At thresholds of <= 350cells/mu l and <= 500cells/mu l the sensitivity was 100% and 95.5% respectively; specificity was 85.7% and 84.2% respectively. The coefficients of repeatability were 4.13%, 5.29% and 9.8% respectively. Discussion The analytic performance of the FACSPresto against the reference standard was very good with better agreement and precision than the PIMA. The FACSPresto had comparable sensitivity at a threshold of 500 cells/mu l and better specificity than the PIMA. However the FACSPresto showed reduced sensitivity at low CD4 count thresholds. Conclusion The FACSPresto can be reliably used as a POC device for enumerating absolute CD4 count and CD4% values.	[Makadzange, Azure Tariro] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA; [Makadzange, Azure Tariro; Bogezi, Carola; Boyd, Kathryn; Gumbo, Anesu; Ndhlovu, Chiratidzo Ellen] Univ Zimbabwe, Coll Hlth Sci, Dept Med, Harare, Zimbabwe; [Mukura, Dorinda; Matubu, Allen] Univ Zimbabwe, Coll Hlth Sci, Dept Obstet & Gynecol, UZ UCSF Collaborat Project, Harare, Zimbabwe	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Zimbabwe; University of Zimbabwe	Makadzange, AT (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA.; Makadzange, AT (corresponding author), Univ Zimbabwe, Coll Hlth Sci, Dept Med, Harare, Zimbabwe.	amakadzange@mgh.harvard.edu	Gumbo, Anesu/ABC-2960-2021; Ndhlovu, Chiratidzo Ellen/N-8763-2013	Makadzange, Azure Tariro/0000-0001-5330-1470; Boyd, Kathryn/0000-0001-6290-8020; Ndhlovu, Chiratidzo Ellen/0000-0001-7863-7974	Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources) [UL1 TR001102]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI104348] Funding Source: NIH RePORTER	Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health.	Bergeron M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041166; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bwana P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145586; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Davies MA, 2014, PEDIATR INFECT DIS J, V33, P608, DOI 10.1097/INF.0000000000000214; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; Faal M, 2011, JAIDS-J ACQ IMM DEF, V58, pE54, DOI 10.1097/QAI.0b013e3182303921; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Fajardo E, 2015, B WORLD HEALTH ORGAN, V93, P623, DOI 10.2471/BLT.14.146480; GOEDERT JJ, 1987, JAMA-J AM MED ASSOC, V257, P331, DOI 10.1001/jama.257.3.331; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Jarvis JN, 2009, CLIN INFECT DIS, V48, P856, DOI 10.1086/597262; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Manabe YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034319; Mandy F, 2008, CYTOM PART B-CLIN CY, V74B, pS27, DOI 10.1002/cyto.b.20414; Mfinanga S, 2015, LANCET, V385, P2173, DOI 10.1016/S0140-6736(15)60164-7; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Mwau M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067612; Nelson LJ, 2014, AIDS, V28, pS217, DOI 10.1097/QAD.0000000000000239; Organization WH, 2013, CONS GUID US ANT DRU, P272; Petersen ML, 2014, AIDS, V28, P2097, DOI 10.1097/QAD.0000000000000349; Phillips A, 2015, NATURE, V528, pS68, DOI 10.1038/nature16046; POLLOCK MA, 1992, ANN CLIN BIOCHEM, V29, P556, DOI 10.1177/000456329202900512; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Scott LE, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0396-2; Stevens W, 2008, NAT REV MICROBIOL, V6, pS29, DOI 10.1038/nrmicro2000; Strauss K, 1996, CYTOMETRY, V26, P52; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wade D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116663; Wade D, 2014, JAIDS-J ACQ IMM DEF, V66, pE98, DOI 10.1097/QAI.0000000000000214; WHO, 2004, SCALING UP ANTIRETRO	34	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157546	10.1371/journal.pone.0157546	http://dx.doi.org/10.1371/journal.pone.0157546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388763	Green Submitted, Green Published, gold			2022-12-26	WOS:000379811500006
J	Aguirre, LF; Montano-Centellas, FA; Gavilanez, MM; Stevens, RD				Aguirre, Luis F.; Montano-Centellas, Flavia A.; Mercedes Gavilanez, M.; Stevens, Richard D.			Taxonomic and Phylogenetic Determinants of Functional Composition of Bolivian Bat Assemblages	PLOS ONE			English	Article							TROPICAL ELEVATIONAL GRADIENT; COMMUNITY STRUCTURE; BIODIVERSITY ASSESSMENT; ENVIRONMENTAL GRADIENT; NEOTROPICAL SAVANNA; DIVERSITY; CONSERVATION; FOREST; CHIROPTERA; DIMENSIONALITY	Understanding diversity patterns and the potential mechanisms driving them is a fundamental goal in ecology. Examination of different dimensions of biodiversity can provide insights into the relative importance of different processes acting upon biotas to shape communities. Unfortunately, patterns of diversity are still poorly understood in hyper-diverse tropical countries. Here, we assess spatial variation of taxonomic, functional and phylogenetic diversity of bat assemblages in one of the least studied Neotropical countries, Bolivia, and determine whether changes in biodiversity are explained by the replacement of species or functional groups, or by differences in richness (i.e., gain or loss of species or functional groups). Further, we evaluate the contribution of phylogenetic and taxonomic changes in the resulting patterns of functional diversity of bats. Using well-sampled assemblages from published studies we examine noctilionoid bats at ten study sites across five ecoregions in Bolivia. Bat assemblages differed from each other in all dimensions of biodiversity considered; however, diversity patterns for each dimension were likely structured by different mechanisms. Within ecoregions, differences were largely explained by species richness, suggesting that the gain or loss of species or functional groups (as opposed to replacement) was driving dissimilarity patterns. Overall, our results suggest that whereas evolutionary processes (i.e., historical connection and dispersal routes across Bolivia) create a template of diversity patterns across the country, ecological mechanisms modify these templates, decoupling the observed patterns of functional, taxonomic and phylogenetic diversity in Bolivian bats. Our results suggests that elevation represents an important source of variability among diversity patterns for each dimension of diversity considered. Further, we found that neither phylogenetic nor taxonomic diversity can fully account for patterns of functional diversity, highlighting the need for examining different dimensions of biodiversity of bats in hyperdiverse ecosystems.	[Aguirre, Luis F.] Univ Mayor San Simon, Ctr Biodiversidad & Genet, Cochabamba, Bolivia; [Montano-Centellas, Flavia A.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA; [Mercedes Gavilanez, M.] Univ Cent Ecuador, Fac Ciencias Med, Escuela Ciencias Biol & Ambientales, Quito, Ecuador; [Stevens, Richard D.] Dept Nat Resources Management, Lubbock, TX USA; [Stevens, Richard D.] Texas Tech Univ Museum, Lubbock, TX 79409 USA	State University System of Florida; University of Florida; Universidad Central del Ecuador; Texas Tech University System; Texas Tech University	Montano-Centellas, FA (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA.	flamontano@ufl.edu	Aguirre, Luis F./AAE-9255-2019; Montaño-Centellas, Flavia/K-8046-2019	Aguirre, Luis F./0000-0002-4194-1523; Montaño-Centellas, Flavia/0000-0003-3115-3950				Acosta LH, 2006, INVENTARIACION HIST; Aguirre LF, 2003, J TROP ECOL, V19, P367, DOI [10.1017/S0266467403003419, 10.1017/s0266467403003419]; Aguirre LF, 2002, J MAMMAL, V83, P775, DOI 10.1644/1545-1542(2002)083<0775:SOANSB>2.0.CO;2; [Anonymous], 2007, HIST NATURAL DISTRIB; [Anonymous], PACKAGE HIER PART R; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Cardoso P, 2015, METHODS ECOL EVOL, V6, P232, DOI 10.1111/2041-210X.12310; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; CHAO A, 1984, SCAND J STAT, V11, P265; Chen J, 2012, PACKAGE GUNIFRAC GEN; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Cisneros LM, 2015, DIVERS DISTRIB, V21, P523, DOI 10.1111/ddi.12277; Cisneros LM, 2014, J ANIM ECOL, V83, P1124, DOI 10.1111/1365-2656.12201; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; De la Riva I, 2014, HERPETOL MONOGR, V28, P46, DOI 10.1655/HERPMONOGRAPHS-D-13-00009; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Dreiss LM, 2015, ECOGRAPHY, V38, P876, DOI 10.1111/ecog.00971; Emmons Louise, 2006, Revista Boliviana de Ecologia y Conservacion Ambiental, V19, P47; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Flores-Saldaña Mónica Gabriela, 2008, Mastozool. neotrop., V15, P309; Gaston K., 2008, PATTERN PROCESS MACR; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Goslee SC, 2010, PLANT ECOL, V206, P279, DOI 10.1007/s11258-009-9641-0; Ibisch PL, 2003, ECORREGIONES ECOSIST, P47; Moya M. Isabel, 2008, Mastozool. neotrop., V15, P349; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; Kalko EKV, 2001, PLANT ECOL, V153, P319, DOI 10.1023/A:1017590007861; Kalko Elisabeth K. V., 1997, P13; Kattan GH, 2004, GLOBAL ECOL BIOGEOGR, V13, P451, DOI 10.1111/j.1466-822X.2004.00117.x; Kaufman L., 1990, FINDING GROUPS DATA, DOI 10.1002/9780470316801; Kunz TH, 2009, ECOLOGICAL BEHAV MET; Legendre P, 2014, GLOBAL ECOL BIOGEOGR, V23, P1324, DOI 10.1111/geb.12207; Maechler M., 2015, PACKAGE CLUSTER FIND; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; R Development Core Team, 2014, R LANG ENV STAT COMP; RALPH CJ, 2004, MONITORING BIRD POPU; Sampaio EM, 2003, STUD NEOTROP FAUNA E, V38, P17, DOI 10.1076/snfe.38.1.17.14035; Scatena F.N., 2011, TROPICAL MONTANE CLO; Selaya AP, 2010, REV BOLIVIANA ECOLOG, V27, P25; Siles L, 2006, REV ELECT MANEJO FAU, P101; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stevens RD, 2015, ECOGRAPHY, V38, P861, DOI 10.1111/ecog.00847; Stevens RD, 2014, GLOBAL ECOL BIOGEOGR, V23, P1115, DOI 10.1111/geb.12192; Stevens RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056853; Stocks G, 2008, BIOTROPICA, V40, P397, DOI 10.1111/j.1744-7429.2007.00393.x; Swenson NG, 2011, AM J BOT, V98, P472, DOI 10.3732/ajb.1000289; Teran M., 2004, ESTRUCTURA COMP ENSA; Vargas A., 2000, ESTRUCTURA COMUNIDAD; Vargas Espinoza Aideé, 2008, Mastozool. neotrop., V15, P297; Velazco PM, 2013, MOL PHYLOGENET EVOL, V68, P683, DOI 10.1016/j.ympev.2013.04.016; Whitehurst AS, 2013, REMOTE SENS-BASEL, V5, P2014, DOI 10.3390/rs5042014; Willig MR, 2016, J TROP ECOL, V32, P421, DOI 10.1017/S0266467415000589; Wilson D. E., 2005, MAMMAL SPECIES WORLD	59	16	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158170	10.1371/journal.pone.0158170	http://dx.doi.org/10.1371/journal.pone.0158170			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384441	Green Submitted, Green Published, gold			2022-12-26	WOS:000379809400036
J	Fabre-Nys, C; Chanvallon, A; Dupont, J; Lardic, L; Lomet, D; Martinet, S; Scaramuzzi, RJ				Fabre-Nys, Claude; Chanvallon, Audrey; Dupont, Joelle; Lardic, Lionel; Lomet, Didier; Martinet, Stephanie; Scaramuzzi, Rex J.			The "Ram Effect": A "Non-Classical" Mechanism for Inducing LH Surges in Sheep	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; PLASMA LUTEINIZING-HORMONE; ILE-DE-FRANCE; ESTROUS-CYCLE; PREOPTIC AREA; TYROSINE-HYDROXYLASE; NORADRENERGIC PROJECTIONS; PROGESTERONE SECRETION; OVARIECTOMIZED EWES; ANOVULATORY EWES	During spring sheep do not normally ovulate but exposure to a ram can induce ovulation. In some ewes an LH surge is induced immediately after exposure to a ram thus raising questions about the control of this precocious LH surge. Our first aim was to determine the plasma concentrations of oestradiol (E2) E2 in anoestrous ewes before and after the "ram effect" in ewes that had a "precocious" LH surge (starting within 6 hours), a "normal" surge (between 6 and 28h) and "late" surge (not detected by 56h). In another experiment we tested if a small increase in circulating E2 could induce an LH surge in anoestrus ewes. The concentration of E2 significantly was not different at the time of ram introduction among ewes with the three types of LH surge. "Precocious" LH surges were not preceded by a large increase in E2 unlike "normal" surges and small elevations of circulating E2 alone were unable to induce LH surges. These results show that the "precocious" LH surge was not the result of E2 positive feedback. Our second aim was to test if noradrenaline (NA) is involved in the LH response to the "ram effect". Using double labelling for Fos and tyrosine hydroxylase (TH) we showed that exposure of anoestrous ewes to a ram induced a higher density of cells positive for both in the A1 nucleus and the Locus Coeruleus complex compared to unstimulated controls. Finally, the administration by retrodialysis into the preoptic area, of NA increased the proportion of ewes with an LH response to ram odor whereas treatment with the alpha 1 antagonist Prazosin decreased the LH pulse frequency and amplitude induced by a sexually active ram. Collectively these results suggest that in anoestrous ewes NA is involved in ram-induced LH secretion as observed in other induced ovulators.	[Fabre-Nys, Claude; Chanvallon, Audrey; Dupont, Joelle; Lardic, Lionel; Lomet, Didier; Martinet, Stephanie] Univ Tours, Inst Francais Cheval & Equitat, INRA, CNRS,UMR Physiol Reprod & Comportements 7247, F-37380 Nouzilly, France; [Scaramuzzi, Rex J.] Royal Vet Coll, Dept Comparat Biomed Sci, Hawkshead Lane South Mimms, London AL9 7TA, Herts, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Universite de Tours; University of London; University of London Royal Veterinary College	Fabre-Nys, C (corresponding author), Univ Tours, Inst Francais Cheval & Equitat, INRA, CNRS,UMR Physiol Reprod & Comportements 7247, F-37380 Nouzilly, France.	claude.fabre@tours.inra.fr			Region Centre (Durarep) [2008 00030333]; Region Centre (Durarep 2) [2011 00064290]; European Union Framework 6 funding program [MEXC-CT-2006-042499]; EU Marie Curie Chair of Excellence [MEXC-CT-2006-042499]; "Convention Industrielle de Formation par la Recherche"; "Association Nationale de la Recherche et de la Technologie"	Region Centre (Durarep)(Region Centre-Val de Loire); Region Centre (Durarep 2)(Region Centre-Val de Loire); European Union Framework 6 funding program; EU Marie Curie Chair of Excellence; "Convention Industrielle de Formation par la Recherche"; "Association Nationale de la Recherche et de la Technologie"(French National Research Agency (ANR))	The research was supported by Grants from the Region Centre (Durarep No 2008 00030333 & Durarep 2 No 2011 00064290) and the European Union Framework 6 funding program (MEXC-CT-2006-042499). RJS was the recipient of an EU Marie Curie Chair of Excellence (MEXC-CT-2006-042499). AC was recipient of a PhD grant funded by the "Convention Industrielle de Formation par la Recherche" between the "Centre Interregional d'Information et de Recherche en Production Ovine" and the "Association Nationale de la Recherche et de la Technologie".	Acosta-Martinez M, 1999, NEUROCHEM INT, V35, P383, DOI 10.1016/S0197-0186(99)00077-7; ADAMS CE, 1973, J REPROD FERTIL, V33, P527, DOI 10.1530/jrf.0.0330527; ADAMS CE, 1981, J REPROD FERTIL, V63, P241, DOI 10.1530/jrf.0.0630241; BAIRD DT, 1976, ENDOCRINOLOGY, V98, P1490, DOI 10.1210/endo-98-6-1490; Bakker J, 2000, FRONT NEUROENDOCRIN, V21, P220, DOI 10.1006/frne.2000.0198; BANKS JA, 1980, ENDOCRINOLOGY, V106, P1677, DOI 10.1210/endo-106-6-1677; BARRACLOUGH CA, 1982, ENDOCR REV, V3, P91, DOI 10.1210/edrv-3-1-91; BAUM MJ, 1990, J NEUROENDOCRINOL, V2, P401, DOI 10.1111/j.1365-2826.1990.tb00425.x; Ben Said S, 2007, BIOL REPROD, V76, P673, DOI 10.1095/biolreprod.106.057406; BROWNGRANT K, 1973, J ENDOCRINOL, V57, P7, DOI 10.1677/joe.0.0570007; CARATY A, 1995, ENDOCRINOLOGY, V136, P3452, DOI 10.1210/en.136.8.3452; CARATY A, 1989, J ENDOCRINOL, V123, P375, DOI 10.1677/joe.0.1230375; Chanvallon A, 2011, ANIMAL, V5, P1594, DOI 10.1017/S1751731111000668; Chanvallon A, 2009, BEHAV BRAIN RES, V205, P272, DOI 10.1016/j.bbr.2009.08.013; Clarke IJ, 2006, DOMEST ANIM ENDOCRIN, V30, P260, DOI 10.1016/j.domaniend.2005.07.006; CONAWAY CH, 1971, BIOL REPROD, V4, P239, DOI 10.1093/biolreprod/4.3.239; CORKER CS, 1969, NATURE, V222, P1063, DOI 10.1038/2221063a0; DAY JR, 1988, BIOL REPROD, V38, P1019, DOI 10.1095/biolreprod38.5.1019; DUFYBARBE L, 1978, BIOL REPROD, V18, P118, DOI 10.1095/biolreprod18.1.118; DYRMUNDSSON OR, 1972, J AGR SCI-CAMBRIDGE, V79, P269, DOI 10.1017/S002185960003224X; ELIAS E, 1984, GEN COMP ENDOCR, V56, P258, DOI 10.1016/0016-6480(84)90039-X; Etgen AM, 2002, J NEUROENDOCRINOL, V14, P213, DOI 10.1046/j.0007-1331.2001.00764.x; Evans NP, 1997, ENDOCRINOLOGY, V138, P5408, DOI 10.1210/en.138.12.5408; Fabre-Nys C, 1991, NEUROENDOCRINE RES M, P295; Fabre-Nys C, 2015, NEUROREPORT, V26, P438, DOI 10.1097/WNR.0000000000000367; Fabre-Nys C, 2015, REPRODUCTION, V149, P511, DOI 10.1530/REP-14-0587; FabreNys C, 1997, EUR J NEUROSCI, V9, P1666, DOI 10.1111/j.1460-9568.1997.tb01524.x; Gelez H, 2006, NEUROSCIENCE, V140, P791, DOI 10.1016/j.neuroscience.2006.02.066; Gibson MJ, 1997, HORM BEHAV, V31, P212, DOI 10.1006/hbeh.1997.1387; GOODMAN AL, 1976, ENDOCRINOLOGY, V99, P852, DOI 10.1210/endo-99-3-852; Goodman R. L., 1994, PHYSL REPRODUCTION, P1919; GOODMAN RL, 1981, J ENDOCRINOL, V89, P229, DOI 10.1677/joe.0.0890229; Goodman RL, 2002, REPRODUCTION, P41; GOODMAN RL, 1980, BIOL REPROD, V23, P415, DOI 10.1095/biolreprod23.2.415; Gore A, 2001, J NEUROENDOCRINOL, V13, P239, DOI 10.1046/j.1365-2826.2001.00618.x; HARDY DF, 1970, PHYSIOL BEHAV, V5, P421, DOI 10.1016/0031-9384(70)90246-5; HAUGER RL, 1977, ENDOCRINOLOGY, V101, P807, DOI 10.1210/endo-101-3-807; Herbison AE, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1415; JOCHLE W, 1975, J REPROD FERTIL, P165; KARSCH FJ, 1979, ENDOCRINOLOGY, V105, P421, DOI 10.1210/endo-105-2-421; Li Q, 2015, NEUROENDOCRINOLOGY, V101, P161, DOI 10.1159/000377702; LINDSAY DR, 1975, PHYSIOL BEHAV, V15, P423, DOI 10.1016/0031-9384(75)90208-5; Maeda K, 2010, BRAIN RES, V1364, P103, DOI 10.1016/j.brainres.2010.10.026; MARTIN GB, 1986, LIVEST PROD SCI, V15, P219, DOI 10.1016/0301-6226(86)90031-X; MAULEON P, 1965, ANN BIOL ANIM BIOCH, V5, P131, DOI 10.1051/rnd:19650109; MILLIGAN SR, 1978, J REPROD FERTIL, V54, P309, DOI 10.1530/jrf.0.0540309; MOENTER SM, 1990, ENDOCRINOLOGY, V127, P1375, DOI 10.1210/endo-127-3-1375; MONTGOMERY GW, 1985, J REPROD FERTIL, V73, P173, DOI 10.1530/jrf.0.0730173; Neill J.D., 1994, PHYSL REPROD, P585; OLDHAM CM, 1979, ANIM REPROD SCI, V1, P283, DOI 10.1016/0378-4320(79)90013-7; Papay R, 2006, J COMP NEUROL, V497, P209, DOI 10.1002/cne.20992; PEARCE DT, 1985, J REPROD FERTIL, V75, P79, DOI 10.1530/jrf.0.0750079; RANDEL RD, 1973, J ANIM SCI, V37, P128, DOI 10.2527/jas1973.371128x; Rawson JA, 2001, J NEUROENDOCRINOL, V13, P129, DOI 10.1046/j.1365-2826.2001.00588.x; Richard P., 1967, ATLAS STEREOTAXIQUE; SCARAMUZZI RJ, 1971, ENDOCRINOLOGY, V88, P1184, DOI 10.1210/endo-88-5-1184; SCOTT CJ, 1992, J NEUROENDOCRINOL, V4, P131, DOI 10.1111/j.1365-2826.1992.tb00356.x; SIGNORET JP, 1980, REPROD NUTR DEV, V20, P457, DOI 10.1051/rnd:19800305; SIGNORET JP, 1975, J ENDOCRINOL, V64, P589, DOI 10.1677/joe.0.0640589; Signoret JP, J REPROD FERT, V31, P327; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219, DOI 10.1210/endo-96-1-219; Spies HG, 1997, BIOL REPROD, V56, P310, DOI 10.1095/biolreprod56.2.310; Szawka RE, 2013, ENDOCRINOLOGY, V154, P363, DOI 10.1210/en.2012-1302; TILLET Y, 1989, J COMP NEUROL, V290, P69, DOI 10.1002/cne.902900106; TILLET Y, 1993, J COMP NEUROL, V330, P195, DOI 10.1002/cne.903300205; Ungerfeld R, 2007, Soc Reprod Fertil Suppl, V64, P207; WEICK RF, 1973, ENDOCRINOLOGY, V93, P1140; Wersinger SR, 1997, BIOL REPROD, V56, P1407, DOI 10.1095/biolreprod56.6.1407; WILDT DE, 1981, BIOL REPROD, V25, P15, DOI 10.1095/biolreprod25.1.15; WRIGHT DE, 1993, BRAIN RES, V621, P272, DOI 10.1016/0006-8993(93)90116-5; WU CH, 1977, BIOL REPROD, V17, P304, DOI 10.1095/biolreprod17.2.304; XIA L, 1992, ENDOCRINOLOGY, V131, P2812, DOI 10.1210/en.131.6.2812; Yamada S, 2006, J REPROD DEVELOP, V52, P115, DOI 10.1262/jrd.17071; Yang SP, 1998, P SOC EXP BIOL MED, V218, P204, DOI 10.3181/00379727-218-44287; Yang SP, 1997, J MOL ENDOCRINOL, V19, P311, DOI 10.1677/jme.0.0190311; Yang SP, 1996, ENDOCRINOLOGY, V137, P2683, DOI 10.1210/en.137.7.2683; ZARROW MX, 1968, J ENDOCRINOL, V40, P343, DOI 10.1677/joe.0.0400343	77	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158530	10.1371/journal.pone.0158530	http://dx.doi.org/10.1371/journal.pone.0158530			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384667	Green Published, gold, Green Submitted			2022-12-26	WOS:000379809400057
J	Schrapers, P; Mebs, S; Goetzl, S; Hennig, SE; Dau, H; Dobbek, H; Haumann, M				Schrapers, Peer; Mebs, Stefan; Goetzl, Sebastian; Hennig, Sandra E.; Dau, Holger; Dobbek, Holger; Haumann, Michael			Axial Ligation and Redox Changes at the Cobalt Ion in Cobalamin Bound to Corrinoid Iron-Sulfur Protein (CoFeSP) or in Solution Characterized by XAS and DFT	PLOS ONE			English	Article							RAY-ABSORPTION SPECTROSCOPY; WOOD-LJUNGDAHL PATHWAY; ACETYL-COA SYNTHESIS; X-RAY; CLOSTRIDIUM-THERMOACETICUM; ELECTRONIC-STRUCTURE; METAL CENTERS; REDUCTIVE ACTIVATION; MANGANESE COMPLEX; B-12 COFACTORS	A cobalamin (Cbl) cofactor in corrinoid iron-sulfur protein (CoFeSP) is the primary methyl group donor and acceptor in biological carbon oxide conversion along the reductive acetylCoA pathway. Changes of the axial coordination of the cobalt ion within the corrin macrocycle upon redox transitions in aqua-, methyl-, and cyano-Cbl bound to CoFeSP or in solution were studied using X-ray absorption spectroscopy (XAS) at the Co K-edge in combination with density functional theory (DFT) calculations, supported by metal content and cobalt redox level quantification with further spectroscopic methods. Calculation of the highly variable pre-edge X-ray absorption features due to core-to-valence (ctv) electronic transitions, XANES shape analysis, and cobalt-ligand bond lengths determination from EXAFS has yielded models for the molecular and electronic structures of the cobalt sites. This suggested the absence of a ligand at cobalt in CoFeSP in a-position where the dimethylbenzimidazole (dmb) base of the cofactor is bound in Cbl in solution. As main species, (dmb) Co-III(OH2), (dmb) Co-II(OH2), and (dmb) Co-III(CH3) sites for solution Cbl and Co-III(OH2), Co-II(OH2), and Co-III(CH3) sites in CoFeSP-Cbl were identified. Our data support binding of a serine residue from the reductive-activator protein (RACo) of CoFeSP to the cobalt ion in the CoFeSP-RACo protein complex that stabilizes Co(II). The absence of an alpha-ligand at cobalt not only tunes the redox potential of the cobalamin cofactor into the physiological range, but is also important for CoFeSP reactivation.	[Schrapers, Peer; Mebs, Stefan; Dau, Holger; Haumann, Michael] Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany; [Goetzl, Sebastian; Hennig, Sandra E.; Dobbek, Holger] Humboldt Univ, Dept Biol, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin	Haumann, M (corresponding author), Free Univ Berlin, Dept Phys, D-14195 Berlin, Germany.	michael.haumann@fu-berlin.de	MIchael, Haumann/A-7087-2013	Dau, Holger/0000-0001-6482-7494	Deutsche Forschungsgemeinschaft [Ha3265/2-1, Ha3265/6-1, Do785/5-2]; Deutsche Forschungsgemeinschaft, Berlin Cluster of Excellence "Unifying Concepts in Catalysis-UniCat" [EXC 314]; Bundesministerium fur Bildung und Forschung [05K14KE1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft, Berlin Cluster of Excellence "Unifying Concepts in Catalysis-UniCat"; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de/), Berlin Cluster of Excellence "Unifying Concepts in Catalysis-UniCat" (EXC 314), to HDo and HDa; Deutsche Forschungsgemeinschaft (http://www.dfg.de/), grants Ha3265/2-1 and Ha3265/6-1 and Bundesministerium fur Bildung und Forschung (http://pt.desy.de/), grant 05K14KE1, to MH; and Deutsche Forschungsgemeinschaft (http://www.dfg.de/), grant Do785/5-2, to HDo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES RH, 1976, ACCOUNTS CHEM RES, V9, P114, DOI 10.1021/ar50099a006; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; Bender G, 2011, METALLOMICS, V3, P797, DOI 10.1039/c1mt00042j; Bengelsdorf FR, 2013, ENVIRON TECHNOL, V34, P1639, DOI 10.1080/09593330.2013.827747; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown KL, 2005, CHEM REV, V105, P2075, DOI 10.1021/cr030720z; Brown KL, 1997, INORG CHEM, V36, P3666, DOI 10.1021/ic9615077; Champloy F, 2000, J SYNCHROTRON RADIAT, V7, P267, DOI 10.1107/S0909049500006336; Chandrasekaran P, 2013, INORG CHEM, V52, P6286, DOI 10.1021/ic3021723; Chandrasekaran P, 2011, DALTON T, V40, P11070, DOI 10.1039/c1dt11331c; Chernev P, 2014, INORG CHEM, V53, P12164, DOI 10.1021/ic502047q; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; Dereven'kov IA, 2016, COORDIN CHEM REV, V309, P68, DOI 10.1016/j.ccr.2015.11.001; Dittrich B, 2007, ANGEW CHEM INT EDIT, V46, P2935, DOI 10.1002/anie.200603901; Frisch G. W., 2013, GAUSSIAN 09; George SD, 2008, J PHYS CHEM A, V112, P12936, DOI 10.1021/jp803174m; Gherasim C, 2013, J BIOL CHEM, V288, P13186, DOI 10.1074/jbc.R113.458810; Giedyk M, 2015, CHEM SOC REV, V44, P3391, DOI 10.1039/c5cs00165j; Giorgetti M, 2000, J BIOL INORG CHEM, V5, P156, DOI 10.1007/s007750050360; Glendening E. D., 2004, NBO 5; Goetzl S, 2011, J MOL BIOL, V411, P96, DOI 10.1016/j.jmb.2011.05.025; HARDER SR, 1989, BIOCHEMISTRY-US, V28, P9080, DOI 10.1021/bi00449a019; Hennig SE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5626; Hennig SE, 2012, P NATL ACAD SCI USA, V109, P5235, DOI 10.1073/pnas.1117126109; Herrmann Wolfgang, 2012, Subcell Biochem, V56, P301, DOI 10.1007/978-94-007-2199-9_16; JABLONSKI PE, 1993, J BIOL CHEM, V268, P325; Jensen KP, 2009, COORDIN CHEM REV, V253, P769, DOI 10.1016/j.ccr.2008.04.015; Jeoung JH, 2014, BIOL CHEM, V395, P545, DOI 10.1515/hsz-2013-0290; Klementiev KV, XANES DACTYLOSCOPE F; Klockenkamper R, 1996, TOTAL REFLECTION X R; Koningsberger D.C., 1988, X RAY ABSORPTION PRI; Koningsberger DC, 2000, TOP CATAL, V10, P143, DOI 10.1023/A:1019105310221; Kratky C., 1999, Chemistry and biochemistry of B12., P9; Krautler B, 2005, BIOCHEM SOC T, V33, P806; KRAUTLER B, 1994, INORG CHEM, V33, P4128; Krewald V, 2015, CHEM SCI, V6, P1676, DOI 10.1039/c4sc03720k; Kung Y, 2012, NATURE, V484, P265, DOI 10.1038/nature10916; Lambertz C, 2014, CHEM SCI, V5, P1187, DOI 10.1039/c3sc52703d; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Leidel N, 2012, J AM CHEM SOC, V134, P14142, DOI 10.1021/ja304970p; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; LINDAHL PA, 1990, J BIOL CHEM, V265, P3873; Matthews RG, 2008, CURR OPIN STRUC BIOL, V18, P658, DOI 10.1016/j.sbi.2008.11.005; Mebs S, 2009, J PHYS CHEM A, V113, P8366, DOI 10.1021/jp902433x; Meister W, 2012, BIOCHEMISTRY-US, V51, P7040, DOI 10.1021/bi300795n; Menon S, 1998, BIOCHEMISTRY-US, V37, P5689, DOI 10.1021/bi9727996; Neese F, 2008, ORCA AN AB INITIO DF; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; Ragsdale SW, 2008, ANN NY ACAD SCI, V1125, P129, DOI 10.1196/annals.1419.015; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; Rehr JJ, 2010, PHYS CHEM CHEM PHYS, V12, P5503, DOI 10.1039/b926434e; ROSSI M, 1985, J AM CHEM SOC, V107, P1729, DOI 10.1021/ja00292a046; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHEURING EM, 1994, BIOCHEMISTRY-US, V33, P6310, DOI 10.1021/bi00186a034; Scheuring EM, 1996, J PHYS CHEM-US, V100, P3344, DOI 10.1021/jp943066n; Seravalli J, 1999, BIOCHEMISTRY-US, V38, P5728, DOI 10.1021/bi982473c; Stich TA, 2006, J AM CHEM SOC, V128, P5010, DOI 10.1021/ja054690o; Stich TA, 2003, J AM CHEM SOC, V125, P5897, DOI 10.1021/ja029328d; Svetlitchnaia T, 2006, P NATL ACAD SCI USA, V103, P14331, DOI 10.1073/pnas.0601420103; Tomson NC, 2015, CHEM SCI, V6, P2474, DOI 10.1039/c4sc03294b; WIRT MD, 1995, BIOCHEMISTRY-US, V34, P5269, DOI 10.1021/bi00015a042; WIRT MD, 1993, J INORG BIOCHEM, V49, P265, DOI 10.1016/0162-0134(93)80062-E; YACHANDRA VK, 1995, METHOD ENZYMOL, V246, P638	67	17	17	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158681	10.1371/journal.pone.0158681	http://dx.doi.org/10.1371/journal.pone.0158681			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384529	Green Submitted, gold, Green Published			2022-12-26	WOS:000379809400075
J	Schuler, MH; Di Bartolomeo, F; Martensson, CU; Daum, G; Becker, T				Schuler, Max-Hinderk; Di Bartolomeo, Francesca; Martensson, Christoph U.; Daum, Guenther; Becker, Thomas			Phosphatidylcholine Affects Inner Membrane Protein Translocases of Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; PHOSPHATIDYLETHANOLAMINE METHYLATION PATHWAY; RESPIRATORY-CHAIN SUPERCOMPLEXES; YEAST SACCHAROMYCES-CEREVISIAE; OUTER-MEMBRANE; PHOSPHATIDYLSERINE DECARBOXYLASE; CONTACT SITES; PRESEQUENCE TRANSLOCASE; MAMMALIAN MITOCHONDRIA; PREPROTEIN TRANSLOCASE	Two protein translocases transport precursor proteins into or across the inner mitochondrial membrane. The presequence translocase (TIM23 complex) sorts precursor proteins with a cleavable presequence either into the matrix or into the inner membrane. The carrier translocase (TIM22 complex) inserts multispanning proteins into the inner membrane. Both protein import pathways depend on the presence of a membrane potential, which is generated by the activity of the respiratory chain. The non-bilayer-forming phospholipids cardiolipin and phosphatidylethanolamine are required for the activity of the respiratory chain and therefore to maintain the membrane potential for protein import. Depletion of cardiolipin further affects the stability of the TIM23 complex. The role of bilayer-forming phospholipids like phosphatidylcholine (PC) in protein transport into the inner membrane and the matrix is unknown. Here, we report that import of presequence-containing precursors and carrier proteins is impaired in PC-deficient mitochondria. Surprisingly, depletion of PC does not affect stability and activity of respiratory supercomplexes, and the membrane potential is maintained. Instead, the dynamic TIM23 complex is destabilized when the PC levels are reduced, whereas the TIM22 complex remains intact. Our analysis further revealed that initial precursor binding to the TIM23 complex is impaired in PC-deficient mitochondria. We conclude that reduced PC levels differentially affect the TIM22 and TIM23 complexes in mitochondrial protein transport.	[Schuler, Max-Hinderk; Martensson, Christoph U.; Becker, Thomas] Univ Freiburg, Fac Med, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany; [Martensson, Christoph U.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Becker, Thomas] Univ Freiburg, BIGSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Di Bartolomeo, Francesca; Daum, Guenther] Graz Univ Technol, Inst Biochem, NaWi Graz, A-8010 Graz, Austria; [Daum, Guenther] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	University of Freiburg; University of Freiburg; University of Freiburg; Graz University of Technology; Utah System of Higher Education; University of Utah	Becker, T (corresponding author), Univ Freiburg, Fac Med, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.becker@biochemie.uni-freiburg.de	Schuler, Max-Hinderk/AAZ-8376-2021; Schuler, Max-Hinderk/AAZ-8388-2021	Schuler, Max-Hinderk/0000-0002-6734-8250; Di Bartolomeo, Francesca/0000-0002-4302-0701	Deutsche Forschungsgemeinschaft [BE4679/2-1, Sonderforschungsbereich 746]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]; Austrian Science Fund Project [P-26133]; Austrian Science Fund (FWF) [P 26133] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Austrian Science Fund Project(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Deutsche Forschungsgemeinschaft Grant BE4679/2-1, Sonderforschungsbereich 746 and the Excellence Initiative of the German Federal and State Governments EXC 294 BIOSS, and by the Austrian Science Fund Project P-26133 (to G. D.). The authors declare that they have no conflicts of interest with the contents of this article.	Baker CD, 2016, MOL BIOL CELL, V27, P2161, DOI 10.1091/mbc.E15-12-0865; Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Becker T, 2013, J BIOL CHEM, V288, P16451, DOI 10.1074/jbc.M112.442392; Becker T, 2012, TRENDS BIOCHEM SCI, V37, P85, DOI 10.1016/j.tibs.2011.11.004; Bottinger L, 2016, J BIOENERG BIOMEMBR, V48, P125, DOI 10.1007/s10863-015-9599-7; Bottinger L, 2013, MOL BIOL CELL, V24, P2609, DOI 10.1091/mbc.E13-02-0106; Bottinger L, 2012, J MOL BIOL, V423, P677, DOI 10.1016/j.jmb.2012.09.001; Bornhovd C, 2006, J BIOL CHEM, V281, P13990, DOI 10.1074/jbc.M512334200; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Chacinska A, 2003, EMBO J, V22, P5370, DOI 10.1093/emboj/cdg532; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; CLANCEY CJ, 1993, J BIOL CHEM, V268, P24580; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Cole LK, 2012, BBA-MOL CELL BIOL L, V1821, P754, DOI 10.1016/j.bbalip.2011.09.009; Cruciat CM, 2000, J BIOL CHEM, V275, P18093, DOI 10.1074/jbc.M001901200; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Dimmer KS, 2012, BBA-BIOMEMBRANES, V1818, P1085, DOI 10.1016/j.bbamem.2011.08.027; Endo T, 2011, BBA-BIOMEMBRANES, V1808, P955, DOI 10.1016/j.bbamem.2010.07.018; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gallas MR, 2006, MOL BIOL CELL, V17, P4051, DOI 10.1091/mbc.E06-04-0366; GAYNOR PM, 1990, BIOCHIM BIOPHYS ACTA, V1045, P156, DOI 10.1016/0005-2760(90)90145-N; Gebert M, 2012, J CELL BIOL, V197, P595, DOI 10.1083/jcb.201110047; Gebert N, 2011, MOL CELL, V44, P811, DOI 10.1016/j.molcel.2011.09.025; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; GREENBERG ML, 1983, J BACTERIOL, V153, P791, DOI 10.1128/JB.153.2.791-799.1983; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Horvath SE, 2013, PROG LIPID RES, V52, P590, DOI 10.1016/j.plipres.2013.07.002; Horvath SE, 2012, J BIOL CHEM, V287, P36744, DOI 10.1074/jbc.M112.398107; Ieva R, 2014, MOL CELL, V56, P641, DOI 10.1016/j.molcel.2014.10.010; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; Kerscher O, 2000, MOL BIOL CELL, V11, P103, DOI 10.1091/mbc.11.1.103; Kerscher O, 1997, J CELL BIOL, V139, P1663, DOI 10.1083/jcb.139.7.1663; KODAKI T, 1987, J BIOL CHEM, V262, P15428; KODAKI T, 1989, EUR J BIOCHEM, V185, P243, DOI 10.1111/j.1432-1033.1989.tb15109.x; Koehler CM, 2000, MOL CELL BIOL, V20, P1187, DOI 10.1128/MCB.20.4.1187-1193.2000; Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369; Kovermann P, 2002, MOL CELL, V9, P363, DOI 10.1016/S1097-2765(02)00446-X; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Marom M, 2011, BBA-BIOMEMBRANES, V1808, P990, DOI 10.1016/j.bbamem.2010.07.011; Martinez-Caballero S, 2007, J BIOL CHEM, V282, P3584, DOI 10.1074/jbc.M607551200; Meisinger C, 2004, DEV CELL, V7, P61, DOI 10.1016/j.devcel.2004.06.003; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mokranjac D, 2005, J BIOL CHEM, V280, P23437, DOI 10.1074/jbc.C500135200; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; NUNNARI J, 1993, SCIENCE, V262, P1997, DOI 10.1126/science.8266095; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Peixoto PMV, 2007, J BIOL CHEM, V282, P18694, DOI 10.1074/jbc.M700775200; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; PREITSCHOPF W, 1993, CURR GENET, V23, P95, DOI 10.1007/BF00352006; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Sauerwald J, 2015, MOL CELL BIOL, V35, P3200, DOI 10.1128/MCB.00107-15; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schneiter Roger, 2006, Methods Mol Biol, V313, P75; Schuler MH, 2015, J BIOL CHEM, V290, P26523, DOI 10.1074/jbc.M115.687921; Schulz C, 2015, TRENDS CELL BIOL, V25, P265, DOI 10.1016/j.tcb.2014.12.001; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136; Song JY, 2014, EMBO REP, V15, P670, DOI 10.1002/embr.201338142; SPERKAGOTTLIEB CDM, 1988, BIOCHIM BIOPHYS ACTA, V946, P227, DOI 10.1016/0005-2736(88)90397-5; SUMMERS EF, 1988, GENETICS, V120, P909; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Tamura Y, 2014, TRAFFIC, V15, P933, DOI 10.1111/tra.12188; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Truscott KN, 2001, NAT STRUCT BIOL, V8, P1074, DOI 10.1038/nsb726; van der Laan M, 2007, NAT CELL BIOL, V9, P1152, DOI 10.1038/ncb1635; Waegemann K, 2015, J MOL BIOL, V427, P1075, DOI 10.1016/j.jmb.2014.07.015; Wagner K, 2010, MOL BIOL CELL, V21, P1494, DOI 10.1091/mbc.E09-12-1023; Wenz LS, 2015, J CELL BIOL, V210, P1047, DOI 10.1083/jcb.201504119; Wenz LS, 2014, EMBO REP, V15, P678, DOI 10.1002/embr.201338144; Wenz T, 2009, BBA-BIOENERGETICS, V1787, P609, DOI 10.1016/j.bbabio.2009.02.012; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yamano K, 2010, EMBO REP, V11, P187, DOI 10.1038/embor.2009.283; Ye CQ, 2016, J BIOENERG BIOMEMBR, V48, P113, DOI 10.1007/s10863-014-9591-7; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991	97	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2016	291	36					18718	18729		10.1074/jbc.M116.722694	http://dx.doi.org/10.1074/jbc.M116.722694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EG	27402832	Green Published, hybrid			2022-12-26	WOS:000383242300010
J	Gregg, CM; Goetzl, S; Jeoung, JH; Dobbek, H				Gregg, Christina M.; Goetzl, Sebastian; Jeoung, Jae-Hun; Dobbek, Holger			AcsF Catalyzes the ATP-dependent Insertion of Nickel into the Ni,Ni-[4Fe4S] Cluster of Acetyl-CoA Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; biosynthesis; iron-sulfur protein; metal ion-protein interaction; metalloenzyme; nickel	CARBON-MONOXIDE DEHYDROGENASE; MULTIENZYME COMPLEX; CFD1-NBP35 COMPLEX; PROTEIN FAMILIES; BIOSYNTHESIS; BINDING; SUBUNIT; METALLOPROTEINS; CLASSIFICATION; MUTAGENESIS	Acetyl-CoA synthase (ACS) catalyzes the reversible condensation of CO, CoA, and a methyl-cation to form acetyl-CoA at a unique Ni,Ni-[4Fe4S] cluster (the A-cluster). However, it was unknown which proteins support the assembly of the A-cluster. We analyzed the product of a gene from the cluster containing the ACS gene, cooC2 from Carboxydothermus hydrogenoformans, named AcsF(Ch), and showed that it acts as a maturation factor of ACS. AcsF(Ch) and inactive ACS form a stable 2:1 complex that binds two nickel ions with higher affinity than the individual components. The nickel-bound ACS-AcsF(Ch) complex remains inactive until MgATP is added, thereby converting inactive to active ACS. AcsF(Ch) is a MinD-type ATPase and belongs to the CooC protein family, which can be divided into homologous subgroups. We propose that proteins of one subgroup are responsible for assembling the Ni,Ni-[4Fe4S] cluster of ACS, whereas proteins of a second subgroup mature the [Ni4Fe4S] cluster of carbon monoxide dehydrogenases.	[Gregg, Christina M.; Goetzl, Sebastian; Jeoung, Jae-Hun; Dobbek, Holger] Humboldt Univ, Inst Biol, Strukturbiol Biochem, Unter den Linden 6, D-10099 Berlin, Germany	Humboldt University of Berlin	Dobbek, H (corresponding author), Humboldt Univ, Inst Biol, Strukturbiol Biochem, Unter den Linden 6, D-10099 Berlin, Germany.	Holger.Dobbek@biologie.hu-berlin.de		Gregg, Christina/0000-0003-4440-4624	Deutsche Forschungsgemeinschaft [DO 785/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by Deutsche Forschungsgemeinschaft Project Grant DO 785/6-1. The authors declare that they have no conflicts of interest with the contents of this article.	Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Bange G, 2013, NAT STRUCT MOL BIOL, V20, P776, DOI 10.1038/nsmb.2605; Bender G, 2011, METALLOMICS, V3, P797, DOI 10.1039/c1mt00042j; Boer JL, 2014, ARCH BIOCHEM BIOPHYS, V544, P142, DOI 10.1016/j.abb.2013.09.002; Boer JL, 2010, BIOCHEMISTRY-US, V49, P5859, DOI 10.1021/bi1004987; Can M, 2014, CHEM REV, V114, P4149, DOI 10.1021/cr400461p; Chung KCC, 2011, FEBS LETT, V585, P291, DOI 10.1016/j.febslet.2010.12.024; Darnault C, 2003, NAT STRUCT BIOL, V10, P271, DOI 10.1038/nsb912; Demchak Barry, 2014, F1000Res, V3, P151, DOI 10.12688/f1000research.4492.2; Denny JA, 2015, CHEM REV, V115, P5248, DOI 10.1021/cr500659u; Dobbek H, 2001, SCIENCE, V293, P1281, DOI 10.1126/science.1061500; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; Drennan CL, 2001, P NATL ACAD SCI USA, V98, P11973, DOI 10.1073/pnas.211429998; Farrugia MA, 2013, J BIOL CHEM, V288, P13178, DOI 10.1074/jbc.R112.446526; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fong YH, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001678; Frazzon J, 2002, MET IONS BIOL SYST, V39, P163; Gencic S, 2003, J BIOL CHEM, V278, P6101, DOI 10.1074/jbc.M210484200; Gencic S, 2010, J BIOL CHEM, V285, P15450, DOI 10.1074/jbc.M109.080994; George SJ, 2005, J AM CHEM SOC, V127, P13500, DOI 10.1021/ja0528329; Hadj-Said J, 2015, BBA-BIOENERGETICS, V1847, P1574, DOI 10.1016/j.bbabio.2015.08.002; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Hu YL, 2013, BBA-BIOENERGETICS, V1827, P1112, DOI 10.1016/j.bbabio.2012.12.001; Inoue T, 2014, BIOSCI BIOTECH BIOCH, V78, P582, DOI 10.1080/09168451.2014.890027; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Jeoung JH, 2007, SCIENCE, V318, P1461, DOI 10.1126/science.1148481; Jeoung JH, 2014, METAL IONS LIFE SCI, V14, P37, DOI 10.1007/978-94-017-9269-1_3; Jeoung JH, 2010, J MOL BIOL, V396, P1165, DOI 10.1016/j.jmb.2009.12.062; Jeoung JH, 2009, BIOCHEMISTRY-US, V48, P11505, DOI 10.1021/bi901443z; Kaluarachchi H, 2010, NAT PROD REP, V27, P681, DOI 10.1039/b906688h; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kerby RL, 1997, J BACTERIOL, V179, P2259, DOI 10.1128/jb.179.7.2259-2266.1997; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Leach MR, 2007, CURR OPIN CHEM BIOL, V11, P159, DOI 10.1016/j.cbpa.2007.01.011; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Lindsley JE, 2000, METH MOL B, V95, P57; Loke HK, 2003, J INORG BIOCHEM, V93, P33, DOI 10.1016/S0162-0134(02)00457-9; Loke HK, 2002, J AM CHEM SOC, V124, P8667, DOI 10.1021/ja025924w; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Netz DJA, 2012, J BIOL CHEM, V287, P12365, DOI 10.1074/jbc.M111.328914; Ribbe MW, 2014, CHEM REV, V114, P4063, DOI 10.1021/cr400463x; Robertson WD, 2013, J BIOL INORG CHEM, V18, P701, DOI 10.1007/s00775-013-1015-3; Seravalli J, 2004, BIOCHEMISTRY-US, V43, P3944, DOI 10.1021/bi036194n; SHIN WS, 1992, BIOCHEMISTRY-US, V31, P12870, DOI 10.1021/bi00166a023; Soriano A, 1999, P NATL ACAD SCI USA, V96, P11140, DOI 10.1073/pnas.96.20.11140; Su Gang, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0813s47; Svetlitchnyi V, 2004, P NATL ACAD SCI USA, V101, P446, DOI 10.1073/pnas.0304262101; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; Waldron KJ, 2009, NAT REV MICROBIOL, V7, P25, DOI 10.1038/nrmicro2057; Watanabe S, 2012, BIOL CHEM, V393, P1089, DOI 10.1515/hsz-2012-0197; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Zamble DB, 2015, METALLOMICS, V7, P588, DOI 10.1039/c5mt90013a; ZEHNDER AJB, 1976, SCIENCE, V194, P1165, DOI 10.1126/science.793008; ZOU XA, 1995, INORG CHEM, V34, P1634, DOI 10.1021/ic00111a003	59	12	12	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18129	18138		10.1074/jbc.M116.731638	http://dx.doi.org/10.1074/jbc.M116.731638			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27382049	Green Published, hybrid			2022-12-26	WOS:000383241800007
J	Rezabkova, L; Kraatz, SHW; Akhmanova, A; Steinmetz, MO; Kammerer, RA				Rezabkova, Lenka; Kraatz, Sebastian H. W.; Akhmanova, Anna; Steinmetz, Michel O.; Kammerer, Richard A.			Biophysical and Structural Characterization of the Centriolar Protein Cep104 Interaction Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biophysics; centriole; cilia; circular dichroism (CD); x-ray crystallography; Cep104; TOG domain	PLUS-END TRACKING; TOG DOMAIN; SEDIMENTATION; XMAP215; PHENIX; CILIA; SIZE	Dysfunction of cilia is associated with common genetic disorders termed ciliopathies. Knowledge on the interaction networks of ciliary proteins is therefore key for understanding the processes that are underlying these severe diseases and the mechanisms of ciliogenesis in general. Cep104 has recently been identified as a key player in the regulation of cilia formation. Using a combination of sequence analysis, biophysics, and x-ray crystallography, we obtained new insights into the domain architecture and interaction network of the Cep104 protein. We solved the crystal structure of the tumor overexpressed gene (TOG) domain, identified Cep104 as a novel tubulin-binding protein, and biophysically characterized the interaction of Cep104 with CP110, Cep97, end-binding (EB) protein, and tubulin. Our results represent a solid platform for the further investigation of the microtubule-EB-Cep104-tubulin-CP110-Cep97 network of proteins. Ultimately, such studies should be of importance for understanding the process of cilia formation and the mechanisms underlying different ciliopathies.	[Rezabkova, Lenka; Kraatz, Sebastian H. W.; Steinmetz, Michel O.; Kammerer, Richard A.] Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Akhmanova, Anna] Univ Utrecht, Dept Biol, Fac Sci, Cell Biol, Padualaan 8, NL-3584 CH Utrecht, Netherlands	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Utrecht University	Kammerer, RA (corresponding author), Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, CH-5232 Villigen, Switzerland.	richard.kammerer@psi.ch	Rezabkova, Lenka/O-8229-2017; Steinmetz, Michel O/AAA-3349-2022	Rezabkova, Lenka/0000-0002-7274-8080; Steinmetz, Michel O/0000-0001-6157-3687; Kraatz, Sebastian/0000-0003-2265-9052; Kammerer, Richard/0000-0003-4570-5197	Swiss National Science Foundation [310030B_138659, 31003A_163449]; EMBO; Marie Curie IEF fellowship	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Marie Curie IEF fellowship(European Commission)	The work was supported in part by Swiss National Science Foundation Grants 310030B_138659 (to M. O. S.) and 31003A_163449 (to R. A. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by EMBO long-term and Marie Curie IEF fellowships.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreu Jose Manuel, 2007, Methods Mol Med, V137, P17, DOI 10.1007/978-1-59745-442-1_2; Ayaz P, 2014, ELIFE, V3, DOI 10.7554/eLife.03069; Ayaz P, 2012, SCIENCE, V337, P857, DOI 10.1126/science.1221698; Bhogaraju S, 2011, EMBO J, V30, P1907, DOI 10.1038/emboj.2011.110; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Das A, 2015, MOL BIOL CELL, V26, P4248, DOI 10.1091/mbc.E15-08-0603; De la Mora-Rey T, 2013, ACTA CRYSTALLOGR F, V69, P723, DOI 10.1107/S1744309113015182; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fox JC, 2014, MOL BIOL CELL, V25, P2375, DOI 10.1091/mbc.E13-08-0501; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Izawa Ichiro, 2015, Cilia, V4, P12, DOI 10.1186/s13630-015-0021-1; Jiang K, 2012, CURR BIOL, V22, P1800, DOI 10.1016/j.cub.2012.07.047; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keller S, 2012, ANAL CHEM, V84, P5066, DOI 10.1021/ac3007522; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Leano JB, 2013, STRUCTURE, V21, P939, DOI 10.1016/j.str.2013.04.018; Mahjoub MR, 2013, ORGANOGENESIS, V9, P61, DOI 10.4161/org.25144; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nachury MV, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0465; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Plotnikova OV, 2008, CANCER RES, V68, P2058, DOI 10.1158/0008-5472.CAN-07-5838; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Slep KC, 2009, BIOCHEM SOC T, V37, P1002, DOI 10.1042/BST0371002; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Srour M, 2015, AM J HUM GENET, V97, P744, DOI 10.1016/j.ajhg.2015.09.009; Tammana TVS, 2013, J CELL SCI, V126, P5018, DOI 10.1242/jcs.133439; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Zhao H., 2013, Curr. Protoc. Protein Sci., DOI [10.1002/0471140864.ps2012s71, DOI 10.1002/0471140864.PS2012S71]; Zhao HY, 2013, ANAL BIOCHEM, V437, P104, DOI 10.1016/j.ab.2013.02.011	38	21	21	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2016	291	35					18496	18504		10.1074/jbc.M116.739771	http://dx.doi.org/10.1074/jbc.M116.739771			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DV9EC	27402853	Green Published, hybrid			2022-12-26	WOS:000383241800039
J	Botting, N; Toseeb, U; Pickles, A; Durkin, K; Conti-Ramsden, G				Botting, Nicola; Toseeb, Umar; Pickles, Andrew; Durkin, Kevin; Conti-Ramsden, Gina			Depression and Anxiety Change from Adolescence to Adulthood in Individuals with and without Language Impairment	PLOS ONE			English	Article							FOLLOW-UP; PSYCHOSOCIAL OUTCOMES; EMOTIONAL HEALTH; CONTROL CHILDREN; YOUNG-PEOPLE; DISORDERS; HISTORY; LIFE; PREVALENCE; CHILDHOOD	This prospective longitudinal study aims to determine patterns and predictors of change in depression and anxiety from adolescence to adulthood in individuals with language impairment (LI). Individuals with LI originally recruited at age 7 years and a comparison group of age-matched peers (AMPs) were followed from adolescence (16 years) to adulthood (24 years). We determine patterns of change in depression and anxiety using the Child Manifest Anxiety Scale-Revised (CMAS-R) and Short Moods and Feelings Questionnaire (SMFQ). In addition to examining associations with gender, verbal and nonverbal skills, we use a time-varying variable to investigate relationships between depression and anxiety symptoms and transitions in educational/employment circumstances. The results show that anxiety was higher in participants with LI than age matched peers and remained so from adolescence to adulthood. Individuals with LI had higher levels of depression symptoms than did AMPs at 16 years. Levels in those with LI decreased post-compulsory schooling but rose again by 24 years of age. Those who left compulsory school provision (regardless of school type) for more choice-driven college but who were not in full-time employment or study by 24 years of age were more likely to show this depression pathway. Verbal and nonverbal skills were not predictive of this pattern of depression over time. The typical female vulnerability for depression and anxiety was observed for AMPs but not for individuals with LI. These findings have implications for service provision, career/employment advice and support for individuals with a history of LI during different transitions from adolescence to adulthood.	[Botting, Nicola] City Univ London, Language & Commun Sci, London, England; [Toseeb, Umar] Manchester Metropolitan Univ, Dept Psychol, Manchester, Lancs, England; [Pickles, Andrew] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Durkin, Kevin] Univ Strathclyde, Sch Psychol Sci & Hlth, Glasgow, Lanark, Scotland; [Conti-Ramsden, Gina] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England	City University London; Manchester Metropolitan University; University of London; King's College London; University of Strathclyde; University of Manchester	Conti-Ramsden, G (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	gina.conti-ramsden@manchester.ac.uk	Pickles, Andrew/A-9625-2011	Pickles, Andrew/0000-0003-1283-0346; Botting, Nicola/0000-0003-1082-9501; Toseeb, Umar/0000-0002-7536-2722	Economic and Social Research Council [RES-062-23-2745]; Nuffield Foundation [EDU-8366, EDU-32083]; Wellcome Trust [060774]; Medical Research Council [G0802307]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; ESRC [ES/I00064X/1] Funding Source: UKRI; MRC [MR/K005863/1, G0600555, G0401546, G0900678, G0802307, MR/J01348X/1, G0400065, G0500272] Funding Source: UKRI; Economic and Social Research Council [ES/I00064X/1] Funding Source: researchfish; Medical Research Council [G0400065, G0401546, G0900678, MR/J01348X/1, MR/K005863/1, G0600555, G0500272] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Nuffield Foundation; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London(General Electric); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Sources of funding for GCR are the Economic and Social Research Council (grant RES-062-23-2745), the Nuffield Foundation (EDU-8366 and EDU-32083), and the Wellcome Trust (060774). Sources of funding for AP are the Medical Research Council (G0802307) and the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, SPSS SURVIVAL GUIDE; Arkkila E, 2008, LOGOP PHONIATR VOCO, V33, P179, DOI 10.1080/14015430802088289; Beitchman JH, 1996, J CHILD PSYCHOL PSYC, V37, P961, DOI 10.1111/j.1469-7610.1996.tb01493.x; Beitchman JH, 2001, J AM ACAD CHILD PSY, V40, P75, DOI 10.1097/00004583-200101000-00019; Beitchman JH, 2014, J AM ACAD CHILD PSY, V53, P1102, DOI 10.1016/j.jaac.2014.07.006; Bishop DVM, 2012, CHILD LANG TEACH THE, V28, P259, DOI 10.1177/0265659012459467; Bishop DVM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015112; BISHOP DVM, 1987, J SPEECH HEAR DISORD, V52, P156, DOI 10.1044/jshd.5202.156; Botting N, 2005, J CHILD PSYCHOL PSYC, V46, P317, DOI 10.1111/j.1469-7610.2004.00355.x; Brownlie EB, 2004, J ABNORM CHILD PSYCH, V32, P453, DOI 10.1023/B:JACP.0000030297.91759.74; Butterworth P, 2012, SOC PSYCH PSYCH EPID, V47, P1013, DOI 10.1007/s00127-011-0409-1; Charman T, 2015, INT J LANG COMM DIS, V50, P84, DOI 10.1111/1460-6984.12116; Clegg J, 2005, J CHILD PSYCHOL PSYC, V46, P128, DOI 10.1111/j.1469-7610.2004.00342.x; Collishaw S, 2004, J CHILD PSYCHOL PSYC, V45, P1350, DOI 10.1111/j.1469-7610.2004.00335.x; Conti-Ramsden G, 1999, J SPEECH LANG HEAR R, V42, P1195, DOI 10.1044/jslhr.4205.1195; Conti-Ramsden G, 2008, J CHILD PSYCHOL PSYC, V49, P516, DOI 10.1111/j.1469-7610.2007.01858.x; Conti-Ramsden G, 2012, J SPEECH LANG HEAR R, V55, P1716, DOI 10.1044/1092-4388(2012/10-0182); Conti-Ramsden G, 2009, INT J LANG COMM DIS, V44, P15, DOI 10.1080/13682820801921601; ContiRamsden G, 1997, J SPEECH LANG HEAR R, V40, P765, DOI 10.1044/jslhr.4004.765; COSTELLO EJ, 1988, J AM ACAD CHILD PSY, V27, P726, DOI 10.1097/00004583-198811000-00011; Dolan P, 2008, J ECON PSYCHOL, V29, P94, DOI 10.1016/j.joep.2007.09.001; Durkin K, 2009, INT J LANG COMM DIS, V44, P36, DOI 10.1080/13682820801921510; Howlin P, 2005, AUTISM, V9, P533, DOI 10.1177/1362361305057871; Howlin P, 2000, J CHILD PSYCHOL PSYC, V41, P561, DOI 10.1017/S0021963099005806; Johnson CJ, 2010, AM J SPEECH-LANG PAT, V19, P51, DOI 10.1044/1058-0360(2009/08-0083); Lindsay G, 2012, LANG SPEECH HEAR SER, V43, P445, DOI 10.1044/0161-1461(2012/11-0069); Lindsay G, 2010, INT J LANG COMM DIS, V45, P561, DOI 10.3109/13682820903324910; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Mok PLH, 2014, J CHILD PSYCHOL PSYC, V55, P516, DOI 10.1111/jcpp.12190; Myers L, 2011, INT J LANG COMM DIS, V46, P739, DOI 10.1111/j.1460-6984.2011.00048.x; Quene H, 2004, SPEECH COMMUN, V43, P103, DOI 10.1016/j.specom 2004.02.004; REYNOLDS CR, 1978, J ABNORM CHILD PSYCH, V6, P271, DOI 10.1007/BF00919131; Semel E., 2006, CLIN EVALUATION LANG, V4th UK ed.; Semel EM, 1987, CLIN EVALUATION LANG; Snowling MJ, 2006, J CHILD PSYCHOL PSYC, V47, P759, DOI 10.1111/j.1469-7610.2006.01631.x; SPSS, 2014, IBM SPSS STAT WIND V; St Clair MC, 2011, J COMMUN DISORD, V44, P186, DOI 10.1016/j.jcomdis.2010.09.004; StataCorp, 2013, STATA STAT SOFTW REL; Stothard SE, 1998, J SPEECH LANG HEAR R, V41, P407, DOI 10.1044/jslhr.4102.407; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Tomblin JB, 1997, J SPEECH LANG HEAR R, V40, P1245, DOI 10.1044/jslhr.4006.1245; Toppelberg CO, 2000, J AM ACAD CHILD PSY, V39, P143, DOI 10.1097/00004583-200002000-00011; Wadman R, 2011, INT J LANG COMM DIS, V46, P641, DOI 10.1111/j.1460-6984.2011.00033.x; Wadman R, 2011, J ADOLESCENCE, V34, P421, DOI 10.1016/j.adolescence.2010.06.010; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1992, WECHSLER INTELLIGENC; Whitehouse AJO, 2009, INT J LANG COMM DIS, V44, P511, DOI 10.1080/13682820802708098; WOOD A, 1995, J CHILD PSYCHOL PSYC, V36, P327, DOI 10.1111/j.1469-7610.1995.tb01828.x; Yew SGK, 2013, J CHILD PSYCHOL PSYC, V54, P516, DOI 10.1111/jcpp.12009	49	20	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0156678	10.1371/journal.pone.0156678	http://dx.doi.org/10.1371/journal.pone.0156678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DQ9CO	27404489	Green Accepted, Green Published, gold			2022-12-26	WOS:000379508200001
J	Li, XY; Liu, NJ; You, LZ; Ke, XL; Liu, HJ; Huang, ML; Waddington, SR				Li, Xiaoyun; Liu, Nianjie; You, Liangzhi; Ke, Xinli; Liu, Haijun; Huang, Malan; Waddington, Stephen R.			Patterns of Cereal Yield Growth across China from 1980 to 2010 and Their Implications for Food Production and Food Security	PLOS ONE			English	Article							USE EFFICIENCY; WHEAT YIELD; TEMPERATURE; IMPACT; RICE	After a remarkable 86% increase in cereal production from 1980 to 2005, recent crop yield growth in China has been slow. County level crop production data between 1980 and 2010 from eastern and middle China were used to analyze spatial and temporal patterns of rice, wheat and maize yield in five major farming systems that include around 90% of China's cereal production. Site-specific yield trends were assessed in areas where those crops have experienced increasing yield or where yields have stagnated or declined. We find that rice yields have continued to increase on over 12.3 million hectares (m. ha) or 41.8% of the rice area in China between 1980 and 2010. However, yields stagnated on 50% of the rice area (around 14.7 m. ha) over this time period. Wheat yields increased on 13.8 m. ha (58.2% of the total harvest area), but stagnated on around 3.8 m. ha (15.8% of the harvest area). Yields increased on a smaller proportion of the maize area (17.7% of harvest area, 5.3 m. ha), while yields have stagnated on over 54% (16.3 m. ha). Many parts of the lowland rice and upland intensive sub-tropical farming systems were more prone to stagnation with rice, the upland intensive sub-tropical system with wheat, and maize in the temperate mixed system. Large areas where wheat yield continues to rise were found in the lowland rice and temperate mixed systems. Land and water constraints, climate variability, and other environmental limitations undermine increased crop yield and agricultural productivity in these systems and threaten future food security. Technology and policy innovations must be implemented to promote crop yields and the sustainable use of agricultural resources to maintain food security in China. In many production regions it is possible to better match the crop with input resources to raise crop yields and benefits. Investments may be especially useful to intensify production in areas where yields continue to improve. For example, increased support to maize production in southern China, where yields are still rising, seems justified.	[Li, Xiaoyun; Liu, Nianjie; You, Liangzhi; Huang, Malan] Huazhong Agr Univ, Coll Econ & Management, Wuhan 430070, Hubei, Peoples R China; [You, Liangzhi] IFPRI, 2033 K St NW, Washington, DC 20006 USA; [Ke, Xinli] Huazhong Agr Univ, Coll Land Management, Wuhan 430070, Hubei, Peoples R China; [Liu, Haijun] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Waddington, Stephen R.] Apartado Postal 4-205, Cuernavaca 62451, Morelos, Mexico	Huazhong Agricultural University; CGIAR; International Food Policy Research Institute (IFPRI); Huazhong Agricultural University; Huazhong Agricultural University	Li, XY (corresponding author), Huazhong Agr Univ, Coll Econ & Management, Wuhan 430070, Hubei, Peoples R China.	lixiaoyun@mail.hzau.edu.cn	Liu, Haijun/AFN-0017-2022	Liu, Haijun/0000-0001-7717-893X	Human Social Science Young Fund of the Ministry of Education of China [12YJC630105]; National Natural Science Foundation of China [71203073]; Fund for Modern Agricultural Industry Technology System [nycytx-35]	Human Social Science Young Fund of the Ministry of Education of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fund for Modern Agricultural Industry Technology System	This work was supported by the Human Social Science Young Fund of the Ministry of Education of China (No. 12YJC630105), the National Natural Science Foundation of China (No. 71203073) and Fund for Modern Agricultural Industry Technology System (No. nycytx-35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandratos N., 2012, 1203 ESA FAO, DOI DOI 10.1016/S0264-8377(03)00047-4; China Institute for Reform and Development, 2010, COMP RUR SURPL LAB T; Clarkson Research Services Ltd, 2015, MARITIME CHINA, V4, P10; Deng XZ, 2015, LAND USE POLICY, V45, P1, DOI 10.1016/j.landusepol.2015.01.007; Dobermann A, 2005, SCI CHINA SER C, V48, P745, DOI 10.1360/062005-268; Fan MS, 2012, J EXP BOT, V63, P13, DOI 10.1093/jxb/err248; Gibbon D., 2001, FARMING SYSTEMS POVE; Gibbon D., 2007, DROUGHT TOLERANT MAI; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Heffer P., 2013, ASSESSMENT FERTILIZE; Huang J, 2008, I CHANGE SUSTAINABLE; Huang JK, 2010, ASIAN J AGRIC DEV, V7, P93; [黄维 Huang Wei], 2010, [地理科学进展, Progress in Geography], V29, P677; Keyzer MA, 2005, ECOL ECON, V55, P187, DOI 10.1016/j.ecolecon.2004.12.002; Li X., 2013, WORLD AGR, V410, P135; Li XY, 2011, FOOD SECUR, V3, P19, DOI 10.1007/s12571-011-0111-x; Lin J, 1996, CAB RES ASIA PROGR P, P161; Liu YanSui, 2009, Scientia Agricultura Sinica, V42, P4269; [刘珍环 Liu Zhenhuan], 2013, [地理学报, Acta Geographica Sinica], V68, P680; Lobell DB, 2005, FIELD CROP RES, V94, P250, DOI 10.1016/j.fcr.2005.01.007; Lobell DB, 2007, ENVIRON RES LETT, V2, P625; Market Early-warning Expert Committee of Ministry of Agriculture, 2015, CHIN AGR OUTL REP 20; Ministiry of Agricultural in China, 2016, CROPP STRUCT ADJ PLA; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; National Bureau of Statistics, 2014, CHIN STAT YB; National Development and Reform Commission, 2008, LONG TERM PLANN OUTL; Nicholls N, 1997, NATURE, V387, P484, DOI 10.1038/387484a0; Niu S, 2011, REPORTING REUTE 1106, phttp; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Qi M, 2014, CHINA POPULATION RES, V24, P127; Ray DK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2296; Shen YanJun, 2011, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V19, P1004, DOI 10.3724/SP.J.1011.2011.01004; Tao FL, 2008, CLIM RES, V38, P83, DOI 10.3354/cr00771; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tong CL, 2003, AGR ECOSYST ENVIRON, V95, P523, DOI 10.1016/S0167-8809(02)00182-2; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; von Braun J, 2008, EUROCHOICES, V7, P30, DOI 10.1111/j.1746-692X.2008.00099.x; VONBRAUN J, 2006, PROMISES CHALLENGES; Waddington SR, 2009, G400836 GCP CGIAR SP; Waddington SR, 2010, FOOD SECUR, V2, P27, DOI 10.1007/s12571-010-0053-8; Wei X., 2015, PLOS ONE, V10; Xu Q, 2010, CHINA LAND SCI, V24, P76; [许月卿 Xu Yueqing], 2005, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V41, P265; [徐志宇 Xu Zhiyu], 2013, [南京农业大学学报, Journal of Nanjing Agricultural University], V36, P79; You LZ, 2009, AGR FOREST METEOROL, V149, P1009, DOI 10.1016/j.agrformet.2008.12.004; Zhang FuSuo, 2008, Acta Pedologica Sinica, V45, P915	49	19	25	6	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0159061	10.1371/journal.pone.0159061	http://dx.doi.org/10.1371/journal.pone.0159061			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27404110	Green Submitted, gold, Green Published			2022-12-26	WOS:000379508200031
J	Schwacha, MG; Rani, M; Nicholson, SE; Lewis, AM; Holloway, TL; Sordo, S; Cap, AP				Schwacha, Martin G.; Rani, Meenakshi; Nicholson, Susannah E.; Lewis, Aaron M.; Holloway, Travis L.; Sordo, Salvador; Cap, Andrew P.			Dermal gamma delta T-Cells Can Be Activated by Mitochondrial Damage-Associated Molecular Patterns	PLOS ONE			English	Article							INFLAMMATORY RESPONSE; ANTIGEN RECEPTORS; THERMAL-INJURY; IMMUNE-SYSTEM; UP-REGULATION; BURN INJURY; WOUND SITE; LYMPHOCYTES; MECHANISMS; NECROSIS	Background Gamma delta T-cells have been shown to be important to the early immunoinflammatory response to injury, independent of infection. This unique T-cell population acts to regulate cell trafficking and the release of cytokines and growth factors. We propose this sterile inflammatory response is in part associated with damage associated molecular patterns (DAMPs) generated by major injury, such as burn, and mediated via toll-like receptors (TLRs). It is unknown whether DAMPs can activate resident gamma delta T-cells that reside in skin. Methods Gamma delta T-cells were isolated from the skin of male C57BL/6 mice by enzymatic digestion. Mitochondrial DAMPs (MTDs) were generated from mitochondria isolated from mouse livers by sonication and centrifugation. Dermal gamma delta T-cells were incubated with MTDs (0500 mu g/ml) for 24 hr and cells and supernatants were collected for analysis. Results MTDs activated dermal gamma delta T-cells, as evidenced by increased TLR2 and TLR4 expression following in vitro exposure. MTDs also induced the production of inflammatory cytokines (IL-1 beta, IL-6), and growth factors (PDGF and VEGF) by gamma delta T-cells. Conclusions These findings herein support the concept that MTDs released after tissue/cellular injury are capable of activating dermal gamma delta T-cells. We propose that the activation of this unique T-cell population is central in the initiation of sterile inflammation and also contributes to the subsequent healing processes.	[Schwacha, Martin G.; Rani, Meenakshi; Nicholson, Susannah E.; Lewis, Aaron M.; Holloway, Travis L.; Sordo, Salvador; Cap, Andrew P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA; [Schwacha, Martin G.; Cap, Andrew P.] US Army, Inst Surg Res, Blood Res, Ft Sam Houston, TX USA	University of Texas System; University of Texas Health San Antonio	Schwacha, MG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Surg, San Antonio, TX 78229 USA.; Schwacha, MG (corresponding author), US Army, Inst Surg Res, Blood Res, Ft Sam Houston, TX USA.	Schwacha@uthscsa.edu	Nicholson, Susannah/AAI-2757-2021; Cap, Andrew Peter/GQZ-4426-2022	Holloway, Courtney Jean/0000-0003-3661-1957	National Institutes of Health [GM079122, 5T32GM079085]; UTHSCSA NIH [KL2 TR001118]; UTHSCSA Department of Surgery NIH T32 Training Grant [5T32GM079085]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001118, UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079122, T32GM079085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTHSCSA NIH; UTHSCSA Department of Surgery NIH T32 Training Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health: GM079122, 5T32GM079085. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; These finding were presented in part at the 38th Annual Conference on Shock in Denver CO. This study was supported by NIH grant GM079122, SEN was supported in part by the UTHSCSA NIH grant KL2 TR001118, and TLH was supported under the UTHSCSA Department of Surgery NIH T32 Training Grant (5T32GM079085). The opinions or assertions contained herein are the private views of the author and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense. The authors declare that they have no competing interests. We thank Qiong Zhang for her excellent technical assistance in the laboratory and LuAnn Kirk for editorial assistance.	Alexander M, 2005, J BURN CARE REHABIL, V26, pS72; Alexander M, 2006, J BURN CARE RES, V27, P18, DOI 10.1097/01.bcr.0000188325.71515.19; ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Cairns B, 2006, J TRAUMA, V61, P293, DOI 10.1097/01.ta.0000228969.46633.bb; Campanholle G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068640; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Daniel T, 2007, SHOCK, V28, P278, DOI 10.1097/shk.0b013e318034264c; Flohe SB, 2008, INNATE IMMUN-LONDON, V14, P333, DOI 10.1177/1753425908100016; Foell D, 2007, NAT CLIN PRACT RHEUM, V3, P382, DOI 10.1038/ncprheum0531; FU YX, 1994, J IMMUNOL, V153, P3101; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; HAAS W, 1993, ANNU REV IMMUNOL, V11, P637, DOI 10.1146/annurev.immunol.11.1.637; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Havran WL, 2005, AM J PHYSIOL-GASTR L, V289, pG627, DOI 10.1152/ajpgi.00224.2005; He J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124469; Hwang PF, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-92; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Lopez RD, 2002, IMMUNOL RES, V26, P207, DOI 10.1385/IR:26:1-3:207; MacLeod AS, 2011, CELL MOL LIFE SCI, V68, P2399, DOI 10.1007/s00018-011-0702-x; Manfredi AA, 2009, CRIT REV IMMUNOL, V29, P69, DOI 10.1615/CritRevImmunol.v29.i1.30; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matsushima A, 2004, SHOCK, V22, P11, DOI 10.1097/01.shk.0000129203.84330.b3; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Nakahira K, 2015, ANTIOXID REDOX SIGN, V23, P1329, DOI 10.1089/ars.2015.6407; NISHIMURA H, 1995, EUR J IMMUNOL, V25, P1465, DOI 10.1002/eji.1830250551; Oppeltz RF, 2012, CYTOKINE, V60, P528, DOI 10.1016/j.cyto.2012.07.003; Rani M, 2011, SHOCK, V35, P47; Rani M, 2016, J BURN CARE RES, V37, pS290; Rani M, 2015, INNATE IMMUN-LONDON, V21, P140, DOI 10.1177/1753425913519350; Rani M, 2014, SHOCK, V42, P133, DOI 10.1097/SHK.0000000000000176; Rani M, 2014, J BURN CARE RES, V35, P46, DOI 10.1097/01.bcr.0000440705.91099.cc; Schwacha MG, 2014, INNATE IMMUN-LONDON, V20, P261, DOI 10.1177/1753425913488969; Schwacha MG, 2009, BURNS, V35, P318, DOI 10.1016/j.burns.2008.08.002; Schwacha MG, 2008, CYTOKINE, V44, P328, DOI 10.1016/j.cyto.2008.09.001; Schwacha MG, 2000, J LEUKOCYTE BIOL, V67, P644, DOI 10.1002/jlb.67.5.644; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Tadema H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024315; Toth B, 2004, J LEUKOCYTE BIOL, V76, P545, DOI 10.1189/jlb.0404219; Zhang JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108156; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	45	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0158993	10.1371/journal.pone.0158993	http://dx.doi.org/10.1371/journal.pone.0158993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403524	Green Published, gold, Green Submitted			2022-12-26	WOS:000379508200026
J	Zimmer, HC; Offord, CA; Auld, TD; Baker, PJ				Zimmer, Heidi C.; Offord, Catherine A.; Auld, Tony D.; Baker, Patrick J.			Establishing a Wild, Ex Situ Population of a Critically Endangered Shade-Tolerant Rainforest Conifer: A Translocation Experiment	PLOS ONE			English	Article							PINE WOLLEMIA-NOBILIS; SEEDLING SURVIVAL; ROOT DEFORMATION; WETNESS DURATION; BLISTER RUST; LOGGING GAPS; CANOPY GAPS; GROWTH; LIGHT; RESTORATION	Translocation can reduce extinction risk by increasing population size and geographic range, and is increasingly being used in the management of rare and threatened plant species. A critical determinant of successful plant establishment is light environment. Wollemia nobilis (Wollemi pine) is a critically endangered conifer, with a wild population of 83 mature trees and a highly restricted distribution of less than 10 km(2). We used under-planting to establish a population of W. nobilis in a new rainforest site. Because its optimal establishment conditions were unknown, we conducted an experimental translocation, planting in a range of different light conditions from deeply shaded to high light gaps. Two years after the experimental translocation, 85% of plants had survived. There were two distinct responses: very high survival (94%) but very low growth, and lower survival (69%) and higher growth, associated with initial plant condition. Overall survival of translocated W. nobilis was strongly increased in planting sites with higher light, in contrast to previous studies demonstrating long-term survival of wild W. nobilis juveniles in deep shade. Trans location by under-planting may be useful in establishing new populations of shade-tolerant plant species, not least by utilizing the range of light conditions that occur in forest understories.	[Zimmer, Heidi C.; Baker, Patrick J.] Univ Melbourne, Sch Ecosyst & Forest Sci, Richmond, Vic, Australia; [Offord, Catherine A.] Australian Bot Garden, Royal Bot Gardens & Domain Trust, Australian PlantBank, Mt Annan, NSW, Australia; [Auld, Tony D.] Off Environm & Heritage NSW, Hurstville, NSW, Australia; [Auld, Tony D.] Univ New South Wales, Ctr Ecosyst Sci, Sydney, NSW, Australia	University of Melbourne; Office of Environment & Heritage - New South Wales; University of New South Wales Sydney	Zimmer, HC (corresponding author), Univ Melbourne, Sch Ecosyst & Forest Sci, Richmond, Vic, Australia.	Heidi.Zimmer@gmail.com		Zimmer, Heidi/0000-0002-8496-7360; Auld, Tony/0000-0002-8766-2829; Baker, Patrick/0000-0002-6560-7124	Australian Research Council Future Fellowship [FT120100715]; Australian Postgraduate Award; Wollemi Pine Recovery Team	Australian Research Council Future Fellowship(Australian Research Council); Australian Postgraduate Award(Australian Government); Wollemi Pine Recovery Team	PJB was supported by an Australian Research Council Future Fellowship (FT120100715). HCZ's doctoral research is funded by an Australian Postgraduate Award and the Wollemi Pine Recovery Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amponsah N. T., 2010, New Zealand Plant Protection, V63, P28; Aoki T, 2013, MYCOLOGIA, V105, P312, DOI 10.3852/12-262; ARAUZ LF, 1989, PHYTOPATHOLOGY, V79, P440, DOI 10.1094/Phyto-79-440; Ashton MS, 2001, FOREST ECOL MANAG, V154, P409, DOI 10.1016/S0378-1127(01)00512-6; Ashton PMS, 1997, J APPL ECOL, V34, P915, DOI 10.2307/2405282; Baryla A, 2001, PLANTA, V212, P696, DOI 10.1007/s004250000439; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Benson John, 2007, Cunninghamia, V10, P255; Brandeis TJ, 2001, CAN J FOREST RES, V31, P302, DOI 10.1139/cjfr-31-2-302; Bullock S, 2000, AUSTRALAS PLANT PATH, V29, P211, DOI 10.1071/AP00037; Burrows GE, 2007, ANN BOT-LONDON, V99, P609, DOI 10.1093/aob/mcm003; CANHAM CD, 1988, ECOLOGY, V69, P786, DOI 10.2307/1941027; Chambers TC, 1998, INT J PLANT SCI, V159, P160, DOI 10.1086/297534; Cole E, 2009, CAN J FOREST RES, V39, P580, DOI 10.1139/X08-198; Coopman RE, 2008, TREE PHYSIOL, V28, P1561, DOI 10.1093/treephys/28.10.1561; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; Dalrymple SE, 2013, RESTOR ECOL, V21, P156, DOI 10.1111/j.1526-100X.2012.00932.x; Davis AS, 2005, NEW FOREST, V30, P295, DOI 10.1007/s11056-005-7480-y; Delcamp M, 2008, J VEG SCI, V19, P209, DOI 10.3170/2008-8-18360; Dey DC, 2012, NEW FOREST, V43, P955, DOI 10.1007/s11056-012-9330-z; Drayton B, 2012, RESTOR ECOL, V20, P299, DOI 10.1111/j.1526-100X.2011.00860.x; Dreistadt SH, 2008, PESTS LANDSCAPE TREE; Dumroese RK, 2013, NEW FOREST, V44, P881, DOI 10.1007/s11056-013-9377-5; Erefur C, 2011, NEW FOREST, V41, P263, DOI 10.1007/s11056-010-9226-8; Fahey RT, 2013, FOREST ECOL MANAG, V292, P139, DOI 10.1016/j.foreco.2012.12.026; Frazer G.W., 1999, GAP LIGHT ANAL GLA; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Guerrant EO, 2007, AUST J BOT, V55, P362, DOI 10.1071/BT06033; HALTER MR, 1993, FOREST ECOL MANAG, V56, P131, DOI 10.1016/0378-1127(93)90108-Y; Hardham AR, 2005, MOL PLANT PATHOL, V6, P589, DOI 10.1111/J.1364-3703.2005.00308.X; Hill KD, 1997, AUST J BOT, V45, P817, DOI 10.1071/BT96053; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; JOHNSON PS, 1984, CAN J FOREST RES, V14, P536, DOI 10.1139/x84-099; Jones W. G., 1995, Telopea, V6, P173; Jorgensen D, 2011, RESTOR ECOL, V19, P705, DOI 10.1111/j.1526-100X.2011.00834.x; Khurana E, 2001, ENVIRON CONSERV, V28, P39, DOI 10.1017/S0376892901000042; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; Krause GH, 2001, PLANT CELL ENVIRON, V24, P1345, DOI 10.1046/j.0016-8025.2001.00786.x; Lefcheck J, R SQUARED GEN LINEAR; Lindstrom A, 1999, PLANT SOIL, V217, P29, DOI 10.1023/A:1004662127182; Maas-Hebner KG, 2005, FOREST ECOL MANAG, V208, P331, DOI 10.1016/j.foreco.2005.01.013; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Macphail MK, 1995, GEOL TODAY, V11, P48; Man RZ, 2009, FOREST ECOL MANAG, V258, P1225, DOI 10.1016/j.foreco.2009.06.012; Mano J, 2000, OXIDATIVE STRESS PLA, P217; Maschinski J., 2012, PLANT REINTRODUCTION; Maschinski J, 2007, BIOL CONSERV, V134, P122, DOI 10.1016/j.biocon.2006.07.012; MAUNDER M, 1992, BIODIVERS CONSERV, V1, P51, DOI 10.1007/BF00700250; MCCONNAUGHAY KDM, 1991, ECOLOGY, V72, P94, DOI 10.2307/1938905; Mengel K., 1995, Iron nutrition in soils and plants. Proceedings of the Seventh International Symposium Zaragoza, Spain, 27 June-2 July 1993., P389; MICHAILIDES TJ, 1992, PHYTOPATHOLOGY, V82, P1399, DOI 10.1094/Phyto-82-1399; Muller H, 2013, BIODIVERS CONSERV, V22, P1837, DOI 10.1007/s10531-013-0504-6; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murcia C, 2014, RESTOR ECOL, V22, P279, DOI 10.1111/rec.12100; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Navarro-Cerrillo RM, 2011, FOREST ECOL MANAG, V262, P2271, DOI 10.1016/j.foreco.2011.08.020; New South Wales Government DOC, 2006, WOLL PIN REC PLAN, P1; Nobis M, 2005, AGR FOREST METEOROL, V128, P243, DOI 10.1016/j.agrformet.2004.10.002; Offord CA, 1999, ANN BOT-LONDON, V84, P1, DOI 10.1006/anbo.1999.0882; Offord CA, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu011; Paquette A, 2006, ECOL APPL, V16, P1575, DOI 10.1890/1051-0761(2006)016[1575:SAGOUT]2.0.CO;2; Parrotta JA, 1997, FOREST ECOL MANAG, V99, P1, DOI 10.1016/S0378-1127(97)00190-4; Peakall R, 2003, MOL ECOL, V12, P2331, DOI 10.1046/j.1365-294X.2003.01926.x; Reusch TBH, 2005, P NATL ACAD SCI USA, V102, P2826, DOI 10.1073/pnas.0500008102; Rigg JL, 2016, PLANT SOIL IN PRESS; Romell E, 2008, FOREST ECOL MANAG, V255, P1452, DOI 10.1016/j.foreco.2007.11.003; Rout TM, 2007, ECOL MODEL, V201, P67, DOI 10.1016/j.ecolmodel.2006.07.022; Ruger N, 2009, J ECOL, V97, P1360, DOI 10.1111/j.1365-2745.2009.01552.x; RUEHLE JL, 1985, CAN J FOREST RES, V15, P586, DOI 10.1139/x85-095; Schulze M, 2008, FOREST ECOL MANAG, V255, P866, DOI 10.1016/j.foreco.2007.09.082; Seddon PJ, 2010, RESTOR ECOL, V18, P796, DOI 10.1111/j.1526-100X.2010.00724.x; Sinclair W. A., 1987, Diseases of trees and shrubs.; Slippers B, 2005, AUSTRALAS PLANT PATH, V34, P213, DOI 10.1071/AP05020; Smith CM, 2013, CAN J FOREST RES, V43, P90, DOI 10.1139/cjfr-2012-0127; Smith JA, 2011, PLANT DIS, V95, P633, DOI 10.1094/PDIS-10-10-0703; Smith JP, 2000, WEST N AM NATURALIST, V60, P165; South DB, 2005, FOREST ECOL MANAG, V204, P385, DOI 10.1016/j.foreco.2004.09.016; Stewart James D., 2000, Western Journal of Applied Forestry, V15, P177; Therneau T, PACKAGE SURVIVAL ANA; Vallee L., 2004, GUIDELINES TRANSLOCA; Webber BL, 2011, TRENDS ECOL EVOL, V26, P495, DOI 10.1016/j.tree.2011.06.007; WHITMORE TC, 1989, ECOLOGY, V70, P536, DOI 10.2307/1940195; Young TP, 2005, ECOL LETT, V8, P662, DOI 10.1111/j.1461-0248.2005.00764.x; Zaczek JJ, 1997, NEW FOREST, V13, P177, DOI 10.1023/A:1006578007777; Zimmer HC, 2014, BIODIVERS CONSERV, V23, P203, DOI 10.1007/s10531-013-0593-2	86	5	5	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2016	11	7							e0157559	10.1371/journal.pone.0157559	http://dx.doi.org/10.1371/journal.pone.0157559			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DQ9CO	27403527	Green Published, Green Submitted, gold			2022-12-26	WOS:000379508200004
J	Bachsais, M; Naddaf, N; Yacoub, D; Salti, S; Alaaeddine, N; Aoudjit, F; Hassan, GS; Mourad, W				Bachsais, Meriem; Naddaf, Nadim; Yacoub, Daniel; Salti, Suzanne; Alaaeddine, Nada; Aoudjit, Fawzi; Hassan, Ghada S.; Mourad, Walid			The Interaction of CD154 with the alpha 5 beta 1 Integrin Inhibits Fas-Induced T Cell Death	PLOS ONE			English	Article							SOLUBLE CD40 LIGAND; MEDIATED APOPTOSIS; ENDOTHELIAL-CELLS; LYMPHOMA-CELLS; PLASMA-LEVELS; CANCER-CELLS; LIPID RAFTS; B-CELLS; ACTIVATION; EXPRESSION	CD154, a critical regulator of the immune response, is usually associated with chronic inflammatory, autoimmune diseases as well as malignant disorders. In addition to its classical receptor CD40, CD154 is capable of binding other receptors, members of the integrin family, the alpha IIb beta 3, alpha M beta 2 and alpha 5 beta 1. Given the role attributed to integrins and particularly the beta 1 integrins in inhibiting apoptotic events in normal as well as malignant T cells, we were highly interested in investigating the role of the CD154/alpha 5 beta 1 interaction in promoting survival of malignant T cells contributing as such to tumor development and/or propagation. To support our hypothesis, we first show that soluble CD154 binds to the T-cell acute lymphoblastic leukemia cell line, Jurkat E6.1 in a alpha 5 beta 1-dependent manner. Binding of soluble CD154 to alpha 5 beta 1 integrin of Jurkat cells leads to the activation of key survival proteins, including the p38 and ERK1/2 mitogen-activated protein kinases (MAPKs), phosphoinositide 3 kinase (PI-3K), and Akt. Interestingly, soluble CD154 significantly inhibits Fas-mediated apoptosis in T cell leukemia-lymphoma cell lines, Jurkat E6.1 and HUT78 cells, an important hallmark of T cell survival during malignancy progression. These anti-apoptotic effects were mainly mediated by the activation of the PI-3K/Akt pathway but also involved the p38 and the ERK1/2 MAPKs cascades. Our data also demonstrated that the CD154-triggered inhibition of the Fas-mediated cell death response was dependent on a suppression of caspase-8 cleavage, but independent of de novo protein synthesis or alterations in Fas expression on cell surface. Together, our results highlight the impact of the CD154/alpha 5 beta 1 interaction in T cell function/survival and identify novel targets for the treatment of malignant disorders, particularly of T cell origin.	[Bachsais, Meriem; Naddaf, Nadim; Yacoub, Daniel; Salti, Suzanne; Hassan, Ghada S.; Mourad, Walid] Ctr Hosp Univ Montreal, Lab Immunol Cellulaire & Mol, 900 Rue St Denis,Room 10-482, Montreal, PQ, Canada; [Alaaeddine, Nada] St Joseph Univ, Dept Pathol, Fac Med, Beirut, Lebanon; [Aoudjit, Fawzi] CHUL, Ctr Rech Immunol & Rhumatol, Boul Laurier, PQ, Canada	Universite de Montreal; Laval University	Mourad, W (corresponding author), Ctr Hosp Univ Montreal, Lab Immunol Cellulaire & Mol, 900 Rue St Denis,Room 10-482, Montreal, PQ, Canada.	mw.mourad@umontreal.ca		Aoudjit, Fawzi/0000-0001-9579-2941; Mourad, Walid/0000-0002-1859-9387; Hassan, Ghada S./0000-0002-1391-5248	Heart and Stroke Foundation of Canada (HSFC) [600663]; Pfizer/FRQS Innovation Fund [60597]	Heart and Stroke Foundation of Canada (HSFC)(Heart & Stroke Foundation of Canada); Pfizer/FRQS Innovation Fund	The study was supported by funds from the Heart and Stroke Foundation of Canada (HSFC): Award number 600663, and the Pfizer/FRQS Innovation Fund: Award number 60597. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alturaihi H, 2015, EUR J IMMUNOL, V45, P592, DOI 10.1002/eji.201444941; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Aoudjit F, 2000, BLOOD, V95, P2044, DOI 10.1182/blood.V95.6.2044; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Bunn PA, 1996, J CELL BIOCHEM, P12; Bussolati B, 2002, INT J CANCER, V100, P654, DOI 10.1002/ijc.10545; Clodi K, 1998, BRIT J HAEMATOL, V103, P270, DOI 10.1046/j.1365-2141.1998.01031.x; De Toni-Costes F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009807; El Fakhry Y, 2012, J BIOL CHEM, V287, P18055, DOI 10.1074/jbc.M111.333989; El Fakhry Y, 2010, EUR J IMMUNOL, V40, P770, DOI 10.1002/eji.200939646; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Forsyth CB, 2002, ARTHRITIS RHEUM, V46, P2368, DOI 10.1002/art.10502; Garcia S, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2941; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; Heeschen C, 2003, NEW ENGL J MED, V348, P1104, DOI 10.1056/NEJMoa022600; Henn V, 1998, NATURE, V391, P591, DOI 10.1038/35393; Hill SC, 2005, J IMMUNOL, V174, P41, DOI 10.4049/jimmunol.174.1.41; Hock BD, 2006, CANCER, V106, P2148, DOI 10.1002/cncr.21816; Hsieh YT, 2013, BLOOD, V121, P1814, DOI 10.1182/blood-2012-01-406272; Ivanoff J, 2005, IMMUNOLOGY, V114, P53, DOI 10.1111/j.1365-2567.2004.02005.x; KARMANN K, 1995, P NATL ACAD SCI USA, V92, P4342, DOI 10.1073/pnas.92.10.4342; Kato K, 1999, J CLIN INVEST, V104, P947, DOI 10.1172/JCI7014; Khanna R, 1997, J IMMUNOL, V159, P5782; KROCZEK RA, 1994, IMMUNOL REV, V138, P39, DOI 10.1111/j.1600-065X.1994.tb00846.x; LEDERMAN S, 1992, J EXP MED, V175, P1091, DOI 10.1084/jem.175.4.1091; Leveille C, 2007, J BIOL CHEM, V282, P5143, DOI 10.1074/jbc.M608342200; Li DX, 2013, BIOCHEM BIOPH RES CO, V436, P467, DOI 10.1016/j.bbrc.2013.05.128; Lin YP, 2009, MOL IMMUNOL, V46, P3328, DOI 10.1016/j.molimm.2009.07.021; Liu CC, 2013, MOL CELL BIOL, V33, P4334, DOI 10.1128/MCB.00580-13; Loubaki L, 2010, MOL IMMUNOL, V47, P2112, DOI 10.1016/j.molimm.2010.03.011; Mach F, 1999, AM J PATHOL, V154, P229, DOI 10.1016/S0002-9440(10)65269-8; Mielczarek-Palacz A, 2013, HUM IMMUNOL, V74, P70, DOI 10.1016/j.humimm.2012.10.004; Mori Y, 2004, BLOOD, V104, P2149, DOI 10.1182/blood-2004-01-0236; Naci D, 2014, CELL SIGNAL, V26, P2008, DOI 10.1016/j.cellsig.2014.05.016; Naci D, 2012, J BIOL CHEM, V287, P17065, DOI 10.1074/jbc.M112.349365; Nadiri A, 2011, EUR J IMMUNOL, V41, P2358, DOI 10.1002/eji.201041143; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Plumas J, 1998, BLOOD, V91, P2875, DOI 10.1182/blood.V91.8.2875.2875_2875_2885; Portt L, 2011, BBA-MOL CELL RES, V1813, P238, DOI 10.1016/j.bbamcr.2010.10.010; Pradelli LA, 2010, CELL MOL LIFE SCI, V67, P1589, DOI 10.1007/s00018-010-0285-y; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Roselli M, 2004, CLIN CANCER RES, V10, P610, DOI 10.1158/1078-0432.CCR-0348-03; Sanguigni V, 2005, CIRCULATION, V111, P412, DOI 10.1161/01.CIR.0000153810.81187.7D; Schattner E, 1996, IMMUNOL RES, V15, P246, DOI 10.1007/BF02918252; Schonbeck U, 2000, AM J PATHOL, V156, P7, DOI 10.1016/S0002-9440(10)64699-8; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Su CC, 2007, J IMMUNOL, V179, P4589, DOI 10.4049/jimmunol.179.7.4589; Tamura N, 2001, J RHEUMATOL, V28, P2583; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Wierda WG, 2000, BLOOD, V96, P2917; Zirlik A, 2007, CIRCULATION, V115, P1571, DOI 10.1161/CIRCULATIONAHA.106.683201	54	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158987	10.1371/journal.pone.0158987	http://dx.doi.org/10.1371/journal.pone.0158987			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391025	gold, Green Submitted, Green Published			2022-12-26	WOS:000380005400182
J	Holliday, V; Surovell, T; Johnson, E				Holliday, Vance; Surovell, Todd; Johnson, Eileen			A Blind Test of the Younger Dryas Impact Hypothesis	PLOS ONE			English	Article							SOUTHERN HIGH-PLAINS; LUBBOCK LAKE SITE; EXTRATERRESTRIAL IMPACT; MURRAY SPRINGS; INDEPENDENT EVALUATION; BLACK MATS; BOUNDARY; NANODIAMONDS; EVENT; LAYER	The Younger Dryas Impact Hypothesis (YDIH) states that North America was devastated by some sort of extraterrestrial event similar to 12,800 calendar years before present. Two fundamental questions persist in the debate over the YDIH: Can the results of analyses for purported impact indicators be reproduced? And are the indicators unique to the lower YD boundary (YDB), i.e., similar to 12.8k cal yrs BP? A test reported here presents the results of analyses that address these questions. Two different labs analyzed identical splits of samples collected at, above, and below the similar to 12.8ka zone at the Lubbock Lake archaeological site (LL) in northwest Texas. Both labs reported similar variation in levels of magnetic micrograins (>300 mg/kg >12.8ka and <11.5ka, but <150 mg/kg 12.8ka to 11.5ka). Analysis for magnetic microspheres in one split, reported elsewhere, produced very low to nonexistent levels throughout the section. In the other split, reported here, the levels of magnetic microspherules and nanodiamonds are low or nonexistent at, below, and above the YDB with the notable exception of a sample <11,500 cal years old. In that sample the claimed impact proxies were recovered at abundances two to four orders of magnitude above that from the other samples. Reproducibility of at least some analyses are problematic. In particular, no standard criteria exist for identification of magnetic spheres. Moreover, the purported impact proxies are not unique to the YDB.	[Holliday, Vance] Univ Arizona, Dept Anthropol, Tucson, AZ 85721 USA; [Holliday, Vance] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA; [Surovell, Todd] Univ Wyoming, Dept Anthropol, Laramie, WY 82071 USA; [Johnson, Eileen] Texas Tech Univ Museum, Lubbock, TX 79409 USA	University of Arizona; University of Arizona; University of Wyoming; Texas Tech University System; Texas Tech University	Holliday, V (corresponding author), Univ Arizona, Dept Anthropol, Tucson, AZ 85721 USA.; Holliday, V (corresponding author), Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA.	vthollid@email.arizona.edu		Surovell, Todd/0000-0001-6587-8621	Argonaut Archaeological Research Fund University of Arizona; College of Arts and Sciences, University of Wyoming	Argonaut Archaeological Research Fund University of Arizona; College of Arts and Sciences, University of Wyoming	Support was provided by Argonaut Archaeological Research Fund [http://www.argonaut.arizona.edu] University of Arizona, to VTH; and Basic Research Grant, College of Arts and Sciences, University of Wyoming to TS.	[Anonymous], 2000, GEOARCHAEOLOGY, DOI DOI 10.1002/(SICI)1520-6548(200003)15:3; Bement LC, 2014, P NATL ACAD SCI USA, V111, P1726, DOI 10.1073/pnas.1309734111; Boslough M, 2012, GEOPHYS MONOGR SER, V198, P13, DOI 10.1029/2012GM001209; Bunch TE, 2012, P NATL ACAD SCI USA, V109, pE1903, DOI 10.1073/pnas.1204453109; Daniel IR, 2008, N CAROLINA ARCHAEOLO, V57, P50; Daulton TL, 2010, P NATL ACAD SCI USA, V107, P16043, DOI 10.1073/pnas.1003904107; Firestone R., 2006, CYCLE COSMIC CATASTR; Firestone R, 2010, J SIB FED U ENG TECH, V3, P30; Firestone RB, 2007, P NATL ACAD SCI USA, V104, P16016, DOI 10.1073/pnas.0706977104; Firestone R.B., 2009, J COSMOL, V2, P256; Firestone RB, 2010, P NATL ACAD SCI USA, V107, pE105, DOI 10.1073/pnas.1003963107; French BM, 2010, EARTH-SCI REV, V98, P123, DOI 10.1016/j.earscirev.2009.10.009; Frison G.C., 2010, PREHISTORIC HUNTER G, V3rd; Haynes C. V., 1995, GEOARCHAEOLOGY, V10, P317, DOI DOI 10.1002/gea.3340100502; Haynes C.Vance., 1992, ICE AGE HUNTERS ROCK, P83; Haynes CV, 2008, P NATL ACAD SCI USA, V105, P6520, DOI 10.1073/pnas.0800560105; Haynes CV, 2010, P NATL ACAD SCI USA, V107, pE106, DOI 10.1073/pnas.1005384107; Haynes CV, 2010, P NATL ACAD SCI USA, V107, P4010, DOI 10.1073/pnas.0908191107; HAYNES CV, 1992, RADIOCARBON AFTER FOUR DECADES, P355; Hofman J. L., 1998, ARCHAEOLOGY GREAT PL, P87; HOLLIDAY V T, 1983, Plains Anthropologist, V28, P165; Holliday V. T., 1997, PALEOINDIAN GEOARCHA; Holliday VT, 2014, J QUATERNARY SCI, V29, P515, DOI 10.1002/jqs.2724; Holliday VT, 2010, CURR ANTHROPOL, V51, P575, DOI 10.1086/656015; HOLLIDAY VT, 1985, GEOL SOC AM BULL, V96, P1483, DOI 10.1130/0016-7606(1985)96<1483:AGOTLL>2.0.CO;2; HOLLIDAY VT, 1985, PLAINS ANTHROPOL, V30, P277, DOI 10.1080/2052546.1985.11909281; HOLLIDAY VT, 1985, CATENA, V12, P61, DOI 10.1016/S0341-8162(85)80005-9; Holliday VT., 2004, SOILS ARCHAEOLOGICAL, DOI [10.1002/9781118786352.wbieg0737, DOI 10.1002/9781118786352.WBIEG0737]; Israde-Alcantara I, 2012, P NATL ACAD SCI USA, V109, pE738, DOI 10.1073/pnas.1110614109; Johnson E., 2012, LUBBOCK LAKE LANDMAR, V21; Johnson E., 1987, LUBBOCK LAKE LATE QU; Kennett DJ, 2008, QUATERNARY SCI REV, V27, P2530, DOI 10.1016/j.quascirev.2008.09.006; Kennett DJ, 2009, SCIENCE, V323, P94, DOI 10.1126/science.1162819; Kennett DJ, 2009, P NATL ACAD SCI USA, V106, P12623, DOI 10.1073/pnas.0906374106; Kennett JP, 2015, P NATL ACAD SCI USA, V112, pE6723, DOI 10.1073/pnas.1520411112; Kennett JP, 2015, P NATL ACAD SCI USA, V112, pE4344, DOI 10.1073/pnas.1507146112; Kurbatov AV, 2010, J GLACIOL, V56, P747, DOI 10.3189/002214310794457191; LeCompte MA, 2013, P NATL ACAD SCI USA, V110, pE1652, DOI 10.1073/pnas.1300425110; LeCompte MA, 2012, P NATL ACAD SCI USA, V109, pE2960, DOI 10.1073/pnas.1208603109; Mahaney WC, 2010, GEOMORPHOLOGY, V116, P48, DOI 10.1016/j.geomorph.2009.10.007; Meltzer DJ, 2014, P NATL ACAD SCI USA, V111, pE2162, DOI 10.1073/pnas.1401150111; Nemeth P, 2015, NATURE SCI REPTS, DOI [10.1038/srep18381, DOI 10.1038/SREP18381]; Paquay FS, 2009, P NATL ACAD SCI USA, V106, P21505, DOI 10.1073/pnas.0908874106; Pigati JS, 2012, P NATL ACAD SCI USA, V109, P7208, DOI 10.1073/pnas.1200296109; Pinter N., 2008, GSA TODAY, V18, P37, DOI [10.1130/GSAT01801GW.1, DOI 10.1130/GSAT01801GW.1]; Pinter N, 2011, EARTH-SCI REV, V106, P247, DOI 10.1016/j.earscirev.2011.02.005; Quade J, 1998, QUATERNARY RES, V49, P129, DOI 10.1006/qres.1997.1959; Sellards E. H., 1952, EARLY MAN IN AM; STAFFORD T, 1981, AM ANTIQUITY, V46, P548, DOI 10.2307/280600; Surovell TA, 2012, J QUAT SCI S, P29; Surovell TA, 2009, P NATL ACAD SCI USA, V106, P18155, DOI 10.1073/pnas.0907857106; Thy P, 2015, J ARCHAEOL SCI, V54, P193, DOI 10.1016/j.jas.2014.11.027; Tian H, 2011, P NATL ACAD SCI USA, V108, P40, DOI 10.1073/pnas.1007695108; Van Hoesel A, 2015, METEORIT PLANET SCI, V50, P483, DOI 10.1111/maps.12435; van Hoesel A, 2014, QUATERNARY SCI REV, V83, P95, DOI 10.1016/j.quascirev.2013.10.033; van Hoesel A, 2012, P NATL ACAD SCI USA, V109, P7648, DOI 10.1073/pnas.1120950109; Wittke J, 2013, PNAS, V110, P2088; Wu YZ, 2013, P NATL ACAD SCI USA, V110, pE3557, DOI 10.1073/pnas.1304059110; Yang ZQ, 2008, DIAM RELAT MATER, V17, P937, DOI 10.1016/j.diamond.2008.01.104	59	11	11	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0155470	10.1371/journal.pone.0155470	http://dx.doi.org/10.1371/journal.pone.0155470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27391147	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400002
J	Moore, JR; Varricchio, DJ				Moore, Jason R.; Varricchio, David J.			The Evolution of Diapsid Reproductive Strategy with Inferences about Extinct Taxa	PLOS ONE			English	Article							WATER-VAPOR CONDUCTANCE; PARENTAL-CARE; DINOSAUR EGGS; PHYLOGENETIC ANALYSIS; TROODON-FORMOSUS; AVIAN EGG; CLUTCHES; BEHAVIOR; EMBRYOS; ORIGIN	Diapsids show an extremely wide range of reproductive strategies. Offspring may receive no parental care, care from only one sex, care from both parents, or care under more complex regimes. Young may vary from independent, super-precocial hatchlings to altricial neonates needing much care before leaving the nest. Parents can invest heavily in a few young, or less so in a larger number. Here we examine the evolution of these traits across a composite phylogeny spanning the extant diapsids and including the limited number of extinct taxa for which reproductive strategies can be well constrained. Generalized estimating equation(GEE)-based phylogenetic comparative methods demonstrate the influences of body mass, parental care strategy and hatchling maturity on clutch volume across the diapsids. The influence of polygamous reproduction is not important despite a large sample size. Applying the results of these models to the dinosaurs supports the hypothesis of paternal care (male only) in derived non-avian theropods, previously suggested based on simpler analyses. These data also suggest that sauropodomorphs did not care for their young. The evolution of parental-care occurs in an almost linear series of transitions. Paternal care rarely gives rise to other care strategies. Where hatchling condition changes, diapsids show an almost unidirectional tendency of evolution towards increased altriciality. Transitions to social monogamy from the ancestral state in diapsids, where both sexes are polygamous, are common. In contrast, once evolved, polygyny and polyandry are very evolutionarily stable. Polygyny and maternal care correlate, as do polyandry and paternal care. Ancestralcharacter estimation (ACE) of these care strategies with the character transition likelihoods estimated from the original data gives good confidence at most important nodes. These analyses suggest that the basalmost diapsids had no parental care. Crocodilians independently evolved maternal care, paternal care evolved in the saurischian line, prior to derived theropod dinosaurs, and the most basal neognaths likely exhibited biparental care. Overall, the evolution of parental care among diapsids shows a persistent trend towards increased care of offspring, and more complex care strategies and behaviors with time. Reversions to reduced care are infrequent.	[Moore, Jason R.] Univ New Mexico, Honors Coll, Albuquerque, NM 87131 USA; [Varricchio, David J.] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	University of New Mexico; Montana State University System; Montana State University Bozeman	Moore, JR (corresponding author), Univ New Mexico, Honors Coll, Albuquerque, NM 87131 USA.	jrm@unm.edu			National Science Foundation (Division of Earth Sciences) [0847777]	National Science Foundation (Division of Earth Sciences)(National Science Foundation (NSF))	This research was supported by National Science Foundation grant #0847777 (Division of Earth Sciences; http://www.nsf.gov/div/index.jsp?div=ear) to DJV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Antunes MT, 1998, MEM ACAD CIEN LISB, V37, P83; Auguie B, 2017, GRIDEXTRA MISCELLANE; Balshine S, 2012, EVOLUTION OF PARENTAL CARE, P62; Bennett P. M., 2002, OX ECOL EV; Betancur-R R, 2015, ECOL LETT, V18, P441, DOI 10.1111/ele.12423; Bever GS, 2009, AM MUS NOVIT, P1, DOI 10.1206/650.1; Birchard GF, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0036; Burley NT, 2002, PHILOS T R SOC B, V357, P241, DOI 10.1098/rstb.2001.0923; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carpenter K., 1999, EGGS NESTS BABY DINO; Chinsamy A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2377; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Clark James M., 1999, American Museum Novitates, V3265, P1; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cui J, 2007, STATA J, V7, P209, DOI 10.1177/1536867X0700700205; Darwin C., 1871, P423; Davies S., 2002, RATITES AND TINAMOUS; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; Deeming DC, 2006, PALAEONTOLOGY, V49, P171, DOI 10.1111/j.1475-4983.2005.00536.x; Deeming DC, 2002, OX ORN SER, V13, P1; deFraipont M, 1996, EVOLUTION, V50, P391, DOI 10.1111/j.1558-5646.1996.tb04501.x; Dong ZM, 1996, CAN J EARTH SCI, V33, P631, DOI 10.1139/e96-046; DUNHAM AE, 1989, GEOL S AM S, V238, P1; Dunning J.B., 2008, AVIAN BODY MASSES, V2; Elliott A., 1992, HDB BIRDS WORLD ALIV; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferguson MWJ., 1985, BIOL REPTILIA, P451; Field DJ, 2014, EVOL DEV, V16, P189, DOI 10.1111/ede.12081; Fisher RA, 1922, PHILOS T ROYAL SOC A, V222, P594; Gardner A, 2011, P ROY SOC B-BIOL SCI, V278, P196, DOI 10.1098/rspb.2010.1171; Gauthier J.A., 1988, Systematics Association Special Volume Series, P103; Geist NR, 1996, SCIENCE, V272, P712, DOI 10.1126/science.272.5262.712; Gill F. B., 1990, ORNITHOLOGY; Grellet-Tinner G, 2006, PALAEOGEOGR PALAEOCL, V232, P294, DOI 10.1016/j.palaeo.2005.10.029; Grellet-Tinner G, 2004, LIFE O PAST, P185; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HANDFORD P, 1985, BIOL J LINN SOC, V25, P77, DOI 10.1111/j.1095-8312.1985.tb00387.x; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Heinroth O., 1922, Journal fuer Ornithologie Leipzig, V70, P172, DOI 10.1007/BF02537515; Henderson DM, 1999, PALEOBIOLOGY, V25, P88; Hirsch K.F., 1990, Journal of Vertebrate Paleontology, V10, P491; Hopp TP, 2004, LIFE O PAST, P234; Horner J.R., 1987, P50; Horner JR, 1999, J VERTEBR PALEONTOL, V19, P607, DOI 10.1080/02724634.1999.10011174; HORNER JR, 1984, SCI AM, V250, P130, DOI 10.1038/scientificamerican0484-130; Horner JR, 2001, PALEOBIOLOGY, V27, P39, DOI 10.1666/0094-8373(2001)027<0039:COOSEA>2.0.CO;2; HORNER JR, 1979, NATURE, V282, P296, DOI 10.1038/282296a0; HORNER JR, 1982, NATURE, V297, P675, DOI 10.1038/297675a0; HORNER JR, 1988, NATURE, V332, P256, DOI 10.1038/332256a0; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; HOYT DF, 1979, AUK, V96, P73; Hugall AF, 2007, SYST BIOL, V56, P543, DOI 10.1080/10635150701477825; Isles TE, 2009, HIST BIOL, V21, P139, DOI 10.1080/08912960903450505; Iverson J.B., 1991, P87, DOI 10.1017/CBO9780511585739.008; Jackson FD, 2008, PALEOBIOLOGY, V34, P229, DOI 10.1666/0094-8373(2008)034[0229:COWVCI]2.0.CO;2; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Johnsgard P.A., 1991, BUSTARDS HEMIPODES S; Jones DN, 1995, MEGAPODES MEGAPODIID; Kavanau JL, 2007, SCI RES ESSAYS, V2, P263; Kavanau JL, 2010, MED HYPOTHESES, V74, P275, DOI 10.1016/j.mehy.2009.09.015; Kavanau JL., 1987, LOVEBIRDS COCKATIELS; Kendeigh S. C., 1952, ILLINOIS BIOL MONOGR; KITCHING J W, 1979, Palaeontologia Africana, V22, P41; Kohler G., 2005, INCUBATION REPTILE E; Lack, 1967, WILDFOWL TRUST ANNU, V18, P125; Lack D., 1968, ECOLOGICAL ADAPTATIO; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; Lyson TR, 2012, BIOL LETTERS, V8, P104, DOI 10.1098/rsbl.2011.0477; M?ller-Schwarze, 1984, BEHAV PENGUINS ADAPT; Mateus I, 1997, CR ACAD SCI II A, V325, P71, DOI 10.1016/S1251-8050(97)83275-2; MCKITRICK MC, 1992, AUK, V109, P828, DOI 10.2307/4088157; Mikhailov Konstantin, 1994, P88; NORELL MA, 1995, NATURE, V378, P774, DOI 10.1038/378774a0; Norell Mark A., 2001, American Museum Novitates, V3315, P1, DOI 10.1206/0003-0082(2001)315<0001:AEODTF>2.0.CO;2; OLSEN PD, 1994, AUST J ZOOL, V42, P307, DOI 10.1071/ZO9940307; Oring W, 1997, BIRDS N AM ONLINE; OWENS IPF, 1995, P ROY SOC B-BIOL SCI, V261, P227, DOI 10.1098/rspb.1995.0141; Owens IPF, 2002, PHILOS T R SOC B, V357, P283, DOI 10.1098/rstb.2001.0929; PAGANELLI CV, 1974, CONDOR, V76, P319, DOI 10.2307/1366345; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Paradis E, 2012, ANAL PHYLOGENETICS E, V2; Paul G., 1988, PREDATORY DINOSAURS; PECZKIS J, 1994, J VERTEBR PALEONTOL, V14, P520; Reisz RR, 2012, P NATL ACAD SCI USA, V109, P2428, DOI 10.1073/pnas.1109385109; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; Ricklefs Robert E., 1998, Oxford Ornithology Series, V8, P366; ROSS HA, 1979, AM NAT, V113, P618, DOI 10.1086/283420; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Ruben JA, 2003, PHYSIOL BIOCHEM ZOOL, V76, P141, DOI 10.1086/375425; RUSSELL DA, 1969, CAN J EARTH SCI, V6, P595, DOI 10.1139/e69-059; Russell DA, 1982, SYLLOGEUS, V37, P1; SABATH K, 1991, Acta Palaeontologica Polonica, V36, P151; Sander PM, 2008, PALAEONTOGR ABT A, V284, P69; Sander PM, 2012, SCIENCE, V337, P806, DOI 10.1126/science.1224301; Sato T, 2005, SCIENCE, V308, P375, DOI 10.1126/science.1110578; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Seddon N, 2003, IBIS, V145, P277, DOI 10.1046/j.1474-919X.2003.00150.x; Shine R, 1988, BIOL REPTILIA, V16, P276; Sillen-Tullberg Birgitta, 1994, Linnean Society Symposium Series, V17, P311; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; Somma L. A., 2003, PARENTAL BEHAV LEPID; Thorbjarnarson JB, 1996, HERPETOLOGICA, V52, P8; Trutnau L, 2006, CROCODYLIANS THEIR N; Tullberg BS, 2002, PHILOS T R SOC B, V357, P251, DOI 10.1098/rstb.2001.0932; Turner AH, 2012, B AM MUS NAT HIST, P5; VANRHIJN J, 1984, NETH J ZOOL, V34, P103, DOI 10.1163/002829684X00092; VANRHIJN JG, 1990, BEHAVIOUR, V115, P153, DOI 10.1163/156853990X00554; Varricchio DJ, 2013, PALEOBIOLOGY, V39, P278, DOI 10.1666/11042; Varricchio David J., 2003, Palaeovertebrata (Montpellier), V32, P149; Varricchio DJ, 2008, SCIENCE, V322, P1826, DOI 10.1126/science.1163245; Varricchio DJ, 1999, J VERTEBR PALEONTOL, V19, P91, DOI 10.1080/02724634.1999.10011125; Varricchio DJ, 2004, J VERTEBR PALEONTOL, V24, P931, DOI 10.1671/0272-4634(2004)024[0931:APAOPD]2.0.CO;2; Varricchio DJ, 1997, NATURE, V385, P247, DOI 10.1038/385247a0; Varricchio DJ, 2004, LIFE O PAST, P215; Varricchio DJ, 2002, J VERTEBR PALEONTOL, V22, P564, DOI 10.1671/0272-4634(2002)022[0564:EAEFTC]2.0.CO;2; Vehrencamp SL, 2000, BEHAV ECOL, V11, P334, DOI 10.1093/beheco/11.3.334; Walters M., 1994, BIRDS EGGS; Watson DM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117678; Weishampel DB, 2008, J VERTEBR PALEONTOL, V28, P1110, DOI 10.1671/0272-4634-28.4.1110; Werner J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072862; WESOLOWSKI T, 1994, AM NAT, V143, P39, DOI 10.1086/285595; Wesolowski T, 2004, BEHAV ECOL, V15, P520, DOI 10.1093/beheco/arh039; Yang R, 2010, MOL BIOL REP, V37, P3057, DOI 10.1007/s11033-009-9878-7; Zelenitsky DK, 2008, PALAEONTOLOGY, V51, P807, DOI 10.1111/j.1475-4983.2008.00770.x; Zelenitsky DK, 2002, CRETACEOUS RES, V23, P297, DOI 10.1006/cres.2002.1010; Zhao ZK., 2000, PALEONTOL SOC KOREA, V4, P115	131	9	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158496	10.1371/journal.pone.0158496	http://dx.doi.org/10.1371/journal.pone.0158496			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391420	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400070
J	Perez-Branguli, F; Zagar, Y; Shanley, DK; Graef, IA; Chedotal, A; Mitchell, KJ				Perez-Branguli, Francesc; Zagar, Yvrick; Shanley, Daniel K.; Graef, Isabella A.; Chedotal, Alain; Mitchell, Kevin J.			Reverse Signaling by Semaphorin-6A Regulates Cellular Aggregation and Neuronal Morphology	PLOS ONE			English	Article							ACTIN-CYTOSKELETAL REARRANGEMENTS; LAMINA-RESTRICTED PROJECTION; HIPPOCAMPAL MOSSY FIBERS; TRANSMEMBRANE SEMAPHORIN; SYNAPSE FORMATION; TYROSINE KINASES; STRUCTURAL BASIS; FAMILY KINASES; SMOOTH-MUSCLE; AXON GUIDANCE	The transmembrane semaphorin, Sema6A, has important roles in axon guidance, cell migration and neuronal connectivity in multiple regions of the nervous system, mediated by context-dependent interactions with plexin receptors, PlxnA2 and PlxnA4. Here, we demonstrate that Sema6A can also signal cell-autonomously, in two modes, constitutively, or in response to higher-order clustering mediated by either PlxnA2-binding or chemically induced multimerisation. Sema6A activation stimulates recruitment of Abl to the cytoplasmic domain of Sema6A and phosiphorylation of this cytoplasmic tyrosine kinase, as well as phos iphorylation of additional cytoskeletal regulators. Sema6A reverse signaling affects the surface area and cellular complexity of non-neuronal cells and aggregation and neurite formation of primary neurons in vitro. Sema6A also interacts with PlxnA2 in cis, which reduces binding by PlxnA2 of Sema6A in trans but not vice versa. These experiments reveal the complex nature of Sema6A biochemical functions and the molecular logic of the context-dependent interactions between Sema6A and PlxnA2.	[Perez-Branguli, Francesc; Shanley, Daniel K.; Mitchell, Kevin J.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; [Perez-Branguli, Francesc; Shanley, Daniel K.; Mitchell, Kevin J.] Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland; [Zagar, Yvrick; Chedotal, Alain] Univ Paris 06, Sorbonne Univ, INSERM UMR S968, CNRS UMR7210,Inst Vis, Paris, France; [Graef, Isabella A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Trinity College Dublin; Trinity College Dublin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Stanford University	Mitchell, KJ (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland.; Mitchell, KJ (corresponding author), Trinity Coll Dublin, Inst Neurosci, Dublin 2, Ireland.	Kevin.Mitchell@tcd.ie	Chedotal, Alain/F-2750-2017	Chedotal, Alain/0000-0001-7577-3794	Science Foundation Ireland [07/IN.1/B969, 09/IN.1/B2614]; Fondation pour la Recherche Medicale (Programme "equipe FRM"); LABEX LIFESENSES - French state funds [ANR-10-LABX-65, ANR-11-IDEX-0004-02]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Fondation pour la Recherche Medicale (Programme "equipe FRM")(Fondation pour la Recherche Medicale); LABEX LIFESENSES - French state funds	This work was supported by grants from Science Foundation Ireland (07/IN.1/B969 and 09/IN.1/B2614) to KJM and by grants to Alain Chedotal from the Fondation pour la Recherche Medicale (Programme "equipe FRM") and the LABEX LIFESENSES (reference ANR-10-LABX-65) supported by French state funds managed by the Agence National pour la Recherche within the Investissements d'Avenir programme under reference ANR-11-IDEX-0004-02.	Andermatt I, 2014, DEVELOPMENT, V141, P3709, DOI 10.1242/dev.112185; Arbuzova A, 2002, BIOCHEM J, V362, P1, DOI 10.1042/0264-6021:3620001; Arpin M, 2011, CELL ADHES MIGR, V5, P199, DOI 10.4161/cam.5.2.15081; Bashaw GJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001941; Bell CH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001134; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Bron R, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-21; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Ebert AM, 2014, DEVELOPMENT, V141, P2473, DOI 10.1242/dev.103499; Eckhardt F, 1997, MOL CELL NEUROSCI, V9, P409, DOI 10.1006/mcne.1997.0644; Faulkner RL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-21; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Godenschwege TA, 2009, J NEUROGENET, V23, P147, DOI 10.1080/01677060802441380; Haklai-Topper L, 2010, EMBO J, V29, P2635, DOI 10.1038/emboj.2010.147; Hernandez SE, 2004, CURR BIOL, V14, P691, DOI 10.1016/j.cub.2004.03.062; Hou TJ, 2006, PLOS COMPUT BIOL, V2, P46, DOI 10.1371/journal.pcbi.0020001; Huang XD, 2008, J CELL BIOL, V183, P711, DOI 10.1083/jcb.200801192; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Jackson RE, 2009, CURR BIOL, V19, pR504, DOI 10.1016/j.cub.2009.04.055; Janssen BJC, 2010, NATURE, V467, P1118, DOI 10.1038/nature09468; Jeong S, 2012, NEURON, V76, P721, DOI 10.1016/j.neuron.2012.09.018; Jia L, 2010, AM J PHYSIOL-CELL PH, V299, pC630, DOI 10.1152/ajpcell.00095.2010; Jones SB, 2004, J NEUROSCI, V24, P8510, DOI 10.1523/JNEUROSCI.1264-04.2004; Kain KH, 2001, J BIOL CHEM, V276, P16185, DOI 10.1074/jbc.M100095200; Kalwa H, 2012, J BIOL CHEM, V287, P29147, DOI 10.1074/jbc.M112.381517; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Kim YT, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00048; Klostermann A, 2000, J BIOL CHEM, V275, P39647, DOI 10.1074/jbc.M006316200; Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Matsuoka RL, 2012, J NEUROSCI, V32, P6859, DOI 10.1523/JNEUROSCI.0267-12.2012; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Mauti O, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-28; Nogi T, 2010, NATURE, V467, P1123, DOI 10.1038/nature09473; Pasterkamp RJ, 2012, NAT REV NEUROSCI, V13, P605, DOI 10.1038/nrn3302; Pecot MY, 2013, NEURON, V77, P299, DOI 10.1016/j.neuron.2012.11.007; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Runker AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026488; Ruenker AE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-34; Siebold C, 2013, SEMIN CELL DEV BIOL, V24, P139, DOI 10.1016/j.semcdb.2012.11.003; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Sun LO, 2015, NEURON, V86, P971, DOI 10.1016/j.neuron.2015.03.064; Sun LO, 2013, SCIENCE, V342, P590, DOI 10.1126/science.1241974; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022; Tawarayama H, 2010, J NEUROSCI, V30, P7049, DOI 10.1523/JNEUROSCI.0073-10.2010; Tegtmeyer N, 2011, EUR J CELL BIOL, V90, P880, DOI 10.1016/j.ejcb.2010.11.006; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Trichet L, 2008, J CELL BIOL, V181, P19, DOI 10.1083/jcb.200710168; Wang T, 2013, J BIOL CHEM, V288, P20713, DOI 10.1074/jbc.M112.439877; Wang YX, 2013, ELIFE, V2, DOI 10.7554/eLife.01279; Yu L, 2010, J NEUROSCI, V30, P12151, DOI 10.1523/JNEUROSCI.1494-10.2010; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452	53	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158686	10.1371/journal.pone.0158686	http://dx.doi.org/10.1371/journal.pone.0158686			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27392094	Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400102
J	Schmidt, D; Peterlik, D; Reber, SO; Lechner, A; Mannel, DN				Schmidt, Dominic; Peterlik, Daniel; Reber, Stefan O.; Lechner, Anja; Maennel, Daniela N.			Induction of Suppressor Cells and Increased Tumor Growth following Chronic Psychosocial Stress in Male Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; NECROSIS-FACTOR; SOCIAL STRESS; INDUCED COLITIS; IMMUNE-SYSTEM; BEARING MICE; INFLAMMATION; EXPANSION; CANCER; EXPRESSION	To study the impact of psychosocial stress on the immune system, male mice were subjected to chronic subordinate colony housing (CSC), a preclinically validated mouse model for chronic psychosocial stress. CSC substantially affected the cell composition of the bone marrow, blood, and spleen by inducing myelopoiesis and enhancing the frequency of regulatory T cells in the CD4 population. Expansion of the myeloid cell compartment was due to cells identified as immature inflammatory myeloid cells having the phenotype of myeloid-derived suppressor cells of either the granulocytic or the monocytic type. Catecholaminergic as well as TNF signaling were implicated in these CSC-induced cellular shifts. Although the frequency of regulatory cells was enhanced following CSC, the high capacity for inflammatory cytokine secretion of total splenocytes indicated an inflammatory immune status in CSC mice. Furthermore, CSC enhanced the suppressive activity of bone marrow-derived myeloid-derived suppressor cells towards proliferating T cells. In line with the occurrence of suppressor cell types such as regulatory T cells and myeloid-derived suppressor cells, transplanted syngeneic fibrosarcoma cells grew better in CSC mice than in controls, a process accompanied by pronounced angiogenesis and clustering of immature myeloid cells in the tumor tissue. In addition, tumor implantation after CSC reinforced the CSC-induced increase in myeloid-derived suppressor cells and regulatory T cell frequencies while the CSC-induced cellular changes eased off in mice without tumor. Together, our data suggest a role for suppressor cells such as regulatory T cells and myeloid-derived suppressor cells in the enhanced tumor growth after chronic psychosocial stress.	[Schmidt, Dominic; Lechner, Anja; Maennel, Daniela N.] Univ Regensburg, Inst Immunol, Regensburg, Germany; [Peterlik, Daniel] Univ Regensburg, Inst Zool, Lab Mol & Cellular Neurobiol, Regensburg, Germany; [Reber, Stefan O.] Univ Regensburg, Dept Behav & Mol Neurobiol, Inst Zool, Regensburg, Germany; [Reber, Stefan O.] Univ Ulm, Clin Psychosomat Med & Psychotherapy, Lab Mol Psychosomat, Ulm, Germany	University of Regensburg; University of Regensburg; University of Regensburg; Ulm University	Mannel, DN (corresponding author), Univ Regensburg, Inst Immunol, Regensburg, Germany.	daniela.maennel@klinik.uni-regensburg.de			Deutsche Forschungsgemeinschaft (DFG) [MA 760/20-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by a grant (MA 760/20-1) by the Deutsche Forschungsgemeinschaft (DFG) to DNM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah DSA, 2011, INT IMMUNOL, V23, P317, DOI 10.1093/intimm/dxr007; Avitsur R, 2005, BRAIN BEHAV IMMUN, V19, P311, DOI 10.1016/j.bbi.2004.09.005; Avitsur R, 2002, J NEUROIMMUNOL, V132, P66, DOI 10.1016/S0165-5728(02)00310-7; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; Cao L, 2012, ANNU REV NEUROSCI, V35, P331, DOI 10.1146/annurev-neuro-062111-150546; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Chen X, 2013, J IMMUNOL, V190, P1076, DOI 10.4049/jimmunol.1202659; Cuenca AG, 2011, MOL MED; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Delano MJ, 2011, J IMMUNOL, V186, P195, DOI 10.4049/jimmunol.1002104; Dhabhar FS, 2009, NEUROIMMUNOMODULAT, V16, P300, DOI 10.1159/000216188; Engler H, 2004, J NEUROIMMUNOL, V148, P106, DOI 10.1016/j.jneuroim.2003.11.011; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gehad AE, 2012, J INVEST DERMATOL, V132, P2642, DOI 10.1038/jid.2012.190; Harle P, 2005, ARTHRITIS RHEUM-US, V52, P1305, DOI 10.1002/art.20987; Heasman SJ, 2003, J ENDOCRINOL, V178, P29, DOI 10.1677/joe.0.1780029; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hu X, 2014, J IMMUNOL, V192, P1320, DOI 10.4049/jimmunol.1203195; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Kim HR, 2012, NEUROIMMUNOMODULAT, V19, P187, DOI 10.1159/000331586; Korner H, 1997, EUR J IMMUNOL, V27, P2600, DOI 10.1002/eji.1830271020; Langgartner D, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00018; Levav I, 2000, AM J PUBLIC HEALTH, V90, P1601, DOI 10.2105/AJPH.90.10.1601; MANNEL DN, 1979, INFECT IMMUN, V24, P573; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Nagaraj S, 2010, J IMMUNOL, V184, P3106, DOI 10.4049/jimmunol.0902661; Okubo Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep03153; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Peters S, 2012, STRESS, V15, P403, DOI 10.3109/10253890.2011.631232; Polz J, 2014, IMMUN INFLAMM DIS, V2, P121, DOI 10.1002/iid3.19; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Powell ND, 2009, BRAIN BEHAV IMMUN, V23, P225, DOI 10.1016/j.bbi.2008.09.010; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Reber SO, 2007, ENDOCRINOLOGY, V148, P670, DOI 10.1210/en.2006-0983; Reber SO, 2008, STRESS, V11, P225, DOI 10.1080/10253890701733351; Reber SO, 2011, BRAIN BEHAV IMMUN, V25, P1153, DOI 10.1016/j.bbi.2011.03.004; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Schmidt D, 2010, BRAIN BEHAV IMMUN, V24, P1097, DOI 10.1016/j.bbi.2010.04.014; Selye H, 1998, J NEUROPSYCH CLIN N, V10, P230; Smigiel KS, 2014, IMMUNOL REV, V259, P40, DOI 10.1111/imr.12170; THOENEN H, 1968, N-S ARCH PHARMAKOL, V261, P271, DOI 10.1007/BF00536990; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Voorhees JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058488; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2012, J LEUKOCYTE BIOL, V91, P167, DOI 10.1189/jlb.0311177; Zhou Q, 2014, CYTOKINE, V65, P56, DOI 10.1016/j.cyto.2013.09.008	51	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0159059	10.1371/journal.pone.0159059	http://dx.doi.org/10.1371/journal.pone.0159059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR6IK	27391954	gold, Green Published, Green Submitted			2022-12-26	WOS:000380005400204
J	Arkhipenko, A; Syan, S; Victoria, GS; Lebreton, S; Zurzolo, C				Arkhipenko, Alexander; Syan, Sylvie; Victoria, Guiliana Soraya; Lebreton, Stephanie; Zurzolo, Chiara			PrPC Undergoes Basal to Apical Transcytosis in Polarized Epithelial MDCK Cells	PLOS ONE			English	Article							GPI-ANCHORED PROTEINS; CELLULAR PRION PROTEIN; 3-DIMENSIONAL CULTURE MODELS; MEMBRANE; TRAFFICKING; PATHWAYS; CLEAVAGE; NEURONS; DISEASE; BRAIN	The Prion Protein (PrP) is an ubiquitously expressed glycosylated membrane protein attached to the external leaflet of the plasma membrane via a glycosylphosphatidylinositol anchor (GPI). While the misfolded PrPSc scrapie isoform is the infectious agent of prion disease, the cellular isoform (PrPC) is an enigmatic protein with unclear function. Of interest, PrP localization in polarized MDCK cells is controversial and its mechanism of trafficking is not clear. Here we investigated PrP traffic in MDCK cells polarized on filters and in three-dimensional MDCK cysts, a more physiological model of polarized epithelia. We found that, unlike other GPI-anchored proteins (GPI-APs), PrP undergoes basolateral-to-apical transcytosis in fully polarized MDCK cells. Following this event full-length PrP and its cleavage fragments are segregated in different domains of the plasma membrane in polarized cells in both 2D and 3D cultures.	[Arkhipenko, Alexander; Syan, Sylvie; Victoria, Guiliana Soraya; Lebreton, Stephanie; Zurzolo, Chiara] Inst Pasteur, Unite Trafic Membranaire & Pathogenese, 25-28 Rue Docteur Roux, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Zurzolo, C (corresponding author), Inst Pasteur, Unite Trafic Membranaire & Pathogenese, 25-28 Rue Docteur Roux, F-75015 Paris, France.	zurzolo@pasteur.fr	Zurzolo, Chiara/AAH-5225-2019	Lebreton, Stephanie/0000-0002-9879-0404	MI CARNOT ICSA/PMI; Agence Nationale de la Recherche [ANR-14-JPCD-0002-01]; Equipe FRM (Fondation Recherche Medicale) [DEQ20140329557]; Universite Paris Saclay ED SDSV, Orsay, France; Ecole Normale Superieure de Paris Rue d'Ulm, Paris, France	MI CARNOT ICSA/PMI; Agence Nationale de la Recherche(French National Research Agency (ANR)); Equipe FRM (Fondation Recherche Medicale); Universite Paris Saclay ED SDSV, Orsay, France; Ecole Normale Superieure de Paris Rue d'Ulm, Paris, France	This work is supported by research grants from the MI CARNOT ICSA/PMI, Agence Nationale de la Recherche (ANR-14-JPCD-0002-01) and Equipe FRM (Fondation Recherche Medicale) 2014 (DEQ20140329557) to C.Z. A.A. was supported by Universite Paris Saclay ED SDSV, Orsay, France, Ecole Normale Superieure de Paris 45-46 Rue d'Ulm, Paris 75005, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Apodaca G, 2012, NAT CELL BIOL, V14, P1235, DOI 10.1038/ncb2635; Boland MP, 2010, J BIOL CHEM, V285, P32282, DOI 10.1074/jbc.M110.123398; Bonifacino JS, 2014, J CELL BIOL, V204, P7, DOI 10.1083/jcb.201310021; Bradke F, 1998, BBA-MOL CELL RES, V1404, P245, DOI 10.1016/S0167-4889(98)00060-3; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Campana V, 2005, TRENDS CELL BIOL, V15, P102, DOI 10.1016/j.tcb.2004.12.002; Campbell L, 2013, BBA-MOL BASIS DIS, V1832, P826, DOI 10.1016/j.bbadis.2013.02.020; Checler F, 2002, TRENDS NEUROSCI, V25, P616, DOI 10.1016/S0166-2236(02)02263-4; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Christensen HM, 2009, J NEUROCHEM, V108, P44, DOI 10.1111/j.1471-4159.2008.05719.x; Davis EM, 2015, CELL REP, V11, P1727, DOI 10.1016/j.celrep.2015.05.026; De Keukeleire B, 2007, BIOCHEM BIOPH RES CO, V354, P949, DOI 10.1016/j.bbrc.2007.01.096; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; DEHOOP MJ, 1993, J CELL SCI, P85; Deora A, 2006, CELL BIOL; Dong SL, 2007, BIOPOLYMERS, V88, P840, DOI 10.1002/bip.20860; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Haigh CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134680; Hanzel D, 1991, Semin Cell Biol, V2, P341; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Klinkert K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11166; Kretzschmar H, 2013, BRAIN PATHOL, V23, P321, DOI 10.1111/bpa.12045; Le Brun AP, 2014, BIOPHYS J, V107, P2313, DOI 10.1016/j.bpj.2014.09.027; LEBIVIC A, 1990, J CELL BIOL, V110, P1533, DOI 10.1083/jcb.110.5.1533; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Li AM, 2007, J NEUROSCI, V27, P852, DOI 10.1523/JNEUROSCI.4244-06.2007; Liang JJ, 2012, PRION, V6, DOI 10.4161/pri.22511; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; LISANTI MP, 1989, J CELL BIOL, V109, P2145, DOI 10.1083/jcb.109.5.2145; LISANTI MP, 1990, J MEMBRANE BIOL, V113, P155, DOI 10.1007/BF01872889; LISANTI MP, 1990, P NATL ACAD SCI USA, V87, P7419, DOI 10.1073/pnas.87.19.7419; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Muniz M, 2014, J CELL SCI, V127, P2793, DOI 10.1242/jcs.148056; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Paladino S, 2002, INT J MED MICROBIOL, V291, P439; Paladino S, 2014, NAT CHEM BIOL, V10, P350, DOI [10.1038/NCHEMBIO.1495, 10.1038/nchembio.1495]; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Pflanzner T, 2012, J CEREBR BLOOD F MET, V32, P628, DOI 10.1038/jcbfm.2012.7; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puig B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024624; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; RODRIGUEZBOULAN E, 1992, ANNU REV CELL BIOL, V8, P395, DOI 10.1146/annurev.cb.08.110192.002143; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuck S, 2006, J CELL BIOL, V172, P963, DOI 10.1083/jcb.200603015; Senatore A, 2013, INT J CELL BIOL, V2013, DOI DOI 10.1155/2013/543803; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Tveit H, 2005, BIOCHEM BIOPH RES CO, V337, P232, DOI 10.1016/j.bbrc.2005.09.031; Uchiyama K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2873; Uelhoff A, 2005, J BIOL CHEM, V280, P5137, DOI 10.1074/jbc.C400560200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Vincent B, 2008, CURR ALZHEIMER RES, V5, P202, DOI 10.2174/156720508783954749; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Wik L, 2012, PRION, V6, DOI 10.4161/pri.22588; ZURZOLO C, 1992, EMBO J, V11, P2337, DOI 10.1002/j.1460-2075.1992.tb05293.x	63	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157991	10.1371/journal.pone.0157991	http://dx.doi.org/10.1371/journal.pone.0157991			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27389581	Green Submitted, Green Published, gold			2022-12-26	WOS:000379811500011
J	de Andrade, FAG; Gomes, MN; Uieda, W; Begot, AL; Ramos, OD; Fernandes, MEB				de Andrade, Fernanda A. G.; Gomes, Murilo N.; Uieda, Wilson; Begot, Alberto L.; Ramos, Ofir de S.; Fernandes, Marcus E. B.			Geographical Analysis for Detecting High-Risk Areas for Bovine/Human Rabies Transmitted by the Common Hematophagous Bat in the Amazon Region, Brazil	PLOS ONE			English	Article							DESMODUS-ROTUNDUS; VAMPIRE BATS; SAO-PAULO; TIME DISTRIBUTION; RACCOON RABIES; UNITED-STATES; MINAS-GERAIS; VIRUS; DYNAMICS; PATTERNS	Background The common hematophagous bat, Desmodus rotundus, is one of the main wild reservoirs of rabies virus in several regions in Latin America. New production practices and changed land use have provided environmental features that have been very favorable for D. rotundus bat populations, making this species the main transmitter of rabies in the cycle that involves humans and herbivores. In the Amazon region, these features include a mosaic of environmental, social, and economic components, which together creates areas with different levels of risk for human and bovine infections, as presented in this work in the eastern Brazilian Amazon. Methodology We geo-referenced a total of 175 cases of rabies, of which 88% occurred in bovines and 12% in humans, respectively, and related these cases to a number of different geographical and biological variables. The spatial distribution was analyzed using the Kernel function, while the association with independent variables was assessed using a multi-criterion Analytical Hierarchy Process (AHP) technique. Findings The spatiotemporal analysis of the occurrence of rabies in bovines and humans found reduction in the number of cases in the eastern state of Para, where no more cases were recorded in humans, whereas high infection rates were recorded in bovines in the northeastern part of the state, and low rates in the southeast. The areas of highest risk for bovine rabies are found in the proximity of rivers and highways. In the case of human rabies, the highest concentration of high-risk areas was found where the highway network coincides with high densities of rural and indigenous populations. Conclusion The high-risk areas for human and bovine rabies are patchily distributed, and related to extensive deforested areas, large herds of cattle, and the presence of highways. These findings provide an important database for the generation of epidemiological models that could support the development of effective prevention measures and controls.	[de Andrade, Fernanda A. G.] Museu Paraense Emilio Goeldi, Campus Pesquisa, Belem, Para, Brazil; [Gomes, Murilo N.] Coordenadoria Def Agr, Escritorio Def Agr Sao Paulo, Sao Paulo, Brazil; [Uieda, Wilson] Univ Estadual Paulista, Dept Zool, Inst Biociencias, Botucatu, SP, Brazil; [Begot, Alberto L.] Secretaria Execut Saude Publ Estado Para, Dept Endemias, Belem, Para, Brazil; [Ramos, Ofir de S.] Lab Nacl Agr Para, Lab Virol, Lanagro, Para, Brazil; [Fernandes, Marcus E. B.] Fed Univ Para, Lab Ecol Manguezal, Campus Braganca, BR-66059 Belem, Para, Brazil; [de Andrade, Fernanda A. G.] Inst Fed Educ Ciencias & Tecnol, Dept Biol, Tucurui, Para, Brazil	Museu Paraense Emilio Goeldi; Universidade Estadual Paulista; Universidade Federal do Para	de Andrade, FAG (corresponding author), Museu Paraense Emilio Goeldi, Campus Pesquisa, Belem, Para, Brazil.; de Andrade, FAG (corresponding author), Inst Fed Educ Ciencias & Tecnol, Dept Biol, Tucurui, Para, Brazil.	fernanda.atanaena@ifpa.edu.br	Fernandes, Marcus/L-6242-2016	Fernandes, Marcus/0000-0003-3894-5248	Para State Research Foundation (FAPESPA), Brazil [146/2008]; Brazilian National Research Council (CNPq) [141121/2007-6]	Para State Research Foundation (FAPESPA), Brazil; Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was made possible by the financial support of the Para State Research Foundation (FAPESPA), Brazil, No. 146/2008, and the Brazilian National Research Council (CNPq), Process 141121/2007-6. These entities played no role in study design, data collection and analysis, or the decision to publish or prepare the manuscript.	Acha PN, 1988, NATURAL HIST VAMPIRE; Andrade FAG, 2008, STUD NEOTROP FAUNA E, V43, P169, DOI 10.1080/01650520802273456; ARELLANOSOTA C, 1988, REV INFECT DIS, V10, pS615; Barbosa TFS, 2008, VIROLOGY, V370, P228, DOI 10.1016/j.virol.2007.10.005; Barbosa TFS, 2007, CAD SAUDE COLET RIO, V15, P329; Fernandes MEB, 2013, BRAZ J INFECT DIS, V17, P251, DOI 10.1016/j.bjid.2012.10.015; Berger F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002258; BRASS DA, 1994, RABIES BATS NATURAL; Camara G, 1996, COMPUT GRAPH, V20, P395, DOI 10.1016/0097-8493(96)00008-8; CHARLTON KM, 1979, CAN J COMP MED, V43, P168; Childs JE, 2000, P NATL ACAD SCI USA, V97, P13666, DOI 10.1073/pnas.240326697; Confalonieri UEC, 2014, ACTA TROP, V129, P33, DOI 10.1016/j.actatropica.2013.09.013; Confalonieri Ulisses E. C., 2005, Estud. av., V19, P221, DOI 10.1590/S0103-40142005000100014; Costa LJC, 2013, T ROY SOC TROP MED H, V107, P684, DOI 10.1093/trstmh/trt080; da Rosa EST, 2006, EMERG INFECT DIS, V12, P1197, DOI 10.3201/eid1708.050929; de Oliveira RS, 2015, REV INST MED TROP SP, V57, P497, DOI 10.1590/S0036-46652015000600006; FERNANDES MEB, 2000, B LAB HIDROBIOLOGIA, V13, P83; Findley J.S., 1993, BATS COMMUNITY PERSP; FLEMING TH, 1972, ECOLOGY, V53, P555, DOI 10.2307/1934771; Foranttini OP, 2004, ECOLOGIA EPIDEMIOLOG; FORMENT WL, 1971, J MAMMAL, V52, P227, DOI 10.2307/1378457; FORNES A, 1974, Journal of Wildlife Diseases, V10, P310; Fundacao Nacional do Indio &mdash; FUNAI, 2010, TEM TERR IND; Gao S, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-8; Gomes MN, 2011, ARQ BRAS MED VET ZOO, V63, P287, DOI 10.1590/S0102-09352011000200003; Gomes MN, 2006, PESQUI VET BRASIL, V26, P38, DOI 10.1590/S0100-736X2006000100008; Gomes MN, 2007, PESQUISA VET BRASIL, V27, P307, DOI 10.1590/S0100-736X2007000700009; Gomes MN, 2010, PREV VET MED, V93, P139, DOI 10.1016/j.prevetmed.2009.10.006; GREENHALL A M, 1983, Mammalian Species, P1, DOI 10.2307/3503895; Guerra MA, 2003, EMERG INFECT DIS, V9, P1143; Guo DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072352; Holmes EC, 2002, VIROLOGY, V292, P247, DOI 10.1006/viro.2001.1271; Instituto Brasilerio de Geografia e Estastica-IBGE, 2010, COD DE MUN; Institutode Pesquisas Espaciais, 2013, TERRAVIEW 4 2 2; Lee DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042466; Lord RD, 1988, NATURAL HIST VAMPIRE; MAPA, 2009, CONTR RAIV HERB MAN; Menezes FL, 2008, ARQ BRAS MED VET ZOO, V60, P566, DOI 10.1590/S0102-09352008000300007; Ministerio do Meio Ambiente-MMA, 2010, DESM AM 1998 2008; Miranda EE, 2005, BRASIL EM RELEVO; MURRAY JD, 1986, PROC R SOC SER B-BIO, V229, P111, DOI 10.1098/rspb.1986.0078; O'Shea TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086261; Pavlovsky E. N., 1967, NATURAL NIDALITY TRA; Pozzobom J, 2001, ESTUD AV-SAO PAULO, V19, P45; Recuenco S, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-14; Schneider MC, 2009, REV PANAM SALUD PUBL, V25, P260, DOI 10.1590/S1020-49892009000300010; Silva F.C., 2008, NAEA PAP BELEM, V226, P1; Silva JA, 2001, ARQ BRAS MED VET ZOO, V53, P263; Sodre MM, 2010, REV INST MED TROP SP, V52, P75, DOI 10.1590/S0036-46652010000200003; Stoner-Duncan B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002867; Taddei VA, 1991, DISTRIBUICAO MORCEGO; Voigt CC, 2012, ETHOLOGY, V118, P260, DOI 10.1111/j.1439-0310.2011.02004.x; Wada MY, 2011, EPIDEMIOL SERV SAUDE, V20, P509, DOI 10.5123/S1679-49742011000400010	53	19	20	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0157332	10.1371/journal.pone.0157332	http://dx.doi.org/10.1371/journal.pone.0157332			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27388498	Green Published, gold, Green Submitted			2022-12-26	WOS:000379811500004
J	Zeng, H; Yang, WH; Lu, CZ; Lin, WQ; Zou, MH; Zhang, HZ; Wan, JF; Huang, XM				Zeng, Hui; Yang, Weihai; Lu, Chaozhong; Lin, Wenqiu; Zou, Minghong; Zhang, Hanzhou; Wan, Jifeng; Huang, Xuming			Effect of CPPU on Carbohydrate and Endogenous Hormone Levels in Young Macadamia Fruit	PLOS ONE			English	Article							ACTINIDIA-DELICIOSA; SHOOT GROWTH; ABSCISSION; YIELD; APPLE; SET; INTEGRIFOLIA; QUALITY; ACCUMULATION; REMOVAL	N-(2-Chloro-4-pyridyl)-N'-phenylurea (CPPU) is a highly active cytokinin-like plant growth regulator that promotes chlorophyll biosynthesis, cell division, and cell expansion. It also increases fruit set and accelerates fruit enlargement. However, there has been no report about the effect of CPPU on fruit development and its physiological mechanism in macadamia. In this study, we investigated the effect of CPPU treatment at early fruit development via foliar spray or raceme soaking at 20 mg.L-1 on fruit set and related physiology in macadamia. Changes in carbohydrate contents and endogenous hormones in leaves, bearing shoots and fruit were also examined. Results showed that CPPU significantly reduced young fruit drop and delayed the wave of fruit drop by 1-2 weeks. The treatment significantly decreased the contents of total soluble sugars and starch in the leaves, but increased them in the bearing shoots and total soluble sugars in the husk (pericarp) and seeds. These findings suggested that CPPU promoted carbohydrate mobilization from the leaves to the fruit. In addition, CPPU increased the contents of indole-3-acetic acid (IAA), gibberellin acid (GA(3)), and zeatin riboside (ZR) and decreased the abscisic acid (ABA) in the husk. Therefore, CPPU treatment reduced the early fruit drop by increasing carbohydrate availability and by modifying the balance among endogenous hormones.	[Zeng, Hui; Huang, Xuming] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China; [Zeng, Hui; Yang, Weihai; Lu, Chaozhong; Lin, Wenqiu; Zou, Minghong; Zhang, Hanzhou; Wan, Jifeng] Chinese Acad Trop Agr Sci, South Subtrop Crop Res Inst, Zhanjiang, Guangdong, Peoples R China; [Zeng, Hui; Yang, Weihai; Lu, Chaozhong; Lin, Wenqiu; Zou, Minghong; Zhang, Hanzhou; Wan, Jifeng] Minist Agr, Key Lab Trop Fruit Biol, Zhanjiang, Guangdong, Peoples R China	South China Agricultural University; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Huang, XM (corresponding author), South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China.	huangxm@scau.edu.cn			National Natural Science Foundation of China [31572082]; Hainan Province Natural Science Foundation [314110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hainan Province Natural Science Foundation	This study was supported by the National Natural Science Foundation of China (Grant No. 31572082) and the Hainan Province Natural Science Foundation (Grant No. 314110).	Antognozzi E, 1997, ACTA HORTIC, P459, DOI 10.17660/ActaHortic.1997.444.70; Antognozzi E, 1996, SCI HORTIC-AMSTERDAM, V65, P37, DOI 10.1016/0304-4238(95)00852-7; Botton A, 2011, PLANT PHYSIOL, V155, P185, DOI 10.1104/pp.110.165779; Brown E, 2010, ACTA HORTIC, V884, P107, DOI 10.17660/ActaHortic.2010.884.11; Chen JianZhong, 2002, Journal of Fruit Science, V19, P139; CJ Xu, 1998, BIOTECHNOLOGY, V8, P41; CURRY EA, 1993, HORTSCIENCE, V28, P115, DOI 10.21273/HORTSCI.28.2.115; Eccher G, 2013, PLANT PHYSIOL, V161, P1952, DOI 10.1104/pp.112.208470; Fang JinBao, 2000, Acta Horticulturae Sinica, V27, P444; GILLASPY G, 1993, PLANT CELL, V5, P1439, DOI 10.1105/tpc.5.10.1439; Gomez-Cadenas A, 2000, PLANTA, V210, P636, DOI 10.1007/s004250050054; He XY, 2015, TROPICAL AGR SCI TEC, V38, P12; He Z., 1993, ENZYME LINKED IMMUNO; Hu Z.Q., 2005, J FRUIT SCI, V5, P34; Li XX, 2011, J PLANT PHYSIOL, V168, P920, DOI 10.1016/j.jplph.2010.11.005; Liu HX, 2001, CHINESE J TROPICAL C, V22, P36; McFadyen L, 2012, FUNCT PLANT BIOL, V39, P481, DOI 10.1071/FP11254; McFadyen L, 2012, SCI HORTIC-AMSTERDAM, V137, P125, DOI 10.1016/j.scienta.2012.01.028; McFadyen LM, 2011, ANN BOT-LONDON, V107, P993, DOI 10.1093/aob/mcr026; NAGAO MA, 1990, SCI HORTIC-AMSTERDAM, V43, P47, DOI 10.1016/0304-4238(90)90035-D; NeSmith DS, 2008, HORTSCIENCE, V43, P1446, DOI 10.21273/HORTSCI.43.5.1446; Ohara Hitoshi, 1997, Journal of the Japanese Society for Horticultural Science, V65, P693, DOI 10.2503/jjshs.65.693; Retamales JB, 2014, CHIL J AGR RES, V74, P157, DOI 10.4067/S0718-58392014000200005; SAKAI WS, 1985, PHYSIOL PLANTARUM, V64, P455, DOI 10.1111/j.1399-3054.1985.tb08522.x; SEDGLEY M, 1981, AUST J BOT, V29, P185, DOI 10.1071/BT9810185; Stopar M, 2001, SCI HORTIC-AMSTERDAM, V87, P65, DOI 10.1016/S0304-4238(00)00169-2; SUGIYAMA N, 1995, SCI HORTIC-AMSTERDAM, V60, P337, DOI 10.1016/0304-4238(94)00712-O; SUGIYAMA N, 1993, J HORTIC SCI, V68, P673, DOI 10.1080/00221589.1993.11516399; [陶丽 Tao Li], 2005, [热带作物学报, Chinese Journal of Tropical Crops], V26, P12; TRUEMAN SJ, 1994, ANN BOT-LONDON, V73, P23, DOI 10.1006/anbo.1994.1003; TRUEMAN SJ, 1994, ANN BOT-LONDON, V74, P667, DOI 10.1006/anbo.1994.1169; Trueman SJ, 1993, THESIS; Trueman SJ, 2010, AFR J AGR RES, V5, P3402; Trueman SJ, 2010, AFR J AGR RES, V5, P1523; Wang YangJie, 1997, Acta Horticulturae Sinica, V24, P84; WILLIAMS RR, 1980, AUST J EXP AGR, V20, P740, DOI 10.1071/EA9800740; Woolley D. J., 1992, Acta Horticulturae, P467; Wu S.R., 1988, PLANT PHYSL COMMUN, V5, P53; Xu H.S., 1995, CHIN J TROP CROPS, V16, P78; Yang JC, 2001, PLANT PHYSIOL, V127, P315, DOI 10.1104/pp.127.1.315; Yang MF, 2015, S CHINA FRUITS, V44, P54; Yang WH, 2009, SCI HORTIC-AMSTERDAM, V120, P194, DOI 10.1016/j.scienta.2008.10.009; Yang ZiQin, 2011, Journal of Fruit Science, V28, P428; Yu JQ, 2001, ACTA AGR NUCL SINICA, V15, P355; Zhang CX, 2009, PLANT GROWTH REGUL, V58, P25, DOI 10.1007/s10725-008-9349-5; Zhang ZL, 1990, GUIDEBOOK EXPT PLANT; Zheng SF, 2011, AGR RES APPL, V2, P20; Zhu H, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-138; Zou MingHong, 2009, Journal of Fruit Science, V26, P98	49	15	19	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 7	2016	11	7							e0158705	10.1371/journal.pone.0158705	http://dx.doi.org/10.1371/journal.pone.0158705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3OC	27387814	Green Submitted, gold, Green Published			2022-12-26	WOS:000379811500039
J	Chen, YY; Yu, YN; Zhang, YY; Li, B; Liu, J; Li, DF; Wu, P; Wang, J; Wang, Z; Wang, YY				Chen, Yin-ying; Yu, Ya-nan; Zhang, Ying-ying; Li, Bing; Liu, Jun; Li, Dong-feng; Wu, Ping; Wang, Jie; Wang, Zhong; Wang, Yong-yan			Quantitative Determination of Flexible Pharmacological Mechanisms Based On Topological Variation in Mice Anti-Ischemic Modular Networks	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; DRUG DISCOVERY; CEREBRAL-ISCHEMIA; MOUSE HIPPOCAMPUS; PATHWAYS; ALLOSTERY; EXPRESSION; PREDICTION; COMPLEXES; OCCLUSION	Targeting modules or signalings may open a new path to understanding the complex pharmacological mechanisms of reversing disease processes. However, determining how to quantify the structural alteration of these signalings or modules in pharmacological networks poses a great challenge towards realizing rational drug use in clinical medicine. Here, we explore a novel approach for dynamic comparative and quantitative analysis of the topological structural variation of modules in molecular networks, proposing the concept of allosteric modules (AMs). Based on the ischemic brain of mice, we optimize module distribution in different compound-dependent modular networks by using the minimum entropy criterion and then calculate the variation in similarity values of AMs under various conditions using a novel method of SimiNEF. The diverse pharmacological dynamic stereo-scrolls of AMs with functional gradient alteration, which consist of five types of AMs, may robustly deconstruct modular networks under the same ischemic conditions. The concept of AMs can not only integrate the responsive mechanisms of different compounds based on topological cascading variation but also obtain valuable structural information about disease and pharmacological networks beyond pathway analysis. We thereby provide a new systemic quantitative strategy for rationally determining pharmacological mechanisms of altered modular networks based on topological variation.	[Chen, Yin-ying; Yu, Ya-nan; Zhang, Ying-ying; Li, Bing; Liu, Jun; Wang, Zhong; Wang, Yong-yan] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China; [Chen, Yin-ying; Wu, Ping; Wang, Jie] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China; [Li, Dong-feng] Peking Univ, Sch Math Sci, Beijing, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Basic Research In Clinical Medicine, CACMS; China Academy of Chinese Medical Sciences; Guang'anmen Hospital, CACMS; Peking University	Wang, Z; Wang, YY (corresponding author), China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing, Peoples R China.; Wang, J (corresponding author), China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China.	jie_wang_0107@yeah.net; zhonw@sina.com; wangyongyan2010@sina.cn	Wang, Zhong/AAY-7574-2020; Yu, Yan/GYV-4514-2022		Hi-Tech Research and Development Program of China (863); "Eleventh Five-Year" National Key Technologies RD Program [2006BAI08B04-06]; National Major Scientific and Technological Special Project for "Significant New Drugs Development" [2013ZX09303301]	Hi-Tech Research and Development Program of China (863)(National High Technology Research and Development Program of China); "Eleventh Five-Year" National Key Technologies RD Program; National Major Scientific and Technological Special Project for "Significant New Drugs Development"	Our research was largely supported by the Hi-Tech Research and Development Program of China (863), the "Eleventh Five-Year" National Key Technologies R&D Program (2006BAI08B04-06), and the National Major Scientific and Technological Special Project for "Significant New Drugs Development" (2013ZX09303301). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AN G, 1993, ANN NEUROL, V33, P457, DOI 10.1002/ana.410330508; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Antal MA, 2009, CURR PROTEIN PEPT SC, V10, P161, DOI 10.2174/138920309787847617; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Blacklock K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071936; Bradley SJ, 2011, MOL PHARMACOL, V79, P874, DOI 10.1124/mol.110.068882; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Ceol A, 2010, NUCLEIC ACIDS RES, V38, pD532, DOI 10.1093/nar/gkp983; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Chen YY, 2012, N-S ARCH PHARMACOL, V385, P797, DOI 10.1007/s00210-012-0743-1; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Csermely P, 2013, PHARMACOL THERAPEUT, V138, P333, DOI 10.1016/j.pharmthera.2013.01.016; Diez D, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-27; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; HIMORI N, 1990, J PHARMACOL METHOD, V23, P311; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Horjales E, 1999, STRUCTURE, V7, P527, DOI 10.1016/S0969-2126(99)80069-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaiser M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/5/110; King BM, 2009, BIOINFORMATICS, V25, P1165, DOI 10.1093/bioinformatics/btp109; Li GD, 2015, ACTA PHARM SIN B, V5, P93, DOI 10.1016/j.apsb.2015.01.005; Li M, 2009, APPL RES COMPUTERS, V1; Liu J, 2012, CNS NEUROL DISORD-DR, V11, P1070; Lorenz DM, 2011, PHYS LIFE REV, V8, P129, DOI 10.1016/j.plrev.2011.02.003; Martin-Villalba A, 1998, MOL BRAIN RES, V62, P158, DOI 10.1016/S0169-328X(98)00239-3; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mihalik A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002187; Nussinov R, 2013, STRUCTURE, V21, P1509, DOI 10.1016/j.str.2013.06.002; Nussinov R, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/4/045004; Nussinov R, 2013, CELL, V153, P293, DOI 10.1016/j.cell.2013.03.034; Nussinov R, 2011, TRENDS PHARMACOL SCI, V32, P686, DOI 10.1016/j.tips.2011.08.004; Papin JA, 2003, TRENDS BIOCHEM SCI, V28, P250, DOI 10.1016/S0968-0004(03)00064-1; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Sidhu PS, 2013, J PHARM PHARMACOL, V1, P1; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Szilagyi A, 2013, CURR TOP MED CHEM, V13, P64, DOI 10.2174/1568026611313010007; [谭跃进 Tan Yuejin], 2004, [系统工程理论与实践, Systems Engineering-Theory & Practice], V24, P1; Thiagalingam S, 2006, CANCER RES, V66, P7379, DOI 10.1158/0008-5472.CAN-06-0993; Urwyler S, 2011, PHARMACOL REV, V63, P59, DOI 10.1124/pr.109.002501; VanWart AT, 2012, J CHEM THEORY COMPUT, V8, P2949, DOI 10.1021/ct300377a; Wang Z, 2013, DRUG DISCOV TODAY, V18, P560, DOI 10.1016/j.drudis.2013.01.009; Wang Z, 2012, EXPERT OPIN DRUG DIS, V7, P667, DOI 10.1517/17460441.2012.692673; Wang Z, 2011, EUR J PHARMACOL, V667, P278, DOI 10.1016/j.ejphar.2011.05.046; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu G, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-36; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yellaboina S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-465; Yu Y, 2016, CRIT REV EU IN PRESS; Zhou CX, 2010, CHINESE PHARMACOL B, V4, P547	56	9	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158379	10.1371/journal.pone.0158379	http://dx.doi.org/10.1371/journal.pone.0158379			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27383195	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400045
J	Plumer, L; Keis, M; Remm, J; Hindrikson, M; Jogisalu, I; Mannil, P; Kubarsepp, M; Saarma, U				Plumer, Liivi; Keis, Marju; Remm, Jaanus; Hindrikson, Maris; Jogisalu, Inga; Mannil, Peep; Kubarsepp, Marko; Saarma, Urmas			Wolves Recolonizing Islands: Genetic Consequences and Implications for Conservation and Management	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; MULTILOCUS GENOTYPE DATA; CANIS-LUPUS; LINKAGE DISEQUILIBRIUM; WOLF POPULATION; DOMESTIC DOGS; MARKERS; HYBRIDIZATION; LOCI; MITOCHONDRIAL	After a long and deliberate persecution, the grey wolf ( Canis lupus) is slowly recolonizing its former areas in Europe, and the genetic consequences of this process are of particular interest. Wolves, though present in mainland Estonia for a long time, have only recently started to recolonize the country's two largest islands, Saaremaa and Hiiumaa. The main objective of this study was to analyse wolf population structure and processes in Estonia, with particular attention to the recolonization of islands. Fifteen microsatellite loci were genotyped for 185 individuals across Estonia. As a methodological novelty, all putative wolf-dog hybrids were identified and removed (n = 17) from the dataset beforehand to avoid interference of dog alleles in wolf population analysis. After the preliminary filtering, our final dataset comprised of 168 "pure" wolves. We recommend using hybrid-removal step as a standard precautionary procedure not only for wolf population studies, but also for other taxa prone to hybridization. STRUCTURE indicated four genetic groups in Estonia. Spatially explicit DResD analysis identified two areas, one of them on Saaremaa island and the other in southwestern Estonia, where neighbouring individuals were genetically more similar than expected from an isolation-by-distance null model. Three blending areas and two contrasting transition zones were identified in central Estonia, where the sampled individuals exhibited strong local differentiation over relatively short distance. Wolves on the largest Estonian islands are part of human-wildlife conflict due to livestock depredation. Negative public attitude, especially on Saaremaa where sheep herding is widespread, poses a significant threat for island wolves. To maintain the long-term viability of the wolf population on Estonian islands, not only wolf hunting quota should be targeted with extreme care, but effective measures should be applied to avoid inbreeding and minimize conflicts with local communities and stakeholders.	[Plumer, Liivi; Keis, Marju; Remm, Jaanus; Hindrikson, Maris; Saarma, Urmas] Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia; [Jogisalu, Inga; Mannil, Peep; Kubarsepp, Marko] Estonian Environm Agcy, Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Saarma, U (corresponding author), Univ Tartu, Inst Ecol & Earth Sci, Dept Zool, Tartu, Estonia.	Urmas.Saarma@ut.ee	Remm, Jaanus/G-9347-2012; Saarma, Urmas/AAC-9813-2019; Hindrikson, Maris/G-4573-2017	Remm, Jaanus/0000-0002-8896-0772; Saarma, Urmas/0000-0002-3222-571X; Hindrikson, Maris/0000-0001-8094-1860	Estonian Ministry of Education and Research [IUT20-32]; Estonian Environmental Investment Centre; European Union through the European Regional Development Fund (Centre of Excellence FIBIR); European Union through the European Regional Development Fund [3.2.0802.11-0043]; Estonian Doctoral School of Ecology and Environmental Sciences	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); Estonian Environmental Investment Centre(Estonian Research Council); European Union through the European Regional Development Fund (Centre of Excellence FIBIR)(European Commission); European Union through the European Regional Development Fund(European Commission); Estonian Doctoral School of Ecology and Environmental Sciences	This work was supported by institutional research funding (IUT20-32) from the Estonian Ministry of Education and Research; the Estonian Environmental Investment Centre; the European Union through the European Regional Development Fund (Centre of Excellence FIBIR); the European Union through the European Regional Development Fund by the program 3.2.0802.11-0043; and the Estonian Doctoral School of Ecology and Environmental Sciences. The authors appreciate the help of Madli Parn with the Structure computings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Andersone Z, 2002, MAMM BIOL, V67, P79, DOI 10.1078/1616-5047-00012; Ausband DE, 2015, ANIM CONSERV, V18, P415, DOI 10.1111/acv.12187; Baltrunaite L, 2013, CENT EUR J BIOL, V8, P440, DOI 10.2478/s11535-013-0154-9; Bivand R., 2013, APPL SPATIAL DATA AN, V2nd; Boitani L, 2015, KEY ACTIONS LARGE CA; Bryan HM, 2015, FUNCT ECOL, V29, P347, DOI 10.1111/1365-2435.12354; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Chhatre VE, 2016, STRAUTO AUTOMATION P; Cornuet JM, 1996, GENETICS, V144, P2001; Coulon A, 2010, MOL ECOL RESOUR, V10, P167, DOI 10.1111/j.1755-0998.2009.02731.x; Czarnomska SD, 2013, CONSERV GENET, V14, P573, DOI 10.1007/s10592-013-0446-2; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabbri E, 2014, MAMM BIOL, V79, P138, DOI 10.1016/j.mambio.2013.10.002; Fabbri E, 2007, MOL ECOL, V16, P1661, DOI 10.1111/j.1365-294X.2007.03262.x; Falush D, 2003, GENETICS, V164, P1567; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; FREDHOLM M, 1995, MAMM GENOME, V6, P11, DOI 10.1007/BF00350887; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Godinho R, 2015, MOL ECOL RESOUR, V15, P317, DOI 10.1111/1755-0998.12313; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hagen SB, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0092; Hindrikson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075765; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; HOLMES NG, 1995, ANIM GENET, V26, P132, DOI 10.1111/j.1365-2052.1995.tb02659.x; Jansson E, 2012, MOL ECOL, V21, P5178, DOI 10.1111/mec.12010; Jedrzejewski W, 2005, ACTA THERIOL, V50, P3, DOI 10.1007/BF03192614; Jedrzejewski W, 2007, ECOGRAPHY, V30, P66, DOI 10.1111/j.2006.0906-7590.04826.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Kubarsepp M, 2013, HUNDI ELUPAIGA KASUT; Kubarsepp Marko, 2003, Acta Zoologica Lituanica, V13, P28; Laikre L, 2013, CONSERV BIOL, V27, P248, DOI 10.1111/j.1523-1739.2012.01965.x; Lam N. S. N., 1983, CARTOGR GEOGR INF SC, V10, P129, DOI [10.1559/152304083783914958, DOI 10.1559/152304083783914958]; Lucchini V, 2002, MOL ECOL, V11, P857, DOI 10.1046/j.1365-294X.2002.01489.x; Mannil P, 2012, STATUS GAME POPULATI; Mannil P, 2013, STATUS GAME POPULATI; Mech D., 2003, WOLVES BEHAV ECOLOGY; Morin PA, 2009, MOL ECOL RESOUR, V9, P1451, DOI 10.1111/j.1755-0998.2009.02672.x; Moura AE, 2014, CONSERV GENET, V15, P405, DOI 10.1007/s10592-013-0547-y; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; OSTRANDER EA, 1993, GENOMICS, V16, P207, DOI 10.1006/geno.1993.1160; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pebesma E. J., 2005, R NEWS, V5; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2013, R LANG ENV STAT COMP; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roux JJL, 2015, ECOL EVOL, V5, P288; Saether BE, 2005, J WILDLIFE MANAGE, V69, P1001, DOI 10.2193/0022-541X(2005)069[1001:MSFTWI]2.0.CO;2; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; Sergio F, 2008, ANNU REV ECOL EVOL S, V39, P1, DOI 10.1146/annurev.ecolsys.39.110707.173545; SHIBUYA H, 1994, ANIM GENET, V25, P122, DOI 10.1111/j.1365-2052.1994.tb00094.x; Sidorovich VE, 2007, CAN J ZOOL, V85, P295, DOI 10.1139/Z07-001; Stahler DR, 2006, J NUTR, V136, p1923S, DOI 10.1093/jn/136.7.1923S; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Valdmann Harri, 2004, Baltic Forestry, V10, P83; Valiere N, 2003, ANIM CONSERV, V6, P83, DOI 10.1017/S1367943003003111; van Oosterhout C, 2004, MOL ECOL NOTES, V2, P377; Veeroja R., 2015, STATUS GAME POPULATI; Verardi A, 2006, MOL ECOL, V15, P2845, DOI 10.1111/j.1365-294X.2006.02995.x; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y	75	8	8	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 6	2016	11	7							e0158911	10.1371/journal.pone.0158911	http://dx.doi.org/10.1371/journal.pone.0158911			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3NH	27384049	Green Published, Green Submitted, gold			2022-12-26	WOS:000379809400091
J	Gao, HJ; Chen, X; Wei, JL; Zhang, YJ; Zhang, LG; Chang, J; Thompson, ML				Gao, Hongjian; Chen, Xi; Wei, Junling; Zhang, Yajie; Zhang, Ligan; Chang, Jiang; Thompson, Michael L.			Decomposition Dynamics and Changes in Chemical Composition of Wheat Straw Residue under Anaerobic and Aerobic Conditions	PLOS ONE			English	Article							SOIL ORGANIC-MATTER; STATE C-13 NMR; LITTER DECOMPOSITION; NITROGEN MINERALIZATION; FIBROUS FEEDS; CROP RESIDUES; PLANT LITTER; CPMAS NMR; CARBON; FRACTIONS	Soil aeration is a crucial factor that regulates crop residue decomposition, and the chemical composition of decomposing crop residues may change the forms and availability of soil nutrients, such as N and P. However, to date, differences in the chemical composition of crop straw residues after incorporation into soil and during its decomposition under anaerobic vs. aerobic conditions have not been well documented. The objective of the present study was to assess changes in the C-containing functional groups of wheat straw residue during its decomposition in anaerobic and aerobic environments. A 12-month incubation experiment was carried out to investigate the temporal variations of mass, carbon, and nitrogen loss, as well as changes in the chemical composition of wheat (Triticum aestivum L) straw residues under anaerobic and aerobic conditions by measuring C-containing functional groups using solid state nuclear magnetic resonance (NMR) spectroscopy. The residual mass, carbon content, and nitrogen content of the straw residue sharply declined during the initial 3 months, and then slowly decreased during the last incubation period from 3 to 12 months. The decomposition rate constant (kappa) for mass loss under aerobic conditions (0.022 d(-1)) was higher than that under anaerobic conditions (0.014 d(-1)). The residual mass percentage of cellulose and hemicellulose in the wheat straw gradually declined, whereas that of lignin gradually increased during the entire 12-month incubation period. The NMR spectra of C-containing functional groups in the decomposing straw under both aerobic and anaerobic conditions were similar at the beginning of the incubation as well as at 1 month, 6 months, and 12 months. The main alterations in C-containing functional groups during the decomposition of wheat straw were a decrease in the relative abundances of O-alkyl C and an increase in the relative abundances of alkyl C, aromatic C and COO/N-C = O functional groups. The NMR signals of alkyl C and aromatic C in decomposing wheat straw residues under anaerobic condition were higher than those under aerobic conditions. The higher mass percentages of lignin and the higher signals of aromatic C and alkyl C functional groups in decomposing wheat residues under anaerobic conditions than under aerobic conditions were due to the slower decomposition rates of aryl C and alkyl C in wheat straw residues under anaerobic conditions.	[Gao, Hongjian; Chen, Xi; Wei, Junling; Zhang, Yajie; Zhang, Ligan; Chang, Jiang] Anhui Agr Univ, Sch Resources & Environm, Hefei 230036, Peoples R China; [Gao, Hongjian] Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Peoples R China; [Thompson, Michael L.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA	Anhui Agricultural University; Anhui Agricultural University; Iowa State University	Gao, HJ (corresponding author), Anhui Agr Univ, Sch Resources & Environm, Hefei 230036, Peoples R China.; Gao, HJ (corresponding author), Anhui Agr Univ, State Key Lab Tea Plant Biol & Utilizat, Hefei 230036, Peoples R China.	hjgao@ahau.edu.cn			National Natural Science Foundation of China [31272254, 31328020]; National Key Technology Support Program of China [2012BAD04B09, 2013BAD07B08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program of China(National Key Technology R&D Program)	This study was jointly funded by the National Natural Science Foundation of China (31272254, 31328020), and the National Key Technology Support Program of China (2012BAD04B09, 2013BAD07B08).	Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; ANDREN O, 1987, ECOLOGY, V68, P1190, DOI 10.2307/1939203; Baldock JA, 1997, AUST J SOIL RES, V35, P1061, DOI 10.1071/S97004; BERG B, 1995, SCAND J FOREST RES, V10, P108, DOI 10.1080/02827589509382874; BERG B, 1993, SCAND J FOREST RES, V8, P457, DOI 10.1080/02827589309382792; BERG B, 1991, CAN J BOT, V69, P1449, DOI 10.1139/b91-187; Bhupinderpal-Singh, 2006, SOIL BIOL BIOCHEM, V38, P32, DOI 10.1016/j.soilbio.2005.03.025; Bierke A, 2008, GEODERMA, V146, P48, DOI 10.1016/j.geoderma.2008.05.004; Cao XY, 2016, GEOCHIM COSMOCHIM AC, V181, P72, DOI 10.1016/j.gca.2016.02.029; Cao XY, 2011, SOIL SCI SOC AM J, V75, P1374, DOI 10.2136/sssaj2010.0382; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Devevre OC, 2000, SOIL BIOL BIOCHEM, V32, P1773, DOI 10.1016/S0038-0717(00)00096-1; DORAN JW, 1987, BIOL FERT SOILS, V5, P68, DOI 10.1007/BF00264349; Dou S, 2008, EUR J SOIL SCI, V59, P532, DOI 10.1111/j.1365-2389.2007.01012.x; Finn D, 2015, SOIL BIOL BIOCHEM, V91, P160, DOI 10.1016/j.soilbio.2015.09.001; Frouz J, 2015, SOIL BIOL BIOCHEM, V91, P23, DOI 10.1016/j.soilbio.2015.08.024; Gong Z.T., 2007, PEDOGENESIS SOIL TAX; Hoorens B, 2003, OECOLOGIA, V137, P578, DOI 10.1007/s00442-003-1365-6; Jensen LS, 2005, PLANT SOIL, V273, P307, DOI 10.1007/s11104-004-8128-y; Johnson JMF, 2007, SOIL SCI SOC AM J, V71, P155, DOI 10.2136/sssaj2005.0419; Johnson RL, 2014, J MAGN RESON, V239, P44, DOI 10.1016/j.jmr.2013.11.009; Kogel-Knabner I, 2006, GEODERMA, V136, P331; Kruse JS, 2004, NUTR CYCL AGROECOSYS, V69, P247, DOI 10.1023/B:FRES.0000035197.57441.cd; Kumar K, 2000, ADV AGRON, V68, P197; Kumar K, 2003, COMMUN SOIL SCI PLAN, V34, P2441, DOI 10.1081/CSS-120024778; Lal R, 2005, ENVIRON INT, V31, P575, DOI 10.1016/j.envint.2004.09.005; Leifeld J, 2005, GEODERMA, V124, P143, DOI 10.1016/j.geoderma.2004.04.009; Li Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0101019; Lu R.Q, 1999, METHODS SOIL AGROCHE, P18; Mahieu N, 1999, SOIL SCI SOC AM J, V63, P307, DOI 10.2136/sssaj1999.03615995006300020008x; Mao JD, 2004, SOLID STATE NUCL MAG, V26, P36, DOI 10.1016/j.ssnmr.2003.09.003; Mao JD, 2007, ORG GEOCHEM, V38, P1277, DOI 10.1016/j.orggeochem.2007.04.005; Mathers NJ, 2007, SOIL BIOL BIOCHEM, V39, P993, DOI 10.1016/j.soilbio.2006.11.009; Mathers NJ, 2003, GEODERMA, V114, P19, DOI 10.1016/S0016-7061(02)00339-7; MELILLO JM, 1989, PLANT SOIL, V115, P189, DOI 10.1007/BF02202587; Olk DC, 2007, EUR J SOIL SCI, V58, P270, DOI 10.1111/j.1365-2389.2006.00836.x; Olk DC, 2006, SOIL BIOL BIOCHEM, V38, P3303, DOI 10.1016/j.soilbio.2006.04.009; Olk DC, 1998, EUR J SOIL SCI, V49, P337, DOI 10.1046/j.1365-2389.1998.00163.x; PRESTON CM, 1987, CAN J SOIL SCI, V67, P187, DOI 10.4141/cjss87-016; Preston CM, 1996, SOIL SCI, V161, P144, DOI 10.1097/00010694-199603000-00002; Rengel Z., 2007, NUTR CYCLING TERREST, P183, DOI [DOI 10.1007/978-3-540-68027-7_7, 10.1007/978-3-540-68027-7_7]; Rivas FA, 2014, BIOL FERT SOILS, V50, P527, DOI 10.1007/s00374-013-0870-y; Skene TM, 1996, AUST J SOIL RES, V34, P413, DOI 10.1071/SR9960413; Tulina AS, 2009, EURASIAN SOIL SCI+, V42, P1241, DOI 10.1134/S1064229309110064; VANSOEST PJ, 1967, J ASSOC OFF ANA CHEM, V50, P50; VANSOEST PJ, 1963, J ASSOC OFF AGR CHEM, V46, P829; Wang J, 2015, J CHINA AGR U, V23, P161; Wang XY, 2012, ENVIRON SCI TECHNOL, V46, P7159, DOI 10.1021/es300522x; Witt C, 2000, PLANT SOIL, V225, P263, DOI 10.1023/A:1026594118145; Wu WX, 2009, J SOIL SEDIMENT, V9, P457, DOI 10.1007/s11368-009-0106-9; Yu ZP, 2015, SOIL BIOL BIOCHEM, V90, P188, DOI 10.1016/j.soilbio.2015.07.026; Zhang Y, 2013, J SOIL SEDIMENT, V13, P24, DOI 10.1007/s11368-012-0592-z	52	40	45	5	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 5	2016	11	7							e0158172	10.1371/journal.pone.0158172	http://dx.doi.org/10.1371/journal.pone.0158172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR3JE	27380023	Green Published, Green Submitted, gold			2022-12-26	WOS:000379798700020
